Citrus Sinensis ID: 014156

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------43
Protein Sequence
MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccHHHHHHHcccccHHHHcccccEEccccccEEEEEEEEEcccccccccEEEEEEEEEEcccccEEEEEEEEcccccEEEEEcccccccHHHHHHHHHHHcccccEEEEcEEEEcccccccEEEEEEEEccccHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccEEEEEEccccHHHHHHcccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccHHHHccccHHHHHHHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccHHHccHHHHccccccccccccccccEEccccccccEEEEEEEEcccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHccccHHHHHHHcHHHHHHHccHccc
Coil and Loop (DISEMBL)
mystgmapalavakpedddvmivdklpakpdddddampvdklpEEINEMKIKGERVEKEMEATvvdgngteTGHIIVTTiggrngqpkqTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQtmrlldhpnvvslkhcffsttdkDELYLNLVLEFVPETVYRVAKHYsrasqrmpLIYVKLYTYQICRALAYIhggigvchrdikpqnllvnphthqvklcdfgsakvlvkgepnisyicsryyrapelifgateyttaIDIWSVGCVLAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikahpwhkifhkrmppeAVDLVSRLLqyspnlrctaleacihpffdelrdpnarlpngrpfpplfnfkpqelKGASKELLSKLIpeharkqcpflgf
Flexible Loop (DISEMBL)
mystgmapalavakpedddvMIVDKlpakpdddddampvdklpEEINemkikgerveKEMEatvvdgngteTGHIIVttiggrngqpKQTISYMAERVVGQGSFGIVFQAKCLETGETVaikkvlqdkrykNRELQtmrlldhpnvvSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHysrasqrmplIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSklipeharkqcpflgf
Low Complexity Region (SEG)
MYSTGMAPALAVAKPEDDDVMIvdklpakpdddddampvdklpEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Disordered region (IsUnstruct)
****************************************************************VDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR************************************************
Disordered Region (DISOPRED)
****************************************************************************VTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPF***
Disordered Region (DISEMBL)
MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Disordered Region (DISPRO)
**************************************************************TVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	429	2.2.26 [Sep-21-2011]
Q8VZD5	410	Shaggy-related protein ki	yes	no	0.941	0.985	0.885	0.0
P43288	405	Shaggy-related protein ki	no	no	0.913	0.967	0.886	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.958	1.0	0.827	0.0
P43289	409	Shaggy-related protein ki	no	no	0.953	1.0	0.806	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	0.923	0.968	0.862	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.920	0.961	0.854	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.953	0.995	0.801	0.0
Q96287	472	Shaggy-related protein ki	no	no	0.890	0.809	0.803	0.0
O04160	468	Shaggy-related protein ki	N/A	no	0.892	0.818	0.785	0.0
Q39012	407	Shaggy-related protein ki	no	no	0.853	0.899	0.825	0.0

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  757 bits (1954), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/410 (88%), Positives = 379/410 (92%), Gaps = 6/410 (1%)

Query: 23  VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
           V  LPA        + ++  +KLPE INEMKIK +   KEMEA VVDGNGTETGHIIVTT
Sbjct: 4   VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
           IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
           LLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV+KHYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           RAPELIFGATEYTT IDIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA+EA +HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360

Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
           LRDPN RLPNGR  PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL  
Sbjct: 361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  733 bits (1892), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/395 (88%), Positives = 371/395 (93%), Gaps = 3/395 (0%)

Query: 35  DAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 94
           D+  VDKLPEE+N+MKI   R +KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM
Sbjct: 14  DSTGVDKLPEEMNDMKI---RDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 70

Query: 95  AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
           AERVVG GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFF
Sbjct: 71  AERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFF 130

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
           STT+KDELYLNLVLE+VPETV+RV KHY++ +QRMPLIYVKLYTYQI RAL+YIH  IGV
Sbjct: 131 STTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGV 190

Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 274
           CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA
Sbjct: 191 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 250

Query: 275 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334
           ID+WS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK
Sbjct: 251 IDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 310

Query: 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP 394
           AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR  AL+  +HPFFDELRDPNARLPNGR  P
Sbjct: 311 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLP 370

Query: 395 PLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
           PLFNFKP ELKG   E+++KL+PEHARKQCP+LG 
Sbjct: 371 PLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  723 bits (1865), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/429 (82%), Positives = 374/429 (87%), Gaps = 18/429 (4%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G+AP     +   D  + VD               D LPEE+++MKI+ +R   EM
Sbjct: 1   MASVGVAPTSGFREVLGDGEIGVD---------------DILPEEMSDMKIRDDR---EM 42

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVG GSFG+VFQAKCLETGETVA
Sbjct: 43  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVA 102

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
           IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETV+RV K
Sbjct: 103 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIK 162

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
           HYS+ +QRMP+IYVKLYTYQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 163 HYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 222

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WSVGCVLAELLLGQPLFPGE GV
Sbjct: 223 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGV 282

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP EAVDLVSRLLQY
Sbjct: 283 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQY 342

Query: 361 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
           SPNLRC AL+   HPFFDELRDPNARLP GR  PPLFNFKP ELKG   E L KL+PEHA
Sbjct: 343 SPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHA 402

Query: 421 RKQCPFLGF 429
           RKQCPFLG 
Sbjct: 403 RKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  721 bits (1862), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/429 (80%), Positives = 377/429 (87%), Gaps = 20/429 (4%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G+ P+ AV                  +   +    D+LPEE+ +MKI+ +   KEM
Sbjct: 1   MASVGIEPSAAVR-----------------ESTGNVTDADRLPEEMKDMKIQDD---KEM 40

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EAT+V+GN TETGHIIVTTIGGRNGQPKQTISYMAERVVG GSFG+VFQAKCLETGETVA
Sbjct: 41  EATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVA 100

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
           IKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETV+RV K
Sbjct: 101 IKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIK 160

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
           HY++ +QRMPL+YVKLYTYQI R+L+YIH  IGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 161 HYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 220

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGV
Sbjct: 221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGV 280

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 340

Query: 361 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
           SPNLRC AL++ +HPFFDELRDPNARLPNGR  PPLFNFKP ELKG   E+++KL+PEHA
Sbjct: 341 SPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHA 400

Query: 421 RKQCPFLGF 429
           RKQCP+L  
Sbjct: 401 RKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  721 bits (1862), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/399 (86%), Positives = 366/399 (91%), Gaps = 3/399 (0%)

Query: 31  DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQT 90
           +    ++ VD+LPEE+N+M+I   R +KE+EA +VDGNGTETGHIIVTTIGGR+GQPKQT
Sbjct: 14  ESSSHSVGVDRLPEEMNDMRI---RDDKEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQT 70

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 150
           ISYMAER+VGQGSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVV LK
Sbjct: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLK 130

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
           HCFFSTT+KDE+YLNLVLE+VPETV+RV KHY++ +QRMPLI VKLYTYQI RAL+YIH 
Sbjct: 131 HCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIFRALSYIHH 190

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
            IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE
Sbjct: 191 TIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           YTTAIDIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY EFKF
Sbjct: 251 YTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKF 310

Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG 390
           PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA  H FFDELRDPN RLPNG
Sbjct: 311 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDELRDPNTRLPNG 370

Query: 391 RPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
           R  PPLFNFK  ELKG S E L KL+PEHARKQCP LG 
Sbjct: 371 RVLPPLFNFKAHELKGVSAENLLKLVPEHARKQCPSLGL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  718 bits (1854), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/399 (85%), Positives = 367/399 (91%), Gaps = 4/399 (1%)

Query: 31  DDDDDAMPVDKLPEEINEMKIKGERVEKEMEA-TVVDGNGTETGHIIVTTIGGRNGQPKQ 89
           D +  ++ V+KLPEE+N+MKI   R +KEMEA T+VDGNGTETGHIIVTTIGG+NGQPKQ
Sbjct: 14  DKNASSVGVEKLPEEMNDMKI---RDDKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQ 70

Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL 149
           TISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL
Sbjct: 71  TISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL 130

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           KHCFFSTT+KDELYLNLVLE+VPETV RV +HY++ +QRMP+IYVKLY+YQICRALAYIH
Sbjct: 131 KHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIH 190

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
             IGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT
Sbjct: 191 NSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 250

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
           EYTTAIDIWS GCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK
Sbjct: 251 EYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 310

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN 389
           FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR TALEA +HPF+D++RDPN RLPN
Sbjct: 311 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFYDDVRDPNTRLPN 370

Query: 390 GRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLG 428
           GR  PPLFNFK  ELKG   E+L KL+P HARKQC   G
Sbjct: 371 GRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCALFG 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  711 bits (1834), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/428 (80%), Positives = 368/428 (85%), Gaps = 19/428 (4%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M + G+APA  +      DV           +   A+ VDKLP+EI  M+IK +   KEM
Sbjct: 1   MATAGVAPASGIV-----DV-----------NASSAIAVDKLPDEILGMRIKDD---KEM 41

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EA VVDGN TE GH+IVTTIGG+NGQPKQTISYMAER VGQGSFG+VFQAKCLETGETVA
Sbjct: 42  EAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVA 101

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
           IKKVLQDKRYKNRELQTMRLLDHPNVV+LKHCFFSTT+KDELYLNLVLEFVPETV+RV +
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIR 161

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
           HYS+ +QRMPLIYVKLY+YQICR+LAYIH  +GV HRDIKPQNLLVNPHTHQ+KLCDFGS
Sbjct: 162 HYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGS 221

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           AKVLVKGEPNISYICSRYYRAPELIFGATEYT+AIDIWS GCVL ELLLGQPLFPG SGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGV 281

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQY 341

Query: 361 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
           SPNLR TALEA +HPFFDELRDPN RLPNGR  PPLFNFK  ELKG   E+L KL+P HA
Sbjct: 342 SPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHA 401

Query: 421 RKQCPFLG 428
           RKQC    
Sbjct: 402 RKQCSLFA 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 310/386 (80%), Positives = 346/386 (89%), Gaps = 4/386 (1%)

Query: 40  DKLPEEINEMKIKGERV----EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 95
           D+LP+ + EMKI+ ER     +K+ME TVV+G+GTETG +I TT+GGR+G+PKQTISYMA
Sbjct: 81  DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 155
           +RVVG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200

Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
           TTDKDELYLNLVLE+VPETVYR +KHY++ +Q MP+I+V+LYTYQICRAL Y+H  +GVC
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260

Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 275
           HRDIKPQNLLVNP THQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT AI
Sbjct: 261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320

Query: 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 335
           D+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIKA
Sbjct: 321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380

Query: 336 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPP 395
           HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC HPFFD+LRDPN  LPNGR  PP
Sbjct: 381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440

Query: 396 LFNFKPQELKGASKELLSKLIPEHAR 421
           LFNF  QEL GAS EL  +LIP H +
Sbjct: 441 LFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2

 Score =  656 bits (1692), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 308/392 (78%), Positives = 343/392 (87%), Gaps = 9/392 (2%)

Query: 38  PVDKLPEEINEMKIK--------GERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQ 89
           P D+LPE +N+M+++        GE  +K+ME  +V+G GTETG +I TT+GGR+G+PKQ
Sbjct: 72  PPDQLPEVMNDMRLREDEPHANRGEE-DKDMEPPIVNGCGTETGQVITTTVGGRDGKPKQ 130

Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL 149
           TISYMA+RVVG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L
Sbjct: 131 TISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRL 190

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           +H FFSTTDKDELYLNLVLEFVPETVYR  KHY++ +Q MP+I V+LYTYQICRAL Y+H
Sbjct: 191 RHSFFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQHMPIILVQLYTYQICRALNYLH 250

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
             +GVCHRDIKPQNLLVN HTHQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGAT
Sbjct: 251 RVVGVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 310

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
           EYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFK
Sbjct: 311 EYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFK 370

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN 389
           FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC HPFFD+LR PN  LPN
Sbjct: 371 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRAPNVSLPN 430

Query: 390 GRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
           GR  PPLFNF  QEL GAS EL  +LIP H +
Sbjct: 431 GRALPPLFNFTAQELAGASTELRQRLIPAHCQ 462

May mediate extracellular signals to regulate transcription in differentiating cells.

Brassica napus (taxid: 3708)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1

 Score =  654 bits (1688), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 303/367 (82%), Positives = 338/367 (92%), Gaps = 1/367 (0%)

Query: 57  EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
           +KEM A V++GN   TGHII TTIGG+NG+PKQTISYMAERVVG GSFGIVFQAKCLETG
Sbjct: 34  DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93

Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
           E+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+E+VPET+Y
Sbjct: 94  ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153

Query: 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
           RV +HY+ ++QRMP+ YVKLYTYQI R LAYIH   GVCHRD+KPQNLLV+P THQVKLC
Sbjct: 154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213

Query: 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
           DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT +IDIWS GCVLAELLLGQPLFPG
Sbjct: 214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPG 273

Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
           E+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct: 274 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 333

Query: 357 LLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
           LLQYSP+LRCTALEAC HPFF+ELR+PNARLPNGRP PPLFNFK QEL GAS EL+++LI
Sbjct: 334 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELINRLI 392

Query: 417 PEHARKQ 423
           PEH R+Q
Sbjct: 393 PEHVRRQ 399

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	429
296087644	412	unnamed protein product [Vitis vinifera]	0.960	1.0	0.895	0.0
359488836	416	PREDICTED: shaggy-related protein kinase	0.946	0.975	0.893	0.0
449515565	410	PREDICTED: shaggy-related protein kinase	0.955	1.0	0.883	0.0
449446680	410	PREDICTED: shaggy-related protein kinase	0.955	1.0	0.878	0.0
297811597	410	kinase family protein [Arabidopsis lyrat	0.955	1.0	0.853	0.0
22326813	410	Shaggy-related protein kinase epsilon [A	0.941	0.985	0.885	0.0
7573313	408	protein kinase MSK-3-like [Arabidopsis t	0.937	0.985	0.882	0.0
619894	409	Petunia Shaggy kinase 4 [Petunia x hybri	0.916	0.960	0.903	0.0
116787052	370	unknown [Picea sitchensis]	0.862	1.0	0.954	0.0
302812402	423	GSK3/shaggy-like protein kinase [Selagin	0.911	0.924	0.881	0.0

>gi|296087644|emb|CBI34900.3| unnamed protein product [Vitis vinifera]

 Score =  794 bits (2050), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 384/429 (89%), Positives = 397/429 (92%), Gaps = 17/429 (3%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G+ PA AV KP                   + M VDKLPEEINEMKI+ ++VEKEM
Sbjct: 1   MASAGIPPASAVGKP-----------------SGNTMFVDKLPEEINEMKIRDDKVEKEM 43

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA
Sbjct: 44  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 103

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
           IKKVLQDKRYKNRELQTMRLLDHPN+VSLKHCFFSTTDKDELYLNLVLE+VPETVYRVAK
Sbjct: 104 IKKVLQDKRYKNRELQTMRLLDHPNIVSLKHCFFSTTDKDELYLNLVLEYVPETVYRVAK 163

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
           HYSRA+QRMPLIYVKLYTYQICRALAYIHG +GVCHRDIKPQNLLVNPH HQ+KLCDFGS
Sbjct: 164 HYSRANQRMPLIYVKLYTYQICRALAYIHGVVGVCHRDIKPQNLLVNPHIHQLKLCDFGS 223

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WSVGCVLAELLLGQPLFPGESGV
Sbjct: 224 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQPLFPGESGV 283

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 284 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 343

Query: 361 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
           SPNLRCTALEACIHPFFDELRD N+RLPNGRP PPLFNFKPQELKGAS ELL+KLIPEHA
Sbjct: 344 SPNLRCTALEACIHPFFDELRDQNSRLPNGRPLPPLFNFKPQELKGASLELLAKLIPEHA 403

Query: 421 RKQCPFLGF 429
           RKQCPFLGF
Sbjct: 404 RKQCPFLGF 412

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488836|ref|XP_002276754.2| PREDICTED: shaggy-related protein kinase epsilon [Vitis vinifera]

 Score =  781 bits (2016), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/423 (89%), Positives = 391/423 (92%), Gaps = 17/423 (4%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G+ PA AV KP                   + M VDKLPEEINEMKI+ ++VEKEM
Sbjct: 1   MASAGIPPASAVGKP-----------------SGNTMFVDKLPEEINEMKIRDDKVEKEM 43

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA
Sbjct: 44  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 103

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
           IKKVLQDKRYKNRELQTMRLLDHPN+VSLKHCFFSTTDKDELYLNLVLE+VPETVYRVAK
Sbjct: 104 IKKVLQDKRYKNRELQTMRLLDHPNIVSLKHCFFSTTDKDELYLNLVLEYVPETVYRVAK 163

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
           HYSRA+QRMPLIYVKLYTYQICRALAYIHG +GVCHRDIKPQNLLVNPH HQ+KLCDFGS
Sbjct: 164 HYSRANQRMPLIYVKLYTYQICRALAYIHGVVGVCHRDIKPQNLLVNPHIHQLKLCDFGS 223

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WSVGCVLAELLLGQPLFPGESGV
Sbjct: 224 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQPLFPGESGV 283

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 284 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 343

Query: 361 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
           SPNLRCTALEACIHPFFDELRD N+RLPNGRP PPLFNFKPQELKGAS ELL+KLIPEHA
Sbjct: 344 SPNLRCTALEACIHPFFDELRDQNSRLPNGRPLPPLFNFKPQELKGASLELLAKLIPEHA 403

Query: 421 RKQ 423
           RKQ
Sbjct: 404 RKQ 406

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449515565|ref|XP_004164819.1| PREDICTED: shaggy-related protein kinase epsilon-like [Cucumis sativus]

 Score =  776 bits (2003), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/429 (88%), Positives = 389/429 (90%), Gaps = 19/429 (4%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S+GM P   V KP                    A+  DKLPE INEMKI+ E+VEKEM
Sbjct: 1   MASSGMGP---VGKP----------------GSGVALFADKLPEGINEMKIRDEKVEKEM 41

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EATVVDGNGTETGHIIVTTIGGRNGQ +QTISYMAER VGQGSFGIVFQAKCLETGETVA
Sbjct: 42  EATVVDGNGTETGHIIVTTIGGRNGQSRQTISYMAERPVGQGSFGIVFQAKCLETGETVA 101

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
           IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV K
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVIK 161

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
           HY++ASQRMPLIYVKLY YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 162 HYTKASQRMPLIYVKLYAYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 221

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS GCVLAELLLGQPLFPGESGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGV 281

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 341

Query: 361 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
           SPNLRCTALEACIHPFFDELRDPN RLPNGRP PPLFNFKPQELKGA+ ELLSKLIPEHA
Sbjct: 342 SPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELKGATLELLSKLIPEHA 401

Query: 421 RKQCPFLGF 429
           RKQC FL F
Sbjct: 402 RKQCSFLDF 410

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446680|ref|XP_004141099.1| PREDICTED: shaggy-related protein kinase epsilon-like [Cucumis sativus]

 Score =  770 bits (1988), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/429 (87%), Positives = 388/429 (90%), Gaps = 19/429 (4%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S+GM P   V KP                    A+  DKLPE INEMKI+ E+VEKEM
Sbjct: 1   MASSGMGP---VGKP----------------GSGVALFADKLPEGINEMKIRDEKVEKEM 41

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EATVVDGNGTETGHIIVTTIGGRNGQ +QTISYMAER VGQGSFGIVFQAKCLETGETVA
Sbjct: 42  EATVVDGNGTETGHIIVTTIGGRNGQSRQTISYMAERPVGQGSFGIVFQAKCLETGETVA 101

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
           IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV K
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVIK 161

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
           HY++A+QRMPLIYVKLY YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 162 HYTKANQRMPLIYVKLYAYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 221

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS GCVLAELLLGQPLFPGESGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGV 281

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 341

Query: 361 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
           SPNLRCTALEA IHPFFDELRDPN RLPNGRP PPLFNFKPQELKGA+ ELLSKLIPEHA
Sbjct: 342 SPNLRCTALEAFIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELKGATLELLSKLIPEHA 401

Query: 421 RKQCPFLGF 429
           RKQC FL F
Sbjct: 402 RKQCSFLDF 410

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297811597|ref|XP_002873682.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297319519|gb|EFH49941.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  759 bits (1960), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/429 (85%), Positives = 385/429 (89%), Gaps = 19/429 (4%)

Query: 1   MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
           M S G  PA +VA  + +                 ++  +KLPE INEMKIK +   KEM
Sbjct: 1   MASVGTLPASSVATKQSNA----------------SICAEKLPEGINEMKIKDD---KEM 41

Query: 61  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
           EA VVDGNGTETGHIIVTTIGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVA
Sbjct: 42  EAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVA 101

Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
           IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV+K
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSK 161

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
           HYSRA+QRMP+IYVKLYTYQICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 162 HYSRANQRMPMIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGS 221

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS GCVLAELLLGQPLFPGESGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGV 281

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQY 341

Query: 361 SPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
           SP+LR TA+EA +HPFFDELRDPN RLPNGRP PPLFNFKPQEL GAS ELLSKLIP+HA
Sbjct: 342 SPSLRSTAMEAIVHPFFDELRDPNTRLPNGRPLPPLFNFKPQELNGASSELLSKLIPDHA 401

Query: 421 RKQCPFLGF 429
           RKQC FL  
Sbjct: 402 RKQCSFLAL 410

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22326813|ref|NP_196968.2| Shaggy-related protein kinase epsilon [Arabidopsis thaliana] gi|46576619|sp|Q8VZD5.1|KSG5_ARATH RecName: Full=Shaggy-related protein kinase epsilon; AltName: Full=ASK-epsilon gi|18086450|gb|AAL57679.1| AT5g14640/T15N1_130 [Arabidopsis thaliana] gi|34365555|gb|AAQ65089.1| At5g14640/T15N1_130 [Arabidopsis thaliana] gi|332004674|gb|AED92057.1| Shaggy-related protein kinase epsilon [Arabidopsis thaliana]

 Score =  757 bits (1954), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/410 (88%), Positives = 379/410 (92%), Gaps = 6/410 (1%)

Query: 23  VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
           V  LPA        + ++  +KLPE INEMKIK +   KEMEA VVDGNGTETGHIIVTT
Sbjct: 4   VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
           IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
           LLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV+KHYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           RAPELIFGATEYTT IDIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA+EA +HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360

Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
           LRDPN RLPNGR  PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL  
Sbjct: 361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7573313|emb|CAB87631.1| protein kinase MSK-3-like [Arabidopsis thaliana]

 Score =  749 bits (1933), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/410 (88%), Positives = 377/410 (91%), Gaps = 8/410 (1%)

Query: 23  VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
           V  LPA        + ++  +KLPE INEMKIK +   KEMEA VVDGNGTETGHIIVTT
Sbjct: 4   VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
           IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
           LLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV+KHYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           RAPELIFGATEYTT IDIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA  A +HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTA--AIVHPFFDE 358

Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
           LRDPN RLPNGR  PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL  
Sbjct: 359 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 408

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|619894|emb|CAA58594.1| Petunia Shaggy kinase 4 [Petunia x hybrida]

 Score =  747 bits (1929), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/394 (90%), Positives = 376/394 (95%), Gaps = 1/394 (0%)

Query: 35  DAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 94
           DAM VDKLPEEINEMKI+ ++ EKEMEA VVDGNGTE GHIIVTTIGG+NG+PKQTISYM
Sbjct: 16  DAMLVDKLPEEINEMKIRDDKAEKEMEAAVVDGNGTEKGHIIVTTIGGKNGEPKQTISYM 75

Query: 95  AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
           AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT+RLLDHPNVV+L+HCFF
Sbjct: 76  AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTIRLLDHPNVVALRHCFF 135

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
           STT+KDELYLNLVLE+VPETVYRV +HYS+A+Q+MP+IYVKLYTYQI RALAYIHG IGV
Sbjct: 136 STTEKDELYLNLVLEYVPETVYRVLRHYSKANQQMPMIYVKLYTYQIFRALAYIHG-IGV 194

Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 274
           CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT A
Sbjct: 195 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTFA 254

Query: 275 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334
           IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK MNPNYTEFKFPQIK
Sbjct: 255 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKSMNPNYTEFKFPQIK 314

Query: 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP 394
           AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR TALEAC H FFDELRDP  RLPNGRP P
Sbjct: 315 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEACTHTFFDELRDPKTRLPNGRPLP 374

Query: 395 PLFNFKPQELKGASKELLSKLIPEHARKQCPFLG 428
           PLFNF+PQELKGAS +LL+KLIPEHA+KQC FLG
Sbjct: 375 PLFNFRPQELKGASADLLNKLIPEHAKKQCTFLG 408

Source: Petunia x hybrida

Species: Petunia x hybrida

Genus: Petunia

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116787052|gb|ABK24355.1| unknown [Picea sitchensis]

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/370 (95%), Positives = 361/370 (97%)

Query: 60  MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETV 119
           MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVG GSFGIVFQAKCLETGETV
Sbjct: 1   MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60

Query: 120 AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVA 179
           AIKKVLQDKRYKNRELQTMRLLDHPN+V LKHCFFSTTDKDELYLNLVLE+VPETVYRVA
Sbjct: 61  AIKKVLQDKRYKNRELQTMRLLDHPNIVCLKHCFFSTTDKDELYLNLVLEYVPETVYRVA 120

Query: 180 KHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239
           KHYSR +QRMPL+YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ+KLCDFG
Sbjct: 121 KHYSRMNQRMPLLYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCDFG 180

Query: 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG 299
           SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS+GCVLAELLLGQPLFPGESG
Sbjct: 181 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSMGCVLAELLLGQPLFPGESG 240

Query: 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 359
           VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ
Sbjct: 241 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 300

Query: 360 YSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEH 419
           YSPNLRCTALEACIHPFFDELRDPN RLPNGRP PPLFNFKPQELKGA+ +LL KLIPEH
Sbjct: 301 YSPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELKGATPDLLIKLIPEH 360

Query: 420 ARKQCPFLGF 429
           ARKQCPFL  
Sbjct: 361 ARKQCPFLNL 370

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302812402|ref|XP_002987888.1| GSK3/shaggy-like protein kinase [Selaginella moellendorffii] gi|302824786|ref|XP_002994033.1| hypothetical protein SELMODRAFT_163279 [Selaginella moellendorffii] gi|300138136|gb|EFJ04915.1| hypothetical protein SELMODRAFT_163279 [Selaginella moellendorffii] gi|300144277|gb|EFJ10962.1| GSK3/shaggy-like protein kinase [Selaginella moellendorffii]

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/395 (88%), Positives = 375/395 (94%), Gaps = 4/395 (1%)

Query: 39  VDKLPEEINEMKIKGERVE----KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 94
           VD+LPEE++EMKI+ ++ +    KE+EATVVDGNGTETGHII TTIGGRNGQPKQTISY+
Sbjct: 29  VDQLPEEMHEMKIRDDKTDHSDDKELEATVVDGNGTETGHIIATTIGGRNGQPKQTISYV 88

Query: 95  AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
           AERVVG GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ MRLLDHPN+V+LKHCFF
Sbjct: 89  AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQIMRLLDHPNIVALKHCFF 148

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
           STTDKDELYLNLVLE+VPETVYR+AKH++R +QRMPL+YVKLYTYQICR+LAYIHGGIGV
Sbjct: 149 STTDKDELYLNLVLEYVPETVYRIAKHHNRMNQRMPLLYVKLYTYQICRSLAYIHGGIGV 208

Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 274
           CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA
Sbjct: 209 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 268

Query: 275 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334
           IDIWS+GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK
Sbjct: 269 IDIWSMGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 328

Query: 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP 394
           AHPWHK+FHKRMPPEAVDLVSRLLQYSPNLRC++LEA  HPFFDELRDPN RLPNGRP P
Sbjct: 329 AHPWHKVFHKRMPPEAVDLVSRLLQYSPNLRCSSLEALAHPFFDELRDPNTRLPNGRPLP 388

Query: 395 PLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
           PL+NFK  ELKGAS ELL++L+PEHARKQ PFL  
Sbjct: 389 PLYNFKQLELKGASPELLNRLVPEHARKQVPFLAL 423

Source: Selaginella moellendorffii

Species: Selaginella moellendorffii

Genus: Selaginella

Family: Selaginellaceae

Order: Selaginellales

Class: Isoetopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	429
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.888	0.929	0.927	7e-196
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.890	0.943	0.893	9.8e-190
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.888	0.931	0.877	2.1e-187
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.871	0.792	0.812	1e-171
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.853	0.888	0.828	4.4e-171
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.853	0.899	0.825	9.1e-171
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.853	0.963	0.825	1e-169
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.864	0.881	0.803	2.8e-169
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.876	0.858	0.733	8.2e-154
UNIPROTKB|Q91757	420	gsk3b "Glycogen synthase kinas	0.825	0.842	0.676	3.4e-132

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1897 (672.8 bits), Expect = 7.0e-196, P = 7.0e-196
 Identities = 356/384 (92%), Positives = 368/384 (95%)

Query:    44 EEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
             E INEMKIK +   KEMEA VVDGNGTETGHIIVTTIGG+NGQPKQTISYMAER+VGQGS
Sbjct:    28 EGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGS 84

Query:   104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
             FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELY
Sbjct:    85 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY 144

Query:   164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
             LNLVLE+VPETVYRV+KHYSRA+QRMP+IYVKLYTYQICRALAYIHGG+GVCHRDIKPQN
Sbjct:   145 LNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQN 204

Query:   224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
             LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT IDIWS GCV
Sbjct:   205 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCV 264

Query:   284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
             LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH
Sbjct:   265 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 324

Query:   344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE 403
             KR PPEAVDLVSRLLQYSPNLR TA+EA +HPFFDELRDPN RLPNGR  PPLFNFKPQE
Sbjct:   325 KRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQE 384

Query:   404 LKGASKELLSKLIPEHARKQCPFL 427
             LKGAS ELLSKLIP+HARKQC FL
Sbjct:   385 LKGASLELLSKLIPDHARKQCSFL 408

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1839 (652.4 bits), Expect = 9.8e-190, P = 9.8e-190
 Identities = 344/385 (89%), Positives = 364/385 (94%)

Query:    44 EEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
             EE+N+MKI   R +KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVG GS
Sbjct:    23 EEMNDMKI---RDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGS 79

Query:   104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
             FG+VFQAKCLETGETVAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELY
Sbjct:    80 FGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY 139

Query:   164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
             LNLVLE+VPETV+RV KHY++ +QRMPLIYVKLYTYQI RAL+YIH  IGVCHRDIKPQN
Sbjct:   140 LNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQN 199

Query:   224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
             LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WS GCV
Sbjct:   200 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCV 259

Query:   284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
             LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH
Sbjct:   260 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 319

Query:   344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE 403
             KRMPPEAVDLVSRLLQYSPNLR  AL+  +HPFFDELRDPNARLPNGR  PPLFNFKP E
Sbjct:   320 KRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHE 379

Query:   404 LKGASKELLSKLIPEHARKQCPFLG 428
             LKG   E+++KL+PEHARKQCP+LG
Sbjct:   380 LKGVPLEMVAKLVPEHARKQCPWLG 404

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1817 (644.7 bits), Expect = 2.1e-187, P = 2.1e-187
 Identities = 337/384 (87%), Positives = 363/384 (94%)

Query:    44 EEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
             EE+ +MKI+ +   KEMEAT+V+GN TETGHIIVTTIGGRNGQPKQTISYMAERVVG GS
Sbjct:    27 EEMKDMKIQDD---KEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGS 83

Query:   104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
             FG+VFQAKCLETGETVAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELY
Sbjct:    84 FGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY 143

Query:   164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
             LNLVLE+VPETV+RV KHY++ +QRMPL+YVKLYTYQI R+L+YIH  IGVCHRDIKPQN
Sbjct:   144 LNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQN 203

Query:   224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
             LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WS GCV
Sbjct:   204 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCV 263

Query:   284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
             LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH
Sbjct:   264 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 323

Query:   344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE 403
             KRMPPEAVDLVSRLLQYSPNLRC AL++ +HPFFDELRDPNARLPNGR  PPLFNFKP E
Sbjct:   324 KRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHE 383

Query:   404 LKGASKELLSKLIPEHARKQCPFL 427
             LKG   E+++KL+PEHARKQCP+L
Sbjct:   384 LKGVPVEMVAKLVPEHARKQCPWL 407

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1669 (592.6 bits), Expect = 1.0e-171, P = 1.0e-171
 Identities = 307/378 (81%), Positives = 340/378 (89%)

Query:    48 EMKIKGER----VEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
             EMKI+ ER     +K+ME TVV+G+GTETG +I TT+GGR+G+PKQTISYMA+RVVG GS
Sbjct:    89 EMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGS 148

Query:   104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
             FG+VFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H FFSTTDKDELY
Sbjct:   149 FGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELY 208

Query:   164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
             LNLVLE+VPETVYR +KHY++ +Q MP+I+V+LYTYQICRAL Y+H  +GVCHRDIKPQN
Sbjct:   209 LNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQN 268

Query:   224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
             LLVNP THQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT AID+WS GCV
Sbjct:   269 LLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCV 328

Query:   284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
             +AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIKAHPWHKIFH
Sbjct:   329 MAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFH 388

Query:   344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE 403
             KRMPPEAVDLVSRLLQYSPNLRCTALEAC HPFFD+LRDPN  LPNGR  PPLFNF  QE
Sbjct:   389 KRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQE 448

Query:   404 LKGASKELLSKLIPEHAR 421
             L GAS EL  +LIP H +
Sbjct:   449 LAGASTELRQRLIPAHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1663 (590.5 bits), Expect = 4.4e-171, P = 4.4e-171
 Identities = 304/367 (82%), Positives = 338/367 (92%)

Query:    57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
             +KEM A V++GN   TGHII TTIGG+NG+PKQTISYMAERVVG GSFGIVFQAKCLETG
Sbjct:    36 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 95

Query:   117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
             E+VAIKKVLQD+RYKNRELQ MRL+DHPNVVSLKHCFFSTT +DEL+LNLV+E+VPET+Y
Sbjct:    96 ESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLY 155

Query:   177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
             RV KHY+ ++QRMP+ YVKLYTYQI R LAYIH   GVCHRD+KPQNLLV+P THQ KLC
Sbjct:   156 RVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLC 215

Query:   237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
             DFGSAKVLVKGE NISYICSRYYRAPELIFGATEYT++IDIWS GCVLAELLLGQPLFPG
Sbjct:   216 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPG 275

Query:   297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
             E+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct:   276 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 335

Query:   357 LLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
             LLQYSP+LRCTALEAC HPFF+ELR+PNARLPNGRP PPLFNFK QEL GAS EL+++LI
Sbjct:   336 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELSGASPELINRLI 394

Query:   417 PEHARKQ 423
             PEH R+Q
Sbjct:   395 PEHVRRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1660 (589.4 bits), Expect = 9.1e-171, P = 9.1e-171
 Identities = 303/367 (82%), Positives = 338/367 (92%)

Query:    57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
             +KEM A V++GN   TGHII TTIGG+NG+PKQTISYMAERVVG GSFGIVFQAKCLETG
Sbjct:    34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93

Query:   117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
             E+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+E+VPET+Y
Sbjct:    94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153

Query:   177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
             RV +HY+ ++QRMP+ YVKLYTYQI R LAYIH   GVCHRD+KPQNLLV+P THQVKLC
Sbjct:   154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213

Query:   237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
             DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT +IDIWS GCVLAELLLGQPLFPG
Sbjct:   214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPG 273

Query:   297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
             E+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct:   274 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 333

Query:   357 LLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
             LLQYSP+LRCTALEAC HPFF+ELR+PNARLPNGRP PPLFNFK QEL GAS EL+++LI
Sbjct:   334 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELINRLI 392

Query:   417 PEHARKQ 423
             PEH R+Q
Sbjct:   393 PEHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1650 (585.9 bits), Expect = 1.0e-169, P = 1.0e-169
 Identities = 303/367 (82%), Positives = 337/367 (91%)

Query:    57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
             +KEM A VVDG+   TGHII TTIGG+NG+PKQTISYMAERVVG GSFGIVFQAKCLETG
Sbjct:     4 DKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 63

Query:   117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
             ETVAIKKVLQD+RYKNRELQ MR++DHPNVV LKHCFFSTT KDEL+LNLV+E+VPE++Y
Sbjct:    64 ETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLY 123

Query:   177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
             RV KHYS A+QRMPL+YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQVK+C
Sbjct:   124 RVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKIC 183

Query:   237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
             DFGSAK LVKGE NISYICSR+YRAPELIFGATEYTT+IDIWS GCVLAELLLGQPLFPG
Sbjct:   184 DFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243

Query:   297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
             E+ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIFHKRMPPEA+D  SR
Sbjct:   244 ENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASR 303

Query:   357 LLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
             LLQYSP+LRCTALEAC HPFFDELR+PNARLPNGRPFPPLFNFK QE+ G+S EL++KLI
Sbjct:   304 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEVAGSSPELVNKLI 362

Query:   417 PEHARKQ 423
             P+H ++Q
Sbjct:   363 PDHIKRQ 369

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1646 (584.5 bits), Expect = 2.8e-169, P = 2.8e-169
 Identities = 298/371 (80%), Positives = 331/371 (89%)

Query:    57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
             E++ E  ++DG G E GH+I TT+ GRNGQ +QT+SY++E VVG GSFG+VFQAKC ETG
Sbjct:    47 ERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETG 106

Query:   117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
             E VAIKKVLQDKRYKNRELQ M++LDHPN V+LKH FFS TD +E+YLNLVLEFVPETV 
Sbjct:   107 EVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVN 166

Query:   177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
             RVA+ YSR +Q MPLIYVKLYTYQICRALAYIH   G+CHRDIKPQNLLVNPHTHQ+K+C
Sbjct:   167 RVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKIC 226

Query:   237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
             DFGSAKVLVKGEPN+SYICSRYYRAPELIFGA+EYTTAIDIWS GCV+AELLLGQPLFPG
Sbjct:   227 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPG 286

Query:   297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
             ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDL+ R
Sbjct:   287 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCR 346

Query:   357 LLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
               QYSPNLRCTALEACIHP FDELRDPN RLPNGRP PPLFNFKPQEL G   E++++L+
Sbjct:   347 FFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLV 406

Query:   417 PEHARKQCPFL 427
             PEHARKQ  F+
Sbjct:   407 PEHARKQNLFM 417

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1500 (533.1 bits), Expect = 8.2e-154, P = 8.2e-154
 Identities = 278/379 (73%), Positives = 322/379 (84%)

Query:    44 EEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
             +EI E+ + G+  +K+M+  ++ GNGTE+G II T   G N Q  +TISY AE V+G GS
Sbjct:    63 KEIREVGL-GD--DKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGS 119

Query:   104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
             FG+VFQAKCLET E VAIKKVLQDKRYKNRELQ MR+LDHPNVV LKH FFSTT+KDELY
Sbjct:   120 FGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELY 179

Query:   164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
             LNLVLE+VPET+YR ++ Y++ +Q MPLIY++LYTYQICRA+ Y+H  +GVCHRDIKPQN
Sbjct:   180 LNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQN 239

Query:   224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
             LLVN  TH+VK+CDFGSAK+L+ GEPNISYICSRYYRAPELIFGATEYT+AID+WSVGCV
Sbjct:   240 LLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCV 299

Query:   284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
             +AEL LG PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIKA PWHKIF 
Sbjct:   300 MAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFR 359

Query:   344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE 403
             +++ PEA+DL SRLLQYSPNLRCTALEAC HPFFD+LRDP A LPNGR  PPLF+F  QE
Sbjct:   360 RQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQE 419

Query:   404 LKGASKELLSKLIPEHARK 422
             L GAS EL  +LIPEHARK
Sbjct:   420 LAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)]

 Score = 1296 (461.3 bits), Expect = 3.4e-132, P = 3.4e-132
 Identities = 243/359 (67%), Positives = 294/359 (81%)

Query:    66 DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
             D +G++   ++ T   G+    +Q ++Y   +V+G GSFG+V+QAK  +TGE VAIKKVL
Sbjct:    31 DKDGSKVTTVVATP--GQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVL 88

Query:   126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
             QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct:    89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query:   185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
             A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct:   149 AKQALPIIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPETAVLKLCDFGSAKQL 207

Query:   245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
             V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct:   208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query:   305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
             EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct:   268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRARTPPEAIALCSRLLEYTPTS 327

Query:   365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
             R T L+AC H FFDELRDPN +LPNGR FP LFNF  QEL  ++  L S LIP HAR Q
Sbjct:   328 RLTPLDACAHSFFDELRDPNLKLPNGREFPALFNFTTQELS-SNPSLSSILIPAHARNQ 385

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IDA

GO:0060070 "canonical Wnt receptor signaling pathway" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.8065	0.9533	1.0	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8860	0.9137	0.9679	no	no
Q96287	KSG8_ARATH	2, ., 7, ., 1, 1, ., 1	0.8031	0.8904	0.8093	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6039	0.8041	0.8914	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.8256	0.8531	0.8992	no	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.8283	0.8531	0.8883	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.8256	0.8531	0.9631	no	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.7690	0.9114	0.9287	no	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5225	0.7529	0.8729	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6656	0.7482	0.8867	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.7587	0.9300	0.95	no	no
O23145	KSG2_ARATH	2, ., 7, ., 1, 1, ., 1	0.7284	0.8694	0.8654	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8621	0.9230	0.9682	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6722	0.8275	0.8452	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6377	0.7715	0.7087	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8275	0.9580	1.0	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8014	0.9533	0.9951	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8546	0.9207	0.9610	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7857	0.8927	0.8183	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6722	0.8275	0.8452	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8853	0.9417	0.9853	yes	no
Q91757	GSK3B_XENLA	2, ., 7, ., 1, 1, ., 2, 6	0.6796	0.8251	0.8428	N/A	no
Q5YJC2	GSK3B_SPECI	2, ., 7, ., 1, 1, ., 1	0.6694	0.8275	0.8452	N/A	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6740	0.8251	0.8428	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	429
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-136
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-93
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-86
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-86
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-85
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-80
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-78
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-77
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-77
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-76
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-75
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-73
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-70
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-68
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-67
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-67
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-66
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-63
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-63
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-61
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-61
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-59
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-59
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-58
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-58
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-58
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-56
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-55
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-55
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-54
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-54
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-54
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-53
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-53
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-53
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-52
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-51
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-51
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-50
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-49
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-49
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-49
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-47
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-47
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-46
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-46
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-46
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-46
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-46
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-45
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-44
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-43
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-41
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-39
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-38
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-38
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-37
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-36
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-36
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-36
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-35
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-34
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-34
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-33
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-33
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-31
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-31
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-30
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-30
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-28
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-24
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-23
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-20
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-20
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-19
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-18
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-18
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-18
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-17
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-17
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-12
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-07
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-04
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.001
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.002
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	0.002
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.002

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  397 bits (1022), Expect = e-136
 Identities = 173/331 (52%), Positives = 242/331 (73%), Gaps = 5/331 (1%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           SY    ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL  M+ L+H N++ LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 152 CFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
            +++     ++  ++LN+V+EF+P+TV++  KHY+R +  +PL  VKLY+YQ+CRALAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    +CHRD+KPQNLL++P+TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
           T YTT ID+WS+GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MNPNY + 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
           KFP +K     K+F K  P +A++ +S+ L+Y P  R   +EA   PFFD+LRDP  +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365

Query: 389 NG-RPFPPLFNFKPQELKGASKELLSKLIPE 418
                 P LFNF   E+K  S     K+IP+
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  282 bits (725), Expect = 7e-93
 Identities = 123/339 (36%), Positives = 185/339 (54%), Gaps = 28/339 (8%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y   + +G G++G+V  A    TG  VAIKK+      L D +   RE++ +R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 147 VSLKHCF--FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           + L       S  D +++Y+  V E +   +++V K      Q +   +++ + YQI R 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYR 260
           L Y+H    V HRD+KP N+LVN     +K+CDFG A+ +   E        Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APEL+  ++ YT AIDIWSVGC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++K 
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 321 M-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           + +     +    P+    P  K+F     PEA+DL+ ++L + P  R TA EA  HP+ 
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Query: 378 DELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
            +L DP    P  +P      F   EL   ++E L +LI
Sbjct: 293 AQLHDPE-DEPVAKPPFDFDFFDDDEL---TEEELKELI 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  264 bits (677), Expect = 3e-86
 Identities = 110/295 (37%), Positives = 171/295 (57%), Gaps = 35/295 (11%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPNVVSLK 150
           +G+G++G+V++A+  +TGE VA+KK+  D   +         RE+  ++ L HPN+V L 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
               +   + +LYL  V E+       + K+  +    +    +K   YQ+ R LAY H 
Sbjct: 65  DVIHT---ERKLYL--VFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
              + HRD+KPQN+L+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 117 -HRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
           +  Y+TA+DIWSVGC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E      P  T+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVTK 228

Query: 328 FK-----FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                  FP+       K+   R+ PE +DL+S++LQY+P  R +A EA  HP+F
Sbjct: 229 LPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  263 bits (673), Expect = 9e-86
 Identities = 115/294 (39%), Positives = 170/294 (57%), Gaps = 20/294 (6%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 146
           Y     +G+G++G+V++A+   TGE VAIKK+              RE++ ++ L+HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           + L   F     K +LYL  V EF+   +Y++ K   R    +P   +K Y YQ+ + LA
Sbjct: 61  IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLA 112

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 265
           + H   G+ HRD+KP+NLL+N     +KL DFG A+       P   Y+ +R+YRAPEL+
Sbjct: 113 FCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 324
            G   Y+T +DIWSVGC+ AELL  +PLFPG+S +DQL +I + LGTP  E         
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 325 -YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
              +F FP+    P  K+F     P+A+DL+S++L Y P+ R TA +A  HP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  261 bits (669), Expect = 4e-85
 Identities = 112/292 (38%), Positives = 169/292 (57%), Gaps = 23/292 (7%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
             +G+G+ GIVF+AK  ETGETVA+KKV   +          RE++ ++   HP VV L 
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
             F   +        LV+E++P  +  V +   R    +P   VK Y   + + +AY+H 
Sbjct: 66  DVFPHGSG-----FVLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHA 117

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGA 268
             G+ HRD+KP NLL++     +K+ DFG A++  + EP +    + +R+YRAPEL++GA
Sbjct: 118 -NGIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 325
            +Y   +D+W+VGC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDY 234

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            +  FP+ K  P  +IF     PEA+DL+  LL Y P+ R +A EA  HP+F
Sbjct: 235 NKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  248 bits (637), Expect = 1e-80
 Identities = 104/290 (35%), Positives = 150/290 (51%), Gaps = 41/290 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 147
           Y     +G+GSFG V+ A+  +TG+ VAIK +      +D+    RE++ ++ L HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L   F    D+D+LYL  V+E+             +   R+     + Y  QI  AL Y
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCE---GGDLFDLLKKRGRLSEDEARFYLRQILSALEY 112

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +H   G+ HRD+KP+N+L++   H VKL DFG A+ L  GE   +++ +  Y APE++ G
Sbjct: 113 LHS-KGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              Y  A+DIWS+G +L ELL G+P FPG+   DQL+E+ K +G P              
Sbjct: 171 -KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK------------- 213

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                    P        + PEA DL+ +LL   P  R TA EA  HPFF
Sbjct: 214 ---------PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  243 bits (623), Expect = 1e-78
 Identities = 96/289 (33%), Positives = 141/289 (48%), Gaps = 39/289 (13%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
            R +G GSFG V++AK   TG+ VA+K + +            RE++ +R L HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              F    DKD LYL  V+E+           Y      +     K    QI R L Y+H
Sbjct: 64  IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGA 268
              G+ HRD+KP+N+L++     VK+ DFG AK L+K      +++ + +Y APE++ G 
Sbjct: 116 S-NGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y   +D+WS+G +L ELL G+P F GE+ +DQL  I ++LG P               
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                    + +        EA DL+ + L   P+ R TA E   HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  241 bits (618), Expect = 2e-77
 Identities = 109/291 (37%), Positives = 164/291 (56%), Gaps = 21/291 (7%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 151
           VVG+G++G+V + +   TGE VAIKK  +   D+  K    RE++ +R L H N+V+LK 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F     K  LYL  V E+V  T+  + +        +P   V+ Y +Q+ +A+AY H  
Sbjct: 68  AFRR---KGRLYL--VFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH 119

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGAT 269
             + HRDIKP+N+LV+     +KLCDFG A+ L      P   Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 327
            Y   +D+W++GC++AELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP +  
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 328 FKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             FP+        + +  ++   A+D +   L+  P  R T  E   HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  240 bits (615), Expect = 5e-77
 Identities = 112/293 (38%), Positives = 175/293 (59%), Gaps = 26/293 (8%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVS 148
           + +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++++R L +HPN+V 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           LK  F    + DELY   V E++   +Y++ K   R  +      ++   YQI + LA+I
Sbjct: 63  LKEVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H   G  HRD+KP+NLLV+     VK+ DFG A+ +    P   Y+ +R+YRAPE++  +
Sbjct: 116 HK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPN 324
           T Y++ +DIW++GC++AEL   +PLFPG S +DQL +I  VLGTPT+++     K  +  
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK- 232

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
              F+FPQ      H++      PEA+DL+  +L++ P  R TA +A  HP+F
Sbjct: 233 -LGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  238 bits (609), Expect = 6e-76
 Identities = 112/302 (37%), Positives = 160/302 (52%), Gaps = 35/302 (11%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 143
           Y   + +G+G++ +V++A+  ETG  VAIKK+   +R +          RE++ ++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
           PN++ L   F          +NLV EF+    E V +        S  +    +K Y   
Sbjct: 62  PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIK------DKSIVLTPADIKSYMLM 110

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SR 257
             R L Y+H    + HRD+KP NLL+      +KL DFG A+    G PN        +R
Sbjct: 111 TLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTR 166

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           +YRAPEL+FGA  Y   +D+WSVGC+ AELLL  P  PG+S +DQL +I + LGTPT E 
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226

Query: 318 IKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
              +   P+Y EFK       P  +IF      +A+DL+ RLL  +PN R TA +A  HP
Sbjct: 227 WPGVTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHP 283

Query: 376 FF 377
           +F
Sbjct: 284 YF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  236 bits (605), Expect = 7e-75
 Identities = 113/309 (36%), Positives = 177/309 (57%), Gaps = 31/309 (10%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRE---LQTMRLLDH 143
           Y   + +G+G++GIV++A    T E VA+KK+        D +   RE   LQ +   DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L +   +  DKD +YL  V E++   ++ V +        +  ++ +   YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLK 118

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------YICSR 257
           AL YIH G  V HRD+KP N+L+N     VKL DFG A+ L + E N        Y+ +R
Sbjct: 119 ALKYIHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           +YRAPE++ G+T YT  +D+WSVGC+L E+LLG+PLFPG S ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 318 IKCMNPNYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
           I+ +   +        P     P  ++   +   +A+DL+ +LL ++PN R TA EA  H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 375 PFFDELRDP 383
           P+  +  +P
Sbjct: 296 PYVAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  231 bits (592), Expect = 7e-73
 Identities = 115/339 (33%), Positives = 187/339 (55%), Gaps = 30/339 (8%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A    TG  VAIKK+   + + +  R L+ +++L    H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 148 SLKHCFFSTT--DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            +       +    +++Y+  V E +   +Y++ K     +Q +   +++ + YQI R L
Sbjct: 67  GILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRA 261
            YIH    V HRD+KP NLL+N     +K+CDFG A++      +      Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++  +  YT AIDIWSVGC+LAE+L  +PLFPG+  + QL  I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 322 -NP---NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            +    NY +   P     PW+K+F     P+A+DL+ ++L ++P+ R T  EA  HP+ 
Sbjct: 238 ISLRARNYIK-SLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Query: 378 DELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
           ++  DP+       PFP  F           KE L +LI
Sbjct: 296 EQYHDPSDEPVAEEPFPFDFELFDD----LPKEKLKELI 330

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  224 bits (573), Expect = 1e-70
 Identities = 95/291 (32%), Positives = 155/291 (53%), Gaps = 22/291 (7%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 151
           +G+G++G V++A+  +TGE VA+KK+  +   K        RE++ ++ L HPN+V LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
              S   K  +Y+  V E++   +  +         +     +K Y  Q+   L Y+H  
Sbjct: 66  IVTSK-GKGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS- 118

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGAT 269
            G+ HRDIK  N+L+N     +KL DFG A+   K       + + + +YR PEL+ GAT
Sbjct: 119 NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 326
            Y   +D+WSVGC+LAEL LG+P+F G + ++QL +I ++ G+PT E    +  + P + 
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWFE 236

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             K  +       + F   + P A+DL+ +LL   P  R +A +A  H +F
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  219 bits (560), Expect = 4e-68
 Identities = 112/342 (32%), Positives = 182/342 (53%), Gaps = 28/342 (8%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPN 145
            Y     +G G++G+V  A    +G+ VAIKK      V    +   REL+ +R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +++++         D   + +V++ +   ++ +      + Q +   +++ + YQ+ R L
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHII----HSDQPLTEEHIRYFLYQLLRGL 120

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYR 260
            YIH    V HRD+KP NLLVN     +++ DFG A+ L             Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APEL+    EYTTAID+WSVGC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 321 MNP----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +       Y +   P+ +  PW KIF K   PEA+DL+S++LQ+ P  R T  +A  HPF
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 418
             +  DP+    +    PP F+F  + ++ + ++L   ++ E
Sbjct: 297 LAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  218 bits (556), Expect = 2e-67
 Identities = 120/337 (35%), Positives = 189/337 (56%), Gaps = 28/337 (8%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y+  + +G+G++GIV  AK  ET E VAIKK+        D +   RE++ +R LDH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 147 VSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           +++K        ++   ++Y+  V E +   ++++     R+SQ +   + + + YQ+ R
Sbjct: 67  IAIKDIM-PPPHREAFNDVYI--VYELMDTDLHQII----RSSQTLSDDHCQYFLYQLLR 119

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAP 262
            L YIH    V HRD+KP NLL+N +   +K+CDFG A+    KG+    Y+ +R+YRAP
Sbjct: 120 GLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 321
           EL+   +EYTTAID+WSVGC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + 
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237

Query: 322 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           N     +    P      + ++F     P A+DL+ ++L + P+ R T  EA  HP+   
Sbjct: 238 NEKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296

Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
           L DP+       PF   F+F+   L     E + +LI
Sbjct: 297 LHDPSDEPVCQTPFS--FDFEEDALTE---EDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  215 bits (549), Expect = 3e-67
 Identities = 103/293 (35%), Positives = 165/293 (56%), Gaps = 30/293 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  +   +       RE+  ++ L+HPN+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHY--SRASQRMPLIYVKLYTYQICRALAYIHG 210
             S     +LYL  V EF+   +    K Y  S     +    +K Y YQ+ + +AY H 
Sbjct: 67  VHSEN---KLYL--VFEFLDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
              V HRD+KPQNLL++     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 118 H-RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 173

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 324
           + +Y+T +DIWS+GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PD 232

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           Y    FP+       K+    +  + +DL+S++L Y P  R +A  A  HP+F
Sbjct: 233 YKP-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  216 bits (551), Expect = 1e-66
 Identities = 105/305 (34%), Positives = 163/305 (53%), Gaps = 26/305 (8%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
           Y     VG G++G V  A   +TG  VAIKK+ +        KR Y  REL+ ++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 145 NVVSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           NV+ L   F   +  ++   + LV   +   +  + K      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
            L YIH   G+ HRD+KP N+ VN    ++K+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++     Y   +DIWSVGC++AELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 324 ----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
               NY +   PQ+    + ++F     P A+DL+ ++L   P+ R TA EA  HP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 380 LRDPN 384
             DP 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  205 bits (524), Expect = 2e-63
 Identities = 104/290 (35%), Positives = 154/290 (53%), Gaps = 27/290 (9%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKH 151
           G+G+F  V +A+  +TG+  AIK +   K +K+       RE+Q +R L  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 152 CFFSTTDKDELYLNLVLEFVPETVY---RVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F   D+    L LV E +   +Y   +  K        +P   VK Y YQ+ ++L ++
Sbjct: 66  VLF---DRKTGRLALVFELMDMNLYELIKGRKRP------LPEKRVKSYMYQLLKSLDHM 116

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H   G+ HRDIKP+N+L+      +KL DFGS + +    P   YI +R+YRAPE +   
Sbjct: 117 HR-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTE 327
             Y   +DIW+VGCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           + FP  K     K+       E +DL+ +LL Y P+ R TA +A  HP+F
Sbjct: 234 YNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  204 bits (521), Expect = 6e-63
 Identities = 118/290 (40%), Positives = 169/290 (58%), Gaps = 21/290 (7%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 151
           +VG+GS+G+V + K  ETG+ VAIKK L+   DK  K    RE++ ++ L H N+V+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F     K  LYL  V EFV  TV    + Y      +    V+ Y +QI R + + H  
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSH 119

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATE 270
             + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T+
Sbjct: 120 -NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 328
           Y  A+DIW+VGC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP +   
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 329 KFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           + P++K   P  K F K +    +DL  + L+  P+ R ++ +   H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  199 bits (508), Expect = 5e-61
 Identities = 104/293 (35%), Positives = 164/293 (55%), Gaps = 30/293 (10%)

Query: 101 QGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFF 154
           +G++G+V++A+  +TGE VA+KK+  +K  +       RE+  +  L HPN+V++K    
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
            +   D++Y+  V+E+V   +  + +      Q      VK    Q+   +A++H    +
Sbjct: 75  GSNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN-WI 127

Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 271
            HRD+K  NLL+N +   +K+CDFG A+    G P   Y   + + +YRAPEL+ GA EY
Sbjct: 128 LHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEY 184

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
           +TAID+WSVGC+ AELL  +PLFPG+S +DQL +I K+LGTPT +      P ++E    
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPGA 240

Query: 332 QIKAHPWH-------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           + K    +       K     +     DL++RLL Y P  R +A +A  HP+F
Sbjct: 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  200 bits (510), Expect = 9e-61
 Identities = 127/345 (36%), Positives = 192/345 (55%), Gaps = 28/345 (8%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y  + V+G+GS+G+V  A    TGE VAIKK+      + D     RE++ +RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V +KH     + ++   + +V E +   +++V K    A+  +   + + + YQ+ RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----ISYICSRYYRAP 262
           YIH    V HRD+KP+N+L N    ++K+CDFG A+V     P       Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 263 ELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-K 319
           EL  G+  ++YT AIDIWS+GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMP---PEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             N     +     K  P    F ++ P   P A+ L+ RLL + P  R TA EA   P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 377 FDELRDPNARLPNGRPFPPL-FNFKPQEL-KGASKELLSKLIPEH 419
           F  L     R P+ +P   L F F+ + L K   +EL+ + I E+
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFERRRLTKEDVRELIYREILEY 336

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  196 bits (501), Expect = 2e-59
 Identities = 112/304 (36%), Positives = 160/304 (52%), Gaps = 27/304 (8%)

Query: 99  VGQGSFGIVFQAKCLET--GETVAIKK---VLQDKRYKNRELQTMRLL----DHPNVVSL 149
           +GQG++GIV  A+  ET   ETVAIKK   V   K    R L+ ++LL     H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 150 KHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
                      +ELYL    E +   ++++     R+ Q +   + + + YQI   L YI
Sbjct: 68  YDMDIVFPGNFNELYL--YEELMEADLHQII----RSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPE 263
           H    V HRD+KP NLLVN    ++K+CDFG A+       +    ++ Y+ +R+YRAPE
Sbjct: 122 HSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKC 320
           ++     YT AID+WSVGC+LAELL  +P+F G+  VDQL +I++VLGTP  E    I  
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
                     P I   P+  IF     P A+DL+ +LL + P  R +  EA  HP+    
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298

Query: 381 RDPN 384
            DP+
Sbjct: 299 HDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  194 bits (496), Expect = 3e-59
 Identities = 102/289 (35%), Positives = 159/289 (55%), Gaps = 21/289 (7%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 152
           +G+GS+G+VF+ +  ETG+ VAIKK ++       K+   RE++ ++ L HPN+V+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           F     + +  L+LV E+   TV    +   R    +P   +K   +Q  +A+ + H   
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKH- 119

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEY 271
              HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTEFK 329
              +D+W++GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  +    
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238

Query: 330 FPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            P+ +   P    F   +   A+  +   LQ  P  R +  E   HP+F
Sbjct: 239 IPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  193 bits (491), Expect = 4e-58
 Identities = 107/304 (35%), Positives = 173/304 (56%), Gaps = 25/304 (8%)

Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDH 143
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK+++        +   REL+ ++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            N++SL   F S    +++Y   V E +   ++R+       S+ +   +++ + YQI R
Sbjct: 69  ENIISLSDIFISP--LEDIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILR 119

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 262
            L Y+H   GV HRD+KP N+L+N +   +K+CDFG A++    +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAP 174

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 321
           E++    +Y   +DIWS GC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234

Query: 322 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           + N   F    P+ +  P+ + F K   P A+DL+ ++L + P  R +A EA  HP+   
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293

Query: 380 LRDP 383
             DP
Sbjct: 294 YHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  191 bits (487), Expect = 4e-58
 Identities = 107/295 (36%), Positives = 167/295 (56%), Gaps = 34/295 (11%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR--MPLIYVKLYTYQICRALAYIHG 210
             +   +++LYL  V EF+ + +    K +  AS    +PL  +K Y +Q+ + LA+ H 
Sbjct: 68  IHT---ENKLYL--VFEFLHQDL----KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 119 H-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       + P  T 
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230

Query: 328 FK-----FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                  FP+     + K+    +  +  DL+S++L Y PN R +A  A  HPFF
Sbjct: 231 LPDYKPSFPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  191 bits (487), Expect = 7e-58
 Identities = 100/295 (33%), Positives = 159/295 (53%), Gaps = 23/295 (7%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNVVSLKH 151
           +G+G++G V++A+   TG+ VA+KK   +   +       RE+  +++L     +V L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR-MPLIYVKLYTYQICRALAYIHG 210
                    +  L LV E++   + +      R   R +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
             GV HRD+KPQNLLV+     +K+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
           +T Y+T +DIWSVGC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 328 FK----FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
            +    FPQ K     +     + PE +DL+ ++L+Y P  R +A  A  HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  188 bits (478), Expect = 1e-56
 Identities = 104/292 (35%), Positives = 169/292 (57%), Gaps = 28/292 (9%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 153
           +G+G++  V++ +   TGE VA+K++  D          RE+  M+ L H N+V L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHY--SRASQR-MPLIYVKLYTYQICRALAYIHG 210
             T +K    L LV E++ + +    K Y  +   +  +    VK +TYQ+ + +A+ H 
Sbjct: 67  IHTENK----LMLVFEYMDKDL----KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
              V HRD+KPQNLL+N    ++KL DFG A+    G P  ++   + + +YRAP+++ G
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 325
           +  Y+T+IDIWSVGC++AE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            +  FP+       ++F     P  +DL+ RLLQ +P LR +A +A  HP+F
Sbjct: 235 -KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  184 bits (470), Expect = 5e-55
 Identities = 113/317 (35%), Positives = 159/317 (50%), Gaps = 46/317 (14%)

Query: 99  VGQGSFGIVFQAKCLE--TGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           +G+G++G V++AK      G+  AIKK   DK           RE+  +R L H NVVSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM-PLIYVKLYTYQICRALAYI 208
              F    DK  +YL  + ++    ++++ K + +A +   P   VK   +QI   + Y+
Sbjct: 68  VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 209 HGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA-------KVLVKGEPNISYICSRY 258
           H    V HRD+KP N+LV    P    VK+ D G A       K L   +P +  I   +
Sbjct: 125 HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKV 309
           YRAPEL+ GA  YT AIDIW++GC+ AELL  +P+F G             DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 310 LGTPTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFHKRMP--PEAVDLVSRLLQY 360
           LGTPT ++   IK M P Y     +FK     ++   K   K      +  DL+ +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 361 SPNLRCTALEACIHPFF 377
            P  R TA EA  HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  183 bits (466), Expect = 9e-55
 Identities = 101/298 (33%), Positives = 160/298 (53%), Gaps = 24/298 (8%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 146
           +Y     +G+GS+  V++ +   TG+ VA+K++ L+ +        RE   ++ L H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V+L H    T       L LV E++   + +           + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
           Y H    V HRD+KPQNLL++    ++KL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 320
           ++ G+TEY+T++D+W VGC+  E+  G+PLFPG + V DQL +I +VLGTPT E      
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            NP +  + FP     P      +    P   +L  + LQY P  R +A EA  HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  183 bits (465), Expect = 1e-54
 Identities = 105/306 (34%), Positives = 171/306 (55%), Gaps = 33/306 (10%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +G+G++G+V++A+   T ET+A+KK+  ++  +       RE+  ++ + H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA-----SQRMPLIYVKLYTYQI 201
           V L+    S     E  L LV E++      + KH   +     + R+    +K Y YQI
Sbjct: 64  VRLQDVVHS-----EKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRL----IKTYLYQI 111

Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRY 258
            R +AY H    V HRD+KPQNLL++  T+ +KL DFG A+    G P  ++   + + +
Sbjct: 112 LRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLW 168

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           YRAPE++ G+  Y+T +DIWSVGC+ AE++  +PLFPG+S +D+L +I ++LGTP  E  
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228

Query: 319 KCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             +   P+Y    FP+        +    + P  VDL+S++L+  P+ R TA  A  H +
Sbjct: 229 PGVTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Query: 377 FDELRD 382
           F +L D
Sbjct: 287 FKDLGD 292

Length = 294

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  183 bits (466), Expect = 1e-54
 Identities = 105/295 (35%), Positives = 155/295 (52%), Gaps = 28/295 (9%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++GIV++A+   +GE VA+KKV  D           RE+  +  L HPN+V LK  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                 K    + LV+E+  + +  +  +            VK    Q+ R L Y+H   
Sbjct: 75  ---VVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHENF 128

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            + HRD+K  NLL+      +K+ DFG A+    G P       + + +YRAPEL+ G T
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            YTTAID+W+VGC+LAELL  +PL PG+S ++QL  II++LGTP        +  P   +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244

Query: 328 FKFPQIKAHPWHKIFHKRMP--PEA-VDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           F  P+    P++ + HK  P   EA + L++ LL Y P  R TA EA    +F E
Sbjct: 245 FTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  182 bits (464), Expect = 2e-54
 Identities = 98/304 (32%), Positives = 155/304 (50%), Gaps = 48/304 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
           +G+G++G V++A+ L TG  VA+KKV    R             RE+  ++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR-MPLIYVKLYTYQICRA 204
           +V L           EL L LV E V + +   A + S+  +  +P   +K    Q+ R 
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDL---ATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           + ++H    + HRD+KPQN+LV     QVK+ DFG A++        S + + +YRAPE+
Sbjct: 120 VDFLHSH-RIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +  ++ Y T +D+WSVGC+ AEL   +PLF G S  DQL +I  V+G P+ EE       
Sbjct: 178 LLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE------- 229

Query: 325 YTEFKFPQIKAHPWHKIFHKR-----------MPPEAVDLVSRLLQYSPNLRCTALEACI 373
                +P+  + P    F              +  E +DL+ ++L ++P+ R +A EA  
Sbjct: 230 -----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283

Query: 374 HPFF 377
           HP+F
Sbjct: 284 HPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  179 bits (457), Expect = 1e-53
 Identities = 102/292 (34%), Positives = 159/292 (54%), Gaps = 28/292 (9%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             S     +  L LV E+  + +    K++   +  +    VK + +Q+ + LA+ H   
Sbjct: 68  LHS-----DKKLTLVFEYCDQDL---KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N +  ++KL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 270 EYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 326
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    ++  P+Y 
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 327 EF-KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            +  +P   +     +   ++     DL+  LL  +P  R +A EA  HP+F
Sbjct: 236 PYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  181 bits (460), Expect = 2e-53
 Identities = 106/297 (35%), Positives = 160/297 (53%), Gaps = 22/297 (7%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 152
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 153 FFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
           F      D  +   LV+ F+   + ++ KH   +  R     ++   YQ+ + L YIH  
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIHAA 137

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
            G+ HRD+KP NL VN    ++K+ DFG A+          Y+ +R+YRAPE+I     Y
Sbjct: 138 -GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHY 193

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 327
           T  +DIWSVGC++AE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY +
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
            K P+ +   +  +      P AV+++ ++L      R TA EA  HP+F+E  DP 
Sbjct: 254 -KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  178 bits (453), Expect = 3e-53
 Identities = 93/291 (31%), Positives = 137/291 (47%), Gaps = 46/291 (15%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLK 150
            ++G+GSFG V+ A   +TGE +A+K V L     +      RE++ +  L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 151 HCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
             + S  D+++  LN+ LE+V   ++  + K + +  + +    ++ YT QI   LAY+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIF 266
              G+ HRDIK  N+LV+     VKL DFG AK L   E        R   Y+ APE+I 
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  EY  A DIWS+GC + E+  G+P +         +  I   G P             
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
               P+I  H         +  EA D + + L+  P  R TA E   HPF 
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  181 bits (458), Expect = 7e-53
 Identities = 92/327 (28%), Positives = 137/327 (41%), Gaps = 48/327 (14%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHP 144
           SY   R +G+GSFG V+ A+  +    VA+K + +    K+       RE+Q +  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 145 -NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            N+V L   F     +DE  L LV+E+V                 +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-------SYICS 256
           AL Y+H   G+ HRDIKP+N+L++     VKL DFG AK+L              + + +
Sbjct: 113 ALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 257 RYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLG 311
             Y APE++ G +    +++ DIWS+G  L ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
           TP                     A P      + +   A DL+ +LL   P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 372 CIHPFFDELRDPNARLPNGRPFPPLFN 398
             H     L+   + L +         
Sbjct: 273 LSHDLLAHLKLKESDLSDLLKPDDSAP 299

Length = 384

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (445), Expect = 1e-52
 Identities = 68/247 (27%), Positives = 118/247 (47%), Gaps = 40/247 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 153
           +G+G FG V+ A+  +TG+ VAIK + ++          RE++ ++ L+HPN+V L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                +DE +L LV+E+    ++            ++    +     QI   L Y+H   
Sbjct: 61  -----EDENHLYLVMEYCEGGSLK---DLLKENEGKLSEDEILRILLQILEGLEYLHS-N 111

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 271
           G+ HRD+KP+N+L++    +VKL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 330
           +   DIWS+G +L EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 331 PQIKAHP 337
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  176 bits (447), Expect = 5e-52
 Identities = 100/297 (33%), Positives = 160/297 (53%), Gaps = 37/297 (12%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLDHPNVVS 148
           +G+G++G+V++ +  +TG+ VA+KK+    R ++          RE+  ++ L HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY---SRASQRMPLIYVKLYTYQICRAL 205
           L+          E  L L+ EF+   +    K Y       Q M    VK Y YQI + +
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDL----KKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 262
            + H    V HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAP
Sbjct: 115 LFCHSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAP 170

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++ G+  Y+T +DIWS+G + AE+   +PLF G+S +DQL  I ++LGTPT +    + 
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230

Query: 323 --PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             P+Y    FP+ K         K +  + +DL+ ++L Y P  R +A +A  HP+F
Sbjct: 231 SLPDYKN-TFPKWKKGSLRSAV-KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  174 bits (443), Expect = 3e-51
 Identities = 97/306 (31%), Positives = 150/306 (49%), Gaps = 39/306 (12%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHC 152
           G+G+FG V++A+ ++TG  VA+KK+L     K+       RE++ ++ L HPNVV L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                DK +     V    P   + ++      S ++    +K Y  Q+   + Y+H   
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN- 134

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------------ICSRYYR 260
            + HRDIK  N+L++ +   +K+ DFG A+      PN               + +R+YR
Sbjct: 135 HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
            PEL+ G   YTTA+DIW +GCV AE+   +P+  G+S +DQL  I K+ GTPT E    
Sbjct: 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW-- 251

Query: 321 MNPNYTEFKFPQIKAHPWH---------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             P +     P       H         +    ++ PE +DL+S+LL   P  R TA +A
Sbjct: 252 --PGWR--SLP--GCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305

Query: 372 CIHPFF 377
             HP+F
Sbjct: 306 LEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  174 bits (443), Expect = 7e-51
 Identities = 104/304 (34%), Positives = 162/304 (53%), Gaps = 25/304 (8%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL---DHPNV 146
           Y + + VG G++G V  A    TGE VAIKK+    Q + +  R  + + LL    H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L   F S    DE     LV+ ++   + ++  H     +      V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLCGL 130

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 264
            YIH   G+ HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE+
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-- 322
           I     Y   +DIWSVGC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +   
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 323 --PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
              +Y +   P+     +  +F  +  P+AVDL+ ++L+   + R TA EA  HP+FD  
Sbjct: 246 AAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303

Query: 381 RDPN 384
           RD +
Sbjct: 304 RDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  173 bits (440), Expect = 4e-50
 Identities = 107/309 (34%), Positives = 163/309 (52%), Gaps = 41/309 (13%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKK---VLQD----KRYKNRELQTMRLLDHPNVVS 148
           +R +G G+FG+V+       G+ VA+KK   V Q+    KR   REL+ +    H NV+S
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 149 --------LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
                       F      +E+Y+  V E +   ++++      + Q +   +VK++ YQ
Sbjct: 64  ALDILQPPHIDPF------EEIYV--VTELMQSDLHKIIV----SPQPLSSDHVKVFLYQ 111

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-----IC 255
           I R L Y+H   G+ HRDIKP NLLVN +   +K+CDFG A+V    EP+ S      + 
Sbjct: 112 ILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
           ++YYRAPE++ G+  YT+A+DIWSVGC+ AELL  + LF  +S + QL  I  +LGTP+ 
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226

Query: 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEAC 372
           E ++                 P   + +        EAV L+ R+L + P+ R +A +A 
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286

Query: 373 IHPFFDELR 381
            HP+ DE R
Sbjct: 287 AHPYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  169 bits (429), Expect = 2e-49
 Identities = 112/292 (38%), Positives = 163/292 (55%), Gaps = 24/292 (8%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 151
           VVG+G++G+V + +  ET E VAIKK          K    REL+ +R L   N+V LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F     + +LYL  V E+V + +  + +         P   V+ Y YQ+ +A+ + H  
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLEEMPNGV---PPEKVRSYIYQLIKAIHWCHKN 119

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGAT 269
             + HRDIKP+NLL++ H   +KLCDFG A+ L +G   N + Y+ +R+YR+PEL+ GA 
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTE 327
            Y  A+D+WSVGC+L EL  GQPLFPGES +DQL  I KVLG    E++K    NP +  
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 328 FKFPQIKAHP--WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            +FP +  HP    + +   +    +DL+  LL+ +P  R    +   HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  170 bits (432), Expect = 3e-49
 Identities = 94/329 (28%), Positives = 163/329 (49%), Gaps = 44/329 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKK-VLQDKR---YKNRELQTMRLLDHPNVVS 148
           YM  R +G GS G+VF A   +  + VA+KK VL D +   +  RE++ +R LDH N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 149 LKHCFFSTTDKDELYLN---------LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
           +      +       +          +V E++   +  V +        +   + +L+ Y
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ 253
           Q+ R L YIH    V HRD+KP N+ +N     +K+ DFG A+++   +P+ S+      
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSE 177

Query: 254 -ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL---VEIIKV 309
            + +++YR+P L+     YT AID+W+ GC+ AE+L G+PLF G   ++Q+   +E + V
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPW--HKIFHKRMP---PEAVDLVSRLLQYSPNL 364
           +    R E+  + P++       ++       +     +P   PEA+D + ++L ++P  
Sbjct: 238 VREEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290

Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPF 393
           R TA EA +HP+      P     +  PF
Sbjct: 291 RLTAEEALMHPYMSCYSCPFDEPVSLHPF 319

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  166 bits (424), Expect = 5e-49
 Identities = 80/285 (28%), Positives = 129/285 (45%), Gaps = 42/285 (14%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
             +G+G FG V++A+   TG+ VAIK + L+ K  K     E+Q ++   HPN+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
           +     KDEL+  +V+EF    ++  + K     +Q +    +     ++ + L Y+H  
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH-S 116

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
            G+ HRDIK  N+L+     +VKL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
               DIWS+G    EL  G+P +  E    + +  I   G P               + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-------------LRNP 220

Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                       ++   E  D + + LQ +P  R TA +   HPF
Sbjct: 221 ------------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  165 bits (418), Expect = 3e-47
 Identities = 103/313 (32%), Positives = 162/313 (51%), Gaps = 25/313 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y     VG G++G V  A      + VA+KK+      L   R   REL+ ++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 147 VSLKHCFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           + L   F   T   + +E+YL  V   +   +  + K      Q++   +V+   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLR 129

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
            L YIH   G+ HRD+KP N+ VN    ++++ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++     Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++V+GTP+ E +K ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 324 NYTEFKF---PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
            +        P +      KIF +   P A+DL+ ++L    + R +A EA  HP+F + 
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Query: 381 RDPNARLPNGRPF 393
            DP    P   P+
Sbjct: 305 HDPEDE-PEAEPY 316

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  163 bits (413), Expect = 5e-47
 Identities = 99/308 (32%), Positives = 168/308 (54%), Gaps = 23/308 (7%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           +Y+    +G+G++  V++ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V+L H    T    E  L LV E++ + +    ++       + +  VKL+ +Q+ R L 
Sbjct: 67  VTL-HDIIHT----EKSLTLVFEYLDKDL---KQYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
           Y H    V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321
           ++ G+T+Y+T ID+W VGC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
           N  +  + +P+ +A   H     R+  +  +L+S+LLQ+    R +A EA  HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 382 DPNARLPN 389
           +   +LP+
Sbjct: 294 ERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  163 bits (414), Expect = 1e-46
 Identities = 107/334 (32%), Positives = 169/334 (50%), Gaps = 28/334 (8%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 312

Query: 387 LPNGRPFPPLFNFKP---QELKGASKELLSKLIP 417
            P   P+   F  +     E K  + + +   +P
Sbjct: 313 -PVADPYDQSFESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  162 bits (412), Expect = 2e-46
 Identities = 104/332 (31%), Positives = 156/332 (46%), Gaps = 55/332 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------------------RELQTMR 139
           +G+G++G V +A    TG+ VAIKKV +     N                   REL+ M 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
            + H N++ L   +         ++NLV++ +   + +V     R ++      VK    
Sbjct: 76  EIKHENIMGLVDVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTES----QVKCILL 126

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----VLVKGEPNISYI 254
           QI   L  +H    + HRD+ P N+ +N      K+ DFG A+                +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 255 CSR----------YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
             R          +YRAPEL+ GA +Y  A+D+WSVGC+ AELL G+PLFPGE+ +DQL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 305 EIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
            I ++LGTP  +   + K + P YTEF   + K     K        +A+DL+  LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLN 300

Query: 362 PNLRCTALEACIHPFFDELRDPNARLPNGRPF 393
           P  R +A EA  H +F    DP    P+  PF
Sbjct: 301 PLERISAKEALKHEYFKS--DPLPCDPSQLPF 330

Length = 335

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  158 bits (402), Expect = 7e-46
 Identities = 90/292 (30%), Positives = 137/292 (46%), Gaps = 55/292 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSLKH 151
           +G+GSFG V   +  +TG+  A+K     K+++ K   +   E   +  ++HP +V L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F     + E  L LVLE+ P  E    ++K       R      + Y  +I  AL Y+H
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGELFSHLSKE-----GRFSEERARFYAAEIVLALEYLH 110

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 268
             +G+ +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 S-LGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y  A+D WS+G +L E+L G+P F  E    ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-CI--HPFF 377
           +FP            + + PEA DL+S LLQ  P  R  +  A  I  HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  159 bits (404), Expect = 8e-46
 Identities = 101/298 (33%), Positives = 162/298 (54%), Gaps = 24/298 (8%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 146
           SY+    +G+GS+  V++      G+ VA+K +             RE   ++ L H N+
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V L H    T +     L  V E++   +   A++  +    +    V+L+ +Q+ R LA
Sbjct: 66  VLL-HDIIHTKET----LTFVFEYMHTDL---AQYMIQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
           YIHG   + HRD+KPQNLL++ +  ++KL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPD 173

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 322
           ++ GAT+Y++A+DIW  GC+  E+L GQP FPG S V +QL +I  VLG PT +    ++
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233

Query: 323 --PNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             PNY    F   K      ++ +   PP+A DL S++L   P  R +A +A +HP+F
Sbjct: 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  160 bits (405), Expect = 9e-46
 Identities = 103/300 (34%), Positives = 165/300 (55%), Gaps = 25/300 (8%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           +Y+    +G+G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V+L       TDK    L LV E++ + +    ++       M +  VK++ YQI R LA
Sbjct: 67  VTLHDIVH--TDKS---LTLVFEYLDKDL---KQYMDDCGNIMSMHNVKIFLYQILRGLA 118

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
           Y H    V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++ G++EY+T ID+W VGC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 324 N--YTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
           N  +  + FP+ K  P   I H  R+  E ++L+++ LQY    R +A EA  H +F  L
Sbjct: 235 NDEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  158 bits (400), Expect = 3e-45
 Identities = 101/298 (33%), Positives = 161/298 (54%), Gaps = 27/298 (9%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           +Y+    +G+G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRAL 205
           V+L H    T    E  L LV E++   +    K Y       M +  VK++ +Q+ R L
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDL----KQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 262
           +Y H    + HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P
Sbjct: 117 SYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPP 172

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--C 320
           +++ G+TEY+T ID+W VGC+L E+  G+P+FPG +  ++L  I ++LGTPT E      
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232

Query: 321 MNPNYTEFKFPQIKAHPWHKIFH-KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            N  +  + FPQ +A P   I H  R+  + +DL+S LL Y    R +A  A  H +F
Sbjct: 233 SNEEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  157 bits (400), Expect = 2e-44
 Identities = 104/319 (32%), Positives = 162/319 (50%), Gaps = 44/319 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKK-------VLQDKR-YKNRELQTMRLLDHP 144
           Y   + +G G+ GIV  A    TG+ VAIKK       V   KR Y  REL  M+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 145 NVVSLKHCFFSTTDKD-----ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
           N++ L + F  T  K      ++YL  V+E +   + +V        +RM  +      Y
Sbjct: 76  NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYL-----LY 125

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           Q+   + ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           RAPE+I G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  +II+ LGTP+ E + 
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 320 CMNP---NYTEFKFPQIKAHPWHKIF------------HKRMPPEAVDLVSRLLQYSPNL 364
            + P   NY E + P+   + + ++F            +K    +A DL+S++L   P  
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 365 RCTALEACIHPFFDELRDP 383
           R +  +A  HP+ +   DP
Sbjct: 302 RISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  152 bits (385), Expect = 8e-43
 Identities = 92/308 (29%), Positives = 151/308 (49%), Gaps = 49/308 (15%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 151
            +G+G++G V++A+  +TGE VA+KKV  D   +       RE++ +R L+H N+V+LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 152 CFFSTTD-----KDELYLNLVLEFVPETVYRVAK----HYSRASQRMPLIYVKLYTYQIC 202
                 D     KD+    LV E++   +  + +    H+S         ++K +  Q+ 
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-------HIKSFMKQLL 126

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYR 260
             L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + + + +YR
Sbjct: 127 EGLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
            PEL+ G   Y  AID+WS GC+L EL   +P+F     + QL  I ++ G+P       
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PA 240

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRM------------PPEAVDLVSRLLQYSPNLRCTA 368
           + P+  +  +       ++ +  K+             P  A+DL+  +L   P+ RCTA
Sbjct: 241 VWPDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293

Query: 369 LEACIHPF 376
            EA   P+
Sbjct: 294 EEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  147 bits (373), Expect = 5e-41
 Identities = 92/298 (30%), Positives = 142/298 (47%), Gaps = 26/298 (8%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH- 151
           +GQG+FG VF+A+  +T + VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 152 CFFSTT----DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           C    T     K   YL  V EF     + +A   S  + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 262
           IH    + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 321
           EL+ G  +Y   ID+W  GC++AE+    P+  G +   QL  I ++ G+ T E      
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252

Query: 322 N-PNYTEFKFPQ-IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
               + + + PQ  K     ++      P A+DL+ +LL   P  R  A  A  H FF
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  142 bits (360), Expect = 1e-39
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 60/294 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y   + +G+GSFG V+  +    G+   +K++       +++     E++ ++ L+HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +     F     +++  L +V+E+     + +  K   +  +  P   +  +  Q+C AL
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICS 256
            Y+H    + HRDIKPQN+ +      VKL DFG +KVL         V G P       
Sbjct: 117 KYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP------- 167

Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            YY +PEL      Y    DIWS+GCVL EL   +  F GE+ + +L    K+L    + 
Sbjct: 168 -YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KG 218

Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
           +   +   Y                       E  +LVS LLQ  P  R +  +
Sbjct: 219 QYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQ 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  139 bits (351), Expect = 5e-38
 Identities = 100/304 (32%), Positives = 160/304 (52%), Gaps = 30/304 (9%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 146
           SY     +G+GS+  V++ K    G+ VA+K + LQ++        RE   ++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V L H    T +     L LV E+V   +    ++  +    +    VKL+ +Q+ R L+
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDL---CQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
           YIH    + HRD+KPQNLL++  T ++KL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPD 173

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 322
           ++ G+TEY+T +D+W VGC+  E++ G   FPG   + DQL  I  VLGTP  +    ++
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233

Query: 323 --PNYTEFKFPQIKA----HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             P++   +F           W+K+ +      A DL S+LLQ  P  R +A  A  H +
Sbjct: 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEY 290

Query: 377 FDEL 380
           F +L
Sbjct: 291 FSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  138 bits (350), Expect = 6e-38
 Identities = 85/321 (26%), Positives = 141/321 (43%), Gaps = 79/321 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 144
           +   +++G+GSF  V  AK  ET +  AIK     +++++K+  Y   E + + RL  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            ++ L + F    D++ LY   VLE+ P   + +  + Y    ++      + Y  +I  
Sbjct: 63  GIIKLYYTF---QDEENLY--FVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEILL 113

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRY- 258
           AL Y+H   G+ HRD+KP+N+L++   H +K+ DFG+AKVL                   
Sbjct: 114 ALEYLH-SKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 259 ----------------YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ 302
                           Y +PEL+        + D+W++GC++ ++L G+P F G +  + 
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EY 228

Query: 303 LV--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
           L   +I+K                  E+ FP               PP+A DL+ +LL  
Sbjct: 229 LTFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVL 259

Query: 361 SPNLRCTALEACI----HPFF 377
            P  R    E       HPFF
Sbjct: 260 DPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  137 bits (348), Expect = 6e-38
 Identities = 91/290 (31%), Positives = 137/290 (47%), Gaps = 48/290 (16%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL---QDKRYK------NRELQTMRLLDHPNVV 147
            ++G GSFG V++   L+ G+  A+K+V      +  +       +E+  +  L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALA 206
                 +  T+++E  L + LE VP     +AK   +  S   P+I  +LYT QI   L 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGG--SLAKLLKKYGSFPEPVI--RLYTRQILLGLE 116

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           Y+H      HRDIK  N+LV+     VKL DFG AK +V+     S+  S Y+ APE+I 
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               Y  A DIWS+GC + E+  G+P +   S ++ +  + K+  +     I        
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                     P H      +  EA D + + LQ  P+LR TA E   HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  135 bits (342), Expect = 9e-37
 Identities = 91/290 (31%), Positives = 141/290 (48%), Gaps = 20/290 (6%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LL------DHPNVVSL 149
           +G G++G V++A+   +G  VA+K V          L T+R   LL      DHPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 150 KH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA-SQRMPLIYVKLYTYQICRALAY 207
              C  S TD+ E  + LV E V + +     +  +     +P   +K    Q  R L +
Sbjct: 68  MDVCATSRTDR-ETKVTLVFEHVDQDL---RTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +H    + HRD+KP+N+LV     QVKL DFG A++          + + +YRAPE++  
Sbjct: 124 LHANC-IVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
           +T Y T +D+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    +     
Sbjct: 182 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTLPR 239

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             F      P        +      L+  +L ++P+ R +A  A  HPFF
Sbjct: 240 GAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  137 bits (345), Expect = 1e-36
 Identities = 97/312 (31%), Positives = 158/312 (50%), Gaps = 31/312 (9%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V  H     +RM  +      YQ+   +
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 136

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 324 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEA 371
            NY E + PQ     + ++F   + P           +A DL+S++L   P+ R +  EA
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 372 CIHPFFDELRDP 383
             HP+     DP
Sbjct: 313 LRHPYITVWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 1e-36
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 20/203 (9%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKH 151
           ++G+G+FG+V++   LETG+ VAIK++ L+  + +      +E+  ++ L HPN+V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
                  +    L ++LE+    ++ ++ K +    + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 269
             GV HRDIK  N+L       VKL DFG A  L     +  S + + Y+ APE+I   +
Sbjct: 118 Q-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 270 EYTTAIDIWSVGCVLAELLLGQP 292
             +TA DIWS+GC + ELL G P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  134 bits (339), Expect = 2e-36
 Identities = 89/295 (30%), Positives = 134/295 (45%), Gaps = 60/295 (20%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYK-NRELQTMRLLDHPNVVSLKHC 152
           V+GQGS G+V++ +   TG+  A+KK+     ++ R +  REL+T+R  + P VV     
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 153 FFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           F+      E  +++VLE++       + +           +P   +     QI + L Y+
Sbjct: 68  FYK-----EGEISIVLEYMDGGSLADLLKKVGK-------IPEPVLAYIARQILKGLDYL 115

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 263
           H    + HRDIKP NLL+N    +VK+ DFG +KVL     N    C+ +     Y +PE
Sbjct: 116 HTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPE 170

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCM 321
            I G + Y+ A DIWS+G  L E  LG+ P L PG+    +L++ I            C 
Sbjct: 171 RIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CD 217

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            P                    +   PE  D +S  LQ  P  R +A E   HPF
Sbjct: 218 GPPP----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  133 bits (336), Expect = 3e-36
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 50/292 (17%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKHC 152
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++ + LL HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
           +     ++++Y+   +E+    T+  + +H     + +    +++YT Q+   LAY+H  
Sbjct: 65  YGVEVHREKVYI--FMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIF 266
            G+ HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+I 
Sbjct: 119 -GIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 267 GAT--EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           G     +  A DIWS+GCV+ E+  G+  +   S +D   +I+  +G          +  
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA--------GHK- 224

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                 P I           ++ PE  D + R L+  P  R TA E   HPF
Sbjct: 225 ------PPIPD-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  131 bits (331), Expect = 2e-35
 Identities = 93/301 (30%), Positives = 142/301 (47%), Gaps = 63/301 (20%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNR------ELQTMRLLDHPNVVSLKH 151
           + +G++G VF AK   TG+  AIK +   D   KN+      E   +     P VV L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            ++S   K  LYL  V+E++P   +  + ++     + +     ++Y  +I  AL Y+H 
Sbjct: 59  -YYSFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHS 111

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISY--------ICSRYYRA 261
             G+ HRD+KP N+L++ + H +KL DFG +KV LV+ + N++         + +  Y A
Sbjct: 112 -NGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE+I G   ++  +D WS+GC+L E L+G P F GE                T EEI   
Sbjct: 170 PEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI--- 209

Query: 322 NPNYTEFKFPQIKAH--PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACIHPF 376
                   F  I      W +     +  EA+DL+S+LL   P  R  A    E   HPF
Sbjct: 210 --------FQNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259

Query: 377 F 377
           F
Sbjct: 260 F 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  129 bits (326), Expect = 2e-34
 Identities = 97/293 (33%), Positives = 151/293 (51%), Gaps = 25/293 (8%)

Query: 99  VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 148
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 149 L-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR-MPLIYVKLYTYQICRALA 206
           L   C  S TD+ E  L LV E V + +     +  +  +  +P   +K   +Q+ R L 
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           ++H    V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 125 FLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
            ++ Y T +D+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P   
Sbjct: 183 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDV 237

Query: 327 EFKFPQIKAHPWHKI--FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                   +     I  F   +     DL+ + L ++P  R +A  A  HP+F
Sbjct: 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  130 bits (328), Expect = 3e-34
 Identities = 98/312 (31%), Positives = 158/312 (50%), Gaps = 31/312 (9%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 132

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 324 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEA 371
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  EA
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308

Query: 372 CIHPFFDELRDP 383
             HP+ +   DP
Sbjct: 309 LQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  128 bits (323), Expect = 2e-33
 Identities = 95/312 (30%), Positives = 157/312 (50%), Gaps = 31/312 (9%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 139

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256

Query: 324 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315

Query: 372 CIHPFFDELRDP 383
             HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  124 bits (315), Expect = 7e-33
 Identities = 81/296 (27%), Positives = 139/296 (46%), Gaps = 60/296 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 149
           + +G GSFG V   +   +G+  A+K     K+++ K+ +    E + ++ + HP +V+L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
              F     +D+  L LV+E+VP  E        + R S R P    + Y  Q+  AL Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGELF-----SHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
           +H  + + +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I 
Sbjct: 117 LH-SLDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               Y  A+D W++G ++ E+L G P F  ++   Q+ E I          ++       
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKI----------LEG------ 213

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFF 377
           + +FP                P+A DL+  LLQ     R   L+  +     HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  122 bits (308), Expect = 1e-31
 Identities = 102/320 (31%), Positives = 157/320 (49%), Gaps = 52/320 (16%)

Query: 99  VGQGSFGIVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 154
           VG+G++G V++AK  +  +    A+K++          RE+  +R L HPNV+SL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQ------RMPLIYVKLYTYQICRALAYI 208
           S  D+    + L+ ++    ++ + K + RAS+      ++P   VK   YQI   + Y+
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIK-FHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 209 HGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRY 258
           H    V HRD+KP N+LV    P   +VK+ D G A++       L   +P    + + +
Sbjct: 125 HAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF---------PGESGVDQLVEIIKV 309
           YRAPEL+ GA  YT AIDIW++GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 310 LGTPTR---EEIKCMNPNYTEFK---------FPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           +G P     E+IK M  + T  K            IK    HK+   +   +A  L+ +L
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKL 297

Query: 358 LQYSPNLRCTALEACIHPFF 377
           L   P  R T+ +A   P+F
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  120 bits (304), Expect = 2e-31
 Identities = 72/291 (24%), Positives = 124/291 (42%), Gaps = 47/291 (16%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL--QDKRYKN---RELQTMRLLDHPNVVSLKH 151
             +G G+ G+V +     TG+ +A+K +    ++  +    REL  +   + P +V    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F++  D     +++ +E++      + K       R+P   +      + + L Y+H  
Sbjct: 67  AFYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
             + HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYT 326
           +   DIWS+G  L EL  G+  +P E+       + L  I+               P   
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
               P++ +  +         P+  D V+  L   P  R +  E   HPF 
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  120 bits (302), Expect = 5e-31
 Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 44/286 (15%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 154
            +G+G+ G V++A    TG+ VAIKK+ L+ +  +    E+  M+   HPN+V     + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 155 STTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                DEL++  V+E++        + +++ R ++   + YV     ++ + L Y+H   
Sbjct: 86  ---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQ-IAYVCR---EVLQGLEYLHSQ- 135

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 271
            V HRDIK  N+L++     VKL DFG A  L K +    S + + Y+ APE+I    +Y
Sbjct: 136 NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
              +DIWS+G +  E+  G+P +  E  +  L  I    G P    +K  NP        
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK--NPE------- 240

Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                        +  PE  D +++ L   P  R +A E   HPF 
Sbjct: 241 -------------KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 2e-30
 Identities = 101/380 (26%), Positives = 153/380 (40%), Gaps = 88/380 (23%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-------LDHPNVVSLK 150
           V+G+G+FG V+  +  +TG+  A+K + +    K  ++  +R         D P +V L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
           +  F    +DE +L LV+E++P           R     P    + Y  ++  AL  +H 
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLM--NLLIR-KDVFPEETARFYIAELVLALDSVHK 119

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----------------------VLVKG 247
            +G  HRDIKP N+L++   H +KL DFG  K                       VLV+ 
Sbjct: 120 -LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 248 EPNISYICSRY-------YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
             +               Y APE++ G T Y    D WS+G +L E+L G P F  ++  
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT-- 234

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 359
             L E        T  +I     N+ E  +FP              + PEA+DL+ RLL 
Sbjct: 235 --LQE--------TYNKII----NWKESLRFPP----------DPPVSPEAIDLICRLLC 270

Query: 360 YSPNLRCTALEACIHPFF--DELRDPNARLPNGRPFPPLF-------NF-KPQELKGASK 409
              +   +  E   HPFF   +  +     P   PF P         NF   ++ K  S 
Sbjct: 271 DPEDRLGSFEEIKSHPFFKGIDWENLRETKP---PFVPELSSPLDTSNFDDFEDDKDLSD 327

Query: 410 ELLSKLIPEHARKQCPFLGF 429
            L       +  KQ  F+GF
Sbjct: 328 YLSQNSKKLNKGKQLAFVGF 347

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  119 bits (299), Expect = 2e-30
 Identities = 101/318 (31%), Positives = 157/318 (49%), Gaps = 48/318 (15%)

Query: 99  VGQGSFGIVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 154
           VG+G++G V++AK  +  +    A+K++          RE+  +R L HPNV++L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQ------RMPLIYVKLYTYQICRALAYI 208
           S +D+    + L+ ++    ++ + K + RAS+      ++P   VK   YQI   + Y+
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIK-FHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 209 HGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRY 258
           H    V HRD+KP N+LV    P   +VK+ D G A++       L   +P    + + +
Sbjct: 125 HAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF---------PGESGVDQLVEIIKV 309
           YRAPEL+ GA  YT AIDIW++GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240

Query: 310 LGTPTR---EEIKCMNPNY----TEFKFPQIKAHPWHKIF--HKRMPPEAVD-LVSRLLQ 359
           +G P     E+I+ M P Y     +F+          K    HK  P   V  L+ +LL 
Sbjct: 241 MGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299

Query: 360 YSPNLRCTALEACIHPFF 377
             P  R T+ +A   P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  116 bits (294), Expect = 4e-30
 Identities = 80/296 (27%), Positives = 127/296 (42%), Gaps = 56/296 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G G FG V   K      T A+K V          + +   E + +   +HP +V L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 152 CFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             F    KD+ Y+ +++E+       T+ R    +   + R        Y   +  A  Y
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +H   G+ +RD+KP+NLL++     VKL DFG AK L  G+   ++  +  Y APE+I  
Sbjct: 109 LHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              Y  ++D WS+G +L ELL G+P F GE   D +             +I   N     
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL-- 213

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFFD 378
            +FP              +   A DL+ +LL+ +P  R   L+  I     H +F+
Sbjct: 214 -EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  116 bits (292), Expect = 6e-30
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 44/236 (18%)

Query: 96  ERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            + +G+G+FG V++             VA+K + +D   +      RE + MR LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY--SRASQRMPLIYVKLYTYQICRA 204
           V L       T+++ L   +V+E++P         Y      + + L  +  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 260
           + Y+       HRD+  +N LV      VK+ DFG ++ L   +         YY+    
Sbjct: 116 MEYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164

Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
                  APE +    ++T+  D+WS G +L E+  LG+  +PG S   +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (289), Expect = 2e-29
 Identities = 66/235 (28%), Positives = 113/235 (48%), Gaps = 43/235 (18%)

Query: 96  ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            + +G+G+FG V++ K      +    VA+K + +D   +      RE + MR LDHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
           V L       T+++ LY  +V+E++          Y R ++ ++ L  +  +  QI R +
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+       HRD+  +N LV      VK+ DFG ++ L   +         YYR     
Sbjct: 116 EYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGGK 164

Query: 261 ------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
                 APE +    ++T+  D+WS G +L E+  LG+  +PG S  ++++E +K
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 3e-29
 Identities = 85/294 (28%), Positives = 131/294 (44%), Gaps = 58/294 (19%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLL---DHPNVVSLK 150
           + +G+FG V+ AK   TG+  AIK      ++   +  N + +   ++   + P V  L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL- 62

Query: 151 HCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
             ++S   KD  YL LV+E++      ++ +           +P  + K Y  ++   + 
Sbjct: 63  --YYSFQSKD--YLYLVMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVE 111

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
            +H   G+ HRDIKP+NLL++   H +KL DFG ++    G  N  ++ +  Y APE I 
Sbjct: 112 DLHQR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETIL 166

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +     D WS+GCV+ E L G P F  E+  D + + I          I     N+ 
Sbjct: 167 GVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWP 213

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFF 377
           E                    PEAVDL++RLL   P  R  A    E   HPFF
Sbjct: 214 EEVKEFCS-------------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  111 bits (279), Expect = 5e-28
 Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 145
           +  E+ +G+G F +V++A CL  G  VA+KKV    + D + +     E+  ++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           V+     F      +   LN+VLE      + R+ KH+ +  + +P   +  Y  Q+C A
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPE 263
           L ++H    + HRDIKP N+ +   T  VKL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHSK-RIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
            I     Y    DIWS+GC+L E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  111 bits (279), Expect = 6e-28
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 22/225 (9%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
            +G+GSFG V + +    G+ +  K++       ++K+    E+  +R L HPN+V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
                 D+    L +V+E+     + ++ +   +  + +   ++     Q+  AL   H 
Sbjct: 67  RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 211 GIG----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 263
                  V HRD+KP N+ ++   + VKL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
            +   + Y    DIWS+GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  110 bits (278), Expect = 8e-28
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 43/228 (18%)

Query: 97  RVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           + +G+G+FG V++      GE     VA+K + +    +       E   M+ L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS-QRMPLIYVKLYTYQICRALA 206
            L       T  + LY  +V E++P         + R   +++ L  +     QI + + 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+       HRD+  +N LV      VK+ DFG ++ + + +         YYR      
Sbjct: 117 YLE-SKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165

Query: 261 ------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                 APE +    ++T+  D+WS G +L E+  LG+  +PG S  +
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  109 bits (275), Expect = 2e-27
 Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 46/290 (15%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 149
           RV+G+G+FG V   +  +T +  A+K     K ++    +N   E + ++ L+HP +V+L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            + F     +DE  + LV++ +     R   H S+   +     VK +  +I  AL Y+H
Sbjct: 66  WYSF-----QDEENMYLVVDLLLGGDLRY--HLSQK-VKFSEEQVKFWICEIVLALEYLH 117

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
              G+ HRDIKP N+L++   H V + DF  A  +       S   +  Y APE++    
Sbjct: 118 SK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
            Y+ A+D WS+G    E L G+  + G S                R++I+          
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAKQETADV-L 220

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTALEACIHPFF 377
           +P                 EA+D +++LL+  P  R      +   HP+F
Sbjct: 221 YP--ATW----------STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (270), Expect = 7e-27
 Identities = 75/288 (26%), Positives = 119/288 (41%), Gaps = 49/288 (17%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 155
            +G+GS+G V++A   ETG+ VAIK V  ++  +   +E+  ++  D P +V     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 156 TTDKDELYLNLVLEF-----VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            TD     L +V+E+     V + +    K  +          +    YQ  + L Y+H 
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEE-------IAAILYQTLKGLEYLHS 117

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 269
                HRDIK  N+L+N    Q KL DFG +  L        + I + ++ APE+I    
Sbjct: 118 -NKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
            Y    DIWS+G    E+  G+P +     +  +  I                P  T   
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPPPT-LS 220

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            P            ++  PE  D V + L   P  R +A++   HPF 
Sbjct: 221 DP------------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  107 bits (270), Expect = 9e-27
 Identities = 78/296 (26%), Positives = 121/296 (40%), Gaps = 52/296 (17%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHC 152
           V+G G+  +V+ A CL   E VAIK++  +K   +     +E+Q M   +HPNVV   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKH-YSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F     DEL+  LV+ ++   ++  + K  Y R      +I   L   ++ + L Y+H 
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELI 265
             G  HRDIK  N+L+      VK+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 321
                Y    DIWS G    EL  G        P +     L+  ++    P+ E     
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQN-DPPSLETGADY 233

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                 F+                       ++S  LQ  P+ R TA E   H FF
Sbjct: 234 KKYSKSFR----------------------KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 87/308 (28%), Positives = 139/308 (45%), Gaps = 67/308 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-------QDKRYKN------RELQTMR 139
           ++   ++G GSFG V+      +GE +A+K+V           R ++      RE+  ++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYT 198
            L H N+V            D  +LN+ LE+VP  +V  +  +Y    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI------- 251
            QI + L Y+H   G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N        
Sbjct: 113 RQILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167

Query: 252 ---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
              S   S ++ APE++   T YT   DIWS+GC++ E+L G+  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223

Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
           +                 E   P+I ++         +  EA+D + +  +   N R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258

Query: 369 LEACIHPF 376
            E   HPF
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  106 bits (268), Expect = 2e-26
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 44/227 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 148
           + +G+G+FG V++ K          VA+K + +D   + R     E + M+ L HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKL--YTYQIC 202
           L       T+++ LY  LVLE++         R ++    + ++  L    L  +  QI 
Sbjct: 61  LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
           + + Y+       HRD+  +N LV      VK+ DFG ++ +   +         YYR  
Sbjct: 116 KGMEYLA-SKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRKK 164

Query: 261 ----------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
                     APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 165 TGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 5e-26
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSL 149
           ++G+G++G V++ K + TG  VA+K +        + D + +   L  +R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +          L +++E+      R        +++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 268
             +GV HRDIK  N+LV  +T  VKLCDFG A +L +      +++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL 303
             Y T  DIWS+G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  103 bits (259), Expect = 3e-25
 Identities = 75/297 (25%), Positives = 135/297 (45%), Gaps = 51/297 (17%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 146
           + +G G+F   +QA+ ++TG  +A+K+V         Q++  +   +E++ M  L+HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +       +T +    + NL +E++   +V  +   Y    +    + +  YT Q+ R L
Sbjct: 66  I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYR 260
           +Y+H    + HRD+K  NLL++    ++++ DFG+A  L       GE     + +  + 
Sbjct: 117 SYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++ G  +Y  + D+WSVGCV+ E+   +P +  E   + L  I K         I  
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                     P I  H         + P   D+  R L+  P  R  + E   HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  102 bits (257), Expect = 5e-25
 Identities = 87/304 (28%), Positives = 145/304 (47%), Gaps = 55/304 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYK------NRELQTM 138
           ++   ++G+G++G V+ A  + TGE +A+K+V          D R K        E++T+
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLY 197
           + LDH N+V          +  E YL++ LE+VP  ++    + Y R  +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV---LVKGEPNISYI 254
           T Q+   LAY+H   G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S  
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 255 CSRYYRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
            S ++ APE+I   ++ Y+  +DIWS+GCV+ E+  G+  +  E                
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---------------- 215

Query: 314 TREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
             E I  M      FK   +  A P        + P A+D ++     +P+ R TA E  
Sbjct: 216 --EAIAAM------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267

Query: 373 IHPF 376
            HPF
Sbjct: 268 QHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  101 bits (253), Expect = 3e-24
 Identities = 88/298 (29%), Positives = 139/298 (46%), Gaps = 49/298 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
           +G+GS GIV  A    TG  VA+KK+  D R + R      E+  MR   HPN+V +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
           + S    DEL++  V+EF+    +  +  H      RM    +      + +AL+++H  
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATE 270
            GV HRDIK  ++L+     +VKL DFG    + K  P   S + + Y+ APE+I     
Sbjct: 135 -GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           Y T +DIWS+G ++ E++ G+P +  E  +  +            + I+   P       
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP------- 232

Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
           P++K    HK+      P     + R+L   P  R TA E   HPF  +   P++ +P
Sbjct: 233 PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 4e-24
 Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 53/295 (17%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVV 147
           +++GQG+FG V+    ++TG  +A+K+V         K        E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
               C      +D+  L++ +E++P  +V    K Y   ++ +     + YT QI   + 
Sbjct: 68  QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAP 262
           Y+H  + + HRDIK  N+L +     VKL DFG++K L      G    S   + Y+ +P
Sbjct: 119 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E+I G   Y    D+WSVGC + E+L  +P +   +  + +  I K+   PT        
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                   PQ+ +H         + P+A + + R    +   R +A E   H F 
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 89/313 (28%), Positives = 136/313 (43%), Gaps = 54/313 (17%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLL---DHPNVVSLKH 151
           VGQG +G VF AK  +TGE VA+K     +L         L    +L       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA-SQRMPLIYVKLYTYQICRALAYIHG 210
            F    D + LYL   +E+VP   +R   +     S+     + + Y  ++  A+  +H 
Sbjct: 69  AF---QDDEYLYL--AMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
            +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE++ G   
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           Y   +D WS+GC+L E L G P F G +  +    +     T  R       P Y + +F
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF 227

Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-----DELRDPNA 385
                          +  EA DL+++L+        +  +   HPFF     +ELR+   
Sbjct: 228 --------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKP 273

Query: 386 RLPNGRPFPPLFN 398
                 PF P   
Sbjct: 274 ------PFVPELE 280

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 52/291 (17%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDK---RYKNRELQTMRLLDHPNVVSLKHCFF 154
           +G G++G V++A+ + TGE VAIK + L+         +E+  ++   HPN+V+    + 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI-YVKLYTYQICRALAYIHGGIG 213
               +D+L+  +V+E+      +     +R       I YV   T +    LAY+H   G
Sbjct: 71  R---RDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK---GLAYLH-ETG 121

Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIFGATE- 270
             HRDIK  N+L+      VKL DFG +  L     +   S+I + Y+ APE+   A E 
Sbjct: 122 KIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEVA--AVER 177

Query: 271 ---YTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
              Y    DIW++G    EL   Q P+F         +  ++ L   ++           
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS---------- 219

Query: 327 EFKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            F  P++K    W  +FH        D + + L   P  R TA +   HPF
Sbjct: 220 NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 86/300 (28%), Positives = 124/300 (41%), Gaps = 62/300 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 146
           Y+  RV+G+G+FG     +  E    V  K+V L     K R     E+  + LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           ++  + F      D+  L + +E+    T+Y       +  Q      V  Y +QI  A+
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICS 256
           +YIH   G+ HRDIK  N+ +      +KL DFG +K+L         V G P       
Sbjct: 115 SYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165

Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            YY +PEL  G  +Y    DIW++GCVL ELL  +  F         + ++         
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDA----TNPLNLV--------- 210

Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            +K +  NYT                      E + LV  LLQ  P  R TA E    P 
Sbjct: 211 -VKIVQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 98.0 bits (244), Expect = 7e-23
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 23/208 (11%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           K C+       E    LV+E+   +   + + + +  Q + +  +    +   + LAY+H
Sbjct: 81  KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAYLH 132

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
                 HRDIK  N+L+      VKL DFGSA ++    P  S++ + Y+ APE+I    
Sbjct: 133 -SHERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILAMD 187

Query: 270 E--YTTAIDIWSVGCVLAELLLGQ-PLF 294
           E  Y   +D+WS+G    EL   + PLF
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 144
           ++  E+ +G+G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           NV+     F    +     LN+VLE      + R+ KH+ +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 262
           AL ++H    V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 118 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
           E I     Y    DIWS+GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 75/297 (25%), Positives = 119/297 (40%), Gaps = 59/297 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 147
           +     +G+GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
                F   +      L +++E+    +   + K       ++   Y+     ++   L 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLE 112

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YY 259
           Y+H   G  HRDIK  N+L++     VKL DFG     V G+   S +  R       ++
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFW 164

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
            APE+I   + Y    DIWS+G    EL  G+P  P  S +  +    +VL        K
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPK 212

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             NP       P ++ + + K F         D VS  L   P  R +A E   H F
Sbjct: 213 N-NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 96.4 bits (240), Expect = 3e-22
 Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 61/291 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTM-------RLLDHPNVV 147
           +V+G+GSFG V  AK    G+  A+ KVLQ K    K  +   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L H  F T DK    L  VL++V   E  +    H  R  +  P    + Y  +I  AL
Sbjct: 60  GL-HYSFQTADK----LYFVLDYVNGGELFF----HLQR-ERSFPEPRARFYAAEIASAL 109

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
            Y+H  + + +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +     Y   +D W +G VL E+L G P F       ++ +   +L  P R     + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218

Query: 325 YT---------------------EFKFPQIKAHP------WHKIFHKRMPP 348
            +                     +  F +IK H       W  + +K++ P
Sbjct: 219 ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.4 bits (235), Expect = 4e-22
 Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 22/219 (10%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNVVSLKHCF 153
           G+GS+G V++ K L   +  A+K+V L     K RE  +  +R+L   +HPN++S K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 154 FSTTDKDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHG 210
               D ++L +  V+E+ P   + +      R  +R  +   +++    Q+ R L  +H 
Sbjct: 69  L---DGNKLCI--VMEYAPFGDLSKAIS--KRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 211 GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
              + HRD+K  N LLV      VK+ D G +KVL K     + I + +Y APE ++   
Sbjct: 122 -QKILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGR 176

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
            Y+   DIWS+GC+L E+    P F   S  D   ++ +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 25/212 (11%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNVVSLKH 151
           V+G+G++G V++A+  +TG+ VAIK  + D           E   +R   +HPN+ +   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 152 CFF---STTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            F       + D+L+  LV+E     +V  + K   +  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 266
           +H    V HRDIK QN+L+     +VKL DFG SA++        ++I + Y+ APE+I 
Sbjct: 129 LHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185

Query: 267 GATE------YTTAIDIWSVGCVLAELLLGQP 292
            A +      Y    D+WS+G    EL  G+P
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 93.8 bits (233), Expect = 7e-22
 Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 16/213 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 146
           Y   RVVG+G+FGIV   +     + V IK++  ++  K+       E Q ++LL HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +     F    DK    L +V+E+ P  T+    +   R +  +    +  +  QI  AL
Sbjct: 62  IEYYENFLE--DKA---LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H  + + HRD+K QN+L++ H   VK+ DFG +K+L       + + +  Y +PEL 
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
            G   Y    DIW++GCVL EL   +  F   +
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 88/316 (27%), Positives = 136/316 (43%), Gaps = 53/316 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 150
           +G+G FG V   +   TG+  A KK L  KR K R+ + M L +           +VSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
           + F +   KD+L L + L    +  Y +             I+   Y  QI   L ++H 
Sbjct: 60  YAFET---KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF---YAAQIICGLEHLHQ 113

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + +RD+KP+N+L++ H + V++ D G A  L  G+       +  Y APE++ G   
Sbjct: 114 -RRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE-V 170

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           Y  ++D +++GC L E++ G+  F       Q  E ++      +EE+K         ++
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-MAVEY 217

Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPNA 385
           P             +  PEA DL   LLQ  P  R      +A E   HP F +L     
Sbjct: 218 PD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR-- 263

Query: 386 RLPNGRPFPPLFNFKP 401
           RL  G   PP   F P
Sbjct: 264 RLEAGMLEPP---FIP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 93.6 bits (232), Expect = 1e-21
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 144
           ++  E+ +G+G F  V++A CL   + VA+KKV    + D + +    +E+  ++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           NV+     F    +     LN+VLE      + ++ K++ +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 262
           A+ ++H    V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
           E I     Y    DIWS+GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 83/300 (27%), Positives = 135/300 (45%), Gaps = 58/300 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
           +V+G+GSFG V  A+   T E  A+K + +D   ++ +++ TM   R+L     HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L H  F T  KD L+   V+E+V   + ++ + +     S R      + Y  +I   L 
Sbjct: 61  L-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQ 110

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           ++H   G+ +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++
Sbjct: 111 FLHER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                Y  A+D W++G +L E+L GQ  F G+   D+L                      
Sbjct: 169 SY-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL---------------------- 204

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACI--HPFFDEL 380
               F  I        + + +  EA  ++   L  +P  R   L   E  I  HPFF E+
Sbjct: 205 ----FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 76/289 (26%), Positives = 126/289 (43%), Gaps = 41/289 (14%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           G+G++G+V + + + TG  +A+K++       + KR       +MR +D P  V+     
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
           F   D     + + +E +  ++ +  K        +P   +      I +AL Y+H  + 
Sbjct: 70  FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--- 270
           V HRD+KP N+L+N    QVKLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           Y    D+WS+G  + EL  G+  FP +S             TP  +++K           
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTPF-QQLK----------- 218

Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
            Q+   P  ++  ++  PE  D V++ L+ +   R    E   HPFF+ 
Sbjct: 219 -QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 87/296 (29%), Positives = 133/296 (44%), Gaps = 55/296 (18%)

Query: 96  ERVV-GQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK---NRELQTMRLLDHPNVVSLK 150
           ERVV G+G++GIV+ A+ L T   +AIK++  +D RY    + E+     L H N+V   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69

Query: 151 HCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIY----VKLYTYQIC 202
              +  +D +  +  + +E VP      + R        S+  PL      +  YT QI 
Sbjct: 70  ---YLGSDSENGFFKIFMEQVPGGSLSALLR--------SKWGPLKDNEQTIIFYTKQIL 118

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRA 261
             L Y+H    + HRDIK  N+LVN ++  VK+ DFG++K L    P   ++  +  Y A
Sbjct: 119 EGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177

Query: 262 PELI-FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           PE+I  G   Y    DIWS+GC + E+  G+P F                       I+ 
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IEL 214

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             P    FK    K HP      + +  EA + + R  +  P+ R +A +    PF
Sbjct: 215 GEPQAAMFKVGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 36/215 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G+FG V   +   +    A+K +       L+ +++ + E + ++ + HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F++  D+  LY+  ++E+VP  E        Y R S R        Y  +I  AL Y+H
Sbjct: 67  -FWTEHDQRFLYM--LMEYVPGGELF-----SYLRNSGRFSNSTGLFYASEIVCALEYLH 118

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRAPE 263
               + +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE
Sbjct: 119 S-KEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPE 168

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           +I  +  +  A+D W++G ++ E+L+G P F  ++
Sbjct: 169 VI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 31/210 (14%)

Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNV 146
           + +G+G FG V      +     TGE VA+K        Q +    RE++ +R LDH N+
Sbjct: 10  KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRAL 205
           V  K             L L++E++P       + Y  R   ++ L  + L++ QIC+ +
Sbjct: 69  VKYKGV---CEKPGGRSLRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRY 258
            Y+ G     HRD+  +N+LV      VK+ DFG AKVL +        EP  S I   +
Sbjct: 123 DYL-GSQRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FW 178

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELL 288
           Y APE +  +  +++A D+WS G  L EL 
Sbjct: 179 Y-APECLRTSK-FSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 92/316 (29%), Positives = 142/316 (44%), Gaps = 60/316 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 151
           +G+GSFG V Q +  +T    A+K + +       E+         +  ++ P +V LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
             FS    ++LYL  VL F+   E  + + +       R  L   + YT ++  AL  +H
Sbjct: 60  --FSFQSPEKLYL--VLAFINGGELFHHLQRE-----GRFDLSRARFYTAELLCALENLH 110

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 268
               V +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G 
Sbjct: 111 K-FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             YT A+D W++G +L E+L G P F  E+ V+++    K+L  P R             
Sbjct: 169 G-YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR------------- 211

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFDELRDPNA 385
            FP                 +A DL+  LL   P  R     A E   HPFF +L     
Sbjct: 212 -FPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WK 256

Query: 386 RLPNGRPFPPLFNFKP 401
           +L      PP   FKP
Sbjct: 257 KLLMKGIQPP---FKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 31/213 (14%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYK--NRELQTMRLLDHPNVV 147
           V+G+G++G V+       G+ +A+K+V  D        K Y+    E+  ++ L H N+V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
                 +  T  D+  +++ +EFVP  ++  +   +      +P      YT QI   +A
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVA 116

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI-------CSRYY 259
           Y+H    V HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQP 292
            APE+I   + Y    DIWS+GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.3 bits (221), Expect = 6e-20
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           + C+       E    LV+E+   +   + + + +  Q + +  V   T+   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
               + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187

Query: 270 E--YTTAIDIWSVGCVLAELLLGQP 292
           E  Y   +D+WS+G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 89.5 bits (222), Expect = 7e-20
 Identities = 90/318 (28%), Positives = 148/318 (46%), Gaps = 59/318 (18%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
           +V+G+GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L  C F T +    +L  V+E++   + ++ +     ++S R      + Y  +I   L 
Sbjct: 61  L-FCTFQTKE----HLFFVMEYLNGGDLMFHI-----QSSGRFDEARARFYAAEIICGLQ 110

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           ++H   G+ +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++
Sbjct: 111 FLHKK-GIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
            G  +Y  ++D WS G +L E+L+GQ  F GE   D+L + I         +        
Sbjct: 169 KG-QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR------- 212

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-TALEACIHPFFDELRDPN 384
                      P    F + +  EA D +S+L +  P  R     +   HPFF   R  +
Sbjct: 213 -----------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGID 255

Query: 385 ARLPNGRPFPPLFNFKPQ 402
                 R  PP   FKP+
Sbjct: 256 WERLEKREIPP--PFKPK 271

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 89.6 bits (222), Expect = 7e-20
 Identities = 98/356 (27%), Positives = 162/356 (45%), Gaps = 68/356 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
           +V+G+GSFG V  A+    GE  A+K + +D    + +++ TM   R+L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L +C F T +    +L  V+EF+   + ++ +     +   R  L     Y  +I   L 
Sbjct: 61  L-YCTFQTKE----HLFFVMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQ 110

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           ++H   G+ +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++
Sbjct: 111 FLHSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
            G  +YT ++D WS G +L E+L+GQ  F G+   D+L E I+V  TP            
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFDELRDPN 384
               +P+     W       +  E+ D++ +L +  P  R   +     HPFF  +   N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255

Query: 385 ARLPNGRPFPPLFNFK---PQELKGASKELLS-KLIPEHARK-------QCPFLGF 429
                 R   P F  K   P +     +E LS K    ++ K       Q  F GF
Sbjct: 256 WTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGF 311

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.5 bits (222), Expect = 8e-20
 Identities = 84/286 (29%), Positives = 136/286 (47%), Gaps = 49/286 (17%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRL-------LDHPNV 146
           +V+GQGSFG VF  + +   + G+  A+K VL+    K R+    ++       ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQICRA 204
           V L H  F T  K    L L+L+F+     R    ++R S+ +      VK Y  ++  A
Sbjct: 61  VKL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALA 110

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 263
           L ++H  +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE
Sbjct: 111 LDHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPT-------- 314
           ++     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P         
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227

Query: 315 --REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFHKRMPP 348
             R   K  NP       P     IK HP      W+K++ + + P
Sbjct: 228 LLRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 89.3 bits (221), Expect = 8e-20
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 49/294 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 151
           +G GSFG V+ A    T E VA+KK+    +  N       +E++ ++ L HPN +  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
           C+       E    LV+E+   +   + + + +  Q + +  +   T+   + LAY+H  
Sbjct: 89  CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 270
             + HRDIK  N+L+     QVKL DFGSA       P  S++ + Y+ APE+I    E 
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEG 195

Query: 271 -YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
            Y   +D+WS+G    EL   +P     + +  L  I                    +  
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQND 236

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
            P ++++ W   F           V   LQ  P  R  + E   H F    R  
Sbjct: 237 SPTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.4 bits (221), Expect = 9e-20
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 22/205 (10%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           K C+       E    LV+E+   +   + + + +  Q + +  +   T+   + LAY+H
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
               + HRDIK  N+L+     QVKL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SH-NMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 270 E--YTTAIDIWSVGCVLAELLLGQP 292
           E  Y   +D+WS+G    EL   +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 73/210 (34%), Positives = 105/210 (50%), Gaps = 26/210 (12%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 147
           +V+G+GSFG V  AK    G+  A+K VLQ K   NR+ Q          ++ + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L H  F TT+K    L  VL+FV   E  + + +  S    R      + Y  +I  AL
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
            Y+H  I + +RD+KP+N+L++   H V L DFG  K  +      +  C +  Y APE+
Sbjct: 110 GYLHS-INIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
           I     Y   +D W +G VL E+L G P F
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 70/208 (33%), Positives = 102/208 (49%), Gaps = 34/208 (16%)

Query: 99  VGQGSFGIVFQAKCL------ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 148
           +G+G+FG V    C        TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTYQICRALA 206
            K   +S   ++   L LV+E++P    R  + KH  R   R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYY 259
           Y+ G     HRD+  +N+LV      VK+ DFG  KVL          EP  S I   ++
Sbjct: 123 YL-GSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAEL 287
            APE +   ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 88/309 (28%), Positives = 139/309 (44%), Gaps = 67/309 (21%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRLLDH---------- 143
           RV+G G++G VF  + +   + G+  A+K VL+    K   +Q  +  +H          
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLK----KATIVQKAKTAEHTRTERQVLEA 60

Query: 144 ----PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR--MPLIYVKLY 197
               P +V+L H  F T  K    L+L+L++V        + ++   QR       V++Y
Sbjct: 61  VRRCPFLVTL-HYAFQTDTK----LHLILDYV-----NGGELFTHLYQREHFTESEVRVY 110

Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC 255
             +I  AL ++H  +G+ +RDIK +N+L++   H V L DFG +K  +  E     S+  
Sbjct: 111 IAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 256 SRYYRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
           +  Y APE+I G +  +  A+D WS+G +  ELL G   F  +   +   EI       +
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------S 221

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEA 371
           R  +K   P      FP            K M  EA D + +LL+  P  R     A E 
Sbjct: 222 RRILKSKPP------FP------------KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263

Query: 372 CIHPFFDEL 380
             HPFF  +
Sbjct: 264 KNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 87/328 (26%), Positives = 146/328 (44%), Gaps = 70/328 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVV 147
           +++  G++G V+  +  ET +  A+KK+ +          + +  R++ T    ++P VV
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVV 64

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           S+  C F T    + +L +V+E+V       + K+       +P+   ++Y  +   AL 
Sbjct: 65  SM-FCSFET----KRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALE 115

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNI-------------- 251
           Y+H   G+ HRD+KP NLL+    H +KL DFG +K+ L+    N+              
Sbjct: 116 YLHN-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 252 SYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
             +C +  Y APE+I     Y   +D W++G +L E L+G   F G++  +   ++I   
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-- 230

Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---T 367
                ++I    P   E                  +P +A DL+SRLL+ +P  R     
Sbjct: 231 -----DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGG 266

Query: 368 ALEACIHPFFDELRDPNARLPNGRPFPP 395
           A E   H FF  L D N  L     F P
Sbjct: 267 AFEVKQHRFFLGL-DWNGLLRQKAEFIP 293

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 86.3 bits (213), Expect = 5e-19
 Identities = 68/242 (28%), Positives = 119/242 (49%), Gaps = 27/242 (11%)

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLL 141
           I++   +++GQG+FG V+    ++TG  +A K+V  D               E+Q ++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQ 200
            H  +V    C     D+ E  L + +E++P  +V    K Y   ++ +     + YT Q
Sbjct: 62  QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICS 256
           I   ++Y+H  + + HRDIK  N+L +     VKL DFG++K L    + G    S   +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            Y+ +PE+I G   Y    D+WS+GC + E+L  +P +   +  + +  I K+   PT  
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNP 228

Query: 317 EI 318
           ++
Sbjct: 229 QL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 88/291 (30%), Positives = 132/291 (45%), Gaps = 54/291 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSLKH 151
           +G GSFG V  AK   TGE  AIK     ++L+ K+ +   +E   +  L HP +V++  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F    D++ +Y   +LEFV   V      + R + R P    K Y  ++  A  Y+H  
Sbjct: 86  SF---QDENRVYF--LLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS- 136

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
             + +RD+KP+NLL++   H VK+ DFG AK +   +   +   +  Y APE+I  +  +
Sbjct: 137 KDIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKGH 192

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
             A+D W++G +L E + G P F  +              TP R   K +       KFP
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFP 235

Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFF 377
                 W   F  R    A DLV  LLQ     R   L+  +     HP+F
Sbjct: 236 N-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 86/297 (28%), Positives = 134/297 (45%), Gaps = 47/297 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
           +G+GS GIV  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           + S    +EL++  ++EF+           +R ++      +      + +AL Y+H   
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHSQ- 136

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 271
           GV HRDIK  ++L+     +VKL DFG    + K  P   S + + Y+ APE+I   T Y
Sbjct: 137 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
            T +DIWS+G ++ E++ G+P +  +S V  +  +        R+              P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------P 233

Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
             K    HKI      P   D + R+L   P  R TA E   HPF  +   P   +P
Sbjct: 234 PPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 87/297 (29%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
           +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +      DEL++  V+EF+          ++R ++      +      + +AL+ +H   
Sbjct: 86  YLV---GDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLKALSVLHAQ- 135

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 271
           GV HRDIK  ++L+  H  +VKL DFG    + K  P   S + + Y+ APELI     Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
              +DIWS+G ++ E++ G+P +  E               P  + +K +  N       
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----- 233

Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
                P  K  HK + P     + RLL   P  R TA E   HPF  +   P+  +P
Sbjct: 234 -----PKLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 153
           +G G+ G V + K + TG  +A K V    +        RELQ M     P +VS    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 154 FSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            +  +     + + +EF+     + +Y+           +P+  +      +   L Y++
Sbjct: 73  LNENN-----ICMCMEFMDCGSLDRIYKKGG-------PIPVEILGKIAVAVVEGLTYLY 120

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
               + HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  
Sbjct: 121 NVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG- 177

Query: 270 EYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
           +YT   D+WS+G  + EL LG+ P        D   + + +L                  
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---------------- 221

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
              QI   P  ++     P +  D V   L   P  R T  + C  P F
Sbjct: 222 -LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 147
           +++G+G+FG V+     +TG  +A+K+V  D   +           E+Q ++ L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
               C     D +E  L++ +E++P  ++    K Y   ++ +     + YT QI + ++
Sbjct: 68  QYYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNISYICSRYYRAP 262
           Y+H  + + HRDIK  N+L +     VKL DFG++K    + + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           E+I G   Y    D+WSV C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 75/299 (25%), Positives = 130/299 (43%), Gaps = 48/299 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
           +G+G++G V++     TG T+A+K++   L + ++     EL  +     P +V     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
           F      E  + + +E++             A++ +P   ++  TY + + L ++     
Sbjct: 69  FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGA 268
           + HRD+KP N+LVN +  QVKLCDFG +  LV      +  C  Y  APE I        
Sbjct: 124 IIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPNY 325
             YT   D+WS+G  + E+ LG+  +P E+  +   QL  I+   G P       +   Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
           +                      +A D V++ L   PN R T  +   HP+  + ++ +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 68/236 (28%), Positives = 114/236 (48%), Gaps = 27/236 (11%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 147
           +++GQG+FG V+     +TG  +A+K+V  D               E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
               C     D  E  L++ +E +P  ++    K Y   ++ +     + YT QI   ++
Sbjct: 68  QYYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAP 262
           Y+H  + + HRDIK  N+L +     VKL DFG++K L    + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           E+I G   Y    DIWSVGC + E+L  +P +   +  + +  I K+   PT   +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 76/283 (26%), Positives = 121/283 (42%), Gaps = 50/283 (17%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFF 154
           G+G+ G V + +   TG   A+K +  D     ++   REL+  +    P +V     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 155 STTDKDELYLNLVLEFVP----ETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              D+    + + +E+      +++Y +V K   R  ++  L  +      + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELI 265
               + HRDIKP N+L+     QVKLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 SR-KIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 314
            G   Y+   D+WS+G  L E+   +  FP E     G  +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 315 ----REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFHKRMP 347
                EE K     C+  + T    P  +  HPW K   K+  
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 86/319 (26%), Positives = 149/319 (46%), Gaps = 61/319 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
           +++G+GSFG VF A+   T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L +C F T  K+ L+   V+E++   + ++ +     ++  +  L     Y  +I   L 
Sbjct: 61  L-YCTFQT--KENLFF--VMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQ 110

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           ++H   G+ +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++
Sbjct: 111 FLHSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
            G  +Y T++D WS G +L E+L+GQ  F G    +              + I+  NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDELRDP 383
             +                 +  EA D++ +L    P  R   ++  I  HPFF E+   
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERR-LGVKGDIRQHPFFREID-- 255

Query: 384 NARLPNGRPFPPLFNFKPQ 402
            + L      PP   FKP+
Sbjct: 256 WSALEEREIEPP---FKPK 271

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 90/361 (24%), Positives = 137/361 (37%), Gaps = 113/361 (31%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 149
           +V+G+G+FG V   +  +TG   A+KK+ + +  +  ++  +R    +L   D+P VV L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK---------LYTYQ 200
            + F     +DE YL L++E++P                M L+  K          Y  +
Sbjct: 67  YYSF-----QDENYLYLIMEYLP------------GGDMMTLLMKKDTFTEEETRFYIAE 109

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGE 248
              A+  IH  +G  HRDIKP NLL++   H +KL DFG              ++L    
Sbjct: 110 TILAIDSIHK-LGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHAL 167

Query: 249 PNISYICSR--------------------Y-------YRAPELIFGATEYTTAIDIWSVG 281
           P+                           Y       Y APE +F  T Y    D WS+G
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLG 226

Query: 282 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 341
            ++ E+L+G P F  +               P     K +N   T  +FP          
Sbjct: 227 VIMYEMLVGYPPFCSD--------------NPQETYRKIINWKET-LQFPD--------- 262

Query: 342 FHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFF-----DELRDPNARLPNGRPFP 394
               + PEA DL+ RL   +          E   HPFF     + +R+  A      P  
Sbjct: 263 -EVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PII 315

Query: 395 P 395
           P
Sbjct: 316 P 316

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 95/337 (28%), Positives = 150/337 (44%), Gaps = 73/337 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
           RV+G+GSFG V  A+  E+G   A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L +C F T D+    L  V+EFV   + ++ + K     S+R      + Y  +I  AL 
Sbjct: 61  L-YCCFQTPDR----LFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALM 110

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           ++H   G+ +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I
Sbjct: 111 FLHDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-I 167

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                Y  ++D W++G +L E+L G   F  E+  D L E I        +E+       
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV------- 213

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTAL--EACI--HPFFDE 379
                          ++   +  +AVD++   +  +P +R     L  E  I  HPFF E
Sbjct: 214 ---------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258

Query: 380 LRDPNARLPNGRPFPPLF-----------NFKPQELK 405
           L   +    N R   P F           NF P  +K
Sbjct: 259 L---DWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIK 292

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 105/409 (25%), Positives = 162/409 (39%), Gaps = 120/409 (29%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 149
           +V+G+G+FG V   +  +TG+  A+K +L+ + +K  +L  ++    +L   D P VVSL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
            + F     +D  YL L++EF+P   +  +   Y   S+ +     + Y  +   A+  +
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGEPNISYICS 256
           H  +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I +
Sbjct: 118 H-KLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175

Query: 257 RY------------------------------------YRAPELIFGATEYTTAIDIWSV 280
           R                                     Y APE IF    Y    D WS+
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234

Query: 281 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWH 339
           G ++ E L+G P F  E+  +   +II                N+ E   FP    H   
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-DIH--- 274

Query: 340 KIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFF-----DELRDPNARLPNGRP 392
                 +  EA DL+ RL+  + N   R  A E   HPFF     D +R   A      P
Sbjct: 275 ------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA------P 322

Query: 393 FPPLFN-------FKPQELKG-----ASKELLSKLIPEHARKQCPFLGF 429
           F P          F   EL+      A K+       E       F+G+
Sbjct: 323 FIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGY 371

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 63/299 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D     L  V+E+    E  + +++    +  R      + Y  +I  A
Sbjct: 58  TALKYSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 213

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
                             F + + PEA  L++ LL+  P  R       A E   H FF
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 86/319 (26%), Positives = 137/319 (42%), Gaps = 55/319 (17%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 148
           RV+G+G FG V   +   TG+  A KK L+ KR K R+ + M L        ++   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L + + +   KD L L L L    +  + +   Y+  +          Y  +I   L  +
Sbjct: 65  LAYAYET---KDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    + +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++   
Sbjct: 119 HRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             YT + D W +GC++ E++ G+  F          E +K      REE++       E 
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRVKEDQE- 222

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--C---TALEACIHPFFDELRDP 383
                        + ++    A  +  +LL   P  R  C    A E   HPFF   R  
Sbjct: 223 ------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF---RTA 267

Query: 384 N-ARLPNGRPFPPLFNFKP 401
           N  RL  G   PP   F P
Sbjct: 268 NFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 24/221 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNVVSLKHC 152
           +G+GSFG+VF+          A+K++ L   ++R +   +   R+L   D   ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
           F      D+  LN+V+E+     ++++ K      + +P   V  +  QI   LA++H  
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFG 267
             + HRDIK  NL ++ +   VK+ D G AK+L     N ++    + + YY +PEL   
Sbjct: 121 -KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-E 174

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
              Y    D+W++G VL E   G+  F   +    +++II+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 83.6 bits (207), Expect = 6e-18
 Identities = 79/305 (25%), Positives = 125/305 (40%), Gaps = 47/305 (15%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV-LQDK-RYKN---RELQTMRLLDHPNVVSLKHC 152
            +G G+ G+V +     +G  +A K + L+ K   +N   REL+ +   + P +V     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 153 FFSTTD-------KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           F+S  +        D   L+ VL               + + R+P   +   +  + R L
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVL---------------KKAGRIPENILGKISIAVLRGL 112

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE +
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 170

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
            G T YT   DIWS+G  L E+ +G+   P         E+  + G P  E     +   
Sbjct: 171 QG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRP 225

Query: 326 TEFKFPQ-------------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                P              I   P  K+       E  D V + L+ +P  R    E  
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285

Query: 373 IHPFF 377
            HPF 
Sbjct: 286 KHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           Y   RVVG+GSFG     + + + +  A+K++   K         +E   +  + HPN+V
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           + K  F     + + +L +V+E+       + K   +  +  P   +  +  Q+C  + +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDL-MQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIF 266
           IH    V HRDIK +N+ +     +VKL DFGSA++L   G    +Y+ + YY  PE I+
Sbjct: 116 IHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IW 172

Query: 267 GATEYTTAIDIWSVGCVLAEL 287
               Y    DIWS+GC+L EL
Sbjct: 173 ENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 41/214 (19%)

Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           RV+G+G FG V    +      TGE VA+K + ++   +N      E+  ++ L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTYQICRAL 205
             K C    +++    L L++E+VP    R  + KH    +Q +      L+  QIC  +
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE-- 263
           AY+H    + HRD+  +N+L++ +   VK+ DFG AK + +G          YYR  E  
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170

Query: 264 ---LIFGATE------YTTAIDIWSVGCVLAELL 288
              + + A E      ++ A D+WS G  L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 85/299 (28%), Positives = 132/299 (44%), Gaps = 59/299 (19%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHP 144
           +V+G+G +G VFQ + +   +TG+  A+K VL+         D  +   E   +  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +V L    F T  K    L L+LE++      +  H  R    M       Y  +I  A
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 263
           L ++H   G+ +RD+KP+N+L++   H VKL DFG  K  +         C    Y APE
Sbjct: 113 LEHLHQ-QGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            I   + +  A+D WS+G ++ ++L G P F  E+    + +I+K          K   P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
            Y                    + PEA DL+ +LL+ +P+ R       A E   HPFF
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 89/316 (28%), Positives = 147/316 (46%), Gaps = 49/316 (15%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTM 138
           G P++ +    +  +G+GS GIV  A    TG+ VA+KK+  D R + R      E+  M
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           R   H NVV + + +      DEL++  V+EF+          ++R ++      +    
Sbjct: 74  RDYHHENVVDMYNSYLV---GDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVC 124

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSR 257
             + RAL+Y+H   GV HRDIK  ++L+     ++KL DFG    + K  P   S + + 
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           Y+ APE+I     Y T +DIWS+G ++ E++ G+P +  E  +  +  I        R+ 
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDN 233

Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +            P++K    HK+    +    +DL   +L   P+ R TA E   HPF 
Sbjct: 234 LP-----------PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275

Query: 378 DELRDPNARLPNGRPF 393
                P+  +P  R +
Sbjct: 276 KLAGPPSCIVPLMRQY 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 47/296 (15%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHC 152
           ++G G+ G V++A  L T   +A+K +  D     ++    EL+ +   D P ++     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 153 FFSTTDKDELYLNLVLEFVPE---TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           FF      E  +++  EF+      VYR          ++P   +      + + L Y+ 
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLW 112

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
             + + HRD+KP N+LVN    QVKLCDFG +  LV      +Y+ +  Y APE I G  
Sbjct: 113 S-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-E 168

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
           +Y    D+WS+G    EL LG+  +P        +  +++L     E+            
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP----------- 217

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 385
            P +    + + F        V  +++ ++  P  R        HPF  +  D NA
Sbjct: 218 -PVLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 94/308 (30%), Positives = 144/308 (46%), Gaps = 64/308 (20%)

Query: 97  RVVGQGSFGIVF---QAKCLETGETVAIKKVLQD----KRYKNRE-LQTMR-LLDH---- 143
           +V+G G++G VF   +    +TG+  A+K VLQ     ++ K  E  +T R +L+H    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTY 199
           P +V+L H  F T  K    L+L+L++V      T      ++S          V+ Y+ 
Sbjct: 65  PFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYSG 112

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY 258
           +I  AL ++H  +G+ +RDIK +N+L++   H V L DFG +K  +  E   +Y  C   
Sbjct: 113 EIILALEHLHK-LGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 259 -YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y APE+I G   +  A+D WS+G ++ ELL G   F  E   +   E+       +R  
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRI 223

Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEAC 372
           +KC  P                  F   + PEA DL+ +LL+  P  R       A E  
Sbjct: 224 LKCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265

Query: 373 IHPFFDEL 380
            HPFF  L
Sbjct: 266 EHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 79/304 (25%), Positives = 118/304 (38%), Gaps = 68/304 (22%)

Query: 100 GQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKHC 152
           G G+FG V++A+  ETG   A K +       L+D      E+  +    HPN+V L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLI--YVKLYTYQICRALAYIH 209
           +F         L +++EF     +  +     R      L    ++    Q+  AL ++H
Sbjct: 71  YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI--- 265
               V HRD+K  N+L+      VKL DFG SAK     +   ++I + Y+ APE++   
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 266 -FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
            F    Y    DIWS+G  L EL   +P                    P  E    +NP 
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPM 214

Query: 325 YTEFKFPQ------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
               K  +       +   W   F+        D +   L   P+ R TA E   HPF  
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Query: 379 ELRD 382
           +  D
Sbjct: 267 DQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 50/287 (17%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----------LDHPNV 146
           ++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           V + + F  T DK    L+ +L+ +   +  Y +++H   +   M     + Y  +I   
Sbjct: 60  VCMSYAF-HTPDK----LSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILG 109

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF----------------------PGESGVDQ 302
           +     Y ++ D +S+GC+L +LL G   F                      P     + 
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226

Query: 303 LVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 348
              +  +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.2 bits (195), Expect = 8e-17
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 28/221 (12%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 150
           + +G+GSFG ++ AK     E   IK++      +++K    +E+  +  + HPN+V+  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLI---YVKLYTYQICRAL 205
             F S  +   L++  V+E+    + + R+ +      QR  L     +  +  QI   L
Sbjct: 65  --FASFQENGRLFI--VMEYCDGGDLMKRINR------QRGVLFSEDQILSWFVQISLGL 114

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPE 263
            +IH    + HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE
Sbjct: 115 KHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
            I     Y    DIWS+GCVL EL   +  F G + + QLV
Sbjct: 173 -ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           +V+G+G+FG V   +   + +  A+K + + +  K         E   M   +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
            H  F    +D+ YL +V+E++P   +  +  +Y      +P  + + YT ++  AL  I
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAI 158

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 263
           H  +G  HRD+KP N+L++   H +KL DFG+    +K + N    C        Y +PE
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213

Query: 264 LIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           ++    G   Y    D WSVG  L E+L+G   F  +S V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 86/322 (26%), Positives = 148/322 (45%), Gaps = 60/322 (18%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIK-----KVLQDKRYKNRELQTMRLLDH----P 144
           +V+G G++G VF  + +   ++G+  A+K      ++Q  +         ++L+H    P
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQIC 202
            +V+L + F + T      L+L+L+++        + ++  SQR       V++Y+ +I 
Sbjct: 66  FLVTLHYAFQTDTK-----LHLILDYI-----NGGELFTHLSQRERFKEQEVQIYSGEIV 115

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YR 260
            AL ++H  +G+ +RDIK +N+L++ + H V L DFG +K   + E   +Y  C    Y 
Sbjct: 116 LALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 261 APELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           AP+++ G    +  A+D WS+G ++ ELL G   F  +   +   EI       +R  +K
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILK 226

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIH 374
              P      +PQ             M   A D++ RLL   P  R       A E   H
Sbjct: 227 SEPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268

Query: 375 PFFDELR-DPNARLPNGRPFPP 395
           PFF ++  D  A      PF P
Sbjct: 269 PFFQKINWDDLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 94/369 (25%), Positives = 155/369 (42%), Gaps = 86/369 (23%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKK----VLQDKR---YKNRELQTMRLLDHPNVVSLK 150
           +VG+G FG V   +   TG+  A+K     VL  +    +   E   + + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           + F    DKD LYL  V+E+ P  + +  + ++  +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-------KVLVK---GEPNISYICSRY 258
           H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K   G P+        
Sbjct: 119 HQ-MGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPD-------- 168

Query: 259 YRAPELI-----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
           Y APE++      G   Y    D WS+G +  E++ G+  F   +       I+      
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------ 222

Query: 314 TREEIKCMNPNYTEF-KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                     N+  F KFP+            ++  + +DL+  LL      R      C
Sbjct: 223 ----------NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261

Query: 373 IHPFFDELRDPNAR--LPNGRPFPPLF-------NF-KPQELKGASKELLSKLIPEH--A 420
            HPFF ++   N R  LP   PF P         NF +P++      +  +  +  +  +
Sbjct: 262 CHPFFSKIDWNNIRNSLP---PFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFS 318

Query: 421 RKQCPFLGF 429
            K  PF+GF
Sbjct: 319 GKDLPFVGF 327

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 91/318 (28%), Positives = 141/318 (44%), Gaps = 53/318 (16%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 148
           RV+G+G FG V   +   TG+  A KK L+ KR K R+ ++M L     L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L + + +   KD L L L L    +  + +   Y              Y  +IC  L  +
Sbjct: 65  LAYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++   
Sbjct: 119 HQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             YT + D W++GC+L E++ GQ  F       Q  + IK      REE++ +     E 
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE- 222

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP 383
                        + ++  P+A  L   LL   P  R       A E   HP F ++   
Sbjct: 223 ------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268

Query: 384 NARLPNGRPFPPLFNFKP 401
             RL  G   PP   FKP
Sbjct: 269 FKRLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 87/315 (27%), Positives = 134/315 (42%), Gaps = 61/315 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 147
           +V+G+GSFG V  AK    G   A+K VLQ K    ++ Q          ++ L HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L H  F T +K    L  VL++V   E  + + +       R      + Y  ++  A+
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
            Y+H  + + +RD+KP+N+L++   H V L DFG  K  V+ E   S  C +  Y APE 
Sbjct: 110 GYLHS-LNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII----------------K 308
           +     Y   +D W +G VL E+L G P F     V Q+ + I                 
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225

Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAH------PWHKIFHKRMPPEAVDLVSRLLQYSP 362
           +L     ++ +       +F   +IK H       W  ++HKR+ P           Y+P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITPP----------YNP 273

Query: 363 NLRCTALEACIHPFF 377
           N+   A      P F
Sbjct: 274 NVAGPADLRHFDPEF 288

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 79/321 (24%), Positives = 136/321 (42%), Gaps = 62/321 (19%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----------LQTMRLLDHPNVVS 148
           +G+G+FG V+Q +  +T    A+K + + +    +E          L    L + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           LK  F + +D     L LV +++   E  + + K    +  R      K Y  ++  AL 
Sbjct: 61  LKFSFQTDSD-----LYLVTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAELVLALE 110

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 265
           ++H    + +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                YT  +D WS+G ++ E+  G   F  E    Q+   I                 +
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIA----------------F 211

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI----HPFFDELR 381
            + +FP+             +  E    V  LL  +P  R  A    +    HPFF ++ 
Sbjct: 212 GKVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI- 259

Query: 382 DPNARLPNGRPFPPLFNFKPQ 402
           D +  L   +  PP   FKP 
Sbjct: 260 DWDL-LSKKQITPP---FKPI 276

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 84/305 (27%), Positives = 136/305 (44%), Gaps = 59/305 (19%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
             HPN+V+              YL+  L  V + ++ V ++ +  S    +    +   Q
Sbjct: 73  NKHPNIVN--------------YLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQ 116

Query: 201 I---CR----ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNIS 252
           I   CR    AL ++H    V HRDIK  N+L+      VKL DFG  A++  +     +
Sbjct: 117 IAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 174

Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            + + Y+ APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   GT
Sbjct: 175 MVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGT 232

Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           P             E + P+            ++     D ++R L+     R +A E  
Sbjct: 233 P-------------ELQNPE------------KLSAIFRDFLNRCLEMDVEKRGSAKELL 267

Query: 373 IHPFF 377
            HPF 
Sbjct: 268 QHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 76/304 (25%), Positives = 146/304 (48%), Gaps = 54/304 (17%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL-----DHPNVV 147
           RV+G+GS+  V   +  +T    A+ KV++ +   + E    +QT + +     +HP +V
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAM-KVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L  CF + +      L  V+EFV   + ++    H  R  +++P  + + Y+ +I  AL
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGGDLMF----HMQR-QRKLPEEHARFYSAEISLAL 109

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPEL 264
            ++H   G+ +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE+
Sbjct: 110 NFLHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI 167

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF--------PGESGVDQLVEII--KVLGTPT 314
           + G  +Y  ++D W++G ++ E++ G+  F        P ++  D L ++I  K +  P 
Sbjct: 168 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR 226

Query: 315 REEIKC-------MNPNYTE-------FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
              +K        +N +  E         F  IK+HP    F + +  + ++    L  Y
Sbjct: 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP----FFRNIDWDLLEQKQVLPPY 282

Query: 361 SPNL 364
            PN+
Sbjct: 283 KPNI 286

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 84/289 (29%), Positives = 128/289 (44%), Gaps = 49/289 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
           +G G++G V++A+ + TGE  AIK +     +D     +E+  M+   H N+V+    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
           S   +D+L++   +EF      +   H +       + YV   T Q    L Y+H   G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHSK-GK 127

Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 270
            HRDIK  N+L+  + H VKL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 271 -YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
            Y    DIW+VG    EL  L  P+F         +  ++ L   T+          + F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFD--------LHPMRALFLMTK----------SNF 226

Query: 329 KFPQIKAH-PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           + P++K    W   FH          V   L  +P  R TA +   HPF
Sbjct: 227 QPPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 23/208 (11%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-----------DHPNV 146
           ++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V + + F +    D+L   L L    +  Y +++H   + + M     + Y  +I   L 
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE++ 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLF 294
             T Y ++ D +S+GC+L +LL G   F
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 69/222 (31%), Positives = 118/222 (53%), Gaps = 25/222 (11%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
           +V+G+GSFG V  A+   T E  AIK + +D   ++ ++  TM   R+L     HP + +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L HC F T D+    L  V+E+V   + ++++ +     S++      + Y  ++  AL 
Sbjct: 61  L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALM 110

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 265
           ++H   GV +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
               EY  ++D W++G ++ E++ GQP F  ++  D L E I
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 26/210 (12%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY--KNRELQTM-------RLLDHPNVV 147
           +V+G+GSFG V  A+  +  E     KVLQ K    K  E   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L H  F T DK    L  VL+++   E  Y + +       R      + Y  +I  AL
Sbjct: 60  GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
            Y+H  + + +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLHS-LNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
           +     Y   +D W +G VL E+L G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 79/324 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR----ELQTMRLLDHPNVVSL 149
           +++G+G  G VF  +   TG+  A+K   K    KR K +    E + +  LDHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F + T     YL LV+++ P   ++R+ +   +  + +     + Y  ++  AL Y+
Sbjct: 67  YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDF-------------------GSAKVLVKGEP 249
           H  +G+ +RD+KP+N+L++   H + L DF                   GS +  V   P
Sbjct: 120 HL-LGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 250 NISYICS-----------RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           + ++                Y APE+I G   + +A+D W++G +L E+L G   F G +
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 358
             +    I+K                  E  FP              +   A DL+ +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269

Query: 359 QYSPNLRC----TALEACIHPFFD 378
              P+ R      A E   HPFF 
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 38/258 (14%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRL 140
           G PK+   Y     +GQG+ G VF A  + TG+ VAIK++   K+ K      E+  M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEF---------VPETVYRVAKHYSRASQRMPL 191
           L +PN+V+    F      DEL+  +V+E+         V ET    A+           
Sbjct: 73  LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTETCMDEAQ----------- 116

Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPN 250
             +     +  +AL ++H    V HRDIK  N+L+      VKL DFG  A++  +    
Sbjct: 117 --IAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKR 172

Query: 251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
            + + + Y+ APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 311 GTPTREEIKCMNPNYTEF 328
           GTP  +  + ++P + +F
Sbjct: 231 GTPELQNPEKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 59/297 (19%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----RLLD------HPNVV 147
           V+G+G FG V  A+  +TGE  AIK + +       E++++    R+ +      HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           +L  CF     +D +    V+E+       +  H    S+         Y   +   L Y
Sbjct: 66  NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHTDVFSEPR----AVFYAACVVLGLQY 116

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
           +H    + +RD+K  NLL++     VK+ DFG  K  +      S  C +  + APE++ 
Sbjct: 117 LHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
             T YT A+D W +G ++ E+L+G+  FPG+                  EE+        
Sbjct: 175 E-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEEEV-------- 209

Query: 327 EFKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
              F  I      +  F   +  EA+ ++ RLL+ +P  R       A +    PFF
Sbjct: 210 ---FDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 31/214 (14%)

Query: 97  RVVGQGSFGIVFQAK-CLETGE--TVAIKKVLQDKRYKNREL-----QTMRLLDHPNVVS 148
           R +G+G FG V+Q        E   VA+K          RE        MR  DHP++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L         ++ +++  V+E  P    R   +       + L  + LY+YQ+  ALAY+
Sbjct: 72  L----IGVITENPVWI--VMELAPLGELR--SYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 209 HGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
                  HRDI  +N+LV +P    VKL DFG ++ L   E    Y  S+      + AP
Sbjct: 124 E-SKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177

Query: 263 ELIFGATEYTTAIDIWSVG-CVLAELLLG-QPLF 294
           E I     +T+A D+W  G C+   L+LG +P  
Sbjct: 178 ESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHPNV 146
           Y+  + +G+GSFG     K  E G+   IK++    +  K  +   +E+  +  + HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY----VKLYTYQIC 202
           V  +  F    +   LY+  V+++           Y + + +  +++    +  +  QIC
Sbjct: 62  VQYQESF---EENGNLYI--VMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 261
            AL ++H    + HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELL 288
           PE I     Y    DIW++GCVL E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 66/242 (27%), Positives = 98/242 (40%), Gaps = 47/242 (19%)

Query: 99  VGQGSFGIVFQAKCLETGE---TVAIK-----KVLQDKRYKNRELQTMRLLDHPNVVSLK 150
           +G G+FG V +   L        VA+K      +   K+   RE   M  LDHP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKH-YSRASQRMPLIYVKLYTYQICRALAYIH 209
                    + L   LV+E  P          Y +  + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLG----PLLKYLKKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 210 GGIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------- 260
               V HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 261 ----APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 313
               APE I     +++  D+WS G  L E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 314 TR 315
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 22/229 (9%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQ----TMRLLDHPNVVSLKHC 152
           +G+G+FG V +     +G  +A+K++    D++ + R L      MR  D P +V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 153 FFSTTDK---DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F   D     EL +++ L+   + VY V K        +P   +        +AL Y+ 
Sbjct: 72  LFREGDCWICMEL-MDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI--FG 267
             + + HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I    
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 315
              Y    D+WS+G  L E+  G+  +P   S  DQL +++K  G P  
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 88/326 (26%), Positives = 142/326 (43%), Gaps = 71/326 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++    +  R      + Y  +I  A
Sbjct: 58  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFD 378
                             F + + PEA  L+S LL+  P  R       A E   H FF 
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256

Query: 379 --ELRDPNARLPNGRPFPPLFNFKPQ 402
               +D   +    +  PP   FKPQ
Sbjct: 257 GIVWQDVYEK----KLVPP---FKPQ 275

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 56/183 (30%), Positives = 97/183 (53%), Gaps = 19/183 (10%)

Query: 133 RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPL 191
           RELQ +   + P +V     F+S  +     +++ +E +   ++ +V K     ++R+P 
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPE 102

Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
             +   +  + R LAY+     + HRD+KP N+LVN    ++KLCDFG +  L+    N 
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN- 160

Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 310
           S++ +R Y +PE + G T Y+   DIWS+G  L EL +G+ P+ P ++      E+  + 
Sbjct: 161 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIF 214

Query: 311 GTP 313
           G P
Sbjct: 215 GRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 97  RVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHPNVVS 148
           R +G GSFG V  A    E    VAIK+  + K  K +       E + +  ++HP  V+
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L   F     KDE YL LVLEFV    +     + R ++R P      Y  QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
              + + +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++  
Sbjct: 148 Q-SLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF 294
              +  A D W++G  + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 74.6 bits (183), Expect = 8e-15
 Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 23/220 (10%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 150
           V+G+GSFG V  A+   T E  AIK      V+QD   +    E + + L D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           H  F T D+    L  V+E+V   + +Y    H  +  +      V  Y  +I   L ++
Sbjct: 67  HSCFQTVDR----LYFVMEYVNGGDLMY----HIQQVGKFKEPQAV-FYAAEISVGLFFL 117

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 267
           H   G+ +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I  
Sbjct: 118 HRR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-A 174

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
              Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 41/236 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y   +V+G+G+FG V   +   + +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           VV L  C F    +D+ YL +V+E++P   +  +  +Y      +P  + K YT ++  A
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYI 254
           L  IH  +G+ HRD+KP N+L++ H H +KL DFG+   + +          G P+    
Sbjct: 155 LDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD---- 208

Query: 255 CSRYYRAPELIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
               Y +PE++    G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 209 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 93/347 (26%), Positives = 144/347 (41%), Gaps = 105/347 (30%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 148
           + +G G+FG V  A  ++T    A+K  L+ K   NR        E   +   D+  VV 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           L   ++S  DKD LY   V++++P       + R+        +  P +  + Y  ++  
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRM--------EVFPEVLARFYIAELTL 112

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG---------SAKVLVKG------- 247
           A+  +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG       
Sbjct: 113 AIESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170

Query: 248 -EPNI-------------------------------SYICSRYYRAPELIFGATEYTTAI 275
            EP+                                S + +  Y APE++     YT   
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLC 229

Query: 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 335
           D WSVG +L E+L+GQP F              +  TPT  ++K +N   T    PQ+K 
Sbjct: 230 DWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK- 274

Query: 336 HPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDEL 380
                     + PEAVDL+++L   +     R  A +   HPFF E+
Sbjct: 275 ----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 82/305 (26%), Positives = 130/305 (42%), Gaps = 50/305 (16%)

Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 137
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 6   RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62

Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKL 196
           +   +HP +V L   F+      +  L +++EF P   V  +     R     P I  ++
Sbjct: 63  LATCNHPYIVKLLGAFYW-----DGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QV 114

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYIC 255
              Q+  AL Y+H  + + HRD+K  N+L+      +KL DFG SAK +   +   S+I 
Sbjct: 115 ICRQMLEALQYLH-SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIG 172

Query: 256 SRYYRAPELIFGAT----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
           + Y+ APE++   T     Y    DIWS+G  L E+   +P                   
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP------------------- 213

Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
            P  E    +NP     K    K+ P       +   E  D +   L   P  R +A + 
Sbjct: 214 -PHHE----LNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266

Query: 372 CIHPF 376
             HPF
Sbjct: 267 LEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 148
           RV+G+G FG V   +   TG+  A K+ L+ KR K R+ ++M L     L+  N   VV+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L + + +   KD L L L +    +  + +   Y+  +          Y  +I   L  +
Sbjct: 65  LAYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H      +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++   
Sbjct: 119 HRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPG 296
             YT + D W +GC++ E++ GQ  F G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 17/204 (8%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 145
           +Y   RVVG+GS+G V   +    G+   IKK+       ++++   +E Q +  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           +V+ +  +    + ++  L +V+ F     +Y   K   +  + +P   V  +  QI  A
Sbjct: 61  IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 263
           L Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PE
Sbjct: 115 LQYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172

Query: 264 LIFGATEYTTAIDIWSVGCVLAEL 287
           L F    Y    D+W++GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 67/236 (28%), Positives = 110/236 (46%), Gaps = 41/236 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y   +V+G+G+FG V   +   T +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           VV L + F     +D+ YL +V+E++P   +  +  +Y      +P  + + YT ++  A
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYI 254
           L  IH  +G  HRD+KP N+L++   H +KL DFG+   + K          G P+    
Sbjct: 155 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 208

Query: 255 CSRYYRAPELIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
               Y +PE++    G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 209 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM------RLLDHPNVVSLK 150
           V+G+GSFG V  A+   T E  AIK + +D   ++ +++ TM       L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           H  F T D+    L  V+E+V   + +Y + +       + P  +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--HAVFYAAEIAIGLFFL 117

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
           H   G+ +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I  
Sbjct: 118 HSK-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
              Y  ++D W+ G +L E+L GQP F GE
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 62/228 (27%), Positives = 116/228 (50%), Gaps = 28/228 (12%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 148
           RV+G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L  CF     + E  L  V+E+V      +  H  R  +++P  + + Y+ +I  AL Y+
Sbjct: 61  LHSCF-----QTESRLFFVIEYVNGG--DLMFHMQR-QRKLPEEHARFYSAEISLALNYL 112

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF--------PGESGVDQLVEII 307
             +Y  ++D W++G ++ E++ G+  F        P ++  D L ++I
Sbjct: 171 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 64/229 (27%), Positives = 116/229 (50%), Gaps = 23/229 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G G+ G+VF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F+S  +     +++ +E +   ++ +V K     + R+P   +   +  + + L Y+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 271 YTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 318
           Y+   DIWS+G  L E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 63/239 (26%), Positives = 113/239 (47%), Gaps = 25/239 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 150
           +G+G FG V   +   TG+  A KK L  KR K +  + M LL+         P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           + F S T     +L LV+  +   +  Y +   Y+   + + +  V  Y+ QI   + ++
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGDLKYHI---YNVGERGLEMERVIHYSAQITCGILHL 111

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H  + + +RD+KP+N+L++      +L D G A  L  G+       +  Y APE I   
Sbjct: 112 HS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
             Y+  +D +++GC + E++ G+  F       + V   ++      +E+K  + N+TE
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.1 bits (176), Expect = 4e-14
 Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 47/299 (15%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTY 199
             +PN+V+    +      DEL++  V+E++   ++  V         ++  +       
Sbjct: 73  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
           +  +AL ++H    V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 123 ECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           + APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   GTP     
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP----- 233

Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +  NP                    +R+     D ++R L+   + R +A E   HPF 
Sbjct: 234 ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 28/234 (11%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVS 148
           RV+G+GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L  CF +T+      L LV+E+V      +  H  R  +++P  + + Y  +IC AL ++
Sbjct: 61  LHSCFQTTSR-----LFLVIEYVNGG--DLMFHMQR-QRKLPEEHARFYAAEICIALNFL 112

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
           H   G+ +RD+K  N+L++   H +KL D+G  K  +      S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 315
             EY  ++D W++G ++ E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 171 E-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 72/276 (26%), Positives = 125/276 (45%), Gaps = 43/276 (15%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD-------H--PNVVSL 149
           +G G+ G V++ +  +TG  +A+K++   +R  N+E     L+D       H  P +V  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              F + +D     + + +E +   + ++ K   R    +P   +   T  I +AL Y+ 
Sbjct: 80  YGYFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGA 268
              GV HRD+KP N+L++  +  VKLCDFG +  LV  +    S  C+ Y  APE I   
Sbjct: 132 EKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPP 189

Query: 269 T---EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT-----PTREE--- 317
               +Y    D+WS+G  L EL  GQ  FP ++   +   + K+L       P  E    
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247

Query: 318 ------IKCMNPNYTEF-KFPQIKAHPWHKIFHKRM 346
                   C+  ++ +  K+ ++  HP+ + +    
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 71/320 (22%), Positives = 116/320 (36%), Gaps = 40/320 (12%)

Query: 97  RVVGQGSFG--IVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVS 148
            ++G+      IV  AK   T   VA+KK+  D   K        E+ T R L HPN++ 
Sbjct: 4   TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRV--AKHYSRASQRMPLIYVKLYTYQICRALA 206
               F       ELY+  V   +           H+      +P + +      +  AL 
Sbjct: 64  YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALD 115

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--------EPNISYICSRY 258
           YIH   G  HR +K  ++L++     V L     +  ++K         +   S + +  
Sbjct: 116 YIHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 259 YRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR-- 315
           + +PE++    + Y    DI+SVG    EL  G   F        L+E  KV GT     
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231

Query: 316 ------EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
                      M+ + +  + P  +       + +         V   LQ  P  R +A 
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290

Query: 370 EACIHPFFDELRDPNARLPN 389
           +   H FF + +  N  L +
Sbjct: 291 QLLNHSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 84/324 (25%), Positives = 141/324 (43%), Gaps = 68/324 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG          E +  K  +     ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 57

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++      +R      + Y  +I  A
Sbjct: 58  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 107

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
           L Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 213

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFD 378
                             F + + PEA  L++ LL+  P  R       A E   H FF 
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255

Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
            +   +  +   +  PP   FKPQ
Sbjct: 256 SINWQD--VVQKKLLPP---FKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 57/242 (23%), Positives = 107/242 (44%), Gaps = 34/242 (14%)

Query: 99  VGQGSFGIVFQAKCLETGET-VAIKKVL-------QDKRYKNRELQTM--------RLLD 142
           +G G+FG V++ +    G+  +A+K++        +DKR +++ +  +          L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYR------VAKHYSRASQRMPLIYVKL 196
           HPN+V     F    + D LY+  V++ +              K      +R+  I+V  
Sbjct: 68  HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV-- 120

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
              Q+  AL Y+H    + HRD+ P N+++     +V + DFG AK         S + +
Sbjct: 121 ---QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGT 176

Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
             Y  PE++     Y    D+W+ GC+L ++   QP F   + +    +I++ +  P  E
Sbjct: 177 ILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235

Query: 317 EI 318
            +
Sbjct: 236 GM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 85/321 (26%), Positives = 144/321 (44%), Gaps = 62/321 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLD---HPNVVSL 149
           +++G+G+FG V   +   +G+  A+K    +V+  K      L   R+L    HP + SL
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           K+ F  T D+    L  V+E+V   E  + +++    +  R      + Y  +I  AL Y
Sbjct: 61  KYSF-QTKDR----LCFVMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
           +H G  + +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE + 
Sbjct: 111 LHSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
              +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      E+IK       
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EDIK------- 213

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELR 381
                          F + +  +A  L+S LL   PN R       A E   H FF  + 
Sbjct: 214 ---------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258

Query: 382 DPNARLPNGRPFPPLFNFKPQ 402
             +    + +  PP   FKPQ
Sbjct: 259 WQDVY--DKKLVPP---FKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 64/271 (23%)

Query: 121 IKKVLQDKRYKNREL---QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP----- 172
           ++K+++ K +   E    Q M+  D+PN + L +    TT K  +   L+++++      
Sbjct: 45  VQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLF 97

Query: 173 ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ 232
           + +        +   ++    VK    Q+  AL  +H    + H DIK +N+L +    +
Sbjct: 98  DLL--------KKEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDR 148

Query: 233 VKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTTAIDIWSVGCVLAEL 287
           + LCD+G  K  + G P      S Y     Y +PE I G   Y  + D W+VG +  EL
Sbjct: 149 IYLCDYGLCK--IIGTP------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL 199

Query: 288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP 347
           L G+   P +   D   E +         +++ +     + K P          F K + 
Sbjct: 200 LTGK--HPFKEDED---EEL---------DLESLLKRQ-QKKLP----------FIKNVS 234

Query: 348 PEAVDLVSRLLQYSPNLRCTALEACI-HPFF 377
             A D V  +L+Y+ N R T     I HPF 
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.5 bits (177), Expect = 1e-13
 Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 49/254 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G FG VF  K   T E    K +      +R K++   E+  MR L H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-------YTY 199
           V     F +  ++ +LY+  ++EF        A   SR  Q+   ++ K+        T 
Sbjct: 75  VRYIDRFLNKANQ-KLYI--LMEFCD------AGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 200 QICRALAYIHG------GIGVCHRDIKPQNLLVNPHTHQV----------------KLCD 237
           Q+  ALAY H       G  V HRD+KPQN+ ++     +                K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 238 FGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLF 294
           FG +K +  G  ++++ C  + YY +PEL+   T+ Y    D+W++GC++ EL  G+  F
Sbjct: 186 FGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Query: 295 PGESGVDQLVEIIK 308
              +   QL+  +K
Sbjct: 244 HKANNFSQLISELK 257

Length = 1021

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
           VG G++G V++A+ L TGE  A+K +      D     +E+  ++   H N+V+    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
           S   +++L+  + +E+      +   H +     + + YV   T Q    LAY+H   G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHSK-GK 127

Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 270
            HRDIK  N+L+  +   VKL DFG +AK+        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 271 -YTTAIDIWSVGCVLAELLLGQP 292
            Y    DIW+VG    EL   QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-----RLLDHPN---VVS 148
           RV+G+G FG V   +   TG+  A KK L+ KR K R+ + M     R+L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L + + +   KD L L L +    +  + +   Y+  +          Y  ++C  L  +
Sbjct: 65  LAYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
                + +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y APE+I   
Sbjct: 119 QRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLF 294
            +YT + D W +GC++ E++ GQ  F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 88/328 (26%), Positives = 137/328 (41%), Gaps = 77/328 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 149
           +V+G+G+FG V   K   TG+  A+K + + +  K  E    R     L+  D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY----SRASQRMPLIYVKLYTYQICRAL 205
            + F     +DE  L LV++      Y V        S+   R+P    + Y  ++  A+
Sbjct: 67  HYAF-----QDENNLYLVMD------YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYIC 255
             +H  +G  HRDIKP N+L++ + H ++L DFGS   L+           G P+  YI 
Sbjct: 116 DSVHQ-LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YIS 171

Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
               +A E   G   Y    D WS+G  + E+L G+  F  ES V+   +I+        
Sbjct: 172 PEILQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-------- 221

Query: 316 EEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEAC 372
                   N+ E F+FP              +  EA DL+ RL+        R    +  
Sbjct: 222 --------NHKEHFQFPPDVTD---------VSEEAKDLIRRLICSPETRLGRNGLQDFK 264

Query: 373 IHPFF-----DELRDPNARLPNGRPFPP 395
            HPFF     D +R+  A      P+ P
Sbjct: 265 DHPFFEGIDWDNIRNSTA------PYVP 286

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.4 bits (169), Expect = 4e-13
 Identities = 68/250 (27%), Positives = 124/250 (49%), Gaps = 22/250 (8%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTY 199
             +PN+V+    +      DEL++  V+E++   ++  V         ++  +       
Sbjct: 74  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
           +  +AL ++H    V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           + APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239

Query: 319 KCMNPNYTEF 328
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.4 bits (167), Expect = 7e-13
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 27/208 (12%)

Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             K      T+     + L++EF+P    +  ++  R   ++ L     Y  QIC+ + Y
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGSLK--EYLPRNKNKINLKQQLKYAVQICKGMDY 124

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YYR 260
           + G     HRD+  +N+LV    HQVK+ DFG  K +   E +  Y   +       ++ 
Sbjct: 125 L-GSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL 288
           APE +  +  Y  A D+WS G  L ELL
Sbjct: 180 APECLIQSKFYI-ASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 68.7 bits (168), Expect = 9e-13
 Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 31/228 (13%)

Query: 82  GRNGQPKQTISYMA-ERV--VGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNR 133
                P    S    ERV  +G G+ G V++     TG   A+K +  +     +R   R
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121

Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY 193
           E++ +R ++HPNVV   H  F    +    + ++LEF+       +   +  +    L  
Sbjct: 122 EIEILRDVNHPNVVKC-HDMFDHNGE----IQVLLEFMD----GGSLEGTHIADEQFLAD 172

Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS 252
           V     QI   +AY+H    + HRDIKP NLL+N     VK+ DFG +++L +  +P  S
Sbjct: 173 V---ARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNS 227

Query: 253 YICSRYYRAPELI-----FGATEYTTAIDIWSVGCVLAELLLGQPLFP 295
            + +  Y +PE I      GA +   A DIWS+G  + E  LG+  FP
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 69/295 (23%), Positives = 124/295 (42%), Gaps = 30/295 (10%)

Query: 102 GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161
           GS G VF A      + V +K  +  K     E   ++ ++HP+V+ +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA---- 130

Query: 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 221
               +VL      +Y    + ++ S+ +P+    +   QI   L Y+H    + HRD+K 
Sbjct: 131 -ITCMVLPHYSSDLY---TYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKT 185

Query: 222 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVG 281
           +N+ +N    QV + D G+A+  V     +    +    APE +    +Y +  DIWS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243

Query: 282 CVLAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEIKCMNPNYT 326
            VL E+L             P    +S    L++II  L       P     + +   + 
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302

Query: 327 EFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
           E+   + + +  +  F +  +P +   LV ++L +   +R +A E   +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 77/289 (26%), Positives = 120/289 (41%), Gaps = 48/289 (16%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 153
           +G G+FG V++A+  ETG  +A  KV+  K  +       E+  +   DHPN+V L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 154 FSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +   +     L +++EF     V  V     R    +    +++   Q   AL Y+H   
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHEN- 122

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE- 270
            + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T  
Sbjct: 123 KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 271 ---YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              Y    D+WS+G  L E+   +P                    P  E    +NP    
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEP--------------------PHHE----LNPMRVL 217

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            K    K+ P       R   E  D + + L+ + + R T  +   HPF
Sbjct: 218 LKIA--KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 23/220 (10%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 150
           V+G+GSFG V  A+   T E  AIK      V+QD   +    E + + L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           H  F T D+    L  V+E+V   + +Y++ +       R    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR----LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 117

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 267
           H   G+ +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I  
Sbjct: 118 HSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
              Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 37/231 (16%)

Query: 102 GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161
           G+ G  F     +T E V IK     +     E   +R ++HP+++ LK  F        
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF-------- 152

Query: 162 LYLNLVLEFVPETVYRVAKH-YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 220
            Y       +P   Y+   + Y  A + + +  +      + RA+ Y+H    + HRDIK
Sbjct: 153 TYNKFTCLILPR--YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIK 209

Query: 221 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY--------RAPELIFGATEYT 272
            +N+ +N H   V L DFG+A   V    N      +YY         APEL+     Y 
Sbjct: 210 AENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYG 261

Query: 273 TAIDIWSVGCVLAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTRE 316
            A+DIWS G VL E+         + G+D       Q+  II+  GT   E
Sbjct: 262 PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312

Length = 391

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 52/244 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 152
           +V+G+G+FG V   +  +TG   A+K + +    +  ++  +R    +L   +   +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 153 FFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
           F+S  DK  LYL  ++EF+P  + +  + K  + + +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQ 119

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------------------------- 239
            +G  HRDIKP NLL++   H VKL DFG                               
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 240 ---SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
               A+   K    ++Y  + +  Y APE +F  T Y    D WS+G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 295 PGES 298
             E+
Sbjct: 237 CSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 79/385 (20%), Positives = 146/385 (37%), Gaps = 61/385 (15%)

Query: 18  DDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIV 77
           D     D    K DD D+    D +    +         + + E+     +  +      
Sbjct: 30  DTSDSKDTTGDKFDDCDELGDSDDVTHATD--------YDADEESLSPQTDVCQEPCETT 81

Query: 78  TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNRE 134
           ++    +    Q   Y     +  GS G VF   C + G+      I K +   +   RE
Sbjct: 82  SSSDPASVVRMQ---YNILSSLTPGSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGRE 136

Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV 194
           +  ++ + H  +++L H +         + + V   +P+    +  +  R+   +PL   
Sbjct: 137 IDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQA 187

Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
                ++  ALAY+HG  G+ HRD+K +N+ ++   + V L DFG+A  L       +  
Sbjct: 188 ITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQ 243

Query: 255 CSRY-----YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIK 308
           C  +       +PEL+     Y    DIWS G VL E+ +    LF  +         +K
Sbjct: 244 CYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ---------VK 293

Query: 309 VLGTPTREEIKCMNPNYTEF-------------KFPQIKAHPWH--KIFHKRMPPEAVD- 352
              +  R  I+CM  +  EF             ++  +   P+    +  K      V+ 
Sbjct: 294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEY 353

Query: 353 LVSRLLQYSPNLRCTALEACIHPFF 377
           L++++L +    R +A +    P F
Sbjct: 354 LIAKMLTFDQEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 16/221 (7%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 156
           +V+G+G+FG V   K   T    A+K + + +  K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 157 T----DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           T     +DE YL LV+++       +    S+   R+P    + Y  ++  A+  IH  +
Sbjct: 65  TLHYAFQDENYLYLVMDYYVGG--DLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-L 121

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF---- 266
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 122 HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
           G  +Y    D WS+G  + E+L G+  F  ES V+   +I+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHC 152
            VVG G++G V++ + ++TG+  AIK   V +D+  + +    M  +   H N+ +    
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 153 FFSTT---DKDELYLNLVLEFV-PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           F   +     D+L+  LV+EF    +V  + K+    + +    ++     +I R LA++
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED--WIAYICREILRGLAHL 137

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF 266
           H    V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I 
Sbjct: 138 HAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIA 194

Query: 267 ----GATEYTTAIDIWSVGCVLAELLLGQP 292
                   Y    DIWS+G    E+  G P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 83/356 (23%), Positives = 122/356 (34%), Gaps = 133/356 (37%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 148
           + +G G+FG V   + ++T    A+K  L+      R        E   +   D+  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI---------YVKLYTY 199
           L   ++S  DKD LY   V++++P                M L+           + Y  
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIP------------GGDMMSLLIRLGIFEEDLARFYIA 108

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPH----------------THQVKL-------- 235
           ++  A+  +H  +G  HRDIKP N+L++                  TH  K         
Sbjct: 109 ELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167

Query: 236 ---------------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGA 268
                          C     +   K            G PN        Y APE++   
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-R 218

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
           T YT   D WSVG +L E+L+GQP F  +              TP   ++K +N      
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVIN------ 258

Query: 329 KFPQIKAHPWHKIFH----KRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFF 377
                    W    H     ++  EA DL+ RL       R     A E   HPFF
Sbjct: 259 ---------WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 43/235 (18%)

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLL-------VNPHTHQ--------VKLCDFGSAKV 243
           +Q   AL Y H  + + H D+KP+N+L       V+P T++        V++CD G    
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-- 295

Query: 244 LVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ 302
             +     + + +R+YR+PE++ G    Y+T  D+WS+GC++ EL  G+ L+     ++ 
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEH 353

Query: 303 LVEIIKVLGT-PTREEIKCMNPN----YTEFKFPQIKAHPWH--KIFHKRMPPEAV---- 351
           L  + K LG  P+    +C        Y      +    P H  +I   R   E +    
Sbjct: 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL 413

Query: 352 --DLVSRLLQYSPNLRCTALEACIHP----FFDELRD-PNARLPNGRPF---PPL 396
             DL+  LL Y    R  A +   HP    ++ E R  PN   P+ R      P+
Sbjct: 414 LCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRPTPI 466

Length = 467

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 52/244 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 152
           +V+G+G+FG V   +  +TG   A+K + +    +  ++  +R    +L   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 153 FFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
           F+S  DK  LYL  ++EF+P  + +  + K  +   +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------------------- 250
            +G  HRDIKP NLL++   H VKL DFG    L K                        
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 251 ----------------ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
                            S + +  Y APE +F  T Y    D WS+G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 295 PGES 298
             E+
Sbjct: 237 CSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 37/228 (16%)

Query: 99  VGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 150
           +G GSFG+V + +   +G     VA+K +  DK         +E   M  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 151 HCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
               +        L +V E  P     + + + A  +        +  +  Y  QI   +
Sbjct: 63  GVVLTHP------LMMVTELAPLGSLLDRLRKDALGH------FLISTLCDYAVQIANGM 110

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+     + HRD+  +N+L+     +VK+ DFG  + L + E +  Y+   + +     
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166

Query: 261 -APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEI 306
            APE +   T ++ A D+W  G  L E+   G+  + G SG   L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 30/226 (13%)

Query: 97  RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE     VAIK + ++   K       E   M  +DHP+VV
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L     S+       + L+ + +P    +  V  H      +  L +      QI + +
Sbjct: 73  RLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW----CVQIAKGM 122

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 123 SYLEE-KRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
           E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 14/217 (6%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLL 141
           P  + ++     +G+G++G VF+    + G   A+K +L      + E++        L 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72

Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
           DHPNVV     ++    K+   L LVLE     +V  + K + +  +RM    +    ++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYY 259
               L ++H    + HRD+K  N+L+      VKL DFG SA++        + + + ++
Sbjct: 133 ALMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 260 RAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQP 292
            APE+I       + Y    D+WS+G    EL  G P
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 69/300 (23%), Positives = 117/300 (39%), Gaps = 71/300 (23%)

Query: 96  ERVVGQGSFGIVFQ--AKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPN 145
            R +GQGSFG+V++  AK +  GE    VAIK V ++   + R     E   M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 146 VVSL-------KHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQ---RMPLIY 193
           VV L       +               +V+E + +   +  +      A       P   
Sbjct: 71  VVRLLGVVSTGQPTL------------VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 194 VKLYTY--QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            K      +I   +AY+       HRD+  +N +V      VK+ DFG  +       +I
Sbjct: 119 QKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DI 169

Query: 252 SYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGES 298
               + YYR            APE +     +TT  D+WS G VL E+  L +  + G S
Sbjct: 170 YE--TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLS 226

Query: 299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 358
             +++++ +   G     E  C +      +        W   ++ +M P  +++VS L 
Sbjct: 227 N-EEVLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 62/240 (25%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIK--------KVLQDKRYKNR 133
           P   + ++ E  +G+G+FG V++ +        +  +VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKH------Y 182
           E + M  L HPN+V    C      K++    L  E++      E + R + H       
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 183 SRASQRMPLIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
              + +  L          QI   + Y+       HRD+  +N LV      VK+ DFG 
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEG-LTVKISDFGL 170

Query: 241 AKVLVKGEPNISYICSRYYR------------APELI-FGATEYTTAIDIWSVGCVLAEL 287
           ++ +   +         YYR             PE I +G  ++TT  DIWS G VL E+
Sbjct: 171 SRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 28/217 (12%)

Query: 97  RVVGQGSFGIVFQAKCLETGET-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 145
           + +G G+FG V +A      ++     VA+K +        R     EL+ M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICR 203
           +V+L     + T    + +  + E+     Y    ++ R  +   L    L  ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YR 260
            +A++     + HRD+  +N+L+  H   VK+CDFG A+ ++     +    +R    + 
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
           APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 211 APESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 21/209 (10%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 153
           +VG G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 154 FSTTD---KDELYLNLVLEFV-PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
                    D+L+  LV+EF    +V  + K+    + +    ++     +I R L+++H
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEE--WIAYICREILRGLSHLH 128

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 266
               V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 129 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185

Query: 267 ---GATEYTTAIDIWSVGCVLAELLLGQP 292
                  Y    D+WS+G    E+  G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 52/241 (21%)

Query: 97  RVVGQGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 145
             +G G+FG V++    +     +G   VA+K        Q+K+   +E   M   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 146 VVS-LKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTYQ 200
           +V  L  C       +  Y+  ++E +      +  R A+        + L  +      
Sbjct: 61  IVKLLGVCL----LNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISYICS 256
           + +   Y+   +   HRD+  +N LV+   +     VK+ DFG A+ + K         S
Sbjct: 115 VAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------S 164

Query: 257 RYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQ 302
            YYR            APE L+ G   +TT  D+WS G ++ E+L LGQ  +P  +  + 
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222

Query: 303 L 303
           L
Sbjct: 223 L 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 14/205 (6%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 153
           +G+G++G V++    + G   A+K +L      + E++        L +HPNVV     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +         L LVLE     +V  + K      QR+    +    Y     L ++H   
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
            + HRD+K  N+L+      VKL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 272 TTA----IDIWSVGCVLAELLLGQP 292
             +     D+WS+G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 61/224 (27%), Positives = 110/224 (49%), Gaps = 22/224 (9%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LLDHPN--VVSL 149
           +V+G+G+FG V   K     +  A+K + + +  K  E    R     L++  N  + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            + F    D++ LYL  V+++       +    S+   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF---QDENNLYL--VMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF- 266
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 120 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 267 ---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
              G  +Y    D WS+G  + E+L G+  F  ES V+   +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 59/206 (28%), Positives = 85/206 (41%), Gaps = 34/206 (16%)

Query: 114 ETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165
            TG  VAIK +  D         R++ RE      L HPN+V+L      + +     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225
            V E+VP    R  +    A   +P         Q+  ALA  H   G+ HRD+KPQN++
Sbjct: 56  AVFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 226 VN-----PHTHQVKLCDFGSAKVLVKGEPNI--------SYICSRYYRAPELIFGATEYT 272
           V+     PH    K+ DFG   +L                 + +  Y APE + G    T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167

Query: 273 TAIDIWSVGCVLAELLLGQPLFPGES 298
              D+++ G +  E L GQ +  G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 30/216 (13%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
             +G+G+FG V++   L+    VA+K          KR   +E + ++  DHPN+V L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
                  K  +Y  +V+E VP           +   R+ +  +   +      + Y+   
Sbjct: 58  -IGVCVQKQPIY--IVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------APE- 263
               HRD+  +N LV    + +K+ DFG    + + E    Y  S   +       APE 
Sbjct: 113 -NCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166

Query: 264 LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGES 298
           L +G   YT+  D+WS G +L E   LG   +PG S
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 153
           +G+GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
              T      L +++E++       A    RA    P    ++ T   +I + L Y+H  
Sbjct: 72  LKGTK-----LWIIMEYLGGGS---ALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE 120

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 270
             + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
           Y +  DIWS+G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 16/219 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y   RV+G G+ G V  AK +  GE  A+K V        DK     E+  +   D  ++
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 147 VSLKHCFFSTTDKDE---LYLNLVLEFVPETVYRVA-KHYSRASQRMPLIYVKLYTYQIC 202
           V     F     ++    L + LVL++      R   K  ++ ++        L   Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 259
            A+ ++H    + HRDIK  N+L+  +   VKL DFG +K+    V  +   ++  + YY
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
            APE I+    Y+   D++S+G +L ELL  +  F GE+
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 55/247 (22%)

Query: 99  VGQGSFGIVFQAK-----CLETGETVAIKKVLQDKRYKN-----RELQTMRLL-DHPNVV 147
           +G+G+FG V +A+           TVA+K +  D   K+      E++ M+++  H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYR--------VAKHYSRASQRMPLIYVKLY-- 197
           +L       T +  LY+  V+E+      R          ++ S    R P   +     
Sbjct: 80  NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 198 ---TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
               YQ+ R + ++       HRD+  +N+LV    H +K+ DFG A+       +I +I
Sbjct: 135 VSFAYQVARGMEFLASK-KCIHRDLAARNVLVT-EDHVMKIADFGLAR-------DIHHI 185

Query: 255 CSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
              YYR            APE +F    YT   D+WS G +L E+  LG   +PG   V+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VE 241

Query: 302 QLVEIIK 308
           +L +++K
Sbjct: 242 ELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 64/237 (27%), Positives = 94/237 (39%), Gaps = 50/237 (21%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 136
           P+  I Y   R +GQG+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 3   PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 137 TMRLLDHPNVVSL--------KHC----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSR 184
            M   DHPN+V L          C    + +  D +E   +          +  +     
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 185 ASQRMPLIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242
               +PL   +      Q+   +AY+     V HRD+  +N LV  +   VK+ DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR 178

Query: 243 VLVKGEPNISYICSRYYRA------------PELIFGATEYTTAIDIWSVGCVLAEL 287
                  NI    + YY+A            PE IF    YTT  D+W+ G VL E+
Sbjct: 179 -------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 26/220 (11%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDH 143
           P++++    ER +G G FG V+      T + VA+K +           +E Q M+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMP-LIYVKLYTYQI 201
             +V L   +   ++++ +Y+  V E++ + ++    K       R+P L+ +     QI
Sbjct: 61  DKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112

Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--- 258
              +AY+       HRD+  +N+LV  +    K+ DFG A+++   E   +   +++   
Sbjct: 113 AEGMAYLES-RNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKFPIK 169

Query: 259 YRAPELI-FGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
           + APE   +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 32/229 (13%)

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVV 147
           +++M E  +G G FG+V   K       VAIK + +    +     E + M  L HP +V
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L   +   T +  LY+  V EF+     +  + +   + S+ M L   +     +C  +
Sbjct: 63  QL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGM 113

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YY 259
            Y+       HRD+  +N LV+  T  VK+ DFG  + ++  E    Y  S        +
Sbjct: 114 EYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307
             PE +F  ++Y++  D+WS G ++ E+   G+  F  +S   ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 16/165 (9%)

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 257 RY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 312
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293

Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
             +E  +   P+YT  +  Q     WH    +R  P   +LV  L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 44/217 (20%)

Query: 98  VVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 147
            +G+G FG VF AK      E GET+ + K LQ  + +N      REL   R L H NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYT--YQI 201
            L        + +  Y  ++LE+      +   R  K      +  PL   +      QI
Sbjct: 72  RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR- 260
              + ++     V HRD+  +N LV+    +VK+    S   L K   N     S YY+ 
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYN-----SEYYKL 175

Query: 261 ----------APELIFGATEYTTAIDIWSVGCVLAEL 287
                     APE +    +++T  D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 153
           +G+GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
              T      L +++E++               +  PL   ++ T   +I + L Y+H  
Sbjct: 72  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATE 270
             + HRDIK  N+L++ H  +VKL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
           Y +  DIWS+G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 61/244 (25%), Positives = 95/244 (38%), Gaps = 56/244 (22%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKC--LETGET---VAIKKVLQD------KRYKNREL 135
            + TI     R +G+G+FG VF  +C  LE       VA+ K L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRA----S 186
           + +    H N+V         T+ D     +V E++      + +       +      S
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 187 QRMPLIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
               L   +L     QI   + Y+     V HRD+  +N LV  +   VK+ DFG ++ +
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG-YDLVVKIGDFGMSRDV 172

Query: 245 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELLL--G 290
                   Y    YYR             PE I     +TT  D+WS G VL E+     
Sbjct: 173 --------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222

Query: 291 QPLF 294
           QP +
Sbjct: 223 QPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 15/168 (8%)

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           Y++Q+ R + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 257 RY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 312
           R    + APE IF    YTT  D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLLQ 359
             ++  +   P     +  +I    W     +R      V+++  LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 22/195 (11%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---ELQTMRLLDHPNVVSLKHCFFS 155
           +G+G FG V        G+ VA+K +  D         E   M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
               + LY+  V E++ +    V    SR    + L     +   +C  + Y+       
Sbjct: 71  --QGNPLYI--VTEYMAKGSL-VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFV 124

Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 272
           HRD+  +N+LV+      K+ DFG AK     E +      +    + APE +    +++
Sbjct: 125 HRDLAARNVLVS-EDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKKFS 177

Query: 273 TAIDIWSVGCVLAEL 287
           T  D+WS G +L E+
Sbjct: 178 TKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 64/295 (21%), Positives = 126/295 (42%), Gaps = 48/295 (16%)

Query: 93  YMAERVVGQGSFGIVF--QAKCLETGETVAIKKVL-------QDKRYKNRELQTMRLLDH 143
           Y+ ++ +G+GSFG V+  + K     E + + K +        +    N+E Q +  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           P +V   H  F   D       ++ E+     +    +      + +    V  +  Q+ 
Sbjct: 62  PAIVKF-HASFLERDA----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 261
             + Y+H    + HRD+K +N+ +    + +K+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE +     Y +  DIWS+GC+L E+      F G+   + L  +++++  PT       
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPT------- 222

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            P+  E                     +   ++  +L   P+LR +A E   +PF
Sbjct: 223 -PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 72/272 (26%), Positives = 113/272 (41%), Gaps = 60/272 (22%)

Query: 115 TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPET 174
           T +T  +K + +   Y +RE  T+     PN+V L     S   +D ++L  VL+     
Sbjct: 17  TQQTFILKGLRKSSEY-SRERLTIIPHCVPNMVCLHKYIVS---EDSVFL--VLQHA--- 67

Query: 175 VYRVAKHYSRASQ--RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ 232
                K +S  S+   +P   VK +  ++  AL  +H    VC RD+ P N+L++   H 
Sbjct: 68  --EGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGH- 123

Query: 233 VKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ 291
           ++L  F       + E +         Y APE + G +E T A D WS+G +L ELL G+
Sbjct: 124 IQLTYFSR---WSEVEDSCDGEAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGK 179

Query: 292 PLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA 350
            L     SG++                       +T    P+             +  EA
Sbjct: 180 TLVECHPSGINT----------------------HTTLNIPEW------------VSEEA 205

Query: 351 VDLVSRLLQYSPNLRCTALEACI-----HPFF 377
             L+ +LLQ++P  R  A  A +     HPFF
Sbjct: 206 RSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 55/238 (23%), Positives = 105/238 (44%), Gaps = 49/238 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNV 146
           + +G+G FG V +A            TVA+K + ++      R    E   ++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL---------- 196
           + L    +    +D   L L++E+     Y   + + R S+++   Y+            
Sbjct: 66  IKL----YGACSQDGPLL-LIVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 197 --------------YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242
                         + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 243 VLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
            + + +  +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 23/218 (10%)

Query: 93  YMAERVVGQGSFGIVFQA-KCLETGETVAIKKV-LQDKR---YKNRELQTMRLLDHPNVV 147
           Y+   +VG+      F A +  +  E V  K V L D+R   Y   EL  +   DH  +V
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 148 SLKHCF-FSTTDKDELYLNLVLEF-VPETVYRVAKHYSRASQRMPL--IYVKLYTYQICR 203
             KH   F + DK    L L++E+     + +  K   R  + +P     V L  YQI  
Sbjct: 129 --KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVL 180

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYR 260
           AL  +H    + HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY 
Sbjct: 181 ALDEVHSR-KMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           APEL +    Y+   D+WS+G +L ELL     F G S
Sbjct: 239 APEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 82/322 (25%), Positives = 128/322 (39%), Gaps = 68/322 (21%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQTMRLLDHPN---VVSLK 150
           +G+G FG V   +   TG+  A KK L  KR K R+     +   R+L   +   +VSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 151 HCFFSTTDKDELYLNLVLEF-----VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + F + TD     L LV+       +   +Y V +      +         YT QI   L
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRAC----FYTAQIISGL 110

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPEL 264
            ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     Y  +  + APEL
Sbjct: 111 EHLHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF--PGESGVDQLVEIIKVLGTPTREEIKCMN 322
           + G  EY  ++D +++G  L E++  +  F   GE          KV     ++ I   +
Sbjct: 169 LQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDS 217

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-------CTALEACIHP 375
             Y +                 +  P +      LL   P  R       C  L    HP
Sbjct: 218 VTYPD-----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--HP 258

Query: 376 FFDELRDPNARLPNGRPFPPLF 397
            F   RD N R       PP F
Sbjct: 259 LF---RDLNWRQLEAGMLPPPF 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 52/231 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRL---LDHPNVVSL 149
           R++G+G  G V+ A        VA+KK+ +D       K R L+  ++   L HP +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 150 KHCFFSTTDKDELY----------LNLVLEFVPETVYRVAKHYSRASQRMPL-IYVKLYT 198
              +   +D D +Y          L  +L+ V +      +   + S    L I+ K   
Sbjct: 68  ---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK--- 121

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV----------LVKGE 248
             IC  + Y+H   GV HRD+KP N+L+      V L D+G+A            +   E
Sbjct: 122 --ICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDE 177

Query: 249 PNISY---------ICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELL 288
            NI Y         + +  Y APE + G  A+E T   DI+++G +L ++L
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 55/300 (18%)

Query: 99  VGQGSFGIVFQAKCL-------ETGETVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 145
           +G+G FG V  A+ L       +   TVA+K +  D   K+      E++ M+++  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--------VAKHYSRASQRMP---LIYV 194
           +++L     + T    LY+  ++E+  +   R            YS    R+P   + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 195 KLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
            L   TYQ+ R + Y+     + HRD+  +N+LV    + +K+ DFG    L +   NI 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFG----LARDVNNID 191

Query: 253 YICSRY-------YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 249

Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FHKRMPPEAVDLVSRLLQYSPN 363
           +++K  G    +   C N  Y   +        WH I  H+    + V+ + R+L  + N
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 49/227 (21%)

Query: 83  RNGQPKQTIS-------YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL 135
           R  +P   ++       +   R +  GS G VF++   +  + V +K           E 
Sbjct: 154 RGCKPPSEVAKVVAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYAS--SVHEA 211

Query: 136 QTMRLLDHPNVVSLKH--------CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ 187
           + +R L HP V++L          C      + +LY  L                    +
Sbjct: 212 RLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL----------------GARLR 255

Query: 188 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247
            + L  V     Q+  A+ YIHG  G+ HRDIK +N+LVN     + L DFG+A    +G
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG 312

Query: 248 EPNISYICSRYY--------RAPELIFGATEYTTAIDIWSVGCVLAE 286
               S+    +Y         APE++ G   YT ++DIWS G V+ E
Sbjct: 313 ----SWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
           +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL---LGV 70

Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGGIG 213
            T +   Y  ++ EF+    Y     Y R   R  +  V L     QI  A+ Y+     
Sbjct: 71  CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-N 124

Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATE 270
             HRD+  +N LV  + H VK+ DFG ++ L+ G+   ++  +++   + APE +    +
Sbjct: 125 FIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNK 181

Query: 271 YTTAIDIWSVGCVLAEL-LLGQPLFPG 296
           ++   D+W+ G +L E+   G   +PG
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 57/289 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTMRLLDHPNVVS 148
           RV+G+G FG V+    +++       A+K +     L++     +E   M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMP----LIYVKLYTY 199
           L            L + L  E  P  V    KH     + R+    P    LI   L   
Sbjct: 61  L------------LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--- 105

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           Q+ + + Y+     V HRD+  +N +++  +  VK+ DFG A+ +   E    Y     +
Sbjct: 106 QVAKGMEYLASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNH 159

Query: 260 RAPEL--IFGATE------YTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVL 310
              +L   + A E      +TT  D+WS G +L EL+  G P +P     D  V +++  
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-- 217

Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 359
           G    +   C +P Y      ++    WH     R  P   +LVSR+ Q
Sbjct: 218 GRRLLQPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 79/334 (23%), Positives = 124/334 (37%), Gaps = 87/334 (26%)

Query: 96  ERVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDKRY-KNRELQT-MRLL----DHP 144
            + +G+G+FG V QA            TVA+K + +     + + L T +++L     H 
Sbjct: 12  GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHL 71

Query: 145 NVV------------------------------SLKHCFFSTTDKD-ELYLNLVLEFVPE 173
           NVV                              S + CF    +K          E   +
Sbjct: 72  NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131

Query: 174 TVYRVAKHYSRASQRM---------------------PLIYVKL--YTYQICRALAYIHG 210
            +  V+   S AS                        PL    L  Y++Q+ R + ++  
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS 191

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 264
              + HRD+  +N+L++   + VK+CDFG A+ + K   +  Y+     R      APE 
Sbjct: 192 RKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRKGDARLPLKWMAPES 246

Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           IF    YTT  D+WS G +L E+  LG   +PG       V+I +      +E  +   P
Sbjct: 247 IFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEFCRRLKEGTRMRAP 298

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
            Y   +   I    WH     R  P   +LV  L
Sbjct: 299 EYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---Y 253
           +TYQ+ R + ++       HRD+  +N+L+      VK+CDFG A+ ++     +S    
Sbjct: 242 FTYQVARGMEFL-ASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGST 299

Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
                + APE IF    YTT  D+WS G +L E+  LG   +PG
Sbjct: 300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 26/199 (13%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
           +G G FG+V+    LE  + VAIK +    + ++ +   E Q M  L HP +V L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 155 STTDKDELYLNLVLEFVPE---TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
             +      + LV EF+     + Y  A+    + +   L+ + L    +C  +AY+   
Sbjct: 70  ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQE--TLLGMCL---DVCEGMAYLESS 119

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 268
             V HRD+  +N LV      VK+ DFG  + ++  +   S   +++   + +PE +F  
Sbjct: 120 -NVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSF 175

Query: 269 TEYTTAIDIWSVGCVLAEL 287
           ++Y++  D+WS G ++ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 19/164 (11%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKN--RELQTMR----LLDHPNVVSLKH 151
           + +G+FG V+  +     +  A+K V + D   KN   ++Q  R    L   P +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL-- 69

Query: 152 CFFSTTDKDELYLNLVLEF-VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            ++S    + +YL  V+E+ +   V  +   Y    + M + Y+     ++  AL Y+H 
Sbjct: 70  -YYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR 122

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
             G+ HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 123 H-GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 35/211 (16%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 147
           E+V+G G FG V + +    G+    VAIK +     DK+  +   E   M   DHPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            L+     +       + ++ E++     +   R         Q + ++        I  
Sbjct: 69  RLEGVVTKSRP-----VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR------GIAS 117

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ICSR 257
            + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R
Sbjct: 118 GMKYL-SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIR 173

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
           +  APE I    ++T+A D+WS G V+ E++
Sbjct: 174 W-TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 147
           E+V+G G FG V   +    G+    VAIK +     +K+ ++   E   M   DHPN++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     T  K  +   +V E++      +     +   +  +I +      I   + Y
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENG--SLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 122 L-SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 178

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G V+ E++
Sbjct: 179 EAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 26/204 (12%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158
           +G+GSFG V++     T E VAIK +  D      E++ ++      +  L  C      
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQ----QEITVLSQC------ 59

Query: 159 KDELYLNLVL-EFVPETVYRVAKHYSRASQRMPLI--------YVKLYTYQICRALAYIH 209
            D  Y+      ++  T   +   Y      + L+        Y+     +I + L Y+H
Sbjct: 60  -DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 268
               + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   
Sbjct: 119 SERKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQ 175

Query: 269 TEYTTAIDIWSVGCVLAELLLGQP 292
           + Y    DIWS+G    EL  G+P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 27/206 (13%)

Query: 97  RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYK-NREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE     VAIK++ +    K N+E+      M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 148 SLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
            L   C  ST       + L+ + +P   +     Y R  +  +   Y+  +  QI + +
Sbjct: 73  RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
            Y+     V HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 123 NYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I     YT   D+WS G  + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 44/221 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLDHPNVVSLKH 151
           ER +G G FG V++         VAIK +  D   K +    E+Q ++ L H +++SL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 152 CFFSTTDKDELYL--------NLVLEFV--PETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
            F   +  + +Y+        +L L F+  PE          +      LI +     Q+
Sbjct: 68  -FAVCSVGEPVYIITELMEKGSL-LAFLRSPE---------GQVLPVASLIDM---ACQV 113

Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPNISYICS 256
              +AY+       HRD+  +N+LV       K+ DFG A+++     +  +  I Y   
Sbjct: 114 AEGMAYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY--- 168

Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPG 296
             + APE       ++T  D+WS G +L E+   GQ  +PG
Sbjct: 169 -KWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 155
           ++G+G FG V Q +   TG+ VA+K +  D   +    E   M  L H N+V L      
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
                   L +V+E + +    V    +R    + +I +  ++  +   + Y+     + 
Sbjct: 71  NG------LYIVMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122

Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 275
           HRD+  +N+LV+      K+ DFG A+V   G  N        + APE +    ++++  
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178

Query: 276 DIWSVGCVLAELL-LGQPLFP 295
           D+WS G +L E+   G+  +P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 147
           +V+G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L     S T      + LV + +P    +  V +H      ++ L +      QI + +
Sbjct: 73  RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC----VQIAKGM 122

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
            Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A 
Sbjct: 123 MYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL--GQP 292
           E I    ++T   D+WS G  + EL+   G+P
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 15/108 (13%)

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
           ++ Q+ + + ++       HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
            +       + APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 30/223 (13%)

Query: 97  RVVGQGSFGIVFQAKCLETGET-VAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
           R +G G FG V++   L    T VA+K +            E Q M+ L HP ++ L   
Sbjct: 12  RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66

Query: 153 FFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMP-LIYVKLYTYQICRALAYI-- 208
           +   T ++ +Y+  V E +   ++    +  +  + ++P LI +     Q+   +AY+  
Sbjct: 67  YAVCTLEEPIYI--VTELMKYGSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLEA 121

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 265
              I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + APE  
Sbjct: 122 QNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAA 176

Query: 266 FGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 305
                ++   D+WS G +L E++  G+  +PG +   V Q V+
Sbjct: 177 L-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 38/226 (16%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ-------TMRLLDHPNV 146
           +++G+G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 147 VSLKHCFFSTTDKDELYLNLV-LEFVPETVYRVAKHYSR---ASQRMPLIYVKLYTYQIC 202
           + L    F  +   ++   +V L F+          YSR     +++PL  +  +   I 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
             + Y+       HRD+  +N ++      V + DFG +K +  G+         YYR  
Sbjct: 124 LGMEYLSNR-NFIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 263 ELI-----FGATE------YTTAIDIWSVGCVLAELL-LGQPLFPG 296
            +      + A E      YT+  D+W+ G  + E+   GQ  +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 30/201 (14%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
           +G G FG+V   K     + VAIK + +    ++    E + M  L HPN+V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67

Query: 156 TTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            T +  +++  V E++         R  K        + +         +C A+ Y+   
Sbjct: 68  CTKQRPIFI--VTEYMANGCLLNYLRERKGKLGTEWLLDM------CSDVCEAMEYLESN 119

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIF 266
            G  HRD+  +N LV    + VK+ DFG A+ ++  +    Y  S+  +     AP  +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173

Query: 267 GATEYTTAIDIWSVGCVLAEL 287
             + +++  D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 27/206 (13%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 148
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 149 --LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
             L  C  ST       + LV + +P   Y     Y R ++ R+    +  +  QI + +
Sbjct: 73  RLLGICLTST-------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
           +Y+   + + HRD+  +N+LV    H VK+ DFG A++L   E        +    + A 
Sbjct: 123 SYLE-EVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I     +T   D+WS G  + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 46/286 (16%)

Query: 97  RVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 147
           R++G+G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNV+
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 148 SLKHCFFSTTDKDELYLNLV-LEFVPETVYRVAKHYSRASQR---MPLIYVKLYTYQICR 203
            L      +  K  L + +V L F+           SR  +    +PL  +  +   I  
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 260
            + Y+       HRD+  +N ++N +   V + DFG +K +  G+         YYR   
Sbjct: 125 GMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGD---------YYRQGC 173

Query: 261 APELIFG--ATE------YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 311
           A +L     A E      YTT  D+W+ G  + E++  GQ  + G    +    +IK  G
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK--G 231

Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
              ++   C+   Y      ++    W      R  P    L  +L
Sbjct: 232 NRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)

Query: 191 LIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           L Y+ L  ++YQ+   + ++     V HRD+  +N+L+      VK+CDFG A+ +++  
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGLARDIMRDS 293

Query: 249 PNIS---YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
             IS         + APE IF    YTT  D+WS G +L E+  LG   +P     +Q  
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352

Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLL 358
             IK          +   P +   +  +I    W + F  R    + V LV  LL
Sbjct: 353 NAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 80/352 (22%), Positives = 134/352 (38%), Gaps = 95/352 (26%)

Query: 98  VVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 149
           V+G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAK-----HYSRASQRMPLIYVKLYTYQICRA 204
           +  F +    +EL++           Y  AK     H+      + + Y+      + +A
Sbjct: 65  RATFIA---DNELWV-----VTSFMAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKA 113

Query: 205 LAYIHGGIGVCHRDIKPQNLLVN-----------------PHTHQVKLC-DFG--SAKVL 244
           L YIH  +G  HR +K  ++L++                  H  ++++  DF   S KVL
Sbjct: 114 LDYIH-HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL 172

Query: 245 VKGEPNISYICSRYYRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL 303
               P +S         PE++    + Y    DI+SVG    EL  G   F        L
Sbjct: 173 ----PWLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219

Query: 304 VEIIKVLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHP 337
           +E  K+ GT                  P+R        E      P  +     +  +HP
Sbjct: 220 LE--KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHP 274

Query: 338 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL-RDPNARLP 388
           +++ F     P     V + LQ +P+ R +A     H FF ++ R  +  LP
Sbjct: 275 YNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 15/108 (13%)

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
           ++YQ+ + ++++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
            +       + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 26/69 (37%), Positives = 37/69 (53%), Gaps = 9/69 (13%)

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 258
           QI  AL  +H   G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   + 
Sbjct: 263 QILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 259 ----YRAPE 263
               Y APE
Sbjct: 319 LDPRYAAPE 327

Length = 566

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHC 152
           ++G+G+FG VF+   L+    VA+K   +D  +  K + L   R+L   DHPN+V L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
               T +  +Y  +V+E VP   +       +    +    +  +       +AY+    
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLESK- 112

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPE-LI 265
              HRD+  +N LV    + +K+ DFG    + + E +  Y  S        + APE L 
Sbjct: 113 NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALN 167

Query: 266 FGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
           +G   Y++  D+WS G +L E   LG   +PG
Sbjct: 168 YG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++V+G G FG VF+      G     VAIK +      K R     E   M    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+               +V +F P  +           + +     +  +YQ+   L  
Sbjct: 70  RLE--------------GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115

Query: 208 IHGGI------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---- 257
           I  G+         HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S     
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIP 173

Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
             + APE I    ++T+A D+WS G V+ E++
Sbjct: 174 IRWTAPEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 24/207 (11%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           E V+G G FG V + +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + ++ EF+      +     +   +  +I +      I   + Y
Sbjct: 69  HLEGVVTKSRP-----VMIITEFMENGA--LDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRA 261
           +   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + A
Sbjct: 122 L-SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELL 288
           PE I    ++T+A D+WS G V+ E++
Sbjct: 180 PEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 25/219 (11%)

Query: 97  RVVGQGSFGIVFQAKCLETGET--VAIK--KVLQDKRYKN----RELQTMRLLDHPNVVS 148
           + +G+G FG V + +  +      VA+K  K+    R +      E   M+  DHPNV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 149 LKHCFFSTTDKDELYLNLV-LEFVPETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRA 204
           L      T + +     +V L F+          YSR     Q +P   +  +   I   
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           + Y+       HRD+  +N ++N + + V + DFG +K +  G+    Y   R  + P +
Sbjct: 125 MEYLSSK-SFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP-V 178

Query: 265 IFGATE------YTTAIDIWSVGCVLAELLL-GQPLFPG 296
            + A E      YTT  D+WS G  + E+   GQ  +PG
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 45/189 (23%), Positives = 73/189 (38%), Gaps = 40/189 (21%)

Query: 120 AIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------KHCFFSTTDKDELYLNLVL-EFV 171
           A     +D     +E++ +  L  PN+  L                 +   LN  L + V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 172 PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231
            ET        S++     L+Y+     QI   + Y+   +   HRD+  +N LV    +
Sbjct: 115 AETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLES-LNFVHRDLATRNCLVGK-NY 167

Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------ELIFGATEYTTAIDIWS 279
            +K+ DFG ++ L        Y    YY    RAP        E +    ++TT  D+W+
Sbjct: 168 TIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWA 217

Query: 280 VGCVLAELL 288
            G  L E+L
Sbjct: 218 FGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 80/331 (24%), Positives = 137/331 (41%), Gaps = 85/331 (25%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR-----ELQ 136
            ++ I+ + E  +GQGSFG+V++  A+ +  GE    VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLI 192
            M+     +VV L         K +  L +V+E +     ++  R  +  +  +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 193 YVK---LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
            ++       +I   +AY++    V HRD+  +N +V  H   VK+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAEL--LLGQPLFP 295
                   YYR            APE +     +TT+ D+WS G VL E+  L  QP + 
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223

Query: 296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 355
           G S  +Q+++ +             M+  Y +         P         P    DL+ 
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 356 RLLQYSPNLRCTALEAC------IHPFFDEL 380
              Q++P +R T LE        +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 64/244 (26%), Positives = 113/244 (46%), Gaps = 47/244 (19%)

Query: 99  VGQGSFGIVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 145
           +G+G FG V  A+ +   +       TVA+K +  D   K+      E++ M+++  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--------VAKHYSRASQRMP---LIYV 194
           +++L     + T    LY+  ++E+  +   R            YS  + ++P   L + 
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 195 KLYT--YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
            L +  YQ+ R + Y+     + HRD+  +N+LV    + +K+ DFG    L +   NI 
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFG----LARDVHNID 188

Query: 253 YICSRY-------YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
           Y            + APE +F    YT   D+WS G +L E+  LG   +PG   V++L 
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELF 246

Query: 305 EIIK 308
           +++K
Sbjct: 247 KLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 23/153 (15%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNR------ELQTMRLLDHPNVVSL 149
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E   +   D+  VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM---PLIYVKLYTYQICRALA 206
              ++S  DKD LY   V++++P               RM   P    + Y  ++  A+ 
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRMGIFPEDLARFYIAELTCAVE 115

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239
            +H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 39/138 (28%), Positives = 56/138 (40%), Gaps = 46/138 (33%)

Query: 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
           G PN        Y APE++   T YT   D WSVG +L E+L+GQP F  ++ ++  +++
Sbjct: 210 GTPN--------YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260

Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH----KRMPPEAVDLVSRLLQYSP 362
           I                              W    H     ++ PEA DL+ +L +  P
Sbjct: 261 IN-----------------------------WQTSLHIPPQAKLSPEASDLIIKLCR-GP 290

Query: 363 NLRC---TALEACIHPFF 377
             R     A E   HPFF
Sbjct: 291 EDRLGKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 26/199 (13%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
           +G G FG+V   K       VAIK + +    ++    E + M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 156 TTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            T +  +Y  +V E++         R      + SQ + +         +C  +AY+   
Sbjct: 68  CTKQRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQLLEM------CKDVCEGMAYLESK 119

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 268
               HRD+  +N LV+     VK+ DFG ++ ++  E   S + S++   +  PE +   
Sbjct: 120 -QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175

Query: 269 TEYTTAIDIWSVGCVLAEL 287
           +++++  D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 39/219 (17%)

Query: 98  VVGQGSFGIVFQAKCLETG----ETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 148
           ++ +G+FG +F    ++      E V +K V              E   +  L H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR--------ASQRMPLIYVKLYTYQ 200
           + H      +   +         P   +   K + +          Q +    +     Q
Sbjct: 73  ILHVCIEDGEPPFVLY-------PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC----- 255
           I   ++Y+H   GV H+DI  +N +++    QVK+ D   ++ L   +    Y C     
Sbjct: 126 IACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLGDNE 179

Query: 256 SRYYR--APELIFGATEYTTAIDIWSVGCVLAELL-LGQ 291
           +R  +  A E +    EY++A D+WS G +L EL+ LGQ
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 27/220 (12%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDH 143
           P++T+     + +G G FG V+          VAIK + Q          E   M+ L H
Sbjct: 4   PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           P +V L    ++   ++ +Y+  + E++ E    V    +    ++ +  +     QI  
Sbjct: 61  PRLVRL----YAVVTQEPIYI--ITEYM-ENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------ 257
            +A+I       HRD++  N+LV+  T   K+ DFG A+++   E    Y          
Sbjct: 114 GMAFIER-KNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPI 167

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
            + APE I   T +T   D+WS G +L E++  G+  +PG
Sbjct: 168 KWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 61/247 (24%), Positives = 111/247 (44%), Gaps = 53/247 (21%)

Query: 99  VGQGSFGIVFQAKCL-------ETGETVAIKKVLQDKRYKN-----RELQTMRLLD-HPN 145
           +G+G FG V +A+         +   TVA+K +  +   K+      E++ M+L+  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA--------------SQRMPL 191
           +++L       T +  LY+  ++E+  +   R    + RA                   L
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLR---EFLRARRPPGPDYTFDITKVPEEQL 131

Query: 192 IYVKLYT--YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
            +  L +  YQ+ R + Y+     + HRD+  +N+LV    + +K+ DFG    L +G  
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFG----LARGVH 185

Query: 250 NISYICSRY-------YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
           +I Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V+
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-VE 243

Query: 302 QLVEIIK 308
           +L ++++
Sbjct: 244 ELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 43/221 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 147
           + V+G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 148 SL-KHCFFSTTDKDELYLNLVLEFVP----------------ETVYRVAKHYSRASQRMP 190
           +L   C      +   YL L +E+ P                +  + +A   +       
Sbjct: 72  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKG 247
           L++   +   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK 
Sbjct: 126 LLH---FAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK- 179

Query: 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
              +  +  R+     L +    YTT  D+WS G +L E++
Sbjct: 180 -KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 52/224 (23%)

Query: 99  VGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSL 149
           +G+G+FG VF A+C     E  + +   K L++     ++   RE + + +L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 150 KHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLIYVKL 196
              F+    +    L +V E++             P+    +A     A  ++ L  +  
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDA-KILAGGEDVAPGQLTLGQMLA 126

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
              QI   + Y+   +   HRD+  +N LV      VK+ DFG ++ +   +        
Sbjct: 127 IASQIASGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD-------- 176

Query: 257 RYYRA------------PELIFGATEYTTAIDIWSVGCVLAELL 288
            YYR             PE I    ++TT  DIWS G VL E+ 
Sbjct: 177 -YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)

Query: 99  VGQGSFGIVFQA--KCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
           +G G+FG V +   K  +    VAIK VL+++  K+      RE + M  LD+P +V + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
                  + + L   LV+E        + K  S     + +  V    +Q+   + Y+ G
Sbjct: 61  ---IGVCEAEALM--LVMEMASGG--PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 211 GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-------YRAP 262
              V HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++++  D+WS G  + E  
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 64/255 (25%), Positives = 105/255 (41%), Gaps = 54/255 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGET-----VAIKKV----LQDKRYKNRELQTMRLLDHPNV 146
           +R +G+G+FG VF A+C     T     VA+K +    L  ++   RE + +  L H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLIY 193
           V     +    D D L   +V E++             P+ +  V     +A   + L  
Sbjct: 70  VKF---YGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           +     QI   + Y+     V HRD+  +N LV  +   VK+ DFG ++ +         
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGANL-LVKIGDFGMSRDVYS------- 175

Query: 254 ICSRYYRA------------PELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFP-GES 298
             + YYR             PE I    ++TT  D+WS G +L E+     QP F    +
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Query: 299 GVDQLVEIIKVLGTP 313
            V + +   +VL  P
Sbjct: 233 EVIECITQGRVLERP 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 72/305 (23%), Positives = 130/305 (42%), Gaps = 65/305 (21%)

Query: 99  VGQGSFGIVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 145
           +G+G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--------VAKHYSRASQRMPLIYVKLY 197
           +++L     + T    LY+  ++E+  +   R            Y     ++P   +   
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 198 -----TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
                 YQ+ R + Y+     + HRD+  +N+LV    + +K+ DFG A+       +I 
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR-------DIH 191

Query: 253 YICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG 299
           +I   YY+            APE +F    YT   D+WS G +L E+  LG   +PG   
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247

Query: 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLL 358
           V++L +++K  G    +   C N  Y   +        WH +  +R    + V+ + R+L
Sbjct: 248 VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRIL 300

Query: 359 QYSPN 363
             + N
Sbjct: 301 ALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 63/294 (21%), Positives = 105/294 (35%), Gaps = 63/294 (21%)

Query: 97  RVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           R +G G+FG V++              VA+K + +    ++      E   M   +H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 147 VSLKHCFFSTTDKDELYLNLVL-------EFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
           V        + ++   ++ L L        F+ E   R  +  S   +   L++      
Sbjct: 72  V---RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD--LLFCARDVA 126

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 257
           + C+ L   H      HRDI  +N L+         K+ DFG A+ + +         + 
Sbjct: 127 KGCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------AS 173

Query: 258 YYR-----------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQL 303
           YYR            P   F    +T+  D+WS G +L E+  LG   +PG +   V + 
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233

Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V     L  P      C  P Y      +I    W      R  P    ++ R+
Sbjct: 234 VTGGGRLDPPK----GCPGPVY------RIMTDCWQHTPEDR--PNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 57/228 (25%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 147
           E V+G+G+FG V +A   + G     AIK + +     D R    EL+ + +L  HPN++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 148 SL-KHCFFSTTDKDELYLNLVLEFVP--------------ETVYRVAKHYSRASQRMPLI 192
           +L   C      ++  YL + +E+ P              ET    AK +  AS      
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST----- 115

Query: 193 YVKLYTYQICRALAYIHGGI------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246
              L + Q+ +  + +  G+         HRD+  +N+LV  +    K+ DFG    L +
Sbjct: 116 ---LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-ASKIADFG----LSR 167

Query: 247 GEPNISYICSRYYRAPELIFGATE------YTTAIDIWSVGCVLAELL 288
           GE    Y+     R P + + A E      YTT  D+WS G +L E++
Sbjct: 168 GEE--VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 34/244 (13%)

Query: 90  TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMR 139
           T+ +M E  +G+  FG V++         E  + VAIK  L+DK     R + +    MR
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62

Query: 140 L-LDHPNVVSL---------KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM 189
             L HPN+V L             FS     +L+  LV+      V       +  S   
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 190 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE- 248
           P  +V + T QI   + ++     V H+D+  +N+LV    + VK+ D G  + +   + 
Sbjct: 123 PADFVHIVT-QIAAGMEFLSSH-HVVHKDLATRNVLVFDKLN-VKISDLGLFREVYAADY 179

Query: 249 ---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
                 S +  R+     +++G  +++   DIWS G VL E+   G   + G S  D ++
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VI 236

Query: 305 EIIK 308
           E+I+
Sbjct: 237 EMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 36/121 (29%), Positives = 56/121 (46%), Gaps = 29/121 (23%)

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           QI   + Y+   +   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 260 R------------APELIFGATEYTTAIDIWSVGCVLAELLL---GQPLFPGESGVDQLV 304
           R            A E I    ++TTA D+W+ G  L E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 305 E 305
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 31/208 (14%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 147
           +++G G FG V +   +  G+++ I    K +QD+  +         +  M  LDH  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 148 SLKH-CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            L   C  ++       L LV +  P    +  V +H      +  L +      QI + 
Sbjct: 73  RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKG 121

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYR 260
           + Y+     + HR++  +N+L+   +  V++ DFG A +L   +    Y       ++  
Sbjct: 122 MYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL 288
              ++FG   YT   D+WS G  + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 29/75 (38%), Positives = 39/75 (52%), Gaps = 5/75 (6%)

Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPN 250
           +K    Q+   L  +H  IG+ HRDIKP+NLLV     QVK+ DFG+A  +  G    P 
Sbjct: 311 IKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPL 368

Query: 251 ISYICSRYYRAPELI 265
              +  RY    EL+
Sbjct: 369 YGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
           +GQG FG V+      T + VAIK +           +E Q M+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
              ++ +Y+  V EF+ + ++    K       ++P + V +   QI   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIER-MNY 123

Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL-IFG 267
            HRD++  N+LV  +    K+ DFG A+++   E    Y   +       + APE  ++G
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEAALYG 178

Query: 268 ATEYTTAIDIWSVGCVLAELLL-GQPLFPG 296
              +T   D+WS G +L EL+  G+  +PG
Sbjct: 179 --RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 25/215 (11%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLDHPNVV 147
           S    + +G G FG V+       G T    K L+           E Q M+ L H  +V
Sbjct: 7   SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
            L    ++   ++ +Y+  V E++ + ++    K     + ++P + V +   Q+   +A
Sbjct: 65  QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           YI   +   HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE
Sbjct: 117 YIER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPE 173

Query: 264 L-IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPG 296
             ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 8/116 (6%)

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSR 257
           Q+  A+ YIH    + HRDIK +N+ +N     V L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVL 310
              +PE++ G   Y    DIWS G +L ++L       G+ G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 55/292 (18%)

Query: 99  VGQGSFGIVFQAKCLETGETVA--IKKVLQDKRYKN------RELQTMRLLDHPNVVS-L 149
           +G G FG V   +    G + A  + K L+     +      +E+Q  R L+HPNV+  L
Sbjct: 3   IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM------PLIYVKLYTYQICR 203
             C  S       YL LVLEF P       K+Y R+++ M        +  ++   ++  
Sbjct: 62  GQCIESIP-----YL-LVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YR 260
            L ++H      H D+  +N  +      VK+ D+G A      +  I+  C      + 
Sbjct: 112 GLLWLH-QADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 261 APEL--IFGA----TEYTTAIDIWSVGCVLAEL--LLGQPLFPGESGVDQLVEIIKVLGT 312
           APEL  I G      + T   +IWS+G  + EL     QP +P  S    L ++++    
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVVR---- 224

Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFH-KRMPPE---AVDLVSRLLQY 360
              ++IK   P           +  W+++     + PE     + V  LL Y
Sbjct: 225 --EQDIKLPKPQ-----LDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 57/226 (25%)

Query: 98  VVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVVSL 149
           V+G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN+++L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 150 -KHCFFSTTDKDELYLNLVLEFVP--------------ETVYRVAKHYSRASQRMPLIYV 194
              C      +   YL L +E+ P              ET    A   S AS        
Sbjct: 62  LGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-------- 107

Query: 195 KLYTYQICRALAYIHGGIG------VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
            L + Q+    A +  G+         HRD+  +N+LV  +    K+ DFG    L +G+
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFG----LSRGQ 162

Query: 249 PNISYICSRYYRAPELIFGATE------YTTAIDIWSVGCVLAELL 288
               Y+     R P + + A E      YTT  D+WS G +L E++
Sbjct: 163 E--VYVKKTMGRLP-VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 65/234 (27%)

Query: 99  VGQGSFGIVFQ------AKCLETGET--------VAIKKVLQD--KRYKN---RELQTMR 139
           +G+G FG V        A+ L  G          VA+K +  D  K  +N   +E++ M 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-------------ETVYRVAKHYSRAS 186
            L +PN++ L      + D     L ++ E++              E+ +  A +    S
Sbjct: 73  RLKNPNIIRLL-GVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 187 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246
               L+Y+ +   QI   + Y+   +   HRD+  +N LV  H + +K+ DFG ++ L  
Sbjct: 128 -IANLLYMAV---QIASGMKYL-ASLNFVHRDLATRNCLVGNH-YTIKIADFGMSRNLYS 181

Query: 247 GEPNISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL 288
           G+         YYR            A E I    ++TTA D+W+ G  L E+ 
Sbjct: 182 GD---------YYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 54/227 (23%)

Query: 96  ERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV 146
           +R +G+G+FG VF A+C     E  + +   K L+D     ++  +RE + +  L H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLIY 193
           V     +    + D L +  V E++             P+ V     +      +  +++
Sbjct: 70  VKF---YGVCVEGDPLIM--VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           +     QI   + Y+     V HRD+  +N LV  +   VK+ DFG ++ +   +     
Sbjct: 125 I---AQQIAAGMVYLASQHFV-HRDLATRNCLVGENL-LVKIGDFGMSRDVYSTD----- 174

Query: 254 ICSRYYRA------------PELIFGATEYTTAIDIWSVGCVLAELL 288
               YYR             PE I    ++TT  D+WS+G VL E+ 
Sbjct: 175 ----YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	429
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK10345	210	hypothetical protein; Provisional	99.82
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.81
smart00090	237	RIO RIO-like kinase.	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.39
KOG1243	690	consensus Protein kinase [General function predict	99.39
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.3
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.24
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.21
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.11
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.97
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
COG4248	637	Uncharacterized protein with protein kinase and he	98.81
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.7
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.62
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.57
PRK09902	216	hypothetical protein; Provisional	98.55
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.53
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.42
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.41
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.35
PF01636	239	APH: Phosphotransferase enzyme family This family	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.15
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.08
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.02
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.95
PLN02876	822	acyl-CoA dehydrogenase	97.86
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.72
KOG2270	520	consensus Serine/threonine protein kinase involved	97.68
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.57
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.54
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.5
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.47
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.46
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.42
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.42
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.36
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.32
PRK10593	297	hypothetical protein; Provisional	97.3
PRK05231	319	homoserine kinase; Provisional	97.17
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.14
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.88
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.75
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.68
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.61
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.6
PLN02236	344	choline kinase	96.57
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.57
PRK12396	409	5-methylribose kinase; Reviewed	96.38
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.36
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.17
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.16
PLN02756	418	S-methyl-5-thioribose kinase	95.53
PTZ00384	383	choline kinase; Provisional	94.97
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	93.94
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.38
PRK10271	188	thiK thiamine kinase; Provisional	92.57
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	92.45
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.27
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.13
COG2334	331	Putative homoserine kinase type II (protein kinase	91.35
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.16

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-72  Score=508.73  Aligned_cols=352  Identities=74%  Similarity=1.208  Sum_probs=330.6

Q ss_pred             cceEEEecCCCCCCCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeecccee
Q 014156           73 GHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC  152 (429)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~  152 (429)
                      ++.......+.........+|.-.+++|+|+||.||.|....+++.||||++..+.+...+|+.+|+.++|||||++..+
T Consensus         6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~   85 (364)
T KOG0658|consen    6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF   85 (364)
T ss_pred             eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence            34444555555555566778999999999999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc
Q 014156          153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  232 (429)
Q Consensus       153 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~  232 (429)
                      |....+.+..|+.+||||++.+|++.++++......++...++-|.+||++||.||| +.||+||||||.|+|+|.+.+.
T Consensus        86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh-~~~IcHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH-SHGICHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH-hcCcccCCCChheEEEcCCCCe
Confidence            887776667889999999999999999999888999999999999999999999999 7999999999999999999889


Q ss_pred             eEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014156          233 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       233 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      +||||||.|+....++...++.+|++|+|||.+.+...|+.+.||||.||++.||+-|++.|+|.+..+++..|++.+|.
T Consensus       165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRP  392 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~  392 (429)
                      |+.+.+.++++++.+..+|++....|.+.+.+..++++.+|+.++|.++|.+|.++.|+|.||||++++++....+++.+
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~  324 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRP  324 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCChhhhccCCHHHHHhhcHHHHhhhCCC
Q 014156          393 FPPLFNFKPQELKGASKELLSKLIPEHARKQCPF  426 (429)
Q Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (429)
                      .|+.++|+..++ +...+++..++|++.+.+...
T Consensus       325 lp~lf~f~~~e~-~~~~~~~~~l~p~~~~~~~~~  357 (364)
T KOG0658|consen  325 LPPLFNFKRAEL-GISPELVNVLIPEHLREQEKD  357 (364)
T ss_pred             CCCccCchHHHh-ccchHHHHhhccHhhhhhccc
Confidence            999999999854 678899999999998887653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-59  Score=422.81  Aligned_cols=321  Identities=39%  Similarity=0.644  Sum_probs=272.3

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .|..++.||+|+||.|+.|.++.+|+.||||++..      ......+|+++|+.++|+||+.+.+++.......-.-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            47778999999999999999999999999998852      234455899999999999999999988663333444589


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|+|+|+.+|..+++.    ++.++...++.+++||++||.|+| +.+|+||||||.|+|++.+. .+||||||+|+...
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiH-SAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIH-SANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhh-cccccccccchhheeeccCC-CEEeccccceeecc
Confidence            9999999988887764    455999999999999999999999 89999999999999999998 79999999999875


Q ss_pred             c---CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 K---GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .   ....+.++.|++|+|||++.....|+.++||||+|||+.||++|++.|+|.+..+++..|...+|.|..+.+....
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            3   4455778899999999999888899999999999999999999999999999999999999999999998887655


Q ss_pred             CC-Ccc--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCC
Q 014156          323 PN-YTE--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNF  399 (429)
Q Consensus       323 ~~-~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  399 (429)
                      .. ...  ...|..+..++...|+ +.++.+++|+.+||.+||.+|+|++|+|.||||..+.++...+.....+..    
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~----  331 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS----  331 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc----
Confidence            22 111  2577888888888887 689999999999999999999999999999999999999887433322211    


Q ss_pred             ChhhhccCCHHHHHhhcHHHHhhhCCC
Q 014156          400 KPQELKGASKELLSKLIPEHARKQCPF  426 (429)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (429)
                        .+.. ...+.++.++.++.-.-+|-
T Consensus       332 --~~~~-~~~~~~r~~i~~e~~~~~~~  355 (359)
T KOG0660|consen  332 --FEHE-LTEEELRELIYKEILDFHPD  355 (359)
T ss_pred             --cccc-ccHHHHHHHHHHHHHhhCcc
Confidence              2222 55788888888887665554

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-60  Score=442.99  Aligned_cols=283  Identities=37%  Similarity=0.663  Sum_probs=253.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh-----HHHHHHHHHHcC-CCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-----KNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+|.++++||.|.||.||+|+...+|+.||||++++....     ..||++.|++|+ |||||++.+++.+..   . .
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~---~-~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND---R-I   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC---c-e
Confidence            45899999999999999999999999999999988754322     248999999999 999999999885433   1 6


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++|||||+.+|+++++..   ...|++..++.|++||++||+|+| ++|+.||||||+|||+.... .|||+|||+|+.
T Consensus        85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiH-k~GfFHRDlKPENiLi~~~~-~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIH-KHGFFHRDLKPENILISGND-VIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHH-hcCcccccCChhheEecccc-eeEecccccccc
Confidence            8999999999999999863   678999999999999999999999 89999999999999999655 799999999999


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  321 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  321 (429)
                      .......+.++.|++|+|||++.....|+.++||||+|||++|+.+-++.|+|.++.+++.+|..++|.|..+.+..-  
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            988888899999999999999998888999999999999999999999999999999999999999999998766541  


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      -.....+.+|+....++...++. .+.++.+||.+||.+||.+||||.++|+||||+..+.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            12334567888888888877777 8999999999999999999999999999999987543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.8e-59  Score=412.60  Aligned_cols=281  Identities=37%  Similarity=0.682  Sum_probs=246.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..|..+.++|+|+||.||+++++.||+.||||++....      ....||+++|++|+|+|+|.++.+|     .....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            35888999999999999999999999999999986532      2335899999999999999999999     555558


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|+|||+.++++.+..   ....++...++.+++|++.|+.|+| +.++|||||||+||||+.++ .+||||||+|+..
T Consensus        77 hLVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cH-k~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCH-KNNCIHRDIKPENILITQNG-VVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhh-hcCeecccCChhheEEecCC-cEEeccchhhHhh
Confidence            89999999988887765   3567999999999999999999999 88999999999999999888 8999999999988


Q ss_pred             c-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--HHhhc
Q 014156          245 V-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCM  321 (429)
Q Consensus       245 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~  321 (429)
                      . .++..+.++.|++|+|||.+.+...|+..+||||+||++.||++|.+.|+|.++.+++..|.+.+|.....  .+-..
T Consensus       152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            7 66777889999999999999998889999999999999999999999999999999999999999977654  44456


Q ss_pred             CCCCccccCCCcCC-CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ++-|..+.+|.... .++...++. ++.-+.||+.+||..||.+|++.+++|.||||+++..
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             CCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence            66677777777653 444555544 7889999999999999999999999999999977543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-59  Score=428.18  Aligned_cols=259  Identities=33%  Similarity=0.477  Sum_probs=213.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----------hhHHHHHHHHHHcCCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  158 (429)
                      ...|.+.+.||+|+||.|.+|..+.||+.||||++.+..           ....+|+++|++|+|||||+++++|     
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence            346999999999999999999999999999999986432           1235899999999999999999988     


Q ss_pred             CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC--CCceEEe
Q 014156          159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLC  236 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~--~~~vkl~  236 (429)
                      ....+.||||||++|+  +++... -.++.+.+...+.+++|++.|+.||| ++||+||||||+|||+..+  ...+||+
T Consensus       246 ~~~ds~YmVlE~v~GG--eLfd~v-v~nk~l~ed~~K~~f~Qll~avkYLH-~~GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGG--ELFDKV-VANKYLREDLGKLLFKQLLTAVKYLH-SQGIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             ecCCceEEEEEEecCc--cHHHHH-HhccccccchhHHHHHHHHHHHHHHH-HcCcccccCCcceEEeccCCcceEEEec
Confidence            3444579999999965  333332 23578889999999999999999999 8899999999999999755  1279999


Q ss_pred             ecCCceecccCCCcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTP  313 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~  313 (429)
                      |||+|+....+....+.||||.|.|||++.+.  ..+..++|+||+||+||.+++|.+||.+..... ...+|.+.-   
T Consensus       322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~---  398 (475)
T KOG0615|consen  322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR---  398 (475)
T ss_pred             ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc---
Confidence            99999999888888899999999999999653  234558999999999999999999998765544 334443320   


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                            ..+....+..++.++++||.+||..||++|||+.|+|+||||+....
T Consensus       399 ----------------------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  399 ----------------------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             ----------------------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence                                  11111233468999999999999999999999999999999996543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.6e-58  Score=398.23  Aligned_cols=282  Identities=38%  Similarity=0.677  Sum_probs=244.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|..+++||+|.||.||+|++..||+.||||+++...      ...-||++.|+.++|+||+.++++|     .....+.
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l~   77 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNLS   77 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCceE
Confidence            6889999999999999999999999999999986432      2335899999999999999999999     4444488


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|+||++.+|...++.   ....++...++.|+.++++||+||| ++.|+||||||.|+||+++| .+||+|||+|+...
T Consensus        78 lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H-~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   78 LVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCH-SKWILHRDLKPNNLLISSDG-QLKIADFGLARFFG  152 (318)
T ss_pred             EEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHH-hhhhhcccCCccceEEcCCC-cEEeecccchhccC
Confidence            9999999998887765   4567899999999999999999999 88999999999999999998 89999999999886


Q ss_pred             cCCCc-ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..... ...+.|++|+|||.++|...|+..+||||.|||+.||+.|.+.|+|.++.+++..|+..+|+|..+.|+.+...
T Consensus       153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            55443 33478999999999999999999999999999999999999999999999999999999999999999877643


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      -...++..++..+....| +..+.++.||+.+||.+||.+|+|+.|+|+|+||+...-|.
T Consensus       233 pdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             ccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence            333334444444444434 45789999999999999999999999999999999855443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8e-58  Score=409.23  Aligned_cols=286  Identities=33%  Similarity=0.558  Sum_probs=252.3

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh------HHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      +....|+.+..|++|+||.||+|+++.|++.||+|+++.+++.      ..||+.+|.+++|||||.+..+.....- + 
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~-d-  150 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM-D-  150 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc-c-
Confidence            3455799999999999999999999999999999999765432      2489999999999999999887765432 2 


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                       .+|||||||+.+|..++...   .++|...+++.++.|++.||+||| ...|+|||||++|+|++..| .+||+|||+|
T Consensus       151 -~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH-~~wilHRDLK~SNLLm~~~G-~lKiaDFGLA  224 (419)
T KOG0663|consen  151 -KIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLH-DNWILHRDLKTSNLLLSHKG-ILKIADFGLA  224 (419)
T ss_pred             -eeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHh-hceeEecccchhheeeccCC-cEEecccchh
Confidence             38899999999998888764   378999999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          242 KVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +.+.... ..+..+.|.+|+|||++.+...|++++|+||+|||+.||+++++.|+|....+++.+|++.+|.|+...|+.
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            9887653 356678899999999999999999999999999999999999999999999999999999999999998865


Q ss_pred             cC--CCCccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          321 MN--PNYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       321 ~~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ..  +.+..+.++..+...++..|... ++....+|++.+|.+||.+|+||.|+|+|+||.+..
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            43  33445677777777888888776 789999999999999999999999999999999844

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.2e-56  Score=443.98  Aligned_cols=330  Identities=52%  Similarity=0.984  Sum_probs=288.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecC---CCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT---DKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~~~~~~lv  167 (429)
                      .+|++.++||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++||||++++++|....   .....++++|
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            4699999999999999999999999999999998777666778999999999999999988775432   2334578899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      |||+++++...+..+......+++..++.++.||+.||.||| +.||+||||||+|||++.+++.+||+|||+|+.....
T Consensus       146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH-~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  224 (440)
T PTZ00036        146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG  224 (440)
T ss_pred             EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence            999999988887776666778999999999999999999999 8899999999999999977657999999999877655


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++.+.++.|..+.+..+++.+..
T Consensus       225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~  304 (440)
T PTZ00036        225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD  304 (440)
T ss_pred             CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence            55566788999999999877667899999999999999999999999999999999999999999999998888888888


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCC-CCCCCCCCCCChhhhcc
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN-GRPFPPLFNFKPQELKG  406 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  406 (429)
                      ..++.+....+...++...++++++||.+||++||.+|+|+.|+|+||||++++++....+. ....|..+++...++..
T Consensus       305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (440)
T PTZ00036        305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKE  384 (440)
T ss_pred             ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHhh
Confidence            88888877777777888899999999999999999999999999999999999887555443 24567788998888877


Q ss_pred             CCHHHHHhhcHHHHh
Q 014156          407 ASKELLSKLIPEHAR  421 (429)
Q Consensus       407 ~~~~~~~~~~~~~~~  421 (429)
                      .+.+...++++....
T Consensus       385 ~~~~~~~~~~~~~~~  399 (440)
T PTZ00036        385 MSDACRRKIIPKCTY  399 (440)
T ss_pred             CCHHHHHHHhhHHHH
Confidence            888888887776443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-57  Score=434.05  Aligned_cols=266  Identities=31%  Similarity=0.508  Sum_probs=227.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc-------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+       ......+|++|.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            469999999999999999999999999999999854       234556899999999999999999999     66667


Q ss_pred             EEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|||+|+|..+ +..+++    ..+.++|.+++.+++||+.||.||| +.+|||||||..|+||+++. .|||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH-~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLH-SLGIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHH-hcCceecccchhheeecCcC-cEEecccceee
Confidence            99999999954 444433    3578999999999999999999999 88999999999999999988 79999999998


Q ss_pred             ecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          243 VLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ..... +...+.||||.|+|||++.. ..++..+||||+|||||.||+|++||...+-.+.+..|...            
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------  233 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------  233 (592)
T ss_pred             eecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------------
Confidence            88744 77788999999999999975 56999999999999999999999999988888888877663            


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLF  397 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~  397 (429)
                           +|.            +|..+|.++++||.+||..||.+|||+.++|.|+||..--.|.....+.....+.+
T Consensus       234 -----~Y~------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~  292 (592)
T KOG0575|consen  234 -----EYS------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRF  292 (592)
T ss_pred             -----Ccc------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcC
Confidence                 233            33458999999999999999999999999999999976555554444333333334

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-57  Score=423.46  Aligned_cols=286  Identities=36%  Similarity=0.600  Sum_probs=242.5

Q ss_pred             CCCCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecC
Q 014156           84 NGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  157 (429)
Q Consensus        84 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  157 (429)
                      .+.+.....|..+++||+|.||.||+|++..+|+.||+|++..+.      ....+|+.||++|+||||++|.+..+.. 
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~-  188 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK-  188 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec-
Confidence            345566778999999999999999999999999999999986543      2345899999999999999999887654 


Q ss_pred             CCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                        ....+|||+|||+.+|..++..   ..-.|++.+++.|+.||+.||+||| .+||+|||||.+|||||.+| .+||+|
T Consensus       189 --~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH-~~gvlHRDIK~SNiLidn~G-~LKiaD  261 (560)
T KOG0600|consen  189 --LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCH-SRGVLHRDIKGSNILIDNNG-VLKIAD  261 (560)
T ss_pred             --CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHh-hcCeeeccccccceEEcCCC-CEEecc
Confidence              2335889999999988777653   3457999999999999999999999 88999999999999999888 899999


Q ss_pred             cCCceecccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          238 FGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       238 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      ||+|+++....  ..++.+.|.+|+|||+++|...|+.++|+||.||||.||++|++.|.|.++.+++..|++.+|.|+.
T Consensus       262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             ccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            99999775443  4677889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcC-CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          316 EEIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       316 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                      ..|.... +.+..+.-..-....+... ...++..+.+|+..||+.||.+|.||.++|+|+||.
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            8876211 1222222112122333333 356899999999999999999999999999999994

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-57  Score=410.16  Aligned_cols=258  Identities=32%  Similarity=0.504  Sum_probs=221.1

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ....+|.++++||+|+||+||.++.+.|++.||+|++++.       ......|..+|..++||+||+++..|     ++
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt   96 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QT   96 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----cc
Confidence            3445799999999999999999999999999999988653       34445799999999999999999888     55


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ...+|+|+||+.|+  ++..+. +..+.+++..+++|+.+|+.||.||| ++|||||||||+|||||.+|| ++|+|||+
T Consensus        97 ~~kLylVld~~~GG--eLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH-~~gIiyRDlKPENILLd~~GH-i~LtDFgL  171 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGG--ELFYHL-QREGRFSEDRARFYLAEIVLALGYLH-SKGIIYRDLKPENILLDEQGH-IKLTDFGL  171 (357)
T ss_pred             CCeEEEEEeccCCc--cHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHeeecCCCc-EEEecccc
Confidence            56699999999975  333332 23688999999999999999999999 899999999999999999995 99999999


Q ss_pred             ceecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          241 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       241 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      |+..... ....++|||+.|||||++.+. .|+..+|+||||+++|+|++|.+||.+.+......+|.+.-         
T Consensus       172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------  241 (357)
T KOG0598|consen  172 CKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------  241 (357)
T ss_pred             chhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------
Confidence            9865444 455668999999999999875 59999999999999999999999999999888888877631         


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCCccccCCCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC----TALEACIHPFFDELRDPN  384 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~~~~~  384 (429)
                                         ....+.-++.++++||+++|+.||.+|+    .+.++.+||||+.+.|..
T Consensus       242 -------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  242 -------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence                               0012223799999999999999999996    688999999999998854

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-56  Score=403.92  Aligned_cols=258  Identities=29%  Similarity=0.497  Sum_probs=213.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+.+.++.||+|+.|+||+|+++.|++.+|+|++...     ...+.+|+++++.++|||||++|++|+....    .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3577788999999999999999999999999998422     3445689999999999999999999976542    388


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      |+||||+++.++.+..   ..+++++.....++.++++||.|||.+++||||||||+||||+++| .|||||||.++...
T Consensus       155 I~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lv  230 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILV  230 (364)
T ss_pred             eehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhh
Confidence            9999999765554432   2478999999999999999999999558999999999999999988 89999999998876


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE--SGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      +. ...+++||..|||||.+.+. .|+.++||||||++++||++|+.||...  .....+..+...+..|+.        
T Consensus       231 nS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP--------  300 (364)
T KOG0581|consen  231 NS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP--------  300 (364)
T ss_pred             hh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC--------
Confidence            66 56789999999999999875 5999999999999999999999999874  122222222222221211        


Q ss_pred             CCccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                                       .++.. +|+++++||..||++||.+|+|+.|+++|||+++...+
T Consensus       301 -----------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  301 -----------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             -----------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence                             12233 79999999999999999999999999999999976554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-55  Score=413.34  Aligned_cols=258  Identities=31%  Similarity=0.557  Sum_probs=224.6

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      +...+|..++.||.|+|++|++|+++.+++.||||++.+.       ..+..+|-.+|.+| .||.|++|+..|     .
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence            3445799999999999999999999999999999987543       24455788999999 899999999888     5


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      +...+|+|+||++ |.|+.++.+    .+.|++..+++|+.||+.||+||| ++|||||||||+|||||.|+ .+||+||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH-~~GIIHRDlKPENILLd~dm-hikITDF  218 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLH-SNGIIHRDLKPENILLDKDG-HIKITDF  218 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeEcCCC-cEEEeec
Confidence            5555899999998 677777765    478999999999999999999999 89999999999999999999 6999999


Q ss_pred             CCceecccCCC--------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014156          239 GSAKVLVKGEP--------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV  304 (429)
Q Consensus       239 G~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  304 (429)
                      |.|+.+.....              ..+++||..|.+||++.. ...++.+|||+||||+|.|+.|.+||.+.++.-.++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            99988743211              145899999999999865 458999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      +|++..                 |            .|++.+++.+++||+++|..||++|+|+.+|.+||||..+.|.+
T Consensus       298 kI~~l~-----------------y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  298 KIQALD-----------------Y------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHhc-----------------c------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            988851                 2            35567899999999999999999999999999999999998876


Q ss_pred             CC
Q 014156          385 AR  386 (429)
Q Consensus       385 ~~  386 (429)
                      .+
T Consensus       349 lw  350 (604)
T KOG0592|consen  349 LW  350 (604)
T ss_pred             hh
Confidence            44

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-54  Score=409.31  Aligned_cols=261  Identities=33%  Similarity=0.552  Sum_probs=219.0

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+|.+++.||+|+||.||+|+.+.||+.||+|++++..       .....|-.+|...++|+||++|..|     .+.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            4568999999999999999999999999999999987643       2334688899999999999999988     777


Q ss_pred             eEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      .++||||||++|+ +..++    ...+.+++.++++|+.+++.|++.|| +.|+|||||||+|+|||..|| +||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH-~~gyIHRDIKPdNlLiD~~GH-iKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIH-QLGYIHRDIKPDNLLIDAKGH-IKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHH-HcCcccccCChhheeecCCCC-Eeeccccc
Confidence            7899999999975 33333    34688999999999999999999999 899999999999999999995 99999999


Q ss_pred             ceeccc----------------------CC-C------c-------------------ccccccccccccccccCCCCCC
Q 014156          241 AKVLVK----------------------GE-P------N-------------------ISYICSRYYRAPELIFGATEYT  272 (429)
Q Consensus       241 a~~~~~----------------------~~-~------~-------------------~~~~gt~~y~aPE~~~~~~~~~  272 (429)
                      |.....                      .. .      .                   .+.+|||.|||||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            853311                      00 0      0                   1457999999999998855 99


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHH
Q 014156          273 TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVD  352 (429)
Q Consensus       273 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  352 (429)
                      ..+|+|||||||||||.|.+||.+.+..+...+|+.....               +.+|.          ...++++++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~----------~~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPE----------EVDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCC----------cCcccHHHHH
Confidence            9999999999999999999999999999999988875211               11111          1236899999


Q ss_pred             HHHhhcCcCCCCCCC---HHHHhcCCCccccCCCCCCC
Q 014156          353 LVSRLLQYSPNLRCT---ALEACIHPFFDELRDPNARL  387 (429)
Q Consensus       353 li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~~~~~  387 (429)
                      ||.+||+ ||.+|+.   +.||..||||+.+.|.+.+.
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~  458 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLRE  458 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhc
Confidence            9999999 9999995   89999999999999976553

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-54  Score=380.58  Aligned_cols=254  Identities=28%  Similarity=0.475  Sum_probs=221.3

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+|..++.||.|+||.|.+++.+.+|..||+|++.+.       .+...+|..+|+.+.||+++++++.|     .+.
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~  116 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDN  116 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccC
Confidence            345799999999999999999999999999999988653       23445799999999999999999888     566


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .++||||||++|+  .+. .+.+..+++++..+++|+.||+.||+||| +.+|++|||||+|||||.+| .+||+|||+|
T Consensus       117 ~~lymvmeyv~GG--ElF-S~Lrk~~rF~e~~arFYAAeivlAleylH-~~~iiYRDLKPENiLlD~~G-~iKitDFGFA  191 (355)
T KOG0616|consen  117 SNLYMVMEYVPGG--ELF-SYLRKSGRFSEPHARFYAAEIVLALEYLH-SLDIIYRDLKPENLLLDQNG-HIKITDFGFA  191 (355)
T ss_pred             CeEEEEEeccCCc--cHH-HHHHhcCCCCchhHHHHHHHHHHHHHHHH-hcCeeeccCChHHeeeccCC-cEEEEeccce
Confidence            6799999999975  222 23345789999999999999999999999 88999999999999999999 5999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      +.....  ..+.||||.|+|||++.. ..|+.++|+|||||++|||+.|.+||.+.+....+.+|...            
T Consensus       192 K~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------  256 (355)
T KOG0616|consen  192 KRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------  256 (355)
T ss_pred             EEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC------------
Confidence            987433  678899999999999976 45999999999999999999999999999998888888773            


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPN  384 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  384 (429)
                           .+            .||..+++++++||+++|+.|-++|.     ...++.+||||+.+.|..
T Consensus       257 -----~v------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  257 -----KV------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             -----cc------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence                 12            34556899999999999999999994     567999999999988753

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.2e-53  Score=384.39  Aligned_cols=292  Identities=34%  Similarity=0.685  Sum_probs=243.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh------hHHHHHHHHHHcCCCC-eeccceeeeecCC-CCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPN-VVSLKHCFFSTTD-KDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~-~~~~  162 (429)
                      ..|..+++||+|+||+||+|+.+.+|+.||+|++..+..      ...+|+.+++.|+|+| ||++++++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            358888899999999999999999999999999865432      2358999999999999 9999998865442 2334


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+++|+||++.++...+.........++...++.+++||+.||+||| ++||+||||||.||||++++ .+||+|||+|+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H-~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH-SHGILHRDLKPQNLLISSSG-VLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCcceEEECCCC-cEeeeccchHH
Confidence            58899999999888877764433356888999999999999999999 88999999999999999987 89999999998


Q ss_pred             ecc-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          243 VLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ... .....+..++|.+|+|||++.+...|+..+||||+|||++||+++++.|.|..+.+++..|++.+|.|+.+.|+..
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            765 3444677889999999999999988999999999999999999999999999999999999999999999888754


Q ss_pred             C--CCCccccCCCcC-CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          322 N--PNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       322 ~--~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                      .  +.|.. .++... ...+.... ++.+++..+++.+||+++|.+|.|+..+|.||||..+......
T Consensus       249 ~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~  314 (323)
T KOG0594|consen  249 SSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ  314 (323)
T ss_pred             cccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence            4  22222 333333 22222222 3456799999999999999999999999999999987654433

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-52  Score=403.44  Aligned_cols=280  Identities=36%  Similarity=0.627  Sum_probs=230.3

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHH---HHHHHHHHcC-C-----CCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLD-H-----PNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-h-----~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|.+.+.||+|+||.|.+|.+..|++.||||+++....+..   .|+++|..|+ |     -|+|+++++|..     ..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----RN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----cc
Confidence            79999999999999999999999999999999988776654   5888888886 3     489999999944     44


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec-CCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~-~~~~~vkl~DFG~a  241 (429)
                      ++|||+|.++.+|+++++.  +....++...++.++.||+.||.+|| +.||||+|||||||||. .+...|||+|||.|
T Consensus       262 HlciVfELL~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~-~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLH-ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            5999999999999999986  33466999999999999999999999 89999999999999984 34447999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      +.....  ..+++.+++|+|||+++|.+ |+.+.||||||||++||++|.++|+|.++.+++..|++.+|.|+...+...
T Consensus       339 c~~~q~--vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQR--VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCCc--ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            876433  33788899999999999865 999999999999999999999999999999999999999999998877543


Q ss_pred             CCCCccccC----CC---c---------------------------CCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014156          322 NPNYTEFKF----PQ---I---------------------------KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT  367 (429)
Q Consensus       322 ~~~~~~~~~----~~---~---------------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  367 (429)
                      ......+.-    +.   .                           ....+...+...-...+.|||.+||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            322211111    00   0                           0111111111122345899999999999999999


Q ss_pred             HHHHhcCCCccccCC
Q 014156          368 ALEACIHPFFDELRD  382 (429)
Q Consensus       368 ~~e~l~hp~f~~~~~  382 (429)
                      +.++|+||||.....
T Consensus       496 p~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  496 PAQALNHPFLTGTSL  510 (586)
T ss_pred             HHHHhcCcccccccc
Confidence            999999999996543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=408.17  Aligned_cols=257  Identities=29%  Similarity=0.487  Sum_probs=222.6

Q ss_pred             CccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcC-CCCeeccceeeeecCC
Q 014156           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTD  158 (429)
Q Consensus        87 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~  158 (429)
                      .....+|+++++||+|+||+|++|..+.+++.||||+++++.       +....|.+|+...+ ||.+++++.+|     
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----  438 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----  438 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence            344568999999999999999999999999999999887642       33446788877775 99999999999     


Q ss_pred             CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ....++|+||||+.|+.   +.+ .+..+.|++..+++|+..|+.||.||| ++||||||||.+|||||.+|+ +||+||
T Consensus       439 QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH-~~~IIYRDlKLdNiLLD~eGh-~kiADF  512 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLH-ENGIIYRDLKLDNLLLDTEGH-VKIADF  512 (694)
T ss_pred             ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHH-hcCceeeecchhheEEcccCc-EEeccc
Confidence            66677999999999874   222 234578999999999999999999999 889999999999999999995 999999


Q ss_pred             CCceecc-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          239 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       239 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      |+|+... .+....++||||.|||||++.+. .|+.++|+|||||+||||+.|.+||.|.++.+....|..-        
T Consensus       513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--------  583 (694)
T KOG0694|consen  513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--------  583 (694)
T ss_pred             ccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence            9998765 56677889999999999999775 4999999999999999999999999999999888887652        


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDPN  384 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~  384 (429)
                               ++            .|+..+|.++.++|+++|+.||++|+.     +.+|..||||+.+.|..
T Consensus       584 ---------~~------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  584 ---------EV------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             ---------CC------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence                     22            244458999999999999999999995     57899999999998754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-54  Score=377.76  Aligned_cols=253  Identities=30%  Similarity=0.525  Sum_probs=211.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHHcCCCCeeccce-eeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKH-CFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~-~~~~~~~~~~~~  163 (429)
                      ..|+++++||+|+||+||++.+..+|..+|.|.+.-      .+...-.|+.+|++|+|||||++++ .|.    .+...
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~----~~~ev   94 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI----EDNEV   94 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh----ccchh
Confidence            369999999999999999999999999999998742      2333447999999999999999988 442    22233


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC--CC--eeecCCCCCCeeecCCCCceEEeec
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG--IG--VCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~~--iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ++||||||+ |+|.++++++....+.+++..++.++.|+|.||.++| +  ..  |+||||||.||+|+.+| .|||+||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH-~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDf  172 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH-SKIPRGTVMHRDIKPANIFLTANG-VVKLGDF  172 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh-ccccccceeeccCcchheEEcCCC-ceeeccc
Confidence            789999998 7888999999999999999999999999999999999 4  34  99999999999999888 8999999


Q ss_pred             CCceecccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          239 GSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       239 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      |+++....... ..+++|||+||+||.+.+. .|+.+|||||+||++|||+.-++||.|.+-.+...+|.++--.|-.. 
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~-  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD-  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-
Confidence            99998755433 3568999999999999765 59999999999999999999999999997766666666541111110 


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                                ..+|.++..||..|+..||..||+.     +|++.++..
T Consensus       251 --------------------------~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  251 --------------------------EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             --------------------------HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence                                      2368999999999999999999986     555555443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-52  Score=399.98  Aligned_cols=253  Identities=32%  Similarity=0.500  Sum_probs=224.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      +-|++++.||.|+-|.|.+|++..||+..|||++.+.       ...+++|+-+|+.+.|||++++|++|     .+..+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence            4599999999999999999999999999999999766       45678999999999999999999999     66667


Q ss_pred             EEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|+|+||++++ |++.+    ...+++++.+++++++||+.|+.||| ..+|+||||||+|+|||.++ +|||+|||+|.
T Consensus        87 lylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH-~~~icHRDLKpENlLLd~~~-nIKIADFGMAs  160 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCH-AFNICHRDLKPENLLLDVKN-NIKIADFGMAS  160 (786)
T ss_pred             EEEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHh-hhcceeccCCchhhhhhccc-CEeeeccceee
Confidence            99999999854 44433    23588999999999999999999999 88999999999999999888 59999999999


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ....+.-..+.||+|+|.|||++.|..+.+.++||||.|||||.||||+.||.+.+....+.++.+.             
T Consensus       161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-------------  227 (786)
T KOG0588|consen  161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-------------  227 (786)
T ss_pred             cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------------
Confidence            8888888888999999999999999888899999999999999999999999987777766666552             


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                          .+.            ++.++|+++++||++||..||++|+|..||++|||+......
T Consensus       228 ----~f~------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  228 ----VFE------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             ----ccc------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence                222            334689999999999999999999999999999999886553

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=379.70  Aligned_cols=254  Identities=30%  Similarity=0.513  Sum_probs=214.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..++|.+.+.||+|+||+||+|+++.++..||||.+.+.      .+....|+.+|+.++|||||+++++.     ....
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            345799999999999999999999999999999988654      23345799999999999999999998     4444


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC-C----CceEEe
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-T----HQVKLC  236 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~-~----~~vkl~  236 (429)
                      ++|+|||||+| +|...+    +..+.+++..++.++.||+.||++|| +.+||||||||+||||+.. +    -.+||+
T Consensus        83 ~i~lVMEyC~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~L~-~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYI----RRRGRLPEATARHFMQQLASALQFLH-ENNIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             eEEEEEEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence            69999999995 444443    34568999999999999999999999 8899999999999999764 1    259999


Q ss_pred             ecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      |||+|+....+....+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.-      
T Consensus       158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~------  230 (429)
T KOG0595|consen  158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN------  230 (429)
T ss_pred             ccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc------
Confidence            9999999988888888999999999999965 459999999999999999999999999888777666443321      


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                          .....++..++..+.+|+...|+.+|..|.+..+-+.|+++..
T Consensus       231 --------------------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  231 --------------------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             --------------------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                                1111233346778889999999999999999999999999865

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-51  Score=394.19  Aligned_cols=251  Identities=33%  Similarity=0.499  Sum_probs=215.3

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHHcC-CCCeeccceeeeecCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTD  158 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~  158 (429)
                      ..+.|.+.+.||+|+||+|++|++..+|+.||+|++.+.         .....+|+.+++.+. ||||+++++++..   
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t---   91 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT---   91 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence            345799999999999999999999999999999976543         223458999999999 9999999998843   


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC-CCceEEe
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLC  236 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~-~~~vkl~  236 (429)
                        ...+++|||||.| .|++.+.   . .+++.+..++.+++||+.|++||| +.||+||||||+|||++.+ + .+||+
T Consensus        92 --~~~~~ivmEy~~gGdL~~~i~---~-~g~l~E~~ar~~F~Qlisav~y~H-~~gi~HRDLK~ENilld~~~~-~~Kl~  163 (370)
T KOG0583|consen   92 --PTKIYIVMEYCSGGDLFDYIV---N-KGRLKEDEARKYFRQLISAVAYCH-SRGIVHRDLKPENILLDGNEG-NLKLS  163 (370)
T ss_pred             --CCeEEEEEEecCCccHHHHHH---H-cCCCChHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEecCCCC-CEEEe
Confidence              3348999999996 5555443   3 688999999999999999999999 8899999999999999988 6 79999


Q ss_pred             ecCCceec-ccCCCcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          237 DFGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       237 DFG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      |||++... .......+.|||+.|+|||++.+.. .-+.++||||+||+||.|++|+.||...+.......|.+.     
T Consensus       164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-----  238 (370)
T KOG0583|consen  164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-----  238 (370)
T ss_pred             ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----
Confidence            99999988 4666778899999999999998766 4468999999999999999999999987776666665442     


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCC-ChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM-PPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                  .+.            ++..+ |+++++||++||..||.+|+|+.+++.||||+.
T Consensus       239 ------------~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 ------------EFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ------------Ccc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                        122            23346 999999999999999999999999999999996

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.4e-51  Score=373.61  Aligned_cols=276  Identities=27%  Similarity=0.441  Sum_probs=227.1

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .....|++++.||.|.-|+||+|+.+.++..+|+|++.+..       ...+.|.+||+.++||.++.+|+.|     ..
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et  148 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ET  148 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ec
Confidence            34457999999999999999999999999999999986532       2334689999999999999999999     67


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ..|.|+|||||+|+-+..+.+ .+..+.|++..+++|+.+++.||+||| ..|||+|||||+||||..+|| |.|+||.+
T Consensus       149 ~~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLH-mlGivYRDLKPENILvredGH-IMLsDFDL  225 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLH-MLGIVYRDLKPENILVREDGH-IMLSDFDL  225 (459)
T ss_pred             cceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHH-hhceeeccCCcceeEEecCCc-EEeeeccc
Confidence            778999999999754444443 345688999999999999999999999 899999999999999999995 99999998


Q ss_pred             ceecc----------------------------------c-C----------------------CCcccccccccccccc
Q 014156          241 AKVLV----------------------------------K-G----------------------EPNISYICSRYYRAPE  263 (429)
Q Consensus       241 a~~~~----------------------------------~-~----------------------~~~~~~~gt~~y~aPE  263 (429)
                      +....                                  . .                      ....+++||-.|.|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            63320                                  0 0                      0112467899999999


Q ss_pred             cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccC
Q 014156          264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH  343 (429)
Q Consensus       264 ~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (429)
                      ++.|.. .+.++|||+|||++|||+.|..||.|.+..+.+.+|...                 +..+|..          
T Consensus       306 vI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------  357 (459)
T KOG0610|consen  306 VIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------  357 (459)
T ss_pred             eeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------
Confidence            998754 899999999999999999999999999999999887652                 2223321          


Q ss_pred             CCCChhHHHHHHhhcCcCCCCCCC----HHHHhcCCCccccCCCCCCCCCCCCCCCCCCC
Q 014156          344 KRMPPEAVDLVSRLLQYSPNLRCT----ALEACIHPFFDELRDPNARLPNGRPFPPLFNF  399 (429)
Q Consensus       344 ~~~s~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  399 (429)
                      +.++..++|||+++|.+||++|+.    |.||.+||||+.++|.-.+-...+..|.+...
T Consensus       358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence            146889999999999999999998    99999999999999986554444444444443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=360.38  Aligned_cols=255  Identities=31%  Similarity=0.463  Sum_probs=216.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+.|.+.++||+|.|+.|+++.+..||+.+|+|++..      +.+..++|++|-+.|+|||||++.+.+     ....+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence            3469999999999999999999999999999997742      345667999999999999999999887     66678


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC--CCceEEeecCCc
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSA  241 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~--~~~vkl~DFG~a  241 (429)
                      .|+|+|++.|+  ++....-. ...+++..+-.+++||+.||.|+| ..||||||+||+|+|+-+.  +.-+||+|||+|
T Consensus        85 ~ylvFe~m~G~--dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH-~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA  160 (355)
T KOG0033|consen   85 HYLVFDLVTGG--ELFEDIVA-REFYSEADASHCIQQILEALAYCH-SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA  160 (355)
T ss_pred             eEEEEecccch--HHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeeeeccCCCceeecccceE
Confidence            99999999975  22222111 145788899999999999999999 7899999999999999432  336999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .....+..-...+|||.|||||++... .|+..+|||+.||+||-|+.|.+||.+.+....+++|++.            
T Consensus       161 i~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g------------  227 (355)
T KOG0033|consen  161 IEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG------------  227 (355)
T ss_pred             EEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc------------
Confidence            998877777788999999999999764 4999999999999999999999999998888888888773            


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                           .+.++.        ..++.+++++++|+++||..||.+|+|+.|+|+|||+++
T Consensus       228 -----~yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  228 -----AYDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             -----ccCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                 222222        234568999999999999999999999999999999986

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.9e-49  Score=373.41  Aligned_cols=277  Identities=33%  Similarity=0.620  Sum_probs=226.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|.+.++||.|+||.||+|++..++..||+|++...     .....+|+.+++.++||||+++++++.     ...+.
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeE
Confidence            34699999999999999999999999999999988532     123457999999999999999998873     33458


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~  153 (288)
T cd07871          79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCH-KRKILHRDLKPQNLLINEKG-ELKLADFGLARAK  153 (288)
T ss_pred             EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEECcCcceeec
Confidence            89999999887766543   2345789999999999999999999 88999999999999999887 7999999999765


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+..+.+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            3322 223456799999999987666689999999999999999999999999998899999999999988887765332


Q ss_pred             --CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                        .+..+.++.....++.. ....+++++++||++||++||.+|||+.|+|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             chhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              22223333332222222 234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.8e-51  Score=387.29  Aligned_cols=249  Identities=31%  Similarity=0.515  Sum_probs=215.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|.+.+.||+|+||.||+|+.+.+.+.||||.+.+..      ....+|++|++.|+|||||.+++.|     +....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            46999999999999999999999999999999885432      2356899999999999999999998     555569


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      |+|+||+.|+|..++..    .+.++++.++.++.|++.||.||| +.+|+|||+||.|||+...+ .+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLh-s~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLH-SNRILHRDMKPQNILLEKGG-TLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH-hcCcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence            99999999988887754    678999999999999999999999 88999999999999999887 7999999999988


Q ss_pred             ccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..+.. .++.-|||.|||||++.+ ..|+..+|+|||||++|||++|++||......+....|..-   |          
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~----------  216 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P----------  216 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C----------
Confidence            66543 345679999999999875 55999999999999999999999999876655555544431   1          


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                      ..++..++.++++||..+|.+||.+|+|..+++.|||.+.-
T Consensus       217 ----------------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  217 ----------------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ----------------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                            12334689999999999999999999999999999999863

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-50  Score=374.05  Aligned_cols=257  Identities=32%  Similarity=0.515  Sum_probs=206.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|...+.||+|+||.||++.+..+|+.+|+|.+...    .....+|+.+|+.|+|||||++++......+   ..+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence            3588999999999999999999999999999988655    4446899999999999999999886432221   46889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC-CCCceEEeecCCceec
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVL  244 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~-~~~~vkl~DFG~a~~~  244 (429)
                      +|||+++ ++.+++..   ..+.+++..++.+.+||+.||.||| ++|||||||||+|||++. ++ .+||+|||+++..
T Consensus        94 ~mEy~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylH-s~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLH-SKGIVHCDIKPANILLDPSNG-DVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCcccceEEEeCCCC-eEEeccCcccccc
Confidence            9999996 44444433   2227999999999999999999999 889999999999999998 45 7999999999876


Q ss_pred             cc----CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 014156          245 VK----GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       245 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ..    ........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+...   .      
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~------  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D------  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C------
Confidence            53    223446789999999999975333345999999999999999999999763 222222222110   0      


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                               ..         ..++..+|+++++||.+||.+||++||||.++|+|||.+.-..
T Consensus       240 ---------~~---------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 ---------SL---------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ---------CC---------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                     11         1355668999999999999999999999999999999976443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-50  Score=372.18  Aligned_cols=259  Identities=29%  Similarity=0.448  Sum_probs=214.0

Q ss_pred             CCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------------hhHHHHHHHHHHcCCCCee
Q 014156           86 QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------RYKNRELQTMRLLDHPNVV  147 (429)
Q Consensus        86 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h~~iv  147 (429)
                      .....++|++++.||+|.||+|.+|++..+++.||||++.+..                  +...+|+.+|++|.|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3456678999999999999999999999999999999885421                  2345899999999999999


Q ss_pred             ccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee
Q 014156          148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR-MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  226 (429)
Q Consensus       148 ~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill  226 (429)
                      +|+.+.-   +.....+|||+|||..+-...    ...... +++.+++.|++.++.||+||| .+|||||||||+|+||
T Consensus       172 ~LiEvLD---DP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH-~QgiiHRDIKPsNLLl  243 (576)
T KOG0585|consen  172 KLIEVLD---DPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLH-YQGIIHRDIKPSNLLL  243 (576)
T ss_pred             EEEEeec---CcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEE
Confidence            9998763   345566999999999653221    122344 899999999999999999999 8899999999999999


Q ss_pred             cCCCCceEEeecCCceecccC------CCcccccccccccccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014156          227 NPHTHQVKLCDFGSAKVLVKG------EPNISYICSRYYRAPELIFG---ATEYTTAIDIWSVGCVLAELLLGQPLFPGE  297 (429)
Q Consensus       227 ~~~~~~vkl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~  297 (429)
                      +.++ .|||+|||.+.....+      ......+|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||-+.
T Consensus       244 ~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  244 SSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             cCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            9997 7999999998766322      12234789999999999876   234577899999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      ...+...+|...                 ...+|..          +.+.++++|||.+||++||+.|++..++..|||.
T Consensus       323 ~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  323 FELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             hHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            888888887662                 2222221          2368899999999999999999999999999999


Q ss_pred             ccc
Q 014156          378 DEL  380 (429)
Q Consensus       378 ~~~  380 (429)
                      ..-
T Consensus       376 t~~  378 (576)
T KOG0585|consen  376 TRD  378 (576)
T ss_pred             ccC
Confidence            754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-50  Score=381.51  Aligned_cols=250  Identities=29%  Similarity=0.474  Sum_probs=214.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..|....+||+|+.|.||.|+...+++.||||++...    ++.+.+|+.+|+.++|+|||++++.|+..++     +|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEE
Confidence            3688899999999999999999999999999998543    4555689999999999999999999977644     899


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||++|+.+..+-.    ...+++..++.++++++.||+||| .+||+|||||.+|||++.++ .+||+|||+|..+..
T Consensus       348 VMEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH-~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLH-ARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISE  421 (550)
T ss_pred             EEeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHH-hcceeeeccccceeEeccCC-cEEEeeeeeeecccc
Confidence            999999654333322    255999999999999999999999 88999999999999999988 799999999987755


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      .. ...+.+|||+|||||++.. ..|++++||||||++++||+-|.+||-..+....+..|... |.|.           
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~-----------  488 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK-----------  488 (550)
T ss_pred             ccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC-----------
Confidence            44 5667899999999999865 45999999999999999999999999988888777776553 2222           


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                                    ...+..+|+.+++||.+||+.|+.+|++|.|+|+||||+
T Consensus       489 --------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  489 --------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             --------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence                          123456899999999999999999999999999999994

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-48  Score=374.80  Aligned_cols=287  Identities=38%  Similarity=0.669  Sum_probs=226.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.++||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            499999999999999999999999999999987532      12345799999999999999999987655444444688


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+++++...+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            9999999887776543    456999999999999999999999 88999999999999999887 79999999997643


Q ss_pred             cCCC----cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          246 KGEP----NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       246 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ....    .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+..+.+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2221    1345789999999987542 4588999999999999999999999999888888888888888887665543


Q ss_pred             cCCCCc-cc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          321 MNPNYT-EF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       321 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      ...... .+  ........++...+ +.+++++.+||.+||..||++|||+.|+|+||||+.+.....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~  301 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER  301 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence            221100 00  00000111111112 246889999999999999999999999999999998777543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.8e-48  Score=369.40  Aligned_cols=282  Identities=32%  Similarity=0.534  Sum_probs=218.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+.+++.++||||+++++++.     .....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeEE
Confidence            46999999999999999999999999999999885321     23457999999999999999999873     334588


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+++++...+..   ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  154 (303)
T cd07869          80 LVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIH-QRYILHRDLKPQNLLISDTG-ELKLADFGLARAKS  154 (303)
T ss_pred             EEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECCCCcceecc
Confidence            9999999887776543   3456899999999999999999999 88999999999999999887 79999999987543


Q ss_pred             cC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .. .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+... .+.+..+....+.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            22 2233467899999999987666688999999999999999999999987543 455666767677766554432211


Q ss_pred             --CCccccCCCcCCCCcccccC-CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          324 --NYTEFKFPQIKAHPWHKIFH-KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       324 --~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                        .+....+.......+...+. ...++++.+||++||++||.+|||+.++|+||||+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence              01000011111111111111 125678999999999999999999999999999988653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-49  Score=325.24  Aligned_cols=279  Identities=35%  Similarity=0.612  Sum_probs=236.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .|.-.++||+|.||+||+|+++.+++.||+|.+..+.      ....+|+.+++.++|.|||++++...     ....+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence            4666789999999999999999999999999986542      34568999999999999999998773     333488


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|+|||..++.....   ..++.+....++.++.|+++||.++| ++++.||||||.|+||+.+| .+||+|||+++..+
T Consensus        78 lvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fch-shnvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCH-SHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhh-hhhhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            999999987665544   45688999999999999999999999 88999999999999999998 89999999998775


Q ss_pred             cCCCc-ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      -.-.. ...+.|.+|++|.++++..-|++..|+||.|||+.|+.. |++.|+|.+-.+++.+|+..+|.|+++.|+.+..
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            44322 345679999999999999999999999999999999986 8999999999999999999999999999987764


Q ss_pred             CCccccCCCcCC-CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          324 NYTEFKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       324 ~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ......+|.++. ..|.... ++++..-+||++++|.-+|..|++++++++||||.+..
T Consensus       233 lpdyk~yp~ypattswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCCCcccCCccccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            433344455443 3344333 45778899999999999999999999999999998754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=360.02  Aligned_cols=272  Identities=27%  Similarity=0.453  Sum_probs=221.0

Q ss_pred             CCCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        85 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ..+.....|.+..+||.|.-++||+|++..+++.||||++.-++     ..+.+|+..++.++||||++++.+|..... 
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-   98 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-   98 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce-
Confidence            34455668999999999999999999999999999999986432     455689999999999999999999865544 


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                          +|+||.||. |+++++++.+..  ..+++..+..+++++++||.||| ++|.||||||+.||||+.+| .|||+||
T Consensus        99 ----LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH-~~G~IHRdvKAgnILi~~dG-~VkLadF  170 (516)
T KOG0582|consen   99 ----LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH-QNGHIHRDVKAGNILIDSDG-TVKLADF  170 (516)
T ss_pred             ----eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH-hcCceecccccccEEEcCCC-cEEEcCc
Confidence                999999998 677888877554  45999999999999999999999 88999999999999999998 7999999


Q ss_pred             CCceecccCCCc-----ccccccccccccccc-cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014156          239 GSAKVLVKGEPN-----ISYICSRYYRAPELI-FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       239 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      |.+..+......     ..++||++|||||++ ....+|+.++||||||++..||++|..||........+..-++  +.
T Consensus       171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~  248 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--ND  248 (516)
T ss_pred             eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CC
Confidence            987665443221     456899999999994 4556799999999999999999999999988777665543332  23


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      |+.-.                 .......-.+.++..++.+|..||.+||.+||||.++|+|+||+......
T Consensus       249 pp~~~-----------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  249 PPTLL-----------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             CCCcc-----------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence            32110                 00111112234677999999999999999999999999999999865543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-50  Score=349.67  Aligned_cols=259  Identities=27%  Similarity=0.460  Sum_probs=219.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------------hhhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      .|.-.+.||+|..++|.++.++.+|..+|+|++...            .+...+|+.||+++ .||+|+.+.++|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            477788999999999999999999999999987321            12223689999987 699999999998     


Q ss_pred             CCceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          159 KDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                      +...++++|+|.|+ |.|++.+..    .-.+++...+.+++|++.|++||| ..+||||||||+|||++.+. ++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylH-a~~IVHRDLKpENILlddn~-~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLH-ARNIVHRDLKPENILLDDNM-NIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHH-HhhhhhcccChhheeecccc-ceEEec
Confidence            77778999999999 666665543    567999999999999999999999 78999999999999999776 799999


Q ss_pred             cCCceecccCCCccccccccccccccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014156          238 FGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       238 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      ||+|+....++.....||||+|.|||.+.     +.++|+..+|+|++|||||.|+.|.+||......-.+..|++..-.
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999884     3467899999999999999999999999877777777777764211


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                                       +..        .-+.++|..++|||++||+.||.+|+|+.|+|.||||..+..-..+
T Consensus       247 -----------------F~s--------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r  295 (411)
T KOG0599|consen  247 -----------------FRS--------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR  295 (411)
T ss_pred             -----------------cCC--------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence                             111        1123578999999999999999999999999999999887654443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-47  Score=371.50  Aligned_cols=287  Identities=31%  Similarity=0.544  Sum_probs=224.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            35799999999999999999999999999999988532      2234579999999999999999998754322 1223


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+|+||||+++++...+.      ..+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus       100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEecCCCcc
Confidence            478999999988766542      34888999999999999999999 88999999999999999887 79999999997


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+......
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            65544444556789999999998764 48999999999999999999999999998888888888888887765433221


Q ss_pred             ----------CCCccccCCCc-CCC--CcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          323 ----------PNYTEFKFPQI-KAH--PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       323 ----------~~~~~~~~~~~-~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                                +.+....+... ...  +.........++++++||.+||.+||.+|||+.|+|+||||..+..+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~  326 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE  326 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccc
Confidence                      11111100000 000  0001112235788999999999999999999999999999988766543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-47  Score=361.73  Aligned_cols=279  Identities=34%  Similarity=0.575  Sum_probs=219.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcC-CCcEEEEEEeccch------hhHHHHHHHHHHc---CCCCeeccceeeeecCCCCc
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~~  161 (429)
                      +|++.+.||+|+||.||+|++.. ++..||+|.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            59999999999999999999864 46889999875321      2234577777665   69999999998754443444


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..+++||||+++++...+...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH-~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            568899999998887766532  2345899999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      +............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            876555444556789999999998654 4899999999999999999999999999998999999888877765544321


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      .. .....+......+.. .+.+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus       237 ~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VA-LPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hc-ccchhccCCCCCCHH-HHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            10 000111111111111 2234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-47  Score=359.27  Aligned_cols=275  Identities=39%  Similarity=0.688  Sum_probs=219.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.++||||+++++++.     ....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEEE
Confidence            599999999999999999999999999999988543      223457999999999999999998873     334589


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||++++++..+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH-KNDIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            9999999887665532   3457899999999999999999999 88999999999999999887 79999999998754


Q ss_pred             cCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014156          246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  322 (429)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  322 (429)
                      ...  ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.+.... 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322  223457899999999987644 8999999999999999999999999988888777777776666554443221 


Q ss_pred             -CCCccccCCCcC-CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          323 -PNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       323 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                       +.+.....+... ...+...+...+|.++.+||++||++||.+|||+.++|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             111111111111 1112223334578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-48  Score=335.58  Aligned_cols=250  Identities=30%  Similarity=0.455  Sum_probs=216.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .++|.+.+.||+|-||.||+|+.+.++..||+|++.+..       ....+|++|-..|+||||+++|++|.     +..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-----d~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-----DSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-----ccc
Confidence            457999999999999999999999999999999986542       33457899999999999999999994     444


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+|+++||.. |.++..+..  ....++++..+..|+.|++.||.|+| .+++|||||||+|+|++.++ .+||+|||.+
T Consensus        96 riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h-~k~VIhRdiKpenlLlg~~~-~lkiAdfGws  171 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCH-LKRVIHRDIKPENLLLGSAG-ELKIADFGWS  171 (281)
T ss_pred             eeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhc-cCCcccCCCCHHHhccCCCC-CeeccCCCce
Confidence            5899999998 556665542  34577999999999999999999999 88999999999999999888 7999999998


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .... .....+.|||..|.+||+..+. .++..+|+|++|++.||++.|.+||...+..+.+++|.+.            
T Consensus       172 V~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------------  237 (281)
T KOG0580|consen  172 VHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------------  237 (281)
T ss_pred             eecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc------------
Confidence            7654 4555678999999999999764 4899999999999999999999999998888888887774            


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                       +..++..++.++.|||.+||.++|.+|.+..|++.|||+..
T Consensus       238 -----------------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  238 -----------------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             -----------------cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                             11244568999999999999999999999999999999865

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.7e-47  Score=368.76  Aligned_cols=288  Identities=31%  Similarity=0.534  Sum_probs=227.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            45799999999999999999999999999999988542      1234479999999999999999987744321 2233


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+|+||||+++++...+.      ..+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence            578999999998776553      34788899999999999999999 88999999999999999887 79999999998


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+....+.
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            76554444556789999999998764 48999999999999999999999999999988888888888887766544332


Q ss_pred             CCC----------ccccCCCc---CCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          323 PNY----------TEFKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       323 ~~~----------~~~~~~~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                      +..          ..+.+...   ...++........+..+++||.+||+.||.+|||+.++|+||||..+..+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~  330 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA  330 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccC
Confidence            211          11110000   00111112223346789999999999999999999999999999987776544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.6e-47  Score=361.01  Aligned_cols=281  Identities=34%  Similarity=0.636  Sum_probs=227.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ....+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence            46999999999999999999999999999999875322     234579999999999999999998743     33488


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCH-RRKVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence            9999999877765543   3456889999999999999999999 88999999999999999887 79999999987653


Q ss_pred             cCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+......
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            322 2234567899999999876666899999999999999999999999999888888999999988887766543321


Q ss_pred             --CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          325 --YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       325 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                        +..+.++......+.. ....+++++++||.+||..||.+|||+.|+|+||||+.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         236 DEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence              1222333322222211 22357899999999999999999999999999999987653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-47  Score=366.20  Aligned_cols=251  Identities=29%  Similarity=0.422  Sum_probs=207.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence            457999999999999999999999999999999886432       234579999999999999999998843     34


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||+.+ +|.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLH-SKDIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence            58899999985 4444443    2467899999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      +.....  ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...            
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------  230 (329)
T PTZ00263        166 KKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------  230 (329)
T ss_pred             eEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence            876332  2356799999999998664 4889999999999999999999999887665554443321            


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  383 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  383 (429)
                           ..            .++..++..+++||.+||+.||.+|++     +.++++||||++..+.
T Consensus       231 -----~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        231 -----RL------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             -----Cc------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                 00            122346889999999999999999997     7999999999886543

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1e-46  Score=355.73  Aligned_cols=279  Identities=30%  Similarity=0.533  Sum_probs=220.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHc---CCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|++.+.||+|+||.||+|++..+++.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4899999999999999999999999999999875321      2234677777665   799999999988655444556


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+++||||+.+++...+...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            68899999998877766432  2345899999999999999999999 88999999999999999887 79999999998


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ............||..|+|||++.+. .++.++||||+||++|+|++|.+||.+....+.+.++....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            76544444556789999999998664 48999999999999999999999999988888888888887776655433211


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      . .....+.......+. .+.+.++..+.+||.+||++||.+|||+.+++.||||
T Consensus       236 ~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 T-LPRGAFSPRGPRPVQ-SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             c-ccccccCCCCCCchH-HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0 000011111111111 2234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-47  Score=365.80  Aligned_cols=256  Identities=32%  Similarity=0.538  Sum_probs=217.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcC-CCCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...|.+.+.||+|.||.||+++.+.+|+.+|+|.+.+..       ....+|+.+|+.+. |||||.+++.|     ...
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence            346999999999999999999999999999999986543       35678999999998 99999999999     444


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC---CceEEee
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCD  237 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~---~~vkl~D  237 (429)
                      ..+++|||+|.| .|++.+...     .+++..+..++.||+.|+.||| +.||+||||||+|+|+....   ..+|++|
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH-~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH-SLGVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCHHHeeeccccCCCCcEEEee
Confidence            468999999995 444444332     3999999999999999999999 89999999999999995442   2799999


Q ss_pred             cCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       238 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ||++.....+......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+......++...-       
T Consensus       183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~-------  254 (382)
T KOG0032|consen  183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD-------  254 (382)
T ss_pred             CCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-------
Confidence            999999887667788999999999999864 459999999999999999999999999998877777665531       


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                +        .+....+..++..+++||++||..||.+|+|+.++|+|||++....
T Consensus       255 ----------~--------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  255 ----------F--------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             ----------C--------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence                      1        1112234568999999999999999999999999999999887543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-47  Score=358.75  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=206.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            599999999999999999999999999999988532       22345799999999999999998877     334468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+.+ +|.+.+.    ..+.+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLH-SKEIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            899999985 4555443    2467899999999999999999999 88999999999999999887 799999999976


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....             
T Consensus       151 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------  214 (291)
T cd05612         151 LRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------  214 (291)
T ss_pred             ccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            5332  2346789999999998654 48999999999999999999999998877665555543310             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  383 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  383 (429)
                                      ..++..+++.+++||++||+.||.+|++     +.++++||||+.+.+.
T Consensus       215 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         215 ----------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             ----------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                            0123446889999999999999999995     9999999999987653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-49  Score=397.13  Aligned_cols=303  Identities=29%  Similarity=0.472  Sum_probs=241.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc-------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|.++++||+|+||.|.+++.+.|++.||+|++.+       +...+..|-.+|-.-+.+=|+.++-.|     .+..
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~  148 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER  148 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence            3479999999999999999999999999999998865       234556788888888999999998888     7778


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      |+|+||||++| +++.++..+    .++|+.++++|+..|+.||.-|| +.|+|||||||+|||||..|| |||+|||.|
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH-~mgyVHRDiKPDNvLld~~GH-ikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLH-SMGYVHRDIKPDNVLLDKSGH-IKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHH-hccceeccCCcceeEecccCc-EeeccchhH
Confidence            89999999985 566665543    37999999999999999999999 999999999999999999995 999999999


Q ss_pred             eecccCCC--cccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          242 KVLVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       242 ~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      -.+...+.  ....+|||.|+|||++..    ...|+..+|+||+||++|||+.|..||+..+-.+.+.+|+...     
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk-----  297 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK-----  297 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh-----
Confidence            77764433  345789999999999842    2458999999999999999999999999999999999988751     


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCccccCCCCCCCCCCCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDELRDPNARLPNGRP  392 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~~~~~~~~~~  392 (429)
                                +.+.||..          ..+|+++++||+++++ +|..|+.   +.++.+||||.++.|.+.+....+-
T Consensus       298 ----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~  356 (1317)
T KOG0612|consen  298 ----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPV  356 (1317)
T ss_pred             ----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCC
Confidence                      11223311          2379999999999887 5788998   9999999999999997766433333


Q ss_pred             CCCC------CCCChhhhccCCHHHHHhhcHHHH-hhhCCCCCC
Q 014156          393 FPPL------FNFKPQELKGASKELLSKLIPEHA-RKQCPFLGF  429 (429)
Q Consensus       393 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  429 (429)
                      +|..      -||+-.+-.....+.+..-+|..+ -.+.||+||
T Consensus       357 vPevssd~DTsnFd~~~dd~~~~e~~p~~~~~~f~Gn~LPFIGf  400 (1317)
T KOG0612|consen  357 VPEVSSDDDTSNFDVDEDDLRDAETFPPRIPKAFSGNHLPFIGF  400 (1317)
T ss_pred             CCcCCCCCccccccccccccchhhccCCCCCCCCcCCcCCeeee
Confidence            3322      234222222233444444455555 468899998

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.8e-47  Score=370.70  Aligned_cols=284  Identities=35%  Similarity=0.565  Sum_probs=224.6

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||+|.+..+|+.||||.+...      .....+|+.+++.++|+||+++++++..........++
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            378899999999999999999999999999987532      12345799999999999999999988544322223588


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+.+++...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            999999987766553    2467999999999999999999999 88999999999999999887 79999999997653


Q ss_pred             cCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+++..+...++.++.+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  223456789999999987766689999999999999999999999999999999999999999888765532211


Q ss_pred             CCcccc--CCCc-CCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          324 NYTEFK--FPQI-KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       324 ~~~~~~--~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ......  .+.. +.......+....++++.+||.+||++||.+|||+.|+|+||||+..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            100000  0000 000000112345688999999999999999999999999999998854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.5e-47  Score=356.44  Aligned_cols=256  Identities=23%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      |++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+++++++.     ...+.+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeEE
Confidence            889999999999999999999999999999875321       12347999999999999999988873     334588


Q ss_pred             EEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+.++ +...+..  .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .++|+|||++...
T Consensus        77 lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05631          77 LVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQ-RERIVYRDLKPENILLDDRG-HIRISDLGLAVQI  152 (285)
T ss_pred             EEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEc
Confidence            999999865 4333322  22346899999999999999999999 88999999999999999877 7999999999876


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..........||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......           
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  220 (285)
T cd05631         153 PEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-----------  220 (285)
T ss_pred             CCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------
Confidence            544444456789999999999764 58999999999999999999999998765433332222211100           


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  383 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  383 (429)
                                    ...++..+++++.+||++||+.||.+|+|     +.++++||||+++.+.
T Consensus       221 --------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         221 --------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             --------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence                          01133457999999999999999999997     8999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-46  Score=366.03  Aligned_cols=285  Identities=32%  Similarity=0.546  Sum_probs=225.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            35799999999999999999999999999999988542      1233479999999999999999998754322 1223


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+++||||+++++...+.      ..+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus        96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~Nill~~~~-~~kl~Dfg~~~  167 (355)
T cd07874          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  167 (355)
T ss_pred             eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence            578999999988766543      34888999999999999999999 88999999999999999887 79999999998


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...++.+..+....+.
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            76554444567889999999998664 58999999999999999999999999998888888888888877766544332


Q ss_pred             CCC----------ccccCCCcCC---CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          323 PNY----------TEFKFPQIKA---HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       323 ~~~----------~~~~~~~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      +..          ....++....   .+.........+.++++||.+||..||.+|||+.|+|+||||..+.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            211          1111111100   011112233456789999999999999999999999999999876554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-48  Score=353.72  Aligned_cols=247  Identities=25%  Similarity=0.440  Sum_probs=218.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|.+.+.||+|.||+|-+|+....|+.||||.+.+++       -.+.+|++||..|+||||+.+|.+|     ++...
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCce
Confidence            47999999999999999999999999999999886543       3456899999999999999999999     44455


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +.|||||.. |.|++.+..    .+.+++.+++.+++||..|+.|+| +.+++|||||.+|||+|.++ ++||+|||++.
T Consensus       128 IvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCH-knrVvHRDLKLENILLD~N~-NiKIADFGLSN  201 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCH-KNRVVHRDLKLENILLDQNN-NIKIADFGLSN  201 (668)
T ss_pred             EEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHh-hccceecccchhheeecCCC-Ceeeeccchhh
Confidence            889999998 567776643    578999999999999999999999 88999999999999999888 79999999999


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .+.......++||+|-|.+||++.|..+-++.+|-|||||+||.|+.|..||.|.+....+.+|...-            
T Consensus       202 ly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga------------  269 (668)
T KOG0611|consen  202 LYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA------------  269 (668)
T ss_pred             hhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc------------
Confidence            99888888999999999999999888877999999999999999999999999998888777775531            


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                           |             +.+.-+.++.-||+.||..||.+|.|+.++-.|=|.+
T Consensus       270 -----Y-------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  270 -----Y-------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -----c-------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                 1             1122477899999999999999999999999997764

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=360.29  Aligned_cols=258  Identities=28%  Similarity=0.425  Sum_probs=228.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+-|.+.+.||+|.|+.|.+|++..||+.||+|++.+.      ...+.+|++.|+.++|||||++|.+.     .....
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTK   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTK   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccce
Confidence            34599999999999999999999999999999998653      24456899999999999999999877     44455


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|+|+|+-++ ++++.+..   ....+.+..++.|+.||+.|+.|+| +..+|||||||+|+.+....+-|||+|||++.
T Consensus        92 lyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCH-qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCH-QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             EEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHh-hhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence            8999999885 67776544   4567999999999999999999999 89999999999999887776689999999999


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .+..+....+.||+..|.|||++.|..+-.+++||||||||||.|++|++||...++.+.+..|+.+..           
T Consensus       168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-----------  236 (864)
T KOG4717|consen  168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-----------  236 (864)
T ss_pred             cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-----------
Confidence            999999999999999999999999988778899999999999999999999999999999999887532           


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                            .            .+..++.++++||.+||..||.+|.|.++|..|+|++.+..+..
T Consensus       237 ------t------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  237 ------T------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             ------c------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence                  2            23347999999999999999999999999999999998776543

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-47  Score=372.55  Aligned_cols=277  Identities=24%  Similarity=0.327  Sum_probs=210.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeec
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|....  ....+|+++++.++||||++++++|..     ..+.++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEec
Confidence            469999999999999999999999999999997543  345689999999999999999998843     3357899999


Q ss_pred             chhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC--C
Q 014156          171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--E  248 (429)
Q Consensus       171 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~--~  248 (429)
                      +.++++..+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+.....  .
T Consensus       165 ~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH-~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLH-ENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHhEEEcCCC-CEEEEeCCccccccccccc
Confidence            99877765543    356899999999999999999999 88999999999999999887 7999999999754322  2


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHHHhhc
Q 014156          249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||....       ...++..+....+.++.+.....
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            23356799999999998664 58999999999999999999998775432       34556666666665442210000


Q ss_pred             CCC----C----ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          322 NPN----Y----TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       322 ~~~----~----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      ...    +    ............|..  ...++.++.+||.+||++||.+|||+.|+|+||||+.+..+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTN--LYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHH--HhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            000    0    000000000001111  11357789999999999999999999999999999886543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.4e-47  Score=362.83  Aligned_cols=245  Identities=27%  Similarity=0.427  Sum_probs=200.4

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++.     ...++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence            46999999999999999999999999886432       22346899999999999999988873     3345889999


Q ss_pred             cchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-C
Q 014156          170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  247 (429)
Q Consensus       170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-~  247 (429)
                      |+.++ +...+.    ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH-~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLH-SCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            99864 433332    3467899999999999999999999 88999999999999999887 799999999875432 2


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            333456799999999998654 5899999999999999999999999877655444333221                 0


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                  ..++..+++++.+||.+||..||.+||     ++.++++||||..+.+
T Consensus       212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         212 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                        013345799999999999999999999     8999999999998654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-46  Score=363.10  Aligned_cols=285  Identities=34%  Similarity=0.607  Sum_probs=226.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            36999999999999999999999999999999886431      233479999999999999999988753321 12234


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .+++++++++++..++.     ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            68999999887766543     356999999999999999999999 88999999999999999887 799999999986


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.......
T Consensus       168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            543  234567899999999987756689999999999999999999999999888888888888888777665433221


Q ss_pred             CCccc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          324 NYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       324 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      .....   ..+......+... ....++.+.+||.+||..||.+|||+.|+|+||||.....+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~  309 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED  309 (343)
T ss_pred             hhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcc
Confidence            11000   1111111111111 1246788999999999999999999999999999998776543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-46  Score=362.83  Aligned_cols=252  Identities=29%  Similarity=0.429  Sum_probs=206.5

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCC-cEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...+|.+.+.||+|+||.||+|.+..++ ..||+|.+...       .....+|+.+++.++||||+++++++.     .
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----D  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----e
Confidence            3457999999999999999999876654 68999988542       123347999999999999999999883     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ..++++||||+.+ +|.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~-~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQ-SLNIVYRDLKPENLLLDKDG-FIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEECCCC-CEEEecCC
Confidence            3458999999975 4554443    2467999999999999999999999 88999999999999999887 79999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      +++....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....         
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------  244 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------  244 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence            9987533  23456799999999998664 48899999999999999999999998877655555443310         


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                                          ..++..+++.+.++|++||+.||.+|+     |+.++++||||+++.+.
T Consensus       245 --------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        245 --------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                                012345789999999999999999996     89999999999987653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.3e-46  Score=352.05  Aligned_cols=283  Identities=32%  Similarity=0.597  Sum_probs=226.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++.     ...+.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence            346999999999999999999999999999999875321     23457999999999999999999884     33458


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCH-RRKVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence            89999999877665543   3456889999999999999999999 88999999999999999887 7999999998764


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            3322 223346788999999987666688999999999999999999999999888888888888888877665543221


Q ss_pred             --CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          324 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       324 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                        .+.....+....... ......+++++.+||.+||+.||.+|||+.|+|+||||+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence              112222222211111 12334678999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.2e-46  Score=355.52  Aligned_cols=278  Identities=31%  Similarity=0.529  Sum_probs=209.0

Q ss_pred             eeEEccCCcEEEEEEEEc--CCCcEEEEEEeccch--hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           96 ERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      .++||+|+||.||+|+++  .+++.||+|.+....  ....+|+.+++.++||||+++++++....   ...+++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEecc
Confidence            358999999999999965  467899999886432  34568999999999999999998875432   34578999999


Q ss_pred             hhhHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CCCceEEeecCCcee
Q 014156          172 PETVYRVAKHYSR-----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKV  243 (429)
Q Consensus       172 ~~~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~~~vkl~DFG~a~~  243 (429)
                      ++++...+.....     ....+++..++.++.||+.||.||| +.||+||||||+|||++.   ....+||+|||+|+.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9988777653211     1235899999999999999999999 889999999999999942   223799999999987


Q ss_pred             cccCC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 014156          244 LVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKVL  310 (429)
Q Consensus       244 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~~  310 (429)
                      .....    ......||+.|+|||++.+...++.++||||+||++|+|++|++||.+...         ..++..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            64322    223467899999999987766689999999999999999999999975432         35677788888


Q ss_pred             CCCCHHHHhhcCCCCc------cccCCCcCCCC---cccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          311 GTPTREEIKCMNPNYT------EFKFPQIKAHP---WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      +.+....+........      .+.........   +........+.++.+||++||++||.+|+|+.|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            8877665543221100      00000000000   0001112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-48  Score=344.29  Aligned_cols=256  Identities=29%  Similarity=0.437  Sum_probs=216.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+|..+++||+|.||+|.+++.+.+++.||||+++++.       .....|-++|+..+||.+..+...|     ...
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence            4567999999999999999999999999999999886542       2223588899999999999987777     445


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..+|+||||.+|+  ++.-+..+ ...+++..+++|...|+.||.||| +.+||+||||.+|+|+|.+|| +||+|||+|
T Consensus       241 drlCFVMeyanGG--eLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLH-s~~ivYRDlKLENLlLDkDGH-IKitDFGLC  315 (516)
T KOG0690|consen  241 DRLCFVMEYANGG--ELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLH-SRNIVYRDLKLENLLLDKDGH-IKITDFGLC  315 (516)
T ss_pred             ceEEEEEEEccCc--eEeeehhh-hhcccchhhhhhhHHHHHHhhhhh-hCCeeeeechhhhheeccCCc-eEeeecccc
Confidence            5699999999976  33333222 577999999999999999999999 789999999999999999995 999999999


Q ss_pred             eecc-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          242 KVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       242 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +... .+....++||||.|+|||++.. .+|+.++|+|.+||+||||++|+.||...+.......|...           
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------  383 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------  383 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence            8653 4556678999999999999965 56999999999999999999999999988776666655542           


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPN  384 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  384 (429)
                            +            ..|+..++++++.|+..+|.+||.+|+     .+.|+.+|+||..+.|..
T Consensus       384 ------d------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 ------D------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ------h------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                  1            135567999999999999999999998     478999999999988743

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.9e-46  Score=372.22  Aligned_cols=282  Identities=22%  Similarity=0.356  Sum_probs=212.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCC------CeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.++||+|+||+||+|.+..+++.||||++....   .....|+.+++.+.|.      ++++++++|..    .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            467999999999999999999999999999999985422   2334678888777554      57777776632    2


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC---------
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---------  231 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~---------  231 (429)
                      ..++|+||+++++++++.+..    .+.+++..++.++.||+.||.|||++.|||||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            235789999999888776643    3579999999999999999999993369999999999999986542         


Q ss_pred             ------ceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014156          232 ------QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE  305 (429)
Q Consensus       232 ------~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  305 (429)
                            .+||+|||.+...  .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  4999999988643  2233457899999999999764 489999999999999999999999999988888888


Q ss_pred             HHHHhCCCCHHHHhhcCCC-----Cccc--cCCCcCCCCccc-----cc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014156          306 IIKVLGTPTREEIKCMNPN-----YTEF--KFPQIKAHPWHK-----IF-HKRMPPEAVDLVSRLLQYSPNLRCTALEAC  372 (429)
Q Consensus       306 i~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~-----~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  372 (429)
                      +.+.++.++..........     +...  ..+......+..     .. ....++.+.+||.+||++||.+|||+.|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            8888887765433211100     0000  000000000000     00 001246788999999999999999999999


Q ss_pred             cCCCccccCC
Q 014156          373 IHPFFDELRD  382 (429)
Q Consensus       373 ~hp~f~~~~~  382 (429)
                      +||||.....
T Consensus       437 ~Hp~~~~~~~  446 (467)
T PTZ00284        437 THPYVLKYYP  446 (467)
T ss_pred             cCccccccCC
Confidence            9999988554

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.7e-46  Score=362.40  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=203.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++..++|+||+++++.+     .....+
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            5999999999999999999999999999999986432       2345689999999999999999888     334458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |+||||+++ +|.+.+.    ..+.+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH-~~givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIH-QLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            999999986 4444443    2467999999999999999999999 88999999999999999887 799999999875


Q ss_pred             cccCC------------------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHH
Q 014156          244 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL  287 (429)
Q Consensus       244 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  287 (429)
                      .....                                    .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence            42210                                    01245799999999998764 589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCC---C
Q 014156          288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN---L  364 (429)
Q Consensus       288 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~  364 (429)
                      ++|+.||.+.+..+...++......               ..+|.          ...+++++++||.+|+. +|.   .
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence            9999999888776666555432100               00111          01368999999999876 454   4


Q ss_pred             CCCHHHHhcCCCccccCCC
Q 014156          365 RCTALEACIHPFFDELRDP  383 (429)
Q Consensus       365 R~t~~e~l~hp~f~~~~~~  383 (429)
                      ||++.|+++||||+.+.+.
T Consensus       284 r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         284 APGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CCCHHHHhCCCCCCCCCHH
Confidence            5899999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5e-46  Score=363.03  Aligned_cols=255  Identities=28%  Similarity=0.463  Sum_probs=204.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++++.     ...
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~~  116 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-----DDK  116 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCC
Confidence            34699999999999999999999999999999988532       223457999999999999999998883     344


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ++++||||+++ +|.+++.     ...+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH-~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a  189 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIH-SMGLIHRDVKPDNMLLDKHG-HLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEECCCC-CEEEEecccc
Confidence            68999999985 5555443     246899999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCCC--cccccccccccccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGEP--NISYICSRYYRAPELIFGAT---EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ........  ....+||+.|+|||++.+..   .++.++||||+||++|+|++|+.||.+.+.......+......    
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~----  265 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS----  265 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc----
Confidence            87643322  23567999999999986432   3788999999999999999999999988776666555432110    


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELR  381 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~  381 (429)
                                 ..++.          ...++..++++|.+||..++.+  |+|+.++++||||+...
T Consensus       266 -----------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         266 -----------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             -----------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence                       00111          1136899999999999866544  89999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-47  Score=338.14  Aligned_cols=284  Identities=36%  Similarity=0.612  Sum_probs=227.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCC----cEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..|+++..||+|.||.||+|....++    +.||||.++.++      ...-+|+.+++.++|||++.+..+|...    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            35999999999999999999655443    378999886552      2335899999999999999999988654    


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC----CCceEE
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH----THQVKL  235 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~----~~~vkl  235 (429)
                      ...+++++||.+.+|+.++.+... ....++...++.++.||+.|++||| +.=|+||||||.||||..+    | .|||
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH-~NWvlHRDLKPaNIlvmgdgperG-~VKI  177 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH-SNWVLHRDLKPANILVMGDGPERG-RVKI  177 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh-hhheeeccCCcceEEEeccCCccC-eeEe
Confidence            335899999999999999987543 2356899999999999999999999 6689999999999999876    5 8999


Q ss_pred             eecCCceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---------hHHH
Q 014156          236 CDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---------GVDQ  302 (429)
Q Consensus       236 ~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---------~~~~  302 (429)
                      +|||+++.+...-.    ....+.|.+|+|||.+.|...|+.+.|||++|||+.||+|-.+.|.+..         ..++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999998765432    2345679999999999999999999999999999999999999998743         2468


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccc--cCCCcCCCCcc-----ccc--CCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          303 LVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWH-----KIF--HKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       303 ~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      +.+|++.+|.|+.+.|+.+.. +.++  .+..+....+.     ..+  .+.-++.+.+|+.+||++||.+|+|+.++|+
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk-~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKK-MPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHcCCCccccchhhhh-CcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            899999999999988876541 1111  11111111111     111  1223566999999999999999999999999


Q ss_pred             CCCccccC
Q 014156          374 HPFFDELR  381 (429)
Q Consensus       374 hp~f~~~~  381 (429)
                      |+||.+-.
T Consensus       337 h~yF~~d~  344 (438)
T KOG0666|consen  337 HPYFTEDP  344 (438)
T ss_pred             ccccccCC
Confidence            99998743

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-46  Score=361.76  Aligned_cols=254  Identities=31%  Similarity=0.521  Sum_probs=207.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|.+.+.||+|+||.||+|++..+++.||||++...       .....+|+.++..++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            599999999999999999999999999999998643       22345789999999999999999887     334468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+.+ +|...+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH-~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVH-KLGFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            999999975 55554432    367999999999999999999999 78999999999999999887 799999999976


Q ss_pred             cccCC------------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014156          244 LVKGE------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL  293 (429)
Q Consensus       244 ~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  293 (429)
                      .....                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54433                              22345789999999998765 589999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-HHHHh
Q 014156          294 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEAC  372 (429)
Q Consensus       294 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-~~e~l  372 (429)
                      |.+.+.......+......               ..++.          ...+++++.+||.+||. ||.+|++ +.+++
T Consensus       230 f~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            9888766555554431100               01111          11268999999999998 9999999 99999


Q ss_pred             cCCCccccCCC
Q 014156          373 IHPFFDELRDP  383 (429)
Q Consensus       373 ~hp~f~~~~~~  383 (429)
                      +||||+.+.+.
T Consensus       284 ~hp~~~~~~~~  294 (350)
T cd05573         284 SHPFFKGIDWE  294 (350)
T ss_pred             cCCCcCCCCHH
Confidence            99999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=353.08  Aligned_cols=317  Identities=35%  Similarity=0.633  Sum_probs=241.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+...     .....+|+.+++.++|+||+++++++..........++
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4699999999999999999999999999999987531     12234699999999999999999876554434445678


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|+||+++++...+.     ...+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus        85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH-~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~  157 (336)
T cd07849          85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD  157 (336)
T ss_pred             EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence            999999987766553     357999999999999999999999 88999999999999999887 79999999987654


Q ss_pred             cCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          246 KGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       246 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ....    .....||+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+...++.+..+.+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            3221    123567899999998766556899999999999999999999999998888888888888887776655432


Q ss_pred             CCCCc-cc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCC
Q 014156          322 NPNYT-EF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN  398 (429)
Q Consensus       322 ~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~  398 (429)
                      ..... .+  ..+.....++.. ..+..++++.+||.+||+.||.+|||+.++++||||+.+.++.......    +++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~----~~~~  312 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAE----EPFP  312 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCC----CCCC
Confidence            21110 00  011111111111 1234688999999999999999999999999999999988764432221    2234


Q ss_pred             CChhhhccCCHHHHHhhcHHH
Q 014156          399 FKPQELKGASKELLSKLIPEH  419 (429)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~  419 (429)
                      ++-.+.....++-++.++-++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~  333 (336)
T cd07849         313 FDFELFDDLPKEKLKELIFEE  333 (336)
T ss_pred             hhhccccccCHHHHHHHHHHH
Confidence            444455556677777665543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.7e-46  Score=356.15  Aligned_cols=245  Identities=30%  Similarity=0.495  Sum_probs=198.8

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|++..+++.||+|++.+..       .....|..++..+ +||||+++++++.     ....+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999886432       2223577777765 7999999999883     334588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  246 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-  246 (429)
                      ||++++ |...+    .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 Ey~~~g~L~~~i----~~~~~l~~~~~~~~~~ql~~~L~~lH-~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLH-DKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            999864 43333    23467999999999999999999999 88999999999999999887 799999999876432 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------  212 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------  212 (320)
T ss_pred             CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            233345678999999999865 458999999999999999999999998887666555443210                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~------~e~l~hp~f~~~~~  382 (429)
                                   ..++..+++++.+||++||+.||.+|+++      .++++||||..+.+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         213 -------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence                         01223478999999999999999999998      89999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.4e-46  Score=360.47  Aligned_cols=256  Identities=26%  Similarity=0.448  Sum_probs=206.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|.+.+.||+|+||+||+|++..+|+.||+|++....       ....+|+.+++.++|+||+++++++.     ...++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeE
Confidence            5999999999999999999999999999999986432       23457889999999999999988773     33458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ +|.+++..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH-~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVH-QMGYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            899999975 55554432   2357999999999999999999999 88999999999999999887 799999999987


Q ss_pred             cccCCCc--ccccccccccccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          244 LVKGEPN--ISYICSRYYRAPELIFG-----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       244 ~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      .......  ....||+.|+|||++..     ...++.++|||||||++|+|++|..||...+....+.++.....     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-----  226 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR-----  226 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            6443322  23468999999999853     34578899999999999999999999988776666555443210     


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                                ...++.          ...+++++.+||.+||+ ||.+|||+.++++||||..+.+.
T Consensus       227 ----------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         227 ----------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             ----------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence                      000111          12468999999999998 99999999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-45  Score=360.72  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=206.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            45799999999999999999999999999999988542       12345789999999999999999887     3444


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ++++||||+++ +|..++.     ...+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~  189 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEcCCC-CEEEEeccce
Confidence            68999999975 4544443     246899999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCC--CcccccccccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGE--PNISYICSRYYRAPELIFGA---TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      .......  .....+||+.|+|||++.+.   ..++.++|||||||++|+|++|.+||.+.+....+..+......    
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----  265 (370)
T cd05596         190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS----  265 (370)
T ss_pred             eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc----
Confidence            7764332  22346799999999998643   23788999999999999999999999988766655555431100    


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRD  382 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~  382 (429)
                                 ..++.          ...+|.++.+||++||..+|.+  |+|+.++++||||+...+
T Consensus       266 -----------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         266 -----------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             -----------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                       01111          1236899999999999999988  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.3e-45  Score=345.88  Aligned_cols=276  Identities=34%  Similarity=0.539  Sum_probs=216.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|.+.+.||+|+||.||+|++..+|+.||+|.+....      ....+|+.+++.++||||+++++++.     +...++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence            4899999999999999999999999999999885321      23457999999999999999999873     334588


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|+||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||+++...
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCH-SHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            9999999887765543   2456999999999999999999999 88999999999999999887 79999999987654


Q ss_pred             cCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ... ......++..|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            322 223346788999999987766678999999999999999998877 556666677777887777776655443221


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      .......+............+.+++++.+||.+||..||.+|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111111111111111112234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=360.68  Aligned_cols=253  Identities=31%  Similarity=0.496  Sum_probs=204.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||++++++|.     ...++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCeE
Confidence            5999999999999999999999999999999986431       22357999999999999999998883     34468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+.+ +|.+.+.    ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .++|+|||+++.
T Consensus        77 ~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIH-KLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            999999975 4444433    2457999999999999999999999 88999999999999999887 799999999875


Q ss_pred             cccCC---------------------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHH
Q 014156          244 LVKGE---------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVL  284 (429)
Q Consensus       244 ~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  284 (429)
                      .....                                       .....+||+.|+|||++.+ ..++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHH
Confidence            43211                                       0113468999999999865 4589999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC
Q 014156          285 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL  364 (429)
Q Consensus       285 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  364 (429)
                      |+|++|..||.+.+..+....+.....               ...++.          ...+++++++||.+||. +|.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence            999999999988776665554433110               000111          11368999999999997 9999


Q ss_pred             CCC---HHHHhcCCCccccCC
Q 014156          365 RCT---ALEACIHPFFDELRD  382 (429)
Q Consensus       365 R~t---~~e~l~hp~f~~~~~  382 (429)
                      |++   +.++++||||+.+.+
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCH
Confidence            998   999999999998755

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=355.59  Aligned_cols=257  Identities=30%  Similarity=0.448  Sum_probs=208.6

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.     ...++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCEE
Confidence            5999999999999999999999999999999886432       23346899999999999999998873     34468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |+||||+++ +|.+++.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALH-ELGYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            999999975 5555443    2467899999999999999999999 88999999999999999887 799999999976


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......          
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  217 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL----------  217 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence            543  33456789999999998765 58999999999999999999999998877666655544321000          


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                           ..+...      .....+++++.+||.+||..+|.+|+|+.++++||||.++.+.
T Consensus       218 -----~~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         218 -----QRPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             -----cCCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence                 000000      0012468999999999999999999999999999999987553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5e-45  Score=352.29  Aligned_cols=322  Identities=34%  Similarity=0.607  Sum_probs=245.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|.+.+.||+|+||.||+|++..+++.||||.+...      .....+|+.+++.++|+||+++++++..........+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            3699999999999999999999999999999987532      2233469999999999999999987755433333458


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|+||+++++...+..    ...+++..+..++.||+.||.||| +.|++||||||+||+++.++ .+||+|||+++..
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLNANC-DLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence            89999999887765542    467999999999999999999999 88999999999999999887 7999999999766


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ... .......+|..|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.+.....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            433 2233456788999999886544588999999999999999999999998888778888888887776655422111


Q ss_pred             -CCccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 014156          324 -NYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFK  400 (429)
Q Consensus       324 -~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  400 (429)
                       ....+  ..+........ ...+.+++++.+||++||+.||++|||+.++++||||..++.+......  +.+..++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~--~~~~~~~~~  315 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC--QTPFSFDFE  315 (337)
T ss_pred             hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC--CCccchhhh
Confidence             00000  01111111111 1234589999999999999999999999999999999999887654332  223344444


Q ss_pred             hhhhccCCHHHHHhhcHHHHhhhC
Q 014156          401 PQELKGASKELLSKLIPEHARKQC  424 (429)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~  424 (429)
                      ..+   .+++.+++++=.++---|
T Consensus       316 ~~~---~~~~~~~~~~~~~~~~~~  336 (337)
T cd07858         316 EDA---LTEEDIKELIYNEMLAYH  336 (337)
T ss_pred             hhh---cCHHHHHHHHHHHHhhcC
Confidence            443   566788887766654333

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-45  Score=352.17  Aligned_cols=245  Identities=28%  Similarity=0.465  Sum_probs=198.5

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|..+++.+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999886432       2234677888777 6999999999873     333588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  246 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-  246 (429)
                      ||+.++ |...+.    ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLH-ERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            999864 333332    3457999999999999999999999 88999999999999999887 799999999875322 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2223445789999999998664 4899999999999999999999999877655544433221                 


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  382 (429)
                                  ...++..++.++.+||++||..||.+|||+     .+++.||||+.+.+
T Consensus       212 ------------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         212 ------------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                        001234578999999999999999999999     99999999988654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-47  Score=352.61  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=207.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ..|+.+++||+|+||.||+|.+..+++.||||++.-+     ...+++|+.+|.+++++||.++|++|+....     ++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HH
Confidence            3588899999999999999999999999999998543     2445689999999999999999999966554     89


Q ss_pred             EEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||.|+ .++++.    ....+.+..+..++++++.||.||| ..+.+|||||+.|||+..++ .+||+|||.+...
T Consensus        88 iiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH-~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLH-SEKKIHRDIKAANILLSESG-DVKLADFGVAGQL  161 (467)
T ss_pred             HHHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhh-hcceecccccccceeEeccC-cEEEEecceeeee
Confidence            999999965 344332    3445588899999999999999999 78999999999999999886 7999999998776


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ...+++||++|||||++.+ ..|+.++||||||++++||++|.+|+.....+..+..|-+.              
T Consensus       162 ~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~--------------  226 (467)
T KOG0201|consen  162 TNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS--------------  226 (467)
T ss_pred             echhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC--------------
Confidence            5443 2367899999999999974 56999999999999999999999999876653332222110              


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                    ....+...+|+.+++|+..||.+||+.||||.++|+|+|++.
T Consensus       227 --------------~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  227 --------------APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             --------------CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence                          011222357899999999999999999999999999999987

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-45  Score=361.41  Aligned_cols=254  Identities=29%  Similarity=0.459  Sum_probs=200.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|++++.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++|+||+++++++.     ...++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            4899999999999999999999999999999985431       23457999999999999999999884     33458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ +|.+++.    ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH-~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVH-KMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            899999985 4544443    2467899999999999999999999 88999999999999999887 799999999753


Q ss_pred             cccCC------------------------------------------------CcccccccccccccccccCCCCCCCcc
Q 014156          244 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI  275 (429)
Q Consensus       244 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~  275 (429)
                      .....                                                .....+||+.|+|||++.+ ..++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCcc
Confidence            21000                                                0123579999999999865 4489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHH
Q 014156          276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS  355 (429)
Q Consensus       276 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  355 (429)
                      |||||||++|+|++|..||...+..+....+......               ...+          ....+++++.+||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIP----------PQVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCC----------CCCCCCHHHHHHHH
Confidence            9999999999999999999887765554444321100               0011          01247899999999


Q ss_pred             hhcCc--CCCCCCCHHHHhcCCCccccCC
Q 014156          356 RLLQY--SPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       356 ~~L~~--dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      +||..  +|..|+|+.++++||||+++.+
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            96655  4455999999999999998765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-45  Score=361.59  Aligned_cols=253  Identities=28%  Similarity=0.461  Sum_probs=202.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|.++++||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++|+||++++++|..     ..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence            4899999999999999999999999999999886432       234579999999999999999998843     3458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ +|...+..    .+.+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH-~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVH-KMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            999999986 45444432    357899999999999999999999 88999999999999999887 799999999753


Q ss_pred             cccC------------------------------------------------CCcccccccccccccccccCCCCCCCcc
Q 014156          244 LVKG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAI  275 (429)
Q Consensus       244 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~  275 (429)
                      ....                                                ......+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001234789999999998664 589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHH
Q 014156          276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS  355 (429)
Q Consensus       276 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  355 (429)
                      |||||||++|+|++|++||.+.+..+....+......               ...|          ....+++++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHH
Confidence            9999999999999999999887766555444331100               0001          11247899999999


Q ss_pred             hhcCcCCCCCCC---HHHHhcCCCccccCC
Q 014156          356 RLLQYSPNLRCT---ALEACIHPFFDELRD  382 (429)
Q Consensus       356 ~~L~~dP~~R~t---~~e~l~hp~f~~~~~  382 (429)
                      +|+ .+|.+|++   +.++++||||+.+.+
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            986 59999997   999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-45  Score=355.83  Aligned_cols=277  Identities=24%  Similarity=0.375  Sum_probs=205.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeec
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      ..|++++.||+|+||.||+|++..+++.||+|+....  ....|+.+++.++|+||+++++++..     ..+.++||++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence            3699999999999999999999999999999975433  33569999999999999999998843     3347899999


Q ss_pred             chhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc
Q 014156          171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  250 (429)
Q Consensus       171 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~  250 (429)
                      +.++++..+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++........
T Consensus       139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLH-AQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence            99887776543   3467899999999999999999999 88999999999999999887 7999999999765444444


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCh---------HHHHHHHHHHhCCCCHHHHhh
Q 014156          251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP-LFPGESG---------VDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~-pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ....||+.|+|||++.+. .++.++|||||||++|+|+++.. +|.....         ...+..+...++..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            556789999999998764 48999999999999999998654 4443221         123334444433322111000


Q ss_pred             cCCCC-cc-ccCCCcCCCCc---ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          321 MNPNY-TE-FKFPQIKAHPW---HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       321 ~~~~~-~~-~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      ..... .. .........++   ...-..+++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            00000 00 00000000000   001112467889999999999999999999999999999864

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-46  Score=362.91  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=201.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|.+++.||+|+||.||+|++..+++.||||++....       ....+|+++++.++||||++++++|.     +..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCee
Confidence            5999999999999999999999999999999885432       23456999999999999999999883     34468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |+||||+++ +|...+.    ....+++..++.++.|++.||+||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH-~~givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVH-KLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            999999975 5555443    2467899999999999999999999 88999999999999999887 799999999863


Q ss_pred             cccCC------------------------------------------------CcccccccccccccccccCCCCCCCcc
Q 014156          244 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI  275 (429)
Q Consensus       244 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~  275 (429)
                      .....                                                .....+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence            21100                                                00124689999999998654 589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHH
Q 014156          276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS  355 (429)
Q Consensus       276 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  355 (429)
                      |||||||++|+|++|.+||.+.+..+.+..+.....               ...+|.          ...++.++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHHH
Confidence            999999999999999999988776665555443110               001111          1136899999999


Q ss_pred             hhcCcCCCCC---CCHHHHhcCCCccccCC
Q 014156          356 RLLQYSPNLR---CTALEACIHPFFDELRD  382 (429)
Q Consensus       356 ~~L~~dP~~R---~t~~e~l~hp~f~~~~~  382 (429)
                      +||. +|.+|   +|+.++++||||+.+.+
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9998 77765   59999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=351.58  Aligned_cols=242  Identities=32%  Similarity=0.517  Sum_probs=197.6

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.     ....+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence            699999999999999999999999885421       22346899999999999999988773     334588999999


Q ss_pred             hhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC-CC
Q 014156          172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  249 (429)
Q Consensus       172 ~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~-~~  249 (429)
                      +++ |...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus        76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLH-KFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            864 444332    2467999999999999999999999 88999999999999999887 7999999998754322 22


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 014156          250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  329 (429)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                    
T Consensus       150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--------------------  208 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--------------------  208 (312)
T ss_pred             cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--------------------
Confidence            3446799999999998764 5899999999999999999999999887665544443321                    


Q ss_pred             CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCCccccC
Q 014156          330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFDELR  381 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~  381 (429)
                               ...++..+++++.+||.+||..||.+|+   ++.++++||||.+..
T Consensus       209 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         209 ---------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                     0013345789999999999999999997   589999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-45  Score=352.77  Aligned_cols=245  Identities=27%  Similarity=0.418  Sum_probs=199.6

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      +.||+|+||.||+|++..+|..||+|++....       ....+|+.+++.++||||++++++|.     ....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            46999999999999999999999999886431       22346899999999999999998873     3345889999


Q ss_pred             cchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC-
Q 014156          170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  247 (429)
Q Consensus       170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~-  247 (429)
                      |++++ +...+    .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 ~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            99865 33332    23467899999999999999999999 88999999999999999887 7999999998754322 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            223346789999999998654 5899999999999999999999999877665544443321                 0


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                      .            .++..+++++.+||.+||..||.+|+     ++.++++||||....+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            0            12345799999999999999999998     8999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-45  Score=353.77  Aligned_cols=245  Identities=26%  Similarity=0.405  Sum_probs=198.5

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||++++.++.     ....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence            46999999999999999999999999886431       23346889999999999999988773     3345889999


Q ss_pred             cchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC-
Q 014156          170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  247 (429)
Q Consensus       170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~-  247 (429)
                      |++++ +...+    .....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLH-SGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            99865 33332    23467999999999999999999999 88999999999999999887 7999999998754322 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            223346789999999998654 4899999999999999999999999876654443332210                 0


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                  ..++..+++++.+||++||..||.+|+     ++.++++||||....+
T Consensus       212 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         212 ------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             ------------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                        013345789999999999999999997     8999999999987544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.9e-45  Score=352.02  Aligned_cols=249  Identities=27%  Similarity=0.443  Sum_probs=201.0

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHH---HHcCCCCeeccceeeeecCCCCce
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      |++.+.||+|+||.||+|.+..+++.||||++....       ....+|++++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            778999999999999999999999999999986432       2233455544   4568999999999883     334


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+|+||||+.++.+....    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~~lv~E~~~~~~L~~~~----~~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACVVLGLQYLH-ENKIVYRDLKLDNLLLDTEG-FVKIADFGLCK  149 (324)
T ss_pred             EEEEEEcCCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEECCCC-cEEeCcccCCc
Confidence            588999999875333221    1357999999999999999999999 88999999999999999887 79999999987


Q ss_pred             eccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          243 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05589         150 EGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-----------  217 (324)
T ss_pred             cCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 2233456789999999998664 58999999999999999999999998877666555443310           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                        ..++..+++++.+||.+||..||.+||     ++.++++||||+++.+
T Consensus       218 ------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         218 ------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                              012345789999999999999999999     7999999999998654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-45  Score=354.61  Aligned_cols=255  Identities=30%  Similarity=0.465  Sum_probs=200.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999864   478999999885421        2234688999999 599999998877     3


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ....+++||||+.+ ++...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLH-KLGIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHeEECCCC-CEEEeeC
Confidence            34458899999986 4444432    2467999999999999999999999 88999999999999999887 7999999


Q ss_pred             CCceecccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          239 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       239 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      |+++......  .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+......    
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence            9997653332  2234678999999999876556788999999999999999999999754322211111111000    


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                           ....++..+++.+.+||.+||..||++|+     ++.++++||||++..+
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                                 00113345789999999999999999999     8889999999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.4e-45  Score=342.48  Aligned_cols=276  Identities=34%  Similarity=0.625  Sum_probs=217.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|++|.||+|++..++..||+|.+...      .....+|+.+++.++||||+++++++..     ...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence            489999999999999999999999999999987532      1334579999999999999999998843     33588


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+.+++...+.... ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCH-SRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999987776654322 2356899999999999999999999 88999999999999999887 79999999987653


Q ss_pred             cCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|+||++||.+....+....+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            322 1223456889999999876666789999999999999999999999998888877777777776655444321100


Q ss_pred             Cccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          325 YTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       325 ~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                       ..+  .++........ .....+++++.+||++||..||.+|||+.+++.||||
T Consensus       233 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 -PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             -HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             000  11111111111 1223479999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-44  Score=356.97  Aligned_cols=280  Identities=22%  Similarity=0.325  Sum_probs=211.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc--CCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ..+|.+++.||.|+||.||+|...  .+++.||+|.+... ....+|+.+++.++||||+++++.+.     ....+|+|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYR-----WKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEe-----eCCEEEEE
Confidence            347999999999999999999754  35678999987654 34468999999999999999998873     33458899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||++.++++..+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .++|+|||+++.....
T Consensus       165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH-~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLH-GRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            9999988777652    3467999999999999999999999 88999999999999999887 7999999999765433


Q ss_pred             CC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhc
Q 014156          248 EP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       248 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ..   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..   ....+..+.+.++....+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   2345789999999998654 48999999999999999999999997654   34556666666554332211000


Q ss_pred             CC----CCccccCCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          322 NP----NYTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~----~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ..    .+..+.........+...+ ...++.++.+||++||.+||.+|||+.|+|+||||.+...
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            00    0000000000000111111 1246788999999999999999999999999999986443

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-45  Score=343.02  Aligned_cols=257  Identities=24%  Similarity=0.362  Sum_probs=206.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|++.++||+|+||.||++.+..+++.||+|++....       ....+|+.+++.++||||+++++++.     ...++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence            3889999999999999999999999999999885421       22346999999999999999988873     33458


Q ss_pred             EEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+.++ +...+..  .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLH-RERIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            9999999864 4333322  22356899999999999999999999 78999999999999999877 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+...+...          
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----------  220 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence            6544444456789999999998654 48999999999999999999999998766544333332221000          


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                                     ...++..+++.+.+||.+||..||.+||     ++.++++||||....+.
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                           0112344789999999999999999999     89999999999886554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.7e-45  Score=355.38  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=203.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++.     ...
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~~~  116 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DDR  116 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence            45799999999999999999999999999999988532       123447889999999999999998873     344


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ++++||||+++ +|..++.     ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHEEECCCC-CEEEEeCCce
Confidence            68999999975 4544443     245899999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCC--CcccccccccccccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGE--PNISYICSRYYRAPELIFGAT---EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      +......  .....+||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......    
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----  265 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS----  265 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence            8764332  223567999999999986432   3788999999999999999999999987766655555432110    


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELR  381 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~  381 (429)
                                 ..++          ....++..+++||.+||..++.+  |+++.++++||||++..
T Consensus       266 -----------~~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         266 -----------LTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             -----------ccCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                       0111          11247899999999999844433  78999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.6e-45  Score=349.08  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=202.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCC-CeeccceeeeecCCCCceE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~~~~  163 (429)
                      +|++++.||+|+||.||+|++..+++.||+|++....       .....|..++..+.|+ +|+++++++..     ...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence            4899999999999999999999999999999886432       2234678888888765 57788777733     335


Q ss_pred             EEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|+||||++++ |...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            88999999854 443332    2467899999999999999999999 88999999999999999887 79999999987


Q ss_pred             eccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          243 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .... .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            5422 2233456789999999998764 48999999999999999999999998877666555543310           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~  382 (429)
                                        ..++..+++++.+||.+||..||.+|+++     .++++||||+.+.+
T Consensus       218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                              11234578999999999999999999986     89999999998655

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-45  Score=346.99  Aligned_cols=247  Identities=30%  Similarity=0.442  Sum_probs=198.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcE-EEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGET-VAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~-vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ...+.+.||+|+||+||+|.++  |.. ||+|++...      ...+.+|+.+|.+++|||||++++++.....    .+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence            3555667999999999999984  445 999988643      2356789999999999999999998854331    47


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-eeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~-iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||++++.+..+.+.. ....++...+..++.||+.|++||| +.+ ||||||||+|||++.+...+||+|||+++.
T Consensus       116 ~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH-~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH-SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh-cCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            8999999965444333321 3578999999999999999999999 788 999999999999998753799999999988


Q ss_pred             cccC-CCcccccccccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          244 LVKG-EPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       244 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .... ...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||.+....+....+......|        
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp--------  265 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP--------  265 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------
Confidence            7654 34445789999999999974 3569999999999999999999999999888744444443321111        


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                         .++..+++.+..||.+||..||..||+..+++.
T Consensus       266 -------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 -------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             -------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                               233447899999999999999999999998764

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=346.54  Aligned_cols=264  Identities=27%  Similarity=0.401  Sum_probs=216.2

Q ss_pred             CccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        87 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      +.....|+.-++||+|+||.||-++.+.||+.||+|.+.+..       ....+|..||..++.+.||.+-..|     .
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----e  255 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----E  255 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----c
Confidence            445567899999999999999999999999999999774332       2234689999999999999987666     3


Q ss_pred             CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ....+|+||..|+|+-+.... +...+..|++..+++|+.+|+.||++|| +.+||+|||||+|||+|..| .|+|+|+|
T Consensus       256 Tkd~LClVLtlMNGGDLkfHi-yn~g~~gF~e~ra~FYAAEi~cGLehlH-~~~iVYRDLKPeNILLDd~G-hvRISDLG  332 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHI-YNHGNPGFDEQRARFYAAEIICGLEHLH-RRRIVYRDLKPENILLDDHG-HVRISDLG  332 (591)
T ss_pred             CCCceEEEEEeecCCceeEEe-eccCCCCCchHHHHHHHHHHHhhHHHHH-hcceeeccCChhheeeccCC-CeEeeccc
Confidence            333499999999976333211 2223468999999999999999999999 88999999999999999988 59999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      +|..+..+......+||.+|||||++.+.. |+...|+|||||++|||+.|+.||..........++-+.....      
T Consensus       333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~------  405 (591)
T KOG0986|consen  333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED------  405 (591)
T ss_pred             eEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc------
Confidence            999998888888889999999999997755 9999999999999999999999997655443333332221111      


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPN  384 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  384 (429)
                                         ...++.++|+++++|++.+|++||++|+     ++.++.+||||+++++..
T Consensus       406 -------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  406 -------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             -------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence                               1234567899999999999999999998     567999999999998864

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-44  Score=345.34  Aligned_cols=277  Identities=30%  Similarity=0.536  Sum_probs=206.2

Q ss_pred             eeEEccCCcEEEEEEEEcC--CCcEEEEEEeccch--hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           96 ERVVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ..+||+|+||.||+|++..  ++..||+|.+....  ....+|+.+++.++||||+++++++....   ...+++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEeee
Confidence            3589999999999999654  56899999886432  34568999999999999999999875432   33578999999


Q ss_pred             hhhHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec----CCCCceEEeecCCce
Q 014156          172 PETVYRVAKHYSR-----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAK  242 (429)
Q Consensus       172 ~~~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~----~~~~~vkl~DFG~a~  242 (429)
                      +++++..+.....     ....+++..++.++.||+.||.||| +.||+||||||+|||+.    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence            9988877653211     1235889999999999999999999 88999999999999993    334 79999999998


Q ss_pred             ecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHH
Q 014156          243 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKV  309 (429)
Q Consensus       243 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~  309 (429)
                      .......    .....||+.|+|||++.+...++.++|||||||++|+|+||++||.....         ..++..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6643321    23456899999999987766689999999999999999999999975432         3456667777


Q ss_pred             hCCCCHHHHhhcCC--CCccc----cCCCcCCCCc---ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          310 LGTPTREEIKCMNP--NYTEF----KFPQIKAHPW---HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       310 ~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      ++.+..+.+.....  .+...    ..........   ........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            77666555433211  11000    0000000000   011112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-46  Score=353.44  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=219.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|.+++++|+|+||.+++++++..+..|++|.+.-.      ++...+|+.+++++.|||||.+++.|..    +..++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----CCceE
Confidence            4699999999999999999999999999999988532      3345689999999999999999999853    34469


Q ss_pred             EEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|||+||+|+ +.+.+..  .+...++++.+..|+.||+.|++||| +.+|+|||||+.|||+++++ .|+|+|||+|+.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH-~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLH-ENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHH-hhhhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            9999999965 4444443  22577999999999999999999999 88999999999999999988 689999999999


Q ss_pred             cccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          244 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      +.... ...+.+||++||+||++.+ ..|+.++|||||||++|||++-+++|.+.+-...+.+|++....|.        
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl--------  226 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL--------  226 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC--------
Confidence            87766 5667899999999999976 4599999999999999999999999999998888888887643332        


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                          +...+.+++.||+.||..+|..||++.++|.+|.+....
T Consensus       227 --------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  227 --------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             --------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence                                234689999999999999999999999999999987543

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.5e-45  Score=352.62  Aligned_cols=248  Identities=27%  Similarity=0.407  Sum_probs=198.9

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+++++.++||||+++++++.     ....+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence            46999999999999999999999999886431       22346888999999999999988773     3345899999


Q ss_pred             cchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-CC
Q 014156          170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GE  248 (429)
Q Consensus       170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-~~  248 (429)
                      |++++.+...   ......+++..++.++.||+.||.|||+..||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus        76 ~~~~~~L~~~---l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          76 YANGGELFFH---LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             CCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCc
Confidence            9986533221   223467999999999999999999999337999999999999999887 799999999875432 22


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 014156          249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  328 (429)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...                 . 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~-  212 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E-  212 (325)
T ss_pred             ccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C-
Confidence            33346799999999998654 5899999999999999999999999877654444333221                 0 


Q ss_pred             cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                                 ..++..+++++.+||.+||+.||.+|+     ++.++++||||....+.
T Consensus       213 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         213 -----------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence                       012345789999999999999999997     99999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.1e-45  Score=358.14  Aligned_cols=253  Identities=28%  Similarity=0.440  Sum_probs=201.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++++.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++|+||+++++.|.     ...++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCEE
Confidence            599999999999999999999999999999988542       223457999999999999999998873     33468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ +|.+++..    .+.+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            899999975 55555432    456899999999999999999999 88999999999999999887 799999999753


Q ss_pred             cccC--------------------------------------------CCcccccccccccccccccCCCCCCCcchHHH
Q 014156          244 LVKG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWS  279 (429)
Q Consensus       244 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  279 (429)
                      ....                                            ......+||+.|+|||++.+ ..++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeee
Confidence            2100                                            00113578999999999865 45899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcC
Q 014156          280 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ  359 (429)
Q Consensus       280 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  359 (429)
                      |||++|+|++|+.||.+.+..+....+......               ...+          ....+++++.+||.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence            999999999999999887765554443221000               0000          11247899999999977 


Q ss_pred             cCCCCCC---CHHHHhcCCCccccCC
Q 014156          360 YSPNLRC---TALEACIHPFFDELRD  382 (429)
Q Consensus       360 ~dP~~R~---t~~e~l~hp~f~~~~~  382 (429)
                      .+|.+|+   |+.++++||||+.+..
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            5999999   9999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-46  Score=340.69  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=215.9

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|..+.+||+|+||+|.+|..+.+.+.||||+++++.-       ..-.|-++|... +-|.+++++.||-.    
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----  421 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----  421 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh----
Confidence            344579999999999999999999999999999998876532       122466666655 46788999988843    


Q ss_pred             CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                       -..+|+||||+.|+  +++-+ .++-+++.+..+.+|+.+|+-||-+|| ++|||+||||.+||++|.+|| |||+|||
T Consensus       422 -mDRLyFVMEyvnGG--DLMyh-iQQ~GkFKEp~AvFYAaEiaigLFFLh-~kgIiYRDLKLDNvmLd~eGH-iKi~DFG  495 (683)
T KOG0696|consen  422 -MDRLYFVMEYVNGG--DLMYH-IQQVGKFKEPVAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEGH-IKIADFG  495 (683)
T ss_pred             -hhheeeEEEEecCc--hhhhH-HHHhcccCCchhhhhhHHHHHHhhhhh-cCCeeeeeccccceEeccCCc-eEeeecc
Confidence             33488999999976  44333 234578999999999999999999999 889999999999999999994 9999999


Q ss_pred             Cceeccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          240 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       240 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +++...- +....++||||.|+|||++.- ..|+.++|+||+||+||||+.|++||.|.++.+..+.|+..         
T Consensus       496 mcKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh---------  565 (683)
T KOG0696|consen  496 MCKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH---------  565 (683)
T ss_pred             cccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---------
Confidence            9987543 345567899999999999864 55999999999999999999999999999999999888874         


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDPN  384 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~  384 (429)
                                          ...+++.+|.++.+++..+|.+.|.+|+.+     .++-.||||+.+.|..
T Consensus       566 --------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  566 --------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             --------------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence                                123667899999999999999999999865     5899999999998864

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.8e-45  Score=350.56  Aligned_cols=246  Identities=26%  Similarity=0.464  Sum_probs=194.7

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|..+++.+ +||||++++++|.     ....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986431       2234688888888 7999999999883     334589999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc-c
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-K  246 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~-~  246 (429)
                      ||++++ |...+.    ..+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++... .
T Consensus        76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLH-ERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            999864 433332    3467999999999999999999999 88999999999999999887 79999999987532 2


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  318 (429)
                      .......+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.....        .+.+.+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            3334456899999999998764 589999999999999999999999963211        1111111100         


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCccccCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFDELRD  382 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t------~~e~l~hp~f~~~~~  382 (429)
                             .            ...++..++.++.+||++||+.||.+|+|      +.++++||||..+.+
T Consensus       220 -------~------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         220 -------K------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             -------C------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   0            00133457899999999999999999997      789999999988655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.8e-44  Score=340.68  Aligned_cols=285  Identities=34%  Similarity=0.543  Sum_probs=224.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++|+||+++++++....   ...
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence            347999999999999999999999999999999875321      12347999999999999999998875422   234


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++||||+++++..++...   ...+++..++.++.||+.||.||| +.|++||||||+||+++.++ .+||+|||++..
T Consensus        83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~  157 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLH-ENFIIHRDLKVSNLLLTDKG-CLKIADFGLART  157 (309)
T ss_pred             EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECccceeee
Confidence            7899999998777766532   356899999999999999999999 88999999999999999887 799999999987


Q ss_pred             cccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          244 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ..... ......++..|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            65432 22234457889999998766668999999999999999999999999999989888888888877665443221


Q ss_pred             C--CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          323 P--NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       323 ~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      .  ....+..+......+... ...+++++.+||++||.+||++|||+.+++.||||++..-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            1  111111111111111111 12368899999999999999999999999999999875554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4e-44  Score=339.29  Aligned_cols=285  Identities=34%  Similarity=0.592  Sum_probs=221.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+. |+||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5999999999999999999999999999999875332      23457999999995 6999999988865554445567


Q ss_pred             EEEeecchhhHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPETVYRVAKHYSRA-SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++++.+.+...... ...+++..++.++.||+.||.||| +.||+||||||+||+++.+...+||+|||++..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH-KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999887776543322 356899999999999999999999 889999999999999998344899999999876


Q ss_pred             cccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          244 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       244 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .... .......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+....+..+....+.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            5332 222234568889999988765668899999999999999999999999988888888888877776655432211


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                      .......++....... ....+.++.++.+||.+||..||.+|||+.+++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            1111111111111111 112235789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-44  Score=340.62  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=198.7

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ||+|+||+||++.+..+++.||+|.+....       .....|+.+++.++|+||+++.+++.     ....+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence            699999999999999999999999885432       22346899999999999999988773     334588999999


Q ss_pred             hhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC-
Q 014156          172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  249 (429)
Q Consensus       172 ~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~-  249 (429)
                      +++ |...+.........+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-QRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            864 43333332334467999999999999999999999 88999999999999999877 799999999976544322 


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 014156          250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  329 (429)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .....||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+.......                
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            2345789999999999764 48899999999999999999999997654332222222111000                


Q ss_pred             CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                               ...++..+++++.+|+.+||+.||.+|+     |+.++++||||+.+.+.
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence                     0112345789999999999999999999     88999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-44  Score=346.54  Aligned_cols=275  Identities=26%  Similarity=0.433  Sum_probs=204.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||.||+|++..++..||+|.+...     .....+|+++++.++||||+++++++...     ..++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   79 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEIS   79 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEE
Confidence            4799999999999999999999999999999987543     23456799999999999999999988443     3478


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ +|.+++.    ....+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  154 (331)
T cd06649          80 ICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (331)
T ss_pred             EEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence            99999986 4544443    2456899999999999999999999434799999999999999887 7999999998765


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH----Hhh
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKC  320 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~----~~~  320 (429)
                      ... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.. .+   ++.+....    ...
T Consensus       155 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~---~~~~~~~~~~~~~~~  228 (331)
T cd06649         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AI---FGRPVVDGEEGEPHS  228 (331)
T ss_pred             ccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH---hcccccccccCCccc
Confidence            332 23446789999999998764 4899999999999999999999999776554322 22   11111000    000


Q ss_pred             cCCCCcc----c------cCC---------CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          321 MNPNYTE----F------KFP---------QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       321 ~~~~~~~----~------~~~---------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ..+....    .      ..+         .+............+++++++||.+||.+||++|||+.++++||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            0000000    0      000         00000000011224688999999999999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-44  Score=347.15  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      +|.+.+.||+|+||.||+|++..+++.||+|++.+..       .....|..++..+ .|++|+++++++.     ....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence            4889999999999999999999999999999886432       1223466676666 5889999988873     3345


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +++||||+++ +|...+.    ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            8899999985 4444332    2467899999999999999999999 88999999999999999887 79999999997


Q ss_pred             eccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          243 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 2233456789999999998764 48999999999999999999999998877666655544310           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDP  383 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  383 (429)
                                        ..++..++.++.+||.+||+.||.+|+++     .++++||||+.+.+.
T Consensus       218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                              01234578999999999999999999984     899999999987653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-46  Score=328.80  Aligned_cols=260  Identities=29%  Similarity=0.466  Sum_probs=207.4

Q ss_pred             ceeEe-eEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHH-cCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           92 SYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        92 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      +|++. ++||-|-.|+|..+.++.||+.+|+|++. +.....+|++.--. -.|||||.++++|...- .+..++.+|||
T Consensus        62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVmE  139 (400)
T KOG0604|consen   62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVME  139 (400)
T ss_pred             hheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeeee
Confidence            45554 58999999999999999999999999664 44555678876433 46999999999885444 45667889999


Q ss_pred             cchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCCceeccc
Q 014156          170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVK  246 (429)
Q Consensus       170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~a~~~~~  246 (429)
                      .++|+ |++.+..  +..+.|++.++..|+.||+.|+.||| +.+|.||||||+|+|....+  -.+||+|||+|+....
T Consensus       140 ~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH-~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  140 CMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLH-SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             cccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHH-hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            99965 4443332  34567999999999999999999999 89999999999999985432  2799999999998876


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHhhcC
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ----LVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .....+.|.||+|.|||++ +...|+..+|+||+||+||.|++|.+||........    ..+|..              
T Consensus       217 ~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~--------------  281 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT--------------  281 (400)
T ss_pred             CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc--------------
Confidence            6777788999999999988 556699999999999999999999999987654321    222222              


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                         ..|.||.-   .     +..+|.+++|+|+++|..+|++|+|+.+++.|||+.....
T Consensus       282 ---gqy~FP~p---E-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  282 ---GQYEFPEP---E-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             ---cCccCCCh---h-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence               12233321   1     1247999999999999999999999999999999987543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-44  Score=346.51  Aligned_cols=245  Identities=28%  Similarity=0.457  Sum_probs=196.2

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHH-cCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|++..+|+.||+|.+....       .....|..++.. ++||||+++++++.     ...++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999886432       223456677765 48999999998883     344689999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  246 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-  246 (429)
                      ||+.++ |...+.    ....+++..+..++.||+.||+||| +.||+||||||+|||++.++ .++|+|||+++.... 
T Consensus        76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLH-SKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            999864 433332    2467899999999999999999999 88999999999999999887 799999999875322 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~--------------  212 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T--------------  212 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence            2223456789999999998764 4899999999999999999999999877665444433221  0              


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-LEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~e~l~hp~f~~~~~  382 (429)
                                   ..++..++.++++||.+||..||.+|+++ .++++||||+...+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         213 -------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence                         01223478999999999999999999998 58889999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.6e-44  Score=347.78  Aligned_cols=286  Identities=32%  Similarity=0.584  Sum_probs=224.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+.+++.++|+||++++++|..... .+...
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4799999999999999999999999999999987532      1233469999999999999999998754322 12235


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .|+||||+.+++...+..      .+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++.
T Consensus        96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~  167 (353)
T cd07850          96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLART  167 (353)
T ss_pred             EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEccCcccee
Confidence            789999999887776532      2889999999999999999999 78999999999999999887 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...........+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...++.|..+....+..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         168 AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            654444445678899999999866 4589999999999999999999999999888888888888888887654433222


Q ss_pred             CCccc--cCCCcCCCCccccc------------CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          324 NYTEF--KFPQIKAHPWHKIF------------HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       324 ~~~~~--~~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      ....+  ..+......+...+            ....+..+++||.+||..||++|||+.|+|.||||+.+-++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~  322 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE  322 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence            11111  00000001111110            2235677999999999999999999999999999987666433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9.6e-45  Score=347.92  Aligned_cols=246  Identities=28%  Similarity=0.464  Sum_probs=199.5

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|++..+++.||+|++..+.       .....|.+++..+ +||||+++++++.     ....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            36999999999999999999999999886432       1233577777765 7999999999884     334588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||++++ +...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++......
T Consensus        76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLH-RHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            999864 433332    3467899999999999999999999 88999999999999999887 7999999998764322


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------  212 (321)
T ss_pred             CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             22345678999999999865 458999999999999999999999999887766665544310                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-------CHHHHhcCCCccccCCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-------TALEACIHPFFDELRDP  383 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-------t~~e~l~hp~f~~~~~~  383 (429)
                       .            .++..++.++.+||.+||+.||.+|+       ++.++++||||..+.+.
T Consensus       213 -~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         213 -V------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             -C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence             0            12234689999999999999999999       99999999999886553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.5e-45  Score=349.38  Aligned_cols=245  Identities=28%  Similarity=0.448  Sum_probs=195.9

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHH-HHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||+||+|++..+|+.||+|++.....       ....|.. +++.++||||+++++.+..     ...+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence            469999999999999999999999998864321       1123333 4577999999999888733     34588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+.++ +...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLH-SLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            999864 433332    3467999999999999999999999 88999999999999999887 7999999998754322


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                       ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             233456789999999998664 48999999999999999999999998877655554443210                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  382 (429)
                                   ..++..+++.+.+||.+||+.||.+|+++    .++++||||..+.+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                         01233478999999999999999999998    69999999988665

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.9e-45  Score=353.33  Aligned_cols=255  Identities=28%  Similarity=0.437  Sum_probs=203.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.++..++|+||+++++.+     ....++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            589999999999999999999999999999988532       12345689999999999999999887     334458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ +|.+.+.    ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .++|+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH-~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIH-QLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            999999986 4444443    2467999999999999999999999 88999999999999999887 799999999865


Q ss_pred             cccCC------------------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHH
Q 014156          244 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL  287 (429)
Q Consensus       244 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  287 (429)
                      .....                                    .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence            42110                                    01235789999999998664 589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-
Q 014156          288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-  366 (429)
Q Consensus       288 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-  366 (429)
                      ++|.+||.+.+.......+......               ..+|.          ...+++++++||.+|+ .||.+|+ 
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~  283 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWKET---------------LVFPP----------EVPISEKAKDLILRFC-TDSENRIG  283 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCc---------------eecCC----------CCCCCHHHHHHHHHhc-cChhhcCC
Confidence            9999999887766655554431000               00110          0126889999999987 4999998 


Q ss_pred             --CHHHHhcCCCccccCCCC
Q 014156          367 --TALEACIHPFFDELRDPN  384 (429)
Q Consensus       367 --t~~e~l~hp~f~~~~~~~  384 (429)
                        ++.++++||||+.+.+..
T Consensus       284 ~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         284 SNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             CCCHHHHhcCCCCCCCCHHH
Confidence              489999999999876643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.4e-44  Score=344.23  Aligned_cols=246  Identities=28%  Similarity=0.493  Sum_probs=196.8

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHH-cCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||+||+|++..+++.||+|++....       .....|..++.. ++||||+++++++..     ...+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999886432       223356677765 589999999988743     33588999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+++ +|...+.    ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus        76 ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLH-SKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99985 4444433    2457899999999999999999999 88999999999999999887 7999999998754322


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                       .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~--------------  212 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N--------------  212 (316)
T ss_pred             CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence             233456789999999998664 4899999999999999999999999887665544433221  0              


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCccccCCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFDELRDP  383 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-e~l~hp~f~~~~~~  383 (429)
                                   ..++..++.++.+||.+||..||.+|+++. ++++||||+.+.+.
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         213 -------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence                         012234688999999999999999999996 89999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-44  Score=345.67  Aligned_cols=245  Identities=29%  Similarity=0.476  Sum_probs=198.3

Q ss_pred             eEEccCCcEEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +.||+|+||.||+|++.   .+++.||+|++....        ....+|+.+++.++||||++++++|..     ...+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeEE
Confidence            68999999999999864   478899999885421        223469999999999999999988743     33588


Q ss_pred             EEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+.++ |...+.    ..+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLH-QQGIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            999999864 433332    3467889999999999999999999 88999999999999999887 7999999998754


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....             
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------  216 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------  216 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            332 223346789999999998664 48899999999999999999999998877665555443310             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                      ..++..+++++.+||.+||+.||++|+     ++.++++||||....+
T Consensus       217 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         217 ----------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                            012344789999999999999999999     8999999999987543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-45  Score=325.66  Aligned_cols=295  Identities=26%  Similarity=0.469  Sum_probs=225.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..+|.++++||+|+|++|.+++.++|.+.||+|+++++-       ...+.|..+...- +||.+|.++.||     ...
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----ccc
Confidence            447999999999999999999999999999999886542       1223465665544 799999999999     556


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..+++|.||++|+  +++.+.. ....++++.+++|...|+.||+||| +.|||+||||.+|+|+|.++ .+||+|+|.+
T Consensus       324 srlffvieyv~gg--dlmfhmq-rqrklpeeharfys~ei~lal~flh-~rgiiyrdlkldnvlldaeg-hikltdygmc  398 (593)
T KOG0695|consen  324 SRLFFVIEYVNGG--DLMFHMQ-RQRKLPEEHARFYSAEICLALNFLH-ERGIIYRDLKLDNVLLDAEG-HIKLTDYGMC  398 (593)
T ss_pred             ceEEEEEEEecCc--ceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHh-hcCeeeeeccccceEEccCC-ceeecccchh
Confidence            6689999999976  4443433 3578999999999999999999999 88999999999999999999 5999999999


Q ss_pred             eecc-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHHhCCC
Q 014156          242 KVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG-------ESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       242 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-------~~~~~~~~~i~~~~~~~  313 (429)
                      +... .+....++||||.|.|||++.+. .|+..+|+|+|||+|+||+.|+.||.-       .+..+.+.+++-.    
T Consensus       399 ke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile----  473 (593)
T KOG0695|consen  399 KEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE----  473 (593)
T ss_pred             hcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh----
Confidence            8654 45566789999999999999875 599999999999999999999999952       2223333332211    


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCccccCCCCCCC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFDELRDPNARL  387 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~~~~~  387 (429)
                                            .  ...++..+|-.+..+++..|.+||.+|+.      ..++..|+||+.+.|.....
T Consensus       474 ----------------------k--qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq  529 (593)
T KOG0695|consen  474 ----------------------K--QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ  529 (593)
T ss_pred             ----------------------h--cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh
Confidence                                  0  01244567888999999999999999984      67999999999988754322


Q ss_pred             CCC-CCCCC-------CCCCC------hhhhccCCHHHHHhhcHHHHhhhCCCCCC
Q 014156          388 PNG-RPFPP-------LFNFK------PQELKGASKELLSKLIPEHARKQCPFLGF  429 (429)
Q Consensus       388 ~~~-~~~~~-------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  429 (429)
                      ... +|+.|       +-+|+      +-+++....+.+.++      .|++|.||
T Consensus       530 k~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i~ri------dqsefegf  579 (593)
T KOG0695|consen  530 KQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIKRI------DQSEFEGF  579 (593)
T ss_pred             cccCCCCCCccccccCccccccccccCCcccCCCCHHHHHhc------chhhcCcc
Confidence            111 12211       11222      223344445556555      78899887

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-44  Score=344.05  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=203.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||.||++++..+++.||+|++.+.       .....+|+.+++.++|+||+++++++.     ...++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCeE
Confidence            599999999999999999999999999999998642       122456888999999999999998883     33458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |+||||+.+ +|..++..   ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVH-QLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            999999975 55554432   2457899999999999999999999 88999999999999999887 799999999876


Q ss_pred             cccCCCc--ccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          244 LVKGEPN--ISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       244 ~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      .......  ...+||+.|+|||++.+    ...++.++||||+||++|+|++|+.||.+.+..+....+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH-----  226 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc-----
Confidence            5443322  23468999999999863    234788999999999999999999999887766655544331100     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDP  383 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~  383 (429)
                                +.++.         ....+++++++||++||..++.+  |+++.++++||||..+++.
T Consensus       227 ----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         227 ----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             ----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence                      00110         11237899999999999765544  7899999999999887653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.3e-44  Score=343.36  Aligned_cols=245  Identities=29%  Similarity=0.475  Sum_probs=195.5

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHH-cCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|++..+++.||+|++....       .....|..++.. ++||||+++++++.     ...++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999886432       112345556554 48999999998873     334588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||++++ |...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus        76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLH-KKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            999854 433332    2467999999999999999999999 88999999999999999887 7999999999765332


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                       ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------  211 (316)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             223456789999999998764 4899999999999999999999999887765554443221                 


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-LEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-~e~l~hp~f~~~~~  382 (429)
                                  ...++..++.++.+||.+||..||.+|+++ .++++||||..+.+
T Consensus       212 ------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         212 ------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence                        001233478999999999999999999986 48889999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-44  Score=342.76  Aligned_cols=315  Identities=37%  Similarity=0.636  Sum_probs=242.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||.|+||.||+|++..+++.||||.+....      ....+|+.+++.++|+||+++++++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4899999999999999999999899999999875422      3445799999999999999999987655433334578


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||+|+++++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH-~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLH-SANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            9999999876665532    347999999999999999999999 88999999999999999887 79999999998765


Q ss_pred             cCC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          246 KGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       246 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...    ......+|..|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+.+..+....+.+..+.+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543    2334567889999999977646899999999999999999999999999998888899888888877655421


Q ss_pred             CCC-Cccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCC
Q 014156          322 NPN-YTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN  398 (429)
Q Consensus       322 ~~~-~~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~  398 (429)
                      ... ...+  ..+......+.. ..+.+++++.+||.+||++||.+|||+.++++||||+++..+....+...++    +
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~----~  309 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSK-LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPF----D  309 (330)
T ss_pred             cccchhhHHhhcccCCcchhHH-hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcc----c
Confidence            111 1110  011111122222 2334789999999999999999999999999999999998876664443332    3


Q ss_pred             CChhhhccCCHHHHHhhcH
Q 014156          399 FKPQELKGASKELLSKLIP  417 (429)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~  417 (429)
                      +.+-+-+...++.++.++.
T Consensus       310 ~~~~~~~~~~~~~~~~~~~  328 (330)
T cd07834         310 FDFFDDDELTEEELKELIY  328 (330)
T ss_pred             ccccchhhcCHHHHhHHhh
Confidence            3222223334455555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.6e-44  Score=344.73  Aligned_cols=247  Identities=25%  Similarity=0.450  Sum_probs=195.1

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|..++..+ .||||+++++++..     ...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999986432       2234688888777 69999999998833     34589999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  246 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-  246 (429)
                      ||++++ |...+.    ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLH-ERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            999864 433332    2467999999999999999999999 88999999999999999887 799999999875332 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCHHHHhh
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.....      .+.+.+....  .        
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------  218 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------  218 (327)
T ss_pred             CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence            3334456799999999998664 589999999999999999999999964221      1122211110  0        


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCccccCCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFDELRDP  383 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~  383 (429)
                                        ...++..++..+.++|.+||..||.+|++      +.++++||||+.+.+.
T Consensus       219 ------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         219 ------------------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence                              00133457899999999999999999998      5799999999987653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-43  Score=333.79  Aligned_cols=276  Identities=39%  Similarity=0.729  Sum_probs=222.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++.+..     ..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence            4899999999999999999999999999999885432      345579999999999999999998843     44588


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|+||+++++.+.+..   ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMH-ANGIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            9999997777766543   2366999999999999999999999 88999999999999999877 79999999987664


Q ss_pred             cCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  .....++..|+|||.+.+...++.++||||+||++|+|++|.++|.+.+....+..+....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            4331  23456889999999987666678999999999999999999999998888888888888888887765543221


Q ss_pred             --CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          324 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       324 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                        .+....++......+.. ..++.+.++.+||.+||..||.+|||+.++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              12222222222222222 2235679999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.7e-43  Score=343.70  Aligned_cols=255  Identities=27%  Similarity=0.356  Sum_probs=198.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ...+|..++.||+|+||.||+|++..+++.||||++...     .....+|+++++.++|+||+++++++.     ....
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~  146 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGE  146 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCe
Confidence            345789999999999999999999999999999988543     233457999999999999999999873     3345


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++||||+.++.+..       .....+..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       147 ~~lv~e~~~~~~L~~-------~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~  217 (353)
T PLN00034        147 IQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAYLH-RRHIVHRDIKPSNLLINSAK-NVKIADFGVSRI  217 (353)
T ss_pred             EEEEEecCCCCcccc-------cccCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCC-CEEEccccccee
Confidence            889999999764321       234567788899999999999999 88999999999999999887 799999999987


Q ss_pred             cccCC-CcccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          244 LVKGE-PNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       244 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      ..... ......||..|+|||++...    ...+.++|||||||++|+|++|+.||......+....+.......     
T Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----  292 (353)
T PLN00034        218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-----  292 (353)
T ss_pred             cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----
Confidence            64332 22346789999999987431    234568999999999999999999997433222111111110000     


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                          .......++.++++||.+||..||++|||+.|+++||||..-..
T Consensus       293 --------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        293 --------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             --------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence                                00122347899999999999999999999999999999987543

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-44  Score=354.32  Aligned_cols=275  Identities=25%  Similarity=0.334  Sum_probs=204.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....  ....+|+++++.|+|+|||++++++...     ...++||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEE
Confidence            4479999999999999999999999999999996432  2345799999999999999999877432     34789999


Q ss_pred             cchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC
Q 014156          170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  249 (429)
Q Consensus       170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~  249 (429)
                      ++.++++..+..   ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+++.......
T Consensus       241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIH-GEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence            999887776543   2346999999999999999999999 88999999999999999887 799999999976533221


Q ss_pred             ---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CC------hHHHHHHHHHHhCCCCHHH--
Q 014156          250 ---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG-ES------GVDQLVEIIKVLGTPTREE--  317 (429)
Q Consensus       250 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~------~~~~~~~i~~~~~~~~~~~--  317 (429)
                         .....||+.|+|||++.+. .++.++|||||||++|||++|..++.. ..      ...++.++++..+....+.  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence               2245689999999999764 489999999999999999998765432 21      1234444444433221110  


Q ss_pred             ------HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          318 ------IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       318 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                            .............+......|...  ..++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                  000000000001111111222221  136788999999999999999999999999999974

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-43  Score=342.36  Aligned_cols=288  Identities=35%  Similarity=0.653  Sum_probs=228.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.... ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            46999999999999999999999999999999885431      23346999999999999999998765433 334568


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+.+++...+.    ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIH-SANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            8999999987666543    2456999999999999999999999 88999999999999999887 7999999999765


Q ss_pred             ccCCC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          245 VKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       245 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      .....     .....|+..|+|||.+.+...++.++|||||||++|+|++|++||.+.+...++..+....+.|+...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            43221     1234688899999998665568999999999999999999999999988888888888888888766543


Q ss_pred             hcCCCCcc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          320 CMNPNYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       320 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                      ........   -.++......+.. +.+..+.++.++|++||+.||.+|||+.+++.||||+....+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~  306 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE  306 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence            22211100   0111111222221 223468999999999999999999999999999999988877654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-43  Score=334.97  Aligned_cols=283  Identities=34%  Similarity=0.595  Sum_probs=220.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|++.+.||+|++|.||+|.+..+|+.||+|.+...      .....+|+++++.++||||+++++++.     ...+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            3699999999999999999999999999999987532      123457999999999999999999884     33458


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+++++...+..  .....+++..++.++.||+.||+||| +.||+||||||+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            89999999877666543  22234688889999999999999999 7899999999999999866557999999999765


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......+++.|+|||.+.+...++.++||||+||++|+|+||++||...+..+.+.+++...+.+....+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            3322 223346788999999987655688999999999999999999999998888888888888777776655432111


Q ss_pred             CCc-cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          324 NYT-EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       324 ~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ... ...++..... ......+.+++++.++|.+||+.||.+||++.++++||||.+++.
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        234 LPDYKSAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             chhhhhhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            000 0001111111 011123457899999999999999999999999999999998653

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-43  Score=334.77  Aligned_cols=282  Identities=37%  Similarity=0.633  Sum_probs=221.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh---------hHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+.....         ....|+.+++.++|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            48899999999999999999999999999998864321         23468999999999999999998843     44


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +.++||||+.+++..++..   ....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLH-SNWILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            5889999997777666543   1236999999999999999999999 88999999999999999887 79999999998


Q ss_pred             ecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.++|.+.+..+.+..+....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            765432 2233456788999998866566889999999999999999999999988887888888777777766554321


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      ...-...........+. .......+..+.+||.+||.+||.+|||+.|++.||||++...+.
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         231 TSLPDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            11101111111111111 112345688999999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.8e-44  Score=358.84  Aligned_cols=260  Identities=25%  Similarity=0.349  Sum_probs=210.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC---CCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---~~~  161 (429)
                      .+|.+.+.||+|+||+||+|++..+|+.||||++...      .....+|+.++..++|+||++++..+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            4799999999999999999999999999999988532      2234578899999999999998876643322   222


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      .++++||||+. ++|.+.+.........+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH-~~~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH-SKHMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence            35789999998 4666666554444567999999999999999999999 88999999999999999887 799999999


Q ss_pred             ceecccC---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          241 AKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       241 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ++.....   ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....       
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-------  261 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-------  261 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-------
Confidence            9765432   223356799999999998664 48999999999999999999999998876655544433210       


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                           ...++..+++++.+||.+||..||.+|||+.++++|||++.+.
T Consensus       262 ---------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        262 ---------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                                 0012345789999999999999999999999999999988643

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-43  Score=335.68  Aligned_cols=279  Identities=36%  Similarity=0.601  Sum_probs=223.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++....   ..+.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            46999999999999999999999999999999885322      12346999999999999999998875432   2458


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+++++..++..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        82 ~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLH-DNWILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            89999999877776543   2246899999999999999999999 88999999999999999887 7999999999876


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ... .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||......+.+.++....+.+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            544 2233456788999999987655578999999999999999999999999988888888888888887765543221


Q ss_pred             --CCccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 --NYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 --~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                        ..............+...++.. +++.+.+||++||+.||++|||+.|+|.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              1111111112222233334444 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.6e-44  Score=344.01  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=203.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|.+.+.||+|+||.||++++..+++.||+|++.+..       ....+|..++..++|+||+++++++     ....+.
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999885421       2234688889999999999999887     334468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |+||||+.+ +|..++..   ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH-~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~  151 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIH-QLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLK  151 (331)
T ss_pred             EEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence            999999975 45444432   2457899999999999999999999 88999999999999999887 799999999976


Q ss_pred             cccCCCc--ccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          244 LVKGEPN--ISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       244 ~~~~~~~--~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      .......  ....||+.|+|||++.+.    ..++.++||||+||++|+|++|+.||.+.+..+....+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER-----  226 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc-----
Confidence            6443222  235689999999988542    34788999999999999999999999887766555544331100     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDP  383 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~  383 (429)
                                ..++.         ....++.++++||.+||..++.+  |+++.++++||||+.+.+.
T Consensus       227 ----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         227 ----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             ----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence                      00111         11236899999999999976655  5689999999999986553

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.1e-43  Score=341.57  Aligned_cols=288  Identities=30%  Similarity=0.509  Sum_probs=217.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCC-------
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-------  159 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-------  159 (429)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|.+...    .....+|+.+++.++||||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            4799999999999999999999999999999987543    23345799999999999999998876443211       


Q ss_pred             --CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          160 --DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       160 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                        .....++||||+++++.+.+.     ...+++..++.++.||+.||.||| +.||+||||||+||+++.++..++|+|
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH-~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCCceEEECC
Confidence              113578999999987665543     256899999999999999999999 889999999999999986665799999


Q ss_pred             cCCceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          238 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       238 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      ||+++.......    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999976532211    1234578899999987665568889999999999999999999999888777776666554433


Q ss_pred             CHHHHhhcCCCCccccC--CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          314 TREEIKCMNPNYTEFKF--PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      .................  ......+.. .+.+.++.++.+||.+||+.||.+|||+.+++.||||+.+..|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~  311 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLR-DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFD  311 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHH-HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCcc
Confidence            33222111100000000  000111111 122357899999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=338.30  Aligned_cols=281  Identities=37%  Similarity=0.614  Sum_probs=214.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcC--CCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|.+.++||+|+||.||+|.+..  +++.||+|.+....       ....+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            48899999999999999999988  89999999886522       3345799999999999999999988542   224


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC----CCCceEEee
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRAS-QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP----HTHQVKLCD  237 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~----~~~~vkl~D  237 (429)
                      .+++||||+++++..++....... ..+++..++.++.||+.||.||| +.||+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-SNWVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            688999999988877765443333 37899999999999999999999 889999999999999998    66 799999


Q ss_pred             cCCceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 014156          238 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV---------DQLV  304 (429)
Q Consensus       238 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~  304 (429)
                      ||++........    .....+|..|+|||.+.+...++.++|||||||++|+|++|++||.+....         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876543322    223467889999998876666889999999999999999999999865432         3455


Q ss_pred             HHHHHhCCCCHHHHhhcCC--CCcc----ccCCCcCCCCcccccC--CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014156          305 EIIKVLGTPTREEIKCMNP--NYTE----FKFPQIKAHPWHKIFH--KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  376 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  376 (429)
                      .++..++.+....+.....  .+..    ..............+.  ...+.++.++|.+||..||++|||+.|+++|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            6666666665543322111  1110    0001111011111111  156789999999999999999999999999999


Q ss_pred             c
Q 014156          377 F  377 (429)
Q Consensus       377 f  377 (429)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-43  Score=332.98  Aligned_cols=275  Identities=36%  Similarity=0.662  Sum_probs=216.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .|++++.||.|++|.||+|++..+|+.||||.+..+.      ....+|+++++.++||||+++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            3889999999999999999999999999999875332      23557999999999999999999873     333578


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+.+++...+..  .....+++..++.++.|++.||+||| +.|++||||+|+||+++.++ .+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            9999998877665543  22356899999999999999999999 88999999999999999887 79999999987654


Q ss_pred             cCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC-
Q 014156          246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  323 (429)
Q Consensus       246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  323 (429)
                      .... .....++..|+|||.+.+...++.++|||||||++|+|+||+.||.+.+..+...++....+.+....+..... 
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            3322 22345688899999887655578899999999999999999999999888888888888777766543321110 


Q ss_pred             -CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 -NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                       .+. ..++......... ..+.++++++++|.+||..||.+|||+.+++.||||
T Consensus       232 ~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYK-PSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHH-hhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence             000 0111111111111 123478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2e-44  Score=346.28  Aligned_cols=245  Identities=29%  Similarity=0.473  Sum_probs=195.2

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHH-HHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||+||+|++..+|+.||+|++....       ....+|.. +++.++||||+++++.+..     ...+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence            46999999999999999999999999885431       11223433 4677899999999887733     33588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  246 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-  246 (429)
                      ||+.++ +...+    .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH-~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLH-SINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            999865 33332    23567999999999999999999999 88999999999999999887 799999999875422 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~----------------  212 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP----------------  212 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            2233456799999999998664 48899999999999999999999998877655554443210                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  382 (429)
                                   ..+++..+..+.++|++||..||.+||++    .+++.||||....+
T Consensus       213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence                         01223478899999999999999999976    59999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-43  Score=331.67  Aligned_cols=275  Identities=37%  Similarity=0.639  Sum_probs=216.6

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++++. |+|++++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            678899999999999999999999999999876431     11235888888885 99999999987543   1134789


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||+++++++.+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++. + .+||+|||+++....
T Consensus        78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMH-RNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            999999887776543   2356899999999999999999999 889999999999999998 5 799999999987655


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC-C
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  325 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  325 (429)
                      ........++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444445668899999998755555788999999999999999999999998888888888887777766543222111 1


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      ..+.++......+ ..+...++.++.+||.+||.+||.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1112222111111 11223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-46  Score=323.82  Aligned_cols=284  Identities=31%  Similarity=0.526  Sum_probs=231.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecC---CCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTT---DKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~---~~~~  161 (429)
                      ..|.-..+||+|.||.||+|+.+.+|+.||+|++.-+.      ....+|+++|..|+|+|++.++..+-...   ....
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            35888889999999999999999999999999764321      12248999999999999999887664332   2344


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..+|+|+.+|..+|..++..   ...+++..++..++.+++.||.|+| +..|+|||+|++|+||+.++ .+||+|||++
T Consensus        97 ~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iH-r~kilHRDmKaaNvLIt~dg-ilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIH-RNKILHRDMKAANVLITKDG-ILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHH-HhhHHhhcccHhhEEEcCCc-eEEeeccccc
Confidence            56889999999988777653   3468999999999999999999999 88999999999999999988 8999999999


Q ss_pred             eecccCC-----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGE-----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      +......     ..+..+.|.+|++||.+.|...|+++.|||+.||||.||.||.+.+.++++..++..|...+|..+.+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            7664332     23455679999999999999999999999999999999999999999999999999999999999988


Q ss_pred             HHhhcC--CCCccccCCCcCCCCcccc---cCC-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          317 EIKCMN--PNYTEFKFPQIKAHPWHKI---FHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       317 ~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~-~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                      .|+.+.  +.|.....+..+....+..   ..+ .-.+++.+|+.+||.+||.+|+++.++|+|.||..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            886554  2333333332222222111   110 12468999999999999999999999999999975

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-44  Score=344.63  Aligned_cols=245  Identities=29%  Similarity=0.470  Sum_probs=199.4

Q ss_pred             eEEccCCcEEEEEEEEc---CCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      +.||+|+||.||++++.   .+|+.||+|++....      ....+|+++++.++||||+++++++.     ....+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            57999999999999863   578999999886432      22346899999999999999998873     33458899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+.+ +|...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus        77 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            999975 4444432    2457899999999999999999999 88999999999999999887 799999999976544


Q ss_pred             C-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 G-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      . .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....               
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------  214 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------  214 (318)
T ss_pred             CCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            3 23345678999999999865 447899999999999999999999998877665555443310               


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  382 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  382 (429)
                        .            .++..+++++.+||++||+.||.+|||     +.+++.||||..+.+
T Consensus       215 --~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         215 --L------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             --C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence              0            123347899999999999999999999     778999999987654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.6e-43  Score=329.26  Aligned_cols=275  Identities=35%  Similarity=0.654  Sum_probs=212.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++|+|++++++++..     ...++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEEE
Confidence            5999999999999999999999999999999875321      234579999999999999999998843     33588


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||++++++..+.   .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus        77 ~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07847          77 LVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCH-KHNCIHRDVKPENILITKQG-QIKLCDFGFARILT  151 (286)
T ss_pred             EEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence            999999987666443   23456899999999999999999999 78999999999999999887 79999999998764


Q ss_pred             cCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC-
Q 014156          246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  323 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  323 (429)
                      ... ......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+....+....+............ 
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            433 223456788899999987655688999999999999999999999998887777766666554433221111100 


Q ss_pred             -CCccccCCCcCC-CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 -NYTEFKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 -~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                       -+.....+.... .+.. .....++..+.+||.+||..||++|||+.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence             000111111100 0111 1123468999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=331.74  Aligned_cols=276  Identities=34%  Similarity=0.635  Sum_probs=215.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+++++.++|+||+++++++.     ...+.+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEE
Confidence            46999999999999999999999899999999875432     23357999999999999999998873     334688


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+++++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCH-QRRVLHRDLKPQNLLISERG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence            9999999877765543   2346899999999999999999999 88999999999999999887 79999999986543


Q ss_pred             cC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .. .......++..|+|||++.+...++.++||||+||++|+|++|+.||.+.. ..+.+..+....+.+..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            22 112233568889999998765668899999999999999999999998765 5566677777777777665543322


Q ss_pred             C--CccccCCCcCCCCcccccCCCCC--hhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 N--YTEFKFPQIKAHPWHKIFHKRMP--PEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~--~~~~~~~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      .  +.....+..........+ ..++  .++.++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1  111122221111111111 1234  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-43  Score=333.46  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=202.3

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+.+++.+.     ...+++
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence            788899999999999999999999999999875321       22346999999999999999988773     334588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+.+ ++...+..  .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~  152 (285)
T cd05630          77 LVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLH-QERIVYRDLKPENILLDDHG-HIRISDLGLAVHV  152 (285)
T ss_pred             EEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEECCCC-CEEEeeccceeec
Confidence            99999975 45444432  22346899999999999999999999 88999999999999999887 7999999999765


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..........||..|+|||++.+. .++.++||||+||++|+|++|+.||..................            
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------  219 (285)
T cd05630         153 PEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------  219 (285)
T ss_pred             CCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------------
Confidence            444443445789999999998664 4899999999999999999999999765432111111111000            


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  383 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  383 (429)
                                   ....++..+++++.+||.+||+.||.+|+|     +.|+++||||+++...
T Consensus       220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         220 -------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             -------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                         001123457899999999999999999999     9999999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-43  Score=340.27  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=200.6

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      |...+.||+|+||.||+|++..+|+.||+|++.++.       .....|..++..+. |++|+++++++.     ....+
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~   76 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDRL   76 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCEE
Confidence            788899999999999999999999999999886432       12335777887776 467778887773     33358


Q ss_pred             EEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |+||||++++ |...+    .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~Ey~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~  150 (323)
T cd05615          77 YFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLH-RRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE  150 (323)
T ss_pred             EEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEeccccccc
Confidence            8999999854 44333    23467999999999999999999999 88999999999999999887 799999999875


Q ss_pred             cccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          244 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       244 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+....            
T Consensus       151 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------  217 (323)
T cd05615         151 HMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------  217 (323)
T ss_pred             cCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence            4322 223345689999999998654 48999999999999999999999998877665555544310            


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  382 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  382 (429)
                                       ..++..++.++.+|+.+||..||.+|++     ..++++||||+.+.+
T Consensus       218 -----------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         218 -----------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                             0123457899999999999999999997     579999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6e-44  Score=343.41  Aligned_cols=246  Identities=26%  Similarity=0.475  Sum_probs=193.1

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|+.++..+ +||||+++++++..     ...+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence            46999999999999999999999999886431       2234677777766 89999999998843     34588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  246 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-  246 (429)
                      ||++++ +...+    .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~----~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            999865 33322    23467999999999999999999999 88999999999999999887 799999999875422 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  318 (429)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....        ...+.+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            2233456789999999998764 589999999999999999999999953111        1111111100         


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCccccCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFDELRD  382 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t------~~e~l~hp~f~~~~~  382 (429)
                             .            ...++..++..+.+||++||..||.+|+|      +.++++||||+.+.+
T Consensus       220 -------~------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         220 -------K------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             -------C------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   0            01134457899999999999999999998      579999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-43  Score=341.03  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.++||+|+||.||++++..+++.||+|++.+..       ....+|+.++..++|+||++++.++.     ....+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCEE
Confidence            5999999999999999999999999999999885421       22456888899999999999988873     33458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+.+ +|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH-~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            899999974 55554432   2457899999999999999999999 88999999999999999887 799999999876


Q ss_pred             cccCCC--cccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          244 LVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       244 ~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ......  ....+||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+..+.+..+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------  225 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------
Confidence            533322  223578999999999852    34578899999999999999999999988776666555443110      


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRD  382 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~  382 (429)
                               ...++.         ....+++++++||++||..++.+  |+++.++++||||..+.+
T Consensus       226 ---------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         226 ---------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             ---------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                     000111         11347899999999999776554  689999999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-43  Score=329.41  Aligned_cols=252  Identities=35%  Similarity=0.566  Sum_probs=202.7

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh------HHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |++++.||+|+||+||++++..+++.||+|++......      ..+|+.+++.++||||+++++.+..     ..+.++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            88999999999999999999999999999998654321      1248999999999999999998854     445789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec-
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-  244 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~-  244 (429)
                      ||||+.+ ++.+.+.    ....+++..+..++.||+.||.+|| +.||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh-~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLH-SKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHH-HTTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             ccccccccccccccc----ccccccccccccccccccccccccc-cccccccccccccccccccc-cccccccccccccc
Confidence            9999998 6766665    3477899999999999999999999 78999999999999999777 7999999999764 


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..........+|..|+|||++.....++.++|+||+|+++++|++|..||......+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            223334456789999999998634568999999999999999999999998874444444433332111111000     


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                       .....+..+.++|.+||..||++|||+.++++||||
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             000123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-43  Score=331.25  Aligned_cols=252  Identities=23%  Similarity=0.375  Sum_probs=196.6

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ||+|+||.||++++..+|+.||+|.+....       .....|+++++.++||||+++++++     ....++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885321       2234589999999999999998877     3344689999999


Q ss_pred             hhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc
Q 014156          172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  250 (429)
Q Consensus       172 ~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~  250 (429)
                      .++ +...+..  .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLH-SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHH-HCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            854 4343322  22345888999999999999999999 88999999999999999877 7999999999876554444


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 014156          251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  330 (429)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ....||..|+|||++.+.. ++.++|+||+||++|+|++|+.||.+.........+....-.             .... 
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~-  216 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVK-  216 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------cccc-
Confidence            4567899999999987655 899999999999999999999999765432221222111000             0000 


Q ss_pred             CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCCCC
Q 014156          331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRDPN  384 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~~~  384 (429)
                                .....+++++.+||++||.+||.+|||+    .++++||||+.+.++.
T Consensus       217 ----------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         217 ----------FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             ----------cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence                      0112478999999999999999999999    6788999999876643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=350.85  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=210.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +.|.|+..||.|+||+||+|.++.++-..|.|++....    ....-|+.||..++||+||++++.|+..+.     ++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEE
Confidence            35999999999999999999999998888899874332    222359999999999999999999876554     899


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc-
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-  245 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~-  245 (429)
                      +.|||+|+-.+-+..  .....+.+..++.+++|+|.||.||| +.+|||||||..|||+.-+| .|+|+|||.+.... 
T Consensus       107 liEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LH-s~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLH-SQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHh-hcchhhhhccccceEEEecC-cEeeecccccccchh
Confidence            999999876554432  34578999999999999999999999 78999999999999999998 79999999975432 


Q ss_pred             cCCCccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          246 KGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ......++.|||+|||||+..    ....|++++||||||++|.||..+.+|-...+.+..+.+|.+.  .|+.      
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPT------  254 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT------  254 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCc------
Confidence            234456789999999999873    3456999999999999999999999999888887777666552  1110      


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                        ..-+...+..+.|||.+||.+||..||++.++|+||||.+.
T Consensus       255 ------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  255 ------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             ------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                              00122347789999999999999999999999999999863

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-43  Score=365.98  Aligned_cols=263  Identities=28%  Similarity=0.401  Sum_probs=210.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ...+|.+++.||+|+||+||+|++..++..||+|.+...      ...+..|+.+++.|+|||||+++++|....   ..
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~~   87 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---NQ   87 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---CC
Confidence            345799999999999999999999999999999987532      233457999999999999999999886432   33


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CeeecCCCCCCeeecCCC----
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-------GVCHRDIKPQNLLVNPHT----  230 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-------~iiHrDlKp~Nill~~~~----  230 (429)
                      .+||||||+++ +|..++.........+++..++.|+.||+.||.||| +.       +||||||||+||||+.+.    
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH-s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH-NLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hcccccccCCceeccCcHHHeEeecCccccc
Confidence            58899999984 676666554444567999999999999999999999 53       599999999999996421    


Q ss_pred             ------------CceEEeecCCceecccCCCcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014156          231 ------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGE  297 (429)
Q Consensus       231 ------------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~  297 (429)
                                  ..+||+|||++.............||+.|+|||++.+. ..++.++||||||||||+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                        24899999999876544444556789999999998543 34789999999999999999999999876


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      +....+...+...  +                  .+        .....+.++.+||.+||..+|.+|||+.++|.||||
T Consensus       247 ~~~~qli~~lk~~--p------------------~l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        247 NNFSQLISELKRG--P------------------DL--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             CcHHHHHHHHhcC--C------------------CC--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            6555444333210  0                  00        012358899999999999999999999999999999


Q ss_pred             cccCCC
Q 014156          378 DELRDP  383 (429)
Q Consensus       378 ~~~~~~  383 (429)
                      +.+..+
T Consensus       299 k~i~~p  304 (1021)
T PTZ00266        299 KNVGPP  304 (1021)
T ss_pred             hhcCCC
Confidence            877554

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-43  Score=354.98  Aligned_cols=253  Identities=27%  Similarity=0.351  Sum_probs=206.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCC-CcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .|.+.+.||+|+||.||+|.+..+ +..||+|.+...    .....+|+.+++.++||||+++++++..     ...+|+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEEE
Confidence            599999999999999999998877 788999976432    2334579999999999999999998843     335889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ +|.+.+.........+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~  220 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH-SRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS  220 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence            9999974 565555444444567899999999999999999999 88999999999999999887 79999999998764


Q ss_pred             cCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ...   .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....           
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-----------  288 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-----------  288 (478)
T ss_pred             CccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            332   1345679999999999865 4589999999999999999999999988776555554433100           


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                       ..++..+++++.+||.+||..||.+|||+.+++.|||++.+
T Consensus       289 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        289 -----------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                             01223478999999999999999999999999999999754

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.7e-44  Score=341.55  Aligned_cols=245  Identities=26%  Similarity=0.420  Sum_probs=195.7

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-------hHHHH-HHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRE-LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||+||+|++..+++.||+|++.....       ....| ..+++.++||||+++++++..     ...+++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence            469999999999999999999999998864321       11223 334677899999999888733     34588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc-
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  246 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-  246 (429)
                      ||+.++ +...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH-~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            999864 433332    3467889999999999999999999 88999999999999999887 799999999875432 


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            2233456799999999998764 58999999999999999999999998877666555443310                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH----HHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL----EACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~----e~l~hp~f~~~~~  382 (429)
                                   ..+++.+++.+.++|.+||+.||.+|+++.    ++++|+||..+.+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence                         012235789999999999999999999876    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.4e-43  Score=329.14  Aligned_cols=276  Identities=34%  Similarity=0.641  Sum_probs=220.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++.+.||.|++|.||+|++..+|..||+|.+...     .....+|+.+++.++|+||+++++++...     ...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence            489999999999999999999999999999988543     23345799999999999999999988443     34789


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||+++++.+.+.... ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCH-ENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            99999998777665422 1356899999999999999999999 88999999999999999887 799999999875533


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      .. ......+|..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+......|....+.... ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            22 22334578899999998766667899999999999999999999999988888888888888777776554332 11


Q ss_pred             ccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          326 TEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       326 ~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      ..+  .++....... ..+.+.+++.+.++|.+||+.||.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            111  1121111111 11223468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=312.08  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=213.8

Q ss_pred             CCCCCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh-----HHHHHHHHH-HcCCCCeeccceeeeec
Q 014156           83 RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-----KNRELQTMR-LLDHPNVVSLKHCFFST  156 (429)
Q Consensus        83 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~-~l~h~~iv~l~~~~~~~  156 (429)
                      ........++.+.+..||+|+-|.|++++.+.+|...|+|.+......     +...+.++. ..+.|+||+.+++|...
T Consensus        84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            334455566788889999999999999999999999999998654221     222333333 33589999999999766


Q ss_pred             CCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          157 TDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                      .+     +++.||.|..-...++..   ..+++++..+-.+...+++||.||..++||+|||+||+|||+|..| ++|||
T Consensus       164 ~d-----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlC  234 (391)
T KOG0983|consen  164 TD-----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLC  234 (391)
T ss_pred             ch-----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEee
Confidence            55     788999998655555443   3467999999999999999999999888999999999999999888 79999


Q ss_pred             ecCCceecccCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCC
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTP  313 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~  313 (429)
                      |||++.++.+....+...|.+.|||||.+..  ...|+.++||||||++++||+||+.||.+. .+.+.+..+.+.  .|
T Consensus       235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--eP  312 (391)
T KOG0983|consen  235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EP  312 (391)
T ss_pred             cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CC
Confidence            9999999988888888899999999999843  356899999999999999999999999985 455566665552  11


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      +.              +          .....+|+++++|+..||++|+.+||...++|+|||+....
T Consensus       313 P~--------------L----------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  313 PL--------------L----------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             CC--------------C----------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            10              0          11234799999999999999999999999999999997643

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-44  Score=344.52  Aligned_cols=245  Identities=27%  Similarity=0.459  Sum_probs=194.3

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHHHHHc---CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ||+|+||+||+|++..+++.||+|++.....       ....|..++..+   .||||++++.++.     ....+++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEE
Confidence            6999999999999999999999999854321       112355566554   6999999998873     334588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+.++ +...+.    ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .++|+|||+++.....
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH-~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLH-KYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            999854 444332    3467999999999999999999999 88999999999999999887 7999999998754332


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                       ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------  212 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------  212 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             23345679999999999876666899999999999999999999999887665544443221                 


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC----TALEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~----t~~e~l~hp~f~~~~~  382 (429)
                      ...++           ...+++++.+||++||..||.+||    ++.++++||||.+..+
T Consensus       213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            00111           123689999999999999999998    7999999999987653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1e-42  Score=335.48  Aligned_cols=295  Identities=36%  Similarity=0.609  Sum_probs=229.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCC--CcEEEEEEeccc------hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLET--GETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|++.+.||+|+||.||+|++..+  +..||+|.+...      .....+|+.+++.+ +||||+++++.+.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            488999999999999999999887  899999987532      12335689999988 5999999988654332 2233


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .++++++|++++|...+.    ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||+++
T Consensus        80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIH-SANVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            477899999987766553    2467899999999999999999999 88999999999999999887 79999999997


Q ss_pred             ecccCCC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      .......     .....||..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..++..++.+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543221     23356899999999886655689999999999999999999999999888888999999888887665


Q ss_pred             HhhcCCCCc-c--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCC
Q 014156          318 IKCMNPNYT-E--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP  394 (429)
Q Consensus       318 ~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~  394 (429)
                      +..+..... .  ..........+.. ..+..+..+.+||.+||+.||.+|||+.+++.||||++++++.....+..+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~  312 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFD  312 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccccccccc
Confidence            443221100 0  0011111111111 22346889999999999999999999999999999999998866655544433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.1e-42  Score=326.95  Aligned_cols=277  Identities=34%  Similarity=0.602  Sum_probs=210.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+.+++.++|+||+++++++.     .....+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence            46999999999999999999999999999999885331     23457999999999999999999873     333578


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+.++++..+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||+++...
T Consensus        80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIH-GQHILHRDLKPQNLLISYLG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence            9999999877665432   2356788889999999999999999 78999999999999999887 79999999987543


Q ss_pred             cC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcC-
Q 014156          246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN-  322 (429)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~-  322 (429)
                      .. .......++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+. .+.+.++....+.|......... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            22 2223345788999999987655678899999999999999999999976543 35556666666766655433221 


Q ss_pred             -CCCccccCCCcCCCCcccccC-CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          323 -PNYTEFKFPQIKAHPWHKIFH-KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       323 -~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                       +.+.....+............ -..++++.+++.+||..||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             111111111111111110000 0136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-42  Score=330.49  Aligned_cols=283  Identities=30%  Similarity=0.488  Sum_probs=215.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCC---CC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---~~  160 (429)
                      .++|.+.+.||+|+||.||+|++..+++.||+|.+....      ....+|+.+++.++||||+++++++.....   ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999999999999999875321      123469999999999999999987754322   22


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ....++||||+++++...+..   ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||+
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIH-RNKILHRDMKAANILITKDG-ILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEECCCC-cEEECcCCC
Confidence            345789999999877666543   2346899999999999999999999 78999999999999999887 799999999


Q ss_pred             ceecccCCC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          241 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       241 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +........     .....++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+.......+....+..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            976543221     123456788999998876555788999999999999999999999988877777777776665554


Q ss_pred             HHHhhcC--CCCccccCCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          316 EEIKCMN--PNYTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       316 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      +.+....  ..+....++..........+ ....+..+.+||.+||..||.+|||+.++|+||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            4332211  00111111111111111111 11246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-42  Score=328.31  Aligned_cols=256  Identities=25%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+.+++++.     .....+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence            788899999999999999999999999999875321       22357999999999999999988773     334588


Q ss_pred             EEeecchhhHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPETVYR-VAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~l~~-~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+.++.+. .+..  .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05632          77 LVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLH-RENTVYRDLKPENILLDDYG-HIRISDLGLAVKI  152 (285)
T ss_pred             EEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEECCCC-CEEEecCCcceec
Confidence            999999865333 3321  22346999999999999999999999 88999999999999999887 7999999999765


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..........|+..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+.......           
T Consensus       153 ~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-----------  220 (285)
T cd05632         153 PEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-----------  220 (285)
T ss_pred             CCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-----------
Confidence            444434456789999999998664 48999999999999999999999998766544443333221100           


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  383 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  383 (429)
                                    ...+...+++++.+|+.+||..||.+|||     +.+++.|+||+.....
T Consensus       221 --------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         221 --------------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             --------------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                          00123457889999999999999999999     8899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5e-43  Score=337.58  Aligned_cols=277  Identities=26%  Similarity=0.415  Sum_probs=202.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||.||+|.+..++..+|+|.+...     .....+|+++++.++|+||++++++|...     .+++
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEEE
Confidence            4799999999999999999999999999999987543     13355899999999999999999988543     3588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+.+ +|.+++..    .+.+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~  154 (333)
T cd06650          80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (333)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence            99999975 55554432    456899999999999999999999445899999999999999887 7999999998765


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--hCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV--LGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~  322 (429)
                      ... ......||..|+|||++.+. .++.++|+|||||++|+|++|+.||......+.. .+...  .+.+.........
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCccc
Confidence            332 22345789999999998664 4899999999999999999999999765543222 11110  0111000000000


Q ss_pred             CC-------CccccCC---------CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          323 PN-------YTEFKFP---------QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       323 ~~-------~~~~~~~---------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      ..       +.....+         .+............++.++++||.+||++||++|||+.|++.||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            00       0000000         0000000000112367899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.1e-43  Score=338.72  Aligned_cols=245  Identities=29%  Similarity=0.431  Sum_probs=194.0

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-------hHHHHH-HHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNREL-QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ++||+|+||.||+|++..+++.||+|++.+...       ...+|. .+++.++||||+++++.+.     ....+++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence            469999999999999999999999998854321       122333 3578899999999988773     334588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||++++ +...+    .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus        76 e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLH-SLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            999864 33322    23467899999999999999999999 88999999999999999887 7999999998754222


Q ss_pred             -CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P-------------  212 (321)
T ss_pred             CCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence             22344678999999999865 44899999999999999999999999887655544433221   0             


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~  382 (429)
                                   ..++...+.++.++|.+||+.||.+|+++    .++++|+||..+.+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence                         01233468899999999999999999976    59999999987655

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-42  Score=335.26  Aligned_cols=285  Identities=35%  Similarity=0.635  Sum_probs=224.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            4699999999999999999999999999999987532      1223469999999999999999887744332 22344


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++|+||+++++.+++..     ..+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++..
T Consensus        95 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~  167 (343)
T cd07851          95 VYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH-SAGIIHRDLKPSNIAVNEDC-ELKILDFGLARH  167 (343)
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEcccccccc
Confidence            789999998887776643     57999999999999999999999 88999999999999999877 799999999976


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  .....+|..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.....
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            5332  33456788999999986655688999999999999999999999998888888888888777776654433221


Q ss_pred             CCcc-c--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          324 NYTE-F--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       324 ~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      .... +  ..+......+.. ....+++.+.+||.+||..||.+|||+.++++||||+++..+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~  309 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED  309 (343)
T ss_pred             hhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence            1000 0  011111111111 12346899999999999999999999999999999998877654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=326.28  Aligned_cols=295  Identities=28%  Similarity=0.500  Sum_probs=222.1

Q ss_pred             CcccceEEEecCCCCCCCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHHcCC--C
Q 014156           70 TETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDH--P  144 (429)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h--~  144 (429)
                      ...|+++.....      ....+|.+...+|+|.||.|..+.+..++..||||+++.-..   ...-|+++|.++.+  |
T Consensus        74 D~dGH~v~~~gD------~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP  147 (415)
T KOG0671|consen   74 DKDGHYVYQVGD------ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDP  147 (415)
T ss_pred             CCCceEEEEecc------ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCC
Confidence            445666654322      224579999999999999999999999999999998865433   33458999999842  2


Q ss_pred             ----CeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCC
Q 014156          145 ----NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK  220 (429)
Q Consensus       145 ----~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlK  220 (429)
                          -+|.+.++|     .....+|||+|.++-++++.+..  +...+++...++.+++|++.+++||| +.+++|-|||
T Consensus       148 ~g~~rcv~m~~wF-----dyrghiCivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh-~~kl~HTDLK  219 (415)
T KOG0671|consen  148 NGKFRCVQMRDWF-----DYRGHICIVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLH-DLKLTHTDLK  219 (415)
T ss_pred             CCceEEEeeehhh-----hccCceEEEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHH-hcceeecCCC
Confidence                256676766     44556899999999888887754  34567999999999999999999999 8899999999


Q ss_pred             CCCeeecCC-------------------CCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHH
Q 014156          221 PQNLLVNPH-------------------THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVG  281 (429)
Q Consensus       221 p~Nill~~~-------------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG  281 (429)
                      |+|||+.+.                   ...|+|+|||.|....  +.....+.|..|+|||++.+-. ++.++||||+|
T Consensus       220 PENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiG  296 (415)
T KOG0671|consen  220 PENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIG  296 (415)
T ss_pred             hheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccC-cCCccCceeee
Confidence            999997211                   1258999999998753  3446778899999999998854 99999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-CCCC--------ccccCCC----c--CCCCcccccCC--
Q 014156          282 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNY--------TEFKFPQ----I--KAHPWHKIFHK--  344 (429)
Q Consensus       282 ~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~--------~~~~~~~----~--~~~~~~~~~~~--  344 (429)
                      |||+||.||..+|...++.+.+..+..++|..+...+... ...|        .+.....    .  ...++......  
T Consensus       297 CIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d  376 (415)
T KOG0671|consen  297 CILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDD  376 (415)
T ss_pred             eEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCc
Confidence            9999999999999999999999888888886665555433 1111        1000000    0  00011111100  


Q ss_pred             CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          345 RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       345 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ..-..+.|||++||.+||.+|+|+.|+|.||||+.+.
T Consensus       377 ~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  377 LEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            1123589999999999999999999999999998754

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-42  Score=332.01  Aligned_cols=283  Identities=35%  Similarity=0.617  Sum_probs=221.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4699999999999999999999999999999987542      1224579999999999999999998754322 12234


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .++|++|+..++....      ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||+++.
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIH-SAGIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6899999987554432      246899999999999999999999 88999999999999999887 799999999876


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......+|..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            432  233456788999999986655588999999999999999999999999888888888888777776655433221


Q ss_pred             CC-cc--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          324 NY-TE--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       324 ~~-~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      .. ..  ...+......+...+ +..++++.+||.+||+.||.+|||+.+++.||||+.+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            10 00  011222222222212 34688999999999999999999999999999999988643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-42  Score=336.01  Aligned_cols=293  Identities=36%  Similarity=0.662  Sum_probs=228.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|.+.+.||+|+||.||+|.+..+++.+|+|++...      .....+|+.+++.+ +||||+++++++..   .+..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence            34799999999999999999999989999999987432      12334699999999 99999999987743   2234


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ..++||||+++++...+..     ..+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus        83 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~  155 (337)
T cd07852          83 DIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIH-SGNVIHRDLKPSNILLNSDC-RVKLADFGLAR  155 (337)
T ss_pred             eEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEEeeccchh
Confidence            5789999999877665432     36888899999999999999999 88999999999999999888 79999999987


Q ss_pred             ecccCC------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          243 VLVKGE------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       243 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ......      ......||..|+|||.+.+...++.++|+|||||++|+|++|++||.+....+....+....+.+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            654322      22235688999999988665668899999999999999999999999988888888888887777765


Q ss_pred             HHhhcCCCCccccC---CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCC
Q 014156          317 EIKCMNPNYTEFKF---PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPF  393 (429)
Q Consensus       317 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~  393 (429)
                      .+..+.........   +......... ..+.++.++.+||.+||+.||++|||+.++++||||+.+..+........+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~  314 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPI  314 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCc
Confidence            54433221111111   1111111111 2234789999999999999999999999999999999988776554444333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=325.13  Aligned_cols=274  Identities=35%  Similarity=0.643  Sum_probs=215.4

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |++.+.||.|++|.||+|.+..+|..||+|++..+.      ....+|+.+++.++|||++++++++.     ...+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            677899999999999999999999999999885332      23457999999999999999999874     3345889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      +|||+++++...+....  ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH-~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCH-SHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999887776654321  136899999999999999999999 78999999999999999876 799999999876532


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC--
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  323 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  323 (429)
                      .. ......++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+..+.+..+.+....+.....  
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            22 122335688899999886655578899999999999999999999999888888888888777776654422111  


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      ++.. .++....... ......++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       232 ~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKP-TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhh-hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            1000 1111111111 11234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.6e-44  Score=306.88  Aligned_cols=284  Identities=30%  Similarity=0.594  Sum_probs=233.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc-chhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ..+|++.+++|+|-|+.||.|.+..+++.++||+++. .+..+.+|+.||..|. ||||++++++..+.   .+....+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCchhH
Confidence            3479999999999999999999999999999998864 3456789999999997 99999999877443   33346789


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      +||++..-+..+      -..++...++.++.|++.||.||| ++||+|||+||.|++||.....++|+|+|+|.++..+
T Consensus       114 FE~v~n~Dfk~l------y~tl~d~dIryY~~elLkALdyCH-S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQL------YPTLTDYDIRYYIYELLKALDYCH-SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHH------hhhhchhhHHHHHHHHHHHHhHHH-hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999987533322      255788889999999999999999 8999999999999999988778999999999999888


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHH-----hhc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEI-----KCM  321 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~-----~~~  321 (429)
                      ......+.+++|--||.+.....|+.+-|+|||||++..|++.+-| |.|.++.+++.+|.+.+|.......     -.+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            8777788899999999998888899999999999999999998866 5688999999999999987543211     123


Q ss_pred             CCCCccccCCCcCCCCcccccCC----CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHK----RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      ++.+.+. +....+.+|...++.    -+++++.|||.++|.+|-.+|+||.|++.||||..++...
T Consensus       267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~  332 (338)
T KOG0668|consen  267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE  332 (338)
T ss_pred             ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence            3444332 222334455444432    3579999999999999999999999999999998876543

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.4e-42  Score=328.34  Aligned_cols=281  Identities=33%  Similarity=0.595  Sum_probs=217.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCC---CC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---~~  160 (429)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+++++.++|+||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            457999999999999999999999999999999874321      234579999999999999999987754432   22


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ...+++|++|+.+++...+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLH-ENHILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            346789999999876665432   3457999999999999999999999 88999999999999999887 799999999


Q ss_pred             ceecccCCC------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014156          241 AKVLVKGEP------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK  308 (429)
Q Consensus       241 a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  308 (429)
                      +........            .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            876533221            12235688899999887655688999999999999999999999999888888888888


Q ss_pred             HhCCCCHHHHhhcC--CCCcc-ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          309 VLGTPTREEIKCMN--PNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       309 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      ..+.+....+....  +.... ....... ...... ...+++.+.+||.+||..||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCC-ccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77766654433211  00000 0000000 011111 12356889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-42  Score=325.52  Aligned_cols=276  Identities=37%  Similarity=0.664  Sum_probs=213.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++     ......+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            5999999999999999999998899999999874321      2345799999999999999999988     3344588


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|+||++++++..+.   .....+++..++.++.||+.||.||| +.||+||||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDLE---KYPNGLDESRVRKYLFQILRGIEFCH-SHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            999999986655432   23346899999999999999999999 78999999999999999887 79999999987654


Q ss_pred             cCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 014156          246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  322 (429)
Q Consensus       246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  322 (429)
                      .... .....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+....+....+...........  
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            3322 2335678899999998765567889999999999999999999998887777777766655543322111100  


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      +.......+............+.++..+.+|+.+||..+|.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0001111222111111111234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=342.50  Aligned_cols=250  Identities=29%  Similarity=0.452  Sum_probs=212.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|.-++.||+|+||.||.|++..+.+.||||++.-..       ..+.+|++.|+.+.|||+|.+.+||....+     .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence            4777889999999999999999999999999985321       223479999999999999999999965443     7


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      |+|||||-|+-.+++.-   ..+++.+.++..|+.+.+.||.||| +.+.||||||..|||++..| .|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLH-S~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH-SHNRIHRDIKAGNILLSEPG-LVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHH-HhhHHhhhccccceEecCCC-eeeeccccchhhc
Confidence            89999999877676654   2467999999999999999999999 89999999999999999887 8999999999765


Q ss_pred             ccCCCccccccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .   ...+++|||+|||||++.  ....|+-++||||||++..||.-.++|+...+.+..+..|.+.-            
T Consensus       177 ~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe------------  241 (948)
T KOG0577|consen  177 A---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------  241 (948)
T ss_pred             C---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC------------
Confidence            3   345789999999999984  23458999999999999999999999999999988888887631            


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                             -|.+....        .|..++.|+..||.+-|.+|||.+++|.|+|...-|
T Consensus       242 -------sPtLqs~e--------WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  242 -------SPTLQSNE--------WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             -------CCCCCCch--------hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                   12222222        378899999999999999999999999999987644

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5e-42  Score=323.57  Aligned_cols=276  Identities=38%  Similarity=0.690  Sum_probs=219.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            599999999999999999999999999999987532      2344579999999999999999998854     33488


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||++++++..+.   .....+++..+..++.||+.||.||| +.|++||||+|+||+++.++ .+||+|||++....
T Consensus        77 iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCH-SHNIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            999999987766443   23456899999999999999999999 88999999999999999877 79999999987765


Q ss_pred             cCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014156          246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  322 (429)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  322 (429)
                      ...  ......++..|+|||++.+...++.++|+||||+++|+|++|++||.+.+..+.+..+....+........... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            443  33446678899999999776468999999999999999999999999888877777777766655543322211 


Q ss_pred             -CCCccccCCCcC-CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          323 -PNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       323 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                       +.+....++... ...+...++..++.++.+||++||..+|++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             111111111111 1112223445568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-42  Score=324.48  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=201.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHH-HHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||+|++..+|+.||||++....     .....|+.+ ++.++||||+++++++...     ...+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcEE
Confidence            5999999999999999999999999999999886432     122234443 6677999999999988432     3478


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|||+++++.+++.........+++..++.++.||+.||.||| +. +++||||||+||+++.++ .+||+|||++...
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~  154 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL  154 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence            99999999887777665444567999999999999999999999 55 999999999999999887 7999999999866


Q ss_pred             ccCCCcccccccccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhh
Q 014156          245 VKGEPNISYICSRYYRAPELIFGA---TEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ..........++..|+|||.+.+.   ..++.++|+||+||++|+|++|+.||.... ..+.+..+....   .      
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~------  225 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---S------  225 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC---C------
Confidence            443333345678899999988542   346889999999999999999999996432 223332222110   0      


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                +.        .....+|.++.+||.+||..+|.+|||+.+++.||||....
T Consensus       226 ----------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         226 ----------PQ--------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ----------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                      00        00123688999999999999999999999999999998744

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-42  Score=332.27  Aligned_cols=285  Identities=35%  Similarity=0.628  Sum_probs=221.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC-CceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-~~~~  163 (429)
                      ++|++.+.||+|+||.||+|.+..++..||+|++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            4699999999999999999999999999999987532      12345799999999999999999887543321 1234


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .++||+|+++++..++.     ...+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++..
T Consensus        95 ~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH-~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~  167 (343)
T cd07880          95 FYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  167 (343)
T ss_pred             EEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeecccccc
Confidence            68999999877665543     257899999999999999999999 88999999999999999887 799999999976


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+++..+.+..+....+..
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            5332  23456788999999986645588999999999999999999999998887777777777666655443332211


Q ss_pred             CCc-c--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          324 NYT-E--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       324 ~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      ... .  ...+......+ ..+.+.+++.+.++|.+||..||.+|||+.+++.||||+..+.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~  309 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED  309 (343)
T ss_pred             hhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence            100 0  01111111111 1123467889999999999999999999999999999999877544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=320.13  Aligned_cols=247  Identities=28%  Similarity=0.452  Sum_probs=199.6

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .|.+.+.||+|++|.||+|.+..+++.||+|.+...         .....+|+.+++.++||||+++++++..     ..
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----DE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----CC
Confidence            589999999999999999999999999999987532         1234579999999999999999998833     33


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++|+||+++ ++.+.+..    ...+++..++.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~  151 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGAS  151 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence            68999999985 44444432    356899999999999999999999 88999999999999999877 7999999998


Q ss_pred             eecccCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      +........    ....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+....       
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------  223 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-------  223 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-------
Confidence            765332111    2345788999999997644 8999999999999999999999997765544433322110       


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                          ....++..++..+.+||.+||..+|.+|||+.++++||||
T Consensus       224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 --------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             --------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                0112334578999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.4e-42  Score=324.73  Aligned_cols=249  Identities=29%  Similarity=0.478  Sum_probs=205.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...       .....+|+++++.++||||+++++++..     ...+
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCeE
Confidence            599999999999999999999999999999988542       2234579999999999999999998843     3458


Q ss_pred             EEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||++ +++.+.+..    ...+++..+..++.||+.||.||| +.||+||||+|.|||++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH-~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLH-SLDIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999995 555555433    467999999999999999999999 88999999999999999887 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+...  .           
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------  214 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K-----------  214 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence            6444  3345689999999988654 4788999999999999999999999877644433333211  0           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                                      ..++..++..+.++|.+||..||.+|+     ++.|+++||||+.+.+.
T Consensus       215 ----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         215 ----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             ----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                            012334689999999999999999999     99999999999988764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5e-42  Score=331.08  Aligned_cols=279  Identities=36%  Similarity=0.572  Sum_probs=218.0

Q ss_pred             cceeE-eeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh------------------hHHHHHHHHHHcCCCCeeccce
Q 014156           91 ISYMA-ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVSLKH  151 (429)
Q Consensus        91 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~l~~  151 (429)
                      .+|.. .+.||.|+||.||+|.+..+++.||+|.+.....                  ...+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            35754 5779999999999999999999999998753211                  2347999999999999999999


Q ss_pred             eeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC
Q 014156          152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  231 (429)
Q Consensus       152 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~  231 (429)
                      ++.     ...+.++||||+++++...+..    ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ 
T Consensus        88 ~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH-~~~i~H~dl~~~nill~~~~-  156 (335)
T PTZ00024         88 VYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLH-KWYFMHRDLSPANIFINSKG-  156 (335)
T ss_pred             EEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHeEECCCC-
Confidence            874     3345889999999887776543    456899999999999999999999 88999999999999999887 


Q ss_pred             ceEEeecCCceecccC---------------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014156          232 QVKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG  296 (429)
Q Consensus       232 ~vkl~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  296 (429)
                      .++|+|||++......               .......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            7999999998765411               1112334678899999987665678999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          297 ESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       297 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+..+.+..+....+.+....+....  +.+..+.  ....... .......+.++.++|.+||..+|.+|||+.++|.|
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT--PRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccC--cCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            99888888888888877665433211  1111100  0000001 11123468899999999999999999999999999


Q ss_pred             CCccccCCC
Q 014156          375 PFFDELRDP  383 (429)
Q Consensus       375 p~f~~~~~~  383 (429)
                      |||+....+
T Consensus       314 ~~~~~~~~~  322 (335)
T PTZ00024        314 EYFKSDPLP  322 (335)
T ss_pred             cccCCCCCC
Confidence            999865433

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-43  Score=332.90  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=195.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ...|+++++||+||.+.||++... +...||+|++...      .....+|+..|.+|+ |.+||+++++-     -...
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDG  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCc
Confidence            347999999999999999999853 4466777765322      223457999999995 89999999976     3356


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ++||||||-+.+|-.++...   ...++..++++|..||+.|+.++| ..||||.||||.|+|+- +| .+||+|||+|.
T Consensus       434 ~lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH-~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~  507 (677)
T KOG0596|consen  434 YLYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIH-QHGIVHSDLKPANFLLV-KG-RLKLIDFGIAN  507 (677)
T ss_pred             eEEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHH-HhceeecCCCcccEEEE-ee-eEEeeeechhc
Confidence            79999999998887777652   334554589999999999999999 89999999999999987 35 79999999998


Q ss_pred             ecccCCC---cccccccccccccccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014156          243 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  309 (429)
Q Consensus       243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  309 (429)
                      .+.....   ..+.+||+.|||||.+...          ...++++||||||||||+|+.|++||..-.  ..+.+ +..
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aK-l~a  584 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAK-LHA  584 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHH-HHh
Confidence            8754432   2357899999999998432          125779999999999999999999995322  12222 222


Q ss_pred             hCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      +..|.           .++.||.+..           ..++.++++.||++||.+|||+.++|+|||++-..
T Consensus       585 I~~P~-----------~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  585 ITDPN-----------HEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             hcCCC-----------ccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            22222           1233444321           23499999999999999999999999999997643

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-42  Score=327.75  Aligned_cols=259  Identities=29%  Similarity=0.506  Sum_probs=208.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            5999999999999999999999999999999885432       2345789999999999999999887     334468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+.+ +|.+++..  .....+++..++.++.||+.||.||| +.|++||||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLH-LLGIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            899999975 55554432  22467899999999999999999999 88999999999999999887 799999999865


Q ss_pred             cccCCC------------------------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014156          244 LVKGEP------------------------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL  293 (429)
Q Consensus       244 ~~~~~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  293 (429)
                      ......                              .....||..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            432211                              1124678899999998664 488999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC----HH
Q 014156          294 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT----AL  369 (429)
Q Consensus       294 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~  369 (429)
                      |.+.+....+..+....                 ..++.          ...++..+.++|.+||..||.+|||    +.
T Consensus       232 f~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKKE-----------------VTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcCC-----------------ccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            98877665554433210                 00000          0126899999999999999999999    99


Q ss_pred             HHhcCCCccccCCCCCCC
Q 014156          370 EACIHPFFDELRDPNARL  387 (429)
Q Consensus       370 e~l~hp~f~~~~~~~~~~  387 (429)
                      ++|+||||+...++..+.
T Consensus       285 ~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         285 EIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHHcCchhhcCChhhccc
Confidence            999999999988877665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=324.99  Aligned_cols=252  Identities=28%  Similarity=0.427  Sum_probs=206.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc--chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      -|.++.+||+|+||.||+|.++.+|..+|||.+.-  +...+-+|+.++++++.|++|++|+.|+...+     +++|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence            38888999999999999999999999999999864  44556689999999999999999999977666     999999


Q ss_pred             cchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC-
Q 014156          170 FVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  247 (429)
Q Consensus       170 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~-  247 (429)
                      ||+. +..++++.   +.+.+++.++..+++..+.||+||| ...-||||||..|||++.+| ..||+|||.|..+.+. 
T Consensus       109 YCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH-~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLH-DLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHH-HHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence            9995 44444432   3578999999999999999999999 78899999999999999998 6999999999765433 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ....+..|||.|||||++.. ..|...+||||||++..||.-|++||.+-.....+.   -.-..|+.        .   
T Consensus       184 AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---MIPT~PPP--------T---  248 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---MIPTKPPP--------T---  248 (502)
T ss_pred             HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeE---eccCCCCC--------C---
Confidence            23456789999999999965 559999999999999999999999997654433221   11111110        0   


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      +.            -+...|.++.||+++||.++|++|-||.++++|||+++-
T Consensus       249 F~------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  249 FK------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             CC------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            00            012347889999999999999999999999999999873

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9e-42  Score=330.53  Aligned_cols=286  Identities=34%  Similarity=0.576  Sum_probs=222.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            4699999999999999999999999999999988542      1234469999999999999999987753321 12234


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .+++++++++++.+++.     ...+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus        97 ~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~  169 (345)
T cd07877          97 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  169 (345)
T ss_pred             EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence            67899999887766543     246899999999999999999999 88999999999999999887 799999999876


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......+|..|+|||.+.+...++.++||||+||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            432  233457789999999886655688999999999999999999999998887777777777777666555433322


Q ss_pred             CCccc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          324 NYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       324 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                      .....   ..+.+....+... ....++++.+||.+||..||.+|+|+.++++||||+++..+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~  312 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  312 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence            11000   0111111111111 12368899999999999999999999999999999987766544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-41  Score=322.08  Aligned_cols=261  Identities=25%  Similarity=0.360  Sum_probs=205.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++.+ +|||++++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            45799999999999999999999999999999988543   23445788899988 899999999988654433344678


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ ++.+++.........+++..++.++.|++.||+||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH-NNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            99999975 555555443344567899999999999999999999 88999999999999999877 7999999998765


Q ss_pred             ccCC-CcccccccccccccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGAT----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      .... ......|+..|+|||.+....    .++.++|||||||++|+|++|++||...+....+..+.+.   +.     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~-----  250 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP-----  250 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC-----
Confidence            4322 223356788999999875432    2678999999999999999999999876554444333221   00     


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                                 +.       ...+...+..+.+||.+||..||.+||++.++++||||+
T Consensus       251 -----------~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 -----------PT-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -----------CC-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                       00       001223577899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-42  Score=325.13  Aligned_cols=260  Identities=26%  Similarity=0.413  Sum_probs=202.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++++.||+|+||.||+|++..++..||+|.+...     .....+|+.+++.++|+||+++++++..     ..+.++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence            589999999999999999999999999999987542     1234579999999999999999998743     345889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||++++.+..+.........+++..+..++.||+.||.|||++.||+||||||+||+++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~  155 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVA  155 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccC
Confidence            9999986533322221111347899999999999999999999446999999999999999876 799999999876533


Q ss_pred             CCCcccccccccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          247 GEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      . ......+++.|+|||.+.+..     .++.++|+|||||++|+|++|..||...........+.......        
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  226 (286)
T cd06622         156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD--------  226 (286)
T ss_pred             C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC--------
Confidence            2 223346788999999885432     35789999999999999999999997654433332222211100        


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                                       ...++..++.++.+||.+||..+|.+||++.++++||||...+..
T Consensus       227 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         227 -----------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             -----------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                             001233478999999999999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-43  Score=300.95  Aligned_cols=258  Identities=27%  Similarity=0.382  Sum_probs=203.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ..+|++.+.||.|||+-||+++...++..||+|++...    .+...+|++..++++|||++++++.............|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            45899999999999999999999999999999988533    34455899999999999999999877665555666789


Q ss_pred             EEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ++++|.. |++++.+......+..+++..+..|+.+|++||++|| ...  ++||||||.|||+..++ .++|.|||.+.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH-~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH-EKEPPYAHRDIKPANILLSDSG-LPVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh-ccCCcccccCCCcceeEecCCC-ceEEEeccCcc
Confidence            9999887 6688888877777778999999999999999999999 667  99999999999999866 89999999986


Q ss_pred             ecccC---C-------CcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014156          243 VLVKG---E-------PNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL  310 (429)
Q Consensus       243 ~~~~~---~-------~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  310 (429)
                      ...-.   .       ......+|..|+|||.+.-  ....+.++|||||||+||.|+.|..||..         +.+..
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~G  248 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQG  248 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------HhhcC
Confidence            54211   1       1123457889999998742  23468899999999999999999999942         11111


Q ss_pred             CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ++....      -....+.+|.          ...+|..+.+||+.||+.||.+||++.+++.+
T Consensus       249 gSlaLA------v~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 GSLALA------VQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CeEEEe------eeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            111100      0001111221          12379999999999999999999999999864

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=322.97  Aligned_cols=274  Identities=40%  Similarity=0.736  Sum_probs=218.9

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+....      ....+|+.+++.++|+||+++++.+..     ....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            567889999999999999998899999999875432      234579999999999999999988743     345889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |+||+++++...+..   ....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCH-SHGILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHH-HCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            999999877666543   2357899999999999999999999 88999999999999999877 799999999877654


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC--
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  323 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  323 (429)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+...++.+..+.+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            43 223356788899999987654689999999999999999999999999988888888888777776655443322  


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      ....+.++....... ....+.++.++.+||.+||..||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            111112222111111 11234578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-42  Score=322.38  Aligned_cols=277  Identities=33%  Similarity=0.599  Sum_probs=216.9

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |.+.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+.+++.++|+|++++++.+....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678899999999999999999999999999986542      23457999999999999999998874431   245889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |+||+++++...+..   ....+++..++.++.||+.||+||| +.|++|+||||+||+++.++ .++|+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH-~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLH-SNGILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            999999876665543   2257899999999999999999999 88999999999999999887 799999999987654


Q ss_pred             CC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          247 GE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..  ......++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            43  1233456888999998876566889999999999999999999999998888888888887777765544322111


Q ss_pred             --CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          325 --YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       325 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                        .................+...+++.+.++|.+||..||.+|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000000111112223348999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.7e-41  Score=326.25  Aligned_cols=283  Identities=37%  Similarity=0.702  Sum_probs=222.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||++++++|....    ..
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----ED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----Cc
Confidence            45799999999999999999999999999999987431      234457999999999999999998875322    24


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .++++||+++++..++.     ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++..
T Consensus        85 ~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH-~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVH-SAGVVHRDLKPSNILINENC-DLKICDFGLARI  157 (328)
T ss_pred             EEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence            77999999887766543     256888889999999999999999 88999999999999999877 799999999875


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.........+.+.++.++.+.......
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            432  223456788999999886645689999999999999999999999998887777777777788777665432211


Q ss_pred             CCc-cc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          324 NYT-EF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       324 ~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                      .-. .+  ..+.....+.. ...+.+++.+.++|++||+.+|.+|||+.+++.||||...+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFS-EKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             hhhHHHHhhccccCCCcHH-HHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence            100 00  00100011111 1123478899999999999999999999999999999988887555

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=320.79  Aligned_cols=275  Identities=39%  Similarity=0.698  Sum_probs=219.4

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |++.+.||+|+||+||+|.+..+++.||||.+....     ....+|+..++.+. |+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            678899999999999999998899999999875432     22346888999999 9999999998844     334789


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||+++++++.+....  ...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIH-KHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888777664321  247899999999999999999999 88999999999999999877 799999999987755


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC--
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--  324 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--  324 (429)
                      ........++..|+|||++.+...++.++|+||||+++++|++|++||.+.+..+....+...++.+....+......  
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            544455678899999998866566889999999999999999999999999888888888888888776544321111  


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      .....++..........+ ...+.++.+||++||..||.+|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            111122222211111112 2347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-43  Score=336.15  Aligned_cols=258  Identities=27%  Similarity=0.420  Sum_probs=218.2

Q ss_pred             CCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           86 QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        86 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      .....+.|.+.+.||+|.|++|.+|++..++..||||.+.+..      ....+|+++|+.|+|||||+++.+..     
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-----  125 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-----  125 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-----
Confidence            3445567999999999999999999999999999999886532      33468999999999999999999884     


Q ss_pred             CceEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ....+|+||||+.++ +++    +....+++.+..++.++.|++.|++||| +++|||||||.+||||+.+. ++||+||
T Consensus       126 t~~~lylV~eya~~ge~~~----yl~~~gr~~e~~ar~~F~q~vsaveYcH-~k~ivHrdLk~eNilL~~~m-nikIaDf  199 (596)
T KOG0586|consen  126 TEATLYLVMEYASGGELFD----YLVKHGRMKEKEARAKFRQIVSAVEYCH-SKNIVHRDLKAENILLDENM-NIKIADF  199 (596)
T ss_pred             ecceeEEEEEeccCchhHH----HHHhcccchhhhhhhhhHHHHHHHHHHh-hcceeccccchhhccccccc-ceeeecc
Confidence            334499999999864 333    3444678888999999999999999999 88999999999999999887 6999999


Q ss_pred             CCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          239 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       239 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      |++..+..+....++||++.|.|||++.+....++.+|+||+|+++|.|+.|..||.+.+-.+.-...+..         
T Consensus       200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g---------  270 (596)
T KOG0586|consen  200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG---------  270 (596)
T ss_pred             ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee---------
Confidence            99999988888899999999999999999887899999999999999999999999887643322211110         


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                              .+.            ++-.++.++.+||+++|..+|.+|++..++..|.|.......
T Consensus       271 --------k~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  271 --------KYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             --------eec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                    011            222478999999999999999999999999999999877655

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=334.05  Aligned_cols=247  Identities=30%  Similarity=0.528  Sum_probs=207.8

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeec
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      ++||+|.||+||-|+++.+|+.||||++.+      ......+|+.||+.+.||.||.+.-.|     +....+++|||-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVMEK  644 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVMEK  644 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEehh
Confidence            789999999999999999999999998843      335566899999999999999985544     333348899999


Q ss_pred             chhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCCceecccCC
Q 014156          171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       171 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~a~~~~~~~  248 (429)
                      +.|+.++.+..  ...+++++...++++.||+.||.||| .++|+|+||||+|||+.+..  -++||||||+|+.+....
T Consensus       645 l~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH-~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  645 LHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLH-FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             hcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhh-hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            99998887765  34588999999999999999999999 88999999999999996543  379999999999998888


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ...+.+|||.|+|||++.. +.|...-|+||+|||+|.-+.|..||.... ..+++++.                    .
T Consensus       722 FRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA--------------------a  780 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA--------------------A  780 (888)
T ss_pred             hhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhcc--------------------c
Confidence            7888999999999999976 459999999999999999999999996543 23333321                    1


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      +-+   +..+|     +.++++++|||..+|+..-.+|.|+...|.|||+++.
T Consensus       781 FMy---Pp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  781 FMY---PPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ccc---CCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            111   22333     3479999999999999999999999999999999874

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=347.16  Aligned_cols=248  Identities=26%  Similarity=0.455  Sum_probs=198.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcC-CCCeeccce-eeeecCCCC-ceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKH-CFFSTTDKD-ELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~~iv~l~~-~~~~~~~~~-~~~  163 (429)
                      .+++|.+.|.+|||+.||+|++...|..||+|++...    .....+|+.+|+.|. |+|||.+++ ........+ ..-
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3699999999999999999999888899999987543    233468999999997 999999999 443333333 455


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecCCCCceEEeecCC
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ++|+||||. |+|.+.+..+..  .+|++.+++.|++|+|+|+.+|| ...  |||||||-|||||+.++ ..||||||.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g-~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADG-NYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence            779999999 699998887555  45999999999999999999999 666  99999999999999888 799999999


Q ss_pred             ceecccCCCc----------ccccccccccccccc--cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014156          241 AKVLVKGEPN----------ISYICSRYYRAPELI--FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK  308 (429)
Q Consensus       241 a~~~~~~~~~----------~~~~gt~~y~aPE~~--~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  308 (429)
                      |.........          .....|+.|+|||++  ......+.|+|||+|||+||.|+....||........+     
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl-----  267 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL-----  267 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-----
Confidence            8654332211          123458999999997  33445899999999999999999999999765322111     


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                   +   ..|.+|..          ++++..+.+||+.||+.||.+||++.+++.
T Consensus       268 -------------n---g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  268 -------------N---GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             -------------e---ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                         1   12333332          347899999999999999999999998875

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.3e-42  Score=322.97  Aligned_cols=252  Identities=26%  Similarity=0.458  Sum_probs=198.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++.+.||+|+||.||+|++..+++.||+|.+..+     .....+|+.+++.++||||+++++.+...     ...++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence            588899999999999999999999999999987543     12345799999999999999999988543     34789


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||++++.+...       ..+++..+..++.|++.||.||| +.||+|+||||+|||++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLW-SLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999998655432       35788899999999999999999 88999999999999999887 799999999976543


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      . ......||..|+|||.+.+. .++.++|+|||||++|+|++|..||......+.   .....+......         
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  216 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------  216 (279)
T ss_pred             c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence            3 23346789999999998764 489999999999999999999999965322111   011111100000         


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                            .+.        ......++++.+||.+||..||.+||++.++++||||.....
T Consensus       217 ------~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         217 ------PPV--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             ------CCC--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence                  000        011236789999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-41  Score=320.09  Aligned_cols=262  Identities=25%  Similarity=0.350  Sum_probs=205.2

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceE
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ....+|++.+.||+|+||.||+|.+..+++.+|+|++...   .....+|+.+++.+ +||||+++++++.........+
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            3445799999999999999999999999999999987542   23455789999998 6999999999886554444556


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .++||||+++ +|.+++.........+++..++.++.|++.||.||| +.+|+||||||+||+++.++ .++|+|||++.
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~  172 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH-VNKTIHRDVKGNNILLTTEG-GVKLVDFGVSA  172 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH-hCCccccCCCHHhEEECCCC-CEEEccCCcee
Confidence            8899999975 555555443344567899999999999999999999 88999999999999999887 69999999987


Q ss_pred             ecccCC-CcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ...... ......|++.|+|||.+..    ...++.++||||+||++|+|++|+.||...+....+..+...   .    
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~----  245 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P----  245 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C----
Confidence            654322 2234568999999998743    234788999999999999999999999766543332221110   0    


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                  .+       ....+..++..+.+||.+||..||.+|||+.|+++|+||
T Consensus       246 ------------~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 ------------PP-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ------------CC-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                        00       001122357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=335.22  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=222.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+..++..||-|+||.|=+++.......+|+|++++.       .+....|-+||..++.|.||++|..|     .+..|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            3577888999999999999987655556899977542       34445789999999999999999998     77888


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|++||-|- |.++..+..    .+.|....+++++..++.|++||| ++|||+|||||+|++++.+| .+||.|||+|+
T Consensus       495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH-~k~iIYRDLKPENllLd~~G-y~KLVDFGFAK  568 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLH-RKGIIYRDLKPENLLLDNRG-YLKLVDFGFAK  568 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHH-hcCceeccCChhheeeccCC-ceEEeehhhHH
Confidence            999999875 566665543    578999999999999999999999 89999999999999999988 79999999999


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .+..+...-++||||.|.|||++.+. ..+.++|.||||+++|||++|.+||.+.+.+..+..|.+.+..          
T Consensus       569 ki~~g~KTwTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------  637 (732)
T KOG0614|consen  569 KIGSGRKTWTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------  637 (732)
T ss_pred             HhccCCceeeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence            99999999999999999999999875 4899999999999999999999999999999999999886421          


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDPN  384 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~  384 (429)
                           +            .++..++..+.+||+++...+|.+|+.     +.+|.+|.||..+.|.-
T Consensus       638 -----i------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  638 -----I------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             -----h------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence                 1            144568899999999999999999996     88999999999988753

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.6e-42  Score=331.16  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=189.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      .+|++.++||+|+||.||+|.+.     .+++.||+|++...     .....+|+.++..+ +||||+++++++...   
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---   83 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP---   83 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC---
Confidence            47999999999999999999752     34578999988542     22345799999999 899999999876432   


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhh------------------------------------------------------
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSR------------------------------------------------------  184 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  184 (429)
                       ...+++||||+++ +|.+.+.....                                                      
T Consensus        84 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          84 -NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence             2247889999985 55555432110                                                      


Q ss_pred             ----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC---cccccccc
Q 014156          185 ----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSR  257 (429)
Q Consensus       185 ----~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~  257 (429)
                          ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.......   .....+++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCc
Confidence                0134788889999999999999999 88999999999999999877 799999999976533221   12234567


Q ss_pred             cccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCC
Q 014156          258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  336 (429)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                      .|+|||++.+. .++.++|||||||++|+|++ |..||.+......+........                         
T Consensus       241 ~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------------------------  294 (338)
T cd05102         241 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-------------------------  294 (338)
T ss_pred             cccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-------------------------
Confidence            89999998664 48999999999999999997 9999987654433332222100                         


Q ss_pred             CcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          337 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       337 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                        ....+..+++++.+||.+||..||.+|||+.++++
T Consensus       295 --~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         295 --RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              00112346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.4e-41  Score=321.49  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=203.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..|++++.||+|+||.||+|++..+++.||+|.+....    ....+|+.+++.++|+||+++++++...     ...++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEE
Confidence            36999999999999999999999999999999885432    2334689999999999999999987432     35889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||++++.+....  ......+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++.....
T Consensus        87 v~e~~~~~~l~~~~--~~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~  162 (292)
T cd06644          87 MIEFCPGGAVDAIM--LELDRGLTEPQIQVICRQMLEALQYLH-SMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVK  162 (292)
T ss_pred             EEecCCCCcHHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHh-cCCeeecCCCcceEEEcCCC-CEEEccCccceeccc
Confidence            99999976543322  222456899999999999999999999 88999999999999999777 799999999865432


Q ss_pred             C-CCcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          247 G-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       247 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      . .......+++.|+|||++.+    ...++.++|+|||||++|+|++|.+||...+......++...   ..       
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-------  232 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EP-------  232 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CC-------
Confidence            2 12234567889999998852    234678999999999999999999999776644433332211   00       


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                               +       ....+..++.++.+||.+||..||++||++.++++||||..+...
T Consensus       233 ---------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         233 ---------P-------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ---------c-------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                     0       001123468899999999999999999999999999999876654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.6e-42  Score=319.06  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=200.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHc-CCCCeeccceeeeecCCC-CceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK-DELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~-~~~~~~  165 (429)
                      +.|.+.+.||+|+||.||+|.+..+++.||+|.+...   .....+|+.+++.+ +|+||+++++++...... ....++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            4699999999999999999999999999999988543   23456788899888 699999999988654322 234678


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ ++.+++..  .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        86 iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~  161 (272)
T cd06637          86 LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  161 (272)
T ss_pred             EEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHEEECCCC-CEEEccCCCceec
Confidence            99999985 55554432  12356899999999999999999999 78999999999999999887 7999999998765


Q ss_pred             ccC-CCcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          245 VKG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ... .......|+..|+|||++.+    ...++.++|+||+||++|+|++|..||...........+...          
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~----------  231 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----------  231 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC----------
Confidence            332 22334578999999999853    234788999999999999999999999765443322221110          


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                       .........++.++.+||.+||..||.+|||+.+++.||||
T Consensus       232 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         232 -----------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -----------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                             00001122468899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7e-43  Score=311.82  Aligned_cols=282  Identities=33%  Similarity=0.544  Sum_probs=228.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC-CceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-~~~~  163 (429)
                      .+|.-++.+|.|.- .|..|.|.-.++.||+|++...      .....+|+..+..++|+||++++.+|...... ...-
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            36999999999999 8888999999999999987432      33456899999999999999999988543321 1123


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|+|||+++.++...+.      -.++-..+..+++|++.|+.||| +.||+||||||+||++..+. .+||.|||+|+.
T Consensus        96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lh-s~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLH-SAGIIHRDLKPSNIVVNSDC-TLKILDFGLART  167 (369)
T ss_pred             HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHH-hcceeecccCcccceecchh-heeeccchhhcc
Confidence            68899999998877665      34667789999999999999999 89999999999999999888 899999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....-..+.++.|++|.|||++.+.. +...+||||+||++.||++|+..|+|.+..++..++...+|.|....+..+.+
T Consensus       168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            76665667889999999999998866 99999999999999999999999999999999999999999999987766553


Q ss_pred             CCccc--cCCCc---------CCCCccccc--CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          324 NYTEF--KFPQI---------KAHPWHKIF--HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       324 ~~~~~--~~~~~---------~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ....+  ..|+.         +...|....  ++.-+..+++|+.+||..||++|.++.++|+||||+-+..
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~  318 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYD  318 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecc
Confidence            22111  11111         111111111  1123456899999999999999999999999999995433

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.2e-42  Score=323.21  Aligned_cols=262  Identities=22%  Similarity=0.349  Sum_probs=202.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|...+.||+|+||.||++.+..+++.||+|.+...     .....+|+.++.++. |+||+++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence            467778999999999999999999999999988542     223456888888886 99999999987542     2367


Q ss_pred             EEeecchhhHHHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|||++.++..+.... ......+++..+..++.|++.||+|||++.||+||||||+||+++.++ .++|+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            89999987655544332 223467999999999999999999999446999999999999999877 7999999999766


Q ss_pred             ccCCCcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ..........|+..|+|||++.+.  ..++.++||||+||++|+|++|+.||.....  ....+.+.....         
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~---------  227 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD---------  227 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC---------
Confidence            544444455788999999998665  3688999999999999999999999976541  112222211100         


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                             .+.+     .......++.++.+||.+||..||.+|||+.+++.||||+....
T Consensus       228 -------~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         228 -------PPIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             -------CCcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence                   0000     01112347899999999999999999999999999999987553

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=8.9e-43  Score=328.04  Aligned_cols=281  Identities=33%  Similarity=0.541  Sum_probs=227.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhH---HHHHHHHHHcC------CCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLD------HPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~------h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|.+....|+|-|++|..|.+...|..||||++....-..   .+|++||+.|+      .-|+++++..|     ..
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~h  505 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KH  505 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hh
Confidence            457999999999999999999999999999999997664333   47999999995      35789998888     45


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ..++|||+|-+.-+|..+++.+.+. -.+....++.|+.|++.||..|. ++||+|.||||+||||+.....+||||||.
T Consensus       506 knHLClVFE~LslNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK-~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  506 KNHLCLVFEPLSLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLK-KCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             cceeEEEehhhhchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHH-hcCeeecccCccceEeccCcceeeeccCcc
Confidence            5569999999999999999988764 56899999999999999999999 999999999999999998888999999999


Q ss_pred             ceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      |.....++. +.+..+..|.|||++.|.. |++..|+||+||+||||.||+..|+|.++.+++...+.+.|.-+..++..
T Consensus       584 A~~~~enei-tPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  584 ASFASENEI-TPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             ccccccccc-cHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            987765543 5677889999999999865 99999999999999999999999999999999999998888776665431


Q ss_pred             c-------CC--CCccccCCCcCCC-------------Cccccc--CCCCC-------hhHHHHHHhhcCcCCCCCCCHH
Q 014156          321 M-------NP--NYTEFKFPQIKAH-------------PWHKIF--HKRMP-------PEAVDLVSRLLQYSPNLRCTAL  369 (429)
Q Consensus       321 ~-------~~--~~~~~~~~~~~~~-------------~~~~~~--~~~~s-------~~~~~li~~~L~~dP~~R~t~~  369 (429)
                      -       ..  +|-......+...             .+...+  .+.++       ..+++||.+||..||++|+|+.
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence            1       01  1111011111100             000000  01122       3589999999999999999999


Q ss_pred             HHhcCCCccc
Q 014156          370 EACIHPFFDE  379 (429)
Q Consensus       370 e~l~hp~f~~  379 (429)
                      ++|.||||..
T Consensus       742 qAL~HpFi~~  751 (752)
T KOG0670|consen  742 QALKHPFITE  751 (752)
T ss_pred             HHhcCCcccC
Confidence            9999999974

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=340.09  Aligned_cols=249  Identities=28%  Similarity=0.450  Sum_probs=202.4

Q ss_pred             EEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecchh
Q 014156           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE  173 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~  173 (429)
                      +||+|.||+||-|+++.|....|||.+...    ......|+..-+.|+|.|||++.+++     ..+.++-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            799999999999999999999999988543    23345899999999999999999987     445577899999997


Q ss_pred             hHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC-c
Q 014156          174 TVYRVAKHYSRASQRM--PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-N  250 (429)
Q Consensus       174 ~l~~~~~~~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~-~  250 (429)
                      +.+..+..  ..-+++  .+.++.+|..||+.||.||| ...|||||||-+|+||+.-.+.+||+|||-+++...-.. .
T Consensus       657 GSLSsLLr--skWGPlKDNEstm~fYtkQILeGLkYLH-en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  657 GSLSSLLR--SKWGPLKDNESTMNFYTKQILEGLKYLH-ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             CcHHHHHH--hccCCCccchhHHHHHHHHHHHHhhhhh-hcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            65444332  223455  89999999999999999999 889999999999999998878999999999988754433 3


Q ss_pred             cccccccccccccccc-CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 014156          251 ISYICSRYYRAPELIF-GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  329 (429)
Q Consensus       251 ~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .++.||..|||||++. |..+|+.++|||||||++.||.||++||......+.  .++++.                   
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVG-------------------  792 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVG-------------------  792 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhc-------------------
Confidence            4678999999999984 456799999999999999999999999975433222  111110                   


Q ss_pred             CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                           .......++..++.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus       793 -----myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  793 -----MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             -----ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                 0111223556689999999999999999999999999999999864

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.1e-42  Score=328.91  Aligned_cols=276  Identities=23%  Similarity=0.348  Sum_probs=197.2

Q ss_pred             EeeEEccC--CcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           95 AERVVGQG--SFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        95 ~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ++++||+|  +|++||++.+..+|+.||+|++..+      .....+|+.+++.++||||+++++++...     ...++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            46789999  7899999999999999999988643      13445799999999999999999988443     34789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ ++.+++...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .++++|||.+....
T Consensus        77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            9999985 455544321  2345899999999999999999999 88999999999999999887 79999998754332


Q ss_pred             cCCC--------cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC---
Q 014156          246 KGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP---  313 (429)
Q Consensus       246 ~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---  313 (429)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|..||............... ..+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~  231 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLL  231 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Cccccc
Confidence            1111        1123457779999998653 35889999999999999999999999865544433222211 000   


Q ss_pred             -----CHHHHhhcCCC------Ccccc-----CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          314 -----TREEIKCMNPN------YTEFK-----FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       314 -----~~~~~~~~~~~------~~~~~-----~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                           ..+.+......      .....     .+.. .......+...+++.+.+||.+||++||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN-GESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccc-cCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence                 00000000000      00000     0000 0001111234568899999999999999999999999999999


Q ss_pred             cccC
Q 014156          378 DELR  381 (429)
Q Consensus       378 ~~~~  381 (429)
                      +++.
T Consensus       311 ~~~~  314 (327)
T cd08227         311 KQIK  314 (327)
T ss_pred             hhcc
Confidence            8754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=316.59  Aligned_cols=261  Identities=28%  Similarity=0.420  Sum_probs=206.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHc-CCCCeeccceeeeecCC-CCceE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      ..++|++.+.||+|+||.||+|.+..+++.+++|++....   ....+|+.+++.+ +|+||+++++++..... ....+
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4568999999999999999999999899999999876432   3456799999998 79999999998866543 33556


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +++||||+++ ++.+++.........+++..++.++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++.
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~  161 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH-ENKVIHRDIKGQNILLTKNA-EVKLVDFGVSA  161 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEEccCC-eEEECCCccce
Confidence            8899999996 555555443333567899999999999999999999 88999999999999999887 79999999987


Q ss_pred             ecccCC-CcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ...... ......|+..|+|||++..    ...++.++|||||||++|+|++|..||........+.++...   +.   
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~---  235 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP---  235 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC---
Confidence            653322 2234568899999998743    234678899999999999999999999765544444333221   00   


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                   +.+       .....++.++.+||.+||..||++|||+.++++|||+
T Consensus       236 -------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 -------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                         000       0112357899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=317.70  Aligned_cols=274  Identities=38%  Similarity=0.682  Sum_probs=222.0

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |++.+.||+|+||.||+|++..+++.||+|.+....      .....|+.+++.++|+|++++++++...     .+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence            667889999999999999999999999999886431      2334689999999999999999887433     45889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |+||+++++...+..   ....+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCH-SHRILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            999999887776654   2256999999999999999999999 78999999999999999877 799999999876543


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+....+..+...++.+....+.......
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 22334567789999998766568999999999999999999999999999888888898888888877665433221


Q ss_pred             -ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          326 -TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       326 -~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                       ....++..........+ +.++..+.++|.+||..||++||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             22233333333333333 2358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=329.98  Aligned_cols=241  Identities=26%  Similarity=0.372  Sum_probs=199.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc---chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      .+++++.||+|-||.||.|.+..+ ..||+|.++.   ....+.+|+++|+.|+|+|||++++++....     -++|||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence            567788999999999999998533 4799998754   2344568999999999999999999884322     388999


Q ss_pred             ecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      |||. |+|++.++.  .....+.......++.|||+|++||+ ++++|||||-..||||+.+. .+||+|||+|+...++
T Consensus       281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLe-s~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLE-SKNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHH-hCCccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence            9998 667777655  34577999999999999999999999 88999999999999999887 8999999999955444


Q ss_pred             CCcccccc---cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          248 EPNISYIC---SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       248 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ... ...|   ...|.|||.+.-. .++.+||||||||+|+||+| |+.||.+.+..+.+..+.+...-|.         
T Consensus       357 ~Y~-~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------  425 (468)
T KOG0197|consen  357 EYT-ASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------  425 (468)
T ss_pred             cee-ecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------
Confidence            332 2222   4569999999654 49999999999999999998 8999999998888887766432221         


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  372 (429)
                                         |..+|+++.+++..||..+|++|||+..+.
T Consensus       426 -------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  426 -------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                               346899999999999999999999998664

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.4e-41  Score=320.33  Aligned_cols=282  Identities=31%  Similarity=0.512  Sum_probs=218.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCC-----
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-----  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-----  158 (429)
                      ..+|++.+.||.|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++.+....+     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            347999999999999999999999999999999885322      233579999999999999999987754331     


Q ss_pred             CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ....++++|+||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCH-KKNFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-cEEeCcc
Confidence            12236889999999877665543   2356899999999999999999999 88999999999999999887 7999999


Q ss_pred             CCceecccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          239 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       239 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      |++........  .....++..|+|||.+.+...++.++|||||||++++|++|++||...+..+.+..+.+..+.+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            99876643321  1223457789999988665557889999999999999999999999888888888888877777655


Q ss_pred             HHhhcCC--CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          317 EIKCMNP--NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       317 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      .++....  .+............+.. ....++..+.++|.+||..||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            4332111  01000000000011111 223468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.2e-41  Score=322.76  Aligned_cols=277  Identities=25%  Similarity=0.408  Sum_probs=201.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++.+.||+|+||.||++.+..++..+|+|.+..+     .....+|+++++.++||||+++++++..     ..++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence            599999999999999999999999999999987543     1234579999999999999999998843     335889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ +|.+.+..    ...+++..+..++.||+.||.|||+..+|+||||||+|||++.++ .++|+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 55444432    367899999999999999999999436999999999999999887 79999999987653


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH-HHHhhcCC-
Q 014156          246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR-EEIKCMNP-  323 (429)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~-  323 (429)
                      ... .....|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+... ...+......... ........ 
T Consensus       152 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DSM-ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ccc-cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            322 2346789999999998654 48899999999999999999999997655322 2222211100000 00000000 


Q ss_pred             CCcc----cc----CCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          324 NYTE----FK----FPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       324 ~~~~----~~----~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ....    ..    ...+.... .... ...++.++.+||.+||..||++|||+.++++||||.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  295 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL  295 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence            0000    00    00000000 0001 1136789999999999999999999999999999987543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-41  Score=316.45  Aligned_cols=278  Identities=35%  Similarity=0.606  Sum_probs=214.7

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHc---CCCCeeccceeeeecCCCCceE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      |++.+.||+|+||.||+|++..+++.||+|.+....      ....+|+.+++.+   +|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999998889999999885321      2234577777665   6999999999987655444556


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++++|||+++++.+.+...  ....+++..++.++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH-~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLH-SHRIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            8899999998776655432  1236899999999999999999999 88999999999999999887 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV-  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence            6554444455678899999998764 48899999999999999999999999988888888887766555433221110 


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                      ......++....... ....+.+++.+.+||.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            000001111111111 11123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=315.28  Aligned_cols=293  Identities=27%  Similarity=0.446  Sum_probs=221.6

Q ss_pred             CCCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHH---HHHHHHHHcC--------CCCeeccceee
Q 014156           85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLD--------HPNVVSLKHCF  153 (429)
Q Consensus        85 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~--------h~~iv~l~~~~  153 (429)
                      |.....++|.+.++||.|.|++||+|.|..+.+.||+|+++....+.+   .|+++|++++        ..+||+|++.|
T Consensus        72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            345556789999999999999999999999999999999977654443   5899998872        24799999988


Q ss_pred             eecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC----
Q 014156          154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH----  229 (429)
Q Consensus       154 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~----  229 (429)
                      .... .+..++|||+|+++.+|+.++....  .+.++...++.|++||+.||.|||.++||||-||||+|||+...    
T Consensus       152 khsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  152 KHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             eecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence            6554 5677899999999999999987643  47799999999999999999999988999999999999997200    


Q ss_pred             ------------------------C-------------------------------------------------------
Q 014156          230 ------------------------T-------------------------------------------------------  230 (429)
Q Consensus       230 ------------------------~-------------------------------------------------------  230 (429)
                                              .                                                       
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                                    0                                                       


Q ss_pred             --------------------------------------------------------------------------------
Q 014156          231 --------------------------------------------------------------------------------  230 (429)
Q Consensus       231 --------------------------------------------------------------------------------  230 (429)
                                                                                                      
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                                                                            


Q ss_pred             --CceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC------CChHHH
Q 014156          231 --HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG------ESGVDQ  302 (429)
Q Consensus       231 --~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~------~~~~~~  302 (429)
                        -+|||+|||.|+....  ..+.-..|+.|+|||++.+.. |++.+||||++|+++||+||..+|..      ..+.+.
T Consensus       389 ~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             cceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence              0134555555444311  122334578899999999865 99999999999999999999999964      235678


Q ss_pred             HHHHHHHhCCCCHHHHhhcC--CCC-----ccccCCCcCCCCcccc------cCCCCChhHHHHHHhhcCcCCCCCCCHH
Q 014156          303 LVEIIKVLGTPTREEIKCMN--PNY-----TEFKFPQIKAHPWHKI------FHKRMPPEAVDLVSRLLQYSPNLRCTAL  369 (429)
Q Consensus       303 ~~~i~~~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~  369 (429)
                      +..|++.+|.-+......-.  +.|     .--.+..++..++..+      |+..-..++.+||.-||+++|.+|+||.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence            99999999887766543211  000     0001112222222211      2223345688999999999999999999


Q ss_pred             HHhcCCCccccCCC
Q 014156          370 EACIHPFFDELRDP  383 (429)
Q Consensus       370 e~l~hp~f~~~~~~  383 (429)
                      ++|+|||+..+..+
T Consensus       546 ~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  546 QCLKHPWLNPVAGP  559 (590)
T ss_pred             HHhcCccccCCCCC
Confidence            99999999987665

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.9e-41  Score=310.10  Aligned_cols=249  Identities=28%  Similarity=0.457  Sum_probs=200.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .|++.+.||+|++|.||++.+..+++.||+|.+..+      .....+|+.+++.++|+|++++++.+..    ...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence            389999999999999999999999999999987532      1234578999999999999999876632    233578


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|||+++ ++.+.+..  .....+++..++.++.|++.||.+|| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH-~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLH-EKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999985 45444432  22356899999999999999999999 88999999999999999877 7999999999866


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......+++.|+|||++.+. .++.++|+||+||++++|++|+.||...+.......+....             
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-------------  218 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            4322 22345678999999998654 48889999999999999999999998766544443332210             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                            .+         ..+..+++.+.+||.+||+.||.+|||+.++++||||
T Consensus       219 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 ------LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00         0123468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.5e-41  Score=318.17  Aligned_cols=253  Identities=26%  Similarity=0.372  Sum_probs=201.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      -|++.+.||.|+||.||+|.+..++..+++|.+....    ....+|+++++.++||||+++++.+..     ....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            3788899999999999999999999999999875432    233468999999999999999998743     2357899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      +||++++.+.....  .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++......
T Consensus        81 ~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~  156 (282)
T cd06643          81 IEFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLH-ENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEccCC-CEEEcccccccccccc
Confidence            99998765443221  23457899999999999999999999 88999999999999999887 7999999998765332


Q ss_pred             C-Cccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          248 E-PNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      . ......+|..|+|||++.    ....++.++|+||+||++|+|++|++||...+..+....+.....  .        
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~--------  226 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--P--------  226 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC--C--------
Confidence            1 223456889999999874    223467899999999999999999999987765555444433110  0        


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                               .       ...+..++.++.+||.+||..||.+|||+.++++||||..
T Consensus       227 ---------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         227 ---------T-------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             ---------C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence                     0       0112346889999999999999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.7e-41  Score=318.62  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=203.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++||||+++++.+..     ...+++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence            3699999999999999999999999999999987532    2334578999999999999999998843     335889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |+||+.++.+.....    ...+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH-~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~  167 (296)
T cd06655          94 VMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEccCccchhccc
Confidence            999998654433221    246899999999999999999999 88999999999999999877 799999999876543


Q ss_pred             CCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      ... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+... ..+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~-----------  234 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE-----------  234 (296)
T ss_pred             ccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc-----------
Confidence            322 233567889999998865 44889999999999999999999999887665544333221 0000           


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                    ...+..+++.+.+||.+||..||.+|||+.+++.||||+..+.
T Consensus       235 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         235 --------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             --------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                          0112347889999999999999999999999999999986553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.9e-41  Score=313.06  Aligned_cols=255  Identities=28%  Similarity=0.418  Sum_probs=201.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++.+.||.|+||+||+|.+..++..+|+|++...     .....+|+.+++.++|+||+++++.+..     ....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEEE
Confidence            599999999999999999999889999999987532     2344579999999999999999887743     335789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      |||++.+ ++.+.+.. ......+++..++.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~ql~~al~~lh-~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLEYLH-SNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999986 44444432 111256899999999999999999999 88999999999999999877 79999999987665


Q ss_pred             cCCCc-----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          246 KGEPN-----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       246 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      .....     ....|+..|+|||.+.....++.++|+|||||++|+|++|..||...+....+.++...   ..      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~------  224 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP------  224 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC------
Confidence            43322     33468889999999876546899999999999999999999999776554443333221   00      


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                        +.     .+..       .....+++.+.+|+.+||..||.+|||+.++++||||
T Consensus       225 --~~-----~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 --PS-----LETG-------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             --CC-----cCCc-------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence              00     0000       0013478999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.7e-41  Score=316.92  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=200.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHc-CCCCeeccceeeeecCC-CCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~-~~~~~~~  165 (429)
                      +.|++.+.||.|+||.||+|++..+++.+|+|++....   .....|+.+++.+ +|+||+++++++..... ....+++
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            46999999999999999999999999999999875432   3345688888888 79999999998864322 2345688


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|||+++ ++.+++...  ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        96 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~  171 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLH-AHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCcchhhh
Confidence            99999986 555555431  2355888999999999999999999 88999999999999999887 7999999998755


Q ss_pred             ccC-CCcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          245 VKG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ... .......|++.|+|||.+..    ...++.++|+|||||++|+|++|..||...........+...   ..     
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~-----  243 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP-----  243 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC-----
Confidence            322 22334568999999998752    234788999999999999999999999765543333221110   00     


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                         .......++.++.+||++||..||.+|||+.|+++||||
T Consensus       244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                               001122468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=306.72  Aligned_cols=260  Identities=27%  Similarity=0.461  Sum_probs=200.6

Q ss_pred             eeEe-eEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |++. +.||+|+|+.|--+....+|..||+|++.+.    +....+|++++..+ .|+||+.++++|     ++....|+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL  153 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL  153 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence            4443 5899999999999999999999999998654    34456899999988 599999999988     55555889


Q ss_pred             Eeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCCcee
Q 014156          167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKV  243 (429)
Q Consensus       167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~a~~  243 (429)
                      |||-|.|+ ++..+.    ....|++.++..+...|+.||.||| .+||.||||||+|||...-.  .-||||||.+..-
T Consensus       154 VfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH-~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLH-TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHh-hcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            99999865 333332    2477999999999999999999999 88999999999999985332  2599999998754


Q ss_pred             cccC--------CCccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH----------
Q 014156          244 LVKG--------EPNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD----------  301 (429)
Q Consensus       244 ~~~~--------~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------  301 (429)
                      +...        ....+.+|+..|||||+..    ....|+.++|.||||||+|.|+.|.+||.|....+          
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            3221        1234567888999999862    23458999999999999999999999998754321          


Q ss_pred             -HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          302 -QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       302 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                       -...++..+.             -..|.||.   ..|     ..+|.++++||+.+|..|+..|.++.++++|||++.+
T Consensus       309 ~CQ~~LFesIQ-------------EGkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  309 VCQNKLFESIQ-------------EGKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHHHHHHHh-------------ccCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence             1111111110             01233332   122     3479999999999999999999999999999999987


Q ss_pred             CCC
Q 014156          381 RDP  383 (429)
Q Consensus       381 ~~~  383 (429)
                      +..
T Consensus       368 ~~e  370 (463)
T KOG0607|consen  368 APE  370 (463)
T ss_pred             chh
Confidence            765

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.1e-41  Score=319.06  Aligned_cols=252  Identities=27%  Similarity=0.412  Sum_probs=201.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|+||+++++.+..     ....++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence            3699999999999999999999999999999987543    2344578999999999999999998753     235889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+.+ ++...+.     ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus        95 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH-~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~  167 (296)
T cd06654          95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (296)
T ss_pred             eecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCC-CEEECccccchhcc
Confidence            9999985 4544432     245889999999999999999999 88999999999999999877 79999999987653


Q ss_pred             cCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+... +.+.          
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~----------  235 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE----------  235 (296)
T ss_pred             ccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC----------
Confidence            322 1233568899999998865 44789999999999999999999999876654333222110 0000          


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                     ...+..++..+.+||.+||..||.+|||+.++++||||...+
T Consensus       236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             ---------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence                           011234688999999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-41  Score=343.13  Aligned_cols=280  Identities=21%  Similarity=0.279  Sum_probs=196.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCC-cEEEEE------------------Eeccc---hhhHHHHHHHHHHcCCCCee
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETG-ETVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVV  147 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~---~~~~~~E~~~l~~l~h~~iv  147 (429)
                      ..+|++++.||+|+||+||+|..+... ...+.|                  .+...   .....+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            357999999999999999998764322 222222                  11111   22345799999999999999


Q ss_pred             ccceeeeecCCCCceEEEEEeecchhhHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee
Q 014156          148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  226 (429)
Q Consensus       148 ~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill  226 (429)
                      ++++++...     .+.|+|++++.++++..+.... ..........++.++.||+.||.||| +.|||||||||+|||+
T Consensus       227 ~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH-~~gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH-DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEE
Confidence            999987432     3478899999887776554311 11223456678889999999999999 8899999999999999


Q ss_pred             cCCCCceEEeecCCceecccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCC--CChHH
Q 014156          227 NPHTHQVKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPG--ESGVD  301 (429)
Q Consensus       227 ~~~~~~vkl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~--~~~~~  301 (429)
                      +.++ .+||+|||+++.......  .....||..|+|||++.+. .++.++|||||||++|||++|..+ |.+  .....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9887 799999999987654322  2346799999999998764 489999999999999999998854 432  23345


Q ss_pred             HHHHHHHHhCCCCHHH-------HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          302 QLVEIIKVLGTPTREE-------IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ++.+++..++....+.       +....    ...+...............++.++.++|.+||++||.+|||+.|+|.|
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYID----SAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhh----hhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            5555555444332210       00000    000000000000000112367889999999999999999999999999


Q ss_pred             CCccccC
Q 014156          375 PFFDELR  381 (429)
Q Consensus       375 p~f~~~~  381 (429)
                      |||....
T Consensus       455 p~f~~~~  461 (501)
T PHA03210        455 PLFSAEE  461 (501)
T ss_pred             hhhhcCC
Confidence            9998744

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=318.84  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=201.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|.+.+.||.|+||.||+|.+..++..+|+|.+....    ....+|+.+++.++|+||+++++.+..     ....++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEEE
Confidence            46999999999999999999998899999999875432    234479999999999999999998843     335889


Q ss_pred             Eeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||++++ +.+.+.   .....+++..++.++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIML---ELERGLTEPQIRYVCRQMLEALNFLH-SHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence            99999874 433332   22356999999999999999999999 88999999999999999887 79999999986543


Q ss_pred             cC-CCcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          246 KG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      .. .......+|+.|+|||.+..    ...++.++|+|||||++|+|++|++||.+.+....+..+...  .+       
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------  225 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP-------  225 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC-------
Confidence            32 22234568999999998742    234678999999999999999999999876554443333211  00       


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                +.       ...+..++.++.+||.+||..||.+|||+.++++||||.+.
T Consensus       226 ----------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         226 ----------PT-------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             ----------CC-------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                      00       00123468899999999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.8e-41  Score=309.18  Aligned_cols=249  Identities=29%  Similarity=0.451  Sum_probs=203.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...      .....+|+.+++.++|||++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            489999999999999999999999999999987532      233457999999999999999998773     334588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ ++.+.+..  .....+++..+..++.|++.||.||| +.||+|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVH-TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999975 55555533  12345899999999999999999999 8899999999999999876657899999999877


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            555444456788999999998654 478899999999999999999999987765544443322100             


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                     ..++..+++++.++|.+||..||.+|||+.++++||||
T Consensus       219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                           01223478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.5e-41  Score=313.71  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=196.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .|.+.+.||+|+||.||+|.+..++..||+|.+...         .....+|+.+++.++||||+++++++...   ...
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence            589999999999999999999999999999987432         12345799999999999999999877432   234


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++++||+++ ++.+.+..    ...+++...+.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH-~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~  153 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence            57899999985 45444432    356889999999999999999999 88999999999999999877 7999999998


Q ss_pred             eecccCC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      .......    ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+...   +.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~---  226 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT---  226 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC---
Confidence            7653211    1123457889999999866 44889999999999999999999999766544333322110   00   


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                                           ...++..+++.+.+|| +||..+|.+|||+.|+++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                 0112234678899999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-43  Score=330.85  Aligned_cols=235  Identities=26%  Similarity=0.429  Sum_probs=198.7

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecch-hh
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ET  174 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~-~~  174 (429)
                      ++-||.|+.|.||+|+.  .++.||||+++.   ..+.+++-|+.|+||||+.+.+++     ....++|||||||. |-
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            46799999999999986  678999998753   334688899999999999999988     56667899999998 56


Q ss_pred             HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCccccc
Q 014156          175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI  254 (429)
Q Consensus       175 l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~  254 (429)
                      |+.+++.    .+.+.......|..+|+.|++||| .+.|||||||.-||||..+. .|||+|||-++.........+++
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH-~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLH-LHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHH-HhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence            6666543    677888999999999999999999 88999999999999999876 89999999999887777778899


Q ss_pred             ccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcC
Q 014156          255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  334 (429)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (429)
                      ||..|||||++.+ ...+.++|||||||+|||||||..||.+.+....+.                           ...
T Consensus       273 GTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw---------------------------GVG  324 (904)
T KOG4721|consen  273 GTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW---------------------------GVG  324 (904)
T ss_pred             hhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEE---------------------------ecc
Confidence            9999999999976 459999999999999999999999997665432211                           111


Q ss_pred             CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       335 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+.+....+..++..++=||+.||.-.|.+||++.++|.|
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            2223334456789999999999999999999999999998

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-41  Score=314.17  Aligned_cols=252  Identities=26%  Similarity=0.474  Sum_probs=198.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....          ....+|+++++.++|+||+++++++.     ..
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence            3788899999999999999999999999999885322          23457999999999999999999873     33


Q ss_pred             eEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ...++|+||+.+. +.+.+.    ....+++..+..++.||+.||.||| +.|++|+||||+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH-~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLH-ENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            3478999999864 444433    2457899999999999999999999 889999999999999987766799999999


Q ss_pred             ceecccCCC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          241 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       241 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +........     .....+|..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+......   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence            876643211     123467889999999865 45889999999999999999999999755433322222221000   


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                                           .....++..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                 000112334789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3e-41  Score=320.17  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=201.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|+||+++++++..     ..+.++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEEE
Confidence            4699999999999999999999999999999988532    2334578999999999999999998843     345889


Q ss_pred             Eeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||++++ +...+.     ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus        94 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH-~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~  166 (297)
T cd06656          94 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  166 (297)
T ss_pred             eecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEECcCccceEcc
Confidence            99999864 444332     256889999999999999999999 88999999999999999877 79999999987654


Q ss_pred             cCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.. .+.+           
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-----------  233 (297)
T cd06656         167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------  233 (297)
T ss_pred             CCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC-----------
Confidence            3322 223567889999999865 4588999999999999999999999976554332211110 0000           


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                    ....+..++..+.+||.+||..||.+|||+.++++||||+..+.
T Consensus       234 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         234 --------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             --------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence                          00112346889999999999999999999999999999987664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-42  Score=333.96  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=201.8

Q ss_pred             eEeeEEccCCcEEEEEEEEcCCCcEEEEEEec-----cc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        94 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-----~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +...+||+|+|-+||+|.|..+|..||--.++     +.   ...+..|+.+|+.|+|||||++|++|.+...   .++.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            34568999999999999999999999854332     22   2455679999999999999999999976543   4577


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+|++..+.++   .|....++++...++.|++||++||.|||+ ...|||||||.+||+|+.+.+.|||+|+|+|...
T Consensus       120 ~iTEL~TSGtLr---~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  120 FITELFTSGTLR---EYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeeecccCCcHH---HHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            899999854333   344456789999999999999999999995 3479999999999999998889999999999877


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..... ....|||.|||||++.  ..|+..+||||||++|+||+|+..||..-....++.+..-.. ..+..        
T Consensus       197 r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG-iKP~s--------  264 (632)
T KOG0584|consen  197 RKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG-IKPAA--------  264 (632)
T ss_pred             hcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC-CCHHH--------
Confidence            55443 3478999999999985  569999999999999999999999998766666655433221 11111        


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                       +.+--.+++++||.+||.. .++|+|+.|+|.||||+.
T Consensus       265 -----------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  265 -----------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             -----------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                             1111368999999999999 999999999999999986

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=315.17  Aligned_cols=249  Identities=27%  Similarity=0.403  Sum_probs=202.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||+++++++...     .++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEEE
Confidence            5889999999999999999999999999999875432     2345799999999999999999887433     45889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      |+||+.+ ++.+.+..     ..+++..++.++.|++.||.||| +.+++||||+|+||+++.++ .++|+|||+++...
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLH-EEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999986 44444332     37899999999999999999999 88999999999999999887 79999999998765


Q ss_pred             cC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .. .......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....              
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------  214 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--------------  214 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence            43 2233456788999999987654 8999999999999999999999997765433332222210              


Q ss_pred             CccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                           .+         .+... ++.++.++|.+||..||++|||+.++++||||.+..
T Consensus       215 -----~~---------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         215 -----PP---------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             -----CC---------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                 00         01112 688999999999999999999999999999998633

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.3e-41  Score=313.91  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=196.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++||||+++++.+...     ..+++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEEE
Confidence            3699999999999999999999999999999988532    23345799999999999999999887432     34789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ ++.+.+.    ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLH-SKGKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999986 4444432    2457899999999999999999999 88999999999999999887 79999999998664


Q ss_pred             cCC-CcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGE-PNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ... ......|+..|+|||.+.+  ...++.++|+||+||++|+|++|+.||...+.......+...             
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence            322 2234568899999998742  334678999999999999999999999654432221111110             


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  376 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  376 (429)
                       .   +..+..       .....++..+.+||++||..||++|||+.++++|+|
T Consensus       225 -~---~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 -N---FQPPKL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             -C---CCCCCC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence             0   000000       011246889999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-41  Score=313.17  Aligned_cols=246  Identities=30%  Similarity=0.504  Sum_probs=197.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------------hhHHHHHHHHHHcCCCCeeccceeeeecCC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  158 (429)
                      +|.+...||.|+||.||+|.+..+++.||+|.+....             ....+|+.+++.++||||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            3788899999999999999998899999999874321             234578999999999999999988743   


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                        ..+.++||||+++ ++...+.    ....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH-~~~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLH-NRGIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHH-hcCcccccCCHHHEEEcCCC-CEEecc
Confidence              3357899999976 4444443    2466899999999999999999999 88999999999999999887 799999


Q ss_pred             cCCceecccCC-------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014156          238 FGSAKVLVKGE-------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL  310 (429)
Q Consensus       238 FG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  310 (429)
                      ||.++......       ......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+....+..+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            99987664221       11234578889999998654 47889999999999999999999998765544433322210


Q ss_pred             CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                         .         ..++..++..+.++|++||+.||.+||++.++++||||
T Consensus       229 -------------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 -------------------S---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -------------------C---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                               0         01223478999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.2e-40  Score=306.90  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=200.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...      .....+|+++++.++||||+++++++..     ....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence            388899999999999999999999999999987532      2334478999999999999999988743     34588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+.+ ++.+.+...  ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||+++..
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH-~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLH-SKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            99999974 555554432  2457899999999999999999999 88999999999999999887 7999999998876


Q ss_pred             ccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..... .....|++.|+|||++.+. .++.++|+|||||++++|++|+.||...+.......+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------  217 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            44322 2334678899999998664 48899999999999999999999998776544443332210             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                            .+         .++..++..+.++|.+||+.+|++||++.++++|||+
T Consensus       218 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 ------FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                  00         1122468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-40  Score=311.07  Aligned_cols=247  Identities=28%  Similarity=0.457  Sum_probs=195.6

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.+....          ....+|+.+++.++|+||+++++++.     ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            488899999999999999986 578899999875321          23457999999999999999999873     33


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      .+.++|+||+.+ ++.+.+.    ....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLH-NNCVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHhEEECCCC-eEEeccchh
Confidence            468899999986 4444432    2356899999999999999999999 88999999999999999887 799999999


Q ss_pred             ceecccC-------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          241 AKVLVKG-------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       241 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      +......       .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....+. 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence            8754211       112235678899999998654 4889999999999999999999999776544433222211000 


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                               ...++..++.++.++|++||..+|.+|||+.++++||||
T Consensus       227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                     011234578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.4e-41  Score=313.24  Aligned_cols=251  Identities=26%  Similarity=0.381  Sum_probs=196.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ..++++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence            36999999999999999999999999999999875432    234578999999999999999988743     335789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ +|.+++.    ..+.+++..++.++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLH-SKGKMHRDIKGANILLTDNG-HVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence            9999985 5554443    2467999999999999999999999 88999999999999999877 79999999987654


Q ss_pred             cCC-Cccccccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGE-PNISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ... ......||..|+|||++.  ....++.++|+|||||++|+|++|..||................            
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~------------  225 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN------------  225 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC------------
Confidence            322 223457899999999874  23347889999999999999999999997654333222211100            


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  376 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  376 (429)
                           ...+..     .  ....++..+.+||.+||+.||++|||+.++++|||
T Consensus       226 -----~~~~~~-----~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         226 -----FQPPKL-----K--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -----CCCCcc-----c--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                 000000     0  01135788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.8e-41  Score=309.86  Aligned_cols=250  Identities=29%  Similarity=0.440  Sum_probs=200.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ++|.+.+.||.|+||.||+|.+..+++.||+|.+....  ....+|+++++.++|+||+++++++...     .++++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEEEE
Confidence            36999999999999999999998889999999886543  4456899999999999999999988443     4588999


Q ss_pred             ecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||++++ +.+.+.   .....+++..++.++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLH-SNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            999964 444332   23467899999999999999999999 88999999999999999887 7999999998776443


Q ss_pred             C-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      . ......++..|+|||++.+. .++.++||||+||++|+|++|+.||...+.......+...   .             
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~-------------  215 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P-------------  215 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C-------------
Confidence            3 22334578899999998664 5889999999999999999999999765543322211110   0             


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                         .+       ....+..++.++.++|.+||+.||.+|||+.++|.||||
T Consensus       216 ---~~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 ---PP-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ---CC-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence               00       001123467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-40  Score=308.65  Aligned_cols=248  Identities=34%  Similarity=0.527  Sum_probs=199.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|+..+.||+|+||.||+|.+..+++.|++|.+....         ....+|+.+++.++|+||+++++++.     ...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence            4778899999999999999998899999999875322         33457999999999999999998773     334


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++++||+++ ++.+.+.    ....+++..+..++.||+.||.||| +.||+|+||+|+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLH-DRNTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            57899999986 4444433    2456889999999999999999999 88999999999999999887 7999999998


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .............++..|+|||.+.....++.++|+|||||++|+|++|+.||...........+.....          
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  219 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE----------  219 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc----------
Confidence            7765444344566889999999886543478999999999999999999999976654333332221100          


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                              .         ..++..+++++.+|+.+||..+|.+|||+.+++.|||+
T Consensus       220 --------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         220 --------L---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             --------C---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                    0         01233478999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-40  Score=309.88  Aligned_cols=245  Identities=29%  Similarity=0.472  Sum_probs=197.0

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ||.|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++.+..     ...+++|+||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence            699999999999999899999999885421       334578999999999999999997743     33478999998


Q ss_pred             hh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc
Q 014156          172 PE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  250 (429)
Q Consensus       172 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~  250 (429)
                      ++ +|.+.+..    ...+++..+..++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH-~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLH-NRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            75 55444432    356899999999999999999999 78999999999999999887 7999999999876554334


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 014156          251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  328 (429)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....  ..+....+.....                 
T Consensus       150 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  211 (262)
T cd05572         150 WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-----------------  211 (262)
T ss_pred             ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence            44578899999998865 448899999999999999999999998765  3223322221000                 


Q ss_pred             cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 014156          329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  382 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  382 (429)
                                ...++...++++.++|.+||..||.+|+|     +.|+++||||+++.+
T Consensus       212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence                      01123345789999999999999999999     999999999998765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.8e-41  Score=317.94  Aligned_cols=256  Identities=29%  Similarity=0.408  Sum_probs=202.6

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .|.....||+|+||.||++.+..++..||||.+...    .....+|+.+++.++|+||+++++.+..     ..+.++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEE
Confidence            355567899999999999999999999999987532    2334579999999999999999988743     3357899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      |||++++.+..+..    .+.+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++......
T Consensus        98 ~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~  171 (292)
T cd06658          98 MEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLH-NQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccc
Confidence            99998754433221    246899999999999999999999 88999999999999999887 7999999998654322


Q ss_pred             C-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      . ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+.......             
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  237 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-------------  237 (292)
T ss_pred             cccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-------------
Confidence            2 2234568899999998865 448899999999999999999999998766555443332211000             


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                                   ......++..+.++|.+||..||++|||+.++++||||.....+..
T Consensus       238 -------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         238 -------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             -------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence                         0011236889999999999999999999999999999998776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-40  Score=307.64  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=203.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|.+.+.||.|+||.||+|.+..++..||+|.+...      ......|+.+++.++|+||+++++.+...   .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            488999999999999999999999999999987532      22344689999999999999998876542   234578


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ++|||+++ ++.+.+.........+++..++.++.||+.||.|||    .+.+|+|+||||+||+++.++ .+||+|||+
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~  156 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGL  156 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccc
Confidence            99999974 566666554444577999999999999999999999    134899999999999999877 799999999


Q ss_pred             ceecccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          241 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       241 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      +........ .....+++.|+|||.+.+. .++.++|+||||+++++|++|+.||...+.......+...          
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------  225 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG----------  225 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC----------
Confidence            987654433 3345789999999998664 4889999999999999999999999877643333222111          


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                               ..         ..++..++..+.+++.+||..+|.+|||+.++++|||+
T Consensus       226 ---------~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ---------KF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ---------CC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                     00         01233578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-40  Score=313.13  Aligned_cols=252  Identities=27%  Similarity=0.375  Sum_probs=197.8

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ||+|+||+||+|.+..+|+.||+|.+...       .....+|+.+++.++||||+++++.+.     .....|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence            68999999999999999999999987532       122346899999999999999988873     334578999999


Q ss_pred             hh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc
Q 014156          172 PE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  250 (429)
Q Consensus       172 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~  250 (429)
                      ++ +|.+.+..  .....+++..+..++.|++.||.||| +.|++||||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~--~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYN--VGEPGFPEARAIFYAAQIICGLEHLH-QRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHH--cCcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 44444432  12246899999999999999999999 88999999999999999887 7999999998765443333


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 014156          251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  330 (429)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...........+.....                   
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  211 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-------------------  211 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-------------------
Confidence            4456788899999986654 88999999999999999999999976554222111111100                   


Q ss_pred             CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCCCC
Q 014156          331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPNA  385 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~~  385 (429)
                            .....++..+++.+.++|.+||..||.+||     ++.++++||||.++.+...
T Consensus       212 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         212 ------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             ------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence                  000112344689999999999999999999     8999999999998887544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=307.92  Aligned_cols=253  Identities=27%  Similarity=0.387  Sum_probs=200.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|.+.+.||.|+||.||+|.+..+++.+|+|.+...    .....+|+.+++.++||||+++++++..     ...+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            3699999999999999999999989999999987643    2345679999999999999999988743     335889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      +|||++++.+.....  .....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++.....
T Consensus        78 ~~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  153 (262)
T cd06613          78 VMEYCGGGSLQDIYQ--VTRGPLSELQIAYVCRETLKGLAYLH-ETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTA  153 (262)
T ss_pred             EEeCCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCChhhEEECCCC-CEEECccccchhhhh
Confidence            999999654333221  22357899999999999999999999 88999999999999999877 799999999876543


Q ss_pred             CC-CcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GE-PNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .. ......++..|+|||.+.+.  ..++.++|+|||||++|+|++|.+||.+.+.......+....-.+.         
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  224 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP---------  224 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc---------
Confidence            22 22345678899999998653  2578899999999999999999999987765544433322100000         


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  376 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  376 (429)
                              .       .......+.++.+||++||..||.+|||+.+++.|+|
T Consensus       225 --------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 --------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             --------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                    0       0011235788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.3e-40  Score=308.67  Aligned_cols=249  Identities=29%  Similarity=0.463  Sum_probs=196.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|++.+.||+|+||.||+|.+..+++.||||.+..+         .....+|+.+++.+.||||+++++++...   ...
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---MER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CCc
Confidence            599999999999999999999999999999987421         12345799999999999999999876332   234


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      +++++|||+++ ++.+.+.    ....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~  153 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLH-SNMIVHRDIKGANILRDSVG-NVKLGDFGAS  153 (265)
T ss_pred             eEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEecCCC-CEEECcCccc
Confidence            57899999985 4544433    2356889999999999999999999 88999999999999999877 7999999998


Q ss_pred             eecccC----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ......    .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..........++..   .+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~---  226 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT---  226 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence            754321    11223457889999999865 4488999999999999999999999976654443332211   110   


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                                           ....+..++..+.++|++||. +|.+|||+.++++|||+.
T Consensus       227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                 011233467889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.9e-40  Score=312.33  Aligned_cols=240  Identities=17%  Similarity=0.204  Sum_probs=191.1

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      ..||+|++|.||+|..  +|+.||+|.+....       ....+|+.++++++||||+++++++.... ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5799999999999987  78999999886431       33448999999999999999999875522 22345789999


Q ss_pred             cchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      |++++ |.+.+.    ..+.+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++..... 
T Consensus       103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP-  176 (283)
T ss_pred             eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc-
Confidence            99965 444443    2457889999999999999999999435999999999999999887 7999999998765332 


Q ss_pred             CcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          249 PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                       .....||..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+......+              
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  241 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------  241 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence             2345688999999998642 458999999999999999999999998877655554443321110              


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                   .++...++++.+||.+||+.||++|||+.++++
T Consensus       242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                         122246889999999999999999999999985

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-40  Score=309.29  Aligned_cols=246  Identities=28%  Similarity=0.449  Sum_probs=200.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+.+.       .....+|+++++.++||||+++++++     ......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            489999999999999999999999999999988543       23345789999999999999999887     344458


Q ss_pred             EEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++|+||+.++ +...+..    ...+++..+..++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLH-SKGIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            8999999864 3333322    357899999999999999999999 88999999999999999887 799999999877


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhc
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...........|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..  ..+......            
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence            65443444566888999999986544 899999999999999999999999876642  222111110            


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH--HHHhcCCCc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA--LEACIHPFF  377 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~--~e~l~hp~f  377 (429)
                                      ....++..++.++.++|.+||..||.+|+++  .|+++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0112334568999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-40  Score=312.13  Aligned_cols=249  Identities=25%  Similarity=0.359  Sum_probs=189.6

Q ss_pred             EEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHH---HcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMR---LLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~---~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .||+|+||.||++.+..+++.+|+|.+....       ....+|..+++   ...||||+.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999875421       11223433333   3479999999887743     2347899


Q ss_pred             eecchhhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+.++.+ ..+    .....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999986533 332    23467999999999999999999999 88999999999999999887 799999999875533


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .. .....||..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------  212 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------  212 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence            32 234568999999998865455889999999999999999999999754322111 1111000               


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDPN  384 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  384 (429)
                                .....++..+++++.++|.+||..||.+|+     |+.++++||||+.+....
T Consensus       213 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         213 ----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             ----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence                      001113345789999999999999999999     699999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.6e-40  Score=305.60  Aligned_cols=248  Identities=27%  Similarity=0.442  Sum_probs=200.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||++++..+|+.||+|.+...      .....+|+.+++.++||||+++++++     ....+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            489999999999999999999999999999987532      22445799999999999999999887     3344688


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+||+.+ ++.+.+..  .....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999975 55554432  12346789999999999999999999 88999999999999999877 7999999999766


Q ss_pred             ccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..... .....|++.|+|||.+.+. .++.++|+|||||++++|++|..||...+..+....+....  .          
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------  218 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--Y----------  218 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--C----------
Confidence            44322 1234578889999998664 48889999999999999999999998766655544443210  0          


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                      ...+..++.++.++|.+||..+|.+||++.++++||||
T Consensus       219 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 ----------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ----------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                            01223468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-40  Score=310.50  Aligned_cols=264  Identities=25%  Similarity=0.394  Sum_probs=200.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|...+.||.|++|.||+|.+..+++.+|+|.+...     .....+|+++++.++||||++++++|...   ....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            589999999999999999999999999999988643     22345799999999999999999887543   2234789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ +|.+++.........+++..+..++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH-~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH-SRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999975 555555444444567899999999999999999999 88999999999999999887 79999999987654


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... ....+............       
T Consensus       157 ~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  227 (287)
T cd06621         157 NSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE-------  227 (287)
T ss_pred             cccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh-------
Confidence            3222 23457888999998865 45889999999999999999999999765220 00011111110000000       


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                           .+...      ......++.+.+||.+||..||++|||+.|++.||||+..
T Consensus       228 -----~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         228 -----LKDEP------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             -----hccCC------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence                 00000      0001246789999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-40  Score=309.68  Aligned_cols=252  Identities=28%  Similarity=0.517  Sum_probs=198.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....     ....+|+++++.++||||+++++.+...     ...++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEEE
Confidence            5888899999999999999999999999999875432     2345789999999999999999887443     45889


Q ss_pred             Eeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||++ ++|.+++..   ....+++..+..++.|++.||+||| + .|++|+||||+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~  151 (265)
T cd06605          77 CMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQL  151 (265)
T ss_pred             EEEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHc-CCCCeecCCCCHHHEEECCCC-CEEEeecccchhh
Confidence            999999 555554433   2267899999999999999999999 6 8999999999999999877 7999999998765


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-HhCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIK-VLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~-~~~~~~~~~~~~~~  322 (429)
                      ...... ...++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+. ........+ ....+.        
T Consensus       152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  221 (265)
T cd06605         152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--------  221 (265)
T ss_pred             HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--------
Confidence            433222 26788899999998664 589999999999999999999999965421 111111111 110000        


Q ss_pred             CCCccccCCCcCCCCcccccCC-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                              +.         .+. .++.++.++|.+||..||.+|||+.+++.||||+.+
T Consensus       222 --------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 --------PR---------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             --------CC---------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                    00         111 168899999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4e-40  Score=308.22  Aligned_cols=252  Identities=31%  Similarity=0.521  Sum_probs=196.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--------------hhhHHHHHHHHHHcCCCCeeccceeeeecC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  157 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  157 (429)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+...              .....+|+.+++.++|+|++++++++..  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence            589999999999999999999889999999987421              1123568999999999999999987733  


Q ss_pred             CCCceEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          158 DKDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                         ....++||||+.++ +.+.+.    ....+++..++.++.||+.||.||| +.|++||||||+||+++.++ .++|+
T Consensus        80 ---~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          80 ---EEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAYLH-SKGILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             ---CCceEEEEecCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHh-hCCeeecCCChhhEEEcCCC-eEEEe
Confidence               33578999999754 444433    2367899999999999999999999 88999999999999999887 79999


Q ss_pred             ecCCceecccCC---CcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014156          237 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       237 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      |||+++......   ......|+..|+|||.+.+.. .++.++|+||||+++|+|++|..||...+....+..+..... 
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  229 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-  229 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-
Confidence            999987653221   122346788999999886543 478899999999999999999999976554433322211100 


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                            ...+.......++.++.++|.+||..+|.+|||+.++|+||||
T Consensus       230 ----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 ----------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----------------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                  0000111223468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.3e-40  Score=303.57  Aligned_cols=248  Identities=32%  Similarity=0.480  Sum_probs=202.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||.|+||.||.+++..+++.+++|.+...      .....+|+.+++.++|+||+++++++..     ...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            489999999999999999999999999999987532      1234579999999999999999998843     34588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|||+++ ++.+.+...  ....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIH-KAGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999985 555554331  1356899999999999999999999 88999999999999999887 7999999999766


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+..+....+...  ...         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence            4433 233456899999999986644 788999999999999999999999877665555544321  000         


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                       .....++.++.++|.+||..+|.+|||+.++++|||+
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                             0113468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.9e-40  Score=313.04  Aligned_cols=253  Identities=29%  Similarity=0.472  Sum_probs=199.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+....       ....+|+.+++.++||||+++++.+.     ...++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCEE
Confidence            5899999999999999999999999999999875432       23347889999999999999998873     33468


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ ++...+.    ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLH-NYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            899999986 4444443    2456899999999999999999999 88999999999999999877 799999999864


Q ss_pred             cccCC----------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014156          244 LVKGE----------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII  307 (429)
Q Consensus       244 ~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  307 (429)
                      .....                ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21110                0112356888999999865 448999999999999999999999998776554444333


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCccccCC
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDELRD  382 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~  382 (429)
                      ....                 ..+.         ....++.++.++|.+||..||.+|||   +.++|+||||...++
T Consensus       230 ~~~~-----------------~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         230 SDDI-----------------EWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             hccc-----------------CCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            2100                 0000         01236889999999999999999998   799999999977554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=326.25  Aligned_cols=244  Identities=31%  Similarity=0.471  Sum_probs=198.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ...|.+...+|.|+|+.|..+.+..+++.+++|++.+......+|+.++... +||||+++.+.+     .+....|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeeee
Confidence            4579999999999999999999999999999999987766666788666554 799999999988     5566689999


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee-cCCCCceEEeecCCceecccC
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill-~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      |.+.|+.+  +.. ... .+.....+..|++||+.|+.||| .+|+|||||||+|||+ +..+ .++|+|||.++.....
T Consensus       396 e~l~g~el--l~r-i~~-~~~~~~e~~~w~~~lv~Av~~LH-~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGEL--LRR-IRS-KPEFCSEASQWAAELVSAVDYLH-EQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHH--HHH-HHh-cchhHHHHHHHHHHHHHHHHHHH-hcCeeecCCChhheeecCCCC-cEEEEEechhhhCchh
Confidence            99997532  222 122 33333778889999999999999 7999999999999999 4665 6999999999876443


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                        ..+.+-|..|.|||++. ...|+.++||||||++||+|++|+.||......   .++...++.+.             
T Consensus       470 --~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~-------------  530 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK-------------  530 (612)
T ss_pred             --hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-------------
Confidence              33446688899999997 456999999999999999999999999876554   23333333222             


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                    +...+|.++++||++||++||.+|+++.+++.||||
T Consensus       531 --------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 --------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                          113489999999999999999999999999999999

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=302.97  Aligned_cols=283  Identities=34%  Similarity=0.554  Sum_probs=221.6

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      -+-.+-||-|+||.||.+.+..+|+.||+|++..-      .....+|+++|..++|.|++...++.--..-.--.-+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34447899999999999999999999999987432      334458999999999999998877542111000001466


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ++|++..+|..++-    ..+.++...++.+++||++||.||| +.||.||||||.|+|++++. .+||||||+|+....
T Consensus       135 ~TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLH-sA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLH-TANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHh-hcchhhccCCCccEEeccCc-eEEecccccccccch
Confidence            88888877665543    3678999999999999999999999 88999999999999999998 899999999987654


Q ss_pred             CC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          247 GE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .+  ..+..+.|.+|+|||++.|...|+.++||||+|||+.||+..+..|...+..+++..|...+|.|+.+.+...-.+
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            33  3445567999999999999999999999999999999999999999999999999999999999999876543322


Q ss_pred             CccccCCCcCCCCcccc---c--CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          325 YTEFKFPQIKAHPWHKI---F--HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~---~--~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ...-.+..-.+.+.-..   +  +..-..+..+++.+||.+||.+|++..+++.|++..+.|
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            21111111000000000   1  112345788999999999999999999999999998865

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.4e-40  Score=304.20  Aligned_cols=250  Identities=33%  Similarity=0.521  Sum_probs=202.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++.+.||.|++|.||+|.+..+++.||+|++...     .....+|+..+..++|+|++++++++..     ...+++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEE
Confidence            588999999999999999999999999999988654     2345679999999999999999998843     345889


Q ss_pred             Eeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ||||++ +++.+.+..    ...+++..+..++.|++.||.||| + .|++||||+|+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh-~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~  150 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVL  150 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh-ccCCCccCCCCHHHEEECCCC-CEEEccCccceec
Confidence            999999 555554432    367899999999999999999999 7 8999999999999999887 7999999999876


Q ss_pred             ccCCCcc-cccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHhh
Q 014156          245 VKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       245 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....   .+....+..   ...      
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~------  220 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP------  220 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC------
Confidence            5443332 45678899999998654 588999999999999999999999977642   222222111   000      


Q ss_pred             cCCCCccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                         ..+... ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus       221 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 -------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             -------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                               011223 688999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6e-40  Score=312.69  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=201.3

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++....     ..
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~~   90 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----TA   90 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----eE
Confidence            5999999999999999999999899999999875321       23457899999999999999999885432     37


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|+||+.+++.+.+..   ....+++..+..++.||+.||.||| +.||+||||+|+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH-~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~  165 (307)
T cd06607          91 WLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLH-SHERIHRDIKAGNILLTEPG-TVKLADFGSASLV  165 (307)
T ss_pred             EEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEECCCC-CEEEeecCcceec
Confidence            89999999887766542   2356899999999999999999999 88999999999999999887 7999999998765


Q ss_pred             ccCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ...   ....++..|+|||++.+  ...++.++||||||+++|+|++|..||.+.+.......+...  .+         
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~---------  231 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS---------  231 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC---------
Confidence            322   24567889999998742  345788999999999999999999999876654443332210  00         


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                              +..        .....+..+.++|.+||..||.+|||+.+++.||||..-.
T Consensus       232 --------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         232 --------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             --------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                    000        0112578899999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.7e-40  Score=309.00  Aligned_cols=249  Identities=26%  Similarity=0.359  Sum_probs=190.6

Q ss_pred             EEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHH---HHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNREL---QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~---~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .||+|+||.||+|.+..+++.||+|.+....       .....|.   ..++...||||+++++++.     .....++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence            4899999999999999999999999875421       1112233   3444568999999988773     33458899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      |||+.++.+...   ......+++..++.++.|++.||.||| +.+|+||||||+||+++.++ .++|+|||++......
T Consensus        76 ~e~~~g~~L~~~---l~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~  150 (278)
T cd05606          76 LDLMNGGDLHYH---LSQHGVFSEAEMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK  150 (278)
T ss_pred             EecCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc
Confidence            999986543322   123467999999999999999999999 78999999999999999887 7999999998755332


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                       ......|+..|+|||.+.+...++.++||||+||++|+|++|+.||.+...............                
T Consensus       151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  213 (278)
T cd05606         151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----------------  213 (278)
T ss_pred             -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----------------
Confidence             223457899999999987555588999999999999999999999976532211110000000                


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                                ....++..++.++.++|.+||..||.+|+     ++.++++||||+...+.
T Consensus       214 ----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         214 ----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             ----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence                      00112334689999999999999999999     99999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.4e-40  Score=322.53  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=189.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|.+.+.||+|+||.||+|++..+     +..||+|.+....     ....+|+.+++.+ +|+||+++++++..   
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~---  113 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH---  113 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence            34799999999999999999986544     3579999886432     2345799999999 89999999998743   


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhh-----------------------------------------------------
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSR-----------------------------------------------------  184 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  184 (429)
                        ...+++||||+.+ +|.+.+.....                                                     
T Consensus       114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence              3347899999984 55554432110                                                     


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc-
Q 014156          185 -------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-  250 (429)
Q Consensus       185 -------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~-  250 (429)
                                   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA-SKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                         1134788889999999999999999 88999999999999999776 7999999999765433221 


Q ss_pred             --ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          251 --ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       251 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                        ....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+........                
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~----------------  332 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY----------------  332 (374)
T ss_pred             eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc----------------
Confidence              122345679999998654 48999999999999999997 9999987554333333322100                


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                 ....+..+++++.++|.+||+.||.+|||+.++++
T Consensus       333 -----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 -----------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -----------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       00112236899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.2e-40  Score=313.12  Aligned_cols=256  Identities=29%  Similarity=0.426  Sum_probs=202.1

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      |.....||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++||||+++++++..     ....++|+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence            44556899999999999999989999999987432    2334578999999999999999998743     33478999


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      ||++++.+..+.    ....+++..++.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.......
T Consensus        98 e~~~~~~L~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          98 EFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLH-SQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDV  171 (297)
T ss_pred             ecCCCCCHHHHH----hhcCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHeEEccCC-cEEEeechhHhhccccc
Confidence            999865333222    1256899999999999999999999 88999999999999999887 79999999986543322


Q ss_pred             -CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          249 -PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                       ......|+..|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+.+..+...   +..            
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~------------  235 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP------------  235 (297)
T ss_pred             ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC------------
Confidence             22345689999999998654 4899999999999999999999999876655544332211   000            


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                                 .......++..+.++|.+||+.+|.+|||+.++++||||.+...+.+.
T Consensus       236 -----------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~  283 (297)
T cd06659         236 -----------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECL  283 (297)
T ss_pred             -----------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcccc
Confidence                       000122468899999999999999999999999999999987665553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.5e-40  Score=312.53  Aligned_cols=253  Identities=19%  Similarity=0.256  Sum_probs=189.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC----------------CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeecc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  149 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l  149 (429)
                      .+|++.+.||+|+||.||+|.+..                ++..||+|.+....     ....+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            469999999999999999998532                34479999875431     234579999999999999999


Q ss_pred             ceeeeecCCCCceEEEEEeecchh-hHHHHHHHhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 014156          150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSR---------------ASQRMPLIYVKLYTYQICRALAYIHGGIG  213 (429)
Q Consensus       150 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~  213 (429)
                      ++++...     ...++||||+.+ ++.+.+.....               ....+++..+..++.||+.||.||| +.|
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~  158 (304)
T cd05096          85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS-SLN  158 (304)
T ss_pred             EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH-HCC
Confidence            9988443     237899999975 55555533211               1134677889999999999999999 889


Q ss_pred             eeecCCCCCCeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-
Q 014156          214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-  289 (429)
Q Consensus       214 iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-  289 (429)
                      |+||||||+|||++.++ .+||+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|+|++ 
T Consensus       159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHc
Confidence            99999999999999887 799999999976543322   1223457789999998654 48999999999999999987 


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH
Q 014156          290 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA  368 (429)
Q Consensus       290 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  368 (429)
                       +..||.+.+..+.+..+..........                     .....+..++..+.+||.+||..||.+|||+
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence             567887766555444433221000000                     0001123468899999999999999999999


Q ss_pred             HHHh
Q 014156          369 LEAC  372 (429)
Q Consensus       369 ~e~l  372 (429)
                      .++.
T Consensus       296 ~~i~  299 (304)
T cd05096         296 SDIH  299 (304)
T ss_pred             HHHH
Confidence            9985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-39  Score=304.13  Aligned_cols=247  Identities=28%  Similarity=0.458  Sum_probs=190.7

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ...||+|+||.||+|.+..++..||+|.+...    .....+|+.+++.++|+||+++++++..     ..+.++|+||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEecC
Confidence            35799999999999999999999999987543    2345689999999999999999988733     34588999999


Q ss_pred             hh-hHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          172 PE-TVYRVAKHYSRASQRM--PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       172 ~~-~l~~~~~~~~~~~~~l--~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      .+ +|...+..   ....+  ++..+..++.||+.||.||| +.||+||||||+||+++.+...++|+|||++.......
T Consensus        88 ~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          88 PGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLH-DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             CCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            85 55444432   12334  78888999999999999999 88999999999999998744589999999987654322


Q ss_pred             C-cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          249 P-NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       249 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      . .....|+..|+|||.+.+. ..++.++|+||+|+++|+|++|+.||................                
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~----------------  227 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF----------------  227 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh----------------
Confidence            2 2234578899999988543 347889999999999999999999996543221111000000                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                .....++..+++++.+|+.+||..+|.+|||+.+++.||||
T Consensus       228 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 ----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                      00111334578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=305.03  Aligned_cols=246  Identities=33%  Similarity=0.507  Sum_probs=191.5

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHH-HHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||.|+||.||+|.+..+++.||+|.+.....       ....|..+ ...++|+|++++++++.     .....++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            569999999999999999999999998854321       11233333 34558999999998883     333588999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+++ +|..++.    ....+++..+..++.||+.||.||| +.||+||||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLH-QRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99986 4444432    2457899999999999999999999 78999999999999999877 799999999876433 


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                        .....++..|+|||.+.+.. ++.++||||+|+++|+|++|..||...+.......+....            ..   
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~---  211 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR------------IN---  211 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc------------cC---
Confidence              23346788899999987654 8899999999999999999999998776654443332210            00   


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCccccCC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDELRD  382 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~  382 (429)
                                +.......+++++.++|.+||+.||++|||   +.|++.||||+++.+
T Consensus       212 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         212 ----------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ----------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                      001112247899999999999999999995   579999999988765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.4e-40  Score=311.34  Aligned_cols=258  Identities=25%  Similarity=0.382  Sum_probs=198.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.++..+ .|+||+++++++..     ..
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~   87 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DS   87 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CC
Confidence            3457999999999999999999999889999999886421     1223466555555 59999999998843     33


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ..+++|||+++.+..+...   ....+++..+..++.||+.||.|||+..||+||||+|+||+++.++ .+||+|||++.
T Consensus        88 ~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~  163 (296)
T cd06618          88 DVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG  163 (296)
T ss_pred             eEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence            5889999998876665543   2347899999999999999999999436999999999999999877 79999999987


Q ss_pred             ecccCCCcccccccccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGA---TEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  318 (429)
                      ............++..|+|||.+.+.   ..++.++||||||+++|+|++|+.||...... +.+..+....        
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------  235 (296)
T cd06618         164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--------  235 (296)
T ss_pred             hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--------
Confidence            66544433445678889999998643   23788999999999999999999999653322 2222221110        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                 .+...       ....++.++.+||.+||..||.+|||+.++++||||....
T Consensus       236 -----------~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         236 -----------PPSLP-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             -----------CCCCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence                       00000       0113678999999999999999999999999999998644

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9e-40  Score=302.90  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=199.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|.+.+.||+|+||.||+|.+..+|..+|+|.+...      .....+|+.+++.++|+||+++++.+.     .....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence            488999999999999999999999999999987532      234457999999999999999998873     334588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+||+.+ ++.+.+..  .....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIH-DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999975 55444432  22335789999999999999999999 7899999999999999987656799999998766


Q ss_pred             ccCCCc-ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...... ....|++.|+|||.+.+. .++.++|+|||||++++|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            433222 234578899999988654 48899999999999999999999998766544443322110             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                            .         ......++.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  0         01123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.8e-40  Score=304.99  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=189.8

Q ss_pred             ceeEeeEE--ccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           92 SYMAERVV--GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        92 ~y~~~~~l--G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      .|.+.+.+  |+|+||.||++.+..++..+|+|.+..... ...|+.....+ +|+||++++++|...     ...++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~~-----~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTL-----KGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEecC-----CeeEEEE
Confidence            46666665  999999999999999999999998754321 11233333323 799999999988443     3588999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+++ +|.+.+..    ...+++..++.++.||+.||.||| +.|++||||||+||+++.++..++|+|||++......
T Consensus        89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            99974 55555432    347999999999999999999999 8899999999999999987657999999998765332


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                         ....++..|+|||++.+. .++.++|+||+||++|+|++|..||........ ..........              
T Consensus       164 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  225 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK--------------  225 (267)
T ss_pred             ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------
Confidence               234678999999998654 488999999999999999999999975543221 1111111000              


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCCccc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEACIHPFFDE  379 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-~~e~l~hp~f~~  379 (429)
                                  .....+.+++.+.+||.+||+.||.+|++ +.++|+||||++
T Consensus       226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                        00112347899999999999999999996 599999999974

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-40  Score=312.57  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=198.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .|+..+.||+|+||.||+|.+..++..||+|.+....     ....+|+.+++.++||||+++++++..     ....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEE
Confidence            4788899999999999999999999999999875322     234579999999999999999998843     335889


Q ss_pred             Eeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||++++ +.+.+.     ...+++..++.++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH-~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLH-SERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHh-cCCeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence            99999864 333332     356899999999999999999999 88999999999999999877 79999999987654


Q ss_pred             cCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+...               
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  216 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------  216 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence            3321 2234578899999998654 5889999999999999999999999755433322211110               


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                   ....+...++.++.++|.+||..+|.+|||+.++++||||..+.
T Consensus       217 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 -------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             -------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                         00012234678999999999999999999999999999998755

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-40  Score=310.06  Aligned_cols=259  Identities=28%  Similarity=0.419  Sum_probs=198.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||+||++.+..+|+.||+|++...     .....+|+++++.++||||+++++++..     ...++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence            4699999999999999999999999999999987533     2334579999999999999999998843     34588


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||++++.+...   ....+.+++..++.++.|++.||.|||+..||+||||||+||+++.++ .++|+|||++....
T Consensus        80 lv~e~~~~~~L~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~  155 (284)
T cd06620          80 MCMEFMDCGSLDRI---YKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELI  155 (284)
T ss_pred             EEEecCCCCCHHHH---HHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchh
Confidence            99999986543322   122457899999999999999999999446999999999999999877 79999999986543


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHhhc
Q 014156          246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ----LVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  321 (429)
                      ... .....||..|+|||++.+. .++.++|+|||||++|+|++|..||........    ...+....    ...+.. 
T Consensus       156 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~-  228 (284)
T cd06620         156 NSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL----QQIVQE-  228 (284)
T ss_pred             hhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH----HHHhhc-
Confidence            222 2345789999999998654 588999999999999999999999986543211    01110000    000000 


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                             ..+.+        ....++.++.+||.+||..||.+|||+.|+++|+||.+-
T Consensus       229 -------~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 -------PPPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             -------cCCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                   00000        001267889999999999999999999999999999663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.2e-39  Score=309.70  Aligned_cols=249  Identities=29%  Similarity=0.435  Sum_probs=201.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|...+.||+|+||.||+|++..++..||+|.+....       ....+|+.+++.++|||++++++++..     ....
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence            3777788999999999999999999999999875321       234578999999999999999998844     3347


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+.+++...+..   ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        97 ~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPG-QVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChhhEEECCCC-CEEEeecCCCccc
Confidence            89999999887766543   3456899999999999999999999 88999999999999999877 7999999998643


Q ss_pred             ccCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .   ......|+..|+|||.+..  ...++.++|+|||||++|+|++|..||...+.......+.... .          
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~----------  237 (313)
T cd06633         172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S----------  237 (313)
T ss_pred             C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C----------
Confidence            2   2234578889999998742  2447889999999999999999999998776655554433210 0          


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                              +.        .....++..+.+||.+||+.+|.+|||+.++++||||+..
T Consensus       238 --------~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         238 --------PT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             --------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                    00        0112357789999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=307.04  Aligned_cols=251  Identities=28%  Similarity=0.474  Sum_probs=198.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcC---CCCeeccceeeeecCCCCceE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   |||++++++++..     ..+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence            388889999999999999999999999999987532     233457888998886   9999999998743     335


Q ss_pred             EEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .++||||+.++ +.+++.     ...+++..+..++.|++.||.||| +.||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIH-KVGVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            78999999764 443332     247899999999999999999999 88999999999999999876 79999999998


Q ss_pred             ecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...... ......|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------  217 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------  217 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence            765433 2234568889999999876566789999999999999999999999765433222111000            


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                             ..+.+        ....++.++.++|.+||..||.+|||+.+++.||||++..
T Consensus       218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                   00000        0112678999999999999999999999999999997754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.5e-40  Score=308.28  Aligned_cols=249  Identities=25%  Similarity=0.377  Sum_probs=199.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .|+..+.||.|+||.||+|.+..++..||+|.+....     ....+|+.+++.++|+||+++++++..     ..+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEEE
Confidence            4888999999999999999999999999999875332     234578999999999999999998843     345899


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ ++.+.+.     ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh-~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLH-SEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999986 4444332     256889999999999999999999 88999999999999999877 79999999997664


Q ss_pred             cCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+...  .            
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------  217 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--N------------  217 (277)
T ss_pred             CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--C------------
Confidence            3332 2234578889999998654 4889999999999999999999999766543332221110  0            


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                    ...+...++..+.+||.+||..+|.+|||+.++++||||....
T Consensus       218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         218 --------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             --------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                          0112234678899999999999999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.5e-39  Score=299.57  Aligned_cols=250  Identities=30%  Similarity=0.494  Sum_probs=202.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|.+.+.||+|+||.||++.+..+++.||+|++...      .....+|+++++.++|+|++++++.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            489999999999999999999989999999988543      23345799999999999999999887433     4588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+||+++ ++...+.........+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-SRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 565555443323477999999999999999999999 78999999999999999876 7999999998776


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......|++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            4443 22345678899999988654 48899999999999999999999997766443333322110             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                            .+         .++..++..+.+++.+||..+|.+|||+.++|+||||
T Consensus       220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                  00         1222468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.3e-40  Score=317.43  Aligned_cols=278  Identities=22%  Similarity=0.307  Sum_probs=195.8

Q ss_pred             eEEccC--CcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ..||+|  +||+||+|++..+|+.||+|++....      ....+|+.+++.++||||++++++|..     ..+.++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence            356666  99999999999999999999875322      334578888999999999999998843     33578999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+.+ ++..++....  ...+++..+..++.||+.||+||| +.||+||||||+|||++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLH-QNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99985 5555544321  345899999999999999999999 88999999999999999887 7999999865332211


Q ss_pred             CCc--------ccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 014156          248 EPN--------ISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  316 (429)
Q Consensus       248 ~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--  316 (429)
                      ...        ....++..|+|||++.+. ..++.++||||+||++|+|++|.+||.+....................  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            110        112345669999998653 347899999999999999999999998776555444433221110000  


Q ss_pred             -------HHhhcCCCCc----cccC-----CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          317 -------EIKCMNPNYT----EFKF-----PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       317 -------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                             .+......+.    ....     .......+.......+++.+.+||++||++||.+|||+.++|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                   0000000000    0000     00000111111223467889999999999999999999999999999887


Q ss_pred             CCC
Q 014156          381 RDP  383 (429)
Q Consensus       381 ~~~  383 (429)
                      ...
T Consensus       315 ~~~  317 (328)
T cd08226         315 KEQ  317 (328)
T ss_pred             HHh
Confidence            664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-39  Score=301.60  Aligned_cols=245  Identities=27%  Similarity=0.431  Sum_probs=196.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|++.+.||.|+||.||++.+..+++.||+|.+...     .....+|+.+++.++|+||+++++++.     ...++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence            488999999999999999999999999999987432     233457889999999999999999873     3345889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ ++...+..  .....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIH-EKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999985 45554432  22456899999999999999999999 88999999999999999877 79999999987664


Q ss_pred             cCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ... ......|++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.....             
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  217 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-------------  217 (255)
T ss_pred             ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-------------
Confidence            322 22345688899999998654 489999999999999999999999987665544443322100             


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                     ..++..++..+.+||.+||..||.+|||+.+++.-
T Consensus       218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                           01123468899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-39  Score=318.93  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=189.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEE-----cCCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      .+|++.+.||+|+||.||+|++     ..++..||+|++....     ....+|+.++..+ +||||+++++++..    
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~----  110 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV----  110 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc----
Confidence            4799999999999999999974     3456789999885322     2345799999999 89999999998733    


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhh-------------------------------------------------------
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYS-------------------------------------------------------  183 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~-------------------------------------------------------  183 (429)
                       ....++||||+++ +|.+.+....                                                       
T Consensus       111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence             3347899999984 5555543211                                                       


Q ss_pred             ----------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          184 ----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       184 ----------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                                      .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~  267 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA-SKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRND  267 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCchhhEEEECCC-cEEEecCccceeccCc
Confidence                            01124788889999999999999999 88999999999999999776 7999999999765433


Q ss_pred             CCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          248 EPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       248 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...   ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+........+.......           
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  335 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-----------  335 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc-----------
Confidence            221   122345679999998664 48999999999999999998 88999776544433333221000           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                      ...+...+.++.+||.+||..||++|||+.++++.
T Consensus       336 ----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 ----------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                            00112357899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-39  Score=308.35  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=200.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ..+|.+.+.||+|+||.||++.+..++..||+|.+...    .....+|+.+++.++||||+++++.+...     ...+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence            35799999999999999999999889999999987532    23345788999999999999999988443     3478


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+||+.+ ++.+.+.     ...+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH-~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHH-hCCEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999985 4444332     245788999999999999999999 88999999999999999877 7999999998655


Q ss_pred             ccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+....+..+.. .+.+          
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~----------  233 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP----------  233 (293)
T ss_pred             cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC----------
Confidence            43322 2334678899999998654 488999999999999999999999977654333222111 0000          


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                              .       ...+..++..+.++|++||..+|.+||++.+++.||||+..+.
T Consensus       234 --------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         234 --------E-------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             --------C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                    0       0012236788999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-39  Score=303.87  Aligned_cols=245  Identities=20%  Similarity=0.213  Sum_probs=190.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|++.+.||+|+||.||+|.+.   ..+..||+|.+....     ....+|+.+++.++||||+++++++..     ..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----GN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CC
Confidence            46999999999999999999865   346789999876432     234579999999999999999988743     23


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ..++||||++++.+.....  .....+++..++.++.||+.||+||| +.|++||||||+|||++.++ .++++|||.+.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~i~~al~~lH-~~~iiH~dikp~nili~~~~-~~~l~dfg~~~  155 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQ  155 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeeccccHhhEEEcCCC-cEEECCCcccc
Confidence            4789999999754443222  22357899999999999999999999 88999999999999999887 79999999876


Q ss_pred             ecccCCCcc--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          243 VLVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       243 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      .........  ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--------  226 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--------  226 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------
Confidence            542221111  2234678999998865 458999999999999999775 9999987766554443322100        


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                          ...+..++..+.+++.+||..+|.+|||+.++++
T Consensus       227 --------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 --------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                0112347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=300.21  Aligned_cols=248  Identities=27%  Similarity=0.460  Sum_probs=197.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...         .....+|+++++.++|+||+++++++...   ...
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence            599999999999999999999999999999987421         12345799999999999999999876432   223


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++++||+++ ++.+.+.    ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~  153 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEECccccc
Confidence            47789999975 4444433    2356889999999999999999999 88999999999999999877 7999999999


Q ss_pred             eecccC----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      +.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++..   .+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~---  226 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT---  226 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC---
Confidence            765321    112235678899999998664 488999999999999999999999987655444333221   111   


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                           ...++..+++.+.++|.+||. +|..|||+.+++.|||.
T Consensus       227 ---------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ---------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ---------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                 112345678999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.4e-39  Score=304.25  Aligned_cols=254  Identities=30%  Similarity=0.463  Sum_probs=200.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .|...+.||+|++|.||++.+..+++.+++|++...    .....+|+.+++.++||||+++++++..     ..+.++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            355567999999999999999889999999987432    2234578999999999999999998743     2347899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      +||+.+ ++.+.+..     ..+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH-AQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999975 44443322     56899999999999999999999 88999999999999999887 799999998765433


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      .. ......|+..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+... ..+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~-----------  234 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK-----------  234 (285)
T ss_pred             CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC-----------
Confidence            21 12335688999999998654 4889999999999999999999999876655444433221 0000           


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                             .       .....++..+.+||++||..+|.+|||+.++++||||++.+++.
T Consensus       235 -------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         235 -------L-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             -------C-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence                   0       01123678999999999999999999999999999999877644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-40  Score=319.84  Aligned_cols=256  Identities=28%  Similarity=0.455  Sum_probs=200.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      -|..++.||-|+||+|.+++...|...||+|.+.+..       .....|-.||..-+.+-||+||..|     .+...+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence            4889999999999999999999999999999885532       2334688899999999999998888     444458


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      |+||+|++|+  +++..+.+ .+-|++..+++|+.++..|+++.| +.|+|||||||+|||||.+|| |||+|||+|.-.
T Consensus       705 YFVMdYIPGG--DmMSLLIr-mgIFeE~LARFYIAEltcAiesVH-kmGFIHRDiKPDNILIDrdGH-IKLTDFGLCTGf  779 (1034)
T KOG0608|consen  705 YFVMDYIPGG--DMMSLLIR-MGIFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGF  779 (1034)
T ss_pred             EEEEeccCCc--cHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHH-hccceecccCccceEEccCCc-eeeeeccccccc
Confidence            8999999965  33322222 478999999999999999999999 999999999999999999995 999999998543


Q ss_pred             c---------cCCC----------------------------------cccccccccccccccccCCCCCCCcchHHHHH
Q 014156          245 V---------KGEP----------------------------------NISYICSRYYRAPELIFGATEYTTAIDIWSVG  281 (429)
Q Consensus       245 ~---------~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG  281 (429)
                      .         .+..                                  ....+||+.|+|||++.. ..|+..+|+||.|
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVG  858 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhh
Confidence            1         1100                                  013568999999999965 4599999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcC
Q 014156          282 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS  361 (429)
Q Consensus       282 ~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  361 (429)
                      ||||||+.|++||......+...+++.+.                         ..++..+..++|+++.+||.++.+ +
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~kv~nw~-------------------------~~l~~~~~~~ls~e~~~li~kLc~-s  912 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQYKVINWR-------------------------NFLHIPYQGNLSKEALDLIQKLCC-S  912 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcceeeeeehh-------------------------hccccccccccCHHHHHHHHHHhc-C
Confidence            99999999999998766544433332211                         011112334689999999998654 6


Q ss_pred             CCCCCC---HHHHhcCCCccccCCCC
Q 014156          362 PNLRCT---ALEACIHPFFDELRDPN  384 (429)
Q Consensus       362 P~~R~t---~~e~l~hp~f~~~~~~~  384 (429)
                      ++.|+.   ++++..||||+.+....
T Consensus       913 ad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  913 ADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             hhhhhcccchhhhhcCccccccchHh
Confidence            788884   67899999999876543

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-39  Score=304.06  Aligned_cols=248  Identities=26%  Similarity=0.393  Sum_probs=198.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      -|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ..+.++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEEE
Confidence            3888899999999999999998899999999875321     234578999999999999999998843     335889


Q ss_pred             Eeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||++++ +...+.     ...+++..+..++.|++.|+.||| +.|++|+||||+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHc-cCCeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            99999864 433332     256899999999999999999999 88999999999999999887 79999999987654


Q ss_pred             cCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .... .....++..|+|||.+.+ ...+.++|+||+||++|+|++|..||...........+... ..            
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------  218 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------  218 (277)
T ss_pred             cchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC------------
Confidence            3221 223467888999998865 34788999999999999999999999765543333322110 00            


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                     ..+...++.++.++|.+||..+|.+||++.++++||||.+.
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                           01223468899999999999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2e-39  Score=301.61  Aligned_cols=245  Identities=32%  Similarity=0.550  Sum_probs=195.4

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ||.|+||.||+|++..+|+.+|+|.+....       ....+|+.+++.++|+||+++++++     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999999899999999885432       2345788999999999999998877     3344588999999


Q ss_pred             hh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC--
Q 014156          172 PE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--  248 (429)
Q Consensus       172 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~--  248 (429)
                      .+ ++.+++..    ...+++..+..++.||+.||.||| +.|++||||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLH-SNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            75 55554432    347899999999999999999999 88999999999999999887 79999999987654332  


Q ss_pred             -------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          249 -------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       249 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                             ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||......+....+...  .         
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~---------  217 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K---------  217 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---------
Confidence                   122345788899999986644 888999999999999999999999877654444333220  0         


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f~~~~~  382 (429)
                            ...+.          ...++..+.+||.+||+.+|.+|||+   .++|+||||+++.+
T Consensus       218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                  00000          01148899999999999999999999   99999999987653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.2e-39  Score=301.20  Aligned_cols=249  Identities=29%  Similarity=0.448  Sum_probs=195.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|++.+.||+|+||.||+|++..+++.||||.+...       .....+|+.+++.++||||+++++++...     ..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            3699999999999999999999999999999976421       12345799999999999999999987543     34


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .++|+||+++ ++..++.........+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence            7899999995 565565554444566899999999999999999999 88999999999999999887 79999999987


Q ss_pred             ecccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 014156          243 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       243 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ....... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||...... ..+.......+.+.      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            6543221 1234678899999998654 4889999999999999999999999654321 12222211111111      


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                          ......+..+.++|.+||..+|++|||+.++++
T Consensus       228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                                011235788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.2e-39  Score=299.00  Aligned_cols=250  Identities=30%  Similarity=0.503  Sum_probs=195.6

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+||+++++.+.     ....++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence            4899999999999999999998899999999875432      23457999999999999999988763     334578


Q ss_pred             EEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+||+.++ +.+.+.    ....+++..++.++.|++.||.||| +.||+|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLH-SHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            999999854 444332    2456889999999999999999999 88999999999999999876 7999999998776


Q ss_pred             ccCCCc-----ccccccccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          245 VKGEPN-----ISYICSRYYRAPELIFGAT--EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       245 ~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ......     ....++..|+|||.+.+..  .++.++||||||+++++|++|+.||...+........... +..    
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----  224 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK----  224 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC----
Confidence            433221     1245788999999986532  3788999999999999999999999765432222211111 000    


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                ..+|.          ...+++.+.+||.+||..+|.+|||+.+++.|||+
T Consensus       225 ----------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         225 ----------PPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ----------CCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                      00110          11358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-39  Score=303.60  Aligned_cols=256  Identities=24%  Similarity=0.312  Sum_probs=195.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ..+|++.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++||||+++++++..    
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   80 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK----   80 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC----
Confidence            4579999999999999999997652     34589999875332     223468889999999999999988733    


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRA------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  232 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~  232 (429)
                       ....++||||+. ++|.+.+......      ....+...+..++.||+.||.||| +.||+||||||+||+++.++ .
T Consensus        81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dikp~nili~~~~-~  157 (288)
T cd05061          81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN-AKKFVHRDLAARNCMVAHDF-T  157 (288)
T ss_pred             -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCCChheEEEcCCC-c
Confidence             234789999997 5666665442211      233567788899999999999999 88999999999999999877 7


Q ss_pred             eEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014156          233 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK  308 (429)
Q Consensus       233 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  308 (429)
                      ++|+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD  236 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999876533221   1122346779999998654 48999999999999999998 7889987665443333221


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCCccccC
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI------HPFFDELR  381 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~~~  381 (429)
                      . +.                  +         ..+...++.+.+++.+||+.||.+|||+.++++      ||||..+.
T Consensus       237 ~-~~------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         237 G-GY------------------L---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             C-CC------------------C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            1 00                  0         012346789999999999999999999999987      99998765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3e-39  Score=303.18  Aligned_cols=245  Identities=32%  Similarity=0.578  Sum_probs=199.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|..+++.+. |+||+++++++.     ....
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCce
Confidence            599999999999999999999999999999987542       123457889999998 999999998873     3345


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .++|||++. +++.+.+..    ...+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh-~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLH-SKGIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            889999995 566555543    357999999999999999999999 88999999999999999887 79999999987


Q ss_pred             ecccCC---------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 014156          243 VLVKGE---------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD  301 (429)
Q Consensus       243 ~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  301 (429)
                      ......                     ......++..|+|||.+.+. .++.++|+||||++++++++|+.||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            654322                     11234568889999988654 48889999999999999999999998776544


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCc
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFF  377 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f  377 (429)
                      ....+...                             ...++..+++.+.+||.+||..||.+|||+    .++++||||
T Consensus       230 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKL-----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhc-----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44333321                             011233468899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=348.79  Aligned_cols=253  Identities=28%  Similarity=0.465  Sum_probs=204.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      -+|.-...||.|.||.||.|.+..+|+..|+|.++-.      .....+|..++..++|||+|++|++-.....     +
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-----v 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-----V 1309 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----H
Confidence            3688888999999999999999999999999976422      2334589999999999999999987644333     7


Q ss_pred             EEEeecchhhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|.||||.++.+ +++.+    ++..++...+.+..|++.|+.||| +.|||||||||.||+++.+| .+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH-~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLH-EHGIVHRDIKPANILLDFNG-LIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHH-hcCceecCCCccceeeecCC-cEEeecccceeE
Confidence            889999996544 44433    456788888899999999999999 88999999999999999888 899999999987


Q ss_pred             cccCC-----CcccccccccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCH
Q 014156          244 LVKGE-----PNISYICSRYYRAPELIFGAT--EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTR  315 (429)
Q Consensus       244 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~  315 (429)
                      +...-     ......||+.|||||++.+..  +...+.|||||||++.||+||+.||...+..-+ +..+-. ..    
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-gh---- 1458 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-GH---- 1458 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-cC----
Confidence            75442     224578999999999996543  456789999999999999999999986544333 322211 11    


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                    .|+         +|.++|.+.++||.+||..||++|.++.|+|.|.|=+...+
T Consensus      1459 --------------~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1459 --------------KPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             --------------CCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence                          122         44568999999999999999999999999999998765443

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.7e-39  Score=299.60  Aligned_cols=245  Identities=22%  Similarity=0.326  Sum_probs=193.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+..+.   ....+|+.+++.++|+||+++++++..     ...++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEEE
Confidence            35999999999999999999999999999999886543   234579999999999999999987733     3347899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+++ ++.+.+..  .....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            999974 55554432  12346899999999999999999999 88999999999999999877 799999999977643


Q ss_pred             CCCcc--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .....  ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....             
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  222 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------  222 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            32211  12235679999988654 48899999999999999998 999998766544433322110             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                     ....+..++.++.++|.+||..||++|||+.++++
T Consensus       223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                           01123457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.9e-39  Score=310.18  Aligned_cols=277  Identities=22%  Similarity=0.287  Sum_probs=193.2

Q ss_pred             eEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        94 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+.+.+|.|  |.||.+++..+++.||+|++...      .....+|+.+++.++|+||+++++++..     ....+++
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~   77 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVV   77 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEE
Confidence            344444444  55666666679999999988543      1345679999999999999999998843     3347899


Q ss_pred             eecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||++++ +.+++...  ....+++..++.++.|++.||+||| +.||+||||||+||+++.++ .+||+|||.+.....
T Consensus        78 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH-~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~  153 (314)
T cd08216          78 SPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIH-SKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIK  153 (314)
T ss_pred             EeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCcceEEEecCC-ceEEecCccceeecc
Confidence            9999854 44444321  2346899999999999999999999 88999999999999999877 799999999875532


Q ss_pred             CCC--------cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-
Q 014156          247 GEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-  316 (429)
Q Consensus       247 ~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-  316 (429)
                      ...        .....++..|+|||++.+. ..++.++|+||+||++|+|++|..||..........+...  +..... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~  231 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLL  231 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcccc
Confidence            211        1233467789999998653 3478899999999999999999999987655443322221  111000 


Q ss_pred             ---HHhhcCCCCccc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          317 ---EIKCMNPNYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       317 ---~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                         ............   .................++.++.+||.+||.+||++|||+.++|+||||+.++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence               000000000000   0000001111122233456789999999999999999999999999999987743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.9e-39  Score=303.84  Aligned_cols=255  Identities=27%  Similarity=0.471  Sum_probs=198.6

Q ss_pred             ceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccc--------hhhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      .|++.+.||.|+||.||+|++.   .+|+.||+|++...        .....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            3889999999999999999875   47899999988542        13345799999999 599999998887     3


Q ss_pred             CceEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ....+++||||++++ +.+.+.    ....+++..+..++.||+.||.||| +.|++||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEECCCC-CEEEeeC
Confidence            334588999999864 444332    2456899999999999999999999 88999999999999999887 7999999


Q ss_pred             CCceecccCC--CcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          239 GSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       239 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |++.......  ......|+..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.......  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            9987654322  22345688999999998643 246789999999999999999999997543322222222211000  


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                             ...++..+++.+.+|+.+||..||.+|+     ++.+++.||||+...+
T Consensus       228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence                                   0012344788999999999999999997     8999999999998775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.3e-39  Score=304.85  Aligned_cols=248  Identities=22%  Similarity=0.297  Sum_probs=194.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCC-----cEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ....+|+.+++.++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-----   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-----
Confidence            46999999999999999999876554     689999885432     234579999999999999999988743     


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  227 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~  227 (429)
                      ....+++|||+++ ++.+.+.....            ....+++..+..++.|++.||.||| +.||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS-SHHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccccceEEEc
Confidence            2347899999984 55555543211            1145888999999999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCceecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014156          228 PHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL  303 (429)
Q Consensus       228 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  303 (429)
                      .++ .++|+|||+++......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            877 79999999997653332   12234567889999988654 48999999999999999998 99999887665544


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..+....                   .         ...+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       237 ~~i~~~~-------------------~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSRQ-------------------L---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCC-------------------c---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4333210                   0         01223578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.4e-39  Score=334.44  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=191.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ++|++.++||+|+||.||+|++..+|+.||+|++..+       .....+|+++++.++||||+++++++..     ...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence            4799999999999999999999999999999988543       1234579999999999999999988733     335


Q ss_pred             EEEEeecchh-hHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSR-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                      .++||||++| ++.+++.....       ....++...+..++.||+.||+||| +.||+||||||+|||++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH-s~GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH-SKGVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH-HCCccccCCchheEEEcCCC-CEEE
Confidence            7899999985 55555543211       1234566778889999999999999 88999999999999999887 7999


Q ss_pred             eecCCceecccCC-------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014156          236 CDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG  296 (429)
Q Consensus       236 ~DFG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  296 (429)
                      +|||+++......                   .....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999997652110                   01124689999999998664 489999999999999999999999977


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+.......  .....|..              .          .-...+++.+.+++.+||..||++|++..+.+.+
T Consensus       234 ~~~~ki~~~--~~i~~P~~--------------~----------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        234 KKGRKISYR--DVILSPIE--------------V----------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             cchhhhhhh--hhccChhh--------------c----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            543322211  10000000              0          0012478899999999999999999987766643

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.1e-39  Score=305.56  Aligned_cols=255  Identities=29%  Similarity=0.423  Sum_probs=200.9

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      |....+||+|+||.||++.+..+++.||+|.+...    .....+|+.+++.++|+||+++++++..     ..+.++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence            34446899999999999999999999999987432    2234578999999999999999998843     33588999


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      ||++++.+..+..    ...+++..++.++.|++.||+||| +.|++||||||+||+++.++ .++|+|||++.......
T Consensus        97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH-~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEcccccceeccccc
Confidence            9998754433221    346899999999999999999999 88999999999999999887 79999999987653322


Q ss_pred             -CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          249 -PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                       ......|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+.....  .         .   
T Consensus       171 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--~---------~---  235 (292)
T cd06657         171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--P---------K---  235 (292)
T ss_pred             ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--c---------c---
Confidence             2233567899999998855 4478999999999999999999999987665544433322110  0         0   


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                        .          .....+++.+.++|.+||..||.+||++.+++.||||.....++.
T Consensus       236 --~----------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~  281 (292)
T cd06657         236 --L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSC  281 (292)
T ss_pred             --c----------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcc
Confidence              0          011236889999999999999999999999999999998765554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.2e-39  Score=295.84  Aligned_cols=249  Identities=27%  Similarity=0.434  Sum_probs=200.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|+||.||++++..+++.+|+|.+...      .....+|+.+++.++|+||+++++++...     ...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence            489999999999999999999999999999987532      22334688999999999999999888432     4588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+||+++ ++...+.........+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh-~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH-EQKILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999975 555555443334467899999999999999999999 88999999999999999876 7999999999776


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.......+...               
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------  216 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------  216 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence            544 3334567889999999865 44888999999999999999999999877654433322211               


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                          .++.         ....++.++.++|.+||..+|.+|||+.++++||++
T Consensus       217 ----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 ----KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ----CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                0011         112468899999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.1e-39  Score=294.54  Aligned_cols=248  Identities=29%  Similarity=0.489  Sum_probs=199.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .|.+.+.||+|++|.||++.+..+++.+++|++....    ....+|+.+++.++|+|++++++++...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            3888999999999999999998899999999886543    3456899999999999999999987443     347899


Q ss_pred             eecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      +||++ +++.+.+..   ....+++..+..++.|++.||.||| +.|++||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLH-SNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhh-cCCEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            99999 455444332   2257899999999999999999999 78999999999999999876 799999999977655


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      ........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+....+..+... ..              
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~--------------  214 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GP--------------  214 (253)
T ss_pred             cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CC--------------
Confidence            43334567888999999986544 889999999999999999999999876544443332220 00              


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  376 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  376 (429)
                          +...       ....++..+.++|.+||..||++|||+.+++.|||
T Consensus       215 ----~~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         215 ----PGLR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ----CCcC-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                0000       01124789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.5e-39  Score=306.87  Aligned_cols=252  Identities=27%  Similarity=0.421  Sum_probs=201.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|...+.||+|+||.||+|++..+++.+|+|.+...       .....+|+++++.++|+|++++++++...     ...
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Cee
Confidence            488889999999999999999999999999987531       11234689999999999999999988543     347


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+.+++...+..   ....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence            89999999877665542   2356899999999999999999999 88999999999999999877 7999999998765


Q ss_pred             ccCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ...   ....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+.... .          
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~----------  231 (308)
T cd06634         166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S----------  231 (308)
T ss_pred             cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-C----------
Confidence            332   34567889999998742  2347889999999999999999999997765544443332210 0          


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                              +.        .....++..+.+||++||..+|.+|||+.++++|||+...+.+
T Consensus       232 --------~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~  276 (308)
T cd06634         232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (308)
T ss_pred             --------CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence                    00        0112367889999999999999999999999999999875443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.4e-39  Score=312.34  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=190.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      .+|++.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.+++.+ +|+||+++++++...   
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~---   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP---   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence            37999999999999999999754     345789999875321     2234689999999 899999999877432   


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhh------------------------------------------------------
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSR------------------------------------------------------  184 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  184 (429)
                       ...++++|||+++ ++.+.+.....                                                      
T Consensus        84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             2347789999985 45444432110                                                      


Q ss_pred             ---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC---ccccccccc
Q 014156          185 ---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRY  258 (429)
Q Consensus       185 ---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~  258 (429)
                         ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .++|+|||++........   .....++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence               1236889999999999999999999 88999999999999999877 799999999986533221   122345678


Q ss_pred             ccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCC
Q 014156          259 YRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP  337 (429)
Q Consensus       259 y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (429)
                      |+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........                         
T Consensus       241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------------  294 (337)
T cd05054         241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-------------------------  294 (337)
T ss_pred             ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-------------------------
Confidence            9999998764 48999999999999999998 99999875443333322221000                         


Q ss_pred             cccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          338 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       338 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                        ...+...++++.+++.+||+.+|.+|||+.++++|
T Consensus       295 --~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 --MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              01123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.2e-38  Score=294.99  Aligned_cols=250  Identities=34%  Similarity=0.503  Sum_probs=200.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|++.+.||+|++|.||+|.+..+++.|++|++....      ....+|+.++++++|+||+++++.+....   ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4888999999999999999999899999999875433      34457999999999999999988874431   24578


Q ss_pred             EEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +++||++ +++.+.+..    ...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLH-SNGIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999996 455444432    347999999999999999999999 78999999999999999877 7999999999877


Q ss_pred             ccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          245 VKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       245 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .....   .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+...  ........          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc----------
Confidence            55543   34456788999999886544 8999999999999999999999998765211  11111100          


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                    ......++..++..+.+||.+||..||.+|||+.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000112334568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3e-39  Score=307.30  Aligned_cols=249  Identities=22%  Similarity=0.295  Sum_probs=189.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcE--EEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..+|.+.+.||+|+||.||+|.+..++..  +|+|.+...     .....+|+.++..+ +|+||+++++++.     ..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence            34799999999999999999998877754  577766432     12345799999999 8999999999873     33


Q ss_pred             eEEEEEeecch-hhHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP  228 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~  228 (429)
                      .+.++||||++ +++.+.+....            .....+++..++.++.||+.||+||| +.||+||||||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dlkp~Nili~~  159 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGE  159 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEecC
Confidence            45889999997 45655554321            11235889999999999999999999 889999999999999998


Q ss_pred             CCCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014156          229 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII  307 (429)
Q Consensus       229 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  307 (429)
                      ++ .+||+|||++.............++..|+|||.+.+. .++.++|||||||++|+|+| |..||.+.+..+....+.
T Consensus       160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  237 (303)
T cd05088         160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  237 (303)
T ss_pred             CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            87 7999999998643222112222345679999988554 48899999999999999998 999997765544333221


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ...                            ....+..+++++.+||.+||..+|.+|||+.+++++
T Consensus       238 ~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCC----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            100                            000122368899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.3e-39  Score=299.20  Aligned_cols=249  Identities=23%  Similarity=0.420  Sum_probs=196.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc---------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|.+.+.||+|+||.||++++..++..+++|.+..         ......+|+.+++.++||||+++++++...     .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence            48999999999999999999988777777776532         112234688899999999999999887432     3


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++|+||+.+ ++...+.........+++..++.++.|++.||.||| +.|++|+||||+||+++. + .++|+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~~l~~~nili~~-~-~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-QRRILHRDLKAKNIFLKN-N-LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-HcCccccCCChhheEeec-C-CEeecccCce
Confidence            47899999985 555555444444567999999999999999999999 889999999999999974 3 6999999998


Q ss_pred             eecccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          242 KVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       242 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ........ .....|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+...  .        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~--------  221 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--P--------  221 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--C--------
Confidence            77644322 234567889999998855 44788999999999999999999999766544433332211  0        


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                               .         ..++..++.++.++|.+||..||.+||++.++++||||
T Consensus       222 ---------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ---------T---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ---------C---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                     0         01223468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.5e-39  Score=334.10  Aligned_cols=141  Identities=25%  Similarity=0.400  Sum_probs=120.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|.+.++||+|+||.||+|++..+++.||||++....       ....+|+.+++.++|+||++++.++.     ...+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECCE
Confidence            46999999999999999999999999999999986432       34567899999999999999987773     3345


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|+||||+.+ +|..++..    .+.+++..++.++.||+.||.||| ..||+||||||+||||+.++ .+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH-~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLH-RHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            8999999964 55555432    356899999999999999999999 78999999999999999887 79999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.6e-39  Score=296.88  Aligned_cols=243  Identities=21%  Similarity=0.296  Sum_probs=190.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|... .+..+|+|.+...   .....+|+.+++.++||||+++++++..     ....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEEE
Confidence            36899999999999999999875 4568999987543   2345679999999999999999988733     3347899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+++ ++.+.+..   ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLE-RNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            999985 45544332   2346899999999999999999999 88999999999999999877 799999999876533


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+.....            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------  219 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------------  219 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            2221  122345679999998654 58899999999999999999 8999988776555554433100            


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                      ...+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       220 ----------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 ----------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            0011235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.9e-39  Score=306.40  Aligned_cols=248  Identities=28%  Similarity=0.422  Sum_probs=201.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|...+.||+|+||.||+|++..++..||+|.+....       ....+|+.+++.++|+|++++++++...     ...
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeE
Confidence            3888999999999999999999999999999875321       2344689999999999999999988443     347


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+.+++.+.+..   ....+++..+..++.||+.||.||| +.||+||||+|+||+++.++ .++|+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH-~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            89999999887765532   2456899999999999999999999 88999999999999999877 7999999998654


Q ss_pred             ccCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ..   .....|+..|+|||.+..  ...++.++|+||+||++|+|++|..||...+.......+......+         
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  243 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------  243 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence            32   234568889999998742  2347889999999999999999999998766555554443321000         


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                        .....+++.+.+||.+||..+|.+|||+.++++|+|+..
T Consensus       244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                              011235788999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-39  Score=299.46  Aligned_cols=251  Identities=21%  Similarity=0.270  Sum_probs=192.1

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCC---CcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCC-CCce
Q 014156           93 YMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  162 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~  162 (429)
                      |.+.+.||+|+||.||+|....+   +..||+|.+..+.      ....+|+..++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56789999999999999987643   4789999886432      234578999999999999999987754433 3344


Q ss_pred             EEEEEeecchh-hHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYS--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      +.++++||+.+ ++...+....  .....+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS-NRNFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchheEEECCCC-eEEECCcc
Confidence            57899999985 4444443221  12346899999999999999999999 78999999999999999877 79999999


Q ss_pred             CceecccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          240 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       240 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            99876443221   11234667999998855 458999999999999999999 889998766544433322210     


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                             ....+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       233 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   001223468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=294.37  Aligned_cols=263  Identities=25%  Similarity=0.345  Sum_probs=204.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-----hHHHHHHH-HHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ...+-+..||.|+||+|++..++.+|+..|+|++.....     ....|... ++.-+.||||++|+..+...+     .
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c  138 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C  138 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence            345666789999999999999999999999999864322     22344443 444579999999999876655     8


Q ss_pred             EEEeecchhhHHHHHHH-hhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPETVYRVAKH-YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~-~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ||.||+|+-++..+.+. +.-....+++..+-.+...++.||+||.....|||||+||+|||++..| .|||||||++..
T Consensus       139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHh
Confidence            89999999765444332 3344578999999999999999999999788999999999999999988 699999999987


Q ss_pred             cccCCCcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHhhc
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCM  321 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  321 (429)
                      ..++-..+.-.|...|||||.+.... .|+.+||+||||++|||+.||..||.+-+  ..+.++.++. |.|+.-.    
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~Vv~gdpp~l~----  291 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQVVIGDPPILL----  291 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHHHHcCCCCeec----
Confidence            76665555667888999999986544 48999999999999999999999997533  2344443332 2222110    


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                   ..    .-.-.++..+..+|..||.+|-+.||...+++.+||++....
T Consensus       292 -------------~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  292 -------------FD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             -------------Cc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence                         00    000136889999999999999999999999999999987554

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-39  Score=308.59  Aligned_cols=244  Identities=23%  Similarity=0.348  Sum_probs=189.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcE----EEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGET----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|++.+.||+|+||.||+|++..+++.    ||+|.+...     .....+|+.+++.++||||+++++++...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            3699999999999999999998766654    899987532     22345688999999999999999877432     


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                       ..++|++|+.+ ++.+.+..   ....+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH-~~~iiH~dlkp~Nill~~~~-~~kl~DfG~  155 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE-ERRLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEecCCC-cEEEccccc
Confidence             14578998874 55554432   2356889999999999999999999 88999999999999999877 799999999


Q ss_pred             ceecccCCCcc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          241 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       241 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ++.........   ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+. ..+......    
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~----  229 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGER----  229 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCC----
Confidence            98765433222   2233667999999865 458999999999999999997 9999977654332 222221000    


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                   .          ..+..++.++.+++.+||..||.+|||+.+++.+
T Consensus       230 -------------~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         230 -------------L----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             -------------C----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                         0          0112367889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.6e-39  Score=300.13  Aligned_cols=249  Identities=22%  Similarity=0.274  Sum_probs=190.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ..+|++.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----   79 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----
Confidence            4579999999999999999998642     35689999875321     22447899999999999999998873     


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRA------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  232 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~  232 (429)
                      .....++||||+++ +|.+.+......      ...+++..+..++.|++.||.||| +.|++||||||+||+++.++ .
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~vH~dlkp~Nil~~~~~-~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF-T  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCcchheEEEcCCC-C
Confidence            33347899999985 555554332111      123577888999999999999999 78999999999999999887 7


Q ss_pred             eEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014156          233 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK  308 (429)
Q Consensus       233 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  308 (429)
                      ++|+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999875533221   1123457789999998654 48999999999999999999 7899987765544433322


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..                   .+         ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~-------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 GG-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CC-------------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            10                   00         1123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.5e-39  Score=296.71  Aligned_cols=244  Identities=18%  Similarity=0.272  Sum_probs=190.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|.+.. +..+|+|.+...   .....+|+.+++.++||||+++++++..     ....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEEE
Confidence            469999999999999999998643 456999987643   2334679999999999999999988732     2347899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+.+ ++.+.+..   ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLE-SKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999975 45444432   2346899999999999999999999 88999999999999999877 799999999876544


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----------  220 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence            3221  122345679999998654 48899999999999999998 99999776654444433221100           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                       ..+...+..+.+++.+||..||.+|||+.+++.+
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                             0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.2e-39  Score=302.47  Aligned_cols=247  Identities=22%  Similarity=0.322  Sum_probs=192.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .+|.+.+.||+|+||.||+|.+..     +++.||+|.+...     .....+|+++++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG----   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence            469999999999999999998743     4678999988543     23445799999999999999999988443    


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhh----------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYS----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH  229 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~  229 (429)
                       ...++||||+.+ +|...+....          .....+++..+..++.||+.||.||| +.||+||||||+||+++.+
T Consensus        81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~h~dlkp~nili~~~  158 (280)
T cd05049          81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA-SQHFVHRDLATRNCLVGYD  158 (280)
T ss_pred             -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeeccccccceEEEcCC
Confidence             348899999985 4444443321          12345788899999999999999999 8899999999999999988


Q ss_pred             CCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014156          230 THQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE  305 (429)
Q Consensus       230 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  305 (429)
                      + .++|+|||+++.......   .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus       159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             C-eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            7 799999999876533221   1233457789999998664 48999999999999999998 9999987766554443


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      +....  .                          ...+..++..+.+||.+||..||.+|||+.|+++
T Consensus       237 ~~~~~--~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         237 ITQGR--L--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHcCC--c--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            32210  0                          0112346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.3e-39  Score=326.06  Aligned_cols=284  Identities=20%  Similarity=0.259  Sum_probs=182.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCC----CcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLET----GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      ...+|.+.+.||+|+||.||+|++..+    +..||+|++.............++...+.++..+...+..... .....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            456899999999999999999999888    8999999875432211111112222333344443333322111 23345


Q ss_pred             EEEEeecchh-hHHHHHHHhhh----------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSR----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  226 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~----------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill  226 (429)
                      +++|+||+++ +|.+++.....                .........+..++.||+.||.||| +.||+||||||+|||+
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH-~~gIiHRDLKP~NILl  288 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH-STGIVHRDVKPQNIIF  288 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH-HCCEEeCcCCHHHEEE
Confidence            7899999985 45554432100                0011123456789999999999999 8899999999999999


Q ss_pred             cCCCCceEEeecCCceecccCC--CcccccccccccccccccCCC---------------------CCCCcchHHHHHHH
Q 014156          227 NPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTTAIDIWSVGCV  283 (429)
Q Consensus       227 ~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DiwslG~i  283 (429)
                      +.+...+||+|||+|+....+.  .....++|+.|+|||.+....                     .++.++||||+||+
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi  368 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI  368 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence            8654479999999997653322  234567899999999763211                     23456799999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCC
Q 014156          284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN  363 (429)
Q Consensus       284 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  363 (429)
                      ||||+++..++  .+....+..++...+...........+..    .+....   ...........+++||.+||++||.
T Consensus       369 L~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        369 FLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRA----SPDLRR---GFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhcccc----chhhhh---hhhhccccchHHHHHHHHHccCCcc
Confidence            99999976554  34444444444443332222111111110    000000   0001112345678999999999999


Q ss_pred             CCCCHHHHhcCCCccccCC
Q 014156          364 LRCTALEACIHPFFDELRD  382 (429)
Q Consensus       364 ~R~t~~e~l~hp~f~~~~~  382 (429)
                      +|||+.++|+||||+....
T Consensus       440 kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        440 QRISAKAALAHPYFDREGL  458 (566)
T ss_pred             cCCCHHHHhCCcCcCCCCc
Confidence            9999999999999987554

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.3e-39  Score=299.56  Aligned_cols=250  Identities=21%  Similarity=0.264  Sum_probs=189.0

Q ss_pred             eEeeEEccCCcEEEEEEEEcCCCc--EEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceEE
Q 014156           94 MAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYL  164 (429)
Q Consensus        94 ~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~~  164 (429)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.+...      .....+|+.+++.++|+||+++++.++.... ......
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467899999999999999877765  6899977432      2234568999999999999999987654322 122346


Q ss_pred             EEEeecchh-hHHHHHHHh--hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          165 NLVLEFVPE-TVYRVAKHY--SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~--~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      +++|||+.+ ++...+...  ......+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  159 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS-SKSFIHRDLAARNCMLNENM-NVCVADFGLS  159 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhheEEcCCC-CEEECCCCcc
Confidence            789999984 444433221  112345899999999999999999999 88999999999999999877 7999999999


Q ss_pred             eecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      +.......   .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+....+....+.... .     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~-----  232 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-R-----  232 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-C-----
Confidence            87643322   112235678999999865 458999999999999999999 889998765544333322110 0     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                            ...+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 ----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                  01123467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.5e-39  Score=296.56  Aligned_cols=238  Identities=21%  Similarity=0.308  Sum_probs=183.7

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      +.||+|+||.||+|.+..+++.||+|.+...     .....+|+++++.++||||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            3689999999999999999999999987532     2335679999999999999999988743     33478999999


Q ss_pred             hhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc
Q 014156          172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  250 (429)
Q Consensus       172 ~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~  250 (429)
                      .++ +.+.+.   .....+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++.........
T Consensus        76 ~~~~L~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLE-SKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            764 444332   23356899999999999999999999 88999999999999999887 7999999998764332111


Q ss_pred             c---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          251 I---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       251 ~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .   ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+....                
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~----------------  213 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----------------  213 (252)
T ss_pred             ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------
Confidence            1   11224569999998654 48899999999999999998 889997655433322221100                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                  ....+...+..+.+|+.+||..||++|||+.++++
T Consensus       214 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         214 ------------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ------------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        00122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-38  Score=300.78  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=191.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|.+.+.||+|+||.||++.+.     .++..+|+|.+...    .....+|+.+++.++||||+++++++..     .
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence            36999999999999999999853     34567999987543    2234579999999999999999988743     3


Q ss_pred             eEEEEEeecch-hhHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYS---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  231 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~  231 (429)
                      .+.++||||+. +++.+.+....         .....+++..+..++.||+.||+||| +.||+||||||+||+++.++ 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH-~~~i~H~dlkp~Nili~~~~-  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENL-  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEccCC-
Confidence            35789999998 45555543321         11235899999999999999999999 88999999999999999887 


Q ss_pred             ceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014156          232 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII  307 (429)
Q Consensus       232 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  307 (429)
                      .++|+|||+++.......   .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            799999999976533221   122334678999999865 458999999999999999998 999998776555444433


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ...                   .+         ..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus       237 ~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGR-------------------VL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCC-------------------cC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            210                   00         012246889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.4e-39  Score=303.36  Aligned_cols=247  Identities=21%  Similarity=0.292  Sum_probs=189.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCc--EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      +|++.+.||+|+||.||+|.+..++.  .+++|.+...     .....+|+.++.++ +||||+++++++..     ...
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~~   77 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RGY   77 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CCc
Confidence            59999999999999999999877764  4688877531     12345799999888 79999999988733     334


Q ss_pred             EEEEeecch-hhHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT  230 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~  230 (429)
                      +++|+||++ +++.+.+.....            ....+++..++.++.||+.||+||| +.||+||||||+|||++.++
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS-EKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCcCCcceEEECCCC
Confidence            789999997 466665543110            1135889999999999999999999 88999999999999999877


Q ss_pred             CceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014156          231 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKV  309 (429)
Q Consensus       231 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~  309 (429)
                       .+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~  234 (297)
T cd05089         157 -ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  234 (297)
T ss_pred             -eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence             7999999998643222111122234569999988654 48999999999999999997 99999877665544433221


Q ss_pred             hCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .                            ....+..++.++.+||.+||..||.+|||+.++++.
T Consensus       235 ~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         235 Y----------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             C----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                            001223478999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=292.47  Aligned_cols=246  Identities=35%  Similarity=0.567  Sum_probs=200.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +|.+.+.||+|++|.||++++..+++.||+|.+....      ....+|+++++.++|+|++++++++..     ..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence            4889999999999999999999899999999885443      234579999999999999999888743     34588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|||+++ ++.+.+.    ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLH-EQGVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 4444433    2367899999999999999999999 88999999999999999876 7999999999876


Q ss_pred             ccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+...........              
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  214 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------  214 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence            54432 23456788999999886544 889999999999999999999999776544333332210              


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                    ....++..++..+.++|.+||..+|++|||+.+++.||||
T Consensus       215 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 --------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                          0011334578999999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=301.66  Aligned_cols=254  Identities=19%  Similarity=0.213  Sum_probs=185.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC---CcEEEEEEeccchhhHH---------------HHHHHHHHcCCCCeecccee
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVVSLKHC  152 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~~iv~l~~~  152 (429)
                      .+|++.+.||+|+||.||+|.+..+   +..+|+|..........               .+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4699999999999999999998877   67788886432221111               12233455689999999886


Q ss_pred             eeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc
Q 014156          153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  232 (429)
Q Consensus       153 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~  232 (429)
                      ..... ....+.+++++++..++...+..    ....++..++.++.|++.||.||| +.+|+||||||+|||++.++ .
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-c
Confidence            64432 23345678899887666555433    234678889999999999999999 88999999999999999877 7


Q ss_pred             eEEeecCCceecccCC--------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014156          233 VKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV  304 (429)
Q Consensus       233 vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  304 (429)
                      ++|+|||+|+......        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999997653221        11234689999999998654 48999999999999999999999998764333222


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ...+.      +.+..+...       .        ...+..++.+.++++.|+..+|.+||+..++++
T Consensus       244 ~~~~~------~~~~~~~~~-------~--------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKC------DFIKRLHEG-------K--------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHH------HHHHHhhhh-------h--------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            21110      000000000       0        011235789999999999999999999999874

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-38  Score=311.78  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=189.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCC-----CcEEEEEEeccc-----hhhHHHHHHHHHHcC-CCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~  158 (429)
                      ..+|++.+.||+|+||.||+|.+...     +..||+|++...     .....+|+++++.+. ||||+++++++.    
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~----  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT----  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence            44799999999999999999987533     357999988542     223457999999996 999999999883    


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhh-----------------------------------------------------
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSR-----------------------------------------------------  184 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  184 (429)
                       ....+++|||||++ +|.+.+.....                                                     
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence             33448899999984 55554432110                                                     


Q ss_pred             ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCee
Q 014156          185 ---------------------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL  225 (429)
Q Consensus       185 ---------------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nil  225 (429)
                                                             ....+++..+..++.||+.||.||| +.||+||||||+|||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA-SKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHhEE
Confidence                                                   1234788888999999999999999 889999999999999


Q ss_pred             ecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014156          226 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD  301 (429)
Q Consensus       226 l~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  301 (429)
                      ++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus       270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99877 799999999986543322   1233467789999998664 48999999999999999997 999997654433


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+........                           ....+..++.++.++|.+||..||++|||+.++.+
T Consensus       348 ~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIKSGY---------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHhcCC---------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3332222100                           00112346889999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-38  Score=295.47  Aligned_cols=245  Identities=24%  Similarity=0.307  Sum_probs=191.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.++||+|+||.||+|.+. ++..||+|.+...   .....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence            347999999999999999999864 5677999987543   234457999999999999999988773     3334789


Q ss_pred             Eeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|||+. +++.+.+..  .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIE-RKNYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 466555433  23456888899999999999999999 78999999999999999877 79999999998764


Q ss_pred             cCCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .....  ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.........+.....           
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  222 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-----------  222 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            33211  123356679999988654 48889999999999999998 9999987665554443322100           


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                             .          .....++.++.+++.+||..+|++|||+.++++
T Consensus       223 -------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 -------M----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -------C----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                   0          011246889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-38  Score=297.57  Aligned_cols=248  Identities=31%  Similarity=0.482  Sum_probs=194.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +|++.+.||+|+||.||+|++..+++.+|+|.+...       .....+|+.+++.++|+||+++++++...     ...
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NEL   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----CeE
Confidence            589999999999999999999999999999977431       12344789999999999999999988542     347


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++|||+.+ ++.+++.........+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++..
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~  155 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGLGRF  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEECcchhhhc
Confidence            899999985 566665544444567899999999999999999999 88999999999999999877 799999999876


Q ss_pred             cccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhc
Q 014156          244 LVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       244 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.... ..........           
T Consensus       156 ~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------  223 (267)
T cd08229         156 FSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-----------  223 (267)
T ss_pred             cccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-----------
Confidence            543322 2245688899999998654 4888999999999999999999999754321 1111111100           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                             ..+.        .....+++.+.++|.+||..||.+|||+.++++
T Consensus       224 -------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         224 -------DYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -------CCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                   0000        011246889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=297.58  Aligned_cols=247  Identities=24%  Similarity=0.305  Sum_probs=192.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .+|++.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++|+||+++++++..     
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-----   80 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-----
Confidence            4799999999999999999987644     3789999875332     234578999999999999999998743     


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCce
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSR------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV  233 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~v  233 (429)
                      ....++||||++ ++|.+.+.....      ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~di~p~nill~~~~-~~  158 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVAEDL-TV  158 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccChheEEEcCCC-CE
Confidence            344789999997 566665543221      1234788899999999999999999 88999999999999999887 79


Q ss_pred             EEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014156          234 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKV  309 (429)
Q Consensus       234 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~  309 (429)
                      ||+|||+++.......   .....+|..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG  237 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence            9999999876543321   2233467889999988654 48999999999999999998 99999876654443333210


Q ss_pred             hCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                       ..                           ..++...+.++.++|.+||+.+|++|||+.+++.
T Consensus       238 -~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 -GH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             00                           0122346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-38  Score=300.29  Aligned_cols=248  Identities=20%  Similarity=0.284  Sum_probs=191.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc----CCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|++.+.||+|+||.||+|.+.    .++..+|+|.+....     ....+|+.+++.++||||+++++++...     
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-----   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----
Confidence            46899999999999999999853    456789999886321     2345799999999999999999887432     


Q ss_pred             eEEEEEeecchh-hHHHHHHHhh-------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYS-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  227 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~-------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~  227 (429)
                      ...++||||+++ ++.+.+....             .....+++..+..++.||+.||.||| +.||+||||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS-SHFFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hcCeehhccccceEEEc
Confidence            347899999985 5555443211             01234788889999999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014156          228 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL  303 (429)
Q Consensus       228 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  303 (429)
                      .++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.....
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            877 799999999976543321   2233456779999998654 48999999999999999998 99999876654433


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..+.... .                           ...+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       237 ~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKRQ-L---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            3332210 0                           01223478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-38  Score=298.00  Aligned_cols=249  Identities=20%  Similarity=0.272  Sum_probs=191.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .+|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++|+||+++++++...    
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   81 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER----   81 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC----
Confidence            469999999999999999999877     77899999875322     2345689999999999999999877433    


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceE
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVK  234 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vk  234 (429)
                       ...++||||+. ++|.+++.....   ....+++..+..++.||+.||+||| +.+++||||||+||+++.++  ..+|
T Consensus        82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchheEEEeccCCCcceE
Confidence             23679999996 466655543221   1235889999999999999999999 78999999999999998653  2599


Q ss_pred             EeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 014156          235 LCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVL  310 (429)
Q Consensus       235 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~  310 (429)
                      |+|||+++.......   ......+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.......+... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-  237 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-  237 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence            999999986532211   1122235679999998664 48999999999999999997 99999876654433322211 


Q ss_pred             CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..                           ..++..++..+.+++.+||+.||.+|||+.++++|
T Consensus       238 ~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00                           01223478899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=292.33  Aligned_cols=238  Identities=35%  Similarity=0.577  Sum_probs=193.9

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ||.|+||.||++.+..+++.||+|.+....       .....|+.+++.++|+||+++++.+     ......++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            699999999999998889999999875432       2455789999999999999999877     3445689999999


Q ss_pred             h-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC-CC
Q 014156          172 P-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  249 (429)
Q Consensus       172 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~-~~  249 (429)
                      . +++.+.+..    ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++ .++|+|||++...... ..
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh-~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLH-SLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            4 666555433    346899999999999999999999 78999999999999999887 7999999998776443 22


Q ss_pred             cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 014156          250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  329 (429)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      .....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+...                    
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------------------  208 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--------------------  208 (250)
T ss_pred             ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--------------------
Confidence            3445678899999998654 4788999999999999999999999776653333332210                    


Q ss_pred             CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCCc
Q 014156          330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFF  377 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~---~e~l~hp~f  377 (429)
                               ...++..++..+.++|++||..||.+|||+   .++++||||
T Consensus       209 ---------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         209 ---------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                     011333468899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-39  Score=333.85  Aligned_cols=259  Identities=28%  Similarity=0.413  Sum_probs=194.6

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCC----
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD----  158 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----  158 (429)
                      +...+|..++.||+||||.||+|+++-+|+.||||++...     ...+.+|++.|.+|+|||||+++..|.....    
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3455788999999999999999999999999999998543     2345689999999999999998765531000    


Q ss_pred             --------------------------------------------------------------------------------
Q 014156          159 --------------------------------------------------------------------------------  158 (429)
Q Consensus       159 --------------------------------------------------------------------------------  158 (429)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------C--------CceEEEEEeecchhhHHHHHHHhhhcCCCC-CHHHHHHHHHHHHHHHHH
Q 014156          159 ----------------------K--------DELYLNLVLEFVPETVYRVAKHYSRASQRM-PLIYVKLYTYQICRALAY  207 (429)
Q Consensus       159 ----------------------~--------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l-~~~~~~~~~~qi~~aL~~  207 (429)
                                            .        ...++||-||||+..+++.+...   +... ....++++++||+.||.|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~---N~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR---NHFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh---cccchhhHHHHHHHHHHHHHHHH
Confidence                                  0        00458999999998777655432   2222 467889999999999999


Q ss_pred             HHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc-------------------cCCCcccccccccccccccccCC
Q 014156          208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-------------------KGEPNISYICSRYYRAPELIFGA  268 (429)
Q Consensus       208 LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~  268 (429)
                      +| ++|||||||||.||++++++ .|||+|||+|+...                   .....++.+||.-|+|||++.+.
T Consensus       713 IH-~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  713 IH-DQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HH-hCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99 88999999999999999887 79999999997721                   01134567899999999999765


Q ss_pred             C--CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCC
Q 014156          269 T--EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM  346 (429)
Q Consensus       269 ~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (429)
                      .  .|+.++|+||||+|++||+.-   |..  .++-...+.. +..+.               +|.   .   ..|..+-
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~yP---F~T--sMERa~iL~~-LR~g~---------------iP~---~---~~f~~~~  843 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLYP---FGT--SMERASILTN-LRKGS---------------IPE---P---ADFFDPE  843 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhcc---CCc--hHHHHHHHHh-cccCC---------------CCC---C---ccccccc
Confidence            5  699999999999999999854   532  2222222211 11111               111   0   0111222


Q ss_pred             ChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          347 PPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       347 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                      -+.-..+|++||+.||++||||.|+|++.||-
T Consensus       844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  844 HPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             chHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            45677899999999999999999999999987

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.2e-38  Score=292.79  Aligned_cols=248  Identities=31%  Similarity=0.504  Sum_probs=194.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ++|++.+.||.|+||.||+|.+..+|+.||+|.+...       .....+|+++++.++|+|++++++++..     ...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            3699999999999999999999989999999977421       2344579999999999999999998844     234


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .++||||+++ +|..++.........+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH-SKRIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999985 666665544344566899999999999999999999 88999999999999999887 79999999987


Q ss_pred             ecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHh
Q 014156          243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~  319 (429)
                      ...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||......  +....+...          
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----------  223 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence            654322 22345678899999998654 4889999999999999999999999654311  111111110          


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                               ..+.        .....++..+.++|.+||..+|++|||+.++++
T Consensus       224 ---------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 ---------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ---------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                     0000        011246789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=293.46  Aligned_cols=242  Identities=26%  Similarity=0.377  Sum_probs=193.7

Q ss_pred             eEEccCCcEEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|++.++.++|+||+++++++..     ...+++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4699999999999999866   8899999886432     344579999999999999999988743     34588999


Q ss_pred             ecch-hhHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          169 EFVP-ETVYRVAKHYSRA-----SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       169 e~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ||+. +++.+.+......     ...+++..+..++.|++.||+||| +.||+||||||+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-SKKFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH-cCCcccCccCcceEEECCCC-cEEEccccccc
Confidence            9995 6666655442111     367999999999999999999999 88999999999999999887 79999999998


Q ss_pred             ecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          243 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      ......   ......++..|+|||.+.+. .++.++||||+||++|+|++ |..||......+....+...         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------  223 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---------  223 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence            765432   22345568889999988654 58999999999999999999 69999887654444433220         


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                         .....+..++.++.+++.+||..||.+|||+.+++++
T Consensus       224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 -------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                               0011233468999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3e-38  Score=297.37  Aligned_cols=257  Identities=26%  Similarity=0.360  Sum_probs=187.3

Q ss_pred             ce-eEeeEEccCCcEEEEEEE----EcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           92 SY-MAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        92 ~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      +| ++.+.||+|+||+||++.    ...++..||+|.+...     .....+|+++++.++||||+++++++...   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            45 899999999999998865    3356789999988643     22345799999999999999998876432   23


Q ss_pred             eEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      .++++||||+.++ +.+.+.     ...+++..++.++.|++.||.||| +.||+||||||+|||++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLH-SQHYIHRDLAARNVLLDNDR-LVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccChheEEEcCCC-cEEEeeccc
Confidence            4578999999864 434332     245999999999999999999999 88999999999999999877 799999999


Q ss_pred             ceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCH
Q 014156          241 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTR  315 (429)
Q Consensus       241 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~  315 (429)
                      ++.......    .....++..|+|||.+.+. .++.++|||||||++|+|++|..||......  ....... .+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~  230 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV  230 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch
Confidence            976643322    1123456679999988654 4889999999999999999999998654321  1111110 000000


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ..+.            ...........+..++.++.+++.+||..||++|||+.++++
T Consensus       231 ~~~~------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         231 VRLI------------ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhh------------hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000            000000011123457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-38  Score=298.41  Aligned_cols=253  Identities=30%  Similarity=0.450  Sum_probs=203.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ..|.+.+.||+|+||.||+|.+..++..||+|++....   ....+|+++++.++|+|++++++++...     ...++|
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv   93 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWVV   93 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEEE
Confidence            35889999999999999999998889999999886443   3456799999999999999999988543     358899


Q ss_pred             eecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      +||++ ++|.+.+...   ...+++..+..++.|++.||.||| +.||+|+||+|+||+++.++ .++|+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH-~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  168 (286)
T cd06614          94 MEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLH-SQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTK  168 (286)
T ss_pred             EeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCChhhEEEcCCC-CEEECccchhhhhcc
Confidence            99999 5666555431   137899999999999999999999 78999999999999999887 799999999765433


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      .. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... +.+.           
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-----------  235 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP-----------  235 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC-----------
Confidence            22 12234578889999988654 4899999999999999999999999876655444333221 0000           


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                    ......++.++.+||.+||+.+|.+|||+.+++.||||+..
T Consensus       236 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         236 --------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             --------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence                          00112367899999999999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=294.36  Aligned_cols=243  Identities=21%  Similarity=0.301  Sum_probs=190.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +|++.+.||+|+||.||+|.+. ++..+|+|.+...   .....+|+.+++.++||||+++++++.     ...+.++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEEE
Confidence            5889999999999999999875 5678999987542   234457999999999999999988773     333578999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+++ ++.+.+..   ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++.....
T Consensus        79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~  153 (256)
T cd05059          79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLE-SNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD  153 (256)
T ss_pred             ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence            99975 45554432   2346899999999999999999999 88999999999999999887 7999999998765433


Q ss_pred             CCcc--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          248 EPNI--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       248 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ....  ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+....              
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------  218 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY--------------  218 (256)
T ss_pred             cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            2211  12234579999988654 48899999999999999999 899998766554443332110              


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                    ....+...+..+.+++.+||..+|++|||+.++++.
T Consensus       219 --------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         219 --------------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             --------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                          001123468999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=292.94  Aligned_cols=244  Identities=23%  Similarity=0.307  Sum_probs=191.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|.+. +++.||+|.+...   .....+|+.+++.++|+||+++++++..     ....++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCeeee
Confidence            46999999999999999999864 4578999988643   2345579999999999999999987733     2347899


Q ss_pred             eecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+. +++.+.+...  ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||+++....
T Consensus        80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99995 6666655431  1346899999999999999999999 88999999999999999887 799999999987653


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+.....            
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------  222 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------  222 (261)
T ss_pred             CcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            2211  11122357999998865 448999999999999999999 9999987765554443322100            


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                      ...+...+..+.+++.+||..+|.+||++.++++
T Consensus       223 ----------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         223 ----------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                            0012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.2e-39  Score=301.55  Aligned_cols=248  Identities=20%  Similarity=0.241  Sum_probs=191.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .+|++.+.||.|+||.||+|.+..+     +..||+|++....     ....+|+.++..++||||+++++.+..     
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence            3588999999999999999987543     5789999886432     234578899999999999999988733     


Q ss_pred             ceEEEEEeecchh-hHHHHHHHh------------hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHY------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  227 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~------------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~  227 (429)
                      ....+++++|+.+ ++...+...            ......+++..+..++.|++.||.||| +.||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH-~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS-SHHVVHKDLATRNVLVF  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HcCccccccchhheEec
Confidence            2347889999884 444444211            011235788889999999999999999 88999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014156          228 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL  303 (429)
Q Consensus       228 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  303 (429)
                      .++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+..
T Consensus       159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            776 799999999876543322   12234567899999986544 8999999999999999998 88899877665544


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..+.....                            ..++..++..+.+|+.+||+.+|.+||++.+++..
T Consensus       237 ~~i~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         237 EMIRNRQV----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            44333100                            01234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=309.90  Aligned_cols=245  Identities=20%  Similarity=0.282  Sum_probs=189.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +...+...||+|+||+||+|++..+   ||||++..+      .+.+.+|+..+++=+|.||+=+.+++..     .. +
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-----p~-~  462 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-----PP-L  462 (678)
T ss_pred             HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-----Cc-e
Confidence            4567889999999999999998544   999988543      3445689999999999999999887732     22 3


Q ss_pred             EEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .||+.+|+|+ |+..+..   ....|.....+.|+.||++|+.||| .++|||||||..|||+..++ .|||+|||++..
T Consensus       463 AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLH-AK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLH-AKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATV  537 (678)
T ss_pred             eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhh-hhhhhhhhccccceEEccCC-cEEEecccceee
Confidence            7899999975 4443322   2367888999999999999999999 78999999999999999876 899999999854


Q ss_pred             cc---cCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          244 LV---KGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       244 ~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      -.   .........|...|||||++.-  ...|+..+|||||||++|||+||..||...+..+.+..+=+....|..   
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~---  614 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL---  614 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc---
Confidence            32   1122233456778999999853  235899999999999999999999999855444433332222111211   


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                           .....+.+.++++|+..||.+++++||++.+||.
T Consensus       615 ---------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  615 ---------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ---------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                 1223456789999999999999999999999886

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-38  Score=294.67  Aligned_cols=245  Identities=22%  Similarity=0.285  Sum_probs=190.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|++.+.||+|+||.||+|.+..+   ...||+|.+....     ....+|+.+++.++||||+++++.+..     ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----SR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----CC
Confidence            4699999999999999999998644   4589999875432     233468999999999999999987733     33


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||+.+ ++.+.+..   ....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLS-EMNYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-CEEECccchh
Confidence            47899999986 44444322   2357899999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCCCc-c--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGEPN-I--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~~~-~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      +........ .  ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----  227 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-----  227 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            876422211 1  12345679999988654 48999999999999999998 99999766554443333221000     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                             ..+..++..+.+|+.+||+.+|++||++.+++++
T Consensus       228 -----------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 -----------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                   0122468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.8e-38  Score=299.05  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=192.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCC-----CcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|++.+.||+|+||.||++.+...     ...+|+|.+....     ....+|+.+++.+ +|+||+++++.+..   
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   87 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ---   87 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC---
Confidence            34799999999999999999987643     3789999876432     2244789999999 89999999987733   


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCee
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL  225 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nil  225 (429)
                        ...++++|||+.+ ++...+....            .....+++..+..++.||+.||.||| +.||+||||||+|||
T Consensus        88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA-SKKCIHRDLAARNVL  164 (293)
T ss_pred             --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCccccccceeeEE
Confidence              3347899999874 5555543311            22456889999999999999999999 889999999999999


Q ss_pred             ecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014156          226 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD  301 (429)
Q Consensus       226 l~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  301 (429)
                      ++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus       165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99877 799999999986643321   112234567999998865 458999999999999999997 999998766544


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ....+....                            ....+...+..+.+|+.+||..||++|||+.+++++
T Consensus       243 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGY----------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            443322110                            001123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.5e-38  Score=297.48  Aligned_cols=247  Identities=23%  Similarity=0.315  Sum_probs=191.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|.+.+.||+|+||.||+|++.     .++..+++|.+....    ....+|+.+++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-----G   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-----C
Confidence            46999999999999999999854     345678999875432    345679999999999999999998733     3


Q ss_pred             eEEEEEeecch-hhHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP  228 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~  228 (429)
                      ...++||||++ +++.+.+....            .....+++..++.++.||+.||.||| +.||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEcc
Confidence            34789999997 45555543321            11245889999999999999999999 889999999999999998


Q ss_pred             CCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014156          229 HTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLV  304 (429)
Q Consensus       229 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  304 (429)
                      ++ .++|+|||++........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+.+.
T Consensus       159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 799999999976543221   2234567889999988664 48899999999999999999 999997766555433


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+....                   .+         ......+..+.+++.+||..||++|||+.++++
T Consensus       237 ~~~~~~-------------------~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQGR-------------------VL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCCC-------------------CC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            322110                   00         012236889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.7e-38  Score=296.10  Aligned_cols=244  Identities=21%  Similarity=0.306  Sum_probs=188.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCc----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.++||+|+||.||+|++..+++    .||+|.+...     .....+|+.+++.+.|+||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            3469999999999999999999877776    4899987532     22344788899999999999998877421    


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                        ..+++++|++ +++.+.+.   .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        82 --~~~l~~~~~~~g~l~~~l~---~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~iiH~dlkp~Nil~~~~~-~~kL~dfG  154 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVR---ENKDRIGSQDLLNWCVQIAKGMSYLE-EVRLVHRDLAARNVLVKSPN-HVKITDFG  154 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccceEEEcCCC-cEEECCCC
Confidence              2568999987 45555443   22456899999999999999999999 88999999999999998777 79999999


Q ss_pred             CceecccCCCcc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          240 SAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       240 ~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +++.........   ...++..|+|||.+.+. .++.++|||||||++|||++ |..||.......... .......+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~--  230 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERL--  230 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcC--
Confidence            998764332211   12346679999998654 48999999999999999998 899997655433322 22211000  


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                               ..+...+.++.+++.+||..||++|||+.+++.
T Consensus       231 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 -------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     011236889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.4e-38  Score=290.27  Aligned_cols=242  Identities=22%  Similarity=0.322  Sum_probs=190.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      .+|++.+.||+|+||.||++..  .|..||+|.+..+.  ....+|+.+++.++|+|+++++++++...    ...++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceEEEE
Confidence            3699999999999999999976  47889999886543  23457999999999999999988764322    2378999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+++ ++.+.+..  .....+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||+++.....
T Consensus        80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE-ANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            99985 56555433  12235889999999999999999999 88999999999999999887 7999999998765332


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .  ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.+..                
T Consensus       156 ~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  216 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------  216 (256)
T ss_pred             C--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2  23344667999998865 458899999999999999997 999997665444333322110                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                  .......+++.+.++|.+||..+|.+|||+.++++
T Consensus       217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        00122347899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6e-38  Score=292.02  Aligned_cols=243  Identities=25%  Similarity=0.327  Sum_probs=189.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.++||+|+||.||+|++..+ ..||+|.+...   .....+|+.+++.++|+||+++++.+.     . .+.++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence            4699999999999999999988655 46999988643   234567999999999999999987652     1 125799


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+++ ++.+.+..  .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999985 55555532  12345789999999999999999999 88999999999999999877 799999999976643


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....++..|+|||...+. .++.++|+|||||++|+|++ |..||.+....+....+.....            
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------------  221 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------  221 (262)
T ss_pred             cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC------------
Confidence            3321  123456679999988654 48999999999999999999 8889987665544433221100            


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                      ......++..+.+||.+||+.||.+|||+.++++
T Consensus       222 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         222 ----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                            0012346889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.9e-38  Score=298.42  Aligned_cols=254  Identities=19%  Similarity=0.237  Sum_probs=191.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCC----------------cEEEEEEeccch-----hhHHHHHHHHHHcCCCCeecc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETG----------------ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  149 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l  149 (429)
                      .+|++.+.||+|+||.||+|.+..++                ..||+|.+....     ....+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            46999999999999999999876543                468999876432     234579999999999999999


Q ss_pred             ceeeeecCCCCceEEEEEeecchh-hHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCC
Q 014156          150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSR-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP  221 (429)
Q Consensus       150 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp  221 (429)
                      ++++...     ...+++|||+.+ ++...+.....       ....+++..++.++.|++.||.||| +.||+||||||
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH-~~~i~H~dlkp  158 (296)
T cd05051          85 LGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLAT  158 (296)
T ss_pred             EEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccccch
Confidence            9887432     347899999974 55555443211       1126899999999999999999999 88999999999


Q ss_pred             CCeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q 014156          222 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFPG  296 (429)
Q Consensus       222 ~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~  296 (429)
                      +||+++.++ .++|+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999886 799999999876543321   2233457789999988654 48999999999999999998  6788877


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+..+.+............                     ......+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            6655544443322110000                     0000112346789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.5e-38  Score=296.96  Aligned_cols=256  Identities=29%  Similarity=0.461  Sum_probs=196.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      +|++.+.||+|+||.||++++.   .+++.||+|.+....        ....+|+.++..+ +||||+++++++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            3889999999999999999864   467899999875321        2334789999999 599999999887     3


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ....+++||||+.+ ++...+.    ....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH-~~~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLH-QLGIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEEEC
Confidence            33458899999986 4443332    2356899999999999999999999 88999999999999999887 7999999


Q ss_pred             CCceecccCCC--cccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          239 GSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       239 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |+++.......  .....|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+....   
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---  226 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK---  226 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence            99876543322  22346788999999885532 3678999999999999999999999654332222222111000   


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCccccCCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFDELRDP  383 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~  383 (429)
                                            .....+..++..+.++|.+||+.||++|||   +.++|+||||+.+.++
T Consensus       227 ----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         227 ----------------------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             ----------------------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                                  000122346889999999999999999998   5678999999998765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6e-38  Score=291.10  Aligned_cols=235  Identities=24%  Similarity=0.318  Sum_probs=182.8

Q ss_pred             EEccCCcEEEEEEEE--cCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           98 VVGQGSFGIVFQAKC--LETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      .||+|+||.||+|.+  ..++..+|+|++....      ....+|+.+++.++||||+++++++.     .. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence            589999999999964  4567899999875332      23457899999999999999988652     11 2578999


Q ss_pred             cchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      |++++ +.+.+.    ....+++..+..++.|++.||.||| +.||+||||||.||+++.++ .+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLE-ETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            99854 544443    2456899999999999999999999 88999999999999999877 79999999997664332


Q ss_pred             Cc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          249 PN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       249 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..    ....++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+....+.+..             
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------  215 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------  215 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            21    12233578999998854 458889999999999999998 999998766554443332210             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                     ...++..+++++.+||.+||+.||.+||++.+|..
T Consensus       216 ---------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         216 ---------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                           00123357899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-38  Score=295.08  Aligned_cols=244  Identities=22%  Similarity=0.319  Sum_probs=194.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|++.++||.|+||.||+|.+.. +..+|+|.+....    ....+|+.+++.++|+||+++++++..     ....++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   79 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEPVYI   79 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCCeEE
Confidence            469999999999999999999877 8899999886442    345579999999999999999887733     334789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ +|.+.+...  ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~  155 (261)
T cd05148          80 ITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLE-EQNSIHRDLAARNILVGEDL-VCKVADFGLARLIK  155 (261)
T ss_pred             EEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccCcceEEEcCCc-eEEEccccchhhcC
Confidence            9999985 666655432  2356899999999999999999999 88999999999999999887 79999999997653


Q ss_pred             cCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |+.||.+.+..+.+..+......           
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  223 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-----------  223 (261)
T ss_pred             CccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-----------
Confidence            3221 112345677999998865 458899999999999999998 89999887765555544321100           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                       ..+..+++.+.+++.+||..||.+|||+.++++
T Consensus       224 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 -----------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                             112346899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-40  Score=302.86  Aligned_cols=266  Identities=25%  Similarity=0.403  Sum_probs=207.1

Q ss_pred             CCCCccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----------hhHHHHHHHHHHcCCCCeecccee
Q 014156           84 NGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHC  152 (429)
Q Consensus        84 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~l~~~  152 (429)
                      ...+....+|.++..||+|||+.||+|.+....+.||+|+-...+           ...-+|.+|-+.|+||.||++|++
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            334556678999999999999999999999999999999753211           112379999999999999999998


Q ss_pred             eeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCeeecCCCCCCeeecCC--
Q 014156          153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPH--  229 (429)
Q Consensus       153 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~iiHrDlKp~Nill~~~--  229 (429)
                      |....+    .+|.|+|||+|+-++   .|....+-+++.+++.|+.||+.||.||.. +..|||-||||.|||+-..  
T Consensus       536 fslDtd----sFCTVLEYceGNDLD---FYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  536 FSLDTD----SFCTVLEYCEGNDLD---FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             eeeccc----cceeeeeecCCCchh---HHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence            855443    378899999986444   344556789999999999999999999984 3479999999999998421  


Q ss_pred             CCceEEeecCCceecccCCC--------ccccccccccccccccc-C--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 014156          230 THQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIF-G--ATEYTTAIDIWSVGCVLAELLLGQPLFPGES  298 (429)
Q Consensus       230 ~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~--~~~~~~~~DiwslG~il~elltg~~pf~~~~  298 (429)
                      .+.+||+|||+++.+.....        .....||.+|++||.+. +  .+..+.++||||+|||+|.++.|+.||....
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            23799999999998854432        22357899999999874 2  3457899999999999999999999996654


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       299 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                      ....+.+....             .+..++.||.-          +-++.++++||++||++.-.+|..+.++-.||||.
T Consensus       689 sQQdILqeNTI-------------lkAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  689 SQQDILQENTI-------------LKATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             hHHHHHhhhch-------------hcceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence            43332221111             11123334332          24799999999999999999999999999999996


Q ss_pred             c
Q 014156          379 E  379 (429)
Q Consensus       379 ~  379 (429)
                      -
T Consensus       746 P  746 (775)
T KOG1151|consen  746 P  746 (775)
T ss_pred             c
Confidence            5

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.7e-38  Score=293.49  Aligned_cols=244  Identities=25%  Similarity=0.332  Sum_probs=189.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+...     .....+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            469999999999999999999865543   7999987532     234457899999999999999998873     233


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      +.++||||+++ ++.+.+.   .....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            57899999985 4544443   22356899999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      .........    ....++..|+|||.+.+. .++.++|+|||||++|++++ |..||.+.+..+....+.+...     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-----  227 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-----  227 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----
Confidence            866433211    111235679999998654 48999999999999999886 9999987665544433322100     


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                   .          ..+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       228 -------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 -------------L----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -------------C----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                         0          011236889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.7e-38  Score=303.68  Aligned_cols=250  Identities=25%  Similarity=0.346  Sum_probs=188.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      ++|++.+.||+|+||.||+|.+.     .+++.||||.+....     ....+|+.++..+ +|+||+++++++....  
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC--
Confidence            47999999999999999999853     467899999886422     2345799999999 6899999998774322  


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhh------------------------------------------------------
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSR------------------------------------------------------  184 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  184 (429)
                        ..+++||||+++ +|.+.+.....                                                      
T Consensus        85 --~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          85 --GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             --CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence              247799999985 45444432110                                                      


Q ss_pred             ---------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC---ccc
Q 014156          185 ---------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NIS  252 (429)
Q Consensus       185 ---------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~  252 (429)
                               ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++........   ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence                     0124678888999999999999999 88999999999999999877 799999999876533221   112


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 014156          253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  331 (429)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ..++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+................                   
T Consensus       241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  300 (343)
T cd05103         241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-------------------  300 (343)
T ss_pred             CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-------------------
Confidence            2346679999998664 48999999999999999997 99999765433332222211000                   


Q ss_pred             CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                              ...+...++++.+++.+||..||.+|||+.++++|
T Consensus       301 --------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 --------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    00112357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.8e-38  Score=296.75  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=190.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|.+.+.||+|+||.||+|.+.     .++..||+|.+....     ....+|+.+++++ +|+||+++++++...  
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG--  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence            347999999999999999999752     345689999875432     2345799999999 799999999987432  


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                         ..+++||||+.+ +|...+..  .....+++..+..++.||+.||.||| +.||+|+||||+|||++.++ .++|+|
T Consensus       112 ---~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~~l~d  184 (302)
T cd05055         112 ---GPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNVLLTHGK-IVKICD  184 (302)
T ss_pred             ---CceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeehhhhccceEEEcCCC-eEEECC
Confidence               347899999984 55554432  11234899999999999999999999 88999999999999999776 799999


Q ss_pred             cCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014156          238 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       238 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      ||+++.......   .....++..|+|||.+.+.. ++.++||||+||++|+|++ |..||.+....+..........  
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~--  261 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--  261 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC--
Confidence            999876543321   11234567899999986644 8899999999999999998 9999987665444433322100  


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                               ....+...++++.+|+.+||..+|++|||+.++++
T Consensus       262 -------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 -------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                     00012236889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.3e-38  Score=298.79  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=188.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC-------CCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  157 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~  157 (429)
                      .+|.+.+.||+|+||.||+|++..       +...+|+|.+..+.     ....+|+.+++.+ +|+||+++++++..  
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence            479999999999999999998643       23579999886432     2344688999999 79999999998733  


Q ss_pred             CCCceEEEEEeecchh-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCe
Q 014156          158 DKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNL  224 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Ni  224 (429)
                         ....++||||+++ +|.+.+.....            ....+++..++.++.||+.||+||| +.|++||||||+||
T Consensus        96 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~Ni  171 (307)
T cd05098          96 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNV  171 (307)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHHhe
Confidence               2347899999985 66665543211            1235888999999999999999999 88999999999999


Q ss_pred             eecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014156          225 LVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGV  300 (429)
Q Consensus       225 ll~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  300 (429)
                      +++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..
T Consensus       172 ll~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         172 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             EEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999887 799999999876543221   1112235679999998664 48999999999999999998 88999765543


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +....+... .                           ....+..++.++.+||.+||..+|.+|||+.+++++
T Consensus       250 ~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEG-H---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcC-C---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            332222110 0                           001223468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2e-38  Score=290.85  Aligned_cols=228  Identities=27%  Similarity=0.332  Sum_probs=180.1

Q ss_pred             CCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecchh-hHHHHHH
Q 014156          102 GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAK  180 (429)
Q Consensus       102 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  180 (429)
                      |.||.||+|++..+++.||+|.+..... ..+|...+....||||+++++++.     .....++||||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            8899999999999999999999876532 344566666678999999999874     33458899999985 5555443


Q ss_pred             HhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCccccccccccc
Q 014156          181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR  260 (429)
Q Consensus       181 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~  260 (429)
                      .    ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALH-REGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            2    345899999999999999999999 88999999999999999887 7999999987655332  23345577899


Q ss_pred             ccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCccc
Q 014156          261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  340 (429)
Q Consensus       261 aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (429)
                      |||.+.+ ..++.++|+||+||++|+|++|..||.......      .               ...            ..
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---------------~~~------------~~  195 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI------N---------------THT------------TL  195 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---------------ccc------------cc
Confidence            9998854 447889999999999999999998874321100      0               000            00


Q ss_pred             ccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCc
Q 014156          341 IFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFF  377 (429)
Q Consensus       341 ~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f  377 (429)
                      .++..+++.+.+||.+||+.||++|+|+     .++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1234478999999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-37  Score=288.84  Aligned_cols=243  Identities=25%  Similarity=0.326  Sum_probs=189.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|.+.+.||+|+||.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+|++++++++.     . ...++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence            4699999999999999999987554 469999875432   33457999999999999999987652     1 126799


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+.+ ++.+.+...  ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIE-RMNYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 666655431  2345789999999999999999999 88999999999999999887 799999999976543


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....++..|+|||...+. .++.++|||||||++|+|++ |..||.+....+....+.... .           
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~-----------  221 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R-----------  221 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-----------
Confidence            3211  123456779999988654 48999999999999999999 899998876555444332210 0           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                      ...+..++..+.+++++||..||.+||++.++++
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         222 ----------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ----------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            0112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.8e-38  Score=296.53  Aligned_cols=246  Identities=22%  Similarity=0.341  Sum_probs=187.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....     ....+|+.+++.++||||+++++.+..     .
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence            37889999999999999998753     23578888775432     234579999999999999999987733     3


Q ss_pred             eEEEEEeecchh-hHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYS--------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK  220 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~--------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlK  220 (429)
                      ...++++||+.+ ++.+.+....                    .....+++..+..++.|++.||.||| +.||+|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-EMKLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH-HCCeehhhhh
Confidence            347889999984 5554443211                    11235788999999999999999999 8899999999


Q ss_pred             CCCeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 014156          221 PQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPG  296 (429)
Q Consensus       221 p~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~  296 (429)
                      |+|||++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999776 799999999876533221   122345678999998865 448999999999999999998 9999977


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .........+....                            ....+..++.++.+|+.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            65433322211100                            00122347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-37  Score=289.77  Aligned_cols=243  Identities=23%  Similarity=0.307  Sum_probs=190.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|+++++||+|+||.||+|.. .+++.||+|.+....   ....+|+.+++.++|+||+++++.+..      ...+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcEEE
Confidence            4699999999999999999985 457889999886532   345679999999999999999876521      136899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+.+ ++.+.+..  .....+++..+..++.|++.||+||| +.|++||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIE-RKNYIHRDLRAANILVSETL-CCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence            999974 55555432  22356899999999999999999999 88999999999999999887 799999999976643


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....++..|+|||.+.+ ..++.++||||||+++|+|++ |++||.+.+..+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-----------  222 (260)
T ss_pred             CCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----------
Confidence            2211  22345678999998865 448899999999999999999 99999877655444433221000           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                       ..+...+.++.++|.+||..+|++|||+.+++.
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 -----------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                             012346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=316.48  Aligned_cols=206  Identities=27%  Similarity=0.376  Sum_probs=170.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc-----chhhHHHHHHHHHHcCCCCeeccceeeeecC-CCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTT-DKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~~~~~  164 (429)
                      .-|...+.||+|+||.||+++++.+|+.||||.+..     ..+..-+|+++|++|+|+|||++.++-.... ..-...-
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            358888999999999999999999999999998865     2344558999999999999999876432111 0002234


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CCCceEEeecCCc
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA  241 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~~~vkl~DFG~a  241 (429)
                      .+|||||.|+.+.-......+...+++.+.+.++..++.||.||| +.||+||||||.||++-.   ..+.-||+|||.|
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr-En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR-ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            689999996544433333455678999999999999999999999 899999999999998732   1236899999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE  297 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  297 (429)
                      +...++....+.+||+.|.+||++.....|+..+|.|||||++|+++||..||-..
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99999998999999999999999875567999999999999999999999999653

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.5e-38  Score=294.14  Aligned_cols=243  Identities=20%  Similarity=0.299  Sum_probs=185.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc----EEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|++.+.||+|+||+||+|.+..+++    .+++|.+....     .....|+.+++.++||||+++++++..     .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----A   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----C
Confidence            469999999999999999999887776    47777764321     223456677889999999999987621     1


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                       ..++++||+. +++.+.+..   ....+++..+..++.||+.||.||| +.|++||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLE-EHRMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence             2567899987 555555432   3456899999999999999999999 88999999999999999877 799999999


Q ss_pred             ceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          241 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       241 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ++.......   .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+...... ..+......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---  230 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERL---  230 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcC---
Confidence            986543322   1223456789999998654 48999999999999999998 9999987654332 2222210000   


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                              ..+...+.++.+++.+||..||.+|||+.|+++
T Consensus       231 ------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         231 ------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                    011225678999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-37  Score=291.49  Aligned_cols=244  Identities=24%  Similarity=0.326  Sum_probs=189.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..|++.+.||+|+||.||+|.+..+++   .||+|.+...     ......|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence            359999999999999999999887665   6999987542     223457999999999999999988773     333


Q ss_pred             EEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||++++ +.+.+.   ...+.+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~l~~al~~lH-~~g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLS-EMNYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccChheEEEcCCC-cEEECCCccc
Confidence            478999999864 444332   22456899999999999999999999 88999999999999999877 7999999998


Q ss_pred             eecccCCCccc---cc---ccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          242 KVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       242 ~~~~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      ...........   ..   .+..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+.....   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~---  229 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR---  229 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc---
Confidence            76543322111   11   1357999999865 448999999999999999886 9999987665544443321100   


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                     .          ..+..++..+.+++.+||..+|.+||++.+++.
T Consensus       230 ---------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         230 ---------------L----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ---------------C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0          012346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=287.52  Aligned_cols=241  Identities=25%  Similarity=0.371  Sum_probs=190.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||.|+||.||+|..  .|+.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            4699999999999999999986  478999999866543   44579999999999999999998743     2347899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+++ ++.+.+..  .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||.++....
T Consensus        79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLE-EKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccchhcccceEEEeCCC-CEEEccccccccccc
Confidence            999984 66555433  11236899999999999999999999 88999999999999999877 799999999987632


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      ...  ....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+...               +
T Consensus       155 ~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------~  216 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------------Y  216 (256)
T ss_pred             ccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------------C
Confidence            221  23345679999988654 48889999999999999997 99999766544333222110               0


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                   ....+..+++.+.++|.+||..+|.+|||+.+++.
T Consensus       217 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 -------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         00112346899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-37  Score=290.50  Aligned_cols=244  Identities=22%  Similarity=0.304  Sum_probs=189.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|+..+.||+|+||.||+|.+..++.   .+|+|.+...     ......|+++++.++|+||+++.+++..     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-----FK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----CC
Confidence            368899999999999999999876654   7999987543     2234578999999999999999988733     23


Q ss_pred             EEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||++++ +...+.   .....+++..+..++.|++.||+||| +.||+||||||+||+++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLS-DMNYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEEcCCC-cEEECCCccc
Confidence            478999999864 333332   23457899999999999999999999 88999999999999999877 7999999998


Q ss_pred             eecccCCCcc----cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ..........    ....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......+   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---  230 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---  230 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence            7664322111    1122456999998865 448899999999999999997 999998766555444443211000   


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                               ....++.++.+++.+||..+|++||++.++++
T Consensus       231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                     11236789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=312.30  Aligned_cols=263  Identities=28%  Similarity=0.409  Sum_probs=216.2

Q ss_pred             CccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCce
Q 014156           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        87 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      +...+.|.+.++||.|.+|.||+++.+.+++..|+|+...+   .+.++.|.++++.+ .|||++.+|++|+........
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            33445699999999999999999999999999999987543   45566788898877 699999999999877767777


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+|+|||||++ +..++.+...  +.++.|.++..|++.++.||.+|| +..++|||||-.|||++.++ .|||+|||++
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH-~nkviHRDikG~NiLLT~e~-~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH-NNKVIHRDIKGQNVLLTENA-EVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh-hcceeeecccCceEEEeccC-cEEEeeeeee
Confidence            89999999995 5566666544  788999999999999999999999 88999999999999999998 7999999998


Q ss_pred             eecccC-CCcccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKG-EPNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ...... ....+.+|||+|||||++...    ..|+.++|+||||++..||.-|.+|+-+......+..|..   .|+..
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPk  247 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPK  247 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCcc
Confidence            665433 344567899999999998543    3477899999999999999999999977665554443321   11111


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                             ..-+++-+.++.+||..||.+|-.+||+..++|+|||+.+
T Consensus       248 -----------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  248 -----------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             -----------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence                                   0112345789999999999999999999999999999985

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2e-37  Score=304.55  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=191.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHHcC-CCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~  158 (429)
                      ..+|.+.+.||+|+||.||+|++.     .+++.||+|++....     ....+|++++..+. ||||+++++++...  
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence            346889999999999999999864     345789999986432     23457999999997 99999999887432  


Q ss_pred             CCceEEEEEeecch-hhHHHHHHHhhh-----------------------------------------------------
Q 014156          159 KDELYLNLVLEFVP-ETVYRVAKHYSR-----------------------------------------------------  184 (429)
Q Consensus       159 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  184 (429)
                         ..+++||||+. |+|.+.+.....                                                     
T Consensus       114 ---~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         114 ---GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ---CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence               34789999998 455555532110                                                     


Q ss_pred             -----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          185 -----------------------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       185 -----------------------------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                                                               ....+++..+..++.||+.||.||| +.||+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrdlkp~N  269 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA-SKNCVHRDLAARN  269 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh-cCCcCcccCCcce
Confidence                                                     1124677788899999999999999 8899999999999


Q ss_pred             eeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014156          224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG  299 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  299 (429)
                      ||++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.....
T Consensus       270 iLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         270 VLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            9999776 799999999986533221   2234567889999998654 48899999999999999998 8999977655


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+..........                           ....+..++.++.+||.+||..+|.+||++.++++.
T Consensus       348 ~~~~~~~~~~~~---------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         348 NEQFYNAIKRGY---------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             hHHHHHHHHcCC---------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            444333322100                           001223468999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-37  Score=289.45  Aligned_cols=242  Identities=23%  Similarity=0.319  Sum_probs=189.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+...   .....+|+.+++.++|+|++++++++.     . ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEEE
Confidence            46999999999999999999865 5667999988643   234568999999999999999987652     1 125799


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+++ ++.+.+..  .....+++..++.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE-RMNYIHRDLRSANILVGDGL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence            999975 55554432  12345899999999999999999999 78999999999999999877 799999999977643


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+..+....+.....            
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  221 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR------------  221 (260)
T ss_pred             cccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            3221  12234567999998865 448899999999999999999 8999987665554444322100            


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  372 (429)
                                      ...+...+..+.+|+.+||..||.+|||+.++.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         222 ----------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                            011234688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-37  Score=288.82  Aligned_cols=236  Identities=23%  Similarity=0.277  Sum_probs=181.6

Q ss_pred             EEccCCcEEEEEEEEc--CCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeec
Q 014156           98 VVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      .||+|+||.||+|.+.  .++..||+|++....     ....+|+.+++.++|+||+++++++.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999765  445679999875432     23457999999999999999988762     1 136799999


Q ss_pred             chhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC
Q 014156          171 VPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  249 (429)
Q Consensus       171 ~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~  249 (429)
                      ++++ |.+.+.   .....+++..++.++.||+.||.||| +.|++||||||+|||++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLS---GKKDEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            9854 443332   23457899999999999999999999 88999999999999999877 799999999876533321


Q ss_pred             c----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          250 N----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       250 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .    ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+.+.. .            
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C------------
Confidence            1    112235679999988654 48899999999999999996 999998776555433332210 0            


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                     ...+...++++.++|.+||..||++||++.++.+
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0122346899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-38  Score=293.34  Aligned_cols=236  Identities=19%  Similarity=0.249  Sum_probs=179.6

Q ss_pred             eEEccCCcEEEEEEEEcCCCc-------EEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           97 RVVGQGSFGIVFQAKCLETGE-------TVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +.||+|+||.||+|.+..++.       .+|+|.+....    ....+|+.+++.++||||+++++.+....     ..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence            368999999999999865543       48888765432    23456888999999999999999885432     367


Q ss_pred             EEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc-------eEEee
Q 014156          166 LVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-------VKLCD  237 (429)
Q Consensus       166 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~-------vkl~D  237 (429)
                      +||||++++ |...+.   .....+++..+..++.||+.||.||| +.||+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLK---KNKNLINISWKLEVAKQLAWALHFLE-DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence            899999865 444332   22346899999999999999999999 8899999999999999876532       79999


Q ss_pred             cCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       238 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ||++......   ....++..|+|||.+.+...++.++|||||||++|+|++|. +||...+...... ....       
T Consensus       152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------  220 (258)
T cd05078         152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------  220 (258)
T ss_pred             cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-------
Confidence            9998655322   23467888999999876556889999999999999999995 6665544332221 1110       


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                            ...++...+.++.+||.+||+.||.+|||+.++++.
T Consensus       221 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                  001223356789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=295.51  Aligned_cols=254  Identities=20%  Similarity=0.272  Sum_probs=189.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCC--------------cEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETG--------------ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKH  151 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~  151 (429)
                      .+|++.+.||+|+||.||+|++..++              ..||+|.+....     ....+|+++++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            46999999999999999999875432              358999886431     23457999999999999999999


Q ss_pred             eeeecCCCCceEEEEEeecchh-hHHHHHHHhh--------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCC
Q 014156          152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYS--------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ  222 (429)
Q Consensus       152 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~  222 (429)
                      ++..     ....++||||+.+ ++.+.+....        .....+++..+..++.|++.||.||| +.|++||||||+
T Consensus        85 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~  158 (295)
T cd05097          85 VCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-SLNFVHRDLATR  158 (295)
T ss_pred             EEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH-hcCeeccccChh
Confidence            8843     2347899999985 4544443211        01124688889999999999999999 889999999999


Q ss_pred             CeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 014156          223 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFPGE  297 (429)
Q Consensus       223 Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~  297 (429)
                      ||+++.++ .+||+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+|++  |..||...
T Consensus       159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999877 799999999876533321   1122346789999988654 48999999999999999998  66888776


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      +..+.+..+.+.......       ..     .         ...++.+++.+.+|+.+||..||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-------~~-----~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         237 SDEQVIENTGEFFRNQGR-------QI-----Y---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ChHHHHHHHHHhhhhccc-------cc-----c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            655544443331100000       00     0         0012336889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-37  Score=290.09  Aligned_cols=248  Identities=21%  Similarity=0.372  Sum_probs=194.2

Q ss_pred             eeEeeEEccCCcEEEEEEEEcC-CCcEEEEEEeccch--------------hhHHHHHHHHH-HcCCCCeeccceeeeec
Q 014156           93 YMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK--------------RYKNRELQTMR-LLDHPNVVSLKHCFFST  156 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~-~l~h~~iv~l~~~~~~~  156 (429)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++. .++||||+++++.+.. 
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-   80 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-   80 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-
Confidence            8889999999999999999887 68899999774211              11235677665 4799999999998743 


Q ss_pred             CCCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          157 TDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                          ..+.+++|||+.+ ++.+.+.........+++..++.++.|++.||.|||+..|++|+||||+||+++.++ .++|
T Consensus        81 ----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l  155 (269)
T cd08528          81 ----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTI  155 (269)
T ss_pred             ----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEE
Confidence                3458899999975 565655544444567999999999999999999999446899999999999999887 7999


Q ss_pred             eecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +|||++.............|+..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+.......+......+  
T Consensus       156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  232 (269)
T cd08528         156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--  232 (269)
T ss_pred             ecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--
Confidence            999999876554444456788899999998764 48999999999999999999999997665544433332211000  


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                               .....+++.+.++|.+||..||++|||+.|+..+
T Consensus       233 -------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 -------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                     0112367899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.7e-38  Score=290.69  Aligned_cols=237  Identities=19%  Similarity=0.207  Sum_probs=177.9

Q ss_pred             eEEccCCcEEEEEEEEcC------------CCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           97 RVVGQGSFGIVFQAKCLE------------TGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      +.||+|+||.||+|+...            ....+|+|.+....    ....+|+.+++.++||||+++++++...    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            368999999999998532            22358888765432    2334678899999999999999987432    


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC------ceE
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH------QVK  234 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~------~vk  234 (429)
                       ...++||||++++.++....  .....+++..+..++.||+.||.||| +.||+||||||+|||++.++.      .++
T Consensus        77 -~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          77 -VENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLE-DKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             -CCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhh-hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence             23679999999765444322  23456899999999999999999999 889999999999999976542      289


Q ss_pred             EeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          235 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       235 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      ++|||++......   ....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+.. .....    
T Consensus       153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~----  224 (262)
T cd05077         153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG----  224 (262)
T ss_pred             eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc----
Confidence            9999998654322   23457888999998865566899999999999999998 588888765432221 11110    


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                .+               ......++++.+||.+||..||.+||++.+++++
T Consensus       225 ----------~~---------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 ----------QC---------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ----------Cc---------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                      00               0011246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-37  Score=292.89  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=189.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|.+.++||+|+||.||+|...     .++..+|+|.+...    .....+|+++++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence            36889999999999999999743     35678999987542    2345679999999999999999887733     2


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSR-----------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH  229 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~-----------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~  229 (429)
                      ...+++|||+.+ ++.+.+.....           ....+++..++.++.||+.||.||| +.||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH-HCCeecccccHhhEEEcCC
Confidence            347899999984 55555433110           0135788999999999999999999 8899999999999999987


Q ss_pred             CCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014156          230 THQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE  305 (429)
Q Consensus       230 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  305 (429)
                      + .+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+....
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            6 799999999876533221   1223346789999988654 48999999999999999998 9999977665554433


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      +....  +                          ...+..+++.+.+||.+||+.||.+||++.+++.
T Consensus       237 ~~~~~--~--------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGR--E--------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCc--c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            32210  0                          0112346899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-37  Score=295.60  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=189.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC-------CCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeec
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  156 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~  156 (429)
                      ..+|.+.+.||+|+||.||+|++..       ....+|+|.+....     ....+|+.+++.+ +||||+++++++.. 
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-   89 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-   89 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence            3579999999999999999998642       34579999876432     2234789999999 69999999998733 


Q ss_pred             CCCCceEEEEEeecchh-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          157 TDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                          ..++++||||+.+ +|.+.+.....            ....+++..+..++.||+.||.||| +.||+||||||+|
T Consensus        90 ----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~N  164 (314)
T cd05099          90 ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE-SRRCIHRDLAARN  164 (314)
T ss_pred             ----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH-HCCeeecccccee
Confidence                3347899999984 56555543211            1245888999999999999999999 8899999999999


Q ss_pred             eeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014156          224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG  299 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  299 (429)
                      ||++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999887 799999999976543211   111223467999999865 458999999999999999999 8999977665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+....+....                            ....+..++.++.+||.+||..||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         243 EELFKLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            44443322110                            00112346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-37  Score=291.38  Aligned_cols=240  Identities=23%  Similarity=0.327  Sum_probs=182.1

Q ss_pred             EEccCCcEEEEEEEEcCCCc--EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEee
Q 014156           98 VVGQGSFGIVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      .||+|+||.||+|++..++.  .+|+|.+...     .....+|+.++..+ +||||+++++++..     ..+.++|||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEEE
Confidence            68999999999999888775  4688877532     12345799999999 89999999998743     334789999


Q ss_pred             cch-hhHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          170 FVP-ETVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       170 ~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                      |+. ++|.+.+.....            ....+++..++.++.|++.||+||| +.|++||||||+||+++.++ .+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nili~~~~-~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENY-VAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccccceEEEcCCC-eEEEC
Confidence            997 466665543211            1235789999999999999999999 88999999999999999887 79999


Q ss_pred             ecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |||++..............+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...      
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------  227 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------  227 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------
Confidence            9999854322111112233567999998855 458999999999999999997 99999776554433332110      


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                               +             ....+..++.++.+|+.+||..||.+|||+.++++
T Consensus       228 ---------~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 ---------Y-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ---------C-------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                     0             00012236789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.8e-37  Score=286.24  Aligned_cols=244  Identities=21%  Similarity=0.321  Sum_probs=190.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+...   .....+|+++++.++|||++++++++.     .....++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence            36999999999999999999875 4678999987643   234567999999999999999988773     33357899


Q ss_pred             eecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+.++ |.+.+.   .....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++.....
T Consensus        78 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLE-SSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            9999865 333322   22356889999999999999999999 88999999999999999776 799999999876543


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+....             
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-------------  218 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-------------
Confidence            3211  122345679999988654 48899999999999999998 999997766544444332110             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                     ....+...+..+.+|+.+||..+|.+|||+.+++++
T Consensus       219 ---------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 ---------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                           000112357899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-37  Score=292.01  Aligned_cols=259  Identities=25%  Similarity=0.371  Sum_probs=187.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEE----cCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           92 SYMAERVVGQGSFGIVFQAKC----LETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      +|++.+.||+|+||.||+|..    ..+++.||+|.+....    ....+|+++++.++||||+++++++....   ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CCc
Confidence            699999999999999999973    4578899999885432    23457999999999999999988764432   234


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +++||||++ ++|.+.+..   ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH-~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~  156 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLG-SKRYVHRDLATRNILVESEN-RVKIGDFGLTK  156 (284)
T ss_pred             eEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHhhEEECCCC-eEEECCCcccc
Confidence            789999997 455554432   2346899999999999999999999 88999999999999999887 79999999998


Q ss_pred             ecccCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHH
Q 014156          243 VLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-TPTREE  317 (429)
Q Consensus       243 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~  317 (429)
                      ........    ....++..|+|||.+.+. .++.++|||||||++|+|++|..++..... .....+..... ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHH
Confidence            65433221    112234569999998654 488999999999999999999877643321 11110000000 000000


Q ss_pred             H-hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 I-KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      + ..+...             ........++.++.+||.+||..+|++|||+.++++
T Consensus       235 ~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         235 LIELLKNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHhcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0 000000             000122457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-37  Score=286.73  Aligned_cols=236  Identities=26%  Similarity=0.357  Sum_probs=183.3

Q ss_pred             eEEccCCcEEEEEEEEcCCC---cEEEEEEeccchh-----hHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLETG---ETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ++||+|+||.||+|.+..++   ..+|+|.+.....     ...+|+.+++.++|+||+++++++.     .. ..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence            46999999999999876554   7899998764432     3457899999999999999988652     11 267999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+.+ ++.+.+..    ...+++..+..++.|++.||.||| ..|++||||||+|||++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh-hcCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            99875 55554432    347899999999999999999999 88999999999999999887 7999999999866443


Q ss_pred             CCcc----cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          248 EPNI----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       248 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ....    ...++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+.... .          
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~----------  216 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-R----------  216 (257)
T ss_pred             CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c----------
Confidence            3211    11234579999988654 48999999999999999998 999998766544433322210 0          


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                       ...+..++..+.++|.+||..||.+|||+.++++
T Consensus       217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             0112346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-37  Score=294.73  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=190.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc-------CCCcEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeec
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFST  156 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~  156 (429)
                      ..+|.+.+.||+|+||.||+|++.       .++..||+|.+...     .....+|+.+++.+ +||||+++++++.. 
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence            457999999999999999999753       23457999987542     13345799999999 89999999998733 


Q ss_pred             CCCCceEEEEEeecchh-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          157 TDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                          ....++||||+.+ +|.+.+.....            ....+++..+..++.||+.||.||| +.||+||||||+|
T Consensus        93 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~N  167 (304)
T cd05101          93 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA-SQKCIHRDLAARN  167 (304)
T ss_pred             ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH-HCCeeecccccce
Confidence                3347899999985 55555543211            1235788889999999999999999 8899999999999


Q ss_pred             eeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014156          224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG  299 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  299 (429)
                      |+++.++ .+||+|||+++.......   .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus       168 ili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         168 VLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999877 799999999987643221   1223456789999998664 48899999999999999998 7889977665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+....+....                            ....+..++.++.+||.+||..+|.+|||+.++++.
T Consensus       246 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            44433322110                            001123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=303.41  Aligned_cols=260  Identities=27%  Similarity=0.366  Sum_probs=187.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ++.|.-...||+|+||.||+|... +|..||||++....    ..+.+|+.++.+++|||+|+++++|.....    ..+
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~  148 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRL  148 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEE
Confidence            356888889999999999999864 45899999885432    347789999999999999999999965432    377


Q ss_pred             EEeecchh-hHHHHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHHHcCC--CeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALAYIHGGI--GVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ||+||+.. +|.+.+..   ... .++|.....|+.++++||+|||...  .|||||||++|||||.+. ++||+|||+|
T Consensus       149 LVYEym~nGsL~d~L~~---~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa  224 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHG---KKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA  224 (361)
T ss_pred             EEEEccCCCCHHHHhCC---CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence            99999995 55454432   222 8899999999999999999999544  499999999999999887 7999999999


Q ss_pred             eeccc-CCCcccc-cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHH-HHhCCCCHH
Q 014156          242 KVLVK-GEPNISY-ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES--GVDQLVEII-KVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~-~~~~~~~~~  316 (429)
                      +.... ....... .||..|+|||.+.. ...+.++|||||||+|+||+||+.+.....  ....+.... ..+...   
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---  300 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---  300 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence            66543 2222222 79999999999865 448999999999999999999998876432  111122211 111111   


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCC-CCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                             ...++--|.+...    .+.. ..-..+..+..+|++.+|.+||+..++++
T Consensus       301 -------~~~eiiD~~l~~~----~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 -------KLREIVDPRLKEG----EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             -------chhheeCCCccCC----CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                   0111111111100    0000 01123667888999999999999999753

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-37  Score=287.16  Aligned_cols=245  Identities=24%  Similarity=0.323  Sum_probs=192.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||.||+|.+. .+..||+|.+...   .....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence            347999999999999999999875 4578999988643   234567999999999999999988763     2234789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+.+ ++.+.+..  .....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh-~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999975 55554432  12346899999999999999999999 88999999999999999887 79999999987664


Q ss_pred             cCCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .....  ....++..|+|||.+.+ ..++.++|+||+||++|+|++ |+.||.+.+....+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------  223 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32111  12234567999998865 448899999999999999998 99999877665555544321100          


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                        ..+...+.++.+++.+||..+|.+|||+.++++
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 ------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                              112235789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.7e-37  Score=286.48  Aligned_cols=239  Identities=25%  Similarity=0.334  Sum_probs=187.3

Q ss_pred             eEEccCCcEEEEEEEEcC-CC--cEEEEEEeccchh-----hHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLE-TG--ETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|++|.||+|.+.. ++  ..||+|.+.....     ...+|+.+++.++||||+++++.+..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999865 33  3699998865433     34579999999999999999988743      3578999


Q ss_pred             ecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||++ +++.+.+....  ...+++..++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLE-SKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHH-hCCccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 55655554321  146899999999999999999999 88999999999999999887 7999999999876442


Q ss_pred             CC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          248 EP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       248 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ..    .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......          
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------  219 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER----------  219 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc----------
Confidence            21    112346778999998865 448999999999999999998 99999877666554444321000          


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                       ...+..++..+.+++.+||..+|++|||+.++++
T Consensus       220 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         220 -----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                             0012246889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-37  Score=293.99  Aligned_cols=254  Identities=19%  Similarity=0.258  Sum_probs=188.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC----------------CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeecc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  149 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l  149 (429)
                      .+|++.+.||+|+||.||+|.+..                ++..+|+|.+....     ....+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            369999999999999999986432                34579999886432     234579999999999999999


Q ss_pred             ceeeeecCCCCceEEEEEeecchh-hHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCC
Q 014156          150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSR-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP  221 (429)
Q Consensus       150 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp  221 (429)
                      ++++...     ...++||||+.+ ++.+.+.....       ....+++..+..++.||+.||.||| +.||+||||||
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dlkp  158 (296)
T cd05095          85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLAT  158 (296)
T ss_pred             EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCeecccCCh
Confidence            9987432     247899999974 66555543221       1134778889999999999999999 88999999999


Q ss_pred             CCeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q 014156          222 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFPG  296 (429)
Q Consensus       222 ~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~  296 (429)
                      +|||++.++ .++|+|||+++.......   .....++..|+|||...+. .++.++|+|||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999877 799999999876533221   1122345779999987654 48999999999999999998  7789977


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+..+.+.........           .......          ..+..+++.+.+|+.+||..||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~-----------~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFRD-----------QGRQVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHhh-----------ccccccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6554444332211100           0000000          012346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-37  Score=289.21  Aligned_cols=242  Identities=26%  Similarity=0.382  Sum_probs=185.4

Q ss_pred             eEeeEEccCCcEEEEEEEEc----CCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           94 MAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        94 ~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...     .....+|++.++.++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999987    34678999998532     2344579999999999999999998863222     7


Q ss_pred             EEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++|+||+. ++|.+.+...  ....+++.....++.||+.||.||| +.+|+|+||+++|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLH-SNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHH-HTTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--ccccccccccccccccccccccccc-cccccccccccccccccccc-cccccccccccc
Confidence            89999998 5666666542  2467899999999999999999999 78999999999999999887 899999999987


Q ss_pred             cccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          244 LVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       244 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ......   .....+...|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+.+..         
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------  222 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------  222 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE---------
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---------
Confidence            632221   12234567899999986644 8999999999999999999 789998876666555543210         


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                         ....+..++..+.++|.+||..||.+|||+.++++
T Consensus       223 -------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 -------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                               01123347899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.7e-37  Score=290.39  Aligned_cols=249  Identities=19%  Similarity=0.243  Sum_probs=190.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC----CCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|.+.+.||+|+||.||+|.+..    ++..|++|.+...     .....+|+.+++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            3479999999999999999999875    3578999987543     22345789999999999999999876543    


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRA----SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                      ....+++++|++ +++...+......    ...+++..+..++.||+.||+||| +.+++||||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KRGVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCHhhEEEcCCC-cEEE
Confidence            223678999987 4555554432211    146899999999999999999999 88999999999999999877 7999


Q ss_pred             eecCCceecccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014156          236 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  311 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  311 (429)
                      +|||+++.+......   ....++..|+|||.+.+. .++.++|||||||++|++++ |+.||...+..+....+.... 
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-  236 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-  236 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence            999999765433211   123456679999998654 48999999999999999999 999998765544322221100 


Q ss_pred             CCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                       ..          .....+++++.+++.+||..||++|||+.++++
T Consensus       237 -----------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 -----------------RL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------------CC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                             00          011236789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-37  Score=297.85  Aligned_cols=248  Identities=21%  Similarity=0.314  Sum_probs=189.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC-------CcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET-------GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  157 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~  157 (429)
                      .+|++.+.||+|+||.||+|++...       +..||+|.+....     ....+|+.+++.+ +||||+++++++..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            4699999999999999999986432       2368999775421     2345789999999 89999999998743  


Q ss_pred             CCCceEEEEEeecchh-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCe
Q 014156          158 DKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNL  224 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Ni  224 (429)
                         ...+++++||+++ +|.+.+.....            ....++...+..++.||+.||.||| +.||+||||||+||
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~Ni  165 (334)
T cd05100          90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA-SQKCIHRDLAARNV  165 (334)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccceE
Confidence               3347899999985 55555543210            1234778888999999999999999 88999999999999


Q ss_pred             eecCCCCceEEeecCCceecccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChH
Q 014156          225 LVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGV  300 (429)
Q Consensus       225 ll~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  300 (429)
                      |++.++ .+||+|||+++........   ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..
T Consensus       166 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         166 LVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             EEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999887 7999999999765432211   122335679999998654 48899999999999999998 88999876654


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +....+....                            ....+..++.++.+||.+||..+|.+|||+.+++++
T Consensus       244 ~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         244 ELFKLLKEGH----------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            4443332110                            001123468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-37  Score=289.86  Aligned_cols=244  Identities=25%  Similarity=0.324  Sum_probs=190.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCc----EEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.+.||+|+||.||+|.+..+|+    .+|+|......     ....+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3479999999999999999999876665    58999775432     234579999999999999999987753     


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                       ...++||||+.+ ++.+.+.   .....+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~di~p~nil~~~~~-~~kL~dfg  154 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLE-EKRLVHRDLAARNVLVKTPQ-HVKITDFG  154 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHH-hCCEEecccCcceEEEcCCC-eEEECCCc
Confidence             237789999975 4544432   23456899999999999999999999 78999999999999999877 79999999


Q ss_pred             CceecccCCCccc---ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          240 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       240 ~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +++..........   ..++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+....+....+.... .   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~---  229 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-R---  229 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-C---
Confidence            9987643332211   123567999998854 458899999999999999998 999998776544333332210 0   


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                              ...+...+..+.+++.+||..||++|||+.++++
T Consensus       230 ------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 ------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                    0112235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-37  Score=285.99  Aligned_cols=242  Identities=26%  Similarity=0.377  Sum_probs=191.0

Q ss_pred             eEeeEEccCCcEEEEEEEEcCCC----cEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           94 MAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        94 ~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ++.+.||.|+||.||++++..++    ..||+|.+....     .....|+.+++.++|+||+++++.+...     ...
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence            46789999999999999998766    899999886432     2445799999999999999999887433     358


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++|||+.+ ++.+.+....  ...+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++..
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh-~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~  152 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLE-SKNFIHRDLAARNCLVGENL-VVKISDFGLSRD  152 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHh-cCCeeecccccceEEEccCC-eEEEcccCCcee
Confidence            899999975 5555543311  122899999999999999999999 88999999999999999887 799999999987


Q ss_pred             cccCCCcc--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          244 LVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       244 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ........  ...++..|+|||.+.+ ..++.++|+||+||++|+|++ |.+||...+.......+.....         
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  222 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------  222 (258)
T ss_pred             cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence            65442221  1236788999998854 458999999999999999998 8899987665555444332100         


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                         ...+..++.++.+++.+||..||.+|||+.++++
T Consensus       223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                               0112236889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-37  Score=288.04  Aligned_cols=245  Identities=21%  Similarity=0.286  Sum_probs=180.2

Q ss_pred             EEccCCcEEEEEEEEcC--CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeec
Q 014156           98 VVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      .||+|+||.||+|....  ....+|+|.+....     ....+|+.+++.++|+||+++++.+..     ....++||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEEe
Confidence            58999999999996532  34578888764321     233578899999999999999988743     3347899999


Q ss_pred             chh-hHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          171 VPE-TVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       171 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      +++ +|.+.+..... .....++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH-hcCEecccccHhheEecCCC-cEEEeccccccccccch
Confidence            985 55555543221 1233567888999999999999999 88999999999999999887 79999999986543221


Q ss_pred             C---cccccccccccccccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          249 P---NISYICSRYYRAPELIFG------ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       249 ~---~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      .   .....++..|+|||++..      ...++.++|||||||++|+|++ |..||......+.+..+.......     
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-----  229 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK-----  229 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc-----
Confidence            1   122345677999998742      2346889999999999999999 788998776655544433321100     


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                 .+       ...+...+++.+.+++..|+ .||.+|||+.++++
T Consensus       230 -----------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 -----------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -----------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                       00       11123457888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.8e-37  Score=284.29  Aligned_cols=237  Identities=23%  Similarity=0.356  Sum_probs=183.3

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      +.||+|+||.||+|.. .++..+|+|.+....     ....+|+.+++.++||||+++++++..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            3689999999999985 468899999875432     234579999999999999999988743     23478999999


Q ss_pred             hhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc
Q 014156          172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  250 (429)
Q Consensus       172 ~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~  250 (429)
                      +++ +.+.+.   .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++.........
T Consensus        75 ~~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLE-SKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            854 443332   23356889999999999999999999 88999999999999999877 7999999998754332211


Q ss_pred             c--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          251 I--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       251 ~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .  ...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+....                 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  211 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----------------  211 (250)
T ss_pred             cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            1  1233567999998865 448899999999999999998 999998766544433322110                 


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                 ....+..++..+.+|+.+||..+|++|||+.++++
T Consensus       212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       00122346899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-37  Score=291.01  Aligned_cols=236  Identities=19%  Similarity=0.216  Sum_probs=177.8

Q ss_pred             EEccCCcEEEEEEEEcCC------------------------CcEEEEEEeccch----hhHHHHHHHHHHcCCCCeecc
Q 014156           98 VVGQGSFGIVFQAKCLET------------------------GETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSL  149 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l  149 (429)
                      .||+|+||.||+|....+                        ...||+|.+....    ....+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999975322                        2358888775432    233467888999999999999


Q ss_pred             ceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC
Q 014156          150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH  229 (429)
Q Consensus       150 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~  229 (429)
                      ++++...     .+.++||||++++.+..+..  .....+++.++..++.||+.||+||| +.||+||||||+|||++..
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLE-DKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-cCCccCCCCCcccEEEecc
Confidence            9987543     24789999999765443322  23467899999999999999999999 8899999999999999754


Q ss_pred             C------CceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCChHHH
Q 014156          230 T------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQ  302 (429)
Q Consensus       230 ~------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~  302 (429)
                      +      ..+|++|||++......   ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||.+....+.
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence            3      14899999998654222   22356788999998866556899999999999999985 69999976554332


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .. .....                             ..++...++.+.++|.+||+.+|.+|||+.+++++
T Consensus       231 ~~-~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         231 ER-FYEKK-----------------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HH-HHHhc-----------------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            11 11100                             00112246789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4e-37  Score=288.33  Aligned_cols=249  Identities=22%  Similarity=0.276  Sum_probs=190.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .+|++.+.||+|+||.||+|+.+.     +.+.+++|.+....     ....+|+++++.++|+||+++++.+     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            469999999999999999999754     34679999875432     2356799999999999999999877     33


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceE
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRA-----SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  234 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vk  234 (429)
                      ..+.++||||++ ++|.+.+......     ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh-hcCcccCcCccceEEEeCCC-cEE
Confidence            345789999998 4555555432211     126899999999999999999999 88999999999999999887 799


Q ss_pred             EeecCCceecccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014156          235 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  311 (429)
Q Consensus       235 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  311 (429)
                      |+|||++.......  ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+...  
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--  234 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--  234 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence            99999986543221  12233557789999988654 47889999999999999998 78899765544433332210  


Q ss_pred             CCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                               .+.......++..+.++|.+||..||.+|||+.+++.+
T Consensus       235 -------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 -------------------------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             -------------------------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                     00001123478899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-37  Score=291.14  Aligned_cols=256  Identities=25%  Similarity=0.369  Sum_probs=187.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEE----cCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKC----LETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      -|++++.||+|+||.||+|+.    ..++..||+|.+...     .....+|+.+++.++||||+++++++...   +..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            488999999999999999974    457889999987533     13345799999999999999998877432   223


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||+++ +|...+.   .....+++..+..++.||+.||+||| +.||+||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~~i~~aL~~lH-~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEH-QVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccchheEEEcCCC-CEEECCCccc
Confidence            47899999975 4444432   22346899999999999999999999 88999999999999999877 7999999998


Q ss_pred             eecccCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC---
Q 014156          242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT---  314 (429)
Q Consensus       242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~---  314 (429)
                      .........    ....++..|+|||.+.+. .++.++|||||||++|+|++++.|+.....  ..   .+..+...   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~  230 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQM  230 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccc
Confidence            766433221    234456779999988654 488999999999999999998866533211  00   00000000   


Q ss_pred             -HH-HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          315 -RE-EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       315 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                       .. .+......             .....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             00 00000000             0011234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.5e-37  Score=291.89  Aligned_cols=247  Identities=24%  Similarity=0.299  Sum_probs=190.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .+|++.+.||+|+||.||+|.+..     ++..||+|.+...     .....+|+.+++.++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-----   79 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-----   79 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----
Confidence            469999999999999999998743     6789999987543     2335579999999999999999987743     


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhh------------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYS------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP  221 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp  221 (429)
                      ....++||||+++ ++.+.+....                  .....+++..+..++.||+.||.||| +.|++||||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH-~~~i~H~dl~p  158 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS-ERKFVHRDLAT  158 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCeecccccH
Confidence            2347899999985 5655554211                  11134788889999999999999999 88999999999


Q ss_pred             CCeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014156          222 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGE  297 (429)
Q Consensus       222 ~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  297 (429)
                      +||+++.++ .++|+|||++........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       159 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         159 RNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             hheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999887 799999999876533221   1122346679999988654 48999999999999999997 88899776


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      +..+....+....                   .         ...+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 AHEEVIYYVRDGN-------------------V---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHhcCC-------------------C---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            6554443322210                   0         0012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=284.79  Aligned_cols=237  Identities=24%  Similarity=0.351  Sum_probs=183.7

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ++||.|+||.||+|.+.. ++.||+|.+...     .....+|+++++.++|+||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence            469999999999999877 999999987543     2344579999999999999999988743     33478999999


Q ss_pred             hhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc
Q 014156          172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  250 (429)
Q Consensus       172 ~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~  250 (429)
                      .++ +.+.+.   .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~l~~~l~---~~~~~~~~~~~~~~~~~~~~~l~~lH-~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLE-SKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            754 444432   22356889999999999999999999 88999999999999999887 7999999998765322211


Q ss_pred             ---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          251 ---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       251 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                         ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+....                
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----------------  212 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----------------  212 (251)
T ss_pred             eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----------------
Confidence               112235669999988654 48999999999999999999 889997765433333221100                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                  ....+..++.++.+++.+||..+|.+|||+.++++
T Consensus       213 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 ------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                        00112346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.8e-37  Score=285.59  Aligned_cols=246  Identities=20%  Similarity=0.235  Sum_probs=180.0

Q ss_pred             eEEccCCcEEEEEEEEc--CCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEee
Q 014156           97 RVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      +.||+|+||.||+|...  .++..+|+|.+....     ....+|+.+++.++||||+++++++..     ....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence            36899999999999854  355789999875432     234569999999999999999987733     334789999


Q ss_pred             cchh-hHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          170 FVPE-TVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       170 ~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      |+++ ++.+.+..... .....++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||+++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            9984 55555543221 1234567788899999999999999 88999999999999999877 7999999998754332


Q ss_pred             CC---cccccccccccccccccCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          248 EP---NISYICSRYYRAPELIFGA------TEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       248 ~~---~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ..   .....++..|+|||++.+.      ..++.++|||||||++|+|++ |..||......+...........     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----  228 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence            21   1234567889999988532      135789999999999999996 99999776554433221111000     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                 ..+       ...+....++.+.+++.+|+ .+|++|||+.+++.
T Consensus       229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                       000       01112236788999999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.2e-37  Score=285.93  Aligned_cols=243  Identities=28%  Similarity=0.372  Sum_probs=188.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|.+.+.||+|+||.||+|.+...   ...||+|......     ....+|+.+++.++||||+++++++..     . 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~-   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N-   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C-
Confidence            3699999999999999999987544   3578999875432     234579999999999999999987632     1 


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||+.+ ++.+.+..   ....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~H~dl~p~nili~~~~-~~~l~d~g~~  154 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLE-SKRFVHRDIAARNVLVSSPD-CVKLGDFGLS  154 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccChheEEEecCC-CeEEccCcee
Confidence            25689999984 55554432   2346899999999999999999999 88999999999999999877 7999999998


Q ss_pred             eecccCCCcc--cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          242 KVLVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       242 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +.........  ...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+....        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--------  225 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE--------  225 (270)
T ss_pred             eecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            7654332211  2223467999998855 458899999999999999986 999998877655544332210        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                          ....+..++..+.++|.+||..+|.+|||+.+++.
T Consensus       226 --------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         226 --------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             --------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                00122457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.2e-37  Score=283.64  Aligned_cols=243  Identities=25%  Similarity=0.344  Sum_probs=189.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+....   ....+|+.+++.++|+||+++++++..      ...+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v   78 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII   78 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence            46999999999999999999854 45679999876533   334579999999999999999887633      236789


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+++ ++.+.+..  .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASL-VCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence            999974 66655543  12345788889999999999999999 88999999999999999877 799999999876543


Q ss_pred             CCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+.......+.....            
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------  221 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------------  221 (260)
T ss_pred             CCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC------------
Confidence            3221  12234567999999865 448889999999999999999 9999987665444433322100            


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                            .          ......+.++.+++.+||..+|++||++.+++.
T Consensus       222 ------~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 ------M----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ------C----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                  0          011346889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-36  Score=282.35  Aligned_cols=240  Identities=23%  Similarity=0.341  Sum_probs=188.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      .+|++.+.||+|+||.||++..  +++.||+|.+..+  .....+|+.+++.++|||++++++++...      ..++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEEEE
Confidence            4699999999999999999864  7889999988643  23446799999999999999998876321      157899


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+.+ ++.+.+...  ....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE-SKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            99984 666655432  2345889999999999999999999 88999999999999999887 7999999998765322


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                        ......+..|+|||.+.+. .++.++|+|||||++|+|++ |++||...+..+....+.+..                
T Consensus       154 --~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------  214 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----------------  214 (254)
T ss_pred             --CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----------------
Confidence              1223345679999988654 48899999999999999997 999998766544333222110                


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                  .......++..+.+++.+||..+|.+|||+.+++.
T Consensus       215 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         215 ------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        00112346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.1e-37  Score=291.96  Aligned_cols=244  Identities=22%  Similarity=0.309  Sum_probs=187.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc----EEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|++.+.||+|+||.||+|.+..+|.    .+|+|.+....     ....+|+.+++.++||||+++++++...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            468999999999999999999887776    46888775432     1345788999999999999999877421     


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                       ..+++++|+++ ++.+.+.   .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dikp~Nill~~~~-~~kL~Dfg~  155 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPN-HVKITDFGL  155 (303)
T ss_pred             -CceeeehhcCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHh-hcCeeccccccceeeecCCC-ceEEccccc
Confidence             14578999984 5555443   22346889999999999999999999 88999999999999998777 799999999


Q ss_pred             ceecccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          241 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       241 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...... ..+......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---  230 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL---  230 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC---
Confidence            9865433221   12334678999998865 448999999999999999997 8999977653332 2222211000   


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                              ..+...+..+.+++.+||..+|.+||++.++++.
T Consensus       231 ------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         231 ------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    0112357889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.7e-37  Score=284.67  Aligned_cols=239  Identities=22%  Similarity=0.334  Sum_probs=178.1

Q ss_pred             eEEccCCcEEEEEEEEcC---CCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +.||+|+||.||+|.+..   .+..+|+|.+...     .....+|+.+++.++||||+++++.+....    ...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence            368999999999998653   3457999987432     123446888999999999999988654322    2367899


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+.+ ++.+.+.   ......++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIR---SETHNPTVKDLIGFGLQVAKGMEYLA-SKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            99985 4544443   22345677788889999999999999 88999999999999999887 7999999998755332


Q ss_pred             CC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          248 EP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       248 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ..     .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+...  .+        
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~--------  220 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR--------  220 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence            11     1123456789999988654 58999999999999999999 46777665544333222110  00        


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                        ...+..+++.+.+++.+||..+|++||++.++++
T Consensus       221 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         221 ------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                              0012235789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-36  Score=281.97  Aligned_cols=245  Identities=19%  Similarity=0.253  Sum_probs=179.3

Q ss_pred             EEccCCcEEEEEEEEcCC--CcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeec
Q 014156           98 VVGQGSFGIVFQAKCLET--GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      .||+|+||.||++....+  ...+++|.+...     .....+|+.+++.++||||+++++.+..     ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence            599999999999975433  235667765432     2334578888999999999999998743     3347899999


Q ss_pred             chh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC-
Q 014156          171 VPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  248 (429)
Q Consensus       171 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~-  248 (429)
                      +.+ +|...+.........+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .++|+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-KHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            985 555555432222345677788899999999999999 88999999999999999887 79999999986432211 


Q ss_pred             --CcccccccccccccccccCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          249 --PNISYICSRYYRAPELIFGA------TEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       249 --~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                        ......++..|+|||++...      ..++.++|||||||++|+|++ |..||...+..+.+..+......       
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-------  227 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV-------  227 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-------
Confidence              12245678899999987421      235778999999999999997 56788776665555544331100       


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                      ..+...+...+++.+.+++..|| .+|.+|||+.++++
T Consensus       228 ----------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 ----------------KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ----------------ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                            00011122346888999999999 78999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-37  Score=310.55  Aligned_cols=244  Identities=24%  Similarity=0.326  Sum_probs=197.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      +-+..+.||+|+||+||+|+...     ....||||.++...     ..+++|++++..|+|||||++++.+...+.   
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P---  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP---  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe---
Confidence            45667899999999999998642     34689999886543     345789999999999999999999854433   


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhh------cC----CCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSR------AS----QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT  230 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~------~~----~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~  230 (429)
                        ++||+|||. |+|.+.+.....      .+    ..++..+...|+.||+.|+.||- ++.+|||||-..|+||..+.
T Consensus       564 --~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs-~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 --LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS-SHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             --eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCcccccchhhhhceeccce
Confidence              889999999 666666544221      11    23888999999999999999998 88999999999999999887


Q ss_pred             CceEEeecCCceecccCCCcc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014156          231 HQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI  306 (429)
Q Consensus       231 ~~vkl~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i  306 (429)
                       .|||+|||+++.....+...   ...-..+|||||.+.-.+ ++++|||||+||+|||+++ |..||.+....+.+..+
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             89999999998765443321   112256799999997654 9999999999999999997 99999999988887776


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 014156          307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA  371 (429)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~  371 (429)
                      .+.--                            ..-+.++|.++.+|+..||..+|.+||++.||
T Consensus       719 ~~g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  719 RAGQL----------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HcCCc----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            65310                            11245689999999999999999999999987

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-36  Score=281.91  Aligned_cols=234  Identities=20%  Similarity=0.196  Sum_probs=178.0

Q ss_pred             eEEccCCcEEEEEEEEcCCC----------cEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           97 RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ....+|+.+++.++||||+++++++.. .     .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence            46899999999999998776          357888765432   345578999999999999999997754 2     2


Q ss_pred             EEEEeecchhhH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC------ceEEe
Q 014156          164 LNLVLEFVPETV-YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH------QVKLC  236 (429)
Q Consensus       164 ~~lv~e~~~~~l-~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~------~vkl~  236 (429)
                      .++||||+.++. ...+..   ....+++..+..++.||+.||.||| +.||+||||||+|||++.++.      .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLE-DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHh-hCCeecccCccceEEEecCccccCCceeEEeC
Confidence            578999998653 333322   2236899999999999999999999 889999999999999987652      49999


Q ss_pred             ecCCceecccCCCcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      |||++.....   .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+........ ..   . 
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~---~-  222 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QD---Q-  222 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hc---C-
Confidence            9999976543   2234567789999998664 358899999999999999999 57788665422211111 10   0 


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                               ...+......+.++|.+||..+|.+|||+.++++
T Consensus       223 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 -------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                     0001112378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-36  Score=283.44  Aligned_cols=242  Identities=22%  Similarity=0.332  Sum_probs=183.9

Q ss_pred             eEEccCCcEEEEEEEEcCCC------cEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           97 RVVGQGSFGIVFQAKCLETG------ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +.||+|+||.||+|++....      +.+|+|.+...     .....+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36899999999999976443      68999977532     2334579999999999999999988743     23478


Q ss_pred             EEeecch-hhHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC----CceEEee
Q 014156          166 LVLEFVP-ETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCD  237 (429)
Q Consensus       166 lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~----~~vkl~D  237 (429)
                      +||||++ +++...+.....   ....+++..+..++.||+.||.||| +.+++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE-QMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH-hCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999997 455555543221   2245788999999999999999999 88999999999999998654    2699999


Q ss_pred             cCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014156          238 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       238 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      ||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... .  
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--  230 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G--  230 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--
Confidence            999876533221   1123456789999998654 48999999999999999998 99999876654443322110 0  


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                               ....+..++..+.+||.+||..+|.+||++.++++
T Consensus       231 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                     00122346889999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-36  Score=283.17  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=187.7

Q ss_pred             eeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc-e
Q 014156           93 YMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE-L  162 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~-~  162 (429)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++..+.      ....+|+++++.++||||+++++.+......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999865   357899999885431      234578999999999999999987755433222 2


Q ss_pred             EEEEEeecchh-hHHHHHHHh--hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          163 YLNLVLEFVPE-TVYRVAKHY--SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ..+++++|+.+ ++...+...  ......+++..++.++.||+.||+||| +.||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS-SKNFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccchhhEEEcCCC-CEEECccc
Confidence            34678899874 443333221  111235788999999999999999999 88999999999999999877 79999999


Q ss_pred             CceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          240 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       240 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +++.......   .....+++.|++||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.... .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~---  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-R---  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-c---
Confidence            9886543321   1223346779999988654 48889999999999999999 889997765543333222110 0   


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                              .......+..+.+++.+||..+|++|||+.+++++
T Consensus       234 ------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         234 ------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    00112367899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=298.70  Aligned_cols=243  Identities=25%  Similarity=0.348  Sum_probs=189.5

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCc---E-EEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGE---T-VAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~---~-vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      -.+.++||+|+||.||+|+.+..+.   . ||+|....+       ....-+|+++++.++|||||++|++......   
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P---  235 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP---  235 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc---
Confidence            3445799999999999998775422   3 899987642       1233479999999999999999998744332   


Q ss_pred             eEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                        +++|||+|.|+ |.+.+.   .....++..+...++.+.+.||+||| ++++|||||-..|+|++.++ .+||+|||+
T Consensus       236 --l~ivmEl~~gGsL~~~L~---k~~~~v~~~ek~~~~~~AA~Gl~YLh-~k~~IHRDIAARNcL~~~~~-~vKISDFGL  308 (474)
T KOG0194|consen  236 --LMLVMELCNGGSLDDYLK---KNKKSLPTLEKLRFCYDAARGLEYLH-SKNCIHRDIAARNCLYSKKG-VVKISDFGL  308 (474)
T ss_pred             --cEEEEEecCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHhHHHHHH-HCCCcchhHhHHHheecCCC-eEEeCcccc
Confidence              78999999975 444333   33346999999999999999999999 88999999999999999876 689999999


Q ss_pred             ceecccCCCcc-cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          241 AKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       241 a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      ++....-.... ..--...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+....        
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~--------  379 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG--------  379 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC--------
Confidence            87543111111 11234679999999765 69999999999999999998 889999998887777764421        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                         ++...+...+.++..++.+|+..||++|+|+.++.+
T Consensus       380 -------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  380 -------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             -------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                               111223346889999999999999999999998864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=311.48  Aligned_cols=247  Identities=20%  Similarity=0.326  Sum_probs=196.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc-----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..-++.+.||+|+||.||.|.......     .||||.+...     ...+.+|..+|+.++|||||+++++.+....  
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~--  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP--  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence            457788999999999999998764322     4999988643     3344589999999999999999999976333  


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                         .+|++|||.+ +|+..++.-+.   ....++......++.||++|++||+ ++++|||||-..|+||+... .|||+
T Consensus       770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe-~~~fvHRDLAaRNCLL~~~r-~VKIa  844 (1025)
T KOG1095|consen  770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE-SKHFVHRDLAARNCLLDERR-VVKIA  844 (1025)
T ss_pred             ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH-hCCCcCcchhhhheeecccC-cEEEc
Confidence               6789999985 55555543211   1456889999999999999999999 88999999999999999886 89999


Q ss_pred             ecCCceecccCCCccc---ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 014156          237 DFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      |||+|+.+...+....   ..-...|||||.+.. ..++.++|||||||++||++| |..||.+.++.+.+.......  
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--  921 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--  921 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence            9999985443332111   111356999999976 459999999999999999998 889999988877766544421  


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                                +-..+..++..+.++|..||+.+|++||++..|++
T Consensus       922 --------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 --------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             --------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                      01123468899999999999999999999999886

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-35  Score=294.94  Aligned_cols=273  Identities=22%  Similarity=0.267  Sum_probs=180.4

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEc----------------CCCcEEEEEEeccchh------------------hHHHH
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCL----------------ETGETVAIKKVLQDKR------------------YKNRE  134 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~E  134 (429)
                      ...+|.+.++||+|+||.||+|.+.                ..++.||||++.....                  ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                2456799998754321                  11135


Q ss_pred             HHHHHHcCCCCe-----eccceeeeecCC---CCceEEEEEeecchh-hHHHHHHHhh-----------h---------c
Q 014156          135 LQTMRLLDHPNV-----VSLKHCFFSTTD---KDELYLNLVLEFVPE-TVYRVAKHYS-----------R---------A  185 (429)
Q Consensus       135 ~~~l~~l~h~~i-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~---------~  185 (429)
                      +.++.+++|.++     ++++++|.....   ......++|+||+++ +|.+++....           .         .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666667766554     556665543211   112236899999985 4544443210           0         1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCcccc--cccccccccc
Q 014156          186 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSRYYRAPE  263 (429)
Q Consensus       186 ~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~--~gt~~y~aPE  263 (429)
                      ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++.....+......  .+|+.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH-~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            123467788999999999999999 88999999999999999887 7999999999765443322222  3478999999


Q ss_pred             cccCCC---------------------CCCCcchHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          264 LIFGAT---------------------EYTTAIDIWSVGCVLAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       264 ~~~~~~---------------------~~~~~~DiwslG~il~elltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .+....                     ....+.||||+||++|+|++|.. ||.+.......   .+.... ....+.. 
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~~-~~~~~r~-  455 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYDN-DLNRWRM-  455 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhccc-hHHHHHh-
Confidence            875321                     11234799999999999999985 77543221111   000000 0000000 


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCC---CCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP---NLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~R~t~~e~l~hp~f~~  379 (429)
                                 +....+........++.++||+.+||..+|   .+|+|+.|+|+||||..
T Consensus       456 -----------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        456 -----------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             -----------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                       000111111233468999999999999876   68999999999999953

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.1e-36  Score=280.21  Aligned_cols=259  Identities=25%  Similarity=0.342  Sum_probs=187.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEc----CCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .|++.+.||+|+||.||+|...    .+++.||+|.+....     ....+|+++++.+.|+||+++++++..   ....
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence            5888899999999999999864    347899999886443     245679999999999999999887633   2234


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      +.++||||+++ ++.+.+..   ....+++..+..++.|++.||+||| +.||+||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG-SQRYIHRDLAARNILVESED-LVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence            57899999975 55554432   2335899999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCHH
Q 014156          242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK-VLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-~~~~~~~~  316 (429)
                      .........    ....++..|+|||.+.+. .++.++|||||||++++|++|..||.........  +.. ..+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~  233 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVT  233 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHH
Confidence            876532221    122345669999988654 4889999999999999999999998653221100  000 00000000


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+.......            .....+..++.++.+|+.+||..+|.+|||+.|+++
T Consensus       234 ~~~~~~~~~------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         234 RLLELLKEG------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHcC------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000000            000112235789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=255.95  Aligned_cols=215  Identities=23%  Similarity=0.425  Sum_probs=176.8

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHH-HcCCCCeeccceeeeecCCCCc
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMR-LLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~-~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+....+..||+|+||.|=+.++..+|...|+|.+....     ....+|+.+.. ....|++|.+|+.++...+   
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd---  119 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD---  119 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc---
Confidence            33445666788999999999999999999999999885432     22234555543 3479999999998876655   


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                        +++.||.|+.++..+..+.....+.+++..+-+++..++.||.|||++..+||||+||+||||+.+| +||+||||++
T Consensus       120 --vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIs  196 (282)
T KOG0984|consen  120 --VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGIS  196 (282)
T ss_pred             --EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccc
Confidence              8999999998887777777778899999999999999999999999888999999999999999998 7999999999


Q ss_pred             eecccCCCcccccccccccccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFG---ATEYTTAIDIWSVGCVLAELLLGQPLFPG-ESGVDQLVEIIK  308 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~  308 (429)
                      ..+.++-..+.-.|...|||||.+..   ...|+.++||||||+++.||.+++.||.. .+..+++.++.+
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            87766655444567778999998842   34689999999999999999999999974 455566665544

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=8.9e-37  Score=282.43  Aligned_cols=281  Identities=30%  Similarity=0.484  Sum_probs=211.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC---CCcEEEEEEec--cchhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVL--QDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~--~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ...|.++++||.|+|++||++.+..   ..+.||+|.+.  .....+..|+++|..+ .+.||+++.+++     ..+..
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCe
Confidence            3469999999999999999999887   78899999874  3456678899999988 589999999988     44555


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +.+|+||++..-...+.      ..++...++.|++.++.||.++| ..|||||||||.|+|.+.....-.|+|||+|..
T Consensus       110 v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h-~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLH-KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             eEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhh-ccCccccCCCccccccccccCCceEEechhHHH
Confidence            89999999964333221      34778899999999999999999 889999999999999998887889999999862


Q ss_pred             ccc-------------------C--------------------------CCcccccccccccccccccCCCCCCCcchHH
Q 014156          244 LVK-------------------G--------------------------EPNISYICSRYYRAPELIFGATEYTTAIDIW  278 (429)
Q Consensus       244 ~~~-------------------~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  278 (429)
                      ...                   +                          .......||++|+|||++......++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            100                   0                          0001345899999999998888889999999


Q ss_pred             HHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhcCCC------------------CccccCCCcCC----
Q 014156          279 SVGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFKFPQIKA----  335 (429)
Q Consensus       279 slG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~----  335 (429)
                      |.|||+..+++++.||- ..++...+.++...+|.........+...                  |.......+..    
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            99999999999998875 45566666666665554332222111111                  11110001111    


Q ss_pred             CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          336 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       336 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ..+......-.+..+.+|+.+||..||.+|+||+++|+||||.+...
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            11222333345668999999999999999999999999999996543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=301.87  Aligned_cols=250  Identities=30%  Similarity=0.452  Sum_probs=189.7

Q ss_pred             eeEeeEEccCCcEE-EEEEEEcCCCcEEEEEEeccchh-hHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEee
Q 014156           93 YMAERVVGQGSFGI-VFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        93 y~~~~~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      |.-.+.+|.|+-|+ ||+|..  .|+.||||++..+.. ...+|+..|+.- +|||||++|..-     .+..+.||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence            55567899999986 699976  788999999876654 678999999988 599999986533     66778999999


Q ss_pred             cchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CC-CceEEeecCCceecc
Q 014156          170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HT-HQVKLCDFGSAKVLV  245 (429)
Q Consensus       170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~-~~vkl~DFG~a~~~~  245 (429)
                      .|..+|.+++..-............+.++.|++.||++|| +.+||||||||.||||+.   ++ -+++|+|||+|+...
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH-sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH-SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH-hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            9999998888762110111111445778899999999999 799999999999999976   23 379999999999886


Q ss_pred             cCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          246 KGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       246 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      .+...    .+..||-+|+|||++.... -+.++||||+||++|..++| ..||...-..  -.+|...           
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~-----------  728 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTG-----------  728 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcC-----------
Confidence            55432    3456899999999997654 57799999999999999986 7999543221  1222221           


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                         ++.-.   .         +.+....++.+||.+|+.++|..||+|.++|.||||-.
T Consensus       729 ---~~~L~---~---------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  729 ---NYTLV---H---------LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             ---cccee---e---------eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence               11110   1         11111228999999999999999999999999999965

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-36  Score=285.88  Aligned_cols=241  Identities=30%  Similarity=0.453  Sum_probs=191.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCC--C--cEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLET--G--ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~--~--~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .-.+.++||.|-||.||.|.....  |  --||||..+.+     .+.+..|..+|+.++|||||++++++....     
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-----  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-----  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----
Confidence            345567999999999999986532  3  35888987653     344557999999999999999999884322     


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                       ++||||+++ |.|...+   ..+...++......|++||+.||.||| +..+|||||-..|||+.+.. -|||+|||++
T Consensus       465 -~WivmEL~~~GELr~yL---q~nk~sL~l~tL~ly~~Qi~talaYLe-SkrfVHRDIAaRNiLVsSp~-CVKLaDFGLS  538 (974)
T KOG4257|consen  465 -MWIVMELAPLGELREYL---QQNKDSLPLRTLTLYCYQICTALAYLE-SKRFVHRDIAARNILVSSPQ-CVKLADFGLS  538 (974)
T ss_pred             -eeEEEecccchhHHHHH---HhccccchHHHHHHHHHHHHHHHHHHH-hhchhhhhhhhhheeecCcc-eeeecccchh
Confidence             789999998 4444433   345678999999999999999999999 88999999999999998877 6999999999


Q ss_pred             eecccCCCcccccc--cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          242 KVLVKGEPNISYIC--SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       242 ~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +.+.+........|  ..-|||||.+ +...++.++|||.|||+|||++. |..||.+..+.+.+..+.+.-        
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--------  609 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--------  609 (974)
T ss_pred             hhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC--------
Confidence            98866654443344  4459999988 44569999999999999999875 999999876655544333211        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  372 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  372 (429)
                                          +...++++++.+..|+.+||+++|.+||++.++.
T Consensus       610 --------------------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  610 --------------------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             --------------------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                                1124567999999999999999999999987653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.9e-34  Score=262.66  Aligned_cols=238  Identities=38%  Similarity=0.624  Sum_probs=190.2

Q ss_pred             CcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecchh-hHH
Q 014156          103 SFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVY  176 (429)
Q Consensus       103 ~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~  176 (429)
                      +||.||+|.+..+++.+|+|++...     .....+|++.++.++|+|++++++++...     ...++++||+++ ++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence            5899999999888999999988543     34556899999999999999999887432     357899999997 666


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCccccccc
Q 014156          177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS  256 (429)
Q Consensus       177 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt  256 (429)
                      ..+..    ...++...+..++.+++.++.||| +.+|+|+||+|.||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLH-SNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHH-HcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            55433    233889999999999999999999 78999999999999999886 7999999999877655445566788


Q ss_pred             ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCC
Q 014156          257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  336 (429)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (429)
                      ..|+|||.+.+ ..++.++|+||+|+++++|++|..||..........+.........                      
T Consensus       150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------  206 (244)
T smart00220      150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF----------------------  206 (244)
T ss_pred             cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Confidence            89999998864 4478899999999999999999999977433333333222100000                      


Q ss_pred             CcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          337 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       337 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                         ......++.++.+++.+||..+|++||++.++++||||
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence               00001167899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-35  Score=280.18  Aligned_cols=242  Identities=23%  Similarity=0.352  Sum_probs=195.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +....++||.|.||.||.|.+++-...||+|.++.+.   ..+..|+.+|+.++|||+|+++++|..     ..-+|||+
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEEE
Confidence            3556789999999999999999988999999987653   445679999999999999999998843     33378999


Q ss_pred             ecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      |||. |+|++.++...+  ..++......++.||..|++||. .+++|||||-..|+|+..+. .||++|||+++.+.. 
T Consensus       343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLE-kknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtg-  417 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTG-  417 (1157)
T ss_pred             ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHH-Hhhhhhhhhhhhhccccccc-eEEeeccchhhhhcC-
Confidence            9987 888887765333  45777788899999999999999 88999999999999999765 899999999998743 


Q ss_pred             CCcccccc---cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          248 EPNISYIC---SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       248 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...+...|   ..-|.|||.+.- ..++.++|||+|||+|||+.| |..||+|-+..+.+..+.+..             
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-------------  483 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-------------  483 (1157)
T ss_pred             CceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-------------
Confidence            33334444   455999998853 448999999999999999998 889999987655544433311             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  372 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  372 (429)
                           .          -.-+..+++.+.+|++.||+++|++||++.|+-
T Consensus       484 -----R----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  484 -----R----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             -----c----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                 1          112346899999999999999999999998863

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=283.85  Aligned_cols=250  Identities=23%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC-C--cEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET-G--ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+..+.++||+|+||.|++|.+... |  ..||||.+..+.     ..+.+|+.+|.+|+|+|++++|++..+..     
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp-----  184 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP-----  184 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence            3567778999999999999998743 3  468999886543     34568999999999999999999875411     


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                       +-||||++. |+|++.+..  .....|.......|+.||+.|+.||. .+++|||||-..|+||-+.. .|||+|||+.
T Consensus       185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLe-skrlvHRDLAARNlllaspr-tVKI~DFGLm  259 (1039)
T KOG0199|consen  185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLE-SKRLVHRDLAARNLLLASPR-TVKICDFGLM  259 (1039)
T ss_pred             -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhhhheecccc-eeeeecccce
Confidence             558999998 566665544  34567889999999999999999999 88999999999999998765 8999999999


Q ss_pred             eecccCCCcccccc----cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGEPNISYIC----SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      +.+..++......+    ...|+|||.+.. ..++.++|+|++||++|||+| |..||.|....+.+.+|-+....    
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL----  334 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL----  334 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC----
Confidence            98877766543322    345999999965 459999999999999999998 78999999988777765432100    


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                              .-++.++.++.+++..||+.+|.+|||+..|...-+..+
T Consensus       335 ------------------------pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  335 ------------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ------------------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence                                    113458999999999999999999999998865444443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=263.17  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=184.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc-chhhHHHHHHHHH--HcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMR--LLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~--~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+-++.+.||+|.||+||+|++  -|+.||||++.. +.....+|.+|.+  .|+|+||+.+++.-...+ .....++||
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLv  287 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLV  287 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEe
Confidence            3688999999999999999998  688999999865 3445567888876  469999999987654333 456679999


Q ss_pred             eecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-------~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ++|.+ |+|++.+..     ..++...+..+++.++.||+|||.       +..|.|||||..||||.+++ ...|+|+|
T Consensus       288 TdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLG  361 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  361 (513)
T ss_pred             eecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeece
Confidence            99998 777776653     678999999999999999999993       34699999999999999988 79999999


Q ss_pred             CceecccCC-----CcccccccccccccccccCCCCC-----CCcchHHHHHHHHHHHHhC----------CCCCCCCCh
Q 014156          240 SAKVLVKGE-----PNISYICSRYYRAPELIFGATEY-----TTAIDIWSVGCVLAELLLG----------QPLFPGESG  299 (429)
Q Consensus       240 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~elltg----------~~pf~~~~~  299 (429)
                      +|.......     .....+||.+|||||++......     -..+||||||.+|||++..          ++||.+--.
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            997664431     23457899999999998543221     1258999999999999843          467754211


Q ss_pred             ----HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          300 ----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       300 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                          .+.+.++.-.                 ....|.+ ...|..   ...-..+-.|++-||..||.-|.||..+.+
T Consensus       442 ~DPs~eeMrkVVCv-----------------~~~RP~i-pnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCV-----------------QKLRPNI-PNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCHHHHhcceee-----------------cccCCCC-Cccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                1111111100                 0001111 111110   011234667899999999999999987653

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=272.78  Aligned_cols=251  Identities=20%  Similarity=0.274  Sum_probs=193.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ....+.++||+|-||.|.++.- ..+.+||+|.++.+     ...+.+|+++|.+|+|||||++.+++.....     ++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence            3578889999999999999984 44689999988643     2445689999999999999999998854433     78


Q ss_pred             EEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+||++ |+|-+.+.....  ..+.......++.||+.|++||. +.++|||||.+.|+|++.+. .+||+|||.++..
T Consensus       612 mI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLe-s~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l  687 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLE-SLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHH-hhchhhccccccceeecCcc-cEEecCccccccc
Confidence            9999998 444444432111  11344455669999999999999 89999999999999999998 7999999999866


Q ss_pred             ccCCCcc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          245 VKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL--LGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       245 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ..+....   ..+-...|||+|.+.-.+ +++++|+|+||++|||++  +...||....+.+...+....+..+......
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence            5544321   233467899999987655 999999999999999986  5789998877766666555543333322111


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                           ..+.-++..+.+||.+||..|-.+|||++++-.
T Consensus       767 ---------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  767 ---------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             ---------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                                 123347889999999999999999999999743

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=282.58  Aligned_cols=245  Identities=24%  Similarity=0.338  Sum_probs=202.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCC---cEEEEEEecc-----chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..-.|.++||.|.||.|++|+.+..|   ..||||.++.     .+..+..|+.||-+++||||++|.++...     ..
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~  703 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SK  703 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cc
Confidence            35678899999999999999988666   4799999864     23444579999999999999999987733     22


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      -+-||+|||+.+.++.+.  +.+.+.|...++..+++.|+.|+.||- ++|+|||||-..||||+++- ..|++|||+++
T Consensus       704 PvMIiTEyMENGsLDsFL--R~~DGqftviQLVgMLrGIAsGMkYLs-dm~YVHRDLAARNILVNsnL-vCKVsDFGLSR  779 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFL--RQNDGQFTVIQLVGMLRGIASGMKYLS-DMNYVHRDLAARNILVNSNL-VCKVSDFGLSR  779 (996)
T ss_pred             eeEEEhhhhhCCcHHHHH--hhcCCceEeehHHHHHHHHHHHhHHHh-hcCchhhhhhhhheeeccce-EEEecccccee
Confidence            377999999965555332  234577999999999999999999998 89999999999999999988 89999999999


Q ss_pred             ecccCC-Ccccccc---cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKGE-PNISYIC---SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~~-~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ...++. ...+..|   ...|.|||.+.- ..++.++||||+|++|||.++ |..||-..++.+.+..|.+....|+.  
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP--  856 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP--  856 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence            875543 2222233   467999999954 459999999999999999775 99999999999999888886655542  


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                                .++|..+..|+..||++|-++||++.+|+.
T Consensus       857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                      357899999999999999999999999876

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.6e-33  Score=305.07  Aligned_cols=253  Identities=21%  Similarity=0.294  Sum_probs=181.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      .|...+.||+|+||.||+|++..++..||+|.+.........|++++++++|||||++++++...     ...++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            46677899999999999999989999999998876555556789999999999999999988443     2378999999


Q ss_pred             hh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc--CCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          172 PE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG--GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       172 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      ++ ++.+.+.       .+++..+..++.||+.||+|||.  +.+|+||||||+||+++.++ ..++. ||.+.....  
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT--  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-ecccccccc--
Confidence            85 4444442       37889999999999999999993  34999999999999999776 56665 666543321  


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                       .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ...+....+.......         ...
T Consensus       835 -~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~  903 (968)
T PLN00113        835 -DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH---------LDM  903 (968)
T ss_pred             -CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc---------hhh
Confidence             123467899999999865 4589999999999999999999999953211 1111111111000000         000


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +.-+.+...   .........++.+++.+||+.||++|||+.|+++.
T Consensus       904 ~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        904 WIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             eeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            000111000   00011123467889999999999999999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=278.28  Aligned_cols=255  Identities=25%  Similarity=0.356  Sum_probs=206.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|.++..+|.|.||.||+|+++.+++..|+|+++.+    ....++|+-+++.++|||||.+++.|.....     +++
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cEE
Confidence            3699999999999999999999999999999998643    3445689999999999999999999866544     899


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      .||||+++.++.+.   ...+.+++.++....+..+.||+||| ++|-+|||||-.|||++..+ .+|+.|||.+..+..
T Consensus        90 cMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylh-s~gk~hRdiKGanilltd~g-DvklaDfgvsaqita  164 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLH-SQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITA  164 (829)
T ss_pred             EEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhh-cCCcccccccccceeecccC-ceeecccCchhhhhh
Confidence            99999987555443   34688999999999999999999999 88999999999999999888 699999999755432


Q ss_pred             C-CCccccccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 G-EPNISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      . ....++.||++|||||+..  ....|...+|||++|++..|+---++|-........+..+-+..             
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~-------------  231 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG-------------  231 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC-------------
Confidence            2 2345789999999999862  33468999999999999999988888776655555544443321             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                       |....+..          ...-++.+-+|++.+|.++|.+|||++.+|+|||...
T Consensus       232 -~qpp~lkD----------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  232 -FQPPTLKD----------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             -CCCCcccC----------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence             11111111          1224778999999999999999999999999999865

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=260.15  Aligned_cols=263  Identities=26%  Similarity=0.328  Sum_probs=187.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc-chhhHHHHHHHHHH--cCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ...+.++||+|.||.||+|+.  +++.||||++.. ++.....|-+|...  ++|+||++++..-.... ....-++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEe
Confidence            467788999999999999986  669999999864 44555667777664  68999999876543322 2244578999


Q ss_pred             ecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc--------CCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG--------GIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--------~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      +|.+ |+|.+++..     ..+++....+++..+++||+|||+        +..|+|||||..||||..|. +..|+|||
T Consensus       288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFG  361 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFG  361 (534)
T ss_pred             eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccc
Confidence            9988 677776654     678999999999999999999995        23699999999999999888 79999999


Q ss_pred             CceecccCCC---cccccccccccccccccCCCCCC-----CcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHh
Q 014156          240 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYT-----TAIDIWSVGCVLAELLLGQPLFP-GESGVDQLVEIIKVL  310 (429)
Q Consensus       240 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~  310 (429)
                      +|.++..+..   ....+||.+|||||++.+...+.     .+.||||+|.+||||++....+. +.-..-++---.+..
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            9988765432   34578999999999997765554     36899999999999998765442 221111111111223


Q ss_pred             CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH
Q 014156          311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL  369 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  369 (429)
                      ..|+.+.+...-..  ....|.++. .|..   .....-+.+.+.-||..||+.|+|+.
T Consensus       442 ~hPt~e~mq~~VV~--kK~RP~~p~-~W~~---h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  442 NHPTLEEMQELVVR--KKQRPKIPD-AWRK---HAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             CCCCHHHHHHHHHh--hccCCCChh-hhhc---CccHHHHHHHHHHHcCCchhhhhhhH
Confidence            34444443321100  011122111 1111   12345689999999999999999985

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=267.14  Aligned_cols=199  Identities=28%  Similarity=0.413  Sum_probs=170.9

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhH------------HHHHHHHHHcC---CCCeecccee
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK------------NRELQTMRLLD---HPNVVSLKHC  152 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~E~~~l~~l~---h~~iv~l~~~  152 (429)
                      ....+|..++.||.|+||.|++|.++.+...|+||.+.+++-..            -.|+.||..|+   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34457999999999999999999999999999999887654222            25999999997   9999999999


Q ss_pred             eeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc
Q 014156          153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  232 (429)
Q Consensus       153 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~  232 (429)
                      |     ++..|+||+||--+.+ .++... ......+++.++..|+.|++.|+++|| ++||||||||-+|+.++++| -
T Consensus       638 F-----Eddd~yyl~te~hg~g-IDLFd~-IE~kp~m~E~eAk~IFkQV~agi~hlh-~~~ivhrdikdenvivd~~g-~  708 (772)
T KOG1152|consen  638 F-----EDDDYYYLETEVHGEG-IDLFDF-IEFKPRMDEPEAKLIFKQVVAGIKHLH-DQGIVHRDIKDENVIVDSNG-F  708 (772)
T ss_pred             e-----ecCCeeEEEecCCCCC-cchhhh-hhccCccchHHHHHHHHHHHhcccccc-ccCceecccccccEEEecCC-e
Confidence            8     6667799999988754 233332 334678999999999999999999999 88999999999999999998 7


Q ss_pred             eEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014156          233 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG  296 (429)
Q Consensus       233 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  296 (429)
                      +||+|||.|..... .....++||..|.|||++.|..+.+..-|||++|++||.++....||..
T Consensus       709 ~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEEeeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999999876544 4556789999999999998888778899999999999999999999853

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-30  Score=264.32  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=186.3

Q ss_pred             eeEeeEEccCCcEEEEEEEEcC-------CCcEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           93 YMAERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      ..+.+.||+|.||.|++|....       ....||+|..+..     ......|+++|+.+ .|+||+.+.+++..    
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~----  373 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ----  373 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence            3566799999999999997431       1457999987532     34455799999988 59999999998844    


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhh---h-------cC--CCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYS---R-------AS--QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  226 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~---~-------~~--~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill  226 (429)
                       ...+++|+||+. |+|+..+....   .       ..  ..++......++.||+.|++||+ +.++|||||-..|||+
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~-~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA-SVPCVHRDLAARNVLI  451 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh-hCCccchhhhhhhEEe
Confidence             344788999998 66666665533   0       00  13888999999999999999999 7899999999999999


Q ss_pred             cCCCCceEEeecCCceecccCCCccc--ccc--cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014156          227 NPHTHQVKLCDFGSAKVLVKGEPNIS--YIC--SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD  301 (429)
Q Consensus       227 ~~~~~~vkl~DFG~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  301 (429)
                      ..+. .+||+|||+|+..........  ..+  ...|||||.+.. ..|+.++||||+|++|||+++ |..||.+-....
T Consensus       452 ~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  452 TKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             cCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            9876 899999999986544433321  122  234999999976 569999999999999999998 889998854223


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+.+..+....                           ..-+..+++++.++++.||..+|.+||++.++..
T Consensus       530 ~l~~~l~~G~r---------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  530 ELLEFLKEGNR---------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            22222221000                           0123347899999999999999999999998864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-31  Score=259.33  Aligned_cols=242  Identities=26%  Similarity=0.340  Sum_probs=190.3

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCc----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+..++||+|+||+||+|.+...|+    +||||++...     ...+..|+-+|..|+|||++++++++....     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            35566899999999999999876665    6888877432     334457899999999999999999874322     


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                       +-||++|++ |.|++.++.   ....+.......|..||++|+.||| .++++||||-..||||.+-. .+||+|||+|
T Consensus       772 -~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe-~qrlVHrdLaaRNVLVksP~-hvkitdfgla  845 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLE-EQRLVHRDLAARNVLVKSPN-HVKITDFGLA  845 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHH-hcchhhhhhhhhheeecCCC-eEEEEecchh
Confidence             568999999 556665543   4577889999999999999999999 88999999999999998776 6999999999


Q ss_pred             eecccCCCcccccc---cccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGEPNISYIC---SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      +............+   .+-|||-|.+.. ..|+.++||||+||++||++| |..|+.+....+.-..+.+..       
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-------  917 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-------  917 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-------
Confidence            98866555443333   455999998865 459999999999999999997 999998876544433222210       


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                           +..-++..+-++..++.+||..|+..||++.++-.
T Consensus       918 ---------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  918 ---------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ---------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                                 01123457889999999999999999999988754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-32  Score=235.71  Aligned_cols=255  Identities=24%  Similarity=0.330  Sum_probs=184.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +.|.|.+.||+|.||.+.+|+++.++..+++|.+....   ..+.+|...--.| -|.||+.-|+..+...+    ++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eEEE
Confidence            46999999999999999999999999999999886542   3344565543344 58999998877665443    5678


Q ss_pred             Eeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee-cCCCCceEEeecCCceec
Q 014156          167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill-~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||++ |+|..-+   .  ...+.+...+.++.|+++||.||| +.++||||||.+|||| +.+..+|||||||+.+..
T Consensus       100 ~qE~aP~gdL~snv---~--~~GigE~~~K~v~~ql~SAi~fMH-sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNV---E--AAGIGEANTKKVFAQLLSAIEFMH-SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eeccCccchhhhhc---C--cccccHHHHHHHHHHHHHHHHHhh-ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999 4443322   1  256888999999999999999999 8899999999999998 556668999999998764


Q ss_pred             ccCCCcccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHh
Q 014156          245 VKGEPNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIK  319 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~  319 (429)
                      +..-...  --+..|.+||.+...    -...+.+|+|.||+++|.++||.+||......+. +.+..+..+....    
T Consensus       174 g~tV~~~--~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~----  247 (378)
T KOG1345|consen  174 GTTVKYL--EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP----  247 (378)
T ss_pred             Cceehhh--hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc----
Confidence            3222111  124559999987432    2246689999999999999999999975433322 2333333222111    


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCCccc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR---CTALEACIHPFFDE  379 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~t~~e~l~hp~f~~  379 (429)
                               ..|        ..| ..+++.+..+.++-|+.++++|   -++......-|...
T Consensus       248 ---------~~P--------~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  248 ---------ALP--------KKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             ---------cCc--------hhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence                     011        111 2379999999999999999999   45555555666643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.4e-29  Score=221.70  Aligned_cols=207  Identities=35%  Similarity=0.574  Sum_probs=172.9

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecch-
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-  172 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~-  172 (429)
                      ||.|++|.||++.+..+++.+++|++....     ....+|+..++.+.|++++++++++...     ...++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence            689999999999998889999999987654     3467899999999999999999887432     45789999999 


Q ss_pred             hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC-CCCceEEeecCCceecccCC-Cc
Q 014156          173 ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKGE-PN  250 (429)
Q Consensus       173 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~-~~~~vkl~DFG~a~~~~~~~-~~  250 (429)
                      +++...+..   ....++...+..++.+++.+|.+|| +.|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLH-SNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            555555432   1146899999999999999999999 789999999999999997 55 79999999997664432 12


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 014156          251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  330 (429)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      ....++..|++||.+.....++.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3355678899999886543678999999999999999                                           


Q ss_pred             CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014156          331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP  375 (429)
Q Consensus       331 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  375 (429)
                                       ..+.+++.+|+..||.+||++.++++|+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1367899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.2e-30  Score=278.23  Aligned_cols=207  Identities=18%  Similarity=0.184  Sum_probs=145.7

Q ss_pred             HcCC-CCeeccceeeeecCC--CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeee
Q 014156          140 LLDH-PNVVSLKHCFFSTTD--KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH  216 (429)
Q Consensus       140 ~l~h-~~iv~l~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiH  216 (429)
                      .++| +||+++++.|-....  .....+++++|+++++|...+..   ....+++..++.+++||+.||.||| ++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH-~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAH-SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHH-hCCeee
Confidence            4455 577777776522221  11223667899999988877643   2356999999999999999999999 889999


Q ss_pred             cCCCCCCeeecCCC------------------CceEEeecCCceecccC-----------------CCcccccccccccc
Q 014156          217 RDIKPQNLLVNPHT------------------HQVKLCDFGSAKVLVKG-----------------EPNISYICSRYYRA  261 (429)
Q Consensus       217 rDlKp~Nill~~~~------------------~~vkl~DFG~a~~~~~~-----------------~~~~~~~gt~~y~a  261 (429)
                      |||||+||||+..+                  ..+||+|||+++.....                 ......+||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999995422                  24667777776542110                 00112457899999


Q ss_pred             cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccc
Q 014156          262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  341 (429)
Q Consensus       262 PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (429)
                      ||++.+.. ++.++|||||||+||||++|.+|+....  ..+..+.... .+..                          
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~--------------------------  233 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ--------------------------  233 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh--------------------------
Confidence            99987654 8999999999999999999998875321  1111111110 0000                          


Q ss_pred             cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          342 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       342 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      .. ...+...+++.+||..||.+|||+.|+|+||||.+.+
T Consensus       234 ~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        234 IL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             hh-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            00 0145677999999999999999999999999998754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2e-28  Score=221.69  Aligned_cols=197  Identities=34%  Similarity=0.586  Sum_probs=163.1

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...     .....+|++.++.++|+|++++++++...     ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence            56788999999999999999888999999988653     34456799999999999999999877432     347899


Q ss_pred             eecchh-hHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQR-MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~-l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +|++++ ++.+.+..    ... +++..+..++.|++.+|.+|| +.+++|+||+|.||+++.++ .++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLH-SLGIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            999997 66555443    223 889999999999999999999 78999999999999999876 79999999998775


Q ss_pred             cCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CChH
Q 014156          246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG-ESGV  300 (429)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~  300 (429)
                      ...  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            543  334456788899999874344577899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-28  Score=209.69  Aligned_cols=203  Identities=25%  Similarity=0.341  Sum_probs=166.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHHcCC-CCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .++|+++++||.|+||.+|+|....+|+.||||.-.+..  .....|.++.+.|++ ..|..+..++     .+..|-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----ccccccee
Confidence            357999999999999999999999999999999876543  344579999999975 4455555544     44556779


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec--CCCCceEEeecCCceec
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN--PHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~--~~~~~vkl~DFG~a~~~  244 (429)
                      ||+.++.+|.+++..   ....++..+++.++-|++.-++|+| .+++|||||||+|+|..  ...+.+.|+|||+|+.+
T Consensus        89 VMdLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH-~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   89 VMDLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVH-LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eeeccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHH-hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            999999988887654   4567999999999999999999999 88999999999999974  34457999999999987


Q ss_pred             ccCC--------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 014156          245 VKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ  302 (429)
Q Consensus       245 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  302 (429)
                      .+..        ......||..|.+-..+.+.. .+.+.|+-|+|.+|..+.-|..||.+......
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk  229 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATK  229 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence            5433        234567999999988877644 78899999999999999999999998654443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=7.3e-28  Score=210.26  Aligned_cols=166  Identities=21%  Similarity=0.192  Sum_probs=123.0

Q ss_pred             hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCcccc
Q 014156          174 TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  253 (429)
Q Consensus       174 ~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~  253 (429)
                      +|.+++..   ....+++..++.++.||+.||.||| +.+      ||+|||++.++ .+|+  ||+++.....    ..
T Consensus         2 sL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH-~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~   64 (176)
T smart00750        2 SLADILEV---RGRPLNEEEIWAVCLQCLRALRELH-RQA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QS   64 (176)
T ss_pred             cHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH-hcC------CcccEeEcCcc-ceee--ccceEeeccc----cC
Confidence            45555432   2456999999999999999999999 666      99999999887 6888  9999876432    23


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCCCCccccCCC
Q 014156          254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  332 (429)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (429)
                      .||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ +..+........                +.
T Consensus        65 ~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~  127 (176)
T smart00750       65 RVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------PR  127 (176)
T ss_pred             CCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------cc
Confidence            689999999999764 489999999999999999999999976543322 222222110000                00


Q ss_pred             cCCCCcccccCCCCCh--hHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          333 IKAHPWHKIFHKRMPP--EAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       333 ~~~~~~~~~~~~~~s~--~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                            .......++.  ++.++|.+||..||.+|||+.++++|+|+..
T Consensus       128 ------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 ------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                  0000011233  6999999999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-26  Score=219.94  Aligned_cols=251  Identities=21%  Similarity=0.209  Sum_probs=188.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCC-cEEEEEEeccch----hhHHHHHHHHHHcCC----CCeeccceeeeecCCCCce
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQDK----RYKNRELQTMRLLDH----PNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~~l~~l~h----~~iv~l~~~~~~~~~~~~~  162 (429)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|......    .....|..++..+..    .++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            6999999999999999999987774 689999775431    146679999998873    56777766542    2445


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC----CceEEeec
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCDF  238 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~----~~vkl~DF  238 (429)
                      +-++||+.++.+|.++.....  .+.++..++..++.|++.+|++|| +.|++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH-~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH-SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH-hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999988776543  578999999999999999999999 89999999999999997543    47999999


Q ss_pred             CCce--ecccCC--------C-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014156          239 GSAK--VLVKGE--------P-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII  307 (429)
Q Consensus       239 G~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  307 (429)
                      |+|+  ......        . ...+.||..|+++.++.+. ..+.+.|+||++.++.+|+.|..||.+........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  321111        1 2235699999999998764 48999999999999999999999997765433332222


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +......               ...         +....+.++..+...+-..+...+|....+...
T Consensus       251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2110000               000         112245677888887777888999987766543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.5e-28  Score=249.92  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=192.2

Q ss_pred             eEeeEEccCCcEEEEEEEEcCCCcEEEEEEec----cchhh------HHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        94 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~----~~~~~------~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .....+|.|++|.|+.+......+.++.|.+.    .....      ...|+.+-..|.|+|++.....+.....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            45678999999999999887777767766543    11111      1235555567899999877665543322     


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ..-+||||+.+|+.++..    ...+....+..++.|++.|++||| ..||.|||||++|+++..++ .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h-~~GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLH-SMGLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHH-hcCceeccCccccEEEecCC-ceEEeecCccee
Confidence            223499999977776643    247888999999999999999999 89999999999999999888 899999999876


Q ss_pred             cccCCC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          244 LVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       244 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      ...+..     ....+|+..|+|||++.+...-....||||.|++++.|++|+.||......+....-...         
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---------  540 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---------  540 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------
Confidence            644332     345788999999999988775566799999999999999999999765443322100000         


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                          .  ...   .+...  ...+...++...+.+|.+||+.||.+|.|+.+|++.+||+.+..+..
T Consensus       541 ----~--~~~---~~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v  596 (601)
T KOG0590|consen  541 ----S--DQR---NIFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV  596 (601)
T ss_pred             ----c--ccc---ccccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence                0  000   00000  01122347888999999999999999999999999999999877543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-26  Score=206.89  Aligned_cols=200  Identities=24%  Similarity=0.344  Sum_probs=167.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEec--cchhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL--QDKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ...|++.++||.|+||..+.|++.-+++.||||.-.  .+.....-|.+..+.|. .++|..+|-+-     ....+-.|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhh
Confidence            347999999999999999999999999999999653  33445567899998885 57777765332     44455678


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC----CCCceEEeecCCce
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP----HTHQVKLCDFGSAK  242 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~----~~~~vkl~DFG~a~  242 (429)
                      |+|+++.+|.+++..   ...+|+..++..++.|++.-++|+| .+.+|+|||||+|+||..    +.+.|.|+|||+|+
T Consensus       102 VidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH-~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  102 VIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVH-EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHH-hcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            999999888887654   5678999999999999999999999 889999999999999943    34479999999999


Q ss_pred             ecccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 014156          243 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG  299 (429)
Q Consensus       243 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  299 (429)
                      .+.+...        ..+..||..||+-...++.. .+.+.|+-|||-+++..|-|..||.|...
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            8866543        23567999999999998865 89999999999999999999999988543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=9.9e-27  Score=213.29  Aligned_cols=248  Identities=19%  Similarity=0.233  Sum_probs=182.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC-----CcEEEEEEeccchhhH-----HHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~-----~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .++++...+-+|.||.||.|.+++.     .+.|.+|.++.....+     ..|...+..+.|||+..+.++.....+  
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~--  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA--  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC--
Confidence            4678888899999999999977643     2345667665544333     256667777899999999887755332  


Q ss_pred             ceEEEEEeecch-hhHHHHHHHh----hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHY----SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                        ..++++.+.+ |+|...+..-    ....+.++..+...++.|++.|++||| +.||||.||-..|++||..- +|||
T Consensus       362 --~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh-~~~ViHkDiAaRNCvIdd~L-qVkl  437 (563)
T KOG1024|consen  362 --TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH-NHGVIHKDIAARNCVIDDQL-QVKL  437 (563)
T ss_pred             --cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH-hcCcccchhhhhcceehhhe-eEEe
Confidence              3556777777 4544444311    112345667778889999999999999 89999999999999999776 8999


Q ss_pred             eecCCceecccCCCcc---cccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014156          236 CDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  311 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  311 (429)
                      +|=.+++-........   +..-...|||||.+... .|+.++|+|||||+||||+| |+.|+..-+..+...-+.... 
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-  515 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-  515 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-
Confidence            9999988765443221   11124569999999764 59999999999999999998 899998777665544333321 


Q ss_pred             CCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                       .+          .-+-++|+++..++.-||+.+|++||+..++..
T Consensus       516 -----------------Rl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 -----------------RL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -----------------ee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                             00          112358999999999999999999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.5e-27  Score=228.08  Aligned_cols=238  Identities=29%  Similarity=0.424  Sum_probs=189.4

Q ss_pred             EEccCCcEEEEEEEE---cCCCcEEEEEEeccc------hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEEE
Q 014156           98 VVGQGSFGIVFQAKC---LETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ++|.|+||.|++++.   ...|..||+|+..+.      ......|..++..++ ||.+|++..+|..     ...++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence            379999999998753   245778999976432      223335777888886 9999999887743     3347889


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      +++..++  ++... ......+.+...+.+...++.|++++| +.||+|||+|++||+++.+| .+++.|||+++.....
T Consensus        76 ld~~rgg--~lft~-l~~~~~f~~~~~~~~~aelaLald~lh-~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~  150 (612)
T KOG0603|consen   76 LDFLRGG--DLFTR-LSKEVMFDELDVAFYLAELALALDHLH-KLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhcccc--hhhhc-cccCCchHHHHHHHHHHHHHHHHhhcc-hhHHHHhcccccceeecccC-ccccCCchhhhHhHhh
Confidence            9999875  22222 223466888889999999999999999 89999999999999999999 5999999999877655


Q ss_pred             CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      ...   |||..|||||++.   ....++|+||+|+++++|+||..||.+    +....|.+..                 
T Consensus       151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-----------------  203 (612)
T KOG0603|consen  151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-----------------  203 (612)
T ss_pred             hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------
Confidence            443   9999999999986   367899999999999999999999987    5555555421                 


Q ss_pred             ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCCCC
Q 014156          328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDPN  384 (429)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~  384 (429)
                                  ..++..++..+++++..++..+|.+|...     .|+++|+||..+.+..
T Consensus       204 ------------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  204 ------------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             ------------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence                        01233478899999999999999999854     7999999999988763

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2e-25  Score=213.50  Aligned_cols=159  Identities=20%  Similarity=0.282  Sum_probs=121.0

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcC-CCcEEEEEEeccc---------hhhHHHHHHHHHHcCCCCeeccceeeeecCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  158 (429)
                      ...+|.+.+.||+|+||+||+|++.. +++.+|||++...         .....+|+++|+.++|+|++..+..+   . 
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~-   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G-   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C-
Confidence            34579999999999999999999876 6788899986422         23356899999999999998532211   1 


Q ss_pred             CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCC-CCCCeeecCCCCceEEee
Q 014156          159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI-KPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDl-Kp~Nill~~~~~~vkl~D  237 (429)
                          ..|+||||++|..+...    .   ...   ...++.|++.||.||| +.||+|||| ||+|||++.++ .+||+|
T Consensus        92 ----~~~LVmE~~~G~~L~~~----~---~~~---~~~~~~~i~~aL~~lH-~~gIiHrDL~KP~NILv~~~~-~ikLiD  155 (365)
T PRK09188         92 ----KDGLVRGWTEGVPLHLA----R---PHG---DPAWFRSAHRALRDLH-RAGITHNDLAKPQNWLMGPDG-EAAVID  155 (365)
T ss_pred             ----CcEEEEEccCCCCHHHh----C---ccc---hHHHHHHHHHHHHHHH-HCCCeeCCCCCcceEEEcCCC-CEEEEE
Confidence                15799999987644321    1   111   1457889999999999 889999999 99999998776 799999


Q ss_pred             cCCceecccCCC---------cccccccccccccccccC
Q 014156          238 FGSAKVLVKGEP---------NISYICSRYYRAPELIFG  267 (429)
Q Consensus       238 FG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~  267 (429)
                      ||+|+.......         .....+++.|+|||.+..
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999987644321         124467888999998843

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=9.5e-24  Score=201.10  Aligned_cols=258  Identities=34%  Similarity=0.466  Sum_probs=194.7

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCC-CeeccceeeeecCCCCceEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHP-NVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~~~~~  164 (429)
                      |.+.+.||.|+||.||++.+.   ..+++|.+...       .....+|+.++..+.|+ +++++++.+..     ....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-----EGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-----CCEE
Confidence            788899999999999999986   78899987533       23345788899999988 79999988822     2226


Q ss_pred             EEEeecchhhHHHHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          165 NLVLEFVPETVYRVAKHYSRAS---QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      +++++++.+..+...   ....   ..++......++.|++.++.|+| +.+++|||+||+||+++..+..++++|||.+
T Consensus        74 ~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H-~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~  149 (384)
T COG0515          74 YLVMEYVDGGSLEDL---LKKIGRKGPLSESEALFILAQILSALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLA  149 (384)
T ss_pred             EEEEecCCCCcHHHH---HHhcccccCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence            789999996544411   1222   27899999999999999999999 8899999999999999977645999999999


Q ss_pred             eecccCC-------CcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Q 014156          242 KVLVKGE-------PNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKV  309 (429)
Q Consensus       242 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~  309 (429)
                      +......       ......||..|+|||.+.+.  ..++...|+||+|++++++++|..||.....   ..........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  229 (384)
T COG0515         150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE  229 (384)
T ss_pred             eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence            8654432       23567889999999998763  4688899999999999999999999877664   3333333333


Q ss_pred             hCCC-CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          310 LGTP-TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       310 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ...+ ..              ...      ...........+.+++.+++..+|..|.+..+...++|......
T Consensus       230 ~~~~~~~--------------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         230 LPTPSLA--------------SPL------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             cCCcccc--------------ccc------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            2221 00              000      00000112367899999999999999999999998877765444

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=1.5e-25  Score=228.19  Aligned_cols=225  Identities=28%  Similarity=0.463  Sum_probs=167.4

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ...+|..++.|..|+||.||+++++.+.+.+|+| ++++.-...+   ++.....|.+                    | 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfv--------------------v-  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFV--------------------V-  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCcce--------------------e-
Confidence            3457999999999999999999999999999995 5444322211   2222222222                    2 


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                          |+-..+++    ..+.++.        +++.+++||| +.||+|||+||+|.+|..-| .+|++|||+++......
T Consensus       136 ----gDc~tllk----~~g~lPv--------dmvla~Eylh-~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLLK----NIGPLPV--------DMVLAVEYLH-SYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhcc----cCCCCcc--------hhhHHhHhhc-cCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhc
Confidence                11112221    2234443        3378999999 89999999999999999888 69999999987643211


Q ss_pred             C----------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014156          249 P----------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       249 ~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      .                ....|||+.|+|||++.. +.|+..+|||++|+|+|+.+.|..||.+.+..+.+.+.+.....
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence            1                123589999999999865 45999999999999999999999999999888877766553221


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCCccccCCC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFDELRDP  383 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~  383 (429)
                      -++                         . ...++++++++|.++|..+|..|.   .+.++.+|+||+.+.|-
T Consensus       277 wpE-------------------------~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WPE-------------------------E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccc-------------------------c-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            111                         1 123689999999999999999997   56788999999998775

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=9.1e-24  Score=194.52  Aligned_cols=195  Identities=23%  Similarity=0.334  Sum_probs=142.0

Q ss_pred             CCCCeeccceeeeecC----------------------CCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHH
Q 014156          142 DHPNVVSLKHCFFSTT----------------------DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY  199 (429)
Q Consensus       142 ~h~~iv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~  199 (429)
                      .|||||++...|.+..                      -.....+|+||..+..+|..++..     +..+....+.++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            6999999988775321                      123445899999999988877653     5577778888999


Q ss_pred             HHHHHHHHHHcCCCeeecCCCCCCeee--cCCC-CceEEeecCCceecccC-------CCcccccccccccccccccCCC
Q 014156          200 QICRALAYIHGGIGVCHRDIKPQNLLV--NPHT-HQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPELIFGAT  269 (429)
Q Consensus       200 qi~~aL~~LH~~~~iiHrDlKp~Nill--~~~~-~~vkl~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~  269 (429)
                      |+++|+.||| ++||.|||||.+||||  |.|. -.+.|+|||+|-.-...       .......|...-||||+....+
T Consensus       349 QlLEav~hL~-~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLH-KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHH-HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999 8999999999999998  3222 26889999987433221       1122344667789999874332


Q ss_pred             CC-----CCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCC
Q 014156          270 EY-----TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK  344 (429)
Q Consensus       270 ~~-----~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (429)
                      ..     -.++|.|+.|.+.||+++...||.+....-.-                  ..+|.+-++|.         ++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------------------~r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------------------TRTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------------------hhhhhhhhCCC---------Ccc
Confidence            11     23789999999999999999999874321110                  01123333333         445


Q ss_pred             CCChhHHHHHHhhcCcCCCCCCCHH
Q 014156          345 RMPPEAVDLVSRLLQYSPNLRCTAL  369 (429)
Q Consensus       345 ~~s~~~~~li~~~L~~dP~~R~t~~  369 (429)
                      .+++.+++|+..+|+.||++|+++.
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCcc
Confidence            6899999999999999999999854

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=5.7e-23  Score=188.59  Aligned_cols=237  Identities=25%  Similarity=0.331  Sum_probs=143.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhH-------HHHHHHHHHcCC----------CCeeccceee-
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDH----------PNVVSLKHCF-  153 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l~h----------~~iv~l~~~~-  153 (429)
                      .+...+.||.|+++.||.+.+..||+.+|+|++.......       .+|.-....+.+          -.++--++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3677889999999999999999999999999874332211       122211111111          0111111111 


Q ss_pred             -------eecCCCCce----EEEEEeecchhhHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHcCCCeeecCC
Q 014156          154 -------FSTTDKDEL----YLNLVLEFVPETVYRVAKHYSRASQR---MPLIYVKLYTYQICRALAYIHGGIGVCHRDI  219 (429)
Q Consensus       154 -------~~~~~~~~~----~~~lv~e~~~~~l~~~~~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDl  219 (429)
                             .........    ..+++|+-+.++|..++.........   +.......+..|+++.+++|| ..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh-~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH-SYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh-hcceEeccc
Confidence                   111111111    14678888888887776554333222   222233455689999999999 889999999


Q ss_pred             CCCCeeecCCCCceEEeecCCceecccCCCcccccccccccccccccCC-------CCCCCcchHHHHHHHHHHHHhCCC
Q 014156          220 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAIDIWSVGCVLAELLLGQP  292 (429)
Q Consensus       220 Kp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~  292 (429)
                      ||+|++++.+| .++|+||+.....+....  ....+..|.+||.....       ..++.+.|.|+||+++|.|.+|+.
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999998 799999998766533222  13345779999976332       236889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCC
Q 014156          293 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR  365 (429)
Q Consensus       293 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  365 (429)
                      ||..........                       +        .+..  ..++|..+++||.+||++||.+|
T Consensus       249 Pf~~~~~~~~~~-----------------------~--------~f~~--C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPE-----------------------W--------DFSR--CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSG-----------------------G--------GGTT--SS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccccc-----------------------c--------cchh--cCCcCHHHHHHHHHHccCCcccC
Confidence            997543211000                       0        0111  11579999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-23  Score=213.19  Aligned_cols=241  Identities=29%  Similarity=0.411  Sum_probs=170.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHH---HHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKN---RELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~---~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .|...+.||++.|=+|.+|++.+ |. |+||++.+..     +...   +|++ ...+++||.+.+.-..     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            58888999999999999998743 44 8999885432     1112   3444 5667999999875443     22334


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .|||-+|+..+|++.+..    ..-+...+.+.|+.|++.||.-+| +.||+|||||.+||||++=. .+.|+||..=+.
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH-~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCH-KLGVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHH-HcCccccccccceEEEeeec-hhhhhcccccCC
Confidence            578899999999887654    344677788889999999999999 89999999999999999755 799999987543


Q ss_pred             cccCC----Cccccccc----ccccccccccCCC----------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014156          244 LVKGE----PNISYICS----RYYRAPELIFGAT----------EYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLV  304 (429)
Q Consensus       244 ~~~~~----~~~~~~gt----~~y~aPE~~~~~~----------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  304 (429)
                      ..-.+    ...-+..|    ..|.|||.+....          ..+++.||||+||++.||++ |++||.    ..++.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHH
Confidence            32111    11112222    3599999885411          25778999999999999988 799994    22222


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ...... ....+..                       +.+--+..++.||..|++.||++|++|++.|+-
T Consensus       246 aYr~~~-~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQL-----------------------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccC-ccCHHHH-----------------------HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            222211 1111111                       011124578999999999999999999999884

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.3e-22  Score=178.56  Aligned_cols=135  Identities=16%  Similarity=0.234  Sum_probs=102.8

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh------------------------------hHHHHHHHHHHcCCCC
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  145 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~~  145 (429)
                      ...||+|+||.||+|.+. +|+.||+|++.....                              ...+|++.+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 899999998854311                              1124889999998877


Q ss_pred             eeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCeeecCCCCCCe
Q 014156          146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI-HGGIGVCHRDIKPQNL  224 (429)
Q Consensus       146 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~~~iiHrDlKp~Ni  224 (429)
                      +.......  .. .    .++||||++++.+....   .....+++..+..++.|++.+|.|| | +.||+||||||+||
T Consensus        81 v~~p~~~~--~~-~----~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H-~~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL--LK-S----HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQ-DCRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE--ec-C----CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHE
Confidence            64332211  11 1    26899999975332111   1235789999999999999999999 7 78999999999999


Q ss_pred             eecCCCCceEEeecCCceec
Q 014156          225 LVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       225 ll~~~~~~vkl~DFG~a~~~  244 (429)
                      |++. + .++|+|||+|...
T Consensus       150 li~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-C-cEEEEEccccccC
Confidence            9984 4 6999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.2e-21  Score=170.94  Aligned_cols=182  Identities=16%  Similarity=0.107  Sum_probs=132.0

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh--------hHHHHHHHHHHcC-CCCeeccceeeeecCCCCceE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+...|++|+||+|+++..  .+.+++.+.+.....        ...+|+++|++|. |+++++++++.     .    
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----
Confidence            34567899999999998864  778888776654332        3568999999995 47788886631     1    


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCC-CCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI-KPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDl-Kp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+++|+|+.|..+...         .+.. ...++.|++.+|.++| +.||+|||| ||+|||++.++ .++|+|||+|.
T Consensus        73 ~~lvmeyI~G~~L~~~---------~~~~-~~~~~~qi~~~L~~lH-~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~  140 (218)
T PRK12274         73 RHLDRSYLAGAAMYQR---------PPRG-DLAYFRAARRLLQQLH-RCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAV  140 (218)
T ss_pred             EEEEEeeecCccHHhh---------hhhh-hHHHHHHHHHHHHHHH-HCcCccCCCCCcceEEEcCCC-CEEEEECCCce
Confidence            5789999988643211         0111 1346789999999999 889999999 79999999877 79999999998


Q ss_pred             ecccCCCc----c----------cccccccccccccccCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCC
Q 014156          243 VLVKGEPN----I----------SYICSRYYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGE  297 (429)
Q Consensus       243 ~~~~~~~~----~----------~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~  297 (429)
                      ........    .          -...++.|++|+...-....+ ...++++.|+.+|.++|++.++-+.
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            55433211    0          012467788887643222233 4678999999999999999887554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=6.5e-22  Score=176.44  Aligned_cols=171  Identities=11%  Similarity=0.124  Sum_probs=123.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhh---------HHHHHHHHHHcCCCCeeccceeeeec
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRY---------KNRELQTMRLLDHPNVVSLKHCFFST  156 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~---------~~~E~~~l~~l~h~~iv~l~~~~~~~  156 (429)
                      .++|+++++||.|+||.||++..  ++..+|+|.+...    ...         .++|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            35799999999999999999765  4678999988532    111         45788899999999999998876543


Q ss_pred             CCC---CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCce
Q 014156          157 TDK---DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV  233 (429)
Q Consensus       157 ~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~v  233 (429)
                      ...   .....++||||++|..+..+       ..+++    ....+++.+|..|| +.|++|||+||+||++++++  +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~-------~~~~~----~~~~~i~~~l~~lH-~~gi~H~Dikp~Nili~~~g--i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDM-------PEISE----DVKAKIKASIESLH-QHGMVSGDPHKGNFIVSKNG--L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHh-------hhccH----HHHHHHHHHHHHHH-HcCCccCCCChHHEEEeCCC--E
Confidence            211   11236789999998533222       12333    24569999999999 88999999999999999766  9


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHH
Q 014156          234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL  288 (429)
Q Consensus       234 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  288 (429)
                      +|+|||.............           .+.. ..+..++|+||||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence            9999998765422111100           2222 33668899999999886654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.9e-21  Score=170.56  Aligned_cols=136  Identities=18%  Similarity=0.230  Sum_probs=104.0

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------------------------hhHHHHHHHHHHcCCCC
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------------------RYKNRELQTMRLLDHPN  145 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~~l~h~~  145 (429)
                      .+.||+|+||.||+|.+. +|+.||||++....                              ....+|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999986 89999999876431                              01246888899999988


Q ss_pred             eeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeecCCCCCCe
Q 014156          146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNL  224 (429)
Q Consensus       146 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~~iiHrDlKp~Ni  224 (429)
                      +........  . .    .++||||++|.......  . ....++...+..++.|++.+|.+|| . .||+||||||+||
T Consensus        81 i~~p~~~~~--~-~----~~lVmE~~~g~~~~~~~--l-~~~~~~~~~~~~i~~~l~~~l~~lH-~~~givHrDlkP~NI  149 (190)
T cd05145          81 VPVPEPILL--K-K----NVLVMEFIGDDGSPAPR--L-KDVPLEEEEAEELYEQVVEQMRRLY-QEAGLVHGDLSEYNI  149 (190)
T ss_pred             CCCceEEEe--c-C----CEEEEEEecCCCchhhh--h-hhccCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCChhhE
Confidence            754333221  1 1    36899999975211110  1 1246788899999999999999999 6 8999999999999


Q ss_pred             eecCCCCceEEeecCCceecc
Q 014156          225 LVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       225 ll~~~~~~vkl~DFG~a~~~~  245 (429)
                      |++ ++ .++|+|||+|....
T Consensus       150 ll~-~~-~~~liDFG~a~~~~  168 (190)
T cd05145         150 LYH-DG-KPYIIDVSQAVELD  168 (190)
T ss_pred             EEE-CC-CEEEEEcccceecC
Confidence            998 55 79999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=8.9e-21  Score=197.11  Aligned_cols=191  Identities=24%  Similarity=0.408  Sum_probs=147.3

Q ss_pred             CccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcC---CCCeeccceeeeecCCCC
Q 014156           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        87 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~  160 (429)
                      ......|.|.+.||+|+||+||+|.... |+.||+|+-+...   .++.  .+++.+|+   -+.|..+..++...+.  
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~--~q~~~RLk~~~~~~~~~~~~a~~~~~~--  768 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC--LQVMERLKPQMLPSIMHISSAHVFQNA--  768 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh--HHHHHhhchhhhcchHHHHHHHccCCc--
Confidence            3445689999999999999999999766 9999999764322   1111  23344444   2344455444433332  


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec------CCCCce
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN------PHTHQV  233 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~------~~~~~v  233 (429)
                         -++|++|.+ |+|++++.    ..+.+++..+.++..|++.-+++|| .++|||+||||+|+||.      .+..-+
T Consensus       769 ---S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH-~~~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  769 ---SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLH-AMGIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             ---ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHH-hcceecccCCcceeEeecccCCCCcccce
Confidence               457999998 78888775    4688999999999999999999999 89999999999999983      222359


Q ss_pred             EEeecCCceecc---cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 014156          234 KLCDFGSAKVLV---KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ  291 (429)
Q Consensus       234 kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  291 (429)
                      +|+|||.+.-+.   ++......++|-.+-.+|+..|. .+++.+|.|.|+.+++.||+|+
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence            999999986543   33344556778889999999775 4999999999999999999998

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.7e-19  Score=160.36  Aligned_cols=135  Identities=19%  Similarity=0.220  Sum_probs=100.0

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHc-----CCCCeeccceeeeecCCCCceEEE
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      -.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     +||||+++++++..... ....+.
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~~   81 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVYD   81 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEEE
Confidence            347899999999995  6667666 69987543    34567899999999     67999999998754321 122234


Q ss_pred             EEeecch---hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHcCCCeeecCCCCCCeeecCCC---CceEEeec
Q 014156          166 LVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL-AYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCDF  238 (429)
Q Consensus       166 lv~e~~~---~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL-~~LH~~~~iiHrDlKp~Nill~~~~---~~vkl~DF  238 (429)
                      +|+||++   ++|.+.+..     ..+++.  ..++.|++.++ +||| +.+|+||||||+|||++..+   ..++|+||
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh-~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLL-DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            7899955   577666643     345555  35678888888 9999 88999999999999997432   27999995


Q ss_pred             CCc
Q 014156          239 GSA  241 (429)
Q Consensus       239 G~a  241 (429)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3.2e-20  Score=163.27  Aligned_cols=240  Identities=15%  Similarity=0.205  Sum_probs=173.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+..+..+|.....|..|+|++..  ..++.|++.-      ..+.+..|.-.|+.+.||||+.+++.+-     ....
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppn  261 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPN  261 (448)
T ss_pred             hhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCC
Confidence            3456677889999999999999844  4566665532      1344557888899999999999999883     3344


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-eeecCCCCCCeeecCCCCceEEe--ecC
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-VCHRDIKPQNLLVNPHTHQVKLC--DFG  239 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~-iiHrDlKp~Nill~~~~~~vkl~--DFG  239 (429)
                      +.++..||+ ++|+.++..  ..+-..+..++..++.+|++|+.|||+--. |.---|....++||.+. +.+|+  |--
T Consensus       262 lv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~k  338 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTK  338 (448)
T ss_pred             ceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccce
Confidence            788999999 777777653  223446777889999999999999995223 33446888889998776 45543  322


Q ss_pred             CceecccCCCcccccccccccccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ++..      .....-+|.||+||.+...+.  .-.++|+|||+++++||.|...||..-...+.-.++.-         
T Consensus       339 fsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------  403 (448)
T KOG0195|consen  339 FSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------  403 (448)
T ss_pred             eeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------
Confidence            2211      112334788999999965432  23468999999999999999999988776654333221         


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  372 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  372 (429)
                                        .-++..+++.+++....|++-|+..||.+||.+..++
T Consensus       404 ------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 ------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                              1123456778899999999999999999999887654

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=2.4e-19  Score=163.22  Aligned_cols=140  Identities=16%  Similarity=0.144  Sum_probs=104.9

Q ss_pred             ceeEeeEEccCCcEEEEEEE-EcCCCcEEEEEEeccch----------------------------hhHHHHHHHHHHcC
Q 014156           92 SYMAERVVGQGSFGIVFQAK-CLETGETVAIKKVLQDK----------------------------RYKNRELQTMRLLD  142 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~  142 (429)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|++....                            ....+|+..++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 66789999999875321                            11347899999987


Q ss_pred             CCCeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-eeecCCCC
Q 014156          143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-VCHRDIKP  221 (429)
Q Consensus       143 h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~-iiHrDlKp  221 (429)
                      +. .+.+...+.. . .    .++||||+++..+....   .....+....+..++.||+.+|.+|| ..| |+||||||
T Consensus       109 ~~-~i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH-~~g~iiH~Dikp  177 (237)
T smart00090      109 EA-GVPVPKPIAW-R-R----NVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLY-KEGELVHGDLSE  177 (237)
T ss_pred             hc-CCCCCeeeEe-c-C----ceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHH-hcCCEEeCCCCh
Confidence            53 3333333321 1 1    36899999985432211   11234566677899999999999999 789 99999999


Q ss_pred             CCeeecCCCCceEEeecCCceec
Q 014156          222 QNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       222 ~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||+++ ++ .++|+|||.|...
T Consensus       178 ~NIli~-~~-~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DG-KVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CC-CEEEEEChhhhcc
Confidence            999999 55 7999999998654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=4.7e-20  Score=176.66  Aligned_cols=180  Identities=29%  Similarity=0.457  Sum_probs=132.9

Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ..|+||.|++|....+..+....+.....+....+.++.|+..|++|    +|.+|||+||.||++..+. .+||.|||+
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFgl  402 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFGL  402 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhhh
Confidence            44689999999965555444434445567788899999999999999    5999999999999998776 899999999


Q ss_pred             ceecccCC-------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCC
Q 014156          241 AKVLVKGE-------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       241 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      ........       ..+...||..||+||.+.+.. |+.++||||||++|+||+.- ...|...   ..+..+      
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~------  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERI---ATLTDI------  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhh------
Confidence            87766555       456678999999999998754 99999999999999999982 2222110   011111      


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                           ....|.+.+..+ -+.-.+|+.+||...|.+||++.+.-.|+|.
T Consensus       473 ---------------------r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 ---------------------RDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ---------------------hcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                                 111111111111 2455789999999999999988888778775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.6e-19  Score=184.08  Aligned_cols=258  Identities=23%  Similarity=0.301  Sum_probs=191.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC-CCcEEEEEEeccc---h---hhHHHHHHHHHHcC-CCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD---K---RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~---~---~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..|.+.+.||+|+|+.|-++.... +...+|.|.+...   .   .....|..+-+.+. |.|++++++..     .+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence            358999999999999999887643 3456677755322   1   12234777777777 99999998877     4445


Q ss_pred             EEEEEeecchhhHHHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      +.+++++|..|+...  ... .......+...+..++.|+..++.|+|...++.|||+||+|.+++..+..+++.|||+|
T Consensus        95 ~~~~~~~~s~g~~~f--~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLF--SKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccccccCcccccccc--cccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence            578899997764222  111 11222577788899999999999999966799999999999999977646999999999


Q ss_pred             eeccc-CCC---cccccc-cccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVK-GEP---NISYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~-~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ..... ...   ....+| ++.|+|||...+........|+||.|+++..+++|..|+..........            
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------------  240 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------------  240 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------------
Confidence            87755 222   234578 9999999999876667889999999999999999999996544322110            


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                               ..+  ... ........+..++..+.+++.++|..+|..|.+..++..+||+..
T Consensus       241 ---------~~~--~~~-~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 ---------SSW--KSN-KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ---------eee--ccc-ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                     000  000 011112234567899999999999999999999999999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-17  Score=162.99  Aligned_cols=205  Identities=24%  Similarity=0.357  Sum_probs=146.3

Q ss_pred             HHHcCCCCeeccceeeeecCCCCceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeee
Q 014156          138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH  216 (429)
Q Consensus       138 l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiH  216 (429)
                      |+.+.|.|+.++++..+...     .+++|.+||. |++.+.+..   ....++......+++.|+.||.|||++....|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            35689999999999886653     3778999999 566665543   45678888888999999999999996544499


Q ss_pred             cCCCCCCeeecCCCCceEEeecCCceecccC---CCcccccccccccccccccCCC------CCCCcchHHHHHHHHHHH
Q 014156          217 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGAT------EYTTAIDIWSVGCVLAEL  287 (429)
Q Consensus       217 rDlKp~Nill~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~el  287 (429)
                      +.|++.|+++|... .+||+|||+.......   .......-...|.|||.+.+..      ..+.+.|+||+|++++|+
T Consensus        73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999877 8999999998665321   1111112234599999986531      146679999999999999


Q ss_pred             HhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCC
Q 014156          288 LLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN  363 (429)
Q Consensus       288 ltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  363 (429)
                      ++...||.......    .+..+.+ .+..              ...|.+..      . ..+.+++..++..||..+|.
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~-~~~~--------------~~rP~i~~------~-~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKK-GGSN--------------PFRPSIEL------L-NELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHh-cCCC--------------CcCcchhh------h-hhcchHHHHHHHHhcccChh
Confidence            99999997633222    2222222 1110              01111110      0 03566899999999999999


Q ss_pred             CCCCHHHHhc
Q 014156          364 LRCTALEACI  373 (429)
Q Consensus       364 ~R~t~~e~l~  373 (429)
                      +||++.++-.
T Consensus       210 ~rPs~~~i~~  219 (484)
T KOG1023|consen  210 KRPSIEQIRS  219 (484)
T ss_pred             hCccHHHHHh
Confidence            9999988743

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=1.7e-17  Score=147.58  Aligned_cols=132  Identities=17%  Similarity=0.148  Sum_probs=99.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch--------------------------hhHHHHHHHHHHcCCCC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPN  145 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~~  145 (429)
                      .|.+.+.||+|+||.||++... +|+.||||++....                          ....+|+.++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3888899999999999999864 79999999764321                          11346788888887774


Q ss_pred             --eeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          146 --VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       146 --iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                        +...++    ..     ..++||||+++..+..+..         ......++.+++.++.++| +.||+||||||+|
T Consensus        95 i~v~~~~~----~~-----~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh-~~gi~H~Dl~p~N  155 (198)
T cd05144          95 FPVPKPID----WN-----RHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAY-KHGIIHGDLSEFN  155 (198)
T ss_pred             CCCCceee----cC-----CceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHH-HCCCCcCCCCccc
Confidence              333322    11     1478999999854332110         1345678899999999999 7899999999999


Q ss_pred             eeecCCCCceEEeecCCceec
Q 014156          224 LLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~~  244 (429)
                      |+++.++ .++|+|||.+...
T Consensus       156 ill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCC-cEEEEECCccccC
Confidence            9999876 8999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=6.6e-17  Score=145.30  Aligned_cols=129  Identities=18%  Similarity=0.314  Sum_probs=98.6

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +.||+|++|.||+|.+  .|..+++|+.....            ....+|+.++..+.|+++.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999987  77789999754211            22346889999999998866554443322     25


Q ss_pred             EEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||++|. +.+.+..    .   .. ....++.+++.+|.+|| +.|++|||++|.|||++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH-~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLH-SAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHH-hCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            6899999864 4333321    1   11 67888999999999999 88999999999999999 44 799999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=2e-16  Score=140.84  Aligned_cols=127  Identities=17%  Similarity=0.283  Sum_probs=92.5

Q ss_pred             EEccCCcEEEEEEEEcCCCcEEEEEEeccc------------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .||+|+||.||+|..  +|..+++|.....            .....+|++++..+.|+++....-++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            389999999999984  6788999975421            122346999999998887544333332221     146


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||++|..+.....  . .. .      .++.|++.+|.+|| +.|++|||++|.||+++ ++ .++++|||++...
T Consensus        74 lv~e~~~g~~l~~~~~--~-~~-~------~~~~~i~~~l~~lH-~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~~  139 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIE--E-GN-D------ELLREIGRLVGKLH-KAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEEECCccHHHHHh--h-cH-H------HHHHHHHHHHHHHH-HCCeecCCCCcceEEEE-CC-cEEEEECCCCcCC
Confidence            8999998653332211  1 11 0      67889999999999 88999999999999999 55 7999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=3.5e-16  Score=137.78  Aligned_cols=131  Identities=21%  Similarity=0.190  Sum_probs=90.0

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhH----------------------------HHHHHHHHHcCCCC--
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN--  145 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~~--  145 (429)
                      .+.||+|+||.||+|.+. +++.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999976 88999999875422110                            13444444443322  


Q ss_pred             eeccceeeeecCCCCceEEEEEeecchhhHH--HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeecCCCCC
Q 014156          146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVY--RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQ  222 (429)
Q Consensus       146 iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~~iiHrDlKp~  222 (429)
                      +.+.+.+    .     ..++||||++++..  ..+....     .. ..++.++.+++.++.++| . .||+||||||+
T Consensus        81 ~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh-~~~~ivH~Dl~p~  144 (187)
T cd05119          81 VPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLY-REAGLVHGDLSEY  144 (187)
T ss_pred             CCceEec----C-----CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHh-hccCcCcCCCChh
Confidence            2222221    1     14789999997211  1111100     11 567889999999999999 6 89999999999


Q ss_pred             CeeecCCCCceEEeecCCceecc
Q 014156          223 NLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       223 Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||+++ ++ .++|+|||.+....
T Consensus       145 Nili~-~~-~~~liDfg~a~~~~  165 (187)
T cd05119         145 NILVD-DG-KVYIIDVPQAVEID  165 (187)
T ss_pred             hEEEE-CC-cEEEEECccccccc
Confidence            99999 55 79999999996553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=3.9e-16  Score=159.49  Aligned_cols=131  Identities=17%  Similarity=0.247  Sum_probs=96.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEec-c---c--------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-Q---D--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~---~--------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      .|...+.||+|+||+||++.+...  .+++|+.. +   .        .....+|+++++.++|++++..+.++....  
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--  409 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--  409 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence            356788999999999999986433  34444321 1   0        123457999999999999887654443321  


Q ss_pred             CceEEEEEeecchhhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                         ..++||||+++..+ +.+.            ....++.|++.+|.+|| +.||+||||||+|||++ ++ .++|+||
T Consensus       410 ---~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH-~~giiHrDlkp~NILl~-~~-~~~liDF  471 (535)
T PRK09605        410 ---EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH-KAGIVHGDLTTSNFIVR-DD-RLYLIDF  471 (535)
T ss_pred             ---CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH-hCCCccCCCChHHEEEE-CC-cEEEEeC
Confidence               25689999986433 3221            34678899999999999 88999999999999994 44 6999999


Q ss_pred             CCceec
Q 014156          239 GSAKVL  244 (429)
Q Consensus       239 G~a~~~  244 (429)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            998753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=6.2e-15  Score=134.55  Aligned_cols=133  Identities=17%  Similarity=0.230  Sum_probs=95.1

Q ss_pred             eEEc-cCCcEEEEEEEEcCCCcEEEEEEeccc-----------------hhhHHHHHHHHHHcCCCCe--eccceeeeec
Q 014156           97 RVVG-QGSFGIVFQAKCLETGETVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNV--VSLKHCFFST  156 (429)
Q Consensus        97 ~~lG-~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~  156 (429)
                      ..|| .|+.|+||.+..  .+..+++|.+...                 .....+|+.++..|.|++|  +..+......
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 888899999876  4778999876321                 1234579999999998875  4454433221


Q ss_pred             CCCCceEEEEEeecchh--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceE
Q 014156          157 TDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  234 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vk  234 (429)
                      . ......++|||+++|  ++...+.     ...+++..    +.||+.+|.+|| +.||+||||||.|||++.++ .++
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH-~~GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFH-DAGVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHH-HCCCCCCCCCchhEEEcCCC-CEE
Confidence            1 111123589999986  4444432     23455443    568999999999 88999999999999999876 799


Q ss_pred             EeecCCcee
Q 014156          235 LCDFGSAKV  243 (429)
Q Consensus       235 l~DFG~a~~  243 (429)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999999865

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=1e-15  Score=149.76  Aligned_cols=251  Identities=25%  Similarity=0.269  Sum_probs=190.0

Q ss_pred             cccceeEeeEEcc--CCcEEEEEEEE--cCCCcEEEEEEec------cchhhHHHHHHHHHHc-CCCCeeccceeeeecC
Q 014156           89 QTISYMAERVVGQ--GSFGIVFQAKC--LETGETVAIKKVL------QDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  157 (429)
Q Consensus        89 ~~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vaiK~~~------~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~  157 (429)
                      ....+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-.      .......+|+...+.+ .|+|.++.+..+    
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~----  187 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW----  187 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc----
Confidence            3346778889999  99999999998  8899999999632      1223334566666666 489999977766    


Q ss_pred             CCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHcCCCeeecCCCCCCeeecCCCCce
Q 014156          158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYIHGGIGVCHRDIKPQNLLVNPHTHQV  233 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~----aL~~LH~~~~iiHrDlKp~Nill~~~~~~v  233 (429)
                       .+...+++-+|+|+..+......   ....++...++....+...    ||.++| ..+|+|-|+||+||++..+....
T Consensus       188 -e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~h-s~~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  188 -EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLH-SNNIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             -ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccC-CCcccccccchhheeccccccee
Confidence             44445889999999766654432   3445888889999999999    999999 88999999999999999883479


Q ss_pred             EEeecCCceecccCCCccc------ccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 014156          234 KLCDFGSAKVLVKGEPNIS------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE--SGVDQLVE  305 (429)
Q Consensus       234 kl~DFG~a~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~  305 (429)
                      +++|||+...+..+.....      ..|...|++||...+  -++...|++++|.+..+..+|..++...  +...++.+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            9999999988766543221      146677999998854  4789999999999999999998776543  32222211


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      +.                              +...+-...+.++...+..|+..+|-.|+++..+++|+++...
T Consensus       341 ~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  341 GY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             cc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            11                              1112223456778889999999999999999999999998753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=3.5e-15  Score=126.02  Aligned_cols=131  Identities=19%  Similarity=0.224  Sum_probs=100.6

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHHcCC--CCeeccceeeeecCCCCceEEEEEeec
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      +.+.||+|.++.||++...  +..+++|......  ....+|+.+++.+.|  .++++++..+..     ....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEEEe
Confidence            4578999999999999973  3789999886553  356789999999976  477777665422     2346789999


Q ss_pred             chhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC--CCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG--IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       171 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +.+.....          ++......++.+++.+|.+||..  .+++|+|++|.||+++..+ .++++|||.+..
T Consensus        75 ~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeeccc----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            98753221          14456677888999999999932  3799999999999999755 799999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=2.1e-15  Score=154.91  Aligned_cols=268  Identities=25%  Similarity=0.276  Sum_probs=188.6

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ....+.+.+-+-+|+++.++.+.-..+|...++|......       +....+-.++....+|.++.....+     ...
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence            3456788889999999999999887888777777543221       1111222233333456666543332     122


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      .-.+++++|+++ ++...+.    ..+..+...++.++..+..+++||| ...+.|||++|.|+|+..++ ..+++|||.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~-s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t  950 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLH-SSLRKHRDLKPDSLLIAYDG-HRPLTDFGT  950 (1205)
T ss_pred             CCcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhccc-cchhhcccccccchhhcccC-CcccCcccc
Confidence            226789999975 3333332    3456777778888899999999999 65699999999999999888 589999984


Q ss_pred             ceeccc---------------------C-----------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHH
Q 014156          241 AKVLVK---------------------G-----------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL  288 (429)
Q Consensus       241 a~~~~~---------------------~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  288 (429)
                      .....-                     .           .......||+.|.+||.+.+.. ....+|+|++|+++++.+
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence            322100                     0           0112346799999999998755 788899999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH
Q 014156          289 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA  368 (429)
Q Consensus       289 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  368 (429)
                      +|.+||...........+....-                         +|.. -+...++++++++.++|..+|.+|..+
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~~~-------------------------~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDI-------------------------PWPE-GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccCCC-------------------------CCCC-CccccChhhhhhhhhhhccCchhccCc
Confidence            99999988776655544433210                         0100 112368899999999999999999998


Q ss_pred             H---HHhcCCCccccCCCCCCCCCCCCCC
Q 014156          369 L---EACIHPFFDELRDPNARLPNGRPFP  394 (429)
Q Consensus       369 ~---e~l~hp~f~~~~~~~~~~~~~~~~~  394 (429)
                      .   ++-.||||+...+......+..++|
T Consensus      1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p 1112 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVP 1112 (1205)
T ss_pred             ccccccccCCccCCCCccccccccCccCC
Confidence            7   8999999999988766554444443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=3.5e-14  Score=128.80  Aligned_cols=242  Identities=18%  Similarity=0.203  Sum_probs=157.2

Q ss_pred             EEEEEEEcCCCcEEEEEEec--------cchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecch-hhHH
Q 014156          106 IVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVY  176 (429)
Q Consensus       106 ~V~~~~~~~~~~~vaiK~~~--------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~-~~l~  176 (429)
                      .||++-+...|..|.--.+.        ...+....-+.-|.++.|.|||+++.+|.+....+.....+++||+. +.+.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            46777666666655433221        11111222334556678999999998886665545555778999998 5566


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCeeecCCCCCCeeecCCCCceEEeecCCceec-----ccCCCc
Q 014156          177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPN  250 (429)
Q Consensus       177 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~-----~~~~~~  250 (429)
                      ..++........+......+|+.||+.||.|||+ ..-|+|+++..+-|++..++ -||+.----....     ......
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek  239 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEK  239 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhh
Confidence            6666666667789999999999999999999994 34799999999999999776 5665421111000     000111


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccc
Q 014156          251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  329 (429)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  329 (429)
                      ....+-++|.|||.=.. ...+.++|||++|+...+|..+..-- .+.+....-..+...+                   
T Consensus       240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-------------------  299 (458)
T KOG1266|consen  240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI-------------------  299 (458)
T ss_pred             hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence            12334677999986432 33677899999999999999887432 1211111111111100                   


Q ss_pred             CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       330 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                   -..-.+--++++.+||.-.|+.||++.+++.||.+-++.
T Consensus       300 -------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  300 -------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             -------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence                         000122345789999999999999999999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=1.8e-13  Score=134.17  Aligned_cols=251  Identities=22%  Similarity=0.198  Sum_probs=175.3

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEc-CCCcEEEEEEeccchh------hHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDKR------YKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~------~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|..+..||.|.|+.|+.+..+ .++..|++|.+.+...      +...|+-+...+ .|.++++++..|..... 
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-
Confidence            34567999999999999999998755 6788999997754322      122455555444 58899998877744332 


Q ss_pred             CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                          .|+-.|||.+....+..   .....+.+...+.+..|++.++.++| +..++|+|+||+||++..++..-++.|||
T Consensus       341 ----~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~-s~~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  341 ----GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIH-SKLFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ----ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhcccccc-chhhhcccccccceeeccchhhhhccccc
Confidence                55888999865545433   22355777888899999999999999 89999999999999998764578999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ++..+. -........+..|-..|++.....+..+.|++|||..+.+.++|.+.-.......   .++..          
T Consensus       413 ~~t~~~-~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~----------  478 (524)
T KOG0601|consen  413 CWTRLA-FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG----------  478 (524)
T ss_pred             cccccc-eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc----------
Confidence            986421 1111112223334235556566668889999999999999999985432221111   11000          


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                  ..       .........+..+.+.++..++..|+.+.++..|.=|...
T Consensus       479 ------------~~-------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  479 ------------DT-------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ------------cc-------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                        00       0011234678899999999999999999999988776543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=7.5e-12  Score=124.04  Aligned_cols=180  Identities=23%  Similarity=0.260  Sum_probs=125.2

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      |.+ ...+-++.+..-.|..+.++.+|.+.......    ....+-++.|+.++||||+++++++.     ....+|+|+
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-----~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-----EEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-----ccCceEEEe
Confidence            555 44444444433345566778888887664432    33457788999999999999999883     333589999


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      |.+..- -..++.       +....+..-+.||+.||.|||.+++++|++|.-+-|+|+..| ..||++|.++.......
T Consensus        89 ErV~Pl-~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   89 ERVRPL-ETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN  159 (690)
T ss_pred             eccccH-HHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence            998631 122222       225566777889999999999788999999999999999988 79999999875543222


Q ss_pred             C-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC
Q 014156          249 P-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG  290 (429)
Q Consensus       249 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg  290 (429)
                      . .....---.|..|+.+..   -.-..|.|.|||++++++.|
T Consensus       160 ~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  160 APAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence            1 111111223667775522   12457999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=3.2e-12  Score=126.77  Aligned_cols=137  Identities=20%  Similarity=0.248  Sum_probs=87.0

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch-hhH-------------------------------------------H
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYK-------------------------------------------N  132 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~-------------------------------------------~  132 (429)
                      +.||.|++|.||+|+. .+|+.||||+..... ...                                           .
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999986 578999999874321 001                                           1


Q ss_pred             HHHHHHHHc----CCCCeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHH-HHHH
Q 014156          133 RELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR-ALAY  207 (429)
Q Consensus       133 ~E~~~l~~l----~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~-aL~~  207 (429)
                      +|++.+.++    +|.+-+.+...+....+    ..++||||++|..+........  ....   ...++.+++. .+..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQ  272 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHH
Confidence            233333333    23333333333322221    1468999998754332222111  1122   2345555555 4678


Q ss_pred             HHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       208 LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +| ..|++|+|+||.||+++.++ .++|+|||++....
T Consensus       273 l~-~~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       273 VL-RDGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HH-hCCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            89 78999999999999998887 79999999997763

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=7.8e-13  Score=132.70  Aligned_cols=141  Identities=18%  Similarity=0.218  Sum_probs=88.0

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh--------------------------------------HH-
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY--------------------------------------KN-  132 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------~~-  132 (429)
                      .|.. +.||+|++|.||+|+.+.+|+.||||+.......                                      .. 
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 6899999999999999888999999988532100                                      01 


Q ss_pred             -----HHHHHHHHc----CCCCeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcC---CCCCHHHHHHHHHH
Q 014156          133 -----RELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS---QRMPLIYVKLYTYQ  200 (429)
Q Consensus       133 -----~E~~~l~~l----~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~---~~l~~~~~~~~~~q  200 (429)
                           +|+.-+.++    .+.+.+.+...|.+..+    ..++||||+.|.-...+......+   ..+.+..+..++.|
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence                 122222222    23333444344432221    146899999985433222211111   12444445555555


Q ss_pred             HHHHHHHHHcCCCeeecCCCCCCeeecCCC---CceEEeecCCceecc
Q 014156          201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSAKVLV  245 (429)
Q Consensus       201 i~~aL~~LH~~~~iiHrDlKp~Nill~~~~---~~vkl~DFG~a~~~~  245 (429)
                      ++        ..|++|+|+||.||+++.++   .+++++|||++....
T Consensus       276 if--------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 VF--------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HH--------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            54        35999999999999998765   269999999987763

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.35  E-value=4.1e-12  Score=109.85  Aligned_cols=125  Identities=15%  Similarity=0.191  Sum_probs=89.4

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeec-cceeeeecCCCCceEEEEEeecc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVS-LKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~-l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ++.|+.|.++.||+++.  .+..|++|......   ....+|+.+++.+.+.+++. ++...     ...  .++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            36789999999999986  47889999875442   33568999999887655543 33221     111  25899999


Q ss_pred             hhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----eeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          172 PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       172 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~-----iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|......        .   .....++.+++.+|..|| ..+     ++|+|++|.||+++ ++ .++++|||.+..
T Consensus        74 ~G~~l~~~--------~---~~~~~~~~~l~~~l~~LH-~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~  136 (170)
T cd05151          74 EGSELLTE--------D---FSDPENLEKIAKLLKKLH-SSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGM  136 (170)
T ss_pred             CCCccccc--------c---ccCHHHHHHHHHHHHHHh-CCCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccC
Confidence            98532210        0   112345679999999999 666     49999999999999 44 699999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.30  E-value=1.5e-11  Score=107.68  Aligned_cols=132  Identities=17%  Similarity=0.192  Sum_probs=92.0

Q ss_pred             eEEccCCcEEEEEEEEcC------CCcEEEEEEecc--------------chh------------hH----HHHHHHHHH
Q 014156           97 RVVGQGSFGIVFQAKCLE------TGETVAIKKVLQ--------------DKR------------YK----NRELQTMRL  140 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~--------------~~~------------~~----~~E~~~l~~  140 (429)
                      .+||.|--+.||.|....      .+..+|||+.+.              +.+            ..    ++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643      357899997521              100            11    268888888


Q ss_pred             cCC--CCeeccceeeeecCCCCceEEEEEeecchhhHH--HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCee
Q 014156          141 LDH--PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY--RVAKHYSRASQRMPLIYVKLYTYQICRALAYI-HGGIGVC  215 (429)
Q Consensus       141 l~h--~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L-H~~~~ii  215 (429)
                      +..  -++...+.+.     .    -++||||++++.+  ..+.     ...++...+..+..|++.+|..| | +.|||
T Consensus        83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H-~~glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYK-ECNLV  147 (197)
T ss_pred             HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHH-hCCee
Confidence            753  3344444321     1    3589999986411  1111     12355556677889999999999 8 88999


Q ss_pred             ecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       216 HrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      |+||++.|||++. + .++|+|||.|....
T Consensus       148 HGDLs~~NIL~~~-~-~v~iIDF~qav~~~  175 (197)
T cd05146         148 HADLSEYNMLWHD-G-KVWFIDVSQSVEPT  175 (197)
T ss_pred             cCCCCHHHEEEEC-C-cEEEEECCCceeCC
Confidence            9999999999974 4 69999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.24  E-value=3.9e-10  Score=108.80  Aligned_cols=214  Identities=19%  Similarity=0.256  Sum_probs=151.0

Q ss_pred             cEEEEEEEEcCCCcEEEEEEeccchh----hHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecchh--hHHH
Q 014156          104 FGIVFQAKCLETGETVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE--TVYR  177 (429)
Q Consensus       104 ~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~--~l~~  177 (429)
                      -.+.|++....+|..|++|++..++.    ....-+++++++.|.|+|++.++|... .-+...+++|++|.++  +|++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHHH
Confidence            35789999999999999999843221    223468899999999999999988733 3455568899999884  5555


Q ss_pred             HHHHh-----------hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          178 VAKHY-----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       178 ~~~~~-----------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      +...-           ...+...++..+|.|+.|+..||.++| +.|..-+-|.|.+||++.+. +++|+..|+......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH-ssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH-SSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH-hcCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence            43211           112345788999999999999999999 77999999999999999776 799988887655433


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHhCCCCHHHHhhcCCC
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQ-LVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..           .  +.+.+    -.+-|.=.||.+++.|.||..- +......+. +..|                  
T Consensus       446 d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------------  490 (655)
T KOG3741|consen  446 DP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------------  490 (655)
T ss_pred             CC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------------
Confidence            22           0  11222    2356999999999999999621 111111111 1111                  


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                        ...++.+++++|.-+..-++.+ -++.+++.|
T Consensus       491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                              1236788888888888888876 577777654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=5.3e-12  Score=125.57  Aligned_cols=161  Identities=22%  Similarity=0.316  Sum_probs=117.5

Q ss_pred             HHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC--------ccc--ccccccccccccccCCCC
Q 014156          201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--------NIS--YICSRYYRAPELIFGATE  270 (429)
Q Consensus       201 i~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~--------~~~--~~gt~~y~aPE~~~~~~~  270 (429)
                      +..|+.|+|.+.++||++|.|++|.++..+ ..||+.|+.+.....+..        ...  ..-...|.|||.+.+ ..
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~  185 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT  185 (700)
T ss_pred             ccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence            448999999888999999999999999888 799999998755433111        001  112456999999976 45


Q ss_pred             CCCcchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChh
Q 014156          271 YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE  349 (429)
Q Consensus       271 ~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  349 (429)
                      .+.++|+||+||++|.+. .|+..+.+.+............                         ..-...+..+++.+
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-------------------------~~~~~~~s~~~p~e  240 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-------------------------NAGAFGYSNNLPSE  240 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-------------------------ccccccccccCcHH
Confidence            889999999999999999 5666665443322221111100                         00011233568999


Q ss_pred             HHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCC
Q 014156          350 AVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP  388 (429)
Q Consensus       350 ~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~  388 (429)
                      +++=|.++|..++..||++.+++..|||.+..-.+.++.
T Consensus       241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aLrfL  279 (700)
T KOG2137|consen  241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKALRFL  279 (700)
T ss_pred             HHHHHHHHhcCCcccCcchhhhhcccccCCchhhhhhhc
Confidence            999999999999999999999999999999776665543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=5.9e-10  Score=94.04  Aligned_cols=140  Identities=19%  Similarity=0.245  Sum_probs=94.9

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEecc------------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ....|-+|+-+.|+++.+  .|+.+.||.-..            .+....+|++.|.++.--.|.--.-+|.+...    
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            456788999999999976  788888884321            12333468888887753332211111222222    


Q ss_pred             EEEEEeecchh--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCce--EEeec
Q 014156          163 YLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV--KLCDF  238 (429)
Q Consensus       163 ~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~v--kl~DF  238 (429)
                       -+|+|||++|  ++.+.+.....  ..........++.+|-..+.-|| ..+|||+||..+||++.+++..+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH-~ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLH-DNDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhh-hCCeecccccccceEEecCCCcCceEEEee
Confidence             3579999998  44444433221  22222333678888999999999 88999999999999998777655  89999


Q ss_pred             CCceec
Q 014156          239 GSAKVL  244 (429)
Q Consensus       239 G~a~~~  244 (429)
                      |++...
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=1e-09  Score=92.97  Aligned_cols=126  Identities=16%  Similarity=0.311  Sum_probs=83.2

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEec-cc-----------hhhHHHHHHHHHHcCCCCe--eccceeeeecCCCCce
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVL-QD-----------KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTDKDEL  162 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~~~~~~~  162 (429)
                      ..+++|+-+.++.+.+  -|..+++|.-. +.           .....+|++++..+.--.|  .-+++  ++...    
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~~----   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPDN----   73 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCCC----
Confidence            3578999999999965  34456777431 11           1223468888887753332  22322  22222    


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                       ..|+|||++|.++....   ...   .    ..++..+-.-+.-|| ..||+|+||.++||++..+  .+.++|||++.
T Consensus        74 -~~I~me~I~G~~lkd~l---~~~---~----~~~~r~vG~~vg~lH-~~givHGDLTtsNiIl~~~--~i~~IDfGLg~  139 (204)
T COG3642          74 -GLIVMEYIEGELLKDAL---EEA---R----PDLLREVGRLVGKLH-KAGIVHGDLTTSNIILSGG--RIYFIDFGLGE  139 (204)
T ss_pred             -CEEEEEEeCChhHHHHH---Hhc---c----hHHHHHHHHHHHHHH-hcCeecCCCccceEEEeCC--cEEEEECCccc
Confidence             45899999996655221   111   1    334556666677899 8899999999999999854  49999999987


Q ss_pred             ec
Q 014156          243 VL  244 (429)
Q Consensus       243 ~~  244 (429)
                      ..
T Consensus       140 ~s  141 (204)
T COG3642         140 FS  141 (204)
T ss_pred             cc
Confidence            53

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.97  E-value=4.1e-09  Score=95.08  Aligned_cols=140  Identities=18%  Similarity=0.189  Sum_probs=90.8

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCC--eeccceeeeecCCCCceEEEEEee
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      +.|+.|..+.||++... +|+.+++|.....     .....+|.++++.+.+.+  +.+++.......  .....++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            57899999999999863 3688999987543     235578999999987633  445544332111  0113568999


Q ss_pred             cchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 014156          170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG---------------------------------------  210 (429)
Q Consensus       170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---------------------------------------  210 (429)
                      |++|..+....   . ...++......++.+++.+|..||+                                       
T Consensus        81 ~i~G~~l~~~~---~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          81 RVDGRVLRDRL---L-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EeCCEecCCCC---C-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            99875222110   0 0234445555555566666655552                                       


Q ss_pred             ----------------CCCeeecCCCCCCeeecCC-CCceEEeecCCcee
Q 014156          211 ----------------GIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  243 (429)
Q Consensus       211 ----------------~~~iiHrDlKp~Nill~~~-~~~vkl~DFG~a~~  243 (429)
                                      ...++|+|+++.||+++.+ ...+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            2357999999999999873 22688999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=4e-09  Score=91.99  Aligned_cols=122  Identities=22%  Similarity=0.282  Sum_probs=75.9

Q ss_pred             EEEEEEEcCCCcEEEEEEeccc------------------------------hhhHHHHHHHHHHcCCCC--eeccceee
Q 014156          106 IVFQAKCLETGETVAIKKVLQD------------------------------KRYKNRELQTMRLLDHPN--VVSLKHCF  153 (429)
Q Consensus       106 ~V~~~~~~~~~~~vaiK~~~~~------------------------------~~~~~~E~~~l~~l~h~~--iv~l~~~~  153 (429)
                      .||.|.. ..|..+|+|+....                              .....+|.+.|..+..-+  +.+.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4889985 56789999975311                              011236999999997653  44544322


Q ss_pred             eecCCCCceEEEEEeecch--hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HHcCCCeeecCCCCCCeeecCCC
Q 014156          154 FSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY-IHGGIGVCHRDIKPQNLLVNPHT  230 (429)
Q Consensus       154 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~-LH~~~~iiHrDlKp~Nill~~~~  230 (429)
                           .    -++||||++  |..+..+...     .++......++.+++..+.. +| ..||+|+||.+.|||++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~-~~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLH-KAGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHH-CTTEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHH-hcCceecCCChhhEEeecc-
Confidence                 1    258999999  6433333221     11133455677788885555 57 8899999999999999965 


Q ss_pred             CceEEeecCCceecc
Q 014156          231 HQVKLCDFGSAKVLV  245 (429)
Q Consensus       231 ~~vkl~DFG~a~~~~  245 (429)
                       .+.|+|||.+....
T Consensus       144 -~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 -KVYIIDFGQAVDSS  157 (188)
T ss_dssp             -CEEE--GTTEEETT
T ss_pred             -eEEEEecCcceecC
Confidence             59999999986543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=4e-08  Score=90.83  Aligned_cols=110  Identities=12%  Similarity=0.138  Sum_probs=75.1

Q ss_pred             HHHHHHHHHHcCCCCee--ccceeeeecCCCCceEEEEEeecchh--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 014156          131 KNRELQTMRLLDHPNVV--SLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA  206 (429)
Q Consensus       131 ~~~E~~~l~~l~h~~iv--~l~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~  206 (429)
                      ..+|...+..|..-+|.  ..+.+.....+.....-++|||++++  ++.+++....  ....+......++.+++..+.
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~  152 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR  152 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence            55788888777433332  22223322222212335689999997  4555543221  234566777889999999999


Q ss_pred             HHHcCCCeeecCCCCCCeeecCC------CCceEEeecCCcee
Q 014156          207 YIHGGIGVCHRDIKPQNLLVNPH------THQVKLCDFGSAKV  243 (429)
Q Consensus       207 ~LH~~~~iiHrDlKp~Nill~~~------~~~vkl~DFG~a~~  243 (429)
                      -|| ..||+|+||++.|||++.+      ...+.|+||+.+..
T Consensus       153 ~LH-~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        153 DMH-AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHH-HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999 8899999999999999752      23799999998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.81  E-value=7.2e-08  Score=91.26  Aligned_cols=258  Identities=16%  Similarity=0.211  Sum_probs=150.6

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh-HHHHHHHHHH-cCCCCeeccceee----eecCCCCceEEEEEe
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-KNRELQTMRL-LDHPNVVSLKHCF----FSTTDKDELYLNLVL  168 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~E~~~l~~-l~h~~iv~l~~~~----~~~~~~~~~~~~lv~  168 (429)
                      ..+.||+|+-+.+|-.-..  +. .+.|+.....-. ..+-+..|.. -.||-+-. .-.|    .... .....+.++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~-rvaWPqa~L~G~-~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNY-RVAWPQATLHGG-RRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHHhccCCCCcchhh-hhcccHHHhhCC-CccceeEEec
Confidence            3467999999999976432  22 244766433211 1122222222 24553322 0001    1111 1222256788


Q ss_pred             ecchhh--HHHHHH--HhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          169 EFVPET--VYRVAK--HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       169 e~~~~~--l~~~~~--~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ..+.+-  ...+..  ...+......+..+.+.++.++.+..-|| ..|.+-+|+.++|+|++.++ .|.|.|=..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH-~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH-EHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH-hcCCcccccCccceeeecCc-eEEEEcccceeec
Confidence            887752  212111  12233445778899999999999999999 88999999999999999777 7889875543333


Q ss_pred             ccCCCccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          245 VKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      .++......+|...|.+||.-.    .....+...|.|.||+++++++.| +.||.|-.....       -..|.+..|.
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~-------ap~p~E~~Ia  240 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD-------APNPLETDIA  240 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC-------CCCcchhhhh
Confidence            4444455667899999999642    112356789999999999999987 899976321000       0001111111


Q ss_pred             hcCCCCcc--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCc--CCCCCCCHH
Q 014156          320 CMNPNYTE--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY--SPNLRCTAL  369 (429)
Q Consensus       320 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~R~t~~  369 (429)
                      .  ..|..  ...+.....+.. .-..-+++++..|..+|++.  ++.-|||+.
T Consensus       241 ~--g~f~ya~~~~~g~~p~P~~-~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         241 H--GRFAYASDQRRGLKPPPRS-IPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             c--ceeeechhccCCCCCCCCC-CChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            0  00000  011111111111 11134789999999999986  467899874

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.70  E-value=8.5e-08  Score=86.30  Aligned_cols=132  Identities=18%  Similarity=0.161  Sum_probs=92.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEec----------cc----------------hhhHHHHHHHHHHcCCC-
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----------QD----------------KRYKNRELQTMRLLDHP-  144 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~----------~~----------------~~~~~~E~~~l~~l~h~-  144 (429)
                      -+.+...||-|--|.||.|.+ ..|..+|||.=.          ..                ....++|.++|.+|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            367778999999999999986 478999999421          00                12234799999988644 


Q ss_pred             -CeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          145 -NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       145 -~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                       .+.+-++         ...-.+|||+++|..+.-        -++.......++..|+.-+..+- +.||||+|+.+-|
T Consensus       171 ~~VP~P~~---------~nRHaVvMe~ieG~eL~~--------~r~~~en~~~il~~il~~~~~~~-~~GiVHGDlSefN  232 (304)
T COG0478         171 VKVPKPIA---------WNRHAVVMEYIEGVELYR--------LRLDVENPDEILDKILEEVRKAY-RRGIVHGDLSEFN  232 (304)
T ss_pred             CCCCCccc---------cccceeeeehcccceeec--------ccCcccCHHHHHHHHHHHHHHHH-HcCccccCCchhe
Confidence             4444432         112468999999843221        12234445555666666666665 6799999999999


Q ss_pred             eeecCCCCceEEeecCCcee
Q 014156          224 LLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~  243 (429)
                      |+++.+| .+.++||--+..
T Consensus       233 IlV~~dg-~~~vIDwPQ~v~  251 (304)
T COG0478         233 ILVTEDG-DIVVIDWPQAVP  251 (304)
T ss_pred             EEEecCC-CEEEEeCccccc
Confidence            9999988 699999976643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.62  E-value=5.3e-07  Score=80.49  Aligned_cols=109  Identities=17%  Similarity=0.257  Sum_probs=74.7

Q ss_pred             hHHHHHHHHHHcCCCCe--eccceeeeecCCCCceEEEEEeecchh--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Q 014156          130 YKNRELQTMRLLDHPNV--VSLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL  205 (429)
Q Consensus       130 ~~~~E~~~l~~l~h~~i--v~l~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL  205 (429)
                      ...+|...+..|..-.|  .+.+.+..... ......++|+|++++  ++.+++..    ....+......++.+++..+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLI  131 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHH
Confidence            34578887777643332  33333332222 222445789999986  34444432    12256667788999999999


Q ss_pred             HHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCCceec
Q 014156          206 AYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVL  244 (429)
Q Consensus       206 ~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~a~~~  244 (429)
                      .-|| ..||+|+|+++.|||++.++  ..+.|+||+.++..
T Consensus       132 ~~lH-~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLH-DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHH-HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999 88999999999999998764  25899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.57  E-value=1.3e-08  Score=100.83  Aligned_cols=246  Identities=18%  Similarity=0.159  Sum_probs=161.5

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCC-eeccceeeeecCCCCceEEEEEeec
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      -|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.+     ..+.+.++++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence            4666678999999999999876665555 6766554 44456889999999999 44443333     566778899999


Q ss_pred             chhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCc
Q 014156          171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  250 (429)
Q Consensus       171 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~  250 (429)
                      ++++-.... ......-.+.......+.+.-.+++++|| +.-=+|||    ||+..+.  ..+..||+....+......
T Consensus       316 ~s~~rs~~~-~~~~se~~~~~~~~~~~~r~et~~l~~l~-~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  316 CSTGRSSAL-EMTVSEIALEQYQFAYPLRKETRPLAELH-SSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hcCCccccc-cCChhhHhhhhhhhhhhhhhhcccccccc-cccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence            986510000 00000111222333445556678899999 53458888    8888753  5899999998776555556


Q ss_pred             ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 014156          251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  330 (429)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  330 (429)
                      .+..+|+.++|||+..... +....|.|++|+-..+|.-|-+|-...                ..... .....   ...
T Consensus       388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P----------------~~~~~-~~g~~---p~s  446 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSP----------------PAVLP-MIGNG---PNS  446 (829)
T ss_pred             ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCC----------------ccccC-CCCCC---CCc
Confidence            6778999999999886544 888999999998877888777765431                00000 00000   000


Q ss_pred             CCcCC-CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          331 PQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       331 ~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      +.... ..|...+.       .++-..|+..-|..|++...++.|.+|...
T Consensus       447 ~~L~~~~aw~~~~~-------~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  447 PMLTDKSAWSPVFH-------RDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccchhhhcCcccc-------cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            11111 22222111       157788999999999999999999999864

>PRK09902 hypothetical protein; Provisional

Probab=98.55  E-value=2.4e-06  Score=75.24  Aligned_cols=139  Identities=12%  Similarity=0.088  Sum_probs=94.6

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEecc----------chhhHHHHHHHHHHcCCCC--eeccceeeeecCCCCceEEEE
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQ----------DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      -|+||.+.|+....  .|..|-+|+-..          ....+.+|+..+..|..-+  +.+.. ++-.........-+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            36788889988764  444688886531          1233458999888885433  33433 222222234455678


Q ss_pred             Eeecch--hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC-ceEEeecCCcee
Q 014156          167 VLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV  243 (429)
Q Consensus       167 v~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~-~vkl~DFG~a~~  243 (429)
                      |+|-++  .+|.+.+..  ....+.+......++.+++..+.-|| ..|+.|+|+-+.|||++.++. .++++||--++.
T Consensus       103 VTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH-~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMH-SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            999888  345444322  11234566777889999999999999 899999999999999986552 499999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.53  E-value=1.7e-06  Score=76.48  Aligned_cols=137  Identities=15%  Similarity=0.183  Sum_probs=84.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhH-------------HHHHHHHHHcCCCCeeccce---ee
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMRLLDHPNVVSLKH---CF  153 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~E~~~l~~l~h~~iv~l~~---~~  153 (429)
                      ..+|.+.+++-......|.+..-  +|+.+.+|.........             .+.+..+..+....+..+-.   +.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            34688999998888888877653  77899999765432211             12333333332222222111   11


Q ss_pred             eecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCce
Q 014156          154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV  233 (429)
Q Consensus       154 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~v  233 (429)
                      .-....-....+++|||++|--+...       ..+++    .+...|..++.-|| +.|+.|+|..|.|++++.+  .+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~-------~~i~e----~~~~ki~~~ikqlH-~~G~~HGD~hpgNFlv~~~--~i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDI-------EDIDE----DLAEKIVEAIKQLH-KHGFYHGDPHPGNFLVSNN--GI  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccc-------hhcCH----HHHHHHHHHHHHHH-HcCCccCCCCcCcEEEECC--cE
Confidence            11111112235689999998422211       11222    23456778899999 8999999999999999855  49


Q ss_pred             EEeecCCce
Q 014156          234 KLCDFGSAK  242 (429)
Q Consensus       234 kl~DFG~a~  242 (429)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=1.6e-06  Score=87.07  Aligned_cols=138  Identities=20%  Similarity=0.194  Sum_probs=81.9

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-hH-------------------------------------------H
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YK-------------------------------------------N  132 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~-------------------------------------------~  132 (429)
                      .-|+.++-|.||+|+.. +|+.||||+....-. ..                                           .
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            46899999999999964 599999997632100 00                                           0


Q ss_pred             HHHHHHHHc----CCCCeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 014156          133 RELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI  208 (429)
Q Consensus       133 ~E~~~l~~l----~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L  208 (429)
                      +|..-+.++    ....-+.+-..|+...+.    -.++|||++|.-...+.....  ..++...+...+.++.----+ 
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~~q~~-  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFLRQLL-  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHHHHHH-
Confidence            233333322    222233444445432222    358999999843333322222  334433333222222221112 


Q ss_pred             HcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       209 H~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                        ..|+.|.|.+|.||+++.++ .+.+.|||+.....
T Consensus       283 --~dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~  316 (517)
T COG0661         283 --RDGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD  316 (517)
T ss_pred             --hcCccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence              23999999999999999997 79999999987653

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.41  E-value=3.2e-06  Score=75.55  Aligned_cols=133  Identities=17%  Similarity=0.182  Sum_probs=88.2

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh----------------------------HHHHHHHHHHcCCCC--e
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY----------------------------KNRELQTMRLLDHPN--V  146 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~E~~~l~~l~h~~--i  146 (429)
                      ..|..|--+.||+|.. .++..+|+|+.......                            ..+|+.-|+++....  +
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3788888889999974 56889999987432110                            124666666664322  2


Q ss_pred             eccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCee
Q 014156          147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL  225 (429)
Q Consensus       147 v~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nil  225 (429)
                      .+-+.++     .    ..|||||++..- .   ...+ ..-.+....+..+..+++..+.-|-...|+||+||..-|||
T Consensus       133 P~Pi~~~-----~----nVLvMEfIg~~g-~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL  199 (268)
T COG1718         133 PEPIAFR-----N----NVLVMEFIGDDG-L---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL  199 (268)
T ss_pred             CCceeec-----C----CeEEEEeccCCC-C---CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence            2322222     1    348999998531 0   0000 01223333677788899999998873589999999999999


Q ss_pred             ecCCCCceEEeecCCceecc
Q 014156          226 VNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       226 l~~~~~~vkl~DFG~a~~~~  245 (429)
                      +. ++ .+.|+|||-|....
T Consensus       200 ~~-~~-~p~iID~~QaV~~~  217 (268)
T COG1718         200 VH-DG-EPYIIDVSQAVTID  217 (268)
T ss_pred             EE-CC-eEEEEECccccccC
Confidence            99 54 69999999886543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.35  E-value=1.5e-06  Score=91.94  Aligned_cols=204  Identities=21%  Similarity=0.312  Sum_probs=131.2

Q ss_pred             HHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 014156          131 KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH  209 (429)
Q Consensus       131 ~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  209 (429)
                      .+.|+..+..+.|+|+++++.+-+.....+ ..+.+..++|.. .+...+    ......+...++.+..+++.||.|+|
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHH
Confidence            345777888899999999876554333222 112223344443 222222    23567899999999999999999999


Q ss_pred             cCCCeeecCCCCC---CeeecCCCCceEEe--ecCCceecccCCCcccccccccccccccccCCC-CCCCcchHHHHHHH
Q 014156          210 GGIGVCHRDIKPQ---NLLVNPHTHQVKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCV  283 (429)
Q Consensus       210 ~~~~iiHrDlKp~---Nill~~~~~~vkl~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~i  283 (429)
                       +....|.-|..+   +..++.++ .+.++  ||+..+.............+..+.++|...... ..+...|+|.+|..
T Consensus       304 -~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  304 -SLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             -HhccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence             554444433333   33334444 45555  888887776665555555666788888764322 12334799999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCC
Q 014156          284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN  363 (429)
Q Consensus       284 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  363 (429)
                      ...+..|..+-....   .....+                                   +........+++.+|+.-+++
T Consensus       382 ~~~~~~~~~i~~~~~---~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~~~~  423 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSA---VPVSLL-----------------------------------DVLSTSELLDALPKCLDEDSE  423 (1351)
T ss_pred             HhhhhhcCccccccc---chhhhh-----------------------------------ccccchhhhhhhhhhcchhhh
Confidence            999998874331110   000000                                   000112678899999999999


Q ss_pred             CCCCHHHHhcCCCccc
Q 014156          364 LRCTALEACIHPFFDE  379 (429)
Q Consensus       364 ~R~t~~e~l~hp~f~~  379 (429)
                      +|+++.+++.|+|.+.
T Consensus       424 ~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  424 ERLSALELLTHPFLRF  439 (1351)
T ss_pred             hccchhhhhhchhccc
Confidence            9999999999999864

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.26  E-value=8.6e-06  Score=73.85  Aligned_cols=75  Identities=19%  Similarity=0.194  Sum_probs=49.4

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCC--eeccceeeeecCCCCceEEEEEeecc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  +.+++...  .........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4679999999999998643  58999987554  345567888888875433  34444322  1112233468899998


Q ss_pred             hhh
Q 014156          172 PET  174 (429)
Q Consensus       172 ~~~  174 (429)
                      +|.
T Consensus        78 ~g~   80 (239)
T PF01636_consen   78 PGR   80 (239)
T ss_dssp             SSE
T ss_pred             ccc
Confidence            864

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.15  E-value=8.1e-06  Score=69.08  Aligned_cols=127  Identities=19%  Similarity=0.315  Sum_probs=83.5

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeec-cceeeeecCCCCceEEEEEee
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVS-LKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~-l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      -++.+.||+|.+|.||++.+  .|..+|+|+-..+  ......|+++|..++-.++-+ +|. + .   .    .++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~-y-g---~----~~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYF-Y-G---E----DFIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEE-e-c---h----hhhhhh
Confidence            45567899999999999987  5668999976544  345678999999998766643 221 1 1   1    245799


Q ss_pred             cchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCC--CCeeecCCCCceEEeecCCceec
Q 014156          170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP--QNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp--~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      |+.|- |......       ....    -+..++.+---|- ..||-|+.|.-  .||++. ++ .+.|+||..|+.-
T Consensus        93 ~i~G~~L~~~~~~-------~~rk----~l~~vlE~a~~LD-~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~k  156 (201)
T COG2112          93 YIDGRPLGKLEIG-------GDRK----HLLRVLEKAYKLD-RLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATFK  156 (201)
T ss_pred             hhcCcchhhhhhc-------ccHH----HHHHHHHHHHHHH-HhccchhhhcCCceeEEec-CC-cEEEEEccchhhc
Confidence            99983 3222110       1222    2334555533444 77999998863  456665 44 6999999998743

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.08  E-value=5.1e-05  Score=68.69  Aligned_cols=69  Identities=17%  Similarity=0.157  Sum_probs=44.5

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCe--eccceeeeecCCCCceEEEEEeecch
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTDKDELYLNLVLEFVP  172 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~~~~~~~~~~lv~e~~~  172 (429)
                      ..||.|..+.||+.    .+..+++|.....  .....+|.++++.+..-.+  .+.+.+.     .......+||++++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            57899999999984    2456788976542  2345789999988854333  3333322     11112467999998


Q ss_pred             hh
Q 014156          173 ET  174 (429)
Q Consensus       173 ~~  174 (429)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            84

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.02  E-value=5e-05  Score=76.15  Aligned_cols=139  Identities=19%  Similarity=0.244  Sum_probs=82.6

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh-----------------------------------H------HHH
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-----------------------------------K------NRE  134 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------~------~~E  134 (429)
                      .+.||.-+.|.||+|+.+. |+.||||+-...-+.                                   .      .+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3679999999999999654 999999975321100                                   0      012


Q ss_pred             HH----HHHHcCCCC---eeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 014156          135 LQ----TMRLLDHPN---VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY  207 (429)
Q Consensus       135 ~~----~l~~l~h~~---iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  207 (429)
                      ++    ..+.+.|-+   -|.+-.+|++....    -.|+||||+|.-.+.+.....  ..++...+..-+.++..-.-+
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~----RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf  318 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTK----RVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIF  318 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCcc----eEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHH
Confidence            22    122234444   22333444433222    468999999743333332222  345555444333333322222


Q ss_pred             HHcCCCeeecCCCCCCeeecCC---CCceEEeecCCceec
Q 014156          208 IHGGIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKVL  244 (429)
Q Consensus       208 LH~~~~iiHrDlKp~Nill~~~---~~~vkl~DFG~a~~~  244 (429)
                      -   .|++|+|=.|.||+++++   +..+.+.|||+....
T Consensus       319 ~---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  319 K---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             h---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            2   389999999999999842   448999999998665

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.95  E-value=7.9e-05  Score=65.18  Aligned_cols=125  Identities=27%  Similarity=0.377  Sum_probs=85.5

Q ss_pred             ceeEeeEEccCCc-EEEEEEEEcCCCcEEEEEEecc--------------c-h----------hhHHHHHHHHHHc---C
Q 014156           92 SYMAERVVGQGSF-GIVFQAKCLETGETVAIKKVLQ--------------D-K----------RYKNRELQTMRLL---D  142 (429)
Q Consensus        92 ~y~~~~~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~--------------~-~----------~~~~~E~~~l~~l---~  142 (429)
                      +++.++.||.|.- |.||+++.  .|+.||+|.+..              . .          ..+..|-+...+|   .
T Consensus        38 ~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   38 DIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             cEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            5888999999999 99999986  788999998311              0 0          1123455555444   5


Q ss_pred             CCCe--eccceeeeecCC-------------CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 014156          143 HPNV--VSLKHCFFSTTD-------------KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY  207 (429)
Q Consensus       143 h~~i--v~l~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  207 (429)
                      +.++  |+++++..-..+             .......||.||+....            .+..    .-+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            5566  888877644311             11223457888776532            1222    224578888999


Q ss_pred             HHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       208 LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      +| +.||+-+|+++.|..   +   -+|+|||.+
T Consensus       180 ~~-k~gI~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  180 LH-KLGIVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             HH-HCCeeeccCcccccc---C---CEEEecccC
Confidence            99 899999999999987   2   379999964

>PLN02876 acyl-CoA dehydrogenase

Probab=97.86  E-value=0.00017  Score=77.95  Aligned_cols=77  Identities=17%  Similarity=0.179  Sum_probs=49.1

Q ss_pred             eeEEccCCcEEEEEEEEcCCC--cEEEEEEecc-----chhhHHHHHHHHHHcC-CCCe--eccceeeeecCCCCceEEE
Q 014156           96 ERVVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~--~~vaiK~~~~-----~~~~~~~E~~~l~~l~-h~~i--v~l~~~~~~~~~~~~~~~~  165 (429)
                      ++.|+.|.+..+|+......+  ..+++|+...     ......+|+++++.+. |.++  .+++..+.+.  ......|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence            467899999999998764332  4677886532     2245678999999995 6664  4444333211  1112356


Q ss_pred             EEeecchhh
Q 014156          166 LVLEFVPET  174 (429)
Q Consensus       166 lv~e~~~~~  174 (429)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            899999874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.72  E-value=0.00033  Score=64.20  Aligned_cols=69  Identities=17%  Similarity=0.111  Sum_probs=41.2

Q ss_pred             EccCCc-EEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEEEeecchhh
Q 014156           99 VGQGSF-GIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEFVPET  174 (429)
Q Consensus        99 lG~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~  174 (429)
                      |..|.. ..||++..  .+..+.+|+.... .....+|+++++.+. +--+.+++.+...   .  ...++||++++|.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~---~--~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD---D--GRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec---C--CccEEEEEeeCCc
Confidence            444444 78899864  3467888876432 134567999988884 2223344443311   1  2256799999874

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.68  E-value=0.00028  Score=66.66  Aligned_cols=138  Identities=16%  Similarity=0.214  Sum_probs=93.4

Q ss_pred             eEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------h------------------------hhHHHHHHHHHHcCC
Q 014156           94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------K------------------------RYKNRELQTMRLLDH  143 (429)
Q Consensus        94 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~------------------------~~~~~E~~~l~~l~h  143 (429)
                      .+..+|..|--+.||.|. ..+|..+|||+.+..      .                        -..+.|++-|++|..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            455688889999999997 567888999976321      0                        112357888888865


Q ss_pred             CCeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       144 ~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                      ..|.-- .-.....      -.|||++++..-+-   .-.-....++...+..+-.|++.-+.-|-..++.||.||.--|
T Consensus       226 aGIP~P-ePIlLk~------hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCP-EPILLKN------HVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCC-Cceeeec------ceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            553221 1111111      24899999853111   1011234567777888888888888888668899999999999


Q ss_pred             eeecCCCCceEEeecCCceec
Q 014156          224 LLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~~  244 (429)
                      +|+. +| .+.|+|.+-+...
T Consensus       296 ~Lyh-dG-~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  296 LLYH-DG-KLYIIDVSQSVEH  314 (520)
T ss_pred             heEE-CC-EEEEEEccccccC
Confidence            9998 44 6999998877543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.57  E-value=4.6e-05  Score=83.00  Aligned_cols=214  Identities=16%  Similarity=-0.004  Sum_probs=133.7

Q ss_pred             HHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 014156          134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI  212 (429)
Q Consensus       134 E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  212 (429)
                      |...++...|+++...+.-...   ....-.+.+++|+. |.+.+.+..-......+....+.....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4445556789988876543321   22223456888887 4555555443333344444444444444477777777432


Q ss_pred             C----eeecCCCCCCeeecCCCCceEEeecCCceeccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHH
Q 014156          213 G----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL  287 (429)
Q Consensus       213 ~----iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  287 (429)
                      +    -+|++||+-|.+|..+. .+|+.++|+.+...+ ........|++.|++|++... ..++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence            3    58999999999999876 799999999983222 222334567889999997643 4578889999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014156          288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT  367 (429)
Q Consensus       288 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  367 (429)
                      ..|..+|.     ..++.+.++.   .        .+-...            .++...|.++-.....+|-+.-..||.
T Consensus      1434 s~~n~~fi-----~flq~~Lkgi---i--------dn~tf~------------sIe~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKGI---I--------DNHTFF------------SIEKLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             hcccHHHH-----HHHHHHHcCc---c--------cccccc------------cccccCCCcccHHHHHHHHHHhhhcch
Confidence            99987772     2223222211   0        000000            111223445555555666666678999


Q ss_pred             HHHHhcCCCcccc
Q 014156          368 ALEACIHPFFDEL  380 (429)
Q Consensus       368 ~~e~l~hp~f~~~  380 (429)
                      -...+.-+.|...
T Consensus      1486 q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1486 QYISLSRDHFAVG 1498 (2724)
T ss_pred             hhhhccccccccc
Confidence            9888888887653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.54  E-value=0.001  Score=60.56  Aligned_cols=31  Identities=32%  Similarity=0.380  Sum_probs=25.1

Q ss_pred             CCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       211 ~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ..+++|+|+.+.||+++.++ ..-|+||+.|.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            34699999999999998543 45699999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.50  E-value=0.0018  Score=58.89  Aligned_cols=69  Identities=20%  Similarity=0.314  Sum_probs=43.3

Q ss_pred             eeEEccCCcEEEEEEEEcC-CCcEEEEEEeccch---hhHHHHHHHHHHcCCCCe-eccceeeeecCCCCceEEEEEeec
Q 014156           96 ERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      ++.|..|-...+|++.... .++.|++|+.....   ....+|+.+++.+....+ .+++..+     .+    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            3567888888999987533 35788899764322   122478888888854443 3333221     11    269999


Q ss_pred             chh
Q 014156          171 VPE  173 (429)
Q Consensus       171 ~~~  173 (429)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.47  E-value=0.0015  Score=57.60  Aligned_cols=127  Identities=19%  Similarity=0.296  Sum_probs=78.0

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccch--------------------hhHHHHHHHHHHcC------CCCeeccc
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------------RYKNRELQTMRLLD------HPNVVSLK  150 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~~iv~l~  150 (429)
                      ..||+|+.=.||.--   .....+||+.....                    ....+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            579999999998754   33456888775544                    33446777776666      77888888


Q ss_pred             eeeeecCCCCceEEEEEeecch---hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec
Q 014156          151 HCFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  227 (429)
Q Consensus       151 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~  227 (429)
                      +......     -..+|+|.+.   |.....+..+.. ...++. .....   +-.-..||- ..+|+.+||+|.||++.
T Consensus        84 G~veT~~-----G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~~---L~~f~~~l~-~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNL-----GLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQA---LDEFKRYLL-DHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCC-----ceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHHH---HHHHHHHHH-HcCCeecCCCcccEEEE
Confidence            8663322     2556777653   322222222222 244555 33333   333345666 66899999999999995


Q ss_pred             CCC--C-ceEEee
Q 014156          228 PHT--H-QVKLCD  237 (429)
Q Consensus       228 ~~~--~-~vkl~D  237 (429)
                      ...  . .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            332  2 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.46  E-value=0.00035  Score=61.23  Aligned_cols=102  Identities=21%  Similarity=0.142  Sum_probs=74.9

Q ss_pred             HHHHHHHHHcCC-CCeeccceeeeecCCCCceEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 014156          132 NRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH  209 (429)
Q Consensus       132 ~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  209 (429)
                      ..|.-+++.+.+ +++.++++.+     .    -++|.||++.+ ++... .....-...++.....++.+++..+++|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            357888888876 6899998877     3    24689999843 32110 00011134688899999999999999998


Q ss_pred             c--CCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          210 G--GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       210 ~--~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      .  ...+.-.|++++|+-++.++ ++|++|...+...
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence            3  13488899999999999777 7999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.42  E-value=0.00037  Score=68.47  Aligned_cols=170  Identities=21%  Similarity=0.284  Sum_probs=108.6

Q ss_pred             HHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 014156          133 RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI  212 (429)
Q Consensus       133 ~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  212 (429)
                      --..+++.+.|+|...++++--.   ... ...+|+|+++.++.+......     +-..       ++.     -|   
T Consensus        31 gr~~~lktl~~~~l~~yl~~~r~---~~~-r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-----~~---   86 (725)
T KOG1093|consen   31 GRFQYLKSLQHDNLCQYLDFSRG---KHE-RVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-----AH---   86 (725)
T ss_pred             hhhHHHHhhcCccceeeEeeecC---ccc-eEEEEehhhccchHHHHHhcc-----cchh-------hhc-----cc---
Confidence            35678888999999987654321   222 267899999998888765311     1100       111     12   


Q ss_pred             CeeecCCCCCCeeecCCCCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q 014156          213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP  292 (429)
Q Consensus       213 ~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~  292 (429)
                      |+.|-     |        .++.+| -++              |. |  |-      ..++++||||+|.++.++..|..
T Consensus        87 ~~~~~-----~--------~~~~td-~~~--------------t~-~--~~------~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   87 GVLHL-----N--------IIYITD-HFL--------------TK-Y--PS------PIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             cccee-----h--------hhhccc-ccc--------------cc-C--CC------CCCcchhhhhHHHHHHHHHHhhH
Confidence            23321     1        344455 000              00 1  10      11249999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014156          293 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  372 (429)
Q Consensus       293 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  372 (429)
                      .+......+.+..+.+....+..-....+..                 .+-..++..+..++.+|+...|..||...++.
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAMEH-----------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----------------HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            9988887777777776654443322211100                 11112567788999999999999999999999


Q ss_pred             cCCCcccc
Q 014156          373 IHPFFDEL  380 (429)
Q Consensus       373 ~hp~f~~~  380 (429)
                      +++-|.++
T Consensus       193 k~~i~~ev  200 (725)
T KOG1093|consen  193 KRCSFTEV  200 (725)
T ss_pred             cCccHHHH
Confidence            99999876

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.42  E-value=0.00068  Score=62.67  Aligned_cols=132  Identities=19%  Similarity=0.223  Sum_probs=72.3

Q ss_pred             EccCCcEEEEEEEEcCCCcEEEEEEeccchh----hHHHHHHHHHHcCCCCee-ccceeeeecCCCCceEEEEEeecchh
Q 014156           99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKR----YKNRELQTMRLLDHPNVV-SLKHCFFSTTDKDELYLNLVLEFVPE  173 (429)
Q Consensus        99 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv-~l~~~~~~~~~~~~~~~~lv~e~~~~  173 (429)
                      +..|-.+.+|+..  .+++.+++|.......    ...+|..+++.+....++ +++...     .    -++|++|++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567777888886  3567888886543221    246789999988644332 222211     1    1478999886


Q ss_pred             hHHH------------HHHHhh---hc---CCCCCHH-HHHHHHHHH---------HHHHHHHHc-------CCCeeecC
Q 014156          174 TVYR------------VAKHYS---RA---SQRMPLI-YVKLYTYQI---------CRALAYIHG-------GIGVCHRD  218 (429)
Q Consensus       174 ~l~~------------~~~~~~---~~---~~~l~~~-~~~~~~~qi---------~~aL~~LH~-------~~~iiHrD  218 (429)
                      ....            +.....   ..   ...++.. .+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            3221            111100   00   1111211 112222121         111222210       12589999


Q ss_pred             CCCCCeeecCCCCceEEeecCCcee
Q 014156          219 IKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       219 lKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +.|.||+++.++  +.|+||..|..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999998765  78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.36  E-value=0.0038  Score=61.10  Aligned_cols=71  Identities=21%  Similarity=0.323  Sum_probs=46.4

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEecc-----------chhhHHHHHHHHHHcC---CCCeeccceeeeecCCCCc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+.||.|.+..||++.+...++.++||.-..           .......|.+.|+.+.   ..++.+++++-     ...
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC
Confidence            3579999999999999754436899997421           1233456777777763   24556665432     111


Q ss_pred             eEEEEEeecchh
Q 014156          162 LYLNLVLEFVPE  173 (429)
Q Consensus       162 ~~~~lv~e~~~~  173 (429)
                        .++|||++++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              4589999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.32  E-value=0.0025  Score=60.56  Aligned_cols=145  Identities=14%  Similarity=0.044  Sum_probs=76.5

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCC--eeccceeeeec-CCCCceEEEEEee
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFST-TDKDELYLNLVLE  169 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~-~~~~~~~~~lv~e  169 (429)
                      .++.++.|....+|++.. . +..+++|+....  ......|.+++..|....  +.+++...-.. ........+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            345677887789998864 3 346888976542  344456777777774322  33332211000 0001123578999


Q ss_pred             cchhhHH------------HHHHHhhhcCCCC--------C-HHHHH--------------HHHHHHHHHHHHHH-----
Q 014156          170 FVPETVY------------RVAKHYSRASQRM--------P-LIYVK--------------LYTYQICRALAYIH-----  209 (429)
Q Consensus       170 ~~~~~l~------------~~~~~~~~~~~~l--------~-~~~~~--------------~~~~qi~~aL~~LH-----  209 (429)
                      |++|...            ..+...-.....+        . ..+..              .....+...++++.     
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9876210            0111110000111        0 00000              00112233455553     


Q ss_pred             -cCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          210 -GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       210 -~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                       ...+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence             136899999999999998775 56899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10593 hypothetical protein; Provisional

Probab=97.30  E-value=0.0058  Score=57.76  Aligned_cols=74  Identities=7%  Similarity=0.006  Sum_probs=48.2

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEecc--chhhHHHHHHHHHHcCCC---CeeccceeeeecCCCCceEEEEEeec
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHP---NVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~---~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      .+.||.|..+.||....  .+..+.+|..+.  .......|...|+.|...   .+.++++++......  ..-++|||+
T Consensus        19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~--g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP--GPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC--CCeEEEEec
Confidence            46799999999999864  223577776543  234677899999988542   455555443221111  225789999


Q ss_pred             chh
Q 014156          171 VPE  173 (429)
Q Consensus       171 ~~~  173 (429)
                      +++
T Consensus        95 i~G   97 (297)
T PRK10593         95 LRG   97 (297)
T ss_pred             cCC
Confidence            885

>PRK05231 homoserine kinase; Provisional

Probab=97.17  E-value=0.0081  Score=57.41  Aligned_cols=30  Identities=30%  Similarity=0.302  Sum_probs=25.2

Q ss_pred             CCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       212 ~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .++||+|+.|.||+++.+. ..-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            4899999999999998553 45799999874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.14  E-value=0.0043  Score=58.57  Aligned_cols=144  Identities=14%  Similarity=0.036  Sum_probs=76.4

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEecc-chhhHHHHHHHHHHcCCCC--eeccceeeeec-CCCCceEEEEEeecc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMRLLDHPN--VVSLKHCFFST-TDKDELYLNLVLEFV  171 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~-~~~~~~~~~lv~e~~  171 (429)
                      .+.|..|....+|++..  .+..+++|+... .......|+.++..|.+..  +.+++...-.. ........++|++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45677888889998864  345789998763 3344567888888875332  33332211000 000011246799998


Q ss_pred             hhhHH------------HHHHHhhhcCCCC--------CHHHHHH------------HHHHHHHHHHHHHc------CCC
Q 014156          172 PETVY------------RVAKHYSRASQRM--------PLIYVKL------------YTYQICRALAYIHG------GIG  213 (429)
Q Consensus       172 ~~~l~------------~~~~~~~~~~~~l--------~~~~~~~------------~~~qi~~aL~~LH~------~~~  213 (429)
                      +|...            ..+.........+        .......            ....+..++.++..      ..+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            75221            0111100000000        0010000            11112233444431      247


Q ss_pred             eeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       214 iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            99999999999999764 56899999774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.88  E-value=0.021  Score=54.09  Aligned_cols=32  Identities=31%  Similarity=0.523  Sum_probs=26.4

Q ss_pred             CCCeeecCCCCCCeeecCC---CCceEEeecCCce
Q 014156          211 GIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAK  242 (429)
Q Consensus       211 ~~~iiHrDlKp~Nill~~~---~~~vkl~DFG~a~  242 (429)
                      ...++|+|+.+.|||++.+   .+.+.|+||..|.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            3478999999999999874   2369999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.75  E-value=0.032  Score=52.97  Aligned_cols=29  Identities=31%  Similarity=0.600  Sum_probs=25.1

Q ss_pred             CCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       212 ~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            58999999999999986 4 58999999763

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.68  E-value=0.03  Score=53.83  Aligned_cols=31  Identities=23%  Similarity=0.261  Sum_probs=25.7

Q ss_pred             CCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       211 ~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ...++||||.+.||+++.++  ++++|+..+..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~--~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHE--TKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCCC--CEEEcCccccc
Confidence            44789999999999998654  88999987753

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.61  E-value=0.0017  Score=60.56  Aligned_cols=131  Identities=16%  Similarity=0.165  Sum_probs=83.3

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEec----------cch----------------hhHHHHHHHHHHcC-CC
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----------QDK----------------RYKNRELQTMRLLD-HP  144 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~----------~~~----------------~~~~~E~~~l~~l~-h~  144 (429)
                      -|.+...||-|--+.||.+-+ ..|...++|.-.          ...                -...+|+..|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            377889999999999999985 567889988321          111                11125777777774 32


Q ss_pred             C-eeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          145 N-VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       145 ~-iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                      . +.+.+++         ..-++|||++.|--+.-..+      -..   +..+...+..-+.-|. +.|+||+|..-=|
T Consensus       172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~d---~~~ly~~lm~~Iv~la-~~GlIHgDFNEFN  232 (465)
T KOG2268|consen  172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VED---PPTLYDDLMGLIVRLA-NHGLIHGDFNEFN  232 (465)
T ss_pred             CCCCCcccc---------cceeeHHHhhcccceeeeee------cCC---hHHHHHHHHHHHHHHH-HcCceecccchhe
Confidence            2 2222221         12468999988732221111      111   2223334444555666 7799999999999


Q ss_pred             eeecCCCCceEEeecCCcee
Q 014156          224 LLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~  243 (429)
                      |+++.++ .++++||--+..
T Consensus       233 imv~dd~-~i~vIDFPQmvS  251 (465)
T KOG2268|consen  233 IMVKDDD-KIVVIDFPQMVS  251 (465)
T ss_pred             eEEecCC-CEEEeechHhhc
Confidence            9999776 699999976543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.60  E-value=0.011  Score=55.29  Aligned_cols=32  Identities=28%  Similarity=0.508  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       212 ~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ..++|+|++|.|||++.++...-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999986453456999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.57  E-value=0.03  Score=54.14  Aligned_cols=32  Identities=28%  Similarity=0.670  Sum_probs=26.8

Q ss_pred             CCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       212 ~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ..++|+|+++.|||++.+...+.|+||..|..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            46899999999999986434799999998754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.57  E-value=0.029  Score=53.91  Aligned_cols=30  Identities=23%  Similarity=0.411  Sum_probs=25.7

Q ss_pred             eeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       214 iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++|+|+.+.|||++++++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975544799999998754

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.38  E-value=0.03  Score=54.46  Aligned_cols=71  Identities=17%  Similarity=0.161  Sum_probs=44.5

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEecc----------chhhHHHHHHHHHHcC--CC-CeeccceeeeecCCCCce
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ----------DKRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~--h~-~iv~l~~~~~~~~~~~~~  162 (429)
                      .+.||.|.-..||++.+...++.++||.-..          ...+...|.++|+.+.  -| ++.++|.+-      .. 
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D------~e-  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD------SV-  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC------cH-
Confidence            5678999999999999743456799996421          1233345777777653  23 455555421      11 


Q ss_pred             EEEEEeecchh
Q 014156          163 YLNLVLEFVPE  173 (429)
Q Consensus       163 ~~~lv~e~~~~  173 (429)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            13478888853

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.36  E-value=0.013  Score=55.68  Aligned_cols=76  Identities=17%  Similarity=0.235  Sum_probs=60.2

Q ss_pred             CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      .+..|.|++|++-++.+...        ......++..++++.+.-+.-+......-|||+...||||+ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            55678999999987754321        23456677788888888888787667899999999999999 77 7999999


Q ss_pred             CCceec
Q 014156          239 GSAKVL  244 (429)
Q Consensus       239 G~a~~~  244 (429)
                      -+++..
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.17  E-value=0.084  Score=50.19  Aligned_cols=32  Identities=13%  Similarity=0.170  Sum_probs=27.3

Q ss_pred             CCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       211 ~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ..+++|+|+.+.|||++.++ .+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            34899999999999998776 689999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.16  E-value=0.067  Score=50.63  Aligned_cols=31  Identities=26%  Similarity=0.463  Sum_probs=27.3

Q ss_pred             CeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       213 ~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      .++|+|+.+.|++++.++ .+=++||+++...
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence            589999999999999887 5889999998653

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.53  E-value=0.23  Score=48.71  Aligned_cols=69  Identities=17%  Similarity=0.242  Sum_probs=44.0

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEecc-----------chhhHHHHHHHHHHcC---CCCeeccceeeeecCCCCc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+.||.|....||++.+  .+..++||+-..           .......|.+.|+.+.   ..++.+++.+.     .+.
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM  109 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence            56789999999999986  345688996531           2223345667776653   23566665543     211


Q ss_pred             eEEEEEeecchh
Q 014156          162 LYLNLVLEFVPE  173 (429)
Q Consensus       162 ~~~~lv~e~~~~  173 (429)
                        -+++||++++
T Consensus       110 --~vlvME~L~~  119 (418)
T PLN02756        110 --ALIGMRYLEP  119 (418)
T ss_pred             --CEEEEeecCC
Confidence              3578999965

>PTZ00384 choline kinase; Provisional

Probab=94.97  E-value=0.35  Score=47.35  Aligned_cols=29  Identities=28%  Similarity=0.382  Sum_probs=24.5

Q ss_pred             CCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       212 ~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ...+|.||-+.||+.+.+  .++++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence            468999999999998754  49999998774

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=93.94  E-value=0.79  Score=42.99  Aligned_cols=72  Identities=15%  Similarity=0.146  Sum_probs=42.0

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcC---CCCeeccceeeeecCCCCceEEEEEeec
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      -.+.++.|....+|+..  .+++.+.+|.-... ......|..-|+.|.   --.+.+++.+.....   .  -++||||
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~---~--~fLlle~   93 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD---D--AFLLLEF   93 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS---C--CEEEEE-
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC---C--ceEEEEe
Confidence            34678899999999987  57788999976532 345678998888884   223445554432221   1  3689999


Q ss_pred             chh
Q 014156          171 VPE  173 (429)
Q Consensus       171 ~~~  173 (429)
                      ++.
T Consensus        94 l~~   96 (288)
T PF03881_consen   94 LEM   96 (288)
T ss_dssp             ---
T ss_pred             ecC
Confidence            863

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.38  E-value=0.081  Score=49.98  Aligned_cols=54  Identities=30%  Similarity=0.365  Sum_probs=34.0

Q ss_pred             HHHHHHHHHHHHHHHHHH---HcCCCeeecCCCCCCeeecCCCC-----------------ceEEeecCCceec
Q 014156          191 LIYVKLYTYQICRALAYI---HGGIGVCHRDIKPQNLLVNPHTH-----------------QVKLCDFGSAKVL  244 (429)
Q Consensus       191 ~~~~~~~~~qi~~aL~~L---H~~~~iiHrDlKp~Nill~~~~~-----------------~vkl~DFG~a~~~  244 (429)
                      ...++.++.||+.-.--+   -+..+.+|-||||+||||-+...                 ..+|.||.+++..
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            345677777875533112   12347999999999999843221                 3567777777543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.57  E-value=0.097  Score=45.52  Aligned_cols=29  Identities=24%  Similarity=0.324  Sum_probs=24.9

Q ss_pred             CeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       213 ~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      -.+|+|+.|.||++..++  ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            469999999999998654  89999998854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=92.45  E-value=0.025  Score=55.86  Aligned_cols=69  Identities=20%  Similarity=0.468  Sum_probs=54.6

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  157 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  157 (429)
                      ....+....++|+|+||+|+.+....++..+|||.+....     ....+|..-+..+.|++++++.+.|....
T Consensus        47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~  120 (516)
T KOG1033|consen   47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERP  120 (516)
T ss_pred             hhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence            3446888899999999999999988888899999875332     22335777788899999999988886544

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.27  E-value=0.14  Score=45.66  Aligned_cols=32  Identities=41%  Similarity=0.687  Sum_probs=20.8

Q ss_pred             CCeeecCCCCCCeee-cCCCCceEEeecCCceec
Q 014156          212 IGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       212 ~~iiHrDlKp~Nill-~~~~~~vkl~DFG~a~~~  244 (429)
                      ..++|+||.+.|||+ +.++ .++|+||..|...
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~n  175 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDG-EVKLIDFEYAGYN  175 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSS-CEEE--GTT-EEE
T ss_pred             ceEeeccCccccEEeccCCC-eEEEecHHHHhhc
Confidence            468999999999999 4444 7999999988653

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.13  E-value=0.25  Score=45.85  Aligned_cols=47  Identities=28%  Similarity=0.402  Sum_probs=34.5

Q ss_pred             HHHHHHHHHHHHHHcC-CCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          196 LYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       196 ~~~~qi~~aL~~LH~~-~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ..+..+-.++.-.+.. .-++|+|+.|+|++.++.+ .++|+||..|..
T Consensus       136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            3444455555555522 3589999999999999766 699999998754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.35  E-value=0.33  Score=46.46  Aligned_cols=29  Identities=31%  Similarity=0.564  Sum_probs=24.9

Q ss_pred             eeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       214 iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +||+|+.|.||+++.+...+-++|||-|.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            99999999999999775337899999874

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.16  E-value=0.47  Score=41.75  Aligned_cols=31  Identities=23%  Similarity=0.313  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCCeeecCCCC----ceEEeecCCce
Q 014156          212 IGVCHRDIKPQNLLVNPHTH----QVKLCDFGSAK  242 (429)
Q Consensus       212 ~~iiHrDlKp~Nill~~~~~----~vkl~DFG~a~  242 (429)
                      ..++|||+.+.||++..++.    .+.|+||..+.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            47899999999999975432    58999999874

subfamily of choline kinases

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	429
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-144
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-144
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-144
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-144
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-144
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-143
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-143
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-143
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-143
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-142
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-142
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-142
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-142
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-141
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-141
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-141
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-141
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-140
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-140
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-140
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-138
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-134
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-93
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-88
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-46
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-45
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-45
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-45
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-45
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-45
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-45
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-45
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-44
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-44
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-44
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-44
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-44
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-44
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-44
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-44
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-44
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-44
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-44
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-44
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-44
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-44
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-44
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-44
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-44
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-44
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-44
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-44
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-44
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-44
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-44
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-44
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-44
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-44
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-44
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-44
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-44
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-44
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-44
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-44
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-44
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-44
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-44
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-44
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-44
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-44
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-44
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-44
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-44
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-44
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-44
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-44
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-44
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-44
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-44
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-44
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-44
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-44
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-43
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-43
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-43
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-43
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-43
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-43
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-43
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-43
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-42
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-42
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-42
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-42
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-42
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-41
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-41
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-40
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-40
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-40
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-40
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-40
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-40
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-40
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-39
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-39
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-39
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-39
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-39
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-39
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-38
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-38
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-38
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-38
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-38
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-38
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-38
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-38
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-38
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-38
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-38
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-38
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-38
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-38
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-38
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-38
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-38
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-38
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-38
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-38
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-38
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-38
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-38
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-38
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-38
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-38
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-38
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-38
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-38
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-38
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-38
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-38
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-38
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-38
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-38
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-38
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-38
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-38
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-38
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-38
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-38
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-38
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-38
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-38
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-38
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-38
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-38
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-38
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-38
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-37
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-37
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-37
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-37
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-37
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-37
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-37
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-34
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-34
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-34
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-34
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-34
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-34
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-33
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-32
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-32
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-32
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-32
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-32
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-32
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-32
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-32
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-32
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-32
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-32
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-32
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-32
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-31
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-31
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-31
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-31
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-31
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-31
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-31
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-31
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-31
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-31
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-31
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-31
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-31
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-31
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-31
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-31
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		9e-31
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-30
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-30
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-30
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-30
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-30
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-30
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-30
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-30
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-30
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-30
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-30
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-30
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-30
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-29
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-29
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-29
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-29
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-29
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-29
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-29
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-29
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		6e-29
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-29
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-28
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-28
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-28
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-28
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-28
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-28
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-28
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-27
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-27
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-27
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-26
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-26
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-26
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-26
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		9e-25
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		9e-25
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-24
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-24
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-24
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-24
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-24
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-24
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-24
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-24
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-24
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-24
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-24
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-24
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-24
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-24
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-24
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-24
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-24
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-24
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-24
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-24
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-24
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-24
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-23
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-23
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-21
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-21
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		8e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-20
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-20
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-19
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-19
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-19
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-19
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-19
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-19
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-19
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-19
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-19
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-18
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-18
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-18
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-18
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-18
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-18
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-18
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-18
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-17
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-17
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-17
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-17
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-17
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-17
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-17
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-17
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-17
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-17
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-17
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-17
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-17
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-17
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-17
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-17
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-16
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-16
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-16
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-16
3soa_A	444	Full-Length Human Camkii Length = 444		2e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-16
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-16
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-16
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-16
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-16
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-16
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-16
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-16
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-16
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-16
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-16
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-16
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-16
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-16
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-16
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-15
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-15
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-15
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-14
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-14
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-14
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-12
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-12
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-12
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-11
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-11
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		8e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-11
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		8e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-06
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		8e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		4e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  507 bits (1306), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 242/360 (67%), Positives = 292/360 (81%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 322 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 380

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  507 bits (1306), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 242/360 (67%), Positives = 292/360 (81%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 386

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  507 bits (1305), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 242/360 (67%), Positives = 292/360 (81%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 35  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 92
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 93  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 152
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 153 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 332 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 390

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  507 bits (1305), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 242/360 (67%), Positives = 292/360 (81%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 76  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 133
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 134 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 193
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 194 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 373 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 431

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  506 bits (1304), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 242/360 (67%), Positives = 292/360 (81%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 33  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 90
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 91  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 150
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 151 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 330 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 388

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  505 bits (1301), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 242/360 (67%), Positives = 292/360 (81%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 365

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  505 bits (1301), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 243/352 (69%), Positives = 288/352 (81%), Gaps = 6/352 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 8   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 67
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 128 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 186
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
           YICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 246
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 307 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 357

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  504 bits (1298), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 241/360 (66%), Positives = 291/360 (80%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 386

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  503 bits (1295), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 243/375 (64%), Positives = 297/375 (79%), Gaps = 12/375 (3%)
Query: 51  IKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQA 110
           ++G +V +       D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QA
Sbjct: 1   MRGSKVSR-------DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQA 51
Query: 111 KCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLE 169
           K  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+
Sbjct: 52  KLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 111
Query: 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH 229
           +VPETVYRVA+HYSRA Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P 
Sbjct: 112 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPD 170
Query: 230 THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL 289
           T  +KLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLL
Sbjct: 171 TAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 230
Query: 290 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE 349
           GQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPE
Sbjct: 231 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE 290
Query: 350 AVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASK 409
           A+ L SRLL+Y+P  R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++ 
Sbjct: 291 AIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNP 349
Query: 410 ELLSKLIPEHARKQC 424
            L + LIP HAR Q 
Sbjct: 350 PLATILIPPHARIQA 364

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  503 bits (1294), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 241/360 (66%), Positives = 291/360 (80%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 371

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  503 bits (1294), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 241/360 (66%), Positives = 291/360 (80%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 360

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  502 bits (1293), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 241/360 (66%), Positives = 291/360 (80%), Gaps = 5/360 (1%)
Query: 66  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
           D +G++   ++ T   G+     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           A Q +P+IYVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 365 RCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
           R T LEAC H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q 
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQA 364

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  501 bits (1289), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 242/349 (69%), Positives = 287/349 (82%), Gaps = 6/349 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
           YICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  499 bits (1285), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 242/351 (68%), Positives = 287/351 (81%), Gaps = 6/351 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 351

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  498 bits (1282), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 241/349 (69%), Positives = 286/349 (81%), Gaps = 6/349 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 4   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 63
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 124 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 182
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 242
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 303 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 350

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  498 bits (1281), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 241/349 (69%), Positives = 286/349 (81%), Gaps = 6/349 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 7   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 66
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 127 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 185
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 245
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 306 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 353

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  498 bits (1281), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 241/349 (69%), Positives = 286/349 (81%), Gaps = 6/349 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  496 bits (1276), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 240/349 (68%), Positives = 285/349 (81%), Gaps = 6/349 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
           YICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 240/349 (68%), Positives = 285/349 (81%), Gaps = 6/349 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K D +YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 240/351 (68%), Positives = 285/351 (81%), Gaps = 6/351 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
           YICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  489 bits (1258), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 237/349 (67%), Positives = 282/349 (80%), Gaps = 6/349 (1%)
Query: 77  VTTIGGRNGQPK---QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR 133
           VTT+    GQ     Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLI 192
           ELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VP TVYRVA+HYSRA Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           YVKLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            ICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
            H FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQEL-SSNPPLATILIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  473 bits (1218), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 224/350 (64%), Positives = 282/350 (80%), Gaps = 5/350 (1%)
Query: 75  IIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE 134
           I V    G+ G+ ++ I+Y   +V+G GSFG+VFQAK +E+ E VAIKKVLQDKR+KNRE
Sbjct: 25  IKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY 193
           LQ MR++ HPNVV LK  F+S  DK DE++LNLVLE+VPETVYR ++HY++  Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           +KLY YQ+ R+LAYIH  IG+CHRDIKPQNLL++P +  +KL DFGSAK+L+ GEPN+S 
Sbjct: 143 IKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
           ICSRYYRAPELIFGAT YTT IDIWS GCV+AEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
           +RE+IK MNPNY E KFPQI+ HP+ K+F  R PP+A+DL+SRLL+Y+P+ R TA+EA  
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 374 HPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
           HPFFDELR   AR+PNGR  PPLFN+  +EL     +L+S+L+P+HA  +
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEEL-SVRPDLISRLVPQHAEAE 370

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  340 bits (871), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 164/369 (44%), Positives = 241/369 (65%), Gaps = 43/369 (11%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 152
           Y   + +G GSFGIV +   +E+G+  A+KKVLQD RYKNREL  M++LDH N++ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 153 FFSTTDKD---------------------------------ELYLNLVLEFVPETVYRVA 179
           F++T D++                                   YLN+++E+VP+T+++V 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 180 KHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239
           K + R+ + +P+  + +Y YQ+ RA+ +IH  +G+CHRDIKPQNLLVN   + +KLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG 299
           SAK L+  EP+++ ICSR+YRAPEL+ GATEYT +ID+WS+GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 359
           +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+DL+ ++L+
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 360 YSPNLRCTALEACIHPFFDELRDP-------NARLPNG--RPFPPLFNFKPQELKGASKE 410
           Y P+LR    EA  HPFFD LR+        N+  P+G  +  P LFNF P EL      
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 411 LLSKLIPEH 419
           +L++++P++
Sbjct: 368 VLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  322 bits (826), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 160/339 (47%), Positives = 227/339 (66%), Gaps = 10/339 (2%)
Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LLDHP 144
           K+   +  ER+ GQG+FG V   K   TG +VAIKKV+QD R++NRELQ M+   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 145 NVVSLKHCFFSTTDKD--ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           N+V L+  F++  ++D  ++YLN+V+E+VP+T++R  ++Y R     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 203 RALAYIH-GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
           R++  +H   + VCHRDIKP N+LVN     +KLCDFGSAK L   EPN++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PELIFG   YTTA+DIWSVGC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 322 NPNYTEFKFPQIKAHPWHKIFHK---RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
           NP++T+      K  PW  +F     +   EA DL+S LLQY P  R    EA  HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 379 ELRDPNARLPNGRPFP-PLFNFKPQELKGASKELLSKLI 416
           EL DP  +LPN +  P  LF F P E++  S+   +KL+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 118/345 (34%), Positives = 190/345 (55%), Gaps = 28/345 (8%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y   + +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H NV+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            ++    ++T +    + +V + +   +Y++ K     SQ++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQILRGLKY 159
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 263
           IH    V HRD+KP NLL+N  T  +K+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321
           ++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 322 --NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
               NY +   P      W K+F K    +A+DL+ R+L ++PN R T  EA  HP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI-PEHARKQ 423
             DP        P    F F   EL    KE L +LI  E AR Q
Sbjct: 336 YYDPTDEPVAEEP----FTFA-MELDDLPKERLKELIFQETARFQ 375

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 106/326 (32%), Positives = 181/326 (55%), Gaps = 29/326 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLLDH---PNV 146
            +  + ++G+G++G+V  A    TGE VAIKK+       +  R L+ +++L H    N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +++    F+    D  + N    ++ + + +   H   ++Q +   +++ + YQ  RA+ 
Sbjct: 72  ITI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YIC 255
            +HG   V HRD+KP NLL+N +   +K+CDFG A+++ +   + S           Y+ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 314
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 315 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 372 CIHPFFDELRDPNARLPNGRPFPPLF 397
             HP+     DPN   P G P PP F
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSF 328

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 112/317 (35%), Positives = 178/317 (56%), Gaps = 32/317 (10%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------REL 135
           G  G P+   ++     +G+G++G+V++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK 195
             ++ L+HPN+V L     +   +++LYL  V EF+ + + +     + A   +PL  +K
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIK 113
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-- 253
            Y +Q+ + LA+ H    V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 114 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 169
Query: 254 -ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            + + +YRAPE++ G   Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 170 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 229
Query: 313 PTREEIKCMN--PNYTEFKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRC 366
           P       +   P+Y    FP+     W  + F K +PP   +   L+S++L Y PN R 
Sbjct: 230 PDEVVWPGVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 283
Query: 367 TALEACIHPFFDELRDP 383
           +A  A  HPFF ++  P
Sbjct: 284 SAKAALAHPFFQDVTKP 300

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 106/326 (32%), Positives = 182/326 (55%), Gaps = 29/326 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLLDH---PNV 146
            +  + ++G+G++G+V  A    TGE VAIKK+       +  R L+ +++L H    N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +++    F+    D  + N    ++ + + +   H   ++Q +   +++ + YQ  RA+ 
Sbjct: 72  ITI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-----EPN------ISYIC 255
            +HG   V HRD+KP NLL+N +   +K+CDFG A+++ +      EP       + ++ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 314
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 315 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 372 CIHPFFDELRDPNARLPNGRPFPPLF 397
             HP+     DPN   P G P PP F
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSF 328

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 112/317 (35%), Positives = 178/317 (56%), Gaps = 32/317 (10%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------REL 135
           G  G P+   ++     +G+G++G+V++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK 195
             ++ L+HPN+V L     +   +++LYL  V EF+ + + +     + A   +PL  +K
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIK 113
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-- 253
            Y +Q+ + LA+ H    V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 114 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 169
Query: 254 -ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            + + +YRAPE++ G   Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 170 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 229
Query: 313 PTREEIKCMN--PNYTEFKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRC 366
           P       +   P+Y    FP+     W  + F K +PP   +   L+S++L Y PN R 
Sbjct: 230 PDEVVWPGVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 283
Query: 367 TALEACIHPFFDELRDP 383
           +A  A  HPFF ++  P
Sbjct: 284 SAKAALAHPFFQDVTKP 300

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 112/309 (36%), Positives = 175/309 (56%), Gaps = 32/309 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 75  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 126
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 127 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297
Query: 384 NARLPNGRP 392
              L   RP
Sbjct: 298 VPHLRLERP 306

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  178 bits (451), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  177 bits (450), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 317 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 73  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 242 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 72  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 241 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 122 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 239 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 74  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 73  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 242 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 122 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 239 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 122 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 239 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 72  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 241 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 122 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 239 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 74  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 72  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 241 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 75  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 126
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 127 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 244 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/303 (35%), Positives = 168/303 (55%), Gaps = 26/303 (8%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     VG+G++G+V++AK    G  VA+K++  D   +       RE+  ++ L HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           VSL     S     E  L LV EF+ + + +V        Q      +K+Y YQ+ R +A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVA 133
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
           + H    + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+
Sbjct: 134 HCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 322
           ++ G+ +Y+T++DIWS+GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +  
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 323 -PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
            P + +  F   +  PW  I       E +DL+S +L + PN R +A +A  HP+F +L 
Sbjct: 250 LPLWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL- 307
Query: 382 DPN 384
           DP 
Sbjct: 308 DPQ 310

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 108/297 (36%), Positives = 167/297 (56%), Gaps = 26/297 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           VG+G++G+V++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             S     E  L LV EF+ + + +V        Q      +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVAHCHQH- 138
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
           +Y+T++DIWS+GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
             F   +  PW  I       E +DL+S +L + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 113/349 (32%), Positives = 187/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + LV   +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 159
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 160 IHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 214
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 275 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 332
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 333 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 376

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 105/326 (32%), Positives = 180/326 (55%), Gaps = 29/326 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLLDH---PNV 146
            +  + ++G+G++G+V  A    TGE VAIKK+       +  R L+ +++L H    N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +++    F+    D  + N    ++ + + +   H   ++Q +   +++ + YQ  RA+ 
Sbjct: 72  ITI----FNIQRPDS-FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YIC 255
            +HG   V HRD+KP NLL+N +   +K+CDFG A+++ +   + S            + 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 314
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 315 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 372 CIHPFFDELRDPNARLPNGRPFPPLF 397
             HP+     DPN   P G P PP F
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSF 328

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 139
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 140 IHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 194
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 255 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 313 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 317 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 73  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 242 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + L++ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLSFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 171/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + +       + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 74  IHT---ENKLYL--VFEFLHQDLKTFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 172/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 72  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 241 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 171/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V E V + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 74  IHT---ENKLYL--VFEHVDQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 147
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 148 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 202
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 262
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 263 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 320
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 321 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 139
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 140 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 194
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 255 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 313 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 172/302 (56%), Gaps = 36/302 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR--MPLIYVKLYTYQICRALAYIHG 210
             +   +++LYL  V EF+   +    K +  AS    +PL  +K Y +Q+ + LA+ H 
Sbjct: 73  IHT---ENKLYL--VFEFLSMDL----KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 325
              Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 326 TEFKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 382 DP 383
            P
Sbjct: 294 KP 295

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 172/302 (56%), Gaps = 36/302 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR--MPLIYVKLYTYQICRALAYIHG 210
             +   +++LYL      V E V++  K +  AS    +PL  +K Y +Q+ + LA+ H 
Sbjct: 70  IHT---ENKLYL------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 325
              Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 326 TEFKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 382 DP 383
            P
Sbjct: 291 KP 292

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 141
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 142 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 196
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 257 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 314
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 315 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 358

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 159
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 160 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 214
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 275 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 332
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 333 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 376

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 171/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+   + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 72  IHT---ENKLYL--VFEFLSMDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 241 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 172/302 (56%), Gaps = 36/302 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR--MPLIYVKLYTYQICRALAYIHG 210
             +   +++LYL  V EF+   +    K +  AS    +PL  +K Y +Q+ + LA+ H 
Sbjct: 74  IHT---ENKLYL--VFEFLSMDL----KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 325
              Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 326 TEFKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 382 DP 383
            P
Sbjct: 295 KP 296

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 139
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 140 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 194
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 255 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 313 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 144
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 145 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 199
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 259
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 260 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 317
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 318 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 145
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 146 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 200
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 260
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 261 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 318
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 319 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 136
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 137 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 191
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 251
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 252 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 309
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 310 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 317 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 171/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+   + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 137
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 138 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 192
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 252
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 253 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 310
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 311 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 354

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 171/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 171/300 (57%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 122 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++  P
Sbjct: 239 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 108/296 (36%), Positives = 170/296 (57%), Gaps = 32/296 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +   +++LYL  V EF+ + + +     + A   +PL  +K Y +Q+ + LA+ H   
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 123 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
            Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 328 FKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF +
Sbjct: 240 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 173/302 (57%), Gaps = 36/302 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR--MPLIYVKLYTYQICRALAYIHG 210
             +   +++LYL  V EF+ + +    K +  AS    +PL  +K Y +Q+ + LA+ H 
Sbjct: 71  IHT---ENKLYL--VFEFLHQDL----KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 325
              Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 326 TEFKFPQIKAHPW-HKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  A  HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 382 DP 383
            P
Sbjct: 292 KP 293

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 110/348 (31%), Positives = 185/348 (53%), Gaps = 31/348 (8%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 141
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 142 IHSA-NVLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 196
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 321 ---MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
              +         P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ 
Sbjct: 257 GINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 378 DELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            +  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 316 AQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 358

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 111/349 (31%), Positives = 188/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAI+K+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 317 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 187/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 141
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 142 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 196
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 257 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 314
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
             +  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 315 LAQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 358

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  174 bits (441), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 187/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K      Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKY 143
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 317 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 112/349 (32%), Positives = 187/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 137
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 138 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 192
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNC 252
Query: 321 M----NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 253 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 310
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 311 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 354

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/341 (31%), Positives = 182/341 (53%), Gaps = 22/341 (6%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
            +G G++G+V  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 152 CFFSTTDKDEL-YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
               T    E   + +VL+ +   ++++      +SQ + L +V+ + YQ+ R L Y+H 
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 265
              V HRD+KP NLLVN +  ++K+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 177 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
               EYT AID+WSVGC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +    
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294
Query: 326 TEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
                   P  +  PW  ++      +A+ L+ R+L++ P+ R +A  A  HPF  +  D
Sbjct: 295 VRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353
Query: 383 PNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
           P+       PF   F+ +    +   + +++++   HAR++
Sbjct: 354 PDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARRE 394

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 105/339 (30%), Positives = 180/339 (53%), Gaps = 57/339 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTM-RLLDHPN 145
           Y   + +G+G++GIV+++    TGE VA+KK+        D +   RE+  +  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +V+L +   +  D+D   + LV +++   ++ V     RA+   P ++ +   YQ+ + +
Sbjct: 71  IVNLLNVLRADNDRD---VYLVFDYMETDLHAVI----RANILEP-VHKQYVVYQLIKVI 122
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------------------- 246
            Y+H G G+ HRD+KP N+L+N   H VK+ DFG ++  V                    
Sbjct: 123 KYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 247 --GEPNIS-YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL 303
              +P ++ Y+ +R+YRAPE++ G+T+YT  ID+WS+GC+L E+L G+P+FPG S ++QL
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH-------------PWHKIFHKRMPP-- 348
             II V+  P+ E+++ +   + +     +K                W  +  K  P   
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 349 ---EAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
              EA+DL+ +LLQ++PN R +A +A  HPF     +PN
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 110/346 (31%), Positives = 186/346 (53%), Gaps = 27/346 (7%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 263
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V      +  +    + +R+YRAPE
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321
           ++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 322 --NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
               NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++
Sbjct: 262 LKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
             DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 320 YYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 110/346 (31%), Positives = 186/346 (53%), Gaps = 27/346 (7%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 144
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 263
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V      +  +    + +R+YRAPE
Sbjct: 145 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321
           ++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 262
Query: 322 --NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
               NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++
Sbjct: 263 LKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
             DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 321 YYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 361

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 111/343 (32%), Positives = 185/343 (53%), Gaps = 33/343 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 153
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
            + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L YIH    
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 266
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 322
            +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 383 PNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
           P+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 319 PSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 107/341 (31%), Positives = 182/341 (53%), Gaps = 22/341 (6%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
            +G G++G+V  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 152 CFFSTTDKDEL-YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
               T    E   + +VL+ +   ++++      +SQ + L +V+ + YQ+ R L Y+H 
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 265
              V HRD+KP NLLVN +  ++K+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 178 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
               EYT AID+WSVGC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +    
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 295
Query: 326 TEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
                   P  +  PW  ++      +A+ L+ R+L++ P+ R +A  A  HPF  +  D
Sbjct: 296 VRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354
Query: 383 PNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
           P+       PF   F+ +    +   + +++++   HAR++
Sbjct: 355 PDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARRE 395

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 166/314 (52%), Gaps = 25/314 (7%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 145
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 146 VVSLKHCFFSTTDKDELY-LNLVLEFVPETVYRV-AKHYSRASQRMPLIYVKLYTYQICR 203
           V+ L   F   +     Y   LV+ F+   + ++    +S          ++   YQ+ +
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEK-------IQYLVYQMLK 155
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 262
            L YIH   GV HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 156 GLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAP 210
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E+I     Y   +DIWSVGC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270
Query: 323 PNYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
               +      PQ     + ++F  R  P+A DL+ ++L+   + R TA +A  HPFF+ 
Sbjct: 271 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329
Query: 380 LRDPNARLPNGRPF 393
            RDP       +PF
Sbjct: 330 FRDPEEETEAQQPF 343

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 111/349 (31%), Positives = 185/349 (53%), Gaps = 33/349 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + +V + +   +Y++ K     +Q +   ++  + YQI R L Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 139
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYR 260
           IH    V HRD+KP NLL+N  T  +K+ DFG A+V    +P+         Y+ +R+YR
Sbjct: 140 IHSA-NVLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYR 194
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE--- 317
           APE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+   
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNX 254
Query: 318 -IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            I     NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 255 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312
Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            ++  DP+       PF   F+    EL    KE L +LI E   +  P
Sbjct: 313 LEQYYDPSDEPIAEAPFK--FDM---ELDDLPKEKLKELIFEETARFQP 356

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/314 (33%), Positives = 166/314 (52%), Gaps = 25/314 (7%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 145
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 146 VVSLKHCFFSTTDKDELY-LNLVLEFVPETVYRV-AKHYSRASQRMPLIYVKLYTYQICR 203
           V+ L   F   +     Y   LV+ F+   + ++    +S          ++   YQ+ +
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK-------IQYLVYQMLK 137
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 262
            L YIH   GV HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAP 192
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E+I     Y   +DIWSVGC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 323 PNYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
               +      PQ     + ++F  R  P+A DL+ ++L+   + R TA +A  HPFF+ 
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311
Query: 380 LRDPNARLPNGRPF 393
            RDP       +PF
Sbjct: 312 FRDPEEETEAQQPF 325

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 112/320 (35%), Positives = 166/320 (51%), Gaps = 31/320 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 149
           +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              F   ++     ++LV +F+   +  + K  S     +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH 129
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 266
               + HRD+KP NLL++     +KL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPN 324
           GA  Y   +D+W+VGC+LAELLL  P  PG+S +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 325 YTEFK-FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
           Y  FK FP I   P H IF      + +DL+  L  ++P  R TA +A    +F     P
Sbjct: 246 YVTFKSFPGI---PLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301
Query: 384 NARLPNGRPFPPLFNFKPQE 403
                  RP  P+   K Q 
Sbjct: 302 TPGCQLPRPNCPVETLKEQS 321

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 165/295 (55%), Gaps = 23/295 (7%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 152
           +G+GS+G+VF+ +  +TG+ VAIKK L+       K+   RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           F     + +  L+LV E+   TV      Y R    +P   VK  T+Q  +A+ + H   
Sbjct: 71  F-----RRKRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKH- 121
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
              HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G T
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGDT 178
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 327
           +Y   +D+W++GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  ++ 
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
            K P  +     ++    +   A+ L+   L   P  R T  +   HP+F+ +R+
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 107/321 (33%), Positives = 163/321 (50%), Gaps = 25/321 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 150
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 151 HCFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             F   T   D  E+YL  V   +   +  + K     SQ +   +V+   YQ+ R L Y
Sbjct: 94  DVFTPATSIEDFSEVYL--VTTLMGADLNNIVK-----SQALSDEHVQFLVYQLLRGLKY 146
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           IH   G+ HRD+KP N+ VN  + ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 147 IHSA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 202
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 262
Query: 328 F---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
                 P +       IF +   P A+DL+ R+L    + R +A EA  H +F +  DP 
Sbjct: 263 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321
Query: 385 ARLPNGRPFPPLFNFKPQELK 405
              P   P+      K + L+
Sbjct: 322 DE-PEAEPYDESVEAKERTLE 341

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 99/289 (34%), Positives = 157/289 (54%), Gaps = 19/289 (6%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 151
           +VG+GS+G+V + +  +TG  VAIKK L+       K+   RE++ ++ L H N+V+L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
                  K   YL  V EFV  T+    + +      +    V+ Y +QI   + + H  
Sbjct: 92  V---CKKKKRWYL--VFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSH 143
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATE 270
             + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE     + +R+YRAPEL+ G  +
Sbjct: 144 -NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 328
           Y  A+D+W++GC++ E+ +G+PLFPG+S +DQL  I+  LG   P  +E+   NP +   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           + P+IK     +  + ++    +DL  + L   P+ R    E   H FF
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 106/321 (33%), Positives = 162/321 (50%), Gaps = 25/321 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 150
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 151 HCFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             F   T   D  E+YL  V   +   +  + K      Q +   +V+   YQ+ R L Y
Sbjct: 94  DVFTPATSIEDFSEVYL--VTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKY 146
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           IH   G+ HRD+KP N+ VN  + ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 147 IHSA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 202
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 262
Query: 328 F---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
                 P +       IF +   P A+DL+ R+L    + R +A EA  H +F +  DP 
Sbjct: 263 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321
Query: 385 ARLPNGRPFPPLFNFKPQELK 405
              P   P+      K + L+
Sbjct: 322 DE-PEAEPYDESVEAKERTLE 341

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/319 (32%), Positives = 165/319 (51%), Gaps = 25/319 (7%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  +  +++G  +A+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F   T  +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
               PQ+    +  +F     P AVDL+ ++L    + R TA EA  HP+F +  DP+  
Sbjct: 289 N-SLPQMPKRNFADVF-IGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE 346
Query: 387 LPNGRPFPPLFNFKPQELK 405
            P   P+   F  +  E++
Sbjct: 347 -PESEPYDQSFESRQLEIE 364

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 159/295 (53%), Gaps = 32/295 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +        L LV E + + + ++          +  +  K +  Q+   +AY H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 328
           +Y+T IDIWSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      PN TE  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW----PNVTELP 232
Query: 329 ----KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                F   +  PW   F K +    +DL+S++L+  PN R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 106/321 (33%), Positives = 161/321 (50%), Gaps = 25/321 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 150
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 151 HCFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             F   T   D  E+YL  V   +   +  + K      Q +   +V+   YQ+ R L Y
Sbjct: 86  DVFTPATSIEDFSEVYL--VTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKY 138
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           IH   G+ HRD+KP N+ VN    ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 139 IHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 194
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 254
Query: 328 F---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
                 P +       IF +   P A+DL+ R+L    + R +A EA  H +F +  DP 
Sbjct: 255 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 313
Query: 385 ARLPNGRPFPPLFNFKPQELK 405
              P   P+      K + L+
Sbjct: 314 DE-PEAEPYDESVEAKERTLE 333

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 101/295 (34%), Positives = 159/295 (53%), Gaps = 32/295 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +        L LV E + + + ++          +  +  K +  Q+   +AY H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 328
           +Y+T IDIWSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      PN TE  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNW----PNVTELP 232
Query: 329 ----KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                F   +  PW   F K +    +DL+S++L+  PN R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 101/295 (34%), Positives = 159/295 (53%), Gaps = 32/295 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             +        L LV E + + + ++          +  +  K +  Q+   +AY H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 328
           +Y+T IDIWSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      PN TE  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW----PNVTELP 232
Query: 329 ----KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                F   +  PW   F K +    +DL+S++L+  PN R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 108/321 (33%), Positives = 162/321 (50%), Gaps = 31/321 (9%)
Query: 82  GRNGQPKQTISYMAERV---------VGQGSFGIVFQAKCLETGETVAIKKV---LQDKR 129
            R+G  +Q ++  A  V         VG G++G V  A    TG  VAIKK+    Q + 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 130 YKNRELQTMRLLDH---PNVVSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRA 185
           +  R  + +RLL H    NV+ L   F      D+     LV+ F+   + ++ KH    
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG 126
Query: 186 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245
             R     ++   YQ+ + L YIH   G+ HRD+KP NL VN    ++K+ DFG A+   
Sbjct: 127 EDR-----IQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ-- 177
Query: 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
                   + +R+YRAPE+I     YT  +DIWSVGC++AE++ G+ LF G   +DQL E
Sbjct: 178 ADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237
Query: 306 IIKVLGTPTREEIKCMNP----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
           I+KV GTP  E ++ +      NY +   P+++   +  I      P AV+L+ ++L   
Sbjct: 238 IMKVTGTPPAEFVQRLQSDEAKNYMK-GLPELEKKDFASIL-TNASPLAVNLLEKMLVLD 295
Query: 362 PNLRCTALEACIHPFFDELRD 382
              R TA EA  HP+F+ L D
Sbjct: 296 AEQRVTAGEALAHPYFESLHD 316

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/309 (32%), Positives = 170/309 (55%), Gaps = 25/309 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           +Y+    +G+G++  V++ K   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V+L H    T    E  L LV E++ + +    ++       + +  VKL+ +Q+ R LA
Sbjct: 63  VTL-HDIIHT----EKSLTLVFEYLDKDL---KQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
           Y H    V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321
           ++ G+T+Y+T ID+W VGC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 322 NPNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
           N  +  + +P+ +A     + H  R+  +  DL+++LLQ+    R +A +A  HPFF  L
Sbjct: 231 NEEFKTYNYPKYRAEAL--LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288
Query: 381 RDPNARLPN 389
            +   +LP+
Sbjct: 289 GERIHKLPD 297

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 162/311 (52%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++  A  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 162/311 (52%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN  + ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 262 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 320 -PVADPYDQSF 329

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 162/311 (52%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN  + ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 266 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 324 -PVADPYDQSF 333

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 266 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 324 -PVADPYDQSF 333

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 153
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 269
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 270 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 327
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 328 -PVADPYDQSF 337

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 280 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 338 -PVADPYDQSF 347

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 279 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 336
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 337 -PVADPYDQSF 346

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 105/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   PF   F
Sbjct: 318 -PVADPFDQSF 327

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 103/307 (33%), Positives = 161/307 (52%), Gaps = 25/307 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K     SQ++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----SQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN  + ++K+ DFG  +     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPF 393
            P   P+
Sbjct: 318 -PVADPY 323

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 271 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 328
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 329 -PVADPYDQSF 338

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 256 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 314 -PVADPYDQSF 323

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 325 -PVADPYDQSF 334

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 265 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 323 -PVADPYDQSF 332

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 106/301 (35%), Positives = 159/301 (52%), Gaps = 34/301 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             S  DK    L LV EF  + +    K++   +  +    VK + +Q+ + L + H   
Sbjct: 70  LHS--DKK---LTLVFEFCDQDL---KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N    ++KL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 270 EYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 329 KFPQIKAHPWHKIFHK------RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
           K P  K +P +           ++     DL+  LL+ +P  R +A EA  HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 383 P 383
           P
Sbjct: 292 P 292

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 272 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 330 -PVADPYDQSF 339

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 272 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 330 -PVADPYDQSF 339

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 266 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 324 -PVADPYDQSF 333

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 272 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 329
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 330 -PVADPYDQSF 339

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 283 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 340
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 341 -PVADPYDQSF 350

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 265 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 323 -PVADPYDQSF 332

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMH 222
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 283 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 340
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 341 -PVADPYDQSF 350

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 262 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 320 -PVADPYDQSF 329

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 280 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 338 -PVADPYDQSF 347

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 271 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 328
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 329 -PVADPYDQSF 338

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 106/301 (35%), Positives = 158/301 (52%), Gaps = 34/301 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
             S  DK    L LV EF  + +    K++   +  +    VK + +Q+ + L + H   
Sbjct: 70  LHS--DKK---LTLVFEFCDQDL---KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N    ++KL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 270 EYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
            Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 329 KFPQIKAHPWHKIFHK------RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
           K P  K +P +           ++     DL+  LL+ +P  R +A EA  HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 383 P 383
           P
Sbjct: 292 P 292

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 266 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 323
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 324 -PVADPYDQSF 333

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 206
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 267 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 325 -PVADPYDQSF 334

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 279 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 336
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 337 -PVADPYDQSF 346

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 262 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 320 -PVADPYDQSF 329

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 265 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 323 -PVADPYDQSF 332

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/307 (33%), Positives = 160/307 (52%), Gaps = 25/307 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 267 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 387 LPNGRPF 393
            P   P+
Sbjct: 325 -PVADPY 330

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 103/307 (33%), Positives = 160/307 (52%), Gaps = 25/307 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 267 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 324
Query: 387 LPNGRPF 393
            P   P+
Sbjct: 325 -PVADPY 330

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 262 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 319
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 320 -PVADPYDQSF 329

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 265 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 322
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 323 -PVADPYDQSF 332

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 142
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 198
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 199 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 258
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 259 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 316
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 317 -PVADPYDQSF 326

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 141
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 142 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 258 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 315
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 316 -PVADPYDQSF 325

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 257 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 314
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 315 -PVADPYDQSF 324

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 257 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 314
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 315 -PVADPYDQSF 324

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 256 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 314 -PVADPYDQSF 323

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 256 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 314 -PVADPYDQSF 323

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 24/298 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 24/298 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 24/298 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 161/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ D+G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 160/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K       ++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CAKLTDDHVQFLIYQILRGLKYIHS 139
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 256 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 314 -PVADPYDQSF 323

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 160/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +     + +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMH 219
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 280 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 337
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 338 -PVADPYDQSF 347

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 160/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DF  A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 160/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+  FG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 160/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ DFG A+     +     + +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 160/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 160/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 160/311 (51%), Gaps = 25/311 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F      +E   + LV   +   +  + K      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
           Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
           +    Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 387 LPNGRPFPPLF 397
            P   P+   F
Sbjct: 318 -PVADPYDQSF 327

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 100/300 (33%), Positives = 163/300 (54%), Gaps = 32/300 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 153
           +G G++  V++     TG  VA+K+V  D          RE+  M+ L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 154 FSTTDKDELYLNLVLEFVPETV--YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            +     E  L LV EF+   +  Y  ++      + + L  VK + +Q+ + LA+ H  
Sbjct: 73  HT-----ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 268
             + HRD+KPQNLL+N    Q+KL DFG A+    G P  ++   + + +YRAP+++ G+
Sbjct: 128 -KILHRDLKPQNLLINKRG-QLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y+T+IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP     + + P+ T+ 
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN----ESLWPSVTKL 239
Query: 329 -KF-PQIKAHPWHKIF-----HKRMPPEA--VDLVSRLLQYSPNLRCTALEACIHPFFDE 379
            K+ P I+  P   +      H + P +   +D +  LLQ +P++R +A +A  HP+F E
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/293 (34%), Positives = 152/293 (51%), Gaps = 19/293 (6%)
Query: 99  VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 148
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 149 L-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   C  S TD+ E  L LV E V + +             +P   +K   +Q+ R L +
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDF 135
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +H    V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  
Sbjct: 136 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
           ++ Y T +D+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +     
Sbjct: 194 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALPR 251
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
             F    A P  K F   +     DL+ + L ++P  R +A  A  HP+F +L
Sbjct: 252 QAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/293 (34%), Positives = 152/293 (51%), Gaps = 19/293 (6%)
Query: 99  VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 148
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 149 L-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   C  S TD+ E  L LV E V + +             +P   +K   +Q+ R L +
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDF 135
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +H    V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  
Sbjct: 136 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
           ++ Y T +D+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +     
Sbjct: 194 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALPR 251
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
             F    A P  K F   +     DL+ + L ++P  R +A  A  HP+F +L
Sbjct: 252 QAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 162/308 (52%), Gaps = 34/308 (11%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 148
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++ +R LDH N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY----SRASQRMPLI--YVKLYTYQIC 202
           +      +  +    +  + E    +VY V ++     +   ++ PL+  + +L+ YQ+ 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTEL--NSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-------IC 255
           R L YIH    V HRD+KP NL +N     +K+ DFG A+++   +P+ S+       + 
Sbjct: 131 RGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHLSEGLV 186
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL---VEIIKVLGT 312
           +++YR+P L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+   +E I V+  
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP---EAVDLVSRLLQYSPNLRCTAL 369
             R+E+  + P Y      +      HK   + +P    EAVD + ++L +SP  R TA 
Sbjct: 247 EDRQELLSVIPVYIRNDMTEP-----HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301
Query: 370 EACIHPFF 377
           EA  HP+ 
Sbjct: 302 EALSHPYM 309

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/312 (30%), Positives = 156/312 (50%), Gaps = 30/312 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN---------RELQTMRL 140
           Y  +R +  GS+G V  A     G  VAIK+V   + D R  N         R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 141 LDH---PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVK 195
           L+H   PN++ L+  F    +     L LV E +   + +V        QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
            R+YRAPEL+     +T  +D+WS GCV+AE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 316 EEIKCMNP----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
           E++   +     +Y       + A  W  +      P A+DL++++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 372 CIHPFFDELRDP 383
             HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/312 (30%), Positives = 156/312 (50%), Gaps = 30/312 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN---------RELQTMRL 140
           Y  +R +  GS+G V  A     G  VAIK+V   + D R  N         R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 141 LDH---PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVK 195
           L+H   PN++ L+  F    +     L LV E +   + +V        QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
            R+YRAPEL+     +T  +D+WS GCV+AE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 316 EEIKCMNP----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
           E++   +     +Y       + A  W  +      P A+DL++++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 372 CIHPFFDELRDP 383
             HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 99/290 (34%), Positives = 150/290 (51%), Gaps = 19/290 (6%)
Query: 99  VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 148
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 149 L-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   C  S TD+ E  L LV E V + +             +P   +K   +Q+ R L +
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDF 135
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +H    V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  
Sbjct: 136 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
           ++ Y T +D+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +     
Sbjct: 194 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALPR 251
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             F    A P  K F   +     DL+ + L ++P  R +A  A  HP+F
Sbjct: 252 QAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 104/338 (30%), Positives = 168/338 (49%), Gaps = 32/338 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V  H     +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 324 -NYTEF--KFPQIK--------AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E   K+P IK          P      K    +A DL+S++L   P+ R +  EA 
Sbjct: 257 RNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 316
Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKE 410
            HP+     DP        P P +++ + +E + A +E
Sbjct: 317 RHPYITVWYDPAEA---EAPPPQIYDAQLEEREHAIEE 351

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 317 QHPYINVWYDP 327

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 149/298 (50%), Gaps = 23/298 (7%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSL 149
            Y   R +G+G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
                    +      LV E V  T ++      +  Q +    ++ Y Y+I +AL Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
             +G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 S-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 270 EYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----MNP 323
            Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT    +        ++P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 324 NYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            + +    +     W +  H      + PEA+D + +LL+Y    R TA EA  HP+F
Sbjct: 268 RFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 317 QHPYINVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGI 132
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 310 QHPYINVWYDP 320

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 159/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVG ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 101/339 (29%), Positives = 169/339 (49%), Gaps = 34/339 (10%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V  H     +RM  +      YQ+   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 137
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 138 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 324 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEA 371
            NY E + P      + ++F   + P           +A DL+S++L   P+ R +  EA
Sbjct: 255 RNYVENR-PAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 372 CIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKE 410
             HP+     DP        P P +++ + +E + A +E
Sbjct: 314 LRHPYITVWYDPAEA---EAPPPQIYDAQLEEREHAIEE 349

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 317 QHPYINVWYDP 327

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 159/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 155/294 (52%), Gaps = 28/294 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G V++A    T ETVAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                      L+L+ E+    +    K Y   +  + +  +K + YQ+   + + H   
Sbjct: 102 IHHNH-----RLHLIFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 213 GVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 265
              HRD+KPQNLL++      T  +K+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 323
            G+  Y+T++DIWS+ C+ AE+L+  PLFPG+S +DQL +I +VLG P       +   P
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           ++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A  A  HP+F
Sbjct: 270 DWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 159/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVG ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 159/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 317 QHPYINVWYDP 327

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 140
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 258 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 317
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 318 QHPYINVWYDP 328

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 138
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 139 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 196
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 197 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 255
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 256 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 315
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 316 QHPYINVWYDP 326

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 177
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 355 QHPYINVWYDP 365

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 140
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 258 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 317
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 318 QHPYINVWYDP 328

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 159/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 317 QHPYINVWYDP 327

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 251 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 310
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 311 QHPYINVWYDP 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 132
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 310 QHPYINVWYDP 320

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 251 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 310
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 311 QHPYINVWYDP 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/311 (31%), Positives = 156/311 (50%), Gaps = 29/311 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 177
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 373 IHPFFDELRDP 383
            HP+ +   DP
Sbjct: 355 QHPYINVWYDP 365

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 159/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 141
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+        + ++ +RYYRAPE+I
Sbjct: 142 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVI 199
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 200 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 258
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 259 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 318 LQHPYINVWYDPS 330

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 158/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 140
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 258 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 317 LQHPYINVWYDPS 329

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 158/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 95/306 (31%), Positives = 154/306 (50%), Gaps = 29/306 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F      +E   + LV+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTE-------FKFPQI---KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
            NY E         FP++      P     +K    +A DL+S++L   P  R +  +A 
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 373 IHPFFD 378
            HP+ +
Sbjct: 317 QHPYIN 322

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 93/313 (29%), Positives = 157/313 (50%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L+  
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGG 85
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V   Y   +       ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLK 136
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 155/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 106
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V          +    ++ Y Y++ +
Sbjct: 107 PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL------YPTLTDYDIRYYIYELLK 157
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 158 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 216
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 270
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 271 AYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 330
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 331 LEAMTHPYFQQVR 343

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 118/408 (28%), Positives = 170/408 (41%), Gaps = 99/408 (24%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNV 146
           Y    ++G GS+G V +A        VAIKK+L+      D +   RE+  +  L+H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 147 VSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           V +            DELY+  VLE          K   R    +  +++K   Y +   
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLEIADSDF----KKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------------ 252
           + Y+H   G+ HRD+KP N LVN     VK+CDFG A+ +   E   S            
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 253 ----------------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL------- 289
                           ++ +R+YRAPELI     YT AID+WS+GC+ AELL        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 290 ----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNY 325
                 PLFPG S                      DQL  I  +LGTP+ E+I+ +    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE- 345
Query: 326 TEFKFPQIKAHPWHKIFHKR-----------MPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                    A  + +IF KR              +A+ L+ R+L ++PN R T  E   H
Sbjct: 346 --------DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397
Query: 375 PFFDELR----DPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 418
           PFF E+R    + NA      PF    N    +L+ A  + + +  PE
Sbjct: 398 PFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 91/310 (29%), Positives = 153/310 (49%), Gaps = 27/310 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 147
            Y   R +G+G +  VF+A  +   E VA+K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           +L         +      LV E V  T ++      +  Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
            H  +G+ HRD+KP N+L++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CHS-MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 268 ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 321
              Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +P + +    +     W +  H      + PEA+D + +LL+Y    R TA EA  HP+F
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 378 DELRDPNARL 387
             +    AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 155/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 86
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V          +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL------YPTLTDYDIRYYIYELLK 137
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 250
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 311 LEAMTHPYFQQVR 323

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 155/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V          +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL------YPTLTDYDIRYYIYELLK 136
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 93/313 (29%), Positives = 156/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V   Y   +       ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLK 136
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 155/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V          +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL------YPTLTDYDIRYYIYELLK 136
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 154/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 28  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 87
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V          +    ++ Y Y++ +
Sbjct: 88  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL------YPTLTDYDIRYYIYELLK 138
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 139 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 197
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 251
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 252 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 311
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 312 LEAMTHPYFQQVR 324

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 154/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 86
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V          +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL------YPTLTDYDIRYYIYELLK 137
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 250
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 311 LEAMTHPYFQQVR 323

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/313 (29%), Positives = 158/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 144
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 145 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +D+WSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 203 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 261
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 262 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 321 LQHPYINVWYDPS 333

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 154/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V          +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL------YPTLTDYDIRYYIYELLK 136
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/313 (29%), Positives = 155/313 (49%), Gaps = 33/313 (10%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDH 143
           Q  +   Y   R VG+G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PN+V L        D+     +L+ E+V  T ++V   Y   +       ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLK 136
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           AL Y H   G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           L+    +Y  ++D+WS+GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 323 PNYTEFKF---PQIKA-------HPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTA 368
               +++    PQ++A        PW K  +      + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 369 LEACIHPFFDELR 381
           LEA  HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/313 (29%), Positives = 158/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +D+WSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 251 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 310 LQHPYINVWYDPS 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 157/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 165/333 (49%), Gaps = 53/333 (15%)
Query: 87  PKQTISYMAE--RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 143
           P   ++Y  E  +V+G+GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 144 -----PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
                 N +++ H   + T ++  ++ +  E +   +Y + K        +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 257
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           +YRAPE+I GA  Y   ID+WS+GC+LAELL G PL PGE   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 318 IKCMNPNYTEFKFPQIKAHPWH------------------KIFHKRMPPEA--------- 350
            K ++ +     F   K +P +                  +    R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 351 ------VDLVSRLLQYSPNLRCTALEACIHPFF 377
                 +D + + L++ P +R T  +A  HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 165/333 (49%), Gaps = 53/333 (15%)
Query: 87  PKQTISYMAE--RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 143
           P   ++Y  E  +V+G+GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 144 -----PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
                 N +++ H   + T ++  ++ +  E +   +Y + K        +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 257
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           +YRAPE+I GA  Y   ID+WS+GC+LAELL G PL PGE   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 318 IKCMNPNYTEFKFPQIKAHPWH------------------KIFHKRMPPEA--------- 350
            K ++ +     F   K +P +                  +    R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 351 ------VDLVSRLLQYSPNLRCTALEACIHPFF 377
                 +D + + L++ P +R T  +A  HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 120/232 (51%), Gaps = 18/232 (7%)
Query: 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225
           LV E V  T ++  +      Q +    ++ Y Y+I +AL Y H  +G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFKQLR------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVM 163
Query: 226 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLA 285
           ++    +++L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS+GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 286 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKAHPWH 339
            ++   +P F G    DQLV I KVLGT    +        ++P + +    +     W 
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWE 282
Query: 340 KIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 387
           +  H      + PEA+D + +LL+Y    R TA EA  HP+F  +    AR+
Sbjct: 283 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARM 334

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 133 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 252 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 310
Query: 364 LRCTALEACIHPFFDELRDPNARL 387
            R TA EA  HP+F  +    AR+
Sbjct: 311 SRLTAREAMEHPYFYTVVKDQARM 334

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 133 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 252 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 310
Query: 364 LRCTALEACIHPFFDELRDPNARL 387
            R TA EA  HP+F  +    AR+
Sbjct: 311 SRLTAREAMEHPYFYTVVKDQARM 334

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 133 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 252 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 310
Query: 364 LRCTALEACIHPFFDELRDPNARL 387
            R TA EA  HP+F  +    AR+
Sbjct: 311 SRLTAREAMEHPYFYTVVKDQARM 334

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 147
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 100
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           +L         +      LV E V  T ++      +  Q +    ++ Y Y+I +AL Y
Sbjct: 101 TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 151
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
            H  +G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 152 CHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 210
Query: 268 ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----M 321
              Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT    +        +
Sbjct: 211 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 270
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +P + +    +     W +  H      + PEA+D + +LL+Y    R TA EA  HP+F
Sbjct: 271 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329
Query: 378 DELRDPNARL 387
             +    AR+
Sbjct: 330 YTVVKDQARM 339

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 119/225 (52%), Gaps = 24/225 (10%)
Query: 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225
           LV E++  T ++      +  Q +    ++ Y Y++ +AL Y H   G+ HRD+KP N++
Sbjct: 112 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 164
Query: 226 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLA 285
           ++    +++L D+G A+     +     + SRY++ PEL+     Y  ++D+WS+GC+LA
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 286 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 336
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 280
Query: 337 PWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            W    H      + PEA+DL+ +LL+Y    R TA EA  HP+F
Sbjct: 281 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 132 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 251 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309
Query: 364 LRCTALEACIHPFFDELRDPNARL 387
            R TA EA  HP+F  +    AR+
Sbjct: 310 SRLTAREAMEHPYFYTVVKDQARM 333

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 133 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 252 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 310
Query: 364 LRCTALEACIHPFFDELRDPNARL 387
            R TA EA  HP+F  +    AR+
Sbjct: 311 SRLTAREAMEHPYFYTVVKDQARM 334

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 133 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 252 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 310
Query: 364 LRCTALEACIHPFFDELRDPNARL 387
            R TA EA  HP+F  +    AR+
Sbjct: 311 SRLTAREAMEHPYFYTVVKDQARM 334

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 93/313 (29%), Positives = 157/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP    +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
            NY E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RNYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 119/225 (52%), Gaps = 24/225 (10%)
Query: 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225
           LV E++  T ++      +  Q +    ++ Y Y++ +AL Y H   G+ HRD+KP N++
Sbjct: 117 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 169
Query: 226 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLA 285
           ++    +++L D+G A+     +     + SRY++ PEL+     Y  ++D+WS+GC+LA
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 286 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 336
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 285
Query: 337 PWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            W    H      + PEA+DL+ +LL+Y    R TA EA  HP+F
Sbjct: 286 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 104/355 (29%), Positives = 167/355 (47%), Gaps = 77/355 (21%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 145
           +Y+ + ++G+GS+G V+ A    T + VAIKKV      L D +   RE+  +  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 146 VVSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           ++ L            DELY+  VLE     + ++ K     ++     ++K   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNI----------- 251
              +IH   G+ HRD+KP N L+N     VK+CDFG A+ +  + + NI           
Sbjct: 141 GENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 252 -----------SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQ-------- 291
                      S++ +R+YRAPELI     YT +IDIWS GC+ AELL + Q        
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 292 --PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMN-PNYTEFKFP 331
             PLFPG                 +S  DQL  I  ++GTPT +++K +N P   ++   
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY--- 315
Query: 332 QIKAHPWHKIFHKR-----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
            IK  P  K  + +     +  + ++L+  +L+++PN R T  +A  HP+  ++R
Sbjct: 316 -IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 12/194 (6%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 132 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 251 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309
Query: 364 LRCTALEACIHPFF 377
            R TA EA  HP+F
Sbjct: 310 SRLTAREAMEHPYF 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 12/194 (6%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 133 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 252 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 310
Query: 364 LRCTALEACIHPFF 377
            R TA EA  HP+F
Sbjct: 311 SRLTAREAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 12/194 (6%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 133 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 192 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 252 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 310
Query: 364 LRCTALEACIHPFF 377
            R TA EA  HP+F
Sbjct: 311 SRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 12/194 (6%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ Y Y+I +AL Y H  +G+ HRD+KP N++++    +++L D+G A+    G+     
Sbjct: 131 IRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 189
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312
           + SRY++ PEL+     Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249
Query: 313 PTREEIKC-----MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPN 363
               +        ++P + +    +     W +  H      + PEA+D + +LL+Y   
Sbjct: 250 EDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 364 LRCTALEACIHPFF 377
            R TA EA  HP+F
Sbjct: 309 SRLTAREAMEHPYF 322

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 150/301 (49%), Gaps = 29/301 (9%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 147
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           +L         +      LV E V  T ++      +  Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
            H  +G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 268 ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 320
              Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           ++P + +    +     W +  H      + PEA+D + +LL+Y    R TA EA  HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 377 F 377
           F
Sbjct: 324 F 324

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 92/313 (29%), Positives = 157/313 (50%), Gaps = 31/313 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L + F      +E   + +V+E +   + +V +      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
            G   Y   +D+WSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
             Y E + P+   + + K+F           +K    +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFDELRDPN 384
             HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 144/285 (50%), Gaps = 44/285 (15%)
Query: 133 RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ----- 187
           RE+  +R L HPNV+SL+  F S  D+    + L+ ++    ++ + K + RAS+     
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIK-FHRASKANKKP 122
Query: 188 -RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV 243
            ++P   VK   YQI   + Y+H    V HRD+KP N+LV    P   +VK+ D G A++
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 244 L---VKGEPNIS-YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF----- 294
               +K   ++   + + +YRAPEL+ GA  YT AIDIW++GC+ AELL  +P+F     
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241
Query: 295 ----PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK-FPQ--------IKAHPW 338
                     DQL  I  V+G P     E+IK M  + T  K F +        IK    
Sbjct: 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301
Query: 339 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
           HK+   +   +A  L+ +LL   P  R T+ +A   P+F  L DP
Sbjct: 302 HKV---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 94/333 (28%), Positives = 162/333 (48%), Gaps = 53/333 (15%)
Query: 87  PKQTISYMAE--RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 143
           P   ++Y  E  +V+G+G FG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 144 -----PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
                 N +++ H   + T ++  ++ +  E +   +Y + K        +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 257
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +     I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSR 263
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           +YRAPE+I GA  Y   ID+WS+GC+LAELL G PL PGE   DQL  +I++LG P +  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ-- 320
Query: 318 IKCMNPNYTEFKFPQIKAHPWH------------------KIFHKRMPPEA--------- 350
            K ++ +     F   K +P +                  +    R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 351 ------VDLVSRLLQYSPNLRCTALEACIHPFF 377
                 +D + + L++ P +R T  +A  HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 146/294 (49%), Gaps = 28/294 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 146 VVSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICR 203
           VV L   C  S TD+ E+ + LV E V + +     +  +A    +P   +K    Q  R
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
            L ++H    + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE
Sbjct: 124 GLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPE 181
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++  +T Y T +D+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    + 
Sbjct: 182 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDV 239
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +     FP     P   +  + M      L+  +L ++P+ R +A  A  H + 
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 145/294 (49%), Gaps = 28/294 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 146 VVSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICR 203
           VV L   C  S TD+ E+ + LV E V + +     +  +A    +P   +K    Q  R
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
            L ++H    + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE
Sbjct: 124 GLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPE 181
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++  +T Y T +D+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    + 
Sbjct: 182 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDV 239
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +     FP     P   +    M      L+  +L ++P+ R +A  A  H + 
Sbjct: 240 SLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 103/360 (28%), Positives = 158/360 (43%), Gaps = 78/360 (21%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 145
           +Y  + ++G+GS+G V+ A      + VAIKKV      L D +   RE+  +  L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 146 VVSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           ++ L            DELY+  VLE     + ++ K     +++    +VK   Y +  
Sbjct: 89  IIRLHDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLL 142
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI------------ 251
              +IH   G+ HRD+KP N L+N     VK+CDFG A+  +  + +I            
Sbjct: 143 GEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEEN 199
Query: 252 ---------------SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ----- 291
                          S++ +R+YRAPELI     YT +IDIWS GC+ AELL        
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 292 ------PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPN---- 324
                 PLFPG                 +S  DQL  I  V+GTP  E++KC+       
Sbjct: 260 NPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIK 319
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
           Y +  FP        K +   +  E +DL+  +L+++   R T  +A  HP+  ++R  N
Sbjct: 320 YIKL-FPTRDGIDLSKKY-SSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKEN 377

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 146/294 (49%), Gaps = 28/294 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 146 VVSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICR 203
           VV L   C  S TD+ E+ + LV E V + +     +  +A    +P   +K    Q  R
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
            L ++H    + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE
Sbjct: 124 GLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPE 181
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++  +T Y T +D+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++    + 
Sbjct: 182 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDV 239
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +     FP     P   +  + M      L+  +L ++P+ R +A  A  H + 
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 146/297 (49%), Gaps = 31/297 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------------RELQTMRLLD--- 142
           +G G++G V++A+   +G  VA+K V    R  N             RE+  +R L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 143 HPNVVSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQ 200
           HPNVV L   C  S TD+ E+ + LV E V + +     +  +A    +P   +K    Q
Sbjct: 73  HPNVVRLMDVCATSRTDR-EIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLMRQ 128
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260
             R L ++H    + HRD+KP+N+LV      VKL DFG A++          + + +YR
Sbjct: 129 FLRGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++  +T Y T +D+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++   
Sbjct: 187 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP- 244
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            + +     FP     P   +  + M      L+  +L ++P+ R +A  A  H + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 102/348 (29%), Positives = 159/348 (45%), Gaps = 61/348 (17%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 142
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 143 HPN---------VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY 193
             N         +V LK  F         +L LV E +   +Y + ++ +     + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTNFRGVSLNL-- 158
Query: 194 VKLYTYQICRALAYIHG-GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
             I SR+YR+PE++ G   Y  AID+WS+GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWH----------------KIFHKRMPPEA----- 350
            P    I    P   +F F ++    W+                +  H  +  E      
Sbjct: 276 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 351 ----------------VDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
                            DL+ R+L Y P  R     A  H FF +  D
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 102/348 (29%), Positives = 159/348 (45%), Gaps = 61/348 (17%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 142
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 143 HPN---------VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY 193
             N         +V LK  F         +L LV E +   +Y + ++ +     + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTNFRGVSLNL-- 158
Query: 194 VKLYTYQICRALAYIHG-GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
             I SR+YR+PE++ G   Y  AID+WS+GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWH----------------KIFHKRMPPEA----- 350
            P    I    P   +F F ++    W+                +  H  +  E      
Sbjct: 276 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 351 ----------------VDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
                            DL+ R+L Y P  R     A  H FF +  D
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 102/348 (29%), Positives = 159/348 (45%), Gaps = 61/348 (17%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 142
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 143 HPN---------VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY 193
             N         +V LK  F         +L LV E +   +Y + ++ +     + L  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTNFRGVSLNL-- 139
Query: 194 VKLYTYQICRALAYIHG-GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
             I SR+YR+PE++ G   Y  AID+WS+GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWH----------------KIFHKRMPPEA----- 350
            P    I    P   +F F ++    W+                +  H  +  E      
Sbjct: 257 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 314
Query: 351 ----------------VDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
                            DL+ R+L Y P  R     A  H FF +  D
Sbjct: 315 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 362

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 149/297 (50%), Gaps = 24/297 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL-KH 151
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L + 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 152 CFFSTT--DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           C    +  ++ +  + LV +F     + +A   S    +  L  +K     +   L YIH
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAPEL 264
               + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR PEL
Sbjct: 143 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           + G  +Y   ID+W  GC++AE+    P+  G +   QL  I ++ G+ T E    ++ N
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-N 259
Query: 325 YTEFKFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           Y  ++  ++      K+  +       P A+DL+ +LL   P  R  + +A  H FF
Sbjct: 260 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 146/299 (48%), Gaps = 28/299 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 153 FFSTTD-----KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             +        K  +YL  V +F     + +A   S    +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 262
           IH    + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           EL+ G  +Y   ID+W  GC++AE+    P+  G +   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + +A  H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 146/299 (48%), Gaps = 28/299 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 153 FFSTTD-----KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             +        K  +YL  V +F     + +A   S    +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 262
           IH    + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           EL+ G  +Y   ID+W  GC++AE+    P+  G +   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + +A  H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 146/299 (48%), Gaps = 28/299 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 153 FFSTTD-----KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             +        K  +YL  V +F     + +A   S    +  L  +K     +   L Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 262
           IH    + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 140 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           EL+ G  +Y   ID+W  GC++AE+    P+  G +   QL  I ++ G+ T E    ++
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + +A  H FF
Sbjct: 258 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 100/357 (28%), Positives = 158/357 (44%), Gaps = 49/357 (13%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 144
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 145 N--------VVSLKHCF-----FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
           N         +   H       F+    + +++ +V E + E +  + K Y      +PL
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG--IPL 130
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVK 246
           IYVK  + Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWY 188
Query: 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG------V 300
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 301 DQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FHKRMP 347
           D + +II++LG            T T    + +  N ++ KF  ++     K  F K   
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 348 PEAVDLVSRLLQYSPNLRCTALEACIHPFF------DELRDPNARL-PNGRPFPPLF 397
            E  D +S +LQ  P  R  A     HP+       +E+R P+  L  +G   P  F
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 100/357 (28%), Positives = 158/357 (44%), Gaps = 49/357 (13%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 144
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 145 N--------VVSLKHCF-----FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
           N         +   H       F+    + +++ +V E + E +  + K Y      +PL
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG--IPL 130
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVK 246
           IYVK  + Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWY 188
Query: 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG------V 300
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 301 DQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FHKRMP 347
           D + +II++LG            T T    + +  N ++ KF  ++     K  F K   
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 348 PEAVDLVSRLLQYSPNLRCTALEACIHPFF------DELRDPNARL-PNGRPFPPLF 397
            E  D +S +LQ  P  R  A     HP+       +E+R P+  L  +G   P  F
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 137/295 (46%), Gaps = 49/295 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR--ASQRMPLIYVKLYTYQICR 203
           ++ L   F     +D+ Y  LV E     VY   + +    + +R   +       Q+  
Sbjct: 111 IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 160
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 161 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 264
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +A  H +
Sbjct: 265 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 137/295 (46%), Gaps = 49/295 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR--ASQRMPLIYVKLYTYQICR 203
           ++ L   F     +D+ Y  LV E     VY   + +    + +R   +       Q+  
Sbjct: 112 IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 161
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 162 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 265
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +A  H +
Sbjct: 266 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 138/295 (46%), Gaps = 49/295 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K + +       DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR--ASQRMPLIYVKLYTYQICR 203
           ++ L   F     +D+ Y  LV E     VY   + +    + +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +A  H +
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 148/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 150
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 209 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 250
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 251 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296
Query: 379 ELRDPN 384
            +   N
Sbjct: 297 SVTWEN 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 148/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 205 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 246
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 247 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292
Query: 379 ELRDPN 384
            +   N
Sbjct: 293 SVTWEN 298

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 146/306 (47%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
             CF    D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 103 YFCF---QDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 154
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 155 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 213 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 254
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 255 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 300
Query: 379 ELRDPN 384
            +   N
Sbjct: 301 SVTWEN 306

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 208 EKSAXKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL--------------- 249
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 379 ELRDPN 384
            +   N
Sbjct: 296 SVTWEN 301

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 148/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 247
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 379 ELRDPN 384
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 138/295 (46%), Gaps = 49/295 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K + +       DK    RE+Q ++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR--ASQRMPLIYVKLYTYQICR 203
           ++ L   F     +D+ Y  LV E     VY   + +    + +R   +       Q+  
Sbjct: 94  IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 143
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 144 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 247
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +A  H +
Sbjct: 248 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 94/311 (30%), Positives = 149/311 (47%), Gaps = 70/311 (22%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIYVKLYTYQICRA 204
              +F+  D ++LY  L            AK+     Y R          + YT +I  A
Sbjct: 98  ---YFTFQDDEKLYFGL----------SYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSA 144
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRA 261
           L Y+HG  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +
Sbjct: 145 LEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIK 319
           PEL+   +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+          
Sbjct: 203 PELLTEKSASKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------- 249
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----I 373
                  E+ FP+       K F     P+A DLV +L  L  +  L C  +E       
Sbjct: 250 -------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 290
Query: 374 HPFFDELRDPN 384
           HPFF+ +   N
Sbjct: 291 HPFFESVTWEN 301

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 208 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL--------------- 249
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 379 ELRDPN 384
            +   N
Sbjct: 296 SVTWEN 301

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 247
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 379 ELRDPN 384
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 150
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 209 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 250
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 251 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296
Query: 379 ELRDPN 384
            +   N
Sbjct: 297 SVTWEN 302

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 208 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 249
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 379 ELRDPN 384
            +   N
Sbjct: 296 SVTWEN 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 247
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 379 ELRDPN 384
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 208 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 249
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 379 ELRDPN 384
            +   N
Sbjct: 296 SVTWEN 301

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 208 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 249
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 379 ELRDPN 384
            +   N
Sbjct: 296 SVTWEN 301

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 73  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 124
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 125 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 183 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 224
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 225 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270
Query: 379 ELRDPN 384
            +   N
Sbjct: 271 SVTWEN 276

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 74  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 126 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 184 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 225
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 226 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
Query: 379 ELRDPN 384
            +   N
Sbjct: 272 SVTWEN 277

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 205 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 246
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 247 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292
Query: 379 ELRDPN 384
            +   N
Sbjct: 293 SVTWEN 298

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 80  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 131
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 132 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 190 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 231
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 232 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 277
Query: 379 ELRDPN 384
            +   N
Sbjct: 278 SVTWEN 283

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 75  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 126
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 127 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 185 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 226
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 227 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272
Query: 379 ELRDPN 384
            +   N
Sbjct: 273 SVTWEN 278

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 147/306 (48%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 76  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 127
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 128 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 186 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 227
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 228 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273
Query: 379 ELRDPN 384
            +   N
Sbjct: 274 SVTWEN 279

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 146/306 (47%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF     A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 206 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 247
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP+       K F     P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 379 ELRDPN 384
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 133/295 (45%), Gaps = 49/295 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR--ASQRMPLIYVKLYTYQICR 203
           +  L   F     +D+ Y  LV E     VY   + +    + +R   +       Q+  
Sbjct: 88  IXKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
            + Y H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
              YT F+ PQ     W     K++   A DL+ + L Y P+ R +A +A  H +
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 144/306 (47%), Gaps = 60/306 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +F+  D ++LY  L      E +      Y R          + YT +I  AL Y+H
Sbjct: 101 ---YFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLH 152
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 266
           G  G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 153 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 324
             +   ++ D+W++GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 211 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 252
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL--LQYSPNLRCTALEAC----IHPFFD 378
             E+ FP                P+A DLV +L  L  +  L C  +E       HPFF+
Sbjct: 253 --EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 298
Query: 379 ELRDPN 384
            +   N
Sbjct: 299 SVTWEN 304

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 144
           ++  E+ +G+G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           NV+     F    +     LN+VLE      + R+ KH+ +  + +P   V  Y  Q+C 
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 262
           AL ++H    V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 148 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
           E I     Y    DIWS+GC+L E+   Q  F G+
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/331 (25%), Positives = 147/331 (44%), Gaps = 62/331 (18%)
Query: 98  VVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
            +G+G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 155 STTDKDEL----YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
                +      ++ +V E +  + Y   K       R+   +++   YQIC+++ ++H 
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 211 GIGVCHRDIKPQNLL---------------------VNPHTHQVKLCDFGSAKVLVKGEP 249
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
           + + + +R+YRAPE+I  A  ++   D+WS+GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 310 LG---------TPTREEIKCMNPNYTEF----KFPQIKAHPWHKIF------HKRMPPEA 350
           LG         T  R+       ++ E     ++      P  +        H+R+    
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL---- 305
Query: 351 VDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
            DL+ ++L+Y P  R T  EA  HPFFD L+
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 85/331 (25%), Positives = 146/331 (44%), Gaps = 62/331 (18%)
Query: 98  VVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
            +G+G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 155 STTDKDEL----YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
                +      ++ +V E +  + Y   K       R+   +++   YQIC+++ ++H 
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 211 GIGVCHRDIKPQNLL---------------------VNPHTHQVKLCDFGSAKVLVKGEP 249
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
           + + +  R+YRAPE+I  A  ++   D+WS+GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 310 LG---------TPTREEIKCMNPNYTEF----KFPQIKAHPWHKIF------HKRMPPEA 350
           LG         T  R+       ++ E     ++      P  +        H+R+    
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL---- 305
Query: 351 VDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
            DL+ ++L+Y P  R T  EA  HPFFD L+
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 136/297 (45%), Gaps = 50/297 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 148
           Y  E  +G+GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 149 LKHCFFSTTDKDELYLNLVL----EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           L   F   TD   +YL + L    E     V++     S A++ M           +  A
Sbjct: 71  LYETFEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAARIMK---------DVLSA 118
Query: 205 LAYIHGGIGVCHRDIKPQNLL--VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
           +AY H  + V HRD+KP+N L   +     +KL DFG A     G+   + + + YY +P
Sbjct: 119 VAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           +++ G   Y    D WS G ++  LL G P F   +  + +++I +  GT          
Sbjct: 178 QVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT---------- 223
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                F FP+     W  +      P+A  L+ RLL  SP  R T+L+A  H +F++
Sbjct: 224 -----FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 136/297 (45%), Gaps = 50/297 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 148
           Y  E  +G+GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 149 LKHCFFSTTDKDELYLNLVL----EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           L   F   TD   +YL + L    E     V++     S A++ M           +  A
Sbjct: 88  LYETFEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAARIMK---------DVLSA 135
Query: 205 LAYIHGGIGVCHRDIKPQNLL--VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
           +AY H  + V HRD+KP+N L   +     +KL DFG A     G+   + + + YY +P
Sbjct: 136 VAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 194
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           +++ G   Y    D WS G ++  LL G P F   +  + +++I +  GT          
Sbjct: 195 QVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT---------- 240
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                F FP+     W  +      P+A  L+ RLL  SP  R T+L+A  H +F++
Sbjct: 241 -----FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 153
           V+G+G++GIV+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
                 +  ++ + +E VP               +     +  YT QI   L Y+H    
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 142
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-GATEY 271
           + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
             A DIWS+GC + E+  G+P F                        +   P    FK  
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 239
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             K HP      + M  EA   + +  +  P+ R  A +  +  F 
Sbjct: 240 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 134/308 (43%), Gaps = 49/308 (15%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 150
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
             F    D    Y+   L    E    + K   R S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 211 GIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y    D+WS G +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
             PQ     W  I       +A DL+ ++L + P+LR TA +   HP+   ++  ++  P
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 389 NGRPFPPL 396
                P L
Sbjct: 289 TISDLPSL 296

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 153
           V+G+G++GIV+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
                 +  ++ + +E VP               +     +  YT QI   L Y+H    
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 128
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-GATEY 271
           + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
             A DIWS+GC + E+  G+P F                        +   P    FK  
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 225
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             K HP      + M  EA   + +  +  P+ R  A +  +  F 
Sbjct: 226 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  SR  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+  +  ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++ + R T  E   HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 150
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
             F    D    Y+   L    E    + K   R S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 211 GIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y    D+WS G +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             PQ     W  I       +A DL+ ++L + P+LR TA +   HP+
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+   +   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F  +T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  D    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EF 223
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 150
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
             F    D    Y+   L    E    + K   R S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 211 GIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y    D+WS G +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             PQ     W  I       +A DL+ ++L + P+LR TA +   HP+
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 56/306 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 139
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
            L+HP ++ +K+ F    D ++ Y+ L L    E   +V       ++R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 121
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 256
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 257 R-YYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
              Y APE++   G   Y  A+D WS+G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 374 HPFFDE 379
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 56/306 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 139
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
            L+HP ++ +K+ F    D ++ Y+ L L    E   +V       ++R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 121
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 256
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 257 R-YYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
              Y APE++   G   Y  A+D WS+G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 374 HPFFDE 379
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 56/306 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 139
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
            L+HP ++ +K+ F    D ++ Y+ L L    E   +V       ++R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 121
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 256
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 257 R-YYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
              Y APE++   G   Y  A+D WS+G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 374 HPFFDE 379
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 56/306 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 139
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
            L+HP ++ +K+ F    D ++ Y+ L L    E   +V       ++R+     KLY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 127
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 256
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 184
Query: 257 R-YYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
              Y APE++   G   Y  A+D WS+G +L   L G P F        L          
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 234
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  EA  
Sbjct: 235 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 280
Query: 374 HPFFDE 379
           HP+  +
Sbjct: 281 HPWLQD 286

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 144/306 (47%), Gaps = 56/306 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 139
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
            L+HP ++ +K+ F    D ++ Y+ L L    E   +V       ++R+     KLY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 120
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 256
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 177
Query: 257 R-YYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
              Y APE++   G   Y  A+D WS+G +L   L G P F        L          
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 227
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  EA  
Sbjct: 228 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 273
Query: 374 HPFFDE 379
           HP+  +
Sbjct: 274 HPWLQD 279

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  SR  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+  +  ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++ + R T  E   HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 142 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 199 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 240
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 241 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 91/323 (28%), Positives = 148/323 (45%), Gaps = 53/323 (16%)
Query: 88  KQTISYMAERV--VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMR 139
           K  +S M +RV  +G G++G V   +   T    AIK + +     +       E+  ++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL--IYVKLY 197
           LLDHPN++ L + FF   DK   YL  V+E      Y+  + +     RM    +   + 
Sbjct: 92  LLDHPNIMKL-YDFFE--DKRNYYL--VME-----CYKGGELFDEIIHRMKFNEVDAAVI 141
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYIC 255
             Q+   + Y+H    + HRD+KP+NLL+        +K+ DFG + V    +     + 
Sbjct: 142 IKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
           + YY APE++    +Y    D+WS+G +L  LL G P F G++  DQ  EI++       
Sbjct: 201 TAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR------- 247
Query: 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
              K     YT F  P+     W     K +   A DL+ ++LQ+    R +A +A  HP
Sbjct: 248 ---KVEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293
Query: 376 FFDELRDPNARLPNGRPFPPLFN 398
           +  E+    ++  +G   P L N
Sbjct: 294 WIKEM---CSKKESGIELPSLAN 313

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 130/288 (45%), Gaps = 41/288 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 152
           +G+G++G+V + + + +G+ +A+K++      Q+++    +L  +MR +D P  V+    
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            F   D     + + +E +  ++ +  K      Q +P   +      I +AL ++H  +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGAT 269
            V HRD+KP N+L+N    QVK+CDFG +  LV           + Y APE I       
Sbjct: 174 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
            Y+   DIWS+G  + EL + +  FP +S            GTP ++             
Sbjct: 233 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 266
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             Q+   P  ++   +   E VD  S+ L+ +   R T  E   HPFF
Sbjct: 267 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 227
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 124 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 181 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 222
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 223 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 133/289 (46%), Gaps = 43/289 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 152
           +G+G++G+V + + + +G+ +A+K++      Q+++    +L  +MR +D P  V+    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            F   D     + + +E +  ++ +  K      Q +P   +      I +AL ++H  +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGA 268
            V HRD+KP N+L+N    QVK+CDFG +  LV     +I   C + Y APE I      
Sbjct: 130 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC-KPYMAPERINPELNQ 187
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y+   DIWS+G  + EL + +  FP +S            GTP ++            
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------ 222
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
              Q+   P  ++   +   E VD  S+ L+ +   R T  E   HPFF
Sbjct: 223 -LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 X-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 137/303 (45%), Gaps = 47/303 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
           +G G+FG+V +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 155 STTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
               +D+  + ++ EF+   E   +VA  +++ S+   + Y++    Q+C+ L ++H   
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 274
Query: 213 GVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TE 270
              H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           Y T  D+WSVG +   LL G   F GE+  + L              +K  + N  +  F
Sbjct: 335 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 380
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP--NARLP 388
             I               +  D + +LL   PN R T  +A  HP+      P  ++++P
Sbjct: 381 SGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427
Query: 389 NGR 391
           + R
Sbjct: 428 SSR 430

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 137/303 (45%), Gaps = 47/303 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
           +G G+FG+V +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 155 STTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
               +D+  + ++ EF+   E   +VA  +++ S+   + Y++    Q+C+ L ++H   
Sbjct: 118 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 168
Query: 213 GVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TE 270
              H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G    
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           Y T  D+WSVG +   LL G   F GE+  + L              +K  + N  +  F
Sbjct: 229 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 274
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP--NARLP 388
             I               +  D + +LL   PN R T  +A  HP+      P  ++++P
Sbjct: 275 SGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 321
Query: 389 NGR 391
           + R
Sbjct: 322 SSR 324

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
           +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +      DEL++  V+EF+          ++R ++      +      + +AL+ +H   
Sbjct: 140 YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 189
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 271
           GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  + Y+ APELI     Y
Sbjct: 190 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 247
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
              +DIWS+G ++ E++ G+P +  E               P  + +K +  N       
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----- 287
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
                P  K  HK + P     + RLL   P  R TA E   HPF  +   P + +P
Sbjct: 288 -----PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 338

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 140/312 (44%), Gaps = 51/312 (16%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P+   SY+   + +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
           MR   H NVV + + +      DEL++  V+EF+          ++R ++      +   
Sbjct: 71  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
              + +AL+ +H   GV HRDIK  ++L+  H  +VKL DFG    + K  P    +   
Sbjct: 122 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 179
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            Y+ APELI     Y   +DIWS+G ++ E++ G+P +  E               P  +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 223
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            +K +  N            P  K  HK + P     + RLL   P  R TA E   HPF
Sbjct: 224 AMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272
Query: 377 FDELRDPNARLP 388
             +   P + +P
Sbjct: 273 LAKAGPPASIVP 284

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 141/312 (45%), Gaps = 51/312 (16%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P+   SY+   + +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 25  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 79
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
           MR   H NVV + + +      DEL++  V+EF+          ++R ++      +   
Sbjct: 80  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 130
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 256
              + +AL+ +H   GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  +
Sbjct: 131 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 188
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            Y+ APELI     Y   +DIWS+G ++ E++ G+P +  E               P  +
Sbjct: 189 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 232
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            +K +  N            P  K  HK + P     + RLL   P  R TA E   HPF
Sbjct: 233 AMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPF 281
Query: 377 FDELRDPNARLP 388
             +   P + +P
Sbjct: 282 LAKAGPPASIVP 293

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
           +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +      DEL++  V+EF+          ++R ++      +      + +AL+ +H   
Sbjct: 217 YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 266
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 271
           GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  + Y+ APELI     Y
Sbjct: 267 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 324
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
              +DIWS+G ++ E++ G+P +  E               P  + +K +  N       
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----- 364
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
                P  K  HK + P     + RLL   P  R TA E   HPF  +   P + +P
Sbjct: 365 -----PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 415

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 141/304 (46%), Gaps = 52/304 (17%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 139
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
            L+HP ++ +K+ F    D ++ Y+ L L    E   +V       ++R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 246
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 257
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 258 YYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
            Y APE++   G   Y  A+D WS+G +L   L G P F        L           +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
           ++I     N+     P++    W ++  K     A+DLV +LL   P  R T  EA  HP
Sbjct: 355 DQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 376 FFDE 379
           +  +
Sbjct: 402 WLQD 405

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 122 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 179 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 220
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 221 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 140/312 (44%), Gaps = 51/312 (16%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P+   SY+   + +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 20  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 74
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
           MR   H NVV + + +      DEL++  V+EF+          ++R ++      +   
Sbjct: 75  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 125
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
              + +AL+ +H   GV HRDIK  ++L+  H  +VKL DFG    + K  P    +   
Sbjct: 126 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 183
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            Y+ APELI     Y   +DIWS+G ++ E++ G+P +  E               P  +
Sbjct: 184 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 227
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            +K +  N            P  K  HK + P     + RLL   P  R TA E   HPF
Sbjct: 228 AMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPF 276
Query: 377 FDELRDPNARLP 388
             +   P + +P
Sbjct: 277 LAKAGPPASIVP 288

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 141/312 (45%), Gaps = 51/312 (16%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P+   SY+   + +G+GS GIV  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 27  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 81
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
           MR   H NVV + + +      DEL++  V+EF+          ++R ++      +   
Sbjct: 82  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 132
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 256
              + +AL+ +H   GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  +
Sbjct: 133 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 190
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            Y+ APELI     Y   +DIWS+G ++ E++ G+P +  E               P  +
Sbjct: 191 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 234
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            +K +  N            P  K  HK + P     + RLL   P  R TA E   HPF
Sbjct: 235 AMKMIRDNLP----------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPF 283
Query: 377 FDELRDPNARLP 388
             +   P + +P
Sbjct: 284 LAKAGPPASIVP 295

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 144/306 (47%), Gaps = 56/306 (18%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 139
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
            L+HP ++ +K+ F    D ++ Y+ L L    E   +V       ++R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 260
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 256
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 317
Query: 257 R-YYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
              Y APE++   G   Y  A+D WS+G +L   L G P F        L          
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 367
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T  EA  
Sbjct: 368 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 413
Query: 374 HPFFDE 379
           HP+  +
Sbjct: 414 HPWLQD 419

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 64/295 (21%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-------SAKVLVKGEPNISYICSRYYRA 261
           H    V HRDIKP+NLL+     ++K+ DFG       S +  + G  +        Y  
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE+I G   +   +D+WS+G +  E L+G+P F   +  +    I +V            
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                EF FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 223 -----EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 96/346 (27%), Positives = 147/346 (42%), Gaps = 90/346 (26%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD 142
           Y  +  +GQGS+G+V  A   +T    AIK + ++K          R K  E++ M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLE-------------FVPETVYRVAK--------- 180
           HPN+  L   +     +DE Y+ LV+E             F+ ++  + A          
Sbjct: 87  HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 181 -------------HYSRAS----QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
                        H  R S    QR  LI   +   QI  AL Y+H   G+CHRDIKP+N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMR--QIFSALHYLHNQ-GICHRDIKPEN 198
Query: 224 LLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE-YTTAID 276
            L + + + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 277 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 336
            WS G +L  LL+G   FPG +  D + +++        +++   NPNY           
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN---------- 301
Query: 337 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
                    + P A DL+S LL  + + R  A+ A  HP+  +  D
Sbjct: 302 --------VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P  TVYR  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 147
           +V+GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQICRAL 205
            L + F     + E  L L+L+F+     R    ++R S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 264
            ++H  +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 313
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 135/294 (45%), Gaps = 44/294 (14%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDHPNVV 147
           +++   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+V
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           +L+  + STT     YL + L    E   R+ +      +   L+       Q+  A+ Y
Sbjct: 70  TLEDIYESTT---HYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSAVKY 121
Query: 208 IHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSR-YYRAPEL 264
           +H   G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y APE 
Sbjct: 122 LHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPE- 177
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +     Y+ A+D WS+G +   LL G P F  E+   +L E IK                
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK--------------EG 222
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
           Y EF+ P          F   +   A D +  LL+  PN R T  +A  HP+ D
Sbjct: 223 YYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 142/302 (47%), Gaps = 46/302 (15%)
Query: 84  NGQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMR 139
           +G  +  +S  +  E  +G+G+  IV++ K   T +  A+K  K   DK+    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLY 197
            L HPN++ LK  F + T+     ++LVLE V   E   R+ +     S+R     VK  
Sbjct: 104 RLSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEK-GYYSERDAADAVK-- 155
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLL-VNPHTHQ-VKLCDFGSAKVLVKGEPNISYIC 255
             QI  A+AY+H   G+ HRD+KP+NLL   P     +K+ DFG +K+ V+ +  +  +C
Sbjct: 156 --QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC 211
Query: 256 SR-YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
               Y APE++ G   Y   +D+WSVG +   LL G   F  E G DQ +          
Sbjct: 212 GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------F 260
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
           R  + C      E+ F      PW       +   A DLV +L+   P  R T  +A  H
Sbjct: 261 RRILNC------EYYF----ISPW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 375 PF 376
           P+
Sbjct: 307 PW 308

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P   VY+  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 147
           +V+GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQICRAL 205
            L + F     + E  L L+L+F+     R    ++R S+ +      VK Y  ++  AL
Sbjct: 91  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 264
            ++H  +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 141 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 313
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 199 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 147
           +V+GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQICRAL 205
            L + F     + E  L L+L+F+     R    ++R S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 264
            ++H  +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 313
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 136/295 (46%), Gaps = 42/295 (14%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVV 147
           ++ +R +G G+FG V   +   +G    IK + +D+          E++ ++ LDHPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +   F    D   +Y+ +      E + R+    +R  + +   YV     Q+  ALAY
Sbjct: 84  KIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARG-KALSEGYVAELMKQMMNALAY 139
Query: 208 IHGGIGVCHRDIKPQNLL---VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
            H    V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y APE+
Sbjct: 140 FHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
                + T   DIWS G V+  LL G   F G S    L E+        +++     PN
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPN 243
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           Y       ++  P        + P+AVDL+ ++L   P  R +A +   H +F +
Sbjct: 244 YA------VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   T      + L+LE+ P   VY+  +  S+  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGR 186
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             +   +D+WS+G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            FP              +   A DL+SRLL+++P+ R    E   HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 144
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           +++ L     S   KDE+ +  V+E+    ++       + S++      + +  QI  A
Sbjct: 69  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 119
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           + Y H    + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 120 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 144
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           +++ L     S   KDE+ +  V+E+    ++       + S++      + +  QI  A
Sbjct: 75  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 125
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           + Y H    + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 126 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 144
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           +++ L     S   KDE+ +  V+E+    ++       + S++      + +  QI  A
Sbjct: 65  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 115
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           + Y H    + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 116 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 144
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           +++ L     S   KDE+ +  V+E+    ++       + S++      + +  QI  A
Sbjct: 74  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 124
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           + Y H    + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 125 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/229 (32%), Positives = 113/229 (49%), Gaps = 17/229 (7%)
Query: 81  GGRN-GQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE--- 134
           GGR+   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNRE   
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 135 --LQTMRLLDHPNVVSLKHC--FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP 190
             +Q M+ L+HPNVVS +           ++L L L +E+      R   +       + 
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVLVKGE 248
              ++     I  AL Y+H    + HRD+KP+N+++ P   ++  K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPG 296
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P 
Sbjct: 179 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           + C+       E    LV+E+   +   + + + +  Q + +  V   T+   + LAY+H
Sbjct: 120 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 171
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
               + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 270 E--YTTAIDIWSVGCVLAELLLGQP 292
           E  Y   +D+WS+G    EL   +P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 128/314 (40%), Gaps = 67/314 (21%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------- 133
           R  + K   SY   R +G G++G V   K        AIK + + +  K R         
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 134 --------ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF------VPETVYRVA 179
                   E+  ++ LDHPN++ L   F     +D+ Y  LV EF        + + R  
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHK 142
Query: 180 KHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCD 237
                A+  M          QI   + Y+H    + HRDIKP+N+L+        +K+ D
Sbjct: 143 FDECDAANIMK---------QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
           FG +    K       + + YY APE++    +Y    D+WS G ++  LL G P F G+
Sbjct: 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250
Query: 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           +  D + ++ K                Y +F       + W     K +  EA +L+  +
Sbjct: 251 NDQDIIKKVEK-------------GKYYFDF-------NDW-----KNISDEAKELIKLM 285
Query: 358 LQYSPNLRCTALEA 371
           L Y  N RCTA EA
Sbjct: 286 LTYDYNKRCTAEEA 299

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/229 (32%), Positives = 113/229 (49%), Gaps = 17/229 (7%)
Query: 81  GGRN-GQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE--- 134
           GGR+   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNRE   
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 135 --LQTMRLLDHPNVVSLKHC--FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP 190
             +Q M+ L+HPNVVS +           ++L L L +E+      R   +       + 
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVLVKGE 248
              ++     I  AL Y+H    + HRD+KP+N+++ P   ++  K+ D G AK L +GE
Sbjct: 121 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 179
Query: 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPG 296
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P 
Sbjct: 180 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 117/230 (50%), Gaps = 26/230 (11%)
Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVV 147
           +V+GQGSFG VF  + +   ++G   A+K +      ++D+     E   +  ++HP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQICRAL 205
            L + F     + E  L L+L+F+     R    ++R S+ +      VK Y  ++   L
Sbjct: 94  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 264
            ++H  +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 144 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 313
           +     ++ + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 202 V-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           + C+       E    LV+E+   +   + + + +  Q + +  V   T+   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
               + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 270 E--YTTAIDIWSVGCVLAELLLGQP 292
           E  Y   +D+WS+G    EL   +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 115/222 (51%), Gaps = 25/222 (11%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
           RV+G+GSFG V  A+  ETG+  A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L  C F T D+    L  V+EFV   + ++ + K     S+R      + Y  +I  AL 
Sbjct: 89  L-FCCFQTPDR----LFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALM 138
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 265
           ++H   G+ +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-I 195
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
                Y  A+D W++G +L E+L G   F  E+  D L E I
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 136/314 (43%), Gaps = 48/314 (15%)
Query: 74  HIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKR 129
           H IVT    + G      +     ++G G FG V + +   TG  +A K +    ++DK 
Sbjct: 75  HRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 130 YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQ 187
               E+  M  LDH N++ L   F S  D     + LV+E+V   E   R+       ++
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 188 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVK 246
              ++++K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+    
Sbjct: 187 LDTILFMK----QICEGIRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 247 GEPNISYICSRYYRAPELI-FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
            E       +  + APE++ +    + T  D+WSVG +   LL G   F G++  + L  
Sbjct: 242 REKLKVNFGTPEFLAPEVVNYDFVSFPT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 365
           I+        EE                          + +  EA + +S+LL    + R
Sbjct: 300 ILACRWDLEDEEF-------------------------QDISEEAKEFISKLLIKEKSWR 334
Query: 366 CTALEACIHPFFDE 379
            +A EA  HP+  +
Sbjct: 335 ISASEALKHPWLSD 348

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 148
           R +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
            K   +S   ++   L L++EF+P    R  ++  +  +R+  I +  YT QIC+ + Y+
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLPYGSLR--EYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRA 261
            G     HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ A
Sbjct: 134 -GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYA 188
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELL 288
           PE +   ++++ A D+WS G VL EL 
Sbjct: 189 PESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 134/308 (43%), Gaps = 51/308 (16%)
Query: 82  GRNGQPKQTISYMAERV--VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ 133
           GR     Q +S   +RV  +G G++G V   K   TG   AIK + +             
Sbjct: 10  GRENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL 69
Query: 134 -ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA--SQRMP 190
            E+  ++ LDHPN++ L   F    DK   YL  V+E     VYR  + +      Q+  
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFF---EDKRNYYL--VME-----VYRGGELFDEIILRQKFS 119
Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGE 248
            +   +   Q+     Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G 
Sbjct: 120 EVDAAVIMKQVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG 178
Query: 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
                + + YY APE++    +Y    D+WS G +L  LL G P F G++  DQ     +
Sbjct: 179 KMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----E 229
Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
           +L    + +     P++T+                  +  EA  LV  +L Y P+ R +A
Sbjct: 230 ILKRVEKGKFSFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISA 271
Query: 369 LEACIHPF 376
            EA  HP+
Sbjct: 272 EEALNHPW 279

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DH 143
            ++  +++G+GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
           P    L H F +   K+ L+   V+E++   + +Y +     ++  +  L     Y  +I
Sbjct: 78  P---FLTHMFCTFQTKENLFF--VMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEI 127
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYR 260
              L ++H   G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y 
Sbjct: 128 ILGLQFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYI 185
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           APE++ G  +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 186 APEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 135/322 (41%), Gaps = 50/322 (15%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 138
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           + LD+P+VV   H FF    +D+ ++ +VLE        +  H  R +   P    + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEICRRRSL-LELHKRRKAVTEP--EARYFM 148
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 257
            Q  + + Y+H    V HRD+K  NL +N     VK+ DFG A K+   GE   +   + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y APE +     ++  +DIWS+GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E     FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 378 DELRDPNARLPNG-RPFPPLFN 398
                P  RLP      PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 133/291 (45%), Gaps = 50/291 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 152
           +G+G+F +V +   +  G+  A K +       +D +   RE +  RLL HPN+V L H 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 88
Query: 153 FFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
             S      L  +LV   E   + V R  ++YS A     +        QI  A+ + H 
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 139
Query: 211 GIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 266
            +GV HRD+KP+NLL+        VKL DFG A + V+GE      +  +  Y +PE + 
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VL 196
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               Y   +D+W+ G +L  LL+G P F  E    +L + IK                  
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------G 239
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            + FP  +   W  +      PEA DL++++L  +P+ R TA EA  HP+ 
Sbjct: 240 AYDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 134/322 (41%), Gaps = 50/322 (15%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 138
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           + LD+P+VV   H FF    +D+ ++ +VLE        +  H  R +   P    + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEICRRRSL-LELHKRRKAVTEP--EARYFM 148
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 257
            Q  + + Y+H    V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y APE +     ++  +DIWS+GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E     FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 378 DELRDPNARLPNG-RPFPPLFN 398
                P  RLP      PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 134/322 (41%), Gaps = 50/322 (15%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 138
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           + LD+P+VV   H FF    +D+ ++ +VLE        +  H  R +   P    + + 
Sbjct: 81  KSLDNPHVVGF-HGFF----EDDDFVYVVLEICRRRSL-LELHKRRKAVTEP--EARYFM 132
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 257
            Q  + + Y+H    V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 133 RQTIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y APE +     ++  +DIWS+GC+L  LL+G+P F                      E
Sbjct: 191 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 227
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E     FF
Sbjct: 228 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 280
Query: 378 DELRDPNARLPNG-RPFPPLFN 398
                P  RLP      PP F+
Sbjct: 281 TSGYAP-MRLPTSCLTVPPRFS 301

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 134/315 (42%), Gaps = 53/315 (16%)
Query: 79  TIGGRNGQPKQTISYMAERV---------VGQGSFGIVFQAKCLETGETVAIK----KVL 125
           ++   NG+   +    AE +         +G G+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 126 QDKRYK-NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYR-VAKHYS 183
           + K      E+  +R + H N+V+L+  + S    + LYL + L    E   R V K + 
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 184 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL--CDFGSA 241
                  LI       Q+  A+ Y+H  +G+ HRD+KP+NLL      + K+   DFG +
Sbjct: 118 TEKDASTLIR------QVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLS 170
Query: 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           K+  KG+   +   +  Y APE +     Y+ A+D WS+G +   LL G P F  E+   
Sbjct: 171 KMEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSK 229
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
              +I+K                  EF  P      W  I        A D +  L++  
Sbjct: 230 LFEQILKA---------------EYEFDSPY-----WDDI-----SDSAKDFIRNLMEKD 264
Query: 362 PNLRCTALEACIHPF 376
           PN R T  +A  HP+
Sbjct: 265 PNKRYTCEQAARHPW 279

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 134/322 (41%), Gaps = 50/322 (15%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 138
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           + LD+P+VV   H FF    +D+ ++ +VLE        +  H  R +   P    + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEICRRRSL-LELHKRRKAVTEP--EARYFM 148
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 257
            Q  + + Y+H    V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y APE +     ++  +DIWS+GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E     FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 378 DELRDPNARLPNG-RPFPPLFN 398
                P  RLP      PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E++P     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYMPGG--DMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 140/320 (43%), Gaps = 50/320 (15%)
Query: 99  VGQGSFGIVFQAKCLETG---ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 155
           +G+G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 27  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 156 TTDKDEL----YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
               D      ++ +  E + +  +   K      Q  PL +V+   YQ+C AL ++H  
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLPHVRHMAYQLCHALRFLHEN 142
Query: 212 IGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGEPNISY 253
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 143 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 199
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-- 311
           + +R+YR PE+I     +    D+WS+GC+L E   G  LF      + LV + K+LG  
Sbjct: 200 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 312 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAV---DLVSRL 357
                  TR++          + N ++ ++ +    P  K +  +   E V   DL+ R+
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRM 317
Query: 358 LQYSPNLRCTALEACIHPFF 377
           L++ P  R T  EA +HPFF
Sbjct: 318 LEFDPAQRITLAEALLHPFF 337

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E++P     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYMPGG--DMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 140/320 (43%), Gaps = 50/320 (15%)
Query: 99  VGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 155
           +G+G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 36  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 93
Query: 156 TTDKDEL----YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
               D      ++ +  E + +  +   K      Q  PL +V+   YQ+C AL ++H  
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLPHVRHMAYQLCHALRFLHEN 151
Query: 212 IGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGEPNISY 253
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 152 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 208
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-- 311
           + +R+YR PE+I     +    D+WS+GC+L E   G  LF      + LV + K+LG  
Sbjct: 209 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 267
Query: 312 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAV---DLVSRL 357
                  TR++          + N ++ ++ +    P  K +  +   E V   DL+ R+
Sbjct: 268 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRM 326
Query: 358 LQYSPNLRCTALEACIHPFF 377
           L++ P  R T  EA +HPFF
Sbjct: 327 LEFDPAQRITLAEALLHPFF 346

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 140/320 (43%), Gaps = 50/320 (15%)
Query: 99  VGQGSFGIVFQAKCLETG---ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 155
           +G+G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 59  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 116
Query: 156 TTDKDEL----YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
               D      ++ +  E + +  +   K      Q  PL +V+   YQ+C AL ++H  
Sbjct: 117 VLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLPHVRHMAYQLCHALRFLHEN 174
Query: 212 IGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGEPNISY 253
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 175 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 231
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-- 311
           + +R+YR PE+I     +    D+WS+GC+L E   G  LF      + LV + K+LG  
Sbjct: 232 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 290
Query: 312 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAV---DLVSRL 357
                  TR++          + N ++ ++ +    P  K +  +   E V   DL+ R+
Sbjct: 291 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLFDLMRRM 349
Query: 358 LQYSPNLRCTALEACIHPFF 377
           L++ P  R T  EA +HPFF
Sbjct: 350 LEFDPAQRITLAEALLHPFF 369

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 49/295 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHPN 145
           Y   + +G G++G V   K   TG   AIK + +              E+  ++ LDHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA--SQRMPLIYVKLYTYQICR 203
           ++ L   F    DK   YL  V+E     VYR  + +      Q+   +   +   Q+  
Sbjct: 66  IMKLYEFF---EDKRNYYL--VME-----VYRGGELFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 261
              Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + YY A
Sbjct: 116 GTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 174
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++    +Y    D+WS G +L  LL G P F G++  DQ     ++L    + +    
Sbjct: 175 PEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGKFSFD 225
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            P++T+                  +  EA  LV  +L Y P+ R +A EA  HP+
Sbjct: 226 PPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           Y+    +G+GSFG V  A   +T + VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           ++ L     + TD     + +V+E+    ++     Y    +RM     + +  QI  A+
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            Y H    + HRD+KP+NLL++ + + VK+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
            G       +D+WS G VL  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 131/297 (44%), Gaps = 50/297 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVA-----IKKVLQDKRYKNRELQTMRLLDHPNVV 147
           YM    +G+G FGIV   +C+ET          +K    D+    +E+  + +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L   F S  +     L ++ EF+   +   R+       ++R  + YV    +Q+C AL
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
            ++H    + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +      +TA D+WS+G ++  LL G   F  E+   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 325 YT--EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           YT  E  F +I               EA+D V RLL      R TA EA  HP+  +
Sbjct: 220 YTFDEEAFKEI-------------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFY 147
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 202
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFY 147
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG    +   + 
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTP 203
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 135/300 (45%), Gaps = 50/300 (16%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 143
           T  Y     +G+G+F +V +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
           PN+V L H   S      L  +LV   E   + V R  ++YS A     +        QI
Sbjct: 63  PNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSR 257
             ++ + H   G+ HRD+KP+NLL+   +    VKL DFG A + V+G+      +  + 
Sbjct: 113 LESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK         
Sbjct: 171 GYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA-------- 220
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                     + FP  +   W  +      PEA DL++++L  +P  R TA EA  HP+ 
Sbjct: 221 --------GAYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 134/300 (44%), Gaps = 62/300 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSL 149
           R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYS--RASQRMPLIYVKLYTYQICRALAY 207
              F     +D   + ++++++        + +S  R SQR P    K Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYI-----EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSR-YYRAPELI 265
           +H    + +RD+KP+N+L++ + H +K+ DFG AK +    P+++Y +C    Y APE++
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV 175
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 176 -STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 217
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL-----QYSPNLRCTALEACIHPFFDEL 380
            E +FP                 +  DL+SRL+     Q   NL+    +   HP+F E+
Sbjct: 218 AELRFPPF------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFY 147
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGT 202
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 113/213 (53%), Gaps = 24/213 (11%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
           +++G+GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +HP    
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 80
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L H F +   K+ L+   V+E++   + +Y +     ++  +  L     Y  +I   L 
Sbjct: 81  LTHMFCTFQTKENLFF--VMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEIILGLQ 133
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 265
           ++H   G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++
Sbjct: 134 FLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
            G  +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 192 LG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFY 147
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGT 202
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFY 147
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 202
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 18  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 77
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 78  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFY 132
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG    +   + 
Sbjct: 133 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTP 188
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 189 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 149/313 (47%), Gaps = 64/313 (20%)
Query: 94  MAERVVGQGSFG-IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 148
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT-----YQICR 203
            ++    TTD+   +L + LE     +  + +  + + + + L   K Y       QI  
Sbjct: 91  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 144
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNI 251
            +A++H  + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 252 SYIC-----SRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
                    +  +RAPEL+  +T+   T +IDI+S+GCV    +L +   P      +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 262
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
            II+  G  + +E+KC++                     + +  EA DL+S+++ + P  
Sbjct: 263 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 300
Query: 365 RCTALEACIHPFF 377
           R TA++   HP F
Sbjct: 301 RPTAMKVLRHPLF 313

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 110/206 (53%), Gaps = 28/206 (13%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA-SQRMPLIYVKLYTYQICRALAYIH 209
              +S   ++   L L++E++P   Y   + Y +A ++R+  I +  YT QIC+ + Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL- 133
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAP 262
           G     HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ AP
Sbjct: 134 GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAP 189
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E +   ++++ A D+WS G VL EL 
Sbjct: 190 ESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 135/300 (45%), Gaps = 50/300 (16%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 143
           T  Y     +G+G+F +V +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
           PN+V L H   S      L  +LV   E   + V R  ++YS A     +        QI
Sbjct: 63  PNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSR 257
             ++ + H   G+ HRD+KP+NLL+   +    VKL DFG A + V+G+      +  + 
Sbjct: 113 LESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK         
Sbjct: 171 GYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA-------- 220
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                     + FP  +   W  +      PEA DL++++L  +P  R TA EA  HP+ 
Sbjct: 221 --------GAYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 149/313 (47%), Gaps = 64/313 (20%)
Query: 94  MAERVVGQGSFG-IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 148
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT-----YQICR 203
            ++    TTD+   +L + LE     +  + +  + + + + L   K Y       QI  
Sbjct: 91  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 144
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNI 251
            +A++H  + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 252 SYIC-----SRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
                    +  +RAPEL+  +T+   T +IDI+S+GCV    +L +   P      +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 262
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
            II+  G  + +E+KC++                     + +  EA DL+S+++ + P  
Sbjct: 263 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 300
Query: 365 RCTALEACIHPFF 377
           R TA++   HP F
Sbjct: 301 RPTAMKVLRHPLF 313

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 33  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFXEPHARFY 147
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGT 202
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 25/221 (11%)
Query: 85  GQPKQTISYMAERV-VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 137
           G P++   Y+A  + +G+GS GIV  A    TG+ VA+KK+  D R + R      E+  
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
           MR   H NVV +   +      DEL++  V+EF+          ++R ++      +   
Sbjct: 96  MRDYHHDNVVDMYSSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
              + RAL+Y+H   GV HRDIK  ++L+     ++KL DFG    + K  P    +   
Sbjct: 147 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGT 204
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
            Y+ APE+I     Y T +DIWS+G ++ E++ G+P +  E
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 44/283 (15%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 149
           R +G+GSFG V   +  +T +  A+K     K ++    +N  +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAK--HYSRASQRMPLIYVKLYTYQICRALAY 207
              ++S  D++++++ + L    +  Y + +  H+   +       VKL+  ++  AL Y
Sbjct: 81  ---WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------VKLFICELVMALDY 130
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +     + HRD+KP N+L++ H H V + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 268 --ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TREE 317
                Y+ A+D WS+G    ELL G+  +   S      EI+    T         ++E 
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEM 247
Query: 318 I----KCMNPN----YTEF----KFPQIKAHPWHKIFHKRMPP 348
           +    K + PN    +++      FP +    W  +F KR+ P
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 85  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 138
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 139 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 194
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 195 SL-TESKFSVASDVWSFGVVLYELF 218

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y  ++ +G+G+F  V  A+ + TG  VA+K +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           PN+V L         + E  L LV+E+     V+     Y  A  RM     +    QI 
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVF----DYLVAHGRMKEKEARAKFRQIV 124
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y AP
Sbjct: 125 SAVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAP 182
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           EL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 162
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 163 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 218
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 219 SL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 82  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 135
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 136 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 191
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 192 SL-TESKFSVASDVWSFGVVLYELF 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 134
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           +++ L     + TD       +V+E+V   E    + KH      R+  +  +    QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQIL 121
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H  + V HRD+KP+N+L++ H    K+ DFG + ++  GE   +   S  Y AP
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
           E+I G       +DIWS G +L  LL G   F  E
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 83  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 136
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 137 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 192
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 193 SL-TESKFSVASDVWSFGVVLYELF 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 84  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 137
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 138 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 193
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 194 SL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 43/289 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V + + + +G+  A+K++       + KR       + R +D P  V+    
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            F   D     + +  E    ++ +  K      Q +P   +      I +AL ++H  +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGA 268
            V HRD+KP N+L+N    QVK CDFG +  LV     +I   C + Y APE I      
Sbjct: 157 SVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC-KPYXAPERINPELNQ 214
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y+   DIWS+G    EL + +  FP +S            GTP ++            
Sbjct: 215 KGYSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ------------ 249
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
              Q+   P  ++   +   E VD  S+ L+ +   R T  E   HPFF
Sbjct: 250 -LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 76  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 129
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 130 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 185
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 186 SL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 131
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWYAPE 187
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 131
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 77  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 130
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 131 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 186
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 187 SL-TESKFSVASDVWSFGVVLYELF 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 131
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFXEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 149
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 149
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 92/326 (28%), Positives = 137/326 (42%), Gaps = 50/326 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSLKH 151
           +G+G F   F+    +T E  A K V +    K       + E+   R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            FF   D    ++ +VLE        +  H  R +   P    + Y  QI     Y+H  
Sbjct: 84  GFFEDND----FVFVVLELCRRRSL-LELHKRRKALTEP--EARYYLRQIVLGCQYLHRN 136
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 270
             V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           ++  +D+WS+GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP-N 389
            +IK + +     K + P A  L+ ++LQ  P  R T  E     FF     P ARLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 390 GRPFPPLFNFKPQELKGASKELLSKL 415
               PP F+  P  L  ++++ L+ L
Sbjct: 284 CLTIPPXFSIAPSSLDPSNRKPLTVL 309

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           +++ L     + TD       +V+E+V   E    + KH      R+  +  +    QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQIL 121
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H  + V HRD+KP+N+L++ H    K+ DFG + ++  GE       S  Y AP
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRDSCGSPNYAAP 179
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
           E+I G       +DIWS G +L  LL G   F  E
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 168
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 257
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 169 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 223
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 224 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 257
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 257
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 257
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 26/221 (11%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RE 134
            P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV 194
            + ++ ++ P +V L++ F     KD   L +V+E+VP     +  H  R   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHA 143
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + Y  QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXL 198
Query: 255 CSR-YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
           C    Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--REL 135
           P Q  +++ +    R +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK 195
           +  + ++ P +V L+   FS  D   LY  +VLE+ P     +  H  R   R    + +
Sbjct: 94  RIQQAVNFPFLVKLE---FSFKDNSNLY--MVLEYAPGG--EMFSHLRRIG-RFSEPHAR 145
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
            Y  QI     Y+H  + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 200
Query: 256 SR-YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
               Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 26/221 (11%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RE 134
            P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV 194
            + ++ ++ P +V L++ F     KD   L +V+E+VP     +  H  R   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHA 143
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + Y  QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXL 198
Query: 255 CSR-YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
           C    Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 133/290 (45%), Gaps = 50/290 (17%)
Query: 99  VGQGSFGIVFQ-AKCLETGETVAI-----KKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 152
           +G+G+F +V +  K L   E  A+     K   +D +   RE +  RLL HPN+V L H 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 77
Query: 153 FFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
             S      L  +LV   E   + V R  ++YS A     +        QI  A+ + H 
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 128
Query: 211 GIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 266
            +GV HR++KP+NLL+        VKL DFG A + V+GE      +  +  Y +PE + 
Sbjct: 129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VL 185
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               Y   +D+W+ G +L  LL+G P F  E    +L + IK                  
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------G 228
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            + FP  +   W  +      PEA DL++++L  +P+ R TA EA  HP+
Sbjct: 229 AYDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 270

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 26/221 (11%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RE 134
            P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV 194
            + ++ ++ P +V L++ F     KD   L +V+E+VP     +  H  R   R    + 
Sbjct: 92  KRILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHA 143
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + Y  QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +
Sbjct: 144 RFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXL 198
Query: 255 CSR-YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
           C    Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 199 CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 134/295 (45%), Gaps = 54/295 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 141
            +   R++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 142 -DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKH--YSRASQRMPLIYVKL 196
            D P +V + + F  T DK    L+ +L+ +   +  Y +++H  +S A  R        
Sbjct: 248 GDCPFIVCMSYAF-HTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMR-------F 295
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           Y  +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +
Sbjct: 296 YAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGT 352
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF-----PGESGVDQLVEIIKV-- 309
             Y APE++     Y ++ D +S+GC+L +LL G   F       +  +D++   + V  
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 412
Query: 310 ---------------LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 348
                          L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 413 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 94/326 (28%), Positives = 138/326 (42%), Gaps = 50/326 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 151
           +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            FF   D    ++ +VLE        +  H  R +   P    + Y  QI     Y+H  
Sbjct: 84  GFFEDND----FVFVVLELCRRRSL-LELHKRRKALTEP--EARYYLRQIVLGCQYLHRN 136
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 270
             V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           ++  +D+WS+GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP-N 389
            +IK + +     K + P A  L+ ++LQ  P  R T  E     FF     P ARLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 390 GRPFPPLFNFKPQELKGASKELLSKL 415
               PP F+  P  L  ++++ L+ L
Sbjct: 284 CLTIPPRFSIAPSSLDPSNRKPLTVL 309

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 109/204 (53%), Gaps = 20/204 (9%)
Query: 96  ERV--VGQGSFGIVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVS 148
           ER+  +G G+ G+V + +   +G  +A K +  + +   +N   RELQ +   + P +V 
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 78
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
               F+S  +     +++ +E +   ++ +V K     ++R+P   +   +  + R LAY
Sbjct: 79  FYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAY 129
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE + G
Sbjct: 130 LREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERLQG 187
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQ 291
            T Y+   DIWS+G  L EL +G+
Sbjct: 188 -THYSVQSDIWSMGLSLVELAVGR 210

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 134/295 (45%), Gaps = 54/295 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 141
            +   R++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 142 -DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKH--YSRASQRMPLIYVKL 196
            D P +V + + F  T DK    L+ +L+ +   +  Y +++H  +S A  R        
Sbjct: 249 GDCPFIVCMSYAF-HTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMR-------F 296
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           Y  +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +
Sbjct: 297 YAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGT 353
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF-----PGESGVDQLVEIIKV-- 309
             Y APE++     Y ++ D +S+GC+L +LL G   F       +  +D++   + V  
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 413
Query: 310 ---------------LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 348
                          L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           PN+V L         + E  L LV+E+     V+     Y  A  RM     +    QI 
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVF----DYLVAHGRMKEKEARAKFRQIV 123
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y AP
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           EL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 94/326 (28%), Positives = 138/326 (42%), Gaps = 50/326 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 151
           +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            FF   D    ++ +VLE        +  H  R +   P    + Y  QI     Y+H  
Sbjct: 88  GFFEDND----FVFVVLELCRRRSL-LELHKRRKALTEP--EARYYLRQIVLGCQYLHRN 140
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 270
             V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 141 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 197
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           ++  +D+WS+GC++  LL+G+P F                      E  C+   Y     
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 231
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP-N 389
            +IK + +     K + P A  L+ ++LQ  P  R T  E     FF     P ARLP  
Sbjct: 232 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 287
Query: 390 GRPFPPLFNFKPQELKGASKELLSKL 415
               PP F+  P  L  ++++ L+ L
Sbjct: 288 CLTIPPRFSIAPSSLDPSNRKPLTVL 313

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 88/323 (27%), Positives = 148/323 (45%), Gaps = 60/323 (18%)
Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIK-----KVLQDKRYKNRELQTMRLLDH----P 144
           +V+G G++G VF  + +   +TG+  A+K      ++Q  +         ++L+H    P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQIC 202
            +V+L + F     + E  L+L+L+++        + ++  SQR       V++Y  +I 
Sbjct: 120 FLVTLHYAF-----QTETKLHLILDYI-----NGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YR 260
            AL ++H  +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y  C    Y 
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 261 APELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           AP+++ G  + +  A+D WS+G ++ ELL G   F  +   +   EI       +R  +K
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILK 280
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIH 374
              P      +PQ             M   A DL+ RLL   P  R       A E   H
Sbjct: 281 SEPP------YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322
Query: 375 PFFDELR-DPNARLPNGRPFPPL 396
            FF ++  D  A      PF P+
Sbjct: 323 LFFQKINWDDLAAKKVPAPFKPV 345

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 134/295 (45%), Gaps = 54/295 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 141
            +   R++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 142 -DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKH--YSRASQRMPLIYVKL 196
            D P +V + + F  T DK    L+ +L+ +   +  Y +++H  +S A  R        
Sbjct: 249 GDCPFIVCMSYAF-HTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMR-------F 296
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           Y  +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +
Sbjct: 297 YAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGT 353
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF-----PGESGVDQLVEIIKV-- 309
             Y APE++     Y ++ D +S+GC+L +LL G   F       +  +D++   + V  
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 413
Query: 310 ---------------LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 348
                          L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 134/295 (45%), Gaps = 54/295 (18%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 141
            +   R++G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 142 -DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKH--YSRASQRMPLIYVKL 196
            D P +V + + F  T DK    L+ +L+ +   +  Y +++H  +S A  R        
Sbjct: 249 GDCPFIVCMSYAF-HTPDK----LSFILDLMNGGDLHYHLSQHGVFSEADMR-------F 296
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           Y  +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +
Sbjct: 297 YAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGT 353
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF-----PGESGVDQLVEIIKV-- 309
             Y APE++     Y ++ D +S+GC+L +LL G   F       +  +D++   + V  
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 413
Query: 310 ---------------LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 348
                          L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           PN+V L         + E  L LV+E+     V+     Y  A  RM     +    QI 
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVF----DYLVAHGRMKEKEARAKFRQIV 123
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y AP
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           EL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y 
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 140
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 257
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 141 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 195
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
           +G+GS GIV  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +      +EL++  ++EF+            R ++      +      + +ALAY+H   
Sbjct: 111 YLVG---EELWV--LMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHAQ- 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
           GV HRDIK  ++L+     +VKL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
            T +DIWS+G ++ E++ G+P +  +S V  +            + ++   P       P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------P 259
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
           ++K    HK+      P   D + R+L   P  R TA E   HPF  +   P   +P
Sbjct: 260 KLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   VA+K + + +  K        RE++    L HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            + F+   D+  +YL  +LE+ P  E    + K  +   QR   I  +L       AL Y
Sbjct: 89  YNYFY---DRRRIYL--ILEYAPRGELYKELQKSCTFDEQRTATIMEEL-----ADALMY 138
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
            HG   V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G
Sbjct: 139 CHGK-KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              +   +D+W +G +  ELL+G P F   S  +    I+KV                 +
Sbjct: 196 RM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-----------------D 237
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            KFP              +P  A DL+S+LL+++P+ R    +   HP+
Sbjct: 238 LKFP------------ASVPTGAQDLISKLLRHNPSERLPLAQVSAHPW 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           R+L   N   L    FS  D   LY  +V+E+VP     +  H  R   R    + + Y 
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 140
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 257
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 141 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 195
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 123/255 (48%), Gaps = 29/255 (11%)
Query: 68  NGTETGHIIVTTIGGRNGQPK-QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ 126
           +G +TG++   TIGG+  Q +   +  + E  +G G+ G V++ +  +TG  +A+K++  
Sbjct: 6   SGKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 127 DKRYKNRELQTMRLLDHPNVVSLKH-------CFFSTTDKDELYLNLVLEFVPETVYRVA 179
            +R  N+E +  R+L   +VV   H       CF +     ++++   +E +     ++ 
Sbjct: 59  -RRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLK 114
Query: 180 KHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239
           K   R    +P   +   T  I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG
Sbjct: 115 K---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFG 170
Query: 240 SAKVLVKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFP 295
            +  LV  +          Y APE I        +Y    D+WS+G  L EL  GQ  FP
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP 228
Query: 296 GESGVDQLVEIIKVL 310
            ++       + KVL
Sbjct: 229 YKNCKTDFEVLTKVL 243

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 87  PKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 138
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           R+L   N   L    FS  D   LY  +V+E+ P     +  H  R   R    + + Y 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 257
            QI     Y+H  + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 130/303 (42%), Gaps = 48/303 (15%)
Query: 99  VGQGSFGIVFQAKCLE--TGETVAIKKVLQ----DKRYKNRELQTMRLLDHPNVVSLKHC 152
           +G G+FG+V   +C+E  TG     K +      DK     E+  M  L HP +++L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 153 FFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
           F     +D+  + L+LEF+   E   R+A    + S+   + Y++    Q C  L ++H 
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHE 167
Query: 211 GIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
              + H DIKP+N++        VK+ DFG A  L   E       +  + APE++    
Sbjct: 168 H-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DRE 225
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
                 D+W++G +   LL G   F GE  ++ L            + +K  +  + E  
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDA 273
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD-ELRDPNARLP 388
           F  +              PEA D +  LLQ  P  R T  +A  HP+   +  +  +R+P
Sbjct: 274 FSSVS-------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
Query: 389 NGR 391
           + R
Sbjct: 321 SSR 323

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 23/226 (10%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------R 133
           G + QP    +Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLI 192
           E++ M++L+HPN+V L         + E  L L++E+     V+     Y  A  RM   
Sbjct: 61  EVRIMKILNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVF----DYLVAHGRMKEK 111
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             +    QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    +
Sbjct: 112 EARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDT 169
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           +  S  Y APEL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 170 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 48/294 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 147
           Y    V+G G+F  V  A+   T + VAIK    K L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK---HYSRASQRMPLIYVKLYTYQICRA 204
           +L   + S      LYL + L    E   R+ +   +  R + R+         +Q+  A
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDA 128
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
           + Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y AP
Sbjct: 129 VKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E +     Y+ A+D WS+G +   LL G P F  E+      +I+K              
Sbjct: 188 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------------- 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
               EF  P      W  I        A D +  L++  P  R T  +A  HP+
Sbjct: 234 --EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 147/337 (43%), Gaps = 52/337 (15%)
Query: 98  VVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKNRELQTMRLLD-----HPNVVSL 149
            +G+G+FG V Q  C++    G  VA+K +   ++YK      + +L+      P+  +L
Sbjct: 40  TLGEGTFGRVVQ--CVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNL 97
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
               F   D    ++ +  E +  + +   K  +      P+  V+   +Q+C+A+ ++H
Sbjct: 98  CVQMFDWFDY-HGHMCISFELLGLSTFDFLKDNNYLP--YPIHQVRHMAFQLCQAVKFLH 154
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQ------------------VKLCDFGSAKVLVKGEPNI 251
               + H D+KP+N+L     ++                  V++ DFGSA      E + 
Sbjct: 155 DN-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DHEHHS 211
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
           + + +R+YRAPE+I     ++   D+WS+GC++ E  +G  LF      + L  + ++LG
Sbjct: 212 TIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILG 270
Query: 312 -TPTREEIKC------------MNPNYTEFKFPQIKAHPWHKIFHKRMPP--EAVDLVSR 356
             P+R   K              + N +  ++ +    P  +          +  DL+  
Sbjct: 271 PIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIES 330
Query: 357 LLQYSPNLRCTALEACIHPFFDELRD--PNARLPNGR 391
           +L+Y P  R T  EA  HPFF  LR   PN    + R
Sbjct: 331 MLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           PN+V L         + E  L LV+E+     V+     Y  A  RM     +    QI 
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVF----DYLVAHGRMKEKEARAKFRQIV 123
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y AP
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           EL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 86  QPKQTISYMAE----RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQT 137
            P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L  
Sbjct: 32  NPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            R+L   N   L    FS  D   LY  +V+E+V      +  H  R   R    + + Y
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVAGG--EMFSHLRRIG-RFSEPHARFY 146
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
             Y APE+I  +  Y  A+D W++G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 40/301 (13%)
Query: 77  VTTIGGRNGQPKQTISYMAERV-----VGQGSFGIVFQAKCLETGETVAIKKVLQ--DKR 129
           + + G     P+Q   + AE +     +G+G++G V +     +G+ +A+K++    D++
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 130 YKNRELQ----TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-YSR 184
            + + L      MR  D P +V      F   D       + +E +  +  +  K+ YS 
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSV 117
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
               +P   +   T    +AL ++   + + HRDIKP N+L++  +  +KLCDFG +  L
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQL 176
Query: 245 VKGEPNISYICSRYYRAPELIFGATE---YTTAIDIWSVGCVLAELLLGQPLFPGESGV- 300
           V           R Y APE I  +     Y    D+WS+G  L EL  G+  +P  + V 
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 301 DQLVEIIKVLGTP---TREEIKCMNPNYTEF-------------KFPQIKAHPWHKIFHK 344
           DQL +++K  G P   +  E +  +P++  F             K+ ++  HP+  ++ +
Sbjct: 237 DQLTQVVK--GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294
Query: 345 R 345
           R
Sbjct: 295 R 295

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 47/284 (16%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLD-HPNVVSL 149
           + ++ +G+GSF I    KC+      A    +  KR +    +E+  ++L + HPN+V L
Sbjct: 14  LKDKPLGEGSFSIC--RKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
              F      D+L+  LV+E +   E   R+ K    +      I  KL +     A+++
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSH 121
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
           +H  +GV HRD+KP+NLL        ++K+ DFG A++       +   C + +Y APEL
Sbjct: 122 MHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM 321
           +     Y  + D+WS+G +L  +L GQ  F            VEI+K +           
Sbjct: 181 L-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--------- 230
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 365
                +F F   +   W     K +  EA DL+  LL   PN R
Sbjct: 231 ----GDFSF---EGEAW-----KNVSQEAKDLIQGLLTVDPNKR 262

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 94/326 (28%), Positives = 137/326 (42%), Gaps = 50/326 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 151
           +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            FF   D    ++ +VLE        +  H  R +   P    + Y  QI     Y+H  
Sbjct: 108 GFFEDND----FVFVVLELCRRRSL-LELHKRRKALTEP--EARYYLRQIVLGCQYLHRN 160
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 270
             V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +     
Sbjct: 161 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 217
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           ++  +D+WS+GC++  LL+G+P F                      E  C+   Y     
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 251
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP-N 389
            +IK + +     K + P A  L+ ++LQ  P  R T  E     FF     P ARLP  
Sbjct: 252 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 307
Query: 390 GRPFPPLFNFKPQELKGASKELLSKL 415
               PP F+  P  L  ++++ L+ L
Sbjct: 308 CLTIPPRFSIAPSSLDPSNRKPLTVL 333

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 131/299 (43%), Gaps = 62/299 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++    +  R      + Y  +I  A
Sbjct: 73  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 122
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE
Sbjct: 123 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 182 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 229
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
                             F + + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 230 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 131/299 (43%), Gaps = 62/299 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++    +  R      + Y  +I  A
Sbjct: 71  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 120
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE
Sbjct: 121 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 180 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 227
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
                             F + + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 228 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 130/299 (43%), Gaps = 62/299 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 213
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++    +  R      + Y  +I  A
Sbjct: 214 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 263
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE
Sbjct: 264 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 322
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +              
Sbjct: 323 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM-------------- 366
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
              E +FP+             + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 367 --EEIRFPRT------------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +S   ++   L L++E++P    R   +  +  +R+  I +  YT QIC+ + Y+ G
Sbjct: 79  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 132
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 263
                HR++  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 TKRYIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWYAPE 188
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   ++++ A D+WS G VL EL 
Sbjct: 189 SL-TESKFSVASDVWSFGVVLYELF 212

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           PN+V L         + E  L LV+E+     V+     Y  A  RM     +    QI 
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVF----DYLVAHGRMKEKEARAKFRQIV 123
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y AP
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           EL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 94/326 (28%), Positives = 137/326 (42%), Gaps = 50/326 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 151
           +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            FF   D    ++ +VLE        +  H  R +   P    + Y  QI     Y+H  
Sbjct: 106 GFFEDND----FVFVVLELCRRRSL-LELHKRRKALTEP--EARYYLRQIVLGCQYLHRN 158
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 270
             V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +     
Sbjct: 159 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 215
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           ++  +D+WS+GC++  LL+G+P F                      E  C+   Y     
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 249
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP-N 389
            +IK + +     K + P A  L+ ++LQ  P  R T  E     FF     P ARLP  
Sbjct: 250 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 305
Query: 390 GRPFPPLFNFKPQELKGASKELLSKL 415
               PP F+  P  L  ++++ L+ L
Sbjct: 306 CLTIPPRFSIAPSSLDPSNRKPLTVL 331

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 131/299 (43%), Gaps = 62/299 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++    +  R      + Y  +I  A
Sbjct: 72  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 121
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE
Sbjct: 122 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 228
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
                             F + + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 229 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 133/299 (44%), Gaps = 50/299 (16%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 143
           T  Y     +G+G+F +V +   L TG   A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
            N+V L H   S      L  +LV   E   + V R  ++YS A     +        QI
Sbjct: 63  SNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSR 257
             A+ + H  +GV HRD+KP+NLL+        VKL DFG A + V+G+      +  + 
Sbjct: 113 LEAVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK         
Sbjct: 171 GYLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA-------- 220
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                     + FP   +  W  +      PEA +L++++L  +P  R TA EA  HP+
Sbjct: 221 --------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 130/299 (43%), Gaps = 62/299 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++    +  R      + Y  +I  A
Sbjct: 211 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 260
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +              
Sbjct: 320 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM-------------- 363
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
              E +FP+             + PEA  L+S LL+  P  R       A E   H FF
Sbjct: 364 --EEIRFPRT------------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 148/317 (46%), Gaps = 68/317 (21%)
Query: 94  MAERVVGQGSFG-IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 148
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT-----YQICR 203
            ++    TTD+   +L + LE     +  + +  + + + + L   K Y       QI  
Sbjct: 73  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNI 251
            +A++H  + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+ + 
Sbjct: 127 GVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 252 SYIC-----SRYYRAPELIFGATEYTT------AIDIWSVGCVLAELLLGQPLFPGESGV 300
                    +  +RAPEL+  +    T      +IDI+S+GCV    +L +   P     
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDH 282
Query: 361 SPNLRCTALEACIHPFF 377
            P  R TA++   HP F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 58/300 (19%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRASQRMPLIYVKLYTY 199
           +++ L     + +D     + +V+E+V      + + +  +   + S+R+          
Sbjct: 77  HIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQ 123
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           QI   + Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y
Sbjct: 124 QILSGVDYCHRHM-VVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRXSCGSPNY 181
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
            APE+I G       +DIWS G +L  LL G   F  +               PT  +  
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------VPTLFKKI 228
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           C    YT    PQ             + P  + L+  +LQ  P  R T  +   H +F +
Sbjct: 229 CDGIFYT----PQY------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           PN+V L         + E  L LV+E+     V+     Y  A  RM     +    QI 
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVF----DYLVAHGRMKEKEARAKFRQIV 123
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G     +  S  Y AP
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAAP 181
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           EL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH 143
           QP++    + +  +G+GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFV-PETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           P+VV     +F  TD     L +V+E+    +V  + +  ++      +  +   T    
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQST---L 135
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRA 261
           + L Y+H  +   HRDIK  N+L+N   H  KL DFG A  L       +  I + ++ A
Sbjct: 136 KGLEYLH-FMRKIHRDIKAGNILLNTEGH-AKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE+I     Y    DIWS+G    E+  G+P +        +  +  +   PT       
Sbjct: 194 PEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT------- 239
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           NP  T F+ P++    W   F         D V + L  SP  R TA +   HPF
Sbjct: 240 NPPPT-FRKPEL----WSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 26/218 (11%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETV---YRVAKHYSRASQRMPLIYVKLYTYQ 200
           PN+V L         + E  L LV+E+        Y VA  + +  +       +    Q
Sbjct: 66  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKE------ARAKFRQ 114
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260
           I  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y 
Sbjct: 115 IVSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYA 172
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           APEL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 147/317 (46%), Gaps = 68/317 (21%)
Query: 94  MAERVVGQGSFG-IVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 148
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT-----YQICR 203
            ++    TTD+   +L + LE     +  + +  + + + + L   K Y       QI  
Sbjct: 73  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNI 251
            +A++H  + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 127 GVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 252 SYIC-----SRYYRAPELIFGATEYTT------AIDIWSVGCVLAELLLGQPLFPGESGV 300
                    +  +RAPEL+  +    T      +IDI+S+GCV    +L +   P     
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDH 282
Query: 361 SPNLRCTALEACIHPFF 377
            P  R TA++   HP F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 58/310 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
            + F    D+  +YL  +LEF P   +Y+  + + R  ++    +++    ++  AL Y 
Sbjct: 81  YNYFH---DRKRIYL--MLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+  +  ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
           T +   +D+W  G +  E L+G P F   S  +    I+ V                 + 
Sbjct: 189 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 230
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
           KFP              +   + DL+S+LL+Y P  R        HP+       N+R  
Sbjct: 231 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR-- 272
Query: 389 NGRPFPPLFN 398
             R  PP++ 
Sbjct: 273 --RVLPPVYQ 280

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 132/293 (45%), Gaps = 57/293 (19%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-------LLDHPNVVSLK 150
           ++G+GSF  V++A+ + TG  VAIK + +   YK   +Q ++        L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 151 HCFFSTTDKDELYLNLVLEF-----VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + F     +D  Y+ LVLE      +   +    K +S    R        + +QI   +
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-------FMHQIITGM 125
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPEL 264
            Y+H   G+ HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE 
Sbjct: 126 LYLHSH-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE- 182
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           I   + +    D+WS+GC+   LL+G+P F  ++  + L +++                 
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV----------------- 225
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             +++ P              +  EA DL+ +LL+ +P  R +      HPF 
Sbjct: 226 LADYEMPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 58/310 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
            + F    D+  +YL  +LEF P   +Y+  + + R  ++    +++    ++  AL Y 
Sbjct: 80  YNYFH---DRKRIYL--MLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
           H    V HRDIKP+NLL+  +  ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
           T +   +D+W  G +  E L+G P F   S  +    I+ V                 + 
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 229
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
           KFP              +   + DL+S+LL+Y P  R        HP+       N+R  
Sbjct: 230 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA----NSR-- 271
Query: 389 NGRPFPPLFN 398
             R  PP++ 
Sbjct: 272 --RVLPPVYQ 279

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G G+ G+VF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F+S  +     +++ +E +   ++ +V K     + R+P   +   +  + + L Y+  
Sbjct: 134 AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 185 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 241
Query: 271 YTTAIDIWSVGCVLAELLLGQ 291
           Y+   DIWS+G  L E+ +G+
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGR 262

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           PN+V L         + E  L L++E+     V+     Y  A  RM     +    QI 
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIV 124
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y AP
Sbjct: 125 SAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           EL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVV 147
           Y    V+G G+F  V  A+   T + VAIK + ++     +     E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK---HYSRASQRMPLIYVKLYTYQICRA 204
           +L   + S      LYL + L    E   R+ +   +  R + R+         +Q+  A
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDA 128
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
           + Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y AP
Sbjct: 129 VKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E +     Y+ A+D WS+G +   LL G P F  E+      +I+K              
Sbjct: 188 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-------------- 232
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
               E++F    +  W  I        A D +  L++  P  R T  +A  HP+
Sbjct: 233 ---AEYEF---DSPYWDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 57/298 (19%)
Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIK--------KVLQDKRYKNRELQTMRLLDHPN 145
           RV+G+G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +V L + F  T  K    L L+LE++  +   +     R    M       Y  +I  AL
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYL--SGGELFMQLEREGIFMEDTAC-FYLAEISMAL 134
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPEL 264
            ++H   G+ +RD+KP+N+++N H   VKL DFG  K  +  G    ++  +  Y APE+
Sbjct: 135 GHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +   + +  A+D WS+G ++ ++L G P F GE+    + +I+K          K   P 
Sbjct: 193 LM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------KLNLPP 242
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
           Y                    +  EA DL+ +LL+ +   R       A E   HPFF
Sbjct: 243 Y--------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 97  RVVGQGSFGIVFQAK--------CLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 148
           +V+G+GSFG V  A+         ++  +  AI K  ++K   +     ++ + HP +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L H  F T DK    L  VL+++   E  Y + +       R      + Y  +I  AL 
Sbjct: 104 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 153
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           Y+H  + + +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE +
Sbjct: 154 YLHS-LNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPE-V 210
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLF 294
                Y   +D W +G VL E+L G P F
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 130/298 (43%), Gaps = 57/298 (19%)
Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIK--------KVLQDKRYKNRELQTMRLLDHPN 145
           RV+G+G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +V L + F  T  K    L L+LE++  +   +     R    M       Y  +I  AL
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYL--SGGELFMQLEREGIFMEDTAC-FYLAEISMAL 134
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 264
            ++H   G+ +RD+KP+N+++N H   VKL DFG  K  +         C    Y APE+
Sbjct: 135 GHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEI 192
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +   + +  A+D WS+G ++ ++L G P F GE+    + +I+K          K   P 
Sbjct: 193 LM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------KLNLPP 242
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
           Y                    +  EA DL+ +LL+ +   R       A E   HPFF
Sbjct: 243 Y--------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 41/237 (17%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 144
            Y   +V+G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            VV L + F     +D+ YL +V+E++P   +  +  +Y      +P  + + YT ++  
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVL 179
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISY 253
           AL  IH  +G  HRD+KP N+L++   H +KL DFG+   + K          G P+   
Sbjct: 180 ALDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--- 234
Query: 254 ICSRYYRAPELI---FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
                Y +PE++    G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 235 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 48/294 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 147
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK---HYSRASQRMPLIYVKLYTYQICRA 204
           +L   + S      LYL + L    E   R+ +   +  R + R+         +Q+  A
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDA 128
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
           + Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y AP
Sbjct: 129 VKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E +     Y+ A+D WS+G +   LL G P F  E+      +I+K              
Sbjct: 188 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------------- 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
               EF  P      W  I        A D +  L++  P  R T  +A  HP+
Sbjct: 234 --EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 114/229 (49%), Gaps = 25/229 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 144
            Y   +V+G+G+FG V   +   + +  A+K + +       D  +   E   M   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            VV L  C F    +D+ YL +V+E++P   +  +  +Y      +P  + K YT ++  
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVL 185
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNI-SYICSRYYRA 261
           AL  IH  +G+ HRD+KP N+L++ H H +KL DFG+  K+   G  +  + + +  Y +
Sbjct: 186 ALDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYIS 243
Query: 262 PELI---FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
           PE++    G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 41/238 (17%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 144
            Y   +V+G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            VV L + F     +D+ YL +V+E++P   +  +  +Y      +P  + + YT ++  
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVL 184
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISY 253
           AL  IH  +G  HRD+KP N+L++   H +KL DFG+   + K          G P+   
Sbjct: 185 ALDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--- 239
Query: 254 ICSRYYRAPELI---FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
                Y +PE++    G   Y    D WSVG  L E+L+G   F  +S V    +I+ 
Sbjct: 240 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 292

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 41/237 (17%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 144
            Y   +V+G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            VV L + F     +D+ YL +V+E++P   +  +  +Y      +P  + + YT ++  
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVL 184
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISY 253
           AL  IH  +G  HRD+KP N+L++   H +KL DFG+   + K          G P+   
Sbjct: 185 ALDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--- 239
Query: 254 ICSRYYRAPELI---FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
                Y +PE++    G   Y    D WSVG  L E+L+G   F  +S V    +I+
Sbjct: 240 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 153
           +G G+ G+VF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
           +S  +     +++ +E +            + + R+P   +   +  + + L Y+     
Sbjct: 101 YSDGE-----ISICMEHMDGGSL---DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 273
           + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 153 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 209
Query: 274 AIDIWSVGCVLAELLLGQ 291
             DIWS+G  L E+ +G+
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G G+ G+VF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            F+S  +     +++ +E +   ++ +V K     + R+P   +   +  + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 271 YTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQ 302
           Y+   DIWS+G  L E+ +G+ P+ P ++  D 
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 48/294 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 147
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK---HYSRASQRMPLIYVKLYTYQICRA 204
           +L   + S      LYL + L    E   R+ +   +  R + R+         +Q+  A
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDA 128
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
           + Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y AP
Sbjct: 129 VKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E +     Y+ A+D WS+G +   LL G P F  E+      +I+K              
Sbjct: 188 E-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------------- 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
               EF  P      W  I        A D +  L++  P  R T  +A  HP+
Sbjct: 234 --EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 18/215 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 153
           +G G+ G+VF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +S  +     +++ +E +   ++ +V K     + R+P   +   +  + + L Y+    
Sbjct: 93  YSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH 143
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+
Sbjct: 144 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 200
Query: 273 TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
              DIWS+G  L E+ +G+      SG   + E++
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 153
           +G G+ G+VF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +S  +     +++ +E +   ++ +V K     + R+P   +   +  + + L Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 273 TAIDIWSVGCVLAELLLGQ 291
              DIWS+G  L E+ +G+
Sbjct: 182 VQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 153
           +G G+ G+VF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +S  +     +++ +E +   ++ +V K     + R+P   +   +  + + L Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 273 TAIDIWSVGCVLAELLLGQ 291
              DIWS+G  L E+ +G+
Sbjct: 182 VQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 153
           +G G+ G+VF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +S  +     +++ +E +   ++ +V K     + R+P   +   +  + + L Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 273 TAIDIWSVGCVLAELLLGQ 291
              DIWS+G  L E+ +G+
Sbjct: 182 VQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 153
           +G G+ G+VF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           +S  +     +++ +E +   ++ +V K     + R+P   +   +  + + L Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 273 TAIDIWSVGCVLAELLLGQ 291
              DIWS+G  L E+ +G+
Sbjct: 182 VQSDIWSMGLSLVEMAVGR 200

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 148
           Y+  + +G+G F  V   + L  G   A+K++L    QD+    RE    RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 149 L-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L  +C      K E +L L   F   T++   +        +    +      ICR L  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS---AKVLVKGEPNISYI-------CSR 257
           IH   G  HRD+KP N+L+      V L D GS   A + V+G      +       C+ 
Sbjct: 150 IHAK-GYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 258 YYRAPELIFGATEYTTA---IDIWSVGCVLAELLLGQ 291
            YRAPEL F    +       D+WS+GCVL  ++ G+
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 128 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 181
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  +  Y 
Sbjct: 182 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SKGYN 237
Query: 273 TAIDIWSVGCVLAELLLGQPLF 294
            A+D W++G ++ E+  G P F
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPF 259

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 108 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 161
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 216
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 128 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLHS-L 181
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 182 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 236
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 34/226 (15%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLD-HPNVVSLKH 151
           RV+ +G F  V++A+ + +G   A+K++L ++  KNR    E+  M+ L  HPN+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF-- 91
Query: 152 CFFSTTDKDELYLNLVLEFVPETVY---RVAKHYSRASQRMPL---IYVKLYTYQICRAL 205
           C  ++  K+E       EF+  T     ++ +   +   R PL     +K++ YQ CRA+
Sbjct: 92  CSAASIGKEESDTGQA-EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAV 149
Query: 206 AYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 257
            ++H     + HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R       
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEEE 207
Query: 258 -------YYRAPELIFGATEYTTA--IDIWSVGCVLAELLLGQPLF 294
                   YR PE+I   + +      DIW++GC+L  L   Q  F
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFAEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 89/313 (28%), Positives = 128/313 (40%), Gaps = 50/313 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSLKH 151
           +G+G F   F+    +T E  A K V +    K       + E+   R L H +VV   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            FF   D    ++ +VLE        +  H  R +   P    + Y  QI     Y+H  
Sbjct: 82  GFFEDND----FVFVVLELCRRRSL-LELHKRRKALTEP--EARYYLRQIVLGCQYLHRN 134
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 270
             V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +     
Sbjct: 135 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 191
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           ++  +D+WS+GC++  LL+G+P F                      E  C+   Y     
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 225
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP-N 389
            +IK + +     K + P A  L+ ++LQ  P  R T  E     FF     P ARLP  
Sbjct: 226 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 281
Query: 390 GRPFPPLFNFKPQ 402
               PP F+  P 
Sbjct: 282 CLTIPPRFSIAPS 294

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKGYN 216
Query: 273 TAIDIWSVGCVLAELLLGQPLF 294
            A+D W++G ++ E+  G P F
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 94  EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 147
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 148 DLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 202
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKGYN 216
Query: 273 TAIDIWSVGCVLAELLLGQPLF 294
            A+D W++G ++ E+  G P F
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/327 (24%), Positives = 139/327 (42%), Gaps = 46/327 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 155
           +G G+FG+    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 156 TTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
            T     +L +V+E+    E   R+       + R      + +  Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHA-MQ 135
Query: 214 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
           VCHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 273 TAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
              D+WS G  L  +L+G  P    E   +    I ++L       ++   P+Y      
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV----- 244
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 391
                         + PE   L+SR+    P  R +  E   H +F  L++  A L N  
Sbjct: 245 -------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDN 289
Query: 392 PFPPLFNFKPQELKGASKELLSKLIPE 418
                F+   Q   G S E + ++I E
Sbjct: 290 TMTTQFDESDQ--PGQSIEEIMQIIAE 314

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 15/202 (7%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 155
           ++G G FG VF+AK    G+T  IK+V  +     RE++ +  LDH N+V    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 156 ----TTDKDELY-----LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
               T+ K+        L + +EF  +          R  +   ++ ++L+  QI + + 
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE-QITKGVD 136
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           YIH    + +RD+KP N+ +   T QVK+ DFG    L           +  Y +PE I 
Sbjct: 137 YIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI- 193
Query: 267 GATEYTTAIDIWSVGCVLAELL 288
            + +Y   +D++++G +LAELL
Sbjct: 194 SSQDYGKEVDLYALGLILAELL 215

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 93/350 (26%), Positives = 150/350 (42%), Gaps = 62/350 (17%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 148
           T  Y  +  +G GS+ +  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           LK  +      D  Y+ +V E +   E + ++ +    + +    +      + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTITKTVE 130
Query: 207 YIHGGIGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 260
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE +     Y  A DIWS+G +L  +L G   F      D   EI+  +G+        
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG------- 238
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF---F 377
                   KF  +    W+ +        A DLVS++L   P+ R TA     HP+   +
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
Query: 378 DELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFL 427
           D+L  P  +L N +  P L       +KGA     S L     R Q P L
Sbjct: 285 DQL--PQYQL-NRQDAPHL-------VKGAMAATYSAL----NRNQSPVL 320

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 102 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLHS-L 155
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 156 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 210
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 211 NKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
            RE Q    L+HP +V++     + T    L   +V+E+V     R   H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
           I V       C+AL + H   G+ HRD+KP N+L++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEV---IADACQALNFSHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSV 173
Query: 252 ----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
               + I +  Y +PE   G +    + D++S+GCVL E+L G+P F G+S V
Sbjct: 174 XQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 136/297 (45%), Gaps = 47/297 (15%)
Query: 91  ISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDKRYKNRELQTMR-LLDHPNVVS 148
           +S +  R V + + G  F  K +E T E ++ +++ + +    RE   +R +  HP++++
Sbjct: 106 VSSVVRRCVHRAT-GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQICRALA 206
           L   + S++     ++ LV + +     R  + +   ++++ L     +     +  A++
Sbjct: 165 LIDSYESSS-----FMFLVFDLM-----RKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           ++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y APE++ 
Sbjct: 215 FLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 267 GATE-----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
            + +     Y   +D+W+ G +L  LL G P F     +  L  I              M
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------------M 318
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
              Y +F  P+     W             DL+SRLLQ  P  R TA +A  HPFF+
Sbjct: 319 EGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/327 (24%), Positives = 138/327 (42%), Gaps = 46/327 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 155
           +G G+FG+    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 156 TTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
            T     +L +V+E+    E   R+       + R      + +  Q+   ++Y H  + 
Sbjct: 86  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHA-MQ 134
Query: 214 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
           VCHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++       
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 273 TAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
              D+WS G  L  +L+G  P    E   +    I ++L       ++   P+Y      
Sbjct: 195 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV----- 243
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 391
                         + PE   L+SR+    P  R +  E   H +F  L++  A L N  
Sbjct: 244 -------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDN 288
Query: 392 PFPPLFNFKPQELKGASKELLSKLIPE 418
                F    Q   G S E + ++I E
Sbjct: 289 TMTTQFAASDQ--PGQSIEEIMQIIAE 313

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 87/304 (28%), Positives = 134/304 (44%), Gaps = 60/304 (19%)
Query: 90  TISYMAERVVGQGSFGIV-----------FQAKCLETGETVAIKKVLQDKRYKNRELQTM 138
           T  Y     +G+G+F +V           + AK + T +  A     +D +   RE +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKL 196
           RLL HPN+V L H   S      L  +LV   E   + V R  ++YS A     +     
Sbjct: 85  RLLKHPNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI----- 136
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--IS 252
             +QI  ++ +IH    + HRD+KP+NLL+        VKL DFG A + V+GE      
Sbjct: 137 --HQILESVNHIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFG 192
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
           +  +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK    
Sbjct: 193 FAGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA--- 247
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                          + FP   +  W  +      PEA +L++++L  +P  R TA +A 
Sbjct: 248 -------------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITADQAL 286
Query: 373 IHPF 376
            HP+
Sbjct: 287 KHPW 290

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY  +V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLY--MVMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ ++  G P F
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 150
           V+G+GSFG V  A    T E  AIK + +D   ++ +++        + LLD P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           H  F T D+    L  V+E+V   + +Y + +   +  +   + Y      +I   L ++
Sbjct: 86  HSCFQTVDR----LYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAA----EISIGLFFL 136
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 267
           H   G+ +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I  
Sbjct: 137 HKR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-A 193
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
              Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKR--YKN---RELQTMRLLDHPNVVSLKHCF 153
           +G G+ G+VF+     +G  +A K +  + +   +N   RELQ +   + P +V     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
           +S  +     +++ +E +            + + R+P   +   +  + + L Y+     
Sbjct: 77  YSDGE-----ISICMEHMDGGSL---DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 273
           + HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T Y+ 
Sbjct: 129 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-THYSV 185
Query: 274 AIDIWSVGCVLAELLLGQ 291
             DIWS+G  L E+ +G+
Sbjct: 186 QSDIWSMGLSLVEMAVGR 203

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 100/338 (29%), Positives = 140/338 (41%), Gaps = 75/338 (22%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 148
           V+G+G+F +V +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 149 LKHCF---------FSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLY 197
           L   +         F   D  +L   +V       VY   VA HY R             
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------------- 137
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---S 252
             QI  AL Y H    + HRD+KP+N+L+    ++  VKL DFG A  L  GE  +    
Sbjct: 138 --QILEALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGG 192
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            + + ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I     
Sbjct: 193 RVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI----- 244
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
             + + K MNP              W  I        A DLV R+L   P  R T  EA 
Sbjct: 245 -IKGKYK-MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEAL 285
Query: 373 IHPFFDELRDPNA---RLPNGRPFPPLFNFKPQELKGA 407
            HP+  E RD  A    LP        FN + ++LKGA
Sbjct: 286 NHPWLKE-RDRYAYKIHLPETVEQLRKFNAR-RKLKGA 321

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 92/328 (28%), Positives = 147/328 (44%), Gaps = 51/328 (15%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTM 138
           QP    ++   RV+G+G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
             ++   VVSL + + +   KD L L L L    +  + +   Y       P      Y 
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYA 292
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 258
            +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  
Sbjct: 293 AEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           Y APE++     YT + D W++GC+L E++ GQ  F       Q  + IK      REE+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEV 397
Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACI 373
           + +           +K  P  + + +R  P+A  L S+LL   P  R      +A E   
Sbjct: 398 ERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 374 HPFFDELRDPNARLPNGRPFPPLFNFKP 401
           HP F +L     RL  G   PP   FKP
Sbjct: 445 HPLFKKLN--FKRLGAGMLEPP---FKP 467

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
            RE Q    L+HP +V++     + T    L   +V+E+V     R   H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
           I V       C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEV---IADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 252 S----YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           +     I +  Y +PE   G +    + D++S+GCVL E+L G+P F G+S V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 128/305 (41%), Gaps = 49/305 (16%)
Query: 84  NGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----- 138
           N   K + +Y  +  +G+G+F +V +     TG   A  K++  K+   R+ Q +     
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREAR 80
Query: 139 --RLLDHPNVVSLKHCFFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYV 194
             R L HPN+V L H          L  +LV   E   + V R  + YS A     +   
Sbjct: 81  ICRKLQHPNIVRL-HDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCI--- 134
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNIS 252
                QI  ++AY H   G+ HR++KP+NLL+        VKL DFG A  +   E    
Sbjct: 135 ----QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
           +  +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK    
Sbjct: 190 FAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA--- 244
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                          + +P   +  W  +      PEA  L+  +L  +P  R TA +A 
Sbjct: 245 -------------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQAL 283
Query: 373 IHPFF 377
             P+ 
Sbjct: 284 KVPWI 288

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 115/228 (50%), Gaps = 28/228 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 148
           RV+G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L  CF     + E  L  V+E+V      +  H  R  +++P  + + Y+ +I  AL Y+
Sbjct: 86  LHSCF-----QTESRLFFVIEYVNGG--DLMFHMQR-QRKLPEEHARFYSAEISLALNYL 137
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 267
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 138 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF--------PGESGVDQLVEII 307
             +Y  ++D W++G ++ E++ G+  F        P ++  D L ++I
Sbjct: 196 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 242

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 148
           RV+G+GS+  V   +  +T    A+K V ++    + ++  ++          +HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L  CF     + E  L  V+E+V      +  H  R  +++P  + + Y+ +I  AL Y+
Sbjct: 75  LHSCF-----QTESRLFFVIEYVNGG--DLMFHMQR-QRKLPEEHARFYSAEISLALNYL 126
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 267
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 127 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF--------PGESGVDQLVEII 307
             +Y  ++D W++G ++ E++ G+  F        P ++  D L ++I
Sbjct: 185 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 143
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++  ++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           PN+V L         + E  L LV E+     V+     + R  ++      +    QI 
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR----QIV 123
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y AP
Sbjct: 124 SAVQYCHQKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           EL  G       +D+WS+G +L  L+ G   F G++
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
            RE Q    L+HP +V++     + T    L   +V+E+V     R   H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
           I V       C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEV---IADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 252 S----YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           +     I +  Y +PE   G +    + D++S+GCVL E+L G+P F G+S V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 92/328 (28%), Positives = 147/328 (44%), Gaps = 51/328 (15%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTM 138
           QP    ++   RV+G+G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
             ++   VVSL + + +   KD L L L L    +  + +   Y       P      Y 
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYA 292
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 258
            +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  
Sbjct: 293 AEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           Y APE++     YT + D W++GC+L E++ GQ  F       Q  + IK      REE+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEV 397
Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACI 373
           + +           +K  P  + + +R  P+A  L S+LL   P  R      +A E   
Sbjct: 398 ERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 374 HPFFDELRDPNARLPNGRPFPPLFNFKP 401
           HP F +L     RL  G   PP   FKP
Sbjct: 445 HPLFKKLN--FKRLGAGMLEPP---FKP 467

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 25/231 (10%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
            RE Q    L+HP +V++     + T    L   +V+E+V     R   H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
           I V       C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEV---IADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 252 S----YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
           +     I +  Y +PE   G +    + D++S+GCVL E+L G+P F G+S
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 115/228 (50%), Gaps = 28/228 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 148
           RV+G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L  CF     + E  L  V+E+V      +  H  R  +++P  + + Y+ +I  AL Y+
Sbjct: 71  LHSCF-----QTESRLFFVIEYVNGG--DLMFHMQR-QRKLPEEHARFYSAEISLALNYL 122
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 267
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 123 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF--------PGESGVDQLVEII 307
             +Y  ++D W++G ++ E++ G+  F        P ++  D L ++I
Sbjct: 181 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 116/228 (50%), Gaps = 28/228 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVA---IKKVLQDKRYKNRELQTMRLL-----DHPNVVS 148
           RV+G+GS+  V   +  +T    A   +KK L +       +QT + +     +HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L  CF     + E  L  V+E+V      +  H  R  +++P  + + Y+ +I  AL Y+
Sbjct: 118 LHSCF-----QTESRLFFVIEYVNGG--DLMFHMQR-QRKLPEEHARFYSAEISLALNYL 169
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFG 267
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++ G+   ++  +  Y APE++ G
Sbjct: 170 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF--------PGESGVDQLVEII 307
             +Y  ++D W++G ++ E++ G+  F        P ++  D L ++I
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 132 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
            RE Q    L+HP +V++     + T    L   +V+E+V     R   H          
Sbjct: 61  -REAQNAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
           I V       C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEV---IADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 252 S----YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           +     I +  Y +PE   G +    + D++S+GCVL E+L G+P F G+S V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 43/295 (14%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 151
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            +    D   +YL   L    E + ++ +    + +    +      + I + + Y+H  
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 212 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
            GV HRD+KP N+L      NP    +++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 266 FGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
                Y    DIWS+G +L  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
               KF  +    W+ +        A DLVS++L   P+ R TA +   HP+  +
Sbjct: 244 ----KF-TLSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 111/233 (47%), Gaps = 25/233 (10%)
Query: 85  GQPKQTISYMAER-----VVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYK 131
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 18  GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 132 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
            RE Q    L+HP +V++     + T    L   +V+E+V     R   H          
Sbjct: 78  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 135
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
           I V       C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 136 IEV---IADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 190
Query: 252 S----YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           +     I +  Y +PE   G +    + D++S+GCVL E+L G+P F G+S V
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 95/350 (27%), Positives = 149/350 (42%), Gaps = 62/350 (17%)
Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 148
           T  Y  +  +G GS+ +  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           LK  +      D  Y+ +V E     E + ++ +    + +    +   L+T  I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV---LFT--ITKTVE 130
Query: 207 YIHGGIGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 260
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE +     Y  A DIWS+G +L   L G   F      D   EI+  +G+        
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG------- 238
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF---F 377
                   KF  +    W+ +        A DLVS+ L   P+ R TA     HP+   +
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHW 284
Query: 378 DELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFL 427
           D+L  P  +L N +  P L       +KGA     S L     R Q P L
Sbjct: 285 DQL--PQYQL-NRQDAPHL-------VKGAXAATYSAL----NRNQSPVL 320

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 155
           ++G G FG VF+AK    G+T  I++V  +     RE++ +  LDH N+V    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 156 ---TTDKDELY-------------------LNLVLEFVPETVYRVAKHYSRASQRMPLIY 193
               T  D L                    L + +EF  +          R  +   ++ 
Sbjct: 79  YDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 138
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++L+  QI + + YIH    + HRD+KP N+ +   T QVK+ DFG    L         
Sbjct: 139 LELFE-QITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRS 195
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
             +  Y +PE I  + +Y   +D++++G +LAELL
Sbjct: 196 KGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 43/292 (14%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 151
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            +    D   +YL   L    E + ++ +    + +    +      + I + + Y+H  
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 212 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
            GV HRD+KP N+L      NP    +++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 266 FGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
                Y    DIWS+G +L  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
               KF  +    W+ +        A DLVS++L   P+ R TA +   HP+
Sbjct: 244 ----KFT-LSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 24/226 (10%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y+  + +G+GSFG     K  E G    IK++       +++    RE+  +  + HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY----VKLYTYQIC 202
           V  +  F    +   LY+  V+++           + R + +  +++    +  +  QIC
Sbjct: 86  VQYRESF---EENGSLYI--VMDYCEG-----GDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 261
            AL ++H    + HRDIK QN+ +      V+L DFG A+VL    E   + I + YY +
Sbjct: 136 LALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
           PE I     Y    DIW++GCVL EL   +  F   S  + +++II
Sbjct: 194 PE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 155
           +G G+FG+    +   T E VA+K + +         RE+   R L HPN+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 156 TTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
            T     +L +++E+    E   R+       + R      + +  Q+   ++Y H  + 
Sbjct: 88  PT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHS-MQ 136
Query: 214 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
           +CHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYD 195
Query: 273 TAI-DIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
             I D+WS G  L  +L+G  P    E   D    I ++L                ++  
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSI 241
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           P             R+ PE   L+SR+    P  R +  E   H +F
Sbjct: 242 PD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 138/327 (42%), Gaps = 46/327 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 155
           +G G+FG+    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 156 TTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
            T     +L +V+E+    E   R+       + R      + +  Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHA-MQ 135
Query: 214 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
           VCHRD+K +N L++     ++K+C FG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 273 TAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
              D+WS G  L  +L+G  P    E   +    I ++L       ++   P+Y      
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV----- 244
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 391
                         + PE   L+SR+    P  R +  E   H +F  L++  A L N  
Sbjct: 245 -------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDN 289
Query: 392 PFPPLFNFKPQELKGASKELLSKLIPE 418
                F+   Q   G S E + ++I E
Sbjct: 290 TMTTQFDESDQ--PGQSIEEIMQIIAE 314

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 152
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            FS  D   LY+  V+E+V      +  H  R   R    + + Y  QI     Y+H  +
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS-L 160
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 271
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-SKGY 215
Query: 272 TTAIDIWSVGCVLAELLLGQPLF 294
             A+D W++G ++ E+  G P F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 142/324 (43%), Gaps = 68/324 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 72
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++      +R      + Y  +I  A
Sbjct: 73  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 122
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 123 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 228
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                             F + + PEA  L++ LL+  P  R       A E   H FF 
Sbjct: 229 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 270
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
            +   +  +   +  PP   FKPQ
Sbjct: 271 SINWQD--VVQKKLLPP---FKPQ 289

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 142/324 (43%), Gaps = 68/324 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                             F + + PEA  L++ LL+  P  R       A E   H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
            +   +  +   +  PP   FKPQ
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 93/357 (26%), Positives = 148/357 (41%), Gaps = 77/357 (21%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKC-LETG--ETVAIKKVLQDKR--YKNRELQTMRLL 141
           P+ +  +  E  +G+G+F  V+ A   L+ G  E +A+K ++          ELQ + + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 142 D-HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
               NV+ +K+CF           + V+  +P   Y   + +      +    V+ Y   
Sbjct: 77  GGQDNVMGVKYCFRKN--------DHVVIAMP---YLEHESFLDILNSLSFQEVREYMLN 125
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----------VLVKGEP- 249
           + +AL  IH   G+ HRD+KP N L N    +  L DFG A+            V+ E  
Sbjct: 126 LFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 250 ------NISYIC-SRY-----------YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ 291
                 N   IC SR            +RAPE++      TTAID+WS G +   LL G+
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244
Query: 292 -PLFPGESGVDQLVEIIKVLGTPTREEIK-----------------------CMNPNYTE 327
            P +     +  L +I+ + G  +RE I+                       C      +
Sbjct: 245 YPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMD 302
Query: 328 FKFPQ----IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
              P+    I+ H  +      +P EA DL+ +LL  +P  R TA EA +HPFF ++
Sbjct: 303 SSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 142/324 (43%), Gaps = 68/324 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                             F + + PEA  L++ LL+  P  R       A E   H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
            +   +  +   +  PP   FKPQ
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 142/324 (43%), Gaps = 68/324 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                             F + + PEA  L++ LL+  P  R       A E   H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
            +   +  +   +  PP   FKPQ
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 142/324 (43%), Gaps = 68/324 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                             F + + PEA  L++ LL+  P  R       A E   H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
            +   +  +   +  PP   FKPQ
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 142/324 (43%), Gaps = 68/324 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 70
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++      +R      + Y  +I  A
Sbjct: 71  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 120
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 121 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 179 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 226
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                             F + + PEA  L++ LL+  P  R       A E   H FF 
Sbjct: 227 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 268
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
            +   +  +   +  PP   FKPQ
Sbjct: 269 SINWQD--VVQKKLLPP---FKPQ 287

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVK--- 68
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 142/324 (43%), Gaps = 68/324 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +LK+ F  T D+    L  V+E+    E  + +++      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 263
           L Y+H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            +    +Y  A+D W +G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                             F + + PEA  L++ LL+  P  R       A E   H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
            +   +  +   +  PP   FKPQ
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           V+G+G FG   +    ETGE + +K+++    + +R   +E++ MR L+HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
                KD+  LN + E++     R          + P      +   I   +AY+H  + 
Sbjct: 73  IGVLYKDK-RLNFITEYIKGGTLRGI--IKSMDSQYPWSQRVSFAKDIASGMAYLH-SMN 128
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV--KGEP-------------NISYICSRY 258
           + HRD+   N LV  + + V + DFG A+++V  K +P               + + + Y
Sbjct: 129 IIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELL 288
           + APE+I G + Y   +D++S G VL E++
Sbjct: 188 WMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 127/300 (42%), Gaps = 49/300 (16%)
Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 140
           K + +Y  +  +G+G+F +V +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           L HPN+V L H          L  +LV   E   + V R  + YS A     +       
Sbjct: 62  LQHPNIVRL-HDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCI------- 111
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICS 256
            QI  ++AY H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +
Sbjct: 112 QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
             Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK        
Sbjct: 171 PGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA------- 221
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                      + +P  +   W  +      PEA  L+  +L  +P  R TA +A   P+
Sbjct: 222 ---------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 50/282 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 265
           HG IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 137/327 (41%), Gaps = 46/327 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 155
           +G G+FG+    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 156 TTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
            T     +L +V+E+    E   R+       + R      + +  Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHA-MQ 135
Query: 214 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
           VCHRD+K +N L++     ++K+C FG +K  V        + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 273 TAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
              D+WS G  L  +L+G  P    E   +    I ++L       ++   P+Y      
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV----- 244
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGR 391
                         + PE   L+SR+    P  R +  E   H +F  L++  A L N  
Sbjct: 245 -------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDN 289
Query: 392 PFPPLFNFKPQELKGASKELLSKLIPE 418
                F+   Q   G S E + ++I E
Sbjct: 290 TMTTQFDESDQ--PGQSIEEIMQIIAE 314

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV--KGEPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 50/282 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 67
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+
Sbjct: 68  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 119
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 265
           HG IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 120 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 216
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 253

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 140
           K + +Y  +  +G+G+F +V +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 60
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           L HPN+V L H          L  +LV   E   + V R  + YS A     +       
Sbjct: 61  LQHPNIVRL-HDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCI------- 110
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICS 256
            QI  ++AY H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +
Sbjct: 111 QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 169
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
             Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK        
Sbjct: 170 PGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA------- 220
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                      + +P  +   W  +      PEA  L+  +L  +P  R TA +A   P+
Sbjct: 221 ---------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 263
Query: 377 F 377
Sbjct: 264 I 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 88  KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 140
           K + +Y  +  +G+G+F +V +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVL--EFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
           L HPN+V L H          L  +LV   E   + V R  + YS A     +       
Sbjct: 62  LQHPNIVRL-HDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCI------- 111
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICS 256
            QI  ++AY H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +
Sbjct: 112 QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
             Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK        
Sbjct: 171 PGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA------- 221
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                      + +P  +   W  +      PEA  L+  +L  +P  R TA +A   P+
Sbjct: 222 ---------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264
Query: 377 F 377
Sbjct: 265 I 265

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +    +    L LV+E++P    R      RA  R+    + LY+ QIC+ + Y+ G
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYL-G 131
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 263
                HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 132 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 187
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +     ++   D+WS G VL EL 
Sbjct: 188 SL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 151
           +G G    V+ A+       VAIK +    R K        RE+     L H N+VS+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
                 ++D+ Y  LV+E++          Y  +   + +     +T QI   + + H  
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGPTL---SEYIESHGPLSVDTAINFTNQILDGIKHAHD- 129
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIFG 267
           + + HRDIKPQN+L++ +   +K+ DFG AK L   E +++     + +  Y +PE   G
Sbjct: 130 MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 268 -ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
            AT+  T  DI+S+G VL E+L+G+P F GE+ V
Sbjct: 187 EATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +    +    L LV+E++P    R      RA  R+    + LY+ QIC+ + Y+ G
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYL-G 132
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 263
                HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 133 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 188
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +     ++   D+WS G VL EL 
Sbjct: 189 SL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 50/282 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 265
           HG IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTY 199
             +PN+V+    +      DEL+  +V+E++   ++  V         ++  +       
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
           +  +AL ++H    V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           + APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 319 KCMNPNYTEF 328
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +    +    L LV+E++P    R      RA  R+    + LY+ QIC+ + Y+ G
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYL-G 144
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 263
                HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 145 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 200
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +     ++   D+WS G VL EL 
Sbjct: 201 SL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 40/305 (13%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           Y  + V+G G+  +V  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY----VKLYTYQICR 203
           S    F     KDEL+L + L     +V  + KH     +    +     +     ++  
Sbjct: 77  SYYTSFVV---KDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG------EPNISYICSR 257
            L Y+H   G  HRD+K  N+L+      V++ DFG +  L  G      +   +++ + 
Sbjct: 133 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            + APE++     Y    DIWS G    EL  G    P        V ++ +   P    
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDP---- 244
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                        P ++     K   K+       ++S  LQ  P  R TA E   H FF
Sbjct: 245 -------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
Query: 378 DELRD 382
            + ++
Sbjct: 292 QKAKN 296

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 137
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 13  RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 69
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKL 196
           +   DHP +V L   ++         L +++EF P   V  +     R     P I V  
Sbjct: 70  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTE-PQIQV-- 121
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYIC 255
              Q+  AL ++H    + HRD+K  N+L+      ++L DFG SAK L   +   S+I 
Sbjct: 122 VCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 256 SRYYRAPELI----FGATEYTTAIDIWSVGCVLAELLLGQP 292
           + Y+ APE++       T Y    DIWS+G  L E+   +P
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 137
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 5   RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 61
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKL 196
           +   DHP +V L   ++         L +++EF P   V  +     R     P I V  
Sbjct: 62  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTE-PQIQV-- 113
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYIC 255
              Q+  AL ++H    + HRD+K  N+L+      ++L DFG SAK L   +   S+I 
Sbjct: 114 VCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIG 171
Query: 256 SRYYRAPELI----FGATEYTTAIDIWSVGCVLAELLLGQP 292
           + Y+ APE++       T Y    DIWS+G  L E+   +P
Sbjct: 172 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 32/223 (14%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKN--RELQTMRLLDHPNVV 147
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +L+          E  L LV+EF     + RV      + +R+P   +  +  QI R + 
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMN 119
Query: 207 YIH--GGIGVCHRDIKPQNLLV-------NPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
           Y+H    + + HRD+K  N+L+       +     +K+ DFG A+   +    +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAY 178
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
            + APE+I  A+ ++   D+WS G +L ELL G+  F G  G+
Sbjct: 179 AWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 99  VGQGSFGIV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 150
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              +     +   L LV+E++P    R      RA  R+    + LY+ QIC+ + Y+ G
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYL-G 128
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 263
                HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 129 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE 184
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +     ++   D+WS G VL EL 
Sbjct: 185 SL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 47/273 (17%)
Query: 116 GETVAIKKVLQDKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEFVPET 174
           G + + ++V + +    +E+  +R +  HPN++ LK  + + T     +  LV + +   
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLM--- 106
Query: 175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTH 231
             +  + +   ++++ L   +  T +I RAL  +   +    + HRD+KP+N+L++   +
Sbjct: 107 --KKGELFDYLTEKVTL--SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN 162
Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE-----YTTAIDIWSVGCVLAE 286
            +KL DFG +  L  GE   S   +  Y APE+I  +       Y   +D+WS G ++  
Sbjct: 163 -IKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 287 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM 346
           LL G P F     +  L  I              M+ NY +F  P+   +          
Sbjct: 222 LLAGSPPFWHRKQMLMLRMI--------------MSGNY-QFGSPEWDDY---------- 256
Query: 347 PPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                DLVSR L   P  R TA EA  HPFF +
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             K      T+     + L++EF+P     + ++  +   ++ L     Y  QIC+ + Y
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSG--SLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPE 263
           + G     HRD+  +N+LV    HQVK+ DFG  K +   +   +    R    ++ APE
Sbjct: 142 L-GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 199
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   +++  A D+WS G  L ELL
Sbjct: 200 CLM-QSKFYIASDVWSFGVTLHELL 223

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTY 199
             +PN+V+    +      DEL+  +V+E++   ++  V         ++  +       
Sbjct: 74  NKNPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
           +  +AL ++H    V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVGTPY 181
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           + APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 319 KCMNPNYTEF 328
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTY 199
             +PN+V+    +      DEL+  +V+E++   ++  V         ++  +       
Sbjct: 75  NKNPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 124
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
           +  +AL ++H    V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 125 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPY 182
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           + APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  
Sbjct: 183 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 240
Query: 319 KCMNPNYTEF 328
           + ++  + +F
Sbjct: 241 EKLSAIFRDF 250

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 136/310 (43%), Gaps = 54/310 (17%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----RELQTM-RLLDHPNVVS 148
           +   ++G+G++  V  A  L+ G+  A+K + +   +      RE++T+ +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVY----RVAKHYS-RASQRMPLIYVKLYTYQICR 203
           L   F     +D+    LV E +         +  KH++ R + R+           +  
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRV--------VRDVAA 122
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDF--GSAKVLVKG-----EPNISYI 254
           AL ++H   G+ HRD+KP+N+L         VK+CDF  GS   L         P ++  
Sbjct: 123 ALDFLHTK-GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP 181
Query: 255 C-SRYYRAPELI----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---QLVEI 306
           C S  Y APE++      AT Y    D+WS+G VL  +L G P F G  G D      E+
Sbjct: 182 CGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEV 241
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
            +V      E I+       +++FP      W  I       EA DL+S+LL      R 
Sbjct: 242 CRVCQNKLFESIQ-----EGKYEFPD---KDWAHI-----SSEAKDLISKLLVRDAKQRL 288
Query: 367 TALEACIHPF 376
           +A +   HP+
Sbjct: 289 SAAQVLQHPW 298

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 97  RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             K      T+     + L++EF+P     + ++  +   ++ L     Y  QIC+ + Y
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSG--SLKEYLPKNKNKINLKQQLKYAVQICKGMDY 129
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPE 263
           + G     HRD+  +N+LV    HQVK+ DFG  K +   +   +    R    ++ APE
Sbjct: 130 L-GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 187
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            +   +++  A D+WS G  L ELL
Sbjct: 188 CLM-QSKFYIASDVWSFGVTLHELL 211

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 121/304 (39%), Gaps = 40/304 (13%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           Y  + V+G G+  +V  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY----VKLYTYQICR 203
           S    F     KDEL+L + L     +V  + KH     +    +     +     ++  
Sbjct: 72  SYYTSFVV---KDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG------EPNISYICSR 257
            L Y+H   G  HRD+K  N+L+      V++ DFG +  L  G      +   +++ + 
Sbjct: 128 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            + APE++     Y    DIWS G    EL  G    P        V ++ +   P    
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDP---- 239
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                        P ++     K   K+       ++S  LQ  P  R TA E   H FF
Sbjct: 240 -------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 286
Query: 378 DELR 381
            + +
Sbjct: 287 QKAK 290

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTY 199
             +PN+V+    +      DEL+  +V+E++   ++  V         ++  +       
Sbjct: 74  NKNPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
           +  +AL ++H    V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPY 181
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           + APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 319 KCMNPNYTEF 328
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 37  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +  K C     D     L LV+E+VP    R   +  R S  + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVPLGSLR--DYLPRHS--IGLAQLLLFAQQICEGMA 148
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYY 259
           Y+H    + HRD+  +N+L++ +   VK+ DFG AK + +G       E   S +   ++
Sbjct: 149 YLHAQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FW 203
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELL 288
            APE +    ++  A D+WS G  L ELL
Sbjct: 204 YAPECL-KEYKFYYASDVWSFGVTLYELL 231

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 128/284 (45%), Gaps = 54/284 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 69
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 263
           HG IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 177
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 217
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 137/329 (41%), Gaps = 50/329 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 155
           +G G+FG+    +  +  E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 156 TTDKDELYLNLVLEFVP--ETVYRV--AKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            T     +L +V+E+    E   R+  A  +S    R        +  Q+   ++Y H  
Sbjct: 87  PT-----HLAIVMEYASGGELFERICNAGRFSEDEAR-------FFFQQLISGVSYAHA- 133
Query: 212 IGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
           + V HRD+K +N L++     ++K+ DFG +K  V      S + +  Y APE++     
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEY 193
Query: 271 YTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
                D+WS G  L  +L+G  P    E   +    I ++L       ++   P+Y    
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN------VQYAIPDYV--- 244
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN 389
                           + PE   L+SR+    P  R +  E   H +F  L++  A L N
Sbjct: 245 ---------------HISPECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMN 287
Query: 390 GRPFPPLFNFKPQELKGASKELLSKLIPE 418
                  F+   Q   G S E + ++I E
Sbjct: 288 DNTMTTQFDESDQ--PGQSIEEIMQIIAE 314

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 48/281 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+    +L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVK--- 69
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 266
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 128/284 (45%), Gaps = 54/284 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 263
           HG IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
           + +G+G+ G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 265
           HG IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 54/304 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F IV + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   F + TD     + L+LE V   E    +A+  S             +  QI   +
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGV 121
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H    + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 122 HYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F GE+  + L  I              +N
Sbjct: 181 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVN 227
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
            ++ E  F                   A D + RLL   P  R T  ++  H +   +R 
Sbjct: 228 YDFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
Query: 383 PNAR 386
            N R
Sbjct: 275 RNVR 278

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTY 199
             +PN+V+    +      DEL+  +V+E++   ++  V         ++  +       
Sbjct: 75  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 124
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
           +  +AL ++H    V HR+IK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 125 ECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 182
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           + APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  +I   GTP  +  
Sbjct: 183 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 240
Query: 319 KCMNPNYTEF 328
           + ++  + +F
Sbjct: 241 EKLSAIFRDF 250

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +  K C     D+ E  L LV+E+VP    R   +  R S  + L  + L+  QIC  +A
Sbjct: 79  IKYKGC---CEDQGEKSLQLVMEYVPLGSLR--DYLPRHS--IGLAQLLLFAQQICEGMA 131
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YY 259
           Y+H    + HR++  +N+L++ +   VK+ DFG AK + +G     Y   R       ++
Sbjct: 132 YLHAQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFW 186
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELL 288
            APE +    ++  A D+WS G  L ELL
Sbjct: 187 YAPECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 47/273 (17%)
Query: 116 GETVAIKKVLQDKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEFVPET 174
           G + + ++V + +    +E+  +R +  HPN++ LK  + + T     +  LV + +   
Sbjct: 42  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLM--- 93
Query: 175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTH 231
             +  + +   ++++ L   +  T +I RAL  +   +    + HRD+KP+N+L++   +
Sbjct: 94  --KKGELFDYLTEKVTL--SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN 149
Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE-----YTTAIDIWSVGCVLAE 286
            +KL DFG +  L  GE       +  Y APE+I  +       Y   +D+WS G ++  
Sbjct: 150 -IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 208
Query: 287 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM 346
           LL G P F     +  L  I              M+ NY +F  P+   +          
Sbjct: 209 LLAGSPPFWHRKQMLMLRMI--------------MSGNY-QFGSPEWDDY---------- 243
Query: 347 PPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                DLVSR L   P  R TA EA  HPFF +
Sbjct: 244 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +  K C     D+ E  L LV+E+VP    R   +  R S  + L  + L+  QIC  +A
Sbjct: 79  IKYKGC---CEDQGEKSLQLVMEYVPLGSLR--DYLPRHS--IGLAQLLLFAQQICEGMA 131
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YY 259
           Y+H    + HR++  +N+L++ +   VK+ DFG AK + +G     Y   R       ++
Sbjct: 132 YLHSQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFW 186
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELL 288
            APE +    ++  A D+WS G  L ELL
Sbjct: 187 YAPECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 47/273 (17%)
Query: 116 GETVAIKKVLQDKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEFVPET 174
           G + + ++V + +    +E+  +R +  HPN++ LK  + + T     +  LV + +   
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLM--- 106
Query: 175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTH 231
             +  + +   ++++ L   +  T +I RAL  +   +    + HRD+KP+N+L++   +
Sbjct: 107 --KKGELFDYLTEKVTL--SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN 162
Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE-----YTTAIDIWSVGCVLAE 286
            +KL DFG +  L  GE       +  Y APE+I  +       Y   +D+WS G ++  
Sbjct: 163 -IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 287 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM 346
           LL G P F     +  L  I              M+ NY +F  P+   +          
Sbjct: 222 LLAGSPPFWHRKQMLMLRMI--------------MSGNY-QFGSPEWDDY---------- 256
Query: 347 PPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                DLVSR L   P  R TA EA  HPFF +
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 46/250 (18%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 150
           V+GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 151 HCFFS--------TTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQI 201
             +          T  K +  L + +E+    T+Y +    +   QR    Y +L+  QI
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QI 125
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI--- 251
             AL+YIH   G+ HRD+KP N+ ++  +  VK+ DFG AK       +L     N+   
Sbjct: 126 LEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 252 -----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
                S I +  Y A E++ G   Y   ID++S+G +  E+     ++P  +G+++ V I
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNI 237
Query: 307 IKVLGTPTRE 316
           +K L + + E
Sbjct: 238 LKKLRSVSIE 247

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 128/284 (45%), Gaps = 54/284 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 263
           HG IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE------------------ 216
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 46/250 (18%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 150
           V+GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 151 HCFFS--------TTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQI 201
             +          T  K +  L + +E+    T+Y +    +   QR    Y +L+  QI
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--YWRLFR-QI 125
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI--- 251
             AL+YIH   G+ HRD+KP N+ ++  +  VK+ DFG AK       +L     N+   
Sbjct: 126 LEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 252 -----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
                S I +  Y A E++ G   Y   ID++S+G +  E+     ++P  +G+++ V I
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNI 237
Query: 307 IKVLGTPTRE 316
           +K L + + E
Sbjct: 238 LKKLRSVSIE 247

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 52/283 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 264
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APEL
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPEL 177
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +     +   +D+WS G VL  +L G+   P +   D   E                   
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------- 216
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
           E VVG+G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG--G 211
            +        + LV+E+          H +         +   +  Q  + +AY+H    
Sbjct: 72  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
             + HRD+KP NLL+      +K+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 181
Query: 272 TTAIDIWSVGCVLAELL 288
           +   D++S G +L E++
Sbjct: 182 SEKCDVFSWGIILWEVI 198

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 52/283 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 151
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            F+    +  +   L LE+    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 264
           G IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APEL
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPEL 177
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +     +   +D+WS G VL  +L G+   P +   D   E                   
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------- 216
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
           E VVG+G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG--G 211
            +        + LV+E+          H +         +   +  Q  + +AY+H    
Sbjct: 71  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
             + HRD+KP NLL+      +K+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 180
Query: 272 TTAIDIWSVGCVLAELL 288
           +   D++S G +L E++
Sbjct: 181 SEKCDVFSWGIILWEVI 197

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 140
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTY 199
           L HPN+V     +    D+    L +V+E+     +  V    ++  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 200 QICRALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 254
           Q+  AL   H    GG  V HRD+KP N+ ++     VKL DFG A++L   E     ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDEDFAKEFV 177
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
            + YY +PE +     Y    DIWS+GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 84/339 (24%), Positives = 144/339 (42%), Gaps = 66/339 (19%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE------LQTMRLLDHPN 145
           +++  R +G G+FG V   + ++  +  A+K V   K+Y          L+ ++  D  N
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 146 VVSLK-HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
              +K H  F   D    ++ L+ E +  ++Y +    +     +  I  KLY  +I +A
Sbjct: 96  NNIVKYHGKFMYYD----HMCLIFEPLGPSLYEIITRNNYNGFHIEDI--KLYCIEILKA 149
Query: 205 LAYIHGGIGVCHRDIKPQNLLVN-PHTHQ-----------------------VKLCDFGS 240
           L Y+   + + H D+KP+N+L++ P+  +                       +KL DFG 
Sbjct: 150 LNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
           A    K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF     +
Sbjct: 209 ATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 301 DQLVEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ-----------IKAHPWH 339
           + L  +  ++           T T    K +N +  +  +P+            K  P +
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINSIKHVKKCLPLY 324
Query: 340 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
           KI    +     D +  +LQ  P LR +  E   H F +
Sbjct: 325 KIIKHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 30/231 (12%)
Query: 85  GQPKQTIS---YMAERVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE---- 134
           G P+  I+    +  R++G+G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 135 -LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY-SRASQRMPLI 192
               M+ LDHP++V L        +++  ++  ++E  P   Y    HY  R    + ++
Sbjct: 75  EAVIMKNLDHPHIVKL----IGIIEEEPTWI--IMELYP---YGELGHYLERNKNSLKVL 125
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
            + LY+ QIC+A+AY+   I   HRDI  +N+LV      VKL DFG ++  ++ E    
Sbjct: 126 TLVLYSLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYK 182
Query: 253 YICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFPGES 298
              +R    + +PE I     +TTA D+W     + E+L    QP F  E+
Sbjct: 183 ASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTYQICRA 204
           V  K C     D+ E  + LV+E+VP    R  + +H    +Q +      L+  QIC  
Sbjct: 73  VKYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 123
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 257
           +AY+H    + HR +  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 124 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 178
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
           ++ APE +    ++  A D+WS G  L ELL
Sbjct: 179 FWYAPECL-KECKFYYASDVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 97  RVVGQGSFGIVFQAKCLE-----TGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 146
           R +G+G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTYQICRA 204
           V  K C     D+ E  + LV+E+VP    R  + +H    +Q +      L+  QIC  
Sbjct: 74  VKYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 124
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 257
           +AY+H    + HR +  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 125 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 179
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
           ++ APE +    ++  A D+WS G  L ELL
Sbjct: 180 FWYAPECL-KECKFYYASDVWSFGVTLYELL 209

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 98/338 (28%), Positives = 136/338 (40%), Gaps = 75/338 (22%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 148
           V+G+G F +V +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 149 LKHCF---------FSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLY 197
           L   +         F   D  +L   +V       VY   VA HY R             
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------------- 139
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---S 252
             QI  AL Y H    + HRD+KP  +L+    ++  VKL  FG A  L  GE  +    
Sbjct: 140 --QILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGG 194
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            + + ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I     
Sbjct: 195 RVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI----- 246
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
             + + K MNP              W  I        A DLV R+L   P  R T  EA 
Sbjct: 247 -IKGKYK-MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEAL 287
Query: 373 IHPFFDELRDPNA---RLPNGRPFPPLFNFKPQELKGA 407
            HP+  E RD  A    LP        FN + ++LKGA
Sbjct: 288 NHPWLKE-RDRYAYKIHLPETVEQLRKFNAR-RKLKGA 323

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 54/304 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F IV + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   F + TD     + L+LE V   E    +A+  S             +  QI   +
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGV 142
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H    + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 143 HYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 201
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F GE+  + L  I              +N
Sbjct: 202 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVN 248
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
            ++ E  F                   A D + RLL   P  R    ++  H +   +R 
Sbjct: 249 YDFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRR 295
Query: 383 PNAR 386
            N R
Sbjct: 296 RNVR 299

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 94  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 148 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 205
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 252
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 253 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     +  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLI--YV 194
           +   DHPN+V L   F+   +     L +++EF     V  V     R     PL    +
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAVMLELER-----PLTESQI 137
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISY 253
           ++   Q   AL Y+H    + HRD+K  N+L       +KL DFG SAK     +   S+
Sbjct: 138 QVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSF 195
Query: 254 ICSRYYRAPELIFGATE----YTTAIDIWSVGCVLAELLLGQP 292
           I + Y+ APE++   T     Y    D+WS+G  L E+   +P
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 80  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 134 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 191
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 238
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 239 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 86  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 140 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 197
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 198 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 244
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 245 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 98/338 (28%), Positives = 136/338 (40%), Gaps = 75/338 (22%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 148
           V+G+G F +V +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 149 LKHCF---------FSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLY 197
           L   +         F   D  +L   +V       VY   VA HY R             
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------------- 137
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---S 252
             QI  AL Y H    + HRD+KP  +L+    ++  VKL  FG A  L  GE  +    
Sbjct: 138 --QILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGG 192
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            + + ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I     
Sbjct: 193 RVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI----- 244
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
             + + K MNP              W  I        A DLV R+L   P  R T  EA 
Sbjct: 245 -IKGKYK-MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEAL 285
Query: 373 IHPFFDELRDPNA---RLPNGRPFPPLFNFKPQELKGA 407
            HP+  E RD  A    LP        FN + ++LKGA
Sbjct: 286 NHPWLKE-RDRYAYKIHLPETVEQLRKFNAR-RKLKGA 321

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 85  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 139 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 196
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 197 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 243
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 244 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 124 Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 178 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 282
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 283 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 97  RVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 148
           R++G+G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRALAY 207
           L        +++  ++  ++E  P   Y    HY  R    + ++ + LY+ QIC+A+AY
Sbjct: 78  L----IGIIEEEPTWI--IMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 264
           +   I   HRDI  +N+LV      VKL DFG ++  ++ E       +R    + +PE 
Sbjct: 129 LE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 185
Query: 265 IFGATEYTTAIDIWSVGCVLAELLL--GQPLFPGES 298
           I     +TTA D+W     + E+L    QP F  E+
Sbjct: 186 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 97  RVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 148
           R++G+G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRALAY 207
           L        +++  ++  ++E  P   Y    HY  R    + ++ + LY+ QIC+A+AY
Sbjct: 74  L----IGIIEEEPTWI--IMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 264
           +   I   HRDI  +N+LV      VKL DFG ++  ++ E       +R    + +PE 
Sbjct: 125 LE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 181
Query: 265 IFGATEYTTAIDIWSVGCVLAELLL--GQPLFPGES 298
           I     +TTA D+W     + E+L    QP F  E+
Sbjct: 182 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 84  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 138 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 195
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 196 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 242
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 243 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     +  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLI--YV 194
           +   DHPN+V L   F+   +     L +++EF     V  V     R     PL    +
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAVMLELER-----PLTESQI 137
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISY 253
           ++   Q   AL Y+H    + HRD+K  N+L       +KL DFG SAK     +   S+
Sbjct: 138 QVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSF 195
Query: 254 ICSRYYRAPELIFGATE----YTTAIDIWSVGCVLAELLLGQP 292
           I + Y+ APE++   T     Y    D+WS+G  L E+   +P
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 130 Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 184 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 241
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 242 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 288
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 289 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 140
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTY 199
           L HPN+V     +    D+    L +V+E+     +  V    ++  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 200 QICRALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 254
           Q+  AL   H    GG  V HRD+KP N+ ++     VKL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
            + YY +PE +     Y    DIWS+GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 80  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 134 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 191
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 238
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 239 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 85/325 (26%), Positives = 135/325 (41%), Gaps = 63/325 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 149
           +V+G+G+F  V   K  +TG+  A+K + +    K  E+   R     L+  D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              F     +DE YL LV+E+       +    S+  +R+P    + Y  +I  A+  +H
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGG--DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFG 267
             +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++  
Sbjct: 180 R-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 268 ATEYTTAI------DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
                         D W++G    E+  GQ  F  +S  +   +I+              
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-------------- 283
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFF- 377
                       K H    +  + +P EA D + RLL   P  R     A +   HPFF 
Sbjct: 284 ----------HYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFF 332
Query: 378 ----DELRDPNARLPNGRPFPPLFN 398
               D LRD    +P   PF P F 
Sbjct: 333 GLDWDGLRD---SVP---PFTPDFE 351

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 79  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 133 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 190
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 191 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 237
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 238 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 78  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 132 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 189
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 236
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 237 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 140
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTY 199
           L HPN+V     +    D+    L +V+E+     +  V    ++  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 200 QICRALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 254
           Q+  AL   H    GG  V HRD+KP N+ ++     VKL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFV 177
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
            + YY +PE +     Y    DIWS+GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 150
           V+G+GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           H  F T D+    L  V+E+V   + +Y + +       R    +   Y  +I   L ++
Sbjct: 87  HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 137
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 267
               G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 138 QSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 194
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
              Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 233

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 120/291 (41%), Gaps = 37/291 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 78  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK             + YY APE + 
Sbjct: 132 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-VL 189
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 236
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 237 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           Y++Q+ R + ++     + HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLSSRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 257 RY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 312
           R    + APE IF    Y+T  D+WS G +L E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
             RE ++   P Y+  +  QI    WH+   +R  P   +LV +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 150
           V+G+GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           H  F T D+    L  V+E+V   + +Y + +       R    +   Y  +I   L ++
Sbjct: 408 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 458
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 267
               G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 459 QSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 515
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
              Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 133/302 (44%), Gaps = 47/302 (15%)
Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVS 148
           IS+  + V+G G+ G +      +  + VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
                +  T+KD  +  + +E    T+    +    A   +  I +     Q    LA++
Sbjct: 83  -----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL---LQQTTSGLAHL 134
Query: 209 HGGIGVCHRDIKPQNLLVN-PHTH---QVKLCDFGSAKVLVKGEPNISYIC----SRYYR 260
           H  + + HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  + 
Sbjct: 135 HS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 261 APELIFGATEY--TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           APE++    +   T  +DI+S GCV    ++ +   P    + +   I+  LG  +   +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS---L 247
Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
            C++P   E                      A +L+ +++   P  R +A     HPFF 
Sbjct: 248 DCLHPEKHEDVI-------------------ARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
Query: 379 EL 380
            L
Sbjct: 289 SL 290

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 28/223 (12%)
Query: 83  RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQT 137
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +  E     +  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLI--YV 194
           +   DHPN+V L   F+   +     L +++EF     V  V     R     PL    +
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAVMLELER-----PLTESQI 137
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISY 253
           ++   Q   AL Y+H    + HRD+K  N+L       +KL DFG SAK     +    +
Sbjct: 138 QVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXF 195
Query: 254 ICSRYYRAPELIFGATE----YTTAIDIWSVGCVLAELLLGQP 292
           I + Y+ APE++   T     Y    D+WS+G  L E+   +P
Sbjct: 196 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 117/293 (39%), Gaps = 37/293 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K  LQD     RE++   R    P++V +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 124 Y------ENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 178 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D WS+G +   LL G P F    G      +    G  TR     +     
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR-----IRXGQY 284
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           EF  P+     W ++       E   L+  LL+  P  R T  E   HP+  +
Sbjct: 285 EFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPWIXQ 327

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/329 (23%), Positives = 126/329 (38%), Gaps = 71/329 (21%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-------- 133
           G +G   Q   Y  +  +G+GS+G+V  A   E   T    KVL  K+   +        
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 134 -----------------------ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170
                                  E+  ++ LDHPNVV L        D +E +L +V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFEL 119
Query: 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT 230
           V +            S+       + Y   + + + Y+H    + HRDIKP NLLV    
Sbjct: 120 VNQGPVMEVPTLKPLSEDQ----ARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDG 174
Query: 231 HQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTT--AIDIWSVGCVLAEL 287
           H +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W++G  L   
Sbjct: 175 H-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP 347
           + GQ  F                     E I C++         +IK+          + 
Sbjct: 234 VFGQCPF-------------------MDERIMCLH--------SKIKSQALEFPDQPDIA 266
Query: 348 PEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            +  DL++R+L  +P  R    E  +HP+
Sbjct: 267 EDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK-NRELQTMRLLDHPNVVSLKHCFF 154
           +VG G++G V++ + ++TG+  AIK   V  D+  +  +E+  ++   H   ++  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 155 STTD----KDELYLNLVLEFV-PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              +     D+L+  LV+EF    +V  + K+    + +    ++     +I R L+++H
Sbjct: 91  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEE--WIAYICREILRGLSHLH 146
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 266
               V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 147 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 203
Query: 267 ----GATEYTTAIDIWSVGCVLAELLLGQP 292
                AT Y    D+WS+G    E+  G P
Sbjct: 204 DENPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 147
           ++   ++GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
            L      TT + ++   L++EF P  ++Y V +  S A   +P     +    +   + 
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMN 126
Query: 207 YIHGGIGVCHRDIKPQNLL--VNPHTHQV-KLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           ++    G+ HR+IKP N++  +      V KL DFG+A+ L   E  +S   +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 264 LIFGAT-------EYTTAIDIWSVGCVLAELLLGQ-PLFPGE 297
           +   A        +Y   +D+WS+G        G  P  P E
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 88/368 (23%), Positives = 141/368 (38%), Gaps = 92/368 (25%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHP 144
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 145 N---VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTY 199
           N   VV L   F   +  +  ++ +V E +   + +  +  +Y    Q +PL  VK    
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSNY----QGLPLPCVKKIIQ 153
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLV--------------------------------- 226
           Q+ + L Y+H    + H DIKP+N+L+                                 
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 227 ---------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
                          N    +VK+ D G+A  + K       I +R YR+ E++ G+  Y
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-Y 270
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNY 325
            T  DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I  +   Y
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKY 328
Query: 326 TEFKFPQ-------IKAHPWHKI--------FHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
           ++  F +        K  PW           + +       D +  +L+  P  R TA E
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 371 ACIHPFFD 378
              HP+ +
Sbjct: 389 CLRHPWLN 396

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 88/368 (23%), Positives = 141/368 (38%), Gaps = 92/368 (25%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHP 144
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 145 N---VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTY 199
           N   VV L   F   +  +  ++ +V E +   + +  +  +Y    Q +PL  VK    
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSNY----QGLPLPCVKKIIQ 137
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLV--------------------------------- 226
           Q+ + L Y+H    + H DIKP+N+L+                                 
Sbjct: 138 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 197
Query: 227 ---------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
                          N    +VK+ D G+A  + K       I +R YR+ E++ G+  Y
Sbjct: 198 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-Y 254
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNY 325
            T  DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I  +   Y
Sbjct: 255 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKY 312
Query: 326 TEFKFPQ-------IKAHPWHKI--------FHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
           ++  F +        K  PW           + +       D +  +L+  P  R TA E
Sbjct: 313 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 372
Query: 371 ACIHPFFD 378
              HP+ +
Sbjct: 373 CLRHPWLN 380

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
              T      L +++E++               +  PL   ++ T   +I + L Y+H  
Sbjct: 75  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 270
             + HRDIK  N+L++ H  +VKL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 180
Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
           Y +  DIWS+G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 90/366 (24%), Positives = 142/366 (38%), Gaps = 90/366 (24%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHP 144
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++LL          P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 145 N---VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTY 199
           N   VV L    F  +  + +++ +V E +   + +  +  +Y    Q +P+  VK    
Sbjct: 93  NKDMVVQLID-DFKISGMNGIHVCMVFEVLGHHLLKWIIKSNY----QGLPVRCVKSIIR 147
Query: 200 QICRALAYIHGGIGVCHRDIKPQN------------------------------------ 223
           Q+ + L Y+H    + H DIKP+N                                    
Sbjct: 148 QVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTA 207
Query: 224 ----LLVNP------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 273
               LLVNP         +VK+ D G+A  + K       I +R YR+ E++ GA  Y+T
Sbjct: 208 PAADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYRSIEVLIGAG-YST 264
Query: 274 AIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNYTE 327
             DIWS  C+  EL  G  LF   SG       D +  II++LG+  R     ++  Y+ 
Sbjct: 265 PADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRH--FALSGKYSR 322
Query: 328 FKFPQ-------IKAHPW---HKIFHKRMPP-----EAVDLVSRLLQYSPNLRCTALEAC 372
             F +        K  PW     +  K   P     +  D +  +L+  P  R +A E  
Sbjct: 323 EFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECL 382
Query: 373 IHPFFD 378
            HP+ +
Sbjct: 383 RHPWLN 388

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 232
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 233 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
              T      L +++E++               +  PL   ++ T   +I + L Y+H  
Sbjct: 95  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 143
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 270
             + HRDIK  N+L++ H  +VKL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 144 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 200
Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
           Y +  DIWS+G    EL  G+P
Sbjct: 201 YDSKADIWSLGITAIELARGEP 222

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 232
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 233 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F IV + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   F + TD     + L+LE V   E    +A+  S             +  QI   +
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGV 128
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H    + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 129 HYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 187
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
           E++          D+WS+G +   LL G   F GE+  + L  I  V
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 147
           ++   ++GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
            L      TT + ++   L++EF P  ++Y V +  S A   +P     +    +   + 
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMN 126
Query: 207 YIHGGIGVCHRDIKPQNLL--VNPHTHQV-KLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
           ++    G+ HR+IKP N++  +      V KL DFG+A+ L   E  +    +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 264 LIFGAT-------EYTTAIDIWSVGCVLAELLLGQ-PLFPGES 298
           +   A        +Y   +D+WS+G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
              T      L +++E++               +  PL   ++ T   +I + L Y+H  
Sbjct: 90  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 270
             + HRDIK  N+L++ H  +VKL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 195
Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
           Y +  DIWS+G    EL  G+P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
              T      L +++E++               +  PL   ++ T   +I + L Y+H  
Sbjct: 75  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 270
             + HRDIK  N+L++ H  +VKL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 180
Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
           Y +  DIWS+G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 46/250 (18%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 150
           V+GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLNHQYVVRYY 68
Query: 151 HCFFS--------TTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQI 201
             +          T  K +  L +  E+    T+Y +    +   QR    Y +L+  QI
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QI 125
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI--- 251
             AL+YIH   G+ HR++KP N+ ++  +  VK+ DFG AK       +L     N+   
Sbjct: 126 LEALSYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 252 -----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
                S I +  Y A E++ G   Y   ID +S+G +  E      ++P  +G ++ V I
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNI 237
Query: 307 IKVLGTPTRE 316
           +K L + + E
Sbjct: 238 LKKLRSVSIE 247

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+LE V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 56/275 (20%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 148 SL---------------KHCFFSTTDKDELYL----NLVLEFVPETVYRVAKHYSRASQR 188
           +L               + C F        YL    N  + + PE +Y+           
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKPEDLYK---------DF 144
Query: 189 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           + L ++  Y++Q+ + + ++     + HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 249 PNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/318 (23%), Positives = 126/318 (39%), Gaps = 51/318 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 148
           +G G F IV + +   TG   A K  K  Q +  +         RE+  +R + HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   + + TD     + L+LE V    ++         S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 208 IHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           +H    + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +          D+WS+G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
                     ++ + + F  +    A D + +LL      R T  EA  HP+   + D  
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV-DTQ 282
Query: 385 ARLPNGRPFPPLFNFKPQ 402
             +        L NFK Q
Sbjct: 283 QAMVRRESVVNLENFKKQ 300

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV---KLCDFG-SAKVLVKGE------PN 250
           +  AL ++H   G+ HRD+KP+N+L   H +QV   K+CDFG  + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 251 ISYIC-SRYYRAPELIFGATE----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
           +   C S  Y APE++   +E    Y    D+WS+G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 365
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 366 CTALEACIHPF 376
            +A +   HP+
Sbjct: 288 LSAAQVLQHPW 298

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG- 210
            F         L++V E++   ++YR+  H S A +++         Y + + + Y+H  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPEL 264
              + HRD+K  NLLV+   + VK+CDFG +++         ++ S+       + APE+
Sbjct: 157 NPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEV 210
Query: 265 IFGATEYTTAIDIWSVGCVLAEL-LLGQP 292
           +        + D++S G +L EL  L QP
Sbjct: 211 LRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTM-RLLDHPNVVSLKH 151
           +G GS+G VF+ +  E G   A+K+ +      +D+  K  E+ +  ++  HP  V L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            +    +   LYL   L         + +H       +P   V  Y      ALA++H  
Sbjct: 125 AW---EEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH-S 175
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFG--------SAKVLVKGEPNISYICSRYYRAPE 263
            G+ H D+KP N+ + P   + KL DFG         A  + +G+P         Y APE
Sbjct: 176 QGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPE 226
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL 303
           L+ G+  Y TA D++S+G  + E+     L  G  G  QL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 115/255 (45%), Gaps = 42/255 (16%)
Query: 157 TDKDELYL-------NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           T+ DE+Y+       + +L+F  E  + + K+Y+     +P+  +K     +  + +YIH
Sbjct: 113 TNYDEVYIIYEYMENDSILKF-DEYFFVLDKNYTCF---IPIQVIKCIIKSVLNSFSYIH 168
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
               +CHRD+KP N+L++ +  +VKL DFG ++ +V  +   S   +  +  PE     +
Sbjct: 169 NEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNES 226
Query: 270 EYTTA-IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
            Y  A +DIWS+G  L  +      F  +     LVE+   + T   E            
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELFNNIRTKNIE------------ 271
Query: 329 KFPQIKAHPWHKIFHKR-------MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF---- 377
            +P  + H  + + +K+       +  E +D +   L+ +P  R T+ +A  H +     
Sbjct: 272 -YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330
Query: 378 -DELRDPNARLPNGR 391
            ++LR+ +  L   R
Sbjct: 331 IEDLREFSKELYKKR 345

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L         ++ ++  +++E       R      + S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 263
                V HRDI  +N+LV+  T  VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL 289
            I     +T+A D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 152
           +V+G+G+FG V   K     +  A+K + + +  K  E    R    +L + +   +   
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            ++  D + LYL +      + +  ++K   R  + M     + Y  ++  A+  +H  +
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM----ARFYLAEMVIAIDSVHQ-L 194
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 266
              HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
           G   Y    D WS+G  + E+L G+  F  ES V+   +I+ 
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 39/230 (16%)
Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMR 139
           G+  Q  S M+   +G G+FG V+ A   E  + V +K     KVL+D   ++ +L  + 
Sbjct: 20  GEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 140 L-------LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS-----Q 187
           L       ++H N++ +   F     +++ +  LV+E          KH S         
Sbjct: 78  LEIAILSRVEHANIIKVLDIF-----ENQGFFQLVME----------KHGSGLDLFAFID 122
Query: 188 RMPLIYVKLYTY---QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
           R P +   L +Y   Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVI-AEDFTIKLIDFGSAAYL 180
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            +G+   ++  +  Y APE++ G       +++WS+G  L  L+  +  F
Sbjct: 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L         ++ ++  +++E       R      + S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 263
                V HRDI  +N+LV+  T  VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL 289
            I     +T+A D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG- 210
            F         L++V E++   ++YR+  H S A +++         Y + + + Y+H  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPEL 264
              + HR++K  NLLV+   + VK+CDFG +++        +++ S+       + APE+
Sbjct: 157 NPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWMAPEV 210
Query: 265 IFGATEYTTAIDIWSVGCVLAEL-LLGQP 292
           +        + D++S G +L EL  L QP
Sbjct: 211 LRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 135/303 (44%), Gaps = 44/303 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 156
           +V+G+G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 157 T----DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                 +DE +L LV+++       +    S+   ++P    + Y  ++  A+  IH  +
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGG--DLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 210
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 266
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 211 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y    D WS+G  + E+L G+  F  ES V+   +I+                N+ 
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 313
Query: 327 E-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL-QYSPNLRCTALEAC-IHPFFDELRDP 383
           E F+FP   +H         +  EA DL+ RL+      L    +E    H FF+ L   
Sbjct: 314 ERFQFP---SHV------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWE 364
Query: 384 NAR 386
           N R
Sbjct: 365 NIR 367

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 148 SL---------------KHCFFSTTDKDELYLNLVL-EFVPETVYRVAKHYSRASQRMPL 191
           +L               + C F        YL     EFVP   Y+VA         + L
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVP---YKVAPE-DLYKDFLTL 147
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 148 EHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXV 205
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 307
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I 
Sbjct: 206 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 257
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +      +E  +   P+YT  +  Q     WH
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 139/315 (44%), Gaps = 68/315 (21%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 149
           +G+G FG+VF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 150 KHCFF--STTDK-----DELYLNLVLEFV-PETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
            + +   +TT+K      ++YL + ++    E +           +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF-LQI 127
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNISY- 253
             A+ ++H   G+ HRD+KP N+        VK+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 254 -----ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
                + ++ Y +PE I G + Y+  +DI+S+G +L EL     L+P  + ++++  +  
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTD 239
Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
           V                   KFP         +F ++ P E V +V  +L  SP  R  A
Sbjct: 240 V----------------RNLKFP--------PLFTQKYPCEYV-MVQDMLSPSPMERPEA 274
Query: 369 LEACIHPFFDELRDP 383
           +    +  F++L  P
Sbjct: 275 INIIENAVFEDLDFP 289

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 35/279 (12%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK--------NRELQTMRLLDHP 144
           Y+   ++G+GS+G V +    ET    A+K + + K  +         +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           NV+ L    ++  +K ++Y+  V+E+    +  +    S   +R P+     Y  Q+   
Sbjct: 67  NVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLD--SVPEKRFPVCQAHGYFCQLIDG 121
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRA 261
           L Y+H   G+ H+DIKP NLL+      +K+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 262 PELIFGATEYTT-AIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV--------LGT 312
           PE+  G   ++   +DIWS G  L  +  G   F G++ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 313 PTREEIKCM---NPNYTEFKFPQIKAHPWHKIFHKRMPP 348
           P  + +K M    P    F   QI+ H W   F K+ PP
Sbjct: 239 PLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPP 273

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 148 SL---------------KHCFFSTTDKDELYLNLVL-EFVPETVYRVAKHYSRASQRMPL 191
           +L               + C F        YL     EFVP   Y+VA         + L
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVP---YKVAPE-DLYKDFLTL 138
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 139 EHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXV 196
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 307
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I 
Sbjct: 197 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 248
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +      +E  +   P+YT  +  Q     WH
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L         ++ +++ + L  + E   +   + YS     + L  + LY YQ+  ALAY
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 126
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +     V HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 127 LESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 181
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL 289
           E I     +T+A D+W  G  + E+L+
Sbjct: 182 ESI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/325 (23%), Positives = 130/325 (40%), Gaps = 51/325 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 148
           +G G F IV + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   + + TD     + L+LE V    ++         S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 208 IHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           +H    + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +          D+WS+G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
                     ++ + + F  +    A D + +LL      R T  EA  HP+   + +  
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283
Query: 385 ARLPNGRPFPPLFNFKPQELKGASK 409
           A +        L NF+ Q ++  SK
Sbjct: 284 A-MVRRESVVNLENFRKQYVRRRSK 307

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 156
           +V+G+G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 157 T----DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                 +DE +L LV+++       +    S+   ++P    + Y  ++  A+  IH  +
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGG--DLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 194
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 266
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
           G  +Y    D WS+G  + E+L G+  F  ES V+   +I+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 148 SL---------------KHCFFSTTDKDELYLNLVL-EFVPETVYRVAKHYSRASQRMPL 191
           +L               + C F        YL     EFVP   Y+VA         + L
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVP---YKVAPE-DLYKDFLTL 138
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 139 EHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXV 196
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 307
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I 
Sbjct: 197 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 248
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +      +E  +   P+YT  +  Q     WH
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L         ++ +++ + L  + E   +   + YS     + L  + LY YQ+  ALAY
Sbjct: 79  L----IGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 129
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +     V HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 130 LESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 184
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL 289
           E I     +T+A D+W  G  + E+L+
Sbjct: 185 ESI-NFRRFTSASDVWMFGVCMWEILM 210

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 148 SL---------------KHCFFSTTDKDELYLNLVL-EFVPETVYRVAKHYSRASQRMPL 191
           +L               + C F        YL     EFVP   Y+VA         + L
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVP---YKVAPE-DLYKDFLTL 147
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 148 EHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDXV 205
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 307
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I 
Sbjct: 206 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 257
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +      +E  +   P+YT  +  Q     WH
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTM 138
           P + +   ++RV+G+G FG+V+  + ++  +     AIK +     +Q      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-Y 197
           R L+HPNV++L            + L       P   +     + R+ QR P +   + +
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             Q+ R + Y+       HRD+  +N +++  +  VK+ DFG A+ ++  E   S    R
Sbjct: 130 GLQVARGMEYL-AEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHR 186
Query: 258 YYRAPELIFGATE------YTTAIDIWSVGCVLAELL 288
           + R P + + A E      +TT  D+WS G +L ELL
Sbjct: 187 HARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L         ++ +++ + L  + E   +   + YS     + L  + LY YQ+  ALAY
Sbjct: 78  L----IGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 128
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +     V HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 129 LESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 183
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL 289
           E I     +T+A D+W  G  + E+L+
Sbjct: 184 ESI-NFRRFTSASDVWMFGVCMWEILM 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L         ++ +++ + L  + E   +   + YS     + L  + LY YQ+  ALAY
Sbjct: 73  L----IGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 123
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +     V HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 124 LESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 178
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL 289
           E I     +T+A D+W  G  + E+L+
Sbjct: 179 ESI-NFRRFTSASDVWMFGVCMWEILM 204

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L         ++ +++ + L  + E   +   + YS     + L  + LY YQ+  ALAY
Sbjct: 104 L----IGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 154
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +     V HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 155 LESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 209
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL 289
           E I     +T+A D+W  G  + E+L+
Sbjct: 210 ESI-NFRRFTSASDVWMFGVCMWEILM 235

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L         ++ +++ + L  + E   +   + YS     + L  + LY YQ+  ALAY
Sbjct: 81  L----IGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 131
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +     V HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 132 LESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL 289
           E I     +T+A D+W  G  + E+L+
Sbjct: 187 ESI-NFRRFTSASDVWMFGVCMWEILM 212

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/325 (23%), Positives = 129/325 (39%), Gaps = 51/325 (15%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 148
           +G G F IV + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   + + TD     + L+LE V    ++         S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 208 IHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           +H    + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +          D+WS+G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
                     ++ + + F       A D + +LL      R T  EA  HP+   + +  
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283
Query: 385 ARLPNGRPFPPLFNFKPQELKGASK 409
           A +        L NF+ Q ++  SK
Sbjct: 284 A-MVRRESVVNLENFRKQYVRRRSK 307

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 41/268 (15%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMP---------LIYVK 195
           +L         K    L +++EF      + Y  +K       + P         L ++ 
Sbjct: 96  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
            Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +    
Sbjct: 152 CYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 256 SRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 311
           +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +   
Sbjct: 210 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 261
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWH 339
              +E  +   P+YT  +  Q     WH
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L         ++ +++ + L  + E   +   + YS     + L  + LY YQ+  ALAY
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 126
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +     V HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 127 LESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 181
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL 289
           E I     +T+A D+W  G  + E+L+
Sbjct: 182 ESI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 148 SL---------------KHCFFSTTDKDELYLNLVL-EFVPETVYRVAKHYSRASQRMPL 191
           +L               + C F        YL     EFVP   Y+VA         + L
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVP---YKVAPE-DLYKDFLTL 147
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 148 EHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYV 205
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 307
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I 
Sbjct: 206 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 257
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +      +E  +   P+YT  +  Q     WH
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 42/269 (15%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKH----YSRASQRMPLIYVKL--- 196
           +L         K    L +++EF       T  R  ++    Y  A + +   ++ L   
Sbjct: 97  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 197 --YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
             Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +   
Sbjct: 153 ICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 255 CSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 310
            +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +  
Sbjct: 211 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEF 262
Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
               +E  +   P+YT  +  Q     WH
Sbjct: 263 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 127/293 (43%), Gaps = 38/293 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           ++++V+G G  G V +     TG+  A+K +    + +       +    P++V +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYIH 209
            +        L +++E +        + +SR  +R    + +    +I R    A+ ++H
Sbjct: 73  ENMHHGKRCLL-IIMECM-----EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
               + HRD+KP+NLL         +KL DFG AK   +    +   C + YY APE + 
Sbjct: 127 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VL 182
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F   +G        + +    +  I+       
Sbjct: 183 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----G 229
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           ++ FP  +   W ++       +A  L+  LL+  P  R T  +   HP+ ++
Sbjct: 230 QYGFPNPE---WSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 127/293 (43%), Gaps = 38/293 (12%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           ++++V+G G  G V +     TG+  A+K +    + +       +    P++V +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYIH 209
            +        L +++E +        + +SR  +R    + +    +I R    A+ ++H
Sbjct: 92  ENMHHGKRCLL-IIMECM-----EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
               + HRD+KP+NLL         +KL DFG AK   +    +   C + YY APE + 
Sbjct: 146 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VL 201
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           G  +Y  + D+WS+G ++  LL G P F   +G        + +    +  I+       
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----G 248
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           ++ FP  +   W ++       +A  L+  LL+  P  R T  +   HP+ ++
Sbjct: 249 QYGFPNPE---WSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 148 SL---------------KHCFFSTTDKDELYLNLVL-EFVPETVYRVAKHYSRASQRMPL 191
           +L               + C F        YL     EFVP   Y+VA         + L
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVP---YKVAPE-DLYKDFLTL 138
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 139 EHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYV 196
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 307
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I 
Sbjct: 197 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 248
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +      +E  +   P+YT  +  Q     WH
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 54/294 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 147
           +G G F +V + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L   + + TD     + L+ E V   E    +A+  S   +         +  QI   +
Sbjct: 78  TLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++          D+WS+G +   LL G   F G++  + L  +              +N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVN 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
             + +  F    A              A D + RLL   P  R T  ++  HP+
Sbjct: 234 YEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 148 SL---------------KHCFFSTTDKDELYLNLVL-EFVPETVYRVAKHYSRASQRMPL 191
           +L               + C F        YL     EFVP   Y+VA         + L
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVP---YKVAPE-DLYKDFLTL 184
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 185 EHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYV 242
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 307
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I 
Sbjct: 243 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 294
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +      +E  +   P+YT  +  Q     WH
Sbjct: 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L         ++ ++  +++E       R      + S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 263
                V HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLL 289
            I     +T+A D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 148 SL---------------KHCFFSTTDKDELYLNLVL-EFVPETVYRVAKHYSRASQRMPL 191
           +L               + C F        YL     EFVP   Y+VA         + L
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVP---YKVAPE-DLYKDFLTL 138
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
            ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 139 EHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYV 196
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEII 307
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I 
Sbjct: 197 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 248
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +      +E  +   P+YT  +  Q     WH
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 144
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 145 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 202
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE 262
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 144
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 145 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 202
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE 262
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 145
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 146 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 203
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE 263
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 132
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 133 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 190
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 250
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 251 CQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 145
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 146 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 203
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSE 263
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 94  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 151
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 152 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 209
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 269
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 270 CQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 159
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 160 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 217
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 277
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 278 CQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 131
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 132 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 189
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 249
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 250 CQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 144
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 145 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 202
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + + 
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE 262
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV---KLCDFG-SAKVLVKGE------PN 250
           +  AL ++H   G+ HRD+KP+N+L   H +QV   K+CDF   + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 251 ISYIC-SRYYRAPELIFGATE----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
           +   C S  Y APE++   +E    Y    D+WS+G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 365
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 366 CTALEACIHPF 376
            +A +   HP+
Sbjct: 288 LSAAQVLQHPW 298

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 38/265 (14%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-----MRLLDHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L +     + +  H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAK-----HYSRASQRMPLIYVKLYT 198
           +L         K    L +++EF       T  R  +     +       + L ++  Y+
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 258
           +Q+ + + ++     + HRD+  +N+L++   + VK+CDFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 259 ---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 314
              + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRL 260
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWH 339
           +E  +   P+YT  +  Q     WH
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWH 285

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 114/256 (44%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E +  V   +   ++R  L     + + +Q+  A+
Sbjct: 70  SGFSGVIRLLDWFERPDSFVL--ILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 128 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 185
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + + +  +  I+ C+  
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 245
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 246 RPSDRPTFEEIQNHPW 261

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 87  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 144
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 145 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 202
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +   
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXE 262
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 145
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 146 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 203
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +   
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXE 263
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 88  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 145
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 146 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 203
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +   
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXE 263
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 74  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 131
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 132 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 189
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +   
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE 249
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 250 CQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 132
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 133 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 190
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +   
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE 250
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 251 CQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 148
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L         ++ ++  +++E       R      + S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL--------VKGEPNISYICSRYYR 260
                V HRDI  +N+LV+ +   VKL DFG ++ +         KG+  I ++      
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWM------ 179
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLL 289
           APE I     +T+A D+W  G  + E+L+
Sbjct: 180 APESI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 102 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 159
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 160 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 217
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +   
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE 277
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 278 CQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 15/267 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 107 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 164
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 165 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 222
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 313
            +R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + +   
Sbjct: 223 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXE 282
Query: 314 TREEIK-CMNPNYTEF-KFPQIKAHPW 338
            +  I+ C+    ++   F +I+ HPW
Sbjct: 283 CQHLIRWCLALRPSDRPTFEEIQNHPW 309

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 82  GRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---- 137
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL      
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 138 -MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YV 194
            M ++    V S         D  E   + VL  + E    V   +   ++R  L     
Sbjct: 75  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELA 132
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      + 
Sbjct: 133 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD 190
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ 291
            +R Y  PE I     +  +  +WS+G +L +++ G 
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 126/318 (39%), Gaps = 51/318 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 148
           +G G F IV + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   + + TD     + L+LE V    ++         S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 208 IHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           +H    + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +          D+WS+G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
                     ++ + + F  +    A D + +LL      R T  EA  HP+   + +  
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283
Query: 385 ARLPNGRPFPPLFNFKPQ 402
           A +        L NF+ Q
Sbjct: 284 A-MVRRESVVNLENFRKQ 300

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 71  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 129 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 186
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + + +  +  I+ C+  
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 246
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 247 RPSDRPTFEEIQNHPW 262

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 116/292 (39%), Gaps = 50/292 (17%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 148
           +G G F IV + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   + + TD     + L+LE V    ++         S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 208 IHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           +H    + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +          D+WS+G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                     ++ + + F       A D + +LL      R T  EA  HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 125/318 (39%), Gaps = 51/318 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 148
           +G G F IV + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L   + + TD     + L+LE V    ++         S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 208 IHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           +H    + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +          D+WS+G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
                     ++ + + F       A D + +LL      R T  EA  HP+   + +  
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283
Query: 385 ARLPNGRPFPPLFNFKPQ 402
           A +        L NF+ Q
Sbjct: 284 A-MVRRESVVNLENFRKQ 300

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           +G+GSFG V++     T E VAIK +       +     +E+  +   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL--IYVKLYTYQICRALAYIHGG 211
             +T      L +++E++               +  PL   Y+     +I + L Y+H  
Sbjct: 87  LKSTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 270
             + HRDIK  N+L++     VKL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 136 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 192
Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
           Y    DIWS+G    EL  G+P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 37/220 (16%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD---------- 142
           Y    ++G+G FG VF    L     VAIK +      +NR L    L D          
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 143 ---------HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY 193
                    HP V+ L   +F T +   L L        E        +   +++ PL  
Sbjct: 88  LWKVGAGGGHPGVIRLLD-WFETQEGFMLVL--------ERPLPAQDLFDYITEKGPLGE 138
Query: 194 --VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
              + +  Q+  A+ + H   GV HRDIK +N+L++      KL DFGS   L+  EP  
Sbjct: 139 GPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ 291
            +  +R Y  PE I     +     +WS+G +L +++ G 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 70  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 128 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 185
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + + +  +  I+ C+  
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 245
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 246 RPSDRPTFEEIQNHPW 261

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 66  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 124 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 181
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + + +  +  I+ C+  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLAL 241
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 242 RPSDRPTFEEIQNHPW 257

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 71  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 129 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 186
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + + +  +  I+ C+  
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 246
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 247 RPSDRPTFEEIQNHPW 262

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 71  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 129 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 186
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + + +  +  I+ C+  
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 246
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 247 RPSDRPTFEEIQNHPW 262

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 66  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 124 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 181
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + + +  +  I+ C+  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 241
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 242 RPSDRPTFEEIQNHPW 257

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 69  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 126
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 127 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 184
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + + +  +  I+ C+  
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 244
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 245 RPSDRPTFEEIQNHPW 260

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158
           +G+GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 154
Query: 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 217
           ++  ++N+ +E +   ++ ++ K      +   L Y+     Q    L Y+H    + H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 209
Query: 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 271
           D+K  N+L++       LCDFG A  L       S +   Y      + APE++ G +  
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-C 268
Query: 272 TTAIDIWSVGCVLAELLLG 290
              +D+WS  C++  +L G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 189 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 195 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 252
Query: 249 PNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 253 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 304
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 305 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158
           VG+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 135
Query: 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 217
           ++  ++N+ +E +   ++ ++ K      +   L Y+     Q    L Y+H    + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHTRR-ILHG 190
Query: 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 271
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 249
Query: 272 TTAIDIWSVGCVLAELLLG 290
              +DIWS  C++  +L G
Sbjct: 250 DAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 88  KQTISYMAER-VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           ++ + +M  +  VG+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +
Sbjct: 54  REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRI 112
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           V L         ++  ++N+ +E +   ++ ++ K      +   L Y+     Q    L
Sbjct: 113 VPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGL 163
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------Y 259
            Y+H    + H D+K  N+L++    +  LCDFG A  L       S +   Y      +
Sbjct: 164 EYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLG 290
            APE++ G       +DIWS  C++  +L G
Sbjct: 223 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 252

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 189 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 197 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 254
Query: 249 PNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 255 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 306
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 307 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ERV+G G FG V   +    G+    VAIK +      K R     E   M   DHPNVV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     T  K  +   +V+EF+      +     +   +  +I +      I   + Y
Sbjct: 108 HLEGVV--TRGKPVM---IVIEFMENGA--LDAFLRKHDGQFTVIQLVGMLRGIAAGMRY 160
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + AP
Sbjct: 161 L-ADMGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G V+ E++
Sbjct: 218 EAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 112/256 (43%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 93  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 150
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 151 RHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 208
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + +    +  I+ C+  
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLAL 268
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 269 RPSDRPTFEEIQNHPW 284

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 189 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 188 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 245
Query: 249 PNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 246 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 297
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 298 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 189 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           + L ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K  
Sbjct: 190 LTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 247
Query: 249 PNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 299
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 300 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 112/256 (43%), Gaps = 14/256 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 147
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI--YVKLYTYQICRAL 205
           S         D  E   + VL  + E    V   +   ++R  L     + + +Q+  A+
Sbjct: 66  SGFSGVIRLLDWFERPDSFVL--ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 124 RHCHN-XGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 181
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-CMNP 323
                +  +  +WS+G +L +++ G  P    E  +   V   + +    +  I+ C+  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLAL 241
Query: 324 NYTEF-KFPQIKAHPW 338
             ++   F +I+ HPW
Sbjct: 242 RPSDRPTFEEIQNHPW 257

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 88  KQTISYMAER-VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
           ++ + +M  +  +G+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +
Sbjct: 68  REEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRI 126
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           V L         ++  ++N+ +E +   ++ ++ K      +   L Y+     Q    L
Sbjct: 127 VPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGL 177
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------Y 259
            Y+H    + H D+K  N+L++    +  LCDFG A  L       S +   Y      +
Sbjct: 178 EYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLG 290
            APE++ G       +DIWS  C++  +L G
Sbjct: 237 MAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 266

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D   V      +
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
              +      L +++E++       A    RA    P    ++ T   +I + L Y+H  
Sbjct: 91  LKGSK-----LWIIMEYLGGG---SALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE 139
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 270
             + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 140 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 196
Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
           Y +  DIWS+G    EL  G+P
Sbjct: 197 YDSKADIWSLGITAIELAKGEP 218

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
           +G G FG V++    +   TVA+K + +D        +E   M+ + HPN+V L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL---LGV 75
Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGGIG 213
            T +   Y  ++ EF+    Y     Y R   R  +  V L     QI  A+ Y+     
Sbjct: 76  CTREPPFY--IITEFM---TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-N 129
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATE 270
             HRD+  +N LV    H VK+ DFG ++ L+ G+   ++  +++   + APE +    +
Sbjct: 130 FIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL-AYNK 186
Query: 271 YTTAIDIWSVGCVLAEL-LLGQPLFPG 296
           ++   D+W+ G +L E+   G   +PG
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158
           +G+GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 135
Query: 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 217
           ++  ++N+ +E +   ++ ++ K      +   L Y+     Q    L Y+H    + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 190
Query: 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 271
           D+K  N+L++       LCDFG A  L         +   Y      + APE++ G +  
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-C 249
Query: 272 TTAIDIWSVGCVLAELLLG 290
              +D+WS  C++  +L G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 38/265 (14%)
Query: 99  VGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 147
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAK-----HYSRASQRMPLIYVKLYT 198
           +L         K    L +++EF       T  R  +     +       + L ++  Y+
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 258
           +Q+ + + ++       HRD+  +N+L++   + VK+ DFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFL-ASRKXIHRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 259 ---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 314
              + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXRRL 260
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWH 339
           +E  +   P+YT  +  Q     WH
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWH 285

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           + +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 315
           R Y  PE I     +  +  +WS+G +L +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 316 EEIK-CMNPNYTEF-KFPQIKAHPW 338
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 147
           +V+G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L     S T      + LV + +P    +  V +H      ++ L     +  QI + +
Sbjct: 81  RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN----WCVQIAKGM 130
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
            Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A 
Sbjct: 131 MYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T   D+WS G  + EL+
Sbjct: 189 ECIH-YRKFTHQSDVWSYGVTIWELM 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 147
           +V+G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L     S T      + LV + +P    +  V +H      ++ L     +  QI + +
Sbjct: 104 RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN----WCVQIAKGM 153
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
            Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    + A 
Sbjct: 154 MYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T   D+WS G  + EL+
Sbjct: 212 ECIH-YRKFTHQSDVWSYGVTIWELM 236

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           HP++V + +    T    +    +V+E+V     + +K      Q++P+     Y  +I 
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEIL 192
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPNISYICSR 257
            AL+Y+H  IG+ + D+KP+N+++     Q+KL D G+   +     + G P        
Sbjct: 193 PALSYLHS-IGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPG------- 242
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            ++APE++   T  T A DI++VG  LA L L  P   G   VD L E   VL T
Sbjct: 243 -FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKT 293

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-------ELQTM 138
           QP     ++  RV+G+G FG VF  +   TG+  A KK+ + +  K +       E + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY---VK 195
             +    +VSL + F + TD     L LV+  +     R   H     +  P        
Sbjct: 240 AKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAI 292
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 254
            YT QI   L ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            +  + APEL+ G  EY  ++D +++G  L E++  +  F
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-------ELQTM 138
           QP     ++  RV+G+G FG VF  +   TG+  A KK+ + +  K +       E + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY---VK 195
             +    +VSL + F + TD     L LV+  +     R   H     +  P        
Sbjct: 240 AKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAI 292
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 254
            YT QI   L ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            +  + APEL+ G  EY  ++D +++G  L E++  +  F
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-------ELQTM 138
           QP     ++  RV+G+G FG VF  +   TG+  A KK+ + +  K +       E + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY---VK 195
             +    +VSL + F + TD     L LV+  +     R   H     +  P        
Sbjct: 240 AKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAI 292
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 254
            YT QI   L ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     Y 
Sbjct: 293 FYTAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA 350
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            +  + APEL+ G  EY  ++D +++G  L E++  +  F
Sbjct: 351 GTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/348 (22%), Positives = 134/348 (38%), Gaps = 46/348 (13%)
Query: 98  VVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 149
           V+G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           +  F +    +EL++             +  H+      + + Y+      + +AL YIH
Sbjct: 92  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 210 GGIGVCHRDIKPQNLLVNPH--------THQVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
             +G  HR +K  ++L++             + +   G  + +V   P  S     +   
Sbjct: 146 -HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 314
             L      Y    DI+SVG    EL  G   F        L+E +      +L T T  
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 315 REEIKCMNPN------------YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP 362
            EE+  M+P+             T    P     P H  +H+   P     V + LQ +P
Sbjct: 265 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP-YHRTFSPHFHHFVEQCLQRNP 322
Query: 363 NLRCTALEACIHPFFDEL-RDPNARLPN-GRPFPPLFNFKPQELKGAS 408
           + R +A     H FF ++ R  +  LP   RP  P+ NF+  + +  S
Sbjct: 323 DARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 370

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 21/222 (9%)
Query: 84  NGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-------ELQ 136
             QP     ++  RV+G+G FG VF  +   TG+  A KK+ + +  K +       E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--- 193
            +  +    +VSL + F + TD     L LV+  +     R   H     +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 252
              YT QI   L ++H    + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
           Y  +  + APEL+ G  EY  ++D +++G  L E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP-LIYVKLYTYQICRALAYIHG 210
            F   + K +L +  V ++   +      H S     M  LI +     Q  R + Y+H 
Sbjct: 72  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLHA 126
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF- 266
              + HRD+K  N+ ++   + VK+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 127 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 267 -GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 79/348 (22%), Positives = 134/348 (38%), Gaps = 46/348 (13%)
Query: 98  VVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 149
           V+G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           +  F +    +EL++             +  H+      + + Y+      + +AL YIH
Sbjct: 76  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 210 GGIGVCHRDIKPQNLLVNPH--------THQVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
             +G  HR +K  ++L++             + +   G  + +V   P  S     +   
Sbjct: 130 -HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 314
             L      Y    DI+SVG    EL  G   F        L+E +      +L T T  
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 315 REEIKCMNPN------------YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP 362
            EE+  M+P+             T    P     P H  +H+   P     V + LQ +P
Sbjct: 249 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHP-YHRTFSPHFHHFVEQCLQRNP 306
Query: 363 NLRCTALEACIHPFFDEL-RDPNARLPN-GRPFPPLFNFKPQELKGAS 408
           + R +A     H FF ++ R  +  LP   RP  P+ NF+  + +  S
Sbjct: 307 DARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 354

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ERV+G G FG V   +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 87  HLEGVVTKSKP-----VMIVTEYMENG--SLDTFLKKNDGQFTVIQLVGMLRGISAGMKY 139
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 140 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 196
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G V+ E++
Sbjct: 197 EAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 63/299 (21%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 146
           +  + +G+G F +V Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 147 VSLKHCFFSTTDKDELYLNLVLEF----------VPETVYRVAKHYSRASQRMPLIYVKL 196
           ++L   + +T++     + L+LE+          +PE    V+++       + LI    
Sbjct: 92  INLHEVYENTSE-----IILILEYAAGGEIFSLCLPELAEMVSEN-----DVIRLIK--- 138
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLVKGEPNISYI 254
              QI   + Y+H    + H D+KPQN+L++       +K+ DFG ++ +         +
Sbjct: 139 ---QILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM 194
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
            +  Y APE I      TTA D+W++G +   LL     F GE   +  + I +V     
Sbjct: 195 GTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----- 248
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
                  N +Y+E  F  +                A D +  LL  +P  R TA E C+
Sbjct: 249 -------NVDYSEETFSSVSQL-------------ATDFIQSLLVKNPEKRPTA-EICL 286

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L     ++T      + L+++ +P    +  V +H      +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP-LIYVKLYTYQICRALAYIHG 210
            F   + K +L +  V ++   +      H S     M  LI +     Q  R + Y+H 
Sbjct: 84  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLHA 138
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 266
              + HRD+K  N+ ++   + VK+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 267 -GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 83  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 134 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 192 SILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 83  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 134 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 192 SILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 147
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L      ++      L LV +++P    +  V +H      ++ L     +  QI + +
Sbjct: 97  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 146
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
            Y+    G+ HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A 
Sbjct: 147 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 263 ELI-FGATEYTTAIDIWSVGCVLAELL 288
           E I FG  +YT   D+WS G  + EL+
Sbjct: 205 ESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 85  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 136 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 194 SILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 166 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 224 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP-LIYVKLYTYQICRALAYIHG 210
             +ST  +    L +V ++   +      H S     M  LI +     Q  R + Y+H 
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLHA 138
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 266
              + HRD+K  N+ ++   + VK+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 267 -GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +P
Sbjct: 163 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 84  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 135 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 193 SILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 168 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 226 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 83  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 134 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 192 SILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 15/120 (12%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
           ++YQ+ + +A++       HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 150 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 208 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 85  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 136 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 194 SILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 82  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 133 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 191 SILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 81  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 132 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 147
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+             + ++ E++      +     +   R  +I +      I   + Y
Sbjct: 94  HLEGVVTKCKP-----VMIITEYMENG--SLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LSD-MSAVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G V+ E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 47/246 (19%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGET-----VAIKKVLQDKRYKNRE-----LQ 136
           P++ + +   +V+G G+FG V  A      +T     VA+K + +      RE     L+
Sbjct: 43  PRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 137 TM-RLLDHPNVVSL-KHCFFSTTDKDELYLNLVLEFV------------------PETVY 176
            M +L  H N+V+L   C  S        + L+ E+                    E  Y
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGP------IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 177 RVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK 234
              K          L +  L  + YQ+ + + ++     V HRD+  +N+LV  H   VK
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV-HRDLAARNVLVT-HGKVVK 212
Query: 235 LCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LG 290
           +CDFG A+ ++     +    +R    + APE +F    YT   D+WS G +L E+  LG
Sbjct: 213 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLG 271
Query: 291 QPLFPG 296
              +PG
Sbjct: 272 VNPYPG 277

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 147
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L      ++      L LV +++P    +  V +H      ++ L     +  QI + +
Sbjct: 79  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 128
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
            Y+    G+ HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 263 ELI-FGATEYTTAIDIWSVGCVLAELL 288
           E I FG  +YT   D+WS G  + EL+
Sbjct: 187 ESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L     ++T      + L+ + +P    +  V +H      +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLITQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
            Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     T  K  + +   +E      + + KH      +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMENGSLDSF-LRKH----DAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 L-SDMGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 L-SDMGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 81  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 132 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 83  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 134 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 192 SILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 88  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 139 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 197 SILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 144
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRV--AKHYSRASQRMPLIYVKLYTYQ 200
           N+V L     +          +V+EFVP  +  +R+    H  + S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 201 ICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 255
           I   + Y+      + HRD++  N+ +        +C    DFG+++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLL 187
Query: 256 SRY-YRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLF 294
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +T      + ++ EF+      +     +   +  +I +      I   + Y
Sbjct: 98  HLEGVVTKSTP-----VMIITEFMENG--SLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 150
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRA 261
           +   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 151 L-ADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELL 288
           PE I    ++T+A D+WS G V+ E++
Sbjct: 209 PEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 147
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+             + ++ E++      +     +   R  +I +      I   + Y
Sbjct: 79  HLEGVVTKCKP-----VMIITEYMENG--SLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G V+ E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 147
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+             + ++ E++      +     +   R  +I +      I   + Y
Sbjct: 73  HLEGVVTKCKP-----VMIITEYMENG--SLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G V+ E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 108 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 161 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 217
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 218 EAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 84  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 135 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 193 SILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 106 RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 156
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 157 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 215 SILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 84  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 135 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 193 SILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +P
Sbjct: 163 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     T  K  + +   +E      + + KH      +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMENGSLDSF-LRKH----DAQFTVIQLVGMLRGIASGMKY 162
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 L-SDMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 84  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 135 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 193 SILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 81  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 132 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 91  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 141
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 142 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 200 SILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 83  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 134 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 192 SILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 88  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 139 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 197 SILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 87  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 137
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 138 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 196 SILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 148
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 149 --LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
             L  C  ST       + LV + +P     +  H      R+    +  +  QI + ++
Sbjct: 83  RLLGICLTST-------VQLVTQLMPYGC--LLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+   + + HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E
Sbjct: 134 YLE-DVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     +T   D+WS G  + EL+
Sbjct: 192 SIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 98  RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 151 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 207
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 208 EAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     T  K  + +   +E      + + KH      +  +I +      I   + Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEXMENGSLDSF-LRKH----DAQFTVIQLVGMLRGIASGMKY 133
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 114/291 (39%), Gaps = 58/291 (19%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 152
           +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYI 208
           +      + LY       +        + +SR   R    + +    +I +    A+ Y+
Sbjct: 80  Y------ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           H  I + HRD+KP+NLL         +KL DFG AK    GE                  
Sbjct: 134 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE------------------ 173
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
              +Y  + D+WS+G ++  LL G P F    G      +    G  TR  +        
Sbjct: 174 ---KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------G 217
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           +++FP  +   W ++       E   L+  LL+  P  R T  E   HP+ 
Sbjct: 218 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 81  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 132 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 150
           +G+G FG+V++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              FS+   D   L LV  ++P     +    S      PL +     +  C+       
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 211 GIGV------CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 261
           GI         HRDIK  N+L++      K+ DFG A+   K    +     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQP 292
           PE + G  E T   DI+S G VL E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +       + +V E++      +     +   +  +I +      I   + Y
Sbjct: 81  RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
           E I    ++T+A D+WS G VL E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 150
           +G+G FG+V++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              FS+   D   L LV  ++P     +    S      PL +     +  C+       
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 211 GIGV------CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 261
           GI         HRDIK  N+L++      K+ DFG A+   K    +     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQP 292
           PE + G  E T   DI+S G VL E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ------TMRLLDHPN 145
           ++  + ++G+G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI--CR 203
           ++ L+    + T++  +Y  +    V   +        R   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 150
Query: 204 ALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--Y 259
            LAY+H      + HRD+K  N+L++     V + DFG AK++   + ++         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ------TMRLLDHPN 145
           ++  + ++G+G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI--CR 203
           ++ L+    + T++  +Y  +    V   +        R   + PL + K     +   R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 142
Query: 204 ALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--Y 259
            LAY+H      + HRD+K  N+L++     V + DFG AK++   + ++         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 75  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 126 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 184 SILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   + + R       N+E+      M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 115 RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 165
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 166 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 224 SILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 40/229 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV----------LQDKRYKNRELQTMRLL-DHPN 145
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 146 VVSL--------------KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
           +V+L              ++C +          + VLE  P   + +A   S AS R  L
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP--AFAIAN--STASTRDLL 167
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
                ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 168 ----HFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 144
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRV--AKHYSRASQRMPLIYVKLYTYQ 200
           N+V L     +          +V+EFVP  +  +R+    H  + S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 201 ICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 255
           I   + Y+      + HRD++  N+ +        +C    DFG ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 256 SRY-YRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLF 294
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 150
           +G+G FG+V++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              FS+   D   L LV  ++P     +    S      PL +     +  C+       
Sbjct: 90  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSW-----HMRCKIAQGAAN 138
Query: 211 GIGV------CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 261
           GI         HRDIK  N+L++      K+ DFG A+   K    +     + +  Y A
Sbjct: 139 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQP 292
           PE + G  E T   DI+S G VL E++ G P
Sbjct: 198 PEALRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRELQ-------TMRLLDHPNVVSLK 150
           +G+GSF  V+  K L+T  TV +    LQD++    E Q        ++ L HPN+V   
Sbjct: 34  IGRGSFKTVY--KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
             + ST  K +  + LV E          K Y +  +   +  ++ +  QI + L ++H 
Sbjct: 92  DSWESTV-KGKKCIVLVTELXTSGTL---KTYLKRFKVXKIKVLRSWCRQILKGLQFLHT 147
Query: 211 GIG-VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
               + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE      
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EE 204
Query: 270 EYTTAIDIWSVG-CVL 284
           +Y  ++D+++ G C L
Sbjct: 205 KYDESVDVYAFGXCXL 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI   + 
Sbjct: 78  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAEGMN 128
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 129 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 187 SILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+++ +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 88  RLLGICLTST------VQLIMQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 139 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 197 SILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 103/264 (39%), Gaps = 81/264 (30%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 149
           +G+G FG+VF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 150 KHCFFST------TDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV--------- 194
            + +  T       + DE++L       P +        S   +RM              
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 195 ---KLYTY---QICR-------------------------------ALAYIHGGIGVCHR 217
              K+Y Y   Q+CR                               A+ ++H   G+ HR
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLMHR 188
Query: 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNISY------ICSRYYRAPEL 264
           D+KP N+        VK+ DFG    + + E       P  +Y      + ++ Y +PE 
Sbjct: 189 DLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ 247
Query: 265 IFGATEYTTAIDIWSVGCVLAELL 288
           I G   Y+  +DI+S+G +L ELL
Sbjct: 248 IHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 97/197 (49%), Gaps = 20/197 (10%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
           +G G FG+V   K  +    VA+K + +    ++   +E QTM  L HP +V     F+ 
Sbjct: 16  LGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVK----FYG 70
Query: 156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
              K E  + +V E++    +    + + +  +   L+ +    Y +C  +A++     +
Sbjct: 71  VCSK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM---CYDVCEGMAFLESHQFI 126
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEY 271
            HRD+  +N LV+     VK+ DFG  + ++  +  +S + +++   + APE +F   +Y
Sbjct: 127 -HRDLAARNCLVDRDL-CVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPE-VFHYFKY 182
Query: 272 TTAIDIWSVGCVLAELL 288
           ++  D+W+ G ++ E+ 
Sbjct: 183 SSKSDVWAFGILMWEVF 199

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 99/244 (40%), Gaps = 60/244 (24%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDKRYK-----NRELQ 136
           P+  I Y+  R +G+G+FG VFQA+       E    VA+K + ++          RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 137 TMRLLDHPNVVSL--------KHC----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSR 184
            M   D+PN+V L          C    + +  D +E   ++     P TV  ++     
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS----PHTVCSLSHSDLS 158
Query: 185 ASQRM------PLIYVK--LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
              R+      PL   +      Q+   +AY+     V HRD+  +N LV      VK+ 
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV-HRDLATRNCLVG-ENMVVKIA 216
Query: 237 DFGSAKVLVKGEPNISYICSRYYRA------------PELIFGATEYTTAIDIWSVGCVL 284
           DFG ++ +   +         YY+A            PE IF    YTT  D+W+ G VL
Sbjct: 217 DFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVL 266
Query: 285 AELL 288
            E+ 
Sbjct: 267 WEIF 270

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNVVS 148
           M    +G GSFG V++ K       V I KV+     Q + ++N E+  +R   H N++ 
Sbjct: 39  MLSTRIGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL- 95
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
               F     KD L   +V ++   +   + KH      +  +  +     Q  + + Y+
Sbjct: 96  ---LFMGYMTKDNL--AIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISY-ICSRYYRAPELI 265
           H    + HRD+K  N+ ++     VK+ DFG A V  +  G   +     S  + APE+I
Sbjct: 149 HAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
                  ++   D++S G VL EL+ G+  +   +  DQ++ ++
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 91  ISYMA-ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLL 141
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
           +HPN++ L+         + + + ++ EF+      +         +  +I +      I
Sbjct: 73  EHPNIIRLEGVV-----TNSMPVMILTEFMENGA--LDSFLRLNDGQFTVIQLVGMLRGI 125
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---- 257
              + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S     
Sbjct: 126 ASGMRYL-AEMSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 258 --YYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
              + APE I    ++T+A D WS G V+ E++
Sbjct: 184 PIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 81  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 132 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 104/238 (43%), Gaps = 49/238 (20%)
Query: 97  RVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 146
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL---------- 196
           + L    +    +D   L L++E+     Y   + + R S+++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAK---YGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 197 --------------YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242
                         + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL-AEMSLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 243 VLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
            + + +  +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 147
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L     ++T      + L+ + +P   +     Y R  +  +   Y+  +  QI + + 
Sbjct: 88  RLLGICLTST------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
           Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E
Sbjct: 139 YLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL 288
            I     YT   D+WS G  + EL+
Sbjct: 197 SILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 40/229 (17%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 145
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 146 VVSL--------------KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL 191
           +V+L              ++C +          + VLE  P         ++ A+  +  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--------FAIANSTLST 163
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
             +  ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 164 RDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 252 SYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 104/238 (43%), Gaps = 49/238 (20%)
Query: 97  RVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 146
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL---------- 196
           + L    +    +D   L L++E+     Y   + + R S+++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAK---YGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 197 --------------YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242
                         + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 243 VLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
            + + +  +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 125/292 (42%), Gaps = 42/292 (14%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            L+        +  L + +V E++     +T  R         Q + ++        +  
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR------GVGA 162
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----Y 258
            + Y+   +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +       
Sbjct: 163 GMRYL-SDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIR 219
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           + APE I   T +++A D+WS G V+ E+L  G+  +   +  D +  +         E 
Sbjct: 220 WTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEG 270
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTA 368
            +   P        Q+    WHK   +R    + V ++  L++   +LR TA
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 144
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRV--AKHYSRASQRMPLIYVKLYTYQ 200
           N+V L     +          +V+EFVP  +  +R+    H  + S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 201 ICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 255
           I   + Y+      + HRD++  N+ +        +C    DF  ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLL 187
Query: 256 SRY-YRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLF 294
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 126 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L+     +T      + ++ EF+      +     +   +  +I +      I   + Y
Sbjct: 72  HLEGVVTKSTP-----VMIITEFMENG--SLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 124
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRA 261
           +   +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 125 L-ADMNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELL 288
           PE I    ++T+A D+WS G V+ E++
Sbjct: 183 PEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 99  VGQGSFGIVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 148
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L     +        + +V E  P    + R+ KH         L  +  Y  Q+   + 
Sbjct: 86  LYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 135
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+     + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 136 YLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 191
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK 308
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 192 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 44/232 (18%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 145
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 146 VVSL--------------KHCFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQR 188
           +V+L              ++C +         LN +    P   E  Y  + +       
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 189 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
             L++   ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++   
Sbjct: 166 RDLLH---FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDS 220
Query: 249 PNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
             I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 221 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 104/238 (43%), Gaps = 49/238 (20%)
Query: 97  RVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 146
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL---------- 196
           + L    +    +D   L L++E+     Y   + + R S+++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAK---YGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 197 --------------YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242
                         + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 243 VLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
            + + +  +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 46/230 (20%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 145
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 146 VVSL--------------KHCFFSTTDKDELYLNLVLEFVPETV-YRVAKHYSRASQRMP 190
           +V+L              ++C +            +L F+       + K   R  +   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGD----------LLNFLRRKAEADLDKEDGRPLELRD 161
Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250
           L++   ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     
Sbjct: 162 LLH---FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNY 216
Query: 251 ISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
           I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 217 IVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 145
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 146 VVSL-KHCFFS----TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
           +V+L   C          +   Y +L+     +    + K   R  +   L++   ++ Q
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH---FSSQ 160
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-- 258
           + + +A++       HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R   
Sbjct: 161 VAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 259 -YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
            + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 219 KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 99  VGQGSFGIVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 148
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L     +        + +V E  P    + R+ KH         L  +  Y  Q+   + 
Sbjct: 80  LYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 129
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+     + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 130 YLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 185
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK 308
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 186 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 100 GQGSFGIVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLKH 151
           G+G FG+V++     T  TVA+KK+         + K+  ++E++      H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
             FS+   D   L LV  + P     +    S      PL +     +  C+       G
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG--SLLDRLSCLDGTPPLSW-----HXRCKIAQGAANG 136
Query: 212 IGV------CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 262
           I         HRDIK  N+L++      K+ DFG A+   K    +     + +  Y AP
Sbjct: 137 INFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQP 292
           E + G  E T   DI+S G VL E++ G P
Sbjct: 196 EALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 96  ERVVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 147
           + V+G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 148 SL-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +L   C      +   YL L +E+ P          SR  +  P   +   T     +  
Sbjct: 90  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 207 YIHGGIGVC------------HRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPNI 251
            +H    V             HRD+  +N+LV  + +  K+ DFG ++   V VK    +
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KTM 200
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
             +  R+     L +    YTT  D+WS G +L E++
Sbjct: 201 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 235

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 144 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHCFF 154
           V  +G FG V++A+ L   E VA+K   +QDK+    E +   L  + H N++      F
Sbjct: 31  VKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQ-----F 83
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGGI 212
              +K    +++ L  +  T +      S   +   + + +L      + R LAY+H  I
Sbjct: 84  IGAEKRGTSVDVDLWLI--TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 213 ---------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYR 260
                     + HRDIK +N+L+  +     + DFG A     G+        + +R Y 
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTAC-IADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 261 APELIFGATEYTTA----IDIWSVGCVLAEL 287
           APE++ GA  +       ID++++G VL EL
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 99  VGQGSFGIVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 148
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L     +        + +V E  P    + R+ KH         L  +  Y  Q+   + 
Sbjct: 76  LYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 125
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+     + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 126 YLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 181
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 182 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 96  ERVVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 147
           + V+G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 148 SL-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +L   C      +   YL L +E+ P          SR  +  P   +   T     +  
Sbjct: 80  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 207 YIHGGIGVC------------HRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPNI 251
            +H    V             HRD+  +N+LV  + +  K+ DFG ++   V VK    +
Sbjct: 134 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KTM 190
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
             +  R+     L +    YTT  D+WS G +L E++
Sbjct: 191 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 225

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
             +ST  +    L +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 99  VGQGSFGIVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 148
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L     +        + +V E  P    + R+ KH         L  +  Y  Q+   + 
Sbjct: 86  LYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 135
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAP 262
           Y+     + HRD+  +NLL+      VK+ DFG  + L + + +      R     + AP
Sbjct: 136 YLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK 308
           E +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 194 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 99  VGQGSFGIVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 148
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L     +        + +V E  P    + R+ KH         L  +  Y  Q+   + 
Sbjct: 76  LYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 125
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+     + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 126 YLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 181
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 182 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F   + K +L   +V ++   +   +  H      +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 268
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 269 TE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 99  VGQGSFGIVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 148
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L     +        + +V E  P    + R+ KH         L  +  Y  Q+   + 
Sbjct: 80  LYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 129
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+     + HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      
Sbjct: 130 YLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC 185
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 186 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET-----VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 145
           ++V+G G FG V++   L+T        VAIK +      K R     E   M    H N
Sbjct: 49  QKVIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           ++ L+             + ++ E++      + K          ++ +      I   +
Sbjct: 108 IIRLEGVISKYKP-----MMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYR 260
            Y+   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 161 KYL-ANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL 288
           APE I    ++T+A D+WS G V+ E++
Sbjct: 218 APEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 99  VGQGSFGIVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 148
           +G GSFG+V + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L     +        + +V E  P    + R+ KH         L  +  Y  Q+   + 
Sbjct: 76  LYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMG 125
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAP 262
           Y+     + HRD+  +NLL+      VK+ DFG  + L + + +      R     + AP
Sbjct: 126 YLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK 308
           E +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 273 TAIDIWSVGCVLAELLLGQPLFPGE 297
              DI+++ CVL E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 86  QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL----QTMRLL 141
           +P+    +   R +G GSFG ++    ++T E VAIK  L++ + K+ +L    +  R+L
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
                +     F    D + L ++L+   + +        ++  S+++ L  V +   Q+
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDL-------FNFCSRKLSLKTVLMLADQM 112
Query: 202 CRALAYIHGGIGVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 242
              + ++H      HRDIKP N L  +    +QV + DFG AK
Sbjct: 113 INRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 91  ISYMA-ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLL 141
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
           +HPN++ L+         + + + ++ EF+      +         +  +I +      I
Sbjct: 75  EHPNIIRLEGVV-----TNSMPVMILTEFMENGA--LDSFLRLNDGQFTVIQLVGMLRGI 127
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---- 257
              + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S     
Sbjct: 128 ASGMRYL-AEMSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 258 --YYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
              + APE I    ++T+A D WS G V+ E++
Sbjct: 186 PIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 45/236 (19%)
Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 145
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 146 VVSL--------------KHC-------FFSTTDKDELYLNLVLEFVPETVYRVAKHYSR 184
           +V+L              ++C       F     +  L  +L     PE +    K   R
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL---DKEDGR 153
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
             +   L++   ++ Q+ + +A++       HRD+  +N+L+  + H  K+ DFG A+ +
Sbjct: 154 PLELRDLLH---FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDI 208
Query: 245 VKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
           +     I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 132/314 (42%), Gaps = 69/314 (21%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 152 C-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ--------RMPLIYVKL-- 196
           C           K +  L +V+E +    +   K Y R+ +        R P    ++  
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISY 253
              +I   +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +        
Sbjct: 135 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKG 192
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 312
           +    + APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +     
Sbjct: 193 LLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV----- 245
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                   M+  Y +         P         P    DL+    Q++PN+R T LE  
Sbjct: 246 --------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIV 283
Query: 373 ------IHPFFDEL 380
                 +HP F E+
Sbjct: 284 NLLKDDLHPSFPEV 297

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 45  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 103
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 104 KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 151
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 152 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 205
Query: 253 YICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303
           Y         +L             ++TT  D+WS G +L EL+  G P +P  +  D  
Sbjct: 206 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 265
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 266 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 309

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 96  ERVVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 147
           + V+G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 148 SL-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +L   C      +   YL L +E+ P          SR  +  P   +   T     +  
Sbjct: 87  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 207 YIHGGIGVC------------HRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPNI 251
            +H    V             HR++  +N+LV  + +  K+ DFG ++   V VK    +
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KTM 197
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
             +  R+     L +    YTT  D+WS G +L E++
Sbjct: 198 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 19  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 77
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 78  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 125
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 126 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 179
Query: 253 YICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303
           Y         +L             ++TT  D+WS G +L EL+  G P +P  +  D  
Sbjct: 180 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 239
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 240 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 283

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 48/292 (16%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 85  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 132
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 133 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSV 190
Query: 253 Y------ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE 305
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  +  D  V 
Sbjct: 191 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 248
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 249 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 87  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 134
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + ++       HRD+  +N +++     VK+ DFG A+ ++  E +  
Sbjct: 135 DLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSV 192
Query: 253 YICSRY-----YRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI 306
           +  +       + A E +    ++TT  D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 193 HNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           +        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 252 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 53/235 (22%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET-----VAIKKV----LQDKRYKNRELQTMRLLDHPNV 146
           +R +G+G+FG VF A+C     T     VA+K +    L  ++   RE + +  L H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLIY 193
           V     +    D D L   +V E++             P+ +  V     +A   + L  
Sbjct: 80  VKF---YGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           +     QI   + Y+       HRD+  +N LV  +   VK+ DFG ++           
Sbjct: 135 MLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANL-LVKIGDFGMSR---------DV 183
Query: 254 ICSRYYRA------------PELIFGATEYTTAIDIWSVGCVLAELLL--GQPLF 294
             + YYR             PE I    ++TT  D+WS G +L E+     QP F
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 84  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 131
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 132 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 185
Query: 253 YICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303
           Y         +L             ++TT  D+WS G +L EL+  G P +P  +  D  
Sbjct: 186 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 245
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 246 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 86  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 133
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 134 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 187
Query: 253 YICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303
           Y         +L             ++TT  D+WS G +L EL+  G P +P  +  D  
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 247
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 248 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 124/292 (42%), Gaps = 42/292 (14%)
Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            L+        +  L + +V E++     +T  R         Q + ++        +  
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR------GVGA 162
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----Y 258
            + Y+   +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       
Sbjct: 163 GMRYL-SDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIR 219
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           + APE I   T +++A D+WS G V+ E+L  G+  +   +  D +  +         E 
Sbjct: 220 WTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEG 270
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTA 368
            +   P        Q+    WHK   +R    + V ++  L++   +LR TA
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 46  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 104
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 105 KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 152
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 153 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 206
Query: 253 YICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303
           Y         +L             ++TT  D+WS G +L EL+  G P +P  +  D  
Sbjct: 207 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 266
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 267 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 310

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 24  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 83  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 131 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 184
Query: 253 YICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303
           Y         +L             ++TT  D+WS G +L EL+  G P +P  +  D  
Sbjct: 185 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 245 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 288

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 113/298 (37%), Gaps = 60/298 (20%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------------E 134
           P   I +  E V+G+G FG V+    L+       KK+    +  NR            E
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 80
Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRM 189
              M+   HPNV+SL            L + L  E  P  V    KH     + R     
Sbjct: 81  GIIMKDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 128
Query: 190 PLIYVKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           P +   + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E
Sbjct: 129 PTVKDLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE 186
Query: 249 PNISYICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG 299
               Y         +L             ++TT  D+WS G +L EL+  G P +P  + 
Sbjct: 187 ----YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 242
Query: 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
            D  V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 243 FDITVYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 22  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 81  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 128
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 129 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 182
Query: 253 YICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303
           Y         +L             ++TT  D+WS G +L EL+  G P +P  +  D  
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 243 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 286

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 86  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 133
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + Y+       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 134 DLIGFGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE---- 187
Query: 253 YICSRYYRAPEL--------IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303
           Y         +L             ++TT  D+WS G +L EL+  G P +P  +  D  
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 247
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 248 VYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 48/292 (16%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 32  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 90
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 91  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 138
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + ++       HRD+  +N +++     VK+ DFG A+ +   E +  
Sbjct: 139 DLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSV 196
Query: 253 Y------ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE 305
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  +  D  V 
Sbjct: 197 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 254
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 255 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 296

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 121/292 (41%), Gaps = 48/292 (16%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 86  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 145 KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 192
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + ++       HRD+  +N +++     VK+ DFG A+ +   E    
Sbjct: 193 DLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE--FD 248
Query: 253 YICSRYYRAPELIFGATE------YTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE 305
            + ++      + + A E      +TT  D+WS G +L EL+  G P +P  +  D  V 
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 309 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 350

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 87  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 134
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + ++       HRD+  +N +++     VK+ DFG A+ +   E +  
Sbjct: 135 DLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSV 192
Query: 253 YICSRY-----YRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI 306
           +  +       + A E +    ++TT  D+WS G +L EL+  G P +P  +  D  V +
Sbjct: 193 HNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           +        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 252 L--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 56/296 (18%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------------E 134
           P   I +  E V+G+G FG V+    L+       KK+    +  NR            E
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 81
Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRM 189
              M+   HPNV+SL            L + L  E  P  V    KH     + R     
Sbjct: 82  GIIMKDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 129
Query: 190 PLIYVKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           P +   + +  Q+ + + ++       HRD+  +N +++     VK+ DFG A+ +   E
Sbjct: 130 PTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE 187
Query: 249 PNISY------ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD 301
            +  +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  +  D
Sbjct: 188 FDSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
             V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 246 ITVYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 56/296 (18%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------------E 134
           P   I +  E V+G+G FG V+    L+       KK+    +  NR            E
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTE 79
Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRM 189
              M+   HPNV+SL            L + L  E  P  V    KH     + R     
Sbjct: 80  GIIMKDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 127
Query: 190 PLIYVKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           P +   + +  Q+ + + ++       HRD+  +N +++     VK+ DFG A+ +   E
Sbjct: 128 PTVKDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE 185
Query: 249 PNISY------ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD 301
            +  +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  +  D
Sbjct: 186 FDSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 243
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
             V ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 244 ITVYLL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 48/292 (16%)
Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 138
           P   I +  E V+G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMPLIY 193
           +   HPNV+SL            L + L  E  P  V    KH     + R     P + 
Sbjct: 86  KDFSHPNVLSL------------LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 133
Query: 194 VKL-YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
             + +  Q+ + + ++       HRD+  +N +++     VK+ DFG A+ +   E +  
Sbjct: 134 DLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSV 191
Query: 253 Y------ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE 305
           +      +  ++     L     ++TT  D+WS G +L EL+  G P +P  +  D  V 
Sbjct: 192 HNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
           ++        +  + + P Y      ++    WH      M P   +LVSR+
Sbjct: 250 LL--------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 153
           +G+G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
              T K  +Y  +V+E V    +        A  R     VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTFLRTEGARLR-----VKTLLQMVGDAAAGMEYLES 231
Query: 214 VC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LIFG 267
            C  HRD+  +N LV    + +K+ DFG ++    G    S    +    + APE L +G
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 268 ATEYTTAIDIWSVGCVLAELL-LGQPLFPGES 298
              Y++  D+WS G +L E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 133/323 (41%), Gaps = 87/323 (26%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 79
Query: 152 C-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ--------RMPLIYVKL-- 196
           C           K +  L +V+E +    +   K Y R+ +        R P    ++  
Sbjct: 80  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 135
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
              +I   +AY++    V HR++  +N +V  H   VK+ DFG  + + +         +
Sbjct: 136 MAAEIADGMAYLNAKKFV-HRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------T 184
Query: 257 RYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
            YYR            APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+
Sbjct: 185 DYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 242
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363
           ++ +             M+  Y +         P         P    DL+    Q++PN
Sbjct: 243 LKFV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPN 275
Query: 364 LRCTALEAC------IHPFFDEL 380
           +R T LE        +HP F E+
Sbjct: 276 MRPTFLEIVNLLKDDLHPSFPEV 298

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 131/314 (41%), Gaps = 69/314 (21%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 152 C-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ--------RMPLIYVKL-- 196
           C           K +  L +V+E +    +   K Y R+ +        R P    ++  
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISY 253
              +I   +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +        
Sbjct: 135 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKG 192
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 312
           +    + APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+++ +     
Sbjct: 193 LLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV----- 245
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                   M+  Y +         P         P    DL+    Q++P +R T LE  
Sbjct: 246 --------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 373 ------IHPFFDEL 380
                 +HP F E+
Sbjct: 284 NLLKDDLHPSFPEV 297

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 132/315 (41%), Gaps = 71/315 (22%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 75
Query: 152 C-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ--------RMPLIYVKL-- 196
           C           K +  L +V+E +    +   K Y R+ +        R P    ++  
Sbjct: 76  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 131
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISY 253
              +I   +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +        
Sbjct: 132 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKG 189
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL--LLGQPLFPGESGVDQLVEIIKVLG 311
           +    + APE +     +TT+ D+WS G VL E+  L  QP + G S  +Q+++ +    
Sbjct: 190 LLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLKFV---- 242
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
                    M+  Y +         P         P    DL+    Q++P +R T LE 
Sbjct: 243 ---------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEI 279
Query: 372 C------IHPFFDEL 380
                  +HP F E+
Sbjct: 280 VNLLKDDLHPSFPEV 294

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 133/323 (41%), Gaps = 87/323 (26%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 152 C-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ--------RMPLIYVKL-- 196
           C           K +  L +V+E +    +   K Y R+ +        R P    ++  
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
              +I   +AY++    V HR++  +N +V  H   VK+ DFG  + + + +        
Sbjct: 135 MAAEIADGMAYLNAKKFV-HRNLAARNCMV-AHDFTVKIGDFGMTRDIYETD-------- 184
Query: 257 RYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
            YYR            APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 241
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363
           ++ +             M+  Y +         P         P    DL+    Q++PN
Sbjct: 242 LKFV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPN 274
Query: 364 LRCTALEAC------IHPFFDEL 380
           +R T LE        +HP F E+
Sbjct: 275 MRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 153
           +G+G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
              T K  +Y  +V+E V    +        A  R     VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTFLRTEGARLR-----VKTLLQMVGDAAAGMEYLES 231
Query: 214 VC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 270
            C  HRD+  +N LV    + +K+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 271 -----YTTAIDIWSVGCVLAELL-LGQPLFPGES 298
                Y++  D+WS G +L E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 99  VGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 155
           VG+G +G V++   L  GE+VA+K      +   ++  E+    LL H N++      F 
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILG-----FI 68
Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM---PLIYVKLYTYQICRALAYIH--- 209
            +D      +  L  +  T Y          QR    P + ++L     C  LA++H   
Sbjct: 69  ASDMTSRNSSTQLWLI--THYHEHGSLYDFLQRQTLEPHLALRLAVSAAC-GLAHLHVEI 125
Query: 210 ----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-----NISYICSRYYR 260
               G   + HRD K +N+LV  +  Q  + D G A +  +G       N   + ++ Y 
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 261 APELI--------FGATEYTTAIDIWSVGCVLAEL 287
           APE++        F + ++T   DIW+ G VL E+
Sbjct: 185 APEVLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 132/323 (40%), Gaps = 87/323 (26%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 77
Query: 152 C-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ--------RMPLIYVKL-- 196
           C           K +  L +V+E +    +   K Y R+ +        R P    ++  
Sbjct: 78  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 133
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
              +I   +AY++    V HRD+  +N +V  H   VK+ DFG  + + +         +
Sbjct: 134 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------T 182
Query: 257 RYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
            YYR            APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+
Sbjct: 183 DYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 240
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363
           ++ +             M+  Y +         P         P    DL+    Q++P 
Sbjct: 241 LKFV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPK 273
Query: 364 LRCTALEAC------IHPFFDEL 380
           +R T LE        +HP F E+
Sbjct: 274 MRPTFLEIVNLLKDDLHPSFPEV 296

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 132/323 (40%), Gaps = 87/323 (26%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 152 C-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ--------RMPLIYVKL-- 196
           C           K +  L +V+E +    +   K Y R+ +        R P    ++  
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
              +I   +AY++    V HRD+  +N +V  H   VK+ DFG  + + +         +
Sbjct: 135 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---------T 183
Query: 257 RYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
            YYR            APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+
Sbjct: 184 AYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 241
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363
           ++ +             M+  Y +         P         P    DL+    Q++P 
Sbjct: 242 LKFV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPK 274
Query: 364 LRCTALEAC------IHPFFDEL 380
           +R T LE        +HP F E+
Sbjct: 275 MRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 132/323 (40%), Gaps = 87/323 (26%)
Query: 97  RVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
           R +GQGSFG+V++  A+ +  GE    VA+K V +    + R    +  L+  +V+    
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFT 78
Query: 152 C-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ--------RMPLIYVKL-- 196
           C           K +  L +V+E +    +   K Y R+ +        R P    ++  
Sbjct: 79  CHHVVRLLGVVSKGQPTL-VVMELM---AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
              +I   +AY++    V HRD+  +N +V  H   VK+ DFG  + + + +        
Sbjct: 135 MAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD-------- 184
Query: 257 RYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
            YYR            APE +     +TT+ D+WS G VL E+  L +  + G S  +Q+
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV 241
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363
           ++ +             M+  Y +         P         P    DL+    Q++P 
Sbjct: 242 LKFV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPK 274
Query: 364 LRCTALEAC------IHPFFDEL 380
           +R T LE        +HP F E+
Sbjct: 275 MRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 8/152 (5%)
Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 152
           Y   R +G GSFG ++    + +GE VAIK      ++    +++         V +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSI 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
            +   + D  Y  +V+E +  ++  +   ++  S++  L  V L   Q+   + YIH   
Sbjct: 71  KWCGAEGD--YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHSK- 124
Query: 213 GVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 242
              HRD+KP N L  +    + V + DFG AK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 46/211 (21%)
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 251
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 252 SYICSRYYRAPELIFGATE----------YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA--VDLVSRLLQ 359
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 360 YSPNLRCTALEACIHPFFDELRDPNARLPNG 390
             P  R +  E   HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 46/211 (21%)
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 251
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 252 SYICSRYYRAPELIFGATE----------YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA--VDLVSRLLQ 359
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 360 YSPNLRCTALEACIHPFFDELRDPNARLPNG 390
             P  R +  E   HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 46/211 (21%)
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 251
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 252 SYICSRYYRAPELIFGATE----------YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA--VDLVSRLLQ 359
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 360 YSPNLRCTALEACIHPFFDELRDPNARLPNG 390
             P  R +  E   HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 46/211 (21%)
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 251
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 252 SYICSRYYRAPELIFGATE----------YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA--VDLVSRLLQ 359
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 259
Query: 360 YSPNLRCTALEACIHPFFDELRDPNARLPNG 390
             P  R +  E   HP+      P  ++  G
Sbjct: 260 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 251
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 252 SYICSRYYRAPELIFGATE----------YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 280
Query: 362 PNLRCTALEACIHPFFDELRDPNARLPNG 390
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 251
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 252 SYICSRYYRAPELIFGATE----------YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 224
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 225 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 260
Query: 362 PNLRCTALEACIHPFFDELRDPNARLPNG 390
           P  R +  E   HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 251
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 252 SYICSRYYRAPELIFGATE----------YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 228
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 229 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 264
Query: 362 PNLRCTALEACIHPFFDELRDPNARLPNG 390
           P  R +  E   HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 43/241 (17%)
Query: 77  VTTIGGRNGQP---KQTI--SYMAERVVGQGSFGIVFQAKCLETGETVAIK---KVLQDK 128
           +TT G  +G P   ++TI  + + +  +G+G FG V++ K    GE VA+K      +  
Sbjct: 23  MTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS 80
Query: 129 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE---LYLNLVLEFVPE-TVYRVAKHYSR 184
            ++  E+    +L H N++     F +  +KD      L LV ++    +++     Y+ 
Sbjct: 81  WFREAEIYQTVMLRHENILG----FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 136
Query: 185 ASQRMPLIYVKLYTYQICRALAYIH-------GGIGVCHRDIKPQNLLVNPHTHQVKLCD 237
             + M  I + L T      LA++H       G   + HRD+K +N+LV  +     + D
Sbjct: 137 TVEGM--IKLALST---ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIAD 190
Query: 238 FG------SAKVLVKGEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAE 286
            G      SA   +   PN   + ++ Y APE++  +      E     DI+++G V  E
Sbjct: 191 LGLAVRHDSATDTIDIAPN-HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 287 L 287
           +
Sbjct: 250 I 250

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 42/209 (20%)
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 251
           K Y   +  A+  IH   G+ H D+KP N L+      +KL DFG A  +      +   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 252 SYICSRYYRAPELIFGATE----------YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           S + +  Y  PE I   +            +   D+WS+GC+L  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 280
Query: 362 PNLRCTALEACIHPFFDELRDPNARLPNG 390
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 50/223 (22%)
Query: 99  VGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSL 149
           +G+G+FG VF A+C     E  + +   K L++     ++   RE + + +L H ++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 107
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRM---------PLIYVKLYTY 199
              FF    +    L +V E++    + R  + +   ++ +         PL   +L   
Sbjct: 108 ---FFGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 200 --QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 257
             Q+   + Y+  G+   HRD+  +N LV      VK+ DFG ++ +           + 
Sbjct: 164 ASQVAAGMVYL-AGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TD 212
Query: 258 YYRA------------PELIFGATEYTTAIDIWSVGCVLAELL 288
           YYR             PE I    ++TT  D+WS G VL E+ 
Sbjct: 213 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 254

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 89/219 (40%), Gaps = 25/219 (11%)
Query: 97  RVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVV 147
           +++G+G FG V +    +   T   VA+K +  D   +        E   M+   HPNV+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRA 204
            L       + +      ++L F+          YSR     + +PL  +  +   I   
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           + Y+       HRD+  +N ++      V + DFG +K +  G+    Y   R  + P +
Sbjct: 160 MEYLSNR-NFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGD---YYRQGRIAKMP-V 213
Query: 265 IFGATE------YTTAIDIWSVGCVLAELLL-GQPLFPG 296
            + A E      YT+  D+W+ G  + E+   G   +PG
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	429
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-99
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-95
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-92
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-92
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-92
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-92
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-91
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-91
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-90
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-90
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-89
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-89
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-88
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-87
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-87
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-87
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-86
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-86
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-86
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-86
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-79
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-65
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-64
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-64
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-62
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-61
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-60
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-59
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-57
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-57
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-56
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-56
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-55
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-54
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-53
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-53
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-53
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-52
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-52
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-52
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-52
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-51
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-51
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-51
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-51
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-51
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-50
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-50
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-50
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-50
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-50
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-49
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-49
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-49
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-49
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-49
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-49
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-48
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-48
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-48
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-48
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-48
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-48
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-48
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-48
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-47
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-47
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-47
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-47
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-47
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-47
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-46
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-46
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-46
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-46
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-46
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-46
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-46
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-45
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-45
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-44
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-44
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-43
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-42
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-42
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-42
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-42
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-41
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-41
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-41
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-41
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-41
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-40
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-40
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-39
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-39
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-39
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-39
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-39
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-39
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-39
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-38
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-38
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-38
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-38
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-37
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-37
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-36
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-36
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-36
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-36
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-36
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-36
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-35
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-35
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-35
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-35
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-35
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-35
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-35
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-35
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-35
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-35
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-34
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-33
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-33
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-33
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-31
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-31
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-29
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-28
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-27
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  640 bits (1652), Expect = 0.0
 Identities = 245/398 (61%), Positives = 300/398 (75%), Gaps = 17/398 (4%)

Query: 29  KPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPK 88
           +     ++    + P     MK+              D +G++   ++ T   G+     
Sbjct: 6   RTTSFAESCKPVQQPSAFGSMKVSR------------DKDGSKVTTVVATP--GQGPDRP 51

Query: 89  QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 148
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 111

Query: 149 LKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+IYVKLY YQ+ R+LAY
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           IH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFG
Sbjct: 172 IHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
           AT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTE
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 387
           FKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC H FFDELRDPN +L
Sbjct: 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350

Query: 388 PNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
           PNGR  P LFNF  QEL  ++  L + LIP HAR Q  
Sbjct: 351 PNGRDTPALFNFTTQELS-SNPPLATILIPPHARIQAA 387

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  632 bits (1631), Expect = 0.0
 Identities = 226/373 (60%), Positives = 287/373 (76%), Gaps = 5/373 (1%)

Query: 57  EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
              +    ++        I V    G+ G+ ++ I+Y   +V+G GSFG+VFQAK +E+ 
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETV 175
           E VAIKKVLQDKR+KNRELQ MR++ HPNVV LK  F+S  DK DE++LNLVLE+VPETV
Sbjct: 66  E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124

Query: 176 YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235
           YR ++HY++  Q MP++ +KLY YQ+ R+LAYIH  IG+CHRDIKPQNLL++P +  +KL
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKL 183

Query: 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFP 295
            DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YTT IDIWS GCV+AEL+ GQPLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 355
           GESG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+ HP+ K+F  R PP+A+DL+S
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303

Query: 356 RLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKL 415
           RLL+Y+P+ R TA+EA  HPFFDELR   AR+PNGR  PPLFN+  +EL     +L+S+L
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRL 362

Query: 416 IPEHARKQCPFLG 428
           +P+HA  +    G
Sbjct: 363 VPQHAEAELLSRG 375

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  605 bits (1563), Expect = 0.0
 Identities = 161/358 (44%), Positives = 230/358 (64%), Gaps = 12/358 (3%)

Query: 73  GHIIVTTIGGRNGQP--KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY 130
           G ++         +   K+   +  ER+ GQG+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 131 KNRELQTMRLL---DHPNVVSLKHCFFSTT--DKDELYLNLVLEFVPETVYRVAKHYSRA 185
           +NRELQ M+ L    HPN+V L+  F++    D+ ++YLN+V+E+VP+T++R  ++Y R 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 186 SQRMPLIYVKLYTYQICRALAYIH-GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
               P I +K++ +Q+ R++  +H   + VCHRDIKP N+LVN     +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
              EPN++YICSRYYRAPELIFG   YTTA+DIWSVGC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK---RMPPEAVDLVSRLLQYS 361
           EI++VLG P+RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 362 PNLRCTALEACIHPFFDELRDPNARLPNGRPFPP-LFNFKPQELKGASKELLSKLIPE 418
           P  R    EA  HP+FDEL DP  +LPN +  P  LF F P E++  S+   +KL+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  588 bits (1518), Expect = 0.0
 Identities = 166/382 (43%), Positives = 243/382 (63%), Gaps = 43/382 (11%)

Query: 85  GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 144
           G    +  Y   + +G GSFGIV +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 145 NVVSLKHCFFSTTDK---------------------------------DELYLNLVLEFV 171
           N++ L   F++T D+                                    YLN+++E+V
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 172 PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231
           P+T+++V K + R+ + +P+  + +Y YQ+ RA+ +IH  +G+CHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDN 179

Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ 291
            +KLCDFGSAK L+  EP+++YICSR+YRAPEL+ GATEYT +ID+WS+GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 292 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAV 351
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 352 DLVSRLLQYSPNLRCTALEACIHPFFDELRDP-------NARLPNG--RPFPPLFNFKPQ 402
           DL+ ++L+Y P+LR    EA  HPFFD LR+        N+  P+G  +  P LFNF P 
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 403 ELKGASKELLSKLIPEHARKQC 424
           EL      +L++++P++     
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  299 bits (767), Expect = 1e-99
 Identities = 103/312 (33%), Positives = 161/312 (51%), Gaps = 22/312 (7%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+GS+G+VF+ +  +TG+ VAIKK L+ +          RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
           F     K  L+L  V E+   TV      Y    + +P   VK  T+Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 271
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 329
              +D+W++GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 330 FPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
            P  +   P    F   +   A+ L+   L   P  R T  +   HP+F+ +R+    L 
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298

Query: 389 NGRPFPPLFNFK 400
                P    + 
Sbjct: 299 KEHDKPAENLYF 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  292 bits (750), Expect = 6e-97
 Identities = 99/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           VG+GS+G+V + +  +TG  VAIKK L+    K       RE++ ++ L H N+V+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                 K   YL  V EFV  T+    + +      +    V+ Y +QI   + + H   
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 271
            + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 329
             A+D+W++GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 330 FPQIKAH-PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
            P+IK   P  + +  ++    +DL  + L   P+ R    E   H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  291 bits (748), Expect = 9e-97
 Identities = 90/315 (28%), Positives = 151/315 (47%), Gaps = 34/315 (10%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 146
           YM  + +G G  G+VF A   +  + VAIKK+ L D    K     RE++ +R LDH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 147 VSLKHCF-----------FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK 195
           V +                S T+ + +Y+  V E++   +  V +        +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--- 252
           L+ YQ+ R L YIH    V HRD+KP NL +N     +K+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 253 -YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
             + +++YR+P L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 312 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
               E+ + +      +          P  ++    +  EAVD + ++L +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 370 EACIHPFFDELRDPN 384
           EA  HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  288 bits (740), Expect = 2e-95
 Identities = 101/329 (30%), Positives = 172/329 (52%), Gaps = 36/329 (10%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLD 142
           +Y+    +G+G++  V++ K   T   VA+K++    R ++         RE+  ++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           H N+V+L         +  L L  V E++      + ++       + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYY 259
           R LAY H    V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 316
           R P+++ G+T+Y+T ID+W VGC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            I      +  + +P+ +A         R+  +  DL+++LLQ+    R +A +A  HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELK 405
           F  L +   +LP+      +F  K  +L+
Sbjct: 285 FLSLGERIHKLPD---TTSIFALKEIQLQ 310

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  289 bits (743), Expect = 2e-95
 Identities = 95/347 (27%), Positives = 159/347 (45%), Gaps = 40/347 (11%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------------RELQT 137
           Y  +R +  GS+G V        G  VAIK+V                       RE++ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 138 MRLLDHPNVVSLKHCF--FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL--IY 193
           +    HPN++ L+  F  F      +LYL  V E +   + +V        QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           ++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
           +  R+YRAPEL+     +T  +D+WS GCV+AE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 314 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
             E++    +P   +Y       + A  W  +      P A+DL++++L+++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 370 EACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
           +A  HP+F+ L DP   L  G      F+F            + K+ 
Sbjct: 313 QALRHPYFESLFDPL-DLTEGLSER--FHFDESVT---DVYDMHKIF 353

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  288 bits (738), Expect = 4e-95
 Identities = 89/303 (29%), Positives = 148/303 (48%), Gaps = 23/303 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMR-LLDHPNVVSL 149
           Y   R +G+G +  VF+A  +   E V +K +  ++ K+ K RE++ +  L   PN+++L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
                    +       V E V  T ++  + Y    Q +    ++ Y Y+I +AL Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNTDFK--QLY----QTLTDYDIRFYMYEILKALDYCH 147

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
              G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 270 EYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYT 326
            Y  ++D+WS+GC+LA ++   +P F G    DQLV I KVLGT    +   K       
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 327 EFK--FPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
            F     +     W +  H      + PEA+D + +LL+Y    R TA EA  HP+F  +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 381 RDP 383
              
Sbjct: 327 VKD 329

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  287 bits (737), Expect = 1e-94
 Identities = 109/349 (31%), Positives = 185/349 (53%), Gaps = 39/349 (11%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 145
           +  + ++G+G++G+V  A    TGE VAIKK+          R    RE++ ++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 146 VVSLKHCFFSTTDKD--ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           ++++ +     + ++  E+Y+  + E +   ++RV       +Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLR 123

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----------- 252
           A+  +HG   V HRD+KP NLL+N     +K+CDFG A+++ +   + S           
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
           ++ +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 313 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
           P  +       +P   E+    P   A P  K+F + + P+ +DL+ R+L + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 369 LEACIHPFFDELRDPNARLPNGRPFPPL-FNFKPQELKGASKELLSKLI 416
            EA  HP+     DPN   P G P PP  F F     +  + + L KLI
Sbjct: 301 KEALEHPYLQTYHDPN-DEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  285 bits (732), Expect = 7e-94
 Identities = 110/342 (32%), Positives = 163/342 (47%), Gaps = 33/342 (9%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 149
           +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              F     K  + L  V +F+   +  + K  S     +   ++K Y     + L Y+H
Sbjct: 78  LDAF---GHKSNISL--VFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 266
               + HRD+KP NLL++     +KL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 323
           GA  Y   +D+W+VGC+LAELLL  P  PG+S +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
           +Y    F      P H IF      + +DL+  L  ++P  R TA +A    +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 384 NARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
                   P P       +E    +  +  K      +   P
Sbjct: 300 GPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLP 341

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  282 bits (724), Expect = 2e-92
 Identities = 107/340 (31%), Positives = 180/340 (52%), Gaps = 33/340 (9%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQD----KR-YKNRELQTMRLLDHPN 145
           Y     +G+G++G+V  A        VAIKK+   +     +R    RE++ +    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 146 VVSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           ++ +       +     ++Y+  V + +   +Y++ K     +Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHICYFLYQILR 139

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYY 259
            L YIH    V HRD+KP NLL+N  T  +K+CDFG A+V      +      Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           RAPE++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 320 CM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           C+ N     +    P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 377 FDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
            ++  DP+   P        F F   EL    KE L +LI
Sbjct: 317 LEQYYDPS-DEP---IAEAPFKF-DMELDDLPKEKLKELI 351

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  281 bits (720), Expect = 2e-92
 Identities = 90/313 (28%), Positives = 157/313 (50%), Gaps = 41/313 (13%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G V++A    T ETVAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                    L+L  + E+    +    K Y   +  + +  +K + YQ+   + + H   
Sbjct: 102 I---HHNHRLHL--IFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 213 GVCHRDIKPQNLLVNPHTH----QVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 265
              HRD+KPQNLL++         +K+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 322
            G+  Y+T++DIWS+ C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
           P++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A  A  HP+F     
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325

Query: 383 PNARLPNGRPFPP 395
                     F P
Sbjct: 326 ---------DFDP 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  279 bits (716), Expect = 5e-92
 Identities = 102/294 (34%), Positives = 164/294 (55%), Gaps = 27/294 (9%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           VG+G++G+V++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                 +  L L  V EF+      + K        +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 326
           +Y+T++DIWS+GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
           +  F   +  PW  I       E +DL+S +L + PN R +A +A  HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  279 bits (715), Expect = 3e-91
 Identities = 102/337 (30%), Positives = 168/337 (49%), Gaps = 32/337 (9%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y   + VG G++G V  A    TG  VAIKK+          +   REL+ ++ + H NV
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 147 VSLKHCFF---STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           + L   F    +  D  + YL  V+ F+   + ++ K      +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 262
            L YIH   G+ HRD+KP NL VN     +K+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 321
           E+I     YT  +DIWSVGC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 322 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           +     +    P+++   +  I      P AV+L+ ++L      R TA EA  HP+F+ 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
           L D     P  + +   F     +    + +   ++ 
Sbjct: 314 LHDTEDE-PQVQKYDDSF-----DDVDRTLDEWKRVT 344

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  275 bits (706), Expect = 9e-91
 Identities = 101/294 (34%), Positives = 157/294 (53%), Gaps = 28/294 (9%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                 K  L L  V E +      + K        +  +  K +  Q+   +AY H   
Sbjct: 69  I---HTKKRLVL--VFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 326
           +Y+T IDIWSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
           +  F   +  PW     K +    +DL+S++L+  PN R TA +A  H +F E 
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  276 bits (708), Expect = 1e-90
 Identities = 94/318 (29%), Positives = 159/318 (50%), Gaps = 37/318 (11%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 149
           +G G++  V++     TG  VA+K+V    +  +         RE+  M+ L H N+V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS--QRMPLIYVKLYTYQICRALAY 207
                    +++L L  V EF+   + +     +  +  + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 264
            H    + HRD+KPQNLL+N    Q+KL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 321
           + G+  Y+T+IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 322 NPNYTEFKFPQIKAHPWHKIFHK----RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            P Y      Q       ++        +    +D +  LLQ +P++R +A +A  HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 378 DELRDPNARLPNGRPFPP 395
            E     A +   R    
Sbjct: 298 AEYYHH-ASMGGSRSHHH 314

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  277 bits (710), Expect = 2e-90
 Identities = 104/337 (30%), Positives = 171/337 (50%), Gaps = 32/337 (9%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y++   VG G++G V  A    +GE VAIKK+          +   REL  ++ + H NV
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 147 VSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           + L   F   +      + YL  V+ F+   + ++         +     ++   YQ+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 262
            L YIH   GV HRD+KP NL VN     +K+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYRAP 192

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 321
           E+I     Y   +DIWSVGC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ + 
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252

Query: 322 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
           +     +    PQ     + ++F  R  P+A DL+ ++L+   + R TA +A  HPFF+ 
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
            RDP       +PF    + + ++L   + +   + I
Sbjct: 312 FRDPEEETEAQQPFD--DSLEHEKL---TVDEWKQHI 343

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  274 bits (703), Expect = 2e-89
 Identities = 105/339 (30%), Positives = 170/339 (50%), Gaps = 36/339 (10%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
           Y     VG G++G V  A   +TG  VA+KK+ +        KR Y  REL+ ++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 145 NVVSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
           NV+ L   F      +   ++YL  V   +   +  + K      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYR 260
            R L YIH    + HRD+KP NL VN    ++K+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++     Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 321 M-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
           + + +   +     Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 378 DELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
            +  DP+   P   P+    + + ++L     +    L 
Sbjct: 316 AQYHDPDDE-PVADPYD--QSLESRDL---LIDEWKSLT 348

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  270 bits (693), Expect = 7e-89
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 28/298 (9%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                   +L L  V EF       + K++   +  +    VK + +Q+ + L + H   
Sbjct: 70  L---HSDKKLTL--VFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
            V HRD+KPQNLL+N    ++KL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 270 EYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 325
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
             +            +   ++     DL+  LL+ +P  R +A EA  HP+F +   P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  271 bits (696), Expect = 5e-88
 Identities = 102/369 (27%), Positives = 180/369 (48%), Gaps = 61/369 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL---QD----KR-YKNRELQTMRLL-DH 143
           Y   + +G+G++GIV+++    TGE VA+KK+    Q+    +R +  RE+  +  L  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
            N+V+L +   +  D+D +YL  V +++   ++ V +     +  +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----------- 252
            + Y+H G G+ HRD+KP N+L+N   H VK+ DFG ++  V      +           
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 253 -----------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
                      Y+ +R+YRAPE++ G+T+YT  ID+WS+GC+L E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 302 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFHKRMP----------- 347
           QL  II V+  P+ E+++ + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 348 ----PEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQE 403
                EA+DL+ +LLQ++PN R +A +A  HPF     +PN             N   + 
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358

Query: 404 LKGASKELL 412
                + L+
Sbjct: 359 SIDDYRNLV 367

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  270 bits (692), Expect = 1e-87
 Identities = 101/350 (28%), Positives = 165/350 (47%), Gaps = 45/350 (12%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQD----KR-YKNRELQTMRLLDHP 144
           Y   + +G G+ GIV  A        VAIKK+    Q+    KR Y  REL  M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 145 NVVSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPL--IYVKLYTY 199
           N++ L + F      +   ++Y+  V+E +   + +V         +M L    +    Y
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVI--------QMELDHERMSYLLY 134

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           Q+   + ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYY
Sbjct: 135 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           RAPE+I G   Y   +DIWSVGC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K
Sbjct: 193 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251

Query: 320 CMNPNYTEF--KFPQIKAHPWHKIFHKRMP-----------PEAVDLVSRLLQYSPNLRC 366
            + P    +    P+   + + K+F   +             +A DL+S++L    + R 
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

Query: 367 TALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
           +  EA  HP+ +   DP+       P  P      +E    + E   +LI
Sbjct: 312 SVDEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREH---TIEEWKELI 357

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  272 bits (698), Expect = 2e-87
 Identities = 109/392 (27%), Positives = 161/392 (41%), Gaps = 83/392 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
           Y    ++G GS+G V +A        VAIKK+L+        KR    RE+  +  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 145 NVVSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           +VV +            DELY  +VLE       ++     R    +  +++K   Y + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLF----RTPVYLTELHIKTLLYNLL 166

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------- 252
             + Y+H   G+ HRD+KP N LVN     VK+CDFG A+ +   E   S          
Sbjct: 167 VGVKYVHSA-GILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 253 ------------------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL----- 289
                             ++ +R+YRAPELI     YT AID+WS+GC+ AELL      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 290 ------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM-N 322
                   PLFPG S                      DQL  I  +LGTP+ E+I+ +  
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

Query: 323 PNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
            +   +   FP+ +     + F      +A+ L+ R+L ++PN R T  E   HPFF E+
Sbjct: 345 EDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

Query: 381 RDPNARLPNGRPFPPLFNFKPQELKGASKELL 412
           R               FN      +   +   
Sbjct: 404 RIAEVETNATEKVRLPFNDWMNMDEPQLRYAF 435

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  266 bits (682), Expect = 5e-87
 Identities = 85/304 (27%), Positives = 140/304 (46%), Gaps = 32/304 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 146
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V L     ++    E+ + LV E V + +             +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDLMRQFLRGLD 134

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
           ++H    + HRD+KP+N+LV      VKL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++  +T Y T +D+WSVGC+ AE+   +PLF G S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
                    FP     P   +    M      L+  +L ++P+ R +A  A  H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

Query: 381 RDPN 384
            + N
Sbjct: 304 -EGN 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  265 bits (680), Expect = 2e-86
 Identities = 97/314 (30%), Positives = 151/314 (48%), Gaps = 33/314 (10%)

Query: 99  VGQGSFGIVFQAK-CLETGETVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNVV 147
           +G+G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNVV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L      +    E  L LV E V + +             +P   +K   +Q+ R L +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDF 135

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 264
           +H    V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEV 190

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +  ++ Y T +D+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P 
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245

Query: 325 YTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
                   F    A P  K     +     DL+ + L ++P  R +A  A  HP+F +L 
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304

Query: 382 DPNARLPNGRPFPP 395
                L +    PP
Sbjct: 305 RCKENLDS--HLPP 316

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  265 bits (680), Expect = 4e-86
 Identities = 92/343 (26%), Positives = 148/343 (43%), Gaps = 37/343 (10%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK-- 150
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 151 -HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
                S  ++ +  + LV +F     + +A   S    +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV--LVKGEPNISY---ICSRYYRAPEL 264
               + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 321
           + G  +Y   ID+W  GC++AE+    P+  G +   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 322 NPNYTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
              Y + +  + +              P A+DL+ +LL   P  R  + +A  H FF   
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318

Query: 381 RDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
                      P P            +  E L+   P      
Sbjct: 319 -----------PMPSDLKGMLSTHLTSMFEYLAP--PRRKHHH 348

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  269 bits (689), Expect = 4e-86
 Identities = 94/331 (28%), Positives = 157/331 (47%), Gaps = 38/331 (11%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
           Y   + +G G+ GIV  A        VAIKK+ +        KR Y  REL  M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 145 NVVSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
           N++SL + F      +   ++YL  V+E +   + +V +        +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERMSYLLYQM 173

Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
              + ++H   G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE+I G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 322 NPNYTEF--KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTA 368
            P    +    P+     + K+F           +K    +A DL+S++L   P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 369 LEACIHPFFDELRDPNARLP-NGRPFPPLFN 398
            +A  HP+ +   DP        + +    +
Sbjct: 351 DDALQHPYINVWYDPAEVEAPPPQIYDKQLD 381

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  267 bits (684), Expect = 9e-86
 Identities = 101/388 (26%), Positives = 162/388 (41%), Gaps = 79/388 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQD-KR-YKNRELQTMRLLDHP 144
           Y+ + ++G+GS+G V+ A    T + VAIKKV      L D KR    RE+  +  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 145 NVVSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
            ++ L            DELY+  VLE     + ++     +    +   ++K   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLF----KTPIFLTEEHIKTILYNLL 139

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------- 252
               +IH   G+ HRD+KP N L+N     VK+CDFG A+ +   +              
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 253 -------------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-------- 291
                        ++ +R+YRAPELI     YT +IDIWS GC+ AELL           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 292 ---PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 328
              PLFPG S                   DQL  I  ++GTPT +++K +  P   ++  
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP 388
            FP  K     + +   +  + ++L+  +L+++PN R T  +A  HP+  ++R       
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE-- 374

Query: 389 NGRPFPPLFNFKPQELKGASKELLSKLI 416
                         +    S+  L  + 
Sbjct: 375 --NFSTKKIILPFDDWMVLSETQLRYIF 400

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  250 bits (641), Expect = 1e-79
 Identities = 96/361 (26%), Positives = 163/361 (45%), Gaps = 53/361 (14%)

Query: 99  VGQGSFGIVFQAKCLE--TGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 154
           VG+G++G V++AK  +    +  A+K++       +  RE+  +R L HPNV+SL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHY-----SRASQRMPLIYVKLYTYQICRALAYIH 209
           S  D+    + L+ ++    ++ + K +     ++   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 210 GGIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVLVKGEPNISY------ICSRYYR 260
               V HRD+KP N+LV    P   +VK+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---------GVDQLVEIIKVLG 311
           APEL+ GA  YT AIDIW++GC+ AELL  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 312 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP 362
            P  +         E   +  ++    +       + +    +   +A  L+ +LL   P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 363 NLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARK 422
             R T+ +A   P+F E            P P    F   ++    +E L++  P+    
Sbjct: 323 IKRITSEQAMQDPYFLED-----------PLPTSDVFAGCQIPYPKREFLTEEEPDDKGD 371

Query: 423 Q 423
           +
Sbjct: 372 K 372

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  213 bits (545), Expect = 5e-65
 Identities = 95/383 (24%), Positives = 162/383 (42%), Gaps = 69/383 (18%)

Query: 43  PEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT---IGGRNGQPKQTISYMAERVV 99
             EI  + +  ++ +         G   + G  +      +  R         Y   +V+
Sbjct: 55  YPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYR---------YEVLKVI 105

Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL------DHPNVVSLK 150
           G+GSFG V +A   +  + VA+K V  +KR+      E++ +  L      +  NV+ + 
Sbjct: 106 GKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165

Query: 151 HCFFSTTDKDELYLN---LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
             F         + N   +  E +   +Y + K      Q   L  V+ + + I + L  
Sbjct: 166 ENF--------TFRNHICMTFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 208 IHGGIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           +H    + H D+KP+N LL       +K+ DFGS+      +   +YI SR+YRAPE+I 
Sbjct: 216 LHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVIL 272

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK------- 319
           GA  Y   ID+WS+GC+LAELL G PL PGE   DQL  +I++LG P+++ +        
Sbjct: 273 GA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331

Query: 320 ----CMNPNYTEFKF---------------PQIKAHPWHKIFHKRMPPEA----VDLVSR 356
                  P Y                     +++  P  + +   +        +D + +
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391

Query: 357 LLQYSPNLRCTALEACIHPFFDE 379
            L++ P +R T  +A  HP+   
Sbjct: 392 CLEWDPAVRMTPGQALRHPWLRR 414

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  209 bits (535), Expect = 3e-64
 Identities = 83/340 (24%), Positives = 139/340 (40%), Gaps = 44/340 (12%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL-----DHP 144
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 145 NVVSLKHC-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
           + +   H       F+    + +++ +V E + E +  + K Y    + +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGSAKVLVKGEPNISYI 254
           Q+   L Y+H   G+ H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIK 308
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP--------------EAVDLV 354
           +LG      ++        F   +       K+    +                E  D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 355 SRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP 394
           S +LQ  P  R  A     HP+  +           R   
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  209 bits (533), Expect = 8e-64
 Identities = 101/382 (26%), Positives = 159/382 (41%), Gaps = 74/382 (19%)

Query: 53  GERVEKEMEATVVDGNGTETGHIIVT---TIGGRNGQPKQTISYMAERVVGQGSFGIVFQ 109
                K+      DG   +    IV        R         Y  + ++G+GSFG V +
Sbjct: 22  SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDR---------YEIDSLIGKGSFGQVVK 72

Query: 110 AKCLETGETVAIKKVLQDKRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKD 160
           A      E VAIK +   K + N    E++ + L+          +V LK  F       
Sbjct: 73  AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM------ 126

Query: 161 ELYLN---LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCH 216
             + N   LV E +   +Y + ++ +   + + L   + +  Q+C AL ++    + + H
Sbjct: 127 --FRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIH 182

Query: 217 RDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 275
            D+KP+N LL NP    +K+ DFGS+     G+    YI SR+YR+PE++ G   Y  AI
Sbjct: 183 CDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGM-PYDLAI 239

Query: 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-----------CMNPN 324
           D+WS+GC+L E+  G+PLF G + VDQ+ +I++VLG P    +              +  
Sbjct: 240 DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGT 299

Query: 325 YTEFKFPQIKAH---PWHKIFH-----KRMPPEA----------------VDLVSRLLQY 360
           +   K    K     P  +  H     +   P                   DL+ R+L Y
Sbjct: 300 WNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359

Query: 361 SPNLRCTALEACIHPFFDELRD 382
            P  R     A  H FF +  D
Sbjct: 360 DPKTRIQPYYALQHSFFKKTAD 381

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  203 bits (518), Expect = 6e-62
 Identities = 80/363 (22%), Positives = 142/363 (39%), Gaps = 78/363 (21%)

Query: 71  ETGHIIV---TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD 127
           E  H        +            ++  R +G G+FG V   + ++  +  A+K V   
Sbjct: 21  EIVHFSWKKGMLLNNA---------FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI 71

Query: 128 KRYKN---RELQTMRLL-----DHPNVVSLKHCFFSTTDKDELYLN---LVLEFVPETVY 176
           K+Y      E   ++ +     ++ N+V     F        +Y +   L+ E +  ++Y
Sbjct: 72  KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF--------MYYDHMCLIFEPLGPSLY 123

Query: 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN-LLVNPHTH---- 231
            +    +       +  +KLY  +I +AL Y+   + + H D+KP+N LL +P+      
Sbjct: 124 EIITRNNY--NGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLI 180

Query: 232 -------------------QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
                               +KL DFG A    K + + S I +R YRAPE+I     + 
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWD 237

Query: 273 TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNP 323
            + D+WS GCVLAEL  G  LF     ++ L  +  ++    +  +         K +N 
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEA--------VDLVSRLLQYSPNLRCTALEACIHP 375
           +  +  +P+  +        K+  P           D +  +LQ  P LR +  E   H 
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357

Query: 376 FFD 378
           F +
Sbjct: 358 FLE 360

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  200 bits (512), Expect = 3e-61
 Identities = 84/361 (23%), Positives = 142/361 (39%), Gaps = 72/361 (19%)

Query: 72  TGHIIVTT---IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQD 127
           + H+I  +   +  R         Y     +G+G+FG V +    + G   VA+K V   
Sbjct: 1   SMHLICQSGDVLSAR---------YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV 51

Query: 128 KRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKDELYLN---LVLEFVPETV 175
            RY      E+Q +  L           V +   F         +     +V E +  + 
Sbjct: 52  DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE--------HHGHICIVFELLGLST 103

Query: 176 YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-------- 227
           Y   K          L +++   YQIC+++ ++H    + H D+KP+N+L          
Sbjct: 104 YDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAY 160

Query: 228 ----------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDI 277
                          +K+ DFGSA      E + + + +R+YRAPE+I     ++   D+
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDV 217

Query: 278 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK---------CMNPNYTEF 328
           WS+GC+L E  LG  +FP     + L  + ++LG   +  I+             ++ E 
Sbjct: 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277

Query: 329 KFPQIKAHPWHKIFHKRMPPE------AVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
                      K   + M  +        DL+ ++L+Y P  R T  EA  HPFFD L+ 
Sbjct: 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

Query: 383 P 383
            
Sbjct: 338 S 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  199 bits (509), Expect = 1e-60
 Identities = 81/371 (21%), Positives = 138/371 (37%), Gaps = 72/371 (19%)

Query: 71  ETGHIIVT---TIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQ 126
           + GH++      +  R         Y     +G+G+FG V +      G   VA+K +  
Sbjct: 5   KEGHLVCRIGDWLQER---------YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN 55

Query: 127 DKRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKDELYLN---LVLEFVPET 174
             +Y+     E+  ++ +      +    V +   F         +     +  E + + 
Sbjct: 56  VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF--------NFHGHMCIAFELLGKN 107

Query: 175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN------- 227
            +   K  +   Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L         
Sbjct: 108 TFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETL 164

Query: 228 -----------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID 276
                           +++ DFGSA      E + + + +R+YR PE+I     +    D
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCD 221

Query: 277 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTE 327
           +WS+GC+L E   G  LF      + LV + K+LG      I               + E
Sbjct: 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE 281

Query: 328 FKFPQIKAHPWHKIFHKRMPPEA------VDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
                       K     M  ++       DL+ R+L++ P  R T  EA +HPFF  L 
Sbjct: 282 NSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341

Query: 382 DPNARLPNGRP 392
                    R 
Sbjct: 342 PEERSFHTSRN 352

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  194 bits (495), Expect = 5e-59
 Identities = 67/301 (22%), Positives = 105/301 (34%), Gaps = 65/301 (21%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHP 144
           S+     +G GS+G VF+ +  E G   A+K+     +  + + R+L  +        HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
             V L+  +    +   LY  L  E    +   + +H       +P   V  Y      A
Sbjct: 118 CCVRLEQAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLA 169

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           LA++H   G+ H D+KP N+ + P     KL DFG    L              Y APEL
Sbjct: 170 LAHLH-SQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +     Y TA D++S+G  + E+     L  G                            
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHG---------------------------- 257

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPP--------EAVDLVSRLLQYSPNLRCTALEACIHPF 376
                        W ++    +PP        E   ++  +L+  P LR TA      P 
Sbjct: 258 ----------GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307

Query: 377 F 377
            
Sbjct: 308 L 308

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  189 bits (481), Expect = 7e-57
 Identities = 70/326 (21%), Positives = 112/326 (34%), Gaps = 56/326 (17%)

Query: 77  VTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKN 132
           +  I  ++        Y+  + +G+G F  V   + L  G   A+K++L    QD+    
Sbjct: 23  MVIIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74

Query: 133 RELQTMRLLDHPNVVSLKHCFF-STTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMP 190
           RE    RL +HPN++ L          K E +  L+L F    T++   +        + 
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--- 247
              +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS          
Sbjct: 133 EDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEG 190

Query: 248 -------EPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
                  +   +  C+  YRAPEL             D+WS+GCVL  ++ G+  +    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 358
                V +  V                 +   PQ            R       L++ ++
Sbjct: 251 QKGDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMM 284

Query: 359 QYSPNLRCTALEACIHPFFDELRDPN 384
              P+ R             +   P 
Sbjct: 285 TVDPHQRPHIPLLLSQLEALQPPAPG 310

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  190 bits (483), Expect = 9e-57
 Identities = 47/350 (13%), Positives = 92/350 (26%), Gaps = 65/350 (18%)

Query: 83  RNGQPKQTIS--------YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK--- 131
                    S              +  G   +VF  + +E  E  A+K            
Sbjct: 46  PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105

Query: 132 ----NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN---------------------L 166
               +        L   +    +         D + +                      L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 167 VLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
           ++       E ++              ++ + + T Q+ R  A +    G+ H    P N
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ-SKGLVHGHFTPDN 224

Query: 224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGC 282
           L + P    + L D  +   +  G    +      Y   E +      +T A++ W +G 
Sbjct: 225 LFIMPDGR-LMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 283 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 342
            +  +      F   +   +       L  P  +                          
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGS 321

Query: 343 HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD-PNARLPNGR 391
              +P     L+ R L +    R   LEA   P F +L++  ++ L  G+
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  188 bits (479), Expect = 1e-56
 Identities = 70/356 (19%), Positives = 125/356 (35%), Gaps = 68/356 (19%)

Query: 56  VEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLET 115
           +      +     GTE  +    ++ GR         Y   + +G G    VFQ    E 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVLN-EK 51

Query: 116 GETVAIKKV----LQDKRYKN--RELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLV 167
            +  AIK V      ++   +   E+  +  L   +  ++ L           + Y+ +V
Sbjct: 52  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMV 106

Query: 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227
           +E     +    K      + +     K Y   +  A+  IH   G+ H D+KP N L+ 
Sbjct: 107 MECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLI- 160

Query: 228 PHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGA----------TEYTTA 274
                +KL DFG A  +     ++   S + +  Y  PE I             ++ +  
Sbjct: 161 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219

Query: 275 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334
            D+WS+GC+L  +  G+  F         +  I             ++PN+ E +FP I 
Sbjct: 220 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDI- 264

Query: 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNG 390
                         +  D++   L+  P  R +  E   HP+      P  ++  G
Sbjct: 265 -----------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  189 bits (482), Expect = 3e-56
 Identities = 69/353 (19%), Positives = 121/353 (34%), Gaps = 69/353 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 145
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 146 -VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            ++ L           + Y+ +V+E     +    K      + +     K Y   +  A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 261
           +  IH   G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 168 VHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 262 PELIFGA----------TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
           PE I             ++ +   D+WS+GC+L  +  G+  F         +  I    
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280

Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
                    ++PN+ E +FP I               +  D++   L+  P  R +  E 
Sbjct: 281 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 318

Query: 372 CIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
             HP+               P   +     +E+K    +L+    P    K  
Sbjct: 319 LAHPYVQ---------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 362

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  187 bits (478), Expect = 3e-56
 Identities = 69/353 (19%), Positives = 121/353 (34%), Gaps = 69/353 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 145
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 146 -VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            ++ L           + Y+ +V+E     +    K      + +     K Y   +  A
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 261
           +  IH   G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 121 VHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 262 PELIFG----------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
           PE I             ++ +   D+WS+GC+L  +  G+  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
                    ++PN+ E +FP I               +  D++   L+  P  R +  E 
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 372 CIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
             HP+               P   +     +E+K    +L+    P    K  
Sbjct: 272 LAHPYVQ---------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 315

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  186 bits (475), Expect = 8e-55
 Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 51/301 (16%)

Query: 91  ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 148
           IS+  + V+G G+ G +   + +     VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
                     KD  +  + +E    T+   V +         P+  ++    Q    LA+
Sbjct: 83  YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 208 IHGGIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAKVLVKGEPNISY---IC-SRYY 259
           +H  + + HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 260 RAPELIFGATE--YTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316
            APE++    +   T  +DI+S GCV   ++  G   F                G   + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236

Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +   +               P            A +L+ +++   P  R +A     HPF
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 377 F 377
           F
Sbjct: 287 F 287

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  181 bits (462), Expect = 1e-54
 Identities = 74/299 (24%), Positives = 118/299 (39%), Gaps = 45/299 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           V          D+    L +V+E+     +  V    ++  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 206 AYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 260
              H    GG  V HRD+KP N+ ++     VKL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           +PE +     Y    DIWS+GC+L EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                 E KF +I           R   E  ++++R+L      R +  E   +P   E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  180 bits (458), Expect = 1e-53
 Identities = 57/304 (18%), Positives = 112/304 (36%), Gaps = 27/304 (8%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 147
           ++   ++GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L      TT      L  ++EF P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 206 AYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 263 ELIFGAT-------EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTP 313
           ++   A        +Y   +D+WS+G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
           +               +      P      + +      +++ +L+          +   
Sbjct: 245 SGAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 374 HPFF 377
               
Sbjct: 303 ETSD 306

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  178 bits (454), Expect = 3e-53
 Identities = 77/306 (25%), Positives = 126/306 (41%), Gaps = 54/306 (17%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
            V+G+G++GIV+  + L     +AIK++  +D RY      E+   + L H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 153 FFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
            +  +  +  ++ + +E VP      + R    +         I    YT QI   L Y+
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTI--GFYTKQILEGLKYL 138

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFG 267
           H    + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  
Sbjct: 139 HDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197

Query: 268 ATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               Y  A DIWS+GC + E+  G+P F       +L E    +                
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM---------------- 235

Query: 327 EFKFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
            FK    K HP        +P     EA   + +  +  P+ R  A +  +  F      
Sbjct: 236 -FKVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

Query: 383 PNARLP 388
                P
Sbjct: 288 KKKTQP 293

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  181 bits (462), Expect = 6e-53
 Identities = 76/314 (24%), Positives = 131/314 (41%), Gaps = 60/314 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMR-LLDHPNVVSLK 150
            ++E+++G GS G V   +    G  VA+K++L D       E++ +    DHPNV+   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY- 74

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVY-RVAKH--YSRASQRMPLIYVKLYTYQICRALAY 207
           +C  +      LY+   LE     +   V          +            QI   +A+
Sbjct: 75  YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGE----PNI 251
           +H  + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     N+
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 252 SYIC-SRYYRAPELIFGATE------YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
           +    +  +RAPEL+  +         T +IDI+S+GCV   +L  G+  F  +    + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247

Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363
             II+                   F   ++K      +       EA DL+S+++ + P 
Sbjct: 248 SNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285

Query: 364 LRCTALEACIHPFF 377
            R TA++   HP F
Sbjct: 286 KRPTAMKVLRHPLF 299

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  177 bits (451), Expect = 1e-52
 Identities = 82/332 (24%), Positives = 126/332 (37%), Gaps = 66/332 (19%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 139
           P+    Y+  R +G+G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYT 198
            L H +VV     F    D D +++  VLE     ++        +  + +     + Y 
Sbjct: 71  SLAHQHVVGFHGFF---EDNDFVFV--VLELCRRRSLL----ELHKRRKALTEPEARYYL 121

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE--------P 249
            QI     Y+H    V HRD+K  NL +N    +VK+ DFG + KV   GE        P
Sbjct: 122 RQIVLGCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179

Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
           N        Y APE++     ++  +D+WS+GC++  LL+G+P F      +  + I K 
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230

Query: 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
                            E+  P              + P A  L+ ++LQ  P  R T  
Sbjct: 231 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 261

Query: 370 EACIHPFFDELRDPNARLPNGRPFPPLFNFKP 401
           E     FF     P          PP F+  P
Sbjct: 262 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 293

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  177 bits (452), Expect = 2e-52
 Identities = 85/346 (24%), Positives = 134/346 (38%), Gaps = 66/346 (19%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 139
           P+    Y+  R +G+G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYT 198
            L H +VV     F    D D +++  VLE     ++        +  + +     + Y 
Sbjct: 97  SLAHQHVVGFHGFF---EDNDFVFV--VLELCRRRSLL----ELHKRRKALTEPEARYYL 147

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE--------P 249
            QI     Y+H    V HRD+K  NL +N    +VK+ DFG + KV   GE        P
Sbjct: 148 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205

Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
           N        Y APE++     ++  +D+WS+GC++  LL+G+P F      +  + I K 
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256

Query: 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
                            E+  P              + P A  L+ ++LQ  P  R T  
Sbjct: 257 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 287

Query: 370 EACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKL 415
           E     FF     P          PP F+  P  L  ++++ L+ L
Sbjct: 288 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 333

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  181 bits (460), Expect = 6e-52
 Identities = 72/309 (23%), Positives = 125/309 (40%), Gaps = 52/309 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
           Y   + +G G++G V   +   T    AIK +               E+  ++LLDHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYTYQIC 202
           + L   F     +D+    LV+E     E    +     ++            +   Q+ 
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------DAAVIIKQVL 146

Query: 203 RALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYR 260
             + Y+H    + HRD+KP+N LL +      +K+ DFG + V    +     + + YY 
Sbjct: 147 SGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++    +Y    D+WS+G +L  LL G P F G++  DQ  EI+         +++ 
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
               +            W  +        A DL+ ++LQ+    R +A +A  HP+  E+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

Query: 381 RDPNARLPN 389
                    
Sbjct: 299 CSKKESGIE 307

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  175 bits (446), Expect = 7e-52
 Identities = 65/313 (20%), Positives = 112/313 (35%), Gaps = 61/313 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 149
           +    V+GQG+FG V +A+        AIKK+   +   +    E+  +  L+H  VV  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 150 KHCFFSTTDKDEL--------YLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTY 199
              +    +  +          L + +E+         +        +       +    
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR---- 123

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 257
           QI  AL+YIH   G+ HRD+KP N+ ++  +  VK+ DFG AK + +    +        
Sbjct: 124 QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 258 -------------YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
                         Y A E++ G   Y   ID++S+G +  E++   P   G       V
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RV 235

Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
            I+K L +                +FP     P    F          ++  L+ + PN 
Sbjct: 236 NILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNK 274

Query: 365 RCTALEACIHPFF 377
           R  A       + 
Sbjct: 275 RPGARTLLNSGWL 287

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  175 bits (446), Expect = 7e-52
 Identities = 78/302 (25%), Positives = 123/302 (40%), Gaps = 60/302 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 145
           +  E+ +G+G F  V++A CL  G  VA+KKV        + +    +E+  ++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           V+     F    + +EL   +VLE      + R+ KH+ +  + +P   V  Y  Q+C A
Sbjct: 94  VIKYYASFI---EDNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYIC 255
           L ++H    V HRDIKP N+ +   T  VKL D G  +           + G P      
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200

Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPT 314
             YY +PE I     Y    DIWS+GC+L E+   Q  F G+   +  L + I+      
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                       +  +P + +             E   LV+  +   P  R         
Sbjct: 252 ------------QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 375 PF 376
             
Sbjct: 292 AK 293

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  179 bits (457), Expect = 1e-51
 Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 53/298 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHPN 145
           Y  +RV+G+GSFG V   K   TG+  A+K +    ++ K  K    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYTYQI 201
           ++ L   F     +D+ Y  LV E     E    +     +S                Q+
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135

Query: 202 CRALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYY 259
              + Y+H    + HRD+KP+N LL +      +++ DFG +      +     I + YY
Sbjct: 136 LSGITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
            APE++ G   Y    D+WS G +L  LL G P F G +  +   +I+        ++++
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVE 240

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                +            W K+        A DL+ ++L Y P++R +A +A  H + 
Sbjct: 241 KGKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  179 bits (457), Expect = 1e-51
 Identities = 74/309 (23%), Positives = 128/309 (41%), Gaps = 52/309 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
           Y    ++G+GSFG V + K   T +  A+K +       +D     RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYTYQIC 202
           + L         +D     +V E     E    + K   +S                Q+ 
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131

Query: 203 RALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYR 260
             + Y+H    + HRD+KP+N LL +      +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++ G   Y    D+WS G +L  LL G P F G++  +   +I+        + ++ 
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
               +            W  I       +A DL+ ++L + P+LR TA +   HP+  + 
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

Query: 381 RDPNARLPN 389
                 + +
Sbjct: 284 SSETPTISD 292

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  172 bits (439), Expect = 4e-51
 Identities = 60/295 (20%), Positives = 101/295 (34%), Gaps = 46/295 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 152
           +    ++G G FG VF+AK    G+T  IK+V  +     RE++ +  LDH N+V    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRV----------AKHYSRASQRMPLIYVKLYTYQIC 202
           +       E           + ++                 R  +++  +       QI 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
           + + YIH    + +RD+KP N+ +   T QVK+ DFG    L           +  Y +P
Sbjct: 133 KGVDYIH-SKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E I    +Y   +D++++G +LAELL                ++                
Sbjct: 191 EQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD-------------- 233

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                             I       +   L+ +LL   P  R    E       
Sbjct: 234 -----------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  172 bits (439), Expect = 5e-51
 Identities = 73/320 (22%), Positives = 137/320 (42%), Gaps = 66/320 (20%)

Query: 85  GQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQ 136
               + I  +    ++G+GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVK 195
               L HP+++ L + F    D + +Y  LVLE      + R  K+  +          +
Sbjct: 64  IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLKNRVK---PFSENEAR 115

Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE------ 248
            + +QI   + Y+H   G+ HRD+   NLL+  +   +K+ DFG + ++ +  E      
Sbjct: 116 HFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC 173

Query: 249 --PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
             PN        Y +PE+    + +    D+WS+GC+   LL+G+P F  ++  + L ++
Sbjct: 174 GTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224

Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
           +                   +++ P      +       +  EA DL+ +LL+ +P  R 
Sbjct: 225 VLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRL 255

Query: 367 TALEACIHPFFDELRDPNAR 386
           +      HPF        ++
Sbjct: 256 SLSSVLDHPFMSRNSSTKSK 275

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  173 bits (441), Expect = 8e-51
 Identities = 64/315 (20%), Positives = 116/315 (36%), Gaps = 48/315 (15%)

Query: 71  ETGHIIVTTIGGRNGQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDK 128
             G ++   +   + + ++ +     +  VG+GSFG V + K  +TG   A+KKV L+  
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95

Query: 129 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQ 187
            ++  EL     L  P +V L         ++  ++N+ +E +   ++ ++ K       
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGC--- 146

Query: 188 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247
            +P      Y  Q    L Y+H    + H D+K  N+L++    +  LCDFG A  L   
Sbjct: 147 -LPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 248 EPNISYICSR------YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
               S +          + APE++ G       +DIWS  C++  +L G   +       
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
             ++I      P                  +I              P     +   L+  
Sbjct: 264 LCLKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKE 297

Query: 362 PNLRCTALEACIHPF 376
           P  R +A+E      
Sbjct: 298 PVHRASAMELRRKVG 312

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  171 bits (436), Expect = 1e-50
 Identities = 80/308 (25%), Positives = 129/308 (41%), Gaps = 64/308 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  ++   +A+K     ++ +        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F    D   +Y  L+LE+ P  TVYR      +   +        Y  ++  AL+Y 
Sbjct: 75  YGYFH---DATRVY--LILEYAPLGTVYR----ELQKLSKFDEQRTATYITELANALSYC 125

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYRA 261
           H    V HRDIKP+NLL+      +K+ DFG +            G  +        Y  
Sbjct: 126 H-SKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLP 175

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE+I G   +   +D+WS+G +  E L+G+P F   +  +    I +V            
Sbjct: 176 PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
                EF FP      +       +   A DL+SRLL+++P+ R    E   HP+     
Sbjct: 223 -----EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265

Query: 382 DPNARLPN 389
              +   N
Sbjct: 266 SKPSNCQN 273

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  171 bits (436), Expect = 1e-50
 Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 56/297 (18%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 151
            +G+GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
            + ST    +  + LV E +   T+    K +    + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147

Query: 211 -GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAP 262
               + HRD+K  N+ +   T  VK+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E+     +Y  ++D+++ G  + E+   +  +       Q+                   
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------- 238

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                ++       P    F K   PE  +++   ++ + + R +  +   H FF E
Sbjct: 239 -----YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  174 bits (443), Expect = 2e-50
 Identities = 61/309 (19%), Positives = 117/309 (37%), Gaps = 32/309 (10%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 147
           ++   ++GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L      TT      L  ++EF P       + +  +  +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125

Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 263 ELIFGAT-------EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTP 313
           ++   A        +Y   +D+WS+G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
           +               +      P      + +      +++ +L+          +   
Sbjct: 245 SGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299

Query: 374 HPFFDELRD 382
             FF E  D
Sbjct: 300 --FFAETSD 306

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  177 bits (450), Expect = 2e-50
 Identities = 79/308 (25%), Positives = 125/308 (40%), Gaps = 63/308 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------------REL 135
           Y   R +G G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPL 191
             ++ LDHPN++ L   F     +D+ Y  LV EF    E   ++     +         
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146

Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEP 249
                   QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K   
Sbjct: 147 -DAANIMKQILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
               + + YY APE++    +Y    D+WS G ++  LL G P F G++  DQ  +II  
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256

Query: 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
                 ++++     +          + W  I       EA +L+  +L Y  N RCTA 
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297

Query: 370 EACIHPFF 377
           EA    + 
Sbjct: 298 EALNSRWI 305

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  172 bits (439), Expect = 2e-50
 Identities = 72/313 (23%), Positives = 122/313 (38%), Gaps = 47/313 (15%)

Query: 74  HIIVTTIGGRNGQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQ 126
           H       G      Q++  Y+  + +G+GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 127 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRA 185
           ++    RE+  +  + HPN+V  +  F    +   LY  +V+++     +++     ++ 
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRIN--AQK 118

Query: 186 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245
                   +  +  QIC AL ++H    + HRDIK QN+ +      V+L DFG A+VL 
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176

Query: 246 KGEPNISYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
                      + YY +PE+      Y    DIW++GCVL EL   +  F   S +  LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234

Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
             I             ++ +Y                       +   LVS+L + +P  
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267

Query: 365 RCTALEACIHPFF 377
           R +        F 
Sbjct: 268 RPSVNSILEKGFI 280

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  172 bits (437), Expect = 4e-50
 Identities = 62/328 (18%), Positives = 128/328 (39%), Gaps = 52/328 (15%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN----------------REL 135
           R + QG F  +   +  +  +  A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRASQRMP 190
           Q +  + +   ++ +      T+ DE+Y+  + E++      +            +  +P
Sbjct: 95  QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250
           +  +K     +  + +YIH    +CHRD+KP N+L++ +   VKL DFG ++ +V  +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206

Query: 251 ISYIC-SRYYRAPELIFGATEY-TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
           I     +  +  PE     + Y    +DIWS+G  L  +      F  +  + +L   I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
                  + I+   P      F     +      +  +  E +D +   L+ +P  R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

Query: 369 LEACIHPFF-----DELRDPNARLPNGR 391
            +A  H +      ++LR+ +  L   R
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYKKR 345

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  172 bits (437), Expect = 1e-49
 Identities = 81/321 (25%), Positives = 126/321 (39%), Gaps = 44/321 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLDHPNVVS 148
           Y     +G G+FG+V +     TG     K        DK     E+  M  L HP +++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L   F    DK E+ L  +LEF+   E   R+A    + S+      V  Y  Q C  L 
Sbjct: 113 LHDAF---EDKYEMVL--ILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163

Query: 207 YIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
           ++H    + H DIKP+N++        VK+ DFG A  L   E       +  + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                     D+W++G +   LL G   F GE  ++ L  + +                 
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-DELRDPN 384
            +++F       +  +      PEA D +  LLQ  P  R T  +A  HP+   +  +  
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316

Query: 385 ARLPNGRPFPPLFNFKPQELK 405
           +R+P+ R        K +   
Sbjct: 317 SRIPSSRYNKIRQKIKEKYAD 337

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  170 bits (432), Expect = 2e-49
 Identities = 84/348 (24%), Positives = 136/348 (39%), Gaps = 84/348 (24%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL---------QDKRYKNRELQTMRLLDH 143
           Y  +  +GQGS+G+V  A   +T    AIK +          +D      E++ M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKL----- 196
           PN+  L   +     +DE Y+ LV+E       + ++      ++ +  +  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 197 ------------------------------YTYQICRALAYIHGGIGVCHRDIKPQN-LL 225
                                            QI  AL Y+H   G+CHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLF 201

Query: 226 VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTTAIDIWS 279
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 280 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
            G +L  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 340 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 387
            +      P A DL+S LL  + + R  A+ A  HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  168 bits (427), Expect = 3e-49
 Identities = 66/318 (20%), Positives = 119/318 (37%), Gaps = 60/318 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNVV 147
           +   + +G+G FG+VF+AK        AIK++        +    RE++ +  L+HP +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 148 SLKHCFF-------STTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTY 199
              + +              ++YL + ++    E +           +            
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFL 125

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 257
           QI  A+ ++H   G+ HRD+KP N+        VK+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLH-SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 258 -----------YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
                       Y +PE I G   Y+  +DI+S+G +L ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
           ++                    KFP +           +  P    +V  +L  SP  R 
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272

Query: 367 TALEACIHPFFDELRDPN 384
            A+    +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  167 bits (425), Expect = 5e-49
 Identities = 83/307 (27%), Positives = 131/307 (42%), Gaps = 52/307 (16%)

Query: 85  GQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM 138
           G  K  I+  Y  E  +G+GS+G V  A    T    A K      ++D     +E++ M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYV 194
           + LDHPN++ L   F     +D   + LV+E     E   RV     +  +         
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108

Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNIS 252
                 +  A+AY H  + V HRD+KP+N L    +    +KL DFG A     G+   +
Sbjct: 109 ARIMKDVLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
            + + YY +P+++ G   Y    D WS G ++  LL G P F   +  + +++I +    
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222

Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                          F FP      W  +      P+A  L+ RLL  SP  R T+L+A 
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260

Query: 373 IHPFFDE 379
            H +F++
Sbjct: 261 EHEWFEK 267

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  171 bits (434), Expect = 5e-49
 Identities = 86/356 (24%), Positives = 151/356 (42%), Gaps = 64/356 (17%)

Query: 51  IKGERVEKEMEATVVDGN----GTETGHIIVTTIGGRNGQPKQTIS----YMAERVVGQG 102
           +  E V K     + + +          + V      + Q     +    Y+  + +G G
Sbjct: 87  VNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSG 146

Query: 103 SFGIVFQAKCLETGETVAIKKVLQDKRYKN------------RELQTMRLLDHPNVVSLK 150
           + G V  A   +T + VAI+ + + K                 E++ ++ L+HP ++ +K
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           + F    D ++ Y+  VLE +   E   +V  +     +R+     KLY YQ+  A+ Y+
Sbjct: 207 NFF----DAEDYYI--VLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYL 255

Query: 209 HGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C +  Y APE++
Sbjct: 256 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVL 313

Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
                  Y  A+D WS+G +L   L G P F        L + I   G            
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG------------ 360

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
              ++ F       W ++       +A+DLV +LL   P  R T  EA  HP+  +
Sbjct: 361 ---KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  168 bits (427), Expect = 6e-49
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 44/290 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVA---IKKVLQDKRYKNRELQTMRLLDHPNVVSL 149
           YM    +G+G FGIV +     + +T     +K    D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
              F      +EL   ++ EF+   +   R+       ++R     +  Y +Q+C AL +
Sbjct: 67  HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117

Query: 208 IHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           +H    + H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y APE +
Sbjct: 118 LH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                 +TA D+WS+G ++  LL G   F  E+  +Q  +II        E I      +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
            E  F +I               EA+D V RLL      R TA EA  HP
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  168 bits (428), Expect = 6e-49
 Identities = 78/345 (22%), Positives = 126/345 (36%), Gaps = 67/345 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR-LLDHPNVV 147
               RV+ +G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 148 SLKHCFF-----STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
                       S T + E    L+ E     +    K    +   +    V    YQ C
Sbjct: 90  QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146

Query: 203 RALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------------E 248
           RA+ ++H     + HRD+K +NLL++     +KLCDFGSA  +                E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 249 PNISYICSRYYRAPELI--FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
             I+   +  YR PE+I  +         DIW++GC+L  L   Q  F   +     + I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRI 261

Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
           +                   ++  P           H         L+  +LQ +P  R 
Sbjct: 262 VNG-----------------KYSIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294

Query: 367 TALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKEL 411
           +  E        E+        N  P  P+     Q     S  L
Sbjct: 295 SIAEVVHQLQ--EIAAA----RNVNPKSPITELLEQNGGYGSATL 333

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  166 bits (423), Expect = 9e-49
 Identities = 52/327 (15%), Positives = 95/327 (29%), Gaps = 90/327 (27%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHPN 145
           +     +G G FG VF+      G   AIK+    L     +   L+ +        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           VV     +    + D + +    E+    ++        R         +K    Q+ R 
Sbjct: 73  VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPH------------------THQVKLCDFGSAKVL-- 244
           L YIH  + + H DIKP N+ ++                        K+ D G    +  
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 245 ---VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
               +G+          + A E++     +    DI+++   +      +PL        
Sbjct: 187 PQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----- 233

Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP-------EAVDLV 354
                                               WH+I   R+P        E  +L+
Sbjct: 234 ---------------------------------GDQWHEIRQGRLPRIPQVLSQEFTELL 260

Query: 355 SRLLQYSPNLRCTALEACIHPFFDELR 381
             ++   P  R +A+    H       
Sbjct: 261 KVMIHPDPERRPSAMALVKHSVLLSAS 287

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  166 bits (422), Expect = 1e-48
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 66/297 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 149
           R +G+G FG V+ A+  +    +A+K     ++ ++       RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            + F    D+  +Y  L+LEF P  E    + KH      R        +  ++  AL Y
Sbjct: 80  YNYFH---DRKRIY--LMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHY 129

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYR 260
            H    V HRDIKP+NLL+      +K+ DFG +            G  +        Y 
Sbjct: 130 CH-ERKVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YL 179

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
            PE+I G   +   +D+W  G +  E L+G P F   S  +    I+ V           
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                 + KFP     P+       +   + DL+S+LL+Y P  R        HP+ 
Sbjct: 228 ------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  165 bits (421), Expect = 2e-48
 Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 58/323 (17%)

Query: 74  HIIVTTIGGRNGQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQ 126
           H    + G  N   + TI   ++ +R +G G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 127 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--------ETVYRV 178
                  E++ ++ LDHPN++ +   F     +D   + +V+E            +    
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 179 AKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLC 236
            K  S         YV     Q+  ALAY H    V H+D+KP+N+L    +    +K+ 
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHSPIKII 169

Query: 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
           DFG A++    E + +   +  Y APE+     + T   DIWS G V+  LL G   F G
Sbjct: 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG 227

Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
            S  +   +                     E  +               + P+AVDL+ +
Sbjct: 228 TSLEEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQ 261

Query: 357 LLQYSPNLRCTALEACIHPFFDE 379
           +L   P  R +A +   H +F +
Sbjct: 262 MLTKDPERRPSAAQVLHHEWFKQ 284

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  172 bits (438), Expect = 3e-48
 Identities = 84/374 (22%), Positives = 148/374 (39%), Gaps = 45/374 (12%)

Query: 27  PAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQ 86
           P +P         ++      ++  +G+ V  +   +    N                  
Sbjct: 93  PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLD 142
                 Y     +G G+FG+V +     TG   A K V      DK    +E+QTM +L 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
           HP +V+L   F    D +E+ +  + EF+   E   +VA  +++ S+   + Y++    Q
Sbjct: 213 HPTLVNLHDAF---EDDNEMVM--IYEFMSGGELFEKVADEHNKMSEDEAVEYMR----Q 263

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           +C+ L ++H      H D+KP+N++     ++++KL DFG    L   +       +  +
Sbjct: 264 VCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF 322

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
            APE+  G        D+WSVG +   LL G   F GE+  +            T   +K
Sbjct: 323 AAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVK 369

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-- 377
             + N  +  F  I               +  D + +LL   PN R T  +A  HP+   
Sbjct: 370 SCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416

Query: 378 DELRDPNARLPNGR 391
                 ++++P+ R
Sbjct: 417 GNAPGRDSQIPSSR 430

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  165 bits (421), Expect = 3e-48
 Identities = 78/308 (25%), Positives = 133/308 (43%), Gaps = 56/308 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 148
           ++   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+V+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIYVKLYTYQIC 202
           L+  +         Y  LV++ V   E   R + +  Y+   AS             Q+ 
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDASL---------VIQQVL 116

Query: 203 RALAYIHGGIGVCHRDIKPQNLLV-NPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYY 259
            A+ Y+H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y
Sbjct: 117 SAVKYLH-ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGY 173

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
            APE +     Y+ A+D WS+G +   LL G P F  E+      +I +           
Sbjct: 174 VAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG---------- 222

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                   ++F    +  W  I        A D +  LL+  PN R T  +A  HP+ D 
Sbjct: 223 -------YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

Query: 380 LRDPNARL 387
               +  +
Sbjct: 268 NTALHRDI 275

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  173 bits (440), Expect = 4e-48
 Identities = 77/318 (24%), Positives = 126/318 (39%), Gaps = 21/318 (6%)

Query: 81  GGRNGQPKQTI--SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----R 133
           GGR+          +  +  +G G FG V +    +TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN-LVLEFVP--ETVYRVAKHYSRASQRMP 190
           E+Q M+ L+HPNVVS +             L  L +E+    +    + +        + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119

Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGE 248
              ++     I  AL Y+H    + HRD+KP+N+++ P   +   K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
               ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
                + E I   +      KF  +   P H         +    +  +L +    R T 
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGTD 292

Query: 369 LEACIHPFFDELRDPNAR 386
            +      F  L    + 
Sbjct: 293 PQNPNVGCFQALDSILSL 310

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  166 bits (422), Expect = 4e-48
 Identities = 83/347 (23%), Positives = 144/347 (41%), Gaps = 64/347 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN--------RELQTMRL 140
           Y+  + +G G+ G V  A   +T + VAIK    +       +          E++ ++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKL 196
           L+HP ++ +K+ F    D ++ Y+  VLE +   E   +V        A+ +       L
Sbjct: 72  LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNKRLKEATCK-------L 118

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYI 254
           Y YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +
Sbjct: 119 YFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176

Query: 255 C-SRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
           C +  Y APE++       Y  A+D WS+G +L   L G P F        L + I   G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235

Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
                          ++ F       W ++       +A+DLV +LL   P  R T  EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272

Query: 372 CIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 418
             HP+  +           +      N      +  ++   S+  P 
Sbjct: 273 LRHPWLQD----EDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPR 315

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  165 bits (421), Expect = 6e-48
 Identities = 70/326 (21%), Positives = 122/326 (37%), Gaps = 59/326 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
           Y     +G G F +V + +   TG   A K          +    +    RE+  ++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYT 198
           HPNV++L   +    +K ++ L  +LE V   E    +A+    +             + 
Sbjct: 73  HPNVITLHEVY---ENKTDVIL--ILELVAGGELFDFLAEKESLTEEE-------ATEFL 120

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
            QI   + Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G      I 
Sbjct: 121 KQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178

Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
            +  + APE I          D+WS+G +   LL G   F G++  + L  +  V     
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                        ++F       +           A D + RLL   P  R T  ++  H
Sbjct: 233 ------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272

Query: 375 PFFDELRDPNARLPNGRPFPPLFNFK 400
           P+    +D    L        +  FK
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFK 297

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  163 bits (416), Expect = 9e-48
 Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 52/299 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y    ++G+GSFG V + K   T +  A+K + +            RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYTYQIC 202
           + L         +D     +V E     E    + K   +S                Q+ 
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131

Query: 203 RALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260
             + Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           APE++ G   Y    D+WS G +L  LL G P F G++  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                 ++ F       W  I       +A DL+ ++L + P+LR TA +   HP+  +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  163 bits (415), Expect = 1e-47
 Identities = 73/312 (23%), Positives = 118/312 (37%), Gaps = 58/312 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
           Y     +G G F IV + +   TG+  A K          +    +    RE+  +R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYT 198
           HPN+++L   F    +K ++ L  +LE V   E    +A+    +             + 
Sbjct: 67  HPNIITLHDIF---ENKTDVVL--ILELVSGGELFDFLAEKESLTEDE-------ATQFL 114

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
            QI   + Y+H    + H D+KP+N+++   N    ++KL DFG A  +  G      I 
Sbjct: 115 KQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172

Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
            +  + APE I          D+WS+G +   LL G   F GE+  + L  I  V     
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                        + F       +           A D + RLL   P  R T  ++  H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266

Query: 375 PFFDELRDPNAR 386
            +   +R  N R
Sbjct: 267 SWIKAIRRRNVR 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  163 bits (416), Expect = 3e-47
 Identities = 73/326 (22%), Positives = 117/326 (35%), Gaps = 59/326 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
           Y     +G G F IV + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYT 198
           H NV++L   +    ++ ++ L  +LE V   E    +A+    S             + 
Sbjct: 74  HHNVITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
            QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I 
Sbjct: 122 KQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
            +  + APE I          D+WS+G +   LL G   F G++  + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                        + F       +           A D + +LL      R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 375 PFFDELRDPNARLPNGRPFPPLFNFK 400
           P+     D    +        L NF+
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFR 298

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  164 bits (418), Expect = 4e-47
 Identities = 74/326 (22%), Positives = 119/326 (36%), Gaps = 59/326 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
           Y     +G G F IV + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYT 198
           HPN+++L   +    ++ ++ L  +LE V   E    +A+    S             + 
Sbjct: 74  HPNIITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
            QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I 
Sbjct: 122 KQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
            +  + APE I          D+WS+G +   LL G   F G++  + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                        + F       + +         A D + +LL      R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 375 PFFDELRDPNARLPNGRPFPPLFNFK 400
           P+     D    +        L NFK
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFK 298

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  163 bits (415), Expect = 5e-47
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 51/297 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 151
           Y  +  +G GS+ +  +     T    A+K + + KR    E++ + R   HPN+++LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYS--RASQRMPLIYVKLYTYQICRAL 205
            +      D  Y+ +V E +   E + ++ +   +S   AS  +         + I + +
Sbjct: 84  VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL---------FTITKTV 129

Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
            Y+H   GV HRD+KP N+L    + +   +++CDFG AK L      +   C +  + A
Sbjct: 130 EYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKC 320
           PE +     Y  A DIWS+G +L  +L G   F           + ++  G         
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--------- 238

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                 +F         W+ +        A DLVS++L   P+ R TA     HP+ 
Sbjct: 239 ------KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  164 bits (416), Expect = 7e-47
 Identities = 69/400 (17%), Positives = 124/400 (31%), Gaps = 101/400 (25%)

Query: 42  LPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAE----- 96
           + E  N +     R   E   +  D         +V+T     GQP +  S + E     
Sbjct: 24  IEELFNRIPQANVRTTSEYMQSAADS--------LVSTSLWNTGQPFRVESELGERPRTL 75

Query: 97  ---RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL----- 141
               V+GQ       +A   ETGE+  +      +R  +        E+  +RLL     
Sbjct: 76  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135

Query: 142 --------------------DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH 181
                                   ++ ++            +L   ++   +T   V   
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195

Query: 182 YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241
           +S   + +        T Q+ R LA +H   G+ H  ++P +++++     V L  F   
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL 253

Query: 242 KVLVKGEPNISYICSRYYRAPELI----------FGATEYTTAIDIWSVGCVLAELLLGQ 291
              V+    +    SR +  PEL              T  T + D W++G V+  +    
Sbjct: 254 ---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 292 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH--KRMPPE 349
                ++ +                                        IF   K +P  
Sbjct: 311 LPITKDAALG-----------------------------------GSEWIFRSCKNIPQP 335

Query: 350 AVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP-NARLP 388
              L+   L+Y    R   L+A   P +++LR   +A LP
Sbjct: 336 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  163 bits (414), Expect = 9e-47
 Identities = 88/305 (28%), Positives = 132/305 (43%), Gaps = 54/305 (17%)

Query: 84  NGQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMR 139
           +G  +  +S  +  E  +G+G+  IV++ K   T +  A+K + +    K    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIY 193
            L HPN++ LK  F       E+ L  VLE V   E   R V K +YS   A+       
Sbjct: 104 RLSHPNIIKLKEIF---ETPTEISL--VLELVTGGELFDRIVEKGYYSERDAAD------ 152

Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNI 251
                 QI  A+AY+H   G+ HRD+KP+NLL   P     +K+ DFG +K++      +
Sbjct: 153 ---AVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-M 207

Query: 252 SYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
             +C +  Y APE I     Y   +D+WSVG +   LL G   F  E G   +   I   
Sbjct: 208 KTVCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL-- 264

Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
                    C      E+ F    +  W ++        A DLV +L+   P  R T  +
Sbjct: 265 --------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQ 302

Query: 371 ACIHP 375
           A  HP
Sbjct: 303 ALQHP 307

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  162 bits (411), Expect = 2e-46
 Identities = 72/329 (21%), Positives = 132/329 (40%), Gaps = 49/329 (14%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 154
           ++V+G G  G V +     TG+  A+K +L D     +E+    +    P++V +    +
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91

Query: 155 STTDKDELYLNLVLEFVP------ETVYRVAKHYS--RASQRMPLIYVKLYTYQICRALA 206
                 +  L +++E +           R  + ++   A++ M           I  A+ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM---------RDIGTAIQ 142

Query: 207 YIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
           ++H    + HRD+KP+NLL  +      +KL DFG AK   +    +   C + YY APE
Sbjct: 143 FLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE 199

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            + G  +Y  + D+WS+G ++  LL G P F   +G      + +         I+    
Sbjct: 200 -VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-- 248

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-DELRD 382
              ++ FP      W ++       +A  L+  LL+  P  R T  +   HP+    +  
Sbjct: 249 ---QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

Query: 383 PNARLPNGRPFPPLFNFKPQELKGASKEL 411
           P   L   R      +   +  +  +  L
Sbjct: 298 PQTPLHTARVLQEDKDHWDEVKEEMTSAL 326

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  163 bits (415), Expect = 2e-46
 Identities = 83/336 (24%), Positives = 136/336 (40%), Gaps = 50/336 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 151
            +  +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 152 CFFSTTDKDELYLNLVLEFVP------ETVYRVAKHYS--RASQRMPLIYVKLYTYQICR 203
             +         L +V+E +           R  + ++   AS+ M           I  
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------KSIGE 172

Query: 204 ALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
           A+ Y+H  I + HRD+KP+NLL  +   +  +KL DFG AK         +   + YY A
Sbjct: 173 AIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE + G  +Y  + D+WS+G ++  LL G P F    G+     +           I+  
Sbjct: 232 PE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-- 280

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
                +++FP      W ++       E   L+  LL+  P  R T  E   HP+  +  
Sbjct: 281 ---MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

Query: 382 D-PNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
             P   L   R        + +++K   +E+ S L 
Sbjct: 330 KVPQTPLHTSRVL-KEDKERWEDVK---EEMTSALA 361

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  164 bits (416), Expect = 4e-46
 Identities = 78/302 (25%), Positives = 123/302 (40%), Gaps = 56/302 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +G+G+F +V +   +  G+  A   +   K          RE +  RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYS--RASQRMPLIYVKLYTYQ 200
           V L       +++   Y  L+ + V   E    +    +YS   AS             Q
Sbjct: 73  VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASH---------CIQQ 118

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SR 257
           I  A+ + H  +GV HR++KP+NLL  +      VKL DFG A  +   +        + 
Sbjct: 119 ILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y +PE +     Y   +D+W+ G +L  LL+G P F  E       +I           
Sbjct: 178 GYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA--------- 227

Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                     + FP   +  W  +      PEA DL++++L  +P+ R TA EA  HP+ 
Sbjct: 228 --------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWI 271

Query: 378 DE 379
             
Sbjct: 272 SH 273

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  160 bits (408), Expect = 7e-46
 Identities = 86/334 (25%), Positives = 125/334 (37%), Gaps = 57/334 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 143
           Y    V+G+G F +V +    ETG+  A+K V   K   +         RE     +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIY----VKLY 197
           P++V L   +       +  L +V EF+   +  + + K            Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135

Query: 198 TYQICRALAYIHGGIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC 255
             QI  AL Y H    + HRD+KP   LL +   +  VKL  FG A  L +         
Sbjct: 136 MRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
            + ++ APE +     Y   +D+W  G +L  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                       ++K        W  I        A DLV R+L   P  R T  EA  H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 375 PFFDELRDPNARLPNGRPFPPLFNFKPQ-ELKGA 407
           P+  E      ++        L  F  + +LKGA
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  158 bits (403), Expect = 7e-46
 Identities = 80/300 (26%), Positives = 120/300 (40%), Gaps = 57/300 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y  +  +G+G+F +V +     TG   A K +   K          RE +  R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIYVKLYTYQ 200
           V L        ++   YL  V + V   E     VA+  YS   AS  +          Q
Sbjct: 68  VRLHDSI---QEESFHYL--VFDLVTGGELFEDIVAREFYSEADASHCI---------QQ 113

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SR 257
           I  ++AY H   G+ HR++KP+NLL+        VKL DFG A  +   E        + 
Sbjct: 114 ILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTP 171

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E       +I           
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-------- 222

Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                     + +P   +  W  +      PEA  L+  +L  +P  R TA +A   P+ 
Sbjct: 223 ---------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  161 bits (409), Expect = 8e-46
 Identities = 74/303 (24%), Positives = 128/303 (42%), Gaps = 43/303 (14%)

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNREL 135
           +  + G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIY 193
             M  LDH N++ L   F     K+++   LV+E+V   E   R+       ++   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           +K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E    
Sbjct: 193 MK----QICEGIRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
              +  + APE +      +   D+WSVG +   LL G   F G++  + L  I+     
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--- 303

Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                          +         +  I       EA + +S+LL    + R +A EA 
Sbjct: 304 --------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEAL 341

Query: 373 IHP 375
            HP
Sbjct: 342 KHP 344

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  160 bits (408), Expect = 9e-46
 Identities = 86/330 (26%), Positives = 130/330 (39%), Gaps = 56/330 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y  +  +G+G+F +V +     TG   A K +   K          RE +  R L HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIYVKLYTYQ 200
           V L        ++   YL  V + V   E     VA+  YS   AS             Q
Sbjct: 91  VRLHDSI---QEESFHYL--VFDLVTGGELFEDIVAREFYSEADASH---------CIQQ 136

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 258
           I  ++AY H   G+ HR++KP+NLL+        VKL DFG A  +   E    +  +  
Sbjct: 137 ILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 195

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           Y +PE +     Y+  +DIW+ G +L  LL+G P F  E       +I            
Sbjct: 196 YLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--------- 245

Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
                    + +P   +  W  +      PEA  L+  +L  +P  R TA +A   P+  
Sbjct: 246 --------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289

Query: 379 ELRDPNARLPNGRPFPPLFNFKP-QELKGA 407
                 + +        L  F   ++LKGA
Sbjct: 290 NRERVASAIHRQDTVDCLKKFNARRKLKGA 319

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  159 bits (405), Expect = 1e-45
 Identities = 74/298 (24%), Positives = 135/298 (45%), Gaps = 45/298 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMRLLD-HPNVVSLK 150
            + ++ +G+GSF I  +    ++ +  A+K + +       +E+  ++L + HPN+V L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIYVKLYTYQICRA 204
             F      D+L+  LV+E +   E   R   K H+S   AS  M          ++  A
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM---------RKLVSA 118

Query: 205 LAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
           ++++H  +GV HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y A
Sbjct: 119 VSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE +     Y  + D+WS+G +L  +L GQ  F            ++++     ++IK  
Sbjct: 178 PE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG 231

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                +F F       W  +       EA DL+  LL   PN R        + +  +
Sbjct: 232 -----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  160 bits (407), Expect = 3e-45
 Identities = 65/384 (16%), Positives = 118/384 (30%), Gaps = 90/384 (23%)

Query: 76  IVTTIGGRNGQPKQTISYMAER--------VVGQGSFGIVFQAKCLETGETVAIKKVLQD 127
           +V+T     GQP +  S + ER        V+GQ       +A   ETGE+  +      
Sbjct: 55  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114

Query: 128 KRYKN-------RELQTMRLL-------------------------DHPNVVSLKHCFFS 155
           +R  +        E+  +RLL                             ++ ++     
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174

Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
                  +L   ++   +T   V   +S   + +        T Q+ R LA +H   G+ 
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLV 233

Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----YRAPELIFGA--- 268
           H  ++P +++++     V L  F        G   +S I   +      A  ++      
Sbjct: 234 HTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHH 290

Query: 269 -TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
            T  T A D W++G  +  +         ++ +                           
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------ 326

Query: 328 FKFPQIKAHPWHKIFH--KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD-PN 384
                        IF   K +P     L+   L+Y    R   L+A   P +++LR   +
Sbjct: 327 -----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375

Query: 385 ARLPNGRPFPPLFNFKPQELKGAS 408
           A LP  +              G S
Sbjct: 376 AALPLYQTDGEPTREGGAPPSGTS 399

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  157 bits (399), Expect = 1e-44
 Identities = 68/311 (21%), Positives = 118/311 (37%), Gaps = 56/311 (18%)

Query: 94  MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 146
           +  + +G+G F +V Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP------ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
           ++L   +    +  E+ L  +LE+          +  +A+  S          V     Q
Sbjct: 92  INLHEVY---ENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSEN-------DVIRLIKQ 139

Query: 201 ICRALAYIHGGIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC-SR 257
           I   + Y+H    + H D+KPQN LL + +    +K+ DFG ++ +      +  I  + 
Sbjct: 140 ILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTP 197

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
            Y APE I      TTA D+W++G +   LL     F GE   +  + I +V        
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------- 248

Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                       +       +  +        A D +  LL  +P  R TA     H + 
Sbjct: 249 ---------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

Query: 378 DELRDPNARLP 388
            +    N   P
Sbjct: 292 QQWDFENLFHP 302

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  154 bits (391), Expect = 7e-44
 Identities = 73/313 (23%), Positives = 126/313 (40%), Gaps = 68/313 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK------------KVLQDKRYK-NRELQTMR 139
           Y  + ++G+G   +V +     T +  A+K            + +Q+ R    +E+  +R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 140 LLD-HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYS--RASQRMPLI 192
            +  HPN++ LK  +     +   +  LV + +   E    + +    S     + M   
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM--- 130

Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
                   +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  + 
Sbjct: 131 ------RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LR 181

Query: 253 YIC-SRYYRAPELIFGATE-----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
            +C +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
           +                    ++F    +  W             DLVSR L   P  R 
Sbjct: 242 MSG-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRY 276

Query: 367 TALEACIHPFFDE 379
           TA EA  HPFF +
Sbjct: 277 TAEEALAHPFFQQ 289

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  151 bits (384), Expect = 9e-43
 Identities = 79/310 (25%), Positives = 127/310 (40%), Gaps = 56/310 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM-RLLDHPNVVSLK 150
           E V+G+G+   V     L T +  A+K    +    +    RE++ + +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYS--RASQRMPLIYVKLYTYQICRA 204
             F     ++E    LV E +     +  + K  H++   AS  +           +  A
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV---------QDVASA 123

Query: 205 LAYIHGGIGVCHRDIKPQNLL-VNP-HTHQVKLCDFGSAKVLVKGE-------PNISYIC 255
           L ++H   G+ HRD+KP+N+L  +P     VK+CDF     +           P +   C
Sbjct: 124 LDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 256 -SRYYRAPELI----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
            S  Y APE++      A+ Y    D+WS+G +L  LL G P F G  G D   +  +  
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242

Query: 311 GTPTR---EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
                   E I+       +++FP      W  I        A DL+S+LL      R +
Sbjct: 243 PACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLS 289

Query: 368 ALEACIHPFF 377
           A +   HP+ 
Sbjct: 290 AAQVLQHPWV 299

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  150 bits (382), Expect = 2e-42
 Identities = 81/308 (26%), Positives = 127/308 (41%), Gaps = 72/308 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
           +++G+GSF  V  A+ L T    AIK      ++++    Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
              F    D ++LY    L +    E +      Y R          + YT +I  AL Y
Sbjct: 96  YFTF---QDDEKLY--FGLSYAKNGELLK-----YIRKIGSFDETCTRFYTAEIVSALEY 145

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------YICSRY 258
           +H G G+ HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+    
Sbjct: 146 LH-GKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
             +PEL+        + D+W++GC++ +L+ G P F   +    + + I           
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII---------- 245

Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP------NLRCTALEAC 372
                   E+ FP            ++  P+A DLV +LL                    
Sbjct: 246 ------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287

Query: 373 IHPFFDEL 380
            HPFF+ +
Sbjct: 288 AHPFFESV 295

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  151 bits (384), Expect = 2e-42
 Identities = 68/314 (21%), Positives = 122/314 (38%), Gaps = 39/314 (12%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHC 152
            +G G+ G+VF+     +G  +A K +   ++        RELQ +   + P +V     
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 153 FFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           F+S  +     +++ +E +     + V + A        R+P   +   +  + + L Y+
Sbjct: 100 FYSDGE-----ISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYL 147

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
                + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G 
Sbjct: 148 REKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT 205

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y+   DIWS+G  L E+ +G+   P     +  +     +     E            
Sbjct: 206 H-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 329 KFPQIKAHPWHKIF---------------HKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
               + + P   IF                     E  D V++ L  +P  R    +  +
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

Query: 374 HPFFDELRDPNARL 387
           H F           
Sbjct: 325 HAFIKRSDAEEVDF 338

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  151 bits (383), Expect = 4e-42
 Identities = 73/310 (23%), Positives = 127/310 (40%), Gaps = 67/310 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------------RELQTMRL 140
           Y  + V+G+G   +V +     TG   A+K +       +            RE   +R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 141 L-DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIY 193
           +  HP++++L   +        ++L  V + +   E       K   S       M    
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMFL--VFDLMRKGELFDYLTEKVALSEKETRSIM---- 206

Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
                  +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  
Sbjct: 207 -----RSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRE 258

Query: 254 IC-SRYYRAPELIFGATE-----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
           +C +  Y APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I+
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318

Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           +                  +++F    +  W             DL+SRLLQ  P  R T
Sbjct: 319 EG-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLT 353

Query: 368 ALEACIHPFF 377
           A +A  HPFF
Sbjct: 354 AEQALQHPFF 363

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  152 bits (385), Expect = 8e-42
 Identities = 84/363 (23%), Positives = 142/363 (39%), Gaps = 71/363 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
           +V+G+G+FG V   K     +  A+K     ++L+         E   +   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            + F    D + LY  LV+++    + +       S+   R+P    + Y  ++  A+  
Sbjct: 140 HYAF---QDDNNLY--LVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI 265
           +H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++
Sbjct: 191 VH-QLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 266 ----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
                G   Y    D WS+G  + E+L G+  F  ES + +    I             M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN-LRCT-ALEACIHPFF-- 377
           N     F+FP              +   A DL+ RL+    + L      +   HPFF  
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344

Query: 378 ---DELRDPNARLPNGRPFPP-------LFNFKPQELKGASKE-LLSKLIPEHARKQCPF 426
              D +R+  A      P+ P         NF   +    + E +        +    PF
Sbjct: 345 IDWDNIRNCEA------PYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPF 398

Query: 427 LGF 429
           +GF
Sbjct: 399 VGF 401

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  148 bits (376), Expect = 1e-41
 Identities = 76/324 (23%), Positives = 127/324 (39%), Gaps = 59/324 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN---RELQTMRLLDHP 144
           Y+   ++G+GS+G V +    ET    A+K     K+ +    +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
           NV+ L    ++   +  +Y  +V+E+      E +  V +       R P+     Y  Q
Sbjct: 67  NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK------RFPVCQAHGYFCQ 117

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SR 257
           +   L Y+H   G+ H+DIKP NLL+      +K+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLH-SQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 258 YYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            ++ PE+  G   ++   +DIWS G  L  +  G   F G++        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
            I         +  P                P   DL+  +L+Y P  R +  +   H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 377 FDELRDPNARLPNGRPFPPLFNFK 400
           F +   P        P PP  + K
Sbjct: 267 FRKKHPPAEAPV---PIPPSPDTK 287

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  151 bits (382), Expect = 1e-41
 Identities = 89/377 (23%), Positives = 138/377 (36%), Gaps = 92/377 (24%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKK-----VLQDKR--YKNRELQTMRLLDHPNVVSL 149
           +V+G+G+F  V   K  +TG+  A+K      +L+         E   +   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
              F    D++ LYL  V+E+    + +       S+  +R+P    + Y  +I  A+  
Sbjct: 127 HFAF---QDENYLYL--VMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYY 259
           +H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+     
Sbjct: 178 VHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 260 RAPELI------FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
            +PE++       G   Y    D W++G    E+  GQ  F  +S   +    I      
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282

Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR---CTALE 370
                  ++        P            + +P EA D + RLL   P  R     A +
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324

Query: 371 ACIHPFF-----DELRDPNARLPNGRPFPPLF-------NF------KPQELKGASKELL 412
              HPFF     D LRD         PF P F       NF          + G  + L 
Sbjct: 325 FRTHPFFFGLDWDGLRDSVP------PFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLS 378

Query: 413 SKLIPEHARKQCPFLGF 429
                       PF+G+
Sbjct: 379 DIREGAPLGVHLPFVGY 395

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  147 bits (374), Expect = 2e-41
 Identities = 72/332 (21%), Positives = 122/332 (36%), Gaps = 66/332 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 151
            +  +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 152 CFFSTTDKDELYLNLVLEFVP------ETVYRVAKHYS--RASQRMPLIYVKLYTYQICR 203
             +         L +V+E +           R  + ++   AS+ M           I  
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------KSIGE 128

Query: 204 ALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
           A+ Y+H  I + HRD+KP+NLL  +   +  +KL DFG AK                   
Sbjct: 129 AIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------------- 173

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
                   +Y  + D+WS+G ++  LL G P F    G+     +           I+  
Sbjct: 174 --------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-- 215

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
                +++FP      W ++       E   L+  LL+  P  R T  E   HP+  +  
Sbjct: 216 ---MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

Query: 382 DPNARLPNGRPFPPLFNFKPQELKGASKELLS 413
                  +          + +++K      L+
Sbjct: 265 KVPQTPLHTSRVLKEDKERWEDVKEEMTSALA 296

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  147 bits (374), Expect = 7e-41
 Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 147
           Y   + +G G+FG+    +   T E VA+K       + +     RE+   R L HPN+V
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
             K    + T    L   +++E+    E   R+         R      + +  Q+   +
Sbjct: 80  RFKEVILTPTH---LA--IIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGV 129

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
           +Y H  + +CHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 265 IFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           +    EY     D+WS G  L  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
              ++  P             R+ PE   L+SR+    P  R +  E   H +F
Sbjct: 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  145 bits (369), Expect = 9e-41
 Identities = 71/320 (22%), Positives = 121/320 (37%), Gaps = 73/320 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--------------- 132
           Y  +  +G+GS+G+V  A         A+K     K+++   +                 
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 133 ----------RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK 180
                     +E+  ++ LDHPNVV L        ++D LY+  V E V     V  V  
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGP-VMEVPT 130

Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
                 + +     + Y   + + + Y+H    + HRDIKP NLLV      +K+ DFG 
Sbjct: 131 L-----KPLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGV 183

Query: 241 AKVLVKGEPNISYIC-SRYYRAPELIFGAT-EYT-TAIDIWSVGCVLAELLLGQPLFPGE 297
           +      +  +S    +  + APE +      ++  A+D+W++G  L   + GQ  F  E
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243

Query: 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
             +  L   IK                    +FP              +  +  DL++R+
Sbjct: 244 R-IMCLHSKIK----------------SQALEFPD----------QPDIAEDLKDLITRM 276

Query: 358 LQYSPNLRCTALEACIHPFF 377
           L  +P  R    E  +HP+ 
Sbjct: 277 LDKNPESRIVVPEIKLHPWV 296

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  147 bits (373), Expect = 2e-40
 Identities = 73/298 (24%), Positives = 134/298 (44%), Gaps = 54/298 (18%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
           R +G+GSFG V   +  +T +  A+K     K ++    R   +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            + F    D+++++  +V++ +   +  Y    H  + +       VKL+  ++  AL Y
Sbjct: 81  WYSF---QDEEDMF--MVVDLLLGGDLRY----HLQQ-NVHFKEETVKLFICELVMALDY 130

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF- 266
           +     + HRD+KP N+L++ H H V + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQ-NQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 267 -GATEYTTAIDIWSVGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP 323
                Y+ A+D WS+G    ELL G+  +   S     ++V   +               
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-HPFFDEL 380
             T   +P                 E V L+ +LL+ +P+ R + L      P+ +++
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  151 bits (383), Expect = 3e-40
 Identities = 82/361 (22%), Positives = 139/361 (38%), Gaps = 74/361 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----------LQTMRLLDHPN 145
           R++G+G FG V+  +  +TG+  A+K  L  KR K ++           L  +   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           +V + + F      D+L    +L+ +   +  Y +++H            ++ Y  +I  
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
            L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ + + +  Y APE
Sbjct: 304 GLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++     Y ++ D +S+GC+L +LL G   F      D             + EI     
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CT---ALEACIHPFFD 378
                                   PE   L+  LLQ   N R  C    A E    PFF 
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 379 ELRDPN-ARLPNGRPFPPLFNFKPQELKGASKELL---------SKLIPEHARKQCPFLG 428
            L   +   +   +  PP     P   +  + +           +K I      Q  +  
Sbjct: 455 SL---DWQMVFLQKYPPP---LIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRN 508

Query: 429 F 429
           F
Sbjct: 509 F 509

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  142 bits (359), Expect = 2e-39
 Identities = 72/289 (24%), Positives = 125/289 (43%), Gaps = 41/289 (14%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNVVSLKH 151
            +G+G++G+V + + + +G+ +A+K++   +  +  K    +L  +MR +D P  V+   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
             F   D     + + +E +  ++ +  K      Q +P   +      I +AL ++H  
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---A 268
           + V HRD+KP N+L+N    QVK+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
             Y+   DIWS+G  + EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             PQ+ A  +          E VD  S+ L+ +   R T  E   HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  141 bits (358), Expect = 2e-39
 Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 50/296 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
                          Y  L LE+    E   R+          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 262
            Y+H GIG+ HRDIKP+NLL++     +K+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLH-GIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 263 ELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           EL+    E+    +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                          PW K     +    + L+ ++L  +P+ R T  +     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  146 bits (371), Expect = 5e-39
 Identities = 91/323 (28%), Positives = 139/323 (43%), Gaps = 61/323 (18%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 148
           RV+G+G FG V   +   TG+  A K  L+ KR K R        E Q +  ++   VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRM-PLIYVKLYTYQICRAL 205
           L + + +   KD L L  VL  +   +  +    H     Q   P      Y  +IC  L
Sbjct: 249 LAYAYET---KDALCL--VLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
             +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++
Sbjct: 300 EDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                YT + D W++GC+L E++ GQ  F                    REE+       
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK------------KKIKREEV------- 397

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDEL 380
                  +K  P  + + +R  P+A  L S+LL   P  R      +A E   HP F   
Sbjct: 398 ----ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF--- 448

Query: 381 RDPN-ARLPNGRPFPPLFNFKPQ 402
           +  N  RL  G   PP   FKP 
Sbjct: 449 KKLNFKRLGAGMLEPP---FKPD 468

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  143 bits (361), Expect = 5e-39
 Identities = 37/315 (11%), Positives = 92/315 (29%), Gaps = 64/315 (20%)

Query: 92  SYMAERVVGQGSFGIVFQAKC-----LETGETVAIK----KVLQDKRYKNRELQTMRLLD 142
                 ++G+G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
               +           ++   L  V E       +  +  + +   + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ----------VKLCDFGSA---KVLVKG 247
           +   +  +H    + H DIKP N ++     +          + L D G +   K+  KG
Sbjct: 181 MLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
               +   +  ++  E++     +   ID + V   +  +L G  +     G        
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------- 290

Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
                    + + +                W++ FH             +L         
Sbjct: 291 ------GECKPEGLFRRL-------PHLDMWNEFFHV------------MLNIPDCHHLP 325

Query: 368 ALEACIHPFFDELRD 382
           +L+          + 
Sbjct: 326 SLDLLRQKLKKVFQQ 340

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  144 bits (365), Expect = 7e-39
 Identities = 94/382 (24%), Positives = 160/382 (41%), Gaps = 72/382 (18%)

Query: 43  PEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS---YMAERVV 99
            E    ++   + ++K+  A +   +G+ + +     +     +PK  ++   +   +++
Sbjct: 97  EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL 156

Query: 100 GQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNVVSL 149
           G+G+FG V   K   TG   A+K      ++           NR LQ  R   HP + +L
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTAL 213

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           K+ F  T D+  L    V+E+    E  +    H SR  +       + Y  +I  AL Y
Sbjct: 214 KYSF-QTHDR--LCF--VMEYANGGELFF----HLSR-ERVFSEDRARFYGAEIVSALDY 263

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
           +H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++ 
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
              +Y  A+D W +G V+ E++ G+  F  +   ++L E+I                   
Sbjct: 323 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------ME 364

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELR 381
           E +FP            + + PEA  L+S LL+  P  R       A E   H FF    
Sbjct: 365 EIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---A 409

Query: 382 DPN-ARLPNGRPFPPLFNFKPQ 402
                 +   +  PP   FKPQ
Sbjct: 410 GIVWQHVYEKKLSPP---FKPQ 428

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  141 bits (358), Expect = 8e-39
 Identities = 77/318 (24%), Positives = 133/318 (41%), Gaps = 57/318 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
           Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           N+V L     +        L L++E+    E    +  H      RM     +    QI 
Sbjct: 75  NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIV 124

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
            A+ Y H    + HRD+K +NLL++     +K+ DFG +     G   +   C +  Y A
Sbjct: 125 SAVQYCH-QKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181

Query: 262 PELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           PEL  G  +Y    +D+WS+G +L  L+ G   F G++ + +L E +             
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------ 227

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
                 +++ P      +       M  +  +L+ R L  +P  R T  +     + +  
Sbjct: 228 ----RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271

Query: 381 RDPNARLPNGRPFPPLFN 398
            + +   P   P   + +
Sbjct: 272 HEEDELKPFVEPELDISD 289

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  141 bits (357), Expect = 9e-39
 Identities = 73/313 (23%), Positives = 128/313 (40%), Gaps = 50/313 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
                          Y  L LE+    E   R+          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 262
            Y+H GIG+ HRDIKP+NLL++     +K+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLH-GIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 263 ELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           EL+    E+    +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
                          PW K     +    + L+ ++L  +P+ R T  +     ++++  
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

Query: 382 DPNARLPNGRPFP 394
              A+ P      
Sbjct: 270 KKGAKRPRVTSGG 282

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  145 bits (367), Expect = 1e-38
 Identities = 73/328 (22%), Positives = 125/328 (38%), Gaps = 54/328 (16%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 148
           RV+G+G FG VF  +   TG+  A K  L  KR K R        E + +  +    +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           L + F +   K +L L  V+  +   +  Y +       +          YT QI   L 
Sbjct: 250 LAYAFET---KTDLCL--VMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLE 303

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
           ++H    + +RD+KP+N+L++   + V++ D G A  L  G+        +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
            G  EY  ++D +++G  L E++  +  F                     +E+       
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARG------------EKVENKEL------- 401

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDEL 380
                 ++        +  +  P + D    LLQ  P  R      +      HP F   
Sbjct: 402 ----KQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF--- 452

Query: 381 RDPNARLPNGRPFPPLFNFKPQELKGAS 408
           RD + R        P F    + +   +
Sbjct: 453 RDISWRQLEAGMLTPPFVPDSRTVYAKN 480

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  140 bits (355), Expect = 1e-38
 Identities = 66/321 (20%), Positives = 117/321 (36%), Gaps = 67/321 (20%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 142
           Y    ++G G FG V+    +     VAIK     ++       N      E+  ++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 143 H--PNVVSLKHCFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLY 197
                V+ L   +F     D   L  +LE      +    + +        +     + +
Sbjct: 105 SGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEELARSF 154

Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 256
            +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS  +L       +    +
Sbjct: 155 FWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGT 211

Query: 257 RYYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
           R Y  PE I     Y   +  +WS+G +L +++ G   F  +       EII+       
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257

Query: 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
                      +  F             +R+  E   L+   L   P+ R T  E   HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 376 FFDELRDPNARLP-NGRPFPP 395
           +  ++  P      +     P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  138 bits (351), Expect = 2e-38
 Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 52/307 (16%)

Query: 81  GGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------R 133
           G ++    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPL 191
           E+Q ++L  HP+++ L     + TD    +  +V+E+V   E    + KH      R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICKH-----GRVEE 110

Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
           +  +    QI  A+ Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 252 SYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
              C S  Y APE+I G       +DIWS G +L  LL G   F  E         +  L
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTL 219

Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
                ++I+        F  P      +       +      L+  +LQ  P  R T  +
Sbjct: 220 ----FKKIR-----GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258

Query: 371 ACIHPFF 377
              H +F
Sbjct: 259 IREHEWF 265

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  140 bits (353), Expect = 3e-38
 Identities = 65/358 (18%), Positives = 122/358 (34%), Gaps = 103/358 (28%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           +   + +G+G FG+VF+AK        AIK++    R        RE++ +  L+HP +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 148 SLKHCF----------------------------------------------------FS 155
              + +                                                      
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
                ++YL + ++   +   +   +   + +            QI  A+ ++H   G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH-SKGLM 186

Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------------VKGEPNISYICSRYYRAP 262
           HRD+KP N+        VK+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E I G   Y+  +DI+S+G +L ELL     F  +    +++  ++              
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
                 KFP         +F ++ P E   +V  +L  SP  R  A +   +  F+ L
Sbjct: 288 ----NLKFP--------LLFTQKYPQEH-MMVQDMLSPSPTERPEATDIIENAIFENL 332

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  137 bits (347), Expect = 2e-37
 Identities = 74/324 (22%), Positives = 118/324 (36%), Gaps = 70/324 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 142
           Y    ++G+G FG VF    L     VAIK     +VL      +      E+  +  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 143 ----HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETV----YRVAKHYSRASQRMPLIYV 194
               HP V+ L   +F T  ++   L  VLE          Y   K        +     
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQDLFDYITEK------GPLGEGPS 141

Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           + +  Q+  A+ + H   GV HRDIK +N+L++      KL DFGS  +L       +  
Sbjct: 142 RCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDF 198

Query: 255 C-SRYYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
             +R Y  PE I    +Y      +WS+G +L +++ G   F  +       EI++    
Sbjct: 199 DGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--- 248

Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
                         E  FP              + P+   L+ R L   P+ R +  E  
Sbjct: 249 --------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

Query: 373 IHPFFDELRDPNARLPNGRPFPPL 396
           + P+     +     P+     PL
Sbjct: 283 LDPWMQTPAEDVPLNPSKGGPAPL 306

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  137 bits (348), Expect = 2e-37
 Identities = 83/322 (25%), Positives = 137/322 (42%), Gaps = 64/322 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 149
           +++G+G+FG V   +   TG   A+K      ++      +   E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           K+ F  T D+  L    V+E+    E  +    H SR  +       + Y  +I  AL Y
Sbjct: 71  KYAF-QTHDR--LCF--VMEYANGGELFF----HLSR-ERVFTEERARFYGAEIVSALEY 120

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIF 266
           +H    V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++ 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
              +Y  A+D W +G V+ E++ G+  F  +   ++L E+I                   
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------ME 220

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELR 381
           E +FP            + + PEA  L++ LL+  P  R       A E   H FF    
Sbjct: 221 EIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---L 265

Query: 382 DPN-ARLPNGRPFPPLFNFKPQ 402
             N   +   +  PP   FKPQ
Sbjct: 266 SINWQDVVQKKLLPP---FKPQ 284

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  138 bits (349), Expect = 7e-37
 Identities = 91/367 (24%), Positives = 139/367 (37%), Gaps = 83/367 (22%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
           +V+G+G+FG V   +   T +  A+K     ++++     +   E   M   + P VV L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            + F     +D+ YL +V+E++P  + V       S     +P  + + YT ++  AL  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVN----LMSN--YDVPEKWARFYTAEVVLALDA 183

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYY 259
           IH  +G  HRD+KP N+L++   H +KL DFG+   + K              YI     
Sbjct: 184 IH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236

Query: 260 RAPELIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            +PE++    G   Y    D WSVG  L E+L+G   F  +S    LV            
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS-------- 283

Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACI 373
             K MN       FP              +  EA +L+   L     +R       E   
Sbjct: 284 --KIMNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329

Query: 374 HPFFDEL--RDPNAR--LPNGRPFPPLF-------NFKPQELKGASKELLSKLIPEHARK 422
           H FF          R  +    P  P         NF   E     +E    +       
Sbjct: 330 HLFFKNDQWAWETLRDTVA---PVVPDLSSDIDTSNFDDLEED-KGEEETFPIPKAFVGN 385

Query: 423 QCPFLGF 429
           Q PF+GF
Sbjct: 386 QLPFVGF 392

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  135 bits (342), Expect = 1e-36
 Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 43/302 (14%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 151
            +G+G++G V +     +G+ +A+K++   + +K  K    +L   MR  D P +V    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 152 CFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
             F   D       + +E +    +  Y+    YS     +P   +   T    +AL ++
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYK--YVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
              + + HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +
Sbjct: 142 KENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200

Query: 269 TE---YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                Y    D+WS+G  L EL  G+  +P  + V   +  + V G P            
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP------------ 247

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 385
                PQ+      + F     P  ++ V+  L    + R    E   HPF     +   
Sbjct: 248 -----PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297

Query: 386 RL 387
            +
Sbjct: 298 EV 299

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  135 bits (341), Expect = 1e-36
 Identities = 67/301 (22%), Positives = 111/301 (36%), Gaps = 46/301 (15%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 151
            +G G+ G V++ +  +TG  +A+K++      +  K    +L   ++  D P +V    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
            F + TD     + + +E +        K   R    +P   +   T  I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCA---EKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FG 267
            GV HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 326
             +Y    D+WS+G  L EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR 386
               P +         H     +    V   L      R    +   H F          
Sbjct: 248 ----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 387 L 387
           +
Sbjct: 297 V 297

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  135 bits (342), Expect = 1e-36
 Identities = 75/294 (25%), Positives = 128/294 (43%), Gaps = 51/294 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 145
           Y+    +G+GSFG V  A   +T + VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           ++ L     + TD   +   +V+E+   E    + +      +RM     + +  QI  A
Sbjct: 71  IIKLYDVITTPTD---IV--MVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
           + Y H    + HRD+KP+NLL++ +   VK+ DFG + ++  G   +   C S  Y APE
Sbjct: 121 IEYCH-RHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPE 177

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           +I G       +D+WS G VL  +L+G+  F  E  +  L + +                
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
               +  P      +       + P A  L+ R++   P  R T  E    P+F
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  134 bits (340), Expect = 3e-36
 Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 68/309 (22%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-------RELQTMRL 140
           Y     +G G+FG V+ A   E  + V +K     KVL+D   ++        E+  +  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETV----YRVAKHYSRASQRMPLIYVKL 196
           ++H N++ +   F    ++      LV+E     +    +           R+       
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDRH------PRLDEPLASY 134

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC- 255
              Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+      C 
Sbjct: 135 IFRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCG 191

Query: 256 SRYYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
           +  Y APE++ G   Y    +++WS+G  L  L+  +  F       +L E ++      
Sbjct: 192 TIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------ 238

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                           P              +  E + LVS LLQ  P  R T  +    
Sbjct: 239 -----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275

Query: 375 PFFDELRDP 383
           P+  +  + 
Sbjct: 276 PWVTQPVNL 284

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  133 bits (338), Expect = 6e-36
 Identities = 84/324 (25%), Positives = 137/324 (42%), Gaps = 66/324 (20%)

Query: 97  RVVGQGSFGIVFQAK---CLETGETVAIKKVLQDKRYKNRELQTM---RLL---DHPNVV 147
           +V+GQGSFG VF  K     +  +  A+K + +        ++T     +L   +HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L + F  T  K  LYL  +L+F+   +   R++K             VK Y  ++  AL
Sbjct: 90  KLHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALAL 139

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
            ++H  +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE+
Sbjct: 140 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +     +T + D WS G ++ E+L G   F G+    + + +I                 
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDE 379
             +   PQ             + PEA  L+  L + +P  R         E   H FF  
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF-- 285

Query: 380 LRDPN-ARLPNGRPFPPLFNFKPQ 402
               +  +L      PP   FKP 
Sbjct: 286 -STIDWNKLYRREIHPP---FKPA 305

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  133 bits (338), Expect = 9e-36
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 70/304 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
           + +G GSFG V   K  E+G   A+K     KV++ K   +   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           +  F     KD   L +V+E+V   E        + R   R    + + Y  QI     Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFS-----HLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRA 261
           +H  + + +RD+KP+NLL++   + +++ DFG AK +        G P           A
Sbjct: 157 LH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE+I     Y  A+D W++G ++ E+  G P F  +    Q+ E I          +   
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG- 253

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPF 376
                + +FP                 +  DL+  LLQ        NL+    +   H +
Sbjct: 254 -----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

Query: 377 FDEL 380
           F   
Sbjct: 297 FATT 300

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  134 bits (339), Expect = 1e-35
 Identities = 79/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLL-----DHP 144
           Y   R +G G F  V+ +  ++  + VA+K V   + Y      E++ ++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 145 N---VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
           N   VV L   F  +      ++ +V E +   + +     +   Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 202 CRALAYIHGGIGVCHRDIKPQNLLV----------------------------------- 226
            + L Y+H    + H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 227 -------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 273
                        N    +VK+ D G+A  +   +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 274 AIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 320
             DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMP------PEAVDLVSRLLQYSPNLRCTALEACIH 374
                      ++K     ++  ++            D +  +L+  P  R TA E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 375 PFFD 378
           P+ +
Sbjct: 393 PWLN 396

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  132 bits (334), Expect = 2e-35
 Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 70/304 (23%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
           R +G GSFG V   +    G   A+K      V++ K   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
              F     +D   + ++++++   E    +     R SQR P    K Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEY 121

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRA 261
           +H    + +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y A
Sbjct: 122 LH-SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++     Y  +ID WS G ++ E+L G   F   +   +  E I              
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL------------- 216

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPF 376
                E +FP                 +  DL+SRL+         NL+    +   HP+
Sbjct: 217 ---NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

Query: 377 FDEL 380
           F E+
Sbjct: 262 FKEV 265

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  132 bits (334), Expect = 2e-35
 Identities = 88/327 (26%), Positives = 139/327 (42%), Gaps = 70/327 (21%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIK---KVLQDKRYKNRELQTM---RLL---DHP 144
           RV+G+G +G VFQ + +    TG+  A+K   K +  +  K+    T     +L    HP
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA-HTKAERNILEEVKHP 81

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
            +V L + F  T  K  LYL  +LE++   E   ++ +                Y  +I 
Sbjct: 82  FIVDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLER-----EGIFMEDTACFYLAEIS 131

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRA 261
            AL ++H   G+ +RD+KP+N+++N   H VKL DFG  K  +         C    Y A
Sbjct: 132 MALGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++   + +  A+D WS+G ++ ++L G P F GE+   + ++ I              
Sbjct: 190 PEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL------------- 234

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPF 376
                +   P              +  EA DL+ +LL+ +   R       A E   HPF
Sbjct: 235 ---KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

Query: 377 FDELRDPN-ARLPNGRPFPPLFNFKPQ 402
           F   R  N   L   +  PP   FKP 
Sbjct: 280 F---RHINWEELLARKVEPP---FKPL 300

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  133 bits (337), Expect = 2e-35
 Identities = 85/323 (26%), Positives = 127/323 (39%), Gaps = 66/323 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHPNVV 147
           +V+G+GSFG V  A+        A+ KVLQ     K +E +  M       + + HP +V
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            L    F T DK  LY   VL+++   E  Y    H  R  +       + Y  +I  AL
Sbjct: 103 GLHFS-FQTADK--LY--FVLDYINGGELFY----HLQR-ERCFLEPRARFYAAEIASAL 152

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 264
            Y+H  + + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE+
Sbjct: 153 GYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +     Y   +D W +G VL E+L G P F   +   ++ + I                 
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR----CTALEACIHPFFDEL 380
               +                +   A  L+  LLQ     R       +E   H FF   
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF--- 297

Query: 381 RDPN-ARLPNGRPFPPLFNFKPQ 402
              N   L N +  PP   F P 
Sbjct: 298 SLINWDDLINKKITPP---FNPN 317

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  132 bits (335), Expect = 3e-35
 Identities = 88/326 (26%), Positives = 141/326 (43%), Gaps = 70/326 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 146
           RV+G+GSFG V  A+  ETG+  A+K      +LQD   +      R L   R  +HP +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
             L  C F T D+  L+   V+EFV   + ++    H  + S+R      + Y  +I  A
Sbjct: 87  TQLFCC-FQTPDR--LF--FVMEFVNGGDLMF----HIQK-SRRFDEARARFYAAEIISA 136

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 263
           L ++H   G+ +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE
Sbjct: 137 LMFLH-DKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++     Y  A+D W++G +L E+L G   F  E+  D L E I                
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL--------------- 237

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR------CTALEACIHPFF 377
              E  +P              +  +A  ++   +  +P +R              HPFF
Sbjct: 238 -NDEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

Query: 378 DELRDPN-ARLPNGRPFPPLFNFKPQ 402
              ++ + A+L + +  PP   F+P+
Sbjct: 285 ---KEIDWAQLNHRQIEPP---FRPR 304

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  132 bits (334), Expect = 3e-35
 Identities = 82/325 (25%), Positives = 127/325 (39%), Gaps = 69/325 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 146
            V+G+GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
             L  C F T D+  LY   V+E+V   + +Y + +       R    +   Y  +I   
Sbjct: 84  TQLHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIG 133

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 263
           L ++    G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE
Sbjct: 134 LFFLQ-SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           +I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I                
Sbjct: 192 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 234

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                 +P            K M  EAV +   L+   P  R         +   H FF 
Sbjct: 235 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF- 280

Query: 379 ELRDPN-ARLPNGRPFPPLFNFKPQ 402
             R  +  +L      PP   +KP+
Sbjct: 281 --RYIDWEKLERKEIQPP---YKPK 300

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  134 bits (340), Expect = 4e-35
 Identities = 78/295 (26%), Positives = 123/295 (41%), Gaps = 52/295 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 145
           Y+    +G G+FG V   K   TG  VA+K     K+          RE+Q ++L  HP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           ++ L     + +D   ++  +V+E+V   E    + K+      R+     +    QI  
Sbjct: 78  IIKLYQVISTPSD---IF--MVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILS 127

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 262
            + Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +   C S  Y AP
Sbjct: 128 GVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAP 184

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E+I G       +DIWS G +L  LL G   F  +  V  L + I               
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC-------------- 229

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                F  P      +       + P  + L+  +LQ  P  R T  +   H +F
Sbjct: 230 --DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  130 bits (329), Expect = 6e-35
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 18/215 (8%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
           E VVG+G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-- 210
               +     + LV+E+    ++Y V  H +         +   +  Q  + +AY+H   
Sbjct: 70  --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
              + HRD+KP NLL+      +K+CDFG+A          +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
           Y+   D++S G +L E++  +  F    G    + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  131 bits (332), Expect = 7e-35
 Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 69/323 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
           +++G+GSFG VF A+  +T +  AIK      VL D   +     TM   R+L    +HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
            +  +   F  T +   L+   V+E++   + +Y +         +  L     Y  +I 
Sbjct: 79  FLTHMFCTF-QTKEN--LFF--VMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEII 128

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRA 261
             L ++H   G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y A
Sbjct: 129 LGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++ G  +Y  ++D WS G +L E+L+GQ  F G+   ++L   I+             
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR------------- 231

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-CIHPFFDEL 380
                   +P            + +  EA DL+ +L    P  R         HP F   
Sbjct: 232 ---MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF--- 273

Query: 381 RDPN-ARLPNGRPFPPLFNFKPQ 402
           R+ N   L      PP   F+P+
Sbjct: 274 REINWEELERKEIDPP---FRPK 293

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  130 bits (328), Expect = 7e-35
 Identities = 76/310 (24%), Positives = 122/310 (39%), Gaps = 46/310 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           Y  + V+G G+  +V  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 148 SLKHCFFSTTDKDELYLNLVLEF-----VPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           S    F     KDEL+  LV++      V + +  +       S  +    +     ++ 
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSR---- 257
             L Y+H   G  HRD+K  N+L+      V++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLH-KNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 258 ---YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
               + APE++     Y    DIWS G    EL  G   +     +  L+  ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                  N        P ++     K   K+       ++S  LQ  P  R TA E   H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

Query: 375 PFFDELRDPN 384
            FF + ++  
Sbjct: 289 KFFQKAKNKE 298

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  132 bits (333), Expect = 8e-35
 Identities = 62/320 (19%), Positives = 113/320 (35%), Gaps = 44/320 (13%)

Query: 93  YMAERVVGQG--SFGIVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHP 144
           Y    V+G+G      V  A+   TGE V ++++      ++       EL   +L +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           N+V  +  F +    +EL+  +V  F+   +   +   +      M  + +      + +
Sbjct: 87  NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLK 139

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--------KVLVKGEPNISYIC 255
           AL YIH  +G  HR +K  ++L++    +V L    S         +  V  +     + 
Sbjct: 140 ALDYIH-HMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 256 SRYYRAPELIF-GATEYTTAIDIWSVGCVLAELLLGQP----------LF-------PGE 297
              + +PE++      Y    DI+SVG    EL  G            L        P  
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
                +      +          ++ + T               +H+   P     V + 
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 358 LQYSPNLRCTALEACIHPFF 377
           LQ +P+ R +A     H FF
Sbjct: 318 LQRNPDARPSASTLLNHSFF 337

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  130 bits (330), Expect = 1e-34
 Identities = 85/329 (25%), Positives = 145/329 (44%), Gaps = 66/329 (20%)

Query: 97  RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDKRYKNREL--QTM---RLL----DHP 144
           +V+G G++G VF  + +   +TG+  A+K + +    +  +    T    ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
            +V+L + F     + +L+L  +L+++   E    +++      +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF---QTETKLHL--ILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIV 169

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-IC-SRYYR 260
            AL ++H  +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y  C +  Y 
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 261 APELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           AP+++ G    +  A+D WS+G ++ ELL G   F  +   +   EI           I 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL 279

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIH 374
                 +E  +PQ             M   A DL+ RLL   P  R       A E   H
Sbjct: 280 -----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322

Query: 375 PFFDELRDPN-ARLPNGRPFPPLFNFKPQ 402
            FF   +  N   L   +   P   FKP 
Sbjct: 323 LFF---QKINWDDLAAKKVPAP---FKPV 345

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  128 bits (323), Expect = 1e-33
 Identities = 73/328 (22%), Positives = 136/328 (41%), Gaps = 65/328 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
           RV+G+GS+  V   +  +T    A+K      V  D+              +     +HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
            +V L  C F T  +  L+   V+E+V   + ++ + +      +++P  + + Y+ +I 
Sbjct: 71  FLVGLHSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEIS 120

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 121 LALNYLH-ERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++ G  +Y  ++D W++G ++ E++ G+  F      D   +        T + +   
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 227

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR------CTALEACIHP 375
                   F  I          + +  +A  ++   L   P  R          +   HP
Sbjct: 228 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277

Query: 376 FFDELRDPN-ARLPNGRPFPPLFNFKPQ 402
           FF   R+ +   +   +  PP   FKP 
Sbjct: 278 FF---RNVDWDMMEQKQVVPP---FKPN 299

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  127 bits (320), Expect = 7e-33
 Identities = 73/328 (22%), Positives = 136/328 (41%), Gaps = 65/328 (19%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
           RV+G+GS+  V   +  +T    A++      V  D+              +     +HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
            +V L  C F T  +  L+   V+E+V   + ++ + +      +++P  + + Y+ +I 
Sbjct: 114 FLVGLHSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEIS 163

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 164 LALNYLH-ERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE++ G  +Y  ++D W++G ++ E++ G+  F      D   +        T + +   
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 270

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTALEACI----HP 375
                   F  I          + +  +A  ++   L   P  R  C           HP
Sbjct: 271 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320

Query: 376 FFDELRDPN-ARLPNGRPFPPLFNFKPQ 402
           FF   R+ +   +   +  PP   FKP 
Sbjct: 321 FF---RNVDWDMMEQKQVVPP---FKPN 342

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  124 bits (313), Expect = 8e-33
 Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 30/224 (13%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHP 144
           E+ +G+G FG+V + + ++    VAIK ++                  RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           N+V L        +       +V+EFVP   +Y         +  +           I  
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHR---LLDKAHPIKWSVKLRLMLDIAL 133

Query: 204 ALAYIHG-GIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISYICSRY 258
            + Y+      + HRD++  N+ +           K+ DFG ++           + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 259 YRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
           + APE I    E YT   D +S   +L  +L G+  F   S   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  129 bits (325), Expect = 2e-32
 Identities = 82/325 (25%), Positives = 128/325 (39%), Gaps = 69/325 (21%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 146
            V+G+GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
             L  CF  T D+  LY   V+E+V   + +Y + +       R    +   Y  +I   
Sbjct: 405 TQLHSCF-QTMDR--LYF--VMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIG 454

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
           L ++    G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE
Sbjct: 455 LFFLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           +I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I                
Sbjct: 513 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 555

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFD 378
                 +P            K M  EAV +   L+   P  R         +   H FF 
Sbjct: 556 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF- 601

Query: 379 ELRDPN-ARLPNGRPFPPLFNFKPQ 402
             R  +  +L      PP   +KP+
Sbjct: 602 --RYIDWEKLERKEIQPP---YKPK 621

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  124 bits (313), Expect = 3e-32
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 49/294 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            +  + C+            LV+E+   +   + + + +    +  + +   T+   + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
           AY+H    + HRD+K  N+L++     VKL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
               E  Y   +D+WS+G    EL   +P     + +  L  I +               
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------NES 270

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                  P +++  W + F         + V   LQ  P  R T+     H F 
Sbjct: 271 -------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFV 309

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  122 bits (308), Expect = 5e-32
 Identities = 67/305 (21%), Positives = 113/305 (37%), Gaps = 54/305 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           +     +G+GSFG VF+     T + VAIK +  ++         +E+  +   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
                +   T      L +++E++       +             +    +     +I +
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLE--------PGPLDETQIATILREILK 130

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAP 262
            L Y+H      HRDIK  N+L++    +VKL DFG + ++        +++ + ++ AP
Sbjct: 131 GLDYLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E+I  +  Y +  DIWS+G    EL  G+P       +  L  I K    PT E      
Sbjct: 189 EVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG----- 241

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
                          + K           + V   L   P+ R TA E   H F      
Sbjct: 242 --------------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAK 279

Query: 383 PNARL 387
             + L
Sbjct: 280 KTSYL 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (304), Expect = 2e-31
 Identities = 75/300 (25%), Positives = 125/300 (41%), Gaps = 47/300 (15%)

Query: 84  NGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR 139
            G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++       K     E+  MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYT 198
              +PN+V+    +      DEL++  V+E++   ++  V          M    +    
Sbjct: 73  ENKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVC 122

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSR 257
            +  +AL ++H    V HRDIK  N+L+      VKL DFG    +   +    + + + 
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           Y+ APE++     Y   +DIWS+G +  E++ G+P +  E+ +  L  I    GTP  + 
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238

Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                                  IF         D ++R L+     R +A E   H F 
Sbjct: 239 -----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  120 bits (303), Expect = 3e-31
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
           +  +G GSFG V +A+    G  VA+K +++   +        RE+  M+ L HPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
                + T    L   +V E++   ++YR+  H S A +++         Y + + + Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 209 HG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 266
           H     + HR++K  NLLV+   + VK+CDFG +++      +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
                    D++S G +L EL   Q  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  118 bits (299), Expect = 5e-31
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 34/220 (15%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPNVV 147
           E ++G G FG V++A  +  G+ VA+K    D             +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 148 SLK-HCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +L+  C      +  L L  V+EF     + RV        +R+P   +  +  QI R +
Sbjct: 70  ALRGVC----LKEPNLCL--VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118

Query: 206 AYIH--GGIGVCHRDIKPQNLLVN-------PHTHQVKLCDFGSAKVLVKGEPNISYICS 256
            Y+H    + + HRD+K  N+L+             +K+ DFG A+   +    +S   +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177

Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
             + APE+I  +  ++   D+WS G +L ELL G+  F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (301), Expect = 8e-31
 Identities = 75/291 (25%), Positives = 126/291 (43%), Gaps = 45/291 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 148
             +   +G+GS GIV  A+   +G  VA+K +     Q +     E+  MR   H NVV 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           +   +      +EL++  ++EF+    +  +         R+    +      + +ALAY
Sbjct: 107 MYKSYLV---GEELWV--LMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAY 156

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 266
           +H   GV HRDIK  ++L+     +VKL DFG  A++        S + + Y+ APE+I 
Sbjct: 157 LHAQ-GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
             + Y T +DIWS+G ++ E++ G+P +  +S V  +  +      P  +          
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN--------- 263

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                   +H    +          D + R+L   P  R TA E   HPF 
Sbjct: 264 --------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (300), Expect = 1e-30
 Identities = 73/300 (24%), Positives = 119/300 (39%), Gaps = 47/300 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 150
           +     +G+GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D P+VV   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 151 HCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
             +F  TD     L +V+E+        + R+        + +    +        + L 
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDIIRLRN------KTLTEDEIATILQSTLKGLE 139

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 265
           Y+H      HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I
Sbjct: 140 YLHFM-RKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                Y    DIWS+G    E+  G+P +     +  +  I      PT  +        
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK-------- 247

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 385
                       W   F         D V + L  SP  R TA +   HPF    +  + 
Sbjct: 248 ---------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (310), Expect = 1e-30
 Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 46/236 (19%)

Query: 78  TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD-------KR 129
             + G+         Y  +  +  G  G ++ A      G  V +K  L           
Sbjct: 76  DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125

Query: 130 YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN-LVLEFVP-ETVYRVAKHYSRASQ 187
               E Q +  + HP++V +   F   TD+    +  +V+E+V  +++ R         Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------Q 177

Query: 188 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL--- 244
           ++P+     Y  +I  AL+Y+H  IG+ + D+KP+N+++     Q+KL D G+   +   
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF 234

Query: 245 --VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
             + G P         ++APE++      T A DI++VG  LA L L  P   G  
Sbjct: 235 GYLYGTP--------GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  118 bits (298), Expect = 2e-30
 Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 48/310 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMR-LLDHPNVVS 148
           +    +VG G++G V++ + ++TG+  AIK +     ++    +E+  ++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 149 LKHCFF-STTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
               F        +  L LV+EF        + +  K        +   ++     +I R
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILR 140

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAP 262
            L+++H    V HRDIK QN+L+     +VKL DFG SA++        ++I + Y+ AP
Sbjct: 141 GLSHLHQH-KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

Query: 263 ELI----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           E+I         Y    D+WS+G    E+  G P       +  L  I +          
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248

Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD 378
              NP       P++K+  W K F           +   L  + + R    +   HPF  
Sbjct: 249 ---NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIR 291

Query: 379 ELRDPNARLP 388
           +  +      
Sbjct: 292 DQPNERQVRI 301

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (296), Expect = 3e-30
 Identities = 72/306 (23%), Positives = 122/306 (39%), Gaps = 52/306 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 148
           +     +G G+FG V++AK  ETG   A K +     ++      E++ +   DHP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           L   ++         L +++EF P    + +             +    +++   Q+  A
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR------GLTEPQIQVVCRQMLEA 129

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPE 263
           L ++H    + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE
Sbjct: 130 LNFLHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 264 LIFGAT----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
           ++   T     Y    DIWS+G  L E+   +P     + +  L++I K    PT     
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT-- 244

Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                             W   F         D +   L  +P  R +A +   HPF   
Sbjct: 245 ---------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVSS 281

Query: 380 LRDPNA 385
           +    A
Sbjct: 282 ITSNKA 287

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  116 bits (293), Expect = 7e-30
 Identities = 68/241 (28%), Positives = 108/241 (44%), Gaps = 39/241 (16%)

Query: 74  HIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------ 127
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 128 ---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYS 183
              KR++ RE+     L H N+VS+        + D  YL  V+E++   T+      Y 
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTL----SEYI 102

Query: 184 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243
            +   + +     +T QI   + + H  + + HRDIKPQN+L++     +K+ DFG AK 
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160

Query: 244 LVKGEPNISY----ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG 299
           L   E +++     + +  Y +PE   G        DI+S+G VL E+L+G+P F GE+ 
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217

Query: 300 V 300
           V
Sbjct: 218 V 218

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (293), Expect = 9e-30
 Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 28/219 (12%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYK---NRELQTMRLLDHP 144
           Y   R+VG+G  G V++A+       VA+K ++      D  ++    RE +T   L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           +VV +           +LY+   +  +             R    +          QI  
Sbjct: 95  HVVPI---HDFGEIDGQLYV--DMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYY 259
           AL   H   G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
            APE    +   T   DI+++ CVL E L G P + G+ 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  115 bits (291), Expect = 1e-29
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 31/221 (14%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKN--RELQTMRLLDHPNVVSLKH 151
             V+G+G FG   +    ETGE + +K++++  ++  +   +E++ MR L+HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
                     L    + E++   T+  + K       + P      +   I   +AY+H 
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH- 125

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------------- 257
            + + HRD+   N LV      V + DFG A+++V  +     + S              
Sbjct: 126 SMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 258 --YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
             Y+ APE+I G   Y   +D++S G VL E++      P 
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  115 bits (290), Expect = 2e-29
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 37/239 (15%)

Query: 78  TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKN 132
           + +  R         Y    ++G G    V  A+ L     VA+K VL     +D  +  
Sbjct: 8   SHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYL 57

Query: 133 R---ELQTMRLLDHPNVVSLKHCFF---STTDKDELYLNLVLEFVP-ETVYRVAKHYSRA 185
           R   E Q    L+HP +V++    +              +V+E+V   T+    +     
Sbjct: 58  RFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHT 109

Query: 186 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245
              M            C+AL + H   G+ HRD+KP N++++  T+ VK+ DFG A+ + 
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIA 167

Query: 246 KGEPNISY----ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
               +++     I +  Y +PE   G +      D++S+GCVL E+L G+P F G+S V
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  115 bits (291), Expect = 3e-29
 Identities = 46/215 (21%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 151
            + +G+G +G V+  K    GE VA+K     ++    RE  +    L+ H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
               T    +LYL  + ++    ++Y   K  +  ++ M    +KL  Y     L ++H 
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSM----LKL-AYSSVSGLCHLHT 152

Query: 211 GI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RY 258
            I        + HRD+K +N+LV  +     + D G A   +     +    +     + 
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 259 YRAPELIFGAT-----EYTTAIDIWSVGCVLAELL 288
           Y  PE++  +      +     D++S G +L E+ 
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  114 bits (288), Expect = 3e-29
 Identities = 47/215 (21%), Positives = 90/215 (41%), Gaps = 32/215 (14%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 151
              VG+G +G V++      GE VA+K    +D++   RE  L    +L H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
              S     +L+L  +  +    ++Y   +  +  +       +++    I   LA++H 
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSC----LRI-VLSIASGLAHLHI 123

Query: 211 GI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RY 258
            I        + HRD+K +N+LV  +     + D G A +  +    +    +     + 
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 259 YRAPELI-----FGATEYTTAIDIWSVGCVLAELL 288
           Y APE++         +    +DIW+ G VL E+ 
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  113 bits (284), Expect = 1e-28
 Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 26/224 (11%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
              F   +   +L +  V ++    ++Y        +  +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 265
           H    + HRD+K  N+ ++   + VK+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  112 bits (282), Expect = 1e-28
 Identities = 28/211 (13%), Positives = 74/211 (35%), Gaps = 22/211 (10%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 149
              + +   G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
                        +  L+  ++P  ++Y V   +   +  +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 209 HG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           H     +    +  ++++++      ++                  + +  + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEALQK 182

Query: 268 --ATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
                   + D+WS   +L EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  111 bits (280), Expect = 9e-28
 Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 32/215 (14%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 151
           +  +G+G FG V++ K    GE VA+K    +++R   RE  +    +L H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH- 209
                    +L+L  V ++    +++     Y+   + M    +KL        LA++H 
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157

Query: 210 ------GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RY 258
                 G   + HRD+K +N+LV  +     + D G A         I    +     + 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 259 YRAPELIFGAT-----EYTTAIDIWSVGCVLAELL 288
           Y APE++  +      E     DI+++G V  E+ 
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  109 bits (275), Expect = 3e-27
 Identities = 57/254 (22%), Positives = 104/254 (40%), Gaps = 37/254 (14%)

Query: 90  TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 146
           ++      V  +G FG V++A+     E VA+K    QDK+    E  + ++  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 147 VS-LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           +  +      T+   +L+L  +  F  + ++    K    +   +      +    + R 
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNEL----CHIA-ETMARG 133

Query: 205 LAYIHGGI---------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
           LAY+H  I          + HRDIK +N+L+  +     + DFG A      E   S   
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAGD 189

Query: 256 SRY------YRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
           +        Y APE++ GA     +    ID++++G VL EL        G      L  
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 306 IIKVLGTPTREEIK 319
             ++   P+ E+++
Sbjct: 250 EEEIGQHPSLEDMQ 263

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (273), Expect = 5e-27
 Identities = 63/335 (18%), Positives = 116/335 (34%), Gaps = 79/335 (23%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
             ++G+G FG V+  +       VAI+ +  ++  ++      RE+   R   H NVV  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 150 K-HCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
              C         L +  +       T+Y V +    A   + +   +    +I + + Y
Sbjct: 95  MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--------Y 259
           +H   G+ H+D+K +N+  +     V + DFG   +   G         +         +
Sbjct: 146 LHA-KGILHKDLKSKNVFYDNGK--VVITDFGLFSI--SGVLQAGRREDKLRIQNGWLCH 200

Query: 260 RAPELIFGATE--------YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
            APE+I   +         ++   D++++G +  EL   +  F  +        II  +G
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMG 256

Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
           T  +  +                           M  E  D++     +    R      
Sbjct: 257 TGMKPNL----SQIG-------------------MGKEISDILLFCWAFEQEER------ 287

Query: 372 CIHPFFDELRDPNARLP--NGRPFPPLFNFKPQEL 404
              P F +L D   +LP  N R   P   +K  EL
Sbjct: 288 ---PTFTKLMDMLEKLPKRNRRLSHPGHFWKSAEL 319

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  104 bits (261), Expect = 3e-25
 Identities = 61/332 (18%), Positives = 119/332 (35%), Gaps = 44/332 (13%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHC 152
             ++G+G +G V++         VA+K     +++    E    R+  ++H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
               T    +   LV+E+ P  ++ +    ++        +      + + R LAY+H  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130

Query: 212 I--------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----- 258
           +         + HRD+  +N+LV        + DFG +  L                   
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 259 ----YRAPELIFGA------TEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVD-QLVEI 306
               Y APE++ GA            +D++++G +  E+ +    LFPGES  + Q+   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
            +V   PT E+++ +     E + P+     W +  +        + +          R 
Sbjct: 250 TEVGNHPTFEDMQVL--VSREKQRPKFPEA-WKE--NSLAVRSLKETIEDCWDQDAEARL 304

Query: 367 TALEACIHPFFDELRDPNARLPNGRPFPPLFN 398
           TA          EL     R  +  P     +
Sbjct: 305 TAQ--XAEERMAELMMIWERNKSVSPTAHHHH 334

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 40/233 (17%)

Query: 96  ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            R +G+G FG V           TGE VA+K +  D   ++     +E+  +R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           +  K C     D     L LV+E+VP       + Y      + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+H      HRD+  +N+L++ +   VK+ DFG AK + +G          YYR      
Sbjct: 149 YLH-AQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGD 198

Query: 261 ------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEI 306
                 APE +     +  A D+WS G  L ELL          +   +L+ I
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 42/351 (11%), Positives = 76/351 (21%), Gaps = 88/351 (25%)

Query: 55  RVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLE 114
           R      +   D      G        GR         Y      G       +QA    
Sbjct: 7   REPDRESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTA 54

Query: 115 TGETVAIKKVL----QDKRYKNR---ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167
               VA+  V                    +  +D P V  +         +    +  V
Sbjct: 55  LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--V 109

Query: 168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV 226
            E++   ++  VA            +        +  A    H   GV      P  + V
Sbjct: 110 AEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRV 162

Query: 227 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAE 286
           +     V L                                        DI  +G  L  
Sbjct: 163 SI-DGDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYA 194

Query: 287 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM 346
           LL+ +   P       L    +        E   ++ +                     +
Sbjct: 195 LLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD---------------------I 232

Query: 347 PPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLF 397
           P +   + +R +Q    +R  +         + ++   A         P+ 
Sbjct: 233 PFQISAVAARSVQGDGGIRSASTLL------NLMQQATAVADRTEVLGPID 277

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 52/238 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 147 VSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRA 204
             L   C         +   L+ + +P   +     Y R  +  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 205 LAYI--HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
           + Y+     +   HRD+  +N+LV      VK+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 261 ---------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 40/215 (18%)

Query: 96  ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            + +G+G+FG V   +       TGE VA+KK LQ    ++     RE++ ++ L H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
           V  K             L L++E++P   Y   + Y +  + R+  I +  YT QIC+ +
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+       HRD+  +N+LV  + ++VK+ DFG  KVL + +         +++     
Sbjct: 128 EYLG-TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVKEPG 177

Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL 288
                  APE +   ++++ A D+WS G VL EL 
Sbjct: 178 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 40/215 (18%)

Query: 96  ERVVGQGSFGIVFQAKCL----ETGETVAIK--KVLQDKRYKN--RELQTMRLLDHPNVV 147
            + +G+G+FG V   +       TGE VA+K  +   ++  ++  RE++ ++ L H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 148 SLKHCFFSTTDKDE-LYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
             K      +     L   L++E++P   Y   + Y +  + R+  I +  YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+       HRD+  +N+LV    ++VK+ DFG  KVL + +         YY+     
Sbjct: 159 EYLG-TKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKEPG 208

Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL 288
                  APE +   ++++ A D+WS G VL EL 
Sbjct: 209 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 43/230 (18%)

Query: 94  MAERVVGQGSFGIVFQAKCLETGET--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 145
           + ++ +G G+FG V +           VA+K +     D   K+    E   M+ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +V +        + +     LV+E            Y + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+       HRD+  +N+L+    H  K+ DFG +K L   E         YY+     
Sbjct: 131 KYL-EESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQTHG 180

Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                  APE + +   ++++  D+WS G ++ E    GQ  + G  G +
Sbjct: 181 KWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 40/233 (17%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
            R++G+G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 147 VSLKH-CFFSTTDKDELYLNLVLEFVPE---TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
             L      S          ++L F+       + +A         +PL  +  +   I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
             + Y+       HRD+  +N ++      V + DFG ++ +  G+         YYR  
Sbjct: 148 CGMEYL-SSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------YYRQG 196

Query: 261 ----------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                     A E L      YT   D+W+ G  + E++  GQ  + G    +
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 39/215 (18%)

Query: 96  ERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            R +G+G FG V   +       TGE VA+K +  +    +     +E++ +R L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS-QRMPLIYVKLYTYQICRAL 205
           V  K      T+     + L++EF+P       K Y   +  ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+       HRD+  +N+LV    HQVK+ DFG  K +   +         YY      
Sbjct: 140 DYLG-SRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKDDR 189

Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL 288
                  APE +  +  +  A D+WS G  L ELL
Sbjct: 190 DSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 91.4 bits (227), Expect = 5e-20
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 29/224 (12%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
               T +   Y  ++ EF+    Y     Y R   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 264
                HR++  +N LV    H VK+ DFG ++++        Y      +      APE 
Sbjct: 336 KKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 390

Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
           +     ++   D+W+ G +L E+   G   +PG       +L+E
Sbjct: 391 LAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 33/213 (15%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
            + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGG 211
               +K  LY  +V E++          Y R+  R  L    L  ++  +C A+ Y+  G
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG 307

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-L 264
               HRD+  +N+LV+   +  K+ DFG  K                 +      APE L
Sbjct: 308 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 358

Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
                +++T  D+WS G +L E+   G+  +P 
Sbjct: 359 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 40/215 (18%)

Query: 96  ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
              +G+G+FG V   +       TG  VA+K  LQ           RE+Q ++ L    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
           V  +        +  L   LV+E++P       + + +  + R+    + LY+ QIC+ +
Sbjct: 87  VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+       HRD+  +N+LV      VK+ DFG AK+L   +         YY      
Sbjct: 141 EYLG-SRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVREPG 190

Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL 288
                  APE +     ++   D+WS G VL EL 
Sbjct: 191 QSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 49/235 (20%), Positives = 84/235 (35%), Gaps = 45/235 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
            +++G+G FG V +    +       VA+K +  D   +        E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS----QRMPLIYVKL--YTYQ 200
           + L       + +      ++L F+    Y     Y   S        +    L  +   
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMK---YGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260
           I   + Y+       HRD+  +N ++      V + DFG +K +  G+         YYR
Sbjct: 156 IALGMEYL-SNRNFLHRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YYR 204

Query: 261 ------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                       A E L      YT+  D+W+ G  + E+   G   +PG    +
Sbjct: 205 QGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.1 bits (219), Expect = 9e-20
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
               T +   Y  ++ EF+    Y     Y R   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-E 128

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE- 263
                HRD+  +N LV  + H VK+ DFG ++++        Y      +      APE 
Sbjct: 129 KKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 183

Query: 264 LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
           L +   +++   D+W+ G +L E+   G   +PG
Sbjct: 184 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 33/218 (15%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
            + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGG 211
               +K  LY  +V E++          Y R+  R  L    L  ++  +C A+ Y+  G
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-G 135

Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-L 264
               HRD+  +N+LV+   +  K+ DFG  K                 +      APE L
Sbjct: 136 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 186

Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                +++T  D+WS G +L E+   G+  +P     D
Sbjct: 187 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 31/224 (13%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
            ++   ++ +Y  +V E++          + +      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-E 297

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 264
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 298 RMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352

Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
                 +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 57/252 (22%), Positives = 94/252 (37%), Gaps = 56/252 (22%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
            + +G G+FG V +A        +   TVA+K +     L ++     EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPL 191
           N+V+L       T        ++ E+                 +             + L
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 192 IYVKLYT--YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
               L +  YQ+ + +A++       HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS- 199

Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
                    Y             APE IF    YT   D+WS G  L EL  LG   +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 297 ESGVDQLVEIIK 308
                +  ++IK
Sbjct: 251 MPVDSKFYKMIK 262

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 31/224 (13%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
            ++   ++ +Y  +V E++          + +      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-E 380

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 264
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 381 RMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 435

Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
                 +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 436 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 45/228 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 150
              +G+G+FG VF  +       VA+K   +      +     E + ++   HPN+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 151 H--CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-YTYQICRALAY 207
              C    T K  +Y  +V+E V          + R       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------- 260
           +       HRD+  +N LV    + +K+ DFG ++    G          Y         
Sbjct: 229 LE-SKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQV 277

Query: 261 -----APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                APE L +G   Y++  D+WS G +L E   LG   +P  S   
Sbjct: 278 PVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 45/236 (19%)

Query: 94  MAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
           V L          + L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+       HRD+  +N+L+  + H  K+ DFG +K L   +         YY      
Sbjct: 124 KYL-EEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARSAG 173

Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
                  APE + F   ++++  D+WS G  + E L  GQ  +    G +    +E
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 87.5 bits (217), Expect = 7e-19
 Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 43/230 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
           E+ +G G FG V+ A   +    VA+K +            E   M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
                 K+ +Y  ++ EF+          + ++ +       KL  ++ QI   +A+I  
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-E 301

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 260
                HRD++  N+LV+      K+ DFG A+V+   E         Y            
Sbjct: 302 QRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPIKW 351

Query: 261 -APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
            APE + FG   +T   D+WS G +L E++  G+  +PG S  +  + +E
Sbjct: 352 TAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 50/237 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 147 VSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRA 204
             L   C         +   L+ + +P   +     Y R  +  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 205 LAYI--HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
           + Y+     +   HRD+  +N+LV      VK+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 261 ---------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
                    A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 46/233 (19%), Positives = 79/233 (33%), Gaps = 46/233 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGET-------VAIKKVLQDKRYKN----RELQTMRLLDHP 144
              +GQG+F  +F+    E G+        V +K + +  R  +         M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 145 NVVSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-YTYQIC 202
           ++V     C       DE  L  V EFV    +     Y + ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENIL--VQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-------VKLCDFGSAKVLVKGEPNISYIC 255
            A+ ++     + H ++  +N+L+     +       +KL D G +  ++  +       
Sbjct: 124 AAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175

Query: 256 SRYYR------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
               +       PE I        A D WS G  L E+   G           
Sbjct: 176 --ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 45/231 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 147
             V+G+G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-YTYQICRALA 206
           SL         +      +VL ++    +   +++ R     P +   + +  Q+ + + 
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+       HRD+  +N +++     VK+ DFG A+ +   E         YY       
Sbjct: 143 YLA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNKTG 191

Query: 261 --------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                   A E L     ++TT  D+WS G +L EL+  G P +P  +  D
Sbjct: 192 AKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 43/230 (18%)

Query: 94  MAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
           V L          + L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+       HR++  +N+L+  + H  K+ DFG +K L   +         YY      
Sbjct: 450 KYL-EEKNFVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARSAG 499

Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                  APE + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 500 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 34/229 (14%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
            +V+G G FG V +   +  GE     V IK +      ++       +  +  LDH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
           V L            L   LV +++P         + R  +  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+    G+ HR++  +N+L+     QV++ DFG A +L   +     +     +     
Sbjct: 129 YYLE-EHGMVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPIKW 183

Query: 261 -APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
            A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 184 MALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 51/243 (20%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTM 138
           P + +   ++RV+G+G FG+V+  + ++  +     AIK    + + +      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP----LIYV 194
           R L+HPNV++L          + L   ++L ++    +     + R+ QR P    LI  
Sbjct: 77  RGLNHPNVLALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS- 128

Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
             +  Q+ R + Y+       HRD+  +N +++  +  VK+ DFG A+ ++  E      
Sbjct: 129 --FGLQVARGMEYLA-EQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE------ 178

Query: 255 CSRYYR--------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGES 298
              YY               A E L      +TT  D+WS G +L ELL  G P +    
Sbjct: 179 ---YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHID 233

Query: 299 GVD 301
             D
Sbjct: 234 PFD 236

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 50/243 (20%)

Query: 97  RVVGQGSFGIVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 146
           R +GQGSFG+V++       +      VAIK V     ++++     E   M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKH-YSRASQRMPLIYVKL--YTY 199
           V L       +        +++E +      +  R  +   +      P    K+     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
           +I   +AY++      HRD+  +N +V      VK+ DFG  + + + +         YY
Sbjct: 146 EIADGMAYLN-ANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YY 194

Query: 260 R------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVE 305
           R            +PE L  G   +TT  D+WS G VL E+  L +  + G S  +Q++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251

Query: 306 IIK 308
            + 
Sbjct: 252 FVM 254

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 43/230 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
              +G G FG V+          VA+K + Q     +    E   M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
            ++   ++ +Y  ++ E++          + +    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-E 126

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 260
                HRD++  N+LV+      K+ DFG A+++   E         Y            
Sbjct: 127 ERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPIKW 176

Query: 261 -APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 305
            APE + +G   +T   D+WS G +L E++  G+  +PG +   V Q +E
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 60/249 (24%), Positives = 101/249 (40%), Gaps = 53/249 (21%)

Query: 97  RVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 145
           + +G+G+FG V +A         T  TVA+K +       + R    EL+ +  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLI 192
           VV+L      T     L   +++EF               E V             + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
           ++  Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K      
Sbjct: 149 HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP---- 202

Query: 253 YICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG 299
                 Y             APE IF    YT   D+WS G +L E+  LG   +PG   
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 300 VDQLVEIIK 308
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 55/224 (24%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT----MRLLDHPNVVSL-K 150
           + ++G G FG V++   L  G  VA+K+   +      E +T    +    HP++VSL  
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 151 HCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRAS--QRMPLIYVKLYTYQIC- 202
            C     +++E+   L+ +++        +Y         S  QR+          +IC 
Sbjct: 103 FC----DERNEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EICI 146

Query: 203 ---RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 258
              R L Y+H    + HRD+K  N+L++ +    K+ DFG +K   + +   +++ +   
Sbjct: 147 GAARGLHYLHTR-AIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQ--THLSTVVK 202

Query: 259 ----YRAPELIFGATEY------TTAIDIWSVGCVLAELLLGQP 292
               Y  P       EY      T   D++S G VL E+L  + 
Sbjct: 203 GTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 45/231 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 147
             V+G+G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP----LIYVKLYTYQICR 203
           SL         +      +VL ++    +   +++ R     P    LI    +  Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 260
            + ++       HRD+  +N +++     VK+ DFG A+ +   E +        +    
Sbjct: 204 GMKFLA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNKTG 255

Query: 261 --------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                   A E L     ++TT  D+WS G +L EL+  G P +P  +  D
Sbjct: 256 AKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 82.2 bits (204), Expect = 7e-18
 Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 48/230 (20%)

Query: 96  ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
            R++G+G FG V++            VA+K   +D    N+     E   M+ LDHP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L        +++  +  +++E  P   Y    HY   ++  + ++ + LY+ QIC+A+A
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 207 YI--HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 260
           Y+     +   HRDI  +N+LV      VKL DFG ++ +   +         YY+    
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174

Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                  +PE + F    +TTA D+W     + E+L  G+  F      D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 82.7 bits (205), Expect = 9e-18
 Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 64/258 (24%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
            + +G+G FG V +A            TVA+K +       + R    E   ++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP-------------------ETVYRVAKHYSRAS 186
           V+ L       +    L   L++E+                      +            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 187 QRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
               L    L  + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDV 200

Query: 245 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LG- 290
            + +          Y             A E +F    YTT  D+WS G +L E++ LG 
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 291 QPLFPGESGVDQLVEIIK 308
            P +PG    ++L  ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 45/231 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 151
            + +G G FG+V   K       VA+K + +    ++   +E QTM  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIH 209
           C    + +  +Y  +V E++         +Y R S    L   +L    Y +C  +A++ 
Sbjct: 72  C----SKEYPIY--IVTEYIS---NGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL- 120

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--------- 260
                 HRD+  +N LV+     VK+ DFG  + ++  +         Y           
Sbjct: 121 ESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVK 170

Query: 261 --APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 305
             APE   +   +Y++  D+W+ G ++ E+  LG+  +   +   V   V 
Sbjct: 171 WSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 43/225 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 151
            + +G G FG+V     L   + VAIK + +    +     E + M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIH 209
           C     ++  +   LV EF+    +     Y R +QR       L      +C  +AY+ 
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL- 120

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--------- 260
               V HRD+  +N LV  +   +K+ DFG  + ++  +         Y           
Sbjct: 121 EEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVK 170

Query: 261 --APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
             +PE   F    Y++  D+WS G ++ E+   G+  +   S  +
Sbjct: 171 WASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 45/230 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 148 SLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-YTYQICRAL 205
            L+       T        +V E++          + R       I   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+   +G  HRD+  +N+LV+ +    K+ DFG ++VL                     
Sbjct: 165 RYL-SDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTTGG 214

Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                  APE + F    +++A D+WS G V+ E+L  G+  +   +  D
Sbjct: 215 KIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 58/259 (22%), Positives = 101/259 (38%), Gaps = 59/259 (22%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQT 137
            ++ I     R +G+G+FG VF A+C           VA+K +    L  ++   RE + 
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----------ETVYRVAKHYSRAS 186
           +  L H ++V          D D L   +V E++                 +        
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 187 QRMPLIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
            +  L   ++     QI   + Y+       HRD+  +N LV  +   VK+ DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDV 183

Query: 245 VKGEPNISYICSRYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LG 290
              +         YYR             PE +++   ++TT  D+WS G +L E+   G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232

Query: 291 -QPLFPGESGVDQLVEIIK 308
            QP +   S   +++E I 
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 43/229 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 148 SLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
            L+       T    +   +V E++          + R    +  +I +      I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
            Y+   +G  HRD+  +N+L+N +    K+ DFG  +VL              Y      
Sbjct: 161 KYL-SDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211

Query: 261 ------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                 +PE + +   ++T+A D+WS G VL E++  G+  +   S  D
Sbjct: 212 IPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 44/228 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
            R +G+G FG V Q   +        VAIK          R     E  TMR  DHP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L         ++ ++  +++E          + + +  +  + L  + LY YQ+  ALA
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+       HRDI  +N+LV+ +   VKL DFG ++ +             YY+      
Sbjct: 131 YLE-SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKL 179

Query: 261 -----APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                APE + F    +T+A D+W  G  + E+L  G   F G    D
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 60/258 (23%), Positives = 96/258 (37%), Gaps = 63/258 (24%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
            +V+G G+FG V  A             VA+K +       ++     EL+ M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP------------------ETVYRVAKHYSRAS 186
           N+V+L       T    +Y  L+ E+                    E  Y   K      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 187 QRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
               L +  L  + YQ+ + + ++       HRD+  +N+LV      VK+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDI 222

Query: 245 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAEL--LLG 290
           +             Y             APE +F    YT   D+WS G +L E+  L  
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 291 QPLFPGESGVDQLVEIIK 308
            P +PG        ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 82.6 bits (204), Expect = 5e-17
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 46/234 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
            R +G+G FG V Q   +        VAIK          R     E  TMR  DHP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
            L         ++ ++  +++E          + + +  +  + L  + LY YQ+  ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
           Y+       HRDI  +N+LV+ +   VKL DFG ++ +             YY+      
Sbjct: 506 YLE-SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKL 554

Query: 261 -----APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 305
                APE + F    +T+A D+W  G  + E+L  G   F G     V   +E
Sbjct: 555 PIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 52/239 (21%)

Query: 96  ERVVGQGSFGIVFQAKC-LETGET--VAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
              +G GSFG+V + +    +G+T  VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRA 204
           ++ L    +       +   +V E  P           R  Q    L  +  Y  Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 205 LAYI--HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
           + Y+     I   HRD+  +NLL+      VK+ DFG  + L + +         +Y   
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181

Query: 261 ----------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
                     APE L      ++ A D W  G  L E+   GQ  + G +G      ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 56/249 (22%), Positives = 97/249 (38%), Gaps = 56/249 (22%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQTMRLLDHPNV 146
           +  +G+G+FG VF A+C           VA+K +       ++   RE + + +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP----------ETVYRVAKHYSRASQRMPLIYVKL 196
           V         T+   L   +V E++                            PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 197 --YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
                Q+   + Y+  G+   HRD+  +N LV      VK+ DFG ++ +   +      
Sbjct: 161 LAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD------ 212

Query: 255 CSRYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LG-QPLFPGESG 299
              YYR             PE +++   ++TT  D+WS G VL E+   G QP +   S 
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265

Query: 300 VDQLVEIIK 308
             + ++ I 
Sbjct: 266 NTEAIDCIT 274

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 57/252 (22%), Positives = 105/252 (41%), Gaps = 57/252 (22%)

Query: 96  ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
            + +G+G FG V  A+ +       +   TVA+K +      +D      E++ M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-----------TVYRVAKHYSRASQRMPL 191
           H N+++L       T    LY  +++E+  +                  +         +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 192 IYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
            +  L   TYQ+ R + Y+       HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 257

Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 297 ESGVDQLVEIIK 308
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 80.7 bits (198), Expect = 6e-17
 Identities = 49/336 (14%), Positives = 95/336 (28%), Gaps = 86/336 (25%)

Query: 99  VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----------RELQTMRLL----- 141
           +G+G FG VFQ         VAIK + ++     N            E+   + L     
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 142 ----DHPNVVSLKHCFF---------------------------STTDKDELYLNLVLEF 170
                    + L                                     D+L++ L  EF
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT 230
               + ++    S  +        K   +Q+  +LA     +   HRD+   N+L+   +
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTS 199

Query: 231 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG 290
              KL    + K                     L     +YT +        V  ++ + 
Sbjct: 200 L-KKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245

Query: 291 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIF- 342
           + LF G+   D   +I +++           +P       +Y   K  +           
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303

Query: 343 -HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
             K++  +  +    +L +S     +A +       
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 47/223 (21%), Positives = 88/223 (39%), Gaps = 43/223 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 149
           Y   R +G+GSFG++F+   L   + VAIK   +         E +T +LL     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            +       ++ L+  LV++ +  ++  +     R   +  +  V +   Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123

Query: 210 GGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YR 260
               + +RDIKP N L+    + + + + + DFG  K          Y          YR
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173

Query: 261 APELIFGATEYTTAI------------DIWSVGCVLAELLLGQ 291
             + + G   Y  +I            D+ ++G V    L G 
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 61/268 (22%), Positives = 105/268 (39%), Gaps = 68/268 (25%)

Query: 87  PKQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 136
           P+  I Y+  R +G+G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYS 183
            M   D+PN+V L            +   L+ E++             P TV  ++    
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 184 RASQRMPLIYVKLYT--------YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235
               R+        +         Q+   +AY+       HRD+  +N LV  +   VK+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGEN-MVVKI 215

Query: 236 CDFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTTAIDIWSVGC 282
            DFG ++ +   +         YY+             PE + +    YTT  D+W+ G 
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264

Query: 283 VLAELL-LG-QPLFPGESGVDQLVEIIK 308
           VL E+   G QP + G +  ++++  ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 57/252 (22%), Positives = 101/252 (40%), Gaps = 57/252 (22%)

Query: 96  ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
            + +G+G+FG V  A+ +            VA+K +      +D      E++ M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----------ETVYRVAKHYSRASQRMPL 191
           H N+++L       T    LY  +++E+                     +    +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 192 IYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
               L    YQ+ R + Y+       HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID- 245

Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
                   YY+            APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 297 ESGVDQLVEIIK 308
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 48/230 (20%), Positives = 89/230 (38%), Gaps = 44/230 (19%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
           ++V+G G FG V++     +       VAIK +      K R     E   M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 147 VSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRA 204
           + L+       +    +   ++ E++          + R       ++ +      I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 260
           + Y+   +   HRD+  +N+LVN +    K+ DFG ++VL              Y     
Sbjct: 160 MKYLA-NMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTSGG 210

Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
                  APE + +    +T+A D+WS G V+ E++  G+  +   S  +
Sbjct: 211 KIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 49/224 (21%), Positives = 91/224 (40%), Gaps = 41/224 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 151
            + +G G FG+V   K       VAIK + +    ++    E + M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY-TYQICRALAYIHG 210
           C    T +  ++  ++ E++         +Y R  +        L     +C A+ Y+  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-E 137

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 260
                HRD+  +N LVN     VK+ DFG ++ ++  E         Y            
Sbjct: 138 SKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRW 187

Query: 261 -APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
             PE L++   ++++  DIW+ G ++ E+  LG+  +   +  +
Sbjct: 188 SPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 56/251 (22%), Positives = 90/251 (35%), Gaps = 58/251 (23%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
              +G+  FG V++         E  + VAIK +        +     E      L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP-----------ETVYRVAKHYSRASQRMPLIYV 194
           VV L       T    L   ++  +                  V       + +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 195 KL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
                  QI   + Y+     V H+D+  +N+LV      VK+ D G  + +   +    
Sbjct: 129 DFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD---- 182

Query: 253 YICSRYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LG-QPLFPGE 297
                YY+            APE +++G  +++   DIWS G VL E+   G QP + G 
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCGY 234

Query: 298 SGVDQLVEIIK 308
           S    +VE+I+
Sbjct: 235 S-NQDVVEMIR 244

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 54/249 (21%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
            + +G G+FG V +A     G+      VA+K +       +K     EL+ M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP---------ETVYRVAKHYSRASQRMPLIYVK 195
           N+V+L       T    +   ++ E+                +    + A          
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 196 L--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
           L  ++ Q+ + +A++       HRD+  +N+L+    H  K+ DFG A+ ++        
Sbjct: 166 LLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS----- 218

Query: 254 ICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LG-QPLFPGESG 299
                Y             APE IF    YT   D+WS G +L E+  LG  P +PG   
Sbjct: 219 ----NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILV 272

Query: 300 VDQLVEIIK 308
             +  +++K
Sbjct: 273 NSKFYKLVK 281

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 54/245 (22%), Positives = 92/245 (37%), Gaps = 52/245 (21%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
            R +G G+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKL--YTY 199
           +V        +      +  ++LE +      +  R  +   R SQ   L  + L     
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 188

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 257
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 189 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 258 YYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 304 VEIIK 308
           +E + 
Sbjct: 296 LEFVT 300

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 57/252 (22%)

Query: 96  ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
            + +G+G+FG V  A+ +       +   TVA+K +      +D      E++ M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-----------TVYRVAKHYSRASQRMPL 191
           H N+++L       T    LY  +++E+  +                  +         +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 192 IYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
            +  L   TYQ+ R + Y+       HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 211

Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 297 ESGVDQLVEIIK 308
              V++L +++K
Sbjct: 263 IP-VEELFKLLK 273

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 53/245 (21%), Positives = 92/245 (37%), Gaps = 52/245 (21%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
            R +G G+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKL--YTY 199
           +V        +      +  +++E +      +  R  +   R SQ   L  + L     
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 147

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 257
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 148 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 258 YYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 304 VEIIK 308
           +E + 
Sbjct: 255 LEFVT 259

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 36/215 (16%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 150
           + ++G+G FG V++ + L  G  VA+K++ +++          E++ + +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKH-YSRASQRMPLIYVKLYTYQIC----RAL 205
                 T  + L   LV  ++      VA     R   + PL + K    +I     R L
Sbjct: 94  GF--CMTPTERL---LVYPYMANG--SVASCLRERPESQPPLDWPK--RQRIALGSARGL 144

Query: 206 AYIHGGIGVC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----- 258
           AY+H        HRD+K  N+L++    +  + DFG AK++   +   +++ +       
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIG 200

Query: 259 YRAPE-LIFG-ATEYTTAIDIWSVGCVLAELLLGQ 291
           + APE L  G ++E T   D++  G +L EL+ GQ
Sbjct: 201 HIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 46/223 (20%), Positives = 81/223 (36%), Gaps = 43/223 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMRLLDH-PNVVSL 149
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            +           Y  +VLE +  ++  +     R      L  V +   Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122

Query: 210 GGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YR 260
               + +RD+KP+N L+    N     + + DF  AK          YI         YR
Sbjct: 123 -SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172

Query: 261 APELIFGATEYTTAI------------DIWSVGCVLAELLLGQ 291
             + + G   Y  +I            D+ ++G +    L G 
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLL-DHPNVVSL 149
           +   R +G GSFG ++    ++T E VAIK      ++     E +  R+L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           +         +  Y  LV++ +  +   +   ++  S+++ L  V +   Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPS---LEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 210 GGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 262
                 HRDIKP N L+      +QV + DFG AK          Y  +       YR  
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170

Query: 263 ELIFGATEYTTAI------------DIWSVGCVLAELLLGQ 291
           + + G   Y  ++            D+ S+G VL   L G 
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.6 bits (181), Expect = 8e-15
 Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 41/221 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 149
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           + C       +  Y  +V+E +  ++  +    SR   +  L  V L   Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122

Query: 210 GGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
                 HRD+KP N L+      + V + DFG AK          Y  +R      YR  
Sbjct: 123 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172

Query: 263 ELIFGATEYTTAI------------DIWSVGCVLAELLLGQ 291
           + + G   Y  +I            D+ S+G VL    LG 
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 44/217 (20%)

Query: 98  VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK----NRELQT----MRLLDHPNVVSL 149
            +G+G FG+V++   +    TVA+KK+            ++       M    H N+V L
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 150 K-HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC----RA 204
                   +D D+L   LV  ++P     +    S      PL +      +I       
Sbjct: 96  LGFS----SDGDDLC--LVYVYMPNG--SLLDRLSCLDGTPPLSWHM--RCKIAQGAANG 145

Query: 205 LAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 257
           + ++H      HRDIK  N+L+           K+ DFG A+   K     + + SR   
Sbjct: 146 INFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTSRIVG 197

Query: 258 -Y-YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP 292
              Y APE + G  E T   DI+S G VL E++ G P
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 56/236 (23%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 147
           + V+G+G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP-----------ETVYRVAKHYSRASQRMPLIYVKL 196
           +L         +  LY  L +E+ P             +          S    L   +L
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 197 --YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 145 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRG----------- 191

Query: 255 CSRYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
               Y             A E L +    YTT  D+WS G +L E++ LG   + G
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 43/250 (17%), Positives = 82/250 (32%), Gaps = 49/250 (19%)

Query: 72  TGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK 131
            G ++    G +         ++  + +G G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 132 N---RELQTMRLLDHPNVVSLK--------------HCFFSTTDKDELYLNLVLEFVPET 174
                EL+  + +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQV 233
           +    +  S  +       V     ++   L YIH      H DIK  NLL+   +  QV
Sbjct: 138 L----QKISGQNGTFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQV 192

Query: 234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI------------DIWSVG 281
            L D+G +        +  Y         +   G  E+ T++            D+  +G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 282 CVLAELLLGQ 291
             +   L G+
Sbjct: 248 YCMLRWLCGK 257

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 40/252 (15%), Positives = 82/252 (32%), Gaps = 50/252 (19%)

Query: 72  TGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG--------ETVAIKK 123
           TG ++    G +         +  +    + + GI+++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 124 VLQDKRYKNRELQTMRLLDHPNVVSLK-----------HCFFSTTDKDELYLNLVLEFVP 172
             +D R  N +    R      V   K            C      +D+    LVL  + 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141

Query: 173 ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTH 231
            ++        +    +    V     ++  AL ++H      H ++  +N+ V+P    
Sbjct: 142 RSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDPEDQS 198

Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI------------DIWS 279
           QV L  +G A        +++Y             G  E+  ++            D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253

Query: 280 VGCVLAELLLGQ 291
           +G  + + L G 
Sbjct: 254 LGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 50/275 (18%), Positives = 87/275 (31%), Gaps = 50/275 (18%)

Query: 49  MKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVF 108
           M++K  +  ++  A          G II                +     +GQG FG ++
Sbjct: 2   MRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAA---------WKVGLPIGQGGFGCIY 52

Query: 109 QA-----KCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK------------- 150
            A     + + +     +K    D      EL+  +    P  +                
Sbjct: 53  LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112

Query: 151 -HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
                      + Y  ++++     +    K Y   ++R     V   + +I   L YIH
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRFGSDL---QKIYEANAKRFSRKTVLQLSLRILDILEYIH 169

Query: 210 GGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
                 H DIK  NLL+N  +  QV L D+G A        + +Y             G 
Sbjct: 170 E-HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGT 224

Query: 269 TEYTTAI------------DIWSVGCVLAELLLGQ 291
            E+ T+I            D+  +G  + + L G 
Sbjct: 225 IEF-TSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 25/125 (20%)

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
           Y++Q+ + + ++       HRD+  +N+L++   + VK+CDFG A+ + K          
Sbjct: 198 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP-------- 247

Query: 257 RYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
             Y             APE IF    YT   D+WS G +L E+  LG   +PG    ++ 
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305

Query: 304 VEIIK 308
              +K
Sbjct: 306 CRRLK 310

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 15/88 (17%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLD-HP 144
            + +G+G+FG V +A         T  TVA+K +       + R    EL+ +  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP 172
           NVV+L      T     L   +++EF  
Sbjct: 87  NVVNLLGA--CTKPGGPLM--VIVEFCK 110

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.4 bits (135), Expect = 1e-08
 Identities = 55/377 (14%), Positives = 97/377 (25%), Gaps = 122/377 (32%)

Query: 122 KKVLQDKRYK------NRELQTMRLLD-------------------------------HP 144
           K +L  +         +    T+RL                                   
Sbjct: 43  KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYS--RASQRM-PLIYVKLY---- 197
              S+    +    +D LY N    F    V R+  +    +A   + P   V +     
Sbjct: 103 RQPSMMTRMYIEQ-RDRLY-NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160

Query: 198 ------TYQICRALAYIH---GGI-----GVCHRD---IKPQNLLVNPHTHQVKLCDFGS 240
                    +C +          I       C+     ++    L+    +Q+   ++ S
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL----YQID-PNWTS 215

Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI----DIWSVGCVLAELLLGQPLFPG 296
                    NI             +  +  Y   +    ++ +     A        F  
Sbjct: 216 ---RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--------FNL 264

Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM---PPEAVDL 353
                      K+L T TR          T+F       H    + H  M   P E   L
Sbjct: 265 SC---------KILLT-TR------FKQVTDFLSAATTTHI--SLDHHSMTLTPDEVKSL 306

Query: 354 VSRLLQYSPNLRCTAL--EAC-IHPFF-----DELRDPNARLPNGRPFPPLFNFKPQELK 405
           + + L    + R   L  E    +P       + +RD  A   N +      +    +L 
Sbjct: 307 LLKYL----DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK------HVNCDKLT 356

Query: 406 GASKELLSKLIPEHARK 422
              +  L+ L P   RK
Sbjct: 357 TIIESSLNVLEPAEYRK 373

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 3e-04
 Identities = 59/396 (14%), Positives = 103/396 (26%), Gaps = 122/396 (30%)

Query: 95  AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVV---SLKH 151
           A+ V+  G  G          G+T     V    + + +             +   +LK+
Sbjct: 150 AKNVLIDGVLGS---------GKTWVALDVCLSYKVQCK---------MDFKIFWLNLKN 191

Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
           C  S     E+   L+ +  P    R + H S    R+  I  +L      R L      
Sbjct: 192 C-NSPETVLEMLQKLLYQIDPNWTSR-SDHSSNIKLRIHSIQAEL------RRL------ 237

Query: 212 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPEL 264
             +  +      LLV     N         +    K+L+  + +    ++ +       L
Sbjct: 238 --LKSKP-YENCLLVLLNVQNAKA--WNAFNLSC-KILLTTRFKQVTDFLSAATTTHISL 291

Query: 265 IFGATEYTT--AIDIWS--VGCVLAEL----LLGQPL-----------FPG------ESG 299
              +   T      +    + C   +L    L   P                        
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351

Query: 300 VDQLVEIIKVLGTPTREEIKCMNPN-----YTEFK-FP---QIKAHP----WHKIFHKRM 346
            D+L  II+         +  + P      +     FP    I        W       +
Sbjct: 352 CDKLTTIIES-------SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD-----V 399

Query: 347 PPEAV-DLVSRLLQYS-----PN------------LRCTAL-EACIH-PFFDELRDPNAR 386
               V  +V++L +YS     P             L+     E  +H    D    P   
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459

Query: 387 LPNGRPFPPL----FNFKPQELKGASKELLSKLIPE 418
             +    P L    ++     LK         L   
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM 495

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	429
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.07
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.0
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.57
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.48
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.16
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.14
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.07
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.06
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.02
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.91
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.39
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.32
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.28
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.15
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.1
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.05
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.96
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.87
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.87
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.82
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.72
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.68
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.39
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.69
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.91

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-63  Score=460.16  Aligned_cols=250  Identities=28%  Similarity=0.438  Sum_probs=202.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++++.++|||||+++++|.     +..
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence            35799999999999999999999999999999998542       234568999999999999999999884     344


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+|+|||||+|++++.+..    .+.+++..++.++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+
T Consensus        87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH-~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCH-RHKIVHRDLKPENLLLDEHL-NVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCChHHeEECCCC-CEEEeecCCCe
Confidence            5899999999988887654    467999999999999999999999 78999999999999999887 79999999998


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .........+.+||+.|||||++.+...++.++||||+||++|+|+||++||.+.+..+.+..+....            
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------  228 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------  228 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence            87666666678999999999999876656789999999999999999999999887766666554421            


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                           +            .++..+|+++++||.+||++||++|||+.|+|+||||+.
T Consensus       229 -----~------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          229 -----Y------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -----C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -----C------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                 0            123458999999999999999999999999999999973

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-63  Score=465.25  Aligned_cols=255  Identities=31%  Similarity=0.528  Sum_probs=219.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.|+|||||+++++|.     +..+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            4699999999999999999999999999999998643       234568999999999999999999983     4446


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|+|||||+| +|.+.+..    .+.+++..++.|+.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+
T Consensus       107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH-~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~  180 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLNEDM-HIQITDFGTAK  180 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence            8999999985 67666543    467999999999999999999999 78999999999999999888 79999999999


Q ss_pred             ecccC---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          243 VLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       243 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      .....   ....+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+.++.+..         
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---------  250 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE---------  250 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------
Confidence            76433   234567999999999999764 48999999999999999999999999988887777776520         


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCCccccCCCCCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE------ACIHPFFDELRDPNAR  386 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e------~l~hp~f~~~~~~~~~  386 (429)
                              +            .++..+|+++++||.+||++||++|+|+.|      +++||||+++.|....
T Consensus       251 --------~------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          251 --------Y------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             --------C------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             --------C------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence                    1            133458999999999999999999999987      5899999999886543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-62  Score=476.65  Aligned_cols=318  Identities=33%  Similarity=0.603  Sum_probs=249.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...      .....+|+++|+.|+|||||++++++..... .....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4699999999999999999999999999999998543      2234579999999999999999998754321 23345


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|||||||+|+|.+.+.    ..+.+++..++.|++||+.||.||| ++|||||||||+|||++.++ .+||+|||+|+.
T Consensus       134 ~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMH-SAQVIHRDLKPSNLLVNENC-ELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCcCcCCCcCccccccCCCC-CEEEeecceeee
Confidence            89999999998877664    3578999999999999999999999 88999999999999999888 799999999986


Q ss_pred             cccC-----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          244 LVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       244 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      ....     ....+.+||+.|||||++.+...++.++||||+||++|||++|++||.+.+..+++..|....+.|+...+
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            5332     23456799999999999988777899999999999999999999999999999999999999999887654


Q ss_pred             hhcCCCCcc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCC
Q 014156          319 KCMNPNYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPP  395 (429)
Q Consensus       319 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~  395 (429)
                      .........   ..++.....+|...+ +.+++++++||.+||++||.+|||+.|+|+||||++++++......    .+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~----~~  362 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDC----AP  362 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCC----SS
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCC----CC
Confidence            332211100   122333333444333 4589999999999999999999999999999999998887654222    22


Q ss_pred             CCCCChhhhccCCHHHHHhhcHHHH
Q 014156          396 LFNFKPQELKGASKELLSKLIPEHA  420 (429)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~  420 (429)
                      .+++.. +....+++.+.+++-++.
T Consensus       363 ~~~~~~-~~~~~~~~~~k~~i~~ei  386 (398)
T 4b99_A          363 PFDFAF-DREALTRERIKEAIVAEI  386 (398)
T ss_dssp             CCCCHH-HHSCCCHHHHHHHHHHHH
T ss_pred             CCCCcc-chhhcCHHHHHHHHHHHH
Confidence            333332 223345666666665543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-61  Score=462.59  Aligned_cols=253  Identities=30%  Similarity=0.424  Sum_probs=215.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..|++.++||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|...     ..+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence            3599999999999999999999999999999998532    34567899999999999999999998543     34899


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      |||||+| +|.+++..     ..+++..++.|+.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999985 55555432     57999999999999999999999 88999999999999999888 79999999998775


Q ss_pred             cC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+...... .          
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~----------  289 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-R----------  289 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-C----------
T ss_pred             CCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-C----------
Confidence            43 34557899999999999865 45999999999999999999999999998887777766542100 0          


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                     ...+..+|+++++||.+||++||++|||+.|+|+||||++...
T Consensus       290 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          290 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             ---------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ---------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence                           0112347999999999999999999999999999999987543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-61  Score=461.81  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=209.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...      .....+|+++++.|+|||||+++++|..     ...
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence            45899999999999999999999999999999998543      2345689999999999999999999854     335


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|||||||+| +|.+.+..  +....+++..++.|+.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+
T Consensus        98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~  173 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDG-TVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEECCCC-CEEEcccccce
Confidence            8999999984 77776643  23456899999999999999999999 88999999999999999888 79999999998


Q ss_pred             ecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...... .....+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+.+.++....           
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-----------  241 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-----------  241 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred             eecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----------
Confidence            764432 23456899999999999764 59999999999999999999999999998888777776531           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                              ++         .++..+|+++++||.+||++||.+|||+.|+|+||||++
T Consensus       242 --------~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 --------FP---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             --------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             --------CC---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                    01         123457999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-60  Score=464.81  Aligned_cols=253  Identities=30%  Similarity=0.435  Sum_probs=215.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc----chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..|+++++||+|+||+||+|+++.+|+.||||++..    ......+|+.+|+.|+|||||+++++|...     ..+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence            469999999999999999999999999999999853    234567899999999999999999998543     34899


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      |||||+| +|.+++..     ..+++..++.|+.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+...
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH-~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999985 55555432     56999999999999999999999 78999999999999999888 79999999998765


Q ss_pred             cC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..... +           
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~-----------  365 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P-----------  365 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----------
T ss_pred             CCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C-----------
Confidence            43 34567899999999999865 4599999999999999999999999999888877776654210 0           


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                    ....+..+|+++++||.+||++||.+|+|+.|+|+||||++...
T Consensus       366 --------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          366 --------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             --------------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             --------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence                          00122357999999999999999999999999999999987543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-60  Score=443.20  Aligned_cols=251  Identities=22%  Similarity=0.340  Sum_probs=206.3

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |++.++||+|+||+||+|.++.+++.||+|++...      ...+.+|+++++.|+|||||+++++|.... ....++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            47888999999999999999999999999998543      234568999999999999999999885533 33456889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecC-CCCceEEeecCCce
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNP-HTHQVKLCDFGSAK  242 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~-~~~~vkl~DFG~a~  242 (429)
                      |||||++ +|.+.+..    .+.+++..++.|+.||+.||+||| ++|  ||||||||+||||+. ++ .+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH-~~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence            9999985 66665543    467999999999999999999999 777  999999999999985 45 79999999997


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .. ......+.+||+.|||||++.+  .|+.++|||||||++|||+||++||.+.+....+.........          
T Consensus       181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----------  247 (290)
T 3fpq_A          181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------  247 (290)
T ss_dssp             GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------
T ss_pred             eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----------
Confidence            54 3344556789999999998864  4899999999999999999999999877665554443321100          


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                      ...++..+++++++||.+||+.||++|||+.|+|+||||++
T Consensus       248 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          248 ----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                            01123457899999999999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.1e-59  Score=463.05  Aligned_cols=332  Identities=71%  Similarity=1.220  Sum_probs=295.4

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceEEEE
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNL  166 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~~~l  166 (429)
                      ....+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++||||++++++|..... .+..++++
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            34557999999999999999999999999999999998777777789999999999999999998865433 45667889


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||+++++++.+..+......+++..++.++.||+.||.||| +.||+||||||+||||+.++..+||+|||+++....
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            9999999998888877777788999999999999999999999 889999999999999997765799999999998766


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      .......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++++.++.|..+.+..+++.+.
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666788999999999997766799999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhhcc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKG  406 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (429)
                      .+.++.+...+|...++..+++++++||.+||.+||.+|||+.|+|+||||++++++....++....+..++|...++..
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS  369 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhcc
Confidence            99999999999999999999999999999999999999999999999999999999888777777888889998887753


Q ss_pred             CCHHHHHhhcHHHHh
Q 014156          407 ASKELLSKLIPEHAR  421 (429)
Q Consensus       407 ~~~~~~~~~~~~~~~  421 (429)
                       ..++...++|++.+
T Consensus       370 -~~~~~~~~~~~~~~  383 (420)
T 1j1b_A          370 -NPPLATILIPPHAR  383 (420)
T ss_dssp             -CGGGHHHHSCTTTT
T ss_pred             -ChhHHHhhCCHhhh
Confidence             33444455555443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.2e-60  Score=461.67  Aligned_cols=331  Identities=50%  Similarity=0.978  Sum_probs=287.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCC-----------
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-----------  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-----------  158 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+.+++.++||||++++++|.....           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            457999999999999999999999999999999998777777789999999999999999998866443           


Q ss_pred             ----------------------CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeee
Q 014156          159 ----------------------KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH  216 (429)
Q Consensus       159 ----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiH  216 (429)
                                            ....++++||||+++++.+.+..+......+++..++.++.||+.||.||| +.||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~gi~H  164 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICH  164 (383)
T ss_dssp             ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEEC
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCcCcc
Confidence                                  345568899999999998888877777788999999999999999999999 889999


Q ss_pred             cCCCCCCeeecCCCCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014156          217 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG  296 (429)
Q Consensus       217 rDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  296 (429)
                      |||||+|||++.+.+.+||+|||+|+............||+.|+|||++.+...++.++||||+||++|+|++|++||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998544489999999999877666667788999999999987766789999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014156          297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  376 (429)
Q Consensus       297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  376 (429)
                      .+..+++..+.+.++.|+.+.+..+++.+....++.+....|...++..+++++.+||.+||++||.+|||+.|+|+|||
T Consensus       245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF  324 (383)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-------CCCCCCCC--CCCCCCCCCChhhhccCCHHHHHhhcHHHHh
Q 014156          377 FDELRD-------PNARLPNG--RPFPPLFNFKPQELKGASKELLSKLIPEHAR  421 (429)
Q Consensus       377 f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (429)
                      |+++++       +....+++  .+.|..++|++.++.....+++.+++|++.+
T Consensus       325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  378 (383)
T 3eb0_A          325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS  378 (383)
T ss_dssp             GHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred             HHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence            998765       33444555  6678899999999998889999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.2e-60  Score=452.22  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=213.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEeec
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      ..|.+.++||+|+||+||+|+++.+|+.||||++..+. ...+|+.+++.|+|||||+++++|..     ..++||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVRE-----GPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEec
Confidence            46999999999999999999999999999999987543 33579999999999999999998844     3358999999


Q ss_pred             chh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC
Q 014156          171 VPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  249 (429)
Q Consensus       171 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~  249 (429)
                      |+| +|.+++..    .+.+++..++.|+.||+.||+||| ++|||||||||+||||+.++..+||+|||+|+.......
T Consensus       132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            985 67666643    367999999999999999999999 889999999999999998875699999999987654321


Q ss_pred             ------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          250 ------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       250 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                            ....+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+.+.++...  .+.         
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~---------  274 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP---------  274 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG---------
T ss_pred             ccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC---------
Confidence                  2235799999999999764 5999999999999999999999999887766655555441  000         


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH-------------hcCCCccccCCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-------------CIHPFFDELRDPN  384 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~-------------l~hp~f~~~~~~~  384 (429)
                                     ...+++.+|+++.+||.+||++||.+|||+.|+             |+|||+.+++.|.
T Consensus       275 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          275 ---------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             ---------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             ---------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                           012445689999999999999999999999997             6799999887764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-60  Score=449.12  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=208.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++++.||+|+||+||+|++.   .+++.||||++.+.      .....+|+++++.++|||||+++++|..     
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----   97 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----   97 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----
Confidence            357999999999999999999874   46889999988532      2345679999999999999999999854     


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+|+|||||+| +|.+.+..    .+.+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFG  171 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEG-HIKLTDFG  171 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECTTS-CEEEESSE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHeEEcCCC-CEEecccc
Confidence            3358999999985 66665543    467999999999999999999999 88999999999999999888 79999999


Q ss_pred             CceecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          240 SAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       240 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+.+..+.+..        
T Consensus       172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------  242 (304)
T 3ubd_A          172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------  242 (304)
T ss_dssp             EEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--------
Confidence            99865443 344567899999999999764 59999999999999999999999999988888777776521        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  383 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  383 (429)
                               .            .++..+|+++++||++||++||++|||     ++|+++||||+++.+.
T Consensus       243 ---------~------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          243 ---------L------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             ---------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------C------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence                     0            123458999999999999999999998     5799999999988754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.1e-59  Score=456.06  Aligned_cols=329  Identities=67%  Similarity=1.180  Sum_probs=297.0

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceEEEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNLV  167 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~~~lv  167 (429)
                      ...+|++.+.||+|+||.||+|++..+++ ||+|++..+.....+|+.+++.++||||++++++|..... ....++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            34579999999999999999999877765 8999887777777789999999999999999999876654 556778899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec-CCCCceEEeecCCceeccc
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~-~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||++++++..+..+......+++..++.++.||+.||.||| +.||+||||||+||||+ .++ .+||+|||+|+....
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA  194 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence            999999988887777666788999999999999999999999 78999999999999999 455 899999999998776


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      +.......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+..+++++.
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66667788999999999997766799999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhhcc
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKG  406 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  406 (429)
                      ...++.+...++...++..+++++.+||.+||++||.+|||+.|+++||||++++++....++....|+.+++...++..
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSV  354 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHT
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhc
Confidence            88999999999999999999999999999999999999999999999999999999988888888889999999888765


Q ss_pred             CCHHHHHhhcHHHHh
Q 014156          407 ASKELLSKLIPEHAR  421 (429)
Q Consensus       407 ~~~~~~~~~~~~~~~  421 (429)
                       ..+++.+++|.+.+
T Consensus       355 -~~~~~~~~~~~~~~  368 (394)
T 4e7w_A          355 -RPDLISRLVPQHAE  368 (394)
T ss_dssp             -CGGGHHHHSCGGGC
T ss_pred             -CHHHHHhhccHhhh
Confidence             44888888887663

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-58  Score=445.67  Aligned_cols=279  Identities=27%  Similarity=0.449  Sum_probs=214.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccch--hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .++|++.+.||+|+||+||+|+++   .+++.||+|.+....  ....+|+++|+.+ +|||||+++++|..     ..+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-----~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-----NDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-----TTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-----CCE
Confidence            456999999999999999999875   467899999886443  3456899999988 69999999998844     345


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|+|||||++ +|.+.+       +.+++..++.++.||+.||+||| ++||+||||||+|||++.+.+.+||+|||+|+
T Consensus        95 ~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH-~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIH-QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            8999999984 555544       35999999999999999999999 88999999999999998875589999999998


Q ss_pred             ecccCC-----------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014156          243 VLVKGE-----------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL  293 (429)
Q Consensus       243 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  293 (429)
                      ......                             ...+.+||+.|+|||++.+...|+.++||||+||++|+|++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            653321                             123457999999999998777799999999999999999999999


Q ss_pred             CC-CCChHHHHHHHHHHhCCCCHHHHhhcCCCC---------------------ccccCCCc----CCCCcccccCCCCC
Q 014156          294 FP-GESGVDQLVEIIKVLGTPTREEIKCMNPNY---------------------TEFKFPQI----KAHPWHKIFHKRMP  347 (429)
Q Consensus       294 f~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~----~~~~~~~~~~~~~s  347 (429)
                      |. +.+..+++..|...+|.+............                     .....|..    ............+|
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            85 567778889998888765443222111000                     00000100    00111112235689


Q ss_pred             hhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          348 PEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       348 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ++++|||++||++||++|+|+.|+|+||||+++.
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.9e-58  Score=430.43  Aligned_cols=260  Identities=24%  Similarity=0.405  Sum_probs=191.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCC-------
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-------  158 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-------  158 (429)
                      .+|++++.||+|+||+||+|+++.+|+.||||++...     .....+|+++|+.|+|||||+++++|.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4699999999999999999999999999999988532     2334589999999999999999999876543       


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                      ....++|+|||||++ +|.+.+... ......++..++.++.||+.||+||| ++|||||||||+||||+.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH-~~~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHH-HCcCccccCcHHHeEECCCC-cEEEcc
Confidence            234568999999985 565555431 11223456778999999999999999 78999999999999999888 799999


Q ss_pred             cCCceecccCCC-------------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014156          238 FGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV  304 (429)
Q Consensus       238 FG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  304 (429)
                      ||+|+.......             ..+.+||+.|||||++.+. .|+.++|||||||++|||++   ||.+.  .+...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence            999987644321             2346899999999999764 59999999999999999996   77543  22222


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      .+...........                         ....++.+.+||.+||+.||.+|||+.|+|+||||+++.+|.
T Consensus       236 ~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            2222211111000                         012467889999999999999999999999999999887654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-56  Score=456.69  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=210.2

Q ss_pred             CccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHH---HHHHHHHcCCCCeeccceeeeec
Q 014156           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFST  156 (429)
Q Consensus        87 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~l~~~~~~~  156 (429)
                      +...++|.++++||+|+||+||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||+++++|   
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f---  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF---  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence            345568999999999999999999999999999999985432       11223   35566677999999999998   


Q ss_pred             CCCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          157 TDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                        .+...+|+|||||+| +|...+..    .+.+++..++.|+.||+.||+||| ++|||||||||+||||+.++ .+||
T Consensus       262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH-~~gIiHRDLKPeNILld~~G-~vKL  333 (689)
T 3v5w_A          262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRI  333 (689)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECTTS-CEEE
T ss_pred             --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHeEEeCCC-CEEe
Confidence              444568999999985 66665543    467999999999999999999999 88999999999999999988 6999


Q ss_pred             eecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCC
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ---LVEIIKVLGT  312 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~~~~  312 (429)
                      +|||+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|||++|++||.+.+..+.   ...+...   
T Consensus       334 ~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---  409 (689)
T 3v5w_A          334 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---  409 (689)
T ss_dssp             CCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---
T ss_pred             cccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---
Confidence            999999876544 345679999999999997656699999999999999999999999976433222   2222110   


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  383 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  383 (429)
                                                ...++..+|+++++||.+||+.||.+|++     +.|+++||||+++.|.
T Consensus       410 --------------------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          410 --------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             --------------------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             --------------------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence                                      01234568999999999999999999998     7999999999998774

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.7e-56  Score=454.50  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=221.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .++|.+++.||+|+||.||+|+++.+|+.||||++...    .....+|+.+|+.|+|||||+++++|.     ....+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence            35799999999999999999999999999999988543    334568999999999999999999984     445689


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC-CCceEEeecCCcee
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  243 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~-~~~vkl~DFG~a~~  243 (429)
                      ||||||+| +|++.+   ......+++..++.|+.||+.||.||| ++||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus       231 iv~E~~~gg~L~~~i---~~~~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          231 MIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEECCCCCBHHHHH---TCTTSCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEeecCCCcHHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999985 555544   233467999999999999999999999 8899999999999999854 23799999999998


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..........+||+.|||||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+........         
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~---------  376 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------  376 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------
T ss_pred             ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---------
Confidence            8776666778999999999999764 589999999999999999999999999988888777665321111         


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                                      ......+|+++++||++||++||.+|||+.|+|+||||+...++.
T Consensus       377 ----------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          377 ----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             ----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                            112245899999999999999999999999999999999877654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.3e-55  Score=410.97  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=204.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|.+.+.||+|+||+||+|++.     .++..||||++...    ...+.+|+++|++|+|||||++++++...     
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence            47999999999999999999875     35789999998643    23456899999999999999999988543     


Q ss_pred             eEEEEEeecch-hhHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYS---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  231 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~  231 (429)
                      ..++||||||+ |+|.+.+....         .....+++..+..++.||+.||.||| +++||||||||+||||+.++ 
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDlKp~NILl~~~~-  165 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENL-  165 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCccCHhhEEECCCC-
Confidence            33889999998 56777665421         22357999999999999999999999 78999999999999999887 


Q ss_pred             ceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014156          232 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII  307 (429)
Q Consensus       232 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  307 (429)
                      .+||+|||+|+.......   .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+.
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            799999999986644332   2235689999999999765 49999999999999999998 899999988777666655


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ....                            ...+..+|+++.+||.+||+.||++|||+.++  |+|++++.
T Consensus       245 ~~~~----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          245 QGRV----------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             cCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            4210                            01234589999999999999999999999999  45776654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3e-53  Score=425.17  Aligned_cols=325  Identities=32%  Similarity=0.518  Sum_probs=238.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+|++++.||+|+||+||+|++..+++.||||++...      .....+|+.+++.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            35799999999999999999999999999999988542      234458999999999999999999886554344456


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|+||||+++++..++..    ...+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+.
T Consensus       132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVH-SAGILHRDLKPANCLVNQDC-SVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHH-hCCcCCCCCChhhEEECCCC-CEeecccccchh
Confidence            889999999988776643    567999999999999999999999 78999999999999999888 799999999987


Q ss_pred             cccCC----------------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh------
Q 014156          244 LVKGE----------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL------  289 (429)
Q Consensus       244 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt------  289 (429)
                      .....                            .....+||+.|+|||++.....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            64221                            23456789999999987666679999999999999999999      


Q ss_pred             -----CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCCcCCCCcccc
Q 014156          290 -----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKI  341 (429)
Q Consensus       290 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  341 (429)
                           |+++|.+.+                    ..+++..++..+|.|..+.+.........   ..++......+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 788887755                    36788889999999998877543321100   01222222223332


Q ss_pred             cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhhccCCHHHHHhhcHHHHh
Q 014156          342 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR  421 (429)
Q Consensus       342 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  421 (429)
                      + +.+++++++||.+||.+||.+|||+.|+|+||||++++++........+...+++    +......+.+...+.++..
T Consensus       366 ~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~e~~  440 (458)
T 3rp9_A          366 F-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN----DWMNMDEPQLRYAFVKEIQ  440 (458)
T ss_dssp             S-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC----TTSCCCHHHHHHHHHHHHT
T ss_pred             C-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc----ccccCCHHHHHHHHHHHHH
Confidence            3 3479999999999999999999999999999999999887654333322222222    1123456666666666666


Q ss_pred             hhCC
Q 014156          422 KQCP  425 (429)
Q Consensus       422 ~~~~  425 (429)
                      .-+|
T Consensus       441 ~~~~  444 (458)
T 3rp9_A          441 RYHP  444 (458)
T ss_dssp             TTCT
T ss_pred             HhCc
Confidence            5444

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-54  Score=403.90  Aligned_cols=247  Identities=22%  Similarity=0.303  Sum_probs=193.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..++++.++||+|+||+||+|++.   ..||||+++..      ...+.+|+.+++.++|||||++++++..    +  .
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--N  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--e
Confidence            346889999999999999999853   35999988532      2345689999999999999999987621    1  2


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ++||||||++ +|.+.+.   .....+++..+..|+.||+.||+||| +++||||||||+||||+.++ .+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~---~~~~~l~~~~~~~i~~qia~gL~yLH-~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLH-AKNIIHRDMKSNNIFLHEGL-TVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCccCHHHEEECCCC-cEEEeeccCce
Confidence            6799999985 5655543   23467999999999999999999999 78999999999999999887 89999999998


Q ss_pred             ecccC---CCcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKG---EPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      .....   ......+||+.|||||++.+.  ..|+.++|||||||+||||+||+.||.+.+....+..+......     
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-----  255 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-----  255 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-----
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-----
Confidence            65432   223456899999999998643  34899999999999999999999999987776666555442111     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                  .|..      ..++..+++++.+||.+||+.||.+|||+.|+++
T Consensus       256 ------------~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          256 ------------SPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             ------------CCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             ------------CCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                        1110      1234468999999999999999999999987753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=407.31  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=196.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|.+.++||+|+||+||+|+++     .+++.||||++...    ...+.+|+++|+.|+|||||++++++...    
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG----  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----
Confidence            346999999999999999999865     36889999998643    23456899999999999999999998443    


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhh-----------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYS-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP  228 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~-----------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~  228 (429)
                       ..++||||||+ |+|.+++....           .....+++..+..|+.||+.||.||| +.+||||||||+||||+.
T Consensus       116 -~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          116 -RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEET
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHhhEEECC
Confidence             33889999998 56666654321           12356999999999999999999999 789999999999999998


Q ss_pred             CCCceEEeecCCceecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014156          229 HTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLV  304 (429)
Q Consensus       229 ~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  304 (429)
                      ++ .+||+|||+|+......   .....+||+.|||||++.+. .++.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus       194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TT-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            87 89999999998764332   22346789999999999764 59999999999999999999 899999988777766


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+.+...                            ...+..+++++.+||.+||+.||++|||+.|++++
T Consensus       272 ~i~~g~~----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGRE----------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTCC----------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCC----------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            6554210                            01234589999999999999999999999999764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.9e-52  Score=415.93  Aligned_cols=325  Identities=30%  Similarity=0.476  Sum_probs=248.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            35799999999999999999999999999999998642      234458999999999999999999886543333345


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|+||||++++|...+..    ...+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+.
T Consensus       105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~-~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIH-ESGIIHRDLKPANCLLNQDC-SVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCHHHeEECCCC-CEEEccCCCccc
Confidence            889999999988876643    467999999999999999999999 78999999999999999887 799999999987


Q ss_pred             cccCC-----------------------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-----------
Q 014156          244 LVKGE-----------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-----------  289 (429)
Q Consensus       244 ~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-----------  289 (429)
                      .....                       .....+||+.|+|||++.....++.++|||||||++|||++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            64332                       23567899999999987666679999999999999999998           


Q ss_pred             CCCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCCcCCCCcccccCCCCChh
Q 014156          290 GQPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFHKRMPPE  349 (429)
Q Consensus       290 g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~  349 (429)
                      |.++|.+.+                 ..+++..++..+|.|..+.+.........   ...+......+...+ +.++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~  337 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD  337 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHH
Confidence            556666654                 46788999999999998877654321100   011221222222222 458999


Q ss_pred             HHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhhccCCHHHHHhhcHHHHhhhCC
Q 014156          350 AVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP  425 (429)
Q Consensus       350 ~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (429)
                      +.+||.+||++||.+|||+.|+|+||||++++++........+...++  +.  ....+.+.+..++.+++..-+|
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~e~~~~~~  409 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPF--DD--WMVLSETQLRYIFLKEVQSFHP  409 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSS--CT--TCCCCHHHHHHHHHHHHHHHCT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCCh--hh--cccCCHHHHHHHHHHHHHHhCc
Confidence            999999999999999999999999999999998765543333222222  21  1235567777777777766554

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.5e-53  Score=424.39  Aligned_cols=286  Identities=31%  Similarity=0.546  Sum_probs=227.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~  162 (429)
                      ..+|++++.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35799999999999999999999999999999998642      2334579999999999999999998854432 2334


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .+|+||||+++++...+.      ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence            578999999998776552      35999999999999999999999 78999999999999999887 79999999998


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ...........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.|..+.+....
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            87666666678999999999999775 59999999999999999999999999999999999999999999888765443


Q ss_pred             CCCccc--cCCCcCCCCcccccCCC-----------CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          323 PNYTEF--KFPQIKAHPWHKIFHKR-----------MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       323 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      .....+  ..+......+...++..           .++++++||.+||.+||.+|||+.|+|+||||+.+.++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  366 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA  366 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence            221111  11111112222222211           156799999999999999999999999999999877654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-52  Score=407.07  Aligned_cols=325  Identities=47%  Similarity=0.866  Sum_probs=259.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHHcCCCCeeccceeeeecCC--CCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTD--KDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--~~~~~~  164 (429)
                      .++|++.+.||+|+||.||+|++..+|+.||||++..+..   ...++++.+..++||||++++++|.....  ....++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            3479999999999999999999999999999998865433   23456677788899999999998876443  445678


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++++...+.........+++..++.++.||+.||.|||. +.||+||||||+|||++...+.+||+|||+++.
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~  181 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK  181 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence            8999999999888777666667889999999999999999999993 469999999999999997333899999999988


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+..+.+....+
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3e3p_A          182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNP  261 (360)
T ss_dssp             CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred             cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhccc
Confidence            76666666778999999999987766689999999999999999999999999999999999999999999998887776


Q ss_pred             CCccccCCCcCCCCcccccCC---CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCC-CCCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHK---RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFP-PLFNF  399 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~-~~~~~  399 (429)
                      .............+|...+..   ..++++.+||.+||++||.+|||+.|+|+||||+++.++....++....+ ....+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  341 (360)
T 3e3p_A          262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRF  341 (360)
T ss_dssp             TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGGGCC
T ss_pred             chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHHHHc
Confidence            665555544444444444332   36789999999999999999999999999999999998877766666665 45567


Q ss_pred             ChhhhccCCHHHHHh
Q 014156          400 KPQELKGASKELLSK  414 (429)
Q Consensus       400 ~~~~~~~~~~~~~~~  414 (429)
                      .+.+.+...++...+
T Consensus       342 ~~~~~~~~~~~~~~~  356 (360)
T 3e3p_A          342 LPNEIEVMSEAQKAK  356 (360)
T ss_dssp             CHHHHHHSCHHHHHH
T ss_pred             CchHHHHHHHHHhhh
Confidence            777776666555443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-53  Score=413.65  Aligned_cols=291  Identities=32%  Similarity=0.621  Sum_probs=226.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|++++.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.+. ||||+++++++...   +...
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence            4799999999999999999999999999999988432      233457999999997 99999999988542   2234


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|+||||+++++...+..     ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+.
T Consensus        86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLH-SGGLLHRDMKPSNILLNAEC-HVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence            789999999988777653     57999999999999999999999 78999999999999999887 799999999986


Q ss_pred             cccC----------------------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 014156          244 LVKG----------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD  301 (429)
Q Consensus       244 ~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  301 (429)
                      ....                      ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321                      122346899999999999876679999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccC------CCcCCCCcccc------------cCCCCChhHHHHHHhhcCcCCC
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEFKF------PQIKAHPWHKI------------FHKRMPPEAVDLVSRLLQYSPN  363 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~------------~~~~~s~~~~~li~~~L~~dP~  363 (429)
                      ++..+...++.|..+.+......+.....      .......+...            ....+++++.+||.+||++||.
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            99999999999998877654332211000      00000011111            1225789999999999999999


Q ss_pred             CCCCHHHHhcCCCccccCCCCCCCCCCC
Q 014156          364 LRCTALEACIHPFFDELRDPNARLPNGR  391 (429)
Q Consensus       364 ~R~t~~e~l~hp~f~~~~~~~~~~~~~~  391 (429)
                      +|||+.|+|+||||+.+.++........
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~~~~~~~~~~  346 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHNPNEEPNCDH  346 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCCGGGCCCCSS
T ss_pred             cCCCHHHHhCCHHHHHhcCCccCCCCCC
Confidence            9999999999999999888765543333

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-53  Score=401.92  Aligned_cols=248  Identities=21%  Similarity=0.247  Sum_probs=201.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .++++.++||+|+||+||+|+..     .+++.||||++...     ...+.+|+.++++|+|||||++++++...    
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~----  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD----  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence            46889999999999999999864     46789999998542     24566899999999999999999988443    


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  227 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~  227 (429)
                       ..++||||||+ |+|.+.+....            .....+++..+..++.||+.||+||| +.+||||||||+||||+
T Consensus       102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEC
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCCCccccceEEC
Confidence             23789999998 56766664321            11346899999999999999999999 78999999999999999


Q ss_pred             CCCCceEEeecCCceecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014156          228 PHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL  303 (429)
Q Consensus       228 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  303 (429)
                      .++ .+||+|||+|+......   .....+||+.|||||++.+. .|+.++|||||||+||||+| |..||.+.+..+.+
T Consensus       180 ~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          180 DKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             GGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             CCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            887 79999999998764332   23456799999999999765 49999999999999999998 89999998877666


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..+.....                            ...+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus       258 ~~i~~~~~----------------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRNRQV----------------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55443110                            01234579999999999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.2e-52  Score=392.88  Aligned_cols=281  Identities=34%  Similarity=0.545  Sum_probs=227.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|++.+.||+|+||+||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++..     ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            36999999999999999999999999999999885321      334579999999999999999998844     3358


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||++++++..+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH-~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            89999999987776543   3567999999999999999999999 78999999999999999887 7999999999876


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ... .......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+..+.+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            433 2334567899999999997766689999999999999999987766 67777788888899988888766543322


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ........+............+.+++++++||.+||+.||.+|||+.|+|+||||+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            11111112222222222234456899999999999999999999999999999999764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.6e-53  Score=404.10  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=202.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC-----CcEEEEEEeccc-----hhhHHHHHHHHHHcCC-CCeeccceeeeecCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQD-----KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDK  159 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~  159 (429)
                      .+|++.+.||+|+||+||+|++..+     ++.||||.+...     ...+.+|+++|+.++| ||||++++++....  
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~--  141 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--  141 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC--
Confidence            4799999999999999999997654     368999988543     2335579999999976 89999999874432  


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  226 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill  226 (429)
                        ..++||||||+ |+|.+++.....            ....+++..+..++.||+.||+||| +++||||||||+|||+
T Consensus       142 --~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH-~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          142 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILL  218 (353)
T ss_dssp             --SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEE
T ss_pred             --CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh-hCCeecCccCccceee
Confidence              23789999998 567776654322            1345899999999999999999999 7899999999999999


Q ss_pred             cCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 014156          227 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQ  302 (429)
Q Consensus       227 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  302 (429)
                      +.++ .+||+|||+|+.......   ....+||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus       219 ~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          219 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             CGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 799999999987654432   2345789999999999765 49999999999999999998 9999998766555


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +..+......+                           ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       297 ~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            54444321111                           1234579999999999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-51  Score=399.67  Aligned_cols=318  Identities=31%  Similarity=0.538  Sum_probs=240.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4699999999999999999999999999999998432      2334589999999999999999998854322 11234


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|+||||++++|..++..     ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence            689999998888777653     57999999999999999999999 78999999999999999887 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+.+..+.|+.+.+..+..
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            543  345678899999999998756699999999999999999999999999999999999999999999887654432


Q ss_pred             CCcc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 014156          324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFK  400 (429)
Q Consensus       324 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  400 (429)
                      ....   ..++......+.. +...+++++.+||.+||.+||.+|||+.++|+||||++++++..... ..    .++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~-~~----~~~~~  329 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ-VQ----KYDDS  329 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C-CC----CCCCC
T ss_pred             HHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCC-CC----CCCCC
Confidence            1100   0223333333333 23457999999999999999999999999999999999887654321 11    23333


Q ss_pred             hhhhccCCHHHHHhhcHHHHhhhC
Q 014156          401 PQELKGASKELLSKLIPEHARKQC  424 (429)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~  424 (429)
                      ..+. ....+.+.+++.++...-+
T Consensus       330 ~~~~-~~~~~~~~~~~~~~~~~~~  352 (367)
T 1cm8_A          330 FDDV-DRTLDEWKRVTYKEVLSFK  352 (367)
T ss_dssp             ------CCHHHHHHHHHHHHHTCC
T ss_pred             hhhh-cCCHHHHHHHHHHHHHHhc
Confidence            2222 3445667777666655433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-51  Score=393.24  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=217.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+++++.++||||+++++++.     ...
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence            4457999999999999999999999999999999985432      23457999999999999999999883     334


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||++ +++.+.+..    .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a  161 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDADM-NIKIADFGFS  161 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSTTCC
T ss_pred             EEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEeccCCCHHHEEEcCCC-CEEEeeccCc
Confidence            5889999997 466665543    367999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .....+......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....           
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  230 (328)
T 3fe3_A          162 NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-----------  230 (328)
T ss_dssp             GGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             eecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            877666666778899999999999876645689999999999999999999999888776666554421           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                            +            .++..+++++.+||++||..||.+|||+.|+++||||+......
T Consensus       231 ------~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  275 (328)
T 3fe3_A          231 ------Y------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED  275 (328)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred             ------C------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence                  0            12234789999999999999999999999999999999866543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.3e-52  Score=393.43  Aligned_cols=280  Identities=35%  Similarity=0.655  Sum_probs=225.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+|++++.||+|+||+||+|++. +|+.||+|++....      ....+|+.+++.++||||+++++++.     ....
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence            357999999999999999999985 58999999885432      33458999999999999999999883     3345


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++||||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        94 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~  168 (311)
T 3niz_A           94 LTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCH-QHRILHRDLKPQNLLINSDG-ALKLADFGLARA  168 (311)
T ss_dssp             EEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCchHhEEECCCC-CEEEccCcCcee
Confidence            889999999988776643   3456999999999999999999999 78999999999999999887 799999999987


Q ss_pred             cccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          244 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       244 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence            6433 233456789999999998776668999999999999999999999999999889999999988887655433221


Q ss_pred             CC--CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          323 PN--YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       323 ~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ..  +....+.......+. .+.+.+++++.+||.+||++||.+|||+.|+|+||||+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWS-SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             ccchhhhcccccccCCcHH-HhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            10  011111122222222 23345789999999999999999999999999999999865

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.1e-51  Score=397.54  Aligned_cols=322  Identities=32%  Similarity=0.604  Sum_probs=253.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||.||+|++..+++.||||++....     ....+|+++++.++||||+++++++..........++
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            47999999999999999999999999999999986322     3345899999999999999999988655434445688


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+++++.+.+..     ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus       107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  179 (364)
T ss_dssp             EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChHhEEECCCC-CEEEEeCcceEecC
Confidence            9999999988887653     56999999999999999999999 78999999999999999887 79999999998764


Q ss_pred             cCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          246 KGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       246 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ....    ....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3322    234588999999998876666899999999999999999999999999999999999999999988776543


Q ss_pred             CCCCc---cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCC
Q 014156          322 NPNYT---EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN  398 (429)
Q Consensus       322 ~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~  398 (429)
                      .....   ....+.....++.. +.+.+++++.+||.+||++||.+|||+.|+|+||||++...+......    ..++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~----~~~~~  334 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFK  334 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCCC
T ss_pred             hhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCC----CCcCC
Confidence            21100   01112222222222 234579999999999999999999999999999999998665443222    12233


Q ss_pred             CChhhhccCCHHHHHhhcHHHHhhhCC
Q 014156          399 FKPQELKGASKELLSKLIPEHARKQCP  425 (429)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  425 (429)
                      ++. ++....++.+..++-++..+-.|
T Consensus       335 ~~~-~~~~~~~~~~~~~~~~e~~~~~~  360 (364)
T 3qyz_A          335 FDM-ELDDLPKEKLKELIFEETARFQP  360 (364)
T ss_dssp             CC------CCHHHHHHHHHHHTGGGCC
T ss_pred             ccc-ccccCCHHHHHHHHHHHHHHhhh
Confidence            332 34556788888888887765544

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.2e-51  Score=392.08  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=212.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++++.||+|+||+||+|++..+|+.||+|++.+.       .....+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence            45799999999999999999999999999999998643       233457999999999999999999884     334


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||+++ +|...+..    .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            58899999986 55554432    467999999999999999999999 78999999999999999888 7999999999


Q ss_pred             eecc-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          242 KVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       242 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +... .+......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...           
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  220 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------  220 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence            8643 33345567899999999998664 5899999999999999999999999988776666555431           


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                            ..            .++..+++++.+||.+||+.||.+||     ++.++++||||+.+.+
T Consensus       221 ------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          221 ------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             ------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------CC------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence                  00            13345799999999999999999999     9999999999998765

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=388.90  Aligned_cols=284  Identities=30%  Similarity=0.519  Sum_probs=228.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHHc---CCCCeeccceeeeecC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLL---DHPNVVSLKHCFFSTT  157 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~  157 (429)
                      ..+|++.+.||+|+||+||+|++..+++.||+|++....         ....+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            347999999999999999999999999999999885321         2445677777766   4999999999987766


Q ss_pred             CCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                      ......+++||||+++++.+.+...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCC-CEEEee
Confidence            5556678999999999888776542  2234999999999999999999999 78999999999999999887 799999


Q ss_pred             cCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       238 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ||+++............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99998776666666778999999999997654 89999999999999999999999999999999999999888877654


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      +..... .....++....... ....+.+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          243 WPRDVS-LPRGAFPPRGPRPV-QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SCSSCS-SCGGGSCCCCCCCH-HHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             ccchhh-ccccccCCCCCCcH-HHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            322110 00111111111111 12345689999999999999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.7e-51  Score=391.34  Aligned_cols=288  Identities=32%  Similarity=0.552  Sum_probs=217.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++++.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++.     ....++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeEE
Confidence            46999999999999999999999999999999885432     34568999999999999999999883     344588


Q ss_pred             EEeecchhhHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          166 LVLEFVPETVYRVAKHYSR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +||||+++++.+.+.....  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH-ENKILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            9999999988887765332  2246899999999999999999999 78999999999999999887 799999999987


Q ss_pred             cccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          244 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       244 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            6433 233456789999999999766668999999999999999999999999999999999999988887655443221


Q ss_pred             C--CCccccCCCcCCCC----cccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          323 P--NYTEFKFPQIKAHP----WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       323 ~--~~~~~~~~~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                      .  .+.. ..+......    +.......+++++.+||.+||+.||.+|||+.|+|+||||+++......
T Consensus       238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          238 KLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             GCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             hhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence            1  1100 011101111    1122334678999999999999999999999999999999998776544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.6e-51  Score=384.97  Aligned_cols=277  Identities=35%  Similarity=0.640  Sum_probs=219.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|++.+.||+|+||.||+|++ .+|+.||+|++....      ....+|+.+++.++||||+++++++...     ..+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence            3699999999999999999998 678999999885332      3345899999999999999999988433     348


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            89999999988776643   3467999999999999999999999 78999999999999999887 7999999999765


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            432 2234457899999999997666689999999999999999999999999999899999988888776543322110


Q ss_pred             --CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          324 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       324 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                        .+. ..++.....++. .+...+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       231 ~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYD-PNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCC-TTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccc-cccccccCccHH-HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence              000 011111111222 2345689999999999999999999999999999999863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-51  Score=399.20  Aligned_cols=319  Identities=31%  Similarity=0.527  Sum_probs=234.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|++++.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999998542      2334579999999999999999998854321 11234


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++|+++++++|.+++..     ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            689999999877766543     57999999999999999999999 78999999999999999887 799999999986


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+.....
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            533  234578999999999987756789999999999999999999999999999999999999999998887654432


Q ss_pred             CCcc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 014156          324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFK  400 (429)
Q Consensus       324 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  400 (429)
                      ....   ...+......+...+ ..+++++.+||.+||++||.+|||+.++|+||||+++.++.....     ..++.+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~-----~~~~~~~  333 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV-----ADPYDQS  333 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCC-----CCCCCGG
T ss_pred             HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCC-----CCCCCcc
Confidence            1100   012222233333322 357899999999999999999999999999999999887754321     1123322


Q ss_pred             hhhhccCCHHHHHhhcHHHHhhhCC
Q 014156          401 PQELKGASKELLSKLIPEHARKQCP  425 (429)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~  425 (429)
                      . +......+.+..++.++...-+|
T Consensus       334 ~-~~~~~~~~~~~~~~~~e~~~~~~  357 (367)
T 2fst_X          334 L-ESRDLLIDEWKSLTYDEVISFVP  357 (367)
T ss_dssp             G-SSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             h-hhccCCHHHHHHHHHHHHHHhcc
Confidence            2 12234567777777777665444

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=393.37  Aligned_cols=287  Identities=33%  Similarity=0.609  Sum_probs=226.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-----hHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||.||+|++..+++.||+|++.....     ...+|+.+++.++||||+++++++...     ..++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence            469999999999999999999999999999998864332     223699999999999999999988433     3478


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus        77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCH-RQKVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            9999999988776654   3456999999999999999999999 78999999999999999887 79999999997654


Q ss_pred             cCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+......
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            332 2344578999999999877667899999999999999999999999999999999999999988876544322111


Q ss_pred             --CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCC
Q 014156          325 --YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLP  388 (429)
Q Consensus       325 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~  388 (429)
                        +..+.++......+. ...+.+++++.+||.+||++||.+|||+.|+|+||||.++.......+
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~  296 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALL-SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLP  296 (324)
T ss_dssp             HHHHHTCCCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSC
T ss_pred             hhhcccccccccchhhh-hhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCC
Confidence              111122222222111 123457999999999999999999999999999999999877554433

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-51  Score=396.50  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=209.0

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...+|+++++||+|+||+||+|+++.+|+.||||++.+..       ....+|..+++.+ +||||++++++|.     .
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~   95 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----T   95 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----e
Confidence            3457999999999999999999999999999999986532       2344788899888 7999999999883     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+|+||||+++ +|...+..    ...+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~g-~ikL~DFG  169 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLH-DKGIIYRDLKLDNVLLDHEG-HCKLADFG  169 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCHHHEEECCCC-CEEEcccc
Confidence            3458999999985 55555433    367999999999999999999999 78999999999999999888 79999999


Q ss_pred             Cceeccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          240 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       240 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +|+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....        
T Consensus       170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  240 (353)
T 3txo_A          170 MCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--------  240 (353)
T ss_dssp             TCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             ceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence            9986432 3344567899999999998764 48999999999999999999999999988877777766521        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCccccCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDELRDP  383 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~------~e~l~hp~f~~~~~~  383 (429)
                                           ..++..+++++.+||++||+.||.+||++      .++++||||+++.+.
T Consensus       241 ---------------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          241 ---------------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence                                 01234479999999999999999999999      899999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-50  Score=392.32  Aligned_cols=256  Identities=25%  Similarity=0.369  Sum_probs=216.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ...|.+.+.||+|+||.||+|++..+|+.||+|++....          ....+|+.+++.++||||++++++|.     
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----   85 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE-----   85 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence            346999999999999999999999999999999886432          34568999999999999999999883     


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC---ceEE
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKL  235 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~---~vkl  235 (429)
                      ....+++||||+. ++|.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++.   .+||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            3345889999996 56655543    3467999999999999999999999 789999999999999987653   6999


Q ss_pred             eecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +|||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus       161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  239 (361)
T 2yab_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE  239 (361)
T ss_dssp             CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             EecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            99999988766666667789999999999865 45899999999999999999999999998877777666543211111


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                               .++..+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus       240 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          240 -------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             -------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence                                     12235799999999999999999999999999999998653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-50  Score=396.56  Aligned_cols=255  Identities=25%  Similarity=0.442  Sum_probs=208.2

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|.++++||+|+||+||+|+++.+++.||+|++.+..       ....+|..++..+ +||||++++++|.     
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----
Confidence            34568999999999999999999999999999999986532       2345788888876 8999999999884     


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ....+++||||+++ +|...+..    ...+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDLKp~NILl~~~g-~ikL~DF  197 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDY  197 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeccCCHHHEEECCCC-CEEEeec
Confidence            34458999999986 55554432    367999999999999999999999 78999999999999999888 7999999


Q ss_pred             CCceec-ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--------HHH-HHHHH
Q 014156          239 GSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV--------DQL-VEIIK  308 (429)
Q Consensus       239 G~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~-~~i~~  308 (429)
                      |+|+.. .........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+....        +.+ ..+..
T Consensus       198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            999863 334455677899999999999764 5899999999999999999999999753221        111 11111


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCccccCC
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDELRD  382 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~------~e~l~hp~f~~~~~  382 (429)
                      .                             ...++..+++++++||++||+.||.+||++      .|+++||||+.+.|
T Consensus       277 ~-----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          277 K-----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             C-----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             c-----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            0                             012344589999999999999999999985      79999999999876


Q ss_pred             C
Q 014156          383 P  383 (429)
Q Consensus       383 ~  383 (429)
                      .
T Consensus       328 ~  328 (396)
T 4dc2_A          328 D  328 (396)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.7e-51  Score=402.48  Aligned_cols=257  Identities=28%  Similarity=0.442  Sum_probs=214.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|.+.++||+|+||+||+|+++.+++.||+|++.+.       .....+|+.+++.++||||++++++|.     ...
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~  142 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DDR  142 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECC
Confidence            45799999999999999999999999999999998542       233558999999999999999999883     344


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ++|+||||++ ++|.+++..     ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH-~~givHrDLKp~NILl~~~g-~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeeECCCC-CEEEecccee
Confidence            6899999996 566665532     46999999999999999999999 78999999999999999888 7999999999


Q ss_pred             eecccCCC--cccccccccccccccccCCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGEP--NISYICSRYYRAPELIFGATE---YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      +.......  ....+||+.|+|||++.+...   ++.++|||||||++|+|++|++||.+.+..+...++......    
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----  291 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS----  291 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc----
Confidence            87654432  336789999999999875432   778999999999999999999999998888777777653100    


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCCC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDP  383 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~  383 (429)
                                 ..+|.          ...+++++++||++||+.+|.+  |+++.|+++||||+++.|.
T Consensus       292 -----------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          292 -----------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             -----------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             -----------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence                       01111          1247999999999999999988  9999999999999997764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6e-51  Score=390.92  Aligned_cols=284  Identities=30%  Similarity=0.569  Sum_probs=225.1

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ....+|++.+.||+|+||+||+|++..+++.||||++....      ....+|+.+++.++||||+++++++..     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence            34568999999999999999999999999999999885432      233479999999999999999998844     3


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC----CceEEee
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCD  237 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~----~~vkl~D  237 (429)
                      ..+++||||+++++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++    ..+||+|
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCH-SRRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            34889999999988777654    456999999999999999999999 78999999999999995332    2599999


Q ss_pred             cCCceecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          238 FGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       238 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+...
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            9999766433 233456789999999999776668999999999999999999999999999999999999988887765


Q ss_pred             HHhhcC--CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          317 EIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       317 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      .+....  +.+ ...++......+...+...+++++.+||.+||++||.+|||+.|+|+||||++..+
T Consensus       261 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          261 TWPGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TSTTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            433211  111 11233333344444455558899999999999999999999999999999998654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-50  Score=401.78  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=217.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|.+.++||+|+||+||+|+++.+++.||+|++.+.       .....+|..++..++||||++++++|.     ...
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCC
Confidence            34799999999999999999999999999999998642       122567999999999999999999883     344


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+|+||||+. ++|...+..   ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            5899999996 566665532   2467999999999999999999999 88999999999999999888 7999999999


Q ss_pred             eecccCCC--ccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          242 KVLVKGEP--NISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       242 ~~~~~~~~--~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +.......  ....+||+.|+|||++.    +...++.++|||||||++|||++|++||.+.+..+...++......   
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---  299 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER---  299 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence            87654433  23468999999999986    2345899999999999999999999999998888877777642100   


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCccccCCCCCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                                  +.+|.         ....+++++++||++||+.+|.+  |+++.|+++||||+.+.|...+
T Consensus       300 ------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          300 ------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             ------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             ------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence                        01111         11347999999999999999988  9999999999999998886543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.5e-51  Score=392.08  Aligned_cols=254  Identities=26%  Similarity=0.462  Sum_probs=212.4

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...+|.+.+.||+|+||.||+|+++.+|+.||||++.+..       .....|..++..+ +||||+++++++.     .
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----T   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----C
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----e
Confidence            3457999999999999999999999999999999986532       2345688888876 9999999999883     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+|+||||+++ +|...+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~vkL~DFG  163 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDG-HIKIADFG  163 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCChhhEEECCCC-CEEEeECh
Confidence            3458999999975 66555543    367999999999999999999999 78999999999999999888 79999999


Q ss_pred             Cceeccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          240 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       240 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +|+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....        
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  234 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------  234 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9986433 2334567899999999999764 48999999999999999999999999888776666654410        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCccccCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFDELRDP  383 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-e~l~hp~f~~~~~~  383 (429)
                                           ..++..+++++.+||.+||+.||.+||++. ++++||||+.+.+.
T Consensus       235 ---------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          235 ---------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             ---------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence                                 012345799999999999999999999998 99999999988653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-50  Score=395.44  Aligned_cols=285  Identities=31%  Similarity=0.553  Sum_probs=216.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|++.+.||+|+||.||+|++..+++.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            4799999999999999999999999999999998542      1234579999999999999999998854321 22336


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++||||+++++.+.+.      ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~  176 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLART  176 (371)
T ss_dssp             EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred             eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHH-HCCeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence            78999999998877653      45899999999999999999999 78999999999999999887 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+..+.+
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            6555445567899999999999764 589999999999999999999999999999999999999888887766543321


Q ss_pred             CCccc--cCCCcCCCCcccccC-----------CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          324 NYTEF--KFPQIKAHPWHKIFH-----------KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       324 ~~~~~--~~~~~~~~~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      ....+  ..+......+...++           ...++++++||++||++||.+|||+.|+|+||||+.+.++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  329 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  329 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHH
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcc
Confidence            11100  011111111111111           11256899999999999999999999999999999876643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=377.63  Aligned_cols=284  Identities=35%  Similarity=0.618  Sum_probs=220.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++...     ...
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence            46999999999999999999999999999999885432      2345799999999999999999988442     347


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||++++++..+.   .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCH-KHNCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            8999999987655433   23567999999999999999999999 78999999999999999887 7999999999876


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 014156          245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  321 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  321 (429)
                      ... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.+..+..........  
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            533 22345678999999999987667899999999999999999999999999999988888888777665433221  


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      ...+.....+............+.+++++.+||.+||+.||.+|||+.|+|+||||+++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            111111222221111111112245899999999999999999999999999999999987654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-50  Score=388.14  Aligned_cols=285  Identities=34%  Similarity=0.572  Sum_probs=226.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++....         ....+|+.+++.++||||+++++++..     
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-----
Confidence            347999999999999999999999999999999885321         234579999999999999999998843     


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ....++||||+++++...+.   .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            33478999999998766553   23456899999999999999999999 78999999999999999887 799999999


Q ss_pred             ceecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          241 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       241 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+.
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            9876433 233456789999999998766668999999999999999999999999999999999999988888766544


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      ..........+......++.. +...+++++++||.+||..||.+|||+.|+|+||||++...+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence            322211111222222222221 23457899999999999999999999999999999998766543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-50  Score=380.39  Aligned_cols=251  Identities=26%  Similarity=0.464  Sum_probs=213.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++.+.       .....+|..+++.++||||+++++++.     ...
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence            45799999999999999999999999999999998643       233457999999999999999999883     334


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+|+||||+.+ +|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChheEEEcCCC-CEEEeecCcc
Confidence            58899999985 66665543    467999999999999999999999 88999999999999999888 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      +....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....           
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  219 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------  219 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred             eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            87533  33467899999999998664 58999999999999999999999999888777776665521           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                            .            .++..+++++.+||.+||..||.+|+     ++.++++||||+++.+.
T Consensus       220 ------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          220 ------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                  0            12345799999999999999999999     99999999999987653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.7e-50  Score=386.90  Aligned_cols=255  Identities=25%  Similarity=0.444  Sum_probs=207.4

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|++.+.||+|+||.||+|+++.+++.||+|++.+..       ....+|..+++.+ +||||++++++|.     
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----
Confidence            34568999999999999999999999999999999986432       2345788999887 8999999999883     


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ....+|+||||+++ +|...+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~DF  154 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDY  154 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEECCCC-CEEEEec
Confidence            33458999999975 66555433    357999999999999999999999 78999999999999999888 7999999


Q ss_pred             CCceecc-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh--------HHH-HHHHHH
Q 014156          239 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG--------VDQ-LVEIIK  308 (429)
Q Consensus       239 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~-~~~i~~  308 (429)
                      |+++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....        ... ...+..
T Consensus       155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  233 (345)
T 3a8x_A          155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  233 (345)
T ss_dssp             GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred             cccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence            9998643 33345567899999999999764 589999999999999999999999975321        111 111111


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCccccCC
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFDELRD  382 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~------~e~l~hp~f~~~~~  382 (429)
                      .                             ...++..+++++++||.+||+.||.+||++      .++++||||+.+.+
T Consensus       234 ~-----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          234 K-----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             C-----------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             C-----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            0                             011334579999999999999999999995      89999999998775


Q ss_pred             C
Q 014156          383 P  383 (429)
Q Consensus       383 ~  383 (429)
                      .
T Consensus       285 ~  285 (345)
T 3a8x_A          285 D  285 (345)
T ss_dssp             H
T ss_pred             H
Confidence            3

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-49  Score=386.70  Aligned_cols=319  Identities=33%  Similarity=0.572  Sum_probs=243.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC-CceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-~~~~  163 (429)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4799999999999999999999999999999998642      23345799999999999999999988544331 1122


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .++||||+++++...+      ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred             EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence            4799999998776644      345999999999999999999999 78999999999999999887 799999999976


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+.....
T Consensus       194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            533  334567899999999997756689999999999999999999999999999999999999999988776654332


Q ss_pred             CCccc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 014156          324 NYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFK  400 (429)
Q Consensus       324 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  400 (429)
                      .....   ..+......+. .+...+++++.+||.+||++||.+|||+.|+|+||||+.++.+........++....   
T Consensus       272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~---  347 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSL---  347 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTT---
T ss_pred             hhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcch---
Confidence            11100   11111111111 223457999999999999999999999999999999999887655433333333222   


Q ss_pred             hhhhccCCHHHHHhhcHHHHhhhCC
Q 014156          401 PQELKGASKELLSKLIPEHARKQCP  425 (429)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~  425 (429)
                        +......+.+.+.+.++.-.=+|
T Consensus       348 --~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          348 --EHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             --SSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             --hhcccchHHHHHHHHHHHHhccc
Confidence              22234456677766666554333

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.6e-51  Score=386.20  Aligned_cols=265  Identities=19%  Similarity=0.215  Sum_probs=185.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh---HHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY---KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +|.+.++||+|+||+||+|++  +|+.||||++......   .+.|+..+..++|||||++++++.... .....+||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence            699999999999999999987  6899999998654322   234555667889999999999886543 2334578999


Q ss_pred             ecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--------CeeecCCCCCCeeecCCCCceEEeecC
Q 014156          169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI--------GVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--------~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      |||+ |+|.+.+..     ..+++..+..++.|++.||+||| +.        +||||||||+||||+.++ .+||+|||
T Consensus        81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH-~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLH-MEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH-CCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-HhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            9998 566666543     56999999999999999999999 54        999999999999999888 79999999


Q ss_pred             CceecccCCCc-----ccccccccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014156          240 SAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  309 (429)
Q Consensus       240 ~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  309 (429)
                      +|+........     ...+||+.|||||++.+..     .++.++|||||||+||||+||.+||......+...... .
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~-~  232 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-V  232 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-S
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc-c
Confidence            99876544322     2457999999999986532     25678999999999999999988774322110000000 0


Q ss_pred             hCCCCHHHHhh-cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          310 LGTPTREEIKC-MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       310 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ...+..+.+.. ....   ...|.++..    ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~---~~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQ---KLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHTTS---CCCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHhcc---cCCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            00000000000 0000   000111000    0011134578899999999999999999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-50  Score=387.23  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=210.6

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++..     .
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~   81 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----P   81 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----C
Confidence            456799999999999999999999999999999988543       2345689999999999999999998843     3


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..+++||||+++++++.+..    .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kl~DFG~s  155 (336)
T 3h4j_B           82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCH-RHKIVHRDLKPENLLLDDNL-NVKIADFGLS  155 (336)
T ss_dssp             SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HHTCCCCCCSTTTEEECTTC-CEEECCSSCT
T ss_pred             CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCchhhEEEcCCC-CEEEEEeccc
Confidence            34889999999988876654    367999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .....+......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.......                  
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------  217 (336)
T 3h4j_B          156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------  217 (336)
T ss_dssp             BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------------
T ss_pred             eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------------
Confidence            87766666667789999999999976554478999999999999999999999764321110                  


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                               ..+..  ....++..+++++.+||++||..||.+|||+.|+++||||+.
T Consensus       218 ---------~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          218 ---------KKVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ---------CCCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             ---------HHHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                     00000  011234568999999999999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.4e-49  Score=394.86  Aligned_cols=280  Identities=31%  Similarity=0.547  Sum_probs=227.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHc------CCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL------DHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l------~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+      +|+||+++++++...    
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~----  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR----  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC----
Confidence            357999999999999999999999999999999987653   3345688888877      577999999988443    


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC-ceEEeecC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~-~vkl~DFG  239 (429)
                       ..+++||||+++++.+.+...  ....+++..++.++.||+.||.||| +.||+||||||+||||+.++. .+||+|||
T Consensus       172 -~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          172 -NHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALH-KNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             -TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH-HHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             -CeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence             348899999999988877652  2345999999999999999999999 789999999999999998762 29999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      +++...  ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|....+.
T Consensus       248 ~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            997653  3344578999999999997654 8999999999999999999999999999999999999999999887665


Q ss_pred             hcCCCCccc---cCC---------------------------CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH
Q 014156          320 CMNPNYTEF---KFP---------------------------QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL  369 (429)
Q Consensus       320 ~~~~~~~~~---~~~---------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  369 (429)
                      ........+   ..+                           ......|...+....++++.+||.+||++||.+|||+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence            332110000   000                           01122333344455688999999999999999999999


Q ss_pred             HHhcCCCcccc
Q 014156          370 EACIHPFFDEL  380 (429)
Q Consensus       370 e~l~hp~f~~~  380 (429)
                      |+|+||||++.
T Consensus       405 e~L~Hpw~~~~  415 (429)
T 3kvw_A          405 QALRHPWLRRR  415 (429)
T ss_dssp             HHHTSTTTC--
T ss_pred             HHhCChhhccC
Confidence            99999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-49  Score=386.50  Aligned_cols=256  Identities=27%  Similarity=0.411  Sum_probs=211.4

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||++++++|.     .
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~   86 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----D   86 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            34568999999999999999999999999999999885432       34457999999999999999999884     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+|+||||+.+ +|...+.    ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~vkL~DFG  160 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQ-NQRIIHRDMKPDNILLDEHG-HVHITDFN  160 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEECCCC-CEEEeccc
Confidence            3458899999975 4544443    3567999999999999999999999 78999999999999999888 79999999


Q ss_pred             CceecccCCCcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCH
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD--QLVEIIKVLGTPTR  315 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~  315 (429)
                      +|+...........+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.+.+...  .+.......     
T Consensus       161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----  235 (384)
T 4fr4_A          161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-----  235 (384)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----
T ss_pred             eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----
Confidence            99987666666778999999999998642  358899999999999999999999997643322  221111110     


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCCccccCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEACIHPFFDELRD  382 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-~~e~l~hp~f~~~~~  382 (429)
                                             ...++..+++++.+||.+||+.||.+||+ +.++++||||+++.+
T Consensus       236 -----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          236 -----------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             -----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             -----------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                                   01133457999999999999999999998 899999999998765

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.3e-49  Score=382.88  Aligned_cols=288  Identities=30%  Similarity=0.568  Sum_probs=226.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---------------hhHHHHHHHHHHcCCCCeeccceeeee
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSLKHCFFS  155 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~l~~~~~~  155 (429)
                      .+|++.+.||+|+||.||+|.+.. |+.||||++....               ....+|+.+++.++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            369999999999999999999754 8999999884321               345689999999999999999999877


Q ss_pred             cCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       156 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                      ........+++||||+++++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl  175 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLADNN-DITI  175 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEE
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCcCEecCCChHHEEEcCCC-CEEE
Confidence            66566667899999999988876653   3457999999999999999999999 78999999999999999887 7999


Q ss_pred             eecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +|||+++............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999987655555566789999999999877566899999999999999999999999999999999999999998887


Q ss_pred             HHHhhcCCC-Ccc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          316 EEIKCMNPN-YTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       316 ~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      +.+...... ...   ..........+. ...+.+++.+.+||.+||+.||.+|||+.|+|+||||+.+..+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  328 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD  328 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence            655322211 000   011111222222 233457899999999999999999999999999999999876543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.5e-49  Score=381.28  Aligned_cols=320  Identities=32%  Similarity=0.588  Sum_probs=240.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357999999999999999999999999999999985321     233479999999999999999987754332334558


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++||||+++++.+.+..     ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLINSNC-DLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence            89999999988776653     57999999999999999999999 78999999999999999887 7999999999876


Q ss_pred             ccCCC-----------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          245 VKGEP-----------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       245 ~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      .....           ....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            43211           2235789999999998765668999999999999999999999999999888888888888776


Q ss_pred             CHHHHhhcCCC--Ccc--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCC
Q 014156          314 TREEIKCMNPN--YTE--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPN  389 (429)
Q Consensus       314 ~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  389 (429)
                      ...........  ...  ...+......+. ...+.+++++.+||.+||..||.+|||+.++|+||||+.+.++......
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~  321 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEG  321 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCC
T ss_pred             chhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccccc
Confidence            53211000000  000  011111111111 2234689999999999999999999999999999999998887655322


Q ss_pred             CCCCCC-CCCCChhhhccCCHHHHHhhcHHH
Q 014156          390 GRPFPP-LFNFKPQELKGASKELLSKLIPEH  419 (429)
Q Consensus       390 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  419 (429)
                       .+.|+ .+++.. .......+.+++++-++
T Consensus       322 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  350 (353)
T 2b9h_A          322 -EPIPPSFFEFDH-YKEALTTKDLKKLIWNE  350 (353)
T ss_dssp             -CCCCGGGGGGGC-CSSCCCHHHHHHHHHHH
T ss_pred             -CCCCcceeeecc-hhhcCCHHHHHHHHHHH
Confidence             23332 222221 12234556666666554

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-50  Score=383.87  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=214.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...   .....+|+.+++.++||||+++++++...     ..+++|
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv   79 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-----EELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEEEE
Confidence            4799999999999999999999999999999988643   23446899999999999999999988443     348899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC--CCCceEEeecCCceec
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVL  244 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~--~~~~vkl~DFG~a~~~  244 (429)
                      |||+++ +|.+.+.   .....+++..++.++.||+.||.||| +.||+||||||+|||++.  ++ .+||+|||+++..
T Consensus        80 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH-~~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~  154 (321)
T 1tki_A           80 FEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCC-CEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeEC
Confidence            999985 5555442   23357999999999999999999999 789999999999999986  44 7999999999887


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..+.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...........       
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------  226 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------  226 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred             CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------
Confidence            666655667899999999998664 478999999999999999999999999888777777666432222221       


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                        ...+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       227 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                              13479999999999999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.6e-50  Score=390.47  Aligned_cols=254  Identities=25%  Similarity=0.413  Sum_probs=207.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-------hHHHHHHH-HHHcCCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...+|++++.||+|+||.||+|+++.+++.||||++.+...       ...+|..+ ++.++||||++++++|.     .
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----T  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----C
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----e
Confidence            44579999999999999999999999999999999865421       12234444 46679999999999884     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+|+||||+++ +|...+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~ikL~DFG  184 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDSQG-HIVLTDFG  184 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEECCCC-CEEEeeCc
Confidence            3458999999985 55555433    467999999999999999999999 88999999999999999888 79999999


Q ss_pred             Cceeccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          240 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       240 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....        
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  255 (373)
T 2r5t_A          185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------  255 (373)
T ss_dssp             BCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------
T ss_pred             cccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------
Confidence            9986433 3345567899999999998764 58999999999999999999999999888777776665420        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCccccCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFDELRDP  383 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----~e~l~hp~f~~~~~~  383 (429)
                                           ..++..+++++++||.+||+.||.+|+++    .++++||||+.+.|.
T Consensus       256 ---------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          256 ---------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             ---------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence                                 01334579999999999999999999986    699999999987763

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-49  Score=377.55  Aligned_cols=255  Identities=23%  Similarity=0.378  Sum_probs=213.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ...|.+.+.||+|+||.||+|++..+|+.||+|++...          .....+|+.+++.++||||+++++++..    
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----   85 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----   85 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            45799999999999999999999999999999988542          2345689999999999999999998843    


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC---ceEE
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKL  235 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~---~vkl  235 (429)
                       ...+++||||+.+ +|.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++.   .+||
T Consensus        86 -~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           86 -KTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             -CCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHH-HCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence             3458899999974 6665543    3467999999999999999999999 789999999999999987652   6999


Q ss_pred             eecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +|||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus       160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (326)
T 2y0a_A          160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  238 (326)
T ss_dssp             CCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             EECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc
Confidence            99999988765555566789999999999865 45899999999999999999999999988877776665543211111


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                               .+...+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus       239 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          239 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             -------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                                     1223478999999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=389.21  Aligned_cols=262  Identities=27%  Similarity=0.435  Sum_probs=215.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.++||+|+||+||+|+++.+|+.||||++.+.       .....+|..++..++||||++++++|.     +..
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~  134 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----DEN  134 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCC
Confidence            45799999999999999999999999999999998642       223457999999999999999999883     344


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ++|+||||+. ++|..++..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH-~~giiHrDLKp~NILld~~g-~vkL~DFGla  209 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVH-RLGYVHRDIKPDNILLDRCG-HIRLADFGSC  209 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccCHHHeeecCCC-CEEEeechhh
Confidence            6899999996 566666543   2357999999999999999999999 88999999999999999888 6999999999


Q ss_pred             eecccCCC--cccccccccccccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          242 KVLVKGEP--NISYICSRYYRAPELIFG------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       242 ~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      +.......  ....+||+.|+|||++..      ...++.++|||||||++|||++|+.||.+.+..+...++...... 
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-  288 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-  288 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-
Confidence            87654433  234689999999999862      345899999999999999999999999998887777776542100 


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCCccccCCCCCC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR---CTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~t~~e~l~hp~f~~~~~~~~~  386 (429)
                                    ..+|.         +...+|+++++||++||+ +|.+|   +++.|+++||||+.+.|...+
T Consensus       289 --------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          289 --------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             --------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             --------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence                          00111         123579999999999999 99998   499999999999999887654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.7e-49  Score=372.34  Aligned_cols=252  Identities=26%  Similarity=0.395  Sum_probs=210.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++++....     .++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EEE
Confidence            34799999999999999999999999999999988532    344568999999999999999999885433     478


Q ss_pred             EEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+. ++|.+.+..     ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence            9999996 456555432     46999999999999999999999 78999999999999999887 7999999999876


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+..... +.         
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~---------  235 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE---------  235 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC---------
T ss_pred             CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC---------
Confidence            5433 33456899999999998764 489999999999999999999999998877766655544211 00         


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                      ...+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       236 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          236 ----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             ----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                            01123478999999999999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.9e-49  Score=382.01  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=213.4

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+|.+++.||+|+||.||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++.     ..
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~  113 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DN  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cC
Confidence            4457999999999999999999999999999999985432       33457999999999999999999884     33


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ..+|+||||++ ++|.+.+..    .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~DFg~  187 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQG-YIQVTDFGF  187 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCccceEEECCCC-CEEEccccc
Confidence            45899999997 566665543    357999999999999999999999 88999999999999999888 799999999


Q ss_pred             ceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ++....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....          
T Consensus       188 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  254 (350)
T 1rdq_E          188 AKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----------  254 (350)
T ss_dssp             CEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             ceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence            987643  23467899999999998764 58999999999999999999999999888777666665420          


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  382 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  382 (429)
                                         ..++..+++++.+||.+||+.||.+||+     +.++++||||+.+.+
T Consensus       255 -------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          255 -------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                               0123457999999999999999999998     999999999998765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.6e-49  Score=381.93  Aligned_cols=259  Identities=29%  Similarity=0.379  Sum_probs=210.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++...         .....+|+.+++.++||||+++++++..     
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            35799999999999999999999999999999988532         3445689999999999999999998844     


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC--ceEEee
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCD  237 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~--~vkl~D  237 (429)
                      ...+++||||++ ++|...+.........+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCChHHeEEecCCCCCcEEEec
Confidence            335889999998 5666666554444556999999999999999999999 789999999999999976542  499999


Q ss_pred             cCCceecccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          238 FGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       238 FG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ||+++....... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+....+..........
T Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~  254 (351)
T 3c0i_A          177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR  254 (351)
T ss_dssp             CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred             CcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence            999987654432 3456799999999998664 48999999999999999999999998743 33333333321111111


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                               ....+++++.+||.+||..||.+|||+.++|+||||++..
T Consensus       255 -------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          255 -------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             -------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                                     1134789999999999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.5e-49  Score=384.26  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=212.6

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...+|.+++.||+|+||.||+|++..+|+.||||++.+..       ....+|..++..+ .||||+++++++.     .
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----C
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----c
Confidence            3457999999999999999999999999999999986432       2345688888877 7999999999883     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+|+||||+++ +|...+..    .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~vkL~DFG  166 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDSEG-HIKIADFG  166 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence            3458999999975 66655543    357999999999999999999999 78999999999999999888 79999999


Q ss_pred             Cceecc-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          240 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       240 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +|+... ........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+....        
T Consensus       167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  237 (353)
T 2i0e_A          167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------  237 (353)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            998643 23344567899999999998654 58999999999999999999999999888777766665520        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRDP  383 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~  383 (429)
                                           ..++..+++++.+||.+||..||.+||+     +.++++||||+.+.+.
T Consensus       238 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          238 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                                 0133458999999999999999999994     6999999999987764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.7e-49  Score=381.08  Aligned_cols=290  Identities=29%  Similarity=0.469  Sum_probs=225.1

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCC---C
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---K  159 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---~  159 (429)
                      ...+|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            3468999999999999999999999999999999885332      234589999999999999999998865332   1


Q ss_pred             CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ....+++||||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDG-VLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEcCCC-CEEEccch
Confidence            1345789999999987776643   3456999999999999999999999 78999999999999999887 79999999


Q ss_pred             CceecccC-----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          240 SAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       240 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      +++.....     .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+.
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99876422     2234567899999999997766689999999999999999999999999999999999988887776


Q ss_pred             HHHHhhcCCC--CccccCCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          315 REEIKCMNPN--YTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       315 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      .+.+......  +................+ ....++++.+||.+||++||.+|||+.|+|+||||.....+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            5433221100  000000000000000000 00136789999999999999999999999999999875443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=391.18  Aligned_cols=289  Identities=30%  Similarity=0.524  Sum_probs=211.3

Q ss_pred             ceeE-eeEEccCCcEEEEEEEEc--CCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMA-ERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .|.+ .++||+|+||.||+|+++  .+++.||||++...  .....+|+.+++.++||||+++++++....   ...+++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeEEE
Confidence            4776 458999999999999966  57899999998654  234568999999999999999999886532   335889


Q ss_pred             EeecchhhHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee----cCCCCceEEee
Q 014156          167 VLEFVPETVYRVAKHYSRA-----SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCD  237 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill----~~~~~~vkl~D  237 (429)
                      ||||++++++..+......     ...+++..++.++.||+.||.||| +.||+||||||+||||    +.++ .+||+|
T Consensus        98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kl~D  175 (405)
T 3rgf_A           98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERG-RVKIAD  175 (405)
T ss_dssp             EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECCSSTTTT-CEEECC
T ss_pred             EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCEeCCCcCHHHeEEecCCCCCC-cEEEEE
Confidence            9999999988877653322     235999999999999999999999 7899999999999999    4455 799999


Q ss_pred             cCCceecccC----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 014156          238 FGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---------VDQLV  304 (429)
Q Consensus       238 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~  304 (429)
                      ||+|+.....    ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+...         .+++.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            9999876432    2234567899999999997766689999999999999999999999987654         47888


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCcc------cc---CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014156          305 EIIKVLGTPTREEIKCMNPNYTE------FK---FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP  375 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  375 (429)
                      .++..++.|....+.........      +.   +.......+........++.+.+||.+||++||.+|||+.|+|+||
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            89999998876544322110000      00   0000000001111223478999999999999999999999999999


Q ss_pred             CccccCCCCC
Q 014156          376 FFDELRDPNA  385 (429)
Q Consensus       376 ~f~~~~~~~~  385 (429)
                      ||.+...+..
T Consensus       336 ~f~~~~~~~~  345 (405)
T 3rgf_A          336 YFLEDPLPTS  345 (405)
T ss_dssp             GGTSSSCCCS
T ss_pred             hhccCCCCcc
Confidence            9998766544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.2e-49  Score=383.68  Aligned_cols=255  Identities=29%  Similarity=0.424  Sum_probs=212.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            357999999999999999999999999999999985432      34558999999999999999999883     3345


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCC
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  240 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~  240 (429)
                      .++||||+.+ +|.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++  ..+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            8899999986 5555443    2467999999999999999999999 78999999999999998653  2599999999


Q ss_pred             ceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +............+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+......        
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--------  248 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--------  248 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred             ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence            9877665555667899999999998654 5899999999999999999999999988877666665543111        


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                               ++.        .....+++++.+||.+||..||.+|||+.++|+||||...
T Consensus       249 ---------~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          249 ---------YPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ---------CCT--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ---------CCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                     110        0112478999999999999999999999999999999753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.9e-49  Score=390.48  Aligned_cols=255  Identities=28%  Similarity=0.394  Sum_probs=209.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ....
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEGH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSSE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECCE
Confidence            457999999999999999999999999999999885432      33468999999999999999999883     3445


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC--CCceEEeecCC
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGS  240 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~--~~~vkl~DFG~  240 (429)
                      .++||||+.+ +|.+.+..    ...+++..+..++.||+.||.||| +.||+||||||+|||++.+  ...+||+|||+
T Consensus        85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH-~~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            8899999985 56555543    467999999999999999999999 7899999999999999842  23799999999


Q ss_pred             ceecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          241 AKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       241 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      +....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+........     
T Consensus       160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-----  233 (444)
T 3soa_A          160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP-----  233 (444)
T ss_dssp             CBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-----
T ss_pred             eEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC-----
Confidence            97765433 23457899999999998654 589999999999999999999999998887777776655321111     


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                  .        .....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       234 ------------~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          234 ------------S--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ------------T--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ------------c--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                        0        1123479999999999999999999999999999999753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-48  Score=377.58  Aligned_cols=277  Identities=26%  Similarity=0.442  Sum_probs=219.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcC-----CCCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----HPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~~iv~l~~~~~~~~~~~~  161 (429)
                      .++|++.++||+|+||.||+|++..+++.||||++....   .....|+.+++.+.     ||||+++++++...     
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----  108 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----  108 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----
Confidence            347999999999999999999999999999999986432   33457999999986     99999999988543     


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC-------------
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-------------  228 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~-------------  228 (429)
                      ..+++||||++++|.+.+...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.             
T Consensus       109 ~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          109 DHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLR-KMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             CeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCcccEEEccccccccccchhcc
Confidence            348899999988888877642  2346999999999999999999999 889999999999999974             


Q ss_pred             ------------CCCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014156          229 ------------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG  296 (429)
Q Consensus       229 ------------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  296 (429)
                                  ++ .+||+|||+++....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus       186 ~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        44 799999999986533  33456889999999999764 489999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCCCCcc-c--------cCCCcCCC--------CcccccCCCCChhHHHHHHhhcC
Q 014156          297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-F--------KFPQIKAH--------PWHKIFHKRMPPEAVDLVSRLLQ  359 (429)
Q Consensus       297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~--------~~~~~~~~~~s~~~~~li~~~L~  359 (429)
                      .+..+.+..+....+.++...+......... +        ..+.....        .....+....++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            9998888888888877776655432211100 0        00000000        00000111235788899999999


Q ss_pred             cCCCCCCCHHHHhcCCCcc
Q 014156          360 YSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       360 ~dP~~R~t~~e~l~hp~f~  378 (429)
                      +||.+|||+.|+|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999996

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.1e-48  Score=370.33  Aligned_cols=291  Identities=33%  Similarity=0.535  Sum_probs=232.6

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEc-CCCcEEEEEEeccch------hhHHHHHHHHHHc---CCCCeeccceeeeecC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTT  157 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~  157 (429)
                      ....+|++.+.||+|+||.||+|++. .+|+.||+|++....      ....+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34567999999999999999999995 678999999885321      2345787777766   8999999999886544


Q ss_pred             CCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                      ......+++||||+++++.+.+...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH-~~gi~H~dlkp~Nili~~~~-~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECS
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHHHeEEcCCC-CEEEec
Confidence            4456678999999999888877542  2345999999999999999999999 78999999999999999887 799999


Q ss_pred             cCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       238 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            9999876544444566789999999998764 489999999999999999999999999999999999998888877654


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      +....... ...+..... .....+...+++.+.+||.+||..||.+|||+.++++||||++++....
T Consensus       243 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~  308 (326)
T 1blx_A          243 WPRDVALP-RQAFHSKSA-QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE  308 (326)
T ss_dssp             SCTTCSSC-GGGSCCCCC-CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred             Cccccccc-hhhhcccCc-chhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence            43211100 001111111 1122345668999999999999999999999999999999998876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.4e-49  Score=383.40  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=195.9

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...   .....+|+.+++.++||||+++++++..     ...++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence            345799999999999999999999999999999998643   2445689999999999999999998843     33588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC-ceEEeecCCcee
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV  243 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~-~vkl~DFG~a~~  243 (429)
                      +||||+.+ +|...+..    .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++. .+||+|||+++.
T Consensus        93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH-~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            99999964 66655533    357999999999999999999999 889999999999999986652 499999999986


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......          
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~----------  237 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV----------  237 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT----------
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC----------
Confidence            5555555567899999999999775534455999999999999999999998755433333322211000          


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                         .+.++          ....+++++.+||.+||..||.+|||+.|+++||||....
T Consensus       238 ---~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          238 ---KYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             ---CCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             ---CCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence               00011          1124789999999999999999999999999999997643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-49  Score=372.79  Aligned_cols=256  Identities=26%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------------------------hhHHHHHHH
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------------------RYKNRELQT  137 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~  137 (429)
                      ...++|++.+.||+|+||.||+|++..+++.||||++....                              ....+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            44568999999999999999999999999999999885432                              234679999


Q ss_pred             HHHcCCCCeeccceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeec
Q 014156          138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR  217 (429)
Q Consensus       138 l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHr  217 (429)
                      ++.++||||+++++++...   ....+++||||++++.+..+    .....+++..++.++.||+.||.||| +.||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~  161 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV----PTLKPLSEDQARFYFQDLIKGIEYLH-YQKIIHR  161 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS----SCSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECC
T ss_pred             HHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecc
Confidence            9999999999999987542   23458899999986432211    12457999999999999999999999 7899999


Q ss_pred             CCCCCCeeecCCCCceEEeecCCceecccCCC-cccccccccccccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCC
Q 014156          218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLF  294 (429)
Q Consensus       218 DlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf  294 (429)
                      ||||+|||++.++ .+||+|||+++....... .....||+.|+|||++.+...  ++.++|||||||++|+|++|+.||
T Consensus       162 Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          162 DIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            9999999999887 799999999987654332 345678999999999865432  377899999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          295 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       295 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+.+.......+....                 ..++          ....+++++.+||.+||..||.+|||+.|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          241 MDERIMCLHSKIKSQA-----------------LEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             CCSSHHHHHHHHHHCC-----------------CCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCccHHHHHHHHhccc-----------------CCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            8876655444433310                 0011          113478999999999999999999999999999


Q ss_pred             CCccc
Q 014156          375 PFFDE  379 (429)
Q Consensus       375 p~f~~  379 (429)
                      |||++
T Consensus       294 p~~~~  298 (298)
T 2zv2_A          294 PWVTR  298 (298)
T ss_dssp             HHHHC
T ss_pred             ccccC
Confidence            99963

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=377.70  Aligned_cols=316  Identities=33%  Similarity=0.571  Sum_probs=239.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC-CceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~-~~~~  163 (429)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            3699999999999999999999999999999998542      12345799999999999999999988543221 1123


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++||||+++++...+      ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            5799999998765533      245999999999999999999999 78999999999999999887 799999999976


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+..+..
T Consensus       176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            532  234567899999999987756689999999999999999999999999999999999999999888776554332


Q ss_pred             CCcc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 014156          324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFK  400 (429)
Q Consensus       324 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  400 (429)
                      ....   ...+......+. .....+++++.+||.+||..||.+|||+.++|+||||+.++.+........+    +...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~----~~~~  328 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP----FDDS  328 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC----CCCT
T ss_pred             HHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCC----Cccc
Confidence            1100   011111111111 1234579999999999999999999999999999999998876544222222    2211


Q ss_pred             hhhhccCCHHHHHhhcHHHHhh
Q 014156          401 PQELKGASKELLSKLIPEHARK  422 (429)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~  422 (429)
                      . +....+.+.+.+.+.++...
T Consensus       329 ~-~~~~~~~~~~~~~~~~~~~~  349 (353)
T 3coi_A          329 L-EHEKLTVDEWKQHIYKEIVN  349 (353)
T ss_dssp             T-TTCCCCHHHHHHHHHHHHHT
T ss_pred             h-hhccCCHHHHHHHHHHHHHh
Confidence            1 12234556677766665544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.1e-49  Score=376.02  Aligned_cols=282  Identities=33%  Similarity=0.597  Sum_probs=225.9

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ....+|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++..     .
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~   96 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----K   96 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----C
Confidence            34568999999999999999999999999999999875332      224579999999999999999998843     3


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ...++||||++++++..+.   .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCH-SHNIIHRDIKPENILVSQSG-VVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHH-HCCEEccCcChheEEEcCCC-cEEEEeCCCc
Confidence            3478999999987666543   23467999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh-
Q 014156          242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-  319 (429)
Q Consensus       242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-  319 (429)
                      +..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+........ 
T Consensus       172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            765433 233456789999999999776568999999999999999999999999999999999988888876654332 


Q ss_pred             -hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          320 -CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       320 -~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                       ...+.+.....+.+..........+.+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence             222333334444444333333344568999999999999999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-48  Score=381.78  Aligned_cols=257  Identities=27%  Similarity=0.403  Sum_probs=212.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++..     ...++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence            35799999999999999999999999999999988643    3345689999999999999999998843     34588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC-CCceEEeecCCcee
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  243 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~-~~~vkl~DFG~a~~  243 (429)
                      +||||+.+ +|.+.+.   .....+++..++.++.||+.||.||| +.||+||||||+|||++.+ ...+||+|||+++.
T Consensus       125 lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999975 5544332   23357999999999999999999999 7899999999999999743 23799999999988


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......           
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-----------  268 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----------  268 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             cCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            766555556789999999999865 45899999999999999999999999988877766665542110           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                            +        .......+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       269 ------~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          269 ------F--------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             ------C--------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ------C--------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                  0        0112235799999999999999999999999999999998643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.4e-49  Score=375.48  Aligned_cols=282  Identities=30%  Similarity=0.535  Sum_probs=218.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEEEe
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++ ||||+++++++...   .....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEEE
Confidence            4799999999999999999999999999999998643 455678999999997 99999999987542   233478999


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      ||++++.+....      ..+++..++.++.||+.||.||| +.||+||||||+|||++.++..+||+|||+++......
T Consensus       113 e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          113 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             ECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            999865333221      34899999999999999999999 88999999999999999776689999999998876666


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHH-hhcCCCCc
Q 014156          249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEI-KCMNPNYT  326 (429)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~  326 (429)
                      ......||+.|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+.+..+....+.+..... ........
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            66677899999999999775668999999999999999999999985 45566666666666554332211 11110000


Q ss_pred             cc---cCCCcCCCCcccc----cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          327 EF---KFPQIKAHPWHKI----FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       327 ~~---~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ..   .........|...    ....+++++.+||.+||++||.+|||+.|+|+||||+++..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            00   0000111111111    12237899999999999999999999999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-48  Score=365.02  Aligned_cols=256  Identities=28%  Similarity=0.431  Sum_probs=206.0

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..++|.+.+.||+|+||.||+|++..++..||+|++....     ....+|+++++.++||||+++++++.     ....
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCe
Confidence            3457999999999999999999999999999999886543     44568999999999999999999883     3345


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CCCceEEeecC
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFG  239 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~~~vkl~DFG  239 (429)
                      .++||||+++ ++.+.+.........+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHS-PIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEESSSSTTC-CEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCCCHHHEEEecCCCCC-CEEEEeee
Confidence            8899999985 777777665555678999999999999999999999 789999999999999943   34 79999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ++.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+.....        
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------  242 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--------  242 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred             cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc--------
Confidence            9987766555566789999999998843  488999999999999999999999988776555444332110        


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                          .+     .         .....+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       243 ----~~-----~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          243 ----NY-----A---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ----CC-----C---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ----cc-----c---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                00     0         011236899999999999999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.2e-49  Score=378.60  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=208.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ..+|.+.+.||+|+||.||+|+++.+|+.||+|++.+......+|++++..+ +||||+++++++.     +..++|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYD-----DGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCEEEEEE
Confidence            4579999999999999999999999999999999987766677899999888 7999999999883     344689999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC---CceEEeecCCceec
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSAKVL  244 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~---~~vkl~DFG~a~~~  244 (429)
                      ||+.+ ++.+.+.    ..+.+++..++.++.||+.||.||| +.||+||||||+|||+..+.   ..+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH-~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99975 5655543    2467999999999999999999999 78999999999999985432   14999999999876


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHhh
Q 014156          245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.   +..+.+..+....          
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~----------  239 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK----------  239 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC----------
T ss_pred             cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC----------
Confidence            543 334456889999999998653 4888999999999999999999999863   2223333332210          


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                             +.+        ...++..+++++.+||++||..||.+|||+.++++||||.++..
T Consensus       240 -------~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          240 -------FSL--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             -------CCC--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             -------ccc--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence                   000        11123458999999999999999999999999999999987543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.8e-48  Score=373.43  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=204.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccch--------hhHHHHHHHHHHcCCCCeeccceeeeecC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  157 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  157 (429)
                      ...+|++.+.||+|+||.||+|++.   .+|+.||+|++.+..        ....+|+.+++.++||||+++++++... 
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-
Confidence            4457999999999999999999985   689999999886431        2345799999999999999999988442 


Q ss_pred             CCCceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          158 DKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                          ..+|+||||+. ++|...+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+
T Consensus        94 ----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~Dlkp~Nill~~~~-~~kl~  163 (327)
T 3a62_A           94 ----GKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQG-HVKLT  163 (327)
T ss_dssp             ----SCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCTTTEEECTTS-CEEEC
T ss_pred             ----CEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-hCCEEcccCCHHHeEECCCC-cEEEE
Confidence                34889999997 456555533    357899999999999999999999 78999999999999999887 79999


Q ss_pred             ecCCceecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          237 DFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       237 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |||+++..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....     
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----  237 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-----  237 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----
Confidence            99999764332 233456799999999998664 48999999999999999999999999888777766665421     


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                              ..++..+++++.+||.+||..||.+||     ++.++++||||+.+.+
T Consensus       238 ------------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          238 ------------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                                    012345789999999999999999999     8999999999998765

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-48  Score=391.39  Aligned_cols=252  Identities=28%  Similarity=0.433  Sum_probs=213.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~   88 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----P   88 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            3457999999999999999999999999999999986432       345689999999999999999998843     3


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ..+++||||++ ++|.+.+    ...+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDLkp~NIll~~~~-~vkL~DFG~  162 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAHM-NAKIADFGL  162 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred             CEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcccccHHHEEEecCC-CeEEEeccc
Confidence            35889999996 4555544    23567999999999999999999999 88999999999999999887 799999999


Q ss_pred             ceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ++....+......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....          
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------  232 (476)
T 2y94_A          163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------  232 (476)
T ss_dssp             CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC----------
T ss_pred             hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------
Confidence            9887666666677899999999999776545789999999999999999999999887766655554321          


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                             +            ..+..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus       233 -------~------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 -------F------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             -------C------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             -------c------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                   0            1223478999999999999999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.4e-48  Score=380.34  Aligned_cols=287  Identities=22%  Similarity=0.329  Sum_probs=208.5

Q ss_pred             ccccceeEeeEEccC--CcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ...++|++.+.||+|  +||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++...   
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---   98 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD---   98 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC---
Confidence            455689999999999  99999999999999999999986432      3345799999999999999999988543   


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                        ..+++||||+.+ ++.+++..  .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus        99 --~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~df  172 (389)
T 3gni_B           99 --NELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILISVDG-KVYLSGL  172 (389)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCG
T ss_pred             --CEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEccc
Confidence              348899999984 66565543  22356999999999999999999999 78999999999999999887 7999999


Q ss_pred             CCceecccCC--------CcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014156          239 GSAKVLVKGE--------PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  309 (429)
Q Consensus       239 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  309 (429)
                      |.+.......        .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            9986543221        12234789999999998763 45899999999999999999999999887666555443321


Q ss_pred             hCC--------CCHHHHhhcC-----CCCcc-----ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 014156          310 LGT--------PTREEIKCMN-----PNYTE-----FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA  371 (429)
Q Consensus       310 ~~~--------~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~  371 (429)
                      ...        +.........     .....     ...+. ........++..+++++.+||.+||++||.+|||+.|+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            100        0000000000     00000     00000 00011122445689999999999999999999999999


Q ss_pred             hcCCCccccCCCC
Q 014156          372 CIHPFFDELRDPN  384 (429)
Q Consensus       372 l~hp~f~~~~~~~  384 (429)
                      |+||||+++....
T Consensus       332 l~hp~f~~~~~~~  344 (389)
T 3gni_B          332 LNHSFFKQIKRRA  344 (389)
T ss_dssp             TTSGGGGGC---C
T ss_pred             hcCHHHHHHhhcc
Confidence            9999999987643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.2e-48  Score=372.07  Aligned_cols=256  Identities=26%  Similarity=0.340  Sum_probs=206.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...     .....+|+.+++.++||||+++++++.     .....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence            35799999999999999999999999999999988533     234568999999999999999999873     33458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ +|.+.+    .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  154 (323)
T 3tki_A           81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATV  154 (323)
T ss_dssp             EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccccchHHEEEeCCC-CEEEEEeeccce
Confidence            899999986 444432    33457999999999999999999999 88999999999999999887 799999999986


Q ss_pred             cccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          244 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       244 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      .....   .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+...............       
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------  227 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  227 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-------
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-------
Confidence            54332   23456899999999999776545789999999999999999999998765433222221110000       


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                    .     .....+++++.+||.+||..||.+|||+.|+++||||++...
T Consensus       228 --------------~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          228 --------------L-----NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             --------------S-----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             --------------C-----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                          0     011247899999999999999999999999999999987543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.7e-48  Score=367.62  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=214.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++...          .....+|+.+++.++||||+++++++..    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----   86 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN----   86 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence            35799999999999999999999999999999988542          2345689999999999999999998843    


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC---ceEE
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKL  235 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~---~vkl  235 (429)
                       ....++||||+. ++|.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++.   .+||
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH-~~~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           87 -RTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             -CCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChHHEEEecCCCCcCCEEE
Confidence             345889999996 46666553    2467899999999999999999999 789999999999999987763   5999


Q ss_pred             eecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             ccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            999999887666555667899999999998654 5899999999999999999999999988777666655442211111


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                               .+...+++.+.+||.+||..||.+|||+.++++||||..+.+
T Consensus       240 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          240 -------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             -------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             -------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence                                     122347899999999999999999999999999999986543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.2e-49  Score=392.40  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=206.4

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++...     
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----
Confidence            4568999999999999999999999999999999986431       2234688888999999999999988443     


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ..+++||||+++ +|...+..    ...+++..++.++.||+.||+||| + .||+||||||+||||+.++ .+||+|||
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~giiHrDlkp~NIll~~~~-~~kl~DFG  294 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDG-HIKITDFG  294 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HHTCCCCCCCCGGGEEECSSS-CEEECCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-hcCCEEECCCCHHHEEECCCC-CEEEccCC
Confidence            348899999986 55444432    467999999999999999999999 6 8999999999999999887 79999999


Q ss_pred             Cceeccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          240 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       240 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +|+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....        
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  365 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------  365 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9976432 3334567899999999999764 48999999999999999999999999887766666554420        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                                           ..++..+++++.+||.+||.+||.+||     |+.|+++||||+.+.+.
T Consensus       366 ---------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          366 ---------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                                 013345799999999999999999999     99999999999987653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.2e-48  Score=361.37  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=214.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence            457999999999999999999999999999999985432      33457999999999999999999883     3345


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCC
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  240 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~  240 (429)
                      .++||||+.+ ++...+..    ...+++..+..++.||+.||.||| +.||+||||||+||+++.++  ..+||+|||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            7899999985 55554433    367999999999999999999999 78999999999999997654  2499999999


Q ss_pred             ceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+........      
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  227 (284)
T 3kk8_A          155 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP------  227 (284)
T ss_dssp             CEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred             eEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC------
Confidence            9887666655667899999999998664 489999999999999999999999998877766666544211110      


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                                         ......+++++.+||.+||+.||.+|||+.|+|+||||++......
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          228 -------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             -------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             -------------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence                               0112347899999999999999999999999999999988665433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-48  Score=397.14  Aligned_cols=258  Identities=28%  Similarity=0.433  Sum_probs=212.2

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ....+|.+.+.||+|+||.||+|++..+|+.||+|++.+.       .....+|+.+++.++||||+++++++.     .
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----T  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----e
Confidence            4456799999999999999999999999999999998543       223457999999999999999998883     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+|+||||+++ +|...+..  .....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH-~~gIvHrDLKPeNILld~~g-~vKL~DFG  331 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLH-RERIVYRDLKPENILLDDHG-HIRISDLG  331 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeccCCchheEEEeCCC-CeEEEecc
Confidence            3458999999974 55555433  12345999999999999999999999 78999999999999999888 79999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHH
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTPTRE  316 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~  316 (429)
                      +|+....+......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..   ..+.......      
T Consensus       332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------  404 (576)
T 2acx_A          332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------  404 (576)
T ss_dssp             TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred             cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence            99887666555667899999999998764 4899999999999999999999999875432   2222222110      


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                                            ...++..+++++++||.+||+.||.+||     ++.|+++||||+.+.+.
T Consensus       405 ----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          405 ----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             ----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                                  0113345899999999999999999999     89999999999987653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=369.52  Aligned_cols=288  Identities=29%  Similarity=0.487  Sum_probs=218.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCC--------
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD--------  158 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--------  158 (429)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++.....        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            47999999999999999999999999999999885432    334579999999999999999987643211        


Q ss_pred             -CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          159 -KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 -~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                       ......++||||+++++.+.+.     .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++..+||+|
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence             2334678999999998777653     367999999999999999999999 789999999999999985555899999


Q ss_pred             cCCceecccC----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          238 FGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       238 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      ||+++.....    .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999865322    122345679999999998765668999999999999999999999999999888888888877666


Q ss_pred             CHHHHhhcCCCCccccCC--CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          314 TREEIKCMNPNYTEFKFP--QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                      ..+...........+...  .....+ ...+.+.+++++.+||.+||+.||.+|||+.++|+||||+....+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~  317 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKP-LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD  317 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCC-HHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred             chhhhhhhhhcCcccccccccCCCCC-hhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence            655443221111100000  000011 11233468999999999999999999999999999999998776543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.2e-48  Score=363.95  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=197.5

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh------hHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ...+|++.+.||+|+||.||+|++..+|+.||+|++.....      ...++...++.++||||+++++++....     
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----
Confidence            34679999999999999999999999999999998864321      1223444577789999999999885432     


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||+++++.+.+.........+++..++.++.||+.||.||| +. ||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALG-QVKMCDFGIS  157 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HHSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence            37899999999988887776666788999999999999999999999 66 999999999999999887 7999999999


Q ss_pred             eecccCCCcccccccccccccccc---cCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGEPNISYICSRYYRAPELI---FGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~  317 (429)
                      +............||+.|+|||++   .....++.++|||||||++|+|++|+.||.... ....+....... .     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-----  231 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-S-----  231 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-C-----
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-C-----
Confidence            877655555556899999999997   234558899999999999999999999998643 333333333210 0     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                   +.        .....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       232 -------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          232 -------------PQ--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             -------------CC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -------------CC--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                         00        0123478999999999999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.3e-48  Score=404.56  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=214.0

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc-CCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...+|.++++||+|+||.||+|+++.+++.||||++.+..       .....|..++..+ .||||++++.+|     ..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            4568999999999999999999999999999999986432       2334688888877 799999999888     34


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+|+||||+++ +|...+..    .+.+++..++.|+.||+.||.||| +.||+||||||+||||+.++ .+||+|||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~gIiHrDLKp~NILl~~~g-~ikL~DFG  487 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDSEG-HIKIADFG  487 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTSEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeccCChhhEEEcCCC-cEEEeecc
Confidence            4468999999985 55555443    367999999999999999999999 78999999999999999888 79999999


Q ss_pred             Cceecc-cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          240 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       240 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +|+... .+......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+....        
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------  558 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------  558 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            998643 3344556789999999999965 458999999999999999999999999988877777665420        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCccccCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFDELRDP  383 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~  383 (429)
                                           ..++..+++++++||++||+.||.+|+++     .|+++||||+.+.|.
T Consensus       559 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          559 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence                                 11344689999999999999999999997     999999999998764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.7e-48  Score=390.99  Aligned_cols=257  Identities=24%  Similarity=0.373  Sum_probs=210.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+|.+.+.||+|+||.||+|+++.+|+.||+|++.+..       ....+|+.+++.++||||++++++|.     ..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~  257 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TK  257 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eC
Confidence            4457999999999999999999999999999999985432       23457999999999999999998883     33


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ..+|+||||++| +|...+.........+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH-~~gIvHrDLKP~NILl~~~g-~vkL~DFGl  335 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDG-NVRISDLGL  335 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH-HcCCcccCCChHHEEEeCCC-CEEEeecce
Confidence            458999999985 565555443333457999999999999999999999 78999999999999999888 799999999


Q ss_pred             ceecccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCH
Q 014156          241 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPTR  315 (429)
Q Consensus       241 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~  315 (429)
                      ++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.    .+....+...      
T Consensus       336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~------  408 (543)
T 3c4z_A          336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ------  408 (543)
T ss_dssp             CEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC------
T ss_pred             eeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc------
Confidence            987755443 334589999999999976 4589999999999999999999999987542    2222222221      


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  382 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  382 (429)
                                             ...++..+++++.+||.+||+.||.+||+     +.++++||||+.+.+
T Consensus       409 -----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          409 -----------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             -----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             -----------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                                   01133458999999999999999999996     589999999998765

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9e-48  Score=377.71  Aligned_cols=283  Identities=28%  Similarity=0.408  Sum_probs=220.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcC--------CCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~~iv~l~~~~~~~~~  158 (429)
                      .++|++.++||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.        |+||++++++|.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            357999999999999999999999999999999987543   33457999999885        788999999875432 


Q ss_pred             CCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeecCCCCCCeeecCCC-------
Q 014156          159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHT-------  230 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-~iiHrDlKp~Nill~~~~-------  230 (429)
                      ....++++||||++++++..+...  ....+++..++.++.||+.||.||| +. ||+||||||+||||+.++       
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH-~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHH-HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence            244568999999999888876542  2356999999999999999999999 76 999999999999998664       


Q ss_pred             -----------------------------------------CceEEeecCCceecccCCCcccccccccccccccccCCC
Q 014156          231 -----------------------------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT  269 (429)
Q Consensus       231 -----------------------------------------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  269 (429)
                                                               ..+||+|||+++.....  ....+||+.|+|||++.+..
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence                                                     26999999999876433  34567899999999997754


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcCCCCcccc----CCCcCC-CCc
Q 014156          270 EYTTAIDIWSVGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIKA-HPW  338 (429)
Q Consensus       270 ~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~  338 (429)
                       ++.++|||||||++|+|++|+.||.+.+      ..+.+..+....+.++...+.........+.    ...+.. .++
T Consensus       270 -~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             -CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             -CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence             8999999999999999999999998655      4567788888888887766543221110000    000000 000


Q ss_pred             c--------cccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          339 H--------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       339 ~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                      .        ..++...++.+.+||.+||++||.+|||+.|+|+||||++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0        0112234567899999999999999999999999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=369.68  Aligned_cols=247  Identities=27%  Similarity=0.362  Sum_probs=196.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHH-cCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|++.++||+|+||+||+|++..+|+.||||++....      .....|+..+.. .+||||+++++++..     ...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence            57999999999999999999999999999999875421      112234444444 499999999998843     334


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++||||+++++...+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLH-SQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            889999999988776654   3457999999999999999999999 78999999999999999887 799999999988


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......   +..  +.           
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~-----------  268 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GY-----------  268 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TC-----------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cC-----------
Confidence            765555556779999999999865  489999999999999999999877755322211   111  00           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                    ....++..+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       269 --------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 --------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             --------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                          011123457999999999999999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.7e-48  Score=389.56  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=213.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----------------hhhHHHHHHHHHHcCCCCeecccee
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNVVSLKHC  152 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~~iv~l~~~  152 (429)
                      ..+|.+++.||+|+||+||+|++..+++.||+|++...                 .....+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            45799999999999999999999999999999988542                 2334579999999999999999998


Q ss_pred             eeecCCCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC
Q 014156          153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  231 (429)
Q Consensus       153 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~  231 (429)
                      +.     ....+++|||||++ +|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++.
T Consensus       115 ~~-----~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          115 FE-----DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLH-KHNIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             EE-----CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESSTTC
T ss_pred             EE-----cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCcHHHEEEecCCC
Confidence            83     34458899999975 56555543    367999999999999999999999 789999999999999987653


Q ss_pred             --ceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014156          232 --QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  309 (429)
Q Consensus       232 --~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  309 (429)
                        .+||+|||+++...........+||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+...
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence              599999999988766666667789999999999853  4899999999999999999999999998887777776653


Q ss_pred             hCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ........                         ...+++++++||++||++||.+|||+.|+|+||||++...
T Consensus       263 ~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          263 KYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            22111111                         1347999999999999999999999999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-47  Score=358.85  Aligned_cols=255  Identities=30%  Similarity=0.453  Sum_probs=214.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++...    .....+|+.+++.++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            34799999999999999999999999999999988542    345568999999999999999999884     334588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee---cCCCCceEEeecCCc
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA  241 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill---~~~~~~vkl~DFG~a  241 (429)
                      +||||+++ ++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||+   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence            99999975 55555433    366999999999999999999999 7899999999999999   5555 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+...........+   
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---  231 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred             eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence            88766666667789999999999854  3899999999999999999999999988877776666553222222211   


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                            ..+++.+.+||.+||+.||.+|||+.++|+||||++...
T Consensus       232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence                                  246899999999999999999999999999999987543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=379.66  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=205.2

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      |...+.||+|+||.||+|++..+|+.||+|++...    .....+|+.+++.++||||+++++++..     ...+++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEE
Confidence            33367899999999999999999999999998643    3445689999999999999999998843     33588999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee--cCCCCceEEeecCCceecc
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill--~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||+++ +|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||+  +.++ .+||+|||+++...
T Consensus       166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMH-QMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK  240 (373)
T ss_dssp             ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence            99975 55554432   2356899999999999999999999 7899999999999999  4444 79999999999876


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........          
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----------  309 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED----------  309 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS----------
T ss_pred             CccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh----------
Confidence            6665566789999999999865 45899999999999999999999999998888777777653211110          


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                     .....+++++++||.+||..||.+|||+.|+|+||||++..
T Consensus       310 ---------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 ---------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ---------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ---------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                           11234799999999999999999999999999999998754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.7e-48  Score=389.58  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=211.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc------chhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..+|++.+.||+|+||+||+|++..+++.||+|++..      ......+|+.+++.++||||+++++++.     ....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence            4579999999999999999999999999999999843      2344568999999999999999999883     3445


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCC
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  240 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~  240 (429)
                      +++||||+.+ +|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            8899999975 55555433    367999999999999999999999 78999999999999996432  2699999999


Q ss_pred             ceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ++...........+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.........     
T Consensus       171 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-----  243 (486)
T 3mwu_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-----  243 (486)
T ss_dssp             TTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS-----
T ss_pred             CeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-----
Confidence            987766655566789999999999865  3899999999999999999999999998887777666553111110     


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                          .....+|+++++||.+||+.||.+|||+.++|+||||+....
T Consensus       244 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          244 --------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             --------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             --------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                                011347899999999999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=369.17  Aligned_cols=256  Identities=28%  Similarity=0.413  Sum_probs=194.0

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++||||+++++++..     ...+++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEEC-----SSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeEEE
Confidence            345799999999999999999999999999999998653  3345579999999999999999998843     335889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CCCceEEeecCCce
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAK  242 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~~~vkl~DFG~a~  242 (429)
                      ||||+.+ +|.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||+++
T Consensus       126 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEESSSSTTC-CEEECCCC---
T ss_pred             EEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCcccEEEecCCCCC-CEEEccCcccc
Confidence            9999974 5555443    3466999999999999999999999 789999999999999975   55 79999999998


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhc
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~  321 (429)
                      ...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......+ ..+.....          
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~----------  268 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY----------  268 (349)
T ss_dssp             -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC----------
T ss_pred             ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC----------
Confidence            76555445567899999999998764 4899999999999999999999999876655533 32222100          


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                             .        ....+...++.++.+||.+||..||.+|||+.++|+||||....
T Consensus       269 -------~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          269 -------Y--------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             -------C--------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             -------c--------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                   0        00112245789999999999999999999999999999998644

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-47  Score=360.03  Aligned_cols=271  Identities=28%  Similarity=0.403  Sum_probs=219.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++.     ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cC
Confidence            345799999999999999999999999999999988543       233457999999999999999999883     33


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ...++||||+++ ++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~  161 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDL-EVKIGDFGL  161 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEcCCC-CEEEEeccC
Confidence            458899999984 55554432    367999999999999999999999 78999999999999999887 799999999


Q ss_pred             ceecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          241 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       241 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      +...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+....         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------  231 (294)
T 2rku_A          162 ATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------  231 (294)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred             ceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc---------
Confidence            9876432 23345678999999999865 448999999999999999999999998877665544433210         


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNF  399 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  399 (429)
                                          ..++..+++.+.+||.+||..||.+|||+.++++||||.+...+..........|+.+.+
T Consensus       232 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (294)
T 2rku_A          232 --------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI  291 (294)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCS
T ss_pred             --------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCccc
Confidence                                012335789999999999999999999999999999999877766554444445555554


Q ss_pred             C
Q 014156          400 K  400 (429)
Q Consensus       400 ~  400 (429)
                      .
T Consensus       292 ~  292 (294)
T 2rku_A          292 A  292 (294)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-47  Score=367.44  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=198.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCC------
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD------  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~------  158 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...     .....+|+.+++.++||||++++++|.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            35799999999999999999999999999999998532     2345689999999999999999998865432      


Q ss_pred             ----------------------------------------------CCceEEEEEeecchh-hHHHHHHHhhhcCCCCCH
Q 014156          159 ----------------------------------------------KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPL  191 (429)
Q Consensus       159 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~  191 (429)
                                                                    ....++++||||+++ +|.+.+... ......++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhh
Confidence                                                          223458899999986 555555432 22234566


Q ss_pred             HHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC-------------Cccccccccc
Q 014156          192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------------PNISYICSRY  258 (429)
Q Consensus       192 ~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~-------------~~~~~~gt~~  258 (429)
                      ..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++......             .....+||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHH-hCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            778999999999999999 78999999999999999887 79999999998765432             2234578999


Q ss_pred             ccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCc
Q 014156          259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  338 (429)
Q Consensus       259 y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (429)
                      |+|||++.+. .++.++|||||||++|+|++|..|+.     +....+..........                      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc----------------------
Confidence            9999999764 48999999999999999999876652     1111111111110000                      


Q ss_pred             ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          339 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       339 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                         .....++++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               001246789999999999999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.2e-47  Score=367.05  Aligned_cols=274  Identities=28%  Similarity=0.421  Sum_probs=220.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++.     ...
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            34799999999999999999999999999999988543       234457999999999999999999884     334


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||+++ ++.+++..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~  188 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDL-EVKIGDFGLA  188 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCEecCCCchhEEEcCCC-CEEEeeccCc
Confidence            58899999985 55554432    367999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+....          
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------  257 (335)
T 2owb_A          189 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE----------  257 (335)
T ss_dssp             EECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------
T ss_pred             eecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC----------
Confidence            876433 233456789999999998764 48999999999999999999999998877666555443310          


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFK  400 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  400 (429)
                             +            .++..+++.+.+||.+||..||.+|||+.++++||||.....+..........++.+...
T Consensus       258 -------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (335)
T 2owb_A          258 -------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA  318 (335)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred             -------C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcccccCCCccccC
Confidence                   0            122357899999999999999999999999999999998766654444444445555544


Q ss_pred             hhhh
Q 014156          401 PQEL  404 (429)
Q Consensus       401 ~~~~  404 (429)
                      +...
T Consensus       319 ~~~~  322 (335)
T 2owb_A          319 PSSL  322 (335)
T ss_dssp             CC--
T ss_pred             cccc
Confidence            4433

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.1e-47  Score=372.67  Aligned_cols=280  Identities=33%  Similarity=0.589  Sum_probs=217.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcC-CC-----CeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-HP-----NVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-h~-----~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++ |+     +|+++++++...    
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~----  128 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR----  128 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC----
Confidence            457999999999999999999999999999999987543   23346888888875 44     488888877443    


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCeeecCCCCCCeeecC--CCCceEEee
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNP--HTHQVKLCD  237 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~~iiHrDlKp~Nill~~--~~~~vkl~D  237 (429)
                       ..+++||||++++|.+.+...  ....+++..++.++.||+.||.|||+ +.||+||||||+||||+.  ++ .+||+|
T Consensus       129 -~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D  204 (382)
T 2vx3_A          129 -NHLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD  204 (382)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred             -CceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence             358899999999988877652  22569999999999999999999994 469999999999999953  44 799999


Q ss_pred             cCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       238 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ||+++....  ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...
T Consensus       205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987643  33467899999999999765 489999999999999999999999999999999999999999888766


Q ss_pred             HhhcCCCCccccCCCcCCCCc--------------------ccccCC-----------------CCChhHHHHHHhhcCc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPW--------------------HKIFHK-----------------RMPPEAVDLVSRLLQY  360 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~-----------------~~s~~~~~li~~~L~~  360 (429)
                      +...... ..+ +..++...|                    ...+..                 ..++++++||.+||++
T Consensus       282 ~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          282 LDQAPKA-RKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HTTCTTH-HHH-EEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHhhHHH-HHH-HHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence            5432110 000 000000000                    000000                 0014789999999999


Q ss_pred             CCCCCCCHHHHhcCCCccccCC
Q 014156          361 SPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       361 dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ||.+|||+.|+|+||||++..+
T Consensus       360 dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC---
T ss_pred             ChhhCCCHHHHhcCcccccCCC
Confidence            9999999999999999987543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.5e-48  Score=391.06  Aligned_cols=257  Identities=31%  Similarity=0.489  Sum_probs=214.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++...       .....+|+.+++.++||||+++++++.     ..
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~   98 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DK   98 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence            345799999999999999999999999999999998432       344568999999999999999999883     34


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec---CCCCceEEee
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN---PHTHQVKLCD  237 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~---~~~~~vkl~D  237 (429)
                      .++++||||+.+ ++.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++   .++ .+||+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~D  172 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMH-KNKIVHRDLKPENLLLESKSKDA-NIRIID  172 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTC-CEEECC
T ss_pred             CEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEecCCCCC-cEEEEe
Confidence            468899999975 5555443    2467999999999999999999999 78999999999999994   344 799999


Q ss_pred             cCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       238 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ||+++...........+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........   
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  247 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE---  247 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            999987766666667789999999999865  489999999999999999999999999888777776655311111   


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                                  .          ..+..+++++++||++||++||.+|||+.++|+||||+.....
T Consensus       248 ------------~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          248 ------------L----------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             ------------S----------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             ------------C----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence                        0          0113479999999999999999999999999999999986553

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.3e-47  Score=369.23  Aligned_cols=253  Identities=27%  Similarity=0.437  Sum_probs=210.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHHc-CCCCeeccceeeeecC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  157 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~  157 (429)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....            ....+|+.+++.+ +||||+++++++..  
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  171 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--  171 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence            47999999999999999999999999999999875321            2345799999999 89999999998733  


Q ss_pred             CCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          158 DKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                         ....++||||+++ ++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+
T Consensus       172 ---~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH-~~gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          172 ---SSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             ---SSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEEC
T ss_pred             ---CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEEE
Confidence               3458899999986 66665542    357999999999999999999999 78999999999999999887 79999


Q ss_pred             ecCCceecccCCCcccccccccccccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  311 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  311 (429)
                      |||++............+||+.|+|||++.+     ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999988766666667789999999999853     23478899999999999999999999988777666665554322


Q ss_pred             CCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                      ......                         ...+++.+.+||.+||..||.+|||+.++|+||||++
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            111111                         1246899999999999999999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.7e-47  Score=368.17  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=209.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ..|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            35999999999999999999999999999999885321       2345799999999999999999988543     34


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .++||||+.|++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence            889999999988776643   3467999999999999999999999 78999999999999999887 899999999976


Q ss_pred             cccCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          244 LVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|+|++|+.||.+.+....+..+.... .         
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~---------  270 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S---------  270 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C---------
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C---------
Confidence            533   235679999999999853  3458999999999999999999999998887776665554421 0         


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                               +.        .....+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       271 ---------~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          271 ---------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             ---------CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---------CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                     00        0123468999999999999999999999999999999763

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-47  Score=387.96  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=210.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|++++.||+|+||+||+|++..++..||+|++...      .....+|+.+++.++||||+++++++.     ....+
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  111 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY  111 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence            4799999999999999999999999999999988543      234568999999999999999999884     33458


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCCc
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSA  241 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~a  241 (429)
                      ++|||||.+ +|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++..+  ..+||+|||++
T Consensus       112 ~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            899999985 55555433    367999999999999999999999 78999999999999997643  25999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ............+||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+........       
T Consensus       187 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------  257 (494)
T 3lij_A          187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD-------  257 (494)
T ss_dssp             EECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred             eECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence            88766666667789999999998853  489999999999999999999999999888777766655321111       


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                        ......+++++++||.+||++||.+|||+.++|+||||++..
T Consensus       258 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          258 ------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             ------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             ------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                              011235799999999999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-47  Score=375.93  Aligned_cols=259  Identities=27%  Similarity=0.396  Sum_probs=197.7

Q ss_pred             ccceeEe-eEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHH-HHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           90 TISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        90 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ..+|.+. ++||+|+||+||+|.+..+|+.||||++... ....+|+.++ +..+||||++++++|.... .+..++|+|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEE
Confidence            4468877 7999999999999999999999999988643 4456788887 4568999999999875422 234568999


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CCCceEEeecCCcee
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKV  243 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~~~vkl~DFG~a~~  243 (429)
                      |||+.+ +|.+.+..  .....+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||+++.
T Consensus       138 ~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~  213 (400)
T 1nxk_A          138 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE  213 (400)
T ss_dssp             EECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCcCcceEEEecCCCCc-cEEEEecccccc
Confidence            999975 66666543  12346999999999999999999999 789999999999999987   44 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHh
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~  319 (429)
                      ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...    ....+...          
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~----------  282 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----------  282 (400)
T ss_dssp             CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----------
T ss_pred             cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----------
Confidence            765555567789999999999865 458999999999999999999999998754322    11222111          


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                             .+.++.        .....+++++.+||++||..||.+|||+.++++||||.+.
T Consensus       283 -------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          283 -------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             -------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                   011111        1123479999999999999999999999999999999764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=368.94  Aligned_cols=245  Identities=24%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHHcCCCCeeccceeeeecC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  157 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  157 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....            ....+|+.+++.++||||+++++++.   
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~---   99 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE---   99 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE---
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            347999999999999999999999999999999886432            23347999999999999999999883   


Q ss_pred             CCCceEEEEEeecchh--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          158 DKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                        ....+++||||+.+  ++...+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||
T Consensus       100 --~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL  171 (335)
T 3dls_A          100 --NQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAEDF-TIKL  171 (335)
T ss_dssp             --CSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEE
T ss_pred             --eCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEeccCHHHEEEcCCC-cEEE
Confidence              34458899999864  5555443    3567999999999999999999999 78999999999999999887 7999


Q ss_pred             eecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +|||+++...........+||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..       
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------  238 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------  238 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence            99999988766666667789999999999977654588999999999999999999999642110      00       


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                      .      ....+..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus       239 ----------------~------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 ----------------A------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             ----------------T------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ----------------h------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                            0      001223478999999999999999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.9e-47  Score=365.89  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=185.0

Q ss_pred             ceeEe---eEEccCCcEEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAE---RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~---~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +|.+.   +.||+|+||.||+|++..+++.||+|++... .....+|+.+++.+. ||||+++++++.     .....++
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~l   83 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFL   83 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEE
Confidence            57765   7899999999999999999999999998654 345568999999997 999999999883     3445889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC--ceEEeecCCcee
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKV  243 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~--~vkl~DFG~a~~  243 (429)
                      ||||+++ +|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|||+++.
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           84 VMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            9999975 66665543    467999999999999999999999 789999999999999976542  699999999986


Q ss_pred             cccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCCH
Q 014156          244 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-------DQLVEIIKVLGTPTR  315 (429)
Q Consensus       244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~~~~  315 (429)
                      ..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..       +.+..+.....    
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~----  233 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF----  233 (325)
T ss_dssp             CCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC----
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC----
Confidence            54432 23456789999999998654 5899999999999999999999999865432       11222111100    


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                           .+.......+++++++||.+||..||.+|||+.++++||||++...
T Consensus       234 ---------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          234 ---------------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             ---------------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             ---------------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence                                 0000111347999999999999999999999999999999987543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7e-48  Score=371.73  Aligned_cols=263  Identities=30%  Similarity=0.458  Sum_probs=207.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....         ....+|+.+++.++||||+++++++.     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence            357999999999999999999999999999999885432         34557999999999999999999883     3


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhh------------------------------------cCCCCCHHHHHHHHHHHHH
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSR------------------------------------ASQRMPLIYVKLYTYQICR  203 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------~~~~l~~~~~~~~~~qi~~  203 (429)
                      ....++||||++ ++|.+.+..+..                                    ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            345889999997 455554421100                                    0112467788899999999


Q ss_pred             HHHHHHcCCCeeecCCCCCCeeecCCCC-ceEEeecCCceecccCC-----CcccccccccccccccccCC-CCCCCcch
Q 014156          204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGA-TEYTTAID  276 (429)
Q Consensus       204 aL~~LH~~~~iiHrDlKp~Nill~~~~~-~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~D  276 (429)
                      ||.||| +.||+||||||+|||++.++. .+||+|||+++......     ......||+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLH-NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHH-HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHH-HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999 789999999999999986542 69999999998764322     12456789999999998642 45889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHh
Q 014156          277 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR  356 (429)
Q Consensus       277 iwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  356 (429)
                      ||||||++|+|++|+.||.+.+..+....+.........                         .....+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHH
Confidence            999999999999999999998887777666553111100                         0112368999999999


Q ss_pred             hcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          357 LLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       357 ~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      ||+.||.+|||+.++|+||||+++.+.
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999987653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-47  Score=356.20  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=209.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...          .....+|+.+++.++||||+++++++..     
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-----   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence            4699999999999999999999999999999988543          3445689999999999999999998843     


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC---ceEEe
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLC  236 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~---~vkl~  236 (429)
                      ....++||||++ ++|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+||+++.++.   .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCChHHEEEecCCCCCCceEEE
Confidence            335889999996 566665543    357999999999999999999999 789999999999999986652   69999


Q ss_pred             ecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      |||++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+......... 
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  232 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-  232 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence            99999877655555566799999999998654 4899999999999999999999999988776665554432111111 


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                                              .....+++.+.+||.+||..||.+|||+.++++||||+.++...
T Consensus       233 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          233 ------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             ------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             ------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence                                    12234789999999999999999999999999999999876543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.1e-47  Score=367.71  Aligned_cols=290  Identities=29%  Similarity=0.476  Sum_probs=221.4

Q ss_pred             CccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcC-----------CCCeecccee
Q 014156           87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHC  152 (429)
Q Consensus        87 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~l~~~  152 (429)
                      +....+|++.+.||+|+||.||+|++..+++.||||++..+.   ....+|+.+++.+.           |+||++++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            344568999999999999999999999999999999987543   33457888888876           8999999998


Q ss_pred             eeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeecCCCCCCeeecCCC-
Q 014156          153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHT-  230 (429)
Q Consensus       153 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-~iiHrDlKp~Nill~~~~-  230 (429)
                      +.... ....++++||||+++++.+++....  ...+++..++.++.||+.||.||| +. ||+||||||+|||++.++ 
T Consensus        95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH-~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHH-HTTCEECSCCSGGGEEEEEEET
T ss_pred             hhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHH-hcCCEEecCCChHHeEEeccCC
Confidence            86543 3445688999999888888776532  356999999999999999999999 76 999999999999995322 


Q ss_pred             ----CceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------hH
Q 014156          231 ----HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES------GV  300 (429)
Q Consensus       231 ----~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~  300 (429)
                          ..+||+|||+++.....  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+      ..
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence                26999999999876433  34567899999999997654 8999999999999999999999998654      45


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccc-------cCCCcCCCCc------ccccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014156          301 DQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPW------HKIFHKRMPPEAVDLVSRLLQYSPNLRCT  367 (429)
Q Consensus       301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t  367 (429)
                      +.+.++...++.++...+.........+       ........+.      ...++..+++++.+||.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            6677888888887765543211100000       0000000000      01122345678999999999999999999


Q ss_pred             HHHHhcCCCccccCCC
Q 014156          368 ALEACIHPFFDELRDP  383 (429)
Q Consensus       368 ~~e~l~hp~f~~~~~~  383 (429)
                      +.|+|+||||++....
T Consensus       328 ~~ell~hp~f~~~~~~  343 (373)
T 1q8y_A          328 AGGLVNHPWLKDTLGM  343 (373)
T ss_dssp             HHHHHTCGGGTTCTTC
T ss_pred             HHHHhhChhhhcccCc
Confidence            9999999999986543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.8e-47  Score=354.46  Aligned_cols=253  Identities=29%  Similarity=0.454  Sum_probs=207.5

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ....+|++.+.||+|+||.||+|++..++..||+|++...       .....+|+.+++.++||||+++++++.     .
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----D   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----c
Confidence            3456899999999999999999999999999999988543       233457999999999999999999884     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ....++||||+++ ++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~dlkp~Nili~~~~-~~~l~Dfg  154 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAG-ELKIADFG  154 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TTTCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHhEEEcCCC-CEEEEecc
Confidence            3458899999984 56555543    356999999999999999999999 88999999999999999887 79999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....         
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------  223 (279)
T 3fdn_A          155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------  223 (279)
T ss_dssp             EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred             ccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC---------
Confidence            98654332 23456789999999998664 48899999999999999999999999887766665554421         


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                          ..++..+++++.+||.+||..||.+|||+.|+++||||+....
T Consensus       224 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          224 --------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             --------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                                0123347899999999999999999999999999999987553

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.5e-47  Score=360.46  Aligned_cols=251  Identities=29%  Similarity=0.442  Sum_probs=206.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .|...+.||+|+||.||+|++..+|+.||||++...    .....+|+.+++.++||||+++++++....     ..++|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-----ELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEEE
Confidence            488889999999999999999999999999988533    234568999999999999999999885433     47899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+++ ++.+++.     ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.....
T Consensus       121 ~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          121 MEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH-AQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK  193 (321)
T ss_dssp             ECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-cEEEeeeeeeeeccc
Confidence            999975 4444332     357999999999999999999999 78999999999999999887 799999999987644


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      .. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..... +            
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~------------  259 (321)
T 2c30_A          194 DVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-P------------  259 (321)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-C------------
T ss_pred             CccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C------------
Confidence            32 3345689999999999865 4589999999999999999999999988877666555443210 0            


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                            ..       .....+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       260 ------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          260 ------KL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             ------CC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ------Cc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                  00       01123689999999999999999999999999999998644

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=359.55  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=211.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...        .....+|+.+++.++||||+++++++...   ...
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EKQ   81 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CCC
Confidence            4799999999999999999999999999999998643        23456899999999999999999987532   223


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ..++||||+++++.+.+...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLH-SQGIVHKDIKPGNLLLTTGG-TLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence            47899999998877766543  2467999999999999999999999 78999999999999999887 79999999998


Q ss_pred             ecccC---CCcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          243 VLVKG---EPNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       243 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      .....   .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+....+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--------  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--------  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--------
Confidence            76432   2223456899999999986532 24779999999999999999999998877666555443310        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA  385 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  385 (429)
                                           ..++..+++.+.+||.+||..||.+|||+.++++||||++...+..
T Consensus       230 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~  275 (305)
T 2wtk_C          230 ---------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE  275 (305)
T ss_dssp             ---------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred             ---------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence                                 0123457899999999999999999999999999999998766543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-46  Score=354.95  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=212.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------------hhhHHHHHHHHHHcC-CCCeeccceeeee
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------------KRYKNRELQTMRLLD-HPNVVSLKHCFFS  155 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~~E~~~l~~l~-h~~iv~l~~~~~~  155 (429)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++...             .....+|+.+++.+. ||||+++++++. 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-   94 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-   94 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec-
Confidence            45799999999999999999999999999999998532             123347999999995 999999999883 


Q ss_pred             cCCCCceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceE
Q 014156          156 TTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  234 (429)
Q Consensus       156 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vk  234 (429)
                          .....++||||++ ++|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+|
T Consensus        95 ----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~k  164 (298)
T 1phk_A           95 ----TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDM-NIK  164 (298)
T ss_dssp             ----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEE
T ss_pred             ----cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEcCCC-cEE
Confidence                3445889999998 466665543    357999999999999999999999 88999999999999999887 799


Q ss_pred             EeecCCceecccCCCccccccccccccccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014156          235 LCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  309 (429)
Q Consensus       235 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  309 (429)
                      |+|||++.............||+.|+|||++.     ....++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99999998876665556678999999999885     2345789999999999999999999999887776665555442


Q ss_pred             hCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      .....                 .        .....++..+.+||.+||..||.+|||+.++++||||++....
T Consensus       245 ~~~~~-----------------~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          245 NYQFG-----------------S--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             CCCCC-----------------T--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             CcccC-----------------c--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            11100                 0        0112468999999999999999999999999999999986654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.1e-47  Score=363.92  Aligned_cols=261  Identities=23%  Similarity=0.334  Sum_probs=208.0

Q ss_pred             cceeEe-eEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCce
Q 014156           91 ISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ++|.+. +.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.+. ||||+++++++.     ...
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-----~~~  102 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-----NTS  102 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-----eCC
Confidence            468888 8999999999999999999999999988542      234567999999985 699999999883     334


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CCCceEEeec
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDF  238 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~~~vkl~DF  238 (429)
                      .+++||||+.+ +|.+.+..  .....+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH-~~givH~Dikp~NIl~~~~~~~~-~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYPLG-DIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence            58899999986 44433211  22367999999999999999999999 789999999999999987   45 7999999


Q ss_pred             CCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          239 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       239 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      |+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+........    
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----  253 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS----  253 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----
T ss_pred             ccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC----
Confidence            999887665555567899999999998654 589999999999999999999999999887777666655321111    


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNAR  386 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  386 (429)
                                           ......+++.+.+||.+||+.||.+|||+.++|+||||+++.+....
T Consensus       254 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~  300 (327)
T 3lm5_A          254 ---------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF  300 (327)
T ss_dssp             ---------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred             ---------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence                                 11223478999999999999999999999999999999988765443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.2e-47  Score=377.99  Aligned_cols=256  Identities=29%  Similarity=0.452  Sum_probs=196.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHHcCCCCeeccceeeeecC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  157 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  157 (429)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++....            ....+|+.+++.++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            357999999999999999999999999999999986432            13468999999999999999999762   


Q ss_pred             CCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceE
Q 014156          158 DKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVK  234 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vk  234 (429)
                        .. ..++||||+.+ +|.+.    ......+++..++.++.||+.||.||| +.||+||||||+|||++.++  ..+|
T Consensus       211 --~~-~~~lv~e~~~~g~L~~~----l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AE-DYYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SS-EEEEEEECCTTCBGGGG----TSSSCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cC-ceEEEEEcCCCCcHHHH----HhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEecCCCcceEE
Confidence              12 26799999986 44332    234577999999999999999999999 78999999999999997543  2599


Q ss_pred             EeecCCceecccCCCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014156          235 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       235 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      |+|||+++...........+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+......+.........
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987765555566789999999999853  345788999999999999999999999875543333332221111


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      ..                        .......+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       363 ~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            00                        011123478999999999999999999999999999999763

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.3e-47  Score=355.08  Aligned_cols=252  Identities=27%  Similarity=0.451  Sum_probs=183.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++.     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence            457999999999999999999999999999999985432       34567999999999999999999883     334


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||+++ ++.+.+.   .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~  159 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRNM-NIKIADFGLA  159 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence            58899999975 5555443   23467999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+..            
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  226 (278)
T 3cok_A          160 TQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------  226 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred             eeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence            876432 223356789999999998654 488999999999999999999999977554332211100            


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                           .            ...++..++.++.+||.+||..||.+|||+.++++||||.+..
T Consensus       227 -----~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          227 -----A------------DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             -----S------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             -----c------------ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                 0            0112345789999999999999999999999999999998643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.2e-46  Score=351.39  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=205.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+...      .....+|+.+++.++||||+++++++.... .+..++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            3599999999999999999999999999999988543      233457999999999999999999876543 345568


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ++||||+++ +|.+.+..    ...+++..++.++.||+.||.||| +.|  |+||||||+|||++.+.+.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHH-cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            899999975 66665543    367999999999999999999999 778  9999999999999833338999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ..... .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+................         
T Consensus       180 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  247 (290)
T 1t4h_A          180 TLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---------  247 (290)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------
T ss_pred             ccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC---------
Confidence            65433 33345678999999998864  4899999999999999999999999886655544433221100         


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                       ...++...++++.+||.+||..||.+|||+.++++||||++
T Consensus       248 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                             01123346889999999999999999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.5e-46  Score=351.11  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=210.3

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...++|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++..     
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   85 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----   85 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----
Confidence            3446799999999999999999999999999999988543       2345689999999999999999998843     


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ....++||||+++ ++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg  159 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGYKG-ELKIADFG  159 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEEcCCC-CEEEeccc
Confidence            3458899999975 66665543    356999999999999999999999 88999999999999999887 79999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....         
T Consensus       160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  228 (284)
T 2vgo_A          160 WSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------  228 (284)
T ss_dssp             TCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred             ccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc---------
Confidence            98765432 23456789999999998764 48999999999999999999999998877666554443210         


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                          ..++..++.++.+||.+||..||.+|||+.++++||||+...
T Consensus       229 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          229 --------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             --------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                                012345789999999999999999999999999999998644

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.2e-47  Score=353.50  Aligned_cols=252  Identities=28%  Similarity=0.408  Sum_probs=200.9

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++..     .
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----P   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence            3457999999999999999999999999999999885432       244579999999999999999998743     3


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ...++||||+. ++|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~  157 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCH-RHMVVHRDLKPENVLLDAHM-NAKIADFGL  157 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HHCSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred             CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCChhhEEECCCC-CEEEeeccc
Confidence            35889999997 466666543    356899999999999999999999 78999999999999999887 799999999


Q ss_pred             ceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +.............||+.|+|||++.+....+.++||||||+++|+|++|+.||.+.+.......+....          
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------  227 (276)
T 2h6d_A          158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV----------  227 (276)
T ss_dssp             GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------
Confidence            9876555444566789999999998765545789999999999999999999998876655554443310          


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                         ..++..++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus       228 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          228 -------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                               01223478999999999999999999999999999999763

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.5e-47  Score=360.06  Aligned_cols=258  Identities=26%  Similarity=0.373  Sum_probs=196.1

Q ss_pred             ccceeEe-eEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ...|.+. +.||+|+||.||+|++..+++.||||++...    .....+|+.+++++ +||||+++++++...     ..
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CE
Confidence            4579995 7899999999999999999999999998543    34456899999884 799999999988543     34


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC--ceEEeecCC
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGS  240 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~--~vkl~DFG~  240 (429)
                      +++||||+. ++|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|||+
T Consensus        86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            889999997 566665543    357999999999999999999999 789999999999999987652  399999999


Q ss_pred             ceecccCC--------CcccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH--------
Q 014156          241 AKVLVKGE--------PNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGV--------  300 (429)
Q Consensus       241 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------  300 (429)
                      +.......        .....+||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+....        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            87653221        12245689999999998541    23788999999999999999999999875421        


Q ss_pred             -------HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          301 -------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       301 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                             .....+......                 ++        ......+++++++||.+||..||.+|||+.|+|+
T Consensus       241 ~~~~~~~~~~~~i~~~~~~-----------------~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYE-----------------FP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCC-----------------CC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHHHHHHHHhccCcc-----------------cC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                   111222111000                 00        0011347899999999999999999999999999


Q ss_pred             CCCccccCC
Q 014156          374 HPFFDELRD  382 (429)
Q Consensus       374 hp~f~~~~~  382 (429)
                      ||||++...
T Consensus       296 hp~~~~~~~  304 (316)
T 2ac3_A          296 HPWVQGCAP  304 (316)
T ss_dssp             STTCC----
T ss_pred             ChhhcCCCC
Confidence            999997654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-47  Score=373.21  Aligned_cols=265  Identities=15%  Similarity=0.141  Sum_probs=189.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHc--CCCCeeccceeee-------
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL--DHPNVVSLKHCFF-------  154 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l--~h~~iv~l~~~~~-------  154 (429)
                      ..|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.|  +||||++++..+.       
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            35999999999999999999999999999999986532       2234675545544  6999888654332       


Q ss_pred             ecCC--------C----CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHHcCCCeee
Q 014156          155 STTD--------K----DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV------KLYTYQICRALAYIHGGIGVCH  216 (429)
Q Consensus       155 ~~~~--------~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~------~~~~~qi~~aL~~LH~~~~iiH  216 (429)
                      ....        .    ....+|+||||++++|.+++.....   .++....      ..++.||+.||+||| +.||+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH-~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQ-SKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHH-HTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHH-HCCCcc
Confidence            1111        0    1145789999999999888876432   2344444      566799999999999 889999


Q ss_pred             cCCCCCCeeecCCCCceEEeecCCceecccCCCcccccccccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014156          217 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGCVLAELLLGQPLFP  295 (429)
Q Consensus       217 rDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~  295 (429)
                      |||||+||||+.++ .+||+|||+|+...  .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.
T Consensus       218 rDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          218 GHFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             TTCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CcCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 79999999998653  22225667899999999864 1358999999999999999999999997


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014156          296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP  375 (429)
Q Consensus       296 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  375 (429)
                      +.....                    ...+............+.......+++++.+||.+||+.||++|||+.++|+||
T Consensus       295 ~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  354 (371)
T 3q60_A          295 LVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP  354 (371)
T ss_dssp             BCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred             CcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence            653210                    001111111111111122222346899999999999999999999999999999


Q ss_pred             CccccCC
Q 014156          376 FFDELRD  382 (429)
Q Consensus       376 ~f~~~~~  382 (429)
                      ||+++.+
T Consensus       355 ~f~~~~~  361 (371)
T 3q60_A          355 EFLQLQN  361 (371)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9988654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-46  Score=352.46  Aligned_cols=253  Identities=19%  Similarity=0.244  Sum_probs=202.9

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  160 (429)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+..+..+ +||||+++++++...    
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~----   83 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED----   83 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET----
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC----
Confidence            3456899999999999999999999999999999988642      23345788888888 999999999988443    


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC---------
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT---------  230 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~---------  230 (429)
                       ...++||||+++ +|.+.+.........+++..++.++.||+.||.||| +.||+||||||+|||++.++         
T Consensus        84 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           84 -DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             -TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC------------
T ss_pred             -CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH-hCCEeecCCCHHHEEEcCCCCCccccccc
Confidence             358899999975 888877765555578999999999999999999999 78999999999999998432         


Q ss_pred             ---------CceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 014156          231 ---------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD  301 (429)
Q Consensus       231 ---------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  301 (429)
                               ..+||+|||++......   ....||+.|+|||++.+...++.++|||||||++|+|++|.+++.....  
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                     26999999999876443   2346899999999997765677899999999999999999987754432  


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                       ...+...                   ..         ..++..+++++.+||.+||..||.+|||+.++++||||.+.
T Consensus       237 -~~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 -WHEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -HHHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -HHHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence             1111110                   00         11334579999999999999999999999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=365.97  Aligned_cols=277  Identities=20%  Similarity=0.300  Sum_probs=206.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....     ....+|+++++.++||||+++++++....   ....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence            357999999999999999999999999999999986432     33458999999999999999998875432   2347


Q ss_pred             EEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee----cCCCCceEEeecC
Q 014156          165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFG  239 (429)
Q Consensus       165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill----~~~~~~vkl~DFG  239 (429)
                      ++||||++ ++|.+.+... .....+++..++.++.||+.||.||| +.||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence            89999997 5666665542 22344999999999999999999999 7899999999999998    6555 79999999


Q ss_pred             CceecccCCCcccccccccccccccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESG----VDQLVEIIK  308 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~  308 (429)
                      +++............||+.|+|||++..       ...++.++|||||||++|+|++|+.||.....    .+.+..+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            9988766666667789999999998852       34589999999999999999999999975433    233333333


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  376 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  376 (429)
                      .........+.........+  .  ...+....+...++..+.+||++||++||.+|||+.|+|+||-
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDW--S--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEE--E--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCcccc--C--ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            21110000000000000000  0  0001111222345668999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.2e-46  Score=359.71  Aligned_cols=281  Identities=27%  Similarity=0.482  Sum_probs=218.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEE-cCCCcEEEEEEeccch---hhHHHHHHHHHHcCCC------CeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKC-LETGETVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~l~~~~~~~~~~~  160 (429)
                      .+|++.+.||+|+||.||+|.+ ..+++.||+|++....   ....+|+.+++.++|+      +++++++++..     
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-----   88 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-----   88 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-----
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-----
Confidence            4799999999999999999998 5688999999986543   3445789999888665      48898887743     


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC-----------
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-----------  229 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~-----------  229 (429)
                      ...+++||||+++++.+.+...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.+           
T Consensus        89 ~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           89 HGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLH-SNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            2358899999998888877542  2246899999999999999999999 7899999999999999863           


Q ss_pred             -------CCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 014156          230 -------THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ  302 (429)
Q Consensus       230 -------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  302 (429)
                             ...+||+|||+++....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                   22699999999986533  33456889999999998764 489999999999999999999999999998888


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCcc----ccCCCc---------CCCCcc--cccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014156          303 LVEIIKVLGTPTREEIKCMNPNYTE----FKFPQI---------KAHPWH--KIFHKRMPPEAVDLVSRLLQYSPNLRCT  367 (429)
Q Consensus       303 ~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t  367 (429)
                      ...+....+..+...+.........    ......         ....+.  .......++++.+||.+||..||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            8888888887776655432211000    000000         000000  0011223577999999999999999999


Q ss_pred             HHHHhcCCCccccCC
Q 014156          368 ALEACIHPFFDELRD  382 (429)
Q Consensus       368 ~~e~l~hp~f~~~~~  382 (429)
                      +.|+++||||+.++.
T Consensus       323 ~~ell~hp~f~~~~~  337 (339)
T 1z57_A          323 LREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHTTSGGGGGGGC
T ss_pred             HHHHhcCHHHHHHhc
Confidence            999999999998764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=368.36  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=204.4

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccc--------hhhHHHHHHHHHHc-CCCCeeccceeeee
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFFS  155 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l-~h~~iv~l~~~~~~  155 (429)
                      ....+|++.+.||+|+||.||+|++.   .+++.||||++...        .....+|+.+++.+ .||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            34568999999999999999999984   58999999988532        23345799999999 69999999988844


Q ss_pred             cCCCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceE
Q 014156          156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK  234 (429)
Q Consensus       156 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vk  234 (429)
                      .     ..+++||||+++ +|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+|
T Consensus       131 ~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~k  199 (355)
T 1vzo_A          131 E-----TKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HVV  199 (355)
T ss_dssp             T-----TEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEE
T ss_pred             C-----ceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-cEE
Confidence            2     347899999985 66665543    357999999999999999999999 78999999999999999887 799


Q ss_pred             EeecCCceecccCC--CcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014156          235 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  311 (429)
Q Consensus       235 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  311 (429)
                      |+|||+++......  .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  279 (355)
T 1vzo_A          200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  279 (355)
T ss_dssp             ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence            99999998654322  23346799999999998753 3478999999999999999999999975433222222221100


Q ss_pred             CCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                              ..                 ...++..++..+.+||.+||..||.+||     |+.++++||||+.+.+
T Consensus       280 --------~~-----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          280 --------KS-----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             --------HC-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             --------cc-----------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                    00                 0113345789999999999999999999     9999999999998765

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.7e-46  Score=366.73  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcC--CCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|.+.+.||+|+||.||+|.+.. ++.||||++....      ....+|+.+++.+.  ||||+++++++..     ..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence            369999999999999999999764 8999999885432      33468999999997  5999999998743     33


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ++++|||+.+++|.+++..    ...+++..++.++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||+++
T Consensus       130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~  202 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DG-MLKLIDFGIAN  202 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH-TTTCCCCCCCGGGEEES-SS-CEEECCCSSSC
T ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEEE-CC-eEEEEecCccc
Confidence            5889999888888777654    457899999999999999999999 88999999999999996 44 79999999998


Q ss_pred             ecccCCC---cccccccccccccccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 014156          243 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIK  308 (429)
Q Consensus       243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~  308 (429)
                      .......   ....+||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||.+.... ..+..+..
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence            7643322   2356799999999998641          35888999999999999999999999765432 22222221


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      .              .             ....++...+.++.+||.+||..||.+|||+.|+|+||||+....+
T Consensus       283 ~--------------~-------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          283 P--------------N-------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             T--------------T-------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             c--------------c-------------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence            0              0             0011223357899999999999999999999999999999865443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.7e-48  Score=380.86  Aligned_cols=255  Identities=19%  Similarity=0.241  Sum_probs=194.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHH---HHHHcCCCCeeccceeee-----
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQ---TMRLLDHPNVVSLKHCFF-----  154 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~---~l~~l~h~~iv~l~~~~~-----  154 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...       .....+|+.   +++.++|||||++++.+.     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35799999999999999999999999999999998532       234457884   455568999999984332     


Q ss_pred             --ecC---------CCCce---EEEEEeecchhhHHHHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCCeeec
Q 014156          155 --STT---------DKDEL---YLNLVLEFVPETVYRVAKHYSRAS---QRMPLIYVKLYTYQICRALAYIHGGIGVCHR  217 (429)
Q Consensus       155 --~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHr  217 (429)
                        ...         +....   ..|+||||++|+|.+.+.......   ..+++..+..++.||+.||.||| +.||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH-HTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecC
Confidence              111         11111   278999999999888876532211   12335778889999999999999 7899999


Q ss_pred             CCCCCCeeecCCCCceEEeecCCceecccCCCcccccccccccccccccCC----------CCCCCcchHHHHHHHHHHH
Q 014156          218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTTAIDIWSVGCVLAEL  287 (429)
Q Consensus       218 DlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el  287 (429)
                      ||||+||||+.++ .+||+|||+|+..  +......+| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999887 7999999999864  223445667 999999998764          2589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014156          288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT  367 (429)
Q Consensus       288 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  367 (429)
                      ++|+.||.+.+.......+                                 ......+++++.+||.+||+.||.+|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            9999999654321111000                                 0011357999999999999999999999


Q ss_pred             HHHHhcCCCccccCC
Q 014156          368 ALEACIHPFFDELRD  382 (429)
Q Consensus       368 ~~e~l~hp~f~~~~~  382 (429)
                      +.++++||||++++.
T Consensus       354 ~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          354 PLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHTSHHHHHHHH
T ss_pred             HHHHhhChHHHHHHH
Confidence            999999999987653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=360.98  Aligned_cols=253  Identities=24%  Similarity=0.326  Sum_probs=198.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCC--CCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~~  161 (429)
                      ..+|++.+.||+|+||.||+|.+ .+++.||||++....      ....+|+.+++.++|  +||+++++++.     ..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence            34799999999999999999987 568999999885321      334579999999987  99999999874     33


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .++++|||+.+++|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH-~~~iiHrDikp~NIll~-~~-~~kl~DFG~a  154 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DG-MLKLIDFGIA  154 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEE-TT-EEEECCCSSS
T ss_pred             CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEE-CC-cEEEeecccc
Confidence            46889999888888877654    467999999999999999999999 78999999999999997 44 7999999999


Q ss_pred             eecccCCC---cccccccccccccccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 014156          242 KVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEII  307 (429)
Q Consensus       242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~  307 (429)
                      +.......   ....+||+.|+|||++.+          ...++.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  234 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  234 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence            87643322   235679999999999853          245788999999999999999999999764332 2222221


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ..                           .....++...+.++.+||.+||..||.+|||+.++|+||||+....
T Consensus       235 ~~---------------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          235 DP---------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             CT---------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             cC---------------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            10                           0011233346789999999999999999999999999999986443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.1e-46  Score=360.26  Aligned_cols=281  Identities=26%  Similarity=0.469  Sum_probs=217.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCC-cEEEEEEeccc---hhhHHHHHHHHHHcCCCC------eeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQD---KRYKNRELQTMRLLDHPN------VVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~------iv~l~~~~~~~~~~~  160 (429)
                      .+|++.+.||+|+||.||+|.+..++ +.||+|++...   .....+|+.+++.+.|++      ++.+++++..     
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-----   93 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-----   93 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-----
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-----
Confidence            47999999999999999999998776 68999998653   234457899999987665      7777777633     


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee--------------
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV--------------  226 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill--------------  226 (429)
                      ...+++||||+++++++.+..  .....+++..++.++.||+.||.||| +.||+||||||+|||+              
T Consensus        94 ~~~~~lv~e~~~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           94 HGHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLH-ENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TTEEEEEEECCCCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CCeEEEEEeccCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEeccccccccccccc
Confidence            235889999999988877654  22356999999999999999999999 8899999999999999              


Q ss_pred             -----cCCCCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH
Q 014156          227 -----NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD  301 (429)
Q Consensus       227 -----~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  301 (429)
                           +.++ .+||+|||+++....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus       171 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 4444 799999999986533  33456899999999999764 58999999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccc----cCCCcC---------CCCccc--ccCCCCChhHHHHHHhhcCcCCCCCC
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIK---------AHPWHK--IFHKRMPPEAVDLVSRLLQYSPNLRC  366 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~  366 (429)
                      .+..+.+..+.++...+.........+    ..+...         ..++..  ......++++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            888888888877776554322110000    000000         000000  00112345799999999999999999


Q ss_pred             CHHHHhcCCCccccCCC
Q 014156          367 TALEACIHPFFDELRDP  383 (429)
Q Consensus       367 t~~e~l~hp~f~~~~~~  383 (429)
                      |+.|+|+||||+++...
T Consensus       327 t~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             CHHHHTTSGGGGGCCHH
T ss_pred             CHHHHhcChhhcCCChh
Confidence            99999999999987653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-46  Score=359.15  Aligned_cols=255  Identities=30%  Similarity=0.467  Sum_probs=202.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHHcCCCCeeccceeeeecCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  158 (429)
                      .+|.+.+.||+|+||.||+|++..+++.||||++....            ....+|+.+++.++||||+++++++..   
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   86 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---   86 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence            47999999999999999999999999999999885432            234589999999999999999987732   


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC--ceEE
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKL  235 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~--~vkl  235 (429)
                        .. .++||||+.+ ++.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||
T Consensus        87 --~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           87 --ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             --SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             --Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEecCCCCCeEEE
Confidence              11 6799999975 5555442    3467999999999999999999999 789999999999999986542  4999


Q ss_pred             eecCCceecccCCCccccccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      +|||+++............||+.|+|||++.  +...++.++|||||||++|+|++|..||........+..........
T Consensus       159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (322)
T 2ycf_A          159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  238 (322)
T ss_dssp             CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred             ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence            9999998765443334567899999999874  34558899999999999999999999998755433332222211100


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      .                        .......+++++.+||.+||..||.+|||+.++|+||||++.
T Consensus       239 ~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          239 F------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             C------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             c------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            0                        011123478999999999999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.5e-46  Score=353.60  Aligned_cols=253  Identities=27%  Similarity=0.427  Sum_probs=208.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ..+|.+.+.||+|+||.||+|++..+|+.||+|++...    .....+|+.+++.++||||+++++++..     ....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEEE
Confidence            34799999999999999999999999999999988643    2345689999999999999999998743     34588


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee---cCCCCceEEeecCCc
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA  241 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill---~~~~~~vkl~DFG~a  241 (429)
                      +||||+++ ++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLTPEENS-KIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence            99999974 66665543    357999999999999999999999 7899999999999999   5555 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+......         
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------  225 (304)
T 2jam_A          157 KMEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE---------  225 (304)
T ss_dssp             CCCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------
T ss_pred             eecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            764332 23456789999999998654 4899999999999999999999999888776666555442110         


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                      +...+...+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus       226 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          226 ----------------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ----------------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                            0111234578999999999999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.5e-46  Score=348.30  Aligned_cols=254  Identities=26%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ....+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEEE
Confidence            47999999999999999999999999999999885432     345689999999999999999998743     33478


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ ++.+.+    .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~  155 (276)
T 2yex_A           82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATVF  155 (276)
T ss_dssp             EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCChHHEEEccCC-CEEEeeCCCcccc
Confidence            99999986 544432    33457999999999999999999999 78999999999999999887 7999999999765


Q ss_pred             ccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          245 VKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       245 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ....   ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+...............  .       
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------  226 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--T-------  226 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC--T-------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc--c-------
Confidence            4332   234567899999999987655457789999999999999999999987654322221111000  0       


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                             ..          .....+++.+.+||.+||..||.+|||+.++++||||++..
T Consensus       227 -------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          227 -------YL----------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             -------TS----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -------cc----------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                   00          01124789999999999999999999999999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-46  Score=358.26  Aligned_cols=260  Identities=25%  Similarity=0.365  Sum_probs=206.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            457999999999999999999999999999999986432       23457888899999999999999876544 2334


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      +.|+||||++ ++|.+++..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATN-AVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence            5689999997 566665543    357999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccCC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      +......    ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+..  
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--  240 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--  240 (311)
T ss_dssp             ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH--
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc--
Confidence            7664332    12345689999999999764 4899999999999999999999999988877666555443211111  


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                             .....+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus       241 -----------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          241 -----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             -----------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             -----------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                                   112347999999999999999999999999999999986544

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.2e-46  Score=350.13  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=209.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.++||||+++++++..     ....
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   96 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSSF   96 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCeE
Confidence            4799999999999999999999999999999998532      2345689999999999999999998743     3457


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCCc
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSA  241 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~a  241 (429)
                      ++||||+.+ ++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+||+++.++  ..+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            899999974 55555433    357999999999999999999999 78999999999999997643  26999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+........       
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  242 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-------  242 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------
T ss_pred             eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence            87655555556678999999999865  389999999999999999999999998877666555444210000       


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                              .          .....+++++.+||.+||..||.+|||+.++|+||||++...
T Consensus       243 --------~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          243 --------L----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             --------S----------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             --------c----------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                    0          011347899999999999999999999999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.5e-46  Score=346.03  Aligned_cols=259  Identities=26%  Similarity=0.386  Sum_probs=211.0

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+...      .....+|+.+++.++||||+++++++....   ..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cc
Confidence            456899999999999999999999999999999988532      233457999999999999999999775432   23


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----eeecCCCCCCeeecCCCCceEEe
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~-----iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                      .+++||||+++ +|.+.+.........+++..++.++.||+.||.||| +.|     |+||||||+|||++.++ .+||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~  158 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLDGKQ-NVKLG  158 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HHC------CCCCCSGGGEEECSSS-CEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh-cccCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence            57899999975 787877665555567999999999999999999999 678     99999999999999887 79999


Q ss_pred             ecCCceecccCCC-cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          237 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       237 DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....     
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-----  232 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-----  232 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----
T ss_pred             cCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-----
Confidence            9999876543322 2345789999999998764 48999999999999999999999998877655554444321     


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                    .         ..++..+++++.+||.+||..||.+|||+.++++|+|+.+-.
T Consensus       233 --------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          233 --------------F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             --------------C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             --------------c---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                          0         012335789999999999999999999999999999998643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=351.02  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=204.6

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHc-CCCCeeccceeeeecCCC-CceE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK-DELY  163 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~-~~~~  163 (429)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++...   .....+|+.+++.+ +||||+++++++...... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            345799999999999999999999999999999988533   34556899999998 899999999988654321 1346


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +++||||+++ +|.+++...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  177 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENA-EVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTC-CEEECCCTTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCcHHHEEEcCCC-CEEEeeCcCce
Confidence            8899999986 777766542  2357899999999999999999999 78999999999999999887 79999999987


Q ss_pred             ecccCC-CcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ...... ......||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+....+..+....       
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------  250 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-------  250 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------
Confidence            654322 2344678999999999852    3458899999999999999999999998877665554433310       


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                  .+        ......+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus       251 ------------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          251 ------------AP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ------------CC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ------------cc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                        00        01123478999999999999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-46  Score=355.15  Aligned_cols=267  Identities=27%  Similarity=0.395  Sum_probs=190.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...     .....+|+.+++.++||||+++++++....     ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   88 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----EL   88 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----Cc
Confidence            45799999999999999999999889999999987543     223447888899999999999999885433     37


Q ss_pred             EEEeecch-hhHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          165 NLVLEFVP-ETVYRVAKHYSR----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       165 ~lv~e~~~-~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ++||||++ ++|.+++.....    ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg  166 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-KNGQIHRDVKAGNILLGEDG-SVQIADFG  166 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTC-CEEECCCH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCCCCChhhEEEcCCC-CEEEEecc
Confidence            89999996 567666654322    2356899999999999999999999 78999999999999999887 79999999


Q ss_pred             CceecccCC------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          240 SAKVLVKGE------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       240 ~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      ++.......      ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+..............  +
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~  244 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--P  244 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--C
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--C
Confidence            987653321      12345789999999998653458999999999999999999999998876655443332210  0


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      .                 ..............+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus       245 ~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          245 P-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             C-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             C-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            0                 000011111233457899999999999999999999999999999987654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.2e-46  Score=356.63  Aligned_cols=267  Identities=23%  Similarity=0.375  Sum_probs=185.1

Q ss_pred             ccccceeEee-EEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           88 KQTISYMAER-VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        88 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ...++|.+.+ .||+|+||.||+|++..+|+.||||++........+....++.+.||||+++++++.... .+..++++
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  103 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI  103 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence            4456899965 699999999999999999999999998766555545555677889999999999875433 33556889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCCcee
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKV  243 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~a~~  243 (429)
                      ||||+.+ +|.+.+..  .....+++..++.++.||+.||.||| +.||+||||||+|||++.++  ..+||+|||+++.
T Consensus       104 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          104 IMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            9999986 67666543  22347999999999999999999999 78999999999999997543  2599999999986


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................           
T Consensus       181 ~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  247 (336)
T 3fhr_A          181 TTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-----------  247 (336)
T ss_dssp             C------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred             cccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-----------
Confidence            6433 3345678999999999855 44888999999999999999999999765543322111111000           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                        ....++        ......+++++.+||.+||..||.+|||+.++|+||||++..
T Consensus       248 --~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          248 --GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             -----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             --cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence              000000        011235799999999999999999999999999999998743

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.6e-45  Score=348.57  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=204.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++||||+++++++...     ...
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeE
Confidence            345799999999999999999999999999999988543    23445799999999999999999988543     247


Q ss_pred             EEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||++++ +...+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus        92 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  166 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAK  166 (302)
T ss_dssp             EEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTS-CEEECCCHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEECCCC-CEEEEECCCCcc
Confidence            8999999864 4443322   3467999999999999999999999 78999999999999999887 799999998754


Q ss_pred             cccC-CCccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          244 LVKG-EPNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       244 ~~~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      .... .......||+.|+|||++.    ....++.++|||||||++|+|++|..||...+.......+..... +     
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-----  240 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-P-----  240 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-c-----
Confidence            3221 1223457899999999884    334588999999999999999999999998877666555443210 0     


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                   .       ...+..++.++.+||.+||..||.+|||+.++++||||+.+.
T Consensus       241 -------------~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          241 -------------T-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             -------------C-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             -------------c-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                         0       011234688999999999999999999999999999998755

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-45  Score=348.98  Aligned_cols=254  Identities=22%  Similarity=0.342  Sum_probs=194.1

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ....+|++.+.||+|+||.||+|++  +|+.||+|++....      ....+|+.+++.++||||+++++++...     
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence            3456899999999999999999986  68899999885432      2345799999999999999999988432     


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecCCCCceEEeec
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ..+++||||+.+ +|.+.+.... ....+++..++.++.||+.||.||| +.|  |+||||||+|||++.++ .+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~ivH~Dikp~NIll~~~~-~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKY-TVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHH-TSSSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCEECCCCChhhEEEeCCC-cEEECCC
Confidence            337899999985 6666554311 1124899999999999999999999 789  99999999999999887 7999999


Q ss_pred             CCceecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          239 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       239 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      |+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....      
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------  256 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------  256 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC------
T ss_pred             CCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------
Confidence            9997654332 23456789999999998764 489999999999999999999999988876665544432110      


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDE  379 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~  379 (429)
                                           ...++..+++++.+||.+||..||.+|||+.++++  +++++.
T Consensus       257 ---------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 ---------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                 01133458999999999999999999999999987  455443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.6e-46  Score=361.32  Aligned_cols=281  Identities=24%  Similarity=0.395  Sum_probs=205.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...     .....+|+.+++.++||||+++++++...     ..+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence            44799999999999999999999999999999988643     23445899999999999999999988543     348


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+..||+||||||+|||++.++ .+||+|||++..
T Consensus       107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  181 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcc
Confidence            899999975 66666543    357999999999999999999999324999999999999999887 799999999876


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHhhc-
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCM-  321 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~-  321 (429)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +.......... 
T Consensus       182 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          182 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            5332 23456789999999998764 58999999999999999999999998876554332221110 00000000000 


Q ss_pred             -CCCCccccCC------------CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          322 -NPNYTEFKFP------------QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       322 -~~~~~~~~~~------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                       ......+...            .+............++.++.+||.+||++||.+|||+.++|+||||+....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence             0000000000            000000111122347889999999999999999999999999999987654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=347.39  Aligned_cols=254  Identities=28%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|.+...  .....+|+.+++.++||||+++++++...     ..+++||
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~  103 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIVM  103 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEe
Confidence            3699999999999999999999999999999988653  34456899999999999999999988543     3478999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||+++ ++.+++..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLH-FMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence            99986 66655532   3467999999999999999999999 88999999999999999887 7999999999776443


Q ss_pred             C-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 014156          248 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  326 (429)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  326 (429)
                      . ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.... .+             
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-------------  243 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP-------------  243 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC-------------
T ss_pred             ccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc-------------
Confidence            2 23456789999999998664 48999999999999999999999998877655544332210 00             


Q ss_pred             cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                           .       ...+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       244 -----~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          244 -----T-------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             -----C-------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             -----c-------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                 0       001223688999999999999999999999999999998744

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.9e-45  Score=347.10  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=201.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|.+...       .....+|+.+++.++||||+++++++.     ...
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence            35799999999999999999999999999999987432       134457999999999999999999873     334


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||+++ +|.+.+..    .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  158 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNK-TLKIFDFGIA  158 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred             eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence            58899999975 66665543    357999999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          242 KVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       242 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      +......  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+............ .+.     
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~-----  231 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VPN-----  231 (294)
T ss_dssp             TTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CCC-----
T ss_pred             cccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CCC-----
Confidence            7654332  22345789999999999764 48999999999999999999999999887665544333210 011     


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                        ....++..+++.+.++|.+||+.||.+||+..+.+.+.|..-+..
T Consensus       232 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          232 ------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             ------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                              111234568999999999999999999997777777766554443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.6e-45  Score=346.40  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=207.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ..|.+.+.||+|+||.||+|++..+++.||+|++...     .....+|+.+++.++||||+++++++...     ..++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence            3699999999999999999999999999999988533     24456899999999999999999988543     3478


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ ++.+++.     ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus        97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQL  169 (303)
T ss_dssp             EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCChheEEECCCC-CEEEeecccceec
Confidence            99999986 5555442     367999999999999999999999 78999999999999999887 7999999999876


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....             
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  235 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-------------  235 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------
T ss_pred             CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-------------
Confidence            5432 23456789999999998654 48899999999999999999999998877655544433210             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                     ...+...++..+.+||.+||..||.+|||+.++++||||...
T Consensus       236 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 ---------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ---------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ---------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                           011234578999999999999999999999999999999763

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.5e-45  Score=343.48  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=197.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCC--------
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTD--------  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~--------  158 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            357999999999999999999999999999999986543   334579999999999999999998765321        


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                      .....+++||||+++ +|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIH-SQGIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHH-hCCeecccCCHHhEEEcCCC-CEEEee
Confidence            235568899999975 77766643   2346788999999999999999999 78999999999999999887 799999


Q ss_pred             cCCceecccC---------------CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 014156          238 FGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ  302 (429)
Q Consensus       238 FG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  302 (429)
                      ||++......               .......||+.|+|||++.+...++.++|||||||++|+|++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765321               122345689999999999765568999999999999999998   5543222222


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                      ........                .        ..+...+....++.+.+||.+||..||.+|||+.++++||||+.
T Consensus       237 ~~~~~~~~----------------~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          237 ILKKLRSV----------------S--------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHST----------------T--------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHhcccc----------------c--------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            11111100                0        00111233456788999999999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-45  Score=354.90  Aligned_cols=271  Identities=20%  Similarity=0.335  Sum_probs=205.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---------------------hhHHHHHHHHHHcCCCCeec
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNVVS  148 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~~iv~  148 (429)
                      .++|++.+.||+|+||.||+|.+  +|+.||+|++....                     ....+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            45799999999999999999998  89999999885432                     55678999999999999999


Q ss_pred             cceeeeecCCCCceEEEEEeecchh-hHHHHHHHh--hhc--CCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeecCCCCC
Q 014156          149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHY--SRA--SQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQ  222 (429)
Q Consensus       149 l~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~-~~iiHrDlKp~  222 (429)
                      +++++..     ...+++||||+++ +|.+.+...  ...  ...+++..++.++.||+.||.||| + .||+||||||+
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~i~H~dl~p~  181 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPS  181 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH-HTSCEECCCCCGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh-ccCCEeecCCChH
Confidence            9998843     3358899999986 544331100  111  467999999999999999999999 6 89999999999


Q ss_pred             CeeecCCCCceEEeecCCceecccCCCcccccccccccccccccCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCh-H
Q 014156          223 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT-AIDIWSVGCVLAELLLGQPLFPGESG-V  300 (429)
Q Consensus       223 Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~-~  300 (429)
                      |||++.++ .+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||.+.+. .
T Consensus       182 Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          182 NILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             hEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999887 7999999999876443 3345678999999999976544655 99999999999999999999988766 3


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      +....+.......+        .....+..+ ... .........+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       260 ~~~~~i~~~~~~~~--------~~~~~~~~~-~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          260 ELFNNIRTKNIEYP--------LDRNHFLYP-LTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHHTSCCCCCC--------CSSSSSTTT-TCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHhccCcCCc--------cchhhhhcc-ccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            43333322100000        000000000 000 00011224689999999999999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.9e-45  Score=350.05  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=203.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHHcC--CCCeeccceeeeecC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTT  157 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~  157 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++.+.  |+||+++++++..  
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~--  119 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--  119 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence            457999999999999999999999999999999985432          23347999999996  5999999998843  


Q ss_pred             CCCceEEEEEeecch--hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          158 DKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                         ....++|||++.  +++.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.+.+.+||
T Consensus       120 ---~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          120 ---PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             ---SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEE
T ss_pred             ---CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeCCCCHHHEEEeCCCCCEEE
Confidence               334789999987  667666543    367999999999999999999999 8899999999999999844348999


Q ss_pred             eecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +|||+++..... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.....      +...      
T Consensus       192 ~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~------  258 (320)
T 3a99_A          192 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG------  258 (320)
T ss_dssp             CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC------
T ss_pred             eeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc------
Confidence            999999876533 334567899999999987655457889999999999999999999965321      1110      


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                             ...++..+++++.+||.+||..||.+|||+.++++||||++...
T Consensus       259 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          259 -----------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             -----------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             -----------------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                                   00123457999999999999999999999999999999987654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.9e-45  Score=349.36  Aligned_cols=264  Identities=24%  Similarity=0.340  Sum_probs=185.4

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHH-HHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+. +++.++||||+++++++..     ..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~   94 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG   94 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence            3457999999999999999999999999999999886432     12223444 6667899999999998853     23


Q ss_pred             EEEEEeecchhhHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          163 YLNLVLEFVPETVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~-~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ..++||||+++++.+++..... ....+++..+..++.|++.||.||| +. ||+||||||+|||++.++ .+||+|||+
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~  172 (327)
T 3aln_A           95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-ENLKIIHRDIKPSNILLDRSG-NIKLCDFGI  172 (327)
T ss_dssp             EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH-HHHSCCCSCCCGGGEEEETTT-EEEECCCSS
T ss_pred             ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh-ccCCEeECCCCHHHEEEcCCC-CEEEccCCC
Confidence            5789999999988777664332 2567999999999999999999999 66 999999999999999887 899999999


Q ss_pred             ceecccCCCccccccccccccccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ++............||+.|+|||++.   ....++.++|||||||++|+|++|+.||.+.+....  .+...        
T Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~--------  242 (327)
T 3aln_A          173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQV--------  242 (327)
T ss_dssp             SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC--------
T ss_pred             ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHH--------
Confidence            98765554445557999999999983   234588999999999999999999999976432110  00000        


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                              .....+     .+.......+++.+.+||.+||..||.+|||+.++++||||.....
T Consensus       243 --------~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          243 --------VKGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             --------CCSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             --------hcCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence                    000000     1111123457899999999999999999999999999999987543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=343.15  Aligned_cols=257  Identities=25%  Similarity=0.421  Sum_probs=198.3

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      |.....||+|+||.||+|++..+++.||+|.+...    .....+|+.+++.++||||+++++++...     ...++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEE
Confidence            44445899999999999999999999999988543    23456899999999999999999988432     3478999


Q ss_pred             ecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      ||++ +++.+++.. ......+++..++.++.||+.||.||| +.||+||||||+||+++...+.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           99 EQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLH-DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             ECCSEEEHHHHHHH-TTCCCTTCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EeCCCCCHHHHHHh-hccCCCccHHHHHHHHHHHHHHHHHHH-hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9996 566665543 222345678999999999999999999 7899999999999999873348999999999876433


Q ss_pred             C-CcccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          248 E-PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      . ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..................             
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  243 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-------------  243 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence            2 23356789999999998643 23788999999999999999999999765433322111111000             


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                   ...++..+++++.+||.+||..||.+|||+.++|+||||+....
T Consensus       244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                         01133457999999999999999999999999999999986543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=345.88  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=188.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++....      ....++..+++.++||||+++++++..     ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence            3467999999999999999999999999999999986432      112234456778899999999998843     33


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||+++.+..+...   ....+++..++.++.||+.||.||| + .||+||||||+|||++.++ .+||+|||++
T Consensus        98 ~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  172 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERG-QIKLCDFGIS  172 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HHHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             cEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH-hhCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence            5889999997655544432   2467999999999999999999999 6 4999999999999999887 7999999999


Q ss_pred             eecccCCCccccccccccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~  316 (429)
                      .............||+.|+|||++.    ....++.++|||||||++|+|++|+.||.... ..+.+..+....  +   
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~---  247 (318)
T 2dyl_A          173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--P---  247 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--C---
T ss_pred             hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--C---
Confidence            8765555555667899999999985    23457889999999999999999999998743 333444433310  0   


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                    +..       .....+++++.+||.+||..||.+|||+.++++||||+++.
T Consensus       248 --------------~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          248 --------------PLL-------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             --------------CCC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             --------------CCC-------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                          000       01124789999999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=344.38  Aligned_cols=254  Identities=25%  Similarity=0.427  Sum_probs=200.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++||||+++++++...     ...+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence            45799999999999999999999999999999987542    23445899999999999999999988543     3478


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+.+ +|.+.+..   ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  158 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENK-NVVVADFGLARLM  158 (310)
T ss_dssp             EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence            99999986 66665543   3467999999999999999999999 78999999999999999887 7999999999876


Q ss_pred             ccCCCc---------------ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014156          245 VKGEPN---------------ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV  309 (429)
Q Consensus       245 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  309 (429)
                      ......               ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------  231 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------  231 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------
Confidence            433221               14579999999999976 45899999999999999999999998653211000      


Q ss_pred             hCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                          .............+..+++.+.+||.+||+.||.+|||+.++++  |++.++.
T Consensus       232 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~  282 (310)
T 3s95_A          232 --------------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM  282 (310)
T ss_dssp             --------------------SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             --------------------HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence                                00000000011224467899999999999999999999999986  6666543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-44  Score=346.90  Aligned_cols=248  Identities=19%  Similarity=0.207  Sum_probs=199.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.+ +||||+++++++..     ..+.++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEE
Confidence            34799999999999999999999999999999988543  34467899999999 99999999988744     335789


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc-----eEEeecCCc
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGSA  241 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~-----vkl~DFG~a  241 (429)
                      ||||++++|.+++...   ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .     +||+|||++
T Consensus        83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           83 VLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVH-SKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTC
T ss_pred             EEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccc
Confidence            9999988888776542   467999999999999999999999 78999999999999998776 4     999999999


Q ss_pred             eecccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Q 014156          242 KVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVL  310 (429)
Q Consensus       242 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~  310 (429)
                      +.......        ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..   +.+..+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            87644332        2456899999999999764 4899999999999999999999999875432   3333332211


Q ss_pred             CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .....+.                        ....++ ++.+||.+||..||.+||++.++++
T Consensus       237 ~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          237 RATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1111110                        112234 9999999999999999999988765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.2e-44  Score=336.34  Aligned_cols=250  Identities=19%  Similarity=0.217  Sum_probs=201.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...  .....+|+.+++.+ +|+|++++++++.     .....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEE
Confidence            34799999999999999999999999999999988543  34567899999999 7999999998773     3335789


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC----ceEEeecCCce
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH----QVKLCDFGSAK  242 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~----~vkl~DFG~a~  242 (429)
                      ||||++++|.+++..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++.    .+||+|||+++
T Consensus        84 v~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999998888887654   2356999999999999999999999 889999999999999986652    39999999998


Q ss_pred             ecccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhC
Q 014156          243 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---GVDQLVEIIKVLG  311 (429)
Q Consensus       243 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~  311 (429)
                      .......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+   ....+..+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            7654322        2456789999999998664 48999999999999999999999998743   3333333333211


Q ss_pred             CCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+...                        .+...+++++.+||.+||+.||.+|||+.++++
T Consensus       239 ~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          239 STPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HSCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            11111                        122347899999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.7e-44  Score=349.15  Aligned_cols=250  Identities=21%  Similarity=0.320  Sum_probs=199.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEc-------CCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeee
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  155 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~  155 (429)
                      ...+|.+.+.||+|+||.||+|++.       .++..||+|++....     ....+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3468999999999999999999875       345679999986432     3345799999999 89999999998843


Q ss_pred             cCCCCceEEEEEeecchh-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCC
Q 014156          156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ  222 (429)
Q Consensus       156 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~  222 (429)
                           ...+|+||||+.+ +|.+.+.....            ....+++..+..++.||+.||.||| +.||+||||||+
T Consensus       159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~  232 (370)
T 2psq_A          159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAAR  232 (370)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGG
T ss_pred             -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchh
Confidence                 2337899999985 77776654221            1245899999999999999999999 789999999999


Q ss_pred             CeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 014156          223 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGES  298 (429)
Q Consensus       223 Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  298 (429)
                      ||||+.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999887 799999999987644322   2334568899999999764 48999999999999999999 999998876


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       299 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..+....+....                            ....+..+++++.+||.+||..||.+|||+.|++++
T Consensus       311 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          311 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGGHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            655444332210                            011234578999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=353.79  Aligned_cols=255  Identities=18%  Similarity=0.209  Sum_probs=202.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEE-----EcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  158 (429)
                      ...+|++.+.||+|+||.||+|+     +..+++.||||++...     .....+|+.+++.++||||+++++++..   
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---  145 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---  145 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence            34579999999999999999999     4457789999998532     2234579999999999999999998843   


Q ss_pred             CCceEEEEEeecch-hhHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--Cc
Q 014156          159 KDELYLNLVLEFVP-ETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQ  232 (429)
Q Consensus       159 ~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~  232 (429)
                        ....++||||+. ++|.+++.....   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++  ..
T Consensus       146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChhhEEEecCCCCce
Confidence              233689999996 577777655321   1245899999999999999999999 78999999999999998544  25


Q ss_pred             eEEeecCCceecccC---CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014156          233 VKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK  308 (429)
Q Consensus       233 vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  308 (429)
                      +||+|||+++.....   .......||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999755322   223345679999999998764 48999999999999999998 9999998877666555443


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                      ...                            ...+..+++.+.+||.+||+.||.+|||+.++++|.++.
T Consensus       302 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          302 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            210                            012235789999999999999999999999999987764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.2e-45  Score=347.20  Aligned_cols=268  Identities=22%  Similarity=0.244  Sum_probs=196.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.++||+|+||.||+|++.  ++.||||++....   ....+|+.+++.++||||+++++++..... ....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence            457999999999999999999874  7899999986433   223468888999999999999998865442 2345789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC----------CeeecCCCCCCeeecCCCCceEE
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI----------GVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~----------~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                      ||||+++ +|.+++..     ..+++..++.++.||+.||.||| +.          ||+||||||+|||++.++ .+||
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH-~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL  172 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLH-EDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI  172 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHT-CCEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH-hhccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence            9999975 77666643     56999999999999999999999 78          999999999999999887 7999


Q ss_pred             eecCCceecccCCC---cccccccccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014156          236 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK  308 (429)
Q Consensus       236 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  308 (429)
                      +|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+............
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987654332   2346789999999998653    2345678999999999999999999987543222111122


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ....+....+......  ....+.+.. .   .-....++++.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~--~~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVH--KKKRPVLRD-Y---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTT--SCCCCCCCG-G---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhc--ccCCCCccc-c---ccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2223333222111000  000000000 0   001123456999999999999999999999985

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=344.68  Aligned_cols=247  Identities=21%  Similarity=0.290  Sum_probs=198.1

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|++.+.||+|+||.||+|++..+++   .||||++...     .....+|+.+++.++||||+++++++..    
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  121 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR----  121 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            345689999999999999999999986655   4999998643     2334579999999999999999998833    


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                       ....++||||+++ +|.+++..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus       122 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Df  195 (325)
T 3kul_A          122 -GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDSNL-VCKVSDF  195 (325)
T ss_dssp             -GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCC
T ss_pred             -CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCcceEEECCCC-CEEECCC
Confidence             3347899999975 66665532   3457999999999999999999999 78999999999999999887 7999999


Q ss_pred             CCceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014156          239 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       239 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      |+++.......    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-  273 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-  273 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-
Confidence            99987644322    1223457789999998654 48999999999999999999 99999888776665554432110 


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                                 ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       274 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          274 ---------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                       122357899999999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.4e-44  Score=333.85  Aligned_cols=246  Identities=20%  Similarity=0.316  Sum_probs=199.9

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ...+|++.+.||+|+||.||+|++. +++.||+|++...   .....+|+.+++.++||||+++++++..     ....+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceE
Confidence            3457999999999999999999976 5778999998643   3445689999999999999999998843     33478


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ ++.+.+..   ....+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++..
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHH-hCCeecCCcchheEEEcCCC-CEEeccccccccc
Confidence            99999986 55555432   3456899999999999999999999 88999999999999999877 7999999999765


Q ss_pred             ccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          245 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       245 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ....  ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....          
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------  225 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred             cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence            3321  22334567889999998654 48999999999999999999 9999988877666555433210          


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                        ...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                              01223468999999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.1e-44  Score=337.51  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=207.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecC-----------C
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT-----------D  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----------~  158 (429)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++........+|+++++.++||||+++++++....           .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            35799999999999999999999999999999999877777889999999999999999998874311           1


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                      .....+++||||+++ +|.+.+...  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~D  165 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIH-SKKLINRDLKPSNIFLVDTK-QVKIGD  165 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHEEEcCCC-CEEECc
Confidence            224457899999996 777766542  2367999999999999999999999 78999999999999999877 799999


Q ss_pred             cCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       238 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||....  .....+..         
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred             chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence            9999887665555667899999999998764 48999999999999999999998874211  11111100         


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                            ..++..+++.+.+||.+||..||.+|||+.++++|.+.-.
T Consensus       234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                  0122347899999999999999999999999999977643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8e-44  Score=338.81  Aligned_cols=254  Identities=24%  Similarity=0.321  Sum_probs=195.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcC--CCCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD--HPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++...      .....+|+.+++.+.  |+||+++++++..     .
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~  100 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D  100 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----S
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----C
Confidence            346999999999999999999975 5889999988532      233457999999997  5999999998743     3


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .++++|||+.+++|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++. + .+||+|||++
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-G-MLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred             CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEEEC-C-eEEEeecccc
Confidence            35889999888888877654    467899999999999999999999 789999999999999974 4 7999999999


Q ss_pred             eecccCCC---cccccccccccccccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Q 014156          242 KVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD-QLVEII  307 (429)
Q Consensus       242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~  307 (429)
                      +.......   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||....... .+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            87643322   2345789999999998641          357889999999999999999999997654322 222211


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      ..              .             ....++...+.++.+||.+||..||.+|||+.++++||||+....+
T Consensus       254 ~~--------------~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          254 DP--------------N-------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             CT--------------T-------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             hc--------------c-------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            10              0             0011233468899999999999999999999999999999865443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.2e-44  Score=346.93  Aligned_cols=257  Identities=17%  Similarity=0.145  Sum_probs=195.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC-----CcEEEEEEeccchhhHHHHHH---------------HHHHcCCCCeeccc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDKRYKNRELQ---------------TMRLLDHPNVVSLK  150 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~E~~---------------~l~~l~h~~iv~l~  150 (429)
                      .+|++.+.||+|+||.||+|.+..+     ++.||||++........+|++               .++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4799999999999999999998764     588999998665444434443               44556799999999


Q ss_pred             eeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec--C
Q 014156          151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN--P  228 (429)
Q Consensus       151 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~--~  228 (429)
                      +++.... .+..+.++||||++++|.+++..   ....+++..++.++.||+.||.||| +.||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH-~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIH-EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeEEecCCHHHEEEecCC
Confidence            9886543 34467899999998787776654   3467999999999999999999999 78999999999999998  6


Q ss_pred             CCCceEEeecCCceecccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH
Q 014156          229 HTHQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV  300 (429)
Q Consensus       229 ~~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  300 (429)
                      ++ .+||+|||+++.......        ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus       190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            66 799999999987643221        1334599999999999764 4899999999999999999999999864333


Q ss_pred             HHHHHHHHH-hCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          301 DQLVEIIKV-LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       301 ~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ......... ........+..+.                   ....+++++.+||.+||..||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCF-------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHS-------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhc-------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            332222221 1111111111000                   01347899999999999999999999998875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-43  Score=333.52  Aligned_cols=246  Identities=22%  Similarity=0.330  Sum_probs=196.1

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----------hhHHHHHHHHHHcCCCCeeccceeeeec
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFST  156 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~l~~~~~~~  156 (429)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++....           ....+|+.+++.++||||+++++++.  
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--   93 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--   93 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET--
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec--
Confidence            34457999999999999999999999999999999884321           34568999999999999999999872  


Q ss_pred             CCCCceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecCCCC--
Q 014156          157 TDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTH--  231 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~~~~--  231 (429)
                         ...  ++||||+. +++.+.+.   .....+++..++.++.||+.||.||| +.|  |+||||||+|||++.++.  
T Consensus        94 ---~~~--~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           94 ---NPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             ---TTT--EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHH-TSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred             ---CCC--eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHH-hCCCCeecCCCCcceEEEeccCCCC
Confidence               222  48999998 56555443   33467999999999999999999999 789  999999999999987652  


Q ss_pred             --ceEEeecCCceecccCCCcccccccccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH
Q 014156          232 --QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ--LVEI  306 (429)
Q Consensus       232 --~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i  306 (429)
                        .+||+|||+++....  ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+....  ...+
T Consensus       165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  242 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI  242 (287)
T ss_dssp             SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred             ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence              299999999975432  3445678999999999842 33468899999999999999999999987554332  2222


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ... +                          ....++..+++++.+||.+||+.||.+|||+.++++
T Consensus       243 ~~~-~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          243 REE-G--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHS-C--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcc-C--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            111 0                          111234467999999999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.5e-44  Score=342.79  Aligned_cols=261  Identities=20%  Similarity=0.256  Sum_probs=187.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCc---EEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.+.||+|+||.||+|++..++.   .||+|++...      .....+|+.+++.++||||+++++++......+
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4479999999999999999999877765   8999988543      234558999999999999999999886543321


Q ss_pred             -ceEEEEEeecchh-hHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          161 -ELYLNLVLEFVPE-TVYRVAKHYSR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       161 -~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                       ....++||||+.+ +|...+.....  ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivH~Dikp~NIli~~~~-~~kl~  179 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS-SRNFIHRDLAARNCMLAEDM-TVCVA  179 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEEEC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH-cCCcccCCCCcceEEEcCCC-CEEEe
Confidence             1224799999986 66666544221  2236899999999999999999999 78999999999999999887 79999


Q ss_pred             ecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 014156          237 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       237 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      |||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..... 
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-  257 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-  257 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred             eccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC-
Confidence            9999987644332   2234567889999998764 48999999999999999999 9999998777665554433110 


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-------HHHHhcCCCccccC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-------ALEACIHPFFDELR  381 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-------~~e~l~hp~f~~~~  381 (429)
                                                 ...+..+++++.+||.+||..||.+|||       +.+++.|||+....
T Consensus       258 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          258 ---------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             ---------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence                                       0123457899999999999999999999       67788899997643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.8e-44  Score=347.50  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=199.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEE-----EcCCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+++++.+ +||||+++++++.... 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-   99 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-   99 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-
Confidence            3579999999999999999998     45667899999986432     3356899999999 7899999999875422 


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhc----------------------------------------------------
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRA----------------------------------------------------  185 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------------------------------------------------  185 (429)
                         ..+++||||+.+ +|.+.+......                                                    
T Consensus       100 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A          100 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             ---SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             ---CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence               236789999985 666666542210                                                    


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCC---ccc
Q 014156          186 ----------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NIS  252 (429)
Q Consensus       186 ----------~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~  252 (429)
                                ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.......   ...
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence                      122899999999999999999999 78999999999999999887 799999999986643322   234


Q ss_pred             ccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 014156          253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  331 (429)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  331 (429)
                      ..||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........+                  
T Consensus       255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------  315 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------  315 (359)
T ss_dssp             CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------
T ss_pred             cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------
Confidence            5678999999998764 48999999999999999998 999998877655554444321110                  


Q ss_pred             CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       332 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                               ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       316 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                     1223478999999999999999999999999876

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=359.58  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=189.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEee
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE  169 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~e  169 (429)
                      +|.+.++||+|+||+|+. ....+|+.||||++... .....+|+.+++.+ +||||+++++++.     ...++|+|||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~lv~E   98 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEEEEEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEEEEEE
Confidence            699999999999999764 34568899999998643 23456899999999 7999999998873     3345889999


Q ss_pred             cchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC----CceEEeecCCceecc
Q 014156          170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCDFGSAKVLV  245 (429)
Q Consensus       170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~----~~vkl~DFG~a~~~~  245 (429)
                      ||+++|.+.+..   ....+.+..+..++.||+.||.||| +.||+||||||+|||++.++    ..+||+|||+|+...
T Consensus        99 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHH-HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHH-HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            999988877653   2334555567789999999999999 78999999999999995322    158899999998765


Q ss_pred             cCC----CcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          246 KGE----PNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       246 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      ...    .....+||+.|+|||++.+  ...++.++|||||||++|+|++ |..||........ ..+.   +...    
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~----  246 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACS----  246 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCC----
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCC----
Confidence            432    2344679999999999864  2457789999999999999999 8999965443222 1111   1100    


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                 .....       .....+..+.+||.+||+.||.+|||+.++++||||..+.
T Consensus       247 -----------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          247 -----------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             -----------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             -----------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence                       00000       0112356689999999999999999999999999998643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.4e-44  Score=342.38  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=184.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----hhHHHHHHHHHHcC-CCCeeccceeeeecCC---CCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTD---KDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~---~~~~  162 (429)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.+. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47999999999999999999999999999999885432    33457999999996 9999999998854322   4455


Q ss_pred             EEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecCCCCceEEeecCC
Q 014156          163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      .+++||||++++|.+.+.... ....+++..++.++.||+.||.||| +.|  |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHH-TSSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            688999999999888776543 3457999999999999999999999 778  99999999999999887 799999999


Q ss_pred             ceecccCCC-------------ccccccccccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014156          241 AKVLVKGEP-------------NISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE  305 (429)
Q Consensus       241 a~~~~~~~~-------------~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  305 (429)
                      ++.......             .....||+.|+|||++.  ....++.++|||||||++|+|++|+.||.+.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            987643321             11456899999999883  234578899999999999999999999975433221110


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .                     +          ........+..+.+||.+||+.||.+|||+.|+++|
T Consensus       265 ~---------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          265 K---------------------Y----------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             ----------------------C----------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             c---------------------c----------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0                     0          001123457889999999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-43  Score=330.18  Aligned_cols=246  Identities=19%  Similarity=0.285  Sum_probs=199.6

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+.+++.++||||+++++++.     .....+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence            4457999999999999999999875 5678999998653   344568999999999999999999873     333478


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ ++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLE-SHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHH-HTTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred             EEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence            99999974 56665543   2346999999999999999999999 78999999999999999887 7999999999876


Q ss_pred             ccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          245 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       245 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .....  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR----------  223 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred             chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence            44332  1234457789999998654 48899999999999999999 9999988877666554433110          


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                        ...+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          224 ------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              01123468899999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.8e-44  Score=357.27  Aligned_cols=258  Identities=28%  Similarity=0.399  Sum_probs=188.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHHHHHc-CCCCeeccceeeeecCCCCceEEEEEe
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ..|.+.+.||+|+||+||.+ ...+|+.||||++..+. ....+|+.+++.+ +||||+++++++     ....++++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEE
Confidence            35778899999999999875 45689999999886543 3446899999876 899999998877     3344589999


Q ss_pred             ecchhhHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC------------Cce
Q 014156          169 EFVPETVYRVAKHYSRASQR---MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT------------HQV  233 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~------------~~v  233 (429)
                      |||+++|.+++.........   .++..++.++.||+.||.||| +.||+||||||+|||++.++            ..+
T Consensus        89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            99999888877642221111   123345779999999999999 78999999999999997532            379


Q ss_pred             EEeecCCceecccCCC-----cccccccccccccccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014156          234 KLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD  301 (429)
Q Consensus       234 kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  301 (429)
                      ||+|||+++.......     ....+||+.|+|||++.+      ...++.++|||||||++|+|++ |..||.+.....
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            9999999987654322     224579999999999865      2458999999999999999999 999997654332


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                        ..+.....                 ..+...     ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 --~~i~~~~~-----------------~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 --SNIIRGIF-----------------SLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             --HHHHHTCC-----------------CCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             --HHHhcCCC-----------------Cccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence              22222110                 011100     0011234688999999999999999999999999999964

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=340.72  Aligned_cols=245  Identities=27%  Similarity=0.424  Sum_probs=195.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHHc----CCCCeeccceeeeec
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVVSLKHCFFST  156 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~~iv~l~~~~~~~  156 (429)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....          ....+|+.+++.+    +||||+++++++.. 
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~-  109 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET-  109 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec-
Confidence            36999999999999999999999999999999985432          2234699999998    89999999998743 


Q ss_pred             CCCCceEEEEEeec-ch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec-CCCCce
Q 014156          157 TDKDELYLNLVLEF-VP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-PHTHQV  233 (429)
Q Consensus       157 ~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~-~~~~~v  233 (429)
                          ....++|||+ +. ++|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+||+++ .++ .+
T Consensus       110 ----~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~-~~  179 (312)
T 2iwi_A          110 ----QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRG-CA  179 (312)
T ss_dssp             -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HHTEECCCCSGGGEEEETTTT-EE
T ss_pred             ----CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChhhEEEeCCCC-eE
Confidence                2346789998 44 667666543    356999999999999999999999 78999999999999998 555 89


Q ss_pred             EEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       234 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      ||+|||++...... ......||+.|+|||++.+....+.++|||||||++|+|++|+.||....      .+...    
T Consensus       180 kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~----  248 (312)
T 2iwi_A          180 KLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA----  248 (312)
T ss_dssp             EECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT----
T ss_pred             EEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh----
Confidence            99999999876543 33456789999999998765544568999999999999999999996431      11110    


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                               ...++..+++++.+||.+||..||.+|||+.++++||||+....
T Consensus       249 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 -------------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             -------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             -------------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                                     00123457899999999999999999999999999999987654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=359.70  Aligned_cols=273  Identities=22%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...     .....+|+++++.++||||+++++++....   ....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence            34799999999999999999999999999999998643     234458999999999999999998875432   2347


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee----cCCCCceEEeecC
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFG  239 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill----~~~~~~vkl~DFG  239 (429)
                      ++||||+++ +|.+.+... .....+++..++.++.||+.||.||| +.||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            899999974 666655432 22344999999999999999999999 7899999999999998    6554 79999999


Q ss_pred             CceecccCCCcccccccccccccccccCC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAIDIWSVGCVLAELLLGQPLFPGES----GVDQLVEIIK  308 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~  308 (429)
                      +++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||....    ..+.+..+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            99887665555567899999999988541       346789999999999999999999997532    2333333333


Q ss_pred             HhCCCCHHHHhhcCC-CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          309 VLGTPTREEIKCMNP-NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                        +.|. ..+..... ....+...  ...+....+...++..+.+||.+||++||.+|||+.++++
T Consensus       242 --~~p~-~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 --GKPS-GAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             --SCCT-TCCEEEECSTTCCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             --CCCc-ccchhheeccCCCcccC--ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence              1221 10000000 00000000  0000011122334567899999999999999999998854

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-43  Score=329.31  Aligned_cols=243  Identities=27%  Similarity=0.424  Sum_probs=187.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..+|++.+.||+|+||.||+|.+  +++.||+|++...        .....+|+.+++.++||||+++++++..     .
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence            45799999999999999999997  4889999987532        2344579999999999999999998843     3


Q ss_pred             eEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC---eeecCCCCCCeeecCC-------C
Q 014156          162 LYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG---VCHRDIKPQNLLVNPH-------T  230 (429)
Q Consensus       162 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~---iiHrDlKp~Nill~~~-------~  230 (429)
                      ...++||||++++ +.+++     ....+++..++.++.||+.||.||| +.|   |+||||||+|||++.+       .
T Consensus        79 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH-~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLH-DEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHH-HSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeecCCchHHEEEecccccccccC
Confidence            3478999999754 44333     2467999999999999999999999 778   9999999999999852       2


Q ss_pred             CceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014156          231 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL  310 (429)
Q Consensus       231 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  310 (429)
                      ..+||+|||++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus       153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             CCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             cceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence            379999999997654433 2356789999999998764 48999999999999999999999998877655544432210


Q ss_pred             CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                                 ....++..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       231 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 ---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                       0111234578999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=343.69  Aligned_cols=251  Identities=20%  Similarity=0.302  Sum_probs=201.2

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCC-------CcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeee
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLET-------GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  154 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~  154 (429)
                      ....+|.+.+.||+|+||.||+|++..+       +..||+|++....     ....+|+++++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            3446899999999999999999997543       3579999986432     3345899999999 9999999999884


Q ss_pred             ecCCCCceEEEEEeecchh-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCC
Q 014156          155 STTDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP  221 (429)
Q Consensus       155 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp  221 (429)
                      .     ...+++||||+++ +|.+.+.....            ....+++..++.++.||+.||.||| +.||+||||||
T Consensus       146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp  219 (382)
T 3tt0_A          146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAA  219 (382)
T ss_dssp             S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCG
T ss_pred             c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCc
Confidence            3     2337899999975 77776654321            1245999999999999999999999 78999999999


Q ss_pred             CCeeecCCCCceEEeecCCceecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014156          222 QNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGE  297 (429)
Q Consensus       222 ~Nill~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  297 (429)
                      +||||+.++ .+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999887 79999999998664432   23345678899999999764 48999999999999999999 99999887


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +..+....+....                            ....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       298 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 PVEELFKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHTTC----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCC----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7655544433210                            001224578999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-44  Score=342.75  Aligned_cols=249  Identities=23%  Similarity=0.295  Sum_probs=199.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ..+|++.+.||+|+||.||+|++.     .+++.||+|++...     .....+|+.+++.++||||+++++++..    
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----  121 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV----  121 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc----
Confidence            347999999999999999999987     35589999998643     2345689999999999999999998843    


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecC
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSR--------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD  218 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrD  218 (429)
                       ...+++||||+++ +|.+.+.....                    ....+++..++.++.||+.||.||| +.||+|||
T Consensus       122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~D  199 (343)
T 1luf_A          122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRD  199 (343)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSC
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCC
Confidence             2347899999985 77776654211                    1257999999999999999999999 78999999


Q ss_pred             CCCCCeeecCCCCceEEeecCCceecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014156          219 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLF  294 (429)
Q Consensus       219 lKp~Nill~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf  294 (429)
                      |||+|||++.++ .+||+|||+++......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||
T Consensus       200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcC
Confidence            999999999887 79999999997653322   22345678999999998764 48999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          295 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       295 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+.+..+....+....                   .         ..++..+++++.+||.+||+.||.+|||+.+++++
T Consensus       278 ~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGN-------------------I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTSCHHHHHHHHHTTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCChHHHHHHHhCCC-------------------c---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            8877666554443210                   0         01234578999999999999999999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.1e-43  Score=330.23  Aligned_cols=250  Identities=22%  Similarity=0.249  Sum_probs=199.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++...  .....+|+.+++.++|++++..+..+...    ..+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEE
Confidence            35799999999999999999999999999999987543  34567899999999999887776655432    2357899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec---CCCCceEEeecCCceec
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~---~~~~~vkl~DFG~a~~~  244 (429)
                      |||++++|.+++..   ....+++..++.++.||+.||.||| +.||+||||||+|||++   .++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence            99998888877653   2457999999999999999999999 78999999999999994   555 7999999999876


Q ss_pred             ccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC
Q 014156          245 VKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTP  313 (429)
Q Consensus       245 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~  313 (429)
                      .....        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.   ...+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            54432        2456789999999998764 489999999999999999999999986432   22333332211111


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ...                        .+...+++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            111                        122357899999999999999999999999876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.9e-43  Score=331.21  Aligned_cols=247  Identities=19%  Similarity=0.265  Sum_probs=197.6

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ....+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+++++.++||||+++++++..     ....
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCe
Confidence            34568999999999999999999875 6778999998643   3445689999999999999999998833     3347


Q ss_pred             EEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+. +++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus        95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCccceEEEcCCC-CEEEcccccccc
Confidence            89999997 456665533   2356999999999999999999999 78999999999999999887 799999999976


Q ss_pred             cccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          244 LVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       244 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      .....  ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.....         
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---------  239 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------  239 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred             ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC---------
Confidence            53321  12234567889999998764 48999999999999999998 9999988877666655543211         


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                         ...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       240 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 -------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                               01223468999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-43  Score=334.64  Aligned_cols=250  Identities=22%  Similarity=0.248  Sum_probs=197.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...  .....+|+.+++.++|++++..+..+....    .+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCC----CceEEE
Confidence            34799999999999999999999999999999976433  345678999999999998888776654322    357899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee---cCCCCceEEeecCCceec
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill---~~~~~~vkl~DFG~a~~~  244 (429)
                      |||+++++.+++..   ....+++..++.++.||+.||.||| +.||+||||||+|||+   +.++ .+||+|||+++..
T Consensus        84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeeeeccCCCC-eEEEecCccceec
Confidence            99998888877653   2457999999999999999999999 7899999999999999   5555 7999999999876


Q ss_pred             ccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Q 014156          245 VKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTP  313 (429)
Q Consensus       245 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~  313 (429)
                      .....        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..   ..+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            54322        2346789999999998764 4899999999999999999999999874432   2222222211011


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      +.                        ......+++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 PI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hh------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11                        0122357899999999999999999999999876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-43  Score=334.76  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=192.6

Q ss_pred             cccceeEeeEEccCCcEEEEEEE----EcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...+|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++....   
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            44689999999999999999998    56789999999986432    34468999999999999999999875432   


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+++||||+++ +|.+.+..   ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENEN-RVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHhhEEEcCCC-eEEEccCc
Confidence            1236799999964 77666543   2345899999999999999999999 78999999999999999887 79999999


Q ss_pred             CceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-
Q 014156          240 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT-  314 (429)
Q Consensus       240 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-  314 (429)
                      +++.......    .....+|..|+|||++.+. .++.++|||||||++|+|++|..||......  .   ....+... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~  233 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQ  233 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCC
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCccc
Confidence            9987643321    2234567889999998764 4899999999999999999999998643211  1   11111110 


Q ss_pred             HH-----HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          315 RE-----EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       315 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ..     .......             ......+..+++++.+||.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          234 GQMIVFHLIELLKN-------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             THHHHHHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cchhHHHHHHHHhc-------------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00     0000000             0011123457999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.2e-44  Score=349.07  Aligned_cols=247  Identities=20%  Similarity=0.275  Sum_probs=198.6

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ....+|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+++++.++||||+++++++..     ..
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~  185 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQ  185 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CC
Confidence            34568999999999999999999999999999999886431     234579999999999999999998843     23


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||++ ++|.+.+..   ....+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||++
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s  260 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKN-VLKISDFGMS  260 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCGGGC
T ss_pred             CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcCCcccCHHHEEEcCCC-cEEECcCCCc
Confidence            3789999997 566665543   2346899999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      +........   ....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.... .     
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~-----  333 (377)
T 3cbl_A          261 REEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-R-----  333 (377)
T ss_dssp             EECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-C-----
T ss_pred             eecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-----
Confidence            865332111   122357789999998654 48999999999999999998 999998877655443332210 0     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                            ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       334 ----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ----------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                  0123457899999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.5e-43  Score=336.73  Aligned_cols=250  Identities=20%  Similarity=0.328  Sum_probs=199.1

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  158 (429)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||+|++....     ....+|+.+++.++||||+++++++..   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence            3457999999999999999999873     456899999986432     334579999999999999999998743   


Q ss_pred             CCceEEEEEeecch-hhHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeec
Q 014156          159 KDELYLNLVLEFVP-ETVYRVAKHYSR--------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR  217 (429)
Q Consensus       159 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHr  217 (429)
                        ....++||||+. ++|.+.+.....                    ....+++..++.++.||+.||.||| +.||+||
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~  174 (314)
T 2ivs_A           98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA-EMKLVHR  174 (314)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH-HTTEECC
T ss_pred             --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH-HCCCccc
Confidence              233789999998 577776654322                    1234899999999999999999999 7899999


Q ss_pred             CCCCCCeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014156          218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPL  293 (429)
Q Consensus       218 DlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p  293 (429)
                      ||||+|||++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999877 799999999987644322   2234568889999998764 48999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          294 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       294 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      |.+.+.......+....                            ....+..+++++.+||.+||..||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            98876655443332210                            01123457999999999999999999999999986


Q ss_pred             C
Q 014156          374 H  374 (429)
Q Consensus       374 h  374 (429)
                      +
T Consensus       305 ~  305 (314)
T 2ivs_A          305 D  305 (314)
T ss_dssp             H
T ss_pred             H
Confidence            4

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.3e-43  Score=334.18  Aligned_cols=250  Identities=23%  Similarity=0.328  Sum_probs=200.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEE-----cCCCcEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|++.+.||+|+||.||+|++     ..+++.||+|++...     .....+|+.+++.+ +||||+++++++...  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC--
Confidence            35799999999999999999985     456789999998643     23455899999999 999999999988432  


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSR--------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                         ...++||||+++ +|.+.+.....              ....+++..++.++.||+.||.||| +.||+||||||+|
T Consensus       100 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~N  175 (313)
T 1t46_A          100 ---GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARN  175 (313)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGG
T ss_pred             ---CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccce
Confidence               236899999975 77776654221              1235899999999999999999999 7899999999999


Q ss_pred             eeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014156          224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG  299 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  299 (429)
                      ||++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus       176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999887 899999999987654432   2234568889999998764 48999999999999999999 9999988766


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .............                           ...+..+++++.+||.+||..||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            5555544432110                           01223478999999999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-43  Score=339.95  Aligned_cols=251  Identities=22%  Similarity=0.294  Sum_probs=199.9

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEE--EEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+.+++.+ +||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----   97 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----   97 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----
Confidence            44568999999999999999999999888865  99987542     23456799999999 89999999998843    


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  226 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill  226 (429)
                       ...+++||||+++ +|.+.+....            .....+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           98 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILV  175 (327)
T ss_dssp             -TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEE
T ss_pred             -CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCccceEEE
Confidence             3358899999975 7777665422            12357999999999999999999999 8899999999999999


Q ss_pred             cCCCCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014156          227 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE  305 (429)
Q Consensus       227 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  305 (429)
                      +.++ .+||+|||+++............+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....
T Consensus       176 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~  253 (327)
T 1fvr_A          176 GENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  253 (327)
T ss_dssp             CGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             cCCC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence            9887 7999999999754433333445678899999998654 48899999999999999998 9999988776554433


Q ss_pred             HHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +....                            ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus       254 ~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          254 LPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            32210                            001223578999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.6e-44  Score=340.23  Aligned_cols=246  Identities=22%  Similarity=0.299  Sum_probs=193.4

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcE----EEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGET----VAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ...+|++.+.||+|+||.||+|++..+++.    ||+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            345799999999999999999999888876    6677653321     23457999999999999999999762     


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      + ...++||||+. +++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus        86 ~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~-~~kl~Df  159 (325)
T 3kex_A           86 G-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNVLLKSPS-QVQVADF  159 (325)
T ss_dssp             B-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHH-HTTCCCSCCSSTTEEESSSS-CEEECSC
T ss_pred             C-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCCccchheEEECCCC-eEEECCC
Confidence            1 12678999998 455555432   2356899999999999999999999 78999999999999999887 7999999


Q ss_pred             CCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          239 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       239 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      |+++.......   .....||..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....    
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----  234 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----  234 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----
Confidence            99987644322   2345678899999999764 48999999999999999999 999998876555444332210    


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                              ....+..+++++.+||.+||..||.+|||+.++++|
T Consensus       235 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 ------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    001223467889999999999999999999999886

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-43  Score=338.83  Aligned_cols=250  Identities=21%  Similarity=0.294  Sum_probs=198.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|.+.+.||+|+||.||+|++.     .++..||+|++...     .....+|+.+++.+ +||||+++++++...  
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS--  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--
Confidence            457999999999999999999973     45678999998643     23456899999999 899999999988442  


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecC
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRA-------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD  218 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrD  218 (429)
                         ..+++||||+++ +|.+.+......                   ...+++..++.++.||+.||.||| +.||+|||
T Consensus       122 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~D  197 (344)
T 1rjb_A          122 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRD  197 (344)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEEETT
T ss_pred             ---CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCcccCC
Confidence               237899999975 777766542210                   134799999999999999999999 78999999


Q ss_pred             CCCCCeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014156          219 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLF  294 (429)
Q Consensus       219 lKp~Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf  294 (429)
                      |||+|||++.++ .+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|+| |..||
T Consensus       198 ikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          198 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999887 899999999987654432   2234568899999998764 48999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          295 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       295 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+......+..+......                           ...+..+++++.+||.+||..||.+|||+.++++|
T Consensus       276 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            887665555444432100                           01223478999999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=336.46  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=197.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++...    .....+|+.+++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            4799999999999999999999999999999987532    234458999999999999999999886432 23446789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+.+ +|.+.+.........+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999986 777777665555678999999999999999999999 78999999999999999887 79999999987653


Q ss_pred             cCCC----------cccccccccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Q 014156          246 KGEP----------NISYICSRYYRAPELIFGAT--EYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGT  312 (429)
Q Consensus       246 ~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~  312 (429)
                      ....          .....||+.|+|||++.+..  .++.++|||||||++|+|++|+.||...... .........   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  262 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---  262 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence            2111          12345799999999986432  2688999999999999999999999431100 000000000   


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                    ....          .....+++++.+||.+||+.||.+|||+.+++++
T Consensus       263 --------------~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 --------------QLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --------------C--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------cCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                          0000          1123478999999999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-43  Score=330.35  Aligned_cols=247  Identities=27%  Similarity=0.364  Sum_probs=188.1

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCC---CcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|++.+.||+|+||.||+|.+..+   +..||+|.+...     .....+|+.+++.++||||+++++++..    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----
Confidence            4456899999999999999999998654   457999987542     2334579999999999999999987621    


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      +  ..++||||+++ +|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus        88 ~--~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Df  160 (281)
T 1mp8_A           88 N--PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDF  160 (281)
T ss_dssp             S--SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred             C--ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHEEECCCC-CEEECcc
Confidence            1  25789999985 66665543   2356999999999999999999999 78999999999999999877 7999999


Q ss_pred             CCceecccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          239 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       239 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |+++.......  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....     
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-----  234 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-----  234 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred             ccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-----
Confidence            99987644332  2234567889999998654 48999999999999999997 999998877666554443210     


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                             ...++..+++++.+||.+||..||.+|||+.+++++
T Consensus       235 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 -----------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                   001234579999999999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.9e-43  Score=331.77  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=192.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHHHHH--cCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||.||+|++  +++.||+|++.... ....+|.+++..  ++||||+++++++.... .....+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence            45799999999999999999987  78999999986543 333457777766  79999999998875543 33456789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-------~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      ||||+++ +|.+.+.     ...+++..+..++.||+.||.|||+       +.||+||||||+|||++.++ .+||+||
T Consensus        84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Df  157 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADL  157 (301)
T ss_dssp             EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeC
Confidence            9999985 6666552     3579999999999999999999993       46999999999999999887 7999999


Q ss_pred             CCceecccCCCc-----ccccccccccccccccCCC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCC
Q 014156          239 GSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAELLLG----------QPLFPGES  298 (429)
Q Consensus       239 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg----------~~pf~~~~  298 (429)
                      |+|+........     ....||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999876544322     2347899999999986643     234689999999999999999          88886532


Q ss_pred             h----HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          299 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       299 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .    ...+.......+                 ..+.++    ...+....++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQ-----------------QRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTTSC-----------------CCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhccC-----------------CCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2    122222111100                 000100    01122235678999999999999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-43  Score=339.56  Aligned_cols=246  Identities=23%  Similarity=0.330  Sum_probs=190.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEE----EEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ...+|++.+.||+|+||.||+|++..+++.+    |+|.+...     .....+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence            3457999999999999999999998887654    77766422     23456799999999999999999988532   


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                        . .++|++|+. +++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus        90 --~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~Df  161 (327)
T 3poz_A           90 --T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDF  161 (327)
T ss_dssp             --S-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred             --C-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCChheEEECCCC-CEEEccC
Confidence              1 557888887 456555433   3467999999999999999999999 78999999999999999887 7999999


Q ss_pred             CCceecccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          239 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       239 G~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      |+|+........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....   
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---  237 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---  237 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC---
Confidence            999876443322   234458899999998764 48999999999999999999 9999988766544333322100   


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                               ...+..++.++.+||.+||+.||.+|||+.+++++
T Consensus       238 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 -------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                     01223468899999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.1e-43  Score=335.92  Aligned_cols=259  Identities=23%  Similarity=0.277  Sum_probs=205.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  158 (429)
                      ...+|++.+.||+|+||.||+|++.     .+++.||+|.+....     ....+|+.+++.++||||+++++++..   
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   99 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---   99 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence            3457999999999999999999876     457899999986432     234579999999999999999998733   


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRA------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH  231 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~  231 (429)
                        ....++||||+++ +|.+.+......      ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ 
T Consensus       100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~NIli~~~~-  175 (322)
T 1p4o_A          100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF-  175 (322)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEECTTC-
T ss_pred             --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCCccCCCccceEEEcCCC-
Confidence              2347899999975 777766553321      245789999999999999999999 78999999999999999887 


Q ss_pred             ceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014156          232 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII  307 (429)
Q Consensus       232 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  307 (429)
                      .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            799999999976543321   2234568899999998764 48999999999999999999 899998877665554443


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC------CCccccC
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH------PFFDELR  381 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h------p~f~~~~  381 (429)
                      ...                   .         ...+..+++.+.+||.+||..||.+|||+.++++|      ++|+++.
T Consensus       255 ~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          255 EGG-------------------L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             TTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             cCC-------------------c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            210                   0         01223578999999999999999999999999886      7776655


Q ss_pred             CC
Q 014156          382 DP  383 (429)
Q Consensus       382 ~~  383 (429)
                      ..
T Consensus       307 ~~  308 (322)
T 1p4o_A          307 FY  308 (322)
T ss_dssp             ST
T ss_pred             cc
Confidence            43

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=338.28  Aligned_cols=257  Identities=15%  Similarity=0.140  Sum_probs=191.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC---CCcEEEEEEeccchhh---------------HHHHHHHHHHcCCCCeeccce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVVSLKH  151 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~~iv~l~~  151 (429)
                      ..+|.+.+.||+|+||.||+|++..   ++..+|+|++......               ..+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3479999999999999999999987   7889999988654321               225667778889999999999


Q ss_pred             eeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC-
Q 014156          152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT-  230 (429)
Q Consensus       152 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~-  230 (429)
                      ++.... .+..++++||||++++|.+++..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ 
T Consensus       116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEESSST
T ss_pred             cccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCcCHHHEEEccCCC
Confidence            886533 33456899999997777665432    347999999999999999999999 78999999999999998654 


Q ss_pred             CceEEeecCCceecccCC--------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hHH
Q 014156          231 HQVKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVD  301 (429)
Q Consensus       231 ~~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~  301 (429)
                      ..+||+|||+++......        ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ...
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence            269999999998764321        11345789999999998764 48999999999999999999999996532 222


Q ss_pred             HHHHHH-HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          302 QLVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       302 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ...... ..............                    -...+++++.+||.+||..||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            222222 21111111111100                    01147899999999999999999999999886

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.8e-44  Score=340.41  Aligned_cols=264  Identities=20%  Similarity=0.275  Sum_probs=197.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ..+|.+.+.||+|+||.||+|++ .+|+.||+|++....     ....+|+.+++.++||||+++++++...     ...
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~  102 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TER  102 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SCC
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC-----Cce
Confidence            34799999999999999999984 468999999886432     2456899999999999999999988433     236


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---CeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ++||||+.+ +|.+.+.........+++..+..++.||+.||.||| +.   ||+||||||+|||++.++ .+||+|||+
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  180 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFGL  180 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH-HSSSSCEECCCCSGGGEEECTTC-CEEECCCSS
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCchhhEEECCCC-CEEeccCcc
Confidence            799999975 777766554444556999999999999999999999 77   999999999999999887 799999999


Q ss_pred             ceecccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCC
Q 014156          241 AKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGTPT  314 (429)
Q Consensus       241 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~  314 (429)
                      ++.......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....    ..........      
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  253 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK------  253 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT------
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH------
Confidence            987643322  23456899999999986644 8999999999999999999999995211    0000111110      


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF  376 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  376 (429)
                              ...................+....+..+.+|+.+||+.||.+|||+.++++|-.
T Consensus       254 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          254 --------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             --------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             --------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                    000011111111111112222334578999999999999999999999998754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.4e-43  Score=331.70  Aligned_cols=255  Identities=19%  Similarity=0.257  Sum_probs=192.4

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcC---CCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ...+|.+.+.||+|+||.||+|.+..   ++..||+|.+...      .....+|+.+++.++||||+++++++......
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            34579999999999999999998765   4568999988533      13345799999999999999999988765544


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYS--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                      .....++||||+.+ ++...+....  .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dikp~NIli~~~~-~~kl~  189 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS-NRNFLHRDLAARNCMLRDDM-TVCVA  189 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH-TTTCCCCCCSGGGEEECTTS-CEEEC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-cEEEe
Confidence            33456899999985 6666553321  23467999999999999999999999 88999999999999999887 79999


Q ss_pred             ecCCceecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 014156          237 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  312 (429)
Q Consensus       237 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  312 (429)
                      |||+++......   ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....  
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--  266 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH--  266 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC--
Confidence            999997664332   12234568899999998764 48999999999999999999 899998877665554443310  


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                                ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus       267 --------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 --------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      011234578999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.5e-43  Score=330.14  Aligned_cols=248  Identities=21%  Similarity=0.317  Sum_probs=202.2

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ....+|++.+.||+|+||.||+|.+..++..||+|.+..+.   ....+|+.+++.++||||+++++++..     ....
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCE
Confidence            34557999999999999999999999999999999986543   345589999999999999999998733     3347


Q ss_pred             EEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||++ ++|.+.+..  .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHH-HHTCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHH-HCCccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence            89999998 577666643  22356999999999999999999999 78999999999999999877 799999999976


Q ss_pred             cccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          244 LVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       244 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      ......  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.......+....          
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~----------  229 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------  229 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred             ccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------
Confidence            643332  2234567889999998764 48999999999999999999 999998876655444332210          


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                        ....+..+++.+.+||.+||..||.+|||+.++++
T Consensus       230 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          230 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                              01123457899999999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-43  Score=332.90  Aligned_cols=251  Identities=18%  Similarity=0.236  Sum_probs=195.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCC-------cEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETG-------ETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  157 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  157 (429)
                      ...+|.+.+.||+|+||.||+|++..++       ..||+|++....    ....+|+.+++.++||||+++++++....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3457999999999999999999998877       469999885432    34457999999999999999999884422


Q ss_pred             CCCceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc----
Q 014156          158 DKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ----  232 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~----  232 (429)
                           ..++||||+. ++|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++..    
T Consensus        86 -----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           86 -----ENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLE-ENTLIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             -----CCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred             -----CCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHh-hCCeECCCcCcceEEEecCCcccccc
Confidence                 3679999998 577666643   2334899999999999999999999 7899999999999999877621    


Q ss_pred             ---eEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 014156          233 ---VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIK  308 (429)
Q Consensus       233 ---vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~  308 (429)
                         +||+|||++.....   .....||+.|+|||++.+...++.++|||||||++|+|++|. +||...+.... .....
T Consensus       157 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~  232 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYE  232 (289)
T ss_dssp             CCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHH
T ss_pred             cceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhh
Confidence               99999999865422   234568899999999976456899999999999999999955 55544443332 22222


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      ..                             ..++...++++.+||.+||+.||.+|||+.++++|  |+++..|
T Consensus       233 ~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p  276 (289)
T 4fvq_A          233 DR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTP  276 (289)
T ss_dssp             TT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC--
T ss_pred             cc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCC
Confidence            10                             01223457889999999999999999999999975  4444443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.2e-43  Score=334.67  Aligned_cols=249  Identities=23%  Similarity=0.322  Sum_probs=199.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCc-----EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|.+.+.||+|+||.||+|.+..+++     .||+|.+...     .....+|+.+++.+ +||||+++++++...  
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG--  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC--
Confidence            3579999999999999999999877664     7999988643     23455899999999 899999999988432  


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhh----------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSR----------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  227 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~  227 (429)
                         ..+++||||+++ +|.+.+.....          ....+++..++.++.||+.||.||| +.||+||||||+|||++
T Consensus       123 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          123 ---GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGCEEE
T ss_pred             ---CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh-cCCcccCCcccceEEEC
Confidence               337899999975 77777654332          1356899999999999999999999 78999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014156          228 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL  303 (429)
Q Consensus       228 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  303 (429)
                      .++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.......
T Consensus       199 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          199 NGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            877 799999999986644332   2234568889999998764 48999999999999999998 99999887665555


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ..+......                           ...+...++.+.+||.+||..||.+|||+.++++
T Consensus       277 ~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          277 YKLVKDGYQ---------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            544432110                           0112346899999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-42  Score=330.51  Aligned_cols=247  Identities=25%  Similarity=0.314  Sum_probs=188.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++...     
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----
Confidence            3457999999999999999999999999999999986432       3345799999999999999999988542     


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ..+++||||+++ +|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~  180 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH-AAGATHRDVKPENILVSADD-FAYLVDFGI  180 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred             CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCcCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence            347899999985 66665543    357999999999999999999999 78999999999999999887 799999999


Q ss_pred             ceecccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          241 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       241 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +.......  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. .+....... .      
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~------  251 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-I------  251 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-C------
T ss_pred             CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-C------
Confidence            87664332  22345789999999998654 5899999999999999999999999876543 222222210 0      


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-CHHHHhc
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-TALEACI  373 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-t~~e~l~  373 (429)
                                        .....++..+++++.+||.+||..||.+|| |+.++++
T Consensus       252 ------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          252 ------------------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ------------------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ------------------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                              001123456899999999999999999999 7777764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=328.39  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=189.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ..+|++.+.||+|+||.||+|++  .++.||+|.+....  ....+|+.+++.++||||+++++++.     +.  .++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            45799999999999999999987  47899999986543  34568999999999999999998763     22  5789


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG---IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |||+++ +|.+.+... .....++...+..++.||+.||.||| +   .||+||||||+|||++.++..+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHH-TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHH-hCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999975 666655431 11234788999999999999999999 6   79999999999999988775589999999976


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||................+.           
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------  221 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-----------  221 (307)
T ss_dssp             -----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC-----------
T ss_pred             cccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC-----------
Confidence            5332  2345689999999998664 5899999999999999999999999764332211110010000           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc-----CCCccccCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFFDELRD  382 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~-----hp~f~~~~~  382 (429)
                                     ...+...+++.+.+||.+||..||.+|||+.++++     .+++.....
T Consensus       222 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          222 ---------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             ---------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             ---------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence                           01123457899999999999999999999999987     355544333

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-42  Score=328.33  Aligned_cols=250  Identities=30%  Similarity=0.475  Sum_probs=188.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++...     .
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence            34799999999999999999999999999999988531       23345799999999999999999988543     2


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||+++ +|.+++.........+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~  183 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGLG  183 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCC---
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCcHHHEEEcCCC-CEEEEeccce
Confidence            47899999986 777777666556678999999999999999999999 78999999999999999887 7999999998


Q ss_pred             eecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHh
Q 014156          242 KVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  319 (429)
                      ....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ..+........        
T Consensus       184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  254 (310)
T 2wqm_A          184 RFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------  254 (310)
T ss_dssp             ---------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--------
T ss_pred             eeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--------
Confidence            7654332 22345789999999998664 4899999999999999999999999764321 12221111100        


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                ++.        .....+++++.+||.+||..||.+|||+.++++
T Consensus       255 ----------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          255 ----------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ----------SCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                      010        112347899999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=335.99  Aligned_cols=244  Identities=23%  Similarity=0.330  Sum_probs=188.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEE----EEEEecc-----chhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETV----AIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|++.+.||+|+||.||+|++..+++.+    |+|.+..     ......+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            457999999999999999999998888765    5665532     234456899999999999999999988532    


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                       . .++|++|+. +++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        90 -~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kL~DfG  162 (327)
T 3lzb_A           90 -T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             -S-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             -C-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh-hCCCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence             1 567888877 466655543   3467999999999999999999999 78999999999999999887 79999999


Q ss_pred             CceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          240 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       240 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....    
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----  237 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----  237 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            9987643322   2234567889999999764 48999999999999999999 9999988766554443322110    


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                              ...+..++.++.+||.+||..||.+|||+.++++
T Consensus       238 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          238 ------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                    0122347899999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-44  Score=354.71  Aligned_cols=253  Identities=21%  Similarity=0.218  Sum_probs=191.8

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCC-CCeeccce---------e-
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDH-PNVVSLKH---------C-  152 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h-~~iv~l~~---------~-  152 (429)
                      ..|.+.+.||+|+||.||+|++..+|+.||||++...       .....+|+.+++.+.| .|...+..         . 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3589999999999999999999999999999988622       2334588888888877 32211111         0 


Q ss_pred             -----------eeecCCCCceEEEEEeecchhhHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecC
Q 014156          153 -----------FFSTTDKDELYLNLVLEFVPETVYRVAKHYS---RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD  218 (429)
Q Consensus       153 -----------~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrD  218 (429)
                                 +..........++++|+++.++|.+++....   .....+++..+..++.||+.||.||| +.||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCC
Confidence                       1000001122367899999988888775432   22345778888899999999999999 88999999


Q ss_pred             CCCCCeeecCCCCceEEeecCCceecccCCCccccccccccccccccc---------CCCCCCCcchHHHHHHHHHHHHh
Q 014156          219 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTTAIDIWSVGCVLAELLL  289 (429)
Q Consensus       219 lKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwslG~il~ellt  289 (429)
                      |||+||||+.++ .+||+|||+++.....  ....+| +.|+|||++.         ....++.++|||||||++|+|++
T Consensus       237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999888 6999999999875433  345677 9999999983         33447889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH
Q 014156          290 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL  369 (429)
Q Consensus       290 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  369 (429)
                      |+.||.+.+.......+                       +.          -...+++++.+||.+||+.||.+|||+.
T Consensus       313 g~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999765432111000                       00          1124789999999999999999999999


Q ss_pred             HHhcCCCccccC
Q 014156          370 EACIHPFFDELR  381 (429)
Q Consensus       370 e~l~hp~f~~~~  381 (429)
                      ++++||||+++.
T Consensus       360 ~~l~~~~~~~~~  371 (413)
T 3dzo_A          360 QAMETPEYEQLR  371 (413)
T ss_dssp             HHTTSHHHHHHH
T ss_pred             HHHhCHHHHHHH
Confidence            999999998753

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.2e-44  Score=342.84  Aligned_cols=265  Identities=20%  Similarity=0.220  Sum_probs=195.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ...+|.+.+.||+|+||.||+|++ .+++.||+|++...    .....+|+.+++.++||||+++++++..     ....
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  110 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEM  110 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TTCC
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeE
Confidence            445799999999999999999996 46899999987543    2345689999999999999999998743     2347


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||+++ +|.+.+.........+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  188 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILLDENF-VPKITDFGISKK  188 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCSTTEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc-CCCeecCCCCHHHEEECCCC-CEEEeecccccc
Confidence            899999985 554443222222346899999999999999999999 78999999999999999887 799999999986


Q ss_pred             cccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          244 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       244 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      .....   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+........     ....  
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~--  260 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESH--  260 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHH--
T ss_pred             cccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcc--
Confidence            53321   22345689999999998664 4899999999999999999999999765432211000000     0000  


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ...     .+..+........+....+..+.+++.+||+.||.+|||+.++++|
T Consensus       261 ~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          261 NNG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             TTT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            000     0111111111122233456789999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.9e-43  Score=332.03  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=198.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEE-----cCCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|++.+.||+|+||.||+|++     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++.... 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-  104 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-  104 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC-
Confidence            34799999999999999999985     3567899999986432     2345799999999 7899999999874322 


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCee
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYSRA------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL  225 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nil  225 (429)
                         ..+++||||+++ +|.+.+......            ...+++..++.++.||+.||.||| +.||+||||||+|||
T Consensus       105 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil  180 (316)
T 2xir_A          105 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNIL  180 (316)
T ss_dssp             ---SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEE
T ss_pred             ---CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH-hCCcccccCccceEE
Confidence               236789999985 676666542211            123899999999999999999999 789999999999999


Q ss_pred             ecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014156          226 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD  301 (429)
Q Consensus       226 l~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  301 (429)
                      ++.++ .+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.....
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99877 799999999986644322   2235678899999998764 48999999999999999998 999998876555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+.........                           ...+..+++++.++|.+||..||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTR---------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCcc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44443332110                           01223478999999999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-42  Score=326.52  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=185.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..++|++.+.||+|+||.||+|++.   ..||+|++...      .....+|+.+++.++||||++++++.. .     .
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~-----~   92 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A-----P   92 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-----S
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-C-----C
Confidence            3457999999999999999999853   35999988532      233568999999999999999988541 1     1


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..++||||+.+ ++.+.+.   .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  167 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH-AKSIIHRDLKSNNIFLHEDN-TVKIGDFGLA  167 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTT-EEEECCCC--
T ss_pred             ccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCccceEEECCCC-CEEEccceec
Confidence            26789999984 5544432   33467999999999999999999999 78999999999999999887 8999999999


Q ss_pred             eecccC---CCcccccccccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKG---EPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      ......   .......||+.|+|||++..  ...++.++|||||||++|+|++|+.||.+....+.+.........+.  
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--  245 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--  245 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC--
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc--
Confidence            765331   22234578999999999852  34478899999999999999999999998777666655544321111  


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                           ....+...+++++.+||.+||..||.+|||+.++++
T Consensus       246 ---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 ---------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ---------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                 001123457899999999999999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.7e-42  Score=322.15  Aligned_cols=245  Identities=14%  Similarity=0.220  Sum_probs=196.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ...+|++.+.||+|+||.||+|++  +++.||+|++...      .....+|+.+++.++||||+++++++....   ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---AP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CC
Confidence            445799999999999999999998  4889999988643      233457899999999999999999874431   23


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecCCCCceEEeecC
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ..++||||+++ +|.+.+..  .....+++..++.++.||+.||.||| +.|  |+||||||+|||++.++ .++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~  158 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDM-TARISMAD  158 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHT-TSSSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred             CeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHh-cCCCceecCCCccceEEEcCCc-ceeEEecc
Confidence            47899999985 77766643  12235899999999999999999999 788  99999999999999887 79999988


Q ss_pred             CceecccCCCcccccccccccccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ++...    ......||+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+.+..+....+......     
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  229 (271)
T 3kmu_A          159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-----  229 (271)
T ss_dssp             SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----
Confidence            87543    2234578999999999876431  233799999999999999999999888776665554432111     


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                            ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus       230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 ----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  1133457999999999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.2e-42  Score=330.89  Aligned_cols=250  Identities=21%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEc-------CCCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeee
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  155 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~  155 (429)
                      ...+|++.+.||+|+||.||+|++.       .++..||+|++....     ....+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3458999999999999999999975       457789999986432     2345799999999 89999999998843


Q ss_pred             cCCCCceEEEEEeecchh-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCC
Q 014156          156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ  222 (429)
Q Consensus       156 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~  222 (429)
                           ...+++||||+++ +|.+.+.....            ....+++..++.++.||+.||.||| +.||+||||||+
T Consensus       113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~  186 (334)
T 2pvf_A          113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAAR  186 (334)
T ss_dssp             -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGG
T ss_pred             -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCccc
Confidence                 3347899999975 77666654221            1234899999999999999999999 789999999999


Q ss_pred             CeeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 014156          223 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGES  298 (429)
Q Consensus       223 Nill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  298 (429)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       187 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          187 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99999887 799999999987654322   2234568889999998764 48999999999999999999 999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       299 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..+....+.....                            ...+..+++++.+||.+||..||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6655544433210                            01233578999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.2e-43  Score=333.95  Aligned_cols=265  Identities=23%  Similarity=0.295  Sum_probs=199.0

Q ss_pred             CccccceeEeeEEccCCcEEEEEEE----EcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCC
Q 014156           87 PKQTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        87 ~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  158 (429)
                      -....+|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++..   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   95 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---   95 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---
Confidence            3445689999999999999999998    56789999999986432    335689999999999999999988754   


Q ss_pred             CCceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEee
Q 014156          159 KDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD  237 (429)
Q Consensus       159 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~D  237 (429)
                      .+...+++||||++ ++|.+++...   ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dikp~NIl~~~~~-~~kl~D  170 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEA-HVKIAD  170 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECC
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCChhhEEECCCC-CEEEcc
Confidence            23345889999996 5666665432   346999999999999999999999 78999999999999999887 799999


Q ss_pred             cCCceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          238 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       238 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      ||++........    .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ........+
T Consensus       171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~  248 (327)
T 3lxl_A          171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVP  248 (327)
T ss_dssp             GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CC
T ss_pred             cccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccc
Confidence            999987644332    2334578889999998664 4789999999999999999999999653321110 000000000


Q ss_pred             CHHH-HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          314 TREE-IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       314 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .... .......             .....+..+++++.+||.+||..||.+|||+.+++++
T Consensus       249 ~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          249 ALSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0000 0000000             0111234579999999999999999999999999653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.2e-42  Score=326.90  Aligned_cols=257  Identities=24%  Similarity=0.365  Sum_probs=194.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEE----EcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...|++.+.||+|+||.||+|+    +..+++.||+|++....     ....+|+.+++.++||||+++++++....   
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence            3469999999999999999998    56789999999986432     44568999999999999999999885432   


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+++||||+++ +|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg  171 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEH-QVKIGDFG  171 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             CceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhh-cCCcccCCCchheEEEcCCC-CEEECccc
Confidence            2347899999975 66665533   3466999999999999999999999 78999999999999999887 89999999


Q ss_pred             CceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          240 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       240 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      ++........    .....||..|+|||++.+. .++.++|||||||++|+|++|..|+....  ..   .....+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM--AL---FLKMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HH---HHHHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh--hH---HhhccCCccc
Confidence            9987654432    2345678889999998764 47889999999999999999998864221  11   1111111110


Q ss_pred             H----H-HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          316 E----E-IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       316 ~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .    . ......             ......+..+++++.+||.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 QMTVTRLVNTLKE-------------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGHHHHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHhc-------------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0    0 000000             0011133468999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-42  Score=322.66  Aligned_cols=245  Identities=20%  Similarity=0.309  Sum_probs=198.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++...   .....+|+.+++.++||||+++++++...     ...++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeEE
Confidence            457999999999999999999985 6788999998653   34556899999999999999999988432     33789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+++ +|.+.+..   ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  155 (267)
T ss_dssp             EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCchheEEECCCC-CEEEcccccccccc
Confidence            9999975 66665543   2356899999999999999999999 88999999999999999877 79999999987653


Q ss_pred             cCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ...  ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||.+.+..+....+.....           
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-----------  223 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----------  223 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred             cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence            221  12234567889999998654 48999999999999999999 8999988776665554433100           


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                       ...+..+++.+.+||.+||..||.+|||+.+++++
T Consensus       224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             01223468999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.7e-42  Score=343.59  Aligned_cols=244  Identities=23%  Similarity=0.320  Sum_probs=196.5

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch--hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ...+|++.+.||+|+||.||+|.+  +|+.||||++..+.  ....+|+.+++.++||||+++++++....    ..+++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~i  264 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI  264 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEE
Confidence            346899999999999999999987  47899999987543  34568999999999999999999875432    23789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+.+ +|.+.+...  ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus       265 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHhhEEECCCC-CEEEeeCCCccccc
Confidence            9999975 777766542  2234799999999999999999999 78999999999999999887 79999999998653


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..  .....+|..|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+....              
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------------  403 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------  403 (450)
T ss_dssp             --------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--------------
T ss_pred             cc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            32  2234668899999999764 48999999999999999998 999998876655544433210              


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                    ....+..+++++.+||.+||..||.+|||+.++++
T Consensus       404 --------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 --------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                          01123457999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-42  Score=325.37  Aligned_cols=247  Identities=27%  Similarity=0.354  Sum_probs=194.8

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcC---CCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|.+.+.||+|+||.||+|++..   ++..||+|.+...     .....+|+.+++.++||||+++++++..    
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   84 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----   84 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----
Confidence            345689999999999999999998654   3456999988643     2345579999999999999999997632    


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                       .. .++||||+.+ +|.+.+..   ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus        85 -~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Df  157 (281)
T 3cc6_A           85 -EP-TWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLE-SINCVHRDIAVRNILVASPE-CVKLGDF  157 (281)
T ss_dssp             -SS-CEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEEEETT-EEEECCC
T ss_pred             -CC-CEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEECCCC-cEEeCcc
Confidence             11 4689999984 66665543   3456999999999999999999999 88999999999999999887 8999999


Q ss_pred             CCceecccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          239 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       239 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |++........  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+......   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---  233 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---  233 (281)
T ss_dssp             CGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---
T ss_pred             CCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---
Confidence            99976543321  2334568889999998654 48999999999999999998 99999877666555444332100   


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                               ..+..+++.+.+||.+||..||.+|||+.+++++
T Consensus       234 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 -------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                     1223478999999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-42  Score=323.50  Aligned_cols=245  Identities=25%  Similarity=0.291  Sum_probs=196.4

Q ss_pred             ccceeEee-EEccCCcEEEEEEEEc--CCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           90 TISYMAER-VVGQGSFGIVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..+|.+.+ .||+|+||.||+|.+.  .++..||+|++...     .....+|+.+++.++||||+++++++ ...    
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~----   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE----   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS----
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC----
Confidence            34687877 9999999999999864  46788999998652     23345799999999999999999987 211    


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                       ..++||||+++ +|.+.+.   .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus        83 -~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~  156 (287)
T 1u59_A           83 -ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRH-YAKISDFGL  156 (287)
T ss_dssp             -SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -CcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCchheEEEcCCC-CEEECcccc
Confidence             26899999986 5555442   23466999999999999999999999 78999999999999999877 899999999


Q ss_pred             ceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          241 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       241 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      +........    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+....     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-----  230 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-----  230 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-----
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-----
Confidence            987643322    1233468899999998654 48899999999999999998 999998877665554433210     


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                             ...++..+++++.+||.+||..||.+|||+.++++|
T Consensus       231 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          231 -----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   011234579999999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.4e-44  Score=368.09  Aligned_cols=285  Identities=25%  Similarity=0.324  Sum_probs=205.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...     .....+|+.+++.++||||+++++++..... .....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            35799999999999999999999999999999987543     2334579999999999999999887643111 12344


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC--ceEEeecCC
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGS  240 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~--~vkl~DFG~  240 (429)
                      .++||||++ ++|.+.+... .....+++..++.++.||+.||.||| +.||+||||||+|||++.++.  .+||+|||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLH-s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHH-HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            679999996 4666655432 22336899999999999999999999 789999999999999986653  489999999


Q ss_pred             ceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........   ........+..
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCS
T ss_pred             ccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhh
Confidence            988766666667789999999999865 45899999999999999999999999876443221110   00000000000


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      .......+.+..  ..+....+...+++.+.+||.+||.+||.+|||+.++++||||+.+..
T Consensus       247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            000001111111  111112233446789999999999999999999999999999987643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=335.87  Aligned_cols=278  Identities=20%  Similarity=0.274  Sum_probs=192.3

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-hHHHHHH--HHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YKNRELQ--TMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~--~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ....+|++.+.||+|+||.||+|++  +++.||||++..... ....|.+  .+..++||||+++++.+......+...+
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            3445799999999999999999976  789999999864332 2223333  3445899999999887665555566678


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---------CeeecCCCCCCeeecCCCCceE
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI---------GVCHRDIKPQNLLVNPHTHQVK  234 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---------~iiHrDlKp~Nill~~~~~~vk  234 (429)
                      ++||||+++ +|.+++..     ...++..++.++.||+.||.||| +.         ||+||||||+||||+.++ .+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH-~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLH-TELPRGDHYKPAISHRDLNSRNVLVKNDG-TCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH-CCBCCGGGCBCCEECSSCSGGGEEECTTS-CEE
T ss_pred             EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHH-hhhccccccccceeecccccceEEEcCCC-cEE
Confidence            899999964 77666643     45689999999999999999999 78         999999999999999887 799


Q ss_pred             EeecCCceecccCC---------CcccccccccccccccccCC------CCCCCcchHHHHHHHHHHHHhCCCCCCC-CC
Q 014156          235 LCDFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTTAIDIWSVGCVLAELLLGQPLFPG-ES  298 (429)
Q Consensus       235 l~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~elltg~~pf~~-~~  298 (429)
                      |+|||+++......         .....+||+.|+|||++.+.      ..++.++|||||||++|+|++|..||.. ..
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998764321         12345789999999998653      2356789999999999999999766533 22


Q ss_pred             hHHHHHHHH-HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc----
Q 014156          299 GVDQLVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI----  373 (429)
Q Consensus       299 ~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~----  373 (429)
                      .......+. .....+....+......  ....+.++.. +  .....+++++.+||.+||..||++|||+.|+++    
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSR--EKQRPKFPEA-W--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTT--SCCCCCCCTT-C--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcc--cccCCCCCcc-c--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            111110111 11122222221110000  0000110000 0  001123457999999999999999999999954    


Q ss_pred             --CCCccc
Q 014156          374 --HPFFDE  379 (429)
Q Consensus       374 --hp~f~~  379 (429)
                        ++|-++
T Consensus       316 ll~~~~~~  323 (336)
T 3g2f_A          316 LMMIWERN  323 (336)
T ss_dssp             HHHCCCC-
T ss_pred             HHHHHHhc
Confidence              666544

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=336.57  Aligned_cols=254  Identities=14%  Similarity=0.120  Sum_probs=195.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC--------CcEEEEEEeccchhhHHHHHHHHHHcCCCCeecc-------------
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET--------GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------------  149 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l-------------  149 (429)
                      .+|++.+.||+|+||.||+|++..+        ++.||+|++... ....+|+.+++.++||||+++             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            4799999999999999999999874        889999988654 456789999999999999984             


Q ss_pred             --ceeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec
Q 014156          150 --KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  227 (429)
Q Consensus       150 --~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~  227 (429)
                        ++++..    ...+.++||||++++|.+++...  ....+++..++.++.||+.||.||| +.||+||||||+|||++
T Consensus       121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLH-ENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCCGGGEEEE
T ss_pred             chhhcccc----CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCHHHEEEc
Confidence              333322    23457899999988888877642  1367999999999999999999999 78999999999999999


Q ss_pred             CCCC-ceEEeecCCceecccCC--------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 014156          228 PHTH-QVKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES  298 (429)
Q Consensus       228 ~~~~-~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  298 (429)
                      .++. .+||+|||+++......        ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            7651 69999999997654322        12345789999999998764 58999999999999999999999998754


Q ss_pred             -hHHHHHHHHHHh-CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          299 -GVDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       299 -~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                       ....+....... ..+.         .        +...   ......+++++.+||.+||..||.+|||+.++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~---------~--------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPG---------P--------FVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCC---------C--------EECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHhccCChh---------h--------hhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence             333333322211 1000         0        0000   0011246899999999999999999999999976

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.4e-42  Score=323.37  Aligned_cols=243  Identities=22%  Similarity=0.276  Sum_probs=194.0

Q ss_pred             ccceeEee-EEccCCcEEEEEEEE--cCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           90 TISYMAER-VVGQGSFGIVFQAKC--LETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||+|++...      .....+|+.+++.++||||+++++++ ...   
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~---   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE---   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence            34799998 999999999999954  566789999988643      23456799999999999999999977 211   


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                        ..++||||+. ++|.+.+..    ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus        91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg  162 (291)
T 1xbb_A           91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFG  162 (291)
T ss_dssp             --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHH-hCCeEcCCCCcceEEEeCCC-cEEEccCC
Confidence              2679999998 566665543    456999999999999999999999 78999999999999999887 89999999


Q ss_pred             CceecccCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          240 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       240 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      ++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+....    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----  237 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----  237 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----
Confidence            99876443321    223457889999998654 47889999999999999999 999998877655444332210    


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                              ...++..+++++.+||.+||+.||.+|||+.++++
T Consensus       238 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 ------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    00123457999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.3e-43  Score=341.26  Aligned_cols=246  Identities=23%  Similarity=0.307  Sum_probs=186.2

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ...+|.+.+.||+|+||.||+|++.   .++..||||++...     .....+|+.+++.++||||+++++++..     
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----  117 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----  117 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence            3457999999999999999999876   46778999998642     2345579999999999999999998843     


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+++||||++ ++|.+++..   ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  192 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINSNL-VCKVSDFG  192 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCcceEEEcCCC-CEEECcCc
Confidence            234789999996 566665542   3457999999999999999999999 78999999999999999887 79999999


Q ss_pred             CceecccCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          240 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       240 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      +++........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....   
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~---  268 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR---  268 (373)
T ss_dssp             ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence            99876433211    122346789999998764 48999999999999999998 9999988776655544332110   


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                               ...+..++..+.+||.+||..||.+|||+.++++
T Consensus       269 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          269 -------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             -------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                     0112347899999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-42  Score=347.76  Aligned_cols=260  Identities=22%  Similarity=0.228  Sum_probs=202.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..++|++.++||+|+||.||+|++..+++.||||++...  .....+|+++++.|.|++++..+..+...    ..+.++
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~----~~~~~l   80 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE----GDYNVL   80 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE----TTEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee----CCEEEE
Confidence            345799999999999999999999999999999987532  34567899999999986655555444332    235789


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee---cCCCCceEEeecCCcee
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill---~~~~~~vkl~DFG~a~~  243 (429)
                      ||||++++|.+++..   ....+++..++.++.||+.||.||| +.||+||||||+||||   +.++ .+||+|||+++.
T Consensus        81 vme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~  155 (483)
T 3sv0_A           81 VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK  155 (483)
T ss_dssp             EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred             EEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCcceEEEecCCCCC-eEEEEeCCccee
Confidence            999998888887753   2467999999999999999999999 7899999999999999   4555 799999999987


Q ss_pred             cccCCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 014156          244 LVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGT  312 (429)
Q Consensus       244 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~  312 (429)
                      ......        .....||+.|+|||++.+. .++.++|||||||+||+|++|+.||.+...   .+.+..+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            654432        1256789999999998764 489999999999999999999999987543   2333333222111


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc----------CCCccccCC
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI----------HPFFDELRD  382 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~----------hp~f~~~~~  382 (429)
                      ...+                        .+...+++++.+||.+||..||.+||++.++++          ++|+..+.|
T Consensus       235 ~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW  290 (483)
T 3sv0_A          235 TSIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDW  290 (483)
T ss_dssp             SCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHH
T ss_pred             ccHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCc
Confidence            1111                        112347899999999999999999999987754          677655443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.6e-43  Score=333.81  Aligned_cols=257  Identities=18%  Similarity=0.206  Sum_probs=198.0

Q ss_pred             ccccceeEeeEEccCCcEEEEEEE-----EcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  157 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  157 (429)
                      ....+|++.+.||+|+||.||+|+     +..+++.||+|.+...     .....+|+.+++.++||||+++++++... 
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-  105 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-  105 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-
Confidence            344589999999999999999999     5567889999998532     23345799999999999999999988432 


Q ss_pred             CCCceEEEEEeecch-hhHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--C
Q 014156          158 DKDELYLNLVLEFVP-ETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--H  231 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~  231 (429)
                          ...++||||++ ++|.+++.....   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++  .
T Consensus       106 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          106 ----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTC
T ss_pred             ----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeecCcCCHhHEEEecCCCcc
Confidence                33689999995 577776654321   1145899999999999999999999 78999999999999998432  2


Q ss_pred             ceEEeecCCceecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014156          232 QVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII  307 (429)
Q Consensus       232 ~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  307 (429)
                      .+||+|||++.......   ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            69999999987553322   22345678899999998664 48999999999999999998 999998877655544433


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                      ... .                           ...+..+++.+.+||.+||..||.+|||+.++++|.|+-.
T Consensus       260 ~~~-~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          260 SGG-R---------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TTC-C---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCC-C---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            210 0                           0122457899999999999999999999999999988743

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-42  Score=350.66  Aligned_cols=246  Identities=21%  Similarity=0.311  Sum_probs=200.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|.+.+.||+|+||.||+|.+..++..||||.+..+   .....+|+.+++.++||||+++++++...     ..+++
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEEE
Confidence            45799999999999999999999988999999998653   34456899999999999999999988432     33789


Q ss_pred             Eeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+. ++|.+.+...  ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGG-CEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChhhEEECCCC-cEEEeecccceecc
Confidence            999998 5777766532  2356899999999999999999999 78999999999999999877 79999999998764


Q ss_pred             cCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ....  .....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....            
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------  436 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------  436 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------------
T ss_pred             CCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence            3321  1233457789999998654 48999999999999999999 999998877655443332210            


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                      ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       437 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 ----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                            01123457899999999999999999999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.9e-42  Score=323.02  Aligned_cols=244  Identities=25%  Similarity=0.367  Sum_probs=186.6

Q ss_pred             cccceeEe-eEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHH-HHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           89 QTISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        89 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.... .+..++++
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l   92 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   92 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence            34568887 7899999999999999999999999988653 4456788887 6679999999999875422 23456889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CCCceEEeecCCce
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAK  242 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~~~vkl~DFG~a~  242 (429)
                      ||||+++ +|.+.+..  .....+++..++.++.||+.||.||| +.||+||||||+|||++.   ++ .+||+|||++.
T Consensus        93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~  168 (299)
T 3m2w_A           93 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  168 (299)
T ss_dssp             EECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEecCCCCC-cEEEecccccc
Confidence            9999975 77776654  22346999999999999999999999 789999999999999987   44 79999999986


Q ss_pred             ecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ...                      ...++.++|||||||++|+|++|+.||.+.+.......+..              
T Consensus       169 ~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------------  212 (299)
T 3m2w_A          169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------------  212 (299)
T ss_dssp             ECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------------
T ss_pred             ccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------------
Confidence            532                      12367899999999999999999999976543221100000              


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                          ....   ....+.......+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       213 ----~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 ----RIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             ----SSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ----HHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                0000   000011111245799999999999999999999999999999998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-42  Score=329.89  Aligned_cols=247  Identities=20%  Similarity=0.279  Sum_probs=191.1

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCC----cEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ...+|.+.+.||+|+||.||+|.+..++    ..||+|.+...     .....+|+.+++.++||||+++++++..    
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  117 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----  117 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----
Confidence            3457999999999999999999987553    35999998643     2234579999999999999999998733    


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                       ....++||||+++ +|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus       118 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Df  191 (333)
T 1mqb_A          118 -YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNL-VCKVSDF  191 (333)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             -CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChheEEECCCC-cEEECCC
Confidence             3347899999986 66655533   3467999999999999999999999 78999999999999999887 7999999


Q ss_pred             CCceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014156          239 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       239 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      |+++.......    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+...... 
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-  269 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-  269 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-
Confidence            99987643321    1223457889999998764 48999999999999999999 99999887766555444321100 


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                                 ..+..+++.+.+||.+||..||.+|||+.+++++
T Consensus       270 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 ---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       1123478999999999999999999999998864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.6e-42  Score=321.70  Aligned_cols=245  Identities=22%  Similarity=0.322  Sum_probs=190.8

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ....+|++.+.||+|+||.||+|.+  +|+.||+|++...  .....+|+.+++.++||||+++++++....    ..++
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~   91 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   91 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceE
Confidence            4456899999999999999999987  5889999998654  234568999999999999999999764322    2367


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+++ +|.+.+....  ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~  167 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  167 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEEECCCCC----
T ss_pred             EEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCcceEEEeCCC-cEEEeeccccccc
Confidence            99999985 7777665422  234789999999999999999999 78999999999999999887 7999999998765


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+...              
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------------  230 (278)
T 1byg_A          168 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------  230 (278)
T ss_dssp             ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT--------------
T ss_pred             ccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC--------------
Confidence            332  2334678899999998654 48999999999999999998 99999877655444332211              


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                    .....+..+++.+.++|.+||..||.+|||+.++++
T Consensus       231 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 --------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                          001123457999999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-42  Score=329.92  Aligned_cols=252  Identities=20%  Similarity=0.283  Sum_probs=186.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh-hHHHHHHHHHH--cCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~--l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|++  +++.||+|++..... ...+|.+++..  ++||||+++++++.... .....+++|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence            5799999999999999999987  489999998864432 23345555554  49999999999876543 222458899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--------CeeecCCCCCCeeecCCCCceEEeec
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI--------GVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--------~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      |||+.+ +|.+.+..     ..+++..++.++.|++.||.||| +.        ||+||||||+|||++.++ .+||+||
T Consensus       114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLH-TEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH-SCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH-HhhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            999975 77776643     56999999999999999999999 77        999999999999999887 7999999


Q ss_pred             CCceecccCCCc-----ccccccccccccccccCCCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCC
Q 014156          239 GSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTTA------IDIWSVGCVLAELLLG----------QPLFPGE  297 (429)
Q Consensus       239 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~------~DiwslG~il~elltg----------~~pf~~~  297 (429)
                      |+++........     ....||+.|+|||++.+.. ++..      +|||||||++|+|++|          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999766433221     2457899999999986644 4443      9999999999999999          6676543


Q ss_pred             Ch----HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          298 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       298 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      ..    .............                 .+.++    .......+++++.+||.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKKL-----------------RPSFP----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSCC-----------------CCCCC----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhcc-----------------Ccccc----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            21    1112111110000                 00000    00011235678999999999999999999999987


Q ss_pred             C
Q 014156          374 H  374 (429)
Q Consensus       374 h  374 (429)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=320.76  Aligned_cols=246  Identities=21%  Similarity=0.315  Sum_probs=191.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCc---EEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...|.+.++||+|+||.||+|.+..+++   .||+|.+....     ....+|+.+++.++||||+++++++.....   
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   96 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG---   96 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS---
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC---
Confidence            3468889999999999999999765554   79999886422     334579999999999999999998854322   


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                       ..++||||+. +++.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus        97 -~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dikp~Nili~~~~-~~kl~Dfg~  170 (298)
T 3pls_A           97 -LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLA-EQKFVHRDLAARNCMLDESF-TVKVADFGL  170 (298)
T ss_dssp             -CCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECCTTS
T ss_pred             -CcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-cEEeCcCCC
Confidence             2468999986 566555532   3467899999999999999999999 78999999999999999887 799999999


Q ss_pred             ceecccC-----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCC
Q 014156          241 AKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       241 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      ++.....     .......+|+.|+|||.+.+. .++.++|||||||++|+|++|. +||...+..+....+.....   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---  246 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---  246 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---
Confidence            9755322     222345678899999998654 4899999999999999999955 55655554444333322110   


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                               ...+..+++.+.+||.+||..||.+|||+.++++
T Consensus       247 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 -------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                     0122347899999999999999999999999886

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.6e-42  Score=323.60  Aligned_cols=246  Identities=21%  Similarity=0.311  Sum_probs=191.7

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCC---cEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..+|++.+.||+|+||.||+|.+..++   ..+|+|.+...     .....+|+.+++.++||||+++++++....    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----
Confidence            346999999999999999999975443   46899987542     233457999999999999999999764322    


Q ss_pred             eEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ...++||||+++ +|.+.+..   ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~  174 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLA-SKKFVHRDLAARNCMLDEKF-TVKVADFGL  174 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred             CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCchheEEECCCC-CEEECcccc
Confidence            236789999986 66665532   3466899999999999999999999 78999999999999999887 799999999


Q ss_pred             ceecccCC-----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          241 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       241 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      ++......     ......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+....    
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~----  249 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----  249 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC----
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC----
Confidence            97654322     22345678899999998664 48999999999999999999 667787766555444433211    


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                              ....+..+++.+.+||.+||..||.+|||+.++++
T Consensus       250 ------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 ------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    00122347899999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.6e-42  Score=343.38  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=198.1

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ...+|.+.+.||+|+||.||+|.+. ++..||||++...   .....+|+.+++.++||||+++++++. .     ..++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~-----~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K-----EPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-----SSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C-----CccE
Confidence            3457999999999999999999975 4678999998643   344568999999999999999998763 1     1267


Q ss_pred             EEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+. ++|.+.+....  ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASL-VCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence            8999997 47777665322  236889999999999999999999 78999999999999999887 7999999999765


Q ss_pred             ccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          245 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       245 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ....  ......+|..|+|||++... .++.++|||||||++|||++ |+.||.+.+..+....+......         
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  404 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---------  404 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---------
T ss_pred             CCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            3321  11233457889999998654 48999999999999999999 99999988877666555442111         


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                         ..+..+++++.+||.+||..||.+|||+.+++.
T Consensus       405 -------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          405 -------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                               112357899999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-41  Score=318.30  Aligned_cols=244  Identities=22%  Similarity=0.296  Sum_probs=196.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+++++.++||||+++++++..     . ..++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~-~~~~   84 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIYI   84 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C-CcEE
Confidence            457999999999999999999964 5678999988643   3445689999999999999999987631     1 2678


Q ss_pred             Eeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+. ++|.+.+...  ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus        85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTL-SCKIADFGLARLIE  160 (279)
T ss_dssp             EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred             EEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHhhEEEcCCC-CEEECCCccccccc
Confidence            999996 5666655321  1236899999999999999999999 78999999999999999887 79999999998765


Q ss_pred             cCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ....  .....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+....            
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------  227 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------  227 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc------------
Confidence            4322  1234567889999998654 48899999999999999999 999998877666554443210            


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                      ....+..+++++.+||.+||..||.+|||+.++++
T Consensus       228 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          228 ----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                            01123457899999999999999999999999876

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-42  Score=334.38  Aligned_cols=244  Identities=16%  Similarity=0.189  Sum_probs=189.3

Q ss_pred             ccceeEeeEEccCCcEEEEEE-----EEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcC---CCCeeccceeeeecCCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQA-----KCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~  160 (429)
                      ..+|.+.+.||+|+||.||+|     .+..+++.||+|++... .....+|+.+++.+.   |+||+++++++....   
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~---  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN---  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS---
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC---
Confidence            457999999999999999999     46778999999998654 334567888888887   899999999885433   


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC----------
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP----------  228 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~----------  228 (429)
                        ..++||||++ ++|.+++..... ....+++..++.++.||+.||+||| +.||+||||||+||||+.          
T Consensus       141 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH-~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 --GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             --CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             --CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEecccccCcccccc
Confidence              3789999997 677777765433 3467999999999999999999999 889999999999999987          


Q ss_pred             -CCCceEEeecCCceeccc---CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014156          229 -HTHQVKLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV  304 (429)
Q Consensus       229 -~~~~vkl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  304 (429)
                       ++ .+||+|||+|+....   .......+||+.|+|||++.+.. ++.++|||||||++|+|+||+.||......    
T Consensus       218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~----  291 (365)
T 3e7e_A          218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG----  291 (365)
T ss_dssp             -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT----
T ss_pred             ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC----
Confidence             55 799999999976542   22334567999999999997654 899999999999999999999999543210    


Q ss_pred             HHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                            .+........     +  ..++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       292 ----------------------~~~~~~~~~~-----~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          292 ----------------------ECKPEGLFRR-----L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ----------------------EEEECSCCTT-----C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ----------------------ceeechhccc-----c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                                  0000000000     0  136778999999999999999766555544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.6e-42  Score=327.25  Aligned_cols=254  Identities=23%  Similarity=0.300  Sum_probs=192.9

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      |...+.||+|+||.||+|.+  +++.||+|++...        .....+|+.+++.++||||+++++++...     ...
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-----DDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----Cce
Confidence            55668999999999999986  6889999988532        23456899999999999999999988432     237


Q ss_pred             EEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ++||||++ +++.+.+.. ......+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus       106 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~  182 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAF-TAKISDFGLARA  182 (307)
T ss_dssp             EEEEECCTTCBHHHHHHT-GGGCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence            89999996 566666543 233467999999999999999999999 78999999999999999887 799999999987


Q ss_pred             cccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC--CCHHHH
Q 014156          244 LVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEI  318 (429)
Q Consensus       244 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~  318 (429)
                      ......   .....||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+..+......  .....+
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence            643322   233578999999998854  3789999999999999999999999876544333333222111  111100


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                        ..        +..      .......+..+.++|.+||..||.+|||+.+++++
T Consensus       261 --~~--------~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          261 --ID--------KKM------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             --SC--------SSC------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --cc--------ccc------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              00        000      00112245779999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=335.97  Aligned_cols=248  Identities=20%  Similarity=0.301  Sum_probs=186.1

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCC---cEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ....|.+.+.||+|+||.||+|++..++   ..||+|.+...     .....+|+.+++.++||||+++++++....   
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---  163 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---  163 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS---
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC---
Confidence            3456999999999999999999876443   46899987532     234457999999999999999999764322   


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                       ...++||||+++ +|.+.+.   .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus       164 -~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~-~~kL~DFG  237 (373)
T 3c1x_A          164 -GSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKF-TVKVADFG  237 (373)
T ss_dssp             -SCCEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             -CCeEEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHH-HCCEecCccchheEEECCCC-CEEEeecc
Confidence             236789999985 6666553   23456889999999999999999999 78999999999999999887 79999999


Q ss_pred             CceecccCCC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014156          240 SAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       240 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      +++.......     .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+....   
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~---  313 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---  313 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC---
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC---
Confidence            9986543321     2334567889999998764 48999999999999999999 778887766544443332210   


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                               ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus       314 -------------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 -------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     001223578999999999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-41  Score=340.27  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=196.3

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++...   .....+|+.+++.++||||+++++++..      ..++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            34579999999999999999999864 467999998643   3445689999999999999999987632      1267


Q ss_pred             EEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +||||+.+ +|.+.+...  ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus       255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChhhEEECCCC-CEEECCCccceec
Confidence            89999975 676666432  2356899999999999999999999 78999999999999999877 7999999999876


Q ss_pred             ccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          245 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       245 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      .....  .....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+....+.+..+.....          
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  399 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------  399 (452)
T ss_dssp             ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             CCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            43321  2234567889999998764 48999999999999999999 9999998877665554433110          


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~  379 (429)
                                        ...+..+++.+.+||.+||..||.+|||+.++++  ..+|..
T Consensus       400 ------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          400 ------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                              0123457899999999999999999999999986  344443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-41  Score=324.19  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=190.4

Q ss_pred             eeEeeEEccCCcEEEEEEEE----cCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           93 YMAERVVGQGSFGIVFQAKC----LETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      |++++.||+|+||.||++..    ..+++.||+|++...     .....+|+.+++.++||||+++++++...   +...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            49999999999999988753    457899999998654     23356899999999999999999988653   2345


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +++||||+++ +|.+.+.     ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH-~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLH-AQHYIHRDLAARNVLLDNDR-LVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCchheEEEcCCC-CEEECCccccc
Confidence            7899999985 6655442     245999999999999999999999 78999999999999999887 79999999998


Q ss_pred             ecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 014156          243 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  316 (429)
Q Consensus       243 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--  316 (429)
                      .......    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......     ....+.....  
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~  256 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMT  256 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchh
Confidence            7754432    2334578889999998764 48899999999999999999999996532211     0000000000  


Q ss_pred             --HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          317 --EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       317 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                        .+...            .........+..+++++.+||.+||..||.+|||+.++++
T Consensus       257 ~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          257 VLRLTEL------------LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHH------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHH------------HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              00000            0000011123457899999999999999999999999984

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.6e-42  Score=321.36  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=187.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC-CCc--EEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ..+|++.+.||+|+||.||+|++.. ++.  .||+|++...       .....+|+.+++.++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            3579999999999999999998643 333  6899987532       23345799999999999999999987432   


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                        . .++||||+. +++.+.+..   ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+||
T Consensus        94 --~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           94 --P-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             --S-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             --C-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHH-hCCcccCCCchheEEEcCCC-CEEEccc
Confidence              1 578999998 566665543   2356899999999999999999999 78999999999999999887 7999999


Q ss_pred             CCceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014156          239 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       239 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      |++........    .....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+.+..+...... 
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-  243 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-  243 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC-
Confidence            99987644332    1234567889999998654 47899999999999999999 99999988776655544331100 


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                                ...+..+++++.++|.+||..||.+|||+.++++
T Consensus       244 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          244 --------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                      0122357899999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.1e-41  Score=343.77  Aligned_cols=244  Identities=25%  Similarity=0.319  Sum_probs=197.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||.||+|.+.. +..||||++...   ...+.+|+.+++.++||||+++++++..      ..+++
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~l  338 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI  338 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccceE
Confidence            4579999999999999999999864 467999998643   2455689999999999999999987632      12679


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+.+ +|.+.+...  ....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+++...
T Consensus       339 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHhhEEEcCCC-cEEEcccccceecC
Confidence            9999975 676666432  2356899999999999999999999 78999999999999999877 79999999997653


Q ss_pred             cCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ...  ......+|..|+|||++.+. .++.++|||||||+||||++ |+.||.+....+.+..+.....           
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------  482 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  482 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            221  11234467889999998764 48999999999999999999 9999998877665554433110           


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                       ...+..+++++.+||.+||..||.+|||+.++++
T Consensus       483 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          483 -----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                             0123457899999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=321.77  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=194.9

Q ss_pred             ccccceeEeeEEccCCcEEEEEEE----EcCCCcEEEEEEeccch----hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++....  
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  115 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--  115 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--
Confidence            344579999999999999999998    45689999999986432    34568999999999999999998775432  


Q ss_pred             CceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                       ...+++||||+++ +|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus       116 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dikp~NIli~~~~-~~kL~Df  189 (326)
T 2w1i_A          116 -RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENEN-RVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCCCcceEEEcCCC-cEEEecC
Confidence             2246799999975 77666543   2356999999999999999999999 78999999999999999887 8999999


Q ss_pred             CCceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          239 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       239 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      |++........    .....+|..|+|||++.+. .++.++|||||||++|+|++|..||....  ...   ....+...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~--~~~---~~~~~~~~  263 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPP--AEF---MRMIGNDK  263 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHH---HHHHCTTC
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCH--HHH---HHhhcccc
Confidence            99987654432    1234567789999998764 48899999999999999999999885421  111   11111111


Q ss_pred             H-H-----HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          315 R-E-----EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       315 ~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      . .     ....+...             .....+..+++++.+||.+||..||.+|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          264 QGQMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CTHHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHHHHhhcC-------------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0 0     00000000             001123457899999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7e-41  Score=322.22  Aligned_cols=254  Identities=20%  Similarity=0.226  Sum_probs=192.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHHHHH--cCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||.||+|++  +|+.||||++.... ....+|.++++.  ++||||+++++++.... .....+++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            4799999999999999999987  68999999986543 344578888887  79999999999875433 222357899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-------~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      |||+++ +|.+.+..     ..+++..++.++.||+.||.|||.       +.||+||||||+|||++.++ .+||+|||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg  192 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  192 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCT
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECC
Confidence            999986 77776643     469999999999999999999993       46999999999999999887 79999999


Q ss_pred             CceecccCCC-----cccccccccccccccccCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCCCCCCh
Q 014156          240 SAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTTAIDIWSVGCVLAELLLG----------QPLFPGESG  299 (429)
Q Consensus       240 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltg----------~~pf~~~~~  299 (429)
                      ++........     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            9987655432     234578999999999865432     23689999999999999999          778865422


Q ss_pred             ----HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          300 ----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       300 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                          ...+........                 ..+.+..    ......++..+.+||.+||..||.+|||+.++++|
T Consensus       273 ~~~~~~~~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          273 SDPSVEEMRKVVCEQK-----------------LRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SSCCHHHHHHHHTTSC-----------------CCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccHHHHHHHHHHHH-----------------hCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                122222111000                 0000000    00112245679999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=347.06  Aligned_cols=242  Identities=25%  Similarity=0.291  Sum_probs=190.5

Q ss_pred             ceeEee-EEccCCcEEEEEEEEc--CCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           92 SYMAER-VVGQGSFGIVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        92 ~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      ++.+.+ .||+|+||.||+|.+.  .++..||||++...     .....+|+++++.++|||||++++++.. .     .
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-----~  409 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----A  409 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----S
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----C
Confidence            456666 8999999999999876  35667999998642     3445689999999999999999998742 1     2


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +++||||+.+ +|.+.+.   .....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+++
T Consensus       410 ~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~  484 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRH-YAKISDFGLSK  484 (613)
T ss_dssp             EEEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCCSTTT
T ss_pred             eEEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHH-HCCEEcCcCCHHHEEEcCCC-cEEEeeccCcc
Confidence            7899999986 4544442   23466999999999999999999999 78999999999999999887 89999999998


Q ss_pred             ecccCCCc----ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ........    ....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+....       
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-------  556 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------  556 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-------
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            65433221    123346789999998654 48999999999999999998 999999887766655443310       


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                           ...++..+++++.+||.+||..||.+|||+.++++
T Consensus       557 ---------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          557 ---------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ---------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                 01123457999999999999999999999998853

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8e-41  Score=346.57  Aligned_cols=240  Identities=23%  Similarity=0.283  Sum_probs=189.9

Q ss_pred             eeEe-eEEccCCcEEEEEEEE--cCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           93 YMAE-RVVGQGSFGIVFQAKC--LETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        93 y~~~-~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      +.+. +.||+|+||.||+|.+  ..+++.||||++...      .....+|+.+++.++|||||++++++.. .     .
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~-----~  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-----S  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----S
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C-----C
Confidence            4443 4899999999999955  456789999998643      2345689999999999999999997731 1     1


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      .++||||+.+ +|.+.+.    ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+
T Consensus       444 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH-~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            6799999985 5655553    3467999999999999999999999 78999999999999999887 89999999998


Q ss_pred             ecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      .......    .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+....       
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-------  589 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------  589 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence            7644322    2233467889999999664 48999999999999999998 999999887766555443321       


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                           ...++..+++++.+||.+||..||.+|||+.++++
T Consensus       590 ---------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          590 ---------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                 00123457999999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3e-43  Score=338.28  Aligned_cols=249  Identities=19%  Similarity=0.196  Sum_probs=182.5

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------hhHHHHHHHHHHcC---------CCCeec
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVVS  148 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~~iv~  148 (429)
                      ..+|++.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35799999999999999999998  78999999986542            44568999998886         555555


Q ss_pred             ccee-----------------eeecCC--------CCceEEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHH
Q 014156          149 LKHC-----------------FFSTTD--------KDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQIC  202 (429)
Q Consensus       149 l~~~-----------------~~~~~~--------~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~  202 (429)
                      +.++                 |.....        .....+|+||||+.++ +++.+.     ...+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence            5444                 322100        0134588999999754 444331     25689999999999999


Q ss_pred             HHHHHHHcCCCeeecCCCCCCeeecCCC-------------------CceEEeecCCceecccCCCcccccccccccccc
Q 014156          203 RALAYIHGGIGVCHRDIKPQNLLVNPHT-------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE  263 (429)
Q Consensus       203 ~aL~~LH~~~~iiHrDlKp~Nill~~~~-------------------~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE  263 (429)
                      .||.|||++.||+||||||+||||+.++                   ..+||+|||+|+.....    ..+||+.|+|||
T Consensus       172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE  247 (336)
T 2vuw_A          172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred             HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence            9999999336999999999999998764                   17999999999876432    458999999999


Q ss_pred             cccCCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccc
Q 014156          264 LIFGATEYTTAIDIWSVGCV-LAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  341 (429)
Q Consensus       264 ~~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (429)
                      ++.+..  +.++||||++++ .+++++|..||.+...... ...+.......                  ..    ....
T Consensus       248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~~----~~~~  303 (336)
T 2vuw_A          248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK------------------TK----CNTP  303 (336)
T ss_dssp             GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS------------------SC----CCSH
T ss_pred             hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC------------------cc----cchh
Confidence            997643  889999998777 7788899999943211111 11222110000                  00    0001


Q ss_pred             cCCCCChhHHHHHHhhcCcCCCCCCCHHHHh-cCCCcc
Q 014156          342 FHKRMPPEAVDLVSRLLQYSPNLRCTALEAC-IHPFFD  378 (429)
Q Consensus       342 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l-~hp~f~  378 (429)
                      ..+.+++++++||++||++|     |+.|+| +||||+
T Consensus       304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            12236889999999999987     999999 999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.9e-41  Score=318.37  Aligned_cols=251  Identities=20%  Similarity=0.279  Sum_probs=191.8

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ...+|++.+.||+|+||.||+|++..   .+|+|++...      .....+|+.+++.++||||+++++++....     
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  102 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-----  102 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-----
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence            34579999999999999999998743   4999988532      123457999999999999999999885432     


Q ss_pred             EEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||+. ++|.+.+.   .....+++..++.++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~  176 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH-AKGILHKDLKSKNVFYD-NG-KVVITDFGLF  176 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTT---SSCCCCCSHHHHHHHHHHHHHHHHHH-HTTCCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred             ceEEEeecccCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChhhEEEe-CC-CEEEeecCCc
Confidence            3789999997 45555442   23346899999999999999999999 78999999999999998 45 7999999998


Q ss_pred             eeccc------CCCcccccccccccccccccC--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014156          242 KVLVK------GEPNISYICSRYYRAPELIFG--------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII  307 (429)
Q Consensus       242 ~~~~~------~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  307 (429)
                      +....      ........||+.|+|||++.+        ...++.++|||||||++|+|++|+.||.+.........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            65421      122234568999999999864        2347889999999999999999999998877665554433


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ... .                  +.        .....++.++.+||.+||..||.+|||+.++++  .|+++..
T Consensus       257 ~~~-~------------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~  302 (319)
T 2y4i_B          257 TGM-K------------------PN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK  302 (319)
T ss_dssp             TTC-C------------------CC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred             cCC-C------------------CC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence            210 0                  00        011246889999999999999999999999986  3444443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.5e-40  Score=342.98  Aligned_cols=246  Identities=27%  Similarity=0.361  Sum_probs=195.9

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCC---CcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ....+|++.+.||+|+||.||+|.+..+   +..||+|.+....     ....+|+.+++.++||||+++++++..    
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            3456899999999999999999998654   4679999875422     344579999999999999999987621    


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      +  .+++||||++ ++|.+.+..   ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus       463 ~--~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDikp~NILl~~~~-~vkL~DF  535 (656)
T 2j0j_A          463 N--PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDF  535 (656)
T ss_dssp             S--SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred             C--ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchHhEEEeCCC-CEEEEec
Confidence            1  2678999998 466665542   2356899999999999999999999 78999999999999999887 7999999


Q ss_pred             CCceecccCCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          239 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       239 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |+++.......  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+.....    
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~----  610 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----  610 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC----
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----
Confidence            99987644322  1234567899999998654 58999999999999999997 9999998887776665544210    


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                              ..++..+++.+.+||.+||..||.+|||+.++++
T Consensus       611 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                    0123457899999999999999999999999875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.6e-41  Score=351.70  Aligned_cols=243  Identities=25%  Similarity=0.348  Sum_probs=195.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC-CCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .++|++.+.||+|+||.||+|.+.. +|+.||||++...     .....+|+.+++.++||||+++++++......+..+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999976 7899999988532     123457999999999999999999887766555556


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      .|+||||++++.+....     ...+++..++.++.||+.||.||| +.||+||||||+|||++.+  .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~-----~~~l~~~~~~~~~~qi~~aL~~lH-~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-SIGLVYNDLKPENIMLTEE--QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecccChHHeEEeCC--cEEEEecccchh
Confidence            78999999864332211     237999999999999999999999 7899999999999999864  699999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....          +.+.         
T Consensus       231 ~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~---------  286 (681)
T 2pzi_A          231 INSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE---------  286 (681)
T ss_dssp             TTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT---------
T ss_pred             cccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc---------
Confidence            6433   456799999999998653  488999999999999999999988642110          0000         


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                 ..     .....++.+.+||.+||..||.+||+..+++.|+|+.-+
T Consensus       287 -----------~~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 -----------DD-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -----------TC-----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----------cc-----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                       00     000136789999999999999999999999999998654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-38  Score=299.30  Aligned_cols=220  Identities=16%  Similarity=0.058  Sum_probs=171.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.++..++||||+++++++...     .
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----A  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----C
Confidence            357999999999999999999999999999999986431       3456799999999999999999988543     3


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ..|+||||+++ +|.+++.      .......+..++.||+.||.||| +.||+||||||+|||++.++ .+||+++|  
T Consensus       105 ~~~lv~e~~~g~~L~~~l~------~~~~~~~~~~i~~ql~~aL~~lH-~~givH~Dikp~NIll~~~g-~~kl~~~~--  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAH-RAGVALSIDHPSRVRVSIDG-DVVLAYPA--  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHT------TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEEETTS-CEEECSCC--
T ss_pred             cEEEEEEecCCCCHHHHHh------cCCChHHHHHHHHHHHHHHHHHH-HCCCccCCCCcccEEEcCCC-CEEEEecc--
Confidence            48899999975 5555542      12455678889999999999999 78999999999999999887 79988443  


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                                       |++|        ++.++|||||||++|+|++|+.||.+.+..+.+..                
T Consensus       175 -----------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------------  213 (286)
T 3uqc_A          175 -----------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------------  213 (286)
T ss_dssp             -----------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----------------
T ss_pred             -----------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----------------
Confidence                             3332        68899999999999999999999987643211100                


Q ss_pred             CCCCccccCCCcC-CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          322 NPNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       322 ~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                             ....+. .......+...+++++.+||.+||+.||.+| |+.++++
T Consensus       214 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          214 -------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             -------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             -------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                   000000 0011112345689999999999999999999 9999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.5e-32  Score=279.10  Aligned_cols=179  Identities=17%  Similarity=0.072  Sum_probs=122.6

Q ss_pred             EEccCCcEEEEEEEEcCCCcEEEEEEeccc--------------hhhHHHHHHHHHHc-CCCCeeccceeeeecCCCCce
Q 014156           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD--------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .++.|++|.+..++....|+.||+|++.++              ...+.+|+++|+++ .|+||+++++++     .+..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            467788888888887788999999988543              12345799999999 799999999988     4445


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+|||||||+| +|.+++.    ..+.+++.   .|+.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH-~~GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALE-KQGFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHH-HTTCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHH-HCCceeccCchHhEEECCCC-CEEEeecccC
Confidence            58999999996 5555443    34667654   57899999999999 88999999999999999888 7999999999


Q ss_pred             eecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q 014156          242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP  292 (429)
Q Consensus       242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~  292 (429)
                      +..... ....+.+||+.|||||++.+.  +...+|+||+|+++++|.++..
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             eeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence            876443 334567899999999999653  6778999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.2e-27  Score=241.19  Aligned_cols=178  Identities=16%  Similarity=0.230  Sum_probs=131.8

Q ss_pred             eEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        94 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ...+.||+|+||.||+|.  ..++.+++|+....            .....+|+++++.++||||+++..++.....   
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence            445689999999999994  46788999976321            1224689999999999999965444433222   


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                        .|+||||++ ++|.+.+..            +..++.||+.||.||| ++||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH-~~gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH-KNDVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH-HTTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH-HCcCccCCCCHHHEEECC---eEEEEECcc
Confidence              478999997 566554321            5688999999999999 889999999999999996   699999999


Q ss_pred             ceecccCCC--------cccccccccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 014156          241 AKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLF  294 (429)
Q Consensus       241 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf  294 (429)
                      |+.......        ....+||+.|+|||++... ..|+..+|+||..+-..+.+.++.+|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            988744322        1356899999999998541 23777889999999999888887666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=2.4e-24  Score=201.15  Aligned_cols=139  Identities=17%  Similarity=0.191  Sum_probs=109.1

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----------------------hhhHHHHHHHHHHcCCCCeecc
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------------------KRYKNRELQTMRLLDHPNVVSL  149 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~E~~~l~~l~h~~iv~l  149 (429)
                      .|.+.+.||+|+||.||+|.+ .+|+.||+|.+...                      .....+|+.+++.++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            355669999999999999999 88999999988532                      223458999999999  5 677


Q ss_pred             ceeeeecCCCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC
Q 014156          150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP  228 (429)
Q Consensus       150 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~  228 (429)
                      +.++.. .     ..++||||+++ +|.+ +          .......++.||+.||.||| +.||+||||||+|||++ 
T Consensus       167 ~~~~~~-~-----~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH-~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          167 PKVYAW-E-----GNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             CCEEEE-E-----TTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEE-
T ss_pred             CeEEec-c-----ceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHH-HCCCEeCCCCHHHEEEE-
Confidence            665522 1     25799999986 4433 1          11235579999999999999 88999999999999999 


Q ss_pred             CCCceEEeecCCceecccCCCccccccccccccccccc
Q 014156          229 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF  266 (429)
Q Consensus       229 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  266 (429)
                      ++ .+||+|||+|+.            +..++|||.+.
T Consensus       228 ~~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 EE-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TT-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             CC-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            66 899999999864            34478898773

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=5.8e-21  Score=175.93  Aligned_cols=136  Identities=18%  Similarity=0.234  Sum_probs=102.3

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcE--EEEEEeccch----------------------------hhHHHHHHHHHHc
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDK----------------------------RYKNRELQTMRLL  141 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l  141 (429)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            388999999999999999998788999  9999864321                            1346799999999


Q ss_pred             CCCCeeccceeeeecCCCCceEEEEEeecchh------hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCee
Q 014156          142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE------TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC  215 (429)
Q Consensus       142 ~h~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~ii  215 (429)
                      .|+++.-. ..+.. .     ..++||||+++      .+.+...       ..++..+..++.||+.||.|||.+.||+
T Consensus       128 ~~~~i~~p-~~~~~-~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~giv  193 (258)
T 1zth_A          128 KEAGVSVP-QPYTY-M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEAELV  193 (258)
T ss_dssp             HHTTCCCC-CEEEE-E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTSCEE
T ss_pred             HhCCCCCC-eEEEc-C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            88764221 11111 1     14689999953      3433211       1234567889999999999999556999


Q ss_pred             ecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       216 HrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ||||||+|||++.   .++|+|||+|...
T Consensus       194 HrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC---cEEEEECcccccC
Confidence            9999999999986   5999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.5e-18  Score=166.47  Aligned_cols=142  Identities=12%  Similarity=0.088  Sum_probs=91.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------------------hhHHHHHHHHHHcCCCCeeccceee
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------RYKNRELQTMRLLDHPNVVSLKHCF  153 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h~~iv~l~~~~  153 (429)
                      -|.+.++||.|+||.||+|.+ .+|+.||||+++...                  .....+.++.....|+|++++++..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            399999999999999999997 469999999864210                  0001122222222334443333221


Q ss_pred             eecCCC-CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC-
Q 014156          154 FSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-  231 (429)
Q Consensus       154 ~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~-  231 (429)
                      +..... .....+|||||++|..+..         ......+..++.||+.+|.+|| +.|||||||||.|||++.++. 
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~~---------l~~~~~~~~l~~qll~~l~~lH-~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMRQ---------VSSVPDPASLYADLIALILRLA-KHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGGG---------CCCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEEEEECS
T ss_pred             CCCCeeeeccCceEEEEecCCccHhh---------hcccHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHEEEeCCCCc
Confidence            110000 0000258999998753221         1112235678899999999999 889999999999999986652 


Q ss_pred             --------ceEEeecCCceec
Q 014156          232 --------QVKLCDFGSAKVL  244 (429)
Q Consensus       232 --------~vkl~DFG~a~~~  244 (429)
                              .+.|+||+-+...
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEET
T ss_pred             ccccccccceEEEEeCCcccC
Confidence                    3889999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=1.5e-11  Score=112.96  Aligned_cols=136  Identities=15%  Similarity=0.111  Sum_probs=99.4

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEecc----chhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ----DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .|++...++.|+.+.||++..  .+..+++|+...    ......+|+.+++.+. +..+.++++++..     ....|+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCceEE
Confidence            488899999999999999974  468999998753    3345678999999985 5566677766532     234789


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-----------------------------------  211 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-----------------------------------  211 (429)
                      |||+++|..+...  .      .+......++.++..+|..||+-                                   
T Consensus        88 v~e~i~G~~l~~~--~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEE--Y------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHH--C------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhc--c------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999998533321  1      01122346778999999999940                                   


Q ss_pred             -----------------------CCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          212 -----------------------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       212 -----------------------~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                                             ..++|+|++|.||+++.++ .+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence                                   4589999999999998543 567999998743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.07  E-value=3.8e-10  Score=103.04  Aligned_cols=133  Identities=17%  Similarity=0.109  Sum_probs=88.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcCCCC--eeccceeeeecCCCCceEEEEEe
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      .|.+....+.|..+.||++.. .+|..+++|..... .....+|+.+++.+.+.+  +.+++.+....     ...++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEEE
Confidence            355554445677799999963 56778999987543 234568999999886544  34465544221     2367899


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----------------------------------
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-----------------------------------  213 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~-----------------------------------  213 (429)
                      ||++|..+. .       ....   ...++.+++..|..|| +..                                   
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLH-TLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHT-TSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            999975322 0       1111   1245667777777777 322                                   


Q ss_pred             -----------------------eeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          214 -----------------------VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       214 -----------------------iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                                             ++|+|++|.||+++.++ .+.|+|||.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~  214 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV  214 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence                                   99999999999998653 566999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.00  E-value=4.1e-10  Score=108.24  Aligned_cols=140  Identities=16%  Similarity=0.152  Sum_probs=97.8

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEec--cc-----hhhHHHHHHHHHHcCC--CCeeccceeeeecCCCCceEEEE
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVL--QD-----KRYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~-----~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ++.|+.|.++.||++..  .+..+++|+..  ..     .....+|+.+++.|..  ..+.+++..+....  .....|+
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence            56789999999999875  34678888765  22     3456789999999974  44566665442221  1123568


Q ss_pred             EeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc------------------------------------
Q 014156          167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG------------------------------------  210 (429)
Q Consensus       167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~------------------------------------  210 (429)
                      ||||++|..+..     .....++......++.+++.+|..||+                                    
T Consensus       119 vme~v~G~~l~~-----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          119 IMEFVSGRVLWD-----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEECCCCBCCCC-----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEecCCeecCC-----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            999999743210     112346777788889999999999994                                    


Q ss_pred             ---------------------CCCeeecCCCCCCeeecCCCC-ceEEeecCCceec
Q 014156          211 ---------------------GIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVL  244 (429)
Q Consensus       211 ---------------------~~~iiHrDlKp~Nill~~~~~-~vkl~DFG~a~~~  244 (429)
                                           ..+++|+|+++.|||++.++. .+.|+||+.+...
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                 146999999999999987652 3689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=3.8e-10  Score=105.94  Aligned_cols=185  Identities=12%  Similarity=0.151  Sum_probs=109.2

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecC-CCCceEEEEEeecchh
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTT-DKDELYLNLVLEFVPE  173 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~~~~~~lv~e~~~~  173 (429)
                      +.++.|....||++.     ..+++|+....  .....+|..+++.+.+..-+.+-..+.... .......|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458999999999873     46889976543  345668999998884322122222222211 1111234689999987


Q ss_pred             hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------------------------------------------
Q 014156          174 TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------------------------------------------  210 (429)
Q Consensus       174 ~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-------------------------------------------  210 (429)
                      ..+....     ...++......++.|++..|..||+                                           
T Consensus       101 ~~l~~~~-----~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A          101 VPLTPLL-----LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             EECCHHH-----HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             eECCccc-----cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            4222110     0235555556666666666666662                                           


Q ss_pred             --------------CCCeeecCCCCCCeeecCC-CCceEEeecCCceecccCCCcccccccccc---ccccccc------
Q 014156          211 --------------GIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYY---RAPELIF------  266 (429)
Q Consensus       211 --------------~~~iiHrDlKp~Nill~~~-~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y---~aPE~~~------  266 (429)
                                    ...++|+|++|.||+++.+ +..+.|+||+.+........   ......+   ..|+...      
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHHHc
Confidence                          1247999999999999874 43688999999875422110   0000001   1222110      


Q ss_pred             CCC-------CCCCcchHHHHHHHHHHHHhCCCCC
Q 014156          267 GAT-------EYTTAIDIWSVGCVLAELLLGQPLF  294 (429)
Q Consensus       267 ~~~-------~~~~~~DiwslG~il~elltg~~pf  294 (429)
                      +..       ......+.|+++.+++.+.+|..+|
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            000       0112258999999999999999776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.48  E-value=1.3e-06  Score=81.83  Aligned_cols=69  Identities=12%  Similarity=-0.041  Sum_probs=44.9

Q ss_pred             eEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCC---eeccceeeeecCCCCceEEEEEeecc
Q 014156           97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN---VVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~---iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      +.++.|....||+.     |..+++|+-...  .....+|..+|+.|.+..   +.+.+.+..  ..  ....++||+++
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~~--~g~~~~v~e~i   95 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--RS--DGNPFVGYRKV   95 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--CT--TSCEEEEEECC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--cC--CCceEEEEecc
Confidence            46788999999988     567888975432  234568999999997532   233333221  11  12356899999


Q ss_pred             hhh
Q 014156          172 PET  174 (429)
Q Consensus       172 ~~~  174 (429)
                      +|.
T Consensus        96 ~G~   98 (306)
T 3tdw_A           96 QGQ   98 (306)
T ss_dssp             CSE
T ss_pred             CCe
Confidence            874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.16  E-value=1e-05  Score=76.58  Aligned_cols=31  Identities=23%  Similarity=0.451  Sum_probs=27.0

Q ss_pred             CCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       211 ~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      ..+++|+|+++.|||++.++ .+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            46899999999999997665 69999999874

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.14  E-value=2.3e-05  Score=71.59  Aligned_cols=71  Identities=11%  Similarity=0.081  Sum_probs=44.9

Q ss_pred             EccCCc-EEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcCC-CCeeccceeeeecCCCCceEEEEEeecchhh
Q 014156           99 VGQGSF-GIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLVLEFVPET  174 (429)
Q Consensus        99 lG~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~~~~~~lv~e~~~~~  174 (429)
                      +..|.. +.||+......+..+++|+-... .....+|...|+.|.. -.+.+++.+...   .  ...++||++++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~---~--~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT---P--DDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE---T--TEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE---C--CeEEEEEEeeCCc
Confidence            334444 47999887667788999976543 2345679999988853 123444443322   1  2367899999864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.02  E-value=2.7e-05  Score=75.53  Aligned_cols=71  Identities=17%  Similarity=0.176  Sum_probs=44.0

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----------hhhHHHHHHHHHHcCC--CC-eeccceeeeecCCCCc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLDH--PN-VVSLKHCFFSTTDKDE  161 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--~~-iv~l~~~~~~~~~~~~  161 (429)
                      .+.||.|..+.||++....+++.+++|.....           ......|.++++.+..  +. +.+++.+  .   ...
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence            46799999999999976556788999975321           1233578888887743  33 3344322  2   111


Q ss_pred             eEEEEEeecchh
Q 014156          162 LYLNLVLEFVPE  173 (429)
Q Consensus       162 ~~~~lv~e~~~~  173 (429)
                        .++|||++++
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              3589999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.91  E-value=2e-05  Score=75.10  Aligned_cols=77  Identities=9%  Similarity=0.063  Sum_probs=47.8

Q ss_pred             EeeEE-ccCCcEEEEEEEEc--C----CCcEEEEEEeccch-------hhHHHHHHHHHHcCC---CCeeccceeeeecC
Q 014156           95 AERVV-GQGSFGIVFQAKCL--E----TGETVAIKKVLQDK-------RYKNRELQTMRLLDH---PNVVSLKHCFFSTT  157 (429)
Q Consensus        95 ~~~~l-G~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~~iv~l~~~~~~~~  157 (429)
                      ..+.| +.|....+|++...  .    ++..+++|......       ....+|+.+++.|..   -.+.+++...... 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~-  102 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG-  102 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS-
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC-
Confidence            44678 88999999988653  1    25678999765432       345789998888742   2345555433211 


Q ss_pred             CCCceEEEEEeecchh
Q 014156          158 DKDELYLNLVLEFVPE  173 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~  173 (429)
                       ......++|||+++|
T Consensus       103 -~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 -DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             -TTTSSCEEEEECCCC
T ss_pred             -CccCCceEEEEecCC
Confidence             100124579999875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.39  E-value=0.00079  Score=62.39  Aligned_cols=65  Identities=14%  Similarity=0.089  Sum_probs=39.8

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCe-eccceeeeecCCCCceEEEEEeecc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      ++.|+.|....+|++      ..+++|+.....   ....+|+.+++.+....+ .+++...     ...  -+++++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            578999999999998      458888765321   123568888877743233 2333322     111  14689998


Q ss_pred             -hh
Q 014156          172 -PE  173 (429)
Q Consensus       172 -~~  173 (429)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             54

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.32  E-value=0.00088  Score=65.29  Aligned_cols=78  Identities=12%  Similarity=-0.052  Sum_probs=47.0

Q ss_pred             CCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCcccccc--cccccccccccCCC--CCCCcchHHHHHHHHHH
Q 014156          211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGAT--EYTTAIDIWSVGCVLAE  286 (429)
Q Consensus       211 ~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~--~~~~~~DiwslG~il~e  286 (429)
                      ...++|+|+++.|||++.++  +.|+||+.+.............+  ...|.+|+......  ......++.+....++.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            56899999999999998654  99999999875422111111111  23466666542111  01122444577777777


Q ss_pred             HHhC
Q 014156          287 LLLG  290 (429)
Q Consensus       287 lltg  290 (429)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.28  E-value=0.0027  Score=58.29  Aligned_cols=73  Identities=14%  Similarity=0.095  Sum_probs=47.9

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ..-++.+|.|..+.||++.. .+|+.|.+|+-...    ......|+..|+.|....-|.+-..+....      -++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~------~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD------RTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET------TEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC------ceEEE
Confidence            44567899999999999974 67899999975432    234578999999885322122222221111      25789


Q ss_pred             ecch
Q 014156          169 EFVP  172 (429)
Q Consensus       169 e~~~  172 (429)
                      |++.
T Consensus        90 e~l~   93 (288)
T 3f7w_A           90 EWVD   93 (288)
T ss_dssp             ECCC
T ss_pred             Eeec
Confidence            9876

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.15  E-value=0.0043  Score=53.90  Aligned_cols=101  Identities=17%  Similarity=0.085  Sum_probs=62.3

Q ss_pred             hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCCCcccc
Q 014156          174 TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  253 (429)
Q Consensus       174 ~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~~~~~~  253 (429)
                      +|.+++..+   ..++++.+++.++.|.+.+|.-+-.+..-..+=+.|..|+|..+| .|.+.+ +.+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            455666553   578999999999999999988762111111233446888888888 565543 1110           


Q ss_pred             cccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q 014156          254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP  292 (429)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~  292 (429)
                      .....+.|||...  ...+.+.=|||||+++|..+--..
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence            1122367888763  335678899999999999986553

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.10  E-value=0.0025  Score=59.38  Aligned_cols=143  Identities=15%  Similarity=0.063  Sum_probs=74.0

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEecc--chhhHHHHHHHHHHcCCCC--eeccceeeeecCCC----CceEEEE
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDK----DELYLNL  166 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~----~~~~~~l  166 (429)
                      -.+.|+.|....+|++... + ..+++|....  .......|+.+++.|....  +.+++..   ....    .....++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-S-CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-C-ccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence            3467888888999998752 3 3688998765  3345567888887774322  2233211   0000    0112568


Q ss_pred             EeecchhhH------------HHHHHHhhhcCCC--------CCHHHHHHH---------------HHHHHHHHHHHHc-
Q 014156          167 VLEFVPETV------------YRVAKHYSRASQR--------MPLIYVKLY---------------TYQICRALAYIHG-  210 (429)
Q Consensus       167 v~e~~~~~l------------~~~~~~~~~~~~~--------l~~~~~~~~---------------~~qi~~aL~~LH~-  210 (429)
                      ++++++|..            -..+.........        .........               ...+...+..+.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999987521            0111111110000        111100000               0113334444441 


Q ss_pred             -----CCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          211 -----GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       211 -----~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                           ..+++|+|+.+.|||++.++ .+.|+||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                 24799999999999998654 457999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.05  E-value=0.008  Score=59.08  Aligned_cols=70  Identities=16%  Similarity=0.219  Sum_probs=44.7

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchh---hHHHHHHHHHHcCCCCe-eccceeeeecCCCCceEEEEEeec
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEF  170 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~~~~lv~e~  170 (429)
                      -++.|+.|-...+|++.....+..+++|+......   ...+|..+++.|...++ .++++++     .+    .+|++|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            34678889999999998644357889997643221   22589999999975555 3455444     11    148898


Q ss_pred             chh
Q 014156          171 VPE  173 (429)
Q Consensus       171 ~~~  173 (429)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.96  E-value=0.0051  Score=60.05  Aligned_cols=69  Identities=16%  Similarity=0.232  Sum_probs=45.2

Q ss_pred             eeEEccCCcEEEEEEEEcC-------CCcEEEEEEecc-ch-hhHHHHHHHHHHcCCCCe-eccceeeeecCCCCceEEE
Q 014156           96 ERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQ-DK-RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~~~~  165 (429)
                      ++.|+.|....||++....       .+..+++|+... .. ....+|..+++.|...++ .++++.+     .+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence            4578889899999998642       257899998743 22 344478888888754333 4454433     21    2


Q ss_pred             EEeecchh
Q 014156          166 LVLEFVPE  173 (429)
Q Consensus       166 lv~e~~~~  173 (429)
                      +|++|++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            68888865

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.87  E-value=0.0082  Score=56.03  Aligned_cols=72  Identities=14%  Similarity=-0.011  Sum_probs=42.3

Q ss_pred             EEccCCcEEEEEEEEcCCCcEEEEEEecc---chhhHHHHHHHHHHcCCCC--eeccceeeeecCC--CCceEEEEEeec
Q 014156           98 VVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTD--KDELYLNLVLEF  170 (429)
Q Consensus        98 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~--~~~~~~~lv~e~  170 (429)
                      .|+ |....||++.. .+|+.+++|....   .......|..+++.|....  +.+++..  ....  ......+++|++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            456 77788998763 3566899998752   2345567888887774222  3333322  1000  001235679999


Q ss_pred             chh
Q 014156          171 VPE  173 (429)
Q Consensus       171 ~~~  173 (429)
                      ++|
T Consensus       109 i~G  111 (328)
T 1zyl_A          109 VGG  111 (328)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.87  E-value=0.0058  Score=56.86  Aligned_cols=71  Identities=18%  Similarity=0.076  Sum_probs=49.3

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcC---CCCeeccceeeeecCCCCceEEEEEeecc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELYLNLVLEFV  171 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~~~~~~lv~e~~  171 (429)
                      .+.|+.|....+|+...  ++..+++|+.... .....+|...|+.|.   ...+.+++.....     ....++|||++
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEec
Confidence            46789999999999974  5678899976543 344568988888874   2445555544321     12367899999


Q ss_pred             hh
Q 014156          172 PE  173 (429)
Q Consensus       172 ~~  173 (429)
                      ++
T Consensus       114 ~G  115 (312)
T 3jr1_A          114 NK  115 (312)
T ss_dssp             CC
T ss_pred             cC
Confidence            75

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.82  E-value=0.0032  Score=60.06  Aligned_cols=69  Identities=12%  Similarity=0.129  Sum_probs=39.4

Q ss_pred             eeEEccCCcEEEEEEEEcC--------CCcEEEEEEeccchh---hHHHHHHHHHHcCCCCe-eccceeeeecCCCCceE
Q 014156           96 ERVVGQGSFGIVFQAKCLE--------TGETVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELY  163 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~~  163 (429)
                      .+.|+.|....+|++....        .+..+++|+......   ....|..+++.|...++ .+++..+     .+   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC---
Confidence            3467788888999987543        136788997643322   23578888888753333 3444332     11   


Q ss_pred             EEEEeecchh
Q 014156          164 LNLVLEFVPE  173 (429)
Q Consensus       164 ~~lv~e~~~~  173 (429)
                       ++||+|++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             468888875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.72  E-value=0.0052  Score=57.63  Aligned_cols=34  Identities=38%  Similarity=0.493  Sum_probs=27.7

Q ss_pred             CCCeeecCCCCCCeeecCC---CCceEEeecCCceec
Q 014156          211 GIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKVL  244 (429)
Q Consensus       211 ~~~iiHrDlKp~Nill~~~---~~~vkl~DFG~a~~~  244 (429)
                      ...++|+|+.+.||+++.+   ...+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4579999999999999864   136899999998653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.68  E-value=0.0099  Score=56.87  Aligned_cols=138  Identities=16%  Similarity=0.240  Sum_probs=74.4

Q ss_pred             eEEccCCcEEEEEEEEcC-------CCcEEEEEEecc---chhhHHHHHHHHHHcCCCCe-eccceeeeecCCCCceEEE
Q 014156           97 RVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQ---DKRYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~~~~  165 (429)
                      +.|..|-...+|++....       +++.|++|+.-.   ......+|.++++.|..-++ .+++..+     .+    .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence            456667777888887532       357889997532   22334579888888743222 3444433     22    1


Q ss_pred             EEeecchhhH------------HHHH---HHhhhc----CCCCC--HHHHHHHHHHHHH-------------------HH
Q 014156          166 LVLEFVPETV------------YRVA---KHYSRA----SQRMP--LIYVKLYTYQICR-------------------AL  205 (429)
Q Consensus       166 lv~e~~~~~l------------~~~~---~~~~~~----~~~l~--~~~~~~~~~qi~~-------------------aL  205 (429)
                      +||||++|..            ..+.   ..+-..    .....  ...+..+..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            6899987521            1111   111111    11111  3445555544322                   12


Q ss_pred             HHHH-------cCCCeeecCCCCCCeeecCC---CCceEEeecCCcee
Q 014156          206 AYIH-------GGIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKV  243 (429)
Q Consensus       206 ~~LH-------~~~~iiHrDlKp~Nill~~~---~~~vkl~DFG~a~~  243 (429)
                      ..|.       ....++|+|+.+.||+++.+   ...+.|+||..|..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332       12369999999999999876   23699999998864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.39  E-value=0.0053  Score=57.90  Aligned_cols=32  Identities=25%  Similarity=0.496  Sum_probs=27.2

Q ss_pred             CCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       212 ~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ..++|+|+.+.||+++.++ .+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG-CEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCC-eEEEEECCCCeeC
Confidence            4799999999999998665 6999999887653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.91  E-value=0.17  Score=48.93  Aligned_cols=31  Identities=19%  Similarity=0.495  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       212 ~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ..++|+|+.+.||+ +.++ .+.|+||..|...
T Consensus       262 ~~~~H~D~~~~N~l-~~~~-~~~~IDwe~a~~~  292 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQN-NIRMIDYEYSAIN  292 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSS-CEEECCCTTCEEE
T ss_pred             ceEECCCCCcccee-cCCC-cEEEEecccCCcC
Confidence            36899999999999 5555 7999999988643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	429
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-127
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-70
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-69
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-66
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-65
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-65
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-65
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-65
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-65
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-64
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-63
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-62
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-61
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-59
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-59
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-59
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-57
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-56
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-55
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-52
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-52
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-52
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-50
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-49
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-48
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-37
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-37
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  370 bits (951), Expect = e-127
 Identities = 241/347 (69%), Positives = 286/347 (82%), Gaps = 4/347 (1%)

Query: 76  IVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL 135
           +V T G    +P Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 136 QTMRLLDHPNVVSLKHCFFST-TDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV 194
           Q MR LDH N+V L++ F+S+   KDE+YLNLVL++VPETVYRVA+HYSRA Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
           KLY YQ+ R+LAYIH   G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
           CSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T LEAC H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 375 PFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
            FFDELRDPN +LPNGR  P LFNF  QEL  ++  L + LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 8e-74
 Identities = 107/345 (31%), Positives = 177/345 (51%), Gaps = 25/345 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKN---RELQTMRLLDHPNVV 147
           Y     +G+G++G+V  A        VAIKK+   + + Y     RE++ +    H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +     + T +    + LV   +   +Y++ K      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRAPE 263
           IH    V HRD+KP NLL+N  T  +K+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321
           ++  +  YT +IDIWSVGC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 322 -NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
                     P     PW+++F      +A+DL+ ++L ++P+ R    +A  HP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 381 RDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
            D     P+  P          EL    KE L +LI E   +  P
Sbjct: 302 YD-----PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 341

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 4e-70
 Identities = 70/305 (22%), Positives = 122/305 (40%), Gaps = 31/305 (10%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           +     +G G+ G+VF+     +G  +A K +  + +        RELQ +   + P +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
                F       E+ +   +E +            + + R+P   +   +  + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMDGGSLD---QVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           +     + HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 326
            T Y+   DIWS+G  L E+ +G+   P       +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 327 EFKF--------------PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
              +                I   P  K+       E  D V++ L  +P  R    +  
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 373 IHPFF 377
           +H F 
Sbjct: 297 VHAFI 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (560), Expect = 2e-69
 Identities = 99/304 (32%), Positives = 149/304 (49%), Gaps = 23/304 (7%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVV 147
             +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L   F     K  + L  V +F+   +          S  +   ++K Y     + L Y
Sbjct: 64  GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
           +H    + HRD+KP NLL++ +   +KL DFG AK         ++   +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
           GA  Y   +D+W+VGC+LAELLL  P  PG+S +DQL  I + LGTPT E+   M     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP--N 384
              F      P H IF      + +DL+  L  ++P  R TA +A    +F     P   
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 385 ARLP 388
            +LP
Sbjct: 293 CQLP 296

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 7e-66
 Identities = 109/335 (32%), Positives = 169/335 (50%), Gaps = 25/335 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y   + VG G++G V  A    TG  VAIKK+ +  + +       REL+ ++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 147 VSLKHCFFS-TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           + L   F    T  D     LV+ F+   + ++ KH     +++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            YIH   G+ HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                YT  +DIWSVGC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 326 TEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD 382
            +      P+++   +  I      P AV+L+ ++L      R TA EA  HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 383 PNARLPNGRPFPPLF---NFKPQELKGAS-KELLS 413
                P  + +   F   +    E K  + KE+LS
Sbjct: 310 TE-DEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLS 343

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 1e-65
 Identities = 103/307 (33%), Positives = 164/307 (53%), Gaps = 21/307 (6%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           +     +G+G++G+V++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V L           E  L LV EF+ + + +     +     +PLI  K Y +Q+ + LA
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLA 116

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 265
           + H    V HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 324
            G   Y+TA+DIWS+GC+ AE++  + LFPG+S +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN 384
             +  FP+     + K+    +  +   L+S++L Y PN R +A  A  HPFF ++  P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 385 ARLPNGR 391
             +P+ R
Sbjct: 293 --VPHLR 297

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-65
 Identities = 100/335 (29%), Positives = 158/335 (47%), Gaps = 24/335 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
           Y     VG G++G V  A   +TG  VA+KK+      +   +   REL+ ++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           + L   F      +E     ++  +         +     Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
           YIH    + HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
               Y   +DIWSVGC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 327 EF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
                   Q+    +  +F     P AVDL+ ++L    + R TA +A  H +F +  DP
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 384 NARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 418
           +   P   P+   F     E +    +    L  +
Sbjct: 311 D-DEPVADPYDQSF-----ESRDLLIDEWKSLTYD 339

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  211 bits (539), Expect = 1e-65
 Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 41/309 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 148
           Y     +G G+FG+V +     TG   A K V+     DK    +E+QTM +L HP +V+
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L   F    D +E+ +  + EF+      + +  +    +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 209 HGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           H      H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
                   D+WSVG +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP--NA 385
                             +  +  D + +LL   PN R T  +A  HP+      P  ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 386 RLPNGRPFP 394
           ++P+ R   
Sbjct: 294 QIPSSRYTK 302

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 2e-65
 Identities = 85/309 (27%), Positives = 143/309 (46%), Gaps = 22/309 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 147 VSLKHCFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           V+L     +     ++ +  + LV +F    +       S    +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLN 128

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-----SYICSRY 258
            L YIH    + HRD+K  N+L+      +KL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           YR PEL+ G  +Y   ID+W  GC++AE+    P+  G +   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 319 KCMNPNYTEFKFPQIKAHP---WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
             ++      K   +K        ++      P A+DL+ +LL   P  R  + +A  H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 376 FFDELRDPN 384
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  210 bits (535), Expect = 2e-65
 Identities = 90/300 (30%), Positives = 148/300 (49%), Gaps = 21/300 (7%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSLK 150
           Y   R +G+G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
                  D       LV E V  T ++      +  Q +    ++ Y Y+I +AL Y H 
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
            +G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 271 YTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
           Y  ++D+WS+GC+LA ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 330 FPQI----KAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
           F  I        W +  H      + PEA+D + +LL+Y    R TA EA  HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 2e-64
 Identities = 97/299 (32%), Positives = 149/299 (49%), Gaps = 17/299 (5%)

Query: 93  YMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQDKRYKN------RELQTMRLL---D 142
           Y     +G+G++G VF+A+ L+  G  VA+K+V      +       RE+  +R L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           HPNVV L      +    E  L LV E V + +             +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLL 126

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
           R L ++H    V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++   + Y T +D+WSVGC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
                  F    A P  K     +     DL+ + L ++P  R +A  A  HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-63
 Identities = 97/299 (32%), Positives = 150/299 (50%), Gaps = 18/299 (6%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V L           +  L LV EF  + + +     +     +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLG 115

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 265
           + H    V HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 266 FGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           FGA  Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
                +P   A         ++     DL+  LL+ +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  203 bits (518), Expect = 2e-62
 Identities = 80/341 (23%), Positives = 128/341 (37%), Gaps = 42/341 (12%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 148
           Y     +G G+FG+V +     TG     K +      DK     E+  M  L HP +++
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L   F    DK E+ L  +LEF+      +    +    +M    V  Y  Q C  L ++
Sbjct: 91  LHDAF---EDKYEMVL--ILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 209 HGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
           H    + H DIKP+N++        VK+ DFG A  L   E       +  + APE++  
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
                   D+W++G +   LL G   F GE  ++ L  + +       +           
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-DELRDPNAR 386
                             + PEA D +  LLQ  P  R T  +A  HP+   +  +  +R
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296

Query: 387 LPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA--RKQCP 425
           +P+ R        K +     + +     I   +  RK  P
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRP 337

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  199 bits (507), Expect = 9e-62
 Identities = 95/295 (32%), Positives = 154/295 (52%), Gaps = 20/295 (6%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y     +G+G++G+V++A+    GET A+KK+  +K  +       RE+  ++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           V L           +  L LV E + + + +           +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 265
           Y H    V HRD+KPQNLL+N    ++K+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 324
            G+ +Y+T IDIWSVGC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
             +  F   +  PW     K +    +DL+S++L+  PN R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-61
 Identities = 69/295 (23%), Positives = 116/295 (39%), Gaps = 44/295 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
                             L LE+                  MP    + + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 264
           +HG IG+ HRDIKP+NLL++   + +K+ DFG A V               +  Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
           +     +   +D+WS G VL  +L G+  +   S   Q     K   T            
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                      +PW KI         + L+ ++L  +P+ R T  +     ++++
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 8e-61
 Identities = 76/333 (22%), Positives = 132/333 (39%), Gaps = 33/333 (9%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 154
            +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 155 STTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
           +     +  L +V+E +    ++   +   R  Q             I  A+ Y+H  I 
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH-SIN 131

Query: 214 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
           + HRD+KP+NLL         +KL DFG AK         +   + YY APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
             + D+WS+G ++  LL G P F    G+     +   +                +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237

Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-DELRDPNARLPNG 390
             +           +  E   L+  LL+  P  R T  E   HP+     + P   L   
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289

Query: 391 RPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
           R        + +++K      L+ +  ++ + +
Sbjct: 290 RVLKE-DKERWEDVKEEMTSALATMRVDYEQIK 321

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 6e-60
 Identities = 57/289 (19%), Positives = 117/289 (40%), Gaps = 40/289 (13%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
           +  +G+GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
            +  + +T K +  + LV E +     +    Y +  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMTSGTLK---TYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 210 -GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
                + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
            +Y  ++D+++ G  + E+   +  +       Q+                         
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
               + +      F K   PE  +++   ++ + + R +  +   H FF
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 8e-60
 Identities = 73/331 (22%), Positives = 131/331 (39%), Gaps = 49/331 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
            +  + C+     +   +  LV+E+   +   + + + +    +  + +   T+   + L
Sbjct: 77  TIQYRGCY---LREHTAW--LVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 128

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
           AY+H    + HRD+K  N+L++     VKL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
               E  Y   +D+WS+G    EL   +P     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
                       +    +          + V   LQ  P  R T+     H F    R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 384 NARLPNGRPFPPLFNFKPQELKGASKELLSK 414
              +   +                 K++L +
Sbjct: 277 TVIMDLIQRTKDAVRELDNLQYRKMKKILFQ 307

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-59
 Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 44/294 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 148
           +     +G G+FG V++A+  ET    A K +     ++      E+  +   DHPN+V 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L   F     ++ L++  ++EF                + +    +++   Q   AL Y+
Sbjct: 74  LLDAF---YYENNLWI--LIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG 267
           H    + HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 268 AT----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
            T     Y    D+WS+G  L E+   +P     + +  L++I                 
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
                     K+ P       R      D + + L+ + + R T  +   HPF 
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-59
 Identities = 71/296 (23%), Positives = 119/296 (40%), Gaps = 45/296 (15%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           V         T+     L +V+E+     +  V    ++  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 206 AYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYR 260
              H    GG  V HRD+KP N+ ++   + VKL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
           +PE +     Y    DIWS+GC+L EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                 E KF +I               E  ++++R+L      R +  E   +P 
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 2e-59
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 38/291 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHPNVVSL 149
           YM    +G+G FGIV +     + +T   K V     D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
              F     +    L ++ EF+      + +  + ++  +    +  Y +Q+C AL ++H
Sbjct: 67  HESF-----ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 210 GGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
               + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+    
Sbjct: 120 S-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH- 177

Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
              +TA D+WS+G ++  LL G   F  E+    +  I+    T   E            
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---------- 227

Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE 379
                          K +  EA+D V RLL      R TA EA  HP+  +
Sbjct: 228 ---------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-59
 Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 48/292 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           +   R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           ++ L   F    D   +YL  +LE+ P           +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF---HDATRVYL--ILEYAPLGTVY---RELQKLSKFDEQRTATYITELANAL 119

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
           +Y H    V HRDIKP+NLL+      +K+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
            G   +   +D+WS+G +  E L+G+P F   +  +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
            EF FP              +   A DL+SRLL+++P+ R    E   HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  195 bits (495), Expect = 5e-59
 Identities = 94/357 (26%), Positives = 156/357 (43%), Gaps = 53/357 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 149
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 150 KH----------CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
                         F+    + +++ +V E + E +  + K Y    + +PLIYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISK 132

Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-----QVKLCDFGSAKVLVKGEPNISYI 254
           Q+   L Y+H   G+ H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIK 308
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 309 VLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FHKRMPPEAVDLVS 355
           +LG      ++      T F          ++K  P   +      F K    E  D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 356 RLLQYSPNLRCTALEACIHPFF------DELRDPNARL-PNGRPFPPLFNFKPQELK 405
            +LQ  P  R  A     HP+       +E+R P+  L  +G   P  F    +E++
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF----EEVR 362

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-59
 Identities = 97/344 (28%), Positives = 165/344 (47%), Gaps = 33/344 (9%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
           Y   + +G G+ GIV  A        VAIKK+ +  + +       REL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 147 VSLKHCFFS-TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +SL + F    T ++   + LV+E +   + +V +        +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGI 132

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            ++H   G+ HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
            G   Y   +DIWSVGC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 326 TEF--KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
             +    P+     + K+F           +K    +A DL+S++L   P  R +  +A 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
            HP+ +   DP        P P +++ +  E +  + E   +LI
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQLDERE-HTIEEWKELI 349

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 73/301 (24%), Positives = 123/301 (40%), Gaps = 43/301 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 148
           Y     +GQG+ G V+ A  + TG+ VAI+++       K     E+  MR   +PN+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
               +      DEL++      V E +   +         M    +     +  +AL ++
Sbjct: 82  YLDSY---LVGDELWV------VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
           H    V HRDIK  N+L+      VKL DFG    +   +   S +  + Y+ APE++  
Sbjct: 133 HS-NQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
              Y   +DIWS+G +  E++ G+P +  E+ +  L  I    GTP             E
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-------------E 235

Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARL 387
            + P            +++     D ++R L      R +A E   H F    +  ++  
Sbjct: 236 LQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

Query: 388 P 388
           P
Sbjct: 284 P 284

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (474), Expect = 1e-56
 Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 42/322 (13%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           Y    V+G G+F  V  A+   T + VAIK + +            E+  +  + HPN+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           +L   +        LYL  +++ V                           +Q+  A+ Y
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVSGGELF---DRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
           +H    + HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                Y+ A+D WS+G +   LL G P F  E+      +I+K                 
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNA 385
                           +   +   A D +  L++  P  R T  +A  HP+       + 
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 386 RLPNGRPFPPLFNFKPQELKGA 407
            +          NF   + K A
Sbjct: 276 NIHQSVSEQIKKNFAKSKWKQA 297

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  184 bits (469), Expect = 3e-56
 Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 54/306 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------------LQDKRYKNRELQTMR 139
           Y  + ++G+G   +V +     T +  A+K +              + +    +E+  +R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 140 LL-DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
            +  HPN++ LK  +     +   +  LV + + +        Y      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELF---DYLTEKVTLSEKETRKIM 116

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 258
             +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE       +  
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 259 YRAPELIFGATE-----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
           Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227

Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
                  M+ NY +F  P+                   DLVSR L   P  R TA EA  
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

Query: 374 HPFFDE 379
           HPFF +
Sbjct: 270 HPFFQQ 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-55
 Identities = 91/329 (27%), Positives = 139/329 (42%), Gaps = 61/329 (18%)

Query: 86  QPKQTI--SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQ 136
           QP++     +   +++G+GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL 196
            M  LDHP  V L   F    D ++LY    L +           Y R          + 
Sbjct: 61  VMSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAKNGELL---KYIRKIGSFDETCTRF 112

Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SY 253
           YT +I  AL Y+HG  G+ HRD+KP+N+L+N   H +++ DFG+AKVL          S+
Sbjct: 113 YTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170

Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
           + +  Y +PEL+        + D+W++GC++ +L+ G P F   +      +IIK+    
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---- 225

Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
                        E+ FP+            +  P+A DLV +LL      R    E   
Sbjct: 226 -------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260

Query: 374 ------HPFFDELRDPNARLPNGRPFPPL 396
                 HPFF+ +      L    P P L
Sbjct: 261 YGPLKAHPFFESVT--WENLHQQTP-PKL 286

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-52
 Identities = 80/357 (22%), Positives = 143/357 (40%), Gaps = 62/357 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT--------MRLLDHP 144
           ++  +++G+GSFG VF A+  +T +  AIK + +D    + +++             +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
            +  +   F     + +  L  V+E++         ++ ++  +  L     Y  +I   
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLNGGDLM---YHIQSCHKFDLSRATFYAAEIILG 115

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
           L ++H   G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           ++ G  +Y  ++D WS G +L E+L+GQ  F G+   +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-HPFFDELRD 382
            Y  +                 +  EA DL+ +L    P  R         HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262

Query: 383 PNARLPNGR---PFPP-------LFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
               L       PF P         NF  + L    +   +     ++  Q  F  F
Sbjct: 263 -WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNF 318

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 3e-52
 Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 56/303 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD 142
           Y    ++G G FG V+    +     VAIK V +D+               E+  ++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 143 --HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
                V+ L   F      D   L  +LE            +      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE---RPDSFVL--ILERPEPVQDL--FDFITERGALQEELARSFFWQ 118

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260
           +  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
            PE I     +  +  +WS+G +L +++ G   F  +       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
                                F +R+  E   L+   L   P+ R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 381 RDP 383
             P
Sbjct: 262 LLP 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 7e-52
 Identities = 65/324 (20%), Positives = 123/324 (37%), Gaps = 51/324 (15%)

Query: 88  KQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------REL 135
           ++ +   Y     +G G F +V + +   TG   A K + + +   +          RE+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK 195
             ++ + HPNV++L   +    +K ++ L  +LE V          +    + +      
Sbjct: 65  SILKEIQHPNVITLHEVY---ENKTDVIL--ILELVAGGELF---DFLAEKESLTEEEAT 116

Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNIS 252
            +  QI   + Y+H  + + H D+KP+N+++   N    ++K+ DFG A  +  G    +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
              +  + APE++          D+WS+G +   LL G   F G++  + L  +  V   
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234

Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
              E                         +       A D + RLL   P  R T  ++ 
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

Query: 373 IHPFFDELRDPNARLPNGRPFPPL 396
            HP+    +D    L +    P  
Sbjct: 270 QHPWIKP-KDTQQALSSAWSHPQF 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  172 bits (436), Expect = 2e-50
 Identities = 71/325 (21%), Positives = 121/325 (37%), Gaps = 57/325 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD 142
           +   R++G+G FG V+  +  +TG+  A+K + + +            +   L  +   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
            P +V + + F      D+L    +L+ +         ++           ++ Y  +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLH---YHLSQHGVFSEADMRFYAAEII 117

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
             L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S   +  Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
           E++     Y ++ D +S+GC+L +LL G   F      D+       L            
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFF 377
                                    PE   L+  LLQ   N R       A E    PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

Query: 378 DELRDPNARLPNGRPFPPLFNFKPQ 402
             L      +   +  PP     P 
Sbjct: 269 RSL--DWQMVFLQKYPPP---LIPP 288

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  170 bits (431), Expect = 4e-50
 Identities = 70/300 (23%), Positives = 126/300 (42%), Gaps = 54/300 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 145
           +   R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           ++ +   F     +D   + ++++++            R SQR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
            Y+H    + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLH-SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDEL 380
            E +FP                 +  DL+SRL+    + R         +   HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (420), Expect = 5e-49
 Identities = 64/295 (21%), Positives = 109/295 (36%), Gaps = 43/295 (14%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
           +V++ +              +V+E+V     R           M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVDGVTLR---DIVHTEGPMTPKRAIEVIADACQAL 124

Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRA 261
            + H   G+ HRD+KP N++++   + VK+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           PE   G        D++S+GCVL E+L G+P F G+S V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
                                H+ +  +   +V + L  +P  R           
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 6e-48
 Identities = 69/318 (21%), Positives = 119/318 (37%), Gaps = 56/318 (17%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           +++G+G+FG V   +   TG   A+K + ++             E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           K+ F      D L        +          +    +       + Y  +I  AL Y+H
Sbjct: 71  KYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
               V +RDIK +NL+++   H +K+ DFG  K  +     +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
           +Y  A+D W +G V+ E++ G+  F  +        I+                   E +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFDELRDPN 384
           FP            + + PEA  L++ LL+  P  R       A E   H FF  +    
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269

Query: 385 ARLPNGRPFPPLFNFKPQ 402
             +   +  PP   FKPQ
Sbjct: 270 QDVVQKKLLPP---FKPQ 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 4e-47
 Identities = 54/290 (18%), Positives = 104/290 (35%), Gaps = 47/290 (16%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
                         L +V ++   +   +  H      +  +I +     Q  + + Y+H
Sbjct: 70  MGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 266
               + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I 
Sbjct: 122 AK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 267 G--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
                 Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++                 
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---------------- 223

Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
              +  P +             P     L++  L+   + R    +    
Sbjct: 224 -RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (399), Expect = 1e-45
 Identities = 57/315 (18%), Positives = 106/315 (33%), Gaps = 54/315 (17%)

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 137
           +G R         Y   R +G GSFG ++    +  GE VAIK      ++     E + 
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            +++     +       +  D    Y  +V+E +  ++      ++  S++  L  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108

Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---- 251
             Q+   + YIH      HRD+KP N L+      + V + DFG AK       +     
Sbjct: 109 ADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 252 ----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
               +   +  Y +     G  E +   D+ S+G VL    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226

Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
           ++        I+ +   Y                     P E    ++       + +  
Sbjct: 227 RISEKKMSTPIEVLCKGY---------------------PSEFATYLNFCRSLRFDDKPD 265

Query: 368 A---LEACIHPFFDE 379
                +   + F  +
Sbjct: 266 YSYLRQLFRNLFHRQ 280

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 2e-43
 Identities = 56/281 (19%), Positives = 102/281 (36%), Gaps = 43/281 (15%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 154
           + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
               +++  L +V E++ +         SR    +    +  ++  +C A+ Y+ G    
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLV-DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNF 124

Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 274
            HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++T 
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180

Query: 275 IDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 333
            D+WS G +L E+   G+  +P     D +  + K                  +   P  
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------KMDAPD- 223

Query: 334 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                        PP   +++         +R + L+    
Sbjct: 224 -----------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  150 bits (380), Expect = 4e-43
 Identities = 50/280 (17%), Positives = 101/280 (36%), Gaps = 33/280 (11%)

Query: 80  IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 137
           +G           Y   R +G+GSFG++F+   L   + VAIK   +         E +T
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
            +LL     +   + F      + L+  LV++ +  ++  +     R   +  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106

Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGEPNI-- 251
             Q+   +  IH    + +RDIKP N L+      + + + + DFG  K           
Sbjct: 107 AKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 252 ------SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
                 +   +  Y +     G  E +   D+ ++G V    L G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 345
             ++        ++ +   + E +F +   +  +  F   
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 5e-42
 Identities = 78/330 (23%), Positives = 135/330 (40%), Gaps = 60/330 (18%)

Query: 93  YMAERVVGQGSFGIVFQAKCL---ETGETVAIKKV--------LQDKRYKNRELQTMRLL 141
           +   +V+G G++G VF  + +   +TG+  A+K +         +   +   E Q +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 142 DH-PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
              P +V+L + F     + +L+L L      E    +++       R     V++Y  +
Sbjct: 86  RQSPFLVTLHYAF---QTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGE 137

Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SR 257
           I  AL ++H  +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y       
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
           Y     +  G + +  A+D WS+G ++ ELL G   F  +   +   EI +         
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 246

Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEAC 372
                    + + P          + + M   A DL+ RLL   P  R       A E  
Sbjct: 247 ------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290

Query: 373 IHPFFDELRDPNARLPNGRPFPPLFNFKPQ 402
            H FF ++      L   +   P   FKP 
Sbjct: 291 EHLFFQKINW--DDLAAKKVPAP---FKPV 315

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (375), Expect = 1e-41
 Identities = 64/318 (20%), Positives = 117/318 (36%), Gaps = 59/318 (18%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
           + +G GSFG V   K  E+G   A+K + + K  K         E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
           +  F   ++   +   +    +   + R          R    + + Y  QI     Y+H
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
             + + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I    
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213

Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
            Y  A+D W++G ++ E+  G P F  +  +    +I                       
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPFFDELRDPN 384
                       F      +  DL+  LLQ        NL+    +   H +F       
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT--DW 302

Query: 385 ARLPNGRPFPPLFNFKPQ 402
             +   +   P   F P+
Sbjct: 303 IAIYQRKVEAP---FIPK 317

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 55/293 (18%), Positives = 104/293 (35%), Gaps = 47/293 (16%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 149
                 +G G FG V+          VA+K + Q     +    E   M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
                    ++ +Y+  + E++           + +  ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFG 267
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 268 ATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
              +T   D+WS G +L E++  G+  +PG +  + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE--ACIHPFF 377
                      +  +     P E   L+    +  P  R T     + +  FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 56/300 (18%), Positives = 112/300 (37%), Gaps = 37/300 (12%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS 148
           + + +  +G+G FG V++ K    GE VA+K     +    ++  E+    +L H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 149 LKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
                 +  +     L LV ++    +++     Y+   + M  +            LA+
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-----LSTASGLAH 115

Query: 208 IHGGI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YIC 255
           +H  I        + HRD+K +N+LV        + D G A         I       + 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 256 SRYYRAPELIFGA-----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
           ++ Y APE++  +      E     DI+++G V  E+     +  G     QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
             P+ EE++ +          +++ +  ++            ++      +   R TAL 
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-39
 Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 47/296 (15%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
                 ++ +Y+  V E++ +             + + L  +     QI   +AY+   +
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATE 270
              HRD++  N+LV  +    K+ DFG A+++   E            + APE       
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 271 YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
           +T   D+WS G +L EL   G+  +PG    + L ++ +    P   E            
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239

Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA--LEACIHPFFDELRDP 383
                            P    DL+ +  +  P  R T   L+A +  +F      
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-39
 Identities = 48/283 (16%), Positives = 94/283 (33%), Gaps = 43/283 (15%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 153
           + +G G FG+V         + VAIK + +    +     E + M  L HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
               ++  + L  V EF+         +            +      +C  +AY+     
Sbjct: 70  ---LEQAPICL--VFEFMEHGCLS--DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-C 121

Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEY 271
           V HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
           ++  D+WS G ++ E+     +        ++VE I                        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216

Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                 +     +        +++   +  P  R         
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (350), Expect = 1e-38
 Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 54/309 (17%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGET---VAIKKVL-----QDKRYKNRELQTMRLLDH 143
               E+V+G G FG V        G+    VAIK +      + +R    E   M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
           PNV+ L+      T    +   ++ EF+            +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------ 257
            + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLA-DMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 316
            + APE I    ++T+A D+WS G V+ E++  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
           +                             P     L+    Q   N R    +      
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287

Query: 377 FDELRDPNA 385
              +R+PN+
Sbjct: 288 DKMIRNPNS 296

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-38
 Identities = 58/299 (19%), Positives = 102/299 (34%), Gaps = 53/299 (17%)

Query: 97  RVVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 146
             +G GSFG+V + +         +VA+K +  D   +        RE+  M  LDH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
           + L     +        + +V E  P           +      L  +  Y  Q+   + 
Sbjct: 74  IRLYGVVLTP------PMKMVTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 263
           Y+       HRD+  +NLL+      VK+ DFG  + L + + +     +    +     
Sbjct: 126 YLES-KRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 264 LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
                  ++ A D W  G  L E+   GQ  + G +G   L +I K      R E     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR 381
                                   P +  +++ +   + P  R T +   +  F  E +
Sbjct: 239 ----------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-38
 Identities = 61/314 (19%), Positives = 107/314 (34%), Gaps = 70/314 (22%)

Query: 96  ERVVGQGSFGIVFQAKCLETGET-----VAIKKVLQDKRYKN-----RELQTM-RLLDHP 144
            +V+G G+FG V  A      +T     VA+K + +            EL+ M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--------------------ETVYRVAKHYSR 184
           N+V+L       T    +Y  L+ E+                      E   +       
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
               +    +  + YQ+ + + ++       HRD+  +N+LV      VK+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214

Query: 245 VKGEPNISYICSR---YYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGV 300
           +     +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
               ++I+               N  +   P                 E   ++     +
Sbjct: 274 ANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSCWAF 306

Query: 361 SPNLRCTALEACIH 374
               R +       
Sbjct: 307 DSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 8e-38
 Identities = 50/284 (17%), Positives = 102/284 (35%), Gaps = 45/284 (15%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 153
           + +G G FG+V   K       VAIK + +    ++    E + M  L H  +V L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
              T +  ++  ++ E++      +  +      R     +      +C A+ Y+     
Sbjct: 69  ---TKQRPIF--IITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQ 120

Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEY 271
             HRD+  +N LVN     VK+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 272 TTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           ++  DIW+ G ++ E+  LG+  +   +  +    I + L                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYR 222

Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
           P +               +   ++        + R T      +
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 8e-38
 Identities = 56/290 (19%), Positives = 112/290 (38%), Gaps = 43/290 (14%)

Query: 96  ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
               T +   Y+    EF+               Q +  + +     QI  A+ Y+    
Sbjct: 82  C---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK-K 134

Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATE 270
              HRD+  +N LV  + H VK+ DFG ++++                + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
           ++   D+W+ G +L E+            + Q+ E+++                  +++ 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235

Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL 380
                        +  P +  +L+    Q++P+ R +  E  IH  F+ +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-37
 Identities = 67/312 (21%), Positives = 111/312 (35%), Gaps = 53/312 (16%)

Query: 97  RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
           +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            L     ++T      + L+ + +P     +  +       +   Y+  +  QI + + Y
Sbjct: 75  RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPEL 264
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 127 LE-DRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           I     YT   D+WS G  + EL+  G   + G        EI  +L    R        
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLPQ----- 234

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP 383
                                    +   ++ +      + R    E  I  F    RDP
Sbjct: 235 -------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274

Query: 384 NARLPNGRPFPP 395
              L        
Sbjct: 275 QRYLVIQGDERM 286

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 5e-37
 Identities = 63/298 (21%), Positives = 104/298 (34%), Gaps = 54/298 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVS 148
           +  +G G+FG V Q       +   VAIK + Q     +     RE Q M  LD+P +V 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
           L              L LV+E        + K      + +P+  V    +Q+   + Y+
Sbjct: 74  LIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 264
                  HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + APE 
Sbjct: 126 EE-KNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
           I    ++++  D+WS G  + E L  GQ  +    G + +  I +        E      
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237

Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI---HPFFD 378
                                  PPE   L+S    Y    R   L         ++ 
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 6e-37
 Identities = 55/299 (18%), Positives = 104/299 (34%), Gaps = 56/299 (18%)

Query: 96  ERVVGQGSFGIVFQAKC--LETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 147
           ++ +G G+FG V +      +  +TVA+K +  +            E   M+ LD+P +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
            +        + +   L  V+E            Y + ++ +    +    +Q+   + Y
Sbjct: 72  RMIGIC----EAESWML--VMEMAELGPLN---KYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPE 263
           +       HRD+  +N+L+    H  K+ DFG +K L   E              + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 264 LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
            I    ++++  D+WS G ++ E    GQ  + G  G +    + K              
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230

Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI---HPFFD 378
                                   P E  DL++    Y    R       +   + ++D
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-36
 Identities = 54/304 (17%), Positives = 108/304 (35%), Gaps = 57/304 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
             V+G+G FG V+    L+        A+K + +            E   M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
           SL         + E    +VL ++     R        +    +  +  +  Q+ + + +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 262
           +       HRD+  +N +++     VK+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           E +    ++TT  D+WS G +L EL+  G P +P  +  D  V +++             
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHP 375
                              +  +  P    +++ +       +R +       + A    
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

Query: 376 FFDE 379
           F  E
Sbjct: 295 FIGE 298

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-35
 Identities = 61/305 (20%), Positives = 106/305 (34%), Gaps = 65/305 (21%)

Query: 96  ERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRYKN-----RELQTM-RLLDHP 144
            + +G G+FG V +A        +   TVA+K +              EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP---------------ETVYRVAKHYSRASQRM 189
           N+V+L       T      +  + E+                                 +
Sbjct: 88  NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 190 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
            L  +  ++YQ+ + +A++       HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200

Query: 250 NISYICSR---YYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVE 305
            +    +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 365
           +IK                             +  +  +  P E  D++       P  R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 366 CTALE 370
            T  +
Sbjct: 293 PTFKQ 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 69/293 (23%), Positives = 103/293 (35%), Gaps = 50/293 (17%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHP 144
               R +G+G FG V Q   +        VAIK               +E  TMR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
           ++V L           E  + +++E       R           + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAP 262
           LAY+       HRDI  +N+LV+ +   VKL DFG ++ +       +        + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
           E I     +T+A D+W  G  + E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                                    PP    L+++   Y P+ R    E    
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (319), Expect = 3e-34
 Identities = 63/319 (19%), Positives = 106/319 (33%), Gaps = 73/319 (22%)

Query: 97  RVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
           R +G+G+FG VFQA+       E    VA+K + ++          RE   M   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP---------------------ETVYRVAKHYSRA 185
           V              + L  + E++                        +   A+  S  
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 186 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245
              +          Q+   +AY+       HRD+  +N LV  +   VK+ DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191

Query: 246 KGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
             +      +      +  PE IF    YTT  D+W+ G VL E+   G   + G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
            +  +                          I A P      +  P E  +L+       
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282

Query: 362 PNLRCTALEACIHPFFDEL 380
           P  R +     IH     +
Sbjct: 283 PADRPSFCS--IHRILQRM 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 1e-33
 Identities = 51/292 (17%), Positives = 95/292 (32%), Gaps = 50/292 (17%)

Query: 92  SYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLD 142
               ++V+G G FG V++     +       VAIK +      K       E   M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
           H N++ L+             + ++ E++        K          ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC----SRY 258
             + Y+   +   HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLA-NMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
           + APE I    ++T+A D+WS G V+ E++        E    ++++ I           
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
                              +        P     L+ +  Q     R    +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-33
 Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 56/300 (18%)

Query: 96  ERVVGQGSFGIVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 147
           + V+G+G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP-------------ETVYRVAKHYSRASQRMPLIYV 194
           +L             YL L +E+ P                       +  +  +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
               + A E +   + YTT  D+WS G +L E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
                         + P                 E  DL+ +  +  P  R +  +  + 
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-32
 Identities = 65/321 (20%), Positives = 111/321 (34%), Gaps = 64/321 (19%)

Query: 93  YMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQD------KRYKNRELQTMRLL 141
               + +G+G+FG V +A         T  TVA+K + +       +   +     + + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-------------ETVYRVAKHYSRASQR 188
            H NVV+L              L +++EF               E V             
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 189 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
           + L ++  Y++Q+ + + ++       HRD+  +N+L++     VK+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 249 PNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLV 304
             +          + APE IF    YT   D+WS G +L E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
             +K                 T  + P                PE    +       P+ 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 365 RCTALEACIHPFFDELRDPNA 385
           R T  E   H     L   NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 9e-32
 Identities = 60/309 (19%), Positives = 112/309 (36%), Gaps = 66/309 (21%)

Query: 93  YMAERVVGQGSFGIVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTM-R 139
            +  + +G+G+FG V  A+ +   +        VA+K +  D   K+      E++ M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRAS 186
           +  H N+++L       T    LY+  ++E+              P  +           
Sbjct: 75  IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 187 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246
           +++    +    YQ+ R + Y+       HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 247 GEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQ 302
            +      +      + APE +F    YT   D+WS G +L E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP 362
           L +++K                      P                 E   ++       P
Sbjct: 246 LFKLLK---------------EGHRMDKP------------SNCTNELYMMMRDCWHAVP 278

Query: 363 NLRCTALEA 371
           + R T  + 
Sbjct: 279 SQRPTFKQL 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 6e-30
 Identities = 59/312 (18%), Positives = 109/312 (34%), Gaps = 63/312 (20%)

Query: 96  ERVVGQGSFGIVFQAKC-----LETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
            R +GQGSFG+V++         E    VAIK V     ++++     E   M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-------TVYRVAKHYSRASQRMPLIYVKLYT 198
           VV         +      +  ++E +            R A   +       L  +    
Sbjct: 85  VV---RLLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--- 255
            +I   +AY++      HRD+  +N +V      VK+ DFG  + + + +          
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 314
              + +PE +     +TT  D+WS G VL E+  L +  + G S    L  +++      
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250

Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------ 368
                                           P    +L+    QY+P +R +       
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

Query: 369 LEACIHPFFDEL 380
           ++  + P F E+
Sbjct: 289 IKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.3 bits (205), Expect = 3e-19
 Identities = 29/205 (14%), Positives = 58/205 (28%), Gaps = 34/205 (16%)

Query: 97  RVVGQGSFGIVFQAKCLETGETVAIKKV--------------LQDKRYKNRELQTMRLLD 142
           +++G+G    VF     E      +K                     + +         +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 143 HPNVVSLKHCFFSTT-DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
              +  L+          +   +  ++E             ++   R+ +         I
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMI 112

Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
              +A  +    + H D+   N+LV      + + DF  +  +  GE     I  R  R 
Sbjct: 113 LEEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRN 167

Query: 262 PELIFGATEYTTAIDIWSVGCVLAE 286
               F    Y T  DI S    + +
Sbjct: 168 IITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	429
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.61
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.6
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.43
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.27

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-64  Score=484.45  Aligned_cols=329  Identities=71%  Similarity=1.224  Sum_probs=292.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceEEEEEe
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNLVL  168 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~~~lv~  168 (429)
                      ..+|+.+++||+|+||+||+|+++.+|+.||||++..+.....+|+++|+.++||||++++++|..... .+..++++||
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            347999999999999999999999999999999998877777799999999999999999998876543 4567889999


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      |||++++...+.........+++..++.++.||+.||+||| ++||+||||||+|||++.++..+||+|||+|+......
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH-~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            99999888887777777788999999999999999999999 88999999999999999887689999999999887777


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 014156          249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  328 (429)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  328 (429)
                      ...+.+||+.|+|||.+.+...++.++||||+||++|||++|++||.+.+..+++..+.+.+|.+..+.+......+...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            67778999999999998877779999999999999999999999999999999999999999999999999888888888


Q ss_pred             cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhhhccCC
Q 014156          329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFKPQELKGAS  408 (429)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (429)
                      .++.....++.......+++++.+||.+||.+||.+|||+.|+|+||||++++++....++....+...++..+|+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~  337 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP  337 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCG
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCCc
Confidence            88888888888888888999999999999999999999999999999999999988888888888888899988886533


Q ss_pred             HHHHHhhcHHHH
Q 014156          409 KELLSKLIPEHA  420 (429)
Q Consensus       409 ~~~~~~~~~~~~  420 (429)
                       ++...++|+++
T Consensus       338 -~~~~~~~p~~~  348 (350)
T d1q5ka_         338 -PLATILIPPHA  348 (350)
T ss_dssp             -GGHHHHSCTTT
T ss_pred             -cccccCCCccc
Confidence             55666666554

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-59  Score=431.90  Aligned_cols=248  Identities=30%  Similarity=0.486  Sum_probs=211.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ..+|++.+.||+|+||+||+|+++.+|+.||+|++.+.       .....+|+++++.++|||||++++++.     +..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence            35799999999999999999999999999999988532       233457999999999999999999884     334


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+|+|||||++ +|.+.+..    ...+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH-~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeeeeccccceecCCC-CEeeccccee
Confidence            58899999985 66555543    467999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      +..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+..           
T Consensus       154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------  220 (263)
T d2j4za1         154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------  220 (263)
T ss_dssp             SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred             eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            766433 34567899999999999764 48999999999999999999999999888776666554310           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                            +            .++..+|+++++||.+||+.||.+|||+.|+|+||||..
T Consensus       221 ------~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         221 ------F------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                  0            133457999999999999999999999999999999964

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-59  Score=435.50  Aligned_cols=255  Identities=32%  Similarity=0.538  Sum_probs=213.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++++.++|||||+++++|.     +...
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence            4699999999999999999999999999999998532       234568999999999999999999884     3345


Q ss_pred             EEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +|+|||||++ +|.+++..    .+.+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+
T Consensus        83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLNEDM-HIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhc-cccEEcCcCCccccccCCCc-eEEecccccce
Confidence            8999999985 56555433    467999999999999999999999 88999999999999999887 79999999998


Q ss_pred             ecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          243 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      ......   .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++.+.          
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~----------  225 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------  225 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT----------
T ss_pred             ecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC----------
Confidence            764332   23456899999999999765 4899999999999999999999999988877776665442          


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCCccccCCCCCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE------ACIHPFFDELRDPNAR  386 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e------~l~hp~f~~~~~~~~~  386 (429)
                             .+            .++..+++++++||++||+.||++|||+.|      +++||||+++.+....
T Consensus       226 -------~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         226 -------EY------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             -------CC------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             -------CC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence                   00            133458999999999999999999999987      5889999998876544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-59  Score=440.12  Aligned_cols=278  Identities=34%  Similarity=0.581  Sum_probs=227.0

Q ss_pred             EeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        95 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++|||||+++++|..     ...+|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence            4679999999999999999999999999885321         234589999999999999999999843     33478


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +||||+.++++..+   ......+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~---~~~~~~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHH---TTCCSSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhh---hhcccCCCHHHHHHHHHHHHHHHHHhh-ccceecccCCcceEEecCCC-ccccccCccccccC
Confidence            99999998765544   234567999999999999999999999 78999999999999999887 79999999998765


Q ss_pred             cCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ... .....+||+.|+|||++.+...++.++||||+||++|+|+||.+||.+.+..+++.++.+.++.|..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            433 3345689999999999877667899999999999999999999999999999999999999998887655433222


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      .....+......++... .+.+++++++||.+||++||++||||.|+|+||||++...|
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             TTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             chhhhhccCCCCChHHh-cccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            22222222223333222 34579999999999999999999999999999999976554

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-59  Score=435.40  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=211.2

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      +|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+++.++|||||+++++|...     .++|+|
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv   95 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVV   95 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEEE
Confidence            699999999999999999999999999999988532    23456899999999999999999998543     348899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||++ +|..++.     ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+....
T Consensus        96 mEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP  168 (293)
T ss_dssp             EECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCcHHHeEECCCC-cEeeccchhheeecc
Confidence            999986 4444332     257999999999999999999999 78999999999999999887 799999999987654


Q ss_pred             CC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      .. .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.... .+.           
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~-----------  235 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE-----------  235 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC-----------
T ss_pred             ccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCC-----------
Confidence            33 34567899999999999764 58999999999999999999999999988877776665431 000           


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                    ...+..+|+++++||.+||..||.+|||+.|+|+||||+.
T Consensus       236 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 --------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             --------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             --------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                          0122357999999999999999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=434.28  Aligned_cols=253  Identities=26%  Similarity=0.344  Sum_probs=207.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...     .....+|+++++.++|||||++++++...     ..+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----cee
Confidence            34799999999999999999999999999999998543     23456899999999999999999998543     358


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |+|||||++ +|.+.+    .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        79 ~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH-~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCccCcccHHHEEECCCC-CEEEccchhhee
Confidence            899999986 554433    33567999999999999999999999 78999999999999999887 799999999987


Q ss_pred             cccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          244 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       244 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      .....   .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+...............       
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------  225 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  225 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence            64432   23457899999999999776655788999999999999999999998765443333322211000       


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                         ......+|+++++||.+||+.||++|||+.|+|+||||++
T Consensus       226 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 -------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                               0011347899999999999999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-58  Score=431.53  Aligned_cols=288  Identities=33%  Similarity=0.539  Sum_probs=235.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCC-CcEEEEEEeccc------hhhHHHHHHHHHHc---CCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQD------KRYKNRELQTMRLL---DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~  159 (429)
                      ..+|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+++.|   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            45899999999999999999999765 677999988532      22345788877766   799999999998766556


Q ss_pred             CceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                      ...+++++|||++++++.+...  .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~ivHrDiKp~NILi~~~~-~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEEecCCCccEEEEcCCC-Ceeecchh
Confidence            6678899999999876665443  34567999999999999999999999 88999999999999999887 79999999


Q ss_pred             CceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014156          240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  319 (429)
Q Consensus       240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  319 (429)
                      +++...........+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+..+.+..+.+..+.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            99877666666678899999999998764 59999999999999999999999999999999999999999988776543


Q ss_pred             hcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                      ....... ..+...... ....+...+++.+++||.+||++||++|||+.|+|+||||+++....
T Consensus       241 ~~~~~~~-~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         241 RDVALPR-QAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             TTCSSCG-GGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccccchh-hhhcccccc-chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence            2211111 111111111 12234567899999999999999999999999999999999987653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-58  Score=436.21  Aligned_cols=252  Identities=26%  Similarity=0.409  Sum_probs=214.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .++|.+++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||++++++|     .+..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            45799999999999999999999999999999998643       23345799999999999999999998     4445


Q ss_pred             EEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ++|+|||||+++ |...+.    ..+.+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|
T Consensus        79 ~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a  152 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhh-hcCccccccCHHHeEecCCC-CEEEeecccc
Confidence            689999999964 444433    3467999999999999999999999 88999999999999999888 7999999999


Q ss_pred             eeccc-CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          242 KVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       242 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +.... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+...           
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-----------  220 (337)
T d1o6la_         153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------  220 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----------
Confidence            87644 3445568899999999999765 5899999999999999999999999998877766655542           


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                            .            ..++..+|+++++||++||++||.+|+     ++.|+++||||+++.+
T Consensus       221 ------~------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         221 ------E------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             ------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------C------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                  0            113456899999999999999999999     4999999999988654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-58  Score=433.12  Aligned_cols=283  Identities=35%  Similarity=0.631  Sum_probs=230.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ++|++++.||+|+||+||+|++..+|+.||||++...      .....+|+++++.++|||||+++++|...     ..+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence            4799999999999999999999999999999998543      23445899999999999999999998543     348


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      |+||||++++++.....  .....+++..++.++.||+.||+||| ++|||||||||+|||++.++ .+||+|||+|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH-~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhh-cCCEEccccCchheeecccC-cceeccCCcceec
Confidence            99999999887766543  33567999999999999999999999 88999999999999999887 7999999999876


Q ss_pred             ccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ... .......||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.+.++....+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            543 3344568999999999987777678999999999999999999999999999999999998888776554332111


Q ss_pred             CCc-cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          324 NYT-EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       324 ~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      ... ...++......+. .....+++++++||++||.+||++|||+.|+|+||||+++..|
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFS-KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchh-hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            000 0011111111111 1234688999999999999999999999999999999988765

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=427.67  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=202.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|.+...      .....+|+++++.++|||||++++++....   ...+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEE
Confidence            4799999999999999999999999999999988543      223457999999999999999999885422   2347


Q ss_pred             EEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----eeecCCCCCCeeecCCCCceEEeec
Q 014156          165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~-----iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                      |+|||||+ |+|.+++.........+++..++.++.||+.||+||| +.|     |+||||||+||||+.++ .+||+||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH-~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HHCC---------CCGGGEEECTTS-CEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-HhcCCCCCEEeCcCchhhcCcCCCC-cEEEeec
Confidence            89999998 5777777666566778999999999999999999999 544     99999999999999887 7999999


Q ss_pred             CCceecccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          239 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       239 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      |+|+...... .....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+....+....       
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-------  230 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------  230 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------
Confidence            9998765433 33457899999999998654 58999999999999999999999999888776666654420       


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF  377 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  377 (429)
                                  .+         .++..+|+++.+||.+||+.||.+|||+.|+|+|||+
T Consensus       231 ------------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 ------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ------------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                        00         1234579999999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4e-58  Score=440.02  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=218.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ++|++++.||+|+||.||+|+++.+|+.||||++...    .....+|+.+++.++|||||+++++|...     ..+|+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence            4799999999999999999999999999999998543    23446899999999999999999988543     34889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC-CCceEEeecCCceec
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVL  244 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~-~~~vkl~DFG~a~~~  244 (429)
                      |||||++ +|.+.+.   ...+.+++..++.++.||+.||.||| ++|||||||||+|||++.+ .+.+||+|||+|+..
T Consensus       101 vmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999985 5555442   23467999999999999999999999 8899999999999999643 237999999999988


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .........+||+.|||||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+........          
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------  245 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD----------  245 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC----------
T ss_pred             ccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence            766666778999999999999764 489999999999999999999999999888888777765322111          


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCC
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPN  384 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  384 (429)
                                     ......+|+++++||.+||++||++|||+.|+|+||||+....+.
T Consensus       246 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         246 ---------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             ---------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred             ---------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence                           112234799999999999999999999999999999999876543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=429.69  Aligned_cols=252  Identities=26%  Similarity=0.386  Sum_probs=209.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .|++++.||+|+||+||+|+++.+|+.||+|++...    .....+|+++++.++|||||++++++...     ..+++|
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lv   87 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWIL   87 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEEE
Confidence            599999999999999999999999999999998542    24456899999999999999999988543     348899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      ||||++ +|..++..   ..+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+....
T Consensus        88 mEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH-~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          88 IEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH-DNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  162 (288)
T ss_dssp             EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHH
T ss_pred             EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEEeecChhheeECCCC-CEEEEechhhhccCC
Confidence            999986 44444332   3467999999999999999999999 88999999999999999888 799999999976543


Q ss_pred             C-CCcccccccccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          247 G-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       247 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      . ......+||+.|+|||++..    ...|+.++|||||||++|+|+||++||.+.+..+.+.++....  +        
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~--------  232 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--P--------  232 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--C--------
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C--------
Confidence            2 22345789999999999842    3457899999999999999999999999988877777665521  0        


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                               +.       ...+..+|+++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       233 ---------~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         233 ---------PT-------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ---------CC-------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ---------CC-------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                     00       0112357999999999999999999999999999999963

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=421.86  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=204.6

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      |++.++||+|+||+||+|++..+++.||+|.+...      .....+|+++++.++|||||+++++|.... .+...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            47888999999999999999999999999988543      233468999999999999999999886543 33456889


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~--iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |||||++ +|.+.+..    ...+++..++.++.||+.||+||| ++|  |+||||||+||||+.+...+||+|||+|+.
T Consensus        90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH-~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHH-HCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999985 55555533    467999999999999999999999 777  999999999999975333799999999975


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .. .......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+.+.......           
T Consensus       165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~-----------  230 (270)
T d1t4ha_         165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----------  230 (270)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----------
T ss_pred             cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC-----------
Confidence            43 333456789999999999864  4899999999999999999999999876655554433221000           


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                                     ...++...++++.+||.+||++||++|||+.|+|+||||+
T Consensus       231 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 ---------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ---------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ---------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                           0113345789999999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-58  Score=433.42  Aligned_cols=252  Identities=26%  Similarity=0.414  Sum_probs=197.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+.+++.++|||||+++++|.     +..++|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            45999999999999999999999999999999986432     23347999999999999999999883     344589


Q ss_pred             EEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC---CCCceEEeecCCc
Q 014156          166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA  241 (429)
Q Consensus       166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~---~~~~vkl~DFG~a  241 (429)
                      +|||||+ ++|.+.+.    ..+.+++..++.++.||+.||+||| +.||+||||||+|||+..   ++ .+||+|||+|
T Consensus        84 lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a  157 (307)
T d1a06a_          84 LIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDS-KIMISDFGLS  157 (307)
T ss_dssp             EEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred             EEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhh-hceeeeEEecccceeecccCCCc-eEEEecccee
Confidence            9999998 56666654    3567999999999999999999999 889999999999999953   44 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      +.........+.+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+.+....+        
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------  228 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--------  228 (307)
T ss_dssp             ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC--------
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC--------
Confidence            887666666678899999999999764 58999999999999999999999999888777666665421110        


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                       .....+.+|+++++||.+||++||.+|||+.|+|+||||+.
T Consensus       229 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         229 -----------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -----------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -----------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                             11123458999999999999999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.9e-58  Score=438.28  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=215.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      +.|++++.||+|+||+||+|+++.+|+.||||++...    .....+|+.+++.|+|||||+++++|.     ....+|+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            4699999999999999999999999999999998643    234457999999999999999999884     3445889


Q ss_pred             Eeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecC-CCCceEEeecCCceec
Q 014156          167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVL  244 (429)
Q Consensus       167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~-~~~~vkl~DFG~a~~~  244 (429)
                      |||||+++ |.+.   .......+++..++.++.||+.||+||| +.||+||||||+||||+. +.+.+||+|||+|+..
T Consensus       104 vmE~~~gg~L~~~---~~~~~~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         104 ILEFLSGGELFDR---IAAEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEECCCCCBHHHH---TTCTTCCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEcCCCChHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccccccccccccCCCeEEEeecccceec
Confidence            99999854 4443   2334457999999999999999999999 889999999999999973 2237999999999988


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+......+.          
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~----------  248 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD----------  248 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred             CCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence            777666778899999999998764 599999999999999999999999999988888777765321111          


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                     ......+|+++++||.+||++||.+|||+.|+|+||||+..
T Consensus       249 ---------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 ---------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             ---------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ---------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                           11234589999999999999999999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=425.74  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=216.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.          .....+|+.+++.++|||||+++++|.     +
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            4699999999999999999999999999999988532          234568999999999999999999984     3


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC---ceEEe
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLC  236 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~---~vkl~  236 (429)
                      ...+|+|||||++ +|.+++..    .+.+++..++.++.||+.||+||| +.||+||||||+|||++.++.   .+||+
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH-~~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhh-hcceeecccccceEEEecCCCcccceEec
Confidence            4458999999985 66665543    367999999999999999999999 889999999999999987653   49999


Q ss_pred             ecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      |||+|+....+.......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+........  
T Consensus       160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--  236 (293)
T d1jksa_         160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--  236 (293)
T ss_dssp             CCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--
T ss_pred             chhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--
Confidence            9999998876666677889999999999976 4589999999999999999999999999888877776655321111  


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                                             ..+++.+|+++++||++||+.||++|||+.|+|+||||+...+
T Consensus       237 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         237 -----------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             -----------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             -----------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence                                   1123457999999999999999999999999999999987544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-57  Score=429.45  Aligned_cols=248  Identities=27%  Similarity=0.418  Sum_probs=209.7

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .|++++.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.++|||||++++++...     ..+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEE
Confidence            5999999999999999999999999999999985432       2345799999999999999999988543     348


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      |+|||||.++++....   .....+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|+..
T Consensus        91 ~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred             EEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence            8999999987665433   23467999999999999999999999 78999999999999999887 8999999999865


Q ss_pred             ccCCCcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ..   ....+||+.|+|||++.+.  ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.....           
T Consensus       166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~-----------  231 (309)
T d1u5ra_         166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------  231 (309)
T ss_dssp             SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------
T ss_pred             CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence            33   3456899999999998642  3588999999999999999999999998887777766654210           


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                              +.        ..+..+|+++++||.+||+.||.+|||+.|+|+||||..
T Consensus       232 --------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             --------CC--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             --------CC--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                    00        112347899999999999999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-57  Score=428.82  Aligned_cols=251  Identities=26%  Similarity=0.439  Sum_probs=214.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++|||||++++++.     ....
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            4699999999999999999999999999999998543       234558999999999999999999984     3445


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|+|||||.|+.+...   ......+++..++.++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+.
T Consensus        79 ~~ivmE~~~gg~l~~~---~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~  153 (316)
T d1fota_          79 IFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNG-HIKITDFGFAKY  153 (316)
T ss_dssp             EEEEECCCCSCBHHHH---HHHTSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTS-CEEECCCSSCEE
T ss_pred             eeeEeeecCCcccccc---ccccccccccHHHHHHHHHHHhhhhhc-cCcEEccccCchheeEcCCC-CEEEecCccceE
Confidence            8999999986533322   233567899999999999999999999 88999999999999999888 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ...+.+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++....             
T Consensus       154 ~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-------------  217 (316)
T d1fota_         154 VPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-------------  217 (316)
T ss_dssp             CSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-------------
T ss_pred             ecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence            643  34467899999999998664 48999999999999999999999999988877777766521             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCCC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRDP  383 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  383 (429)
                                      ..+++.+++++.++|.+||.+||.+|+     |++++|+||||+++.+.
T Consensus       218 ----------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         218 ----------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence                            013345899999999999999999996     99999999999997654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=429.29  Aligned_cols=316  Identities=31%  Similarity=0.548  Sum_probs=240.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|++++.||+|+||+||+|+++.+|+.||||++...      .....+|+++|+.++|||||+++++|..... .....
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            4799999999999999999999999999999998642      1234579999999999999999998865432 23345


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|+||||++.++..+...     ..+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.
T Consensus        98 ~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH-~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~  170 (346)
T d1cm8a_          98 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  170 (346)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHH-hCCCcccccCcchhhccccc-ccccccccceec
Confidence            789999998877666543     67999999999999999999999 88999999999999999888 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  ......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+.....
T Consensus       171 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         171 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            643  345678999999999998777789999999999999999999999999999999999999999988876654332


Q ss_pred             CCcc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 014156          324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFK  400 (429)
Q Consensus       324 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  400 (429)
                      ....   ...+......+.. ....+++++++||++||.+||.+|||+.|+|+||||+.++++.... ...    .+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~-~~~----~~~~~  322 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP-QVQ----KYDDS  322 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-------CCC----CCCCC
T ss_pred             hhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc-cCC----CCCCc
Confidence            1110   1222333333332 3346899999999999999999999999999999999988654432 111    12222


Q ss_pred             hhhhccCCHHHHHhhcHHHHhh
Q 014156          401 PQELKGASKELLSKLIPEHARK  422 (429)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~  422 (429)
                      ..+. ....+.+++++-+++..
T Consensus       323 ~~~~-~~~~~e~k~~~~~e~~~  343 (346)
T d1cm8a_         323 FDDV-DRTLDEWKRVTYKEVLS  343 (346)
T ss_dssp             ------CCHHHHHHHHHHHHHT
T ss_pred             hhhh-hcCHHHHHHHHHHHhhc
Confidence            2222 23467777777766654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-58  Score=436.17  Aligned_cols=280  Identities=25%  Similarity=0.425  Sum_probs=206.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++..+     .....+|+.+|+.++|||||+++++|..     ...+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence            45799999999999999999999999999999998543     2345689999999999999999999843     3358


Q ss_pred             EEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      |+||||+.+ +|..++..    .+.+++..++.++.||+.||.|||++.||+||||||+||||+.++ .+||+|||+|+.
T Consensus        80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  154 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence            899999995 56655543    367999999999999999999999335999999999999999888 799999999987


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .... ...+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ...+....+.+.........
T Consensus       155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            6443 23467899999999999875 499999999999999999999999987664432 22222222211110000000


Q ss_pred             CC--Cccc---cCCC---------cCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          323 PN--YTEF---KFPQ---------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       323 ~~--~~~~---~~~~---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                      ..  ....   ..+.         +............+|.++++||.+||++||.+|||+.|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            00  0000   0000         0000001111224688999999999999999999999999999998644

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-56  Score=425.23  Aligned_cols=323  Identities=33%  Similarity=0.592  Sum_probs=248.7

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  165 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~  165 (429)
                      .+|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++||||+++++++.........+++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            36999999999999999999999999999999986432     2345799999999999999999998665545555678


Q ss_pred             EEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      +++++++++|.+++..     ..+++..++.++.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+...
T Consensus        88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH-~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCcceEEECCCC-CEEEcccCceeecc
Confidence            8888888888887753     57999999999999999999999 88999999999999999887 79999999998764


Q ss_pred             cCC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          246 KGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       246 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      ...    .....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+...........+........
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            332    2345678999999999866667899999999999999999999999999998888888888888776644321


Q ss_pred             CCCC---ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCC
Q 014156          322 NPNY---TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFN  398 (429)
Q Consensus       322 ~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~  398 (429)
                      ....   .....+.....++... ...+++++++||.+||++||.+|||+.|+|+||||+....+......    ....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~----~~~~~  315 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFK  315 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCC-
T ss_pred             hhhhhhcccccCCccCCCCHHHh-CCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccc----cCccC
Confidence            1100   0012222233333332 34579999999999999999999999999999999987776443211    12233


Q ss_pred             CChhhhccCCHHHHHhhcHHHHhhhCCC
Q 014156          399 FKPQELKGASKELLSKLIPEHARKQCPF  426 (429)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  426 (429)
                      ++ .+.....++.+..++-++..+..|-
T Consensus       316 ~~-~~~~~~~~~~l~~l~~~e~~~~~~~  342 (345)
T d1pmea_         316 FD-MELDDLPKEKLKELIFEETARFQPG  342 (345)
T ss_dssp             --------CCHHHHHHHHHHHSGGGSTT
T ss_pred             CC-hhhhhCCHHHHHHHHHHHHHhcCCC
Confidence            33 4455567788888888888777663

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-56  Score=414.61  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=215.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------------hhHHHHHHHHHHcC-CCCeeccceeeeec
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFFST  156 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~l~~~~~~~  156 (429)
                      .+|++.+.||+|+||+||+|++..+|+.||||++.+..             ....+|+.+++.++ ||||++++++|.  
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--   80 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--   80 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence            47999999999999999999999999999999985421             23457999999997 999999999984  


Q ss_pred             CCCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEE
Q 014156          157 TDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL  235 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl  235 (429)
                         +...+|+|||||++ +|.+++..    .+.+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||
T Consensus        81 ---~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          81 ---TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             ---CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEE
T ss_pred             ---cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccccccceEEEcCCC-CeEE
Confidence               34458999999984 77776643    467999999999999999999999 88999999999999999887 7999


Q ss_pred             eecCCceecccCCCcccccccccccccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014156          236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL  310 (429)
Q Consensus       236 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  310 (429)
                      +|||+|+...........+||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999998876666667889999999999852     3447889999999999999999999999988877777666531


Q ss_pred             CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      ..+.                         .....++|+++++||.+||+.||.+|||+.|+|+||||++.
T Consensus       232 ~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         232 YQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            1100                         01123489999999999999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-56  Score=428.39  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+++|+.++|||||+++++|.     ...
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----ccc
Confidence            457999999999999999999999999999999985421       23458999999999999999999884     344


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||+.+ ++...+..    .+.+++..++.++.||+.||.||| ++|||||||||+||||+.++ .+||+|||+|
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH-~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a  188 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCcCCHHHcccCCCC-CEEeeeceee
Confidence            58899999985 44444432    367999999999999999999999 88999999999999999887 7999999999


Q ss_pred             eecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014156          242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  321 (429)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  321 (429)
                      +....  .....+||+.|||||++.+. .++.++|||||||++|+|+||+.||.+.+....+..+....           
T Consensus       189 ~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------  254 (350)
T d1rdqe_         189 KRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----------  254 (350)
T ss_dssp             EECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             eeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-----------
Confidence            87643  33467899999999999764 58999999999999999999999999988777777665521           


Q ss_pred             CCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                        ..++..+++++.+||++||.+||.+|+     |+.++++||||+.+.+
T Consensus       255 ------------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         255 ------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ------------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                              012345899999999999999999995     9999999999998765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-56  Score=418.17  Aligned_cols=277  Identities=34%  Similarity=0.603  Sum_probs=223.0

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      ++|+++++||+|+||+||+|+++ +|+.||||++...      .....+|+.+|+.++|||||+++++|....     ..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence            47999999999999999999985 7899999998543      234568999999999999999999985433     37


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      +++|+++.++++..+.   ...+.+++..++.++.||+.||+||| +.|||||||||+|||++.++ .+||+|||+|...
T Consensus        76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhc-cCcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            8999999988766553   34578999999999999999999999 78999999999999999887 7999999999876


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .... ......||+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+++.++....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            4432 234557899999999998777789999999999999999999999999999999999999888877654432211


Q ss_pred             CCc-cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          324 NYT-EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       324 ~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                      ... ..........+ ...+...+++++++||++||++||++|||+.|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCC-GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcc-hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            100 00111111112 22344568999999999999999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-56  Score=430.63  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=206.8

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHH---HHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||+++++|..    
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----   78 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----   78 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence            357999999999999999999999999999999985321       11223   4566667789999999998843    


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeec
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF  238 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DF  238 (429)
                       ...+|+|||||+ ++|...+..    ...+++..++.++.||+.||.||| ++|||||||||+|||++.++ .+||+||
T Consensus        79 -~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH-~~~iiHrDlKP~NILl~~~g-~iKl~DF  151 (364)
T d1omwa3          79 -PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDL  151 (364)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECSSS-CEEECCC
T ss_pred             -CCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHH-HCCccceeeccceeEEcCCC-cEEEeee
Confidence             345889999998 566655543    467899999999999999999999 88999999999999999887 7999999


Q ss_pred             CCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          239 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       239 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      |+|+..... .....+||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+...........      
T Consensus       152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------  224 (364)
T d1omwa3         152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------  224 (364)
T ss_dssp             TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred             ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence            999876544 3446789999999999976666899999999999999999999999876543332211111000      


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCccccCC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFDELRD  382 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~  382 (429)
                                          ...++..+|+++++||.+||++||.+|||     |.|+++||||+++.+
T Consensus       225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                                11234568999999999999999999999     799999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=424.62  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=216.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....   ....+|+++|+.++|||||+++++|..     ...+|+|
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEE
Confidence            47999999999999999999999999999999986543   335689999999999999999999854     3358999


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC-CceEEeecCCceecc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT-HQVKLCDFGSAKVLV  245 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~-~~vkl~DFG~a~~~~  245 (429)
                      ||||+| +|.+.+.   .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ ..+||+|||+++...
T Consensus        80 mE~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH-~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          80 FEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             ECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999985 5655443   23447999999999999999999999 88999999999999997543 379999999998876


Q ss_pred             cCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      ........+||+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+..+.+..+.+.........        
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------  226 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA--------  226 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH--------
T ss_pred             cCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh--------
Confidence            66666677899999999998664 589999999999999999999999999988888888776432222221        


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                                       .+.+|+++++||.+||.+||.+|||+.|+|+||||++
T Consensus       227 -----------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         227 -----------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -----------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                             2347999999999999999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-56  Score=419.63  Aligned_cols=251  Identities=27%  Similarity=0.484  Sum_probs=210.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHH-HHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      ++|.+++.||+|+||+||+|+++.+|+.||||++.++.       ....+|..++ +.++|||||++++++..     ..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence            46999999999999999999999999999999986432       2233566655 46899999999999843     44


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+|+|||||++ +|..++..    ...+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH-~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCcccceeecCCC-ceeccccchh
Confidence            58999999985 55555433    467999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccC-CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014156          242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  320 (429)
Q Consensus       242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  320 (429)
                      +..... ......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+...  .+       
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------  220 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------  220 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence            866443 334457899999999999764 5899999999999999999999999998877776666441  10       


Q ss_pred             cCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCccccCC
Q 014156          321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFDELRD  382 (429)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~-e~l~hp~f~~~~~  382 (429)
                                          .+++.+|+++.+||++||+.||.+|||+. ++++||||+++++
T Consensus       221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence                                13345899999999999999999999995 8999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-56  Score=414.86  Aligned_cols=245  Identities=26%  Similarity=0.398  Sum_probs=203.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----------hhHHHHHHHHHHcC--CCCeeccceeeeecCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTD  158 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~  158 (429)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+..          ....+|+.+++.++  |||||+++++|..   
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~---   80 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER---   80 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC---
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee---
Confidence            47999999999999999999999999999999986432          22357999999997  8999999998843   


Q ss_pred             CCceEEEEEeecchh--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          159 KDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                        ...+++||||+.+  ++...+..    ...+++..++.++.||+.||+||| +.||+||||||+|||++.+...+||+
T Consensus        81 --~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          81 --PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             --SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             --CCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCcccceEEecCCCeEEEC
Confidence              3458899999964  44444432    467999999999999999999999 88999999999999998765589999


Q ss_pred             ecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       237 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      |||+|+..... .....+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+      .+.+.       
T Consensus       154 DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-------  219 (273)
T d1xwsa_         154 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------  219 (273)
T ss_dssp             CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred             ccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence            99999875433 34567899999999999776656788999999999999999999997532      11110       


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELR  381 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  381 (429)
                                            ...++..+|+++++||++||++||++|||+.|+|+||||+++.
T Consensus       220 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 ----------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ----------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ----------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                                  0123456899999999999999999999999999999998754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4e-55  Score=417.38  Aligned_cols=282  Identities=30%  Similarity=0.513  Sum_probs=223.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc-hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEEEe
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ++|+++++||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.+. ||||++++++|...   ...++++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence            4799999999999999999999999999999998654 345668999999995 99999999987543   233478999


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccCC
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  248 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~~  248 (429)
                      |||+++.+..      ..+.+++..++.++.||+.||+||| ++||+||||||+||||+.+++.+||+|||+|+......
T Consensus       112 e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH-~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHh-hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999754321      2357999999999999999999999 88999999999999999777679999999999887766


Q ss_pred             CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 014156          249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTE  327 (429)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  327 (429)
                      .....+||+.|+|||.+.+...++.++||||+||++|+|++|+.||... +..++...+...++.+....+.........
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            6777889999999999987777899999999999999999999999764 455666777777765544333221111110


Q ss_pred             ccC----CCcCCCCcc----cccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCC
Q 014156          328 FKF----PQIKAHPWH----KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRD  382 (429)
Q Consensus       328 ~~~----~~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  382 (429)
                      ..+    .......+.    ......+++++++||++||++||.+|||+.|+|+||||+.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            000    011111111    1122347899999999999999999999999999999998765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=406.32  Aligned_cols=283  Identities=34%  Similarity=0.545  Sum_probs=227.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      .+|++++.||+|+||+||+|++..+|+.||||++..+      .....+|+.+++.++||||+++++++..     ....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----ccce
Confidence            3799999999999999999999999999999998533      2344689999999999999999998843     3457


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|++++.++.+..+.   ...+.+++..++.++.|++.||+||| +.||+||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH-~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhh-cCCEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            8999999987655433   34678999999999999999999999 78999999999999999887 7999999999877


Q ss_pred             ccCC-CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      .... ......+++.|+|||++.+...++.++||||+||++|+|++|+.| |.+.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            5443 333456788999999987766689999999999999999999987 55667777788888887777665443222


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      ........+..............+++.+++||++||++||.+||||.|+|+||||+++..|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            2111112222222223334456789999999999999999999999999999999987654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=421.10  Aligned_cols=263  Identities=26%  Similarity=0.377  Sum_probs=208.2

Q ss_pred             ccceeEee-EEccCCcEEEEEEEEcCCCcEEEEEEeccchhhHHHHHHHHHH-cCCCCeeccceeeeecCCCCceEEEEE
Q 014156           90 TISYMAER-VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        90 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .++|.++. .||+|+||+||+|++..+++.||||++.. .....+|+.++.+ ++|||||+++++|.... ....++|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence            45799875 59999999999999999999999998864 3456689988654 58999999999885432 334568999


Q ss_pred             eecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC--CceEEeecCCceec
Q 014156          168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVL  244 (429)
Q Consensus       168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~--~~vkl~DFG~a~~~  244 (429)
                      ||||+ |+|.+.+..  +....+++..++.++.||+.||+||| +.||+||||||+|||++.+.  ..+||+|||+|+..
T Consensus        88 mEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH-~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          88 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHH-HcCCccccccccccccccccccccccccccceeeec
Confidence            99998 577776643  22357999999999999999999999 88999999999999997532  26999999999988


Q ss_pred             ccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 014156          245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  324 (429)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  324 (429)
                      .........+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+.......+......            
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~------------  231 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------------  231 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS------------
T ss_pred             cCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc------------
Confidence            777667778999999999998664 4899999999999999999999999877655444333321100            


Q ss_pred             CccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccc
Q 014156          325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDE  379 (429)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  379 (429)
                       ..+.+|.        .....+|+++++||++||++||++|||+.|+|+||||.+
T Consensus       232 -~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 -GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -CSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -CCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence             0111111        111247899999999999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-55  Score=420.06  Aligned_cols=284  Identities=31%  Similarity=0.546  Sum_probs=219.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|+++++||+|+||+||+|+++.+|+.||||++...      .....+|+.+++.++|||||+++++|..... ....+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            4699999999999999999999999999999998643      2234589999999999999999998864432 24467


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +|+|||||.++++..+      ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH-~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhh-hcccccccCCcccccccccc-ceeeechhhhhc
Confidence            8999999999877654      356999999999999999999999 78999999999999999888 699999999988


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..........+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+....+..+....+.+..+.+.....
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            7776666778899999999999774 589999999999999999999999999999999999999998888776654332


Q ss_pred             CCccc--cCCCcCCCCcccc-----------cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCC
Q 014156          324 NYTEF--KFPQIKAHPWHKI-----------FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDP  383 (429)
Q Consensus       324 ~~~~~--~~~~~~~~~~~~~-----------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  383 (429)
                      .....  ..+......+...           .....++++++||++||.+||++||||+|+|+||||++..++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence            21110  0000011111110           111246789999999999999999999999999999987664

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=411.48  Aligned_cols=286  Identities=29%  Similarity=0.444  Sum_probs=221.0

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCC---CC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD  160 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---~~  160 (429)
                      .++|++++.||+|+||+||+|++..+|+.||||++..+      .....+|+.+|+.++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            46899999999999999999999999999999987533      2234589999999999999999988754321   12


Q ss_pred             ceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ...+++||||+.++++...   ......+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~l~~lH-~~~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH---TCTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchh---hhcccccccHHHHHHHHHHHHHHHHhc-cCCEEecCcCchheeecCCC-cEEeeecce
Confidence            3347899999998766543   334578999999999999999999999 88999999999999999888 799999999


Q ss_pred             ceecccC-----CCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014156          241 AKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  315 (429)
Q Consensus       241 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  315 (429)
                      |+.....     ......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..+.+..+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9765422     22334679999999999987777999999999999999999999999999999999999998888775


Q ss_pred             HHHhhcCCCCccccCCC--cCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          316 EEIKCMNPNYTEFKFPQ--IKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                      +................  .........+ ....++++++||.+||++||++|||+.|+|+||||+.-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            54322211100000000  0000000000 01247789999999999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=414.29  Aligned_cols=314  Identities=31%  Similarity=0.522  Sum_probs=239.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch------hhHHHHHHHHHHcCCCCeeccceeeeecCC-CCceE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  163 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~~~~  163 (429)
                      .+|++++.||+|+||+||+|++..+|+.||||++.+..      ....+|+.+|+.++|||||+++++|..... .+..+
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999986432      234589999999999999999998865432 22334


Q ss_pred             EEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      +++++++++++|.+++.     .+++++..++.++.||+.||+||| ++||+||||||+|||++.++ .+|++|||+|..
T Consensus        98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH-~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred             EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHH-hCCCcccccCCccccccccc-cccccccchhcc
Confidence            55666666677776653     367999999999999999999999 88999999999999999887 799999999976


Q ss_pred             cccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ..  .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.......
T Consensus       171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            53  3345577899999999987777789999999999999999999999999999999999999988888765543221


Q ss_pred             CCcc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCC
Q 014156          324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDELRDPNARLPNGRPFPPLFNFK  400 (429)
Q Consensus       324 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  400 (429)
                      ....   ...+......+... ...+++++++||++||++||.+|||+.|+|+||||+++.++....     ...++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~-----~~~~~~~~  322 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYDQS  322 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC-----CCCCCCCG
T ss_pred             hhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC-----CCCCCCCc
Confidence            1100   11222222222222 245799999999999999999999999999999999988765432     22233333


Q ss_pred             hhhhccCCHHHHHhhcHHHH
Q 014156          401 PQELKGASKELLSKLIPEHA  420 (429)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~  420 (429)
                      . +......+.++.++-++.
T Consensus       323 ~-~~~~~~~~~~k~~~~~e~  341 (348)
T d2gfsa1         323 F-ESRDLLIDEWKSLTYDEV  341 (348)
T ss_dssp             G-GGCCCCHHHHHHHHHHHH
T ss_pred             c-cchhcCHHHHHHHHHHHh
Confidence            2 223445555566554443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.2e-53  Score=392.03  Aligned_cols=256  Identities=25%  Similarity=0.374  Sum_probs=201.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch-------hhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .++|++.+.||+|+||+||+|++..+|+.||||++..+.       ....+|+++++.++|||||++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            346999999999999999999999999999999985421       23458999999999999999999886544 3445


Q ss_pred             EEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      ++|+||||++|+ |...+.    ..+.+++..++.++.||+.||+||| +.||+||||||+|||++.++ .++|+|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH-~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATN-AVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHH-hCCccCccccCcccccCccc-cceeehhhhh
Confidence            688999999964 443332    3467999999999999999999999 88999999999999999887 7999999998


Q ss_pred             eecccCC----CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          242 KVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       242 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      +......    .....+||+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+..+.+.++......+.   
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---  234 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---  234 (277)
T ss_dssp             EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG---
T ss_pred             hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC---
Confidence            7653322    33456899999999998764 589999999999999999999999999888777766655211111   


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcc
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFD  378 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  378 (429)
                                            ....+.+|+++.+||.+||++||.+||+..+.+.|+|++
T Consensus       235 ----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                  123346899999999999999999999555555666654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-52  Score=390.81  Aligned_cols=252  Identities=20%  Similarity=0.282  Sum_probs=202.2

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++..+   .....+|+++++.++|||||++++++...     ..+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEE
Confidence            34799999999999999999999999999999998644   34456899999999999999999988433     23789


Q ss_pred             Eeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      |||||++ ++...+..  .....+++..++.++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHH-HCCcccCccccCeEEECCCC-cEEEccccceeecC
Confidence            9999985 55555533  23467899999999999999999999 78999999999999999887 79999999998764


Q ss_pred             cCCCc--ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          246 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       246 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      .....  ....||+.|+|||++.+. .++.++|||||||++|||++|..||........+.++.....            
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~------------  233 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------  233 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC------------
Confidence            43322  234578999999998765 489999999999999999997766555444444444333110            


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCcccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFDEL  380 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  380 (429)
                                     ...++..+++++.+||.+||+.||.+|||+.|+++  +|+.+
T Consensus       234 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         234 ---------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ---------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                           11233468999999999999999999999999975  45443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=386.72  Aligned_cols=248  Identities=21%  Similarity=0.276  Sum_probs=195.3

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  163 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~  163 (429)
                      .++|++.+.||+|+||+||+|+.   +..||||++...      ...+.+|+.++++++|||||++++++..    .  .
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--Q   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred             cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--E
Confidence            35699999999999999999975   346999988532      2345589999999999999999986521    1  2


Q ss_pred             EEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCce
Q 014156          164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  242 (429)
Q Consensus       164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~  242 (429)
                      +++|||||+ |+|.+.+.   .....+++..+..++.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHh-cCCEeccccCHHHEEEcCCC-CEEEcccccee
Confidence            679999998 56666553   23467999999999999999999999 78999999999999999887 79999999997


Q ss_pred             ecccCC---CcccccccccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014156          243 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  317 (429)
Q Consensus       243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  317 (429)
                      ......   ......||+.|||||++.+.  ..++.++|||||||++|||+||+.||.+.+....+.........++   
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p---  229 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP---  229 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            764322   23456789999999998643  3478999999999999999999999998877766655544321111   


Q ss_pred             HhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                          ....++..+++++.+||.+||..||.+|||+.|++++
T Consensus       230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                0112345689999999999999999999999999876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-52  Score=394.49  Aligned_cols=249  Identities=21%  Similarity=0.300  Sum_probs=200.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc-----EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      .+|++.++||+|+||+||+|++..+++     .||+|.+...     .....+|+.+++.+ +|||||++++++...   
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~---  113 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS---  113 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC---
Confidence            479999999999999999999876554     6999987532     23345799999988 899999999988443   


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCC
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSR-------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI  219 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~-------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDl  219 (429)
                        ..+++|||||+ |+|.+.+.....                   ....+++..++.++.||+.||+||| ++|||||||
T Consensus       114 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH-~~~IiHRDl  190 (325)
T d1rjba_         114 --GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDL  190 (325)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEEETTC
T ss_pred             --CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccC
Confidence              33789999998 466666643211                   1245899999999999999999999 789999999


Q ss_pred             CCCCeeecCCCCceEEeecCCceecccCCCc---ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014156          220 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFP  295 (429)
Q Consensus       220 Kp~Nill~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~  295 (429)
                      ||+|||++.++ .+||+|||+|+........   ....||+.|||||++.+. .++.++|||||||++|||+| |++||.
T Consensus       191 Kp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         191 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             chhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999887 8999999999876554432   245679999999998764 48999999999999999998 899999


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       296 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +.+..+.+.++......                           ...+..+|+++.+||.+||+.||++|||+.|+++|
T Consensus       269 ~~~~~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCC---------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            87776666665542111                           11234579999999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-52  Score=382.30  Aligned_cols=244  Identities=20%  Similarity=0.313  Sum_probs=189.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||+||+|++. +++.||||++..+   .....+|+++++.++|||||++++++....     .+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEE
Confidence            36999999999999999999975 5678999998643   344568999999999999999999885433     37899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+++ +|.+.+.   .....+++..+..++.||+.||.||| +.+|+||||||+||||+.++ .+||+|||+|+....
T Consensus        79 ~E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH-~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          79 FEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred             EEecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhh-ccceeecccchhheeecCCC-CeEecccchheeccC
Confidence            999985 4555443   23467899999999999999999999 78999999999999999887 799999999987654


Q ss_pred             CCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+.....            
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------  220 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------  220 (263)
T ss_dssp             -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------------
T ss_pred             CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            332  2345789999999998764 49999999999999999999 5677766666555555443210            


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                      ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       221 ----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         221 ----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            01233478999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.2e-52  Score=388.73  Aligned_cols=245  Identities=24%  Similarity=0.317  Sum_probs=187.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|++.++||+|+||+||+|+++.+++   .||||.+...     .....+|+++|+.++|||||++++++....     
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-----  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-----
Confidence            469999999999999999999887765   5889987532     234568999999999999999999884432     


Q ss_pred             EEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++|||||+++ |.+++.   ...+.+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla  175 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVNSNL-VCKVSDFGLS  175 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred             EEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHh-hCCCccCccccceEEECCCC-cEEECCcccc
Confidence            378999999965 444332   33457999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccCCCc------ccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          242 KVLVKGEPN------ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       242 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      +........      ....||+.|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+.+..+.....   
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---  251 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---  251 (299)
T ss_dssp             --------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence            876443221      224578999999998764 58999999999999999998 8999998887666555443210   


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                               ...+..+++++.+||.+||+.||.+|||+.|++++
T Consensus       252 -------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 -------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                     01234578999999999999999999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=378.46  Aligned_cols=244  Identities=19%  Similarity=0.265  Sum_probs=201.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.++||+|+||+||+|+++ +++.||||++...   .....+|+.++++++||||+++++++...     ..+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEE
Confidence            46999999999999999999974 7789999998653   34556899999999999999999988433     237899


Q ss_pred             eecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||+.+ ++...+.   .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH-~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHH-HTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHh-hcCcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            999985 4444432   33467899999999999999999999 78999999999999999887 799999999986644


Q ss_pred             CCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.....            
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~------------  219 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------  219 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred             CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            332  2346789999999999764 48999999999999999998 8999998887766655543210            


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                      ...+...++++.+||++||+.||++|||+.++++|
T Consensus       220 ----------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         220 ----------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                            11234578999999999999999999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=382.41  Aligned_cols=249  Identities=22%  Similarity=0.298  Sum_probs=199.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      .+|++.+.||+|+||+||+|+++ ++..||||++...   .....+|+.++++++|||||++++++..    +  .+++|
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~--~~~iv   85 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIYII   85 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----C--CeEEE
Confidence            47999999999999999999975 5788999998643   3445689999999999999999987632    1  15789


Q ss_pred             eecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||++++ |.+.+..  .....+++..+..++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+....
T Consensus        86 ~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH-~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTL-SCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCccchhheeeeccc-ceeeccccceEEccC
Confidence            9999854 4443322  22346899999999999999999999 78999999999999999887 799999999987754


Q ss_pred             CCC--cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 014156          247 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  323 (429)
Q Consensus       247 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  323 (429)
                      ...  .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+....             
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-------------  227 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-------------  227 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------
T ss_pred             CccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            432  2345789999999998764 489999999999999999995 55566555555444443210             


Q ss_pred             CCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCccc
Q 014156          324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDE  379 (429)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~  379 (429)
                                     ....+..+++++.+||.+||+.||++|||+.++++  |+||..
T Consensus       228 ---------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         228 ---------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                           01123457999999999999999999999999988  788853

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=383.42  Aligned_cols=249  Identities=24%  Similarity=0.294  Sum_probs=199.7

Q ss_pred             cceeEeeE-EccCCcEEEEEEEEcC--CCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERV-VGQGSFGIVFQAKCLE--TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~-lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|.+.+. ||+|+||+||+|.++.  ++..||||++...     .....+|++++++++|||||++++++.. .     
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~-----   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C-----
Confidence            46888885 9999999999998764  4557999998542     2334589999999999999999997632 1     


Q ss_pred             EEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++|||||++ +|.+++   ......+++..+..++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l---~~~~~~l~~~~~~~i~~qi~~gL~ylH-~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla  156 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRH-YAKISDFGLS  156 (285)
T ss_dssp             SEEEEEECCTTEEHHHHH---TTCTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHh---hccccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCcCchhheeeccCC-ceeeccchhh
Confidence            16799999996 554443   233467999999999999999999999 78999999999999999887 8999999999


Q ss_pred             eecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      +.......    .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+..      
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~------  229 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------  229 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------
T ss_pred             hcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            87654332    2245688999999998764 48999999999999999998 999999887766555543310      


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCCccc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA---CIHPFFDE  379 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~---l~hp~f~~  379 (429)
                                            ...+++.+|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       230 ----------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         230 ----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                                  011334689999999999999999999999877   67888753

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=392.62  Aligned_cols=257  Identities=28%  Similarity=0.457  Sum_probs=206.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc---CCCcEEEEEEeccc--------hhhHHHHHHHHHHcCC-CCeeccceeeeecC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLLDH-PNVVSLKHCFFSTT  157 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~  157 (429)
                      ..+|++++.||+|+||+||+|++.   .+|+.||||++...        .....+|++++++++| |||+++++++..  
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--  100 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  100 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence            357999999999999999999874   46899999987532        2334579999999977 799999988844  


Q ss_pred             CCCceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEe
Q 014156          158 DKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC  236 (429)
Q Consensus       158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~  236 (429)
                         ...++++|||+.+ +|...+..    .+.+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+
T Consensus       101 ---~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH-~~~ivHrDiKp~Nill~~~~-~vkL~  171 (322)
T d1vzoa_         101 ---ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HVVLT  171 (322)
T ss_dssp             ---TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEES
T ss_pred             ---CCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhh-cCCEEeccCCccceeecCCC-CEEEe
Confidence               3358899999985 55554433    467889999999999999999999 88999999999999999887 79999


Q ss_pred             ecCCceecccC--CCcccccccccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014156          237 DFGSAKVLVKG--EPNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  313 (429)
Q Consensus       237 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  313 (429)
                      |||+|+.....  .......||+.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+.....
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            99999876432  2234567899999999986543 47889999999999999999999998876555544444321000


Q ss_pred             CHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCccccCC
Q 014156          314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFDELRD  382 (429)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  382 (429)
                                               ...++..+|+++++||.+||.+||.+||     |+.|+|+||||+++.+
T Consensus       252 -------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         252 -------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             -------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence                                     0113345899999999999999999999     5899999999998764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=381.57  Aligned_cols=241  Identities=22%  Similarity=0.293  Sum_probs=191.9

Q ss_pred             eEEccCCcEEEEEEEEc--CCCcEEEEEEeccc------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           97 RVVGQGSFGIVFQAKCL--ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ++||+|+||+||+|.+.  .+++.||||++...      .....+|++++++++|||||++++++.. .    . .++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~----~-~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E----S-WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S----S-EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C----C-EEEEE
Confidence            47999999999999864  45678999988542      2335689999999999999999997732 1    1 57899


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecccC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  247 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~~  247 (429)
                      |||++ +|.+++.    ....+++..+..++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+.....
T Consensus        87 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH-~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          87 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD  160 (277)
T ss_dssp             ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHH-hCCcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence            99985 5555443    3567999999999999999999999 78999999999999999887 8999999999876443


Q ss_pred             CC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          248 EP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       248 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ..    .....||+.|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+....+.+..            
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~------------  227 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------  227 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence            32    2234689999999998764 48999999999999999998 899999887665554443210            


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCCcc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA---CIHPFFD  378 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~---l~hp~f~  378 (429)
                                      ...++..+|+++.+||.+||+.||.+|||+.++   |+|+|++
T Consensus       228 ----------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         228 ----------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                            011334579999999999999999999999998   5666654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=373.57  Aligned_cols=245  Identities=20%  Similarity=0.258  Sum_probs=185.9

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCC----cEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      ..|++.++||+|+||+||+|.++.++    ..||||++...     .....+|+.+++.++|||||++++++....    
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~----   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK----   82 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC----
Confidence            36999999999999999999987654    47999988532     223458999999999999999999884432    


Q ss_pred             eEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                       .+++||||+.++++...  .......+++..+..++.||+.||+||| +.+|+||||||+||||+.++ .+||+|||+|
T Consensus        83 -~~~~v~e~~~~~~l~~~--~~~~~~~~~~~~~~~i~~~i~~gl~~lH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla  157 (283)
T d1mqba_          83 -PMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNL-VCKVSDFGLS  157 (283)
T ss_dssp             -SEEEEEECCTTEEHHHH--HHHTTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred             -ceEEEEEecccCcchhh--hhcccccccHHHHHHHHHHHHHhhhhcc-ccccccCccccceEEECCCC-eEEEcccchh
Confidence             37899999986544332  2234467999999999999999999999 78999999999999999887 7999999999


Q ss_pred             eecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHH
Q 014156          242 KVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       242 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      +.......    .....||+.|+|||++.+. .++.++|||||||++|||++|..| |.+.+..+.+..+....      
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------  230 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------  230 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC------
Confidence            87644322    2235679999999998764 599999999999999999996555 54444444333332210      


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                                            ....+..++.++.+||.+||..||++|||+.|+++
T Consensus       231 ----------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         231 ----------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ----------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                  01123457899999999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=373.96  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=195.4

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc---hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      ..+|++.+.||+|+||+||+|+++.+ +.||||++...   ...+.+|+.++++++|||||++++++.. .   .  +++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~---~--~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E---P--IYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S---S--CEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-C---C--eEE
Confidence            45799999999999999999998655 57999998643   3456689999999999999999997632 1   1  578


Q ss_pred             Eeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceecc
Q 014156          167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  245 (429)
Q Consensus       167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~  245 (429)
                      ||||+.++ +...+..  .....+++..++.++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+...
T Consensus        89 v~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH-~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHh-hhheecccccceEEEECCCC-cEEEcccchhhhcc
Confidence            99999965 4443322  23457999999999999999999999 78999999999999999887 79999999998764


Q ss_pred             cCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014156          246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMN  322 (429)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  322 (429)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|||++|. +||.+....+.+..+.....           
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-----------  232 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  232 (285)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            333  22346789999999999764 4899999999999999999965 55555555555544433110           


Q ss_pred             CCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCcccc
Q 014156          323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFDEL  380 (429)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~  380 (429)
                                       ..++..+++++.+||.+||+.||++|||+.+++.  ++||...
T Consensus       233 -----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         233 -----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                             1123457999999999999999999999999987  8898764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=375.08  Aligned_cols=244  Identities=27%  Similarity=0.361  Sum_probs=188.1

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCC---cEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCce
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  162 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~  162 (429)
                      .+|++.+.||+|+||.||+|++..++   ..||||.+...     .....+|+.+++.++|||||++++++..      .
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------N   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------S
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence            47999999999999999999987553   46889987532     2334589999999999999999998731      1


Q ss_pred             EEEEEeecchhh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCc
Q 014156          163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  241 (429)
Q Consensus       163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a  241 (429)
                      .+++||||++++ +...+.   .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+|
T Consensus        81 ~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a  155 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDFGLS  155 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred             eEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhc-ccCeeccccchhheeecCCC-cEEEccchhh
Confidence            267999999854 444332   33467999999999999999999999 88999999999999999887 8999999999


Q ss_pred             eecccCC--CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014156          242 KVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  318 (429)
Q Consensus       242 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  318 (429)
                      +......  ......||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+..+....        
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~--------  226 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------  226 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred             eeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            8764332  22345679999999999764 48999999999999999998 899999888777666554321        


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                          ...+++.+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       227 --------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         227 --------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                011345689999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=378.53  Aligned_cols=244  Identities=23%  Similarity=0.330  Sum_probs=192.6

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCc----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCc
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~  161 (429)
                      .+|+++++||+|+||+||+|++..+|+    .||+|.+...     .....+|+.+++.++|||||++++++...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            369999999999999999999988876    5788877432     23456899999999999999999987532     


Q ss_pred             eEEEEEeecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      . .+++++|+. +++.+.+.   .....+++..++.++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             C-eeEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHH-HcCcccCcchhhcceeCCCC-CeEeecccc
Confidence            1 445666665 56655443   34577999999999999999999999 78999999999999999887 799999999


Q ss_pred             ceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014156          241 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  316 (429)
Q Consensus       241 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  316 (429)
                      |+.......   .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.... .+   
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~---  232 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL---  232 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CC---
T ss_pred             ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CC---
Confidence            987654332   2234679999999998765 48999999999999999998 789998877655544443321 00   


Q ss_pred             HHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                              ..+..+++++.+||.+||..||.+|||+.|+++|
T Consensus       233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                    1234578999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=372.80  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=188.5

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeecCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~  159 (429)
                      .+|++.+.||+|+||.||+|++..     +++.||||++....     ....+|..++.++ .|+||+.+++++....  
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--   90 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--   90 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC--
Confidence            479999999999999999999754     45689999885432     2233566666665 6889999988764332  


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeee
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV  226 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill  226 (429)
                        ..+++|||||+ |+|.+++.....            ....+++..++.++.||+.||+||| ++|||||||||+||||
T Consensus        91 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILL  167 (299)
T ss_dssp             --SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEE
T ss_pred             --CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH-hCCCcCCcCCccceeE
Confidence              23679999998 566666654322            1345899999999999999999999 7899999999999999


Q ss_pred             cCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 014156          227 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQ  302 (429)
Q Consensus       227 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~  302 (429)
                      +.++ .+||+|||+|+.......   .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||.+.+..+.
T Consensus       168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 799999999986543322   2346789999999999764 489999999999999999986 578887766665


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      +..+......+                           .++..+++++++||.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55544421111                           1234578999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=365.24  Aligned_cols=244  Identities=22%  Similarity=0.331  Sum_probs=192.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEE
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ..+|++.++||+|+||.||+|++  +|..||||++..+  .+...+|++++++++||||+++++++....+    .+++|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~----~~~lv   79 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG----GLYIV   79 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC----cEEEE
Confidence            45799999999999999999997  5789999999654  3445689999999999999999998754322    26899


Q ss_pred             eecch-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceeccc
Q 014156          168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  246 (429)
Q Consensus       168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~~~  246 (429)
                      |||++ |++.+.+...  ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+++....
T Consensus        80 ~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH-~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEEECCCCC------
T ss_pred             EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccc-cCceeccccchHhheecCCC-CEeecccccceecCC
Confidence            99997 4666665432  2235899999999999999999999 78999999999999999888 799999999986533


Q ss_pred             CCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 014156          247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  325 (429)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  325 (429)
                      .  .....+|..|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+....+.+.                
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~----------------  216 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------------  216 (262)
T ss_dssp             --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT----------------
T ss_pred             C--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----------------
Confidence            2  3345678999999999765 48999999999999999998 78889887766655544321                


Q ss_pred             ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                  ....++..+++++.+||++||..||.+|||+.+++++
T Consensus       217 ------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 ------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                        0112344678999999999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=367.20  Aligned_cols=243  Identities=24%  Similarity=0.327  Sum_probs=188.4

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCC-C--cEEEEEEeccc-------hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLET-G--ETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      .+|++.+.||+|+||.||+|+...+ +  ..||||++..+       .....+|+.+++.++|||||++++++...    
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~----   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence            4699999999999999999986533 3  36899987532       13346899999999999999999988421    


Q ss_pred             ceEEEEEeecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecC
Q 014156          161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG  239 (429)
Q Consensus       161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG  239 (429)
                        .+++||||+++ ++.+.+..   ....+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||
T Consensus        84 --~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          84 --PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             --SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             --chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhh-hCCEeeeeecHHHhcccccc-ceeeccch
Confidence              25789999984 44443332   3456999999999999999999999 78999999999999999887 89999999


Q ss_pred             CceecccCCC----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014156          240 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  314 (429)
Q Consensus       240 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  314 (429)
                      +++.......    .....||..|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....  
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~--  233 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--  233 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC--
Confidence            9987654432    2234578899999999764 58999999999999999998 89999998888777665442111  


Q ss_pred             HHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014156          315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC  372 (429)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  372 (429)
                                               ...+..+|+++.+||.+||..||++|||+.+++
T Consensus       234 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         234 -------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                                     112345789999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-49  Score=368.64  Aligned_cols=256  Identities=21%  Similarity=0.259  Sum_probs=198.2

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+....    ...++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~----~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEET----TEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecC----CEEEEEE
Confidence            4699999999999999999999999999999987543  345668999999999888766655443322    2478999


Q ss_pred             ecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC--CCceEEeecCCceeccc
Q 014156          169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLVK  246 (429)
Q Consensus       169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~--~~~vkl~DFG~a~~~~~  246 (429)
                      ||+++++...+..   ....+++..+..++.|++.||+||| ++||+||||||+|||++..  ...+||+|||+|+....
T Consensus        83 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9999887765543   3567999999999999999999999 7899999999999997542  23699999999988754


Q ss_pred             CCC--------cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC---CCCH
Q 014156          247 GEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG---TPTR  315 (429)
Q Consensus       247 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---~~~~  315 (429)
                      ...        .....||+.|+|||++.+. .++.++|||||||++|||+||+.||.+....+....+.+...   .++.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            322        2345799999999998764 489999999999999999999999987665544333322110   0010


Q ss_pred             HHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH---HHhcCCCccc
Q 014156          316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACIHPFFDE  379 (429)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~---e~l~hp~f~~  379 (429)
                                              ..+...+|+++.+||.+||+.||++||++.   ++|+|+|.+.
T Consensus       238 ------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 ------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                                    112345899999999999999999999987   4577776543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-48  Score=376.44  Aligned_cols=289  Identities=28%  Similarity=0.450  Sum_probs=211.4

Q ss_pred             ccccceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch---hhHHHHHHHHHHcC-----------CCCeeccceee
Q 014156           88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCF  153 (429)
Q Consensus        88 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~l~~~~  153 (429)
                      ...++|+++++||+|+||+||+|+++.+|+.||||++.++.   ....+|+.+++.++           |+||+++++++
T Consensus        10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            34457999999999999999999999999999999997653   33457888888775           57899998877


Q ss_pred             eecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCC--
Q 014156          154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--  231 (429)
Q Consensus       154 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~--  231 (429)
                      .... ......+++++++.++......  ......+++..++.++.||+.||+|||+..||+||||||+||||+.++.  
T Consensus        90 ~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKG-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEE-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             eecc-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            5432 2222333344444444333332  3445789999999999999999999995489999999999999976542  


Q ss_pred             ---ceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------hHHH
Q 014156          232 ---QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES------GVDQ  302 (429)
Q Consensus       232 ---~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~  302 (429)
                         .++++|||.|.....  .....+||+.|+|||++.+. .++.++||||+||++++|++|+.||...+      ..+.
T Consensus       167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               499999999986543  33567899999999998764 48999999999999999999999997543      3456


Q ss_pred             HHHHHHHhCCCCHHHHhhcCCCCcc-------ccCCCcCCCCc------ccccCCCCChhHHHHHHhhcCcCCCCCCCHH
Q 014156          303 LVEIIKVLGTPTREEIKCMNPNYTE-------FKFPQIKAHPW------HKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL  369 (429)
Q Consensus       303 ~~~i~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  369 (429)
                      +...+..+|.++.+.+.........       .........++      ...+....++++++||.+||++||.+|||+.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            6777788888777655322111000       01111111111      1112233567899999999999999999999


Q ss_pred             HHhcCCCccccCC
Q 014156          370 EACIHPFFDELRD  382 (429)
Q Consensus       370 e~l~hp~f~~~~~  382 (429)
                      |+|+||||++...
T Consensus       324 e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         324 GLVNHPWLKDTLG  336 (362)
T ss_dssp             HHHTCGGGTTCTT
T ss_pred             HHhcCcccCCCCC
Confidence            9999999997643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=371.55  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             cccceeEeeEEccCCcEEEEEEEEcCCCcE--EEEEEecc-----chhhHHHHHHHHHHc-CCCCeeccceeeeecCCCC
Q 014156           89 QTISYMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQ-----DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        89 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~-----~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~  160 (429)
                      ..++|++.++||+|+||+||+|+++.+|..  ||||.+..     ......+|+++|+.+ +|||||++++++...    
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----   83 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----   83 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC----
Confidence            346899999999999999999999888874  67777642     223456899999998 799999999988543    


Q ss_pred             ceEEEEEeecch-hhHHHHHHHh------------hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeec
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHY------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN  227 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~------------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~  227 (429)
                       ..+++||||++ |+|.+++...            ......+++..+..++.||+.||.||| +.||+||||||+|||++
T Consensus        84 -~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH-~~~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          84 -GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVG  161 (309)
T ss_dssp             -TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC
T ss_pred             -CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh-cCCccccccccceEEEc
Confidence             34889999999 5666665432            123467999999999999999999999 78999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCCcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHH
Q 014156          228 PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEI  306 (429)
Q Consensus       228 ~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i  306 (429)
                      .++ .+||+|||+|+............||..|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+.+..+
T Consensus       162 ~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         162 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CCC-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            887 7999999999876555555566789999999999764 4899999999999999999965 678777766655443


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      .+..                            ...++..+++++.+||.+||+.||++|||+.|+++|
T Consensus       240 ~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         240 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2210                            011334579999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-48  Score=367.88  Aligned_cols=247  Identities=23%  Similarity=0.293  Sum_probs=197.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCC
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  160 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~  160 (429)
                      ++|++++.||+|+||+||+|+++     .+++.||||++...     ...+.+|+.+++.++||||+++++++....   
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~---   89 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK---   89 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC---
Confidence            46999999999999999999975     35678999998543     234568999999999999999999885432   


Q ss_pred             ceEEEEEeecch-hhHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCC
Q 014156          161 ELYLNLVLEFVP-ETVYRVAKHYS--------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI  219 (429)
Q Consensus       161 ~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDl  219 (429)
                        ..++||||+. ++|.+.+....                    .....+++..+..++.||+.||+||| +.+||||||
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH-~~~ivHrDl  166 (301)
T d1lufa_          90 --PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDL  166 (301)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCC
T ss_pred             --ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc-cCCeEeeEE
Confidence              3778999998 56666554311                    11235889999999999999999999 889999999


Q ss_pred             CCCCeeecCCCCceEEeecCCceecccCC---CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCC
Q 014156          220 KPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFP  295 (429)
Q Consensus       220 Kp~Nill~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~  295 (429)
                      ||+||||+.++ .+||+|||+|+......   ......||+.|+|||.+.+. .++.++|||||||++|||++|. +||.
T Consensus       167 Kp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         167 ATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             SGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCC
Confidence            99999999887 79999999998654332   22346788999999999764 4999999999999999999985 7888


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       296 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      +.+..+.+..+....                   .         ..++..+++++.+||.+||+.||++|||+.|+++
T Consensus       245 ~~~~~e~~~~v~~~~-------------------~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         245 GMAHEEVIYYVRDGN-------------------I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TSCHHHHHHHHHTTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCC-------------------C---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            887777665544310                   0         0123468999999999999999999999999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=365.12  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=192.1

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcCCC-------cEEEEEEeccch-----hhHHHHHHHHHHc-CCCCeeccceeeeec
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLETG-------ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  156 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~l~~~~~~~  156 (429)
                      ..+|++.+.||+|+||.||+|++..++       ..||||++..+.     ....+|...+.++ +|||||++++++.. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            358999999999999999999976554       379999885432     2334677788777 89999999998843 


Q ss_pred             CCCCceEEEEEeecchh-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          157 TDKDELYLNLVLEFVPE-TVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                          ...+++||||+.+ ++.+++....            .....+++..++.++.||+.||+||| +.|||||||||+|
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH-~~~ivHrDiKp~N  165 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARN  165 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh-hCCEEeeeecccc
Confidence                3347899999984 5666554321            12356899999999999999999999 8899999999999


Q ss_pred             eeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014156          224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG  299 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  299 (429)
                      ||++.++ .+||+|||+++.......   .....||+.|+|||.+.+. .|+.++|||||||++|||++ |.+||.+.+.
T Consensus       166 iLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         166 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             EEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            9999887 799999999987654432   3346789999999999764 59999999999999999998 7899987776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+....+... ..                           ..++..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~i~~~-~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 EELFKLLKEG-HR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHTT-CC---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcC-CC---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            5544433221 00                           1123457999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-48  Score=363.48  Aligned_cols=254  Identities=23%  Similarity=0.271  Sum_probs=202.6

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEcC-----CCcEEEEEEeccch-----hhHHHHHHHHHHcCCCCeeccceeeeecCCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  159 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  159 (429)
                      ..+|++.+.||+|+||+||+|.+..     ++..||||++....     ....+|+.+++.++|||||++++++....  
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--
Confidence            3579999999999999999998753     35789999986432     23458999999999999999999884332  


Q ss_pred             CceEEEEEeecch-hhHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCc
Q 014156          160 DELYLNLVLEFVP-ETVYRVAKHYSR------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ  232 (429)
Q Consensus       160 ~~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~  232 (429)
                         ..++||||+. |++.+++.....      ....+++..+..++.|++.||.||| +.+|+||||||+||||+.++ .
T Consensus        97 ---~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH-~~~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          97 ---PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEECTTC-C
T ss_pred             ---ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeeceEcCCceeecCCc-e
Confidence               3789999998 455555543221      1245788999999999999999999 78999999999999999887 7


Q ss_pred             eEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 014156          233 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIK  308 (429)
Q Consensus       233 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~  308 (429)
                      +||+|||+|+.......   .....||+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999987644332   2334689999999999765 488999999999999999998 588888777766665543


Q ss_pred             HhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCCccc
Q 014156          309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI------HPFFDE  379 (429)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~  379 (429)
                      ..                            ....+..+++.+.+||.+||+.||++|||+.++++      +|+|++
T Consensus       251 ~~----------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         251 GG----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             TC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CC----------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            21                            01123457899999999999999999999999987      677665

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=360.50  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=198.9

Q ss_pred             ccceeEeeEEccCCcEEEEEEEEc-----CCCcEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCeeccceeeeecCC
Q 014156           90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  158 (429)
Q Consensus        90 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~  158 (429)
                      ..+|++.++||+|+||.||+|++.     .+++.||||++...     .....+|+.+++.+ +|||||++++++...  
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--
Confidence            357999999999999999999863     46679999998643     22345799999998 699999999988433  


Q ss_pred             CCceEEEEEeecchh-hHHHHHHHhh--------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCC
Q 014156          159 KDELYLNLVLEFVPE-TVYRVAKHYS--------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN  223 (429)
Q Consensus       159 ~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~N  223 (429)
                         ..+++|||||++ ++...+....              .....+++..+..++.||+.||+||| ++||+||||||+|
T Consensus       100 ---~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH-~~~ivHrDLKp~N  175 (311)
T d1t46a_         100 ---GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARN  175 (311)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGG
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccccccc
Confidence               337899999985 5555554321              12346899999999999999999999 7899999999999


Q ss_pred             eeecCCCCceEEeecCCceecccCCC---cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 014156          224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG  299 (429)
Q Consensus       224 ill~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  299 (429)
                      ||++.++ .+||+|||+++.......   ....+||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+.
T Consensus       176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999887 899999999987654332   2345789999999999764 48999999999999999998 6777777777


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      .+.+.++......+                           ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            66666655431111                           123347899999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.6e-47  Score=356.96  Aligned_cols=249  Identities=19%  Similarity=0.217  Sum_probs=198.3

Q ss_pred             cceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc--hhhHHHHHHHHHHcCC-CCeeccceeeeecCCCCceEEEEE
Q 014156           91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLV  167 (429)
Q Consensus        91 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~~~~~~lv  167 (429)
                      ++|++++.||+|+||+||+|++..+|+.||||++...  .....+|+++++.|.| +|++.+++++..     ....++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccEEE
Confidence            4799999999999999999999999999999987543  3445789999999976 899998887733     3347899


Q ss_pred             eecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCC----CCceEEeecCCcee
Q 014156          168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAKV  243 (429)
Q Consensus       168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~----~~~vkl~DFG~a~~  243 (429)
                      |||+++++...+..   ....++...+..++.|++.||+||| +.||+||||||+|||++.+    .+.+||+|||+|+.
T Consensus        80 me~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH-~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHH-HCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99999988776643   3457999999999999999999999 8899999999999999642    23799999999987


Q ss_pred             cccCC--------CcccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Q 014156          244 LVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGT  312 (429)
Q Consensus       244 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~~~~~~  312 (429)
                      .....        .....+||+.|||||++.+. .++.++|||||||++|+|+||..||.+.....   ....+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            64331        23346799999999999764 59999999999999999999999998654332   23333222111


Q ss_pred             CCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014156          313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI  373 (429)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  373 (429)
                      +...                        .+.+++|+++.+++..|+..+|++||+...+.+
T Consensus       235 ~~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1111                        123457899999999999999999999876643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=358.01  Aligned_cols=245  Identities=19%  Similarity=0.239  Sum_probs=187.4

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCC---cEEEEEEeccc-----hhhHHHHHHHHHHcCCCCeeccceeeeecCCCCceEE
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  164 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~  164 (429)
                      +...++||+|+||+||+|++..++   ..||||++...     ...+.+|++++++++|||||++++++....    ...
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence            344688999999999999986543   36899988532     234568999999999999999999875432    247


Q ss_pred             EEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCCCceEEeecCCceec
Q 014156          165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  244 (429)
Q Consensus       165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~~  244 (429)
                      ++|||||+++.+..+.  ......+++..+..++.|++.||.||| +.+|+||||||+||||+.++ .+||+|||+++..
T Consensus       105 ~lv~E~~~~g~l~~~~--~~~~~~~~~~~~~~i~~qia~gL~~lH-~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~  180 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKF-TVKVADFGLARDM  180 (311)
T ss_dssp             EEEEECCTTCBHHHHH--HCTTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCT
T ss_pred             EEEEEEeecCchhhhh--ccccccchHHHHHHHHHHHHHhhhhhc-ccCcccCCccHHhEeECCCC-CEEEecccchhhc
Confidence            8999999965443322  233456788889999999999999999 88999999999999999887 7999999999876


Q ss_pred             ccCCC-----cccccccccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Q 014156          245 VKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEI  318 (429)
Q Consensus       245 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~  318 (429)
                      .....     .....||+.|+|||.+.+. .++.++|||||||++|||+||..||........ ...+...  .      
T Consensus       181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~------  251 (311)
T d1r0pa_         181 YDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R------  251 (311)
T ss_dssp             TTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C------
T ss_pred             cccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C------
Confidence            44322     2235689999999998764 489999999999999999998877765433222 2222111  0      


Q ss_pred             hhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                                          ....+..+++++.+||.+||..||++|||+.|+++|
T Consensus       252 --------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 --------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                011234578999999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=353.89  Aligned_cols=267  Identities=19%  Similarity=0.198  Sum_probs=186.8

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccchhh-H--HHHHHHHHHcCCCCeeccceeeeecCCCCceEEEEEe
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-K--NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  168 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~h~~iv~l~~~~~~~~~~~~~~~~lv~  168 (429)
                      +|.+.+.||+|+||.||+|+.  +|+.||||++..+... .  +.|+..+..++|||||++++++.... .....+++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence            699999999999999999986  7899999998654322 2  23444556789999999999886654 3445688999


Q ss_pred             ecchh-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCeeecCCCCCCeeecCCCCceEEeecCC
Q 014156          169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  240 (429)
Q Consensus       169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-------~~~iiHrDlKp~Nill~~~~~~vkl~DFG~  240 (429)
                      ||+++ +|...+..     ..+++.....++.|++.||.|||+       +.||+||||||+||||+.++ .+||+|||+
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl  154 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL  154 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTT
T ss_pred             ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCc
Confidence            99985 66666543     469999999999999999999993       25999999999999999887 799999999


Q ss_pred             ceecccCCC-----cccccccccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014156          241 AKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL  310 (429)
Q Consensus       241 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  310 (429)
                      ++.......     .....||+.|+|||++.+..     .++.++|||||||+||||+||..||............ ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~  233 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVP  233 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSC
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-ccc
Confidence            987754432     23467999999999986532     1466899999999999999999887432211100000 000


Q ss_pred             CCCCHHHHhhcCCCCccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014156          311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH  374 (429)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  374 (429)
                      ..+..+.+.....  .....|.++.    ..........+.+|+.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~--~~~~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         234 SDPSVEEMRKVVC--EQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHT--TSCCCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHh--ccccCCCCCc----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0011111100000  0000011100    00011123468999999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.2e-25  Score=195.78  Aligned_cols=160  Identities=17%  Similarity=0.133  Sum_probs=117.5

Q ss_pred             eeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccch----------------------hhHHHHHHHHHHcCCCCeeccc
Q 014156           93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK  150 (429)
Q Consensus        93 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~l~  150 (429)
                      |.+.++||+|+||+||+|++ .+|+.||||++....                      ....+|...+..+.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            57889999999999999997 478999999763210                      1123578888999999998876


Q ss_pred             eeeeecCCCCceEEEEEeecchhhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeecCCCCCCeeecCCC
Q 014156          151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT  230 (429)
Q Consensus       151 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~~iiHrDlKp~Nill~~~~  230 (429)
                      ++.     .    .+++|||+++...          ..++...+..++.|++.+|.||| ++||+||||||+|||++.+ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH-~~giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHh-hCCEEEccCChhheeeeCC-
Confidence            542     2    2589999997421          22455567789999999999999 8899999999999999964 


Q ss_pred             CceEEeecCCceecccCCCcccccccccccc------cccccCCCCCCCcchHHHHHHHH
Q 014156          231 HQVKLCDFGSAKVLVKGEPNISYICSRYYRA------PELIFGATEYTTAIDIWSVGCVL  284 (429)
Q Consensus       231 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~DiwslG~il  284 (429)
                       .++|+|||+|.....+...       .|..      .+.+ . ..|+.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHHH
Confidence             4999999999765433211       1111      1222 2 3478899999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.10  E-value=5.5e-06  Score=73.12  Aligned_cols=76  Identities=17%  Similarity=0.092  Sum_probs=47.9

Q ss_pred             ceeEeeEEccCCcEEEEEEEEcCCCcEEEEEEeccc----hhhHHHHHHHHHHcC-CCCeeccceeeeecCCCCceEEEE
Q 014156           92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        92 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~~~~~~l  166 (429)
                      .|++.+..+.++.+.||+..  .++..+++|+....    .....+|...+..+. +-.+.+++.....     ....++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-----~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-----CCceEE
Confidence            46777766666667999886  35667888877533    234567888888774 2223444443311     124678


Q ss_pred             Eeecchhh
Q 014156          167 VLEFVPET  174 (429)
Q Consensus       167 v~e~~~~~  174 (429)
                      ||++++|.
T Consensus        88 v~~~l~G~   95 (263)
T d1j7la_          88 LMSEADGV   95 (263)
T ss_dssp             EEECCSSE
T ss_pred             EEEecccc
Confidence            99999864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.61  E-value=0.00026  Score=66.14  Aligned_cols=71  Identities=18%  Similarity=0.166  Sum_probs=42.4

Q ss_pred             eeEEccCCcEEEEEEEEcCCCcEEEEEEecc-----------chhhHHHHHHHHHHcC-C--CCeeccceeeeecCCCCc
Q 014156           96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD-H--PNVVSLKHCFFSTTDKDE  161 (429)
Q Consensus        96 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~~~~~~  161 (429)
                      .+.||.|....||++.+..+++.+++|.-..           .......|.+.|+.+. +  ..+.+++.+  +.   ..
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~---~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---EM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---TT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC---CC
Confidence            3568999999999998877788999996421           1123346888887663 2  234444332  21   11


Q ss_pred             eEEEEEeecchh
Q 014156          162 LYLNLVLEFVPE  173 (429)
Q Consensus       162 ~~~~lv~e~~~~  173 (429)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              2479999864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.60  E-value=0.00016  Score=63.05  Aligned_cols=68  Identities=16%  Similarity=0.102  Sum_probs=41.7

Q ss_pred             ccCC-cEEEEEEEEcCCCcEEEEEEeccch-hhHHHHHHHHHHcCCCC--eeccceeeeecCCCCceEEEEEeecchh
Q 014156          100 GQGS-FGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEFVPE  173 (429)
Q Consensus       100 G~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~~~~~~lv~e~~~~  173 (429)
                      ..|. -+.||+... ..+..+++|...... .....|...++.|....  +.+++.+...   .  ...++||++++|
T Consensus        19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~---~--~~~~~v~~~i~G   90 (255)
T d1nd4a_          19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE---A--GRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC---S--SCEEEEEECCSS
T ss_pred             CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc---c--cceEEEEEeeec
Confidence            3443 467898874 456778889765433 34567888888775433  3344443321   1  236789999975

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.55  E-value=0.0067  Score=54.51  Aligned_cols=37  Identities=19%  Similarity=-0.003  Sum_probs=27.4

Q ss_pred             EEEEEEEEcCCCcEEEEEEecc---chhhHHHHHHHHHHcC
Q 014156          105 GIVFQAKCLETGETVAIKKVLQ---DKRYKNRELQTMRLLD  142 (429)
Q Consensus       105 g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~  142 (429)
                      -.||++.. .+|..|++|+...   ....+..|...+..|.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLV   75 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence            48999974 6788999998754   2345667888887774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.43  E-value=0.0098  Score=54.97  Aligned_cols=68  Identities=16%  Similarity=0.238  Sum_probs=43.1

Q ss_pred             eEEccCCcEEEEEEEEcC-------CCcEEEEEEeccc--hhhHHHHHHHHHHcCCCCe-eccceeeeecCCCCceEEEE
Q 014156           97 RVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNL  166 (429)
Q Consensus        97 ~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~~~~~~l  166 (429)
                      +.|+.|-.-.+|++....       ..+.|.+++.-..  .....+|..+++.+.-.++ .++++++     .+    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----ce
Confidence            578888888999987542       3456777765422  2234578888888753344 3555544     22    36


Q ss_pred             Eeecchh
Q 014156          167 VLEFVPE  173 (429)
Q Consensus       167 v~e~~~~  173 (429)
                      |++|++|
T Consensus       119 I~efi~g  125 (395)
T d1nw1a_         119 LEEYIPS  125 (395)
T ss_dssp             EECCCCE
T ss_pred             EEEEecc
Confidence            8888865

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.27  E-value=0.016  Score=51.42  Aligned_cols=32  Identities=28%  Similarity=0.228  Sum_probs=26.8

Q ss_pred             CCCeeecCCCCCCeeecCCCCceEEeecCCcee
Q 014156          211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  243 (429)
Q Consensus       211 ~~~iiHrDlKp~Nill~~~~~~vkl~DFG~a~~  243 (429)
                      ..|+||+|+.++||+++.+. ..-|+||+.|..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhccccc-ceeEeccccccc
Confidence            35899999999999999765 567999998753